PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Godal, T; Klausner, R				Godal, Tore; Klausner, Richard			Innovating for every woman and every child	LANCET			English	Editorial Material									[Godal, Tore] Minist Foreign Affairs, N-0032 Oslo, Norway; [Klausner, Richard] Column Grp, San Francisco, CA USA		Godal, T (corresponding author), Minist Foreign Affairs, N-0032 Oslo, Norway.	Tore.Godal@mfa.no						[Anonymous], SAVING LIVES BIRTH G; Shah R, 2011, SCIENCE, V333, P385, DOI 10.1126/science.1210733	2	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 7	2012	379	9810					E1	E2		10.1016/S0140-6736(11)61393-7	http://dx.doi.org/10.1016/S0140-6736(11)61393-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	873WC	21908037				2022-12-28	WOS:000298913000001
J	Djamei, A; Schipper, K; Rabe, F; Ghosh, A; Vincon, V; Kahnt, J; Osorio, S; Tohge, T; Fernie, AR; Feussner, I; Feussner, K; Meinicke, P; Stierhof, YD; Schwarz, H; Macek, B; Mann, M; Kahmann, R				Djamei, Armin; Schipper, Kerstin; Rabe, Franziska; Ghosh, Anupama; Vincon, Volker; Kahnt, Joerg; Osorio, Sonia; Tohge, Takayuki; Fernie, Alisdair R.; Feussner, Ivo; Feussner, Kirstin; Meinicke, Peter; Stierhof, York-Dieter; Schwarz, Heinz; Macek, Boris; Mann, Matthias; Kahmann, Regine			Metabolic priming by a secreted fungal effector	NATURE			English	Article							PATHOGEN USTILAGO-MAYDIS; YEAST CHORISMATE MUTASE; ARABIDOPSIS-THALIANA; MAIZE; IDENTIFICATION; GENES; EXPRESSION; PROTEIN	Maize smut caused by the fungus Ustilago maydis is a widespread disease characterized by the development of large plant tumours. U. maydis is a biotrophic pathogen that requires living plant tissue for its development and establishes an intimate interaction zone between fungal hyphae and the plant plasma membrane. U. maydis actively suppresses plant defence responses by secreted protein effectors(1,2). Its effector repertoire comprises at least 386 genes mostly encoding proteins of unknown function(1,3,4) and expressed exclusively during the biotrophic stage(3). The U. maydis secretome also contains about 150 proteins with probable roles in fungal nutrition, fungal cell wall modification and host penetration as well as proteins unlikely to act in the fungal-host interface(4) like a chorismate mutase. Chorismate mutases are key enzymes of the shikimate pathway and catalyse the conversion of chorismate to prephenate, the precursor for tyrosine and phenylalanine synthesis. Root-knot nematodes inject a secreted chorismate mutase into plant cells likely to affect development(5,6). Here we show that the chorismate mutase Cmu1 secreted by U. maydis is a virulence factor. The enzyme is taken up by plant cells, can spread to neighbouring cells and changes the metabolic status of these cells through metabolic priming. Secreted chorismate mutases are found in many plant-associated microbes and might serve as general tools for host manipulation.	[Djamei, Armin; Schipper, Kerstin; Rabe, Franziska; Ghosh, Anupama; Vincon, Volker; Kahnt, Joerg; Kahmann, Regine] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Schipper, Kerstin] Univ Marburg, Zentrum Synthet Mikrobiol, D-35032 Marburg, Germany; [Osorio, Sonia; Tohge, Takayuki; Fernie, Alisdair R.] Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; [Feussner, Ivo] Univ Gottingen, Albrecht von Haller Inst, D-37077 Gottingen, Germany; [Feussner, Kirstin; Meinicke, Peter] Univ Gottingen, Inst Microbiol & Genet, D-37077 Gottingen, Germany; [Stierhof, York-Dieter] Univ Tubingen, Ctr Plant Mol Biol, D-72076 Tubingen, Germany; [Schwarz, Heinz] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Macek, Boris; Mann, Matthias] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society; Philipps University Marburg; Max Planck Society; University of Gottingen; University of Gottingen; Eberhard Karls University of Tubingen; Max Planck Society; Max Planck Society	Kahmann, R (corresponding author), Max Planck Inst Terr Microbiol, Karl von Frisch Str 10, D-35043 Marburg, Germany.	kahmann@mpi-marburg.mpg.de	Macek, Boris/N-1442-2015; Tohge, Takayuki/G-7924-2017; Mann, Matthias/A-3454-2013; Kahmann, Regine/AAS-1230-2021; Schipper, Kerstin/H-4656-2011; Djamei, Armin/AAL-8909-2021; Osorio, Sonia/M-2258-2014; Feussner, Ivo/H-9320-2013	Macek, Boris/0000-0002-1206-2458; Tohge, Takayuki/0000-0001-5555-5650; Mann, Matthias/0000-0003-1292-4799; Djamei, Armin/0000-0002-8087-9566; Osorio, Sonia/0000-0002-0159-6091; Feussner, Ivo/0000-0002-9888-7003; Ghosh, Anupama/0000-0002-4200-5091	DFG [DJ64/1-1]; collaborative research Center [SFB593]; LOEWE program of the State of Hesse	DFG(German Research Foundation (DFG)); collaborative research Center; LOEWE program of the State of Hesse	We are thankful to N. Amrhein and H.-U. Mosch for their comments on the manuscript. We thank B. Valent and C. H. Khang for alerting us to the fact that Magnaporthe grisea possesses a secreted chorismate mutase, and are grateful to M. Dickman for allowing us to cite his unpublished results. We thank T. Brefort, E. Morschel, A. Kaever and M. Landesfeind for experimental support. We acknowledge advice by P. Kast, thank P. Schulze-Lefert for the Gateway-compatible plant transformation vectors, and D. Sicker for providing DIBOA and DIMBOA standards. We acknowledge technical assistance by R. Wissel, S. Loser, D. Vogel, F. Raths, G. Sowa, K. Bolte, M. Johannsen and P. Meyer. Our work was supported through DFG project DJ64/1-1, the collaborative research Center SFB593, and the LOEWE program of the State of Hesse.	BANUETT F, 1989, P NATL ACAD SCI USA, V86, P5878, DOI 10.1073/pnas.86.15.5878; Basse CW, 2002, MOL MICROBIOL, V43, P75, DOI 10.1046/j.1365-2958.2002.02742.x; Bekal S, 2003, MOL PLANT MICROBE IN, V16, P439, DOI 10.1094/MPMI.2003.16.5.439; BOHLMANN R, 1996, THESIS L MAXIMILIAN; BOLKER M, 1995, CAN J BOT, V73, pS320; Brachmann A, 2001, MOL MICROBIOL, V42, P1047, DOI 10.1046/j.1365-2958.2001.02699.x; DEWIT PJGM, 1982, PHYSIOL PLANT PATHOL, V21, P1, DOI 10.1016/0048-4059(82)90002-9; Di Stasio M, 2009, MOL MICROBIOL, V73, P73, DOI 10.1111/j.1365-2958.2009.06747.x; Doehlemann G, 2008, PLANT J, V56, P181, DOI 10.1111/j.1365-313X.2008.03590.x; Doehlemann G, 2008, J PLANT PHYSIOL, V165, P29, DOI 10.1016/j.jplph.2007.05.016; Doehlemann G, 2011, MOL MICROBIOL, V81, P751, DOI 10.1111/j.1365-2958.2011.07728.x; Doehlemann G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000290; Doyle EA, 2003, MOL PLANT MICROBE IN, V16, P123, DOI 10.1094/MPMI.2003.16.2.123; Eberhard J, 1996, PLANT J, V10, P815, DOI 10.1046/j.1365-313X.1996.10050815.x; EBERHARD J, 1993, FEBS LETT, V334, P233, DOI 10.1016/0014-5793(93)81718-F; GILCHRIST DG, 1987, METHOD ENZYMOL, V142, P450; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; Horst RJ, 2010, PLANT PHYSIOL, V152, P293, DOI 10.1104/pp.109.147702; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kaever A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-92; Krappmann S, 1999, J BIOL CHEM, V274, P22275, DOI 10.1074/jbc.274.32.22275; Loubradou G, 2001, MOL MICROBIOL, V40, P719, DOI 10.1046/j.1365-2958.2001.02424.x; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Mobley EM, 1999, GENE, V240, P115, DOI 10.1016/S0378-1119(99)00423-0; Mortensen P, 2010, J PROTEOME RES, V9, P393, DOI 10.1021/pr900721e; Mueller O, 2008, FUNGAL GENET BIOL, V45, pS63, DOI 10.1016/j.fgb.2008.03.012; Naranjo MA, 2003, PLANTA, V217, P417, DOI 10.1007/s00425-003-1017-4; Olsen JV, 2004, P NATL ACAD SCI USA, V101, P13417, DOI 10.1073/pnas.0405549101; Pommerrenig B, 2011, PLANT CELL, V23, P1904, DOI 10.1105/tpc.110.079657; SAMBROOK JFE, 1989, MOL CLONING LAB MANU, P1200; Sasso S, 2005, FEBS J, V272, P375, DOI 10.1111/j.1742-4658.2004.04478.x; Schnappauf G, 1997, P NATL ACAD SCI USA, V94, P8491, DOI 10.1073/pnas.94.16.8491; Schnappauf G, 1998, P NATL ACAD SCI USA, V95, P2868, DOI 10.1073/pnas.95.6.2868; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shimada Y, 2009, AUST DENT J, V54, P347, DOI 10.1111/j.1834-7819.2009.01161.x; Skibbe DS, 2010, SCIENCE, V328, P89, DOI 10.1126/science.1185775; UEKI S, 2008, NAT PROTOC, V4, P71; WILLE AC, 1984, PLANTA, V160, P129, DOI 10.1007/BF00392861	39	363	380	9	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2011	478	7369					395	+		10.1038/nature10454	http://dx.doi.org/10.1038/nature10454			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	21976020				2022-12-28	WOS:000296021100048
J	Noah, MA; Peek, GJ; Finney, SJ; Griffiths, MJ; Harrison, DA; Grieve, R; Sadique, MZ; Sekhon, JS; McAuley, DF; Firmin, RK; Harvey, C; Cordingley, JJ; Price, S; Vuylsteke, A; Jenkins, DP; Noble, DW; Bloomfield, R; Walsh, TS; Perkins, GD; Menon, D; Taylor, BL; Rowan, KM				Noah, Moronke A.; Peek, Giles J.; Finney, Simon J.; Griffiths, Mark J.; Harrison, David A.; Grieve, Richard; Sadique, M. Zia; Sekhon, Jasjeet S.; McAuley, Daniel F.; Firmin, Richard K.; Harvey, Christopher; Cordingley, Jeremy J.; Price, Susanna; Vuylsteke, Alain; Jenkins, David P.; Noble, David W.; Bloomfield, Roxanna; Walsh, Timothy S.; Perkins, Gavin D.; Menon, David; Taylor, Bruce L.; Rowan, Kathryn M.			Referral to an Extracorporeal Membrane Oxygenation Center and Mortality Among Patients With Severe 2009 Influenza A(H1N1)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; CRITICALLY-ILL PATIENTS; CRITICAL-CARE SERVICES; H1N1 INFLUENZA; ORGAN FAILURE; VOLUME; OPTIMIZATION; MULTIVARIATE; VENTILATION	Context Extracorporeal membrane oxygenation (ECMO) can support gas exchange in patients with severe acute respiratory distress syndrome (ARDS), but its role has remained controversial. ECMO was used to treat patients with ARDS during the 2009 influenza A(H1N1) pandemic. Objective To compare the hospital mortality of patients with H1N1-related ARDS referred, accepted, and transferred for ECMO with matched patients who were not referred for ECMO. Design, Setting, and Patients A cohort study in which ECMO-referred patients were defined as all patients with H1N1-related ARDS who were referred, accepted, and transferred to 1 of the 4 adult ECMO centers in the United Kingdom during the H1N1 pandemic in winter 2009-2010. The ECMO-referred patients and the non-ECMO-referred patients were matched using data from a concurrent, longitudinal cohort study (Swine Flu Triage study) of critically ill patients with suspected or confirmed H1N1. Detailed demographic, physiological, and comorbidity data were used in 3 different matching techniques (individual matching, propensity score matching, and GenMatch matching). Main Outcome Measure Survival to hospital discharge analyzed according to the intention-to-treat principle. Results Of 80 ECMO-referred patients, 69 received ECMO (86.3%) and 22 died (27.5%) prior to discharge from the hospital. From a pool of 1756 patients, there were 59 matched pairs of ECMO-referred patients and non-ECMO-referred patients identified using individual matching, 75 matched pairs identified using propensity score matching, and 75 matched pairs identified using GenMatch matching. The hospital mortality rate was 23.7% for ECMO-referred patients vs 52.5% for non-ECMO-referred patients (relative risk [RR], 0.45 [95% CI, 0.26-0.79]; P=.006) when individual matching was used; 24.0% vs 46.7%, respectively (RR, 0.51 [95% CI, 0.31-0.81]; P=.008) when propensity score matching was used; and 24.0% vs 50.7%, respectively (RR, 0.47 [95% CI, 0.31-0.72]; P=.001) when GenMatch matching was used. The results were robust to sensitivity analyses, including amending the inclusion criteria and restricting the location where the non-ECMO-referred patients were treated. Conclusion For patients with H1N1-related ARDS, referral and transfer to an ECMO center was associated with lower hospital mortality compared with matched non-ECMO-referred patients. JAMA. 2011;306(15):1659-1668 Published online October 5, 2011. doi:10.1001/jama.2011.1471 www.jama.com	[Noah, Moronke A.; Peek, Giles J.; Finney, Simon J.; Harvey, Christopher] Glenfield Hosp, Heartlink ECMO Ctr, Groby Rd, Leicester LE3 9QP, Leics, England; [Finney, Simon J.; Griffiths, Mark J.; Cordingley, Jeremy J.; Price, Susanna] Royal Brompton Hosp, Dept Anaesthesia, London SW3 6LY, England; [Harrison, David A.; Rowan, Kathryn M.] Intens Care Natl Audit & Res Ctr, London, England; [Grieve, Richard; Sadique, M. Zia] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Sekhon, Jasjeet S.] Univ Calif Berkeley, Travers Dept Polit Sci, Berkeley, CA 94720 USA; [McAuley, Daniel F.] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Vuylsteke, Alain; Jenkins, David P.] Papworth Hosp, Dept Anaesthesia, Cambridge CB3 8RE, England; [Noble, David W.; Bloomfield, Roxanna] Aberdeen Royal Infirm, Dept Anaesthesia, Aberdeen, Scotland; [Walsh, Timothy S.] Univ Edinburgh, Dept Crit Care Med, Edinburgh, Midlothian, Scotland; [Perkins, Gavin D.] Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Menon, David] Univ Cambridge, Div Anaesthesia, Cambridge, England; [Taylor, Bruce L.] Portsmouth Hosp NHS Trust, Dept Crit Care, Portsmouth, Hants, England	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Royal Brompton Hospital; Intensive Care National Audit & Research Centre; University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California Berkeley; Queens University Belfast; Papworth Hospital; University of Aberdeen; University of Edinburgh; University of Warwick; University of Cambridge; Portsmouth Hospitals NHS Trust	Peek, GJ (corresponding author), Glenfield Hosp, Heartlink ECMO Ctr, Groby Rd, Leicester LE3 9QP, Leics, England.	giles.peek@uhl-tr.nhs.uk	Perkins, Gavin/E-7613-2010; Price, Susanna/AAH-7515-2021; Peek, Giles/I-1530-2019; Harrison, David A/O-4355-2018; Finney, Simon/A-2168-2012; Vuylsteke, Alain/AAF-2108-2020	Harrison, David A/0000-0002-9002-9098; Finney, Simon/0000-0001-8219-1952; Noah, Abiodun Moronke/0000-0002-4008-8532; McAuley, Daniel/0000-0002-3283-1947; Rowan, Kathryn/0000-0001-8217-5602; peek, giles/0000-0002-1313-6498; Perkins, Gavin/0000-0003-3027-7548; Grieve, Richard/0000-0001-8899-1301; Sadique, Zia/0000-0001-5814-0258; Griffiths, Mark/0000-0002-1615-1896	Society of Critical Care Medicine; European Society of Intensive Care Medicine; Avalon Labs; GlaxoSmithKline; (Intensive Care National Audit AMP; Research Centre) from the National Institute for Health Research; AstraZeneca; Medtronic; National Institute for Health Research; UK Health Technology; ESRC [ES/G00188X/1] Funding Source: UKRI; MRC [G106/1173, G0901697] Funding Source: UKRI; Economic and Social Research Council [ES/G00188X/1] Funding Source: researchfish; Medical Research Council [G0901697, G106/1173] Funding Source: researchfish; National Institute for Health Research [09/86/01, PDA/03/07/026] Funding Source: researchfish	Society of Critical Care Medicine; European Society of Intensive Care Medicine; Avalon Labs; GlaxoSmithKline(GlaxoSmithKline); (Intensive Care National Audit AMP; Research Centre) from the National Institute for Health Research; AstraZeneca(AstraZeneca); Medtronic(Medtronic); National Institute for Health Research(National Institute for Health Research (NIHR)); UK Health Technology; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Peek reported that money has been paid to his institution (Glenfield Hospital) as grants from the Society of Critical Care Medicine, the European Society of Intensive Care Medicine, Avalon Labs, and Chalice Medical for travel and accommodation to facilitate his attendance at international conferences. Dr Griffiths reported that money was paid to him from GlaxoSmithKline for development of assets for acute lung injury and he has grants pending with GlaxoSmithKline for such development of assets. Dr Harrison reported that money has been paid to his institution (Intensive Care National Audit & Research Centre) from the National Institute for Health Research as research grant funding for the SwiFT study. Dr McAuley reported that he has consulted for, sat on advisory boards for, and received lecture fees from GlaxoSmithKline and received lecture fees from AstraZeneca for educational meetings. Dr Harvey reported that money has been paid to him from Avalon Labs for the cost of flights to attend an extracorporeal membrane oxygenation (ECMO) conference. Dr Price reported that she has received royalties as a textbook editor for cardiovascular critical care from Wiley-Blackwell; payment for the development of educational materials and honoraria from Medtronic; and reimbursement from Medtronic for travel undertaken to give educational lectures and accommodations for the European Society of Cardiology meeting in 2010 and 2011. Dr Jenkins reported that he has received reimbursement from Chalice Medical (UK distributor for Levitronix ECMO pump) for travel expenses to the Extracorporeal Life Support Organization conference in 2010. Dr Perkins reported that money was paid to his institution (University of Warwick) from GlaxoSmithKline for his work as a member of an advisory board for novel treatment of acute respiratory distress syndrome; and he received lecture fees from GlaxoSmithKline. Dr Menon reported that his institution has received grant support from the National Institute for Health Research, UK Health Technology; he serves as a paid consultant or member of a data and safety monitoring board for Solvay, GlaxoSmithKline, Brainscope, Ornim Medical, Shire Medical, and Neurovive; he has received an honorarium from GlaxoSmithKline for one lecture at the London Hospital; money is paid to his institution for a patent registered for a new positron emission tomography ligand for assessing mitochondrial function; and he receives royalties from the University of Cambridge Press as a co-editor of a textbook on neuroanesthesia and critical care. Dr Rowan reported that money was paid to her institution (Intensive Care National Audit & Research Centre) from the National Institute for Health Research as research grant funding for the SwiFT study. No other authors reported disclosures.r The SwiFT study was funded by the National Institute for Health Research and has been published in full in the Health Technology Assessment journal series.	Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bellingan G, 2005, PLOS MED, V2, P480, DOI 10.1371/journal.pmed.0020130; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Diamond A, GENETIC MATCHING EST; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Ely EW, 2002, ANN INTERN MED, V136, P25, DOI 10.7326/0003-4819-136-1-200201010-00007; Freed DH, 2010, CAN J ANAESTH, V57, P240, DOI 10.1007/s12630-009-9253-0; Glance LG, 2007, MED CARE, V45, P292, DOI 10.1097/01.mlr.0000252225.26917.91; Hager DN, 2005, AM J RESP CRIT CARE, V172, P1241, DOI 10.1164/rccm.200501-048CP; Imai Y, 2003, JAMA-J AM MED ASSOC, V289, P2104, DOI 10.1001/jama.289.16.2104; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Mebane WR, 2011, J STAT SOFTW, V42, P1; Meduri GU, 2007, CHEST, V131, P954, DOI 10.1378/chest.06-2100; Monchi M, 1998, AM J RESP CRIT CARE, V158, P1076, DOI 10.1164/ajrccm.158.4.9802009; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; Morris AH, 2010, CHEST, V138, P778, DOI 10.1378/chest.10-1792; Park PK, 2010, CHEST, V138, P776, DOI 10.1378/chest.10-1791; Peek GJ, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14350; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Peek GJ, 1997, CHEST, V112, P759, DOI 10.1378/chest.112.3.759; Pinhu L, 2003, LANCET, V361, P332, DOI 10.1016/S0140-6736(03)12329-X; Rajan SS, 2011, MED CARE, V49, P649, DOI 10.1097/MLR.0b013e318215c42e; Ramsahai RR, 2011, HEALTH SERV OUTCOME, V11, P95, DOI 10.1007/s10742-011-0075-5; Roch A, 2010, INTENS CARE MED, V36, P1899, DOI 10.1007/s00134-010-2021-3; Rowan KM, 2010, HEALTH TECHNOL ASSES, V14, P335, DOI 10.3310/hta14550-05; Sekhon J. S., 1998, POLIT ANAL, V7, P187, DOI DOI 10.HTTP://DX.D0I.0RG/10.1093/PAN/7.1.187; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Sekhon JS, 2012, HEALTH ECON, V21, P695, DOI 10.1002/hec.1748; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Suchyta MR, 2003, CHEST, V124, P1871, DOI 10.1378/chest.124.5.1871; Tang BMP, 2009, CRIT CARE MED, V37, P1594, DOI 10.1097/CCM.0b013e31819fb507; Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC; Terragni PP, 2009, ANESTHESIOLOGY, V111, P826, DOI 10.1097/ALN.0b013e3181b764d2; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; ZAPOL WM, 1979, JAMA-J AM MED ASSOC, V242, P2193, DOI 10.1001/jama.242.20.2193; Zwischenberger JB, 2009, LANCET, V374, P1307, DOI 10.1016/S0140-6736(09)61630-5	43	549	589	2	92	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2011	306	15					1659	1668		10.1001/jama.2011.1471	http://dx.doi.org/10.1001/jama.2011.1471			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834MA	21976615	Bronze			2022-12-28	WOS:000295963200025
J	Sun, B; Johnson, DS; Patel, G; Smith, BY; Pandey, M; Patel, SS; Wang, MD				Sun, Bo; Johnson, Daniel S.; Patel, Gayatri; Smith, Benjamin Y.; Pandey, Manjula; Patel, Smita S.; Wang, Michelle D.			ATP-induced helicase slippage reveals highly coordinated subunits	NATURE			English	Article							T7 DNA HELICASE; HEXAMERIC HELICASES; BACTERIOPHAGE T7; FORCE GENERATION; SINGLE-MOLECULE; PACKAGING MOTOR; GENE-4 PROTEIN; MECHANISM; TRANSLOCATION; RECOGNITION	Helicases are vital enzymes that carry out strand separation of duplex nucleic acids during replication, repair and recombination(1,2). Bacteriophage T7 gene product 4 is a model hexameric helicase that has been observed to use dTTP, but not ATP, to unwind double-stranded (ds)DNA as it translocates from 5' to 3' along single-stranded (ss)DNA(2-6). Whether and how different subunits of the helicase coordinate their chemo-mechanical activities and DNA binding during translocation is still under debate(1,7). Here we address this question using a single-molecule approach to monitor helicase unwinding. We found that T7 helicase does in fact unwind dsDNA in the presence of ATP and that the unwinding rate is even faster than that with dTTP. However, unwinding traces showed a remarkable sawtooth pattern where processive unwinding was repeatedly interrupted by sudden slippage events, ultimately preventing unwinding over a substantial distance. This behaviour was not observed with dTTP alone and was greatly reduced when ATP solution was supplemented with a small amount of dTTP. These findings presented an opportunity to use nucleotide mixtures to investigate helicase subunit coordination. We found that T7 helicase binds and hydrolyses ATP and dTTP by competitive kinetics such that the unwinding rate is dictated simply by their respective maximum rates V(max), Michaelis constants K(M) and concentrations. In contrast, processivity does not follow a simple competitive behaviour and shows a cooperative dependence on nucleotide concentrations. This does not agree with an uncoordinated mechanism where each subunit functions independently, but supports a model where nearly all subunits coordinate their chemo-mechanical activities and DNA binding. Our data indicate that only one subunit at a time can accept a nucleotide while other subunits are nucleotide-ligated and thus they interact with the DNA to ensure processivity. Such subunit coordination may be general to many ring-shaped helicases and reveals a potential mechanism for regulation of DNA unwinding during replication.	[Sun, Bo; Johnson, Daniel S.; Smith, Benjamin Y.; Wang, Michelle D.] Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Sun, Bo; Johnson, Daniel S.; Smith, Benjamin Y.; Wang, Michelle D.] Cornell Univ, Howard Hughes Med Inst, Ithaca, NY 14853 USA; [Patel, Gayatri; Pandey, Manjula; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Cornell University; Cornell University; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center	Wang, MD (corresponding author), Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA.	patelss@umdnj.edu; mwang@physics.cornell.edu		Sun, Bo/0000-0002-4590-7795; Johnson, Daniel/0000-0001-8906-0509	National Institutes of Health [GM059849, GM55310]; National Science Foundation [MCB-0820293]; Cornell's Molecular Biophysics Training Grant [T32GM008267]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055310, R01GM059849, T32GM008267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Cornell's Molecular Biophysics Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Wang laboratory for critical reading of the manuscript. We also thank M. A. Hall for assistance with single-molecule assays, data acquisition and data analysis. We wish to acknowledge support from National Institutes of Health grants (GM059849 to M. D. W.; GM55310 to S. S. P.), National Science Foundation grant (MCB-0820293 to M. D. W.) and Cornell's Molecular Biophysics Training Grant (T32GM008267) Traineeship (to D.S.J. and B.Y.S.).	Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028; Hingorani MM, 1996, BIOCHEMISTRY-US, V35, P2218, DOI 10.1021/bi9521497; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Koch SJ, 2002, BIOPHYS J, V83, P1098, DOI 10.1016/S0006-3495(02)75233-8; Lee SJ, 2010, J BIOL CHEM, V285, P31462, DOI 10.1074/jbc.M110.156067; Liao JC, 2005, J MOL BIOL, V350, P452, DOI 10.1016/j.jmb.2005.04.051; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; MATHEWS CK, 1972, J BIOL CHEM, V247, P7430; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MATSON SW, 1983, J BIOL CHEM, V258, P4009; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; PATEL SS, 1992, J BIOL CHEM, V267, P15013; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Peterman EJG, 2003, BIOPHYS J, V84, P1308, DOI 10.1016/S0006-3495(03)74946-7; Shundrovsky A, 2006, NAT STRUCT MOL BIOL, V13, P549, DOI 10.1038/nsmb1102; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Sun B, 2008, EMBO J, V27, P3279, DOI 10.1038/emboj.2008.240; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Tsay JM, 2009, P NATL ACAD SCI USA, V106, P14355, DOI 10.1073/pnas.0904364106; Yu X, 1996, NAT STRUCT BIOL, V3, P740, DOI 10.1038/nsb0996-740	28	77	78	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2011	478	7367					132	U148		10.1038/nature10409	http://dx.doi.org/10.1038/nature10409			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21927003	Green Accepted			2022-12-28	WOS:000295575400049
J	Appleby, J				Appleby, John			DATA BRIEFING Which is the best health system in the world?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Appleby J, 2001, J Health Serv Res Policy, V6, P220, DOI 10.1258/1355819011927521; BJORNBERG A, EUROHEALTH CONSUMER; Davies K, 2010, MIRROR MIRROR WALL P; Jacobs R., 2004, CHE TECHNICAL PAPER, V29; OECD, OECD HLTH DAT 2011 F; Schoen C, 2010, HEALTH AFFAIR, V29, P2323, DOI 10.1377/hlthaff.2010.0862; Smith P. C, 2002, MEASURING IMPROVING; World Health Organization, 2000, WORLD HLTH REP 2000	8	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 4	2011	343								d6267	10.1136/bmj.d6267	http://dx.doi.org/10.1136/bmj.d6267			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	832CR	21971429				2022-12-28	WOS:000295779300006
J	Srivastava, R				Srivastava, Ranjana			Critical conversations: navigating between hope and truth	LANCET			English	Editorial Material							CARE		So Hlth Network, Melbourne, Vic 3168, Australia		Srivastava, R (corresponding author), So Hlth Network, Melbourne, Vic 3168, Australia.	ranjana.srivastava@southernhealth.org.au						Back AL, 2009, MASTERING COMMUNICAT; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; GARNER H, 2009, SPARE ROOM; Srivastava R, 2010, TELL ME TRUTH CONVER; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678	5	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2011	378	9798					1213	1214		10.1016/S0140-6736(11)61530-4	http://dx.doi.org/10.1016/S0140-6736(11)61530-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	831IO	21969979				2022-12-28	WOS:000295723600013
J	Arnon, TI; Xu, Y; Lo, C; Pham, T; An, J; Coughlin, S; Dorn, GW; Cyster, JG				Arnon, Tal I.; Xu, Ying; Lo, Charles; Trung Pham; An, Jinping; Coughlin, Shaun; Dorn, Gerald W.; Cyster, Jason G.			GRK2-Dependent S1PR1 Desensitization Is Required for Lymphocytes to Overcome Their Attraction to Blood	SCIENCE			English	Article							RECEPTOR KINASE 2; B-CELLS; LYMPH-NODES; EGRESS; RECIRCULATION; EXPRESSION; CHEMOKINES; AGONISTS; ROLES; GRK2	Lymphocytes egress from lymphoid organs in response to sphingosine-1-phosphate (S1P); minutes later they migrate from blood into tissue against the S1P gradient. The mechanisms facilitating cell movement against the gradient have not been defined. Here, we show that heterotrimeric guanine nucleotide-binding protein-coupled receptor kinase-2 (GRK2) functions in down-regulation of S1P receptor-1 (S1PR1) on blood-exposed lymphocytes. T and B cell movement from blood into lymph nodes is reduced in the absence of GRK2 but is restored in S1P-deficient mice. In the spleen, B cell movement between the blood-rich marginal zone and follicles is disrupted by GRK2 deficiency and by mutation of an S1PR1 desensitization motif. Moreover, delivery of systemic antigen into follicles is impaired. Thus, GRK2-dependent S1PR1 desensitization allows lymphocytes to escape circulatory fluids and migrate into lymphoid tissues.	[Arnon, Tal I.; Xu, Ying; Lo, Charles; Trung Pham; An, Jinping; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Arnon, Tal I.; Xu, Ying; Lo, Charles; Trung Pham; An, Jinping; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Coughlin, Shaun] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Dorn, Gerald W.] Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogenom, St Louis, MO 63110 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Washington University (WUSTL)	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu		Arnon, Tal/0000-0003-4629-5820; Pham, Trung/0000-0003-2724-2547	NIH [AI74847]; Research Exchange Grant; Osaka University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074847] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Exchange Grant; Osaka University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Caron and M. von Zastrow for GRK2<SUP>+/-</SUP> mice; J. Green for helpful input; and O. Bannard, J. Green, A. Reboldi, and S. Rosen for comments on the manuscript. T. I. A. was a Jane Coffin Childs Memorial Fellow, and J. G. C. is an Investigator of the Howard Hughes Medical Institute. This work was supported in part by NIH grant AI74847 and by a Research Exchange Grant with Osaka University. The data reported in this paper are tabulated in the main text and in the supporting online material. Use of both the GRK2<SUP>f/f</SUP> mice and S1PR1<SUP>TSS</SUP> mice will require a material transfer agreement.	Alon R, 2009, MICROCIRCULATION, V16, P3, DOI 10.1080/10739680802026076; Brown MJ, 2003, BLOOD, V102, P3890, DOI 10.1182/blood-2002-12-3807; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Ferguson AR, 2004, INT IMMUNOL, V16, P1411, DOI 10.1093/intimm/dxh142; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Johnston B, 2002, SEMIN IMMUNOL, V14, P83, DOI 10.1006/smim.2001.0345; Kraal G, 2006, INT REV CYTOL, V250, P175, DOI 10.1016/S0074-7696(06)50005-1; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Matkovich SJ, 2006, CIRC RES, V99, P996, DOI 10.1161/01.RES.0000247932.71270.2c; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Penela P, 2009, CELL ADHES MIGR, V3, P19, DOI 10.4161/cam.3.1.7149; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; SMITH ME, 1983, IMMUNOLOGY, V49, P83; Tang MLK, 1998, J IMMUNOL, V160, P5113; Thangada S, 2010, J EXP MED, V207, P1475, DOI 10.1084/jem.20091343; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Vroon A, 2005, J IMMUNOL, V174, P4400, DOI 10.4049/jimmunol.174.7.4400; Vroon A, 2004, J LEUKOCYTE BIOL, V75, P901, DOI 10.1189/jlb.0403136; Watterson KR, 2002, J BIOL CHEM, V277, P5767, DOI 10.1074/jbc.M110647200	29	144	149	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051					1898	1903		10.1126/science.1208248	http://dx.doi.org/10.1126/science.1208248			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960637	Green Accepted			2022-12-28	WOS:000295365800059
J	Nittler, LR; Starr, RD; Weider, SZ; McCoy, TJ; Boynton, WV; Ebel, DS; Ernst, CM; Evans, LG; Goldsten, JO; Hamara, DK; Lawrence, DJ; McNutt, RL; Schlemm, CE; Solomon, SC; Sprague, AL				Nittler, Larry R.; Starr, Richard D.; Weider, Shoshana Z.; McCoy, Timothy J.; Boynton, William V.; Ebel, Denton S.; Ernst, Carolyn M.; Evans, Larry G.; Goldsten, John O.; Hamara, David K.; Lawrence, David J.; McNutt, Ralph L., Jr.; Schlemm, Charles E., II; Solomon, Sean C.; Sprague, Ann L.			The Major-Element Composition of Mercury's Surface from MESSENGER X-ray Spectrometry	SCIENCE			English	Article							IRON-SILICATE FRACTIONATION; CHEMICAL-COMPOSITION; METEORITE; ORIGIN; CRUST	X-ray fluorescence spectra obtained by the MESSENGER spacecraft orbiting Mercury indicate that the planet's surface differs in composition from those of other terrestrial planets. Relatively high Mg/Si and low Al/Si and Ca/Si ratios rule out a lunarlike feldspar-rich crust. The sulfur abundance is at least 10 times higher than that of the silicate portion of Earth or the Moon, and this observation, together with a low surface Fe abundance, supports the view that Mercury formed from highly reduced precursor materials, perhaps akin to enstatite chondrite meteorites or anhydrous cometary dust particles. Low Fe and Ti abundances do not support the proposal that opaque oxides of these elements contribute substantially to Mercury's low and variable surface reflectance.	[Nittler, Larry R.; Weider, Shoshana Z.; Solomon, Sean C.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Starr, Richard D.] Catholic Univ Amer, Dept Phys, Washington, DC 20064 USA; [McCoy, Timothy J.] Smithsonian Inst, Washington, DC 20013 USA; [Boynton, William V.; Hamara, David K.; Sprague, Ann L.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Ebel, Denton S.] Amer Museum Nat Hist, Dept Earth & Planetary Sci, New York, NY 10024 USA; [Ernst, Carolyn M.; Goldsten, John O.; Lawrence, David J.; McNutt, Ralph L., Jr.; Schlemm, Charles E., II] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Evans, Larry G.] Comp Sci Corp, Lanham, MD 20706 USA	Carnegie Institution for Science; Catholic University of America; Smithsonian Institution; University of Arizona; American Museum of Natural History (AMNH); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Nittler, LR (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	lnittler@ciw.edu	Ernst, Carolyn M/I-4902-2012; McNutt, Ralph L/E-8006-2010; Lawrence, David J/E-7463-2015	Ernst, Carolyn M/0000-0002-9434-7886; McNutt, Ralph L/0000-0002-4722-9166; Lawrence, David J/0000-0002-7696-6667; McCoy, Timothy/0000-0002-4573-3553; Weider, Shoshana/0000-0003-1034-909X	NASA [NAS5-97271, NASW-00002]	NASA(National Aeronautics & Space Administration (NASA))	We thank the MESSENGER team for the development, cruise, orbit insertion, and Mercury orbital operations of the MESSENGER spacecraft. The NASA Discovery Program under contract NAS5-97271 to The Johns Hopkins University Applied Physics Laboratory and NASW-00002 to the Carnegie Institution of Washington supports the MESSENGER mission to Mercury. Several of the authors are supported by NASA's MESSENGER Participating Scientist Program.	Benz W, 2007, SPACE SCI REV, V132, P189, DOI 10.1007/s11214-007-9284-1; Blewett DT, 2011, SCIENCE, V333, P1856, DOI 10.1126/science.1211681; Brown SM, 2009, EARTH PLANET SC LETT, V286, P446, DOI 10.1016/j.epsl.2009.07.010; Burbine TH, 2002, METEORIT PLANET SCI, V37, P1233, DOI 10.1111/j.1945-5100.2002.tb00892.x; Clark PE, 1997, J GEOPHYS RES-PLANET, V102, P16361, DOI 10.1029/97JE01086; Denevi BW, 2008, ICARUS, V197, P239, DOI 10.1016/j.icarus.2008.04.021; Denevi BW, 2009, SCIENCE, V324, P613, DOI 10.1126/science.1172226; Ebel DS, 2011, PLANET SPACE SCI, V59, P1888, DOI 10.1016/j.pss.2011.07.017; Fegley B, 2005, TREATISE GEOCHEM, V1, P487; FEGLEY B, 1987, EARTH PLANET SC LETT, V82, P207, DOI 10.1016/0012-821X(87)90196-8; Head JW, 2011, SCIENCE, V333, P1853, DOI 10.1126/science.1211997; HOWARD HT, 1974, SCIENCE, V185, P179, DOI 10.1126/science.185.4146.179; Hunten D.M., 1988, MERCURY, P562; Kerber L, 2009, EARTH PLANET SC LETT, V285, P263, DOI 10.1016/j.epsl.2009.04.037; Lawrence DJ, 2010, ICARUS, V209, P195, DOI 10.1016/j.icarus.2010.04.005; LEWIS JS, 1973, ANNU REV PHYS CHEM, V24, P339, DOI 10.1146/annurev.pc.24.100173.002011; Lodders K., 1998, PLANETARY SCI COMPAN; McCoy TJ, 1999, METEORIT PLANET SCI, V34, P735, DOI 10.1111/j.1945-5100.1999.tb01386.x; MORGAN JW, 1980, P NATL ACAD SCI USA, V77, P6973, DOI 10.1073/pnas.77.12.6973; Nittler LR, 2001, METEORIT PLANET SCI, V36, P1673, DOI 10.1111/j.1945-5100.2001.tb01856.x; Papike J.J., 1998, REV MINERALOGY, V36, P5; Peplowski PN, 2011, SCIENCE, V333, P1850, DOI 10.1126/science.1211576; Rieder R, 1997, SCIENCE, V278, P1771, DOI 10.1126/science.278.5344.1771; Robinson MS, 2008, SCIENCE, V321, P66, DOI 10.1126/science.1160080; Robinson MS, 2001, METEORIT PLANET SCI, V36, P841, DOI 10.1111/j.1945-5100.2001.tb01921.x; Schlemm CE, 2007, SPACE SCI REV, V131, P393, DOI 10.1007/s11214-007-9248-5; Solomon SC, 2003, EARTH PLANET SC LETT, V216, P441, DOI 10.1016/S0012-821X(03)00546-6; Solomon SC, 2001, PLANET SPACE SCI, V49, P1445, DOI 10.1016/S0032-0633(01)00085-X; Sprague AL, 2009, PLANET SPACE SCI, V57, P364, DOI 10.1016/j.pss.2009.01.006; SPRAGUE AL, 1995, ICARUS, V118, P211, DOI 10.1006/icar.1995.1186; TAYLOR GJ, 2003, METEORITES COMETS PL, V1, P477; WARREN PH, 1985, ANNU REV EARTH PL SC, V13, P201, DOI 10.1146/annurev.ea.13.050185.001221; WEIDENSCHILLING SJ, 1978, ICARUS, V35, P99, DOI 10.1016/0019-1035(78)90064-7; Wurz P, 2010, PLANET SPACE SCI, V58, P1599, DOI 10.1016/j.pss.2010.08.003	35	303	306	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051					1847	1850		10.1126/science.1211567	http://dx.doi.org/10.1126/science.1211567			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960623				2022-12-28	WOS:000295365800043
J	Welp, LR; Keeling, RF; Meijer, HAJ; Bollenbacher, AF; Piper, SC; Yoshimura, K; Francey, RJ; Allison, CE; Wahlen, M				Welp, Lisa R.; Keeling, Ralph F.; Meijer, Harro A. J.; Bollenbacher, Alane F.; Piper, Stephen C.; Yoshimura, Kei; Francey, Roger J.; Allison, Colin E.; Wahlen, Martin			Interannual variability in the oxygen isotopes of atmospheric CO2 driven by El Nino	NATURE			English	Article							TERRESTRIAL GROSS; CARBON-DIOXIDE; DELTA-O-18; MODEL; O-18; VEGETATION; PATTERNS	The stable isotope ratios of atmospheric CO2 (O-18/O-16 and C-13/C-12) have been monitored since 1977 to improve our understanding of the global carbon cycle, because biosphere-atmosphere exchange fluxes affect the different atomic masses in a measurable way(1). Interpreting the O-18/O-16 variability has proved difficult, however, because oxygen isotopes in CO2 are influenced by both the carbon cycle and the water cycle(2). Previous attention focused on the decreasing O-18/O-16 ratio in the 1990s, observed by the global Cooperative Air Sampling Network of the US National Oceanic and Atmospheric Administration Earth System Research Laboratory. This decrease was attributed variously to a number of processes including an increase in Northern Hemisphere soil respiration(3); a global increase in C-4 crops at the expense of C-3 forests(4); and environmental conditions, such as atmospheric turbulence(5) and solar radiation(6), that affect CO2 exchange between leaves and the atmosphere. Here we present 30 years' worth of data on O-18/O-16 in CO2 from the Scripps Institution of Oceanography global flask network and show that the interannual variability is strongly related to the El Nino/Southern Oscillation. We suggest that the redistribution of moisture and rainfall in the tropics during an El Nino increases the O-18/O-16 ratio of precipitation and plant water, and that this signal is then passed on to atmospheric CO2 by biosphere-atmosphere gas exchange. We show how the decay time of the El Nino anomaly in this data set can be useful in constraining global gross primary production. Our analysis shows a rapid recovery from El Nino events, implying a shorter cycling time of CO2 with respect to the terrestrial biosphere and oceans than previously estimated. Our analysis suggests that current estimates of global gross primary production, of 120 petagrams of carbon per year(7), may be too low, and that a best guess of 150-175 petagrams of carbon per year better reflects the observed rapid cycling of CO2. Although still tentative, such a revision would present a new benchmark by which to evaluate global biospheric carbon cycling models.	[Welp, Lisa R.; Keeling, Ralph F.; Bollenbacher, Alane F.; Piper, Stephen C.; Yoshimura, Kei; Wahlen, Martin] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Meijer, Harro A. J.] Univ Groningen, Ctr Isotope Res, NL-9747 AG Groningen, Netherlands; [Francey, Roger J.; Allison, Colin E.] CSIRO Marine & Atmospher Res, Aspendale, Vic 3195, Australia	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Groningen; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Welp, LR (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, 9500 Gilman Dr, La Jolla, CA 92093 USA.	lwelp@ucsd.edu; rkeeling@ucsd.edu	Francey, Roger J/A-2345-2012; Yoshimura, Kei/F-2041-2010; Meijer, Harro A J/A-5787-2012	Yoshimura, Kei/0000-0002-5761-1561; Welp, Lisa/0000-0001-7125-0478; Meijer, Harro A.J./0000-0001-8744-5632; Allison, Colin/0000-0002-7796-6917	US National Science Foundation (NSF) [ATM06-32770]; US Department of Energy (DOE) [DE-SC0005099]; US National Aeronautics and Space Administration (NASA) [NNX11AF36G]	US National Science Foundation (NSF)(National Science Foundation (NSF)); US Department of Energy (DOE)(United States Department of Energy (DOE)); US National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA))	The authors thank S. Walker for programming assistance and all those involved with flask collection and analysis. This work was supported by the US National Science Foundation (NSF) under grant ATM06-32770, by the US Department of Energy (DOE) under grant DE-SC0005099 and by the US National Aeronautics and Space Administration (NASA) under grant NNX11AF36G. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of NSF, DOE or NASA.	Allison CE, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007345; Appenzeller C, 1996, J GEOPHYS RES-ATMOS, V101, P15071, DOI 10.1029/96JD00821; Assonov SS, 2010, ATMOS CHEM PHYS, V10, P8575, DOI 10.5194/acp-10-8575-2010; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Bollenbacher A. F, 2000, CALIBRATION METHODOL; Ciais P, 1997, J GEOPHYS RES-ATMOS, V102, P5857, DOI 10.1029/96JD02360; Cobb KM, 2007, EARTH PLANET SC LETT, V263, P207, DOI 10.1016/j.epsl.2007.08.024; Cuntz M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003153; Curtis S, 2000, J CLIMATE, V13, P2786, DOI 10.1175/1520-0442(2000)013<2786:EIBOPO>2.0.CO;2; Dai A, 2000, GEOPHYS RES LETT, V27, P1283, DOI 10.1029/1999GL011140; Ebisuzaki W, 1997, J CLIMATE, V10, P2147, DOI 10.1175/1520-0442(1997)010<2147:AMTETS>2.0.CO;2; Evans MN, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001406; FARQUHAR GD, 1993, NATURE, V363, P439, DOI 10.1038/363439a0; Gat J. R., 2001, ENV ISOTOPES HYDROLO, VII, p[55, 56]; Gillon J, 2001, SCIENCE, V291, P2584, DOI 10.1126/science.1056374; Hoag KJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021011; Ishizawa M, 2002, TELLUS B, V54, P307, DOI 10.1034/j.1600-0889.2002.201312.x; Keeling C. D., 2001, 0106 SCRIPPS I OC; Keeling CD., 2005, HIST ATMOSPHERIC CO2, P83, DOI DOI 10.1007/0-387-27048-5_5; Lee XH, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003331; Montzka SA, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007665; Randerson JT, 1997, GLOBAL BIOGEOCHEM CY, V11, P535, DOI 10.1029/97GB02268; Still CJ, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2007JG000675; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Thompson LG, 2000, QUATERNARY SCI REV, V19, P19, DOI 10.1016/S0277-3791(99)00052-9; Vuille M, 2005, CLIM DYNAM, V25, P401, DOI 10.1007/s00382-005-0049-9; Willett KM, 2008, J CLIMATE, V21, P5364, DOI 10.1175/2008JCLI2274.1; Wingate L, 2009, P NATL ACAD SCI USA, V106, P22411, DOI 10.1073/pnas.0905210106; Yoshimura K, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010074; Zhao MS, 2005, REMOTE SENS ENVIRON, V95, P164, DOI 10.1016/j.rse.2004.12.011	30	162	167	4	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2011	477	7366					579	582		10.1038/nature10421	http://dx.doi.org/10.1038/nature10421			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21956330	Green Submitted, Green Published			2022-12-28	WOS:000295320900037
J	Bevan, M				Bevan, Michael			GENOMICS Endless variation most beautiful	NATURE			English	Editorial Material							ARABIDOPSIS-THALIANA; WIDE ASSOCIATION		John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Bevan, M (corresponding author), John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	michael.bevan@jic.ac.uk			BBSRC [BBS/E/J/000CA352] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA352] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		[Anonymous], 1861, ORIGIN SPECIES MEANS; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Cao J., 2011, NATURE GENET; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Hamblin MT, 2011, TRENDS GENET, V27, P98, DOI 10.1016/j.tig.2010.12.003; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x	12	2	2	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2011	477	7365					415	416		10.1038/477415a	http://dx.doi.org/10.1038/477415a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21938062				2022-12-28	WOS:000295080500029
J	Yang, YL; Atasoy, D; Su, HH; Sternson, SM				Yang, Yunlei; Atasoy, Deniz; Su, Helen H.; Sternson, Scott M.			Hunger States Switch a Flip-Flop Memory Circuit via a Synaptic AMPK-Dependent Positive Feedback Loop	CELL			English	Article							ACTIVATED PROTEIN-KINASE; ARCUATE NUCLEUS; BETA-ENDORPHIN; SIGNAL-TRANSDUCTION; ENERGY HOMEOSTASIS; NPY/AGRP NEURONS; GHRELIN RECEPTOR; MESSENGER-RNA; FOOD-INTAKE; LEPTIN	Synaptic plasticity in response to changes in physiologic state is coordinated by hormonal signals across multiple neuronal cell types. Here, we combine cell-type-specific electrophysiological, pharmacological, and optogenetic techniques to dissect neural circuits and molecular pathways controlling synaptic plasticity onto AGRP neurons, a population that regulates feeding. We find that food deprivation elevates excitatory synaptic input, which is mediated by a presynaptic positive feedback loop involving AMP-activated protein kinase. Potentiation of glutamate release was triggered by the orexigenic hormone ghrelin and exhibited hysteresis, persisting for hours after ghrelin removal. Persistent activity was reversed by the anorexigenic hormone leptin, and optogenetic photostimulation demonstrated involvement of opioid release from POMC neurons. Based on these experiments, we propose a memory storage device for physiological state constructed from bistable synapses that are flipped between two sustained activity states by transient exposure to hormones signaling energy levels.	[Yang, Yunlei; Atasoy, Deniz; Su, Helen H.; Sternson, Scott M.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Sternson, SM (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	sternsons@janelia.hhmi.org	Atasoy, Deniz/AAR-7917-2020; Atasoy, Deniz/B-3414-2018	Atasoy, Deniz/0000-0002-3325-8820; 	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This research was funded by the Howard Hughes Medical Institute. We thank L. Scheffer for discussion of digital electronic circuits; J. Cox for mouse husbandry; Y. Aponte for assistance with animal studies; Y. Li and Z. Zhang for assistance with biochemistry; and K. Moses, S. Eddy, K. Svoboda, G. Murphy, and C. Zuker for comments on the manuscript. Leptin was provided by Amylin Pharmaceuticals. Y.Y. performed the experiments. H.S. performed western blots. D.A. made the initial finding of deprivation-induced plasticity. Y.Y. and S.M.S. designed the study, analyzed the data, and wrote the paper.	Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Appleyard SM, 2003, ENDOCRINOLOGY, V144, P1753, DOI 10.1210/en.2002-221096; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Boelen A, 2006, J ENDOCRINOL, V190, P537, DOI 10.1677/joe.1.06872; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Endo K, 2000, J PHYSIOL-LONDON, V524, P769, DOI 10.1111/j.1469-7793.2000.00769.x; Evans AM, 2005, J BIOL CHEM, V280, P41504, DOI 10.1074/jbc.M510040200; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gordon GRJ, 2006, J PHYSIOL-LONDON, V576, P341, DOI 10.1113/jphysiol.2006.110270; GRANDISON L, 1977, NEUROPHARMACOLOGY, V16, P533, DOI 10.1016/0028-3908(77)90019-3; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; HOLM S, 1979, SCAND J STAT, V6, P65; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Horowitz P., 2015, ART ELECT; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Li C, 1999, BRAIN RES, V824, P267, DOI 10.1016/S0006-8993(99)01217-2; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Luquet S, 2007, PEPTIDES, V28, P214, DOI 10.1016/j.peptides.2006.08.036; Martianez T, 2009, J BIOL CHEM, V284, P23902, DOI 10.1074/jbc.M109.026054; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Silva RM, 2001, J PHARMACOL EXP THER, V297, P590; Smith RG, 2005, ENDOCR REV, V26, P346, DOI 10.1210/er.2004-0019; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Tanaka K, 2008, NEURON, V59, P608, DOI 10.1016/j.neuron.2008.06.026; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	44	297	301	2	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 16	2011	146	6					991	1002		10.1016/j.cell.2011.07.039	http://dx.doi.org/10.1016/j.cell.2011.07.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925320	Green Accepted, Bronze			2022-12-28	WOS:000295258100020
J	Shah, PL; Slebos, DJ; Cardoso, PFG; Cetti, E; Voelker, K; Levine, B; Russell, ME; Goldin, J; Brown, M; Cooper, JD; Sybrecht, GW				Shah, P. L.; Slebos, D-J; Cardoso, P. F. G.; Cetti, E.; Voelker, K.; Levine, B.; Russell, M. E.; Goldin, J.; Brown, M.; Cooper, J. D.; Sybrecht, G. W.		EASE Trial Study Grp	Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial	LANCET			English	Article							MEDICAL THERAPY; SURGERY; BYPASS	Background Airway bypass is a bronchoscopic lung-volume reduction procedure for emphysema whereby transbronchial passages into the lung are created to release trapped air, supported with paclitaxel-coated stents to ease the mechanics of breathing. The aim of the EASE (Exhale airway stents for emphysema) trial was to evaluate safety and efficacy of airway bypass in people with severe homogeneous emphysema. Methods We undertook a randomised, double-blind, sham-controlled study in 38 specialist respiratory centres worldwide. We recruited 315 patients who had severe hyperinflation (ratio of residual volume [RV] to total lung capacity of >= 0.65). By computer using a random number generator, we randomly allocated participants (in a 2:1 ratio) to either airway bypass (n=208) or sham control (107). We divided investigators into team A (masked), who completed pre-procedure and post-procedure assessments, and team B (unmasked), who only did bronchoscopies without further interaction with patients. Participants were followed up for 12 months. The 6-month co-primary efficacy endpoint required 12% or greater improvement in forced vital capacity (FVC) and 1 point or greater decrease in the modified Medical Research Council dyspnoea score from baseline. The composite primary safety endpoint incorporated five severe adverse events. We did Bayesian analysis to show the posterior probability that airway bypass was superior to sham control (success threshold, 0.965). Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00391612. Findings All recruited patients were included in the analysis. At 6 months, no difference between treatment arms was noted with respect to the co-primary efficacy endpoint (30 of 208 for airway bypass vs 12 of 107 for sham control; posterior probability 0.749, below the Bayesian success threshold of 0.965). The 6-month composite primary safety endpoint was 14.4% (30 of 208) for airway bypass versus 11.2% (12 of 107) for sham control (judged non-inferior, with a posterior probability of 1.00 [Bayesian success threshold >0.95]). Interpretation Although our findings showed safety and transient improvements, no sustainable benefit was recorded with airway bypass in patients with severe homogeneous emphysema.	[Cetti, E.] Royal Brompton Hosp, London SW3 6NP, England; [Shah, P. L.] Royal Brompton & Harefield NHS Fdn Trust, NIHR Resp Biomed Res Unit, London, England; [Slebos, D-J] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Cardoso, P. F. G.] Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor, Sao Paulo, Brazil; [Cetti, E.] Univ London Imperial Coll Sci Technol & Med, London, England; [Voelker, K.] Sarasota Mem Hosp, Sarasota, FL USA; [Levine, B.] Pulm Associates, Phoenix, AZ USA; [Russell, M. E.] Broncus Technol, Mountain View, CA USA; [Goldin, J.; Brown, M.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Goldin, J.; Brown, M.] MedQIA, Los Angeles, CA USA; [Cooper, J. D.] Hosp Univ Penn, Philadelphia, PA USA; [Sybrecht, G. W.] Univ Klinikum Saarlandes, Homburg, Germany	Royal Brompton Hospital; Royal Brompton & Harefield NHS Foundation Trust; University of Groningen; Universidade de Sao Paulo; Imperial College London; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Pennsylvania; Pennsylvania Medicine; Universitatsklinikum des Saarlandes	Shah, PL (corresponding author), Royal Brompton Hosp, London SW3 6NP, England.	pallav.shah@imperial.ac.uk	Harper, Richart W/F-9359-2013; Cardoso, Paulo F.G./C-5768-2012; Keating, Dominic T/H-8961-2019; Shah, Pallav L/AAB-2758-2019	Harper, Richart W/0000-0001-8097-6465; Keating, Dominic T/0000-0001-6150-6927; Shah, Pallav L/0000-0002-9052-4638; HEILI-FRADES, SARAH/0000-0003-4901-6487; Cardoso, Paulo/0000-0003-0749-4165; burghuber, otto/0000-0002-8419-621X; Hind, Matthew/0000-0002-9966-9446; Goldin, Jonathan/0000-0003-3007-9947; Kerstjens, Huib/0000-0001-7705-7927; Kemp, Samuel/0000-0002-6639-0166; Westall, Glen/0000-0002-3711-068X; Adamali, Huzaifa/0000-0002-8230-175X	Broncos Technologies	Broncos Technologies	Broncos Technologies.	[Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Brown MS, 2007, COMPUT MED IMAG GRAP, V31, P332, DOI 10.1016/j.compmedimag.2007.02.014; Cardoso PFG, 2007, J THORAC CARDIOV SUR, V134, P974, DOI 10.1016/j.jtcvs.2007.05.040; Choong CK, 2006, J THORAC CARDIOV SUR, V131, P60, DOI 10.1016/j.jtcvs.2005.07.057; Choong CK, 2005, J THORAC CARDIOV SUR, V129, P632, DOI 10.1016/j.jtcvs.2004.07.062; Choong Cliff K, 2009, Thorac Surg Clin, V19, P239, DOI 10.1016/j.thorsurg.2009.04.003; Cooper JD, 2010, CHEST, V138, P243, DOI 10.1378/chest.10-0829; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; Fessler HE, 2002, AM J RESP CRIT CARE, V165, P34, DOI 10.1164/ajrccm.165.1.2101149; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Lausberg HF, 2003, ANN THORAC SURG, V75, P393, DOI 10.1016/S0003-4975(02)04553-8; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; Naunheim KS, 2006, ANN THORAC SURG, V82, P431, DOI 10.1016/j.athoracsur.2006.05.069; Sciurba FC, 2010, NEW ENGL J MED, V363, P1233, DOI 10.1056/NEJMoa0900928; Shah PL, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-1; Weder W, 2009, ANN THORAC SURG, V87, P229, DOI 10.1016/j.athoracsur.2008.10.012	17	149	162	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2011	378	9795					997	1005		10.1016/S0140-6736(11)61050-7	http://dx.doi.org/10.1016/S0140-6736(11)61050-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HO	21907863				2022-12-28	WOS:000295193200025
J	Wang, WQ; Li, GW; Chen, CY; Xie, XS; Zhuang, XW				Wang, Wenqin; Li, Gene-Wei; Chen, Chongyi; Xie, X. Sunney; Zhuang, Xiaowei			Chromosome Organization by a Nucleoid-Associated Protein in Live Bacteria	SCIENCE			English	Article							H-NS PROTEIN; ESCHERICHIA-COLI; STRUCTURING PROTEIN; DNA; BINDING; OLIGOMERIZATION; LOCALIZATION; EXPRESSION; MICROSCOPY; DYNAMICS	Bacterial chromosomes are confined in submicrometer-sized nucleoids. Chromosome organization is facilitated by nucleoid-associated proteins (NAPs), but the mechanisms of action remain elusive. In this work, we used super-resolution fluorescence microscopy, in combination with a chromosome-conformation capture assay, to study the distributions of major NAPs in live Escherichia coli cells. Four NAPs-HU, Fis, IHF, and StpA-were largely scattered throughout the nucleoid. In contrast, H-NS, a global transcriptional silencer, formed two compact clusters per chromosome, driven by oligomerization of DNA-bound H-NS through interactions mediated by the amino-terminal domain of the protein. H-NS sequestered the regulated operons into these clusters and juxtaposed numerous DNA segments broadly distributed throughout the chromosome. Deleting H-NS led to substantial chromosome reorganization. These observations demonstrate that H-NS plays a key role in global chromosome organization in bacteria.	[Li, Gene-Wei; Chen, Chongyi; Xie, X. Sunney; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Wang, Wenqin; Li, Gene-Wei; Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Chen, Chongyi] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu; zhuang@chemistry.harvard.edu	Wang, Wenqin/E-9418-2012; Li, Gene-Wei/E-7657-2010; Chen, Chongyi/D-4178-2015	Chen, Chongyi/0000-0002-0504-5369; Li, Gene-Wei/0000-0001-7036-8511	NIH [GM 096450]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096450] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Hinton for providing the antibody to H-NS, J. Kaguni for providing the antibody to HU, M. Umbarger and S. Adhya for 3C protocols and discussions, and B. Huang for help with image analysis algorithm. This work was supported in part by the NIH (grant GM 096450 to X.Z. and X.S.X., and NIH Director's Pioneer Award to X.S.X.). G.-W.L. was a NSF predoctoral fellow. X.Z. is a Howard Hughes Medical Institute Investigator.	[Anonymous], DYNAMICS BACTERIAL C; Badaut C, 2002, J BIOL CHEM, V277, P41657, DOI 10.1074/jbc.M206037200; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Biteen JS, 2008, NAT METHODS, V5, P947, DOI 10.1038/nmeth.1258; Dame RT, 2006, NATURE, V444, P387, DOI 10.1038/nature05283; Deich J, 2004, P NATL ACAD SCI USA, V101, P15921, DOI 10.1073/pnas.0404200101; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Egner A, 2007, BIOPHYS J, V93, P3285, DOI 10.1529/biophysj.107.112201; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Eltsov M, 2006, J STRUCT BIOL, V156, P246, DOI 10.1016/j.jsb.2006.07.007; Espeli O, 2006, J STRUCT BIOL, V156, P304, DOI 10.1016/j.jsb.2006.07.010; Fang FC, 2008, CURR OPIN MICROBIOL, V11, P113, DOI 10.1016/j.mib.2008.02.011; Gitai Z, 2005, TRENDS MICROBIOL, V13, P221, DOI 10.1016/j.tim.2005.03.006; Grainger DC, 2006, NUCLEIC ACIDS RES, V34, P4642, DOI 10.1093/nar/gkl542; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hommais F, 2001, MOL MICROBIOL, V40, P20, DOI 10.1046/j.1365-2958.2001.02358.x; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Johnson Reid C., 2005, P65; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; Lee SF, 2011, BIOPHYS J, V100, pL31, DOI 10.1016/j.bpj.2011.02.022; Li GW, 2009, NAT PHYS, V5, P294, DOI 10.1038/NPHYS1222; Liu YJ, 2010, GENE DEV, V24, P339, DOI 10.1101/gad.1883510; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; MCGOVERN V, 1994, BIOCHIMIE, V76, P1019, DOI 10.1016/0300-9084(94)90026-4; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; REIDL J, 1991, J BACTERIOL, V173, P4862, DOI 10.1128/jb.173.15.4862-4876.1991; Reyes-Larnothe R, 2008, TRENDS MICROBIOL, V16, P238, DOI 10.1016/j.tim.2008.02.003; Rimsky S, 2004, CURR OPIN MICROBIOL, V7, P109, DOI 10.1016/j.mib.2004.02.001; ROBINOW C, 1994, MICROBIOL REV, V58, P211, DOI 10.1128/MMBR.58.2.211-232.1994; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Smits WK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001207; Smyth CP, 2000, MOL MICROBIOL, V36, P962, DOI 10.1046/j.1365-2958.2000.01917.x; Spurio R, 1997, EMBO J, V16, P1795, DOI 10.1093/emboj/16.7.1795; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Ueguchi C, 1997, J MOL BIOL, V274, P145, DOI 10.1006/jmbi.1997.1381; Vora T, 2009, MOL CELL, V35, P247, DOI 10.1016/j.molcel.2009.06.035	42	275	290	2	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2011	333	6048					1445	1449		10.1126/science.1204697	http://dx.doi.org/10.1126/science.1204697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21903814	Green Accepted			2022-12-28	WOS:000294672200042
J	Bush, LM; Perez, MT				Bush, Larry M.; Perez, Maria T.			The Anthrax Attacks 10 Years Later	ANNALS OF INTERNAL MEDICINE			English	Article							OUTBREAK	Ten years ago, just weeks after the September 11 attacks, the United States experienced a deliberate act of bioterrorism. Through use of the postal service, anthrax spores were widely disseminated, including to homes, the Senate, and major newsrooms, resulting in morbidity and mortality and effectively disrupting our way of life and revealing our vulnerability. Even though such attacks had been the subject of much writing and had been planned for, detection of and the appropriate response to an attack with an agent from the so-called "Category 'A' List" had only been considered in theoretical terms. What transpired during the following difficult weeks, including how public health and federal government agencies performed, has been both praised and criticized. An intertwined epi-demiologic and criminal investigation of such magnitude was unprecedented in U.S. history. To address the question of whether we as a nation are now better prepared for future threats involving biologic agents, it is important to learn from the lessons of the 2001 anthrax attacks, including the critical role of clinicians in surveillance. As physicians involved in diagnosing anthrax in the index case and alerting authorities, we offer our perspective on these events a decade after their occurrence.	JFK Med Ctr, Atlantis, FL 33462 USA; Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University	Bush, LM (corresponding author), 5503 S Congress Ave,Suite 104, Atlantis, FL 33462 USA.							[Anonymous], 2002, ANTHR AM CHRON AN FA; Brachman P S, 1980, Ann N Y Acad Sci, V353, P83, DOI 10.1111/j.1749-6632.1980.tb18910.x; Broad WA, 2002, NY TIMES        0916; Bush LM, 2001, NEW ENGL J MED, V345, P1607, DOI 10.1056/NEJMoa012948; Cole L.A., 2009, ANTHRAX LETT BIOTERR; Henning Kelly J, 2004, MMWR Suppl, V53, P5; HEYMAN D, 2002, LESSONS ANTHRAX ATTA; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Kolata G, 2001, NY TIMES        1005; McGlown K.J., 2011, ANTICIPATE RESPOND R; MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702; Musgrave J., 2011, PALM BEACH POST 0430; Torok TJ, 1997, JAMA-J AM MED ASSOC, V278, P389, DOI 10.1001/jama.278.5.389; Wiser M, 2011, PALM BEACH POST 0719	14	21	21	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2012	156	1	1				41	U87		10.7326/0003-4819-155-12-201112200-00373	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-00373			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872VK	21969275				2022-12-28	WOS:000298837600006
J	Mayer, C; Khoramnia, R				Mayer, Christian; Khoramnia, Ramin			Purtscher-like retinopathy caused by acute pancreatitis	LANCET			English	Editorial Material									[Mayer, Christian] Tech Univ Munich, Klinikum Rechts Isar, Eye Clin, D-81675 Munich, Germany; [Khoramnia, Ramin] Univ Heidelberg, Dept Ophthalmol, Heidelberg, Germany	Technical University of Munich; Ruprecht Karls University Heidelberg	Mayer, C (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Eye Clin, Ismaninger Str 22, D-81675 Munich, Germany.	christian.mayer@mri.tum.de	Khoramnia, Ramin/AAR-8358-2020	Khoramnia, Ramin/0000-0002-6237-7773					0	4	5	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 5	2011	378	9803					1653	1653		10.1016/S0140-6736(11)60474-1	http://dx.doi.org/10.1016/S0140-6736(11)60474-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844ST	21944377	Bronze			2022-12-28	WOS:000296768300030
J	Jolly, K; Aveyard, P				Jolly, Kate; Aveyard, Paul			Provision of commercial weight management programmes	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE; INTERVENTION; OBESITY; HEALTH; DIET; UK		[Jolly, Kate; Aveyard, Paul] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Jolly, K (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England.	c.b.jolly@bham.ac.uk	Jolly, Kate/AAA-1341-2019	Jolly, Kate/0000-0002-6224-2115; Aveyard, Paul/0000-0002-1802-4217				Gibbs HD, 2004, J HUM NUTR DIET, V17, P191, DOI 10.1111/j.1365-277X.2004.00517.x; Hardcastle S, 2008, PATIENT EDUC COUNS, V70, P31, DOI 10.1016/j.pec.2007.09.014; Heshka S, 2003, JAMA-J AM MED ASSOC, V289, P1792, DOI 10.1001/jama.289.14.1792; Jebb SA, 2011, LANCET, V378, P1485, DOI 10.1016/S0140-6736(11)61344-5; Jolly K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-439; NANCHAHAL K, 2009, BR J GEN PRACT, pE157; Rock CL, 2007, OBESITY, V15, P939, DOI 10.1038/oby.2007.614; Rock CL, 2010, JAMA-J AM MED ASSOC, V304, P1803, DOI 10.1001/jama.2010.1503; Truby H, 2006, BMJ-BRIT MED J, V332, P1309, DOI 10.1136/bmj.38833.411204.80; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; World Health Organization, 2011, OB; World Health Organization, 2011, NONC DIS MENT HLTH G	12	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 22	2011	378	9801					1444	1445		10.1016/S0140-6736(11)61186-0	http://dx.doi.org/10.1016/S0140-6736(11)61186-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	838VC	21906799				2022-12-28	WOS:000296319600006
J	Baker, M				Baker, Monya			BRIGHT LIGHT, BETTER LABELS	NATURE			English	Editorial Material							LOCALIZATION MICROSCOPY; FLUORESCENT PROTEIN; SUPERRESOLUTION; CELLS											Annibale P, 2011, NAT METHODS, V8, P527, DOI 10.1038/nmeth.1627; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Grotjohann T., 2011, NATURE; Gunewardene MS, 2011, BIOPHYS J, V101, P1522, DOI 10.1016/j.bpj.2011.07.049; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Holden SJ, 2011, NAT METHODS, V8, P279, DOI 10.1038/nmeth0411-279; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Klein T, 2011, NAT METHODS, V8, P7, DOI 10.1038/nmeth0111-7b; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sengupta P., 2011, NATURE METH; Subach FV, 2010, J AM CHEM SOC, V132, P6481, DOI 10.1021/ja100906g; Subach OM, 2011, NAT METHODS, V8, P771, DOI 10.1038/nmeth.1664	14	11	12	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2011	478	7367					137	142		10.1038/478137a	http://dx.doi.org/10.1038/478137a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21979054				2022-12-28	WOS:000295575400051
J	Berghmans, R; Schouten, HC				Berghmans, Ron; Schouten, Harry C.			A PATIENT'S JOURNEY Sir Karl Popper, swans, and the general practitioner	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Berghmans, Ron] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Hlth Eth & Soc, NL-6200 MD Maastricht, Netherlands; [Schouten, Harry C.] Univ Hosp Maastricht, Dept Internal Med, NL-6202 AZ Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Berghmans, R (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Hlth Eth & Soc, POB 616, NL-6200 MD Maastricht, Netherlands.	r.berghmans@maastrichtuniversity.nl						[Anonymous], 1993, N ENGL J MED, V329, P987; Groopman J., 2008, DOCTORS THINK	2	6	6	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 3	2011	343								d5469	10.1136/bmj.d5469	http://dx.doi.org/10.1136/bmj.d5469			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	832CQ	21968125	Bronze			2022-12-28	WOS:000295779200001
J	Harper, KC; Sigman, MS				Harper, Kaid C.; Sigman, Matthew S.			Three-Dimensional Correlation of Steric and Electronic Free Energy Relationships Guides Asymmetric Propargylation	SCIENCE			English	Article							MOLECULAR-FIELDS; ENANTIOSELECTIVITY; CATALYSIS; DESIGN; ORGANOCATALYSIS; SELECTIVITY; LIGANDS; STATE	Chemical reaction outcomes are often rationalized on the basis of independent analyses of steric and electronic effects. We applied three-dimensional free energy relationships correlating steric and electronic effects to design and optimize a ligand class for the enantioselective Nozaki-Hiyama-Kishi propargylation of ketones. The resultant mathematical model describing the steric and electronic parameter relationship is highly reliant on the synergistic interactions of these two effects.	[Harper, Kaid C.; Sigman, Matthew S.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Sigman, MS (corresponding author), Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA.	sigman@chem.utah.edu		Harper, Kaid/0000-0003-3894-4851	NSF [CHE-0749506]	NSF(National Science Foundation (NSF))	Supported by NSF grant CHE-0749506.	Allemann C, 2004, ACCOUNTS CHEM RES, V37, P558, DOI 10.1021/ar0300524; Anslyn E. V., 2006, MODERN PHYS ORGANIC, P441; CASALNUOVO AL, 1994, J AM CHEM SOC, V116, P9869, DOI 10.1021/ja00101a007; CHARTON M, 1975, J AM CHEM SOC, V97, P3694, DOI 10.1021/ja00846a023; CHARTON M, 1976, J ORG CHEM, V41, P2217, DOI 10.1021/jo00874a035; CHARTON M, 1975, J AM CHEM SOC, V97, P3691, DOI 10.1021/ja00846a022; CHARTON M, 1975, J AM CHEM SOC, V97, P1552, DOI 10.1021/ja00839a047; Cheong PHY, 2011, CHEM REV, V111, P5042, DOI 10.1021/cr100212h; Deming S.N., 1993, EXPT DESIGN CHEMOMET, V2nd ed., DOI DOI 10.4137/ACI.S11612; Denmark SE, 2011, J ORG CHEM, V76, P4337, DOI 10.1021/jo2005457; Ding CH, 2011, CHEM REV, V111, P1914, DOI 10.1021/cr100284m; Donoghue PJ, 2008, J CHEM THEORY COMPUT, V4, P1313, DOI 10.1021/ct800132a; Donoghue PJ, 2009, J AM CHEM SOC, V131, P410, DOI 10.1021/ja806246h; Dudding T, 2004, P NATL ACAD SCI USA, V101, P5770, DOI 10.1073/pnas.0307256101; Fandrick KR, 2011, J AM CHEM SOC, V133, P10332, DOI 10.1021/ja2028958; Gustafson JL, 2010, ORG LETT, V12, P2794, DOI 10.1021/ol100927m; Hammett LP, 1937, J AM CHEM SOC, V59, P96, DOI 10.1021/ja01280a022; HANSCH C, 1991, CHEM REV, V91, P165, DOI 10.1021/cr00002a004; Hansch C., 1995, EXPLORING QSAR FUNDA, P69; Harper KC, 2011, P NATL ACAD SCI USA, V108, P2179, DOI 10.1073/pnas.1013331108; HUBERT AJ, 1967, J CHEM SOC C, P1984, DOI 10.1039/j39670001984; Ianni J.C., 2006, ANGEW CHEM, V118, P5628; Jensen KH, 2010, J ORG CHEM, V75, P7194, DOI 10.1021/jo1013806; Jones JE, 1924, P R SOC LOND A-CONTA, V106, P463, DOI 10.1098/rspa.1924.0082; Jones JE, 1924, P R SOC LOND A-CONTA, V106, P441, DOI 10.1098/rspa.1924.0081; Kozlowski MC, 2003, J AM CHEM SOC, V125, P6614, DOI 10.1021/ja0293195; Kozlowski MC, 2003, J ORG CHEM, V68, P2061, DOI 10.1021/jo020401s; Lipkowitz KB, 2003, J ORG CHEM, V68, P4648, DOI 10.1021/jo0267697; Lipkowitz KB, 2002, J AM CHEM SOC, V124, P14255, DOI 10.1021/ja0207192; List B, 2002, TETRAHEDRON, V58, P5573, DOI 10.1016/S0040-4020(02)00516-1; Miller JJ, 2008, ANGEW CHEM INT EDIT, V47, P771, DOI 10.1002/anie.200704257; Miller JJ, 2007, J AM CHEM SOC, V129, P2752, DOI 10.1021/ja068915m; Nelson DW, 1997, J AM CHEM SOC, V119, P1840, DOI 10.1021/ja961464t; Norrby PO, 1999, J AM CHEM SOC, V121, P10186, DOI 10.1021/ja992023n; Oslob JD, 1997, ORGANOMETALLICS, V16, P3015, DOI 10.1021/om9700371; Palucki M, 1998, J AM CHEM SOC, V120, P948, DOI 10.1021/ja973468j; Shi SL, 2010, J AM CHEM SOC, V132, P6638, DOI 10.1021/ja101948s; Sigman MS, 2009, J ORG CHEM, V74, P7633, DOI 10.1021/jo901698t; TAFT RW, 1952, J AM CHEM SOC, V74, P3120, DOI 10.1021/ja01132a049; Taft RW, 1956, STERIC EFFECTS ORGAN; Uyeda C, 2011, J AM CHEM SOC, V133, P5062, DOI 10.1021/ja110842s; Walsh R, 2009, FUNDAMENTALS ASYMMET, P1; Zuend SJ, 2007, J AM CHEM SOC, V129, P15872, DOI 10.1021/ja0735352; Zuend SJ, 2009, J AM CHEM SOC, V131, P15358, DOI 10.1021/ja9058958	44	152	157	6	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051					1875	1878		10.1126/science.1206997	http://dx.doi.org/10.1126/science.1206997			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960632				2022-12-28	WOS:000295365800052
J	Brocklehurst, P; Farrell, B; King, A; Juszczak, E; Darlow, B; Haque, K; Salt, A; Stenson, B; Tarnow-Mordi, W				Brocklehurst, Peter; Farrell, Barbara; King, Andrew; Juszczak, Edmund; Darlow, Brian; Haque, Khalid; Salt, Alison; Stenson, Ben; Tarnow-Mordi, William		INIS Collaborative Grp	Treatment of Neonatal Sepsis with Intravenous Immune Globulin	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNOGLOBULIN; PREVENTION; INFANTS	BACKGROUND Neonatal sepsis is a major cause of death and complications despite antibiotic treatment. Effective adjunctive treatments are needed. Newborn infants are relatively deficient in endogenous immunoglobulin. Meta-analyses of trials of intravenous immune globulin for suspected or proven neonatal sepsis suggest a reduced rate of death from any cause, but the trials have been small and have varied in quality. METHODS At 113 hospitals in nine countries, we enrolled 3493 infants receiving antibiotics for suspected or proven serious infection and randomly assigned them to receive two infusions of either polyvalent IgG immune globulin (at a dose of 500 mg per kilogram of body weight) or matching placebo 48 hours apart. The primary outcome was death or major disability at the age of 2 years. RESULTS There was no significant between-group difference in the rates of the primary outcome, which occurred in 686 of 1759 infants (39.0%) who received intravenous immune globulin and in 677 of 1734 infants (39.0%) who received placebo (relative risk, 1.00; 95% confidence interval, 0.92 to 1.08). Similarly, there were no significant differences in the rates of secondary outcomes, including the incidence of subsequent sepsis episodes. In follow-up of 2-year-old infants, there were no significant differences in the rates of major or nonmajor disability or of adverse events. CONCLUSIONS Therapy with intravenous immune globulin had no effect on the outcomes of suspected or proven neonatal sepsis. (Funded by the United Kingdom Medical Research Council and others; INIS Current Controlled Trials number, ISRCTN94984750.)	[Brocklehurst, Peter] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England; [Darlow, Brian] Univ Otago, Christchurch, New Zealand; [Haque, Khalid] Childrens Hosp Complex, Lahore, Pakistan; [Haque, Khalid] Univ London, London WC1E 7HU, England; [Salt, Alison] UCL, London WC1E 6BT, England; [Stenson, Ben] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland; [Tarnow-Mordi, William] Univ Sydney, Sydney, NSW 2006, Australia	University of Oxford; University of Otago; University of London; University of London; University College London; Royal Infirmary of Edinburgh; University of Edinburgh; University of Sydney	Brocklehurst, P (corresponding author), Univ Oxford, Natl Perinatal Epidemiol Unit, Old Rd Campus, Oxford OX3 7LF, England.	peter.brocklehurst@npeu.ox.ac.uk	Saker, Samir H/Y-4774-2018; Greisen, Gorm/AAA-6463-2022; Pritchard, Margo A/G-5188-2010	Saker, Samir H/0000-0003-2793-0972; Greisen, Gorm/0000-0001-8042-3262; Pritchard, Margo A/0000-0002-1058-9117; Peters, Mark/0000-0003-3653-4808; Robledo, Kristy/0000-0003-0213-7652; Jamieson, Nina/0000-0002-8776-5000	United Kingdom Medical Research Council; National Health and Medical Research Council of Australia; Health Research Council of New Zealand; MRC [G9900825] Funding Source: UKRI; Medical Research Council [G9900825] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Health Research Council of New Zealand(Health Research Council of New Zealand); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the United Kingdom Medical Research Council, the National Health and Medical Research Council of Australia, and the Health Research Council of New Zealand.	Ahmed SS, 2006, J BANGLADESH COLL PH, V24, P97, DOI DOI 10.3329/jbcps.v24i3.158; [Anonymous], 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; BALEY JE, 1988, CLIN PERINATOL, V15, P755, DOI 10.1016/S0095-5108(18)30672-9; Bayley N, 1993, BAYLEY SCALES INFANT; CHRISTENSEN RD, 1991, J PEDIATR-US, V118, P606, DOI 10.1016/S0022-3476(05)83389-X; ERDEM G, 1993, TURKISH J PEDIATR, V35, P277; HAQUE KN, 1988, AM J DIS CHILD, V142, P1293, DOI 10.1001/archpedi.1988.02150120047038; INIS Study Collaborative Group, 2008, BMC Pregnancy Childbirth, V8, P52, DOI 10.1186/1471-2393-8-52; Jenson HB, 1998, SEMIN PERINATOL, V22, P50, DOI 10.1016/S0146-0005(98)80007-4; Johnson A, 1997, ARCH DIS CHILD-FETAL, V76, pF61, DOI 10.1136/fn.76.1.F61; Laupland KB, 2007, CRIT CARE MED, V35, P2686, DOI 10.1097/01.CCM.0000295312.13466.1C; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Melvan JN, 2010, INT REV IMMUNOL, V29, P315, DOI 10.3109/08830181003792803; Mohan PV, 2004, ARCH DIS CHILD-FETAL, V89, pF5, DOI 10.1136/fn.89.1.F5; Murphy DJ, 1997, BMJ-BRIT MED J, V314, P404, DOI 10.1136/bmj.314.7078.404; Nelson KB, 1998, ANN NEUROL, V44, P665, DOI 10.1002/ana.410440413; *NEON PER EP UN, 1994, DIS PER CAR MEAS HLT; Ohlsson A, 2010, COCHRANE DB SYST REV, V3; Ohlsson A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000361.pub3; Samatha S, 1997, KARNATAKA PEDIAT J, V11, P1; Saudino KJ, 1998, BRIT J DEV PSYCHOL, V16, P349, DOI 10.1111/j.2044-835X.1998.tb00757.x; Shah DK, 2008, J PEDIATR-US, V153, P170, DOI 10.1016/j.jpeds.2008.02.033; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shenoi A, 1999, Indian Pediatr, V36, P1113; SIDIROPOULOS D, 1986, PEDIATR INFECT DIS J, V5, pS193; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Tarnow-Mordi W, 2010, CLIN PERINATOL, V37, P481, DOI 10.1016/j.clp.2009.12.002	27	188	195	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2011	365	13					1201	1211		10.1056/NEJMoa1100441	http://dx.doi.org/10.1056/NEJMoa1100441			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825YO	21962214	Bronze			2022-12-28	WOS:000295318400008
J	Luo, JJ				Luo, Jing-Jia			CLIMATE SCIENCE Ocean dynamics not required?	NATURE			English	Editorial Material							EQUATORIAL PACIFIC		[Luo, Jing-Jia] JAMSTEC, Res Inst Global Change, Kanazawa Ku, Kanagawa 2360001, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Luo, JJ (corresponding author), JAMSTEC, Res Inst Global Change, Kanazawa Ku, 3173-25 Showa Machi, Kanagawa 2360001, Japan.	luo@jamstec.go.jp	Luo, Jing-Jia/T-9612-2019; Luo, Jing-Jia/B-2481-2008	Luo, Jing-Jia/0000-0003-2181-0638; Luo, Jing-Jia/0000-0003-2181-0638				BJERKNES J, 1969, MON WEATHER REV, V97, P163, DOI 10.1175/1520-0493(1969)097<0163:ATFTEP>2.3.CO;2; Clement A, 2011, J CLIMATE, V24, P4056, DOI 10.1175/2011JCLI3973.1; Dommenget D, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044888; HASSELMANN K, 1976, TELLUS, V28, P473, DOI 10.1111/j.2153-3490.1976.tb00696.x; Karnauskas KB, 2009, J CLIMATE, V22, P4316, DOI 10.1175/2009JCLI2936.1; Luo JJ, 2001, J GEOPHYS RES-OCEANS, V106, P22211, DOI 10.1029/2000JC000471; Neelin J. D., 1998, J GEOPHYS RES; Timmermann A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013369; Vecchi GA, 2007, J CLIMATE, V20, P4316, DOI 10.1175/JCLI4258.1	9	4	4	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 29	2011	477	7366					544	546		10.1038/477544a	http://dx.doi.org/10.1038/477544a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21956325				2022-12-28	WOS:000295320900028
J	Wegner, G				Wegner, Gary			COSMOLOGY Gravity tested on large scales	NATURE			English	Editorial Material							GRAVITATIONAL REDSHIFT; GALAXY CLUSTERS		[Wegner, Gary] Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA	Dartmouth College	Wegner, G (corresponding author), Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA.	gary.wegner@dartmouth.edu						Broadhurst T, 2000, ASTROPHYS J, V533, pL93, DOI 10.1086/312630; CAPPI A, 1995, ASTRON ASTROPHYS, V301, P6; De Felice A, 2010, LIVING REV RELATIV, V13, DOI 10.12942/lrr-2010-3; Hao JG, 2010, ASTROPHYS J SUPPL S, V191, P254, DOI 10.1088/0067-0049/191/2/254; Kim YR, 2004, ASTROPHYS J, V607, P164, DOI 10.1086/383218; MILGROM M, 1983, ASTROPHYS J, V270, P371, DOI 10.1086/161131; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; Reyes R, 2010, NATURE, V464, P256, DOI 10.1038/nature08857; Skordis C, 2009, CLASSICAL QUANT GRAV, V26, DOI 10.1088/0264-9381/26/14/143001; Will CM, 2006, LIVING REV RELATIV, V9, DOI 10.12942/lrr-2006-3; Wojtak R, 2011, NATURE, V477, P567, DOI 10.1038/nature10445	11	1	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 29	2011	477	7366					541	543		10.1038/477541a	http://dx.doi.org/10.1038/477541a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21956323				2022-12-28	WOS:000295320900026
J	Cheng, W; Arunajadai, SG; Moffitt, JR; Tinoco, I; Bustamante, C				Cheng, Wei; Arunajadai, Srikesh G.; Moffitt, Jeffrey R.; Tinoco, Ignacio, Jr.; Bustamante, Carlos			Single-Base Pair Unwinding and Asynchronous RNA Release by the Hepatitis C Virus NS3 Helicase	SCIENCE			English	Article							DNA HELICASES; MECHANISM; TRANSLOCATION; REVEAL; UVRD; RESOLUTION; DYNAMICS; MOLECULE; MONOMER; ATP	Nonhexameric helicases use adenosine triphosphate (ATP) to unzip base pairs in double-stranded nucleic acids (dsNAs). Studies have suggested that these helicases unzip dsNAs in single-base pair increments, consuming one ATP molecule per base pair, but direct evidence for this mechanism is lacking. We used optical tweezers to follow the unwinding of double-stranded RNA by the hepatitis C virus NS3 helicase. Single-base pair steps by NS3 were observed, along with nascent nucleotide release that was asynchronous with base pair opening. Asynchronous release of nascent nucleotides rationalizes various observations of its dsNA unwinding and may be used to coordinate the translocation speed of NS3 along the RNA during viral replication.	[Cheng, Wei] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA; [Arunajadai, Srikesh G.] Columbia Univ, Dept Biostat, New York, NY 10032 USA; [Moffitt, Jeffrey R.] Harvard Univ, Ctr Syst Biol, Cambridge, MA 02138 USA; [Tinoco, Ignacio, Jr.; Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Dept Mol & Cellular Biol, Dept Phys, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of Michigan System; University of Michigan; Columbia University; Harvard University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Cheng, W (corresponding author), Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, 428 Church St, Ann Arbor, MI 48109 USA.	chengwe@umich.edu; carlos@alice.berkeley.edu		Bustamante, Carlos/0000-0002-2970-0073	University of Michigan at Ann Arbor; University of Michigan; March of Dimes Foundation [5_FY10_490]; NIH [5R01GM010840, 5R01GM032543]; U.S. Department of Energy [LBNL_DE_AC0376SF00098]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032543, R01GM010840] Funding Source: NIH RePORTER	University of Michigan at Ann Arbor(University of Michigan System); University of Michigan(University of Michigan System); March of Dimes Foundation(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Cheng lab members, especially X. Hou and H. Song, for critical reading of the manuscript; J. Yu for critical discussions; J. Vieregg for providing the all-AU RNA hairpin for WLC calibration of RNA elasticity; and Henkel Corporation for providing Ablefilm adhesive film for making microfluidic chambers. Supported by the University of Michigan at Ann Arbor, the Ara Paul Professorship fund at the University of Michigan, and March of Dimes Foundation research grant 5_FY10_490 (W. C.); NIH grant 5R01GM010840 (I. T.); U.S. Department of Energy grant LBNL_DE_AC0376SF00098; and NIH grant 5R01GM032543 (C. B.). W. C. is a Basil O'Connor Starter Scholar of the March of Dimes Foundation. W. C. prepared experimental materials and conducted the experiments; W. C., S. G. A., and J. R. M. performed the analysis; and W. C., S. G. A., J. R. M., I. T., and C. B. wrote the paper. The authors declare no competing financial interests.	Appleby TC, 2011, J MOL BIOL, V405, P1139, DOI 10.1016/j.jmb.2010.11.034; Arunajadai SG, 2009, MATH BIOSCI, V220, P57, DOI 10.1016/j.mbs.2009.04.003; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cheng W, 2007, P NATL ACAD SCI USA, V104, P13954, DOI 10.1073/pnas.0702315104; Cheng W, 2010, OPT LETT, V35, P2988, DOI 10.1364/OL.35.002988; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Donmez I, 2007, J BIOL CHEM, V282, P21116, DOI 10.1074/jbc.M702136200; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Eoff RL, 2006, NAT STRUCT MOL BIOL, V13, P242, DOI 10.1038/nsmb1055; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Jennings TA, 2009, J BIOL CHEM, V284, P4806, DOI 10.1074/jbc.M805540200; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Rajagopal V, 2010, J BIOL CHEM, V285, P17821, DOI 10.1074/jbc.M110.114785; Raney KD, 2010, J BIOL CHEM, V285, P22725, DOI 10.1074/jbc.R110.125294; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Serebrov V, 2009, J BIOL CHEM, V284, P2512, DOI 10.1074/jbc.M805460200; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3	28	106	106	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1746	1749		10.1126/science.1206023	http://dx.doi.org/10.1126/science.1206023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940894	Green Accepted			2022-12-28	WOS:000295121500042
J	Finkbeiner, A				Finkbeiner, Ann			The world's most independent defence science advisers	NATURE			English	Editorial Material												anniekf@gmail.com							0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2011	477	7365					397	399		10.1038/477397a	http://dx.doi.org/10.1038/477397a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	822WH	21938048	Bronze			2022-12-28	WOS:000295080500015
J	Schott, JM; Warren, JD; Barkhof, F; Rossor, MN; Fox, NC				Schott, Jonathan M.; Warren, Jason D.; Barkhof, Frederik; Rossor, Martin N.; Fox, Nick C.			RATIONAL IMAGING Suspected early dementia	BRITISH MEDICAL JOURNAL			English	Editorial Material							TEMPORAL-LOBE ATROPHY; ALZHEIMERS-DISEASE; LEWY BODIES; COGNITIVE IMPAIRMENT; DIAGNOSIS; GUIDELINES; MANAGEMENT; PET		[Schott, Jonathan M.; Warren, Jason D.; Rossor, Martin N.; Fox, Nick C.] UCL, Inst Neurol, Dementia Res Ctr, London WC1N 3BG, England; [Barkhof, Frederik] Vrije Univ Amsterdam Med Ctr, Radiol & Image Anal Ctr IAC, Amsterdam, Netherlands	University of London; University College London; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Schott, JM (corresponding author), UCL, Inst Neurol, Dementia Res Ctr, London WC1N 3BG, England.	j.schott@ucl.ac.uk	Schott, Jonathan M/A-9065-2011; Barkhof, Frederik/AAJ-6226-2020; Rossor, Martin/C-1598-2008	Schott, Jonathan M/0000-0003-2059-024X; Barkhof, Frederik/0000-0003-3543-3706; Warren, Jason/0000-0002-5405-0826; Rossor, Martin/0000-0001-8215-3120	Medical Research Council [G0801306, G0601846] Funding Source: Medline; Wellcome Trust [091673] Funding Source: Medline; Department of Health Funding Source: Medline; Alzheimers Research UK [ART-EG2010B-1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10123] Funding Source: researchfish; MRC [G0801306, G0601846] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Department of Health; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Burton EJ, 2009, BRAIN, V132, P195, DOI 10.1093/brain/awn298; Chan D, 2001, ANN NEUROL, V49, P433, DOI 10.1002/ana.92.abs; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; Cordonnier C, 2011, BRAIN, V134, P335, DOI 10.1093/brain/awq321; Duara R, 2008, NEUROLOGY, V71, P1986, DOI 10.1212/01.wnl.0000336925.79704.9f; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Foster NL, 2007, BRAIN, V130, P2616, DOI 10.1093/brain/awm177; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; Harvey RJ, 2003, J NEUROL NEUROSUR PS, V74, P1206, DOI 10.1136/jnnp.74.9.1206; Hort J, 2010, EUR J NEUROL, V17, P1236, DOI 10.1111/j.1468-1331.2010.03040.x; Inzitari D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2477; Kipps CM, 2009, BRAIN, V132, P2566, DOI 10.1093/brain/awp077; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; Likeman M, 2005, ARCH NEUROL-CHICAGO, V62, P1410, DOI 10.1001/archneur.62.9.1410; Macfarlane RG, 2007, J NEUROL NEUROSUR PS, V78, P664, DOI 10.1136/jnnp.2006.094821; McKeith I, 2007, LANCET NEUROL, V6, P305, DOI 10.1016/S1474-4422(07)70057-1; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; (NICE) NIfHaCE, 2011, CG42 DEM NICE GUID; Scheltens P, 2002, LANCET NEUROL, V1, P13, DOI 10.1016/S1474-4422(02)00002-9; Schott JM, 2006, PRACT NEUROL, V6, P143	21	4	4	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 20	2011	343								d5568	10.1136/bmj.d5568	http://dx.doi.org/10.1136/bmj.d5568			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	826AF	21933826	Green Published, Bronze			2022-12-28	WOS:000295323000002
J	Baba, S; Kondo, K; Kanaya, K; Suzukawa, K; Sato, T; Kurata, H; Hiruma, T; Fujita, H; Yahagi, N; Yamasoba, T				Baba, Shintaro; Kondo, Kenji; Kanaya, Kaori; Suzukawa, Keigo; Sato, Taku; Kurata, Hideaki; Hiruma, Takahiro; Fujita, Hidenobu; Yahagi, Naoki; Yamasoba, Tatsuya			Tsunami sinusitis	LANCET			English	Editorial Material									[Baba, Shintaro] Univ Tokyo, Grad Sch Med, Dept Otolaryngol & Head & Neck Surg, Fac Med,Bunkyo Ku, Tokyo 1138655, Japan; [Kurata, Hideaki; Hiruma, Takahiro; Fujita, Hidenobu; Yahagi, Naoki] Univ Tokyo, Grad Sch Med, Dept Emergency & Crit Care Med, Bunkyo Ku, Tokyo 1138655, Japan	University of Tokyo; University of Tokyo	Baba, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Otolaryngol & Head & Neck Surg, Fac Med,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	sbaba-tky@umin.ac.jp						Kaewlai R, 2007, EMERG RADIOL, V14, P395, DOI 10.1007/s10140-007-0655-4; Limchawalit K, 2005, NEW ENGL J MED, V352, pE23, DOI 10.1056/NEJMicm050461; Maegele M, 2006, CRIT CARE, V10, DOI 10.1186/cc4868; National Police Agency of Japan, DAM SIT POL COUNT AS	4	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 17	2011	378	9796					1116	1116		10.1016/S0140-6736(11)60832-5	http://dx.doi.org/10.1016/S0140-6736(11)60832-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829BE	21924991				2022-12-28	WOS:000295548900028
J	Iversen, T; Solberg, TK; Romner, B; Wilsgaard, T; Twisk, J; Anke, A; Nygaard, O; Hasvold, T; Ingebrigtsen, T				Iversen, Trond; Solberg, Tore K.; Romner, Bertil; Wilsgaard, Tom; Twisk, Jos; Anke, Audny; Nygaard, Oystein; Hasvold, Toralf; Ingebrigtsen, Tor			Effect of caudal epidural steroid or saline injection in chronic lumbar radiculopathy: multicentre, blinded, randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							LOW-BACK-PAIN; MORRIS DISABILITY QUESTIONNAIRE; NERVE ROOT COMPRESSION; RADICULAR PAIN; PERIRADICULAR INFILTRATION; COST-EFFECTIVENESS; DISC HERNIATION; CORTICOSTEROID INJECTIONS; COGNITIVE INTERVENTION; NATURAL-HISTORY	Objective To assess the efficacy of caudal epidural steroid or saline injection in chronic lumbar radiculopathy in the short (6 weeks), intermediate (12 weeks), and long term (52 weeks). Design Multicentre, blinded, randomised controlled trial. Setting Outpatient multidisciplinary back clinics of five Norwegian hospitals. Participants Between October 2005 and February 2009, 461 patients assessed for inclusion (presenting with lumbar radiculopathy > 12 weeks). 328 patients excluded for cauda equina syndrome, severe paresis, severe pain, previous spinal injection or surgery, deformity, pregnancy, ongoing breast feeding, warfarin therapy, ongoing treatment with non-steroidal anti-inflammatory drugs, body mass index > 30, poorly controlled psychiatric conditions with possible secondary gain, and severe comorbidity. Interventions Subcutaneous sham injections of 2 mL 0.9% saline, caudal epidural injections of 30 mL 0.9% saline, and caudal epidural injections of 40 mg triamcinolone acetonide in 29 mL 0.9% saline. Participants received two injections with a two week interval. Main outcome measures Primary: Oswestry disability index scores. Secondary: European quality of life measure, visual analogue scale scores for low back pain and for leg pain. Results Power calculations required the inclusion of 41 patients per group. We did not allocate 17 of 133 eligible patients because their symptoms improved before randomisation. All groups improved after the interventions, but we found no statistical or clinical differences between the groups over time. For the sham group (n=40), estimated change in the Oswestry disability index from the adjusted baseline value was -4.7 (95% confidence intervals -0.6 to -8.8) at 6 weeks, -11.4 (-6.3 to -14.5) at 12 weeks, and -14.3 (-10.0 to -18.7) at 52 weeks. For the epidural saline intervention group (n=39) compared with the sham group, differences in primary outcome were -0.5 (-6.3 to 5.4) at 6 weeks, 1.4 (-4.5 to 7.2) at 12 weeks, and -1.9 (-8.0 to 4.3) at 52 weeks; for the epidural steroid group (n=37), corresponding differences were -2.9 (-8.7 to 3.0), 4.0 (-1.9 to 9.9), and 1.9 (-4.2 to 8.0). Analysis adjusted for duration of leg pain, back pain, and sick leave did not change this trend. Conclusions Caudal epidural steroid or saline injections are not recommended for chronic lumbar radiculopathy.	[Iversen, Trond; Anke, Audny] Univ Hosp N Norway, Dept Rehabil, N-9038 Tromso, Norway; [Solberg, Tore K.] Univ Hosp N Norway, Dept Neurosurg, N-9038 Tromso, Norway; [Solberg, Tore K.; Nygaard, Oystein] N Norway Reg Hlth Author, Norwegian Registry Spine Surg, Tromso, Norway; [Romner, Bertil] Rigshosp, Dept Neurosurg, Ctr Neurosci, DK-2100 Copenhagen, Denmark; [Iversen, Trond; Wilsgaard, Tom; Hasvold, Toralf] Univ Tromso, Dept Community Med, Fac Hlth Sci, Tromso, Norway; [Twisk, Jos] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Anke, Audny; Ingebrigtsen, Tor] Inst Clin Med, Fac Hlth Sci, Tromso, Norway; [Nygaard, Oystein] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; Rigshospitalet; University of Copenhagen; UiT The Arctic University of Tromso; Vrije Universiteit Amsterdam; Norwegian University of Science & Technology (NTNU)	Iversen, T (corresponding author), Univ Hosp N Norway, Dept Rehabil, N-9038 Tromso, Norway.	Trond.Iversen@unn.no	Rajendran, Devan/A-3251-2011	Ingebrigtsen, Tor/0000-0001-5966-9786; Anke, Audny/0000-0002-2491-2560	North Norway Regional Health Authority; Health Region Nord-Trondelag, Norway; Health Region Nord-Trondelag	North Norway Regional Health Authority; Health Region Nord-Trondelag, Norway; Health Region Nord-Trondelag	The study was supported by the North Norway Regional Health Authority and Health Region Nord-Trondelag, Norway.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: this study was supported by the North Norway Regional Health Authority and Health Region Nord-Trondelag; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.	Ackerman WE, 2007, ANESTH ANALG, V104, P1217, DOI 10.1213/01.ane.0000260307.16555.7f; Arden NK, 2005, RHEUMATOLOGY, V44, P1399, DOI 10.1093/rheumatology/kei028; Armon C, 2007, NEUROLOGY, V68, P723, DOI 10.1212/01.wnl.0000256734.34238.e7; Autio RA, 2004, SPINE, V29, P1601, DOI 10.1097/01.BRS.0000132511.46818.67; Beliveau P, 1971, Rheumatol Phys Med, V11, P40, DOI 10.1093/rheumatology/11.1.40; BREIVIK H, 1976, ADV PAIN RES THER, V1, P927; Brox JI, 2003, SPINE, V28, P1913; BUSH K, 1992, SPINE, V17, P1205, DOI 10.1097/00007632-199210000-00013; BUSH K, 1991, SPINE, V16, P572, DOI 10.1097/00007632-199105000-00015; Buttermann GR, 2004, J BONE JOINT SURG AM, V86A, P670, DOI 10.2106/00004623-200404000-00002; Carette S, 1997, NEW ENGL J MED, V336, P1634, DOI 10.1056/NEJM199706053362303; Chen CP, 2010, ARCH PHYS MED REHAB, V91, P358, DOI 10.1016/j.apmr.2009.11.019; Chen CPC, 2004, ANESTHESIOLOGY, V101, P181, DOI 10.1097/00000542-200407000-00028; Chou R, 2009, SPINE, V34, P1066, DOI 10.1097/BRS.0b013e3181a1390d; Cohen SP, 2009, ANESTHESIOLOGY, V110, P1116, DOI 10.1097/ALN.0b013e3181a05aa0; Conn A, 2009, PAIN PHYSICIAN, V12, P109; Copay AG, 2008, SPINE J, V8, P968, DOI 10.1016/j.spinee.2007.11.006; CUCKLER JM, 1985, J BONE JOINT SURG AM, V67A, P63, DOI 10.2106/00004623-198567010-00009; Dashfield AK, 2005, BRIT J ANAESTH, V94, P514, DOI 10.1093/bja/aei084; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Fairbank JCT, 2007, BRIT MED J, V335, P112, DOI 10.1136/bmj.39275.951343.BE; Friedly J, 2007, SPINE, V32, P1754, DOI 10.1097/BRS.0b013e3180b9f96e; Ghahreman A, 2010, PAIN MED, V11, P1149, DOI 10.1111/j.1526-4637.2010.00908.x; Giraudeau B, 2004, ANN RHEUM DIS, V63, P1180, DOI 10.1136/ard.2003.015792; GOEBERT HW, 1961, ANESTH ANALG, V40, P130; Goupille P, 1998, SEMIN ARTHRITIS RHEU, V28, P60, DOI 10.1016/S0049-0172(98)80029-2; Grotle M, 2003, J REHABIL MED, V35, P241, DOI 10.1080/16501970306094; Grotle M, 2006, J REHABIL MED, V38, P346, DOI 10.1080/16501970600722403; Hagen EM, 2010, SCAND J PUBLIC HEALT, V38, P731, DOI 10.1177/1403494810382472; Hagg O, 2003, EUR SPINE J, V12, P12, DOI 10.1007/s00586-002-0464-0; HELIOVAARA M, 1987, J EPIDEMIOL COMMUN H, V41, P251, DOI 10.1136/jech.41.3.251; Hopayian K, 2001, BRIT MED J, V323, P681, DOI 10.1136/bmj.323.7314.681; Karppinen J, 2001, SPINE, V26, P1059, DOI 10.1097/00007632-200105010-00015; Karppinen J, 2001, SPINE, V26, P2587, DOI 10.1097/00007632-200112010-00013; Klocke R, 2003, J ULTRAS MED, V22, P1229, DOI 10.7863/jum.2003.22.11.1229; Koes BW, 2007, BMJ-BRIT MED J, V334, P1313, DOI 10.1136/bmj.39223.428495.BE; Koes BW, 1995, PAIN, V63, P279, DOI 10.1016/0304-3959(95)00124-7; Komori Hiromich, 2002, J Orthop Sci, V7, P56, DOI 10.1007/s776-002-8416-0; Konstantinou K, 2008, SPINE, V33, P2464, DOI 10.1097/BRS.0b013e318183a4a2; Laerum E, 2006, J REHABIL MED, V38, P255, DOI 10.1080/16501970600613461; Luijsterburg PAJ, 2007, EUR SPINE J, V16, P881, DOI 10.1007/s00586-007-0367-1; Manchikanti L, 2008, PAIN PHYSICIAN, V11, P801; MATHEWS JA, 1987, BRIT J RHEUMATOL, V26, P416; Mendoza-Lattes Sergio, 2009, Iowa Orthop J, V29, P91; Muramoto T, 1997, INT ORTHOP, V21, P172, DOI 10.1007/s002640050144; NELEMANS PJ, 2000, COCHRANE DB SYST REV, V2; Nelson DA, 2001, J NEUROL NEUROSUR PS, V70, P433, DOI 10.1136/jnnp.70.4.433; Ng L, 2005, SPINE, V30, P857, DOI 10.1097/01.brs.0000158878.93445.a0; Novak S, 2008, ARCH PHYS MED REHAB, V89, P543, DOI 10.1016/j.apmr.2007.11.008; Nygaard OP, 1997, SPINE, V22, P2484, DOI 10.1097/00007632-199711010-00004; Owlia M. B., 2007, SMJ Singapore Medical Journal, V48, P241; Peul WC, 2008, BRIT MED J, V336, P1355, DOI 10.1136/bmj.a143; Price C, 2005, HEALTH TECHNOL ASSES, V9, P1; Rabinovitch DL, 2009, SPINE J, V9, P509, DOI 10.1016/j.spinee.2009.03.003; Rathmell James P, 2007, Perm J, V11, P54; RIDLEY MG, 1988, BRIT J RHEUMATOL, V27, P295; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; *ROYAL COLL AN, 2002, REC US EP INJ TREATM, P695; RYDEVIK B, 1984, SPINE, V9, P7, DOI 10.1097/00007632-198401000-00004; SAAL JA, 1990, SPINE, V15, P683, DOI 10.1097/00007632-199007000-00013; Sayegh FE, 2009, SPINE, V34, P1441, DOI 10.1097/BRS.0b013e3181a4804a; Sethee J, 2009, CURR PAIN HEADACHE R, V13, P31, DOI 10.1007/s11916-009-0007-z; Skouen JS, 2002, SPINE, V27, P901, DOI 10.1097/00007632-200205010-00002; Solberg TK, 2005, EUR SPINE J, V14, P1000, DOI 10.1007/s00586-005-0898-2; Stanczak J, 2003, AM J ROENTGENOL, V181, P1255, DOI 10.2214/ajr.181.5.1811255; Stitz MY, 1999, SPINE, V24, P1371, DOI 10.1097/00007632-199907010-00016; Storheim K, 2003, J REHABIL MED, V35, P132, DOI 10.1080/16501970310010484; Twisk JWR, 2008, EUR J EPIDEMIOL, V23, P655, DOI 10.1007/s10654-008-9279-6; Vad VB, 2002, SPINE, V27, P11, DOI 10.1097/00007632-200201010-00005; Waddell G, 2004, BACK PAIN REVOLUTION; WATTS RW, 1995, ANAESTH INTENS CARE, V23, P564, DOI 10.1177/0310057X9502300506; WEBER H, 1993, SPINE, V18, P1433, DOI 10.1097/00007632-199309010-00006; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; Wilson-MacDonald J, 2005, J BONE JOINT SURG BR, V87B, P352, DOI 10.1302/0301-620X.87B3.15338; 1990, HLTH POLICY, V16, P199	75	92	93	0	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 13	2011	343								d5278	10.1136/bmj.d5278	http://dx.doi.org/10.1136/bmj.d5278			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822VI	21914755	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000295077500009
J	Robinson, S; de Reuille, PB; Chan, J; Bergmann, D; Prusinkiewicz, P; Coen, E				Robinson, Sarah; de Reuille, Pierre Barbier; Chan, Jordi; Bergmann, Dominique; Prusinkiewicz, Przemyslaw; Coen, Enrico			Generation of Spatial Patterns Through Cell Polarity Switching	SCIENCE			English	Article							STOMATAL DEVELOPMENT; STEM-CELLS; ARABIDOPSIS; DIVISIONS; DIFFERENTIATION; INITIATION; LINEAGE; NICHE; YEAST	The mechanisms that generate dynamic spatial patterns within proliferating tissues are poorly understood, largely because of difficulties in unravelling interactions between cell specification, polarity, asymmetric division, rearrangements, and growth. We address this problem for stomatal spacing in plants, which offer the simplifying advantage that cells do not rearrange. By tracking lineages and gene activities over extended periods, we show that limited stem cell behavior of stomatal precursors depends on maintenance of the SPEECHLESS (SPCH) transcription factor in single daughter cells. Modeling shows how this property can lead to observed stereotypical stomata lineages through a postmitotic polarity-switching mechanism. The model predicts the location of a polarity determinant BASL over multiple divisions, which we validate experimentally. Our results highlight the dynamic two-way interactions between stem cells and their neighborhood during developmental patterning.	[Robinson, Sarah; Chan, Jordi; Coen, Enrico] John Innes Ctr, Norwich NR4 7UH, Norfolk, England; [de Reuille, Pierre Barbier] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Bergmann, Dominique] Stanford Univ, Stanford, CA 94305 USA; [Prusinkiewicz, Przemyslaw] Univ Calgary, Dept Comp Sci, Calgary, AB T2N 1N4, Canada	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia; Stanford University; University of Calgary	Coen, E (corresponding author), John Innes Ctr, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	enrico.coen@jic.ac.uk	Barbier de Reuille, Pierre/J-5017-2012; Robinson, Sarah/AAX-6505-2020	Barbier de Reuille, Pierre/0000-0002-9970-765X; Bergmann, Dominique/0000-0003-0873-3543; Robinson, Sarah/0000-0001-7643-1059	UK Biotechnology and Biological Sciences Research Council [BB/F005997/1]; Natural Sciences and Engineering Research Council [130084]; NIH [1RO1GM086632-02]; BBSRC [BB/F005997/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000152, BB/F005997/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086632] Funding Source: NIH RePORTER	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Bangham, G. Calder, S. Fox, S. Sauret-Gueto, and J. Avondo for their help with this work, as well as horticultural services, the media kitchen staff, and computing. This work was funded by the UK Biotechnology and Biological Sciences Research Council (BB/F005997/1), Natural Sciences and Engineering Research Council (Discovery grant 130084), and NIH (1RO1GM086632-02).	Barton MK, 2007, PLANT CELL, V19, P1140, DOI 10.1105/tpc.107.051177; Bergmann DC, 2004, CURR OPIN PLANT BIOL, V7, P26, DOI 10.1016/j.pbi.2003.10.001; BIERHORST DW, 1977, AM J BOT, V64, P125, DOI 10.2307/2442101; Dong J, 2009, CELL, V137, P1320, DOI 10.1016/j.cell.2009.04.018; Errera L., 1888, BOTTANISCHES CENTRAL, V34, P395, DOI DOI 10.1002/CPLX.20074; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Geisler M, 2000, PLANT CELL, V12, P2075, DOI 10.1105/tpc.12.11.2075; Harkins HA, 2001, MOL BIOL CELL, V12, P2497, DOI 10.1091/mbc.12.8.2497; Harrison CJ, 2009, CURR BIOL, V19, P461, DOI 10.1016/j.cub.2009.02.050; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Lai LB, 2005, PLANT CELL, V17, P2754, DOI 10.1105/tpc.105.034116; Lampard GR, 2008, SCIENCE, V322, P1113, DOI 10.1126/science.1162263; LUCK J, 1995, ACTA BIOTHEOR, V43, P95, DOI 10.1007/BF00709436; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; MITCHISON GJ, 1972, NATURE, V239, P110, DOI 10.1038/239110a0; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; SACHS T, 1991, DEV CELL BIOL SERIES; Sahlin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011750; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; VANDENBERG C, 1995, NATURE, V378, P62, DOI 10.1038/378062a0; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173; Zahner JE, 1996, MOL CELL BIOL, V16, P1857	24	92	98	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2011	333	6048					1436	1440		10.1126/science.1202185	http://dx.doi.org/10.1126/science.1202185			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21903812	Green Accepted			2022-12-28	WOS:000294672200040
J	Yuan, Q; Xiang, Y; Yan, ZQ; Han, C; Jan, LY; Jan, YN				Yuan, Quan; Xiang, Yang; Yan, Zhiqiang; Han, Chun; Jan, Lily Yeh; Jan, Yuh Nung			Light-Induced Structural and Functional Plasticity in Drosophila Larval Visual System	SCIENCE			English	Article							CIRCADIAN CLOCK; NEURONS; MELANOGASTER; EXPRESSION; GENE; CRYPTOCHROME; CIRCUIT; GROWTH; MEMORY; SENSOR	How to build and maintain a reliable yet flexible circuit is a fundamental question in neurobiology. The nervous system has the capacity for undergoing modifications to adapt to the changing environment while maintaining its stability through compensatory mechanisms, such as synaptic homeostasis. Here, we describe our findings in the Drosophila larval visual system, where the variation of sensory inputs induced substantial structural plasticity in dendritic arbors of the postsynaptic neuron and concomitant changes to its physiological output. Furthermore, our genetic analyses have identified the cyclic adenosine monophosphate (cAMP) pathway and a previously uncharacterized cell surface molecule as critical components in regulating experience-dependent modification of the postsynaptic dendrite morphology in Drosophila.	[Yuan, Quan; Xiang, Yang; Yan, Zhiqiang; Han, Chun; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol & Biochem, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol & Biochem, 1550 4th St, San Francisco, CA 94158 USA.	yuhnung.jan@ucsf.edu	Yuan, Quan/E-7688-2013	Han, Chun/0000-0001-7319-8095; Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498	Autism; Human Frontier Science Program; Jane Coffins Child postdoctoral fellowship; NIH [2R37NS040929]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS040929] Funding Source: NIH RePORTER	Autism; Human Frontier Science Program(Human Frontier Science Program); Jane Coffins Child postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Desplan, J. Blau, J. Hall, K. Scott, U. Heberlein, and A. Sehgal for reagents and fly lines; S. Barshow for the technical support; and P. Soba and M. Klassen for critical reading of the manuscript. Q.Y. was supported by an Autism Speaks postdoctoral fellowship. Y.X. and Z.Y. are recipients of the long-term fellowship from Human Frontier Science Program. C.H. was supported by a Jane Coffins Child postdoctoral fellowship. This work is supported by NIH grant 2R37NS040929 to Y.N.J. Also, Q.Y., Y.X, C.H., and Z.Y. are postdoctoral associates and L.Y.J. and Y.N.J. are investigators of the Howard Hughes Medical Institute.	Barth M, 1997, J NEUROSCI, V17, P1493; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Dolezelova E, 2007, GENETICS, V177, P329, DOI 10.1534/genetics.107.076513; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Eresh S, 1997, EMBO J, V16, P2014, DOI 10.1093/emboj/16.8.2014; Fernandez MP, 2008, PLOS BIOL, V6, P518, DOI 10.1371/journal.pbio.0060069; Fogle KJ, 2011, SCIENCE, V331, P1409, DOI 10.1126/science.1199702; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kaneko M, 1997, J NEUROSCI, V17, P6745; Kawasaki F, 2004, J NEUROSCI, V24, P282, DOI 10.1523/JNEUROSCI.3553-03.2004; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Malpel S, 2002, DEVELOPMENT, V129, P1443; Mazzoni EO, 2005, NEURON, V45, P293, DOI 10.1016/j.neuron.2004.12.038; Murphey RK, 2003, DEVELOPMENT, V130, P3671, DOI 10.1242/dev.00598; Nelson SB, 2008, NEURON, V60, P477, DOI 10.1016/j.neuron.2008.10.020; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Nitabach MN, 2005, J NEUROBIOL, V62, P1, DOI 10.1002/neu.20053; Sachse S, 2007, NEURON, V56, P838, DOI 10.1016/j.neuron.2007.10.035; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Sprecher SG, 2008, NATURE, V454, P533, DOI 10.1038/nature07062; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tripodi M, 2008, PLOS BIOL, V6, P2172, DOI 10.1371/journal.pbio.0060260; Vogel C, 2003, DEVELOPMENT, V130, P6317, DOI 10.1242/dev.00848; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576	32	60	61	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2011	333	6048					1458	1462		10.1126/science.1207121	http://dx.doi.org/10.1126/science.1207121			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21903815	Green Accepted			2022-12-28	WOS:000294672200046
J	Augustin, YS; Birch, M; Bodini, C; Boulton, F; Robertson, E; Spada, VM; Weingarten, M				Augustin, Yolanda Sydney; Birch, Marion; Bodini, Chiara; Boulton, Frank; Robertson, Elicia; Spada, Valentina Maria; Weingarten, Miri			Prevention of torture by doctors and organisations	LANCET			English	Editorial Material									[Birch, Marion; Boulton, Frank] Medact, London N1 6HT, England; [Augustin, Yolanda Sydney] Royal Marsden NHS Trust, London, England; [Bodini, Chiara; Spada, Valentina Maria] Univ Bologna, Ctr Int Hlth, Bologna, Italy; [Robertson, Elicia] UCL, London, England; [Weingarten, Miri] Phys Human Rights Israel, London, England	Royal Marsden NHS Foundation Trust; University of Bologna; University of London; University College London	Birch, M (corresponding author), Medact, London N1 6HT, England.	marionbirch@medact.org	Bodini, Chiara/H-6991-2017	Bodini, Chiara/0000-0001-7629-2394				[Anonymous], WMA DECL TOK GUID PH; COBAIN I, 2010, GUARDIAN LONDON 1105; EVEN D, 2010, HAARETZ TEL AVI 0314; International Dual Loyalty Working Group, 2002, DUAL LOYALT HUM RIGH; Medact, 2011, PREV TORT ROL PHYS T; Miles SH, 2004, LANCET, V364, P725, DOI 10.1016/S0140-6736(04)16902-X; NATHANSON VH, 2011, BAHA MOUSA INQUIRY; *OFF HIGH COMM HUM, 2007, SPEC RAPP TORT CONCL; *OFF UN HIGH COMM, 2005, COMM HUM RIGHTS 62 S; Ozkalipci O., 2010, ATLAS TORTURE USE ME; *PCATI, 2007, TICK BOMBS TEST TORT; Polatin PB, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c973; SIDDIQUE H, 2010, GUARDIAN LONDON 1109; *STAT ATT, 2001, STAT ATT LEG P BOLZ; 2010, PHYS HUMAN RIGHTS IS	15	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 17	2011	378	9809					E22	E23		10.1016/S0140-6736(11)61300-7	http://dx.doi.org/10.1016/S0140-6736(11)61300-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865EL	21906800				2022-12-28	WOS:000298293600001
J	Rosen, BA; Salehi-Khojin, A; Thorson, MR; Zhu, W; Whipple, DT; Kenis, PJA; Masel, RI				Rosen, Brian A.; Salehi-Khojin, Amin; Thorson, Michael R.; Zhu, Wei; Whipple, Devin T.; Kenis, Paul J. A.; Masel, Richard I.			Ionic Liquid-Mediated Selective Conversion of CO2 to CO at Low Overpotentials	SCIENCE			English	Article							CARBON-DIOXIDE; REDUCTION; SOLUBILITY; METHANOL	Electroreduction of carbon dioxide (CO2)-a key component of artificial photosynthesis-has largely been stymied by the impractically high overpotentials necessary to drive the process. We report an electrocatalytic system that reduces CO2 to carbon monoxide (CO) at overpotentials below 0.2 volt. The system relies on an ionic liquid electrolyte to lower the energy of the (CO2)(-) intermediate, most likely by complexation, and thereby lower the initial reduction barrier. The silver cathode then catalyzes formation of the final products. Formation of gaseous CO is first observed at an applied voltage of 1.5 volts, just slightly above the minimum (i.e., equilibrium) voltage of 1.33 volts. The system continued producing CO for at least 7 hours at Faradaic efficiencies greater than 96%.	[Rosen, Brian A.; Salehi-Khojin, Amin; Zhu, Wei; Masel, Richard I.] Dioxide Mat, Champaign, IL 61820 USA; [Thorson, Michael R.; Whipple, Devin T.; Kenis, Paul J. A.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Masel, RI (corresponding author), Dioxide Mat, 60 Hazelwood Dr, Champaign, IL 61820 USA.	rich.masel@dioxidematerials.com	Kenis, Paul J A/S-7229-2016; Masel, Richard I/E-1957-2011	Kenis, Paul J A/0000-0001-7348-0381; Masel, Richard I/0000-0002-7392-6299	U.S. Department of Energy (DOE) [DE-SC0004453]; Dioxide Materials; DOE Office of Science; DOE [DE-AC05-06OR23100]	U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Dioxide Materials; DOE Office of Science(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE))	Supported in part by the U.S. Department of Energy (DOE) under grant DE-SC0004453 and by Dioxide Materials. B.A.R. was supported in part by an award from the DOE Office of Science Graduate Fellowship Program (DOE SCGF). The DOE SCGF Program was made possible in part by the American Recovery and Reinvestment Act of 2009 and is administered by the Oak Ridge Institute for Science and Education (ORISE) for DOE. ORISE is managed by Oak Ridge Associated Universities (ORAU) under DOE contract DE-AC05-06OR23100. The following patent applications are related to the work here: 12/830338, "Novel Catalyst Mixtures" (R.I.M.); 13/174365, "Novel Catalyst Mixtures" (R.I.M.); PCT/US11/42809, "Novel Catalyst Mixtures" (R.I.M.); PCT/US/11/30098, "Novel Catalyst Mixtures" (R.I.M. and B.A.R.); and 61/499225, "Inexpensive Carbon Dioxide Sensor" (R.I.M. and B.A.R.). All opinions expressed in this paper are those of the authors and do not necessarily reflect the policies and views of DOE, ORAU, or ORISE. Author contributions: R.I.M. conceived the project and led the work; B.A.R., R.I.M., A.S.-K., P.J.A.K., and M.R.T. planned the experiments; D.T.W., P.J.A.K., and R.I.M. designed the cell; B.A.R. took all of the data that appear in the paper; all of the measurements in this paper were done at Dioxide Materials; A.S.-K., W.Z., and M.R.T. took confirming data; and R.I.M. and P.J.A.K. supervised the work. The paper was drafted by R.I.M., A.S.-K., and P.J.A.K. with other authors offering critical comments. We thank G. Kaul for assistance in the electrochemical work.	Barnes AS, 2008, J PHYS CHEM C, V112, P13709, DOI 10.1021/jp803349z; Bell A. T., 2008, PNNL17214 US DEP EN; BOCKRIS JO, 1989, J ELECTROCHEM SOC, V136, P2521, DOI 10.1149/1.2097455; CHANDRASEKARAN K, 1987, SURF SCI, V185, P495, DOI 10.1016/S0039-6028(87)80173-5; Cole EB, 2010, J AM CHEM SOC, V132, P11539, DOI 10.1021/ja1023496; DuBois D. L., 2006, ENCY ELECTROCHEMIS A, P202; Dubois MR, 2009, ACCOUNTS CHEM RES, V42, P1974, DOI 10.1021/ar900110c; Hammarstrom L, 2009, ACCOUNTS CHEM RES, V42, P1859, DOI 10.1021/ar900267k; Hollinger AS, 2010, J POWER SOURCES, V195, P3523, DOI 10.1016/j.jpowsour.2009.12.063; Hori Y, 2008, MOD ASP ELECTROCHEM, P89; Islam MM, 2008, J PHYS CHEM C, V112, P1269, DOI 10.1021/jp7096185; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Lim BH, 2009, KOREAN J CHEM ENG, V26, P1130, DOI 10.1007/s11814-009-0188-5; Maiti A, 2009, CHEMSUSCHEM, V2, P628, DOI 10.1002/cssc.200900086; Masel R.I., 2001, CHEM KINETICS CATALY; Morris AJ, 2011, CHEMSUSCHEM, V4, P191, DOI 10.1002/cssc.201000379; SESHADRI G, 1994, J ELECTROANAL CHEM, V372, P145, DOI 10.1016/0022-0728(94)03300-5; Shokouhi M, 2010, J CHEM ENG DATA, V55, P1663, DOI 10.1021/je900716q; Soriano AN, 2008, J CHEM ENG DATA, V53, P2550, DOI 10.1021/je8003657; Tang JB, 2009, IND ENG CHEM RES, V48, P9113, DOI 10.1021/ie900292p; Tollefson J, 2010, NATURE, V466, P541, DOI 10.1038/466541a; Whipple DT, 2010, J PHYS CHEM LETT, V1, P3451, DOI 10.1021/jz1012627; Whipple DT, 2010, ELECTROCHEM SOLID ST, V13, pD109, DOI 10.1149/1.3456590	23	1031	1077	59	1456	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2011	334	6056					643	644		10.1126/science.1209786	http://dx.doi.org/10.1126/science.1209786			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	21960532				2022-12-28	WOS:000296494700047
J	Chelton, DB; Gaube, P; Schlax, MG; Early, JJ; Samelson, RM				Chelton, Dudley B.; Gaube, Peter; Schlax, Michael G.; Early, Jeffrey J.; Samelson, Roger M.			The Influence of Nonlinear Mesoscale Eddies on Near-Surface Oceanic Chlorophyll	SCIENCE			English	Article							ROSSBY WAVES; PLANETARY-WAVES; SARGASSO SEA; SATELLITE; EVOLUTION; SPEED	Oceanic Rossby waves have been widely invoked as a mechanism for large-scale variability of chlorophyll (CHL) observed from satellites. High-resolution satellite altimeter measurements have recently revealed that sea-surface height (SSH) features previously interpreted as linear Rossby waves are nonlinear mesoscale coherent structures (referred to here as eddies). We analyze 10 years of measurements of these SSH fields and concurrent satellite measurements of upper-ocean CHL to show that these eddies exert a strong influence on the CHL field, thus requiring reassessment of the mechanism for the observed covariability of SSH and CHL. On time scales longer than 2 to 3 weeks, the dominant mechanism is shown to be eddy-induced horizontal advection of CHL by the rotational velocities of the eddies.	[Chelton, Dudley B.; Gaube, Peter; Schlax, Michael G.; Samelson, Roger M.] Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Early, Jeffrey J.] NW Res Associates Inc, Bellevue, WA 98009 USA	Oregon State University; NorthWest Research Associates	Chelton, DB (corresponding author), Oregon State Univ, Coll Ocean & Atmospher Sci, 104 COAS Adm Bldg, Corvallis, OR 97331 USA.	chelton@coas.oregonstate.edu			NASA [NNX08AI80G, NNX08AR37G]; NSF [0621134]	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	We thank D. McGillicuddy and T. Farrar for discussions throughout the course of this study. We also thank L.-L. Fu, V. Combes, D. Siegel, P. Cipollini, E. Shulenberger, and two anonymous reviewers for helpful comments on the manuscript. This research was supported by NASA grants NNX08AI80G and NNX08AR37G and NSF Award 0621134.	Charria G, 2006, J MAR RES, V64, P43, DOI 10.1357/002224006776412340; Chelton DB, 1996, SCIENCE, V272, P234, DOI 10.1126/science.272.5259.234; Chelton DB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030812; Chelton DB, 2011, PROG OCEANOGR, V91, P167, DOI 10.1016/j.pocean.2011.01.002; Cipollini P, 2001, GEOPHYS RES LETT, V28, P323, DOI 10.1029/1999GL011231; Dandonneau Y, 2003, SCIENCE, V302, P1548, DOI 10.1126/science.1090729; Ducet N, 2000, J GEOPHYS RES-OCEANS, V105, P19477, DOI 10.1029/2000JC900063; Early JJ, 2011, J PHYS OCEANOGR, V41, P1535, DOI 10.1175/2011JPO4601.1; FALKOWSKI PG, 1991, NATURE, V352, P55, DOI 10.1038/352055a0; FLIERL GR, 1981, GEOPHYS ASTRO FLUID, V18, P39, DOI 10.1080/03091928108208773; Gill AE, 1982, ATMOSPHERE OCEAN DYN; Gutknecht E, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005291; Killworth PD, 1997, J PHYS OCEANOGR, V27, P1946, DOI 10.1175/1520-0485(1997)027<1946:TSOOAT>2.0.CO;2; Killworth PD, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001768; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; McGillicuddy DJ, 1999, J GEOPHYS RES-OCEANS, V104, P13381, DOI 10.1029/1999JC900021; MCWILLIAMS JC, 1979, J PHYS OCEANOGR, V9, P1155, DOI 10.1175/1520-0485(1979)009<1155:OTEOIN>2.0.CO;2; Siegel DA, 2008, DEEP-SEA RES PT II, V55, P1218, DOI 10.1016/j.dsr2.2008.01.012; Siegel DA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047660; Siegel DA, 1999, J GEOPHYS RES-OCEANS, V104, P13359, DOI 10.1029/1999JC900051; Siegel DA, 2001, NATURE, V409, P576, DOI 10.1038/35054659; Tailleux R, 2001, J PHYS OCEANOGR, V31, P1461, DOI 10.1175/1520-0485(2001)031<1461:TEOBPD>2.0.CO;2; Uz BM, 2001, NATURE, V409, P597, DOI 10.1038/35054527	23	376	400	9	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2011	334	6054					328	332		10.1126/science.1208897	http://dx.doi.org/10.1126/science.1208897			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	21921157				2022-12-28	WOS:000296052500040
J	Potyk, D				Potyk, Darryl			Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery	ANNALS OF INTERNAL MEDICINE			English	Letter									Univ Washington, Sch Med, Spokane, WA 99204 USA	University of Washington; Washington State University	Potyk, D (corresponding author), Univ Washington, Sch Med, Spokane, WA 99204 USA.							Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Devereaux PJ, 2011, ANN INTERN MED, V154, P523, DOI 10.7326/0003-4819-154-8-201104190-00003; Fleisher LA, 2007, J AM COLL CARDIOL, V50, P1707, DOI 10.1016/j.jacc.2007.09.001; LANDESBERG G, 1993, LANCET, V341, P715, DOI 10.1016/0140-6736(93)90486-Z; MANGANO DT, 1990, ANESTHESIOLOGY, V72, P153, DOI 10.1097/00000542-199001000-00025	5	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2011	155	7					477	477		10.7326/0003-4819-155-7-201110040-00014	http://dx.doi.org/10.7326/0003-4819-155-7-201110040-00014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	833OC	21969349				2022-12-28	WOS:000295893800009
J	Chiarle, R; Zhang, Y; Frock, RL; Lewis, SM; Molinie, B; Ho, YJ; Myers, DR; Choi, VW; Compagno, M; Malkin, DJ; Neuberg, D; Monti, S; Giallourakis, CC; Gostissa, M; Alt, FW				Chiarle, Roberto; Zhang, Yu; Frock, Richard L.; Lewis, Susanna M.; Molinie, Benoit; Ho, Yu-Jui; Myers, Darienne R.; Choi, Vivian W.; Compagno, Mara; Malkin, Daniel J.; Neuberg, Donna; Monti, Stefano; Giallourakis, Cosmas C.; Gostissa, Monica; Alt, Frederick W.			Genome-wide Translocation Sequencing Reveals Mechanisms of Chromosome Breaks and Rearrangements in B Cells	CELL			English	Article							END-JOINING PATHWAY; CLASS SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; DNA BREAKS; C-MYC; HYPERMUTATION; LYMPHOCYTES; CANCER; IDENTIFICATION; TRANSCRIPTION	Whereas chromosomal translocations are common pathogenetic events in cancer, mechanisms that promote them are poorly understood. To elucidate translocation mechanisms in mammalian cells, we developed high-throughput, genome-wide translocation sequencing (HTGTS). We employed HTGTS to identify tens of thousands of independent translocation junctions involving fixed I-SceI meganuclease-generated DNA double-strand breaks (DSBs) within the c-myc oncogene or IgH locus of B lymphocytes induced for activation-induced cytidine deaminase (AID)-dependent IgH class switching. DSBs translocated widely across the genome but were preferentially targeted to transcribed chromosomal regions. Additionally, numerous AID-dependent and AID-independent hot spots were targeted, with the latter comprising mainly cryptic I-SceI targets. Comparison of translocation junctions with genome-wide nuclear run-ons revealed a marked association between transcription start sites and translocation targeting. The majority of translocation junctions were formed via end-joining with short microhomologies. Our findings have implications for diverse fields, including gene therapy and cancer genomics.	[Chiarle, Roberto; Zhang, Yu; Frock, Richard L.; Lewis, Susanna M.; Ho, Yu-Jui; Myers, Darienne R.; Choi, Vivian W.; Compagno, Mara; Malkin, Daniel J.; Gostissa, Monica; Alt, Frederick W.] Childrens Hosp, Howard Hughes Med Inst, Immune Dis Inst, Program Cellular & Mol Med, Boston, MA 02115 USA; [Chiarle, Roberto; Zhang, Yu; Frock, Richard L.; Lewis, Susanna M.; Ho, Yu-Jui; Myers, Darienne R.; Choi, Vivian W.; Compagno, Mara; Malkin, Daniel J.; Gostissa, Monica; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Chiarle, Roberto; Zhang, Yu; Frock, Richard L.; Lewis, Susanna M.; Ho, Yu-Jui; Myers, Darienne R.; Choi, Vivian W.; Compagno, Mara; Malkin, Daniel J.; Gostissa, Monica; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Chiarle, Roberto; Compagno, Mara] Univ Turin, Dept Biomed Sci & Human Oncol, I-10126 Turin, Italy; [Chiarle, Roberto; Compagno, Mara] Univ Turin, CERMS, I-10126 Turin, Italy; [Molinie, Benoit; Giallourakis, Cosmas C.] Massachusetts Gen Hosp, Gastrointestinal Unit, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Neuberg, Donna] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; [Monti, Stefano] 5 Cambridge Ctr, Broad Inst, Cambridge, MA 02142 USA; [Monti, Stefano] Boston Univ, Sch Med, Sect Computat Biomed, Boston, MA 02118 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Turin; University of Turin; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Boston University	Zhang, Y (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Immune Dis Inst, Program Cellular & Mol Med, Boston, MA 02115 USA.	zhang@idi.harvard.edu; cgiallourakis@partners.org; gostissa@idi.harvard.edu; alt@enders.tch.harvard.edu	Frock, Richard/I-6934-2019	Frock, Richard/0000-0001-6963-4931; Monti, Stefano/0000-0002-9376-0660; CHIARLE, Roberto/0000-0003-1564-8531; Choi, Vivian/0000-0003-4787-0735; Ho, Yu-jui/0000-0002-7540-024X	NIH [5P01CA92625, AI070837, 5T32CA070083-13]; Leukemia and Lymphoma Society of America (LLS); AIRC [ERC-2009-StG, 242965]; V Foundation; CRI postdoctoral fellowship; NATIONAL CANCER INSTITUTE [T32CA070083, P01CA092625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society of America (LLS)(Leukemia and Lymphoma Society); AIRC(Fondazione AIRC per la ricerca sul cancro); V Foundation; CRI postdoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Barry Sleckman for providing unpublished information about circular PCR translocation cloning of RAG-generated DSBs. This work was supported by NIH grant 5P01CA92625 and a Leukemia and Lymphoma Society of America (LLS) SCOR grant to F. W. A., grants from AIRC and grant FP7 ERC-2009-StG (Proposal No. 242965-"Lunely'') to R. C., an NIH KO8 grant AI070837 to C. C. G., and a V Foundation Scholar award to M. G. Y.Z. was supported by CRI postdoctoral fellowship and R. L. F. by NIH training grant 5T32CA070083-13. F. W. A. is an Investigator of the Howard Hughes Medical Institute. F. W. A. is a member of the scientific advisory board of Cellectis Pharmaceuticals.	Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Arnould S, 2011, PROTEIN ENG DES SEL, V24, P27, DOI 10.1093/protein/gzq083; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dudley DD, 2002, P NATL ACAD SCI USA, V99, P9984, DOI 10.1073/pnas.152333499; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Giallourakis CC, 2010, P NATL ACAD SCI USA, V107, P22207, DOI 10.1073/pnas.1015954107; Gomez-Gonzalez B, 2007, P NATL ACAD SCI USA, V104, P8409, DOI 10.1073/pnas.0702836104; Gostissa M, 2011, ANNU REV IMMUNOL, V29, P319, DOI 10.1146/annurev-immunol-031210-101329; Gostissa M, 2009, P NATL ACAD SCI USA, V106, P2265, DOI 10.1073/pnas.0812763106; Handel EM, 2011, CURR GENE THER, V11, P28, DOI 10.2174/156652311794520120; Haffner MC, 2011, CLIN CANCER RES, V17, P3858, DOI 10.1158/1078-0432.CCR-10-2044; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; Kovalchuk AL, 2007, J EXP MED, V204, P2989, DOI 10.1084/jem.20070882; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Li XL, 2006, GENE DEV, V20, P1838, DOI 10.1101/gad.1438306; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Mahowald GK, 2009, P NATL ACAD SCI USA, V106, P18339, DOI 10.1073/pnas.0902545106; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pavri R, 2011, ADV IMMUNOL, V110, P1, DOI 10.1016/B978-0-12-387663-8.00005-3; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Reynaud S, 2005, J IMMUNOL, V174, P6176, DOI 10.4049/jimmunol.174.10.6176; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Shaffer DR, 2006, NAT MED, V12, P14, DOI 10.1038/nm0106-14; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Unniraman S, 2004, NAT IMMUNOL, V5, P1117, DOI 10.1038/ni1127; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386; Zhang Y, 2010, ADV IMMUNOL, V106, P93, DOI 10.1016/S0065-2776(10)06004-9; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	46	330	342	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					107	119		10.1016/j.cell.2011.07.049	http://dx.doi.org/10.1016/j.cell.2011.07.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962511	Green Accepted, Bronze			2022-12-28	WOS:000295396700019
J	Klein, IA; Resch, W; Jankovic, M; Oliveira, T; Yamane, A; Nakahashi, H; Di Virgilio, M; Bothmer, A; Nussenzweig, A; Robbiani, DF; Casellas, R; Nussenzweig, MC				Klein, Isaac A.; Resch, Wolfgang; Jankovic, Mila; Oliveira, Thiago; Yamane, Arito; Nakahashi, Hirotaka; Di Virgilio, Michela; Bothmer, Anne; Nussenzweig, Andre; Robbiani, Davide F.; Casellas, Rafael; Nussenzweig, Michel C.			Translocation-Capture Sequencing Reveals the Extent and Nature of Chromosomal Rearrangements in B Lymphocytes	CELL			English	Article							CLASS-SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; SOMATIC HYPERMUTATION; CELL LYMPHOMA; C-MYC; DNA BREAKS; FOLLICULAR LYMPHOMA; GENOMIC INSTABILITY; CANCER GENOME; BCL6 GENE	Chromosomal rearrangements, including translocations, require formation and joining of DNA double strand breaks (DSBs). These events disrupt the integrity of the genome and are frequently involved in producing leukemias, lymphomas and sarcomas. Despite the importance of these events, current understanding of their genesis is limited. To examine the origins of chromosomal rearrangements we developed-Translocation Capture Sequencing (TC-Seq), a method to document chromosomal rearrangements genome-wide, in primary cells. We examined over 180,000 rearrangements obtained from 400 million B lymphocytes, revealing that proximity between DSBs, transcriptional activity and chromosome territories are key determinants of genome rearrangement. Specifically, rearrangements tend to occur in cis and to transcribed genes. Finally, we find that activation-induced cytidine deaminase (AID) induces the rearrangement of many genes found as translocation partners in mature B cell lymphoma.	[Yamane, Arito; Nakahashi, Hirotaka; Casellas, Rafael] NCI, Ctr Canc Res, Bethesda, MD 20892 USA; [Klein, Isaac A.; Jankovic, Mila; Oliveira, Thiago; Di Virgilio, Michela; Bothmer, Anne; Robbiani, Davide F.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Nussenzweig, Andre] NCI, Expt Immunol Branch, Bethesda, MD 20892 USA; [Resch, Wolfgang; Yamane, Arito; Nakahashi, Hirotaka; Casellas, Rafael] NIAMSD, NIH, Bethesda, MD 20892 USA; [Oliveira, Thiago] Univ Sao Paulo, Natl Inst Sci & Technol Stem Cells & Cell Therapy, Dept Genet, Med Sch Ribeirao Preto, BR-14051140 Ribeirao Preto, SP, Brazil; [Oliveira, Thiago] Ctr Cell Based Therapy, BR-14051140 Ribeirao Preto, SP, Brazil	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Universidade de Sao Paulo	Casellas, R (corresponding author), NCI, Ctr Canc Res, Bethesda, MD 20892 USA.	casellar@mail.nih.gov; nussen@mail.rockefeller.edu	Yamane, Arito/A-2959-2013; Di Virgilio, Michela/AAE-9298-2022; Oliveira, Thiago Y/HGA-3848-2022; Oliveira, Thiago Y/ABF-5186-2020; Robbiani, Davide F./AAF-7662-2019; Nussenzweig, Michel/AAE-7292-2019	Oliveira, Thiago Y/0000-0002-2654-0879; Oliveira, Thiago Y/0000-0002-2654-0879; Robbiani, Davide F./0000-0001-7379-3484; Di Virgilio, Michela/0000-0001-5189-0793; Resch, Wolfgang/0000-0001-7594-5963	NIH MSTP [GM07739]; NIH [AI037526]; NYSTEM [C023046]; Starr Cancer Consortium; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI037526, R01AI037526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM; Starr Cancer Consortium; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all the members of the Nussenzweig and Casellas labs for valuable input and advice; Klara Velinzon and Svetlana Mazel for FACSorting; and David Bosque and Thomas Eisenreich for animal management. We also thank Scott Dewell of the Rockefeller Genomics Resource Center and Gustavo Gutierrez of the NIAMS genome facility for high-throughput sequencing and guidance; as well as Christopher Mason of the Weill Cornell Medical College for assistance with data analysis. I. A. K. was supported by NIH MSTP grant GM07739, and is a Cancer Research Institute Predoctoral Fellow and a William Randolph Hearst Foundation Fellow. A. B. is a Cancer Research Institute Predoctoral Fellow. This work was supported by NIH grant #AI037526 to M.C.N., NYSTEM #C023046, The Starr Cancer Consortium and the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health. M.C.N. is an HHMI investigator.	Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Akasaka T, 2003, BLOOD, V102, P1443, DOI 10.1182/blood-2002-08-2482; Argast GM, 1998, J MOL BIOL, V280, P345, DOI 10.1006/jmbi.1998.1886; Bea S, 2009, BLOOD, V113, P3059, DOI 10.1182/blood-2008-07-170183; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; CORY S, 1985, EMBO J, V4, P675, DOI 10.1002/j.1460-2075.1985.tb03682.x; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; DAN L, 1992, NUCLEIC ACIDS RES, V20, P1967, DOI 10.1093/nar/20.8.1967; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Einerson RR, 2006, LEUKEMIA, V20, P1790, DOI 10.1038/sj.leu.2404340; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; GAUWERKY CE, 1989, P NATL ACAD SCI USA, V86, P8867, DOI 10.1073/pnas.86.22.8867; Gesk S, 2006, BLOOD, V108, P1109, DOI 10.1182/blood-2006-01-0015; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100; Gostissa M, 2009, NATURE, V462, P803, DOI 10.1038/nature08633; Gottipati P, 2009, MUTAGENESIS, V24, P203, DOI 10.1093/mutage/gen072; Honjo T, 2002, NAT IMMUNOL, V3, P800, DOI 10.1038/ni0902-800; HUPPI K, 1990, P NATL ACAD SCI USA, V87, P6964, DOI 10.1073/pnas.87.18.6964; Iida S, 1999, LEUKEMIA LYMPHOMA, V34, P25, DOI 10.3109/10428199909083377; Impera L, 2008, ONCOGENE, V27, P6187, DOI 10.1038/onc.2008.214; Jankovic M, 2010, P NATL ACAD SCI USA, V107, P187, DOI 10.1073/pnas.0908946107; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Mahowald GK, 2009, P NATL ACAD SCI USA, V106, P18339, DOI 10.1073/pnas.0902545106; Mao X, 2002, GENE CHROMOSOME CANC, V35, P144, DOI 10.1002/gcc.10104; Mottok A, 2009, BLOOD, V114, P4503, DOI 10.1182/blood-2009-06-225839; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakamura Y, 2008, CANCER GENET CYTOGEN, V182, P144, DOI 10.1016/j.cancergencyto.2008.01.013; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; Rabbitts TH, 2009, CELL, V137, P391, DOI 10.1016/j.cell.2009.04.034; Ramiro Almudena, 2007, Adv Immunol, V94, P75, DOI 10.1016/S0065-2776(06)94003-6; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Riggi N, 2007, CANCER LETT, V254, P1, DOI 10.1016/j.canlet.2006.12.009; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Rosebeck S, 2011, SCIENCE, V331, P468, DOI 10.1126/science.1198946; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Staszewski O, 2011, MOL CELL, V41, P232, DOI 10.1016/j.molcel.2011.01.007; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Storb U, 2007, ADV EXP MED BIOL, V596, P83; Takeuchi Y, 2003, GENE DEV, V17, P1497, DOI 10.1101/gad.1085403; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tsai AG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S1; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; Ueda C, 2002, ONCOGENE, V21, P368, DOI 10.1038/sj.onc.1205099; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yoshida S, 1999, ONCOGENE, V18, P7994, DOI 10.1038/sj.onc.1203293; Zhang Y, 2010, ADV IMMUNOL, V106, P93, DOI 10.1016/S0065-2776(10)06004-9	66	268	272	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2011	147	1					95	106		10.1016/j.cell.2011.07.048	http://dx.doi.org/10.1016/j.cell.2011.07.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962510	Bronze, Green Accepted			2022-12-28	WOS:000295396700018
J	Chung, KY; Rasmussen, SGF; Liu, T; Li, S; DeVree, BT; Chae, PS; Calinski, D; Kobilka, BK; Woods, VL; Sunahara, RK				Chung, Ka Young; Rasmussen, Soren G. F.; Liu, Tong; Li, Sheng; DeVree, Brian T.; Chae, Pil Seok; Calinski, Diane; Kobilka, Brian K.; Woods, Virgil L., Jr.; Sunahara, Roger K.			Conformational changes in the G protein Gs induced by the beta(2) adrenergic receptor	NATURE			English	Article							HETEROTRIMERIC G-PROTEINS; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; COUPLED RECEPTOR; MECHANISM; INTERFACE; DYNAMICS; EXCHANGE; HYDROGEN/DEUTERIUM; ACTIVATION	G protein-coupled receptors represent the largest family of membrane receptors(1) that instigate signalling through nucleotide exchange on heterotrimeric G proteins. Nucleotide exchange, or more precisely, GDP dissociation from the G protein alpha-subunit, is the key step towards G protein activation and initiation of downstream signalling cascades. Despite a wealth of biochemical and biophysical studies on inactive and active conformations of several heterotrimeric G proteins, the molecular underpinnings of G protein activation remain elusive. To characterize this mechanism, we applied peptide amide hydrogen-deuterium exchange mass spectrometry to probe changes in the structure of the heterotrimeric bovine G protein, Gs (the stimulatory G protein for adenylyl cyclase) on formation of a complex with agonist-bound human beta(2) adrenergic receptor (beta(2)AR). Here we report structural links between the receptor-binding surface and the nucleotide-binding pocket of Gs that undergo higher levels of hydrogen-deuterium exchange than would be predicted from the crystal structure of the beta(2)AR-Gs complex. Together with X-ray crystallographic and electron microscopic data of the beta(2)AR-Gs complex (from refs 2, 3), we provide a rationale for a mechanism of nucleotide exchange, whereby the receptor perturbs the structure of the amino-terminal region of the alpha-subunit of Gs and consequently alters the 'P-loop' that binds the beta-phosphate in GDP. As with the Ras family of small-molecular-weight G proteins, P-loop stabilization and beta-phosphate coordination are key determinants of GDP (and GTP) binding affinity.	[DeVree, Brian T.; Calinski, Diane; Sunahara, Roger K.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Chung, Ka Young; Rasmussen, Soren G. F.; Kobilka, Brian K.] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Rasmussen, Soren G. F.] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Liu, Tong; Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Med, Biomed Sci Grad Program, La Jolla, CA 92023 USA; [Liu, Tong; Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, UCSD DXMS Prote Resource, La Jolla, CA 92023 USA; [Chae, Pil Seok] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Chae, Pil Seok] Hanyang Univ, Dept Bionano Engn, Ansan 426791, South Korea	University of Michigan System; University of Michigan; Stanford University; University of Copenhagen; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; Hanyang University	Sunahara, RK (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.	kobilka@stanford.edu; vwoods@ucsd.edu; sunahara@umich.edu	Chung, Ka Young/AAO-7984-2020; DeVree, Brian T/F-6205-2011; Sunahara, Roger/AAJ-8667-2020	Chung, Ka Young/0000-0001-9038-9571; Kobilka, Brian/0000-0001-5958-3990; DeVree, Brian/0000-0003-0582-8125; Rasmussen, Soren/0000-0002-1853-1841	American Lung Association [RT-166882-N]; Lundbeck Foundation; National Institute of General Medical Sciences (NIGMS) [GM008270, GM083118, GM068603]; National Institute of Neural Disorders and Stroke [NS28471]; NHLBI [HL071078]; Mather Charitable Foundation; Michigan Diabetes Research and Training Center; National Institute of Diabetes and Digestive and Kidney Diseases [P60DK-20572]; University of Michigan; NIH [AI076961, AI081982, AI2008031, CA118595, GM20501, GM066170, GM093325, RR029388]; Lundbeck Foundation [R37-2009-3457] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R21CA118595] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029388] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072106, R01AI081982, R21AI076961, P01AI068730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093325, R01GM083118, F32GM020501, R01GM020501, R01GM068603, T32GM008270, R01GM066170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070899, R37NS028471, R01NS028471] Funding Source: NIH RePORTER	American Lung Association; Lundbeck Foundation(Lundbeckfonden); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neural Disorders and Stroke; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Mather Charitable Foundation; Michigan Diabetes Research and Training Center; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Michigan(University of Michigan System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lundbeck Foundation(Lundbeckfonden); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J.J.G. Tesmer and G. Skiniotis for discussions. This work was supported by an American Lung Association senior research training fellowship (RT-166882-N, to K.Y.C.), the Lundbeck Foundation (a junior group leader fellowship, to S. G. F. R.), a National Institute of General Medical Sciences (NIGMS) molecular biophysics training grant (GM008270, to B. T. D), a National Institute of Neural Disorders and Stroke grant (NS28471, to B. K. K.), a NHLBI grant (HL071078, to B. K. K.), the Mather Charitable Foundation (B. K. K.), NIGMS grants GM083118 (to B. K. K. and R. K. S.) and GM068603 (to R. K. S.), a Michigan Diabetes Research and Training Center grant, the National Institute of Diabetes and Digestive and Kidney Diseases (P60DK-20572, to R. K. S.), the University of Michigan Biological Sciences Scholars Program (R. K. S.), and by the NIH (grants AI076961, AI081982, AI2008031, CA118595, GM20501, GM066170, GM093325 and RR029388 (to V.L.W.)).	Abzalimov RR, 2009, J AM SOC MASS SPECTR, V20, P1514, DOI 10.1016/j.jasms.2009.04.006; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Engen JR, 2009, ANAL CHEM, V81, P7870, DOI 10.1021/ac901154s; Englander SW, 2007, Q REV BIOPHYS, V40, P287, DOI 10.1017/S0033583508004654; Gilchrist A, 1998, J BIOL CHEM, V273, P14912, DOI 10.1074/jbc.273.24.14912; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Konermann L, 2008, J MASS SPECTROM, V43, P1021, DOI 10.1002/jms.1435; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Li S, 2011, J BIOL CHEM, V286, P17889, DOI 10.1074/jbc.M111.224535; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Tsutsui Y, 2007, CURR MED CHEM, V14, P2344, DOI 10.2174/092986707781745596; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Zhang X, 2010, ANAL CHEM, V82, P1100, DOI 10.1021/ac902484p	25	279	284	1	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 29	2011	477	7366					611	U143		10.1038/nature10488	http://dx.doi.org/10.1038/nature10488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21956331	Green Accepted			2022-12-28	WOS:000295320900044
J	Sheikh, Z; Khan, S; Khan, A				Sheikh, Zishan; Khan, Shahnawaz; Khan, Afroze			PICTURE QUIZ An unfortunate teenager	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MARFAN-SYNDROME; MISSENSE MUTATION		[Sheikh, Zishan] Wexham Pk Hosp, Slough SL2 4HL, Berks, England; [Khan, Shahnawaz] Queen Victoria Hosp, E Grinstead RH19 3DZ, England; [Khan, Afroze] Charing Cross Hosp, London W6 8RF, England	Imperial College London	Sheikh, Z (corresponding author), Wexham Pk Hosp, Slough SL2 4HL, Berks, England.	zishansheikh@hotmail.com						[Anonymous], 2010, EUR HEART J, V31, P2915; de Vries BBA, 2007, EUR J HUM GENET, V15, P930, DOI 10.1038/sj.ejhg.5201865; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; ELHABBAL MH, 1992, AM HEART J, V123, P752, DOI 10.1016/0002-8703(92)90516-X; Foot C L, 2006, Crit Care Resusc, V8, P15; Germain DP, 2002, ANN VASC SURG, V16, P391, DOI 10.1007/s10016-001-0229-y; Gott VL, 2002, ANN THORAC SURG, V73, P438, DOI 10.1016/S0003-4975(01)03336-7; Gray JR, 1998, CLIN GENET, V54, P124; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Maumenee I H, 1981, Trans Am Ophthalmol Soc, V79, P684; National Marfan Foundation, 2010, 2010 REV GHENT NOS; PYERITZ RE, 1983, AM J MED, V74, P797, DOI 10.1016/0002-9343(83)91070-7; SPONSELLER PD, 1995, J BONE JOINT SURG AM, V77A, P867, DOI 10.2106/00004623-199506000-00007; WOOD JR, 1984, THORAX, V39, P780, DOI 10.1136/thx.39.10.780	14	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 29	2011	343								d6170	10.1136/bmj.d6170	http://dx.doi.org/10.1136/bmj.d6170			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829KC	21963811				2022-12-28	WOS:000295577500005
J	Inglesby, TV				Inglesby, Thomas V.			Progress in Disaster Planning and Preparedness Since 2001	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Inglesby, Thomas V.] Univ Pittsburgh, Med Ctr, Ctr Biosecur, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Inglesby, TV (corresponding author), Univ Pittsburgh, Med Ctr, Ctr Biosecur, Pier 4 Bldg,621 E Pratt St,Ste 210, Baltimore, MD 21202 USA.	tinglesby@upmc-biosecurity.org						*CDCP, PUBL HLTH PREP MOB S; *FED EM MAN AG COM, CIT CORPS; Federal Emergency Management Agency, WHOL COMM APPR EM MA; Franco, 2009, HOSP RISING CHALLENG; Franco C, 2011, BIOSECUR BIOTERROR, V9, P117, DOI 10.1089/bsp.2011.0018; Institute of Medicine, 2009, GUID EST CRIS STAND; Merchant RM, 2011, NEW ENGL J MED, V365, P289, DOI 10.1056/NEJMp1103591; Norris FH, 2008, AM J COMMUN PSYCHOL, V41, P127, DOI 10.1007/s10464-007-9156-6; *NYC GOV, MAYOR BLOOMB UPD NEW	9	16	16	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 28	2011	306	12					1372	1373		10.1001/jama.2011.1359	http://dx.doi.org/10.1001/jama.2011.1359			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825FQ	21903817				2022-12-28	WOS:000295257000027
J	Bellis, MA				Bellis, Mark A.			PERSONAL VIEW UK drinking guidelines are better for the alcohol industry than the public	BRITISH MEDICAL JOURNAL			English	Editorial Material							HEART-DISEASE; METAANALYSIS; MORTALITY; RISK		Liverpool John Moores Univ, Liverpool L3 2ET, Merseyside, England	Liverpool John Moores University	Bellis, MA (corresponding author), Liverpool John Moores Univ, Liverpool L3 2ET, Merseyside, England.	m.a.bellis@ljmu.ac.uk	Bellis, Mark A./HGA-2019-2022					2010, AM J EPIDEMIOL, V171, P633, DOI DOI 10.1093/AJE/KWP451; 2011, BRIT MED J, V342, pD3950, DOI DOI 10.1136/BMJ.D3950; 2009, DRUG ALCOHOL REV, V28, P441, DOI DOI 10.1111/J.1465-3362.2009.00052.X; 2011, BRIT MED J, V342, pD671, DOI DOI 10.1136/BMJ.D671; 2010, BRIT MED J, V341, pC5957, DOI DOI 10.1136/BMJ.C5957; 2006, ARCH INTERNAL MED, V166, P2437; 2008, INT J METH PSYCH RES, V17, P141, DOI DOI 10.1002/MPR.259	7	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 27	2011	343								d6023	10.1136/bmj.d6023	http://dx.doi.org/10.1136/bmj.d6023			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829JV	21952446				2022-12-28	WOS:000295576600006
J	Cappa, C; Wardlaw, T; Morgan, R				Cappa, Claudia; Wardlaw, Tessa; Morgan, Richard			Disparities by sex in early childhood and adolescence	LANCET			English	Editorial Material									[Cappa, Claudia; Wardlaw, Tessa; Morgan, Richard] UNICEF, Div Policy & Practice, Stat & Monitoring Sect, New York, NY 10017 USA	UNICEF	Cappa, C (corresponding author), UNICEF, Div Policy & Practice, Stat & Monitoring Sect, New York, NY 10017 USA.	ccappa@unicef.org						[Anonymous], 2011, WORLD POP PROSP 2010; Beal C. R., 1994, BOYS GIRLS DEV GENDE; Eccles J. S., 1990, J SOC ISSUES, V46, P186, DOI 10.1111/j.1540-4560.1990.tb01929.x; Freire H, 2011, ED GREEN IDEAS BRING; Waldron I., 1998, TOO YOUNG GENES GEND, P64	5	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 24	2011	378	9797					1122	1123		10.1016/S0140-6736(11)61303-2	http://dx.doi.org/10.1016/S0140-6736(11)61303-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829RH	21908038				2022-12-28	WOS:000295601500006
J	Cai, WS; Vasudev, AP; Brongersma, ML				Cai, Wenshan; Vasudev, Alok P.; Brongersma, Mark L.			Electrically Controlled Nonlinear Generation of Light with Plasmonics	SCIENCE			English	Article							ENHANCED 2ND-HARMONIC GENERATION; SUBWAVELENGTH METAL APERTURES; HARMONIC GENERATION; ANTENNAS; CHIP	Plasmonics provides a route to develop ultracompact optical devices on a chip by using extreme light concentration and the ability to perform simultaneous electrical and optical functions. These properties also make plasmonics an ideal candidate for dynamically controlling nonlinear optical interactions at the nanoscale. We demonstrate electrically tunable harmonic generation of light from a plasmonic nanocavity filled with a nonlinear medium. The metals that define the cavity also serve as electrodes that can generate high direct current electric fields across the nonlinear material. A fundamental wave at 1.56 micrometers was frequency doubled and modulated in intensity by applying a moderate external voltage to the electrodes, yielding a voltage-dependent nonlinear generation with a normalized magnitude of similar to 7% per volt.	[Cai, Wenshan; Vasudev, Alok P.; Brongersma, Mark L.] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA	Stanford University	Brongersma, ML (corresponding author), Stanford Univ, Geballe Lab Adv Mat, 476 Lomita Mall, Stanford, CA 94305 USA.	brongersma@stanford.edu	Brongersma, Mark L/R-6099-2016	Brongersma, Mark L/0000-0003-1777-8970	Air Force Office of Scientific Research [FA9550-10-C-0007, FA9550-10-1-0264]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	We acknowledge funding from the Air Force Office of Scientific Research (G. Pomrenke; STTR Phase I grant no. FA9550-10-C-0007 and grant no. FA9550-10-1-0264). We also gratefully acknowledge F. Afshinmanesh, E. S. Barnard, Y. C. Jun, and D. Kong for their assistance during various phases of the experiment.	Airola M, 2005, J OPT A-PURE APPL OP, V7, pS118, DOI 10.1088/1464-4258/7/2/016; Atwater HA, 2007, SCI AM, V296, P56, DOI 10.1038/scientificamerican0407-56; Barnard ES, 2008, OPT EXPRESS, V16, P16529, DOI 10.1364/OE.16.016529; Brongersma ML, 2010, SCIENCE, V328, P440, DOI 10.1126/science.1186905; Cai WS, 2010, ADV MATER, V22, P5120, DOI 10.1002/adma.201001440; Chen K, 2007, NANO LETT, V7, P254, DOI 10.1021/nl062090x; Danckwerts M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.026104; Ebbesen TW, 2008, PHYS TODAY, V61, P44, DOI 10.1063/1.2930735; Fan W, 2006, NANO LETT, V6, P1027, DOI 10.1021/nl0604457; Foster MA, 2006, NATURE, V441, P960, DOI 10.1038/nature04932; Genevet P, 2010, NANO LETT, V10, P4880, DOI 10.1021/nl102747v; Harutyunyan H, 2010, NANO LETT, V10, P5076, DOI 10.1021/nl1033304; Kim S, 2008, NATURE, V453, P757, DOI 10.1038/nature07012; Klein MW, 2006, SCIENCE, V313, P502, DOI 10.1126/science.1129198; Leuthold J, 2010, NAT PHOTONICS, V4, P535, DOI [10.1038/NPHOTON.2010.185, 10.1038/nphoton.2010.185]; Muhlschlegel P, 2005, SCIENCE, V308, P1607, DOI 10.1126/science.1111886; Nahata A, 2003, OPT LETT, V28, P423, DOI 10.1364/OL.28.000423; QUAIL JC, 1983, PHYS REV LETT, V50, P1987, DOI 10.1103/PhysRevLett.50.1987; Schon P, 2010, OPT LETT, V35, P4063, DOI 10.1364/OL.35.004063; Schouten HF, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.053901; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/NMAT2630, 10.1038/nmat2630]; TERHUNE RW, 1962, PHYS REV LETT, V8, P404, DOI 10.1103/PhysRevLett.8.404; van Nieuwstadt JAH, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.146102; Xu TJ, 2009, OPT EXPRESS, V17, P23582, DOI 10.1364/OE.17.023582; Zia R, 2004, J OPT SOC AM A, V21, P2442, DOI 10.1364/JOSAA.21.002442; Zia R, 2007, NAT NANOTECHNOL, V2, P426, DOI 10.1038/nnano.2007.185; Zia R, 2006, MATER TODAY, V9, P20, DOI 10.1016/S1369-7021(06)71572-3	27	214	215	3	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1720	1723		10.1126/science.1207858	http://dx.doi.org/10.1126/science.1207858			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940887				2022-12-28	WOS:000295121500034
J	Homoud, MK				Homoud, Munther K.			New-onset atrial fibrillation was associated with increased risk for mortality in initially healthy, middle-aged women	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION		Tufts Med Ctr, Boston, MA USA	Tufts Medical Center	Homoud, MK (corresponding author), Tufts Med Ctr, Boston, MA USA.							Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Lehto M, 2005, EUR HEART J, V26, P350, DOI 10.1093/eurheartj/ehi064; Pedersen OD, 2006, EUR HEART J, V27, P290, DOI 10.1093/eurheartj/ehi629; Schmitt J, 2009, EUR HEART J, V30, P1038, DOI 10.1093/eurheartj/ehn579	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6							JC3-12	10.7326/0003-4819-155-6-201109200-02012	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-02012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930849				2022-12-28	WOS:000295033400011
J	Saheecha, S; Monaghan, M; Reiken, J; Millar, L				Saheecha, Saad; Monaghan, Mark; Reiken, Joseph; Millar, Lynne			PICTURE QUIZ A 71 year old man with right sided facial droop	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LEFT-VENTRICULAR ANEURYSM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; EMBOLIC STROKE; MANAGEMENT; THROMBUS		[Saheecha, Saad] St Helier Hosp, Carshalton SM5 1AA, Surrey, England; [Monaghan, Mark; Reiken, Joseph] Kings Coll Hosp London, London, England; [Millar, Lynne] St Georges Hosp NHS Trust, London, England	St Helier Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; St Georges University London	Saheecha, S (corresponding author), St Helier Hosp, Carshalton SM5 1AA, Surrey, England.	saads@doctors.org.uk						Alberts MJ, 1997, AM J CARDIOL, V80, pD35; [Anonymous], 2010, BRIT NATL FORMULARY; [Anonymous], 2008, MAN PAT STROK TIA AS; Chowdhury UK, 2009, TEX HEART I J, V36, P331; DEWITT LD, 1988, STROKE, V19, P393, DOI 10.1161/01.STR.19.3.393; Elijovich L, 2010, CURR ATHEROSCLER REP, V12, P316, DOI 10.1007/s11883-010-0121-8; Engel J, 2002, AM J EMERG MED, V20, P238, DOI 10.1053/ajem.2002.32634; Frances C, 1998, J AM COLL CARDIOL, V32, P557, DOI 10.1016/S0735-1097(98)00290-3; Galougahi KK, 2010, INTERN MED J, V40, P813, DOI 10.1111/j.1445-5994.2009.02103.x; Glower DD, 2003, CARDIAC SURG ADULT, P771; GLOWER DD, 1997, LEFT VENTRICULAR ANE, P677; Manning WJ, 1997, AM J CARDIOL, V80, pD19; Murtagh Blaithnead, 2006, Curr Atheroscler Rep, V8, P310, DOI 10.1007/s11883-006-0009-9; National Institute for Health and Clinical Excellence, 2008, DIAGN IN MAN AC STRO; Rustemli A, 2007, ECHOCARDIOGR-J CARD, V24, P301, DOI 10.1111/j.1540-8175.2007.00393.x; Sorescu D, 2003, AM J MED SCI, V326, P31; Stemer A, 2010, CURR NEUROL NEUROSCI, V10, P29, DOI 10.1007/s11910-009-0076-8; STRATTON JR, 1989, WESTERN J MED, V151, P172; Vojacek J, 2008, EUR HEART J, V29, P2258, DOI 10.1093/eurheartj/ehn110; Weir NU, 2008, POSTGRAD MED J, V84, P133, DOI 10.1136/pgmj.2007.066563; Zoffoli G, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-11	21	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2011	343								d5121	10.1136/bmj.d5121	http://dx.doi.org/10.1136/bmj.d5121			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	826AE	21930812				2022-12-28	WOS:000295322900001
J	Doyle, LR; Carter, JA; Fabrycky, DC; Slawson, RW; Howell, SB; Winn, JN; Orosz, JA; Prsa, A; Welsh, WF; Quinn, SN; Latham, D; Torres, G; Buchhave, LA; Marcy, GW; Fortney, JJ; Shporer, A; Ford, EB; Lissauer, JJ; Ragozzine, D; Rucker, M; Batalha, N; Jenkins, JM; Borucki, WJ; Koch, D; Middour, CK; Hall, JR; McCauliff, S; Fanelli, MN; Quintana, EV; Holman, MJ; Caldwell, DA; Still, M; Stefanik, RP; Brown, WR; Esquerdo, GA; Tang, SM; Furesz, G; Geary, JC; Berlind, P; Calkins, ML; Short, DR; Steffen, JH; Sasselov, D; Dunham, EW; Cochran, WD; Boss, A; Haas, MR; Buzasi, D; Fischer, D				Doyle, Laurance R.; Carter, Joshua A.; Fabrycky, Daniel C.; Slawson, Robert W.; Howell, Steve B.; Winn, Joshua N.; Orosz, Jerome A.; Prsa, Andrej; Welsh, William F.; Quinn, Samuel N.; Latham, David; Torres, Guillermo; Buchhave, Lars A.; Marcy, Geoffrey W.; Fortney, Jonathan J.; Shporer, Avi; Ford, Eric B.; Lissauer, Jack J.; Ragozzine, Darin; Rucker, Michael; Batalha, Natalie; Jenkins, Jon M.; Borucki, William J.; Koch, David; Middour, Christopher K.; Hall, Jennifer R.; McCauliff, Sean; Fanelli, Michael N.; Quintana, Elisa V.; Holman, Matthew J.; Caldwell, Douglas A.; Still, Martin; Stefanik, Robert P.; Brown, Warren R.; Esquerdo, Gilbert A.; Tang, Sumin; Furesz, Gabor; Geary, John C.; Berlind, Perry; Calkins, Michael L.; Short, Donald R.; Steffen, Jason H.; Sasselov, Dimitar; Dunham, Edward W.; Cochran, William D.; Boss, Alan; Haas, Michael R.; Buzasi, Derek; Fischer, Debra			Kepler-16: A Transiting Circumbinary Planet	SCIENCE			English	Article							GIANT PLANETS; BINARY; PERFORMANCE; RADII; MASS	We report the detection of a planet whose orbit surrounds a pair of low-mass stars. Data from the Kepler spacecraft reveal transits of the planet across both stars, in addition to the mutual eclipses of the stars, giving precise constraints on the absolute dimensions of all three bodies. The planet is comparable to Saturn in mass and size and is on a nearly circular 229-day orbit around its two parent stars. The eclipsing stars are 20 and 69% as massive as the Sun and have an eccentric 41-day orbit. The motions of all three bodies are confined to within 0.5 degrees of a single plane, suggesting that the planet formed within a circumbinary disk.	[Doyle, Laurance R.; Slawson, Robert W.; Jenkins, Jon M.; Quintana, Elisa V.; Caldwell, Douglas A.] SETI Inst, Carl Sagan Ctr Study Life Universe, Mountain View, CA 94043 USA; [Carter, Joshua A.; Quinn, Samuel N.; Latham, David; Torres, Guillermo; Ragozzine, Darin; Holman, Matthew J.; Stefanik, Robert P.; Brown, Warren R.; Esquerdo, Gilbert A.; Tang, Sumin; Furesz, Gabor; Geary, John C.; Sasselov, Dimitar] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Fabrycky, Daniel C.; Fortney, Jonathan J.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Middour, Christopher K.; Hall, Jennifer R.; McCauliff, Sean] NASA, Ames Res Ctr, Orbital Sci Corp, Moffett Field, CA 94035 USA; [Winn, Joshua N.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Winn, Joshua N.] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Orosz, Jerome A.; Welsh, William F.] San Diego State Univ, Dept Astron, San Diego, CA 92182 USA; [Prsa, Andrej] Villanova Univ, Dept Astron & Astrophys, Villanova, PA 19085 USA; [Buchhave, Lars A.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Furesz, Gabor] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Star & Planet Format, DK-1350 Copenhagen, Denmark; [Marcy, Geoffrey W.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Shporer, Avi] Las Cumbres Observ Global Telescope Network, Goleta, CA 93117 USA; [Shporer, Avi] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Ford, Eric B.] 211 Bryant Space Sci Ctr, Gainesville, FL 32611 USA; [Rucker, Michael; Batalha, Natalie] San Jose State Univ, Dept Phys, San Jose, CA 95192 USA; [Fanelli, Michael N.; Still, Martin] NASA, Ames Res Ctr, Bay Area Environm Res Inst, Moffett Field, CA 94035 USA; [Buchhave, Lars A.] Konkoly Observ Budapest, H-1121 Budapest, Hungary; [Berlind, Perry; Calkins, Michael L.] Smithsonian Astrophys Observ, Fred Lawrence Whipple Observ, Amado, AZ 85645 USA; [Short, Donald R.] San Diego State Univ, Dept Math, San Diego, CA 92182 USA; [Steffen, Jason H.] FermiLab Ctr Particle Astrophys, Batavia, IL 60510 USA; [Dunham, Edward W.] Lowell Observ, Flagstaff, AZ 86001 USA; [Cochran, William D.] Univ Texas Austin, McDonald Observ, Austin, TX 78712 USA; [Boss, Alan] Carnegie Inst Sci, Washington, DC 20015 USA; [Buzasi, Derek] Eureka Sci, Oakland, CA 94602 USA; [Fischer, Debra] Yale Univ, Dept Astron, New Haven, CT 06511 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of California System; University of California Santa Cruz; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); California State University System; San Diego State University; Villanova University; University of Copenhagen; Niels Bohr Institute; University of Copenhagen; University of California System; University of California Berkeley; University of California System; University of California Santa Barbara; California State University System; San Jose State University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Astronomy & Earth Sciences; Smithsonian Institution; California State University System; San Diego State University; University of Texas System; University of Texas Austin; Carnegie Institution for Science; Eureka Scientific; Yale University	Doyle, LR (corresponding author), SETI Inst, Carl Sagan Ctr Study Life Universe, 189 Bernardo Ave, Mountain View, CA 94043 USA.	ldoyle@seti.org	Ford, Eric B./AAB-5479-2019; Steffen, Jason H./A-4320-2013; Cochran, William D/M-4421-2014; Ragozzine, Darin/C-4926-2013; Shporer, Avi/Y-2777-2019; Buchhave, Lars A./ABF-2000-2020; Welsh, William/AAS-3445-2021; Fischer, Debra A/C-1639-2014; Carter, Joshua A/A-8280-2013; Caldwell, Douglas A/L-7911-2014; Fortney, Jonathan/F-8813-2014	Ford, Eric B./0000-0001-6545-639X; Cochran, William D/0000-0001-9662-3496; Shporer, Avi/0000-0002-1836-3120; Buchhave, Lars A./0000-0003-1605-5666; Fischer, Debra A/0000-0003-2221-0861; Caldwell, Douglas A/0000-0003-1963-9616; Fabrycky, Daniel/0000-0003-3750-0183; Fortney, Jonathan/0000-0002-9843-4354; Buzasi, Derek/0000-0002-1988-143X; Steffen, Jason/0000-0003-2202-3847; Batalha, Natalie/0000-0002-7030-9519	NASA's Science Mission Directorate; NASA [NNX08AR15G, HF-51267.01-A, HF-51272.01-A, NAS 5-26555, NNX09AB33G]; Space Telescope Science Institute	NASA's Science Mission Directorate; NASA(National Aeronautics & Space Administration (NASA)); Space Telescope Science Institute(Space Telescope Science Institute)	NASA's Science Mission Directorate provided funding for the Kepler Discovery mission. L. R. D. acknowledges the NASA Kepler Participating Scientist Program (grant no. NNX08AR15G) and helpful discussions with the Kepler Science Team. J.A.C. and D. C. F. acknowledge support for this work provided by NASA through Hubble Fellowship grants HF-51267.01-A and HF-51272.01-A awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy for NASA, under contract NAS 5-26555. J.N.W. is grateful for support from the NASA Origins program (grant NNX09AB33G). The Kepler data used in this analysis can be downloaded from http://archive.stsci.edu/prepds/kepler_hlsp.	Beuermann K, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/201015472; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Caldwell DA, 2010, ASTROPHYS J LETT, V713, pL92, DOI 10.1088/2041-8205/713/2/L92; Carter JA, 2011, SCIENCE, V331, P562, DOI 10.1126/science.1201274; Deeg HJ, 2008, ASTRON ASTROPHYS, V480, P563, DOI 10.1051/0004-6361:20079000; Deeg HJ, 1998, ASTRON ASTROPHYS, V338, P479; Doyle LR, 2000, ASTROPHYS J, V535, P338, DOI 10.1086/308830; Guillot T, 2005, ANNU REV EARTH PL SC, V33, P493, DOI 10.1146/annurev.earth.32.101802.120325; Haghighipour N, 2010, ASTROPHYS SPACE SC L, V366, P285, DOI 10.1007/978-90-481-8687-7_11; Hessman F. V., NAMING CONVENTION US; Howell SB, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/1/19; IRWIN JB, 1952, ASTROPHYS J, V116, P211, DOI 10.1086/145604; Jenkins JM, 2010, ASTROPHYS J LETT, V713, pL87, DOI 10.1088/2041-8205/713/2/L87; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; Kopal Z., 1959, CLOSE BINARY SYSTEMS; Lee JW, 2009, ASTRON J, V137, P3181, DOI 10.1088/0004-6256/137/2/3181; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Prsa A, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/3/83; Quintana EV, 2006, ICARUS, V185, P1, DOI 10.1016/j.icarus.2006.06.016; Scholl H, 2007, MON NOT R ASTRON SOC, V380, P1119, DOI 10.1111/j.1365-2966.2007.12145.x; Schwarz R, 2011, MON NOT R ASTRON SOC, V414, P2763, DOI 10.1111/j.1365-2966.2011.18594.x; Slawson R. W., KEPLER ECLIPSING BIN; Sybilski P, 2010, MON NOT R ASTRON SOC, V405, P657, DOI 10.1111/j.1365-2966.2010.16490.x; Torres G, 2010, ASTRON ASTROPHYS REV, V18, P67, DOI 10.1007/s00159-009-0025-1; Trilling DE, 2007, ASTROPHYS J, V658, P1289, DOI 10.1086/511668	29	494	498	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2011	333	6049					1602	1606		10.1126/science.1210923	http://dx.doi.org/10.1126/science.1210923			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921192	Green Submitted			2022-12-28	WOS:000294900900035
J	Mylonakis, E; Muse, VV; Mino-Kenudson, M				Mylonakis, Eleftherios; Muse, Victorine V.; Mino-Kenudson, Mari			A Man with Pemphigus Vulgaris and Lung Nodules Cryptococcal infection of the lung and central nervous system	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MENINGITIS; NEOFORMANS; THERAPY; ERA; MANAGEMENT; DIAGNOSIS		[Mylonakis, Eleftherios] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Muse, Victorine V.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Mino-Kenudson, Mari] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Mylonakis, Eleftherios] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Muse, Victorine V.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Mino-Kenudson, Mari] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Mylonakis, E (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.				Harvard Medical School Department of Continuing Education; Astellas; T2 Biosystems; Pfizer; Biomedical Systems	Harvard Medical School Department of Continuing Education; Astellas(Astellas Pharmaceuticals); T2 Biosystems; Pfizer(Pfizer); Biomedical Systems	This case was discussed at the postgraduate course Infectious Diseases of Adults, sponsored by the Harvard Medical School Department of Continuing Education, Course Directors Stephen B. Calderwood, Nesli Basgoz, and Jay A. Fishman.; Dr. Mylonakis reports receiving grant support from Astellas and T2 Biosystems, fees for board membership from Astellas, and lecture fees from Pfizer. Dr. Muse reports receiving consulting fees and lecture fees from Biomedical Systems. No other potential conflict of interest relevant to this article was reported.	CAMPBELL GD, 1966, AM REV RESPIR DIS, V94, P236; D'Souza CA, 2001, MOL CELL BIOL, V21, P3179, DOI 10.1128/MCB.21.9.3179-3191.2001; De Jesus M, 2010, VIRULENCE, V1, P500, DOI 10.4161/viru.1.6.13451; DIAMOND RD, 1974, ANN INTERN MED, V80, P176, DOI 10.7326/0003-4819-80-2-176; DUNCAN RA, 1993, NEW ENGL J MED, V328, P393, DOI 10.1056/NEJM199302113280604; Kumar R, 2008, CLIN MICROBIOL REV, V21, P209, DOI 10.1128/CMR.00025-07; LAZCANO O, 1993, MODERN PATHOL, V6, P80; McGowan K, 2002, NEW ENGL J MED, V347, P517, DOI 10.1056/NEJMcpc020108; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Mylonakis E, 2002, P NATL ACAD SCI USA, V99, P15675, DOI 10.1073/pnas.232568599; Pappas PG, 2001, CLIN INFECT DIS, V33, P690, DOI 10.1086/322597; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Pukkila-Worley R, 2008, EXPERT OPIN PHARMACO, V9, P551, DOI 10.1517/14656566.9.4.551; Sethi NK, 2007, EUR J GASTROEN HEPAT, V19, P913, DOI 10.1097/MEG.0b013e3282cf4ed9; Xu B, 2010, CLIN NUCL MED, V35, P567, DOI 10.1097/RLU.0b013e3181e4db84	15	1	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2011	365	11					1043	1050		10.1056/NEJMcpc1102201	http://dx.doi.org/10.1056/NEJMcpc1102201			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819UR	21916643				2022-12-28	WOS:000294857300014
J	Rabe, KF; Wedzicha, JA				Rabe, Klaus F.; Wedzicha, Jadwiga A.			Chronic Obstructive Pulmonary Disease 3 Controversies in treatment of chronic obstructive pulmonary disease	LANCET			English	Article							CARDIOSELECTIVE BETA-BLOCKERS; AIRWAY BACTERIAL LOAD; ACUTE EXACERBATIONS; LUNG-FUNCTION; SALMETEROL/FLUTICASONE PROPIONATE; DOUBLE-BLIND; FLUTICASONE PROPIONATE; MYOCARDIAL-INFARCTION; ANTIBIOTIC-TREATMENT; INHALED BUDESONIDE	Chronic obstructive pulmonary disease (COPD) is a chronic disorder with substantial comorbidity and major effects attributable to the high morbidity and mortality rates. Despite an increasing evidence base, some important controversies in COPD management still exist. The classic way to define COPD has been based on spirometric criteria, but more relevant diagnostic methods are needed that can be used to describe COPD severity and comorbidity. Initiation of interventions earlier in the natural history of the disease to slow disease progression is debatable, there are many controversies about the role of inhaled corticosteroids in the management of COPD, and long-term antibiotics for prevention of exacerbation have had a resurgence in interest. Novel therapeutic drugs are urgently needed for optimum management of the acute COPD exacerbation. COPD is a complex disease and consists of several clinically relevant phenotypes that in future will guide its management.	[Rabe, Klaus F.] Univ Kiel, D-24118 Kiel, Germany; [Rabe, Klaus F.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Wedzicha, Jadwiga A.] UCL, Acad Unit Resp Med, London, England	University of Kiel; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; University College London	Rabe, KF (corresponding author), Univ Kiel, Olshaussenstr 40, D-24118 Kiel, Germany.	k.f.rabe@kh-grosshansdorf.de	Rabe, Klaus F./AAW-6296-2021	Rabe, Klaus F./0000-0002-7020-1401	Altana Pharma; Novartis; AstraZeneca; Merck Sharp and Dohme; GlaxoSmithKline; MedImmune; Chiesi; Pfizer; Boehringer Ingelheim; Nycomed; Bayer	Altana Pharma; Novartis(Novartis); AstraZeneca(AstraZeneca); Merck Sharp and Dohme(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); MedImmune(AstraZenecaMedimmune); Chiesi(Chiesi Pharmaceuticals Inc); Pfizer(Pfizer); Boehringer Ingelheim(Boehringer Ingelheim); Nycomed; Bayer(Bayer AG)	KFR has received grants from Altana Pharma, Novartis, AstraZeneca, and Merck Sharp and Dohme for research projects; and has provided legal consultancy services or expert testimony to AstraZeneca, Chiesi, Novartis, Merck Sharp and Dohme, and GlaxoSmithKline. JAW has received honoraria, payment for lectures or advisory boards, or research grants from GlaxoSmithKline, MedImmune, Novartis, Chiesi, Pfizer, Boehringer Ingelheim, Nycomed, Bayer, AstraZeneca, and Merck Sharp and Dohme.	Alexeeff SE, 2007, AM J RESP CRIT CARE, V176, P742, DOI 10.1164/rccm.200705-656OC; Altose MD, 2000, NEW ENGL J MED, V343, P1902; [Anonymous], 1980, Ann Intern Med, V93, P391; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P675, DOI 10.1164/rccm.2112096; Barnes NC, 2006, AM J RESP CRIT CARE, V173, P736, DOI 10.1164/rccm.200508-1321OC; Beaglehole R, 2003, LANCET, V362, P903, DOI 10.1016/S0140-6736(03)14335-8; Bischoff EWMA, 2011, THORAX, V66, P26, DOI 10.1136/thx.2009.127621; Bourbeau J, 2008, THORAX, V63, P831, DOI 10.1136/thx.2007.086041; Bourbeau J, 2007, THORAX, V62, P938, DOI 10.1136/thx.2006.071068; Bridevaux PO, 2008, THORAX, V63, P768, DOI 10.1136/thx.2007.093724; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PMA, 2011, CHEST, V139, P505, DOI 10.1378/chest.09-2992; Calverley PMA, 2009, LANCET, V374, P685, DOI 10.1016/S0140-6736(09)61255-1; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Cazzola M, 2008, EUR RESPIR J, V31, P416, DOI 10.1183/09031936.00099306; Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Daniels JMA, 2010, AM J RESP CRIT CARE, V181, P150, DOI 10.1164/rccm.200906-0837OC; Davies L, 1999, LANCET, V354, P456, DOI 10.1016/S0140-6736(98)11326-0; Decramer M, 2010, THORAX, V65, P837, DOI 10.1136/thx.2009.133355; Decramer M, 2009, LANCET, V374, P1171, DOI 10.1016/S0140-6736(09)61298-8; Donaldson GC, 2010, CHEST, V137, P1091, DOI 10.1378/chest.09-2029; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Dransfield MT, 2008, THORAX, V63, P301, DOI 10.1136/thx.2007.081893; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Fabbri LM, 2008, EUR RESPIR J, V31, P204, DOI 10.1183/09031936.00114307; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; Fabbri LM, 2011, THORAX, V66, P745, DOI 10.1136/thoraxjnl-2011-200406; Fabbri LM, 2009, LANCET, V374, P695, DOI 10.1016/S0140-6736(09)61252-6; Feary JR, 2010, THORAX, V65, P956, DOI 10.1136/thx.2009.128082; Ferguson GT, 2008, RESP MED, V102, P1099, DOI 10.1016/j.rmed.2008.04.019; FLENLEY DC, 1981, LANCET, V1, P681; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Hattotuwa KL, 2002, AM J RESP CRIT CARE, V165, P1592, DOI 10.1164/rccm.2105025; Hill AT, 2000, AM J MED, V109, P288, DOI 10.1016/S0002-9343(00)00507-6; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Horwich TB, 2007, SEMIN DIALYSIS, V20, P549, DOI 10.1111/j.1525-139X.2007.00346.x; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jenkins CR, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-59; Johansson Gunnar, 2008, Prim Care Respir J, V17, P169, DOI 10.3132/pcrj.2008.00037; Johnston AK, 2008, THORAX, V63, P599, DOI 10.1136/thx.2007.088112; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Khurana V, 2007, CHEST, V131, P1282, DOI 10.1378/chest.06-0931; Kuzma Anne Marie, 2008, Proc Am Thorac Soc, V5, P567, DOI 10.1513/pats.200708-125ET; Lacasse Yves, 2006, Evid Based Med, V11, P84, DOI 10.1136/ebm.11.3.84; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; Luppi Fabrizio, 2008, Proc Am Thorac Soc, V5, P848, DOI 10.1513/pats.200809-101TH; Maltais F, 2002, AM J RESP CRIT CARE, V165, P698, DOI 10.1164/ajrccm.165.5.2109093; Mancini GBJ, 2006, J AM COLL CARDIOL, V47, P2554, DOI 10.1016/j.jacc.2006.04.039; Mannino DM, 2012, CHEST, V141, P73, DOI 10.1378/chest.11-0797; McEvoy RD, 2009, THORAX, V64, P561, DOI 10.1136/thx.2008.108274; Miravitlles M, 2009, EUR RESPIR J, V34, P1066, DOI 10.1183/09031936.00195608; Miravitlles M, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-58; MONSO E, 1995, AM J RESP CRIT CARE, V152, P1316, DOI 10.1164/ajrccm.152.4.7551388; Moody A, 2004, THORAX, V59, P1; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; *NIH CLIN EXC, CHRON OBSTR PULM DIS; O'Donnell DE, 2009, THORAX, V64, P216, DOI 10.1136/thx.2008.103598; Ofir D, 2008, AM J RESP CRIT CARE, V177, P622, DOI 10.1164/rccm.200707-1064OC; OShaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852, DOI 10.1164/ajrccm.155.3.9117016; Patel IS, 2004, AM J RESP CRIT CARE, V170, P400, DOI 10.1164/rccm.200305-648OC; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; Puhan MA, 2009, LANCET, V374, P704, DOI 10.1016/S0140-6736(09)61301-5; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2007, AM J CARDIOL, V100, P1659, DOI 10.1016/j.amjcard.2007.09.072; Roede BM, 2008, THORAX, V63, P968, DOI 10.1136/thx.2008.095349; Rosell A, 2005, ARCH INTERN MED, V165, P891, DOI 10.1001/archinte.165.8.891; ROSELL A, 1995, THORAX, V50, P758; Salpeter SR, 2003, RESP MED, V97, P1094, DOI 10.1016/S0954-6111(03)00168-9; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Seemungal TAR, 2008, AM J RESP CRIT CARE, V178, P1139, DOI 10.1164/rccm.200801-145OC; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-10; Shelton RJ, 2006, HEART, V92, P331, DOI 10.1136/hrt.2004.059758; Sin DD, 2009, LANCET, V374, P712, DOI 10.1016/S0140-6736(09)61250-2; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Stallberg B, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-11; STAYKOVA T, 2003, COCHRANE DB SYST REV, V1; Stockley RA, 2000, CHEST, V117, P1638, DOI 10.1378/chest.117.6.1638; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Thompson WH, 1996, AM J RESP CRIT CARE, V154, P407, DOI 10.1164/ajrccm.154.2.8756814; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Tinetti ME, 2004, AM J MED, V116, P179, DOI 10.1016/j.amjmed.2003.09.031; Troosters T, 2010, EUR RESPIR J, V36, P65, DOI 10.1183/09031936.00127809; van Gestel YRBM, 2008, AM J RESP CRIT CARE, V178, P695, DOI 10.1164/rccm.200803-384OC; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; Vestbo J, 2009, THORAX, V64, P939, DOI 10.1136/thx.2009.113662; Vogelmeier C, 2011, NEW ENGL J MED, V364, P1093, DOI 10.1056/NEJMoa1008378; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; White AJ, 2003, THORAX, V58, P680, DOI 10.1136/thorax.58.8.680; Wilkinson TMA, 2004, AM J RESP CRIT CARE, V169, P1298, DOI 10.1164/rccm.200310-1443OC; Wilkinson TMA, 2003, AM J RESP CRIT CARE, V167, P1090, DOI 10.1164/rccm.200210-1179OC; Wilson R, 2006, THORAX, V61, P337, DOI 10.1136/thx.2005.045930; World Health Organization, 2007, GLOB SURV PREV CONTR	104	52	56	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2011	378	9795					1038	1047		10.1016/S0140-6736(11)61295-6	http://dx.doi.org/10.1016/S0140-6736(11)61295-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HO	21907867				2022-12-28	WOS:000295193200029
J	Feng, XL; Guo, SF; Hipgrave, D; Zhu, J; Zhang, LL; Song, L; Yang, Q; Guo, Y; Ronsmans, C				Feng, Xing Lin; Guo, Sufang; Hipgrave, David; Zhu, Jun; Zhang, Lingli; Song, Li; Yang, Qing; Guo, Yan; Ronsmans, Carine			China's facility-based birth strategy and neonatal mortality: a population-based epidemiological study	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; HEALTH SYSTEM REFORM; CHILDREN YOUNGER; SERVICE-DELIVERY; SHANXI PROVINCE; CARE; NEWBORN; DEATHS; CHALLENGES; MANAGEMENT	Background China's success in improving the quality of and access to obstetric care in hospitals offers an opportunity to examine the effect of a large-scale facility-based strategy on neonatal mortality. We aimed to establish this effect by assessing how the institutional strategy of intrapartum care has affected neonatal mortality and its regional inequalities. Methods We did a population-based epidemiological study of China's National Maternal and Child Mortality Surveillance System from 1996 to 2008. We used data from 116 surveillance sites in China (37 urban districts and 79 rural counties) to examine neonatal mortality by cause, socioeconomic region, and place of birth, with Poisson regression to calculate relative risks. Rural counties were categorised into types 1-4, with type 4 being the least developed. We report attributable risks and preventable fractions for hospital births versus home births. Findings Neonatal mortality decreased by 62% between 1996 and 2008. The rate of neonatal mortality was much lower for hospital births than for home births in all regions, with relative risks (RR) ranging from 0.30 (95% CI 0.22-0.40) in type 2 rural counties, to 0.52 (0.33-0.83) in type 4 counties (p<0.0001). The proportion of neonatal deaths prevented by hospital birth ranged from 70% (95% CI 59.7-77.8) to 48% (16.9-67.3). Babies born in urban hospitals had a low rate of neonatal mortality (5.7 per 1000 livebirths); but those born in hospitals in type 4 rural counties were almost four times more likely to die than were children born in urban hospitals (RR 3.80, 2.53-5.72). Interpretation Other countries can learn from China's substantial progress in reducing neonatal mortality. The major effect of China's facility-based strategy on neonatal mortality is much greater than that reported for community-based interventions. Our findings will provide a great impetus for countries to increase demand for and quality of facility-based intrapartum care.	[Feng, Xing Lin; Guo, Yan] Peking Univ, Dept Hlth Policy & Adm, Sch Publ Hlth, Beijing 100191, Peoples R China; [Guo, Sufang; Hipgrave, David] UNICEF China, Beijing, Peoples R China; [Zhu, Jun] Sichuan Univ, Natl Off Maternal & Child Hlth Surveillance China, W China Hosp 2, Chengdu 610064, Peoples R China; [Zhang, Lingli; Song, Li; Yang, Qing] Minist Hlth, Dept Maternal & Child Hlth & Community Hlth, Beijing, Peoples R China; [Ronsmans, Carine] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England	Peking University; Sichuan University; University of London; London School of Hygiene & Tropical Medicine	Guo, Y (corresponding author), Peking Univ, Dept Hlth Policy & Adm, Sch Publ Hlth, Beijing 100191, Peoples R China.	guoyan@bjmu.edu.cn; carine.Ronsmans@lshtm.ac.uk	Feng, Xing Lin/D-8734-2011	Feng, Xing Lin/0000-0003-3588-1859	China Medical Board, UNICEF China	China Medical Board, UNICEF China	Funding China Medical Board, UNICEF China.	Anand S, 2008, LANCET, V372, P1774, DOI 10.1016/S0140-6736(08)61363-X; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Banister J, 2004, POP STUD-J DEMOG, V58, P55, DOI 10.1080/0032472032000183753; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Bhutta ZA, 2011, LANCET, V377, P403, DOI 10.1016/S0140-6736(10)62274-X; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Center for Health Statistics and Information, 2009, AN REP NAT HLTH SERV; Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; Chinese Ministry of Health (MOH), 2010, NAT HLTH STAT YB 201; Clark RB, 2004, 10 YEARS NEONATAL RE; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Department of Maternal and Child Health and Community Health Ministry of Health, 2006, CHIN NAT MAT CHILD H; Feng XL, 2010, BJOG-INT J OBSTET GY, V117, P1527, DOI 10.1111/j.1471-0528.2010.02707.x; Feng XL, 2011, B WORLD HEALTH ORGAN, V89, P432, DOI 10.2471/BLT.10.085274; Friberg IK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000295; Gao YQ, 2009, B WORLD HEALTH ORGAN, V87, P913, DOI 10.2471/BLT.08.060426; Gao Y, 2010, REPROD HEALTH MATTER, V18, P35, DOI 10.1016/S0968-8080(10)36523-2; Gao Y, 2010, INT J GYNECOL OBSTET, V110, P181, DOI 10.1016/j.ijgo.2010.05.001; Harris A, 2010, HEALTH POLICY PLANN, V25, P311, DOI 10.1093/heapol/czp062; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000389; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S10; Long QA, 2011, B WORLD HEALTH ORGAN, V89, P144, DOI 10.2471/BLT.10.079434; Mulholland K, 2010, LANCET, V376, P89, DOI 10.1016/S0140-6736(10)61073-2; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Zhang DQ, 2008, LANCET, V372, P1865, DOI 10.1016/S0140-6736(08)61355-0; Zhao Liyun, 2008, Wei Sheng Yan Jiu, V37, P65	31	78	83	3	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2011	378	9801					1493	1500		10.1016/S0140-6736(11)61096-9	http://dx.doi.org/10.1016/S0140-6736(11)61096-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838VC	21924764				2022-12-28	WOS:000296319600023
J	Pruszynski, JA; Kurtzer, I; Nashed, JY; Omrani, M; Brouwer, B; Scott, SH				Pruszynski, J. Andrew; Kurtzer, Isaac; Nashed, Joseph Y.; Omrani, Mohsen; Brouwer, Brenda; Scott, Stephen H.			Primary motor cortex underlies multi-joint integration for fast feedback control	NATURE			English	Article							LATENCY STRETCH REFLEXES; CORTICOMOTONEURONAL CELLS; HUMAN ARM; RESPONSES; MOTION; MONKEY; MOVEMENTS; NEURONS; PERTURBATIONS	A basic difficulty for the nervous system is integrating locally ambiguous sensory information to form accurate perceptions about the outside world(1-4). This local-to-global problem is also fundamental to motor control of the arm, because complex mechanical interactions between shoulder and elbow allow a particular amount of motion at one joint to arise from an infinite combination of shoulder and elbow torques(5). Here we show, in humans and rhesus monkeys, that a transcortical pathway through primary motor cortex (M1) resolves this ambiguity during fast feedback control. We demonstrate that single M1 neurons of behaving monkeys can integrate shoulder and elbow motion information into motor commands that appropriately counter the underlying torque within about 50 milliseconds of a mechanical perturbation. Moreover, we reveal a causal link between M1 processing and multi-joint integration in humans by showing that shoulder muscle responses occurring 50 milliseconds after pure elbow displacement can be potentiated by transcranial magnetic stimulation. Taken together, our results show that transcortical processing through M1 permits feedback responses to express a level of sophistication that rivals voluntary control; this provides neurophysiological support for influential theories positing that voluntary movement is generated by the intelligent manipulation of sensory feedback(6,7).	[Pruszynski, J. Andrew; Kurtzer, Isaac; Nashed, Joseph Y.; Omrani, Mohsen; Brouwer, Brenda; Scott, Stephen H.] Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada; [Pruszynski, J. Andrew] Umea Univ, Dept Integrat Med Biol, Physiol Sect, SE-90187 Umea, Sweden; [Kurtzer, Isaac] New York Coll Osteopath Med, Dept Neurosci & Histol, Old Westbury, NY 11568 USA; [Brouwer, Brenda] Queens Univ, Sch Rehabil Therapy, Kingston, ON K7L 3N6, Canada; [Scott, Stephen H.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Scott, Stephen H.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Umea University; New York Institute Technology; Queens University - Canada; Queens University - Canada; Queens University - Canada	Scott, SH (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.	steve.scott@queensu.ca	Pruszynski, J. Andrew/E-4522-2011	Pruszynski, J. Andrew/0000-0003-0786-0081; Omrani, Mohsen/0000-0002-0461-1947	Canadian Institutes of Health Research (CIHR); National Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Canadian Institutes of Health Research (CIHR) and the National Sciences and Engineering Research Council of Canada (NSERC). J.A.P., I.K. and M.O. received salary awards from CIHR. We thank K. Moore and J. Peterson for technical support, and G. Blohm, B. Edin, R. Flanagan, R. Johansson, A. Kahn and D. Munoz for comments on the manuscript.	Angelaki DE, 2004, NATURE, V430, P560, DOI 10.1038/nature02754; CHENEY PD, 1984, J PHYSIOL-LONDON, V349, P249, DOI 10.1113/jphysiol.1984.sp015155; COLE KJ, 1984, EXP BRAIN RES, V56, P582; DAY BL, 1991, J PHYSIOL-LONDON, V433, P41, DOI 10.1113/jphysiol.1991.sp018413; EVARTS EV, 1973, SCIENCE, V179, P501, DOI 10.1126/science.179.4072.501; EVARTS EV, 1976, J NEUROPHYSIOL, V39, P1069, DOI 10.1152/jn.1976.39.5.1069; FETZ EE, 1980, J NEUROPHYSIOL, V44, P751, DOI 10.1152/jn.1980.44.4.751; FROMM C, 1977, NEUROSCI LETT, V5, P259, DOI 10.1016/0304-3940(77)90076-3; GIELEN CCAM, 1988, J PHYSIOL-LONDON, V407, P275, DOI 10.1113/jphysiol.1988.sp017415; Green AM, 2010, CURR OPIN NEUROBIOL, V20, P353, DOI 10.1016/j.conb.2010.04.009; Green DM, 1966, SIGNAL DETECTION THE; Herter TM, 2009, J NEUROPHYSIOL, V101, P150, DOI 10.1152/jn.90230.2008; HOLLERBACH JM, 1982, BIOL CYBERN, V44, P67, DOI 10.1007/BF00353957; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Kurtzer IL, 2008, CURR BIOL, V18, P449, DOI 10.1016/j.cub.2008.02.053; Lewis GN, 2004, EXP BRAIN RES, V156, P72, DOI 10.1007/s00221-003-1767-z; Pack CC, 2003, NEURON, V39, P671, DOI 10.1016/S0896-6273(03)00439-2; PALMER E, 1992, J PHYSIOL-LONDON, V449, P429, DOI 10.1113/jphysiol.1992.sp019094; Pei YC, 2011, NEURON, V69, P536, DOI 10.1016/j.neuron.2010.12.033; PICARD N, 1992, J NEUROPHYSIOL, V68, P1882, DOI 10.1152/jn.1992.68.5.1882; Porter R, 1993, CORTICOSPINAL FUNCTI; Pruszynski JA, 2008, J NEUROPHYSIOL, V100, P224, DOI 10.1152/jn.90262.2008; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Scott SH, 2003, CURR OPIN NEUROBIOL, V13, P671, DOI 10.1016/j.conb.2003.10.012; Scott SH, 2001, NATURE, V413, P161, DOI 10.1038/35093102; Shemmell J, 2010, CLIN NEUROPHYSIOL, V121, P1680, DOI 10.1016/j.clinph.2010.02.166; SOECHTING JF, 1988, J NEUROPHYSIOL, V59, P1296, DOI 10.1152/jn.1988.59.4.1296; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963	30	194	196	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 20	2011	478	7369					387	+		10.1038/nature10436	http://dx.doi.org/10.1038/nature10436			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	21964335	Green Accepted			2022-12-28	WOS:000296021100046
J	Sansjofre, P; Ader, M; Trindade, RIF; Elie, M; Lyons, J; Cartigny, P; Nogueira, ACR				Sansjofre, P.; Ader, M.; Trindade, R. I. F.; Elie, M.; Lyons, J.; Cartigny, P.; Nogueira, A. C. R.			A carbon isotope challenge to the snowball Earth	NATURE			English	Article							ORGANIC-CARBON; CAP DOLOSTONE; CO2 LEVELS; FRACTIONATION; OXYGEN; PHYTOPLANKTON; EVOLUTION; TEMPERATURE; EXCURSIONS; ATMOSPHERE	The snowball Earth hypothesis postulates that the planet was entirely covered by ice for millions of years in the Neoproterozoic era, in a self-enhanced glaciation caused by the high albedo of the ice-covered planet. In a hard-snowball picture, the subsequent rapid unfreezing resulted from an ultra-greenhouse event attributed to the buildup of volcanic carbon dioxide (CO2) during glaciation(1). High partial pressures of atmospheric CO2 (p(CO2); from 20,000 to 90,000 p. p. m. v.) in the aftermath of the Marinoan glaciation (similar to 635 Myr ago) have been inferred from both boron and triple oxygen isotopes(2,3). These p(CO2) values are 50 to 225 times higher than present-day levels. Here, we re-evaluate these estimates using paired carbon isotopic data for carbonate layers that cap Neoproterozoic glacial deposits and are considered to record post-glacial sea level rise(1). The new data reported here for Brazilian cap carbonates, together with previous ones for time-equivalent units(4-8), provide p(CO2) estimates lower than 3,200 p. p. m. v.-and possibly as low as the current value of similar to 400 p. p. m. v. Our new constraint, and our reinterpretation of the boron and triple oxygen isotope data, provide a completely different picture of the late Neoproterozoic environment, with low atmospheric concentrations of carbon dioxide and oxygen that are inconsistent with a hard-snowball Earth.	[Sansjofre, P.; Ader, M.; Cartigny, P.] Univ Paris Diderot, Equipe Geochim Isotopes Stables, Inst Phys Globe Paris, UMR CNRS 7154, F-75238 Paris 05, France; [Sansjofre, P.; Trindade, R. I. F.] Univ Sao Paulo, Dept Geofis, Inst Astron Geofis & Ciencias Atmosfer, BR-05508900 Sao Paulo, Brazil; [Elie, M.] Nancy Univ, UMR CNRS G2R 7566, CNRS, F-54506 Vandoeuvre Les Nancy, France; [Lyons, J.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; [Nogueira, A. C. R.] Fed Univ Para, Fac Geol, Inst Geociencias, BR-66075110 Belem, Para, Brazil	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universidade de Sao Paulo; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; University of California System; University of California Los Angeles; Universidade Federal do Para	Sansjofre, P (corresponding author), Univ Paris Diderot, Equipe Geochim Isotopes Stables, Inst Phys Globe Paris, UMR CNRS 7154, F-75238 Paris 05, France.	sansjofre@ipgp.fr	IMPMC, ROCKS @/U-8478-2017; Cartigny, Pierre/A-6251-2011; ader, magali/A-5613-2011; Trindade, Ricardo IF/A-8146-2008	ader, magali/0000-0002-9239-1509; Trindade, Ricardo IF/0000-0001-9848-9550; NOGUEIRA, AFONSO/0000-0002-5225-9255	French MRT doctoral fellowship; SETSI grant; INSU (SYSTER) grants; INCT-Geociam programme; FAPESP; CNPq; NASA Astrobiology Institute [NNA09DA76]	French MRT doctoral fellowship; SETSI grant; INSU (SYSTER) grants; INCT-Geociam programme; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NASA Astrobiology Institute	We thank the Geochemistry division of IFP Energie nouvelle for performing Rock-Eval analyses. The work benefited from discussions with M. Bonifacie, G. LeHir, G. Paris and H. Strauss. Research was supported by a French MRT doctoral fellowship and a SETSI grant to P. S., and two INSU (SYSTER) grants to M. A.. R. I. F. T. and A.C.R.N. were supported by the INCT-Geociam programme, and by FAPESP and CNPq grants. J.L. was supported by the NASA Astrobiology Institute under cooperative agreement NNA09DA76 to the Penn State Astrobiology Research Center. This is IPGP contribution 3211.	Ader M, 2009, EARTH PLANET SC LETT, V288, P213, DOI 10.1016/j.epsl.2009.09.024; Balci N, 2007, GEOCHIM COSMOCHIM AC, V71, P3796, DOI 10.1016/j.gca.2007.04.017; Bao HM, 2008, NATURE, V453, P504, DOI 10.1038/nature06959; Behar F, 2001, OIL GAS SCI TECHNOL, V56, P111, DOI 10.2516/ogst:2001013; Bristow TF, 2008, GEOLOGY, V36, P863, DOI 10.1130/G24968A.1; Corsetti FA, 2006, PALAEOGEOGR PALAEOCL, V232, P114, DOI 10.1016/j.palaeo.2005.10.030; Corsetti FA, 2003, GEOL SOC AM BULL, V115, P916, DOI 10.1130/B25066.1; Crafts-Brandner SJ, 2000, P NATL ACAD SCI USA, V97, P13430, DOI 10.1073/pnas.230451497; de Alvarenga CJS, 2004, PRECAMBRIAN RES, V131, P1, DOI 10.1016/j.precamres.2003.12.006; Elie M, 2007, TERRA NOVA, V19, P303, DOI 10.1111/j.1365-3121.2007.00754.x; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Font E, 2005, GEOPHYS J INT, V163, P491, DOI 10.1111/j.1365-246X.2005.02776.x; GOERICKE R, 1994, GLOBAL BIOGEOCHEM CY, V8, P85, DOI 10.1029/93GB03272; Guo QJ, 2007, PALAEOGEOGR PALAEOCL, V254, P140, DOI 10.1016/j.palaeo.2007.03.014; Hayes JM, 1999, CHEM GEOL, V161, P103, DOI 10.1016/S0009-2541(99)00083-2; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Huber R, 2000, FEMS MICROBIOL REV, V24, P615, DOI 10.1111/j.1574-6976.2000.tb00562.x; Jiang GQ, 2010, EARTH PLANET SC LETT, V299, P159, DOI 10.1016/j.epsl.2010.08.031; Kasemann SA, 2005, EARTH PLANET SC LETT, V231, P73, DOI 10.1016/j.epsl.2004.12.006; KAUFMAN AJ, 1991, PRECAMBRIAN RES, V49, P301, DOI 10.1016/0301-9268(91)90039-D; Kaufman AJ, 2003, NATURE, V425, P279, DOI 10.1038/nature01902; Knauth LP, 2009, NATURE, V460, P728, DOI 10.1038/nature08213; LAWS EA, 1995, GEOCHIM COSMOCHIM AC, V59, P1131, DOI 10.1016/0016-7037(95)00030-4; Li C, 2010, SCIENCE, V328, P80, DOI 10.1126/science.1182369; McFadden KA, 2008, P NATL ACAD SCI USA, V105, P3197, DOI 10.1073/pnas.0708336105; MOOK WG, 1974, EARTH PLANET SC LETT, V22, P169, DOI 10.1016/0012-821X(74)90078-8; NARBONNE GM, 1994, GEOL SOC AM BULL, V106, P1281, DOI 10.1130/0016-7606(1994)106<1281:ICABOT>2.3.CO;2; Pancost RD, 1999, ORG GEOCHEM, V30, P319, DOI 10.1016/S0146-6380(99)00004-2; Popp BN, 1998, GEOCHIM COSMOCHIM AC, V62, P69, DOI 10.1016/S0016-7037(97)00333-5; Riccardi A, 2007, PALAEOGEOGR PALAEOCL, V248, P73, DOI 10.1016/j.palaeo.2006.11.010; Rost B, 2003, LIMNOL OCEANOGR, V48, P55, DOI 10.4319/lo.2003.48.1.0055; Royer DL, 2001, EARTH-SCI REV, V54, P349, DOI 10.1016/S0012-8252(00)00042-8; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; Shen B, 2008, EARTH PLANET SC LETT, V265, P209, DOI 10.1016/j.epsl.2007.10.005; SHEPPARD SM, 1970, CONTRIB MINERAL PETR, V26, P161, DOI 10.1007/BF00373200; Weiss R.F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2; Werne JP, 2004, MAR CHEM, V92, P275, DOI 10.1016/j.marchem.2004.06.031; Young SA, 2008, PALAEOGEOGR PALAEOCL, V270, P166, DOI 10.1016/j.palaeo.2008.09.006; Zeebe R.E., 2001, ELSEV OCEANOGR SERIE	39	61	64	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2011	478	7367					93	U103		10.1038/nature10499	http://dx.doi.org/10.1038/nature10499			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21979050				2022-12-28	WOS:000295575400041
J	Pearse, RM; Holt, PJE; Grocott, MPW				Pearse, Rupert M.; Holt, Peter J. E.; Grocott, Michael P. W.			Managing perioperative risk in patients undergoing elective non-cardiac surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Review							POPULATION-BASED COHORT; PULMONARY COMPLICATIONS; ABDOMINAL-SURGERY; SURGICAL-PATIENTS; MAJOR SURGERY; MORTALITY; METAANALYSIS; ANESTHESIA; SURVIVAL; PROGRAM		[Pearse, Rupert M.] Queen Marys Univ London, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Holt, Peter J. E.] St George Hosp, Vasc Inst, Dept Outcomes Res, London, England; [Grocott, Michael P. W.] Univ Southampton, Southampton SO17 1BJ, Hants, England; [Grocott, Michael P. W.] UCLH UCL Comprehens Biomed Res Ctr, Surg Outcomes Res Ctr, London, England	University of London; Queen Mary University London; St Georges University London; University of Southampton; University of London; University College London	Pearse, RM (corresponding author), Royal London Hosp, Intens Care Unit, London E1 1BB, England.	r.pearse@qmul.ac.uk	Grocott, Michael/C-4394-2008; Holt, Peter J.E./B-2003-2013; Pearse, Rupert/H-5426-2011	Grocott, Michael/0000-0002-9484-7581; Holt, Peter J.E./0000-0002-5739-2813; Pearse, Rupert/0000-0002-4373-5934	LiDCO Ltd; BOC Medical; Smiths Medical; Deltex Medical; National Institute for Health Research [CS/08/08/17, CL-2007-16-002] Funding Source: researchfish	LiDCO Ltd; BOC Medical; Smiths Medical; Deltex Medical; National Institute for Health Research(National Institute for Health Research (NIHR))	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that we have received no support from any company for the submitted work; RMP and MPWG have the following relationships with companies that might have an interest in the submitted work: RMP has received a research grant from LiDCO Ltd and honoraria from Covidien, Pulsion Medical Systems and Edwards Lifesciences. MPWG has received unrestricted grant funding from BOC Medical, Smiths Medical and Deltex Medical. The authors have no other relationships or activities that could appear to have influenced the submitted work.	[Anonymous], CARDIOQ ODM OES DOPP; [Anonymous], 2011, BRIT CONSENSUS GUIDE; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Conde M, 2008, CLIN EVID, V2008, P2201; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Devereaux PJ, 2005, BMJ-BRIT MED J, V331, P313, DOI 10.1136/bmj.38503.623646.8F; Donati A, 2004, BRIT J ANAESTH, V93, P393, DOI 10.1093/bja/aeh210; Eskicioglu C, 2009, J GASTROINTEST SURG, V13, P2321, DOI 10.1007/s11605-009-0927-2; Ferreyra GP, 2008, ANN SURG, V247, P617, DOI 10.1097/SLA.0b013e3181675829; Fleisher LA, 2007, CIRCULATION, V116, P1971, DOI 10.1161/CIRCULATIONAHA.107.185700; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Gouvas N, 2009, INT J COLORECTAL DIS, V24, P1119, DOI 10.1007/s00384-009-0703-5; Hamilton MA, 2011, ANESTH ANALG, V112, P1392, DOI 10.1213/ANE.0b013e3181eeaae5; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Head J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1469; Hennis PJ, 2011, POSTGRAD MED J, V87, P550, DOI 10.1136/pgmj.2010.107185; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jhanji S, 2008, ANAESTHESIA, V63, P695, DOI 10.1111/j.1365-2044.2008.05560.x; Jhanji S, 2008, ANAESTHESIA, V63, P172, DOI 10.1111/j.1365-2044.2007.05318.x; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Maessen J, 2007, BRIT J SURG, V94, P224, DOI 10.1002/bjs.5468; MEGUID MM, 1988, AM J SURG, V156, P341, DOI 10.1016/S0002-9610(88)80182-X; Meyhoff CS, 2009, JAMA-J AM MED ASSOC, V302, P1543, DOI 10.1001/jama.2009.1452; Myles PS, 2003, ANESTHESIOLOGY, V99, P982; Pasquina P, 2006, CHEST, V130, P1887, DOI 10.1378/chest.130.6.1887; Pearse RM, 2006, CRIT CARE, V10, DOI 10.1186/cc4928; Pearse RM, 2008, CRIT CARE MED, V36, P1323, DOI 10.1097/CCM.0b013e31816a091b; Popping DM, 2008, ARCH SURG-CHICAGO, V143, P990, DOI 10.1001/archsurg.143.10.990; Rodseth RN, 2008, ANAESTHESIA, V63, P1226, DOI 10.1111/j.1365-2044.2008.05574.x; Sear JW, 2008, BRIT J ANAESTH, V101, P135, DOI 10.1093/bja/aen194; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Wijeysundera DN, 2008, LANCET, V372, P562, DOI 10.1016/S0140-6736(08)61121-6; Wijeysundera DN, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5526; Wind J, 2006, BRIT J SURG, V93, P800, DOI 10.1002/bjs.5384	35	79	80	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 5	2011	343								d5759	10.1136/bmj.d5759	http://dx.doi.org/10.1136/bmj.d5759			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832CS	21976704				2022-12-28	WOS:000295779400001
J	Cooke, PA; Gormley, GJ; Gilliland, A; Cupples, ME				Cooke, P. A.; Gormley, G. J.; Gilliland, A.; Cupples, M. E.			10 MINUTE CONSULTATION Dyspepsia	BRITISH MEDICAL JOURNAL			English	Editorial Material							TREAT		[Cooke, P. A.; Gormley, G. J.; Gilliland, A.; Cupples, M. E.] Queens Univ, Dept Gen Practice, Belfast BT9 7HR, Antrim, North Ireland	Queens University Belfast	Cooke, PA (corresponding author), Queens Univ, Dept Gen Practice, Belfast BT9 7HR, Antrim, North Ireland.	pcooke03@qub.ac.uk	Cooke, Philip/GRO-1618-2022	Cupples, Margaret/0000-0002-4248-9700	Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; ESRC [ES/G007438/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Delaney BC, 2008, BMJ-BRIT MED J, V336, P651, DOI 10.1136/bmj.39479.640486.AE; Gillen D, 1999, AM J GASTROENTEROL, V94, P75; McNulty C, 2005, BMJ-BRIT MED J, V330, P105, DOI 10.1136/bmj.330.7483.105; NICE, 2004, NICE CLIN GUID; Thomson ABR, 2010, WORLD J GASTROENTERO, V16, P2323, DOI 10.3748/wjg.v16.i19.2323	5	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 30	2011	343								d6234	10.1136/bmj.d6234	http://dx.doi.org/10.1136/bmj.d6234			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829KD	21964545				2022-12-28	WOS:000295577600002
J	Gold, KJ				Gold, Katherine J.			In the Still of the Night	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gold, Katherine J.] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA; [Gold, Katherine J.] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gold, KJ (corresponding author), Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA.	ktgold@umich.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 28	2011	306	12					1303	1304		10.1001/jama.2011.1361	http://dx.doi.org/10.1001/jama.2011.1361			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825FQ	21954469				2022-12-28	WOS:000295257000001
J	Nosonovsky, M				Nosonovsky, Michael			MATERIALS SCIENCE Slippery when wetted	NATURE			English	Editorial Material							SURFACES; WATER		Univ Wisconsin, Coll Engn & Appl Sci, Dept Mech Engn, Milwaukee, WI 53211 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Nosonovsky, M (corresponding author), Univ Wisconsin, Coll Engn & Appl Sci, Dept Mech Engn, Milwaukee, WI 53211 USA.	nosonovs@uwm.edu	Nosonovsky, Michael/B-2228-2012; Nosonovsky, Michael/AAS-1411-2020					Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Bohn HF, 2004, P NATL ACAD SCI USA, V101, P14138, DOI 10.1073/pnas.0405885101; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; NOSONOVSKY M, BIOMIMETICS IN PRESS; Tuteja A, 2008, P NATL ACAD SCI USA, V105, P18200, DOI 10.1073/pnas.0804872105; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447	7	150	157	4	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2011	477	7365					412	413		10.1038/477412a	http://dx.doi.org/10.1038/477412a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21938059				2022-12-28	WOS:000295080500026
J	Pan, A; Sun, Q; Okereke, OI; Rexrode, KM; Hu, FB				Pan, An; Sun, Qi; Okereke, Olivia I.; Rexrode, Kathryn M.; Hu, Frank B.			Depression and Risk of Stroke Morbidity and Mortality A Meta-analysis and Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; FOLLOW-UP; ISCHEMIC-STROKE; META-ANALYSIS; OLDER-ADULTS; CARDIOVASCULAR MORBIDITY; PSYCHOLOGICAL DISTRESS; POSTMENOPAUSAL WOMEN; PUBLICATION BIAS	Context Several studies have suggested that depression is associated with an increased risk of stroke; however, the results are inconsistent. Objective To conduct a systematic review and meta-analysis of prospective studies assessing the association between depression and risk of developing stroke in adults. Data Sources A search of MEDLINE, EMBASE, and PsycINFO databases (to May 2011) was supplemented by manual searches of bibliographies of key retrieved articles and relevant reviews. Study Selection We included prospective cohort studies that reported risk estimates of stroke morbidity or mortality by baseline or updated depression status assessed by self-reported scales or clinician diagnosis. Data Extraction Two independent reviewers extracted data on depression status at baseline, risk estimates of stroke, study quality, and methods used to assess depression and stroke. Hazard ratios (HRs) were pooled using fixed-effect or random-effects models when appropriate. Associations were tested in subgroups representing different participant and study characteristics. Publication bias was evaluated with funnel plots and Begg test. Results The search yielded 28 prospective cohort studies (comprising 317 540 participants) that reported 8478 stroke cases (morbidity and mortality) during a follow-up period ranging from 2 to 29 years. The pooled adjusted HRs were 1.45 (95% CI, 1.29-1.63; P for heterogeneity <.001; random-effects model) for total stroke, 1.55 (95% CI, 1.25-1.93; P for heterogeneity=.31; fixed-effects model) for fatal stroke (8 studies), and 1.25 (95% CI, 1.11-1.40; P for heterogeneity=.34; fixed-effects model) for ischemic stroke (6 studies). The estimated absolute risk differences associated with depression were 106 cases for total stroke, 53 cases for ischemic stroke, and 22 cases for fatal stroke per 100 000 individuals per year. The increased risk of total stroke associated with depression was consistent across most subgroups. Conclusion Depression is associated with a significantly increased risk of stroke morbidity and mortality. JAMA. 2011;306(11):1241-1249 www.jama.com	[Pan, An; Sun, Qi; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02215 USA; [Okereke, Olivia I.; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Okereke, Olivia I.] Brigham & Womens Hosp, Dept Med, Dept Psychiat, Boston, MA 02115 USA; [Sun, Qi; Okereke, Olivia I.; Hu, Frank B.] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA; [Rexrode, Kathryn M.] Brigham & Womens Hosp, Div Prevent Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 655 Huntington Ave, Boston, MA 02215 USA.	frank.hu@channing.harvard.edu	Hu, Frank/C-1919-2013; Okereke, Olivia I/R-9934-2016; Rexrode, Kathryn M/I-1177-2018; Pan, An/C-5572-2011; Okereke, Olivia/AAF-7031-2021	Pan, An/0000-0002-1089-7945; Rexrode, Kathryn/0000-0003-3387-8429	Merck; National Institutes of Health [HL034594, HL088521]; National Heart, Lung, and Blood Institute [K99HL098459]; National Institute on Aging [K08AG029813]; National Institute of Mental Health [R01MH091448]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594, K99HL098459, R01HL088521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG029813] Funding Source: NIH RePORTER	Merck(Merck & Company); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Hu reported that his institute is receiving a grant from Merck for research on the genetics of diabetes mellitus; The project was supported by grants HL034594 and HL088521 from the National Institutes of Health. Dr Sun was supported by a career development award K99HL098459 from the National Heart, Lung, and Blood Institute. Dr Okereke was supported by a career development award K08AG029813 from the National Institute on Aging, and R01MH091448 from the National Institute of Mental Health. No other disclosures were reported.	Arbelaez JJ, 2007, J AM GERIATR SOC, V55, P1825, DOI 10.1111/j.1532-5415.2007.01393.x; Avendano M, 2006, STROKE, V37, P1368, DOI 10.1161/01.STR.0000221702.75002.66; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bos MJ, 2008, J NEUROL NEUROSUR PS, V79, P997, DOI 10.1136/jnnp.2007.134965; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Everson SA, 1998, ARCH INTERN MED, V158, P1133, DOI 10.1001/archinte.158.10.1133; Glymour MM, 2010, NEUROLOGY, V75, P2063, DOI 10.1212/WNL.0b013e318200d70e; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Gonzalez O., 2010, Morbidity and Mortality Weekly Report, V59, P1229; Gump BB, 2005, STROKE, V36, P98, DOI 10.1161/01.STR.0000149626.50127.d0; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Jonas BS, 2000, PSYCHOSOM MED, V62, P463, DOI 10.1097/00006842-200007000-00001; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kawamura TL, 2007, J INVEST MED, V55, P106, DOI 10.2310/6650.2007.06040; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Larson SL, 2001, STROKE, V32, P1979, DOI 10.1161/hs0901.094623; Lee HC, 2008, BIOL PSYCHIAT, V64, P912, DOI 10.1016/j.biopsych.2008.07.006; Liebetrau M, 2008, STROKE, V39, P1960, DOI 10.1161/STROKEAHA.107.490797; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; May M, 2002, STROKE, V33, P7, DOI 10.1161/hs0102.100529; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Nabi H, 2010, INT J EPIDEMIOL, V39, P1016, DOI 10.1093/ije/dyq050; Nilsson FM, 2004, EUR ARCH PSY CLIN N, V254, P387, DOI 10.1007/s00406-004-0519-9; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Ohira T, 2001, STROKE, V32, P903, DOI 10.1161/01.STR.32.4.903; Ostir GV, 2001, PSYCHOSOM MED, V63, P210, DOI 10.1097/00006842-200103000-00003; Ostir GV, 2003, J GERONTOL A-BIOL, V58, P531; Pan A, 2011, STROKE, V42, P2770, DOI 10.1161/STROKEAHA.111.617043; Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356; Patten SB, 2009, PSYCHOSOM MED, V71, P273, DOI 10.1097/PSY.0b013e3181988e5f; Peters R, 2010, AGE AGEING, V39, P439, DOI 10.1093/ageing/afq042; Ramasubbu R, 2003, CAN J PSYCHIAT, V48, P250, DOI 10.1177/070674370304800409; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Salaycik KJ, 2007, STROKE, V38, P16, DOI 10.1161/01.STR.0000251695.39877.ca; Shimbo D, 2005, AM J CARDIOL, V96, P1016, DOI 10.1016/j.amjcard.2005.05.064; SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789; Simons LA, 1998, STROKE, V29, P1341, DOI 10.1161/01.STR.29.7.1341; SIMONSICK EM, 1995, PSYCHOSOM MED, V57, P427, DOI 10.1097/00006842-199509000-00003; Smoller JW, 2009, ARCH INTERN MED, V169, P2128, DOI 10.1001/archinternmed.2009.436; Strazzullo P, 2010, STROKE, V41, pE418, DOI 10.1161/STROKEAHA.109.576967; Strine TW, 2008, GEN HOSP PSYCHIAT, V30, P127, DOI 10.1016/j.genhosppsych.2007.12.008; Sturmer T, 2006, BRIT MED J, V332, P1359, DOI 10.1136/bmj.38833.479560.80; Surtees PG, 2008, NEUROLOGY, V70, P788, DOI 10.1212/01.wnl.0000304109.18563.81; Thomas AJ, 2004, J AFFECT DISORDERS, V79, P81, DOI 10.1016/S0165-0327(02)00349-x; Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723; VOGT T, 1994, AM J PUBLIC HEALTH, V84, P227, DOI 10.2105/AJPH.84.2.227; Wassertheil-Smoller S, 2004, ARCH INTERN MED, V164, P289, DOI 10.1001/archinte.164.3.289; WassertheilSmoller S, 1996, ARCH INTERN MED, V156, P553, DOI 10.1001/archinte.156.5.553; WHO, 2001, WORLD HLTH REPORT 20; Whooley MA, 1998, ARCH INTERN MED, V158, P2129, DOI 10.1001/archinte.158.19.2129; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Wouts L, 2008, ARCH GEN PSYCHIAT, V65, P596, DOI 10.1001/archpsyc.65.5.596; Yasuda N, 2002, J AM GERIATR SOC, V50, P313, DOI 10.1046/j.1532-5415.2002.50064.x	57	486	500	0	66	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2011	306	11					1241	1249		10.1001/jama.2011.1282	http://dx.doi.org/10.1001/jama.2011.1282			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822HB	21934057	Green Accepted			2022-12-28	WOS:000295033500025
J	Bauer, DC				Bauer, Douglas C.			Current use of levothyroxine was associated with increased risk for fractures in patients >= 70 years of age	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							THYROID-STIMULATING HORMONE; WOMEN		Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bauer, DC (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.			Bauer, Douglas/0000-0001-5261-7721				Bauer DC, 2001, ANN INTERN MED, V134, P561, DOI 10.7326/0003-4819-134-7-200104030-00009; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Flynn RW, 2010, J CLIN ENDOCR METAB, V95, P186, DOI 10.1210/jc.2009-1625	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6							JC3-5	10.7326/0003-4819-155-6-201109200-02005	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930842				2022-12-28	WOS:000295033400004
J	Dunn, A				Dunn, Andrew			4 clinical decision rules plus D-dimer testing each had high sensitivity and low specificity for excluding acute pulmonary embolism	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PROBABILITY		Mt Sinai Sch Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Dunn, A (corresponding author), Mt Sinai Sch Med, New York, NY 10029 USA.							Ten Cate-Hoek AJ, 2005, J THROMB HAEMOST, V3, P2465, DOI 10.1111/j.1538-7836.2005.01556.x; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6							JC3-11	10.7326/0003-4819-155-6-201109200-02011	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930848				2022-12-28	WOS:000295033400010
J	Williams, SA; Maecker, HL; French, DM; Liu, JF; Gregg, A; Silverstein, LB; Cao, TC; Carano, RAD; Dixit, VM				Williams, Samuel A.; Maecker, Heather L.; French, Dorothy M.; Liu, Jinfeng; Gregg, Andrew; Silverstein, Leah B.; Cao, Tim C.; Carano, Richard A. D.; Dixit, Vishva M.			USP1 Deubiquitinates ID Proteins to Preserve a Mesenchymal Stem Cell Program in Osteosarcoma	CELL			English	Article							LOOP-HELIX PROTEINS; UBIQUITIN-PROTEASOME PATHWAY; FANCONI-ANEMIA PATHWAY; OSTEOBLAST DIFFERENTIATION; RETINOBLASTOMA PROTEIN; GROWTH ARREST; IN-VIVO; CANCER; GENE; MICE	Inhibitors of DNA binding (IDs) antagonize basic-helix-loop-helix (bHLH) transcription factors to inhibit differentiation and maintain stem cell fate. ID ubiquitination and proteasomal degradation occur in differentiated tissues, but IDs in many neoplasms appear to escape degradation. We show that the deubiquitinating enzyme USP1 promotes ID protein stability and stem cell-like characteristics in osteosarcoma. USP1 bound, deubiquitinated, and thereby stabilized ID1, ID2, and ID3. A subset of primary human osteosarcomas coordinately overexpressed USP1 and ID proteins. USP1 knockdown in osteosarcoma cells precipitated ID protein destabilization, cell-cycle arrest, and osteogenic differentiation. Conversely, ectopic USP1 expression in mesenchymal stem cells stabilized ID proteins, inhibited osteoblastic differentiation, and enhanced proliferation. Consistent with USP1 functioning in normal mesenchymal stem cells, USP1-deficient mice were osteopenic. Our observations implicate USP1 in preservation of the stem cell state that characterizes osteosarcoma and identify USP1 as a target for differentiation therapy.	[Williams, Samuel A.; Gregg, Andrew; Silverstein, Leah B.; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Maecker, Heather L.] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [French, Dorothy M.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Liu, Jinfeng] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Cao, Tim C.; Carano, Richard A. D.] Genentech Inc, Dept Biomed Imaging, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	高, 雨莉/HGU-8187-2022; dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; Liu, Jinfeng/0000-0002-0343-8222; Maecker, Heather/0000-0002-5378-1141; Williams, Samuel/0000-0003-2642-3039				Bounpheng MA, 1999, FASEB J, V13, P2257, DOI 10.1096/fasebj.13.15.2257; Ciarapica R, 2009, ONCOGENE, V28, P1881, DOI 10.1038/onc.2009.56; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; Di Fiore R, 2009, J CELL PHYSIOL, V219, P301, DOI 10.1002/jcp.21667; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Funato N, 2001, MOL CELL BIOL, V21, P7416, DOI 10.1128/MCB.21.21.7416-7428.2001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; KASTAN MB, 1991, CANCER RES, V51, P6304; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Kim D, 1999, MOL CELL BIOL, V19, P8240; Kim JM, 2009, DEV CELL, V16, P314, DOI 10.1016/j.devcel.2009.01.001; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Maeda Y, 2004, J CELL BIOCHEM, V93, P337, DOI 10.1002/jcb.20154; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Matsumoto T, 1998, CANCER LETT, V129, P61, DOI 10.1016/S0304-3835(98)00080-9; Miller CW, 1996, CANCER GENET CYTOGEN, V86, P136, DOI 10.1016/0165-4608(95)00216-2; Nielsen GP, 1998, AM J PATHOL, V153, P159, DOI 10.1016/S0002-9440(10)65556-3; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nishimori H, 2002, ONCOGENE, V21, P8302, DOI 10.1038/sj.onc.1206025; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Oh JH, 2006, CLIN ORTHOP RELAT R, P216, DOI 10.1097/01.blo.0000188063.56091.69; Ozaki T, 2003, CANCER GENET CYTOGEN, V140, P145, DOI 10.1016/S0165-4608(02)00685-4; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Parmar K, 2010, STEM CELLS, V28, P1186, DOI 10.1002/stem.437; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Roa S, 2008, P NATL ACAD SCI USA, V105, P16248, DOI 10.1073/pnas.0808182105; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Stock C, 2000, GENE CHROMOSOME CANC, V28, P329, DOI 10.1002/1098-2264(200007)28:3<329::AID-GCC11>3.0.CO;2-F; Suh JH, 2008, BIOCHEM BIOPH RES CO, V367, P97, DOI 10.1016/j.bbrc.2007.12.100; Tang N, 2008, CLIN ORTHOP RELAT R, V466, P2114, DOI 10.1007/s11999-008-0335-z; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; WEINTRAUB H, 1994, GENE DEV, V8, P2203, DOI 10.1101/gad.8.18.2203; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Yokota Y, 2002, J CELL PHYSIOL, V190, P21, DOI 10.1002/jcp.10042; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	51	168	176	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2011	146	6					917	929		10.1016/j.cell.2011.07.040	http://dx.doi.org/10.1016/j.cell.2011.07.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925315	Bronze			2022-12-28	WOS:000295258100014
J	Gale, EAM; Yudkin, JS				Gale, Edwin A. M.; Yudkin, John S.			Commentary: Politics of affordable insulin	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gale, Edwin A. M.] Univ Bristol, Bristol, Avon, England; [Yudkin, John S.] UCL, London, England	University of Bristol; University of London; University College London	Gale, EAM (corresponding author), Univ Bristol, Bristol, Avon, England.	Edwin.Gale@bristol.ac.uk	Yudkin, John S/C-1988-2008					18th Expert Committee on the Selection and Use of Essential Medicines, 2011, REV EV COMP INS HUM; [Anonymous], 2011, BBC NEWS        0824; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Currie CJ, 2010, DIABETIC MED, V27, P744, DOI 10.1111/j.1464-5491.2009.02849.x; Gale EAM, 2000, DIABETIC MED, V17, P209; *HAI GLOB, LIF SAV INS LARG UN; Hauber A, 2006, DIABETOLOGIA, V49, P247, DOI 10.1007/s00125-005-0108-0; *HOP WORLDW, EL LILL PROV LIF CHI; *NAT COLL CTR CHRO, 2008, TYP 2 DIAB NAT CLIN; *NOVONORDISK, NOVO NORD LEAD IN LE; World Health Organization, 2009, PREQ PROGR UN PROGR; World Health Organization, 2011, UN REP 18 EXP COMM S; Yudkin JS, 2011, LANCET, V377, P1220, DOI 10.1016/S0140-6736(10)61112-9	13	4	4	0	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2011	343								d5675	10.1136/bmj.d5675	http://dx.doi.org/10.1136/bmj.d5675			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822VM	21917829				2022-12-28	WOS:000295078100004
J	Prosser, BL; Ward, CW; Lederer, WJ				Prosser, Benjamin L.; Ward, Christopher W.; Lederer, W. J.			X-ROS Signaling: Rapid Mechano-Chemo Transduction in Heart	SCIENCE			English	Article							RETICULUM CA2+ LEAK; NADPH OXIDASE; VENTRICULAR MYOCYTES; AXIAL STRETCH; INHIBITOR; PRESSURE; INCREASE; SPARKS	We report that in heart cells, physiologic stretch rapidly activates reduced-form nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 (NOX2) to produce reactive oxygen species (ROS) in a process dependent on microtubules (X-ROS signaling). ROS production occurs in the sarcolemmal and t-tubule membranes where NOX2 is located and sensitizes nearby ryanodine receptors (RyRs) in the sarcoplasmic reticulum (SR). This triggers a burst of Ca2+ sparks, the elementary Ca2+ release events in heart. Although this stretch-dependent "tuning" of RyRs increases Ca2+ signaling sensitivity in healthy cardiomyocytes, in disease it enables Ca2+ sparks to trigger arrhythmogenic Ca2+ waves. In the mouse model of Duchenne muscular dystrophy, hyperactive X-ROS signaling contributes to cardiomyopathy through aberrant Ca2+ release from the SR. X-ROS signaling thus provides a mechanistic explanation for the mechanotransduction of Ca2+ release in the heart and offers fresh therapeutic possibilities.	[Ward, Christopher W.] Univ Maryland, Sch Nursing, Baltimore, MD 21209 USA; [Prosser, Benjamin L.; Lederer, W. J.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol BioMET, Baltimore, MD 21209 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Ward, CW (corresponding author), Univ Maryland, Sch Nursing, Baltimore, MD 21209 USA.	ward@son.umaryland.edu; jlederer@umaryland.edu		Prosser, Benjamin/0000-0003-3696-9131	NIH [T32 HL072751-07, R01 HL106059, P01 HL67849, R01 HL36974, RC2 NR011968, S10 RR023028]; Leducq North American-European Atrial Fibrillation Research Alliance; European Union; Georg August University; Maryland Stem Cell Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023028] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106059, P01HL067849, R01HL036974, T32HL072751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [RC2NR011968] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq North American-European Atrial Fibrillation Research Alliance; European Union(European Commission); Georg August University; Maryland Stem Cell Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	We thank S. Martin for antibodies to tubulin subunits and for discussion, G. Shi for technical assistance, and M. Williams for NOX2<SUP>-/-</SUP> animals. B.L.P is supported by an NIH training grant (T32 HL072751-07) to the Training Program in Cardiovascular Cell Biology. This work was supported by NIH grants R01 HL106059, P01 HL67849, R01 HL36974, RC2 NR011968, and S10 RR023028; Leducq North American-European Atrial Fibrillation Research Alliance; European Union Seventh Framework Program (FP7), Georg August University, "Identification and therapeutic targeting of common arrhythmia trigger mechanisms"; and the Maryland Stem Cell Research Fund. World Precision Instruments (WPI, Sarasota, FL, USA and SI-Heidelberg), Gabe Sinclair (Fourhourday, Baltimore, MD, USA), and Siskiyou (Grants Pass, OR, USA) supported instrumentation and equipment development.	Akki A, 2009, J MOL CELL CARDIOL, V47, P15, DOI 10.1016/j.yjmcc.2009.04.004; Best A, 1996, J BIOL CHEM, V271, P3756; Byrne JA, 2003, CIRC RES, V93, P802, DOI 10.1161/01.RES.0000099504.30207.F5; Cannell MB, 2009, CIRC RES, V104, P715, DOI 10.1161/CIRCRESAHA.109.195511; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; Donoso P, 2011, FRONT BIOSCI-LANDMRK, V16, P553, DOI 10.2741/3705; Fauconnier J, 2010, P NATL ACAD SCI USA, V107, P1559, DOI 10.1073/pnas.0908540107; Hein S, 2000, CARDIOVASC RES, V45, P273, DOI 10.1016/S0008-6363(99)00268-0; Hidalgo C, 2006, J BIOL CHEM, V281, P26473, DOI 10.1074/jbc.M600451200; Iribe G, 2008, PROG BIOPHYS MOL BIO, V97, P298, DOI 10.1016/j.pbiomolbio.2008.02.012; Iribe G, 2009, CIRC RES, V104, P787, DOI 10.1161/CIRCRESAHA.108.193334; Jung C, 2008, CARDIOVASC RES, V77, P766, DOI 10.1093/cvr/cvm089; Knoll R, 2003, J MOL MED, V81, P750, DOI 10.1007/s00109-003-0488-x; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Murdoch CE, 2006, CARDIOVASC RES, V71, P208, DOI 10.1016/j.cardiores.2006.03.016; Prosser BL, 2010, J GEN PHYSIOL, V136, P135, DOI 10.1085/jgp.201010406; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Sanchez G, 2008, CARDIOVASC RES, V77, P380, DOI 10.1093/cvr/cvm011; Santana LF, 1996, CIRC RES, V78, P166, DOI 10.1161/01.RES.78.1.166; Terentyev D, 2008, CIRC RES, V103, P1466, DOI 10.1161/CIRCRESAHA.108.184457; Toh R, 2006, BIOPHYS J, V90, P1723, DOI 10.1529/biophysj.105.074062; Ullrich ND, 2009, AM J PHYSIOL-HEART C, V297, pH1992, DOI 10.1152/ajpheart.00602.2009; Williams IA, 2007, AM J PHYSIOL-HEART C, V293, pH1969, DOI 10.1152/ajpheart.00489.2007; Williams IA, 2007, AM J PHYSIOL-HEART C, V292, pH846, DOI 10.1152/ajpheart.00688.2006; Yasuda S, 2005, NATURE, V436, P1025, DOI 10.1038/nature03844	27	392	399	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2011	333	6048					1440	1445		10.1126/science.1202768	http://dx.doi.org/10.1126/science.1202768			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21903813				2022-12-28	WOS:000294672200041
J	Sacco, RL; Smith, SC; Holmes, D; Shurin, S; Brawley, O; Cazap, E; Glass, R; Komajda, M; Koroshetz, W; Mayer-Davis, E; Mbanya, JC; Sledge, G; Varmus, H				Sacco, R. L.; Smith, S. C.; Holmes, D.; Shurin, S.; Brawley, O.; Cazap, E.; Glass, R.; Komajda, M.; Koroshetz, W.; Mayer-Davis, E.; Mbanya, J. C.; Sledge, G.; Varmus, H.			Accelerating progress on non-communicable diseases	LANCET			English	Editorial Material									[Sacco, R. L.] Amer Heart Assoc, Dallas, TX 75231 USA; [Smith, S. C.] World Heart Federat, Geneva, Switzerland; [Holmes, D.] Amer Coll Cardiol, Washington, DC USA; [Shurin, S.] NHLBI, NIH, Bethesda, MD 20892 USA; [Glass, R.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Koroshetz, W.] NINDS, NIH, Bethesda, MD 20892 USA; [Varmus, H.] NCI, NIH, Bethesda, MD 20892 USA; [Brawley, O.] Amer Canc Soc, Atlanta, GA 30329 USA; [Cazap, E.] Union Int Canc Control, Geneva, Switzerland; [Komajda, M.] European Soc Cardiol, Sophia Antipolis, France; [Mayer-Davis, E.] Amer Diabet Assoc, Alexandria, VA USA; [Mbanya, J. C.] Int Diabet Federat, Brussels, Belgium; [Sledge, G.] Amer Soc Clin Oncol, Alexandria, VA USA	American College of Cardiology; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Cancer Society; American Diabetes Association; American Society of Clinical Oncology	Sacco, RL (corresponding author), Amer Heart Assoc, Dallas, TX 75231 USA.	rsacco@med.miami.edu	Sacco, Ralph/Y-9278-2019; Mbanya, Jean Claude N/T-5147-2018	Mbanya, Jean Claude N/0000-0001-9651-8653				[Anonymous], PREV HLTH AM INV DIS; [Anonymous], 2011, BURD BEST BUYS RED E; Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Behan D., 2005, EC EFFECTS ENV TOBAC; Dall TM, 2009, AM J HEALTH PROMOT, V23, P412, DOI 10.4278/ajhp.080930-QUAN-226; Organization W. H, 2009, 2008 2013 ACT PLAN G; Organization WH, 2016, GLOBAL STATUS REPORT; Sacco RL, 2011, CIRCULATION, V123, P2653, DOI 10.1161/CIR.0b013e318220dec1; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2010, GLOB STRAT RED HARMF	12	16	18	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2013	382	9895					E4	E5		10.1016/S0140-6736(11)61477-3	http://dx.doi.org/10.1016/S0140-6736(11)61477-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215WE	21933747				2022-12-28	WOS:000324240700001
J	Gabor, NM; Song, JCW; Ma, Q; Nair, NL; Taychatanapat, T; Watanabe, K; Taniguchi, T; Levitov, LS; Jarillo-Herrero, P				Gabor, Nathaniel M.; Song, Justin C. W.; Ma, Qiong; Nair, Nityan L.; Taychatanapat, Thiti; Watanabe, Kenji; Taniguchi, Takashi; Levitov, Leonid S.; Jarillo-Herrero, Pablo			Hot Carrier-Assisted Intrinsic Photoresponse in Graphene	SCIENCE			English	Article							PHOTODETECTORS; GENERATION	We report on the intrinsic optoelectronic response of high-quality dual-gated monolayer and bilayer graphene p-n junction devices. Local laser excitation (of wavelength 850 nanometers) at the p-n interface leads to striking six-fold photovoltage patterns as a function of bottom-and top-gate voltages. These patterns, together with the measured spatial and density dependence of the photoresponse, provide strong evidence that nonlocal hot carrier transport, rather than the photovoltaic effect, dominates the intrinsic photoresponse in graphene. This regime, which features a long-lived and spatially distributed hot carrier population, may offer a path to hot carrier-assisted thermoelectric technologies for efficient solar energy harvesting.	[Gabor, Nathaniel M.; Song, Justin C. W.; Ma, Qiong; Nair, Nityan L.; Taychatanapat, Thiti; Levitov, Leonid S.; Jarillo-Herrero, Pablo] MIT, Dept Phys, Cambridge, MA 02139 USA; [Song, Justin C. W.] Harvard Univ, Harvard Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Taychatanapat, Thiti] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan	Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; National Institute for Materials Science	Jarillo-Herrero, P (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	pjarillo@mit.edu	Song, Justin CW/M-1353-2017; WATANABE, Kenji/H-2825-2011; Watanabe, Kenji/ABB-2135-2021; TANIGUCHI, Takashi/H-2718-2011; Jarillo-Herrero, Pablo/E-3755-2013	Song, Justin CW/0000-0002-5175-6970; WATANABE, Kenji/0000-0003-3701-8119; Watanabe, Kenji/0000-0003-3701-8119; Gabor, Nathaniel/0000-0002-0351-2787; Jarillo-Herrero, Pablo/0000-0001-8217-8213; Levitov, Leonid/0000-0002-4268-731X	Air Force Office of Scientific Research; NSF; Packard Foundation	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation)	We thank M. Baldo, P. McEuen, P. Kim, and A. Yacoby for valuable discussions. Supported by the Air Force Office of Scientific Research, a NSF Early Career Award (P.J.H.), and the Packard Foundation. Sample fabrication was performed at the NSF-funded MIT Center for Materials Science and Engineering and Harvard Center for Nanoscale Science.	Ashcroft N.W., 1976, SOLID STATE PHYS; Bistritzer R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.206410; Castro EV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.216802; Checkelsky JG, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.081413; Gabor NM, 2009, SCIENCE, V325, P1367, DOI 10.1126/science.1176112; Huard B, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.236803; Hwang EH, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.235415; Kraemer D, 2011, NAT MATER, V10, P532, DOI [10.1038/NMAT3013, 10.1038/nmat3013]; Lee EJH, 2008, NAT NANOTECHNOL, V3, P486, DOI 10.1038/nnano.2008.172; Lemme M. C., 2011, NANO LETT, DOI [10.1021/nl2019068, DOI 10.1021/NL2019068]; McCann E, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.161403; Mueller T, 2010, NAT PHOTONICS, V4, P297, DOI 10.1038/NPHOTON.2010.40; Nazin G, 2010, NAT PHYS, V6, P870, DOI [10.1038/nphys1745, 10.1038/NPHYS1745]; Ozyilmaz B, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.166804; Ohta T, 2006, SCIENCE, V313, P951, DOI 10.1126/science.1130681; Park J, 2009, NANO LETT, V9, P1742, DOI 10.1021/nl8029493; ROSS RT, 1982, J APPL PHYS, V53, P3813, DOI 10.1063/1.331124; Song J. C., 2011, NANO LETT, DOI [10.1021/nl202318u, DOI 10.1021/NL202318U]; Strait J. H., 2011, NANO LETT, DOI [10.1021/nl202800h, DOI 10.1021/NL202800H]; Sukhovatkin V, 2009, SCIENCE, V324, P1542, DOI 10.1126/science.1173812; Sun D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.157402; Sze S., 1981, PHYS SEMICONDUCTOR D, V2nd ed., P85; Wei P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.166808; Williams JR, 2007, SCIENCE, V317, P638, DOI 10.1126/science.1144657; Winzer T, 2010, NANO LETT, V10, P4839, DOI 10.1021/nl1024485; Xia FN, 2009, NAT NANOTECHNOL, V4, P839, DOI [10.1038/nnano.2009.292, 10.1038/NNANO.2009.292]; Zuev YM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096807	28	759	776	17	788	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2011	334	6056					648	652		10.1126/science.1211384	http://dx.doi.org/10.1126/science.1211384			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	21979935	Green Submitted			2022-12-28	WOS:000296494700049
J	Koes, B				Koes, Bart			Management of low back pain in primary care: a new approach	LANCET			English	Editorial Material									Erasmus Univ, Med Ctr, Dept Gen Practice, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Koes, B (corresponding author), Erasmus Univ, Med Ctr, Dept Gen Practice, NL-3000 CA Rotterdam, Netherlands.	b.koes@erasmusmc.nl	Koes, Bart w/K-4614-2016	Koes, Bart w/0000-0002-0450-9969				Foster NE, 2011, MANUAL THER, V16, P3, DOI 10.1016/j.math.2010.05.013; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Kamper SJ, 2010, BEST PRACT RES CL RH, V24, P181, DOI 10.1016/j.berh.2009.11.003; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Kuijpers T, 2011, EUR SPINE J, V20, P40, DOI 10.1007/s00586-010-1541-4; Rubinstein SM, 2010, EUR SPINE J, V19, P1213, DOI 10.1007/s00586-010-1356-3; Stanton TR, 2010, PHYS THER, V90, P843, DOI 10.2522/ptj.20090233; van Middelkoop M, 2011, EUR SPINE J, V20, P19, DOI 10.1007/s00586-010-1518-3; van Tulder MW, 2006, EUR SPINE J, V15, pS64, DOI 10.1007/s00586-005-1048-6	9	3	3	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 29	2011	378	9802					1530	1532		10.1016/S0140-6736(11)61033-7	http://dx.doi.org/10.1016/S0140-6736(11)61033-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844SL	21963003				2022-12-28	WOS:000296767500008
J	Manney, GL; Santee, ML; Rex, M; Livesey, NJ; Pitts, MC; Veefkind, P; Nash, ER; Wohltmann, I; Lehmann, R; Froidevaux, L; Poole, LR; Schoeberl, MR; Haffner, DP; Davies, J; Dorokhov, V; Gernandt, H; Johnson, B; Kivi, R; Kyro, E; Larsen, N; Levelt, PF; Makshtas, A; McElroy, CT; Nakajima, H; Parrondo, MC; Tarasick, DW; von der Gathen, P; Walker, KA; Zinoviev, NS				Manney, Gloria L.; Santee, Michelle L.; Rex, Markus; Livesey, Nathaniel J.; Pitts, Michael C.; Veefkind, Pepijn; Nash, Eric R.; Wohltmann, Ingo; Lehmann, Ralph; Froidevaux, Lucien; Poole, Lamont R.; Schoeberl, Mark R.; Haffner, David P.; Davies, Jonathan; Dorokhov, Valery; Gernandt, Hartwig; Johnson, Bryan; Kivi, Rigel; Kyro, Esko; Larsen, Niels; Levelt, Pieternel F.; Makshtas, Alexander; McElroy, C. Thomas; Nakajima, Hideaki; Concepcion Parrondo, Maria; Tarasick, David W.; von der Gathen, Peter; Walker, Kaley A.; Zinoviev, Nikita S.			Unprecedented Arctic ozone loss in 2011	NATURE			English	Article							STRATOSPHERIC POLAR VORTEX; MICROWAVE LIMB SOUNDER; CHEMICAL DEPLETION; CLOUD OBSERVATIONS; TRANSPORT; MLS; CLIMATOLOGY; ANTARCTICA; CHEMISTRY; DYNAMICS	Chemical ozone destruction occurs over both polar regions in local winter-spring. In the Antarctic, essentially complete removal of lower-stratospheric ozone currently results in an ozone hole every year, whereas in the Arctic, ozone loss is highly variable and has until now been much more limited. Here we demonstrate that chemical ozone destruction over the Arctic in early 2011 was-for the first time in the observational record-comparable to that in the Antarctic ozone hole. Unusually long-lasting cold conditions in the Arctic lower stratosphere led to persistent enhancement in ozone-destroying forms of chlorine and to unprecedented ozone loss, which exceeded 80 per cent over 18-20 kilometres altitude. Our results show that Arctic ozone holes are possible even with temperatures much milder than those in the Antarctic. We cannot at present predict when such severe Arctic ozone depletion may be matched or exceeded.	[Manney, Gloria L.; Santee, Michelle L.; Livesey, Nathaniel J.; Froidevaux, Lucien] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Manney, Gloria L.] New Mexico Inst Min & Technol, Socorro, NM 87801 USA; [Rex, Markus; Wohltmann, Ingo; Lehmann, Ralph; Gernandt, Hartwig; von der Gathen, Peter] Alfred Wegener Inst Polar & Marine Res, D-14473 Potsdam, Germany; [Pitts, Michael C.] NASA, Langley Res Ctr, Hampton, VA 23681 USA; [Veefkind, Pepijn; Levelt, Pieternel F.] Royal Netherlands Meteorol Inst, NL-3730 AE De Bilt, Netherlands; [Veefkind, Pepijn; Levelt, Pieternel F.] Delft Univ Technol, NL-2600 GA Delft, Netherlands; [Nash, Eric R.; Haffner, David P.] Sci Syst & Applicat Inc, Lanham, MD 20706 USA; [Poole, Lamont R.] Sci Syst & Applicat Inc, Hampton, VA 23666 USA; [Schoeberl, Mark R.] Sci & Technol Corp, Lanham, MD 20706 USA; [Davies, Jonathan; McElroy, C. Thomas; Tarasick, David W.] Environm Canada, Toronto, ON M3H 5T4, Canada; [Dorokhov, Valery] Cent Aerol Observ, Dolgoprudnyi 141700, Russia; [Johnson, Bryan] NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA; [Kivi, Rigel; Kyro, Esko] Finnish Meteorol Inst, Arctic Res Ctr, Sodankyla 99600, Finland; [Larsen, Niels] Danish Meteorol Inst, Danish Climate Ctr, DK-2100 Copenhagen, Denmark; [Levelt, Pieternel F.] Eindhoven Univ Technol, NL-5600 MB Eindhoven, Netherlands; [Makshtas, Alexander; Zinoviev, Nikita S.] Arctic & Antarctic Res Inst, St Petersburg 199397, Russia; [Nakajima, Hideaki] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Concepcion Parrondo, Maria] Natl Inst Aerosp Technol, Torrejon De Ardoz 28850, Spain; [Walker, Kaley A.] Univ Toronto, Toronto, ON M5S 1A7, Canada	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); New Mexico Institute of Mining Technology; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; National Aeronautics & Space Administration (NASA); NASA Langley Research Center; Royal Netherlands Meteorological Institute; Delft University of Technology; Science Systems and Applications Inc; Science Systems and Applications Inc; Environment & Climate Change Canada; National Oceanic Atmospheric Admin (NOAA) - USA; Finnish Meteorological Institute; Danish Meteorological Institute DMI; Eindhoven University of Technology; Arctic & Antarctic Research Institute; National Institute for Environmental Studies - Japan; University of Toronto	Manney, GL (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	Gloria.L.Manney@jpl.nasa.gov; Michelle.L.Santee@jpl.nasa.gov	Santee, MIchelle/R-5762-2019; von der Gathen, Peter/B-8515-2009; Wohltmann, Ingo/C-1301-2010; Nakajima, Hideaki/M-8845-2019; Rex, Markus/A-6054-2009; Haffner, David/V-5341-2019; Levelt, Pieternel/AAE-3835-2022; Nakajima, Hideaki/A-4309-2012; Larsen, Niels/G-3145-2014; Livesey, Nathaniel/AGQ-7257-2022	von der Gathen, Peter/0000-0001-7409-1556; Wohltmann, Ingo/0000-0003-4606-6788; Nakajima, Hideaki/0000-0002-2742-1230; Rex, Markus/0000-0001-7847-8221; Nakajima, Hideaki/0000-0002-2742-1230; Larsen, Niels/0000-0002-1582-661X; Tarasick, David/0000-0001-9869-0692	OMI; CALIPSO; Match science teams; Aura project; Environment Canada; Canadian Space Agency; Academy of Finland; EC DG Research; NASA; Grants-in-Aid for Scientific Research [20244077] Funding Source: KAKEN	OMI; CALIPSO; Match science teams; Aura project; Environment Canada(CGIAR); Canadian Space Agency(Canadian Space Agency); Academy of Finland(Academy of Finland); EC DG Research; NASA(National Aeronautics & Space Administration (NASA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the MLS (especially A. Lambert, D. Miller, W. Read, M. Schwartz, P. Stek, J. Waters), OMI (especially P. K. Bhartia, G. Jaross, G. Labow), CALIPSO and Match science teams, as well as A. Douglass, J. Joiner and the Aura project, for their support. We also thank W. Daffer and R. Fuller for programming assistance at JPL; the many observers whose work went into obtaining the ozone-sonde measurements; the ozone scientists who participated in the discussion of the 2011 Arctic ozone loss and appropriate definition of an Arctic ozone hole (including, but not limited to, N. Harris, G. Bodeker, G. Braathen, M. Kurylo, R. Salawitch); and especially P. Newman and K. Minschwaner for discussions and comments. Meteorological analyses were provided by NASA's Global Modeling and Assimilation Office (GMAO) and by the European Centre for Medium-Range Weather Forecasts. We thank S. Pawson of GMAO for advice on usage of the MERRA reanalysis. Ozone-sonde measurements at Alert, Eureka, Resolute Bay, Churchill and Goose Bay were funded by Environment Canada. Additional ozone sondes were flown at Eureka as part of the Canadian Arctic Atmospheric Chemistry Experiment (ACE) Validation Campaign and were funded by the Canadian Space Agency. Academy of Finland provided partial funding for performing and processing ozone-sonde measurements in Jokioinen and Sodankyla. Ozone soundings and work at AWI were partially funded by the EC DG Research through the RECONCILE project. Work at the Jet Propulsion Laboratory, California Institute of Technology, and at Science Systems and Applications Inc., was done under contract with NASA.	ANDERSON JG, 1989, J GEOPHYS RES-ATMOS, V94, P11465, DOI 10.1029/JD094iD09p11465; BUTCHART N, 1986, J ATMOS SCI, V43, P1319, DOI 10.1175/1520-0469(1986)043<1319:TAOTSP>2.0.CO;2; Butchart N, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014995; Charlton-Perez AJ, 2010, ATMOS CHEM PHYS, V10, P9473, DOI 10.5194/acp-10-9473-2010; DOUGLASS AR, 1995, J GEOPHYS RES-ATMOS, V100, P13967, DOI 10.1029/95JD00698; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; Fromm MD, 1999, J GEOPHYS RES-ATMOS, V104, P24341, DOI 10.1029/1999JD900273; GERNANDT H, 1987, GEOPHYS RES LETT, V14, P84, DOI 10.1029/GL014i001p00084; HANSON D, 1988, GEOPHYS RES LETT, V15, P855, DOI 10.1029/GL015i008p00855; Harris NRP, 2010, ATMOS CHEM PHYS, V10, P8499, DOI 10.5194/acp-10-8499-2010; Hood LL, 2001, J GEOPHYS RES-ATMOS, V106, P20925, DOI 10.1029/2001JD900093; HOSKINS BJ, 1985, Q J ROY METEOR SOC, V111, P877, DOI 10.1256/smsqj.47001; Hostetler CA, 2006, CALIOP ALGORITHM THE; Hunt WH, 2009, J ATMOS OCEAN TECH, V26, P1214, DOI 10.1175/2009JTECHA1223.1; Kramer M, 2003, J ATMOS CHEM, V45, P51, DOI 10.1023/A:1024056026432; Levelt PF, 2006, IEEE T GEOSCI REMOTE, V44, P1093, DOI 10.1109/TGRS.2006.872333; Livesey N. J., 2010, VERSION 3 3 LEVEL 2; Manney GL, 1996, GEOPHYS RES LETT, V23, P3203, DOI 10.1029/96GL02453; Manney GL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024494; MANNEY GL, 1994, NATURE, V370, P429, DOI 10.1038/370429a0; Manney GL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002634; MANNEY GL, 1994, GEOPHYS RES LETT, V21, P2405, DOI 10.1029/94GL02368; MANNEY GL, 1995, J ATMOS SCI, V52, P3069, DOI 10.1175/1520-0469(1995)052<3069:LTCUDP>2.0.CO;2; Manney GL, 1997, GEOPHYS RES LETT, V24, P2697, DOI 10.1029/97GL52827; Manney GL, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008709; Manney GL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038586; McPeters R, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008802; MCPETERS RD, 1998, NASA TECHNICAL PUBLI; MOLINA LT, 1987, J PHYS CHEM-US, V91, P433, DOI 10.1021/j100286a035; Newman PA, 2009, ATMOS CHEM PHYS, V9, P2113, DOI 10.5194/acp-9-2113-2009; Newman PA, 2001, J GEOPHYS RES-ATMOS, V106, P19999, DOI 10.1029/2000JD000061; Orsolini YJ, 2009, Q J ROY METEOR SOC, V135, P1020, DOI 10.1002/qj.409; Petzoldt K, 1999, ANN GEOPHYS-ATM HYDR, V17, P231, DOI 10.1007/s00585-999-0231-1; Pitts MC, 2009, ATMOS CHEM PHYS, V9, P7577, DOI 10.5194/acp-9-7577-2009; Polvani LM, 2000, J ATMOS SCI, V57, P3663, DOI 10.1175/1520-0469(2000)057<3663:TTDSOB>2.0.CO;2; POOLE LR, 1994, J GEOPHYS RES-ATMOS, V99, P13083, DOI 10.1029/94JD00411; Rex M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026731; Rex M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018844; Rex M, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000533; Rex M, 1998, J GEOPHYS RES-ATMOS, V103, P5843, DOI 10.1029/97JD03127; Rex M, 1999, J ATMOS CHEM, V32, P35, DOI 10.1023/A:1006093826861; Rex M, 1997, NATURE, V389, P835, DOI 10.1038/39849; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Santee ML, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009057; Santee ML, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003335; SCHOEBERL MR, 1991, SCIENCE, V251, P46, DOI 10.1126/science.251.4989.46; Smit HGJ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007308; SOLOMON PM, 1987, NATURE, V328, P411, DOI 10.1038/328411a0; Solomon S, 1999, REV GEOPHYS, V37, P275, DOI 10.1029/1999RG900008; SOLOMON S, 1986, NATURE, V321, P755, DOI 10.1038/321755a0; Tegtmeier S, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034250; Tilmes S, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026925; VONDERGATHEN P, 1995, NATURE, V375, P131, DOI 10.1038/375131a0; WATERS JW, 1993, NATURE, V362, P597, DOI 10.1038/362597a0; Waters JW, 2006, IEEE T GEOSCI REMOTE, V44, P1075, DOI 10.1109/TGRS.2006.873771; Wohltmann I, 2010, GEOSCI MODEL DEV, V3, P585, DOI 10.5194/gmd-3-585-2010; Woollings T, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012742; World Meteorological Organization, 2007, 50 WORLD MET ORG GLO; World Meteorological Organization, 2011, 52 WORLD MET ORG GLO	59	436	470	9	267	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2011	478	7370					469	U65		10.1038/nature10556	http://dx.doi.org/10.1038/nature10556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	21964337				2022-12-28	WOS:000296194200034
J	Cheong, R; Rhee, A; Wang, CJ; Nemenman, I; Levchenko, A				Cheong, Raymond; Rhee, Alex; Wang, Chiaochun Joanne; Nemenman, Ilya; Levchenko, Andre			Information Transduction Capacity of Noisy Biochemical Signaling Networks	SCIENCE			English	Article							NF-KAPPA-B; STOCHASTIC GENE-EXPRESSION; SINGLE-CELL; TEMPORAL CONTROL; DYNAMICS; POPULATION; OSCILLATIONS; VARIABILITY; ACTIVATION; ALPHA	Molecular noise restricts the ability of an individual cell to resolve input signals of different strengths and gather information about the external environment. Transmitting information through complex signaling networks with redundancies can overcome this limitation. We developed an integrative theoretical and experimental framework, based on the formalism of information theory, to quantitatively predict and measure the amount of information transduced by molecular and cellular networks. Analyzing tumor necrosis factor (TNF) signaling revealed that individual TNF signaling pathways transduce information sufficient for accurate binary decisions, and an upstream bottleneck limits the information gained via multiple integrated pathways. Negative feedback to this bottleneck could both alleviate and enhance its limiting effect, despite decreasing noise. Bottlenecks likewise constrain information attained by networks signaling through multiple genes or cells.	[Cheong, Raymond; Rhee, Alex; Wang, Chiaochun Joanne; Levchenko, Andre] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Nemenman, Ilya] Emory Univ, Dept Phys, Atlanta, GA 30322 USA; [Nemenman, Ilya] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Johns Hopkins University; Emory University; Emory University	Levchenko, A (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	alev@jhu.edu		Nemenman, Ilya/0000-0003-3024-4244	NIH [GM072024, RR020839, CA132629]; Johns Hopkins University; Los Alamos National Laboratory; NATIONAL CANCER INSTITUTE [R01CA132629] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072024] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University(Johns Hopkins University); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Hoffmann, M. Simon, S. Shvartsman, C. Cohen-Saidon, and U. Alon for sharing data and materials; A. Ganesan and H. Chang for experimental assistance; and P. Iglesias, Y. Qi, and A. Feinberg for insightful discussions and reviewing drafts of the manuscript. This work was supported by NIH grants GM072024 and RR020839 (R.C., A.R., C.J.W., and A.L.) and CA132629 (I.N.), the Medical Scientist Training Program at the Johns Hopkins University (R.C.), and, in early stages of the work, the Los Alamos National Laboratory Directed Research and Development program (I.N.).	Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bao XR, 2010, BIOPHYS J, V99, P2414, DOI 10.1016/j.bpj.2010.08.043; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; Cheong R, 2009, MOL CELL PROTEOMICS, V8, P433, DOI 10.1074/mcp.M800291-MCP200; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Coppey M, 2008, CURR BIOL, V18, P915, DOI 10.1016/j.cub.2008.05.034; Cover TM, 1991, ELEMENTS INFORM THEO; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Francis K, 1997, P NATL ACAD SCI USA, V94, P12258, DOI 10.1073/pnas.94.23.12258; Fuller D, 2010, P NATL ACAD SCI USA, V107, P9656, DOI 10.1073/pnas.0911178107; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Krishna S, 2006, P NATL ACAD SCI USA, V103, P10840, DOI 10.1073/pnas.0604085103; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Mehta P, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.79; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nemenman I, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000025; Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Perkins TJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.83; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Schneidman E, 2003, J NEUROSCI, V23, P11539; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Thierfelder S, 2011, APPL BIOCHEM BIOTECH, V163, P954, DOI 10.1007/s12010-010-9099-5; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513; Ziv E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001077	41	309	312	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2011	334	6054					354	358		10.1126/science.1204553	http://dx.doi.org/10.1126/science.1204553			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	21921160	Green Accepted			2022-12-28	WOS:000296052500047
J	Cooper, PN; Westby, M; Pitcher, DW; Bullock, I				Cooper, Paul N.; Westby, Maggie; Pitcher, David W.; Bullock, Ian			Synopsis of the National Institute for Health and Clinical Excellence Guideline for Management of Transient Loss of Consciousness	ANNALS OF INTERNAL MEDICINE			English	Article							IMPLANTABLE LOOP-RECORDER; UNEXPLAINED SYNCOPE; DIAGNOSTIC YIELD; RECURRENT SYNCOPE; MECHANISM; PRESYNCOPE; UTILITY; DISEASE	Description: Transient loss of consciousness (TLoC) is common and often leads to incorrect diagnosis, unnecessary investigation, or inappropriate choice of specialist referral. In August 2010, the National Institute for Health and Clinical Excellence published a guideline that addressed the initial assessment of and most appropriate specialist referral for persons who have experienced TLoC. The guideline focused on correct diagnosis and relevant specialist referral and did not make treatment recommendations. This synopsis describes the principal recommendations concerning assessment and referral of a patient with TLoC. Methods: The National Clinical Guideline Centre developed the guidelines by using the standard methodology of the National Institute for Health and Clinical Excellence. A multidisciplinary guideline panel generated review questions, discussed evidence, and formulated recommendations. The panel included a technical team from the National Clinical Guideline Centre, who reviewed and graded all relevant evidence identified from literature searches published in English up to November 2009 and performed health-economic modeling. Both guideline development and final modifications were informed by comments from stakeholders and the public. Recommendations: The panel made clear recommendations regarding the assessment of a person after TLoC, which emphasized the importance of clinical reasoning in diagnosis. Persons with uncomplicated faint, situational syncope, or orthostatic hypotension should receive electrocardiography but do not otherwise require immediate further investigation or specialist referral. Persons with features that suggest epilepsy should be referred for specialist neurologic assessment; brief seizure-like activity was recognized as a common occurrence during syncope that should not be regarded as indicating epilepsy. Persons with a suspected cardiac cause for TLoC or in whom TLoC is unexplained after initial assessment should receive specialist cardiovascular assessment. Guidance was provided on the appropriate choices of cardiovascular investigation, according to the presenting clinical circumstances.	[Cooper, Paul N.; Westby, Maggie; Pitcher, David W.; Bullock, Ian] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England	Royal College of Physicians	Cooper, PN (corresponding author), Greater Manchester Neurosci Ctr, Dept Neurol, Stott Lane, Salford M6 8HD, Greater Manches, England.	paul.cooper@manchester.ac.uk	Cooper, Paul N/L-9819-2013; Westby, Maggie/GWZ-2119-2022; Westby, Maggie/O-8794-2014	Cooper, Paul N/0000-0002-7232-3365; Westby, Maggie/0000-0003-4273-3942	NICE; Brunel University	NICE; Brunel University	Dr. Cooper: Support for travel to meetings for study or other purposes: Medtronic; Employment: NICE. Dr. Westby: Grant (money to institution): NICE; Fees for participation in review activities, such as data monitoring boards, statistical analysis, end point committees, and the like: NICE; Payment for writing or reviewing the manuscript: NICE; Consultancy (money to institution): Brunel University. Dr. Pitcher: Support for travel to meetings for study or other purposes: NICE; Travel, accommodations, or meeting expenses unrelated to activities listed: Roche Pharmaceuticals; Other: Vice Chairman of the Resuscitation Council (United Kingdom). Dr. Bullock: Grant: NICE.	[Anonymous], 2008, GUID METH TECHN APPR; [Anonymous], 2011, PAT STOR MISD STRATF; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Boersma L, 2004, EUROPACE, V6, P70, DOI 10.1016/j.eupc.2003.09.006; Brignole M, 2005, EUROPACE, V7, P273, DOI 10.1016/j.eupc.2005.02.116; Donateo P, 2003, J AM COLL CARDIOL, V41, P93, DOI 10.1016/S0735-1097(02)02621-9; Farwell DJ, 2006, EUR HEART J, V27, P351, DOI 10.1093/eurheartj/ehi602; Fitzpatrick AP, 2006, HEART, V92, P559, DOI 10.1136/hrt.2005.068650; Fogel RI, 1997, AM J CARDIOL, V79, P207, DOI 10.1016/S0002-9149(96)00717-5; Hill J, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00007; Krahn AD, 1998, AM J CARDIOL, V82, P117, DOI 10.1016/S0002-9149(98)00237-9; Krahn AD, 2004, AM HEART J, V148, P326, DOI 10.1016/j.ahj.2004.01.024; Krahn AD, 2002, PACE, V25, P37, DOI 10.1046/j.1460-9592.2002.00037.x; Krahn CD, 2001, AM HEART J, V141, P817, DOI 10.1067/mhj.2001.114196; LINZER M, 1990, AM J CARDIOL, V66, P214, DOI 10.1016/0002-9149(90)90591-N; Lombardi F, 2005, EUROPACE, V7, P19, DOI 10.1016/j.eupc.2004.09.003; Moya A, 2001, CIRCULATION, V104, P1261, DOI 10.1161/hc3601.095708; *NAT COLL CTR PRIM, 2004, EP DIAGN MAN EP AD C; National Institute for Health and Clinical Excellence, 2009, GUID MAN; National Institute for Health and Clinical Excellence, 2010, TRANS LOSS CONSC AD; Nierop PR, 2000, PACE, V23, P1532, DOI 10.1046/j.1460-9592.2000.01532.x; Parry SW, 2009, HEART, V95, P416, DOI 10.1136/hrt.2007.136457; Pezawas T, 2008, HEART, V94, DOI 10.1136/hrt.2007.116616; Pierre B, 2008, EUROPACE, V10, P477, DOI 10.1093/europace/eun039; Rockx MA, 2005, AM HEART J, V150, DOI 10.1016/j.ahn.2005.08.003; Schuchert A, 2003, PACE, V26, P1837, DOI 10.1046/j.1460-9592.2003.t01-1-00277.x; Seidl K, 2003, Z KARDIOL, V92, P147, DOI 10.1007/s00392-003-0897-4; Westby M, 2010, TRANSIENT LOSS CONSC; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25	29	12	12	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8					543	U120		10.7326/0003-4819-155-8-201110180-00368	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00368			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	21930835				2022-12-28	WOS:000296066300021
J	Ringel, R; Sologub, M; Morozov, YI; Litonin, D; Cramer, P; Temiakov, D				Ringel, Rieke; Sologub, Marina; Morozov, Yaroslav I.; Litonin, Dmitry; Cramer, Patrick; Temiakov, Dmitry			Structure of human mitochondrial RNA polymerase	NATURE			English	Article							TRANSCRIPTION FACTOR-A; YEAST MITOCHONDRIAL; PROMOTER RECOGNITION; CRYSTAL-STRUCTURE; INITIATION; ELONGATION; COMPLEX; TRANSLATION; SPECIFICITY; TRANSITION	Transcription of the mitochondrial genome is performed by a single-subunit RNA polymerase (mtRNAP) that is distantly related to the RNAP of bacteriophage T7, the pol I family of DNA polymerases, and single-subunit RNAPs from chloroplasts(1-4). Whereas T7 RNAP can initiate transcription by itself, mtRNAP requires the factors TFAM and TFB2M for binding and melting promoter DNA(5-7). TFAM is an abundant protein that binds and bends promoter DNA 15-40 base pairs upstream of the transcription start site, and stimulates the recruitment of mtRNAP and TFB2M to the promoter(8,9). TFB2M assists mtRNAP in promoter melting and reaches the active site of mtRNAP to interact with the first base pair of the RNA-DNA hybrid(10). Here we report the X-ray structure of human mtRNAP at 2.5 angstrom resolution, which reveals a T7-like catalytic carboxy-terminal domain, an amino-terminal domain that remotely resembles the T7 promoter-binding domain, a novel pentatricopeptide repeat domain, and a flexible N-terminal extension. The pentatricopeptide repeat domain sequesters an AT-rich recognition loop, which binds promoter DNA in T7 RNAP, probably explaining the need for TFAM during promoter binding. Consistent with this, substitution of a conserved arginine residue in the AT-rich recognition loop, or release of this loop by deletion of the N-terminal part of mtRNAP, had no effect on transcription. The fingers domain and the intercalating hairpin, which melts DNA in phage RNAPs, are repositioned, explaining the need for TFB2M during promoter melting. Our results provide a new venue for the mechanistic analysis of mitochondrial transcription. They also indicate how an early phage-like mtRNAP lost functions in promoter binding and melting, which were provided by initiation factors in trans during evolution, to enable mitochondrial gene regulation and the adaptation of mitochondrial function to changes in the environment.	[Ringel, Rieke; Litonin, Dmitry; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Ringel, Rieke; Litonin, Dmitry; Cramer, Patrick] Univ Munich, Dept Biochem, CIPSM, D-81377 Munich, Germany; [Sologub, Marina; Morozov, Yaroslav I.; Litonin, Dmitry; Temiakov, Dmitry] Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ 08084 USA	University of Munich; University of Munich; Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center	Cramer, P (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@lmb.uni-muenchen.de; d.temiakov@umdnj.edu			US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Deutsche Forschungsgemeinschaft [SFB646, TR5, FOR1068]; Nanosystems Initiative Munich NIM; European Research Council ERC; Jung-Stiftung; UMDNJ Foundation [PC25-11]	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Nanosystems Initiative Munich NIM; European Research Council ERC(European Research Council (ERC)); Jung-Stiftung; UMDNJ Foundation	We thank A. Cheung and D. Kostrewa for help with crystallography, and W. T. McAllister and M. Anikin for the critical reading of the manuscript. We acknowledge the crystallization facility at the Max Planck Institute of Biochemistry, Martinsried. Part of this work was performed at the Swiss Light Source at the Paul Scherrer Institut, Villigen, Switzerland. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Company, which operates the facility. P. C. was supported by the Deutsche Forschungsgemeinschaft, SFB646, TR5, FOR1068, the Nanosystems Initiative Munich NIM, an Advanced Investigator Grant from the European Research Council ERC, and the Jung-Stiftung. D. T. was supported by the UMDNJ Foundation, grant no. PC25-11.	Aphasizheva I, 2011, MOL CELL, V42, P106, DOI 10.1016/j.molcel.2011.02.021; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Cliften PF, 1997, GENE DEV, V11, P2897, DOI 10.1101/gad.11.21.2897; DAIRAGHI DJ, 1995, BBA-MOL BASIS DIS, V1271, P127, DOI 10.1016/0925-4439(95)00019-Z; Durniak KJ, 2008, SCIENCE, V322, P553, DOI 10.1126/science.1163433; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; Gleghorn ML, 2008, MOL CELL, V32, P707, DOI 10.1016/j.molcel.2008.11.010; Hammani K, 2011, J BIOL CHEM, V286, P21361, DOI 10.1074/jbc.M111.230516; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Lightowlers Robert N, 2008, Biochem J, V416, pe5, DOI 10.1042/BJ20081942; Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nayak D, 2009, J BIOL CHEM, V284, P13641, DOI 10.1074/jbc.M900718200; Rodeheffer MS, 2001, J BIOL CHEM, V276, P8616, DOI 10.1074/jbc.M009901200; Savkina M, 2010, J BIOL CHEM, V285, P3957, DOI 10.1074/jbc.M109.051003; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	30	142	147	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2011	478	7368					269	273		10.1038/nature10435	http://dx.doi.org/10.1038/nature10435			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21947009	Green Published			2022-12-28	WOS:000295782800056
J	Rasmussen, M; Guo, XS; Wang, Y; Lohmueller, KE; Rasmussen, S; Albrechtsen, A; Skotte, L; Lindgreen, S; Metspalu, M; Jombart, T; Kivisild, T; Zhai, WW; Eriksson, A; Manica, A; Orlando, L; De La Vega, FM; Tridico, S; Metspalu, E; Nielsen, K; Avila-Arcos, MC; Moreno-Mayar, JV; Muller, C; Dortch, J; Gilbert, MTP; Lund, O; Wesolowska, A; Karmin, M; Weinert, LA; Wang, B; Li, J; Tai, SS; Xiao, F; Hanihara, T; van Driem, G; Jha, AR; Ricaut, FX; de Knijff, P; Migliano, AB; Romero, IG; Kristiansen, K; Lambert, DM; Brunak, S; Forster, P; Brinkmann, B; Nehlich, O; Bunce, M; Richards, M; Gupta, R; Bustamante, CD; Krogh, A; Foley, RA; Lahr, MM; Balloux, F; Sicheritz-Ponten, T; Villems, R; Nielsen, R; Wang, J; Willerslev, E				Rasmussen, Morten; Guo, Xiaosen; Wang, Yong; Lohmueller, Kirk E.; Rasmussen, Simon; Albrechtsen, Anders; Skotte, Line; Lindgreen, Stinus; Metspalu, Mait; Jombart, Thibaut; Kivisild, Toomas; Zhai, Weiwei; Eriksson, Anders; Manica, Andrea; Orlando, Ludovic; De La Vega, Francisco M.; Tridico, Silvana; Metspalu, Ene; Nielsen, Kasper; Avila-Arcos, Maria C.; Moreno-Mayar, J. Victor; Muller, Craig; Dortch, Joe; Gilbert, M. Thomas P.; Lund, Ole; Wesolowska, Agata; Karmin, Monika; Weinert, Lucy A.; Wang, Bo; Li, Jun; Tai, Shuaishuai; Xiao, Fei; Hanihara, Tsunehiko; van Driem, George; Jha, Aashish R.; Ricaut, Francois-Xavier; de Knijff, Peter; Migliano, Andrea B.; Romero, Irene Gallego; Kristiansen, Karsten; Lambert, David M.; Brunak, Soren; Forster, Peter; Brinkmann, Bernd; Nehlich, Olaf; Bunce, Michael; Richards, Michael; Gupta, Ramneek; Bustamante, Carlos D.; Krogh, Anders; Foley, Robert A.; Lahr, Marta M.; Balloux, Francois; Sicheritz-Ponten, Thomas; Villems, Richard; Nielsen, Rasmus; Wang, Jun; Willerslev, Eske			An Aboriginal Australian Genome Reveals Separate Human Dispersals into Asia	SCIENCE			English	Article							Y-CHROMOSOME; NEW-GUINEA; SEQUENCE; SETTLEMENT; HISTORY; MODEL	We present an Aboriginal Australian genomic sequence obtained from a 100-year-old lock of hair donated by an Aboriginal man from southern Western Australia in the early 20th century. We detect no evidence of European admixture and estimate contamination levels to be below 0.5%. We show that Aboriginal Australians are descendants of an early human dispersal into eastern Asia, possibly 62,000 to 75,000 years ago. This dispersal is separate from the one that gave rise to modern Asians 25,000 to 38,000 years ago. We also find evidence of gene flow between populations of the two dispersal waves prior to the divergence of Native Americans from modern Asian ancestors. Our findings support the hypothesis that present-day Aboriginal Australians descend from the earliest humans to occupy Australia, likely representing one of the oldest continuous populations outside Africa.	[Wang, Yong; Lohmueller, Kirk E.; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Wang, Yong; Lohmueller, Kirk E.; Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Rasmussen, Morten; Lindgreen, Stinus; Orlando, Ludovic; Avila-Arcos, Maria C.; Moreno-Mayar, J. Victor; Gilbert, M. Thomas P.; Krogh, Anders; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Rasmussen, Morten; Lindgreen, Stinus; Orlando, Ludovic; Avila-Arcos, Maria C.; Moreno-Mayar, J. Victor; Gilbert, M. Thomas P.; Krogh, Anders; Willerslev, Eske] Univ Copenhagen, Dept Biol, DK-1350 Copenhagen, Denmark; [Rasmussen, Morten; Guo, Xiaosen; Gilbert, M. Thomas P.; Kristiansen, Karsten; Wang, Jun; Willerslev, Eske] BGI Shenzhen, Sino Danish Genom Ctr, Shenzhen 518083, Peoples R China; [Guo, Xiaosen; Wang, Bo; Li, Jun; Tai, Shuaishuai; Xiao, Fei; Kristiansen, Karsten; Wang, Jun] BGI Shenzhen, Shenzhen Key Lab Trans Biotechnol, Shenzhen 518083, Peoples R China; [Rasmussen, Simon; Nielsen, Kasper; Lund, Ole; Wesolowska, Agata; Brunak, Soren; Gupta, Ramneek; Sicheritz-Ponten, Thomas] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Albrechtsen, Anders; Skotte, Line; Lindgreen, Stinus; Kristiansen, Karsten; Krogh, Anders; Nielsen, Rasmus; Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Metspalu, Mait; Metspalu, Ene; Karmin, Monika; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, EE-510101 Tartu, Estonia; [Metspalu, Mait; Metspalu, Ene; Karmin, Monika; Villems, Richard] Estonian Bioctr, EE-510101 Tartu, Estonia; [Jombart, Thibaut; Weinert, Lucy A.; Balloux, Francois] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modeling, London W2 1PG, England; [Kivisild, Toomas; Migliano, Andrea B.; Foley, Robert A.; Lahr, Marta M.] Univ Cambridge, Dept Biol Anthropol, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 1QH, England; [Zhai, Weiwei] Chinese Acad Sci, Beijing Inst Genom, Beijing 100029, Peoples R China; [Eriksson, Anders; Manica, Andrea] Univ Cambridge, Dept Zool, Evolutionary Ecol Grp, Cambridge CB2 3EJ, England; [De La Vega, Francisco M.; Bustamante, Carlos D.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Tridico, Silvana; Bunce, Michael] Murdoch Univ, Sch Biol Sci & Biotechnol, Ancient DNA Lab, Murdoch, WA 6150, Australia; [Moreno-Mayar, J. Victor] Univ Nacl Autonoma Mexico, Undergrad Program Genom Sci, Cuernavaca 62210, Morelos, Mexico; [Muller, Craig] Goldfields Land & Sea Council Aboriginal Corp, Kalgoorlie, WA 6430, Australia; [Dortch, Joe] Univ Western Australia, Crawley, WA 6009, Australia; [Hanihara, Tsunehiko] Kitasato Univ, Sch Med, Dept Anat, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [van Driem, George] Univ Bern, Sprachwissensch Inst, CH-3000 Bern 9, Switzerland; [Jha, Aashish R.; Romero, Irene Gallego] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Ricaut, Francois-Xavier] Univ Toulouse 3, CNRS, UMR 5288, Lab Anthropol Mol & Imagerie Synth, F-31073 Toulouse 3, France; [de Knijff, Peter] Leiden Univ, Med Ctr, Dept Human & Clin Genet, NL-2333 ZA Leiden, Netherlands; [Migliano, Andrea B.] UCL, Dept Anthropol, London WC1E 6BT, England; [Lambert, David M.] Griffith Univ, Sch Biomol & Phys Sci, Nathan, Qld 4111, Australia; [Lambert, David M.] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; [Brunak, Soren] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Forster, Peter] Univ Cambridge, Murray Edwards Coll, Cambridge CB3 0DF, England; [Forster, Peter; Brinkmann, Bernd] Inst Forens Genet, D-48161 Munster, Germany; [Nehlich, Olaf; Richards, Michael] Max Planck Inst Evolutionary Anthropol, Dept Human Evoluat, D-04103 Leipzig, Germany; [Richards, Michael] Univ British Columbia, Dept Anthropol, Vancouver, BC V6T 1Z1, Canada; [Sicheritz-Ponten, Thomas] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2800 Lyngby, Denmark; [Villems, Richard] Estonian Acad Sci, EE-10130 Tallinn, Estonia; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Copenhagen; University of Copenhagen; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Technical University of Denmark; University of Copenhagen; University of Tartu; Estonian Biocentre; Imperial College London; University of Cambridge; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Cambridge; Stanford University; Murdoch University; Universidad Nacional Autonoma de Mexico; University of Western Australia; Kitasato University; University of Bern; University of Chicago; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; University College London; Griffith University; Griffith University; University of Copenhagen; University of Cambridge; Max Planck Society; University of British Columbia; Technical University of Denmark; Estonian Academy of Sciences; Novo Nordisk Foundation; University of Copenhagen	Nielsen, R (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	rasmus_nielsen@berkeley.edu; wangj@genomics.org.cn; ewillerslev@snm.ku.dk	Rasmussen, Simon/AAA-2308-2020; Balloux, Francois/X-7856-2019; Wang, Jun/A-7261-2013; Richards, Michael/O-3717-2016; Manica, Andrea/N-9013-2019; Lund, Ole/F-4437-2014; Gilbert, Marcus TP/A-8936-2013; Albrechtsen, Anders/K-4281-2013; Dortch, Joe/C-6296-2014; Orlando, Ludovic/A-8932-2013; Eriksson, Anders/C-9767-2010; Kristiansen, Karsten/J-5148-2014; Willerslev, Eske/A-9619-2011; wang, yong/G-8398-2011; Kivisild, Toomas/P-5889-2017; Ricaut, Francois Xavier/G-1206-2010; De La Vega, Francisco/H-3832-2011; Richards, Michael/A-9374-2008; Gupta, Ramneek/G-7278-2012; Lindgreen, Stinus/B-5594-2014; Manica, Andrea/B-5497-2008; Metspalu, Mait/G-8671-2015; de Knijff, Peter/Y-2519-2018; Balloux, Francois/D-4783-2009; Rasmussen, Simon/G-6258-2016; wang, yong/J-6713-2013; Willerslev, Eske/AAA-5686-2019; Nielsen, Rasmus/D-4405-2009; Moreno-Mayar, J. Víctor/AAB-3732-2022; Nehlich, Olaf/A-3767-2010; Krogh, Anders/M-1541-2014; Skotte, Line/F-7359-2014; Sicheritz-Ponten, Thomas/A-4325-2017; Brunak, Soren/O-6621-2016; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Rasmussen, Simon/0000-0001-6323-9041; Balloux, Francois/0000-0003-1978-7715; Richards, Michael/0000-0001-5274-8887; Manica, Andrea/0000-0003-1895-450X; Lund, Ole/0000-0003-1108-0491; Gilbert, Marcus TP/0000-0002-5805-7195; Albrechtsen, Anders/0000-0001-7306-031X; Dortch, Joe/0000-0002-0510-5456; Orlando, Ludovic/0000-0003-3936-1850; Eriksson, Anders/0000-0003-3436-3726; Kristiansen, Karsten/0000-0002-6024-0917; Willerslev, Eske/0000-0002-7081-6748; Kivisild, Toomas/0000-0002-6297-7808; Richards, Michael/0000-0001-5274-8887; Gupta, Ramneek/0000-0001-6841-6676; Lindgreen, Stinus/0000-0001-5104-1054; Manica, Andrea/0000-0003-1895-450X; Metspalu, Mait/0000-0003-3099-9161; de Knijff, Peter/0000-0002-0899-771X; Balloux, Francois/0000-0003-1978-7715; Rasmussen, Simon/0000-0001-6323-9041; wang, yong/0000-0001-8772-7349; Nielsen, Rasmus/0000-0003-0513-6591; Moreno-Mayar, J. Víctor/0000-0002-7712-4496; Nehlich, Olaf/0000-0002-4993-5013; Zhai, Weiwei/0000-0001-7938-0226; Bunce, Michael/0000-0002-0302-4206; Nielsen, Kasper/0000-0002-5510-7767; Migliano, Andrea/0000-0003-4364-2735; Bustamante, Carlos D./0000-0002-4187-7920; Krogh, Anders/0000-0002-5147-6282; Gallego Romero, Irene/0000-0003-1613-8998; Mirazon Lahr, Marta/0000-0001-5752-5770; van Driem, George/0000-0002-7185-0657; Skotte, Line/0000-0002-7398-1271; Avila-Arcos, Maria C./0000-0003-1691-1696; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; RICAUT, Francois-Xavier/0000-0001-7609-7898; Brunak, Soren/0000-0003-0316-5866; Karmin, Monika/0000-0001-9827-5579; Tai, Shuaishuai/0000-0001-8204-6982; Jha, Aashish/0000-0003-3227-1086; Wang, Jun/0000-0002-8540-8931; Lambert, David/0000-0002-5821-3637; Wang, Jun/0000-0002-2113-5874	Biotechnology and Biological Sciences Research Council [BB/H008802/1, BB/H005854/1] Funding Source: Medline; NHGRI NIH HHS [R01 HG003229] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BB/H008802/2] Funding Source: researchfish; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; BBSRC [BB/H008802/1, BB/H005854/1, BB/H008802/2] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Binladen J, 2006, GENETICS, V172, P733, DOI 10.1534/genetics.105.049718; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Endicott P, 2009, TRENDS ECOL EVOL, V24, P515, DOI 10.1016/j.tree.2009.04.006; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hudjashov G, 2007, P NATL ACAD SCI USA, V104, P8726, DOI 10.1073/pnas.0702928104; Ingman M, 2003, GENOME RES, V13, P1600, DOI 10.1101/gr.686603; Karafet TM, 2010, MOL BIOL EVOL, V27, P1833, DOI 10.1093/molbev/msq063; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Lahr M. M, 1996, EVOLUTION MODERN HUM; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Summerhayes GR, 2010, SCIENCE, V330, P78, DOI 10.1126/science.1193130; Pellekaan SMV, 2006, AM J PHYS ANTHROPOL, V131, P282, DOI 10.1002/ajpa.20426; Whitehouse P, 2004, P NATL ACAD SCI USA, V101, P5692, DOI 10.1073/pnas.0400233101	27	428	437	4	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2011	334	6052					94	98		10.1126/science.1211177	http://dx.doi.org/10.1126/science.1211177			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21940856	Green Accepted, Green Published			2022-12-28	WOS:000295580300047
J	Franosch, T; Grimm, M; Belushkin, M; Mor, FM; Foffi, G; Forro, L; Jeney, S				Franosch, Thomas; Grimm, Matthias; Belushkin, Maxim; Mor, Flavio M.; Foffi, Giuseppe; Forro, Laszlo; Jeney, Sylvia			Resonances arising from hydrodynamic memory in Brownian motion	NATURE			English	Article							OPTICAL-TWEEZERS; COMPLEX FLUIDS; ACTIN NETWORKS; SINGLE CELLS; TECHNOLOGIES	Observation of the Brownian motion of a small probe interacting with its environment provides one of the main strategies for characterizing soft matter(1-4). Essentially, two counteracting forces govern the motion of the Brownian particle. First, the particle is driven by rapid collisions with the surrounding solvent molecules, referred to as thermal noise. Second, the friction between the particle and the viscous solvent damps its motion. Conventionally, the thermal force is assumed to be random and characterized by a Gaussian white noise spectrum. The friction is assumed to be given by the Stokes drag, suggesting that motion is overdamped at long times in particle tracking experiments, when inertia becomes negligible. However, as the particle receives momentum from the fluctuating fluid molecules, it also displaces the fluid in its immediate vicinity. The entrained fluid acts back on the particle and gives rise to long-range correlations(5,6). This hydrodynamic 'memory' translates to thermal forces, which have a coloured, that is, non-white, noise spectrum. One hundred years after Perrin's pioneering experiments on Brownian motion(7-9), direct experimental observation of this colour is still elusive(10). Here we measure the spectrum of thermal noise by confining the Brownian fluctuations of a microsphere in a strong optical trap. We show that hydrodynamic correlations result in a resonant peak in the power spectral density of the sphere's positional fluctuations, in strong contrast to overdamped systems. Furthermore, we demonstrate different strategies to achieve peak amplification. By analogy with microcantilever-based sensors(11,12), our results reveal that the particle-fluid-trap system can be considered a nanomechanical resonator in which the intrinsic hydrodynamic backflow enhances resonance. Therefore, instead of being treated as a disturbance, details in thermal noise could be exploited for the development of new types of sensor and particle-based assay in lab-on-a-chip applications(13,14).	[Grimm, Matthias; Jeney, Sylvia] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland; [Franosch, Thomas] Univ Erlangen Nurnberg, Inst Theoret Phys, D-91058 Erlangen, Germany; [Grimm, Matthias; Mor, Flavio M.; Forro, Laszlo; Jeney, Sylvia] Ecole Polytech Fed Lausanne, Lab Phys Complex Matter, CH-1015 Lausanne, Switzerland; [Belushkin, Maxim; Foffi, Giuseppe] Ecole Polytech Fed Lausanne, Inst Theoret Phys, CH-1015 Lausanne, Switzerland	University of Basel; University of Erlangen Nuremberg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Jeney, S (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.	sylvia.jeney@epfl.ch	Foffi, Giuseppe/C-3923-2009; Foffi, Giuseppe/AAZ-7559-2021	Foffi, Giuseppe/0000-0002-7444-1453; Foffi, Giuseppe/0000-0002-7444-1453	Swiss National Science Foundation (SNF) [200021-113529, 206021-121396]; NCCR Nanoscale Science; German Academic Exchange Service (DAAD); National Competence Center in Biomedical Imaging (NCCBI); SNF [PP0022_119006]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); NCCR Nanoscale Science(Swiss National Science Foundation (SNSF)European Commission); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); National Competence Center in Biomedical Imaging (NCCBI); SNF	S.J. acknowledges the Swiss National Science Foundation (SNF; grant nos 200021-113529 and 206021-121396). M. G. is supported by NCCR Nanoscale Science and the German Academic Exchange Service (DAAD) and F. M. M. is supported by the National Competence Center in Biomedical Imaging (NCCBI). M. B. and G. F. acknowledge support from the SNF (grant no. PP0022_119006). We thank W. Offner and R. Koszali for technical help and U. Aebi, B. U. Felderhof, H. Flyvbjerg, S. Melchionna, E. Sackmann and R. G. Winkler for discussions.	ALDER BJ, 1967, PHYS REV LETT, V18, P988, DOI 10.1103/PhysRevLett.18.988; ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; Berg-Sorensen K, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/038; Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; Bormuth V, 2008, OPT EXPRESS, V16, P13831, DOI 10.1364/OE.16.013831; Braeckmans K, 2002, NAT REV DRUG DISCOV, V1, P447, DOI 10.1038/nrd817; Burg TP, 2007, NATURE, V446, P1066, DOI 10.1038/nature05741; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; CLERCX HJH, 1992, PHYS REV A, V46, P1942, DOI 10.1103/PhysRevA.46.1942; Craighead H, 2006, NATURE, V442, P387, DOI 10.1038/nature05061; Di Leonardo R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.010601; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Gompper G, 2009, ADV POLYM SCI, V221, P1, DOI 10.1007/12_2008_5; Hanggi P, 2005, CHAOS, V15, DOI 10.1063/1.1895505; HINCH EJ, 1975, J FLUID MECH, V72, P499, DOI 10.1017/S0022112075003102; Huang RX, 2011, NAT PHYS, V7, P576, DOI [10.1038/NPHYS1953, 10.1038/nphys1953]; Jeney S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/25/255102; Jeney S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.240604; Lukic B, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011112; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a; Pedersen L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.189801; Perrin J, 1909, ANN CHIM PHYS, V18, P5; Perrin J, 1920, ATOMS; Peterman EJG, 2003, REV SCI INSTRUM, V74, P3246, DOI 10.1063/1.1584085; Pralle A, 1999, MICROSC RES TECHNIQ, V44, P378, DOI 10.1002/(SICI)1097-0029(19990301)44:5<378::AID-JEMT10>3.0.CO;2-Z; Vladimirsky V., 1945, ZH EKSP TEOR FIZ+, V15, P258; WANG MC, 1945, REV MOD PHYS, V17, P323, DOI 10.1103/RevModPhys.17.323	31	256	258	0	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2011	478	7367					85	88		10.1038/nature10498	http://dx.doi.org/10.1038/nature10498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21979048				2022-12-28	WOS:000295575400039
J	Najmabadi, H; Hu, H; Garshasbi, M; Zemojtel, T; Abedini, SS; Chen, W; Hosseini, M; Behjati, F; Haas, S; Jamali, P; Zecha, A; Mohseni, M; Puttmann, L; Vahid, LN; Jensen, C; Moheb, LA; Bienek, M; Larti, F; Mueller, I; Weissmann, R; Darvish, H; Wrogemann, K; Hadavi, V; Lipkowitz, B; Esmaeeli-Nieh, S; Wieczorek, D; Kariminejad, R; Firouzabadi, SG; Cohen, M; Fattahi, Z; Rost, I; Mojahedi, F; Hertzberg, C; Dehghan, A; Rajab, A; Banavandi, MJS; Hoffer, J; Falah, M; Musante, L; Kalscheuer, V; Ullmann, R; Kuss, AW; Tzschach, A; Kahrizi, K; Ropers, HH				Najmabadi, Hossein; Hu, Hao; Garshasbi, Masoud; Zemojtel, Tomasz; Abedini, Seyedeh Sedigheh; Chen, Wei; Hosseini, Masoumeh; Behjati, Farkhondeh; Haas, Stefan; Jamali, Payman; Zecha, Agnes; Mohseni, Marzieh; Puettmann, Lucia; Vahid, Leyla Nouri; Jensen, Corinna; Moheb, Lia Abbasi; Bienek, Melanie; Larti, Farzaneh; Mueller, Ines; Weissmann, Robert; Darvish, Hossein; Wrogemann, Klaus; Hadavi, Valeh; Lipkowitz, Bettina; Esmaeeli-Nieh, Sahar; Wieczorek, Dagmar; Kariminejad, Roxana; Firouzabadi, Saghar Ghasemi; Cohen, Monika; Fattahi, Zohreh; Rost, Imma; Mojahedi, Faezeh; Hertzberg, Christoph; Dehghan, Atefeh; Rajab, Anna; Banavandi, Mohammad Javad Soltani; Hoffer, Julia; Falah, Masoumeh; Musante, Luciana; Kalscheuer, Vera; Ullmann, Reinhard; Kuss, Andreas Walter; Tzschach, Andreas; Kahrizi, Kimia; Ropers, H. Hilger			Deep sequencing reveals 50 novel genes for recessive cognitive disorders	NATURE			English	Article							LINKED MENTAL-RETARDATION; INTELLECTUAL DISABILITY; BINDING-PROTEIN; FRAMESHIFT MUTATION; IDENTIFICATION; FAMILY; DISRUPTION; ENCODES; SRD5A3; SCREEN	Common diseases are often complex because they are genetically heterogeneous, with many different genetic defects giving rise to clinically indistinguishable phenotypes. This has been amply documented for early-onset cognitive impairment, or intellectual disability, one of the most complex disorders known and a very important health care problem worldwide. More than 90 different gene defects have been identified for X-chromosome-linked intellectual disability alone, but research into the more frequent autosomal forms of intellectual disability is still in its infancy. To expedite the molecular elucidation of autosomal-recessive intellectual disability, we have now performed homozygosity mapping, exon enrichment and next-generation sequencing in 136 consanguineous families with autosomal-recessive intellectual disability from Iran and elsewhere. This study, the largest published so far, has revealed additional mutations in 23 genes previously implicated in intellectual disability or related neurological disorders, as well as single, probably disease-causing variants in 50 novel candidate genes. Proteins encoded by several of these genes interact directly with products of known intellectual disability genes, and many are involved in fundamental cellular processes such as transcription and translation, cell-cycle control, energy metabolism and fatty-acid synthesis, which seem to be pivotal for normal brain development and function.	[Hu, Hao; Garshasbi, Masoud; Chen, Wei; Zecha, Agnes; Puettmann, Lucia; Jensen, Corinna; Moheb, Lia Abbasi; Bienek, Melanie; Mueller, Ines; Weissmann, Robert; Wrogemann, Klaus; Lipkowitz, Bettina; Esmaeeli-Nieh, Sahar; Hoffer, Julia; Musante, Luciana; Kalscheuer, Vera; Ullmann, Reinhard; Kuss, Andreas Walter; Tzschach, Andreas; Ropers, H. Hilger] Max Planck Inst Mol Genet, Dept Human Mol Genet, D-14195 Berlin, Germany; [Najmabadi, Hossein; Garshasbi, Masoud; Abedini, Seyedeh Sedigheh; Hosseini, Masoumeh; Behjati, Farkhondeh; Mohseni, Marzieh; Vahid, Leyla Nouri; Moheb, Lia Abbasi; Larti, Farzaneh; Darvish, Hossein; Firouzabadi, Saghar Ghasemi; Fattahi, Zohreh; Banavandi, Mohammad Javad Soltani; Falah, Masoumeh; Kahrizi, Kimia] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran 19857, Iran; [Najmabadi, Hossein; Hadavi, Valeh; Kariminejad, Roxana] Kariminejad Najmabadi Pathol & Genet Ctr, Tehran 14667, Iran; [Zemojtel, Tomasz; Haas, Stefan] Max Planck Inst Mol Genet, Dept Computat Mol Biol, D-14195 Berlin, Germany; [Chen, Wei] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Jamali, Payman] Shahroud Welf Org, Semnan 36156, Iran; [Wrogemann, Klaus] Univ Manitoba, Dept Biochem & Mol Genet, Winnipeg, MB R3E0J9, Canada; [Wieczorek, Dagmar] Univ Klinikum Essen, Inst Humangenet, D-45122 Essen, Germany; [Cohen, Monika] Kinderzentrum Muenchen, D-81377 Munich, Germany; [Rost, Imma] Zentrum Humangenet & Lab Med Dr Klein & Dr Rost, D-82152 Martinsried, Germany; [Mojahedi, Faezeh] Mashhad Med Genet Counseling Ctr, Mashhad 91767, Iran; [Hertzberg, Christoph] Vivantes Klinikum Neukolln, D-12351 Berlin, Germany; [Dehghan, Atefeh] Yazd Welf Org, Yazd 89178, Iran; [Rajab, Anna] Royal Hosp, Genet Unit, Minist Hlth, Directorate Gen Hlth Affairs, Muscat 113, Oman	Max Planck Society; Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Manitoba; University of Duisburg Essen; VIivantes Klinikum Neukolln; The Royal Hospital, Sultanate of Oman	Ropers, HH (corresponding author), Max Planck Inst Mol Genet, Dept Human Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	kkahrizi@uswr.ac.ir; ropers@molgen.mpg.de	Chen, Wei/C-1273-2011; Najmabadi, Hossein/P-8182-2017; Abedini, Seyedeh Sedigheh/AAG-3694-2021; Wieczorek, Dagmar/AAU-6008-2021; Kahrizi, Kimia/D-7989-2017; Tzschach, Andreas/I-2648-2019; Larti, Farzaneh/D-8522-2017; Falah, Masoumeh/AAX-2996-2020; Behjati, Farkhondeh/D-8497-2017; Fattahi, Zohreh/Z-5165-2019; Musante, Luciana/AAA-5726-2021; banavandi, mohammad javad soltani/AAU-4254-2021; Falah, Masoumeh/L-2712-2018	Wieczorek, Dagmar/0000-0003-2812-6492; Tzschach, Andreas/0000-0002-6840-965X; Falah, Masoumeh/0000-0002-2800-4199; Behjati, Farkhondeh/0000-0001-6343-0452; Musante, Luciana/0000-0002-2742-1484; Falah, Masoumeh/0000-0002-2800-4199; Kuss, Andreas/0000-0002-9401-4627; Garshasbi, Masoud/0000-0002-5508-7903; Haas, Stefan/0000-0003-3418-3688; Abedini, Seyedeh Sedigheh/0000-0003-2671-2295; Chen, Wei/0000-0003-3263-1627; Kalscheuer, Vera/0000-0001-6898-3259; Najmabadi, Hossein/0000-0002-6084-7778	Max Planck Innovation Funds; German Federal Ministry of Education and Research through the MRNET [01GS08161]; Iranian National Science Foundation; EU	Max Planck Innovation Funds; German Federal Ministry of Education and Research through the MRNET; Iranian National Science Foundation(Iran National Science Foundation (INSF)); EU(European Commission)	We express our gratitude to the patients and their families for their participation in the study. We thank S. Nakhee and K. Javan for their support; S. Arzhangi, S. Banihashemi, M. Kasiri, H. Khodaee, M. Schlicht and M. Gerloff for contributing to this project in various ways; G. Eder for her assistance with the preparation of the manuscript; and S. Shoichet for critically reading the manuscript. This work was supported by the Max Planck Innovation Funds, the German Federal Ministry of Education and Research through the MRNET (grant 01GS08161, to H. H. R.), the Iranian National Science Foundation and the EU-FP7 project GENCODYS.	Abou Jamra R, 2011, AM J HUM GENET, V88, P788, DOI 10.1016/j.ajhg.2011.04.019; Alazami AM, 2011, NEUROGENETICS, V12, P333, DOI 10.1007/s10048-011-0291-8; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Boison D, 2002, P NATL ACAD SCI USA, V99, P6985, DOI 10.1073/pnas.092642899; Cantagrel V, 2010, CELL, V142, P203, DOI 10.1016/j.cell.2010.06.001; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Freude K, 2004, AM J HUM GENET, V75, P305, DOI 10.1086/422507; Garshasbi M, 2008, AM J HUM GENET, V82, P1158, DOI 10.1016/j.ajhg.2008.03.018; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Hurov KE, 2010, GENE DEV, V24, P1939, DOI 10.1101/gad.1934210; Jaffe AB, 2004, MOL CELL BIOL, V24, P1736, DOI 10.1128/MCB.24.4.1736-1746.2004; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Kahrizi K, 2011, EUR J HUM GENET, V19, P115, DOI 10.1038/ejhg.2010.132; Kaufman L, 2010, J NEURODEV DISORD, V2, P182, DOI 10.1007/s11689-010-9055-2; Klein U, 1997, J BIOL CHEM, V272, P19099, DOI 10.1074/jbc.272.31.19099; Kuss AW, 2011, HUM GENET, V129, P141, DOI 10.1007/s00439-010-0907-3; Laumonnier F, 2007, AM J HUM GENET, V80, P205, DOI 10.1086/511441; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Mir A, 2009, AM J HUM GENET, V85, P909, DOI 10.1016/j.ajhg.2009.11.009; Moheb LA, 2008, EUR J HUM GENET, V16, P270, DOI 10.1038/sj.ejhg.5201967; Motazacker MM, 2007, AM J HUM GENET, V81, P792, DOI 10.1086/521275; Najmabadi H, 2007, HUM GENET, V121, P43, DOI 10.1007/s00439-006-0292-0; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Pak C, 2011, P NATL ACAD SCI USA, V108, P12390, DOI 10.1073/pnas.1107103108; Putoux A, 2011, NAT GENET, V43, P601, DOI 10.1038/ng.826; Raas-Rothschild A, 2002, AM J HUM GENET, V70, P1062, DOI 10.1086/339766; Rafiq MA, 2011, AM J HUM GENET, V89, P176, DOI 10.1016/j.ajhg.2011.06.006; Ramser J, 2004, J MED GENET, V41, P679, DOI 10.1136/jmg.2004.019000; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shoichet SA, 2003, AM J HUM GENET, V73, P1341, DOI 10.1086/380309; Singh Baljinder, 2007, Hum Mutat, V28, P524, DOI 10.1002/humu.9491; Sodersten E, 2010, CELL CYCLE, V9, P4866, DOI 10.4161/cc.9.24.14154; Steinfeld R, 2009, AM J HUM GENET, V85, P354, DOI 10.1016/j.ajhg.2009.08.005; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Yildirim Y, 2011, HUM MOL GENET, V20, P1886, DOI 10.1093/hmg/ddr070; Zamponi GW, 2010, PFLUG ARCH EUR J PHY, V460, P395, DOI 10.1007/s00424-009-0772-x; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599	43	642	662	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2011	478	7367					57	63		10.1038/nature10423	http://dx.doi.org/10.1038/nature10423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21937992				2022-12-28	WOS:000295575400034
J	Schott, GD				Schott, G. D.			The art of medicine Doodling and the default network of the brain	LANCET			English	Editorial Material									Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Schott, GD (corresponding author), Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	g.schott@ucl.ac.uk						Andrade J, 2010, APPL COGNITIVE PSYCH, V24, P100, DOI 10.1002/acp.1561; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Gombrich Ernst H., 1999, USES IMAGES STUDIES, P212; Maclay W S, 1938, Proc R Soc Med, V31, P1337; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295	5	13	13	1	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 24	2011	378	9797					1133	1134		10.1016/S0140-6736(11)61496-7	http://dx.doi.org/10.1016/S0140-6736(11)61496-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829RH	21969958				2022-12-28	WOS:000295601500014
J	Rasio, FA				Rasio, Frederic A.			A Black Widow's Best Friend?	SCIENCE			English	Editorial Material							PLANETS; PULSARS		[Rasio, Frederic A.] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA; [Rasio, Frederic A.] Northwestern Univ, CIERA, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Rasio, FA (corresponding author), Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA.	rasio@northwestern.edu		Rasio, Frederic/0000-0002-7132-418X				Bailes M, 2011, SCIENCE, V333, P1717, DOI 10.1126/science.1208890; Bodenheimer P, 2002, ANNU REV EARTH PL SC, V30, P113, DOI 10.1146/annurev.earth.30.091201.140357; Deloye CJ, 2003, ASTROPHYS J, V598, P1217, DOI 10.1086/379063; Durisen R. H., 2007, PROTOSTARS PLANETS, P607; EICHLER D, 1988, NATURE, V336, P557, DOI 10.1038/336557a0; Hessels JWT, 2006, SCIENCE, V311, P1901, DOI 10.1126/science.1123430; Naoz S, 2011, NATURE, V473, P187, DOI 10.1038/nature10076; RASIO FA, 1992, ASTRON ASTROPHYS, V256, pL35; TAVANI M, 1992, NATURE, V356, P320, DOI 10.1038/356320a0; THORSETT SE, 1992, ASTROPHYS J, V387, pL69, DOI 10.1086/186307; WOLSZCZAN A, 1994, SCIENCE, V264, P538, DOI 10.1126/science.264.5158.538; WOLSZCZAN A, 1992, NATURE, V355, P145, DOI 10.1038/355145a0; EXTRASOLAR PLANETS C	13	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1712	1713		10.1126/science.1212489	http://dx.doi.org/10.1126/science.1212489			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	823KQ	21940883				2022-12-28	WOS:000295121500029
J	Blazes, D; Russell, K				Blazes, David; Russell, Kevin			Joining forces	NATURE			English	Editorial Material							INFECTION		[Blazes, David; Russell, Kevin] Armed Forces Hlth Surveillance Ctr, Silver Spring, MD 20904 USA		Blazes, D (corresponding author), Armed Forces Hlth Surveillance Ctr, Silver Spring, MD 20904 USA.	david.blazes@us.army.mil						Grabenstein JD, 2006, EPIDEMIOL REV, V28, P3, DOI 10.1093/epirev/mxj003; Lewis SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019750; Peake J. B., 2011, DEFENSE DEP ENDURING; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Russell KL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S2-S2	5	6	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2011	477	7365					395	396		10.1038/477395a	http://dx.doi.org/10.1038/477395a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	822WH	21938047	Bronze			2022-12-28	WOS:000295080500014
J	Saleeby, E; Brindis, CD				Saleeby, Erin; Brindis, Claire D.			Women, Reproductive Health, and Health Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Saleeby, Erin] Univ Calif Los Angeles, David Geffen Sch Med, Robert Wood Johnson Fdn Clin Scholars Program, Dept Obstet & Gynecol, Los Angeles, CA 90024 USA; [Saleeby, Erin] Univ Calif Los Angeles, David Geffen Sch Med, Robert Wood Johnson Fdn Clin Scholars Program, Dept Med, Los Angeles, CA 90024 USA; [Brindis, Claire D.] Univ Calif San Francisco, Dept Pediat, Bixby Ctr Global Reprod Hlth,Div Adolescent Med, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA USA; [Brindis, Claire D.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Bixby Ctr Global Reprod Hlth, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA USA	Robert Wood Johnson Foundation (RWJF); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Robert Wood Johnson Foundation (RWJF); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Saleeby, E (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Robert Wood Johnson Fdn Clin Scholars Program, Dept Obstet & Gynecol, 911 Broxton Ave,Ste 314, Los Angeles, CA 90024 USA.	esaleeby@mednet.ucla.edu		Brindis, Claire/0000-0002-2284-3936				Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], 2011, CAL PREGN ASS MORT R; [Anonymous], 2011, CLIN PREV SERV WOM C; Cleland K, 2011, NEW ENGL J MED, V364, DOI 10.1056/NEJMp1104373; Harper MA, 2004, ANN EPIDEMIOL, V14, P274, DOI 10.1016/S1047-2797(03)00128-5; *KAIS FAM FDN, 2010, WOM HLTH POL FACTS W; Mansour D, 2010, EUR J CONTRACEP REPR, V15, P4, DOI 10.3109/13625180903427675; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mosher William D, 2010, Vital Health Stat 23, P1; Peipert JF, 2011, OBSTET GYNECOL, V117, P1105, DOI 10.1097/AOG.0b013e31821188ad	10	9	9	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2011	306	11					1256	1257		10.1001/jama.2011.1342	http://dx.doi.org/10.1001/jama.2011.1342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HB	21934061				2022-12-28	WOS:000295033500029
J	Miller, LH; Su, XZ				Miller, Louis H.; Su, Xinzhuan			Artemisinin: Discovery from the Chinese Herbal Garden	CELL			English	Editorial Material							FALCIPARUM; MEFLOQUINE; QINGHAOSU; DRUG	This year's Lasker DeBakey Clinical Research Award goes to Youyou Tu for the discovery of artemisinin and its use in the treatment of malaria-a medical advance that has saved millions of lives across the globe, especially in the developing world.	[Miller, Louis H.; Su, Xinzhuan] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Miller, LH (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.	lmiller@niaid.nih.gov		Su, Xinzhuan/0000-0003-3246-3248	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000892, ZIAAI000241] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI000241-27] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		[Anonymous], 1979, CHINESE MED J-PEKING, V92, P811; Charman SA, 2011, P NATL ACAD SCI USA, V108, P4400, DOI 10.1073/pnas.1015762108; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; JIANG JB, 1982, LANCET, V2, P285; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; LI GQ, 1984, LANCET, V2, P1360; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; TRENHOLME GM, 1975, SCIENCE, V190, P792, DOI 10.1126/science.1105787; Tu YY, 1981, 4 M WHO SCI WORK GRO; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Zhang JF, 2006, DETAILED CHRONOLOGIC	15	260	277	2	120	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2011	146	6					855	858		10.1016/j.cell.2011.08.024	http://dx.doi.org/10.1016/j.cell.2011.08.024			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21907397	Green Accepted, Bronze			2022-12-28	WOS:000295258100006
J	Christoffersen, M; Frikke-Schmidt, R; Schnohr, P; Jensen, GB; Nordestgaard, BG; Tybjaerg-Hansen, A				Christoffersen, Mette; Frikke-Schmidt, Ruth; Schnohr, Peter; Jensen, Gorm B.; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne			Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR RISK-FACTORS; CORONARY HEART-DISEASE; ANKLE-BRACHIAL INDEX; MORTALITY; ATHEROSCLEROSIS; PALPEBRARUM; ASSOCIATION; MEN	Objective To test the hypothesis that xanthelasmata and arcus corneae, individually and combined, predict risk of ischaemic vascular disease and death in the general population. Design Prospective population based cohort study. Setting The Copenhagen City Heart Study. Participants 12 745 people aged 20-93 years free of ischaemic vascular disease at baseline and followed from 1976-8 until May 2009 with 100% complete follow-up. Main outcome measures Hazard ratios for myocardial infarction, ischaemic heart disease, ischaemic stroke, ischaemic cerebrovascular disease, and death; odds ratios for severe atherosclerosis. Results 563 (4.4%) of participants had xanthelasmata and 3159 (24.8%) had arcus corneae at baseline. During 33 years' follow-up (mean 22 years), 1872 developed myocardial infarction, 3699 developed ischaemic heart disease, 1498 developed ischaemic stroke, 1815 developed ischaemic cerebrovascular disease, and 8507 died. Multifactorially adjusted hazard/odds ratios for people with versus those without xanthelasmata were 1.48 (95% confidence interval 1.23 to 1.79) for myocardial infarction, 1.39 (1.20 to 1.60) for ischaemic heart disease, 0.94 (0.73 to 1.21) for ischaemic stroke, 0.91 (0.72 to 1.15) for ischaemic cerebrovascular disease, 1.69 (1.03 to 2.79) for severe atherosclerosis, and 1.14 (1.04 to 1.26) for death. The corresponding hazard/odds ratios for people with versus those without arcus corneae were non-significant. In people with versus those without both xanthelasmata and arcus corneae, hazard/odds ratios were 1.47 (1.09 to 1.99) for myocardial infarction, 1.56 (1.25 to 1.94) for ischaemic heart disease, 0.87 (0.57 to 1.31) for ischaemic stroke, 0.86 (0.58 to 1.26) for ischaemic cerebrovascular disease, 2.75 (0.75 to 10.1) for severe atherosclerosis, and 1.09 (0.93 to 1.28) for death. In all age groups in both women and men, absolute 10 year risk of myocardial infarction, ischaemic heart disease, and death increased in the presence of xanthelasmata. The highest absolute 10 year risks of ischaemic heart disease of 53% and 41% were found in men aged 70-79 years with and without xanthelasmata. Corresponding values in women were 35% and 27%. Conclusion Xanthelasmata predict risk of myocardial infarction, ischaemic heart disease, severe atherosclerosis, and death in the general population, independently of well known cardiovascular risk factors, including plasma cholesterol and triglyceride concentrations. In contrast, arcus corneae is not an important independent predictor of risk.	[Christoffersen, Mette; Frikke-Schmidt, Ruth; Tybjaerg-Hansen, Anne] Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Schnohr, Peter; Jensen, Gorm B.; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Bispebjerg Hosp, Copenhagen City Heart Study, DK-2400 Copenhagen, Denmark; [Jensen, Gorm B.] Univ Copenhagen, Hvidovre Hosp, Dept Cardiol, DK-2650 Hvidovre, Denmark; [Nordestgaard, Borge G.] Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital	Tybjaerg-Hansen, A (corresponding author), Copenhagen Univ Hosp, Rigshosp, Sect Mol Genet KB 4111, Dept Clin Biochem KB 3011, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark.	at-h@rh.regionh.dk	Nordestgaard, Borge Gronne/ABF-1310-2020; Christoffersen, Mette/AFE-8953-2022; Hug, Balthasar L./G-1568-2010	Christoffersen, Mette/0000-0001-6614-0899; Nordestgaard, Borge/0000-0002-1954-7220; Frikke-Schmidt, Ruth/0000-0003-4084-5027	Rigshospitalet; Lundbeck Foundation; Danish Medical Research Council; Danish Heart Foundation	Rigshospitalet; Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Heart Foundation	This study was funded by the Research Fund at Rigshospitalet, the Lundbeck Foundation, the Danish Medical Research Council, and the Danish Heart Foundation. The sponsors had no role in the design of the study; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. The views expressed in this paper are those of the authors and not those of any funding body or others whose support is acknowledged.	Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; BATES MC, 1989, SOUTHERN MED J, V82, P570, DOI 10.1097/00007611-198905000-00008; BERGMAN R, 1994, J AM ACAD DERMATOL, V30, P236, DOI 10.1016/S0190-9622(94)70023-0; Chan CC, 2008, INT J CLIN PRACT, V62, P221, DOI 10.1111/j.1742-1241.2007.01540.x; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; DOUSTEBLAZY P, 1982, ANN INTERN MED, V96, P164, DOI 10.7326/0003-4819-96-2-164; Eldrup N, 2006, EUR HEART J, V27, P316, DOI 10.1093/eurheartj/ehi644; Fernandez A, 2007, ATHEROSCLEROSIS, V193, P235, DOI 10.1016/j.atherosclerosis.2006.08.060; Fernandez AB, 2009, AM J CARDIOL, V103, P64, DOI 10.1016/j.amjcard.2008.08.030; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; JONSSON A, 1976, LANCET, V1, P372; KAHAN A, 1967, AM J OPHTHALMOL, V63, P320, DOI 10.1016/0002-9394(67)91557-7; Kamstrup PR, 2008, CIRCULATION, V117, P176, DOI 10.1161/CIRCULATIONAHA.107.715698; KLEIN B, 1975, ARCH INTERN MED, V135, P509, DOI 10.1001/archinte.135.4.509; Langsted A, 2011, J INTERN MED, V270, P65, DOI 10.1111/j.1365-2796.2010.02333.x; MENOTTI A, 1987, J EPIDEMIOL COMMUN H, V41, P243, DOI 10.1136/jech.41.3.243; Menotti A, 1998, ARCH GERONTOL GERIAT, V26, P99, DOI 10.1016/S0167-4943(97)00035-6; Murabito JM, 2003, ARCH INTERN MED, V163, P1939, DOI 10.1001/archinte.163.16.1939; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; Noel B, 2007, J EUR ACAD DERMATOL, V21, P1244, DOI 10.1111/j.1468-3083.2007.02252.x; Ozdol S, 2008, INT J DERMATOL, V47, P785, DOI 10.1111/j.1365-4632.2008.03690.x; PARKER F, 1968, AM J PATHOL, V53, P537; PEDACE FJ, 1965, J AMER MED ASSOC, V193, P893, DOI 10.1001/jama.1965.03090110031008; PEDERSEN TR, 1994, LANCET, V344, P1383; PEER J, 1983, BRIT J OPHTHALMOL, V67, P795, DOI 10.1136/bjo.67.12.795; RIBERA M, 1995, AM J MED, V99, P485, DOI 10.1016/S0002-9343(99)80224-1; RIFKIND BM, 1965, LANCET, V1, P312; ROSENMAN RH, 1974, NEW ENGL J MED, V291, P1322, DOI 10.1056/NEJM197412192912503; Schnohr P, 2002, EUR HEART J, V23, P620, DOI 10.1053/euhj.2001.2842; SEGAL P, 1986, CIRCULATION, V73, P108; Thygesen K, 2007, EUR HEART J, V28, P2525; Tursen U, 2006, J EUR ACAD DERMATOL, V20, P260, DOI 10.1111/j.1468-3083.2006.01418.x; WATANABE A, 1981, ATHEROSCLEROSIS, V38, P283, DOI 10.1016/0021-9150(81)90044-7	35	50	52	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2011	343								d5497	10.1136/bmj.d5497	http://dx.doi.org/10.1136/bmj.d5497			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822VP	21920887	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000295078400002
J	Reece, SY; Hamel, JA; Sung, K; Jarvi, TD; Esswein, AJ; Pijpers, JJH; Nocera, DG				Reece, Steven Y.; Hamel, Jonathan A.; Sung, Kimberly; Jarvi, Thomas D.; Esswein, Arthur J.; Pijpers, Joep J. H.; Nocera, Daniel G.			Wireless Solar Water Splitting Using Silicon-Based Semiconductors and Earth-Abundant Catalysts	SCIENCE			English	Article							OXYGEN-EVOLVING CATALYST; HYDROGEN-PRODUCTION; PHOTOSYSTEM-II; PHOTOELECTROCHEMICAL DEVICE; CRYSTAL-STRUCTURE; TRIPLE STACK; OXIDATION; ENERGY; PHOTOANODES; PHOSPHATE	We describe the development of solar water-splitting cells comprising earth-abundant elements that operate in near-neutral pH conditions, both with and without connecting wires. The cells consist of a triple junction, amorphous silicon photovoltaic interfaced to hydrogen- and oxygen-evolving catalysts made from an alloy of earth-abundant metals and a cobalt|borate catalyst, respectively. The devices described here carry out the solar-driven water-splitting reaction at efficiencies of 4.7% for a wired configuration and 2.5% for a wireless configuration when illuminated with 1 sun (100 milliwatts per square centimeter) of air mass 1.5 simulated sunlight. Fuel-forming catalysts interfaced with light-harvesting semiconductors afford a pathway to direct solar-to-fuels conversion that captures many of the basic functional elements of a leaf.	[Reece, Steven Y.; Hamel, Jonathan A.; Sung, Kimberly; Jarvi, Thomas D.; Esswein, Arthur J.] Sun Catalytix, Cambridge, MA 02139 USA; [Pijpers, Joep J. H.; Nocera, Daniel G.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Pijpers, Joep J. H.] Fdn Fundamental Res Matter, Inst Atom & Mol Phys, NL-1098 XG Amsterdam, Netherlands	Massachusetts Institute of Technology (MIT); AMOLF	Reece, SY (corresponding author), Sun Catalytix, Cambridge, MA 02139 USA.	streece@suncatalytix.com; tjarvi@suncatalytix.com; nocera@mit.edu			ARPA-E [DE-AR0000036]; National Science Foundation [CHE-0533150]; AFOSR [FA9550-09-1-0689]; Chesonis Family Foundation; Foundation for Fundamental Research on Matter (FOM); Netherlands Organization for Scientific Research (NWO)	ARPA-E; National Science Foundation(National Science Foundation (NSF)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Chesonis Family Foundation; Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Sun Catalytix acknowledges Xunlight Corporation for providing the 3jn-a-Si cells and ARPA-E (DE-AR0000036) for funding. D.G.N. acknowledges support with grants from the National Science Foundation (CHE-0533150), AFOSR FA9550-09-1-0689, and the Chesonis Family Foundation. J.J.H.P. performed work as part of the Fellowships for Young Energy Scientists program of the Foundation for Fundamental Research on Matter (FOM), which is financially supported by the Netherlands Organization for Scientific Research (NWO). NWO is also gratefully acknowledged for supplying a Rubicon grant to J.J.H.P. J. Turner and E. Miller are acknowledged for helpful discussions.	Abbott D, 2010, P IEEE, V98, P42, DOI 10.1109/JPROC.2009.2035162; [Anonymous], GERM COMM SUMM; Barber J, 2008, INORG CHEM, V47, P1700, DOI 10.1021/ic701835r; Barber J, 2007, PHILOS T R SOC A, V365, P1007, DOI 10.1098/rsta.2006.1962; Betley TA, 2008, INORG CHEM, V47, P1849, DOI 10.1021/ic701972n; Chen YW, 2011, NAT MATER, V10, P539, DOI [10.1038/nmat3047, 10.1038/NMAT3047]; CONWAY BE, 1986, INT J HYDROGEN ENERG, V11, P533, DOI 10.1016/0360-3199(86)90020-0; Cook TR, 2010, CHEM REV, V110, P6474, DOI 10.1021/cr100246c; DELAHOY AE, 1985, INT J HYDROGEN ENERG, V10, P113, DOI 10.1016/0360-3199(85)90043-6; Deng X., 2003, HDB PHOTOVOLTAIC SCI, P505; Esswein AJ, 2011, ENERG ENVIRON SCI, V4, P499, DOI 10.1039/c0ee00518e; Gibson T.L., 2003, [No title captured], Patent No. [7,052,587, 7052587, 7 052 587]; Kanan MW, 2008, SCIENCE, V321, P1072, DOI 10.1126/science.1162018; Kanan MW, 2010, J AM CHEM SOC, V132, P13692, DOI 10.1021/ja1023767; Kelly NA, 2006, INT J HYDROGEN ENERG, V31, P1658, DOI 10.1016/j.ijhydene.2005.12.014; Khaselev O, 1998, SCIENCE, V280, P425, DOI 10.1126/science.280.5362.425; Khaselev O, 2001, INT J HYDROGEN ENERG, V26, P127, DOI 10.1016/S0360-3199(00)00039-2; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Licht S, 2000, J PHYS CHEM B, V104, P8920, DOI 10.1021/jp002083b; LIN GH, 1989, APPL PHYS LETT, V55, P386, DOI 10.1063/1.101879; Lutterman DA, 2009, J AM CHEM SOC, V131, P3838, DOI 10.1021/ja900023k; Nocera DG, 2009, CHEMSUSCHEM, V2, P387, DOI 10.1002/cssc.200900040; Pijpers JJH, 2011, P NATL ACAD SCI USA, V108, P10056, DOI 10.1073/pnas.1106545108; Risch M, 2009, J AM CHEM SOC, V131, P6936, DOI 10.1021/ja902121f; Rocheleau RE, 1998, ENERG FUEL, V12, P3, DOI 10.1021/ef9701347; Seabold JA, 2011, CHEM MATER, V23, P1105, DOI 10.1021/cm1019469; Sproviero EM, 2008, J AM CHEM SOC, V130, P6728, DOI 10.1021/ja801979n; Stachurski J. Z. O., 1982, U.S. Patent, Patent No. [4,354,915, 4354915]; Steinmiller EMP, 2009, P NATL ACAD SCI USA, V106, P20633, DOI 10.1073/pnas.0910203106; Surendranath Y, 2010, J AM CHEM SOC, V132, P16501, DOI 10.1021/ja106102b; Surendranath Y, 2009, J AM CHEM SOC, V131, P2615, DOI 10.1021/ja807769r; Symes MD, 2011, J AM CHEM SOC, V133, P5174, DOI 10.1021/ja110908v; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Walter MG, 2010, CHEM REV, V110, P6446, DOI 10.1021/cr1002326; Zhang XG, 2001, SILICON ITS OXIDE; Zhong DK, 2011, ENERG ENVIRON SCI, V4, P1759, DOI 10.1039/c1ee01034d; Zhong DK, 2010, J AM CHEM SOC, V132, P4202, DOI 10.1021/ja908730h; Zhong DK, 2009, J AM CHEM SOC, V131, P6086, DOI 10.1021/ja9016478	38	1326	1358	18	1369	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2011	334	6056					645	648		10.1126/science.1209816	http://dx.doi.org/10.1126/science.1209816			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	21960528				2022-12-28	WOS:000296494700048
J	Basu, S; Stuckler, D; Bitton, A; Glantz, SA				Basu, Sanjay; Stuckler, David; Bitton, Asaf; Glantz, Stanton A.			Projected effects of tobacco smoking on worldwide tuberculosis control: mathematical modelling analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FRAMEWORK CONVENTION; CIGARETTE-SMOKING; IMPACT; PROSPECTS; EPIDEMICS; MORTALITY	Objectives Almost 20% of people smoke tobacco worldwide-a percentage projected to rise in many poor countries. Smoking has been linked to increased individual risk of tuberculosis infection and mortality, but it remains unclear how these risks affect population-wide tuberculosis rates. Design We constructed a state transition, compartmental, mathematical model of tuberculosis epidemics to estimate the impact of alternative future smoking trends on tuberculosis control. We projected tuberculosis incidence, prevalence, and mortality in each World Health Organization region from 2010 to 2050, and incorporated changing trends in smoking, case detection, treatment success, and HIV prevalence. Results The model predicted that smoking would produce an excess of 18 million tuberculosis cases (standard error 16-20) and 40 million deaths from tuberculosis (39-41) between 2010 and 2050, if smoking trends continued along current trajectories. The effect of smoking was anticipated to increase the number of tuberculosis cases by 7% (274 million v 256 million) and deaths by 66% (101 million v 61 million), compared with model predictions that did not account for smoking. Smoking was also expected to delay the millennium development goal target to reduce tuberculosis mortality by half from 1990 to 2015. The model estimated that aggressive tobacco control (achieving a 1% decrease in smoking prevalence per year down to eradication) would avert 27 million smoking attributable deaths from tuberculosis by 2050. However, if the prevalence of smoking increased to 50% of adults (as observed in countries with high tobacco use), the model estimated that 34 million additional deaths from tuberculosis would occur by 2050. Conclusions Tobacco smoking could substantially increase tuberculosis cases and deaths worldwide in coming years, undermining progress towards tuberculosis mortality targets. Aggressive tobacco control could avert millions of deaths from tuberculosis.	[Basu, Sanjay; Glantz, Stanton A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Basu, Sanjay] San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA 94110 USA; [Basu, Sanjay; Stuckler, David] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England; [Stuckler, David] Univ Cambridge, Dept Sociol, Cambridge, England; [Bitton, Asaf] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Bitton, Asaf] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Basu, S (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	sanjay.basu@ucsf.edu	Stuckler, David/H-2261-2012	Stuckler, David/0000-0002-1288-8401	US Centers for Disease Control and Prevention [R36-CI000607-01]; National Institutes of Health [T32-GM07205-32]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [R36CI000607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	SB is supported partly by the US Centers for Disease Control and Prevention (R36-CI000607-01) and the National Institutes of Health (T32-GM07205-32). The sponsors had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study, and all authors had final responsibility for the decision to submit for publication.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; American Cancer Society, 2009, TOB ATL; ANDERSON R M, 1991; Basu S, 2009, INT J TUBERC LUNG D, V13, P652; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106; Bitton A, 2010, ADDICTION, V105, P2184, DOI 10.1111/j.1360-0443.2010.03060.x; Bolker B, 2008, ECOLOGICAL MODELS DA; Broek JBM, 1992, INT C AIDS, V8, pC314; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; Crothers K, 2009, AIDS EDUC PREV, V21, P40, DOI 10.1521/aeap.2009.21.3_supp.40; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Dye C, 2000, P NATL ACAD SCI USA, V97, P8180, DOI 10.1073/pnas.140102797; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Dye C, 2008, J R SOC INTERFACE, V5, P653, DOI 10.1098/rsif.2007.1138; El Sony A, 2007, INT J TUBERC LUNG D, V11, P150; Esson K. M, 2004, MILLENNIUM DEV GOALS; Food and Agriculture Organization of the United Nations, 2010, PROJ TOB PROD CONS T; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; John RM, 2009, TOB CONTROL, V18, P138, DOI 10.1136/tc.2008.027466; Leon-Garcia A., 2008, PROBABILITY STAT RAN; Lightwood JM, 2008, PLOS MED, V5, P1214, DOI 10.1371/journal.pmed.0050178; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Muggli ME, 2003, TOB CONTROL, V12, P104, DOI 10.1136/tc.12.1.104; NIEMAN RB, 1993, AIDS, V7, P705, DOI 10.1097/00002030-199305000-00015; One News, 2011, ONE NEWS; Otanez MG, 2009, AM J PUBLIC HEALTH, V99, P1759, DOI 10.2105/AJPH.2008.146217; Pakhale SS, 1998, FOOD CHEM TOXICOL, V36, P1131, DOI 10.1016/S0278-6915(98)00071-4; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Stop TB Partnership, 2006, GLOB PLAN STOP TB 20; Taylor AL, 2000, B WORLD HEALTH ORGAN, V78, P920; U.N. Population Division Department of Economic and Social Affairs, 2008, WORLD POP PROSP; UNAIDS, 2010, AIDS EP UPD 2009; Wen CP, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-156; WHO, 2010, GLOB TUB CONTR 2010; Williams BG, 2005, P NATL ACAD SCI USA, V102, P9619, DOI 10.1073/pnas.0501615102; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; Wilson D., 2010, NY TIMES; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2005, WHO UN MON TB TOB CO; World Health Organization, 2010, GLOB TB DAT; World Health Organization, 2006, STOP TB STRAT BUILD; World Health Organization, 2009, WHO REP GLOB TOB EP; World Health Organization, 2010, WHO GLOB HLTH OBS GH; Zeltner T., 2000, TOBACCO CO STRATEGIE	49	61	61	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 4	2011	343								d5506	10.1136/bmj.d5506	http://dx.doi.org/10.1136/bmj.d5506			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	832CR	21972295	hybrid, Green Published			2022-12-28	WOS:000295779300001
J	Gabut, M; Samavarchi-Tehrani, P; Wang, XC; Slobodeniuc, V; O'Hanlon, D; Sung, HK; Alvarez, M; Talukder, S; Pan, Q; Mazzoni, EO; Nedelec, S; Wichterle, H; Woltjen, K; Hughes, TR; Zandstra, PW; Nagy, A; Wrana, JL; Blencowe, BJ				Gabut, Mathieu; Samavarchi-Tehrani, Payman; Wang, Xinchen; Slobodeniuc, Valentina; O'Hanlon, Dave; Sung, Hoon-Ki; Alvarez, Manuel; Talukder, Shaheynoor; Pan, Qun; Mazzoni, Esteban O.; Nedelec, Stephane; Wichterle, Hynek; Woltjen, Knut; Hughes, Timothy R.; Zandstra, Peter W.; Nagy, Andras; Wrana, Jeffrey L.; Blencowe, Benjamin J.			An Alternative Splicing Switch Regulates Embryonic Stem Cell Pluripotency and Reprogramming	CELL			English	Article							DNA-BINDING; TRANSCRIPTIONAL NETWORK; SEQUENCE SPECIFICITY; FOXP1; DIFFERENTIATION; PROLIFERATION; MICROARRAY; COMPLEXITY; DROSOPHILA; DIVERSITY	Alternative splicing (AS) is a key process underlying the expansion of proteomic diversity and the regulation of gene expression. Here, we identify an evolutionarily conserved embryonic stem cell (ESC)-specific AS event that changes the DNA-binding preference of the forkhead family transcription factor FOXP1. We show that the ESC-specific isoform of FOXP1 stimulates the expression of transcription factor genes required for pluripotency, including OCT4, NANOG, NR5A2, and GDF3, while concomitantly repressing genes required for ESC differentiation. This isoform also promotes the maintenance of ESC pluripotency and contributes to efficient reprogramming of somatic cells into induced pluripotent stem cells. These results reveal a pivotal role for an AS event in the regulation of pluripotency through the control of critical ESC-specific transcriptional programs.	[Gabut, Mathieu; Wang, Xinchen; Slobodeniuc, Valentina; O'Hanlon, Dave; Talukder, Shaheynoor; Pan, Qun; Hughes, Timothy R.; Blencowe, Benjamin J.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Gabut, Mathieu; Wang, Xinchen; Slobodeniuc, Valentina; O'Hanlon, Dave; Alvarez, Manuel; Talukder, Shaheynoor; Pan, Qun; Hughes, Timothy R.; Zandstra, Peter W.; Blencowe, Benjamin J.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Samavarchi-Tehrani, Payman; Wrana, Jeffrey L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Sung, Hoon-Ki; Woltjen, Knut; Nagy, Andras] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Stem Cells & Tissue Engn, Toronto, ON M5G 1X5, Canada; [Samavarchi-Tehrani, Payman; Nagy, Andras; Wrana, Jeffrey L.; Blencowe, Benjamin J.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Alvarez, Manuel; Zandstra, Peter W.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5T 1P7, Canada; [Mazzoni, Esteban O.; Nedelec, Stephane; Wichterle, Hynek] Columbia Univ, Med Ctr, New York, NY 10032 USA	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; Columbia University	Blencowe, BJ (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 160 Coll St, Toronto, ON M5S 3E1, Canada.	b.blencowe@utoronto.ca	GABUT, Mathieu/M-7624-2017; Sung, Hoon-Ki/A-1922-2016; Nedelec, Stéphane/G-8469-2017; Sung, Hoon-Ki/G-3049-2013; Wrana, Jeffrey/F-8857-2013; Nagy, Andras/G-6465-2013; Hoon, Dave SB/C-7146-2018; Martinat, Cecile/F-6777-2010	GABUT, Mathieu/0000-0001-7343-5361; Sung, Hoon-Ki/0000-0001-6677-9385; Nedelec, Stéphane/0000-0001-8044-2498; Nagy, Andras/0000-0003-4311-0413; Hoon, Dave SB/0000-0003-1915-3683; Martinat, Cecile/0000-0002-5234-1064; mazzoni, esteban/0000-0001-8994-681X; Wichterle, Hynek/0000-0002-7817-0080; Wang, Xinchen/0000-0002-5198-6581; Woltjen, Knut/0000-0003-2293-1183	Canadian Institutes for Health Research (CIHR); Canadian Cancer Society; Genome Canada (through the Ontario Genomics Institute); Ontario Ministry of Research and Innovation; Ontario Research Fund; NIH [P01 NS055923]; C.H. Best Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055923] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Genome Canada (through the Ontario Genomics Institute)(Genome Canada); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Ontario Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); C.H. Best Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	B.J.B. dedicates this paper to the memory of S. Levine (1911-2011). We are grateful to D. Schmidt, D. Odom, Q. Morris, N. Barbosa-Morais, S. Mavadadi, and H. van Bakel for advice on data analysis and to A. Golipour for assistance with the iPSC reprogramming experiments. L. Attisano, D. Geschwind, and K.-H. Krause kindly provided valuable reagents, and A. Saltzman, B. Raj, J. Calarco, J. Ellis, H. Han, N. Barbosa-Morais, and M. Q.-Vallieres provided helpful comments on the manuscript. Our research was supported by grants from the Canadian Institutes for Health Research (CIHR) to B. J. B., J. L. W., A. N., P.W.Z., and T. R. H., a grant from the Canadian Cancer Society to B. J. B., a grant from Genome Canada (through the Ontario Genomics Institute) to B. J. B. and others, a grant from the Ontario Ministry of Research and Innovation to A. N., and a grant from the Ontario Research Fund to J. L. W., B. J. B., and others. E.O.M., S. N., and H. W. were supported by NIH grant P01 NS055923. E.O.M. is the David and Sylvia Lieb Fellow of the Damon Runyon Cancer Research Foundation (DRG-1937-07). M. G. was supported by post-doctoral fellowships from the C.H. Best Foundation and CIHR. J. L. W. is an International Scholar of the HHMI.	Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Brown PJ, 2008, BLOOD, V111, P2816, DOI 10.1182/blood-2007-09-115113; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Fic W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000253; Forch P, 2003, Prog Mol Subcell Biol, V31, P127; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Jaeger SA, 2010, GENOMICS, V95, P185, DOI 10.1016/j.ygeno.2010.01.002; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Koh KP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008109; Konstantoulas CJ, 2010, J NEUROCHEM, V113, P836, DOI 10.1111/j.1471-4159.2010.06650.x; Koon HB, 2007, EXPERT OPIN THER TAR, V11, P955, DOI 10.1517/14728222.11.7.955; Kubo H, 2009, GENES CELLS, V14, P407, DOI 10.1111/j.1365-2443.2009.01281.x; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Kunarso G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-155; Lam KN, 2011, NUCLEIC ACIDS RES, V39, P4680, DOI 10.1093/nar/gkq1303; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Mayshar Y, 2008, STEM CELLS, V26, P767, DOI 10.1634/stemcells.2007-1037; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pritsker M, 2005, P NATL ACAD SCI USA, V102, P14290, DOI 10.1073/pnas.0502132102; Rao DS, 2010, IMMUNITY, V33, P48, DOI 10.1016/j.immuni.2010.06.013; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Rowan S, 2010, GENE DEV, V24, P980, DOI 10.1101/gad.1890410; Salomonis N, 2010, P NATL ACAD SCI USA, V107, P10514, DOI 10.1073/pnas.0912260107; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Stroud JC, 2006, STRUCTURE, V14, P159, DOI 10.1016/j.str.2005.10.005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Zhang YZ, 2010, GENE DEV, V24, P1746, DOI 10.1101/gad.1929210	45	246	263	0	70	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					132	146		10.1016/j.cell.2011.08.023	http://dx.doi.org/10.1016/j.cell.2011.08.023			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21924763	Bronze			2022-12-28	WOS:000295396700021
J	Cuntz, M				Cuntz, Matthias			CARBON CYCLE A dent in carbon's gold standard	NATURE			English	Editorial Material							GLOBAL DISTRIBUTION		[Cuntz, Matthias] UFZ Helmholtz Ctr Environm Res, D-04318 Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Cuntz, M (corresponding author), UFZ Helmholtz Ctr Environm Res, Permoserstr 15, D-04318 Leipzig, Germany.	matthias.cuntz@ufz.de						Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Keeling CD., 2005, HIST ATMOSPHERIC CO2, P83, DOI DOI 10.1007/0-387-27048-5_5; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Stimler K, 2010, NEW PHYTOL, V186, P869, DOI 10.1111/j.1469-8137.2010.03218.x; Welp LR, 2011, NATURE, V477, P579, DOI 10.1038/nature10421; Werner M, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD900253	7	24	25	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 29	2011	477	7366					547	548		10.1038/477547a	http://dx.doi.org/10.1038/477547a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21956328				2022-12-28	WOS:000295320900030
J	Graves, N; Barnett, AG; Clarke, P				Graves, Nicholas; Barnett, Adrian G.; Clarke, Philip			Funding grant proposals for scientific research: retrospective analysis of scores by members of grant review panel	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; QUALITY; ABILITY; CHANCE; SYSTEM	Objective To quantify randomness and cost when choosing health and medical research projects for funding. Design Retrospective analysis. Setting Grant review panels of the National Health and Medical Research Council of Australia. Participants Panel members' scores for grant proposals submitted in 2009. Main outcome measures The proportion of grant proposals that were always, sometimes, and never funded after accounting for random variability arising from differences in panel members' scores, and the cost effectiveness of different size assessment panels. Results 59% of 620 funded grants were sometimes not funded when random variability was taken into account. Only 9% (n=255) of grant proposals were always funded, 61% (n=1662) never funded, and 29% (n=788) sometimes funded. The extra cost per grant effectively funded from the most effective system was $A18 541 (11 pound 848; (sic)13 482; $19 343). Conclusions Allocating funding for scientific research in health and medicine is costly and somewhat random. There are many useful research questions to be addressed that could improve current processes.	[Graves, Nicholas; Barnett, Adrian G.] Queensland Univ Technol, Sch Publ Hlth & Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia; [Clarke, Philip] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	Queensland University of Technology (QUT); University of Sydney	Graves, N (corresponding author), Queensland Univ Technol, Sch Publ Hlth & Inst Hlth & Biomed Innovat, 60 Musk Ave, Kelvin Grove, Qld 4059, Australia.	n.graves@qut.edu.au	Barnett, Adrian/I-9850-2012	Barnett, Adrian/0000-0001-6339-0374; Graves, Nicholas/0000-0002-5559-3267; Clarke, Philip/0000-0002-7555-5348	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Project grant funding process of National Health and Medical Research Council of Australia	ABRAMS PA, 1991, SOC STUD SCI, V21, P111, DOI 10.1177/030631291021001006; [Anonymous], 2010, NATURE, V464, P465, DOI 10.1038/464465a; Australian Government, 2010, NHMRC RES FUND FACTS; Baxt WG, 1998, ANN EMERG MED, V32, P310, DOI 10.1016/S0196-0644(98)70006-X; BENNETT M, 1982, HEALTH POLICY EDUC, V3, P173, DOI 10.1016/0165-2281(82)90035-2; BIRKETT NJ, 1994, CAN MED ASSOC J, V150, P1227; COLE S, 1981, SCIENCE, V214, P881, DOI 10.1126/science.7302566; Demicheli V, 2011, COCHRANE DB SYST REV, V2; Godlee F, 1998, JAMA-J AM MED ASSOC, V280, P237, DOI 10.1001/jama.280.3.237; Gong M, 2010, WHY DO GROUPS COOPER; Greenberg DS, 1998, LANCET, V351, P425, DOI 10.1016/S0140-6736(05)78370-7; Hodgson C, 1997, J CLIN EPIDEMIOL, V50, P1189, DOI 10.1016/S0895-4356(97)00167-4; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000016.pub3; Johnson VE, 2008, P NATL ACAD SCI USA, V105, P11076, DOI 10.1073/pnas.0804538105; Kaplan D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002761; Mayo NE, 2006, J CLIN EPIDEMIOL, V59, P842, DOI 10.1016/j.jclinepi.2005.12.007; Melin G., 2006, Science and Public Policy, V33, P702, DOI 10.3152/147154306781778579; Powell K, 2010, NATURE, V467, P383, DOI 10.1038/467383a; Research Councils UK, 2006, REP RES COUNC UK EFF; Schroter S, 2006, JAMA-J AM MED ASSOC, V295, P314, DOI 10.1001/jama.295.3.314; Schroter S, 2004, BRIT MED J, V328, P673, DOI 10.1136/bmj.38023.700775.AE; Schroter S, 2008, J ROY SOC MED, V101, P507, DOI 10.1258/jrsm.2008.080062; Schroter S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-62; Van Noorden R, 2010, NATURE, V466, P420, DOI 10.1038/466420b; Van Noorden R, 2010, NATURE, V464, P474, DOI 10.1038/464474a	25	64	64	2	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 27	2011	343								d4797	10.1136/bmj.d4797	http://dx.doi.org/10.1136/bmj.d4797			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829JV	21951756	Green Published, hybrid			2022-12-28	WOS:000295576600001
J	Beirle, S; Boersma, KF; Platt, U; Lawrence, MG; Wagner, T				Beirle, Steffen; Boersma, K. Folkert; Platt, Ulrich; Lawrence, Mark G.; Wagner, Thomas			Megacity Emissions and Lifetimes of Nitrogen Oxides Probed from Space	SCIENCE			English	Article							NOX EMISSIONS; SATELLITE	Megacities are immense sources of air pollutants, with large impacts on air quality and climate. However, emission inventories in many of them still are highly uncertain, particularly in developing countries. Satellite observations allow top-down estimates of emissions to be made for nitrogen oxides (NOx = NO + NO2), but require poorly quantified a priori information on the NOx lifetime. We present a method for the simultaneous determination of megacity NOx emissions and lifetimes from satellite measurements by analyzing the downwind patterns of NO2 separately for different wind conditions. Daytime lifetimes are similar to 4 hours at low and mid-latitudes, but similar to 8 hours in wintertime for Moscow. The derived NOx emissions are generally in good agreement with existing emission inventories, but are higher by a factor of 3 for the Saudi Arabian capital Riyadh.	[Beirle, Steffen; Lawrence, Mark G.; Wagner, Thomas] Max Planck Inst Chem, D-55128 Mainz, Germany; [Boersma, K. Folkert] Koninklijk Nederlands Meteorol Inst, NL-3732 GK De Bilt, Netherlands; [Boersma, K. Folkert] Eindhoven Univ Technol, NL-5612 AZ Eindhoven, Netherlands; [Platt, Ulrich] Heidelberg Univ, Inst Umweltphys, D-69120 Heidelberg, Germany	Max Planck Society; Royal Netherlands Meteorological Institute; Eindhoven University of Technology; Ruprecht Karls University Heidelberg	Beirle, S (corresponding author), Max Planck Inst Chem, Joh Joachim Becherweg 27, D-55128 Mainz, Germany.	steffen.beirle@mpic.de	Boersma, Klaas/H-4559-2012; Boersma, Klaas/Q-8393-2019	Boersma, Klaas/0000-0002-4591-7635; Boersma, Klaas/0000-0002-4591-7635; Lawrence, Mark/0000-0002-2178-4903; Beirle, Steffen/0000-0002-7196-0901	European Union [212520]	European Union(European Commission)	The research leading to these results received funding from the European Union's Seventh Framework Programme FP/2007-2011 within the project MEGAPOLI (grant 212520). We acknowledge the free use of tropospheric NO<INF>2</INF> column data from the OMI sensor from www.temis.nl. We thank the ECMWF for providing wind fields. EDGAR NO<INF>x</INF> emissions for 2005 were provided by the European Commission, Joint Research Centre (JRC)-Netherlands Environmental Assessment Agency (PBL) (EDGAR version 4.1, http://edgar.jrc.ec.europa.eu/, 2010). We thank S. Dorner for valuable assistance in processing ECMWF data.	Beirle S, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020312; Beirle S, 2003, ATMOS CHEM PHYS, V3, P2225, DOI 10.5194/acp-3-2225-2003; Boersma KF, 2007, ATMOS CHEM PHYS, V7, P2103, DOI 10.5194/acp-7-2103-2007; Butler D, 2008, NATURE, V455, P142, DOI 10.1038/455142b; Butler TM, 2008, ATMOS ENVIRON, V42, P703, DOI 10.1016/j.atmosenv.2007.09.060; Konovalov IB, 2006, ATMOS CHEM PHYS, V6, P1747, DOI 10.5194/acp-6-1747-2006; Kunhikrishnan T, 2004, ATMOS ENVIRON, V38, P581, DOI 10.1016/j.atmosenv.2003.09.074; Lawrence MG, 2007, ATMOS CHEM PHYS, V7, P3969, DOI 10.5194/acp-7-3969-2007; Leue C, 2001, J GEOPHYS RES-ATMOS, V106, P5493, DOI 10.1029/2000JD900572; Levelt PF, 2006, IEEE T GEOSCI REMOTE, V44, P1093, DOI 10.1109/TGRS.2006.872333; Martin RV, 2008, ATMOS ENVIRON, V42, P7823, DOI 10.1016/j.atmosenv.2008.07.018; Martin RV, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003453; Molina MJ, 2004, J AIR WASTE MANAGE, V54, P644, DOI 10.1080/10473289.2004.10470936; Pandis S. N., 2006, ATMOSPHERIC CHEM PHY; Richter A, 2005, NATURE, V437, P129, DOI 10.1038/nature04092; Ryerson TB, 1998, J GEOPHYS RES-ATMOS, V103, P22569, DOI 10.1029/98JD01620; SPICER CW, 1982, SCIENCE, V215, P1095, DOI 10.1126/science.215.4536.1095	17	281	295	13	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2011	333	6050					1737	1739		10.1126/science.1207824	http://dx.doi.org/10.1126/science.1207824			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940891				2022-12-28	WOS:000295121500039
J	Halpern, DF; Eliot, L; Bigler, RS; Fabes, RA; Hanish, LD; Hyde, J; Liben, LS; Martin, CL				Halpern, Diane F.; Eliot, Lise; Bigler, Rebecca S.; Fabes, Richard A.; Hanish, Laura D.; Hyde, Janet; Liben, Lynn S.; Martin, Carol Lynn			The Pseudoscience of Single-Sex Schooling	SCIENCE			English	Editorial Material							GENDER; BRAIN		[Halpern, Diane F.] Claremont Mckenna Coll, Claremont, CA 91711 USA; [Eliot, Lise] Rosalind Franklin Univ, N Chicago, IL 60064 USA; [Bigler, Rebecca S.] Univ Texas Austin, Austin, TX 78712 USA; [Fabes, Richard A.; Hanish, Laura D.; Martin, Carol Lynn] Arizona State Univ, Tempe, AZ 85287 USA; [Hyde, Janet] Univ Wisconsin, Madison, WI 53706 USA; [Liben, Lynn S.] Penn State Univ, University Pk, PA 16802 USA	Claremont Colleges; Claremont Graduate School; Claremont McKenna College; Rosalind Franklin University Medical & Science; University of Texas System; University of Texas Austin; Arizona State University; Arizona State University-Tempe; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Halpern, DF (corresponding author), Claremont Mckenna Coll, Claremont, CA 91711 USA.	diane.halpern@cmc.edu	Fabes, Richard/AAN-1363-2021; /ABF-7278-2020; Martin, Carol/AAS-8916-2020; /AGH-3726-2022; Hanish, Laura/AAN-1297-2021	Fabes, Richard/0000-0002-9539-8992; Martin, Carol/0000-0003-0666-023X; Hanish, Laura/0000-0003-4540-2655				Adair J. G, 2000, ENCY PSYCHOL, V4, P66; Beaman R, 2006, EDUC REV, V58, P339, DOI 10.1080/00131910600748406; Bigler RS, 2006, ADV CHILD DEV BEHAV, V34, P39, DOI 10.1016/S0065-2407(06)80004-2; Eliot L, 2013, SEX ROLES, V69, P363, DOI 10.1007/s11199-011-0037-y; Fabes RA, 1997, DEV PSYCHOL, V33, P693, DOI 10.1037/0012-1649.33.4.693; Gaertner S.L., 2010, INTERGROUP ATTITUDES, P204; Halpern D.F., 2012, SEX DIFFERENCES COGN, V4th; Harker R, 2000, BRIT J SOCIOL EDUC, V21, P203, DOI 10.1080/713655349; Hayes AR, 2011, SEX ROLES, V65, P693, DOI 10.1007/s11199-010-9903-2; Hilliard LJ, 2010, CHILD DEV, V81, P1787, DOI 10.1111/j.1467-8624.2010.01510.x; LEHMANN C, 2010, URBAN PREP WHOLE STO; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Leonard D, 2007, RES000221085 ESRC; Levit N, 2005, U ILLINOIS LAW REV, P455; LIBERMAN M, 2008, SEXUAL PSEUDOSCIENCE; Liu HS, 2009, P NATL ACAD SCI USA, V106, P20499, DOI 10.1073/pnas.0908073106; Marsh HW, 1996, AUST J EDUC, V40, P147, DOI 10.1177/000494419604000203; MARTIN CL, 1981, CHILD DEV, V52, P1119, DOI 10.2307/1129498; Martin CL, 2001, DEV PSYCHOL, V37, P431, DOI 10.1037//0012-1649.37.3.431; MEMRICK A, 2011, GASTON GAZETTE  0115, pA1; Orfield G., 2008, URBAN REV, V40, DOI [DOI 10.1007/S11256-007-0073-7, 10.1007/s11256-007-0073-7]; Organization for Economic Cooperation and Development, 2009, EQ PREP LIF; Patterson MM, 2011, SEX ROLES, V65, P737, DOI 10.1007/s11199-010-9904-1; Policy and Program Studies Service of the US Department of Education's Office of Planning Evaluation and Policy Development, 2005, SINGL SEX VERS COED; Sax L, 2005, WHY GENDER MATTERS; Sax L., 2006, EDUC HORIZONS, V84, P190; Shear M. D., 2009, WASHINGTON POST 0723; Smithers A., 1996, PARADOX SINGLE SEX C; SWEET L, 2010, CHICAGO SUN TIM 0727; Thomson T., 2004, SINGLE SEX SCH FINAL; TIBBLES K, 2009, TODAY SHOW      0303	31	141	140	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1706	1707		10.1126/science.1205031	http://dx.doi.org/10.1126/science.1205031			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	823KQ	21940879				2022-12-28	WOS:000295121500025
J	Fedorkow, D				Fedorkow, Donna			Annual screening with CA-125 and transvaginal ultrasonography did not reduce ovarian cancer incidence or mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McMaster Univ, Hamilton, ON, Canada	McMaster University	Fedorkow, D (corresponding author), McMaster Univ, Hamilton, ON, Canada.							JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Nielsen C, 1999, MED CLIN N AM, V83, P1323, DOI 10.1016/S0025-7125(05)70169-3	3	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6							JC3-8	10.7326/0003-4819-155-6-201109200-02008	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930845				2022-12-28	WOS:000295033400007
J	Griffin, EE; Odde, DJ; Seydoux, G				Griffin, Erik E.; Odde, David J.; Seydoux, Geraldine			Regulation of the MEX-5 Gradient by a Spatially Segregated Kinase/Phosphatase Cycle	CELL			English	Article							C-ELEGANS EMBRYOS; PROTEIN PHOSPHATASE 2A; AU-RICH ELEMENT; PAR PROTEINS; CAENORHABDITIS-ELEGANS; MESSENGER-RNA; KINASE; POLARITY; PHOSPHORYLATION; ASYMMETRY	Protein concentration gradients encode spatial information across cells and tissues and often depend on spatially localized protein synthesis. Here, we report that a different mechanism underlies the MEX-5 gradient. MEX-5 is an RNA-binding protein that becomes distributed in a cytoplasmic gradient along the anterior-to-posterior axis of the one-cell C. elegans embryo. We demonstrate that the MEX-5 gradient is a direct consequence of an underlying gradient in MEX-5 diffusivity. The MEX-5 diffusion gradient arises when the PAR-1 kinase stimulates the release of MEX-5 from slow-diffusive, RNA-containing complexes in the posterior cytoplasm. PAR-1 directly phosphorylates MEX-5 and is antagonized by the spatially uniform phosphatase PP2A. Mathematical modeling and in vivo observations demonstrate that spatially segregated phosphorylation and dephosphorylation reactions are sufficient to generate stable protein concentration gradients in the cytoplasm. The principles demonstrated here apply to any spatially segregated modification cycle that affects protein diffusion and do not require protein synthesis or degradation.	[Griffin, Erik E.; Seydoux, Geraldine] Johns Hopkins Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Ctr Cell Dynam, Baltimore, MD 21205 USA; [Odde, David J.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; University of Minnesota System; University of Minnesota Twin Cities	Seydoux, G (corresponding author), Johns Hopkins Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Ctr Cell Dynam, 725 N Wolfe St,PCTB 706, Baltimore, MD 21205 USA.	gseydoux@jhmi.edu	Odde, David/H-4925-2011; SEYDOUX, Geraldine/AAA-2005-2020; Odde, David/AAY-1720-2020	Odde, David/0000-0001-7731-2799; Seydoux, Geraldine/0000-0001-8257-0493	National Institutes of Health [R01HD37047, R01 GM71522]; American Cancer Society [PF-08-158-01-DDC]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Motegi for providing the Dendra2 construct, S. He for help with sucrose gradients, and N. Perkins and E. Pryce at the JHU Integrated Imaging Center for assistance with FCS. We thank K. Kemphues for providing strains and antibodies. We thank A. Cuenca for generation of the GFP::PAR-1 transgenic strain. We thank S. Kuo for helpful conversations and members of the Seydoux lab for helpful comments on the manuscript. This work was supported by the National Institutes of Health (Grants R01HD37047 [G.S.] and R01 GM71522 [D.J.O.]) and the American Cancer Society (Grant PF-08-158-01-DDC [E.E.G.]). G.S. is an Investigator of the Howard Hughes Medical Institute.	Berg H, 1993, RANDOM WALKS BIOL EX; Boyd L, 1996, DEVELOPMENT, V122, P3075; Brown GC, 1999, FEBS LETT, V457, P452, DOI 10.1016/S0014-5793(99)01058-3; Budirahardja Y, 2008, DEVELOPMENT, V135, P1303, DOI 10.1242/dev.019075; Cheeks RJ, 2004, CURR BIOL, V14, P851, DOI 10.1016/j.cub.2004.05.022; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; Coppey M, 2008, CURR BIOL, V18, P915, DOI 10.1016/j.cub.2008.05.034; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Daniels BR, 2010, DEVELOPMENT, V137, P2579, DOI 10.1242/dev.051326; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gallo CM, 2008, DEV BIOL, V323, P76, DOI 10.1016/j.ydbio.2008.07.008; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Hurd D, 2003, DEV BIOL, V253, P54, DOI 10.1006/dbio.2002.0866; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Kao GT, 2004, DEVELOPMENT, V131, P755, DOI 10.1242/dev.00987; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; Krahn MP, 2009, DEV CELL, V16, P901, DOI 10.1016/j.devcel.2009.04.011; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Lin J, 2009, J IMMUNOL, V183, P1215, DOI 10.4049/jimmunol.0803887; Lipkow K, 2008, CELL MOL BIOENG, V1, P84, DOI 10.1007/s12195-008-0008-8; Lippincott-Schwartz J, 2008, METHOD CELL BIOL, V85, P45, DOI 10.1016/S0091-679X(08)85003-0; Little SC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000596; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Marx A, 2010, FASEB J, V24, P1637, DOI 10.1096/fj.09-148064; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Moravcevic K, 2010, CELL, V143, P966, DOI 10.1016/j.cell.2010.11.028; Nam SC, 2007, DEV BIOL, V306, P624, DOI 10.1016/j.ydbio.2007.03.522; Pagano JM, 2007, J BIOL CHEM, V282, P8883, DOI 10.1074/jbc.M700079200; Rivers DM, 2008, J CELL BIOL, V180, P877, DOI 10.1083/jcb.200710018; Schlaitz AL, 2007, CELL, V128, P115, DOI 10.1016/j.cell.2006.10.050; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Severson AF, 2003, J CELL BIOL, V161, P21, DOI 10.1083/jcb.200210171; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Su TT, 1998, GENE DEV, V12, P1495, DOI 10.1101/gad.12.10.1495; Tenlen JR, 2008, DEVELOPMENT, V135, P3665, DOI 10.1242/dev.027060; Vaknin A, 2004, P NATL ACAD SCI USA, V101, P17072, DOI 10.1073/pnas.0407812101; Wartlick O, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001255; Yoder JH, 2004, EMBO J, V23, P111, DOI 10.1038/sj.emboj.7600025	46	95	103	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 16	2011	146	6					954	967		10.1016/j.cell.2011.08.012	http://dx.doi.org/10.1016/j.cell.2011.08.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925318	Green Accepted, Bronze			2022-12-28	WOS:000295258100017
J	Hughes, R; Nordholt, J				Hughes, Richard; Nordholt, Jane			Refining Quantum Cryptography	SCIENCE			English	Editorial Material							KEY DISTRIBUTION; FIELD-TEST; NETWORK		[Hughes, Richard; Nordholt, Jane] Los Alamos Natl Lab, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Hughes, R (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.	hughes@lanl.gov						Chen TY, 2010, OPT EXPRESS, V18, P27217, DOI 10.1364/OE.18.027217; Lydersen L, 2010, NAT PHOTONICS, V4, P686, DOI 10.1038/NPHOTON.2010.214; Pironio S, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/4/045021; Sasaki M, 2011, OPT EXPRESS, V19, P10387, DOI 10.1364/OE.19.010387; Takenaka H., 2011, P IEEE ICSOS, DOI [10.1109/ICSOS.2011.5783653, DOI 10.1109/ICSOS.2011.5783653]; Wang SA, 2010, OPT LETT, V35, P2454, DOI 10.1364/OL.35.002454; Xin H, 2011, SCIENCE, V332, P904, DOI 10.1126/science.332.6032.904	8	21	22	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2011	333	6049					1584	1586		10.1126/science.1208527	http://dx.doi.org/10.1126/science.1208527			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921186	Green Published			2022-12-28	WOS:000294900900028
J	Sugioka, K; Mizumoto, K; Sawa, H				Sugioka, Kenji; Mizumoto, Kota; Sawa, Hitoshi			Wnt Regulates Spindle Asymmetry to Generate Asymmetric Nuclear beta-Catenin in C. elegans	CELL			English	Article							ADENOMATOUS POLYPOSIS-COLI; CELL-DIVISION AXES; CAENORHABDITIS-ELEGANS; MITOTIC SPINDLE; MICROTUBULE GROWTH; TUMOR-SUPPRESSOR; FATE SPECIFICATION; EPITHELIAL-CELLS; APC; EMBRYOS	Extrinsic signals received by a cell can induce remodeling of the cytoskeleton, but the downstream effects of cytoskeletal changes on gene expression have not been well studied. Here, we show that during telophase of an asymmetric division in C. elegans, extrinsic Wnt signaling modulates spindle structures through APR-1/APC, which in turn promotes asymmetrical nuclear localization of WRM-1/beta-catenin and POP-1/TCF. APR-1 that localized asymmetrically along the cortex established asymmetric distribution of astral microtubules, with more microtubules found on the anterior side. Perturbation of the Wnt signaling pathway altered this microtubule asymmetry and led to changes in nuclear WRM-1 asymmetry, gene expression, and cell-fate determination. Direct manipulation of spindle asymmetry by laser irradiation altered the asymmetric distribution of nuclear WRM-1. Moreover, laser manipulation of the spindles rescued defects in nuclear POP-1 asymmetry in wnt mutants. Our results reveal a mechanism in which the nuclear localization of proteins is regulated through the modulation of microtubules.	[Sugioka, Kenji; Mizumoto, Kota; Sawa, Hitoshi] RIKEN Ctr Dev Biol, Lab Cell Fate Decis, Kobe, Hyogo 6500047, Japan; [Sugioka, Kenji; Sawa, Hitoshi] Kobe Univ, Dept Biol, Grad Sch Sci, Kobe, Hyogo 6578501, Japan; [Sawa, Hitoshi] Natl Inst Genet, Multicellular Org Lab, Mishima, Shizuoka 4118540, Japan	RIKEN; Kobe University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Sawa, H (corresponding author), RIKEN Ctr Dev Biol, Lab Cell Fate Decis, Kobe, Hyogo 6500047, Japan.	hisawa@lab.nig.ac.jp		Sawa, Hitoshi/0000-0001-9774-7976; Sugioka, Kenji/0000-0002-5830-9639; Mizumoto, Kota/0000-0001-8091-4483	National Institutes of Health National Center for Research Resources; Ministry of Education, Culture, Sports, Science, and Technology of Japan; RIKEN	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN	We thank Rueyling Lin for the anti-POP-1 antibody, Morris Maduro for pMM414, Yuji Kohara for cDNAs, Geraldine Seydoux for the pID3.01B, Joel Rothman, Francis J. McNally, Shohei Mitani, and the Caenorhabditis Genetics Center (funded by the National Institutes of Health National Center for Research Resources) for strains, Asako Sugimoto, Mika Toya, Bob Goldstein, Kumiko Oishi, Yukinobu Arata, Yukimasa Shibata, and Shinji Ihara for technical advice and helpful discussion, and Hazuki Hiraga for proofreading of our manuscript. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to H.S.K.S. was supported by the Junior Research Associate Program, RIKEN.	Batut J, 2007, DEV CELL, V12, P261, DOI 10.1016/j.devcel.2007.01.010; BRENNER S, 1974, GENETICS, V77, P71; Brocardo M, 2008, TRENDS CELL BIOL, V18, P587, DOI 10.1016/j.tcb.2008.09.002; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Chen Z, 2001, DEVELOPMENT, V128, P4911; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Cui HY, 2002, EXP CELL RES, V280, P12, DOI 10.1006/excr.2002.5506; D'Agostino I, 2006, DEV BIOL, V292, P244, DOI 10.1016/j.ydbio.2005.11.046; Edgar LG, 1995, METHOD CELL BIOL, V48, P303; Eleftheriou A, 2001, J BIOL CHEM, V276, P25883, DOI 10.1074/jbc.M102656200; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; GOLDSTEIN B, 1995, J CELL BIOL, V129, P1071, DOI 10.1083/jcb.129.4.1071; Goldstein B, 2006, DEV CELL, V10, P391, DOI 10.1016/j.devcel.2005.12.016; GOLDSTEIN B, 1995, DEVELOPMENT, V121, P1227; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Gundersen GG, 2004, CURR OPIN CELL BIOL, V16, P106, DOI 10.1016/j.ceb.2003.11.010; HERMAN MA, 1995, CELL, V83, P101, DOI 10.1016/0092-8674(95)90238-4; Hopkins SC, 2000, BIOCHEMISTRY-US, V39, P2805, DOI 10.1021/bi992474k; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Labbe JC, 2004, J CELL BIOL, V167, P245, DOI 10.1083/jcb.200406008; Lalli G, 2003, J CELL SCI, V116, P4639, DOI 10.1242/jcs.00727; Lee JY, 2003, DEVELOPMENT, V130, P307, DOI 10.1242/dev.00211; Lin RL, 1998, CELL, V92, P229, DOI 10.1016/S0092-8674(00)80917-4; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Lo MC, 2004, CELL, V117, P95, DOI 10.1016/S0092-8674(04)00203-X; Maduro MF, 2005, DEV BIOL, V285, P510, DOI 10.1016/j.ydbio.2005.06.022; Maduro MF, 2002, DEV BIOL, V248, P128, DOI 10.1006/dbio.2002.0721; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mizumoto K, 2007, TRENDS CELL BIOL, V17, P465, DOI 10.1016/j.tcb.2007.08.004; Mizumoto K, 2007, DEV CELL, V12, P287, DOI 10.1016/j.devcel.2007.01.004; Motegi F, 2006, DEV CELL, V10, P509, DOI 10.1016/j.devcel.2006.03.001; MUNEMITSU S, 1994, CANCER RES, V54, P3676; Nakamura K, 2005, GENE DEV, V19, P1749, DOI 10.1101/gad.1323705; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Phillips BT, 2009, DEV CELL, V17, P27, DOI 10.1016/j.devcel.2009.07.002; Praitis V, 2001, GENETICS, V157, P1217; Purro SA, 2008, J NEUROSCI, V28, P8644, DOI 10.1523/JNEUROSCI.2320-08.2008; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Roth DM, 2007, TRAFFIC, V8, P673, DOI 10.1111/j.1600-0854.2007.00564.x; Sawa H, 2000, MOL CELL, V6, P617, DOI 10.1016/S1097-2765(00)00060-5; Schlesinger A, 1999, GENE DEV, V13, P2028, DOI 10.1101/gad.13.15.2028; Schlessinger K, 2007, J CELL BIOL, V178, P355, DOI 10.1083/jcb.200701083; Schneider SQ, 2007, DEV CELL, V13, P73, DOI 10.1016/j.devcel.2007.05.002; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Sugioka K, 2010, GENES CELLS, V15, P397, DOI 10.1111/j.1365-2443.2010.01388.x; Takeshita H, 2005, GENE DEV, V19, P1743, DOI 10.1101/gad.1322805; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Walston T, 2004, DEV CELL, V7, P831, DOI 10.1016/j.devcel.2004.10.008; Wiechens N, 2001, CURR BIOL, V11, P18, DOI 10.1016/S0960-9822(00)00045-2; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	60	59	68	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 16	2011	146	6					941	953		10.1016/j.cell.2011.07.043	http://dx.doi.org/10.1016/j.cell.2011.07.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925317	Bronze			2022-12-28	WOS:000295258100016
J	Warner, E				Warner, Ellen			Breast-Cancer Screening	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COST-EFFECTIVENESS ANALYSIS; RANDOMIZED-TRIAL; FOLLOW-UP; AGE 40; MAMMOGRAPHY; WOMEN; MORTALITY; RISK; OVERDIAGNOSIS; MODEL	A healthy, 42-year-old white woman wants to discuss breast-cancer screening. She has no breast symptoms, had menarche at the age of 14 years, gave birth to her first child at the age of 26 years, is moderately overweight, drinks two glasses of wine most evenings, and has no family history of breast or ovarian cancer. She has never undergone mammography. She notes that a friend who maintained the "healthiest lifestyle possible" is now being treated for metastatic breast cancer, and she wants to avoid the same fate. What would you advise?	Univ Toronto, Sunnybrook Hlth Sci Ctr, Div Med Oncol, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Warner, E (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Div Med Oncol, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	ellen.warner@sunnybrook.ca			Amersham Health; Bayer Schering Pharma; AstraZeneca	Amersham Health; Bayer Schering Pharma(Bayer AG); AstraZeneca(AstraZeneca)	Dr. Warner reports receiving grant support from Amersham Health, consulting fees from Bayer Schering Pharma, and lecture fees from AstraZeneca. No other potential conflict of interest relevant to this article was reported.	Ahern CH, 2009, CANCER EPIDEM BIOMAR, V18, P718, DOI 10.1158/1055-9965.EPI-08-0918; Alexander FE, 1999, LANCET, V353, P1903, DOI 10.1016/S0140-6736(98)07413-3; American Cancer Society, GLOB CANC FACTS FIG; Amir E, 2010, JNCI-J NATL CANCER I, V102, P680, DOI 10.1093/jnci/djq088; [Anonymous], SEER STAT FACT SHEET; [Anonymous], IBIS BREAST CANC RIS; Armstrong K, 2007, ANN INTERN MED, V146, P516, DOI 10.7326/0003-4819-146-7-200704030-00008; Bailey SL, 2010, JNCI-J NATL CANCER I, V102, P1263, DOI 10.1093/jnci/djq271; Barton MB, 2004, J NATL CANCER I, V96, P529, DOI 10.1093/jnci/djh083; Baum M, 2002, EUR J CANCER, V38, P745, DOI 10.1016/S0959-8049(02)00033-3; Berg AO, 2002, ANN INTERN MED, V137, P344, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00011; Berg WA, 2008, JAMA-J AM MED ASSOC, V299, P2151, DOI 10.1001/jama.299.18.2151; Berg WA, 2010, JAMA-J AM MED ASSOC, V303, P168, DOI 10.1001/jama.2009.1993; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Bjurstam N, 2003, CANCER-AM CANCER SOC, V97, P2387, DOI 10.1002/cncr.11361; Boulos S, 2005, BREAST, V14, P340, DOI 10.1016/j.breast.2005.07.002; Brewer NT, 2007, ANN INTERN MED, V146, P502, DOI 10.7326/0003-4819-146-7-200704030-00006; Christiansen CL, 2000, JNCI-J NATL CANCER I, V92, P1657, DOI 10.1093/jnci/92.20.1657; Corsetti V, 2008, EUR J CANCER, V44, P539, DOI 10.1016/j.ejca.2008.01.009; Decarli A, 2006, J NATL CANCER I, V98, P1686, DOI 10.1093/jnci/djj463; del Carmen MG, 2007, AM J ROENTGENOL, V188, P1147, DOI 10.2214/AJR.06.0619; Drossaert CHC, 2001, J MED SCREEN, V8, P204, DOI 10.1136/jms.8.4.204; Duffy SW, 2010, J MED SCREEN, V17, P25, DOI 10.1258/jms.2009.009094; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Goel A, 2007, BREAST CANCER RES TR, V102, P339, DOI 10.1007/s10549-006-9334-5; HABBEMA JDF, 1986, JNCI-J NATL CANCER I, V77, P317; Helvie MA, 2010, RADIOL CLIN N AM, V48, P917, DOI 10.1016/j.rcl.2010.06.009; Hendrick R E, 1997, J Natl Cancer Inst Monogr, P87; Hendrick RE, 2011, AM J ROENTGENOL, V196, pW112, DOI 10.2214/AJR.10.5609; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Jonsson H, 2007, J MED SCREEN, V14, P87, DOI 10.1258/096914107781261918; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; KERLIKOWSKE K, 1995, CANCER, V76, P1679, DOI 10.1002/1097-0142(19951101)76:9<1679::AID-CNCR2820760928>3.0.CO;2-Y; Kosters J P, 2003, Cochrane Database Syst Rev, pCD003373, DOI 10.1002/14651858.CD003373; Lund MJ, 2009, BREAST CANCER RES TR, V113, P357, DOI 10.1007/s10549-008-9926-3; Mandelblatt JS, 2010, ANN INTERN MED, V152, P136; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; Moss S, 2005, BREAST CANCER RES, V7, P230, DOI 10.1186/bcr1314; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; National Cancer Institute, BREAST CANC RISK ASS; National Cancer Institute, CANC CONTR RES EARL; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Nystrom L, 2002, LANCET, V360, P724; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Pisani P, 2006, INT J CANCER, V118, P149, DOI 10.1002/ijc.21343; Pisano ED, 2006, NEW ENGL J MED, V355, P1840; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Silverstein MJ, 2001, WORLD J SURG, V25, P767, DOI 10.1007/s00268-001-0003-x; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; Tice JA, 2008, BREAST CANCER RES TR, V107, P157, DOI 10.1007/s10549-007-9545-4; Tice JA, 2009, PRIMARY CARE, V36, P533, DOI 10.1016/j.pop.2009.04.003; Wai ES, 2005, BRIT J CANCER, V92, P961, DOI 10.1038/sj.bjc.6602393; Welch HG, 2008, JNCI-J NATL CANCER I, V100, P228, DOI 10.1093/jnci/djn013; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; White E, 2004, JNCI-J NATL CANCER I, V96, P1832, DOI 10.1093/jnci/djh337; Yaffe MJ, 2011, RADIOLOGY, V258, P98, DOI 10.1148/radiol.10100655	58	117	125	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2011	365	11					1025	1032		10.1056/NEJMcp1101540	http://dx.doi.org/10.1056/NEJMcp1101540			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819UR	21916640				2022-12-28	WOS:000294857300010
J	Masten, SV; Foss, RD; Marshall, SW				Masten, Scott V.; Foss, Robert D.; Marshall, Stephen W.			Graduated Driver Licensing and Fatal Crashes Involving 16-to 19-Year-Old Drivers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TEENAGE DRIVERS; NOVICE DRIVERS; INVOLVEMENT; SYSTEMS; STATES	Context In the United States, graduated driver licensing (GDL) systems allow full, unrestricted licensure for drivers younger than 18 years only after an initial period of supervised driving and an intermediate period of unsupervised driving that limits driving at night, transporting multiple young passengers, or both. Objective To estimate the association of GDL programs with involvement in fatal crashes among 16- to 19-year-old drivers. Design, Setting, and Participants Pooled cross-sectional time series analysis of quarterly 1986-2007 incidence of fatal crashes involving drivers aged 16 to 19 years for all 50 states and the District of Columbia combined. Main Outcome Measures Population-based rates of fatal crash involvement for 16-, 17-, 18-, and 19-year-old drivers. Rate ratios and 95% CIs comparing state-quarters with stronger (restrictions on both nighttime driving and allowed passengers) or weaker (restrictions on either nighttime driving or allowed passengers) GDL programs with state-quarters without GDL. Results Fatal crash incidence among teen drivers increased with age, from 28.2 per 100 000 person-years (16-year-old drivers) to 36.9 per 100 000 (17-year-olds), before reaching a plateau of 46.2 per 100 000 (18-year-olds) and 44.0 per 100 000 (19-year-olds). After adjusting for potential confounders, stronger GDL programs were associated with lower incidence of fatal crashes for 16-year-old drivers, compared with programs having none of the key GDL elements (rate ratio, 0.74 [95% CI, 0.65-0.84]). However, stronger GDL programs were associated with higher fatal crash incidence for 18-year-old drivers (rate ratio, 1.12 [95% CI, 1.01-1.23]). Rate ratios for 17-year-olds (0.91 [95% CI, 0.83-1.01]), 19-year-olds (1.05 [95% CI, 0.98-1.13]), and 16- to 19-year-olds combined (0.97 [95% CI, 0.92-1.03]) were not statistically different from the null. Conclusions In the United States, stronger GDL programs with restrictions on nighttime driving as well as allowed passengers, relative to programs with none of the key GDL elements, were associated with substantially lower fatal crash incidence for 16-year-old drivers but somewhat higher fatal crash incidence for 18-year-old drivers. Future studies should seek to determine what accounts for the increase among 18-year-old drivers and whether refinements in GDL programs can reduce this association. JAMA. 2011;306(10):1098-1103 www.jama.com	[Masten, Scott V.] Calif Dept Motor Vehicles, Res & Dev Branch, Sacramento, CA 95818 USA; [Foss, Robert D.] Univ N Carolina, Highway Safety Res Ctr, Chapel Hill, NC USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Masten, SV (corresponding author), Calif Dept Motor Vehicles, Res & Dev Branch, 2570 24th St,MS H-126, Sacramento, CA 95818 USA.	scott.masten@dmv.ca.gov	Foss, Robert/W-1750-2019	Foss, Robert/0000-0002-1150-5763; Marshall, Stephen/0000-0002-2664-9233				Allison P, 2005, FIXED EFFECTS REGRES, P1; American Association of Motor Vehicle Administrators, 1999, COMP DAT STAT PROV L; American Automobile Association Foundation for Traffic Safety, 2007, NAT REV GRAD DRIV LI; [Anonymous], EFF DAT US GRAD DRIV; Benichou J, 2001, STAT METHODS MED RES, V10, P195, DOI 10.1191/096228001680195157; Bureau of the Census United States Department of Commerce, 1990 1999 ANN TIM SE; Bureau of the Census United States Department of Commerce, HIST ANN TIM SER STA; Chen LH, 2000, JAMA-J AM MED ASSOC, V283, P1578, DOI 10.1001/jama.283.12.1578; Chen LH, 2006, PEDIATRICS, V118, P56, DOI 10.1542/peds.2005-2281; Dee TS, 2005, J HEALTH ECON, V24, P571, DOI 10.1016/j.jhealeco.2004.09.013; Federal Highway Administration United States Department of Transportation, 1984, DRIV LIC ADM REQ FEE; Federal Highway Administration United States Department of Transportation, 1996, HIGHW STAT SER MOT F; Federal Highway Administration United States Department of Transportation, 1988, DRIV LIC ADM REQ FEE; Federal Highway Administration United States Department of Transportation, 1996, DRIV LIC ADM REQ FEE; Federal Highway Administration United States Department of Transportation, 1986, DRIV LIC ADM REQ FEE; Federal Highway Administration United States Department of Transportation, HIGHW STAT SUMM 1995; Federal Highway Administration United States Department of Transportation, 1990, DRIV LIC ADM REQ FEE; Federal Highway Administration United States Department of Transportation, 1992, DRIV LIC ADM REQ FEE; Federal Highway Administration United States Department of Transportation, 1994, DRIV LIC ADM REQ FEE; Federal Highway Administration United States Department of Transportation. National Household Travel Survey Web site, NUMB VEH MIL VMT AG; Foss R, 2003, J SAFETY RES, V34, P79, DOI 10.1016/S0022-4375(02)00083-X; Foss RD, 2001, JAMA-J AM MED ASSOC, V286, P1588, DOI 10.1001/jama.286.13.1588; Foss RD, 2007, J SAFETY RES, V38, P185, DOI 10.1016/j.jsr.2007.02.006; Freeman DG, 2007, CONTEMP ECON POLICY, V25, P293, DOI 10.1111/j.1465-7287.2007.00039.x; Hauer E, 2010, ACCIDENT ANAL PREV, V42, P1128, DOI 10.1016/j.aap.2009.12.027; HOSMER DW, 1991, AM J PUBLIC HEALTH, V81, P1630, DOI 10.2105/AJPH.81.12.1630; Lam LT, 2003, ACCIDENT ANAL PREV, V35, P913, DOI 10.1016/S0001-4575(02)00099-4; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lovenheim MF, 2010, J HEALTH ECON, V29, P62, DOI 10.1016/j.jhealeco.2009.10.001; Males M, 2007, J SAFETY RES, V38, P651, DOI 10.1016/j.jsr.2007.09.002; Masten SV, 2010, ACCIDENT ANAL PREV, V42, P1647, DOI 10.1016/j.aap.2010.04.002; Mayhew DR, 2003, ACCIDENT ANAL PREV, V35, P683, DOI 10.1016/S0001-4575(02)00047-7; McCartt AT, 2010, TRAFFIC INJ PREV, V11, P240, DOI 10.1080/15389580903578854; McCartt AT, 2003, ACCIDENT ANAL PREV, V35, P311, DOI 10.1016/S0001-4575(02)00006-4; McCartt AT, 2001, JAMA-J AM MED ASSOC, V286, P1631, DOI 10.1001/jama.286.13.1631; MCCULLAGH P, 1989, GEN LINEAR MODELS, P204; McKnight AJ, 2003, ACCIDENT ANAL PREV, V35, P921, DOI 10.1016/S0001-4575(02)00100-8; McKnight AJ, 2002, INJURY PREV, V8, P32; National Center for Injury Prevention and Control, 1999, WEB BAS INJ STAT QUE; National Highway Traffic Safety Administration, FAT AN REP SYST; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Rios A, 2006, ANN EMERG MED, V47, P361, DOI 10.1016/j.annemergmed.2006.01.007; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Shope JT, 2007, J SAFETY RES, V38, P165, DOI 10.1016/j.jsr.2007.02.004; Shope JT, 2001, JAMA-J AM MED ASSOC, V286, P1593, DOI 10.1001/jama.286.13.1593; Shope JT, 2003, J SAFETY RES, V34, P63, DOI 10.1016/S0022-4375(02)00080-4; *US BUR CENS, STAT SINGL YEAR AG S; US Bureau of Labor Statistics, LOC AR UN STAT; Vanlaar W, 2009, ACCIDENT ANAL PREV, V41, P1104, DOI 10.1016/j.aap.2009.06.024; Wagenaar AC, 2007, J SAFETY RES, V38, P493, DOI 10.1016/j.jsr.2007.06.001; Wagenaar AC, 2007, ALCOHOL CLIN EXP RES, V31, P1399, DOI 10.1111/j.1530-0277.2007.00441.x; Waller PF, 2003, J SAFETY RES, V34, P17, DOI 10.1016/S0022-4375(02)00076-2; Williams AF, 2003, J SAFETY RES, V34, P5, DOI 10.1016/S0022-4375(02)00075-0; Williams AF, 2011, TRAFFIC INJ PREV, V12, P207, DOI 10.1080/15389588.2011.573353	54	93	93	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2011	306	10					1098	1103		10.1001/jama.2011.1277	http://dx.doi.org/10.1001/jama.2011.1277			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	819DS	21917580				2022-12-28	WOS:000294806200023
J	Sothern, M				Sothern, Matthew			PERSONAL VIEW The blood service should ask donors about practice, not just partners	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ St Andrews, Dept Geog & Sustainable Dev, St Andrews KY16 9AL, Fife, Scotland	University of St Andrews	Sothern, M (corresponding author), Univ St Andrews, Dept Geog & Sustainable Dev, St Andrews KY16 9AL, Fife, Scotland.	mbs10@st-andrews.ac.uk		Kesby, Mike/0000-0001-7789-870X				2007, INT J STD AIDS, V18, P810, DOI DOI 10.1258/095646207782717027; 2010, J SEX RES, V47, P123, DOI DOI 10.1080/00224490903402538; 2010, SEX TRANSM DIS, V37, P369, DOI DOI 10.1097/OLQ.0B013E3181CBF77D; 2011, BRIT MED J, V342, pD2078, DOI DOI 10.1136/BMJ.D2078; 2010, SEX TRANSM DIS, V37, P425, DOI DOI 10.1097/OLQ.0B013E3181D13ED8; 2010, SEX TRANSM INFECT, V86, pS45, DOI DOI 10.1136/STI.2010.042283	6	2	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2011	343								d5793	10.1136/bmj.d5793	http://dx.doi.org/10.1136/bmj.d5793			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822VM	21917842	Green Submitted			2022-12-28	WOS:000295078100010
J	O'Doherty, JE; Lebedev, MA; Ifft, PJ; Zhuang, KZ; Shokur, S; Bleuler, H; Nicolelis, MAL				O'Doherty, Joseph E.; Lebedev, Mikhail A.; Ifft, Peter J.; Zhuang, Katie Z.; Shokur, Solaiman; Bleuler, Hannes; Nicolelis, Miguel A. L.			Active tactile exploration using a brain-machine-brain interface	NATURE			English	Article							CORTICAL CONTROL; CORTEX; ARM; NEURONS; STIMULATION; GRIP; SKIN	Brain-machine interfaces(1,2) use neuronal activity recorded from the brain to establish direct communication with external actuators, such as prosthetic arms. It is hoped that brain-machine interfaces can be used to restore the normal sensorimotor functions of the limbs, but so far they have lacked tactile sensation. Here we report the operation of a brain-machine-brain interface (BMBI) that both controls the exploratory reaching movements of an actuator and allows signalling of artificial tactile feedback through intracortical microstimulation (ICMS) of the primary somatosensory cortex. Monkeys performed an active exploration task in which an actuator (a computer cursor or a virtual-reality arm) was moved using a BMBI that derived motor commands from neuronal ensemble activity recorded in the primary motor cortex. ICMS feedback occurred whenever the actuator touched virtual objects. Temporal patterns of ICMS encoded the artificial tactile properties of each object. Neuronal recordings and ICMS epochs were temporally multiplexed to avoid interference. Two monkeys operated this BMBI to search for and distinguish one of three visually identical objects, using the virtual-reality arm to identify the unique artificial texture associated with each. These results suggest that clinical motor neuroprostheses might benefit from the addition of ICMS feedback to generate artificial somatic perceptions associated with mechanical, robotic or even virtual prostheses.	[O'Doherty, Joseph E.; Ifft, Peter J.; Zhuang, Katie Z.; Nicolelis, Miguel A. L.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [O'Doherty, Joseph E.; Lebedev, Mikhail A.; Ifft, Peter J.; Zhuang, Katie Z.; Nicolelis, Miguel A. L.] Duke Univ, Ctr Neuroengn, Durham, NC 27710 USA; [Lebedev, Mikhail A.; Nicolelis, Miguel A. L.] Duke Univ, Dept Neurobiol, Durham, NC 27710 USA; [Shokur, Solaiman; Bleuler, Hannes] Ecole Polytech Fed Lausanne, STIIMT, CH-1015 Lausanne, Switzerland; [Nicolelis, Miguel A. L.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA; [Nicolelis, Miguel A. L.] Edmond & Lily Safra Int Inst Neurosci Natal, BR-59066060 Natal, RN, Brazil	Duke University; Duke University; Duke University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Duke University	Nicolelis, MAL (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.	nicoleli@neuro.duke.edu	Incemaq, Inct/J-8752-2013; O'Doherty, Joseph E/D-5116-2009; Lebedev, Mikhail A/H-5066-2016	O'Doherty, Joseph E/0000-0001-8175-5699; Lebedev, Mikhail A/0000-0003-0355-8723; Shokur, Solaiman/0000-0003-2251-7142	DARPA [N66001-06-C-2019]; TATRC [W81XWH-08-2-0119]; NIH [NS073125, DP1OD006798]; NICHD/OD [RC1HD063390]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [RC1HD063390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073125] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006798] Funding Source: NIH RePORTER	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); TATRC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD/OD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Dimitrov for conducting the animal neurosurgeries; G. Lehew and J. Meloy for building brain implants; J. Fruh for rendering the virtual-reality monkey arm; T. Phillips, L. Oliveira and S. Halkiotis for technical support; and E. Thomson and Z. Li for comments. This research was supported by DARPA (award N66001-06-C-2019), TATRC (award W81XWH-08-2-0119), the NIH (award NS073125), NICHD/OD (award RC1HD063390) and NIH Director's Pioneer Award DP1OD006798, to M.A.L.N. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Office of the NIH Director or the NIH.	Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Chatterjee A, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-40; Cisek P, 2004, NATURE, V431, P993, DOI 10.1038/nature03005; Dushanova J, 2010, EUR J NEUROSCI, V31, P386, DOI 10.1111/j.1460-9568.2009.07067.x; Fitzsimmons NA, 2007, J NEUROSCI, V27, P5593, DOI 10.1523/JNEUROSCI.5297-06.2007; FLANAGAN JR, 1993, EXP BRAIN RES, V95, P131; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; James TW, 2007, CAN J EXP PSYCHOL, V61, P219, DOI 10.1037/cjep2007023; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; KACZMAREK KA, 1991, IEEE T BIO-MED ENG, V38, P1, DOI 10.1109/10.68204; Lebedev MA, 2005, J NEUROSCI, V25, P4681, DOI 10.1523/JNEUROSCI.4088-04.2005; LEBEDEV MA, 1994, J NEUROPHYSIOL, V72, P1654, DOI 10.1152/jn.1994.72.4.1654; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; Li Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006243; Liu Y, 2005, EXP BRAIN RES, V167, P571, DOI 10.1007/s00221-005-0052-8; London BM, 2008, IEEE T NEUR SYS REH, V16, P32, DOI 10.1109/TNSRE.2007.907544; Marasco PD, 2009, BRAIN, V132, P1441, DOI 10.1093/brain/awp082; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Nicolelis MAL, 2009, NAT REV NEUROSCI, V10, P530, DOI 10.1038/nrn2653; O'Doherty JE, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.020.2009; RICHER F, 1993, EXP BRAIN RES, V93, P173; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Tkach D, 2008, CURR OPIN NEUROBIOL, V18, P589, DOI 10.1016/j.conb.2008.09.016; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582	30	374	396	16	268	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2011	479	7372					228	U106		10.1038/nature10489	http://dx.doi.org/10.1038/nature10489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	21976021	Green Accepted			2022-12-28	WOS:000298030800042
J	Cools, F				Cools, Filip			A new method of surfactant administration in preterm infants	LANCET			English	Editorial Material							CPAP		Univ Ziekenhuis Brussel, B-1090 Brussels, Belgium	University Hospital Brussels; Vrije Universiteit Brussel	Cools, F (corresponding author), Univ Ziekenhuis Brussel, B-1090 Brussels, Belgium.	filip.cools@uzbrussel.be		Cools, Filip/0000-0002-6581-7009				Bhandari V, 2005, PEDIATRICS, V116, P352, DOI 10.1542/peds.2004-2123; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; Gopel W, 2011, LANCET, V378, P1627, DOI 10.1016/S0140-6736(11)60986-0; Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788; Sandri F, 2010, PEDIATRICS, V125, pE1402, DOI 10.1542/peds.2009-2131; Seger N, 2009, COCHRANE DB SYST REV, V2; VERDER H, 1994, NEW ENGL J MED, V331, P1051, DOI 10.1056/NEJM199410203311603	7	5	5	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 5	2011	378	9803					1607	1608		10.1016/S0140-6736(11)61339-1	http://dx.doi.org/10.1016/S0140-6736(11)61339-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844ST	21963185				2022-12-28	WOS:000296768300008
J	Hoffman, SJ				Hoffman, Steven J.			Ending medical complicity in state-sponsored torture	LANCET			English	Editorial Material							MILITARY		McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4L6, Canada	McMaster University	Hoffman, SJ (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4L6, Canada.	hoffmans@mcmaster.ca		Hoffman, Steven/0000-0002-2064-3711				Amnesty International, 2009, AMN INT REP 2009 STA; Bassiouni M. Cherif, 2006, CASE RSRV J INT L, V37, P389; Benatar SR, 2008, AM J PUBLIC HEALTH, V98, P2161, DOI 10.2105/AJPH.2007.124644; BRADBURY SG, 2005, RE APPL 18 U S C 234; ESPERSEN O, 1991, J MED ETHICS, V17, P64, DOI 10.1136/jme.17.Suppl.64; Iacopino V, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001027; MAZZETTI M, 2009, NY TIMES        0406; Miles SH, 2004, LANCET, V364, P725, DOI 10.1016/S0140-6736(04)16902-X; Miles Steven H, 2010, Torture, V20, P23; Nagan Winston P., 2001, HARVARD HUMAN RIGHTS, V87, P87; Nicholl DJ, 2007, LANCET, V370, P823, DOI 10.1016/S0140-6736(07)61402-0; Physicians for Human Rights, 2008, BROK LAWS BROK LIV M; Polatin PB, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c973; Reventlow M, 2010, ESSEX HUMAN RIGHTS R, V6, P148; Seltzer A, 2010, LANCET, V375, P872, DOI 10.1016/S0140-6736(09)61633-0	15	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 29	2011	378	9802					1535	1537		10.1016/S0140-6736(11)60816-7	http://dx.doi.org/10.1016/S0140-6736(11)60816-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	844SL	21944647				2022-12-28	WOS:000296767500011
J	Elemans, CPH; Mead, AF; Jakobsen, L; Ratcliffe, JM				Elemans, Coen P. H.; Mead, Andrew F.; Jakobsen, Lasse; Ratcliffe, John M.			Superfast Muscles Set Maximum Call Rate in Echolocating Bats	SCIENCE			English	Article							KINETICS; DESIGN; MYOSIN; SPEED	As an echolocating bat closes in on a flying insect, it increases call emission to rates beyond 160 calls per second. This high call rate phase, dubbed the terminal buzz, has proven enigmatic because it is unknown how bats are able to produce calls so quickly. We found that previously unknown and highly specialized superfast muscles power rapid call rates in the terminal buzz. Additionally, we show that laryngeal motor performance, not overlap between call production and the arrival of echoes at the bat's ears, limits maximum call rate. Superfast muscles are rare in vertebrates and always associated with extraordinary motor demands on acoustic communication. We propose that the advantages of rapid auditory updates on prey movement selected for superfast laryngeal muscle in echolocating bats.	[Elemans, Coen P. H.; Jakobsen, Lasse; Ratcliffe, John M.] Univ So Denmark, Inst Biol, DK-5230 Odense M, Denmark; [Mead, Andrew F.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Southern Denmark; University of Pennsylvania	Elemans, CPH (corresponding author), Univ So Denmark, Inst Biol, DK-5230 Odense M, Denmark.	coen@biology.sdu.dk; jmr@biology.sdu.dk		Elemans, Coen/0000-0001-6306-5715; Jakobsen, Lasse/0000-0002-8496-5576	Danish Research Council (FNU); Carlsberg Foundation; Grass Foundation; Company of Biologists; Oticon Foundation; FNU	Danish Research Council (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council); Carlsberg Foundation(Carlsberg Foundation); Grass Foundation; Company of Biologists; Oticon Foundation; FNU(Danish Natural Science Research Council)	We thank R. Suthers for permission to reprint Fig. 3 from (7); R. Langill, P. Martensen, and F. Mortensen for technical assistance; G. Lutz for providing carbon microspheres; T. Gardner for sparse time-frequency Matlab scripts; and F. Jensen, D. Canfield, A. Surlykke, and A. West for use of equipment. F. Andrade, S. Brinklov, P. Faure, B. Fenton, B. Galef, J. van Leeuwen, P. Madsen, M. Nydam, A. Surlykke, H. ter Hofstede, and S. Zawadzki commented on the manuscript. This study was funded by grants from the Danish Research Council (FNU), Carlsberg Foundation, and Grass Foundation to C. P. H. E.; Company of Biologists to A. F. M.; Oticon Foundation to L. J.; and FNU to J. M. R. Animal capture and experimentation was approved by Skov- og Naturstyrelsen (Denmark). C. P. H. E. and J. M. R. conceived of the study. C. P. H. E. and A. F. M. conducted physiological experiments; C. P. H. E., L. J., and J. M. R. conducted behavioral experiments. All authors contributed to data analysis. C. P. H. E. and J. M. R. wrote the manuscript. The data reported in this paper are available from C.P.H.E and J.M.R.	Briggs MM, 2000, J EXP BIOL, V203, P2485; DURANT GE, 1988, THESIS INDIANA U; Elemans CPH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002581; Elemans CPH, 2004, NATURE, V431, P146, DOI 10.1038/431146a; Gardner TJ, 2006, P NATL ACAD SCI USA, V103, P6094, DOI 10.1073/pnas.0601707103; Ghose K, 2006, PLOS BIOL, V4, P865, DOI 10.1371/journal.pbio.0040108; Griffin DR, 1958, LISTENING DARK; Hiryu S, 2010, P NATL ACAD SCI USA, V107, P7048, DOI 10.1073/pnas.1000429107; Hoh JFY, 2005, ACTA PHYSIOL SCAND, V183, P133, DOI 10.1111/j.1365-201X.2004.01402.x; Jakobsen L, 2010, P NATL ACAD SCI USA, V107, P13930, DOI 10.1073/pnas.1006630107; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; KALKO EKV, 1989, BEHAV ECOL SOCIOBIOL, V24, P225, DOI 10.1007/BF00295202; Li ZB, 2000, INVEST OPHTH VIS SCI, V41, P3770; Metzner W, 2010, HBK BEHAV NEUROSCI, V19, P403, DOI 10.1016/B978-0-12-374593-4.00037-1; Nasipak BT, 2008, DEV GENES EVOL, V218, P389, DOI 10.1007/s00427-008-0225-0; Ratcliffe John M., 2009, P201; REGER JF, 1978, J ULTRA MOL STRUCT R, V63, P275, DOI 10.1016/S0022-5320(78)80052-5; REVEL JP, 1962, J CELL BIOL, V12, P571, DOI 10.1083/jcb.12.3.571; Rome LC, 1998, NEWS PHYSIOL SCI, V13, P261, DOI 10.1152/physiologyonline.1998.13.6.261; Rome LC, 1999, P NATL ACAD SCI USA, V96, P5826, DOI 10.1073/pnas.96.10.5826; Rome LC, 2006, ANNU REV PHYSIOL, V68, P193, DOI 10.1146/annurev.physiol.68.040104.105418; Rome LC, 1996, P NATL ACAD SCI USA, V93, P8095, DOI 10.1073/pnas.93.15.8095; Saillant PA, 2007, J ACOUST SOC AM, V121, P3001, DOI 10.1121/1.2714920; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SUTHERS RA, 1982, J COMP PHYSIOL, V145, P529, DOI 10.1007/BF00612818; SUTHERS RA, 1973, AM ZOOL, V13, P1215; Thomas JA, 2004, ECHOLOCATION BATS DO	27	70	71	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051					1885	1888		10.1126/science.1207309	http://dx.doi.org/10.1126/science.1207309			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960635				2022-12-28	WOS:000295365800055
J	Maltagliati, L; Montmessin, F; Fedorova, A; Korablev, O; Forget, F; Bertaux, JL				Maltagliati, L.; Montmessin, F.; Fedorova, A.; Korablev, O.; Forget, F.; Bertaux, J. -L.			Evidence of Water Vapor in Excess of Saturation in the Atmosphere of Mars	SCIENCE			English	Article							GENERAL-CIRCULATION MODEL; MARTIAN ATMOSPHERE; ICE CLOUDS; VERTICAL-DISTRIBUTION; EXPRESS; TROPOSPHERE; DEUTERIUM; ABUNDANCE; BEHAVIOR	The vertical distribution of water vapor is key to the study of Mars' hydrological cycle. To date, it has been explored mainly through global climate models because of a lack of direct measurements. However, these models assume the absence of supersaturation in the atmosphere of Mars. Here, we report observations made using the SPICAM (Spectroscopy for the Investigation of the Characteristics of the Atmosphere of Mars) instrument onboard Mars Express that provide evidence of the frequent presence of water vapor in excess of saturation, by an amount far surpassing that encountered in Earth's atmosphere. This result contradicts the widespread assumption that atmospheric water on Mars cannot exist in a supersaturated state, directly affecting our long-term representation of water transport, accumulation, escape, and chemistry on a global scale.	[Maltagliati, L.; Montmessin, F.; Bertaux, J. -L.] Lab Atmospheres Milieux Observat Spatiales LATMOS, F-78280 Guyancourt, France; [Fedorova, A.; Korablev, O.] Space Res Inst IKI, Moscow 117997, Russia; [Forget, F.] Lab Meteorol Dynam LMD, F-75252 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Ecole des Ponts ParisTech; UDICE-French Research Universities; Sorbonne Universite	Maltagliati, L (corresponding author), Lab Atmospheres Milieux Observat Spatiales LATMOS, F-78280 Guyancourt, France.	luca.maltagliati@latmos.ipsl.fr	Fedorova, Anna A/L-5116-2013; Korablev, Oleg I/K-6770-2017; Korablev, Oleg/L-5083-2013	Korablev, Oleg I/0000-0003-1115-0656; Korablev, Oleg/0000-0003-1115-0656; Montmessin, Franck/0000-0002-4187-1457; Fedorova, Anna/0000-0002-4176-2955	Centre National d'Etudes Spatiales (CNES); Centre National de la Recherche Scientifique; Universite Versailles St Quentin en Yvelines in France; Roscosmos in Russia; Russian Foundation for Basic Research [10-02-93116]	Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Versailles St Quentin en Yvelines in France; Roscosmos in Russia; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	We thank L. Montabone for his expertise on MCS data, A. Maattanen for the helpful discussions, and the three anonymous reviewers for their comments that greatly contributed to improve the paper. Mars Express is a space mission of ESA. We thank Centre National d'Etudes Spatiales (CNES), Centre National de la Recherche Scientifique, and Universite Versailles St Quentin en Yvelines in France and Roscosmos in Russia for funding SPICAM. The present analysis was performed with postdoctoral support provided by CNES to L. M. A. F. and O.K. acknowledge Russian Foundation for Basic Research grant 10-02-93116. SPICAM raw data are archived in the Planetary Data System.	Bertaux JL, 2001, J GEOPHYS RES-PLANET, V106, P32879, DOI 10.1029/2000JE001358; Clancy RT, 2000, J GEOPHYS RES-PLANET, V105, P9553, DOI 10.1029/1999JE001089; Clancy RT, 1996, ICARUS, V122, P36, DOI 10.1006/icar.1996.0108; DAVIES DW, 1979, J GEOPHYS RES, V84, P2875, DOI 10.1029/JB084iB06p02875; Fedorova AA, 2009, ICARUS, V200, P96, DOI 10.1016/j.icarus.2008.11.006; Fouchet T, 2007, ICARUS, V190, P32, DOI 10.1016/j.icarus.2007.03.003; Gettelman A, 2006, J CLIMATE, V19, P6089, DOI 10.1175/JCLI3955.1; Goff J. A., 1946, PROC 52 ANN M AM SOC, P95; JAKOSKY BM, 1982, J GEOPHYS RES, V87, P2999, DOI 10.1029/JB087iB04p02999; Kleinbohl A, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003358; Krasnopolsky V, 2000, ICARUS, V148, P597, DOI 10.1006/icar.2000.6534; Lammer H, 1996, GEOPHYS RES LETT, V23, P3353, DOI 10.1029/96GL03153; Lefevre F, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002268; Lefevre F, 2008, NATURE, V454, P971, DOI 10.1038/nature07116; Maattanen A, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002308; Maltagliati L, 2011, ICARUS, V213, P480, DOI 10.1016/j.icarus.2011.03.030; MICHELANGELI DV, 1993, ICARUS, V102, P261, DOI 10.1006/icar.1993.1048; MILLOUR E, 2008, LPI CONTRIBUTIONS, V1447, P9029; Montmessin F, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002902; Montmessin F, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002284; Montmessin F, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001520; Richardson MI, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001804; Rodin AV, 1997, ICARUS, V125, P212, DOI 10.1006/icar.1996.5602; Smith M.D, 2008, MARS WAT CYCL WORKSH; Smith M. D., 2002, J GEOPHYS RES, V107, P25, DOI DOI 10.1029/2001JE001522; Smith MD, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003288; Sprague AL, 2006, ICARUS, V184, P372, DOI 10.1016/j.icarus.2006.05.021; Tschimmel A, 2008, ICARUS, V195, P557, DOI 10.1016/j.icarus.2008.01.018	28	101	102	3	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051					1868	1871		10.1126/science.1207957	http://dx.doi.org/10.1126/science.1207957			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960630				2022-12-28	WOS:000295365800050
J	Penagarikano, O; Abrahams, BS; Herman, EI; Winden, KD; Gdalyahu, A; Dong, HM; Sonnenblick, LI; Gruver, R; Almajano, J; Bragin, A; Golshani, P; Trachtenberg, JT; Peles, E; Geschwind, DH				Penagarikano, Olga; Abrahams, Brett S.; Herman, Edward I.; Winden, Kellen D.; Gdalyahu, Amos; Dong, Hongmei; Sonnenblick, Lisa I.; Gruver, Robin; Almajano, Joel; Bragin, Anatol; Golshani, Peyman; Trachtenberg, Joshua T.; Peles, Elior; Geschwind, Daniel H.			Absence of CNTNAP2 Leads to Epilepsy, Neuronal Migration Abnormalities, and Core Autism-Related Deficits	CELL			English	Article							ADHESION MOLECULE TAG-1; MOUSE MODELS; FUNCTIONAL CONNECTIVITY; CORTICAL INTERNEURONS; NEUREXIN SUPERFAMILY; MYELINATED AXONS; GENE-EXPRESSION; ANIMAL-MODELS; NETWORK; CHANNELS	Although many genes predisposing to autism spectrum disorders (ASD) have been identified, the biological mechanism(s) remain unclear. Mouse models based on human disease-causing mutations provide the potential for understanding gene function and novel treatment development. Here, we characterize a mouse knockout of the Cntnap2 gene, which is strongly associated with ASD and allied neurodevelopmental disorders. Cntnap2(-/-) mice show deficits in the three core ASD behavioral domains, as well as hyperactivity and epileptic seizures, as have been reported in humans with CNTNAP2 mutations. Neuropathological and physiological analyses of these mice before the onset of seizures reveal neuronal migration abnormalities, reduced number of interneurons, and abnormal neuronal network activity. In addition, treatment with the FDA-approved drug risperidone ameliorates the targeted repetitive behaviors in the mutant mice. These data demonstrate a functional role for CNTNAP2 in brain development and provide a new tool for mechanistic and therapeutic research in ASD.	[Penagarikano, Olga; Winden, Kellen D.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet, Los Angeles, CA 90095 USA; [Penagarikano, Olga; Abrahams, Brett S.; Geschwind, Daniel H.] Univ Calif Los Angeles, Ctr Autism Res & Treatment, Los Angeles, CA 90095 USA; [Penagarikano, Olga; Abrahams, Brett S.; Geschwind, Daniel H.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Gdalyahu, Amos; Gruver, Robin; Trachtenberg, Joshua T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Peles, Elior] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Weizmann Institute of Science	Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet, Los Angeles, CA 90095 USA.	dhg@ucla.edu	Penagarikano, Olga/AAJ-2223-2020	Penagarikano, Olga/0000-0001-8153-8221; Peles, Elior/0000-0002-3325-0597; Bragin, Anatol/0000-0003-1207-8481	NIH/NIMH [R01 MH081754-02R]; NIH ACE Center [1P50-HD055784-01, 5R01-MH081754-04]; NIH [NS50220]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Incumbent of the Hanna Hertz Professorial Chair for Multiple Sclerosis and Neuroscience; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050220] Funding Source: NIH RePORTER	NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH ACE Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Incumbent of the Hanna Hertz Professorial Chair for Multiple Sclerosis and Neuroscience; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the UCLA behavioral testing core and its supervisor, Dr. Ravi Ponnusamy, for assistance with behavioral testing. We also thank Dr. Alcino Silva, codirector of the core, for his critical discussions about mouse behavioral testing; Dr. Stephanie White for the UsV equipment and software; Dr. Carolyn Houser for assistance with GAD1 IHC; and Dr. William Yang and Dr. Istvan Mody for helpful discussions. We would also like to thank Jamee Bomar and Dr. Asami Oguro-Ando for help with floating IHC and helpful discussions; Greg Osborn for help with UsV analysis; Clark Rosensweig for help with mouse genotyping; Dr. Irina Voineagu and Lauren Kawaguchi for critically reading the manuscript; and Dr. Eric Wexler for useful discussions on drug treatment. This work was supported by grants NIH/NIMH R01 MH081754-02R to D.H.G.; NIH ACE Center 1P50-HD055784-01 to D.H.G. (Project II) and Network grant 5R01-MH081754-04 to D. H. G.; NIH/NS50220 to E.P.; and Dr. Miriam and Sheldon G. Adelson Medical Research Foundation to D.H.G. and E.P.E.P. is the Incumbent of the Hanna Hertz Professorial Chair for Multiple Sclerosis and Neuroscience.	Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; APA, 2000, DIAGN STAT MAN MENT; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Chadman KK, 2009, AM J MED GENET B, V150B, P1, DOI 10.1002/ajmg.b.30777; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; COSTA RM, 2007, BRAIN PATHOL, V17, P448; Damarla SR, 2010, AUTISM RES, V3, P273, DOI 10.1002/aur.153; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Denaxa M, 2005, DEV BIOL, V288, P87, DOI 10.1016/j.ydbio.2005.09.021; Denaxa M, 2001, DEVELOPMENT, V128, P4635; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gerlai R, 2000, BEHAV BRAIN RES, V109, P219, DOI 10.1016/S0166-4328(99)00175-8; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Gittis AH, 2010, J NEUROSCI, V30, P2223, DOI 10.1523/JNEUROSCI.4870-09.2010; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Horresh I, 2008, J NEUROSCI, V28, P14213, DOI 10.1523/JNEUROSCI.3398-08.2008; Inda MC, 2006, P NATL ACAD SCI USA, V103, P2920, DOI 10.1073/pnas.0511197103; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; Lewis MH, 2007, BEHAV BRAIN RES, V176, P66, DOI 10.1016/j.bbr.2006.08.023; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; McDougle CJ, 2008, J CLIN PSYCHIAT, V69, P15; McDougle CJ, 2000, CHILD ADOL PSYCH CL, V9, P201; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Morante-Oria J, 2003, P NATL ACAD SCI USA, V100, P12468, DOI 10.1073/pnas.1633692100; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Scott-Van Zeeland AA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001344; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Szczypka MS, 2001, NEURON, V30, P819, DOI 10.1016/S0896-6273(01)00319-1; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Villalobos ME, 2005, NEUROIMAGE, V25, P916, DOI 10.1016/j.neuroimage.2004.12.022; Vitali R, 2004, BEHAV BRAIN RES, V153, P129, DOI 10.1016/j.bbr.2003.11.007; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhou MM, 2010, P NATL ACAD SCI USA, V107, P4401, DOI 10.1073/pnas.0915173107	62	638	666	0	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2011	147	1					235	246		10.1016/j.cell.2011.08.040	http://dx.doi.org/10.1016/j.cell.2011.08.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962519	Bronze, Green Accepted			2022-12-28	WOS:000295396700029
J	Shalala, DE				Shalala, Donna E.			Bernadine Healy (1944-2011)	SCIENCE			English	Biographical-Item									[Shalala, Donna E.] Univ Miami, Coral Gables, FL 33124 USA; [Shalala, Donna E.] US Dept HHS, Washington, DC USA	University of Miami	Shalala, DE (corresponding author), Univ Miami, Coral Gables, FL 33124 USA.								0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 30	2011	333	6051					1836	1836		10.1126/science.1213786	http://dx.doi.org/10.1126/science.1213786			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960620				2022-12-28	WOS:000295365800040
J	Enyeart, PJ; Ellington, AD				Enyeart, Peter J.; Ellington, Andrew D.			SYNTHETIC BIOLOGY A yeast for all reasons	NATURE			English	Editorial Material							GENOME		[Enyeart, Peter J.] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Ellington, Andrew D.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Enyeart, PJ (corresponding author), Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA.	peter.enyeart@mail.utexas.edu; andy.ellington@mail.utexas.edu						Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Dymond JS, 2009, GENETICS, V181, P13, DOI 10.1534/genetics.108.096784; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Sharma SS, 2007, METAB ENG, V9, P133, DOI 10.1016/j.ymben.2006.10.002	8	8	8	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2011	477	7365					413	414		10.1038/477413a	http://dx.doi.org/10.1038/477413a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21938060				2022-12-28	WOS:000295080500027
J	Merry, AF; Webster, CS; Hannam, J; Mitchell, SJ; Henderson, R; Reid, P; Edwards, KE; Jardim, A; Pak, N; Cooper, J; Hopley, L; Frampton, C; Short, TG				Merry, Alan F.; Webster, Craig S.; Hannam, Jacqueline; Mitchell, Simon J.; Henderson, Robert; Reid, Papaarangi; Edwards, Kylie-Ellen; Jardim, Anisoara; Pak, Nick; Cooper, Jeremy; Hopley, Lara; Frampton, Chris; Short, Timothy G.			Multimodal system designed to reduce errors in recording and administration of drugs in anaesthesia: prospective randomised clinical evaluation	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICATION ERROR; INTENSIVE-CARE; SAFETY; WORKLOAD; TECHNOLOGY; HAWTHORNE; ACCURACY; TIME	Objective To clinically evaluate a new patented multimodal system (SAFERSleep) designed to reduce errors in the recording and administration of drugs in anaesthesia. Design Prospective randomised open label clinical trial. Setting Five designated operating theatres in a major tertiary referral hospital. Participants Eighty nine consenting anaesthetists managing 1075 cases in which there were 10 764 drug administrations. Intervention Use of the new system (which includes customised drug trays and purpose designed drug trolley drawers to promote a well organised anaesthetic workspace and aseptic technique; pre-filled syringes for commonly used anaesthetic drugs; large legible colour coded drug labels; a barcode reader linked to a computer, speakers, and touch screen to provide automatic auditory and visual verification of selected drugs immediately before each administration; automatic compilation of an anaesthetic record; an on-screen and audible warning if an antibiotic has not been administered within 15 minutes of the start of anaesthesia; and certain procedural rules-notably, scanning the label before each drug administration) versus conventional practice in drug administration with a manually compiled anaesthetic record. Main outcome measures Primary: composite of errors in the recording and administration of intravenous drugs detected by direct observation and by detailed reconciliation of the contents of used drug vials against recorded administrations; and lapses in responding to an intermittent visual stimulus (vigilance latency task). Secondary: outcomes in patients; analyses of anaesthetists' tasks and assessments of workload; evaluation of the legibility of anaesthetic records; evaluation of compliance with the procedural rules of the new system; and questionnaire based ratings of the respective systems by participants. Results The overall mean rate of drug errors per 100 administrations was 9.1 (95% confidence interval 6.9 to 11.4) with the new system (one in 11 administrations) and 11.6 (9.3 to 13.9) with conventional methods (one in nine administrations) (P=0.045 for difference). Most were recording errors, and, though fewer drug administration errors occurred with the new system, the comparison with conventional methods did not reach significance. Rates of errors in drug administration were lower when anaesthetists consistently applied two key principles of the new system (scanning the drug barcode before administering each drug and keeping the voice prompt active) than when they did not: mean 6.0 (3.1 to 8.8) errors per 100 administrations v 9.7 (8.4 to 11.1) respectively (P=0.004). Lapses in the vigilance latency task occurred in 12% (58/471) of cases with the new system and 9% (40/473) with conventional methods (P=0.052). The records generated by the new system were more legible, and anaesthetists preferred the new system, particularly in relation to long, complex, and emergency cases. There were no differences between new and conventional systems in respect of outcomes in patients or anaesthetists' workload. Conclusions The new system was associated with a reduction in errors in the recording and administration of drugs in anaesthesia, attributable mainly to a reduction in recording errors. Automatic compilation of the anaesthetic record increased legibility but also increased lapses in a vigilance latency task and decreased time spent watching monitors.	[Merry, Alan F.; Hannam, Jacqueline; Mitchell, Simon J.; Edwards, Kylie-Ellen; Jardim, Anisoara; Pak, Nick; Cooper, Jeremy; Hopley, Lara; Short, Timothy G.] Univ Auckland, Dept Anaesthesiol, Fac Med & Hlth Sci, Auckland 1142, New Zealand; [Merry, Alan F.; Mitchell, Simon J.; Cooper, Jeremy; Hopley, Lara; Short, Timothy G.] Auckland City Hosp, Dept Anaesthesia, Auckland, New Zealand; [Webster, Craig S.] Univ Auckland, Ctr Med & Hlth Sci Educ, Auckland 1142, New Zealand; [Henderson, Robert] Air New Zealand, Human Factors Grp, Auckland 1142, New Zealand; [Frampton, Chris] Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Med, Christchurch 8140, New Zealand	University of Auckland; Auckland City Hospital; University of Auckland; University of Otago	Merry, AF (corresponding author), Univ Auckland, Dept Anaesthesiol, Fac Med & Hlth Sci, Private Bag 92-019, Auckland 1142, New Zealand.	a.merry@auckland.ac.nz	Reid, Papaarangi M/J-3851-2017	Reid, Papaarangi M/0000-0003-2364-4776; Webster, Craig/0000-0002-6997-4263; Merry, Alan/0000-0001-7100-009X; Mitchell, Simon/0000-0002-5149-6371; Hannam, Jacqueline A/0000-0003-2974-7397; Short, Timothy/0000-0001-9374-1710	Health Research Council of New Zealand [07/269R]; Green Lane Research and Educational Fund	Health Research Council of New Zealand(Health Research Council of New Zealand); Green Lane Research and Educational Fund	This project was supported by grant 07/269R from the Health Research Council of New Zealand and a supplementary grant from the Green Lane Research and Educational Fund. These funders were not involved in the study design; in collection, analysis and interpretation of data; in writing the report; or in the decision to submit the article for publication.	Abeysekera A, 2005, ANAESTHESIA, V60, P220, DOI 10.1111/j.1365-2044.2005.04123.x; *AM SOC TEST MAT, 1995, STAND SPEC US APPL D; *AUSTR NZ COLL AN, 2001, 6 PS AUSTR NZ COLL A; BLOCK FE, 1989, J CLIN MONITOR, V5, P284, DOI 10.1007/BF01618261; Borg G, 1977, SIMPLE RATING METHOD; *CAN STAND ASS, 1998, Z264398 CAN STAND AS; CURRIE M, 1993, ANAESTH INTENS CARE, V21, P596, DOI 10.1177/0310057X9302100517; Davis P, 2006, LANCET, V367, P1920, DOI 10.1016/S0140-6736(06)68847-8; De Amici D, 2000, ANESTH ANALG, V91, P1043, DOI 10.1097/00000539-200010000-00068; DeYoung JL, 2009, AM J HEALTH-SYST PH, V66, P1110, DOI 10.2146/ajhp080355; Donaldson L., 2005, ORG MEMORY REPORT EX; DRIPPS RD, 1997, INTRO ANESTHESIA; Eichhorn J, 2010, CIRCULATION, V25, P1; Evley R, 2010, BRIT J ANAESTH, V105, P289, DOI 10.1093/bja/aeq194; GIBBS RF, 1989, J CLIN MONITOR, V5, P251, DOI 10.1007/BF01618257; Helmons PJ, 2009, AM J HEALTH-SYST PH, V66, P1202, DOI 10.2146/ajhp080357; Institute of Medicine, 2000, ERR IS HUM BUILD SAF; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; *INT ORG STAND, 2008, 268252008 ISO; KENNEDY PJ, 1976, ANESTH ANALG, V55, P374; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; MCDONALD JS, 1988, BRIT J ANAESTH, V61, P738, DOI 10.1093/bja/61.6.738; Merry AF, 2008, ANAESTHESIA, V63, P1349, DOI 10.1111/j.1365-2044.2008.05638.x; MERRY AF, 1995, NEW ZEAL MED J, V108, P185; Merry AF, 2002, ANAESTHESIA, V57, P256, DOI 10.1046/j.0003-2409.2001.02397.x; Merry AF, 2001, ANESTH ANALG, V93, P385, DOI 10.1097/00000539-200108000-00030; Merry AF, 2008, NEW ZEAL MED J, V121, P6; Orser BA, 2004, CAN J ANAESTH, V51, P756, DOI 10.1007/BF03018447; ORSER BA, 1994, CAN J ANAESTH, V41, P120, DOI 10.1007/BF03009804; PARSONS HM, 1974, SCIENCE, V183, P922, DOI 10.1126/science.183.4128.922; Poon EG, 2010, NEW ENGL J MED, V362, P1698, DOI 10.1056/NEJMsa0907115; Reich DL, 2000, ANESTH ANALG, V91, P612, DOI 10.1213/00000539-200009000-00022; ROWE L, 1992, BRIT J ANAESTH, V68, P381, DOI 10.1093/bja/68.4.381; Runciman B., 2007, SAFETY ETHICS HEALTH; Schiff GD, 2010, NEW ENGL J MED, V362, P1066, DOI 10.1056/NEJMp0911734; *STAND NZ, 1996, ASNZS43751996; Stewart M, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-19; Storr Julie Ann, 2009, World Hosp Health Serv, V45, P23; Tenner Edward., 1997, WHY THINGS BITE BACK; Webster CS, 2010, ANAESTHESIA, V65, P490, DOI 10.1111/j.1365-2044.2010.06325.x; Webster CS, 2005, ANAESTHESIA, V60, P843, DOI 10.1111/j.1365-2044.2005.04331.x; Webster CS, 2004, ANAESTHESIA, V59, P80, DOI 10.1111/j.1365-2044.2004.03457.x; Webster CS, 2001, ANAESTH INTENS CARE, V29, P494, DOI 10.1177/0310057X0102900508; Weinger M B, 1996, Acta Anaesthesiol Sin, V34, P27; Weinger MB, 2004, ANESTH ANALG, V98, P1419, DOI 10.1213/01.ANE.0000106838.66901.D2; Weinger MB, 1997, ANESTHESIOLOGY, V87, P144, DOI 10.1097/00000542-199707000-00019; WEINGER MB, 1994, ANESTHESIOLOGY, V80, P77, DOI 10.1097/00000542-199401000-00015; ZOLLINGER RM, 1977, J SURG RES, V22, P419, DOI 10.1016/0022-4804(77)90165-2	48	122	124	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	2011	343								d5543	10.1136/bmj.d5543	http://dx.doi.org/10.1136/bmj.d5543			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	826AJ	21940742	hybrid, Green Published			2022-12-28	WOS:000295323400001
J	Lo Re, V; Teal, V; Localio, AR; Amorosa, VK; Kaplan, DE; Gross, R				Lo Re, Vincent, III; Teal, Valerie; Localio, A. Russell; Amorosa, Valerianna K.; Kaplan, David E.; Gross, Robert			Relationship Between Adherence to Hepatitis C Virus Therapy and Virologic Outcomes	ANNALS OF INTERNAL MEDICINE			English	Article							INTERFERON-ALPHA-2B PLUS RIBAVIRIN; INITIATED ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; PEGINTERFERON ALPHA-2A; COMBINATION THERAPY; SUSTAINED RESPONSE; PHARMACY RECORDS; VIRAL LOAD; INFECTION; COMPLICATIONS	Background: Adherence to therapy with pegylated interferon and ribavirin for hepatitis C virus (HCV) infection has been incompletely examined. Objective: To evaluate the relationship between adherence to HCV therapy and early and sustained virologic response, assess changes in adherence over time, and examine risk factors for nonadherence. Design: Retrospective cohort study. Setting: National Veterans Affairs Hepatitis C Clinical Case Registry. Patients: 5706 HCV-infected patients (genotypes 1, 2, 3, or 4) with at least 1 prescription for both pegylated interferon and ribavirin between 2003 and 2006 and HCV RNA results before and after treatment initiation. Measurements: Adherence was calculated over 12-week intervals by using pharmacy refill data. End points included early virologic response (decrease of >= 2 log(10) HCV RNA at 12 weeks) and sustained virologic response (undetectable HCV RNA 24 weeks after the end of treatment). Results: Early virologic response increased with higher levels of adherence to ribavirin therapy over the initial 12 weeks (patients with HCV genotype 1 or 4, 25 of 68 [37%] with <= 40% adherence vs. 1367 of 2187 [63%] with 91% to 100% adherence [P < 0.001]; patients with HCV genotype 2 or 3, 12 of 18 [67%] with <= 40% adherence vs. 651 of 713 [91%] with 91% to 100% adherence [P < 0.001]). Among patients with HCV genotype 1 or 4, sustained response increased with higher adherence to ribavirin therapy over the second, third, and fourth 12-week intervals. Results were similar for adherence to interferon therapy. Mean adherence to therapy with interferon and ribavirin decreased by 3.4 and 6.6 percentage points per 12-week interval, respectively (P for trend < 0.001 for each drug). Patients who received growth factors or thyroid medications during treatment had higher mean adherence to antiviral therapy. Limitation: This was an observational study without standardized timing for outcome measurements. Conclusion: Early and sustained virologic responses increased with higher levels of adherence to interferon and ribavirin therapy. Adherence to therapy with both antivirals decreased over time, but more so for ribavirin.	[Lo Re, Vincent, III] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Lo Re, V (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, 836 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	vincentl@mail.med.upenn.edu	Re, Vincent Lo/N-7817-2015	Kaplan, David/0000-0002-3839-336X; Teal, Valerie/0000-0001-7116-5353	Department of Veterans Affairs; National Institutes of Health [K01 AI070001]; Agency for Healthcare Research and Quality Centers for Education and Research on Therapeutics [HS10399]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI070001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK060455] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality Centers for Education and Research on Therapeutics(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This material is based on work supported in part by the Department of Veterans Affairs. The contents do not represent the views of the Department of Veterans Affairs or the U.S. Government.; By grant K01 AI070001 from the National Institutes of Health (Dr. Lo Re), grant HS10399 from the Agency for Healthcare Research and Quality Centers for Education and Research on Therapeutics cooperative agreement (Drs. Lo Re, Localio, and Gross), and a Department of Veterans Affairs Competitive Pilot Project Fund grant (Drs. Lo Re and Amorosa).	Backus LI, 2009, J AM MED INFORM ASSN, V16, P775, DOI 10.1197/jamia.M3203; Balding DJ, 2004, APPL LONGITUDINAL AN; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Berenguer J, 2009, HEPATOLOGY, V50, P407, DOI 10.1002/hep.23020; Berlin JA, 1999, BIOMETRICS, V55, P470, DOI 10.1111/j.0006-341X.1999.00470.x; Braithwaite RS, 2007, AIDS, V21, P1579, DOI 10.1097/QAD.0b013e3281532b31; Chapman RH, 2005, ARCH INTERN MED, V165, P1147, DOI 10.1001/archinte.165.10.1147; Coverdale SA, 2004, AM J GASTROENTEROL, V99, P636, DOI 10.1111/j.1572-0241.2004.04085.x; ELIXHAUSER A, 1990, MED CARE, V28, P882, DOI 10.1097/00005650-199010000-00003; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gross R, 2002, AIDS, V16, P1835, DOI 10.1097/00002030-200209060-00021; Gross R, 2001, AIDS, V15, P2109, DOI 10.1097/00002030-200111090-00006; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Heisler M, 2008, CIRCULATION, V117, P2884, DOI 10.1161/CIRCULATIONAHA.107.724104; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Kwo PY, 2010, LANCET, V376, P705, DOI 10.1016/S0140-6736(10)60934-8; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Lo Re V, 2009, CLIN INFECT DIS, V48, P186, DOI 10.1086/595685; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2002, GASTROENTEROLOGY, V123, P1061, DOI 10.1053/gast.2002.35950; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Raptopoulou M, 2005, J VIRAL HEPATITIS, V12, P91, DOI 10.1111/j.1365-2893.2005.00549.x; Reddy KR, 2007, CLIN GASTROENTEROL H, V5, P124, DOI 10.1016/j.cgh.2006.10.008; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Shiffman ML, 2007, GASTROENTEROLOGY, V132, P103, DOI 10.1053/j.gastro.2006.11.011; Shiratori Y, 2005, ANN INTERN MED, V142, P105, DOI 10.7326/0003-4819-142-2-200501180-00009; STEINER JF, 1988, MED CARE, V26, P814, DOI 10.1097/00005650-198808000-00007; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Thompson AJV, 2009, J VIRAL HEPATITIS, V16, P377, DOI 10.1111/j.1365-2893.2009.01124.x; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; Weiss JJ, 2008, ALIMENT PHARM THER, V28, P289, DOI 10.1111/j.1365-2036.2008.03718.x; Weiss JJ, 2009, ALIMENT PHARM THER, V30, P14, DOI 10.1111/j.1365-2036.2009.04004.x; Yee HS, 2006, AM J GASTROENTEROL, V101, P2360, DOI 10.1111/j.1572-0241.2006.00754.x	37	56	57	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6					353	U46		10.7326/0003-4819-155-6-201109200-00003	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930852	Green Accepted			2022-12-28	WOS:000295033400014
J	Yang, T; Wu, MC				Yang, Tian; Wu, Meng-chao			Discrimination against hepatitis B carriers in China	LANCET			English	Editorial Material									[Yang, Tian; Wu, Meng-chao] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai 200438, Peoples R China	Naval Medical University	Wu, MC (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai 200438, Peoples R China.	Mengchao_wu@sina.com	Yang, Tian/W-6668-2019; Yang, Tian/M-5484-2018	Yang, Tian/0000-0003-1544-0976				[Anonymous], 2009, CHINA DAILY     0305; *BEJ YIR CTR, 2009, PLEA HALT BIAS HEP S; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; NI CC, 2004, HEPATITIS B CAUSE DI; 2009, CHINA RADIO INT 0106; 2007, XINHUA NEWS AGE 0714; 2010, PEOPLES DAILY   0327; 2009, CHINA CENTRAL T 1230; 2005, CHINA DAILY     0121	10	33	42	1	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2011	378	9796					1059	1059		10.1016/S0140-6736(11)61460-8	http://dx.doi.org/10.1016/S0140-6736(11)61460-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829BE	21924982				2022-12-28	WOS:000295548900008
J	Brantley, JN; Wiggins, KM; Bielawski, CW				Brantley, Johnathan N.; Wiggins, Kelly M.; Bielawski, Christopher W.			Unclicking the Click: Mechanically Facilitated 1,3-Dipolar Cycloreversions	SCIENCE			English	Article							TERMINAL ALKYNES; OLIGONUCLEOTIDES; CHEMISTRY; AZIDES; FORCE; MECHANOCHEMISTRY; CYCLOADDITION; STRESS	The specific targeting of covalent bonds in a local, anisotropic fashion using mechanical methods offers useful opportunities to direct chemical reactivity down otherwise prohibitive pathways. Here, we report that embedding the highly inert 1,2,3-triazole moiety (which is often prepared using the canonical "click" coupling of azides and alkynes) within a poly(methyl acrylate) chain renders it susceptible to ultrasound-induced cycloreversion, as confirmed by comprehensive spectroscopic and chemical analyses. Such reactivity offers the opportunity to develop triazoles as mechanically labile protecting groups or for use in readily accessible materials that respond to mechanical force.	[Brantley, Johnathan N.; Wiggins, Kelly M.; Bielawski, Christopher W.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Bielawski, CW (corresponding author), Univ Texas Austin, Dept Chem & Biochem, 1 Univ Stn A1590, Austin, TX 78712 USA.	bielawski@cm.utexas.edu			Army Research Office [W911NF-07-1-0409]; Robert A. Welch Foundation [F-1621]	Army Research Office; Robert A. Welch Foundation(The Welch Foundation)	We are grateful to the Army Research Office (grant W911NF-07-1-0409) and the Robert A. Welch Foundation (grant F-1621) for their generous financial support.	Agnew HD, 2009, ANGEW CHEM INT EDIT, V48, P4944, DOI 10.1002/anie.200900488; Antoni P, 2010, MACROMOLECULES, V43, P6625, DOI 10.1021/ma101242u; Caruso MM, 2009, CHEM REV, V109, P5755, DOI 10.1021/cr9001353; Davis DA, 2009, NATURE, V459, P68, DOI 10.1038/nature07970; Hein JE, 2009, ANGEW CHEM INT EDIT, V48, P8018, DOI 10.1002/anie.200903558; Hickenboth CR, 2007, NATURE, V446, P423, DOI 10.1038/nature05681; Iha RK, 2009, CHEM REV, V109, P5620, DOI 10.1021/cr900138t; Khramov DM, 2005, CHEM COMMUN, P4958, DOI 10.1039/b508679e; Kochhar GS, 2010, ANGEW CHEM INT EDIT, V49, P7452, DOI 10.1002/anie.201003978; Kryger MJ, 2010, J AM CHEM SOC, V132, P4558, DOI 10.1021/ja1008932; Lenhardt JM, 2010, SCIENCE, V329, P1057, DOI 10.1126/science.1193412; Lenhardt JM, 2009, J AM CHEM SOC, V131, P10818, DOI 10.1021/ja9036548; Lietard J, 2008, J ORG CHEM, V73, P191, DOI 10.1021/jo702177c; Potisek SL, 2007, J AM CHEM SOC, V129, P13808, DOI 10.1021/ja076189x; Pourceau G, 2009, J ORG CHEM, V74, P6837, DOI 10.1021/jo9014563; Ribas-Arino J, 2009, ANGEW CHEM INT EDIT, V48, P4190, DOI 10.1002/anie.200900673; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Seela F, 2010, J ORG CHEM, V75, P284, DOI 10.1021/jo902300e; Seo TS, 2003, J ORG CHEM, V68, P609, DOI 10.1021/jo026615r; SUSLICK KS, 1983, J AM CHEM SOC, V105, P5781, DOI 10.1021/ja00356a014; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Wiggins KM, 2010, J AM CHEM SOC, V132, P3256, DOI 10.1021/ja910716s; Yamada T, 2011, J ORG CHEM, V76, P1198, DOI 10.1021/jo101761g	23	153	158	3	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1606	1609		10.1126/science.1207934	http://dx.doi.org/10.1126/science.1207934			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921193				2022-12-28	WOS:000294900900036
J	Gunther, C; Martini, E; Wittkopf, N; Amann, K; Weigmann, B; Neumann, H; Waldner, MJ; Hedrick, SM; Tenzer, S; Neurath, MF; Becker, C				Guenther, Claudia; Martini, Eva; Wittkopf, Nadine; Amann, Kerstin; Weigmann, Benno; Neumann, Helmut; Waldner, Maximilian J.; Hedrick, Stephen M.; Tenzer, Stefan; Neurath, Markus F.; Becker, Christoph			Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis	NATURE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CELL-DEATH; INNATE IMMUNITY; CROHNS-DISEASE; APOPTOSIS; NECROSIS; GUT; EXPRESSION; INTESTINE; INTEGRITY	Dysfunction of the intestinal epithelium is believed to result in the excessive translocation of commensal bacteria into the bowel wall that drives chronic mucosal inflammation in Crohn's disease, an incurable inflammatory bowel disease in humans characterized by inflammation of the terminal ileum(1). In healthy individuals, the intestinal epithelium maintains a physical barrier, established by the tight contact of cells. Moreover, specialized epithelial cells such as Paneth cells and goblet cells provide innate immune defence functions by secreting mucus and antimicrobial peptides, which hamper access and survival of bacteria adjacent to the epithelium(2). Epithelial cell death is a hallmark of intestinal inflammation and has been discussed as a possible pathogenic mechanism driving Crohn's disease in humans(3). However, the regulation of epithelial cell death and its role in intestinal homeostasis remain poorly understood. Here we demonstrate a critical role for caspase-8 in regulating necroptosis of intestinal epithelial cells (IECs) and terminal ileitis. Mice with a conditional deletion of caspase-8 in the intestinal epithelium (Casp8(Delta IEC)) spontaneously developed inflammatory lesions in the terminal ileum and were highly susceptible to colitis. Casp8(Delta IEC) mice lacked Paneth cells and showed reduced numbers of goblet cells, indicating dysregulated antimicrobial immune cell functions of the intestinal epithelium. Casp8(Delta IEC) mice showed increased cell death in the Paneth cell area of small intestinal crypts. Epithelial cell death was induced by tumour necrosis factor (TNF)-alpha, was associated with increased expression of receptor-interacting protein 3 (Rip3; also known as Ripk3) and could be inhibited on blockade of necroptosis. Lastly, we identified high levels of RIP3 in human Paneth cells and increased necroptosis in the terminal ileum of patients with Crohn's disease, suggesting a potential role of necroptosis in the pathogenesis of this disease. Together, our data demonstrate a critical function of caspase-8 in regulating intestinal homeostasis and in protecting IECs from TNF-alpha-induced necroptotic cell death.	[Guenther, Claudia; Martini, Eva; Wittkopf, Nadine; Weigmann, Benno; Neumann, Helmut; Waldner, Maximilian J.; Neurath, Markus F.; Becker, Christoph] Univ Erlangen Nurnberg, Dept Med 1, D-91054 Erlangen, Germany; [Amann, Kerstin] Univ Erlangen Nurnberg, Dept Nephropathol, D-91054 Erlangen, Germany; [Hedrick, Stephen M.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Tenzer, Stefan] Johannes Gutenberg Univ Mainz, Inst Immunol, D-55131 Mainz, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of California System; University of California San Diego; Johannes Gutenberg University of Mainz	Becker, C (corresponding author), Univ Erlangen Nurnberg, Dept Med 1, D-91054 Erlangen, Germany.	christoph.becker@uk-erlangen.de	Hedrick, Stephen M/E-9171-2010; Tenzer, Stefan/AAE-2180-2020; Becker, Christoph/A-6694-2008; hongbo, yi/G-9615-2011; Becker, Christoph/L-2996-2016	Tenzer, Stefan/0000-0003-3034-0017; Becker, Christoph/0000-0002-1388-1041; Hedrick, Stephen/0000-0002-6345-8751	Interdisciplinary Center for Clinical Research (IZKF) of the University Erlangen-Nuremberg; European Community [202230]; Welcome Trust [WT087768MA]; NIH [AI037988]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037988] Funding Source: NIH RePORTER	Interdisciplinary Center for Clinical Research (IZKF) of the University Erlangen-Nuremberg; European Community(European Commission); Welcome Trust(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research leading to these results has received funding from the Interdisciplinary Center for Clinical Research (IZKF) of the University Erlangen-Nuremberg and the European Community's 7th Framework Program (FP7/2007-2013) under grant agreement no. 202230, acronym GENINCA. E. M. received funding from the Welcome Trust (WT087768MA) and S. M. H. was supported by NIH grant AI037988. The authors thank A. Watson for critical reading of the manuscript, A. Nikolaev, S. Wallmuller, V. Buchert and M. Klewer for technical assistance and J. Mudter, R. Atreya and C. Neufert for sampling biopsies.	Arijs I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007984; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Elphick DA, 2005, GUT, V54, P1802, DOI 10.1136/gut.2005.068601; HALL PA, 1994, J CELL SCI, V107, P3569; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; LEWIN K, 1969, GUT, V10, P804, DOI 10.1136/gut.10.10.804; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Maelfait J, 2008, BIOCHEM PHARMACOL, V76, P1365, DOI 10.1016/j.bcp.2008.07.034; Mayhew TM, 1999, HISTOL HISTOPATHOL, V14, P257, DOI 10.14670/HH-14.257; Mielgo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007879; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Sanders DSA, 2005, J CLIN PATHOL, V58, P568, DOI 10.1136/jcp.2004.021840; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Valmiki MG, 2009, CELL MOL LIFE SCI, V66, P814, DOI 10.1007/s00018-008-8489-0; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vercammen D, 1997, CYTOKINE, V9, P801, DOI 10.1006/cyto.1997.0252; Wehkamp J, 2008, MUCOSAL IMMUNOL, V1, pS67, DOI 10.1038/mi.2008.48; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	30	600	630	2	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2011	477	7364					335	U108		10.1038/nature10400	http://dx.doi.org/10.1038/nature10400			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21921917	Green Accepted			2022-12-28	WOS:000294852400032
J	Parsons, HM; Tuttle, TM; Kuntz, KM; Begun, JW; McGovern, PM; Virnig, BA				Parsons, Helen M.; Tuttle, Todd M.; Kuntz, Karen M.; Begun, James W.; McGovern, Patricia M.; Virnig, Beth A.			Association Between Lymph Node Evaluation for Colon Cancer and Node Positivity Over the Past 20 Years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLORECTAL-CANCER; RECTAL-CANCER; SURVIVAL; POPULATION; MICROMETASTASES; RESECTION; SURGERY; NUMBER; STAGE; ADENOCARCINOMA	Context Among patients surgically treated for colon cancer, better survival has been demonstrated in those with more lymph nodes evaluated. The presumed mechanism behind this association suggests that a more extensive lymph node evaluation reduces the risk of understaging, leading to improved survival. Objective To further evaluate the mechanism behind lymph node evaluation and survival by examining the association between more extensive lymph node evaluation, identification of lymph node-positive cancers, and hazard of death. Design Observational cohort study. Setting Surveillance, Epidemiology, and End Results (SEER) program data from 1988 through 2008. Patients 86 394 patients surgically treated for colon cancer. Main Outcome Measure We examined the relationship between lymph node evaluation and node positivity using Cochran-Armitage tests and multivariate logistic regression. The association between lymph node evaluation and hazard of death was evaluated using Cox proportional hazards modeling. Results The number of lymph nodes evaluated increased from 1988 to 2008 but did not result in a significant overall increase in lymph node positivity. During 1988-1990, 34.6% of patients (3875/11 200) had 12 or more lymph nodes evaluated, increasing to 73.6% (9798/13 310) during 2006-2008 (P<.001); however, the proportion of node-positive cancers did not change with time (40% in 1988-1990, 42% in 2006-2008, P=.53). Although patients with high levels of lymph node evaluation were only slightly more likely to be node positive (adjusted odds ratio for 30-39 nodes vs 1-8 nodes, 1.11; 95% CI, 1.02-1.20), these patients experienced significantly lower hazard of death compared with those with fewer nodes evaluated (adjusted hazard ratio for 30-39 nodes vs 1-8 nodes, 0.66; 95% CI, 0.62-0.71; unadjusted 5-year mortality, 35.3%). Conclusion The number of lymph nodes evaluated for colon cancer has markedly increased in the past 2 decades but was not associated with an overall shift toward higher-staged cancers, questioning the upstaging mechanism as the primary basis for improved survival in patients with more lymph nodes evaluated. JAMA. 2011;306(10):1089-1097 www.jama.com	[Parsons, Helen M.] NCI, Appl Res Program, Bethesda, MD 20892 USA; [Tuttle, Todd M.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Kuntz, Karen M.; Begun, James W.; Virnig, Beth A.] Univ Minnesota, Div Hlth Policy & Management, Minneapolis, MN 55455 USA; [McGovern, Patricia M.] Univ Minnesota, Div Environm Hlth Sci, Minneapolis, MN 55455 USA; [Tuttle, Todd M.; Virnig, Beth A.] Masonic Canc Ctr, Minneapolis, MN USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Parsons, HM (corresponding author), NCI, Appl Res Program, Execut Plaza N,6130 Execut Blvd,MSC 7344, Bethesda, MD 20892 USA.	helen.parsons@nih.gov		Tuttle, Todd/0000-0001-6603-2062; Begun, James/0000-0003-1924-6126				[Anonymous], IS COL CANC STAG; [Anonymous], 1997, AJCC CANC STAGING MA; [Anonymous], ASCO NCCN QUAL MEAS; [Anonymous], UND CHANG 6 7 ED AJC; [Anonymous], 1997, J CLIN PATHOL; Baxter NN, 2010, DIS COLON RECTUM, V53, P65, DOI 10.1007/DCR.0b013e3181c70425; Baxter NN, 2009, J SURG ONCOL, V99, P265, DOI 10.1002/jso.21197; Baxter NN, 2005, INT J RADIAT ONCOL, V61, P426, DOI 10.1016/j.ijrobp.2004.06.259; Bernini A, 2000, CANCER DETECT PREV, V24, P72; Bilimoria KY, 2008, J NATL CANCER I, V100, P1310, DOI 10.1093/jnci/djn293; Bui L, 2006, J SURG ONCOL, V93, P439, DOI 10.1002/jso.20499; Chang GJ, 2007, J NATL CANCER I, V99, P433, DOI 10.1093/jnci/djk092; Chen SL, 2006, ANN SURG, V244, P602, DOI 10.1097/01.sla.0000237655.11717.50; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; FIELDING LP, 1991, J GASTROEN HEPATOL, V6, P325, DOI 10.1111/j.1440-1746.1991.tb00867.x; Goldstein NS, 2002, AM J SURG PATHOL, V26, P179, DOI 10.1097/00000478-200202000-00004; Gross CP, 2006, JAMA-J AM MED ASSOC, V296, P2815, DOI 10.1001/jama.296.23.2815; Ho SB, 2004, CLIN CANCER RES, V10, P5777, DOI 10.1158/1078-0432.CCR-03-0507; Institute of Medicine, 2006, PERF MEAS ACC IMPR; Le Voyer TE, 2003, J CLIN ONCOL, V21, P2912, DOI 10.1200/JCO.2003.05.062; Liefers GJ, 1998, NEW ENGL J MED, V339, P223, DOI 10.1056/NEJM199807233390403; Meissner HI, 2006, CANCER EPIDEM BIOMAR, V15, P389, DOI 10.1158/1055-9965.EPI-05-0678; National Cancer Institute's, SURV EP END RES SEER; Nattinger AB, 1997, J CLIN EPIDEMIOL, V50, P939, DOI 10.1016/S0895-4356(97)00099-1; Nelson H, 2001, JNCI-J NATL CANCER I, V93, P583, DOI 10.1093/jnci/93.8.583; NIVATVONGS S, 1991, DIS COLON RECTUM, V34, P323, DOI 10.1007/BF02050592; Okabe S, 2004, J GASTROINTEST SURG, V8, P1032, DOI 10.1016/j.gassur.2004.09.038; Otchy D, 2004, DIS COLON RECTUM, V47, P1269, DOI 10.1007/s10350-004-0598-8; Peng CYJ, 2002, J EDUC RES, V96, P3, DOI 10.1080/00220670209598786; Simunovic M, 2007, JAMA-J AM MED ASSOC, V298, P2194, DOI 10.1001/jama.298.18.2194; Wong SL, 2007, JAMA-J AM MED ASSOC, V298, P2149, DOI 10.1001/jama.298.18.2149; Yoshimatsu K, 2005, HEPATO-GASTROENTEROL, V52, P1703	32	138	144	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2011	306	10					1089	1097		10.1001/jama.2011.1285	http://dx.doi.org/10.1001/jama.2011.1285			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819DS	21917579				2022-12-28	WOS:000294806200022
J	Antoniou, T; Gomes, T; Mamdani, MM; Yao, Z; Hellings, C; Garg, AX; Weir, MA; Juurlink, DN				Antoniou, Tony; Gomes, Tara; Mamdani, Muhammad M.; Yao, Zhan; Hellings, Chelsea; Garg, Amit X.; Weir, Matthew A.; Juurlink, David N.			Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study	BRITISH MEDICAL JOURNAL			English	Article							CONGESTIVE-HEART-FAILURE; MECHANISM; THERAPY; DYSFUNCTION; INHIBITORS; MORBIDITY; COHORT	Objectives To characterise the risk of admission to hospital for hyperkalaemia in elderly patients treated with trimethoprim-sulfamethoxazole in combination with spironolactone. Design Population based nested case-control study. Setting Ontario, Canada, from 1 April 1992 to 1 March 2010. Participants Cases were residents of Ontario aged 66 years or above receiving chronic treatment with spironolactone and admitted to hospital with hyperkalaemia within 14 days of receiving a prescription for either trimethoprim-sulfamethoxazole, amoxicillin, norfloxacin, or nitrofurantoin. Up to four controls for each case were identified from the same cohort, matched on age, sex, and presence or absence of chronic kidney disease and diabetes, and required to have received one of the study antibiotics within 14 days before the case's index date. Main outcome measures Odds ratio for association between admission to hospital with hyperkalaemia and receipt of a study antibiotic in the preceding 14 days, adjusted for conditions and drugs that may influence risk of hyperkalaemia. Results During the 18 year study period, 6903 admissions for hyperkalaemia were identified, 306 of which occurred within 14 days of antibiotic use. Of these, 248 (81%) cases were matched to 783 controls. 10.8% (17 859/165 754) of spironolactone users received at least one prescription for trimethoprim-sulfamethoxazole. Compared with amoxicillin, prescription of trimethoprim-sulfamethoxazole was associated with a marked increase in the risk of admission to hospital for hyperkalaemia (adjusted odds ratio 12.4, 95% confidence interval 7.1 to 21.6). The population attributable fraction was 59.7%, suggesting that approximately 60% of all cases of hyperkalaemia in older patients taking spironolactone and treated with an antibiotic for a urinary tract infection could be avoided if trimethoprim-sulfamethoxazole was not prescribed. Treatment with nitrofurantoin was also associated with an increase in the risk of hyperkalaemia (adjusted odds ratio 2.4, 1.3 to 4.6), but no such risk was found with norfloxacin (adjusted odds ratio 1.6, 0.8 to 3.4) Conclusions Among older patients receiving spironolactone, treatment with trimethoprim-sulfamethoxazole was associated with a major increase in the risk of admission to hospital for hyperkalaemia. This drug combination should be avoided when possible.	[Antoniou, Tony; Gomes, Tara; Mamdani, Muhammad M.; Juurlink, David N.] Univ Toronto, Toronto, ON, Canada; [Antoniou, Tony] St Michaels Hosp, Dept Family & Community Med, Toronto, ON M5B 1W8, Canada; [Gomes, Tara; Mamdani, Muhammad M.; Yao, Zhan; Hellings, Chelsea; Garg, Amit X.; Juurlink, David N.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Mamdani, Muhammad M.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Mamdani, Muhammad M.] King Saud Univ, Riyadh, Saudi Arabia; [Garg, Amit X.; Weir, Matthew A.] Univ Western Ontario, Div Nephrol, London, ON, Canada; [Juurlink, David N.] Sunnybrook Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; King Saud University; Western University (University of Western Ontario); University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Antoniou, T (corresponding author), 410 Sherbourne St,4th Floor, Toronto, ON M4X 1K2, Canada.	tantoniou@smh.toronto.on.ca	Hug, Balthasar L./G-1568-2010; Garg, Amit X/G-3295-2011; Weir, Matthew/G-3354-2011	Gomes, Tara/0000-0002-1468-1965	Ontario HIV Treatment Network; Canadian Institutes of Health Research; Ontario Drug Policy Research Network; Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care (MOHLTC); GlaxoSmithKline; Merck; Pfizer	Ontario HIV Treatment Network; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Drug Policy Research Network; Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Pfizer(Pfizer)	TA is supported by a post-doctoral fellowship award from the Ontario HIV Treatment Network. AG is supported by a clinician scientist award from the Canadian Institutes of Health Research. This project was supported by research funds from the Ontario Drug Policy Research Network and by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The sponsors had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript. The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.; All authors have completed the Unified Competing Interest form at www.icmje.org_disclosure.pdf (available on request from the corresponding author). During the past three years, TA has received unrestricted research grants from GlaxoSmithKline, Merck, and Pfizer for different studies. All other authors declare no support from any company for the submitted work; no relationships with any companies that might have an interest in the submitted work in the previous 3 years; and no non-financial interests that may be relevant to the submitted work.	APPEL GB, 1981, NEPHRON, V27, P313, DOI 10.1159/000182077; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Bozkurt B, 2003, J AM COLL CARDIOL, V41, P211, DOI 10.1016/S0735-1097(02)02694-3; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cruz CS, 2003, NEPHROL DIAL TRANSPL, V18, P1814, DOI 10.1093/ndt/gfg295; Desai AS, 2007, J AM COLL CARDIOL, V50, P1959, DOI 10.1016/j.jacc.2007.07.067; EiamOng S, 1996, KIDNEY INT, V49, P1372, DOI 10.1038/ki.1996.193; Hanley JA, 2001, J EPIDEMIOL COMMUN H, V55, P508, DOI 10.1136/jech.55.7.508; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Jager LP, 1997, EUR J PHARMACOL, V331, P325, DOI 10.1016/S0014-2999(97)01052-2; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Lim PO, 2001, J HYPERTENS, V19, P353, DOI 10.1097/00004872-200103000-00001; LUBIN JH, 1984, BIOMETRICS, V40, P63, DOI 10.2307/2530744; Mamdani M, 2004, LANCET, V363, P1751, DOI 10.1016/S0140-6736(04)16299-5; MARINELLA MA, 1997, INFECT DIS CLIN PRAC, V6, P257; Martin Jennifer, 2003, N Z Med J, V116, pU542; Masoudi FA, 2005, CIRCULATION, V112, P39, DOI 10.1161/CIRCULATIONAHA.104.527549; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Perazella MA, 2000, DRUG SAFETY, V22, P227, DOI 10.2165/00002018-200022030-00006; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; PONCE SP, 1985, MEDICINE, V64, P357, DOI 10.1097/00005792-198511000-00001; Rocha R, 2002, DRUGS, V62, P723, DOI 10.2165/00003495-200262050-00001; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schrier RW, 2010, CLIN J AM SOC NEPHRO, V5, P1132, DOI 10.2215/CJN.01410210; Svensson M, 2004, J CARD FAIL, V10, P297, DOI 10.1016/j.cardfail.2003.10.012; VELAZQUEZ H, 1993, ANN INTERN MED, V119, P296, DOI 10.7326/0003-4819-119-4-199308150-00008	28	45	46	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 12	2011	343								d5228	10.1136/bmj.d5228	http://dx.doi.org/10.1136/bmj.d5228			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822UZ	21911446	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000295076500001
J	Sarwar, U; Townley, WA; Nicolaou, M; Khan, MS				Sarwar, U.; Townley, W. A.; Nicolaou, M.; Khan, M. S.			PICTURE QUIZ A darkly pigmented lesion with recent changes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SENTINEL-NODE BIOPSY; CUTANEOUS MELANOMA; EXCISION MARGINS; UK GUIDELINES; RISK; DISSECTION; ULTRASOUND; MANAGEMENT; NEVI; MM		[Sarwar, U.; Townley, W. A.; Nicolaou, M.; Khan, M. S.] Salisbury Dist Hosp, Dept Plast Surg, Salisbury, Wilts, England	Salisbury District Hospital	Sarwar, U (corresponding author), Salisbury Dist Hosp, Dept Plast Surg, Salisbury, Wilts, England.	u.sarwar@doctors.org.uk						Amersi Farin, 2007, Adv Surg, V41, P241, DOI 10.1016/j.yasu.2007.05.015; Balch Charles M, 2003, Semin Surg Oncol, V21, P43, DOI 10.1002/ssu.10020; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Balch CM, 2001, ANN SURG ONCOL, V8, P101, DOI 10.1007/s10434-001-0101-x; Cascinelli N, 1998, LANCET, V351, P793, DOI 10.1016/S0140-6736(97)08260-3; Cust AE, 2011, INT J CANCER, V128, P2425, DOI 10.1002/ijc.25576; de Vries M, 2009, ANN SURG ONCOL, V16, P2840, DOI 10.1245/s10434-009-0602-6; Dennis LK, 2008, ANN EPIDEMIOL, V18, P614, DOI 10.1016/j.annepidem.2008.04.006; Desai Anu, 2006, Sci Aging Knowledge Environ, V2006, ppe13, DOI 10.1126/sageke.2006.9.pe13; Fitzpatrick T. B., 1975, J MED ESTHETIQUE, V2, P33, DOI DOI 10.1159/000251345; Garbe C, 2008, DTSCH ARZTEBL INT, V105, P845, DOI 10.3238/arztebl.2008.0845; Garbe C, 2010, EUR J CANCER, V46, P270, DOI 10.1016/j.ejca.2009.10.032; Gershenwald JE, 1999, J CLIN ONCOL, V17, P976, DOI 10.1200/JCO.1999.17.3.976; Grob JJ, 1998, ARCH DERMATOL, V134, P103, DOI 10.1001/archderm.134.1.103-a; Krengel S, 2006, BRIT J DERMATOL, V155, P1, DOI 10.1111/j.1365-2133.2006.07218.x; Marsden JR, 2010, BRIT J DERMATOL, V163, P238, DOI [10.1111/j.1365-2133.2010.09883.x, 10.1016/j.bjps.2010.07.006]; McMasters KM, 2001, J CLIN ONCOL, V19, P2851, DOI 10.1200/JCO.2001.19.11.2851; Morton DL, 2005, ANN SURG, V242, P302, DOI 10.1097/01.sla.0000181092.50141.fa; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; National Institute for Health and Clinical Excellence, 2006, IMPR OUTC PEOPL SKIN; Ng PC, 2003, J AM ACAD DERMATOL, V48, P420, DOI 10.1067/mjd.2003.106; Roberts DLL, 2002, BRIT J DERMATOL, V146, P7, DOI 10.1046/j.1365-2133.2001.04614.x; Schafer-Hesterberg G, 2007, EXPERT REV ANTICANC, V7, P1707, DOI 10.1586/14737140.7.12.1707; Testori A, 2009, ANN ONCOL, V20, P22, DOI 10.1093/annonc/mdp257; Thomas JM, 2006, BRIT J SURG, V93, P129, DOI 10.1002/bjs.5255; Thomas JM, 2004, NEW ENGL J MED, V350, P757, DOI 10.1056/NEJMoa030681; Thomas JM, 2009, J PLAST RECONSTR AES, V62, P442, DOI 10.1016/j.bjps.2009.01.027; Topping A, 2004, BRIT J PLAST SURG, V57, P97, DOI 10.1016/j.bjps.2003.03.002; van Akkooi ACJ, 2006, ANN ONCOL, V17, P1578, DOI 10.1093/annonc/mdl176; van Akkooi ACJ, 2010, ANN SURG ONCOL, V17, P660, DOI 10.1245/s10434-009-0807-8; VERONESI U, 1991, NEW ENGL J MED, V325, P292; Voit C, 2010, J CLIN ONCOL, V28, P847, DOI 10.1200/JCO.2009.25.7428; Voit CA, 2009, J CLIN ONCOL, V27, P4994, DOI 10.1200/JCO.2008.19.0033; Wrightson WR, 2003, ANN SURG ONCOL, V10, P676, DOI 10.1245/ASO.2003.10.001	35	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2011	343								d5375	10.1136/bmj.d5375	http://dx.doi.org/10.1136/bmj.d5375			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819SJ	21908531				2022-12-28	WOS:000294850000002
J	Grotjohann, T; Testa, I; Leutenegger, M; Bock, H; Urban, NT; Lavoie-Cardinal, F; Willig, KI; Eggeling, C; Jakobs, S; Hell, SW				Grotjohann, Tim; Testa, Ilaria; Leutenegger, Marcel; Bock, Hannes; Urban, Nicolai T.; Lavoie-Cardinal, Flavie; Willig, Katrin I.; Eggeling, Christian; Jakobs, Stefan; Hell, Stefan W.			Diffraction-unlimited all-optical imaging and writing with a photochromic GFP	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; STIMULATED-EMISSION; RESOLUTION BARRIER; DENDRITIC SPINES; STRUCTURAL BASIS; MICROSCOPY; NANOSCOPY; BREAKING; LIGHT; DEPLETION	Lens-based optical microscopy failed to discern fluorescent features closer than 200 nm for decades, but the recent breaking of the diffraction resolution barrier by sequentially switching the fluorescence capability of adjacent features on and off is making nanoscale imaging routine. Reported fluorescence nanoscopy variants switch these features either with intense beams at defined positions or randomly, molecule by molecule. Here we demonstrate an optical nanoscopy that records raw data images from living cells and tissues with low levels of light. This advance has been facilitated by the generation of reversibly switchable enhanced green fluorescent protein (rsEGFP), a fluorescent protein that can be reversibly photoswitched more than a thousand times. Distributions of functional rsEGFP-fusion proteins in living bacteria and mammalian cells are imaged at <40-nanometre resolution. Dendritic spines in living brain slices are super-resolved with about a million times lower light intensities than before. The reversible switching also enables all-optical writing of features with subdiffraction size and spacings, which can be used for data storage.	[Grotjohann, Tim; Testa, Ilaria; Leutenegger, Marcel; Bock, Hannes; Urban, Nicolai T.; Lavoie-Cardinal, Flavie; Willig, Katrin I.; Eggeling, Christian; Jakobs, Stefan; Hell, Stefan W.] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Jakobs, Stefan] Univ Gottingen, Sch Med, D-37075 Gottingen, Germany	Max Planck Society; University of Gottingen	Jakobs, S (corresponding author), Max Planck Inst Biophys Chem, Dept NanoBiophoton, Fassberg 11, D-37077 Gottingen, Germany.	sjakobs@gwdg.de; shell@gwdg.de	Willig, Katrin/AAH-5418-2020; Jakobs, Stefan/F-4898-2012	Willig, Katrin/0000-0002-1860-334X; Jakobs, Stefan/0000-0002-8028-3121; Testa, Ilaria/0000-0003-4005-4997; Urban, Nicolai/0000-0001-7643-9755	Deutsche Forschungsgemeinschaft (DFG) through the DFG-Research Center for Molecular Physiology of the Brain; DFG	Deutsche Forschungsgemeinschaft (DFG) through the DFG-Research Center for Molecular Physiology of the Brain(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	We thank J. Jethwa for careful reading and M. Andresen, T. Brakemann, S. Lobermann, R. Schmitz-Salue and A. C. Stiel for discussions and support, as well as T. Gilat and F. Voss (MPI of Neurobiology, Munich) for help with the slice culture preparation and A. Schonle for adapting the software Imspector. We thank The Project Gutenberg for making Grimm's Fairy Tales available in electronic format, L. Rothfield (University of Connecticut Health Center) for providing the plasmid pLE7, R. Wedlich-Soldner (MPI of Biochemistry, Munich) for the lifeact-YFP construct and V. Stein (MPI of Neurobiology, Munich) for the virus protocol. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) through the DFG-Research Center for Molecular Physiology of the Brain (to S. J.) and by a Gottfried-Wilhelm-Leibniz prize of the DFG (to S.W.H.).	Adam V, 2010, J BIOTECHNOL, V149, P289, DOI 10.1016/j.jbiotec.2010.04.001; Adam V, 2008, P NATL ACAD SCI USA, V105, P18343, DOI 10.1073/pnas.0805949105; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Andresen M, 2005, P NATL ACAD SCI USA, V102, P13070, DOI 10.1073/pnas.0502772102; Andresen M, 2007, P NATL ACAD SCI USA, V104, P13005, DOI 10.1073/pnas.0700629104; Andrew TL, 2009, SCIENCE, V324, P917, DOI 10.1126/science.1167704; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bizzarri R, 2010, J AM CHEM SOC, V132, P85, DOI 10.1021/ja9014953; Bossi M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/11/275; Brakemann T, 2010, J BIOL CHEM, V285, P14603, DOI 10.1074/jbc.M109.086314; Dedecker P, 2007, J AM CHEM SOC, V129, P16132, DOI 10.1021/ja076128z; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Fischer J, 2010, ADV MATER, V22, P3578, DOI 10.1002/adma.201000892; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hein B, 2008, P NATL ACAD SCI USA, V105, P14271, DOI 10.1073/pnas.0807705105; Heintzmann R, 2002, J OPT SOC AM A, V19, P1599, DOI 10.1364/JOSAA.19.001599; Hell S.W., 1997, T FLUOR SP, P361; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hell SW, 2009, NAT PHOTONICS, V3, P381, DOI 10.1038/NPHOTON.2009.112; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Hell SW, 2004, CURR OPIN NEUROBIOL, V14, P599, DOI 10.1016/j.conb.2004.08.015; Hell SW, 2004, PHYS LETT A, V326, P140, DOI 10.1016/j.physleta.2004.03.082; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Hell SW, 2003, APPL PHYS A-MATER, V77, P859, DOI 10.1007/s00339-003-2292-4; HELL SW, 1995, APPL PHYS B-LASERS O, V60, P495, DOI 10.1007/BF01081333; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Henderson JN, 2007, P NATL ACAD SCI USA, V104, P6672, DOI 10.1073/pnas.0700059104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Hopt A, 2001, BIOPHYS J, V80, P2029, DOI 10.1016/S0006-3495(01)76173-5; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Li LJ, 2009, SCIENCE, V324, P910, DOI 10.1126/science.1168996; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Nagerl UV, 2008, P NATL ACAD SCI USA, V105, P18982, DOI 10.1073/pnas.0810028105; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schwentker MA, 2007, MICROSC RES TECHNIQ, V70, P269, DOI 10.1002/jemt.20443; Scott TF, 2009, SCIENCE, V324, P913, DOI 10.1126/science.1167610; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vats P, 2007, P NATL ACAD SCI USA, V104, P17795, DOI 10.1073/pnas.0708739104; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	47	338	356	3	255	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					204	208		10.1038/nature10497	http://dx.doi.org/10.1038/nature10497			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21909116				2022-12-28	WOS:000295782800041
J	Morse, RB; Hall, M; Fieldston, ES; McGwire, G; Anspacher, M; Sills, MR; Williams, K; Oyemwense, N; Mann, KJ; Simon, HK; Shah, SS				Morse, Rustin B.; Hall, Matthew; Fieldston, Evan S.; McGwire, Gerd; Anspacher, Melanie; Sills, Marion R.; Williams, Kristi; Oyemwense, Naomi; Mann, Keith J.; Simon, Harold K.; Shah, Samir S.			Hospital-Level Compliance With Asthma Care Quality Measures at Children's Hospitals and Subsequent Asthma-Related Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERFORMANCE-MEASURES; MORTALITY-RATES; HEART-FAILURE; US HOSPITALS; OF-CARE	Context The Children's Asthma Care (CAC) measure set evaluates whether children admitted to hospitals with asthma receive relievers (CAC-1) and systemic corticosteroids (CAC-2) and whether they are discharged with a home management plan of care (CAC-3). It is the only Joint Commission core measure applicable to evaluate the quality of care for hospitalized children. Objectives To evaluate longitudinal trends in CAC measure compliance and to determine if an association exists between compliance and outcomes. Design, Setting, and Patients Cross-sectional study using administrative data and CAC compliance data for 30 US children's hospitals. A total of 37 267 children admitted with asthma between January 1, 2008, and September 30, 2010, with follow-up through December 31, 2010, accounted for 45 499 hospital admissions. Hospital-level CAC measure compliance data were obtained from the National Association of Children's Hospitals and Related Institutions. Readmission and postdischarge emergency department (ED) utilization data were obtained from the Pediatric Health Information System. Main Outcome Measures Children's Asthma Care measure compliance trends; postdischarge ED utilization and asthma-related readmission rates at 7, 30, and 90 days. Results The minimum quarterly CAC-1 and CAC-2 measure compliance rates reported by any hospital were 97.1% and 89.5%, respectively. Individual hospital CAC-2 compliance exceeded 95% for 97.9% of the quarters. Lack of variability in CAC-1 and CAC-2 compliance precluded examination of their association with the specified outcomes. Mean CAC-3 compliance was 40.6% (95% CI, 34.1%-47.1%) and 72.9% (95% CI, 68.8%-76.9%) for the initial and final 3 quarters of the study, respectively. The mean 7-, 30-, and 90-day postdischarge ED utilization rates were 1.5% (95% CI, 1.3%-1.6%), 4.3% (95% CI, 4.0%-4.5%), and 11.1% (95% CI, 10.5%-11.7%) and the mean quarterly 7-, 30-, and 90-day readmission rates were 1.4% (95% CI, 1.2%-1.6%), 3.1% (95% CI, 2.8%-3.3%), and 7.6% (95% CI, 7.2%-8.1%). There was no significant association between overall CAC-3 compliance (odds ratio [OR] for 5% improvement in compliance) and post-discharge ED utilization rates at 7 days (OR, 1.00; 95% CI, 0.98-1.02), 30 days (OR, 0.97; 95% CI, 0.90-1.04), and 90 days (OR, 0.96; 95% CI, 0.77-1.18). In addition, there was no significant association between overall CAC-3 compliance (OR for 5% improvement in compliance) and readmission rates at 7 days (OR, 1.00; 95% CI, 0.99-1.02), 30 days (OR, 0.99; 95% CI, 0.96-1.02), and 90 days (OR, 1.01; 95% CI, 0.90-1.12). Conclusion Among children admitted to pediatric hospitals for asthma, there was high hospital-level compliance with CAC-1 and CAC-2 quality measures and moderate compliance with the CAC-3 measure but no association between CAC-3 compliance and subsequent ED visits and asthma-related readmissions. JAMA. 2011;306(13):1454-1460	[Morse, Rustin B.] Univ Arizona, Coll Med, Phoenix Childrens Hosp, Phoenix, AZ 85016 USA; [Hall, Matthew] Child Hlth Corp Amer, Shawnee Mission, KS USA; [Fieldston, Evan S.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; [McGwire, Gerd] Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Anspacher, Melanie] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Sills, Marion R.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Aurora, CO USA; [Williams, Kristi; Mann, Keith J.] Univ Missouri Kansas City Sch Med, Childrens Mercy Hosp & Clin, Kansas City, KS USA; [Oyemwense, Naomi] Childrens Hosp, Boston, MA 02115 USA; [Simon, Harold K.] Emory Univ, Sch Med, Atlanta, GA USA; [Shah, Samir S.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	Phoenix Children's Hospital; University of Arizona; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Children's National Health System; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Mercy Hospital; Harvard University; Boston Children's Hospital; Emory University; Cincinnati Children's Hospital Medical Center	Morse, RB (corresponding author), Univ Arizona, Coll Med, Phoenix Childrens Hosp, 1919 E Thomas Rd, Phoenix, AZ 85016 USA.	rmorse@phoenixchildrens.com	McGwire, Gerd/E-3638-2011; Hall, Matt/AAT-1349-2021; Shah, Samir/B-2661-2015	Hall, Matt/0000-0001-7778-5887; Shah, Samir/0000-0001-7902-7000; Sills, Marion/0000-0003-1322-0822	Robert Wood Johnson Physician Faculty Scholars Program; Agency for Healthcare Research and Quality [R01 HS019862]; National Institute of Allergy and Infectious Diseases [K01 A173729]; Child Health Corporation of America	Robert Wood Johnson Physician Faculty Scholars Program(Robert Wood Johnson Foundation (RWJF)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Child Health Corporation of America	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Shah's institution received money from the Robert Wood Johnson Physician Faculty Scholars Program and from grants R01 HS019862 from the Agency for Healthcare Research and Quality and K01 A173729 from the National Institute of Allergy and Infectious Diseases. Dr Shah's institution also receives funds from the Child Health Corporation of America for Dr Shah's role as Executive Council member of the Pediatric Research in Inpatient Settings Network, a research network affiliated with the Academic Pediatric Association, the American Academy of Pediatrics, and the Society of Hospital Medicine. Dr Sills has a grant or a grant pending from the Agency for Healthcare Research and Quality. No other disclosures were reported.	Agency for Healthcare research and Quality, UND QUAL MEAS; [Anonymous], SPEC MAN NAT HOSP IN; Bhogal S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005306.pub2; Chassin MR, 2010, NEW ENGL J MED, V363, P683, DOI 10.1056/NEJMsb1002320; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Ducharme FM, 2011, AM J RESP CRIT CARE, V183, P195, DOI 10.1164/rccm.201001-0115OC; Feudtner C, 2009, PEDIATRICS, V123, P286, DOI 10.1542/peds.2007-3395; Fonarow GC, 2009, JAMA-J AM MED ASSOC, V302, P792, DOI 10.1001/jama.2009.1180; Jha AK, 2009, NEW ENGL J MED, V361, P2637, DOI 10.1056/NEJMsa0904859; *JOINT COMM, FACTS ORYX PERF MEAS; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; Landon BE, 2006, ARCH INTERN MED, V166, P2511, DOI 10.1001/archinte.166.22.2511; Mongelluzzo J, 2008, JAMA-J AM MED ASSOC, V299, P2048, DOI 10.1001/jama.299.17.2048; *NAT ASS CHILDR HO, CHILDR ASTHM CAR CAC; National Quality Forum, NQF END STAND; Patterson ME, 2010, MED CARE, V48, P210, DOI 10.1097/MLR.0b013e3181ca3eb4; Shah SS, 2009, CLIN INFECT DIS, V49, P1369, DOI 10.1086/606048; The Joint Commission, CHILDR ASTHM CAR CAC; Toelle BG, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002171.PUB2; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778	21	91	91	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 5	2011	306	13					1454	1460		10.1001/jama.2011.1385	http://dx.doi.org/10.1001/jama.2011.1385			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	828MZ	21972307	Bronze			2022-12-28	WOS:000295506900024
J	Ho, GC; Krimigis, SM; Gold, RE; Baker, DN; Slavin, JA; Anderson, BJ; Korth, H; Starr, RD; Lawrence, DJ; McNutt, RL; Solomon, SC				Ho, George C.; Krimigis, Stamatios M.; Gold, Robert E.; Baker, Daniel N.; Slavin, James A.; Anderson, Brian J.; Korth, Haje; Starr, Richard D.; Lawrence, David J.; McNutt, Ralph L., Jr.; Solomon, Sean C.			MESSENGER Observations of Transient Bursts of Energetic Electrons in Mercury's Magnetosphere	SCIENCE			English	Article							MAGNETIC-FIELD; PARTICLE; SPACECRAFT	The MESSENGER spacecraft began detecting energetic electrons with energies greater than 30 kilo-electron volts (keV) shortly after its insertion into orbit about Mercury. In contrast, no energetic protons were observed. The energetic electrons arrive as bursts lasting from seconds to hours and are most intense close to the planet, distributed in latitude from the equator to the north pole, and present at most local times. Energies can exceed 200 keV but often exhibit cutoffs near 100 keV. Angular distributions of the electrons about the magnetic field suggest that they do not execute complete drift paths around the planet. This set of characteristics demonstrates that Mercury's weak magnetic field does not support Van Allen-type radiation belts, unlike all other planets in the solar system with internal magnetic fields.	[Ho, George C.; Krimigis, Stamatios M.; Gold, Robert E.; Anderson, Brian J.; Korth, Haje; Lawrence, David J.; McNutt, Ralph L., Jr.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Krimigis, Stamatios M.] Acad Athens, Off Space Res & Technol, Athens 11527, Greece; [Baker, Daniel N.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Slavin, James A.] NASA, Heliophys Sci Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Slavin, James A.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Starr, Richard D.] Catholic Univ Amer, Dept Phys, Washington, DC 20064 USA; [Solomon, Sean C.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Academy of Athens; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Michigan System; University of Michigan; Catholic University of America; Carnegie Institution for Science	Ho, GC (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	george.ho@jhuapl.edu	Krimigis, Stamatios/G-4591-2019; Lawrence, David J/E-7463-2015; Korth, Haje/C-3182-2016; Slavin, James A/H-3170-2012; Ho, George/GMW-9642-2022; Ho, George/G-3650-2015; McNutt, Ralph L/E-8006-2010; Anderson, Brian J/I-8615-2012	Krimigis, Stamatios/0000-0003-2781-2386; Lawrence, David J/0000-0002-7696-6667; Korth, Haje/0000-0001-7394-7439; Slavin, James A/0000-0002-9206-724X; Ho, George/0000-0003-1093-2066; Ho, George/0000-0003-1093-2066; McNutt, Ralph L/0000-0002-4722-9166; 	NASA [NAS5-97271, NASW-00002]	NASA(National Aeronautics & Space Administration (NASA))	We thank the MESSENGER team for the development, cruise, orbit insertion, and Mercury orbital operations of the MESSENGER spacecraft. G. C. H. thanks M. Johnson, L. Brown, and J. Vandegriff for graphics support. The NASA Discovery Program under contract NAS5-97271 to The Johns Hopkins University Applied Physics Laboratory and contract NASW-00002 to the Carnegie Institution of Washington supports the MESSENGER mission to Mercury. MESSENGER data are available from NASA's Planetary Data System archive.	Anderson BJ, 2011, SCIENCE, V333, P1859, DOI 10.1126/science.1211001; Andrews GB, 2007, SPACE SCI REV, V131, P523, DOI 10.1007/s11214-007-9272-5; ARMSTRONG TP, 1975, J GEOPHYS RES-SPACE, V80, P4015, DOI 10.1029/JA080i028p04015; BAKER DN, 1987, J GEOPHYS RES, V92, P4707, DOI 10.1029/JA092iA05p04707; Christon S. P., 1987, MAGNETOTAIL PHYS, P393; Ho GC, 2011, PLANET SPACE SCI, V59, P2016, DOI 10.1016/j.pss.2011.01.011; HOSHINO M, 2007, ENERGY BUDGET HIGH E, P108; KRIMIGIS SM, 1979, DYNAMICS MAGNETOSPHE, P599; Mauk BH, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015660; MCILWAIN CE, 1961, J GEOPHYS RES, V66, P3681, DOI 10.1029/JZ066i011p03681; NESS NF, 1974, SCIENCE, V185, P151, DOI 10.1126/science.185.4146.151; Nittler LR, 2011, SCIENCE, V333, P1847, DOI 10.1126/science.1211567; Peplowski PN, 2011, SCIENCE, V333, P1850, DOI 10.1126/science.1211576; SARRIS ET, 1976, GEOPHYS RES LETT, V3, P437, DOI 10.1029/GL003i008p00437; SIMPSON JA, 1974, SCIENCE, V185, P160, DOI 10.1126/science.185.4146.160; SISCOE GL, 1975, J GEOPHYS RES-SPACE, V80, P4359, DOI 10.1029/JA080i031p04359; Slavin JA, 2010, SCIENCE, V329, P665, DOI 10.1126/science.1188067; Zurbuchen TH, 2011, SCIENCE, V333, P1862, DOI 10.1126/science.1211302	18	32	32	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 30	2011	333	6051					1865	1868		10.1126/science.1211141	http://dx.doi.org/10.1126/science.1211141			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960629				2022-12-28	WOS:000295365800049
J	Banzi, R; Cinquini, M; Liberati, A; Moschetti, I; Pecoraro, V; Tagliabue, L; Moja, L				Banzi, Rita; Cinquini, Michela; Liberati, Alessandro; Moschetti, Ivan; Pecoraro, Valentina; Tagliabue, Ludovica; Moja, Lorenzo			Speed of updating online evidence based point of care summaries: prospective cohort analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SYSTEMATIC REVIEWS; CLINICAL-TRIALS; GUIDELINES; QUALITY; GRADE; CITATION	Objective To evaluate the ability of international point of care information summaries to update evidence relevant to medical practice. Design Prospective cohort bibliometric analysis. Setting Top five point of care information summaries (Clinical Evidence, EBMGuidelines, eMedicine, Dynamed, UpToDate) ranked for coverage of medical conditions, editorial quality, and evidence based methodology. Main outcome measures From June 2009 to May 2010 we measured the incidence of research findings relating to potentially eligible newsworthy evidence. As samples, we chose systematic reviews rated as relevant by international research networks (such as, Evidence-Based Medicine, ACP Journal Club, and the Cochrane Collaboration). Every month we assessed whether each sampled review was cited in at least one chapter of the five summaries. The cumulative updating rate was analysed with Kaplan-Meier curves. Results From April to December 2009, 128 reviews were retrieved; 53% (68) from the literature surveillance journals and 47% (60) from the Cochrane Library. At nine months, Dynamed had cited 87% of the sampled reviews, while the other summaries had cited less than 50%. The updating speed of Dynamed clearly led the others. For instance, the hazard ratios for citations in EBM Guidelines and Clinical Evidence versus the top performer were 0.22 (95% confidence interval 0.17 to 0.29) and 0.03 (0.01 to 0.05). Conclusions Point of care information summaries include evidence relevant to practice at different speeds. A qualitative analysis of updating mechanisms is needed to determine whether greater speed corresponds to more appropriate incorporation of new information.	[Banzi, Rita; Liberati, Alessandro; Moschetti, Ivan; Pecoraro, Valentina; Tagliabue, Ludovica; Moja, Lorenzo] Mario Negri Inst Pharmacol Res, Italian Cochrane Ctr, I-20156 Milan, Italy; [Liberati, Alessandro] Univ Modena & Reggio Emilia, Dept Oncol Hematol & Resp Dis, Modena, Italy; [Tagliabue, Ludovica; Moja, Lorenzo] Univ Milan, Dept Publ Hlth Microbiol & Virol, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Universita di Modena e Reggio Emilia; University of Milan	Banzi, R (corresponding author), Mario Negri Inst Pharmacol Res, Italian Cochrane Ctr, Via G La Masa 19, I-20156 Milan, Italy.	rita.banzi@marionegri.it	Banzi, Rita/AAA-6381-2020; Moja, Pasquale Lorenzo/CAH-0318-2022; Cinquini, Michela/ABF-9686-2020; MOSCHETTI, IVAN/ABF-9728-2020	Banzi, Rita/0000-0002-2211-3300; Moja, Pasquale Lorenzo/0000-0001-6680-6507; Cinquini, Michela/0000-0003-4452-9478; MOSCHETTI, IVAN/0000-0003-4047-6655; Pecoraro, Valentina/0000-0002-1800-0936	AIFA; Italian Medicines Agency (AIFA)	AIFA; Italian Medicines Agency (AIFA)	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. It was part of the AIFA's contract to run a series of investigations about point of care products, and this is one of the studies that have emerged from this activity.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. In 2003-8 the Italian Cochrane Centre received grants from the Italian Medicines Agency (AIFA) for the Italian translations of one of the products assessed in the study (Clinical Evidence). The Italian Cochrane Centre is part of the Cochrane Collaboration, which forms a publishing partnership with Wiley-Blackwell to deliver the Cochrane Library through Wiley InterScience. The content of the paper does not represent any official view of the Cochrane Collaboration but solely that of the authors.	Banzi R, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1288; CHALMERS I, 1994, BMJ-BRIT MED J, V309, P862, DOI 10.1136/bmj.309.6958.862; Clark S, 2010, LANCET, V376, P10, DOI 10.1016/S0140-6736(10)61001-X; Clarke M, 2010, LANCET, V376, P20, DOI 10.1016/S0140-6736(10)61045-8; Cook DJ, 1997, ANN INTERN MED, V127, P210, DOI 10.7326/0003-4819-127-3-199708010-00006; Gartlehner G, 2004, INT J QUAL HEALTH C, V16, P399, DOI 10.1093/intqhc/mzh081; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Johnston ME, 2003, INT J TECHNOL ASSESS, V19, P646, DOI 10.1017/S0266462303000606; Kostoff RN, 1998, SCIENTOMETRICS, V43, P27, DOI 10.1007/BF02458392; McKinlay RJ, 2008, J CLIN EPIDEMIOL, V61, P449, DOI 10.1016/j.jclinepi.2007.10.016; Moher D, 2007, J CLIN EPIDEMIOL, V60, P1095, DOI 10.1016/j.jclinepi.2007.03.008; Moja L, 2011, INT J CLIN PRACT, V65, P6, DOI 10.1111/j.1742-1241.2010.02441.x; Parmelli E, 2011, ANN ONCOL, V22, P188, DOI 10.1093/annonc/mdq324; Sarli CC, 2010, J MED LIBR ASSOC, V98, P17, DOI 10.3163/1536-5050.98.1.008; Shekelle P, 2001, BMJ-BRIT MED J, V323, P155, DOI 10.1136/bmj.323.7305.155; Shekelle PG, 2001, JAMA-J AM MED ASSOC, V286, P1461, DOI 10.1001/jama.286.12.1461; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Young C, 2005, LANCET, V366, P107, DOI 10.1016/S0140-6736(05)66846-8	22	37	41	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2011	343								d5856	10.1136/bmj.d5856	http://dx.doi.org/10.1136/bmj.d5856			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	826AK	21948588	Green Published, hybrid			2022-12-28	WOS:000295323500002
J	Chang, HJ				Chang, Huan J.			Periocular Rash	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TINEA-CAPITIS; CHILDREN					tina.chang@jama-archives.org						Arenas R, 2006, INT J DERMATOL, V45, P215, DOI 10.1111/j.1365-4632.2004.02449.x; Basak SAF, 2011, ARCH OPHTHALMOL-CHIC, V129, P306, DOI 10.1001/archophthalmol.2011.14; Kocak M, 2002, J DERMATOL, V29, P131, DOI 10.1111/j.1346-8138.2002.tb00235.x; RASMUSSEN JE, 1978, ARCH DERMATOL, V114, P371, DOI 10.1001/archderm.114.3.371	4	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2011	306	11					1263	1264		10.1001/jama.2011.1290	http://dx.doi.org/10.1001/jama.2011.1290			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HB	21934064				2022-12-28	WOS:000295033500032
J	Levi, M				Levi, Marcel			Dabigatran led to less major bleeding than warfarin in younger but not older patients with atrial fibrillation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Levi, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.		Levi, Marcel/AAZ-8559-2020					Beasley BN, 2011, NEW ENGL J MED, V364, P1788, DOI 10.1056/NEJMp1103050; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Levi MM, 2010, NETH J MED, V68, P68	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6							JC3-3	10.7326/0003-4819-155-6-201109200-02003	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930840				2022-12-28	WOS:000295033400002
J	Bunn, M; Heinonen, O				Bunn, Matthew; Heinonen, Olli			Preventing the Next Fukushima	SCIENCE			English	Editorial Material									[Bunn, Matthew; Heinonen, Olli] Harvard Univ, Belfer Ctr Sci & Int Affairs, Cambridge, MA 02138 USA	Harvard University	Bunn, M (corresponding author), Harvard Univ, Belfer Ctr Sci & Int Affairs, Cambridge, MA 02138 USA.	matthew_bunn@harvard.edu	Bunn, Matthew/A-8807-2009					BEYEA J, 1982, B ATOM SCI, V38, P52, DOI 10.1080/00963402.1982.11455779; Bunn M., 2009, INNOVATIONS, V4, P173; Bunn M., 2010, SECURING BOMB 2010 S; *COMM EM PERS, 2008, REINF GLOB NUCL ORD; *INT NUCL SAF GROU, 2010, INSAG24 IAEA; Meserve RA, 2009, DAEDALUS-US, V138, P100, DOI 10.1162/daed.2009.138.4.100; National Research Council, 2006, SAF SEC COMM SPENT N; Normile D, 2011, SCIENCE, V332, P22, DOI 10.1126/science.332.6025.22; Nuclear Emergency Response Headquarters Government of Japan, 2011, REP JAP GOV IAEA MIN	9	20	20	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1580	1581		10.1126/science.1209668	http://dx.doi.org/10.1126/science.1209668			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	820JE	21921183				2022-12-28	WOS:000294900900025
J	Leibfarth, FA; Hawker, CJ				Leibfarth, Frank A.; Hawker, Craig J.			Mechanically Throwing a Reaction into Reverse	SCIENCE			English	Editorial Material									[Leibfarth, Frank A.] Univ Calif Santa Barbara, Mat Res Lab, Dept Mat, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Leibfarth, FA (corresponding author), Univ Calif Santa Barbara, Mat Res Lab, Dept Mat, Santa Barbara, CA 93106 USA.	frank.leibfarth@gmail.com; hawker@mrl.ucsb.edu	Hawker, Craig J/G-4971-2011	Hawker, Craig J/0000-0001-9951-851X; Leibfarth, Frank/0000-0001-7737-0331				Best MD, 2009, BIOCHEMISTRY-US, V48, P6571, DOI 10.1021/bi9007726; Brantley JN, 2011, SCIENCE, V333, P1606, DOI 10.1126/science.1207934; Finn MG, 2010, CHEM SOC REV, V39, P1231, DOI 10.1039/c003740k; Hawker CJ, 2005, SCIENCE, V309, P1200, DOI 10.1126/science.1109778; Hickenboth CR, 2007, NATURE, V446, P423, DOI 10.1038/nature05681; Lenhardt JM, 2010, SCIENCE, V329, P1057, DOI 10.1126/science.1193412; Whitesides GM, 2011, NATURE, V469, P21, DOI 10.1038/469021a	7	9	9	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1582	1583		10.1126/science.1210892	http://dx.doi.org/10.1126/science.1210892			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921184				2022-12-28	WOS:000294900900026
J	Liu, PF; Erez, A; Nagamani, SCS; Dhar, SU; Kolodziejska, KE; Dharmadhikari, AV; Cooper, ML; Wiszniewska, J; Zhang, F; Withers, MA; Bacino, CA; Campos-Acevedo, LD; Delgado, MR; Freedenberg, D; Garnica, A; Grebe, TA; Hernandez-Almaguer, D; Immken, L; Lalani, SR; McLean, SD; Northrup, H; Scaglia, F; Strathearn, L; Trapane, P; Kang, SHL; Patel, A; Cheung, SW; Hastings, PJ; Stankiewicz, P; Lupski, JR; Bi, WM				Liu, Pengfei; Erez, Ayelet; Nagamani, Sandesh C. Sreenath; Dhar, Shweta U.; Kolodziejska, Katarzyna E.; Dharmadhikari, Avinash V.; Cooper, M. Lance; Wiszniewska, Joanna; Zhang, Feng; Withers, Marjorie A.; Bacino, Carlos A.; Daniel Campos-Acevedo, Luis; Delgado, Mauricio R.; Freedenberg, Debra; Garnica, Adolfo; Grebe, Theresa A.; Hernandez-Almaguer, Dolores; Immken, LaDonna; Lalani, Seema R.; McLean, Scott D.; Northrup, Hope; Scaglia, Fernando; Strathearn, Lane; Trapane, Pamela; Kang, Sung-Hae L.; Patel, Ankita; Cheung, Sau Wai; Hastings, P. J.; Stankiewicz, Pawel; Lupski, James R.; Bi, Weimin			Chromosome Catastrophes Involve Replication Mechanisms Generating Complex Genomic Rearrangements	CELL			English	Article							COPY-NUMBER; SACCHAROMYCES-CEREVISIAE; GENE AMPLIFICATION; MOLECULAR ANALYSIS; CHROMOTHRIPSIS; DUPLICATIONS; ARCHITECTURE; BREAKPOINTS; MICROARRAY; DISORDERS	Complex genomic rearrangements (CGRs) consisting of two or more breakpoint junctions have been observed in genomic disorders. Recently, a chromosome catastrophe phenomenon termed chromothripsis, in which numerous genomic rearrangements are apparently acquired in one single catastrophic event, was described in multiple cancers. Here, we show that constitutionally acquired CGRs share similarities with cancer chromothripsis. In the 17 CGR cases investigated, we observed localization and multiple copy number changes including deletions, duplications, and/or triplications, as well as extensive translocations and inversions. Genomic rearrangements involved varied in size and complexities; in one case, array comparative genomic hybridization revealed 18 copy number changes. Breakpoint sequencing identified characteristic features, including small templated insertions at breakpoints and microhomology at breakpoint junctions, which have been attributed to replicative processes. The resemblance between CGR and chromothripsis suggests similar mechanistic underpinnings. Such chromosome catastrophic events appear to reflect basic DNA metabolism operative throughout an organism's life cycle.	[Liu, Pengfei; Erez, Ayelet; Nagamani, Sandesh C. Sreenath; Dhar, Shweta U.; Kolodziejska, Katarzyna E.; Dharmadhikari, Avinash V.; Cooper, M. Lance; Wiszniewska, Joanna; Zhang, Feng; Withers, Marjorie A.; Bacino, Carlos A.; Lalani, Seema R.; Scaglia, Fernando; Kang, Sung-Hae L.; Patel, Ankita; Cheung, Sau Wai; Hastings, P. J.; Stankiewicz, Pawel; Lupski, James R.; Bi, Weimin] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lalani, Seema R.; Strathearn, Lane; Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Strathearn, Lane] Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Erez, Ayelet; Nagamani, Sandesh C. Sreenath; Dhar, Shweta U.; Bacino, Carlos A.; Lalani, Seema R.; Scaglia, Fernando; Strathearn, Lane; Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Daniel Campos-Acevedo, Luis; Hernandez-Almaguer, Dolores] Univ Autonoma Nuevo Leon, Dept Genet, Univ Hosp, Monterrey 64460, NL, Mexico; [Delgado, Mauricio R.] Texas Scottish Rite Hosp Crippled Children, Dallas, TX 75219 USA; [Freedenberg, Debra] Vanderbilt Univ, Div Med Genet, Med Ctr, Nashville, TN 37232 USA; [Garnica, Adolfo] St Francis Hosp, Tulsa, OK 74136 USA; [Grebe, Theresa A.] Phoenix Childrens Hosp, Div Genet & Metab, Phoenix, AZ 85016 USA; [Immken, LaDonna] Specially Children, Austin, TX 78723 USA; [McLean, Scott D.] San Antonio Mil Med Ctr, Dept Pediat, San Antonio, TX 78234 USA; [Northrup, Hope] Univ Texas Med Sch Houston, Div Med Genet, Dept Pediat, Houston, TX 77030 USA; [Trapane, Pamela] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Texas Scottish Rite Hospital for Children; Vanderbilt University; St. Francis Hospital - Oklahoma; Phoenix Children's Hospital; San Antonio Military Medical Center; University of Texas System; University of Texas Health Science Center Houston; Children's Hospital of Wisconsin	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jlupski@bcm.edu	Lalani, Seema/AAI-5090-2020; Liu, Pengfei/U-9743-2019; Strathearn, Lane/B-1740-2013; Dharmadhikari, Avinash Vijay/AAA-1514-2021; Patel, Ankita/D-3247-2013; Zhang, Feng/C-7735-2009; Stankiewicz, Paweł/AAP-7906-2021	Liu, Pengfei/0000-0002-4177-709X; Strathearn, Lane/0000-0001-5870-8843; Dharmadhikari, Avinash Vijay/0000-0003-4182-4543; Zhang, Feng/0000-0003-4556-8276; Stankiewicz, Paweł/0000-0002-6456-7490; Trapane, Pamela/0000-0001-9201-882X; Nagamani, Sandesh/0000-0001-6818-7367	National Institute of Neurological Disorders and Stroke, National Institutes of Health [R01 NS058529]; National Institutes of General Medical Science [R01 GM064022]; BCM IDDRC [P30HD024064]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; LCRC from the Osteogenesis Imperfecta Foundation; National Urea Cycle Disorders Foundation;  [DK081735-02]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK081735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of General Medical Science; BCM IDDRC; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); LCRC from the Osteogenesis Imperfecta Foundation; National Urea Cycle Disorders Foundation; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the patients and their families for participation in this research, the Molecular Cytogenetics Laboratories in the MGL at BCM (https://www.bcm.edu/geneticlabs/) for providing technical support, Dr. Katarzyna Derwinska for helpful discussion, and Roche NimbleGen for supplying NimbleGen aCGH materials. This work was supported in part by National Institute of Neurological Disorders and Stroke, National Institutes of Health grant R01 NS058529 to J.R.L., National Institutes of General Medical Science grant R01 GM064022 to P.J.H., and the BCM IDDRC P30HD024064 funded from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. A.E. is supported by DK081735-02 and S.C.S.N. is supported by a fellowship grants by the LCRC from the Osteogenesis Imperfecta Foundation and the National Urea Cycle Disorders Foundation. J.R.L. is a consultant for Athena Diagnostics, has stock ownership in 23andMe and Ion Torrent Systems and is a coinventor on multiple United States and European patents for DNA diagnostics. The Department of Molecular and Human Genetics derives revenue from clinical testing by high-resolution human genome analysis.	Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; BATISTA DAS, 1994, AM J MED GENET, V53, P255, DOI 10.1002/ajmg.1320530311; Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Borg K, 2005, HUM GENET, V118, P267, DOI 10.1007/s00439-005-0021-0; Branzei D, 2010, GENE DEV, V24, P5, DOI 10.1101/gad.1884810; Carvalho C.M., 2011, NAT GENET IN PRESS; Carvalho CMB, 2012, CLIN GENET, V81, P532, DOI 10.1111/j.1399-0004.2011.01716.x; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; Chen JM, 2010, SEMIN CANCER BIOL, V20, P222, DOI 10.1016/j.semcancer.2010.05.007; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; Deem A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000594; Doksani Y, 2009, CELL, V137, P247, DOI 10.1016/j.cell.2009.02.016; FUTCHER AB, 1986, J THEOR BIOL, V119, P197, DOI 10.1016/S0022-5193(86)80074-1; Gajecka M, 2010, AM J MED GENET A, V152A, P3074, DOI 10.1002/ajmg.a.33733; Green BM, 2010, SCIENCE, V329, P943, DOI 10.1126/science.1190966; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Hicks WM, 2010, SCIENCE, V329, P82, DOI 10.1126/science.1191125; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Liu PF, 2011, HUM MOL GENET, V20, P1975, DOI 10.1093/hmg/ddr078; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Lupski JR, 2010, NAT GENET, V42, P1036, DOI 10.1038/ng1210-1036; Magrangeas F, 2011, BLOOD, V118, P675, DOI 10.1182/blood-2011-03-344069; Morrow DM, 1997, GENETICS, V147, P371; Ou Z, 2008, GENET MED, V10, P278, DOI 10.1097/GIM.0b013e31816b4420; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Yatsenko SA, 2009, HUM MOL GENET, V18, P1924, DOI 10.1093/hmg/ddp114; Zhang F, 2010, AM J HUM GENET, V86, P892, DOI 10.1016/j.ajhg.2010.05.001; Zhang F, 2009, TRENDS GENET, V25, P298, DOI 10.1016/j.tig.2009.05.005; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	37	301	307	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 16	2011	146	6					888	902		10.1016/j.cell.2011.07.042	http://dx.doi.org/10.1016/j.cell.2011.07.042			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925314	Green Accepted, Bronze			2022-12-28	WOS:000295258100012
J	Clark, CJ; Elias, DO; Prum, RO				Clark, Christopher J.; Elias, Damian O.; Prum, Richard O.			Aeroelastic Flutter Produces Hummingbird Feather Songs	SCIENCE			English	Article							SELECTION; SOUND; TAIL	During courtship flights, males of some hummingbird species produce diverse sounds with tail feathers of varying shapes. We show that these sounds are produced by air flowing past a feather, causing it to aeroelastically flutter and generate flutter-induced sound. Scanning laser doppler vibrometery and high-speed video of individual feathers of different sizes and shapes in a wind tunnel revealed multiple vibratory modes that produce a range of acoustic frequencies and harmonic structures. Neighboring feathers can be aerodynamically coupled and flutter either at the same frequency, resulting in sympathetic vibrations that increase loudness, or at different frequencies, resulting in audible interaction frequencies. Aeroelastic flutter is intrinsic to stiff airfoils such as feathers and thus explains tonal sounds that are common in bird flight.	[Clark, Christopher J.; Prum, Richard O.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Clark, Christopher J.; Prum, Richard O.] Yale Univ, Peabody Museum Nat Hist, New Haven, CT 06520 USA; [Elias, Damian O.] Univ Calif Berkeley, Berkeley, CA 94720 USA	Yale University; Yale University; University of California System; University of California Berkeley	Clark, CJ (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, POB 208105, New Haven, CT 06520 USA.		Elias, Damian O/C-4954-2013	Prum, Richard/0000-0002-4741-7132	NSF [IOS-0920353, IOS-1021385]; Division Of Integrative Organismal Systems [1021385] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank T. Feo, A. McCallum, M. Girard, J. Windmill, J. Jackson, F. Montealegre-Z, the Prum lab, and three anonymous reviewers for input, and A. Varma for use of a photo. G. Weston-Murphy and M. Schmook kindly provided access to the wind tunnel at the Department of Mechanical Engineering, Yale University. Funded by NSF grant IOS-0920353 to R.O.P. and C.J.C. and NSF grant IOS-1021385 to D.O.E. Feathers were collected and imported under relevant permits. C.J.C. and R.O.P. initiated the project, C.J.C. collected and analyzed data, D.O.E. provided SLDV, R.O.P. provided support, and all authors contributed to the writing. Data are available from the authors upon request.	Bisplinghoff RL, 1996, AEROELASTICITY; Bradbury Jack W., 1998, pi; Clark CJ, 2010, AM NAT, V175, P27, DOI 10.1086/648560; Clark CJ, 2008, P R SOC B, V275, P955, DOI 10.1098/rspb.2007.1619; Clark CJ, 2011, CURR ZOOL, V57, P187, DOI 10.1093/czoolo/57.2.187; Clark CJ, 2009, P ROY SOC B-BIOL SCI, V276, P3047, DOI 10.1098/rspb.2009.0508; CRIGHTON DG, 1975, PROG AEROSPACE SCI, V16, P31, DOI DOI 10.1016/0376-0421(75)90010-X; Delacour J., 2004, CURASSOWS RELATED BI; Feo TJ, 2010, AUK, V127, P787, DOI 10.1525/auk.2010.09263; LAUBER LE, 2005, BOWHUNTERS GUIDE ACC; Manela A, 2009, J SOUND VIB, V321, P994, DOI 10.1016/j.jsv.2008.10.009; McGuire JA, 2007, SYST BIOL, V56, P837, DOI 10.1080/10635150701656360; NOWICKI S, 1986, SCIENCE, V231, P1297, DOI 10.1126/science.3945824; Prum RO, 1998, ANIM BEHAV, V55, P977, DOI 10.1006/anbe.1997.0647; PRUM RO, 2005, PEABODY MUSEUM SPECI, P245; Schuchmann K.-L., 1999, HDB BIRDS WORLD, P468; Sheldon WG., 1967, BOOK AM WOODCOCK; Traylor M.A., 1982, LIVING BIRD, V19, P7	18	47	47	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2011	333	6048					1430	1433		10.1126/science.1205222	http://dx.doi.org/10.1126/science.1205222			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21903810				2022-12-28	WOS:000294672200038
J	Higgs, DR; Engel, JD; Stamatoyannopoulos, G				Higgs, Douglas R.; Engel, James Douglas; Stamatoyannopoulos, George			Thalassaemia	LANCET			English	Article							BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; MURINE BETA-THALASSEMIA; FETAL-HEMOGLOBIN LEVELS; GLOBIN GENE-EXPRESSION; CORD BLOOD TRANSPLANTATION; HUMAN GAMMA-GLOBIN; IRON OVERLOAD; PULMONARY-HYPERTENSION; HEREDITARY PERSISTENCE	Thalassaemia is one of the most common genetic diseases worldwide, with at least 60 000 severely affected individuals born every year. Individuals originating from tropical and subtropical regions are most at risk. Disorders of haemoglobin synthesis (thalassaemia) and structure (eg, sickle-cell disease) were among the first molecular diseases to be identified, and have been investigated and characterised in detail over the past 40 years. Nevertheless, treatment of thalassaemia is still largely dependent on supportive care with blood transfusion and iron chelation. Since 1978, scientists and clinicians in this specialty have met regularly in an international effort to improve the management of thalassaemia, with the aim of increasing the expression of unaffected fetal genes to improve the deficiency in adult beta-globin synthesis. In this Seminar we discuss important advances in the understanding of the molecular and cellular basis of normal and abnormal expression of globin genes. We will summarise new approaches to the development of tailored pharmacological agents to alter regulation of globin genes, the first trial of gene therapy for thalassaemia, and future prospects of cell therapy.	[Higgs, Douglas R.] John Radcliff Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England; [Higgs, Douglas R.] John Radcliff Hosp, Biomed Res Ctr, Natl Inst Hlth Res, Oxford OX3 9DS, England; [Engel, James Douglas] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Stamatoyannopoulos, George] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Stamatoyannopoulos, George] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA	University of Oxford; University of Oxford; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Higgs, DR (corresponding author), John Radcliff Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England.	doug.higgs@imm.ox.ac.uk		Higgs, Douglas/0000-0003-3579-8705	HemaQuest; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL114368] Funding Source: NIH RePORTER; MRC [MC_UU_12009/4] Funding Source: UKRI; Medical Research Council [MC_UU_12009/4, G1000801b] Funding Source: researchfish	HemaQuest; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	GS has received payment for board membership and holds stock for HemaQuest, and has received royalties from University of Washington. All other authors declare that they have no conflicts of interest.	Aydinok Y, 2007, HAEMATOLOGICA, V92, P1599, DOI 10.3324/haematol.11414; Bank A, 2005, ANN NY ACAD SCI, V1054, P308, DOI 10.1196/annals.1345.007; BITTLES AH, 1991, SCIENCE, V252, P789, DOI 10.1126/science.2028254; Boncimino A, 2010, TRANSFUS APHER SCI, V42, P277, DOI 10.1016/j.transci.2010.03.006; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187; BRITTENHAM GM, 1994, NEW ENGL J MED, V331, P567, DOI 10.1056/NEJM199409013310902; Cantor AB, 2005, INT J HEMATOL, V81, P378, DOI 10.1532/IJH97.04180; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Cao A, OBSTET GYNECOL CLIN, V29, P305; Cappellini MD, 2006, BLOOD, V107, P3455, DOI 10.1182/blood-2005-08-3430; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Cohen Alan R, 2004, Hematology Am Soc Hematol Educ Program, P14; de Laat W, 2008, CURR TOP DEV BIOL, V82, P117, DOI 10.1016/S0070-2153(07)00005-1; DRISCOLL MC, 1989, P NATL ACAD SCI USA, V86, P7470, DOI 10.1073/pnas.86.19.7470; Dzierzak E, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P3; Fibach E, 2010, ANN NY ACAD SCI, V1202, P10, DOI 10.1111/j.1749-6632.2010.05577.x; Forget BG, 1998, ANN NY ACAD SCI, V850, P38, DOI 10.1111/j.1749-6632.1998.tb10460.x; FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949; Galanello R, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-11; Galarneau G, 2010, NAT GENET, V42, P1049, DOI 10.1038/ng.707; Gardenghi S, 2010, ANN NY ACAD SCI, V1202, P221, DOI 10.1111/j.1749-6632.2010.05595.x; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gaziev D, 2000, BONE MARROW TRANSPL, V25, P815, DOI 10.1038/sj.bmt.1702242; Gaziev J, 2005, ANN NY ACAD SCI, V1054, P196, DOI 10.1196/annals.1345.024; Gaziev Javid, 2005, Curr Hematol Rep, V4, P126; Giardine B, 2011, NAT GENET, V43, P295, DOI 10.1038/ng.785; Goren A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000046; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; Hall JG, 2004, J PEDIAT HEMATOL ONC, V26, P382, DOI 10.1097/00043426-200406000-00010; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Harteveld CL, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-13; Higgs DR, 2008, NEW ENGL J MED, V358, P964, DOI 10.1056/NEJMcibr0708823; Higgs DR, 2008, CURR OPIN HEMATOL, V15, P176, DOI 10.1097/MOH.0b013e3282f734c4; Imren S, 2002, P NATL ACAD SCI USA, V99, P14380, DOI 10.1073/pnas.212507099; Jaing TH, 2005, BIOL BLOOD MARROW TR, V11, P349, DOI 10.1016/j.bbmt.2005.02.003; Kaiser J, 2010, SCIENCE, V330, P1462, DOI 10.1126/science.330.6010.1462-b; Kiefer CM, 2008, MUTAT RES-FUND MOL M, V647, P68, DOI 10.1016/j.mrfmmm.2008.07.014; KIOUSSIS D, 1983, NATURE, V306, P662, DOI 10.1038/306662a0; Kohn DB, 2010, CLIN IMMUNOL, V135, P247, DOI 10.1016/j.clim.2009.12.003; Krishnamurti Lakshmanan, 2008, Curr Probl Pediatr Adolesc Health Care, V38, P6, DOI 10.1016/j.cppeds.2007.10.002; La Nasa G, 2005, BONE MARROW TRANSPL, V36, P971, DOI 10.1038/sj.bmt.1705173; La Nasa G, 2002, BLOOD, V99, P4350, DOI 10.1182/blood.V99.12.4350; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Lawson SE, 2003, BRIT J HAEMATOL, V120, P289, DOI 10.1046/j.1365-2141.2003.04065.x; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Lo YM, 2002, HEMATOL ONCOL CLIN N, V24, P1179; LUCARELLI G, 1990, NEW ENGL J MED, V322, P417, DOI 10.1056/NEJM199002153220701; Lucarelli G, 2008, BLOOD REV, V22, P53, DOI 10.1016/j.blre.2007.10.001; Mabaera R, 2007, BLOOD, V110, P1343, DOI 10.1182/blood-2007-01-068635; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; May C, 2002, BLOOD, V99, P1902, DOI 10.1182/blood.V99.6.1902; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Miles J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000630; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Nuinoon M, 2010, HUM GENET, V127, P303, DOI 10.1007/s00439-009-0770-2; Old JM, 2003, BLOOD REV, V17, P43, DOI 10.1016/S0268-960X(02)00061-9; Olivieri N, 1998, BAILLIERE CLIN HAEM, V11, P147, DOI 10.1016/S0950-3536(98)80073-5; Olivieri NF, 2008, BRIT J HAEMATOL, V141, P388, DOI 10.1111/j.1365-2141.2008.07126.x; Olivieri NF, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P357; OLIVIERI NF, 1994, NEW ENGL J MED, V331, P574, DOI 10.1056/NEJM199409013310903; Pace BS, 2006, DEV DYNAM, V235, P1727, DOI 10.1002/dvdy.20802; Palis J, 2008, CURR OPIN HEMATOL, V15, P155, DOI 10.1097/MOH.0b013e3282f97ae1; Palstra RJ, 2008, ADV GENET, V61, P107, DOI 10.1016/S0065-2660(07)00004-1; Pennell DJ, 2010, BLOOD, V115, P2364, DOI 10.1182/blood-2009-04-217455; Perrine SP, 2008, PEDIATR ANN, V37, P339, DOI 10.3928/00904481-20080501-10; Persons DA, 2003, BLOOD, V101, P2175, DOI 10.1182/blood-2002-07-2211; Persons Derek A, 2009, Hematology Am Soc Hematol Educ Program, P690, DOI 10.1182/asheducation-2009.1.690; Philipsen S, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P24; Phrommintikul A, 2006, HEART, V92, P1467, DOI 10.1136/hrt.2005.079970; Pinto FO, 2008, BRIT J HAEMATOL, V141, P309, DOI 10.1111/j.1365-2141.2008.07016.x; Porter JB, 2010, ANN NY ACAD SCI, V1202, P87, DOI 10.1111/j.1749-6632.2010.05582.x; Rees DC, 1998, ANN NY ACAD SCI, V850, P334, DOI 10.1111/j.1749-6632.1998.tb10490.x; Rivella S, 2003, BLOOD, V101, P2932, DOI 10.1182/blood-2002-10-3305; Sadelain M, 2007, HUM GENE THER, V18, P1, DOI 10.1089/hum.2006.151; Sankaran VG, 2010, BRIT J HAEMATOL, V149, P181, DOI 10.1111/j.1365-2141.2010.08105.x; Singer ST, 2006, AM J HEMATOL, V81, P670, DOI 10.1002/ajh.20640; Smiers FJ, 2010, PEDIATR CLIN N AM, V57, P181, DOI 10.1016/j.pcl.2010.01.003; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; Stamatoyannopoulos G, 2001, MOL BASIS BLOOD DIS, P136; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taher AT, 2011, BRIT J HAEMATOL, V152, P512, DOI 10.1111/j.1365-2141.2010.08486.x; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thein SL, 2008, BRIT J HAEMATOL, V141, P357, DOI 10.1111/j.1365-2141.2008.07084.x; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; Thein SL, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P323; Thein SL, 2009, HUM MOL GENET, V18, pR216, DOI 10.1093/hmg/ddp401; Trompeter S, 2009, BRIT J HAEMATOL, V144, P308, DOI 10.1111/j.1365-2141.2008.07482.x; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Voon HPJ, 2008, HAEMATOL-HEMATOL J, V93, P1868, DOI 10.3324/haematol.13490; Weatherall DJ, 2010, HEMATOL ONCOL CLIN N, V24, P1021, DOI 10.1016/j.hoc.2010.08.010; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348; Weatherall DJ, 2001, BRIT J HAEMATOL, V115, P729, DOI 10.1046/j.1365-2141.2001.03227.x; Weatherall DJ., 2001, THALASSAEMIA SYNDROM, V4th ed; Yannaki E, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001626; Ye L, 2009, P NATL ACAD SCI USA, V106, P9826, DOI 10.1073/pnas.0904689106; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637	100	272	292	7	60	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2012	379	9813					373	383		10.1016/S0140-6736(11)60283-3	http://dx.doi.org/10.1016/S0140-6736(11)60283-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889BA	21908035				2022-12-28	WOS:000300047300044
J	Simmons, G; Glynn, SA; Komaroff, AL; Mikovits, JA; Tobler, LH; Hackett, J; Tang, N; Switzer, WM; Heneine, W; Hewlett, IK; Zhao, JQ; Lo, SC; Alter, HJ; Linnen, JM; Gao, K; Coffin, JM; Kearney, MF; Ruscetti, FW; Pfost, MA; Bethel, J; Kleinman, S; Holmberg, JA; Busch, MP				Simmons, Graham; Glynn, Simone A.; Komaroff, Anthony L.; Mikovits, Judy A.; Tobler, Leslie H.; Hackett, John, Jr.; Tang, Ning; Switzer, William M.; Heneine, Walid; Hewlett, Indira K.; Zhao, Jiangqin; Lo, Shyh-Ching; Alter, Harvey J.; Linnen, Jeffrey M.; Gao, Kui; Coffin, John M.; Kearney, Mary F.; Ruscetti, Francis W.; Pfost, Max A.; Bethel, James; Kleinman, Steven; Holmberg, Jerry A.; Busch, Michael P.		Blood XMRV Sci Res Working Grp	Failure to Confirm XMRV/MLVs in the Blood of Patients with Chronic Fatigue Syndrome: A Multi-Laboratory Study	SCIENCE			English	Article							VIRUS-RELATED VIRUS; RETROVIRUS XMRV; CELLS; CONTAMINATION; SEQUENCES; ABSENCE; DONORS; DETECT	Murine leukemia viruses (MLVs), including xenotropic-MLV-related virus (XMRV), have been controversially linked to chronic fatigue syndrome (CFS). To explore this issue in greater depth, we compiled coded replicate samples of blood from 15 subjects previously reported to be XMRV/MLV-positive (14 with CFS) and from 15 healthy donors previously determined to be negative for the viruses. These samples were distributed in a blinded fashion to nine laboratories, which performed assays designed to detect XMRV/MLV nucleic acid, virus replication, and antibody. Only two laboratories reported evidence of XMRV/MLVs; however, replicate sample results showed disagreement, and reactivity was similar among CFS subjects and negative controls. These results indicate that current assays do not reproducibly detect XMRV/MLV in blood samples and that blood donor screening is not warranted.	[Simmons, Graham; Tobler, Leslie H.; Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA 94118 USA; [Simmons, Graham; Tobler, Leslie H.; Busch, Michael P.] Univ Calif San Francisco, San Francisco, CA 94118 USA; [Glynn, Simone A.] NHLBI, Transfus Med & Cellular Therapeut Branch, NIH, Bethesda, MD 20892 USA; [Komaroff, Anthony L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Komaroff, Anthony L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Mikovits, Judy A.; Pfost, Max A.] Univ Nevada, Whittemore Peterson Inst, Reno, NV 89557 USA; [Hackett, John, Jr.; Tang, Ning] Abbott Labs, Abbott Pk, IL 60064 USA; [Switzer, William M.; Heneine, Walid] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; [Hewlett, Indira K.; Zhao, Jiangqin] US FDA, Off Blood Res, Rockville, MD 20852 USA; [Lo, Shyh-Ching] US FDA, Off Cellular Tissue & Gene Therapies Review, Bethesda, MD 20892 USA; [Alter, Harvey J.] NIH, Dept Transfus Med, Bethesda, MD 20892 USA; [Linnen, Jeffrey M.; Gao, Kui] Gen Probe, San Diego, CA 92121 USA; [Coffin, John M.] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Kearney, Mary F.; Ruscetti, Francis W.] NCI, Frederick, MD 21702 USA; [Bethel, James] WESTAT Corp, Rockville, MD 20850 USA; [Kleinman, Steven] Univ British Columbia, Dept Pathol, Victoria, BC V9A4W4, Canada; [Holmberg, Jerry A.] US Dept HHS, Rockville, MD 20852 USA	Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Nevada System of Higher Education (NSHE); University of Nevada Reno; Abbott Laboratories; Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; Tufts University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Westat; University of British Columbia	Busch, MP (corresponding author), Blood Syst Res Inst, San Francisco, CA 94118 USA.	mbusch@bloodsystems.org	Haleyur Giri Setty, Mohan Kumar/F-5841-2014; Simmons, Graham/G-3523-2012; Kearney, Mary/AAU-8132-2020	Haleyur Giri Setty, Mohan Kumar/0000-0001-6423-1420; Simmons, Graham/0000-0002-9615-7023; Kearney, Mary/0000-0003-3839-6576; Zhao, Jiangqin/0000-0003-4672-0735	National Heart, Lung, and Blood Institute REDS-II Central Laboratory [N01 HB-57181]; F. M. Kirby Foundation; NATIONAL CANCER INSTITUTE [ZIABC010252] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute REDS-II Central Laboratory; F. M. Kirby Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge the tremendous effort contributed by all Blood XMRV Scientific Research Working Group (SRWG) members; the roster of the SRWG is listed as supporting material on Science Online. The authors acknowledge the many laboratory members from all of the contributing laboratories, including I. Steffen, I. Wilson, L. Pitina, K. Murcia, P. Loanzon, S. Ng, and N. Gefter at the Blood Systems Research Institute; H. Zheng, H. Jia, S. Tang, and A. Shankar at CDC; C. Puccinelli, S. Rawat, A. McKenzie, K. Hagen, and D. T. Cramer at WPI; J. Carrick at Gen-Probe; D. Bertolette, Y. Huang, and C. Sadowski at NCI/Ruscetti; E. Anderson, J. Spindler, and A. Wiegand at DRP; K. Devadas, M. K. H. G. Setty, S. Tang, P. H. Zhang, and D. S. Gaddam in the Office of Blood Research and Review, FDA; B. Li, N. Pripuzova, and G.-C. Hung in the Office of Cellular, Tissue and Gene Therapies, FDA; R. Wang from the clinical center NIH; G. Leckie at Abbott Molecular; and X. Qiu at Abbott Diagnostics. The laboratory work was funded by the National Heart, Lung, and Blood Institute REDS-II Central Laboratory Contract to Blood Systems Research Institute (N01 HB-57181). J.M.C. was a research professor of the American Cancer Society with support from the F. M. Kirby Foundation. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the NIH, CDC, FDA, or the Department of Health and Human Services. M. P. B. is a member of the Scientific Advisory Board of Gen-Probe, which provides blood screening assays for pathogen nucleic acids. S. K. is a paid consultant to Novartis Diagnostics, a distributor of blood donor screening assays, and to Cerus Corporation, a manufacturer of pathogen inactivation systems for blood components. WPI has filed patent applications related to methods of testing XMRVs and variants in blood. Abbott Laboratories has filed patent applications relating to detection of XMRV by use of immunoassays and molecular-based assays. Gen-Probe has filed patent applications relating to the assays they performed in this paper.	COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Gray ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018096; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Katzourakis A, 2011, J VIROL; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Mikovits JA, 2010, VIRULENCE, V1, P386, DOI 10.4161/viru.1.5.12486; Onlamoon N, 2011, J VIROL, V85, P4547, DOI 10.1128/JVI.02411-10; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Qiu XX, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-68; Satterfield BC, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-12; Shin CH, 2011, J VIROL, V85, P7195, DOI 10.1128/JVI.00693-11; Simmons G, 2011, TRANSFUSION, V51, P643, DOI 10.1111/j.1537-2995.2011.03063.x; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-112; Tang SX, 2011, TRANSFUSION, V51, P463, DOI 10.1111/j.1537-2995.2010.02932.x; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Van Kuppeveld FJ, 2011, LANCET, DOI 10:1016/50140-67-36(11)60899-4	21	71	73	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 11	2011	334	6057					814	817		10.1126/science.1213841	http://dx.doi.org/10.1126/science.1213841			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845US	21940862	Green Accepted, Green Submitted			2022-12-28	WOS:000296849600049
J	Pellegrino, M; Steinbach, N; Stensmyr, MC; Hansson, BS; Vosshall, LB				Pellegrino, Maurizio; Steinbach, Nicole; Stensmyr, Marcus C.; Hansson, Bill S.; Vosshall, Leslie B.			A natural polymorphism alters odour and DEET sensitivity in an insect odorant receptor	NATURE			English	Article							AEDES-AEGYPTI; DROSOPHILA-MELANOGASTER; REPELLENT DEET; CELLULAR BASIS; MOSQUITOS; DIPTERA; SUPERFAMILY; ATTRACTION; INHIBITION; CULICIDAE	Blood-feeding insects such as mosquitoes are efficient vectors of human infectious diseases because they are strongly attracted by body heat, carbon dioxide and odours produced by their vertebrate hosts. Insect repellents containing DEET (N,N-diethyl-meta-toluamide) are highly effective, but the mechanism by which this chemical wards off biting insects remains controversial despite decades of investigation(1-11). DEET seems to act both at close range as a contact chemo-repellent, by affecting insect gustatory receptors(12), and at long range, by affecting the olfactory system(1-11). Two opposing mechanisms for the observed behavioural effects of DEET in the gas phase have been proposed: that DEET interferes with the olfactory system to block host odour recognition(1-7) and that DEET actively repels insects by activating olfactory neurons that elicit avoidance behaviour(8-11). Here we show that DEET functions as a modulator of the odour-gated ion channel formed by the insect odorant receptor complex(13,14). The functional insect odorant receptor complex consists of a common co-receptor, ORCO (ref. 15) (formerly called OR83B; ref. 16), and one or more variable odorant receptor subunits that confer odour selectivity(17). DEET acts on this complex to potentiate or inhibit odour-evoked activity or to inhibit odour-evoked suppression of spontaneous activity. This modulation depends on the specific odorant receptor and the concentration and identity of the odour ligand. We identify a single amino-acid polymorphism in the second transmembrane domain of receptor OR59B in a Drosophila melanogaster strain from Brazil that renders OR59B insensitive to inhibition by the odour ligand and modulation by DEET. Our data indicate that natural variation can modify the sensitivity of an odour-specific insect odorant receptor to odour ligands and DEET. Furthermore, they support the hypothesis that DEET acts as a molecular 'confusant' that scrambles the insect odour code, and provide a compelling explanation for the broad-spectrum efficacy of DEET against multiple insect species.	[Pellegrino, Maurizio; Steinbach, Nicole; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [Vosshall, Leslie B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Stensmyr, Marcus C.; Hansson, Bill S.] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, D-07745 Jena, Germany	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Max Planck Society	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave,Box 63, New York, NY 10065 USA.	leslie.vosshall@rockefeller.edu	Hansson, Bill/G-2774-2013	Hansson, Bill/0000-0002-4811-1223; Vosshall, Leslie/0000-0002-6060-8099; Stensmyr, Marcus/0000-0003-4009-9212	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; NIH [RO1 DC008600]; Max Planck Society; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008600] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck Society); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank C. Bargmann, K. Lee, K. Scott, L. Stowers and members of the Vosshall lab for discussion and comments on the manuscript; and K. Weniger for technical assistance with the SPME and GC-MS experiments. This work was funded in part by a grant to R. Axel and L. B. V. from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative and by a grant to L. B. V. from the NIH (RO1 DC008600). L. B. V. is an investigator of the Howard Hughes Medical Institute. M. C. S. and B. S. H. are supported by the Max Planck Society.	Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; DAVIS EE, 1976, J COMP PHYSIOL, V105, P43, DOI 10.1007/BF01380052; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Dogan EB, 1999, MED VET ENTOMOL, V13, P97, DOI 10.1046/j.1365-2915.1999.00145.x; Dogan EB, 1999, J MED ENTOMOL, V36, P788, DOI 10.1093/jmedent/36.6.788; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gross SP, 2003, CURR BIOL, V13, P1660, DOI 10.1016/j.cub.2003.08.032; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kline DL, 2003, J MED ENTOMOL, V40, P463, DOI 10.1603/0022-2585-40.4.463; Laish-Farkash A, 2010, J CARDIOVASC ELECTR, V21, P1365, DOI 10.1111/j.1540-8167.2010.01844.x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; MCIVER SB, 1981, J MED ENTOMOL, V18, P357, DOI 10.1093/jmedent/18.5.357; Menashe I, 2007, PLOS BIOL, V5, P2462, DOI 10.1371/journal.pbio.0050284; Nichols AS, 2010, J BIOL CHEM, V285, P11854, DOI 10.1074/jbc.M109.058321; Pellegrino Maurizio, 2010, J Vis Exp, P1, DOI 10.3791/1725; Reeder NL, 2001, J ECON ENTOMOL, V94, P1584, DOI 10.1603/0022-0493-94.6.1584; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107; Stensmyr MC, 2003, J EXP BIOL, V206, P715, DOI 10.1242/jeb.00143; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105	36	125	137	4	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2011	478	7370					511	U106		10.1038/nature10438	http://dx.doi.org/10.1038/nature10438			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	21937991	Green Accepted			2022-12-28	WOS:000296194200042
J	Gostin, LO				Gostin, Lawrence O.			Mandatory HPV Vaccination and Political Debate	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P630; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P626; Centers for Disease Control and Prevention (CDC), 2011, REP HLTH FOLL HPV VA; Dorell Christina, 2011, Morbidity and Mortality Weekly Report, V60, P1117; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Insinga RP, 2005, PHARMACOECONOMICS, V23, P1107, DOI 10.2165/00019053-200523110-00004; Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1; McGreal C, 2011, M BACHMANN HPV ROW P; National Cancer Institute, CERV CANC; National Conference of State Legislatures, 2011, HPV VACC STAT LEG ST	10	34	34	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2011	306	15					1699	1700		10.1001/jama.2011.1525	http://dx.doi.org/10.1001/jama.2011.1525			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834MA	21979129	Green Published			2022-12-28	WOS:000295963200029
J	Gaensler, BM; Haverkorn, M; Burkhart, B; Newton-McGee, KJ; Ekers, RD; Lazarian, A; McClure-Griffiths, NM; Robishaw, T; Dickey, JM; Green, AJ				Gaensler, B. M.; Haverkorn, M.; Burkhart, B.; Newton-McGee, K. J.; Ekers, R. D.; Lazarian, A.; McClure-Griffiths, N. M.; Robishaw, T.; Dickey, J. M.; Green, A. J.			Low-Mach-number turbulence in interstellar gas revealed by radio polarization gradients	NATURE			English	Article							GALACTIC PLANE SURVEY; H-ALPHA SURVEY; MAGNETOHYDRODYNAMIC TURBULENCE; DEPOLARIZATION CANALS; MHD TURBULENCE; DENSITY; SIMULATIONS; EMISSION; ISM; ANISOTROPY	The interstellar medium of the Milky Way is multiphase(1), magnetized(2) and turbulent(3). Turbulence in the interstellar medium produces a global cascade of random gas motions, spanning scales ranging from 100 parsecs to 1,000 kilometres (ref. 4). Fundamental parameters of interstellar turbulence such as the sonic Mach number (the speed of sound) have been difficult to determine, because observations have lacked the sensitivity and resolution to image the small-scale structure associated with turbulent motion(5-7). Observations of linear polarization and Faraday rotation in radio emission from the Milky Way have identified unusual polarized structures that often have no counterparts in the total radiation intensity or at other wavelengths(8-12), and whose physical significance has been unclear(13-15). Here we report that the gradient of the Stokes vector (Q, U), where Q and U are parameters describing the polarization state of radiation, provides an image of magnetized turbulence in diffuse, ionized gas, manifested as a complex filamentary web of discontinuities in gas density and magnetic field. Through comparison with simulations, we demonstrate that turbulence in the warm, ionized medium has a relatively low sonic Mach number, M-s less than or similar to 2. The development of statistical tools for the analysis of polarization gradients will allow accurate determinations of the Mach number, Reynolds number and magnetic field strength in interstellar turbulence over a wide range of conditions.	[Gaensler, B. M.; Newton-McGee, K. J.; Robishaw, T.; Green, A. J.] Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia; [Haverkorn, M.] ASTRON, NL-7991 PD Dwingeloo, Netherlands; [Haverkorn, M.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Haverkorn, M.] Radboud Univ Nijmegen, Dept Astrophys, IMAPP, NL-6500 GL Nijmegen, Netherlands; [Burkhart, B.; Lazarian, A.] Univ Wisconsin, Dept Astron, Madison, WI 53711 USA; [Newton-McGee, K. J.; Ekers, R. D.; McClure-Griffiths, N. M.] CSIRO Astron & Space Sci, Australia Telescope Natl Facil, Epping, NSW 1710, Australia; [Dickey, J. M.] Univ Tasmania, Sch Math & Phys, Hobart, Tas 7001, Australia	University of Sydney; Leiden University; Leiden University - Excl LUMC; Radboud University Nijmegen; University of Wisconsin System; University of Wisconsin Madison; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania	Gaensler, BM (corresponding author), Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia.	bryan.gaensler@sydney.edu.au	Robishaw, Timothy/B-2654-2014; Ekers, Ron/AAY-6012-2020; Gaensler, Bryan M/F-8655-2010; Dickey, John M/C-6156-2013	Robishaw, Timothy/0000-0002-4217-5138; Ekers, Ron/0000-0002-3532-9928; Dickey, John M/0000-0002-6300-7459; Green, Anne/0000-0002-9980-111X; McClure-Griffiths, Naomi/0000-0003-2730-957X; Gaensler, Bryan/0000-0002-3382-9558; Burkhart, Blakesley/0000-0001-5817-5944	Commonwealth of Australia; Australian Research Council [FF0561298, FL100100114, FS100100033]; National Science Foundation [AST0808118]; NASA Wisconsin Space Grant Institution; Center for Magnetic Self-Organization in Astrophysical and Laboratory Plasmas	Commonwealth of Australia(Australian Government); Australian Research Council(Australian Research Council); National Science Foundation(National Science Foundation (NSF)); NASA Wisconsin Space Grant Institution; Center for Magnetic Self-Organization in Astrophysical and Laboratory Plasmas	We thank S. Brown, A. Hill, R. Kissmann, A. MacFadyen, M.-M. Mac Low, E. Petroff, P. Slane and X. Sun for discussions. The Australia Telescope Compact Array is funded by the Commonwealth of Australia for operation as a National Facility managed by CSIRO. B. M. G. and T. R. acknowledge the support of the Australian Research Council through grants FF0561298, FL100100114 and FS100100033. B. B. acknowledges support from the National Science Foundation Graduate Research Fellowship and the NASA Wisconsin Space Grant Institution. A. L. acknowledges the support of the National Science Foundation through grant AST0808118 and of the Center for Magnetic Self-Organization in Astrophysical and Laboratory Plasmas. We thank the staff of the Australia Telescope National Facility, especially M. Calabretta, R. Haynes, D. McConnell, J. Reynolds, R. Sault, R. Wark and M. Wieringa, for their support of the Southern Galactic Plane Survey.	ARMSTRONG JW, 1995, ASTROPHYS J, V443, P209, DOI 10.1086/175515; Beresnyak A, 2005, ASTROPHYS J, V624, pL93, DOI 10.1086/430702; Burkhart B, 2010, ASTROPHYS J, V708, P1204, DOI 10.1088/0004-637X/708/2/1204; Burkhart B, 2009, ASTROPHYS J, V693, P250, DOI 10.1088/0004-637X/693/1/250; Chepurnov A, 2010, ASTROPHYS J, V710, P853, DOI 10.1088/0004-637X/710/1/853; Cho JY, 2003, MON NOT R ASTRON SOC, V345, P325, DOI 10.1046/j.1365-8711.2003.06941.x; de Avillez MA, 2005, ASTRON ASTROPHYS, V436, P585, DOI 10.1051/0004-6361:20042146; EYINK GL, 1995, J STAT PHYS, V78, P353, DOI 10.1007/BF02183353; Ferriere KM, 2001, REV MOD PHYS, V73, P1031, DOI 10.1103/RevModPhys.73.1031; Fletcher A, 2007, EAS PUBLICATIONS, V23, P109, DOI 10.1051/eas:2007008; Gaensler BM, 2008, PUBL ASTRON SOC AUST, V25, P184, DOI 10.1071/AS08004; Gaensler BM, 2001, ASTROPHYS J, V549, P959, DOI 10.1086/319468; Gaustad JE, 2001, PUBL ASTRON SOC PAC, V113, P1326, DOI 10.1086/323969; Gray AD, 1998, NATURE, V393, P660, DOI 10.1038/31413; Haverkorn H, 2000, ASTRON ASTROPHYS, V356, pL13; Haverkorn M, 2006, ASTROPHYS J SUPPL S, V167, P230, DOI 10.1086/508467; Haverkorn M, 2004, ASTRON ASTROPHYS, V421, P1011, DOI 10.1051/0004-6361:20034444; Hill AS, 2008, ASTROPHYS J, V686, P363, DOI 10.1086/590543; Kissmann R, 2008, MON NOT R ASTRON SOC, V391, P1577, DOI 10.1111/j.1365-2966.2008.13974.x; Kowal G, 2007, ASTROPHYS J, V658, P423, DOI 10.1086/511515; Kritsuk AG, 2007, ASTROPHYS J, V665, P416, DOI 10.1086/519443; Lemaster MN, 2009, ASTROPHYS J, V691, P1092, DOI 10.1088/0004-637X/691/2/1092; McClure-Griffiths NM, 2001, ASTROPHYS J, V551, P394, DOI 10.1086/320095; Newton-McGee K. J., 2009, THESIS U SYDNEY, P83; Parker QA, 2005, MON NOT R ASTRON SOC, V362, P689, DOI 10.1111/j.1365-2966.2005.09350.x; Ransom RR, 2008, ASTROPHYS J, V684, P1009, DOI 10.1086/590656; Shukurov A, 2003, MON NOT R ASTRON SOC, V342, P496, DOI 10.1046/j.1365-8711.2003.06582.x; Uyaniker B, 2002, ASTROPHYS J, V575, P225, DOI 10.1086/341266; WHITLEY D, 1994, STAT COMPUT, V4, P65, DOI 10.1007/BF00175354; WIERINGA MH, 1993, ASTRON ASTROPHYS, V268, P215	30	123	123	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2011	478	7368					214	217		10.1038/nature10446	http://dx.doi.org/10.1038/nature10446			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21976022	Green Published, Green Submitted			2022-12-28	WOS:000295782800043
J	Ehret, GB; Munroe, PB; Rice, KM; Bochud, M; Johnson, AD; Chasman, DI; Smith, AV; Tobin, MD; Verwoert, GC; Hwang, SJ; Pihur, V; Vollenweider, P; O'Reilly, PF; Amin, N; Bragg-Gresham, JL; Teumer, A; Glazer, NL; Launer, L; Zhao, JH; Aulchenko, Y; Heath, S; Sober, S; Parsa, A; Luan, JA; Arora, P; Dehghan, A; Zhang, F; Lucas, G; Hicks, AA; Jackson, AU; Peden, JF; Tanaka, T; Wild, SH; Rudan, I; Igl, W; Milaneschi, Y; Parker, AN; Fava, C; Chambers, JC; Fox, ER; Kumari, M; Go, MJ; van der Harst, P; Kao, WHL; Sjogren, M; Vinay, DG; Alexander, M; Tabara, Y; Shaw-Hawkins, S; Whincup, PH; Liu, YM; Shi, G; Kuusisto, J; Tayo, B; Seielstad, M; Sim, X; Nguyen, KDH; Lehtimaki, T; Matullo, G; Wu, Y; Gaunt, TR; Onland-Moret, NC; Cooper, MN; Platou, CGP; Org, E; Hardy, R; Dahgam, S; Palmen, J; Vitart, V; Braund, PS; Kuznetsova, T; Uiterwaal, CSPM; Adeyemo, A; Palmas, W; Campbell, H; Ludwig, B; Tomaszewski, M; Tzoulaki, I; Palmer, ND; Aspelund, T; Garcia, M; Chang, YPC; O'Connell, JR; Steinle, NI; Grobbee, DE; Arking, DE; Kardia, SL; Morrison, AC; Hernandez, D; Najjar, S; McArdle, WL; Hadley, D; Brown, MJ; Connell, JM; Hingorani, AD; Day, INM; Lawlor, DA; Beilby, JP; Lawrence, RW; Clarke, R; Hopewell, JC; Ongen, H; Dreisbach, AW; Li, YL; Young, JH; Bis, JC; Kahonen, M; Viikari, J; Adair, LS; Lee, NR; Chen, MH; Olden, M; Pattaro, C; Bolton, JAH; Kottgen, A; Bergmann, S; Mooser, V; Chaturvedi, N; Frayling, TM; Islam, M; Jafar, TH; Erdmann, J; Kulkarni, SR; Bornstein, SR; Grassler, J; Groop, L; Voight, BF; Kettunen, J; Howard, P; Taylor, A; Guarrera, S; Ricceri, F; Emilsson, V; Plump, A; Barroso, IS; Khaw, KT; Weder, AB; Hunt, SC; Sun, YV; Bergman, RN; Collins, FS; Bonnycastle, LL; Scott, LJ; Stringham, HM; Peltonen, L; Perola, M; Vartiainen, E; Brand, SM; Staessen, JA; Wang, TJ; Burton, PR; Artigas, MS; Dong, YB; Snieder, H; Wang, XL; Zhu, HD; Lohman, KK; Rudock, ME; Heckbert, SR; Smith, NL; Wiggins, KL; Doumatey, A; Shriner, D; Veldre, G; Viigimaa, M; Kinra, S; Prabhakaran, D; Tripathy, V; Langefeld, CD; Rosengren, A; Thelle, DS; Corsi, AM; Singleton, A; Forrester, T; Hilton, G; McKenzie, CA; Salako, T; Iwai, N; Kita, Y; Ogihara, T; Ohkubo, T; Okamura, T; Ueshima, H; Umemura, S; Eyheramendy, S; Meitinger, T; Wichmann, HE; Cho, YS; Kim, HL; Lee, JY; Scott, J; Sehmi, JS; Zhang, WH; Hedblad, B; Nilsson, P; Smith, GD; Wong, A; Narisu, N; Stancakova, A; Raffel, LJ; Yao, J; Kathiresan, S; O'Donnell, CJ; Schwartz, SM; Ikram, MA; Longstreth, WT; Mosley, TH; Seshadri, S; Shrine, NRG; Wain, LV; Morken, MA; Swift, AJ; Laitinen, J; Prokopenko, I; Zitting, P; Cooper, JA; Humphries, SE; Danesh, J; Rasheed, A; Goel, A; Hamsten, A; Watkins, H; Bakker, SJL; van Gilst, WH; Janipalli, CS; Mani, KR; Yajnik, CS; Hofman, A; Mattace-Raso, FUS; Oostra, BA; Demirkan, A; Isaacs, A; Rivadeneira, F; Lakatta, EG; Orru, M; Scuteri, A; Ala-Korpela, M; Kangas, AJ; Lyytikainen, LP; Soininen, P; Tukiainen, T; Wurtz, P; Ong, RTH; Dorr, M; Kroemer, HK; Volker, U; Volzke, H; Galan, P; Hercberg, S; Lathrop, M; Zelenika, D; Deloukas, P; Mangino, M; Spector, TD; Zhai, GJ; Meschia, JF; Nalls, MA; Sharma, P; Terzic, J; Kumar, MVK; Denniff, M; Zukowska-Szczechowska, E; Wagenknecht, LE; Fowkes, FGR; Charchar, FJ; Schwarz, PEH; Hayward, C; Guo, XQ; Rotimi, C; Bots, ML; Brand, E; Samani, NJ; Polasek, O; Talmud, PJ; Nyberg, F; Kuh, D; Laan, M; Hveem, K; Palmer, LJ; van der Schouw, YT; Casas, JP; Mohlke, KL; Vineis, P; Raitakari, O; Ganesh, SK; Wong, TY; Tai, ES; Cooper, RS; Laakso, M; Rao, DC; Harris, TB; Morris, RW; Dominiczak, AF; Kivimaki, M; Marmot, MG; Miki, T; Saleheen, D; Chandak, GR; Coresh, J; Navis, G; Salomaa, V; Han, BG; Zhu, XF; Kooner, JS; Melander, O; Ridker, PM; Bandinelli, S; Gyllensten, UB; Wright, AF; Wilson, JF; Ferrucci, L; Farrall, M; Tuomilehto, J; Pramstaller, PP; Elosua, R; Soranzo, N; Sijbrands, EJG; Altshuler, D; Loos, RJF; Shuldiner, AR; Gieger, C; Meneton, P; Uitterlinden, AG; Wareham, NJ; Gudnason, V; Rotter, JI; Rettig, R; Uda, M; Strachan, DP; Witteman, JCM; Hartikainen, AL; Beckmann, JS; Boerwinkle, E; Vasan, RS; Boehnke, M; Larson, MG; Jarvelin, MR; Psaty, BM; Abecasis, GR; Chakravarti, A; Elliott, P; van Duijn, CM; Newton-Cheh, C; Levy, D; Caulfield, MJ; Johnson, T				Ehret, Georg B.; Munroe, Patricia B.; Rice, Kenneth M.; Bochud, Murielle; Johnson, Andrew D.; Chasman, Daniel I.; Smith, Albert V.; Tobin, Martin D.; Verwoert, Germaine C.; Hwang, Shih-Jen; Pihur, Vasyl; Vollenweider, Peter; O'Reilly, Paul F.; Amin, Najaf; Bragg-Gresham, Jennifer L.; Teumer, Alexander; Glazer, Nicole L.; Launer, Lenore; Zhao, Jing Hua; Aulchenko, Yurii; Heath, Simon; Sober, Siim; Parsa, Afshin; Luan, Jian'an; Arora, Pankaj; Dehghan, Abbas; Zhang, Feng; Lucas, Gavin; Hicks, Andrew A.; Jackson, Anne U.; Peden, John F.; Tanaka, Toshiko; Wild, Sarah H.; Rudan, Igor; Igl, Wilmar; Milaneschi, Yuri; Parker, Alex N.; Fava, Cristiano; Chambers, John C.; Fox, Ervin R.; Kumari, Meena; Go, Min Jin; van der Harst, Pim; Kao, Wen Hong Linda; Sjogren, Marketa; Vinay, D. G.; Alexander, Myriam; Tabara, Yasuharu; Shaw-Hawkins, Sue; Whincup, Peter H.; Liu, Yongmei; Shi, Gang; Kuusisto, Johanna; Tayo, Bamidele; Seielstad, Mark; Sim, Xueling; Khanh-Dung Hoang Nguyen; Lehtimaki, Terho; Matullo, Giuseppe; Wu, Ying; Gaunt, Tom R.; Onland-Moret, N. Charlotte; Cooper, Matthew N.; Platou, Carl G. P.; Org, Elin; Hardy, Rebecca; Dahgam, Santosh; Palmen, Jutta; Vitart, Veronique; Braund, Peter S.; Kuznetsova, Tatiana; Uiterwaal, Cuno S. P. M.; Adeyemo, Adebowale; Palmas, Walter; Campbell, Harry; Ludwig, Barbara; Tomaszewski, Maciej; Tzoulaki, Ioanna; Palmer, Nicholette D.; Aspelund, Thor; Garcia, Melissa; Chang, Yen-Pei C.; O'Connell, Jeffrey R.; Steinle, Nanette I.; Grobbee, Diederick E.; Arking, Dan E.; Kardia, Sharon L.; Morrison, Alanna C.; Hernandez, Dena; Najjar, Samer; McArdle, Wendy L.; Hadley, David; Brown, Morris J.; Connell, John M.; Hingorani, Aroon D.; Day, Ian N. M.; Lawlor, Debbie A.; Beilby, John P.; Lawrence, Robert W.; Clarke, Robert; Hopewell, Jemma C.; Ongen, Halit; Dreisbach, Albert W.; Li, Yali; Young, J. Hunter; Bis, Joshua C.; Kahonen, Mika; Viikari, Jorma; Adair, Linda S.; Lee, Nanette R.; Chen, Ming-Huei; Olden, Matthias; Pattaro, Cristian; Bolton, Judith A. Hoffman; Koettgen, Anna; Bergmann, Sven; Mooser, Vincent; Chaturvedi, Nish; Frayling, Timothy M.; Islam, Muhammad; Jafar, Tazeen H.; Erdmann, Jeanette; Kulkarni, Smita R.; Bornstein, Stefan R.; Graessler, Juergen; Groop, Leif; Voight, Benjamin F.; Kettunen, Johannes; Howard, Philip; Taylor, Andrew; Guarrera, Simonetta; Ricceri, Fulvio; Emilsson, Valur; Plump, Andrew; Barroso, Ine S.; Khaw, Kay-Tee; Weder, Alan B.; Hunt, Steven C.; Sun, Yan V.; Bergman, Richard N.; Collins, Francis S.; Bonnycastle, Lori L.; Scott, Laura J.; Stringham, Heather M.; Peltonen, Leena; Perola, Markus; Vartiainen, Erkki; Brand, Stefan-Martin; Staessen, Jan A.; Wang, Thomas J.; Burton, Paul R.; Artigas, Maria Soler; Dong, Yanbin; Snieder, Harold; Wang, Xiaoling; Zhu, Haidong; Lohman, Kurt K.; Rudock, Megan E.; Heckbert, Susan R.; Smith, Nicholas L.; Wiggins, Kerri L.; Doumatey, Ayo; Shriner, Daniel; Veldre, Gudrun; Viigimaa, Margus; Kinra, Sanjay; Prabhakaran, Dorairaj; Tripathy, Vikal; Langefeld, Carl D.; Rosengren, Annika; Thelle, Dag S.; Corsi, Anna Maria; Singleton, Andrew; Forrester, Terrence; Hilton, Gina; McKenzie, Colin A.; Salako, Tunde; Iwai, Naoharu; Kita, Yoshikuni; Ogihara, Toshio; Ohkubo, Takayoshi; Okamura, Tomonori; Ueshima, Hirotsugu; Umemura, Satoshi; Eyheramendy, Susana; Meitinger, Thomas; Wichmann, H. -Erich; Cho, Yoon Shin; Kim, Hyung-Lae; Lee, Jong-Young; Scott, James; Sehmi, Joban S.; Zhang, Weihua; Hedblad, Bo; Nilsson, Peter; Smith, George Davey; Wong, Andrew; Narisu, Narisu; Stancakova, Alena; Raffel, Leslie J.; Yao, Jie; Kathiresan, Sekar; O'Donnell, Christopher J.; Schwartz, Stephen M.; Ikram, M. Arfan; Longstreth, W. T., Jr.; Mosley, Thomas H.; Seshadri, Sudha; Shrine, Nick R. G.; Wain, Louise V.; Morken, Mario A.; Swift, Amy J.; Laitinen, Jaana; Prokopenko, Inga; Zitting, Paavo; Cooper, Jackie A.; Humphries, Steve E.; Danesh, John; Rasheed, Asif; Goel, Anuj; Hamsten, Anders; Watkins, Hugh; Bakker, Stephan J. L.; van Gilst, Wiek H.; Janipalli, Charles S.; Mani, K. Radha; Yajnik, Chittaranjan S.; Hofman, Albert; Mattace-Raso, Francesco U. S.; Oostra, Ben A.; Demirkan, Ayse; Isaacs, Aaron; Rivadeneira, Fernando; Lakatta, Edward G.; Orru, Marco; Scuteri, Angelo; Ala-Korpela, Mika; Kangas, Antti J.; Lyytikainen, Leo-Pekka; Soininen, Pasi; Tukiainen, Taru; Wurtz, Peter; Ong, Rick Twee-Hee; Doerr, Marcus; Kroemer, Heyo K.; Voelker, Uwe; Voelzke, Henry; Galan, Pilar; Hercberg, Serge; Lathrop, Mark; Zelenika, Diana; Deloukas, Panos; Mangino, Massimo; Spector, Tim D.; Zhai, Guangju; Meschia, James F.; Nalls, Michael A.; Sharma, Pankaj; Terzic, Janos; Kumar, M. V. Kranthi; Denniff, Matthew; Zukowska-Szczechowska, Ewa; Wagenknecht, Lynne E.; Fowkes, F. Gerald R.; Charchar, Fadi J.; Schwarz, Peter E. H.; Hayward, Caroline; Guo, Xiuqing; Rotimi, Charles; Bots, Michiel L.; Brand, Eva; Samani, Nilesh J.; Polasek, Ozren; Talmud, Philippa J.; Nyberg, Fredrik; Kuh, Diana; Laan, Maris; Hveem, Kristian; Palmer, Lyle J.; van der Schouw, Yvonne T.; Casas, Juan P.; Mohlke, Karen L.; Vineis, Paolo; Raitakari, Olli; Ganesh, Santhi K.; Wong, Tien Y.; Tai, E. Shyong; Cooper, Richard S.; Laakso, Markku; Rao, Dabeeru C.; Harris, Tamara B.; Morris, Richard W.; Dominiczak, Anna F.; Kivimaki, Mika; Marmot, Michael G.; Miki, Tetsuro; Saleheen, Danish; Chandak, Giriraj R.; Coresh, Josef; Navis, Gerjan; Salomaa, Veikko; Han, Bok-Ghee; Zhu, Xiaofeng; Kooner, Jaspal S.; Melander, Olle; Ridker, Paul M.; Bandinelli, Stefania; Gyllensten, Ulf B.; Wright, Alan F.; Wilson, James F.; Ferrucci, Luigi; Farrall, Martin; Tuomilehto, Jaakko; Pramstaller, Peter P.; Elosua, Roberto; Soranzo, Nicole; Sijbrands, Eric J. G.; Altshuler, David; Loos, Ruth J. F.; Shuldiner, Alan R.; Gieger, Christian; Meneton, Pierre; Uitterlinden, Andre G.; Wareham, Nicholas J.; Gudnason, Vilmundur; Rotter, Jerome I.; Rettig, Rainer; Uda, Manuela; Strachan, David P.; Witteman, Jacqueline C. M.; Hartikainen, Anna-Liisa; Beckmann, Jacques S.; Boerwinkle, Eric; Vasan, Ramachandran S.; Boehnke, Michael; Larson, Martin G.; Jarvelin, Marjo-Riitta; Psaty, Bruce M.; Abecasis, Goncalo R.; Chakravarti, Aravinda; Elliott, Paul; van Duijn, Cornelia M.; Newton-Cheh, Christopher; Levy, Daniel; Caulfield, Mark J.; Johnson, Toby		Int Consortium Blood Pressure Geno; CARDIoGRAM Consortium; CKDGen Consortium; KidneyGen Consortium; EchoGen Consortium; CHARGE-HF Consortium	Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk	NATURE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; HYPERTENSION; LOCI; METAANALYSIS; POPULATION; CLONING; HEALTH	Blood pressure is a heritable trait(1) influenced by several biological pathways and responsive to environmental stimuli. Over one billion people worldwide have hypertension (>= 140 mm Hg systolic blood pressure or >= 90 mm Hg diastolic blood pressure)(2). Even small increments in blood pressure are associated with an increased risk of cardiovascular events(3). This genome-wide association study of systolic and diastolic blood pressure, which used a multi-stage design in 200,000 individuals of European descent, identified sixteen novel loci: six of these loci contain genes previously known or suspected to regulate blood pressure (GUCY1A3-GUCY1B3, NPR3-C5orf23, ADM, FURIN-FES, GOSR2, GNAS-EDN3); the other ten provide new clues to blood pressure physiology. A genetic risk score based on 29 genome-wide significant variants was associated with hypertension, left ventricular wall thickness, stroke and coronary artery disease, but not kidney disease or kidney function. We also observed associations with blood pressure in East Asian, South Asian and African ancestry individuals. Our findings provide new insights into the genetics and biology of blood pressure, and suggest potential novel therapeutic pathways for cardiovascular disease prevention.	[Ehret, Georg B.; Pihur, Vasyl; Khanh-Dung Hoang Nguyen; Arking, Dan E.; Hilton, Gina; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD 21205 USA; [Ehret, Georg B.; Bochud, Murielle] CHU Vaudois, Inst Social & Prevent Med IUMSP, CH-1005 Lausanne, Switzerland; [Ehret, Georg B.; Bochud, Murielle] Univ Lausanne, CH-1005 Lausanne, Switzerland; [Ehret, Georg B.] Univ Hosp Geneva, Dept Specialties Internal Med, CH-1211 Geneva 14, Switzerland; [Munroe, Patricia B.; Shaw-Hawkins, Sue; Caulfield, Mark J.; Johnson, Toby] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Genome Ctr, London EC1M 6BQ, England; [Rice, Kenneth M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Johnson, Andrew D.; Hwang, Shih-Jen; Wang, Thomas J.; Vasan, Ramachandran S.; Larson, Martin G.; Levy, Daniel] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; [Johnson, Andrew D.; Hwang, Shih-Jen; Levy, Daniel] NHLBI, Bethesda, MD 20824 USA; [Chasman, Daniel I.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Smith, Albert V.; Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, IS-101 Reykajvik, Iceland; [Smith, Albert V.; Aspelund, Thor; Gudnason, Vilmundur] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Tobin, Martin D.; Burton, Paul R.; Artigas, Maria Soler; Shrine, Nick R. G.; Wain, Louise V.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Verwoert, Germaine C.; Amin, Najaf; Aulchenko, Yurii; Dehghan, Abbas; Ikram, M. Arfan; Hofman, Albert; Mattace-Raso, Francesco U. S.; Demirkan, Ayse; Isaacs, Aaron; Rivadeneira, Fernando; Sijbrands, Eric J. G.; Uitterlinden, Andre G.; Witteman, Jacqueline C. M.; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Verwoert, Germaine C.; Dehghan, Abbas; Mattace-Raso, Francesco U. S.; Rivadeneira, Fernando; Sijbrands, Eric J. G.; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Verwoert, Germaine C.; Dehghan, Abbas; Ikram, M. Arfan; Uitterlinden, Andre G.; Witteman, Jacqueline C. M.] NGI, NCHA, NL-3000 CA Rotterdam, Netherlands; [Hwang, Shih-Jen; Levy, Daniel] NHLBI, Ctr Populat Studies, Bethesda, MD 20824 USA; [Vollenweider, Peter] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland; [O'Reilly, Paul F.; Chambers, John C.; Zhang, Weihua; Wurtz, Peter; Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London W2 1PG, England; [Bragg-Gresham, Jennifer L.; Abecasis, Goncalo R.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48103 USA; [Teumer, Alexander; Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, D-17487 Greifswald, Germany; [Glazer, Nicole L.; Bis, Joshua C.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Glazer, Nicole L.; Bis, Joshua C.; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Glazer, Nicole L.; Bis, Joshua C.; Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Launer, Lenore; Garcia, Melissa; Harris, Tamara B.] NIA, Lab Epidemiol, NIH, Bethesda, MD 20892 USA; [Zhao, Jing Hua; Luan, Jian'an; Loos, Ruth J. F.; Wareham, Nicholas J.] Inst Metab Sci, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Heath, Simon; Lathrop, Mark; Zelenika, Diana] Commiss Energie Atom, Inst Genom, Ctr Natl Genotypage, F-91057 Evry, France; [Sober, Siim; Org, Elin; Veldre, Gudrun; Laan, Maris] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Parsa, Afshin; Chang, Yen-Pei C.; O'Connell, Jeffrey R.; Steinle, Nanette I.; Shuldiner, Alan R.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Arora, Pankaj; Kathiresan, Sekar; O'Donnell, Christopher J.; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Ctr Human Genet Res, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Zhang, Feng; Mangino, Massimo; Spector, Tim D.; Zhai, Guangju; Soranzo, Nicole] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Lucas, Gavin; Elosua, Roberto] Inst Municipal Invest Med, E-08003 Barcelona, Spain; [Hicks, Andrew A.; Pattaro, Cristian; Pramstaller, Peter P.] European Acad Bozen Bolzano EURAC, Inst Med Genet, Bolzano, Italy; [Hicks, Andrew A.; Pattaro, Cristian; Pramstaller, Peter P.] Univ Lubeck, Affiliated Inst, Lubeck, Germany; [Jackson, Anne U.; Scott, Laura J.; Stringham, Heather M.; Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA; [Peden, John F.; Ongen, Halit; Goel, Anuj; Watkins, Hugh; Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford OX3 7BN, England; [Tanaka, Toshiko; Milaneschi, Yuri; Ferrucci, Luigi] NIA, Clin Res Branch, Baltimore, MD 21250 USA; [Wild, Sarah H.; Rudan, Igor; Campbell, Harry; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Rudan, Igor; Campbell, Harry] Univ Edinburgh, Coll Med & Vet Med, Inst Genet & Mol Med, Edinburgh EH8 9AG, Midlothian, Scotland; [Rudan, Igor] Univ Split, Croatian Ctr Global Hlth, Split 21000, Croatia; [Igl, Wilmar; Gyllensten, Ulf B.] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; [Parker, Alex N.] Amgen Inc, Cambridge, MA 02139 USA; [Fava, Cristiano; Sjogren, Marketa; Hedblad, Bo; Nilsson, Peter; Melander, Olle] Lund Univ, Dept Clin Sci, S-20502 Malmo, Sweden; [Fava, Cristiano] Univ Verona, Dept Med, I-37134 Verona, Italy; [Chambers, John C.; Sehmi, Joban S.; Kooner, Jaspal S.] Ealing Gen Hosp, London UB1 3HJ, England; [Fox, Ervin R.; Dreisbach, Albert W.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Kumari, Meena; Taylor, Andrew] UCL, Genet Epidemiol Grp, London WC1E 6BT, England; [Go, Min Jin; Cho, Yoon Shin; Kim, Hyung-Lae; Lee, Jong-Young; Han, Bok-Ghee] Natl Inst Hlth, Ctr Genome Sci, Seoul 122701, South Korea; [van der Harst, Pim; van Gilst, Wiek H.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9713 GZ Groningen, Netherlands; [Kao, Wen Hong Linda; Bolton, Judith A. Hoffman; Koettgen, Anna; Coresh, Josef] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD 21205 USA; [Kao, Wen Hong Linda; Young, J. Hunter; Coresh, Josef] Johns Hopkins Univ, Dept Med, Baltimore, MD 21205 USA; [Vinay, D. G.; Janipalli, Charles S.; Mani, K. Radha; Kumar, M. V. Kranthi; Chandak, Giriraj R.] CSIR, CCMB, Hyderabad 500007, Andhra Pradesh, India; [Alexander, Myriam; Khaw, Kay-Tee; Danesh, John; Saleheen, Danish] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Tabara, Yasuharu; Miki, Tetsuro] Ehime Univ, Grad Sch Med, Dept Basic Med Res, Toon 7910295, Japan; [Tabara, Yasuharu; Miki, Tetsuro] Ehime Univ, Grad Sch Med, Dept Geriatr Med, Toon 7910295, Japan; [Whincup, Peter H.; Hadley, David; Strachan, David P.] St Georges Univ London, Div Community Hlth Sci, London SW17 0RE, England; [Liu, Yongmei; Rudock, Megan E.; Prokopenko, Inga] Wake Forest Univ, Bowman Gray Sch Med, Div Publ Hlth Sci, Winston Salem, NC 27157 USA; [Shi, Gang] Washington Univ St Louis, Sch Med, Div Biostat, St Louis, MO USA; [Shi, Gang] Washington Univ St Louis, Sch Med, Dept Genet, St Louis, MO USA; [Kuusisto, Johanna; Stancakova, Alena; Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio 70210, Finland; [Kuusisto, Johanna; Stancakova, Alena; Laakso, Markku] Kuopio Univ Hosp, Kuopio 70210, Finland; [Tayo, Bamidele; Cooper, Richard S.] Loyola Univ, Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA; [Seielstad, Mark] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Seielstad, Mark] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Seielstad, Mark; Ong, Rick Twee-Hee] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore; [Sim, Xueling; Ong, Rick Twee-Hee; Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Mol Epidemiol, Singapore 117597, Singapore; [Lehtimaki, Terho; Lyytikainen, Leo-Pekka] Univ Tampere, Dept Clin Chem, Tampere 33521, Finland; [Lehtimaki, Terho; Kahonen, Mika; Lyytikainen, Leo-Pekka] Tampere Univ Hosp, Tampere 33521, Finland; [Matullo, Giuseppe; Ricceri, Fulvio] Univ Turin, Dept Genet Biol & Biochem, I-10126 Turin, Italy; [Matullo, Giuseppe; Guarrera, Simonetta; Ricceri, Fulvio; Vineis, Paolo] Human Genet Fdn HUGEF, I-10126 Turin, Italy; [Wu, Ying; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Gaunt, Tom R.; Day, Ian N. M.; Lawlor, Debbie A.; Smith, George Davey] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Onland-Moret, N. Charlotte; Uiterwaal, Cuno S. P. M.; Grobbee, Diederick E.; Bots, Michiel L.; van der Schouw, Yvonne T.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Onland-Moret, N. Charlotte] Univ Med Ctr Utrecht, Dept Med Genet DBG, Complex Genet Sect, NL-3508 GA Utrecht, Netherlands; [Cooper, Matthew N.; Lawrence, Robert W.] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Crawley, WA 6009, Australia; [Platou, Carl G. P.; Hveem, Kristian] Norwegian Univ Sci & Technol, HUNT Res Ctr, Dept Publ Hlth & Gen Practice, N-7600 Levanger, Norway; [Hardy, Rebecca; Wong, Andrew; Kuh, Diana] MRC Unit Lifelong Hlth & Ageing, London WC1B 5JU, England; [Dahgam, Santosh; Nyberg, Fredrik] Univ Gothenburg, Dept Publ Hlth & Community Med, Inst Med, Sahlgrenska Acad, S-40530 Gothenburg, Sweden; [Palmen, Jutta; Cooper, Jackie A.; Humphries, Steve E.; Talmud, Philippa J.] UCL, Ctr Cardiovasc Genet, London WC1E 6JF, England; [Vitart, Veronique; Hayward, Caroline; Wright, Alan F.] MRC Human Genet Unit, Edinburgh EH2, Midlothian, Scotland; [Vitart, Veronique; Hayward, Caroline; Wright, Alan F.] Inst Genet & Mol Med, Edinburgh EH2, Midlothian, Scotland; [Braund, Peter S.; Tomaszewski, Maciej; Denniff, Matthew; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Braund, Peter S.; Tomaszewski, Maciej; Burton, Paul R.; Samani, Nilesh J.] Glenfield Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Kuznetsova, Tatiana; Staessen, Jan A.] Univ Leuven, Studies Coordinating Ctr, Div Hypertens & Cardiac Rehabil, Dept Cardiovasc Dis, B-3000 Louvain, Belgium; [Adeyemo, Adebowale; Doumatey, Ayo; Shriner, Daniel; Rotimi, Charles] Natl Human Genome Res Inst, Ctr Res Genom & Global Hlth, New York, NY 10027 USA; [Palmas, Walter] Columbia Univ, New York, NY 10027 USA; [Ludwig, Barbara; Bornstein, Stefan R.; Graessler, Juergen] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Med 3, D-01307 Dresden, Germany; [Tzoulaki, Ioanna] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London W2 1PG, England; [Tzoulaki, Ioanna] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece; [Palmer, Nicholette D.; Langefeld, Carl D.; Wagenknecht, Lynne E.] Wake Forest Univ Hlth Sci, Winston Salem, NC 27157 USA; [Kardia, Sharon L.; Sun, Yan V.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Morrison, Alanna C.] Univ Texas Houston Hlth Sci Ctr, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Hernandez, Dena; Singleton, Andrew; Nalls, Michael A.] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Najjar, Samer] NIA, Cardiovasc Sci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Najjar, Samer] Washington Hosp Ctr, Div Cardiol, Washington, DC 20010 USA; [McArdle, Wendy L.] Univ Bristol, ALSPAC Lab, Bristol BS8 2BN, Avon, England; [Hadley, David] Univ S Florida, Pediat Epidemiol Ctr, Tampa, FL 33612 USA; [Brown, Morris J.] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; [Connell, John M.] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; [Hingorani, Aroon D.] UCL, Genet Epidemiol Grp, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Beilby, John P.] PathW Lab Med, Mol Genet, Nedlands, WA 6009, Australia; [Clarke, Robert; Hopewell, Jemma C.] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Clarke, Robert; Hopewell, Jemma C.] Univ Oxford, Epidemiol Studies Unit, Oxford OX3 7LF, England; [Li, Yali; Zhu, Xiaofeng] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, Tampere 33521, Finland; [Viikari, Jorma] Univ Turku, Dept Med, Turku 20521, Finland; [Viikari, Jorma] Turku Univ Hosp, Turku 20521, Finland; [Adair, Linda S.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Lee, Nanette R.] Univ San Carlos, Off Populat Studies Fdn, Cebu 6000, Philippines; [Chen, Ming-Huei] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Chen, Ming-Huei] Boston Univ, Sch Med, Framingham Heart Study, Boston, MA 02118 USA; [Olden, Matthias] Univ Med Ctr Regensburg, Dept Internal Med 2, D-93053 Regensburg, Germany; [Olden, Matthias] Univ Med Ctr Regensburg, Dept Epidemiol & Prevent Med, D-93053 Regensburg, Germany; [Koettgen, Anna] Univ Hosp Freiburg, Div Renal, D-79095 Freiburg, Germany; [Bergmann, Sven; Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, CH-1015 Lausanne, Switzerland; [Bergmann, Sven] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Mooser, Vincent] GlaxoSmithKline, Div Genet, Philadelphia, PA 19101 USA; [Chaturvedi, Nish] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London SW7 2AZ, England; [Frayling, Timothy M.] Univ Exeter, Peninsula Med Sch, Exeter EX4 4QJ, Devon, England; [Islam, Muhammad; Jafar, Tazeen H.] Aga Khan Univ, Dept Community Hlth Sci, Karachi 74800, Pakistan; [Islam, Muhammad; Jafar, Tazeen H.] Aga Khan Univ, Dept Med, Karachi 74800, Pakistan; [Erdmann, Jeanette] Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Kulkarni, Smita R.; Yajnik, Chittaranjan S.] KEM Hosp & Res Ctr, Diabet Unit, Pune 411011, Maharashtra, India; [Groop, Leif] Univ Hosp, Diabet & Endocrinol Res Unit, Dept Clin Sci, S-20502 Malmo, Sweden; [Groop, Leif] Lund Univ, S-20502 Malmo, Sweden; [Voight, Benjamin F.; Altshuler, David; Newton-Cheh, Christopher] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02139 USA; [Kettunen, Johannes] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki 00251, Finland; [Kettunen, Johannes; Peltonen, Leena] Biomedicum, Inst Mol Med, FIMM, Helsinki 00251, Finland; [Howard, Philip] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Emilsson, Valur; Plump, Andrew] Merck Res Lab, Rahway, NJ 07065 USA; [Barroso, Ine S.; Peltonen, Leena; Deloukas, Panos; Soranzo, Nicole] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, S Cambs, England; [Barroso, Ine S.] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 OQQ, England; [Weder, Alan B.] Univ Michigan, Sch Med, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Hunt, Steven C.] Univ Utah, Sch Med, Salt Lake City, UT 84132 USA; [Bergman, Richard N.] Univ So Calif, Keck Sch Med, Dept Phys & Biophys, Los Angeles, CA 90033 USA; [Collins, Francis S.; Bonnycastle, Lori L.; Narisu, Narisu; Morken, Mario A.; Swift, Amy J.] NHGRI, NIH, Bethesda, MD 20892 USA; [Peltonen, Leena; Perola, Markus; Vartiainen, Erkki; Salomaa, Veikko] Natl Inst Hlth & Welf, Helsinki 00271, Finland; [Peltonen, Leena] Broad Inst, Cambridge, MA 02142 USA; [Brand, Stefan-Martin] Univ Munster, Dept Mol Genet Cardiovasc Dis, Leibniz Inst Arteriosclerosis Res, D-48149 Munster, Germany; [Brand, Stefan-Martin] Univ Munster, Fac Med, Dept Mol Genet Cardiovasc Dis, D-48149 Munster, Germany; [Wang, Thomas J.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Dong, Yanbin; Snieder, Harold; Wang, Xiaoling; Zhu, Haidong] Med Coll Georgia, Dept Pediat, Georgia Prevent Inst, Augusta, GA 30912 USA; [Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Unit Genet Epidemiol & Bioinformat, Dept Epidemiol, NL-9713 GZ Groningen, Netherlands; [Lohman, Kurt K.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Div Publ Hlth Sci, Winston Salem, NC 27157 USA; [Heckbert, Susan R.; Smith, Nicholas L.; Schwartz, Stephen M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Heckbert, Susan R.; Smith, Nicholas L.; Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98124 USA; [Smith, Nicholas L.] Vet Hlth Adm Off Res & Dev, Seattle Epidemiol Res & Informat Ctr, Seattle, WA 98108 USA; [Wiggins, Kerri L.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Veldre, Gudrun] Univ Tartu, Dept Cardiol, EE-51014 Tartu, Estonia; [Viigimaa, Margus] Tallinn Univ Technol, Inst Biomed Engn, EE-19086 Tallinn, Estonia; [Viigimaa, Margus] N Estonia Med Ctr, Ctr Cardiol, EE-13419 Tallinn, Estonia; [Kinra, Sanjay] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Prabhakaran, Dorairaj; Tripathy, Vikal] Publ Hlth Fdn India, S Asia Network Chron Dis, New Delhi 100016, India; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Emergency & Cardiovasc Med, S-41685 Gothenburg, Sweden; [Thelle, Dag S.] Univ Oslo, Inst Basic Med Sci, Dept Biostat, N-0317 Oslo, Norway; [Corsi, Anna Maria] Tuscany Reg Hlth Agcy, I-50129 Florence, Italy; [Forrester, Terrence; McKenzie, Colin A.] Univ W Indies, Res Inst Trop Med, Kingston 7, Jamaica; [Salako, Tunde] Univ Ibadan, Ibadan, Nigeria; [Iwai, Naoharu; Okamura, Tomonori] Natl Cerebral & Cardiovasc Res Ctr, Dept Genom Med, Suita, Osaka 5658565, Japan; [Iwai, Naoharu; Okamura, Tomonori] Natl Cerebral & Cardiovasc Res Ctr, Dept Prevent Cardiol, Suita, Osaka 5658565, Japan; [Kita, Yoshikuni; Ohkubo, Takayoshi; Okamura, Tomonori; Ueshima, Hirotsugu] Shiga Univ Med Sci, Dept Hlth Sci, Otsu, Shiga 5202192, Japan; [Ogihara, Toshio] Osaka Univ, Grad Sch Med, Dept Geriatr Med, Suita, Osaka 5650871, Japan; [Ohkubo, Takayoshi] Tohoku Univ, Grad Sch Pharmaceut Sci & Med, Sendai, Miyagi 9808578, Japan; [Ueshima, Hirotsugu] Shiga Univ Med Sci, Lifestyle Related Dis Prevent Ctr, Otsu, Shiga 5202192, Japan; [Umemura, Satoshi] Yokohama City Univ, Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 2360004, Japan; [Eyheramendy, Susana] Pontificia Univ Catolica Chile, Dept Stat, Santiago, Chile; [Meitinger, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Human Genet, D-85764 Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-81675 Munich, Germany; [Wichmann, H. -Erich; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Epidemiol, D-85764 Neuherberg, Germany; [Wichmann, H. -Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, D-81377 Munich, Germany; [Wichmann, H. -Erich] Klinikum Grosshadern, D-81377 Munich, Germany; [Scott, James; Sehmi, Joban S.; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London W12 0HS, England; [Raffel, Leslie J.; Yao, Jie; Guo, Xiuqing; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Kathiresan, Sekar] Broad Inst Harvard & MIT, Cambridge Ctr 5, Cambridge, MA 02142 USA; [O'Donnell, Christopher J.] NHLBI, Framingham, MA 01702 USA; [O'Donnell, Christopher J.] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; [Longstreth, W. T., Jr.] Univ Washington, Dept Neurol & Med, Seattle, WA 98195 USA; [Mosley, Thomas H.] Univ Mississippi, Med Ctr, Dept Geriatr Med, Jackson, MS 39216 USA; [Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Oulu 90220, Finland; [Prokopenko, Inga] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Zitting, Paavo] Lapland Cent Hosp, Dept Physiatr, Rovaniemi 96101, Finland; [Rasheed, Asif; Saleheen, Danish] Ctr Noncommunicable Dis, Karachi 74800, Pakistan; [Hamsten, Anders] Karolinska Inst, Dept Med, Atherosclerosis Res Unit, S-17177 Stockholm, Sweden; [Oostra, Ben A.] Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Lakatta, Edward G.; Scuteri, Angelo] NIA, Gerontol Res Ctr, Baltimore, MD 21224 USA; [Orru, Marco; Uda, Manuela] CNR, Ist Neurogenet & Neurofarmacol, I-09042 Cagliari, Italy; [Orru, Marco] Presidio Osped Santa Barbara, Div Med, Unita Operat Semplice Cardiol, I-09016 Iglesias, Italy; [Ala-Korpela, Mika; Kangas, Antti J.; Soininen, Pasi; Tukiainen, Taru; Wurtz, Peter] Univ Oulu, Inst Clin Med, Computat Med Res Grp, Oulu, Finland; [Ala-Korpela, Mika] 90014 Univ Oulu, Bioctr Oulu, Clin Res Ctr, Oulu, Finland; [Ala-Korpela, Mika; Soininen, Pasi] Univ Eastern Finland, Dept Biosci, NMR Metabon Lab, Kuopio 70211, Finland; [Ala-Korpela, Mika] 90014 Univ Oulu, Dept Internal Med, Oulu, Finland; [Tukiainen, Taru; Wurtz, Peter] 00014 Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Tukiainen, Taru] Aalto Univ, Dept Biomed Engn & Computat Sci, Sch Sci & Technol, Espoo 00076, Finland; [Ong, Rick Twee-Hee] NUS Grad Sch Integrat Sci & Engn NGS, Ctr Life Sci CeLS, Singapore 117456, Singapore; [Doerr, Marcus] Ernst Moritz Arndt Univ Greifswald, Dept Internal Med B, D-17487 Greifswald, Germany; [Kroemer, Heyo K.] Ernst Moritz Arndt Univ Greifswald, Inst Pharmacol, D-17487 Greifswald, Germany; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, D-17487 Greifswald, Germany; [Galan, Pilar; Hercberg, Serge] Univ Paris 13, Inst Natl Rech Agron U1125, Inst Natl Sante & Rech Med U557, F-93017 Bobigny, France; [Meschia, James F.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Sharma, Pankaj] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Cerebrovasc Unit ICCRU, London W6 8RF, England; [Terzic, Janos] Univ Split, Fac Med, Split 21000, Croatia; [Zukowska-Szczechowska, Ewa] Med Univ Silesia, Dept Internal Med Diabetol & Nephrol, PL-41800 Zabrze, Poland; [Fowkes, F. Gerald R.] Univ Edinburgh, Sch Med, Div Community Hlth Sci, Publ Hlth Sci Sect, Edinburgh EH8 9AG, Midlothian, Scotland; [Charchar, Fadi J.] Univ Ballarat, Sch Sci & Engn, Ballarat, Vic 3353, Australia; [Schwarz, Peter E. H.] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Med 3, D-01307 Dresden, Germany; [Brand, Eva] Univ Hosp Munster, Munster, Germany; [Polasek, Ozren] Univ Zagreb, Andrija Stampar Sch Publ Hlth, Dept Med Stat Epidemiol & Med Informat, Zagreb 10000, Croatia; [Nyberg, Fredrik] AstraZeneca R&D, S-43183 Molndal, Sweden; [Palmer, Lyle J.] Ontario Inst Canc Res, Toronto, ON M5G 1L7, Canada; [Palmer, Lyle J.] Univ Toronto, Samuel Lunenfeld Inst Med Res, Toronto, ON M5S 1A1, Canada; [Casas, Juan P.] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Population Hlth, London WC1E 7HT, England; [Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku 20521, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol, Turku 20521, Finland; [Ganesh, Santhi K.] Univ Michigan, Med Ctr, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Wong, Tien Y.] Singapore Eye Res Inst, Singapore 168751, Singapore; [Wong, Tien Y.] Natl Univ Singapore, Dept Ophthalmol, Singapore 119074, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 119074, Singapore; [Tai, E. Shyong] Duke Natl Univ Singapore, Grad Sch Med, Singapore 169857, Singapore; [Rao, Dabeeru C.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Morris, Richard W.] UCL, Dept Primary Care & Populat Hlth, London NW3 2PF, England; [Dominiczak, Anna F.] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Coresh, Josef] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Navis, Gerjan] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, NL-9713 GZ Groningen, Netherlands; [Ridker, Paul M.] Brigham & Womens Hosp, Div Cardiol, Boston, MA 02215 USA; [Bandinelli, Stefania] ASF, Geriatr Rehabil Unit, I-50100 Florence, Italy; [Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki 00271, Finland; [Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki 00014, Finland; [Tuomilehto, Jaakko] S Ostrobothnia Cent Hosp, Seinajoki 60220, Finland; [Tuomilehto, Jaakko] Hosp Univ La Paz, Red RECAVA Grp RD06 0014 0015, Madrid 28046, Spain; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, I-39100 Bolzano, Italy; [Elosua, Roberto] CIBER Epidemiol & Salud Publ, Barcelona 08003, Spain; [Altshuler, David] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Shuldiner, Alan R.] Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21201 USA; [Meneton, Pierre] Ctr Rech Cordeliers, Inst Natl Sante & Rech Med U872, F-75006 Paris, France; [Rettig, Rainer] Ernst Moritz Arndt Univ Greifswald, Inst Physiol, D-17487 Greifswald, Germany; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Med Obstet & Gynecol, Oulu 90014, Finland; [Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Boerwinkle, Eric] Ctr Human Genet, Houston, TX 77030 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Div Epidemiol & Prevent, Boston, MA 02215 USA; [Larson, Martin G.] Boston Univ, Dept Math, Boston, MA 02215 USA; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu 90014, Finland; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Oulu 90101, Finland; [Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC HPA Ctr Environm & Hlth, London W2 1PG, England; [van Duijn, Cornelia M.] NGI Erasmus Med Ctr, Ctr Med Syst Biol CMSB 1 2, Rotterdam, Netherlands	Johns Hopkins University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Geneva; University of London; Queen Mary University London; University of Washington; University of Washington Seattle; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Brigham & Women's Hospital; University of Iceland; Icelandic Heart Association; University of Leicester; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Imperial College London; University of Michigan System; University of Michigan; Ernst Moritz Arndt Universitat Greifswald; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Cambridge; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Tartu; University System of Maryland; University of Maryland Baltimore; Harvard University; Massachusetts General Hospital; University of London; King's College London; European Academy of Bozen-Bolzano; University of Lubeck; University of Michigan System; University of Michigan; University of Oxford; Wellcome Centre for Human Genetics; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Edinburgh; University of Edinburgh; University of Split; Uppsala University; Amgen; Lund University; University of Verona; Imperial College London; University of Mississippi; University of Mississippi Medical Center; University of London; University College London; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; University of Groningen; Johns Hopkins University; Johns Hopkins University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Cambridge; Ehime University; Ehime University; St Georges University London; Wake Forest University; Wake Forest Baptist Medical Center; Washington University (WUSTL); Washington University (WUSTL); University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Loyola University Chicago; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Tampere University; Tampere University; Tampere University Hospital; University of Turin; University of North Carolina; University of North Carolina Chapel Hill; University of Bristol; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Western Australia; Norwegian University of Science & Technology (NTNU); University of Gothenburg; University of London; University College London; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; KU Leuven; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Columbia University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Imperial College London; University of Ioannina; Wake Forest University; Wake Forest University School of Medicine; University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); MedStar Washington Hospital Center; University of Bristol; State University System of Florida; University of South Florida; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Dundee; University of London; University College London; University of Oxford; University of Oxford; Case Western Reserve University; Tampere University; University of Turku; University of Turku; University of North Carolina; University of North Carolina Chapel Hill; University of San Carlos; Boston University; Boston University; Framingham Heart Study; University of Regensburg; University of Regensburg; University of Freiburg; University of Lausanne; Swiss Institute of Bioinformatics; GlaxoSmithKline; Imperial College London; University of Exeter; Aga Khan University; Aga Khan University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; Lund University; Skane University Hospital; Lund University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Finland National Institute for Health & Welfare; University of Helsinki; University of London; Queen Mary University London; Merck & Company; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Finland National Institute for Health & Welfare; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Munster; University of Munster; Harvard University; Massachusetts General Hospital; University System of Georgia; Augusta University; University of Groningen; Wake Forest University; Wake Forest Baptist Medical Center; University of Washington; University of Washington Seattle; Group Health Cooperative; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Washington; University of Washington Seattle; University of Tartu; Tallinn University of Technology; University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; University of Gothenburg; University of Oslo; University West Indies Mona Jamaica; University of Ibadan; Shiga University of Medical Science; Osaka University; Tohoku University; Shiga University of Medical Science; Yokohama City University; Pontificia Universidad Catolica de Chile; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Imperial College London; Cedars Sinai Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Framingham Heart Study; University of Washington; University of Washington Seattle; University of Mississippi; University of Mississippi Medical Center; Boston University; Finnish Institute of Occupational Health; University of Oxford; Wellcome Centre for Human Genetics; Karolinska Institutet; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Consiglio Nazionale delle Ricerche (CNR); University of Oulu; University of Oulu; University of Eastern Finland; University of Oulu; University of Helsinki; Aalto University; National University of Singapore; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Mayo Clinic; Imperial College London; University of Split; Medical University Silesia; University of Edinburgh; Federation University Australia; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Munster; University of Zagreb; AstraZeneca; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of Turku; University of Turku; University of Michigan System; University of Michigan; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore; Washington University (WUSTL); University of London; University College London; University of Glasgow; Johns Hopkins University; University of Groningen; Harvard University; Brigham & Women's Hospital; Finland National Institute for Health & Welfare; University of Helsinki; Hospital Universitario La Paz; Krankenhaus Bozen; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Ernst Moritz Arndt Universitat Greifswald; University of Oulu; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Boston University; Boston University; University of Oulu; Finland National Institute for Health & Welfare; Imperial College London	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD 21205 USA.	p.b.munroe@qmul.ac.uk; aravinda@jhmi.edu; cnewtoncheh@chgr.mgh.harvard.edu; levyd@nhlbi.nih.gov; m.j.caulfield@qmul.ac.uk	sharma, pankaj/HGE-4423-2022; Colaus, PsyColaus/K-6607-2013; Wong, Tien Yin/AAC-9724-2020; Lee, Jong-Young/M-6319-2013; Dominiczak, Anna F/P-9390-2017; Khaw, Kay-Tee/AAZ-3209-2021; Rotter, Jerome/AAY-6598-2021; Pramstaller, Peter P/C-2357-2008; Prokopenko, Inga/AAU-9895-2020; Gaunt, Tom R/O-3918-2014; Ricceri, Fulvio/I-9910-2018; Stancakova, Alena/AAN-6723-2020; Rivadeneira, Fernando/O-5385-2015; zhang, weihua/GXV-1334-2022; Spector, Tim D/F-6533-2012; EHRET, Georg B/A-9532-2009; Singleton, Andrew B/C-3010-2009; Tzoulaki, Ioanna/ABE-6269-2020; Amin, Najaf N/D-1859-2012; Kottgen, Anna/D-2920-2012; Hardy, Rebecca/AFR-1989-2022; Bochud, Murielle/A-3981-2010; Aspelund, Thor/K-7022-2019; Hveem, Kristian/AFV-4683-2022; Prabhakaran, Dorairaj/B-4147-2011; Hayward, Caroline/M-8818-2016; Abecasis, Goncalo R/B-7840-2010; Kuh, Diana/L-6019-2014; Laan, Maris/A-4100-2011; Boban, Mladen/E-2777-2017; Seielstad, Mark/T-7841-2019; Matullo, Giuseppe/K-6383-2016; Aulchenko, Yurii/M-8270-2013; Loos, Ruth/GON-5877-2022; Lakatta, Edward G/AAL-1447-2020; Dörr, Marcus/F-1919-2010; Serge, Hercberg/F-3038-2017; König, Inke R/A-4544-2009; Staessen, Jan A/A-1065-2011; Levy, Daniel/ABF-6873-2021; Raitakari, Olli/AAQ-7389-2021; Kuznetsova, Tatiana/ABI-5662-2020; Meneton, Pierre/T-1216-2019; Palmer, Lyle John/K-3196-2014; Kivimaki, Mika/B-3607-2012; Ramachandran, Vasan/Y-2527-2019; Dehghan, Abbas/ABE-7377-2020; Aspelund, Thor/C-5983-2008; Erdmann, Jeanette/A-4417-2009; Peters, Annette/A-6117-2011; Meschia, James/GPP-1636-2022; Munzel, Thomas/A-2912-2014; Polasek, Ozren/B-6002-2011; Kronenberg, Florian/B-1736-2008; Girelli, Domenico/B-1183-2008; Viigimaa, Margus/AAX-3864-2020; van Gilst, Wiek/R-1806-2019; Cavalieri, Margherita/G-8053-2012; Maxwell, Patrick H/C-5557-2008; Sijbrands, Eric/A-1065-2009; Rice, Kenneth M/A-4150-2013; Cooper, Matthew N/J-4420-2014; Giallauria, Francesco/B-5681-2013; Grobbee, Diederick/C-7651-2014; HERCBERG, Serge/B-4429-2008; Artigas, María Soler/L-6529-2013; Eggermann, Thomas/F-3807-2014; Fava, Cristiano/K-9590-2015; Pilar, Galan/F-2908-2017; Franke, Andre/B-2151-2010; Feitosa, Mary F/K-8044-2012; Raso, Francesco Mattace-/L-2541-2015; Loos, Ruth J F/Q-2862-2016; Rudan, Igor/I-1467-2012; Gale, Daniel/D-5594-2013; Onland-Moret, N. Charlotte/G-9185-2011; Gudnason, Vilmundur/AAE-7126-2019; Zhu, Xiaofeng/O-6874-2019; Teumer, Alexander/S-7438-2019; Ikram, M. Arfan/AAM-5225-2021; Wong, Andrew/AAE-6995-2019; Hadley, David/I-6902-2012; Hicks, Andrew Anthony/E-9518-2017; Marmot, M G/Y-3920-2019; Deloukas, Panos/B-2922-2013; Fuchsberger, Christian/C-9646-2010; Guarrera, Simonetta/AAB-8482-2022; Lyytikäinen, Leo-Pekka/C-8544-2016; Narisu, Narisu/T-6908-2019; Beckmann, Jacques S/A-9772-2008; Arora, Pankaj/F-3437-2011; Bakker, Stephan J. L./J-4023-2015; Smith, Albert Vernon/K-5150-2015; Mangino, Massimo/F-5134-2011; Prokopenko, Inga/H-3241-2014; van der Schouw, Yvonne T./F-8327-2014; Schnabel, Renate B/F-6527-2014; Altshuler, David M/A-4476-2009; Charchar, Fadi/I-6656-2017; Lehtimäki, Terho/AAD-1094-2022; Willenborg, Christina/D-2668-2012; Palmer, Lyle John/N-1948-2019; Davey Smith, George/A-7407-2013; Org, Elin/AAJ-9631-2021; Schalling, Martin/F-1518-2015; Levy, Daniel/ABB-2752-2021; Boehm, Bernhard Otto/F-8750-2015; Heath, Simon C/J-4138-2012; Johnson, Andrew D/G-6520-2013; gurrapu, gopi/A-9801-2011; Burton, Paul R/H-7527-2016; Shukla, Sharvari/AAK-3469-2020; Uda, Manuela/AAC-2645-2019; Ahmadi, Kourosh R/B-6379-2012; Maria, Hernandez-Fuentes/B-5011-2010; Campbell, Harry/E-2959-2010; Zgaga, Lina/Q-9415-2018; bandinelli, stefania/AAL-4570-2020; Wong, Andrew/M-8899-2016; Meitinger, Thomas/O-1318-2015; Lucas, Gavin/D-4346-2012; Erdmann, Jeanette/P-7513-2014; DEMIRKAN, AYSE/G-9313-2016; Okamura, Tomonori/L-1693-2013; Soininen, Pasi/B-9716-2008; Sim, Xueling/AAZ-6652-2020; Shi, Gang/D-3301-2016; Hwang, Shih-Jen/HGU-5826-2022; Stark, Klaus/D-3813-2009; Kuznetsova, Tatiana/I-6882-2013; Gudnason, Vilmundur/K-6885-2015; Wichmann, Heinz Erich/AAA-5695-2022; Wilson, James F/A-5704-2009; Tai, E Shyong/J-9831-2013; Thelle, Dag Steinar/ABD-1867-2020; Lightstone, Liz/M-4331-2014; Ziegler, Andreas/G-4246-2012; Hypponen, Elina/B-2596-2014; Dehghan, Abbas/B-9896-2008	Wong, Tien Yin/0000-0002-8448-1264; Lee, Jong-Young/0000-0002-0092-9958; Dominiczak, Anna F/0000-0003-4913-3608; Gaunt, Tom R/0000-0003-0924-3247; Ricceri, Fulvio/0000-0001-8749-9737; Stancakova, Alena/0000-0002-1375-0252; Rivadeneira, Fernando/0000-0001-9435-9441; EHRET, Georg B/0000-0002-5730-0675; Tzoulaki, Ioanna/0000-0002-4275-9328; Bochud, Murielle/0000-0002-5727-0218; Aspelund, Thor/0000-0002-7998-5433; Prabhakaran, Dorairaj/0000-0002-3172-834X; Hayward, Caroline/0000-0002-9405-9550; Kuh, Diana/0000-0001-7386-2857; Laan, Maris/0000-0002-8519-243X; Boban, Mladen/0000-0003-1570-9621; Matullo, Giuseppe/0000-0003-0674-7757; Aulchenko, Yurii/0000-0002-7899-1575; Dörr, Marcus/0000-0001-7471-475X; Serge, Hercberg/0000-0002-3168-1350; König, Inke R/0000-0003-0504-6465; Staessen, Jan A/0000-0002-3026-1637; Levy, Daniel/0000-0003-1843-8724; Kuznetsova, Tatiana/0000-0003-4293-4576; Palmer, Lyle John/0000-0002-1628-3055; Kivimaki, Mika/0000-0002-4699-5627; Ramachandran, Vasan/0000-0001-7357-5970; Aspelund, Thor/0000-0002-7998-5433; Peters, Annette/0000-0001-6645-0985; Meschia, James/0000-0002-4475-8142; Munzel, Thomas/0000-0001-5503-4150; Polasek, Ozren/0000-0002-5765-1862; Kronenberg, Florian/0000-0003-2229-1120; Girelli, Domenico/0000-0001-9684-1899; van Gilst, Wiek/0000-0003-2968-8585; Maxwell, Patrick H/0000-0002-0338-2679; Sijbrands, Eric/0000-0001-8857-7389; Rice, Kenneth M/0000-0001-5779-4495; Cooper, Matthew N/0000-0003-1139-3682; Giallauria, Francesco/0000-0003-4119-9397; Grobbee, Diederick/0000-0003-4472-4468; HERCBERG, Serge/0000-0002-3168-1350; Artigas, María Soler/0000-0002-3213-1107; Fava, Cristiano/0000-0002-8910-7378; Pilar, Galan/0000-0003-1706-3107; Franke, Andre/0000-0003-1530-5811; Feitosa, Mary F/0000-0002-0933-2410; Loos, Ruth J F/0000-0002-8532-5087; Rudan, Igor/0000-0001-6993-6884; Gale, Daniel/0000-0002-9170-1579; Onland-Moret, N. Charlotte/0000-0002-2360-913X; Gudnason, Vilmundur/0000-0001-5696-0084; Teumer, Alexander/0000-0002-8309-094X; Wong, Andrew/0000-0003-2079-4779; Hicks, Andrew Anthony/0000-0001-6320-0411; Marmot, M G/0000-0002-2431-6419; Deloukas, Panos/0000-0001-9251-070X; Lyytikäinen, Leo-Pekka/0000-0002-7200-5455; Beckmann, Jacques S/0000-0002-9741-1900; Arora, Pankaj/0000-0003-2420-3550; Bakker, Stephan J. L./0000-0003-3356-6791; Smith, Albert Vernon/0000-0003-1942-5845; Mangino, Massimo/0000-0002-2167-7470; Prokopenko, Inga/0000-0003-1624-7457; van der Schouw, Yvonne T./0000-0002-4605-435X; Altshuler, David M/0000-0002-7250-4107; Charchar, Fadi/0000-0002-6164-9941; Lehtimäki, Terho/0000-0002-2555-4427; Willenborg, Christina/0000-0001-5217-6882; Palmer, Lyle John/0000-0002-1628-3055; Davey Smith, George/0000-0002-1407-8314; Schalling, Martin/0000-0001-5011-2922; Heath, Simon C/0000-0002-9550-0897; Johnson, Andrew D/0000-0001-6369-5178; Shukla, Sharvari/0000-0002-7029-5532; Uda, Manuela/0000-0002-4890-6456; Maria, Hernandez-Fuentes/0000-0002-7558-9441; Campbell, Harry/0000-0002-6169-6262; Zgaga, Lina/0000-0003-4089-9703; Wong, Andrew/0000-0003-2079-4779; Erdmann, Jeanette/0000-0002-4486-6231; Okamura, Tomonori/0000-0003-0488-0351; Sim, Xueling/0000-0002-1233-7642; Stark, Klaus/0000-0002-7832-1942; Kuznetsova, Tatiana/0000-0003-3564-7405; Gudnason, Vilmundur/0000-0001-5696-0084; Wilson, James F/0000-0001-5751-9178; Thelle, Dag Steinar/0000-0002-4417-5967; Org, Elin/0000-0003-1451-9375; Bergmann, Sven/0000-0002-6785-9034; Lakatta, Edward/0000-0002-4772-0035; Chandak, Giriraj Ratan/0000-0002-3095-9453; Kleefstra, Nanne/0000-0003-1473-8519; Stumvoll, Michael/0000-0001-6225-8240; Wain, Louise/0000-0003-4951-1867; Tobin, Martin/0000-0002-3596-7874; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Magi, Reedik/0000-0002-2964-6011; Pramstaller, Peter P/0000-0002-9831-8302; Johnson, Toby/0000-0002-5998-3270; Terzic, Janos/0000-0003-3228-2076; Melander, Olle/0000-0002-2581-484X; Kloss-Brandstatter, Anita/0000-0002-0873-6704; Kleber, Marcus/0000-0003-0663-7275; Stritzke, Jan/0000-0003-3143-7005; Meitinger, Thomas/0000-0002-8838-8403; Watkins, Hugh/0000-0002-5287-9016; Couper, David/0000-0002-4313-9235; Zhu, Xiaofeng/0000-0003-0037-411X; Ongen, Halit/0000-0002-4197-5790; Amin, Najaf/0000-0002-8944-1771; Forouhi, Nita/0000-0002-5041-248X; Talmud, Philippa/0000-0002-5560-1933; Preuss, Michael/0000-0001-5266-8465; Lightstone, Liz/0000-0002-4603-4076; Lawlor, Debbie A/0000-0002-6793-2262; Hingorani, Aroon/0000-0001-8365-0081; Nyberg, Fredrik/0000-0003-0892-5668; Barroso, Ines/0000-0001-5800-4520; Org, Elin/0000-0001-8688-9717; Wild, Philipp/0000-0003-4413-9752; Lucas, Gavin/0000-0003-4166-9416; Glazer, Nicole/0000-0002-6397-609X; Aherrahrou, Zouhair/0000-0002-1241-8733; Viigimaa, Margus/0000-0001-5575-5978; Elliott, Paul/0000-0002-7511-5684; Demirkan, Ayse/0000-0002-7546-0867; Fuchsberger, Christian/0000-0002-5918-8947; Beilby, John/0000-0002-4915-2254; Hardy, Rebecca/0000-0001-9949-0799; Humphries, Stephen E/0000-0002-8221-6547; Kumari, Meena/0000-0001-9716-1035; Eyheramendy, Susana/0000-0003-4723-9660; Tomaszewski, Maciej/0000-0001-8215-6567; Emilsson, Valur/0000-0001-9982-0524; Soranzo, Nicole/0000-0003-1095-3852; Alexander, Myriam/0000-0002-6848-9370; Seielstad, Mark/0000-0001-5783-1401; Larson, Martin/0000-0002-9631-1254; Kahonen, Mika/0000-0002-4510-7341; Gieger, Christian/0000-0001-6986-9554; Wurtz, Peter/0000-0002-5832-0221; Ziegler, Andreas/0000-0002-8386-5397; Hopewell, Jemma/0000-0002-3870-8018; Morris, Richard/0000-0001-7240-4563; Quertermous, Thomas/0000-0002-7645-9067; O'Reilly, Paul/0000-0001-7515-0845; SCUTERI, ANGELO/0000-0003-4784-5441; Whincup, Peter/0000-0002-5589-4107; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Devuyst, Olivier/0000-0003-3744-4767; Munroe, Patricia/0000-0002-4176-2947; Felix, Janine/0000-0002-9801-5774; Chen, Ming-Huei/0000-0003-3551-8726; s, hema/0000-0002-3440-9475; Seshadri, Sudha/0000-0001-6135-2622; Taylor, Andrew/0000-0003-4194-7113; Goel, Anuj/0000-0003-2307-4021; Hypponen, Elina/0000-0003-3670-9399; Adeyemo, Adebowale/0000-0002-3105-3231; Abecasis, Goncalo/0000-0003-1509-1825; Van Duijn, Cornelia/0000-0002-2374-9204; ELOSUA, ROBERTO/0000-0001-8235-0095; Tukiainen, Taru/0000-0002-5404-8398; Ala-Korpela, Mika/0000-0001-5905-1206; Kovacs, Peter/0000-0002-0290-5423; Ikram, Mohammad Arfan/0000-0003-0372-8585; Wang, Thomas/0000-0003-4063-6508; Voight, Benjamin/0000-0002-6205-9994; Tai, E Shyong/0000-0003-2929-8966; Mattace-Raso, Francesco/0000-0002-1688-6497; Sternberg, Michael/0000-0002-1884-5445; Shriner, Daniel/0000-0003-1928-5520; Caulfield, Mark/0000-0001-9295-3594; Bergman, Richard/0000-0003-1539-4471; Lord, Graham/0000-0003-2069-4743; Shuldiner, Alan/0000-0001-9921-4305; Dehghan, Abbas/0000-0001-6403-016X; Volker, Uwe/0000-0002-5689-3448; Morrison, Alanna/0000-0001-6381-4296; Kangas, Antti/0000-0001-7492-1732; Nitsch, Dorothea/0000-0001-5767-248X; Shrine, Nick/0000-0003-3641-4371	NIH/NHLBI; MRC [G0000934, G0700931, MC_U137686857, MC_UP_A100_1003, MC_U123092723, G0701863, G0601966, MC_U106188470, G0600331, G0902313, G0600705, G0902037, G0801056, MC_U123092720, G0501942, G0400874, G9521010, MC_U127561128, MC_PC_U127527180, MC_PC_U127561128] Funding Source: UKRI; Austrian Science Fund (FWF) [P 20545] Funding Source: researchfish; British Heart Foundation [RG/07/008/23674, RG/08/008/25291, RG/08/014/24067, RG/08/013/25942] Funding Source: researchfish; Kidney Research UK [RP24/2/2006] Funding Source: researchfish; Medical Research Council [G0700931, MC_PC_U127561128, G0902037, G0801056, MC_U106179471, MC_PC_U127527180, G0000934, G0701863, G9521010, G0401527, G1000143, G0501942, MC_U127561128, MC_U106188470, MC_UP_A100_1003, G0801056B, G0600705, MC_U123092720, G19/35, G0600331, G8802774, MC_U137686857, MC_U123092723, G0902313, G0100222, G0601966, G0400874] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10315] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095165, N01HC095169, N01HC085085, N01HC035129, N01HC095166, N01HC055015, N01HC085082, N01HC085086, N01HC015103, N01HC045133, N01HC095162, N01HC055019, N01HC055018, N01HC075150, N01HC095159, N01HC055016, N01HC085084, N01HC055020, N01HC085083, N01HC095160, N01HC095168, N01HC085079, N01HC095167, N01HC095161, N01HC055222, N01HC095164, N01HC025195, N01HC085080, N01HC085081, N01HC055022, N01HC095163, N01HC055021] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD013107] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R01TW005596, R03TW007165, R01TW008288] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA094143, P01CA055075, U01CA086308, P01CA087969] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023250, UL1RR024156, U54RR020278, M01RR010284, P20RR020649, UL1RR025005, M01RR000425, M01RR016500] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045508, R01HL073410, ZIAHL006002, U01HL072515, R01HL087647, R01HL086694, R01HL087652, U01HL084756, R01HL064278, R01HL071250, U01HL054527, R01HL036310, U01HL080295, R01HL043851, U01HL054473, R01HL105756, R01HL071259, R01HL071252, R01HL085144, ZIAHL006001, R01HL059367, R01HL071258, K23HL080025, R01HL087679, R01HL088119, U10HL054512, R01HL089650, R01HL071251, U01HL054466, R01HL086718, R01HL087660, R01HL071051, R01HL061019, R01HL060919, R01HL087641, R01HL056931, R01HL085251, U01HL054512, R01HL098283, R37HL045508, R01HL060894, U01HL084729, R37HL051021, R01HL053353, U01HL054471, R01HL071205] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004738, R01HG003054, U01HG004729, U01HG004438, U01HG004436, U01HG004399, U01HG004735, U01HG004415, U01HG004728, U01HG004423, U01HG004422, U01HG004402, U01HG004446, RC2HG005581, U01HG004726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE018903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066574, P30DK056350, R01DK058845, U01DK062370, R01DK075787, R56DK062370, R01DK078150, R01DK062370, P30DK063491, R01DK072193, U01DK062418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033, P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008016, U01GM074518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268, R01MH063706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS069208, R01NS042733, R01NS039987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG007480, R01AG018728, ZIAAG001050, R01AG032098, R01AG013196, N01AG062103, R37AG013196, R01AG017644, N01AG012100, N01AG062101] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD009164] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); British Heart Foundation(British Heart Foundation); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	A number of the participating studies and authors are members of the CHARGE and Global BPgen consortia. Many funding mechanisms by NIH/NHLBI, European and private funding agencies contributed to this work and a full list is provided in section 21 of the Supplementary Materials.	BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; He L, 2009, TOXICOL APPL PHARM, V238, P250, DOI 10.1016/j.taap.2009.02.017; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Ishimitsu T, 2006, PHARMACOL THERAPEUT, V111, P909, DOI 10.1016/j.pharmthera.2006.02.004; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewis JB, 2010, J AM SOC NEPHROL, V21, P1086, DOI 10.1681/ASN.2010030236; Li NF, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-124; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; Meyer TE, 2009, AM J HYPERTENS, V22, P163, DOI 10.1038/ajh.2008.336; Mussig K, 2005, J CLIN ENDOCR METAB, V90, P4362, DOI 10.1210/jc.2005-0136; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pushkin A, 1999, J BIOL CHEM, V274, P16569, DOI 10.1074/jbc.274.23.16569; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; SCHENK DB, 1987, P NATL ACAD SCI USA, V84, P1521, DOI 10.1073/pnas.84.6.1521; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Turnbull F, 2008, BMJ-BRIT MED J, V336, P1121, DOI 10.1136/bmj.39548.738368.BE	28	1463	1499	5	400	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2011	478	7367					103	109		10.1038/nature10405	http://dx.doi.org/10.1038/nature10405			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21909115	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000295575400043
J	Elser, J; Bennett, E				Elser, James; Bennett, Elena			A broken biogeochemical cycle	NATURE			English	Editorial Material							PHOSPHORUS		[Elser, James] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Bennett, Elena] McGill Univ, Dept Nat Resource Sci, Montreal, PQ, Canada; [Bennett, Elena] McGill Univ, McGill Sch Environm, Montreal, PQ, Canada	Arizona State University; Arizona State University-Tempe; McGill University; McGill University	Elser, J (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	j.elser@asu.edu	Elser, James/A-7082-2008; Elser, James J/AAL-6199-2020; Bennett, Elena/A-9553-2008	Elser, James/0000-0002-1460-2155; Elser, James J/0000-0002-1460-2155; Bennett, Elena/0000-0003-3944-2925				Childers DL, 2011, BIOSCIENCE, V61, P117, DOI 10.1525/bio.2011.61.2.6; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Gaxiola RA, 2011, CHEMOSPHERE, V84, P840, DOI 10.1016/j.chemosphere.2011.01.062; Golovan SP, 2001, NAT BIOTECHNOL, V19, P741, DOI 10.1038/90788; Sutton MA, 2011, NATURE, V472, P159, DOI 10.1038/472159a; Van Kauwenbergh S. J., 2010, TECHNICAL B IFDC	7	582	614	29	555	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2011	478	7367					29	31		10.1038/478029a	http://dx.doi.org/10.1038/478029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21979027	Bronze			2022-12-28	WOS:000295575400014
J	Novarino, G; Akizu, N; Gleeson, JG				Novarino, Gaia; Akizu, Naiara; Gleeson, Joseph G.			Modeling Human Disease in Humans: The Ciliopathies	CELL			English	Review							BARDET-BIEDL-SYNDROME; POLYCYSTIC KIDNEY-DISEASE; MECKEL-GRUBER-SYNDROME; BASAL BODY PROTEOME; JOUBERT-SYNDROME; INTRAFLAGELLAR TRANSPORT; DEVELOPMENTAL DISORDER; TRIALLELIC INHERITANCE; RETINAL DEGENERATION; CILIA FUNCTION	Soon, the genetic basis of most human Mendelian diseases will be solved. The next challenge will be to leverage this information to uncover basic mechanisms of disease and develop new therapies. To understand how this transformation is already beginning to unfold, we focus on the ciliopathies, a class of multi-organ diseases caused by disruption of the primary cilium. Through a convergence of data involving mutant gene discovery, proteomics, and cell biology, more than a dozen phenotypically distinguishable conditions are now united as ciliopathies. Sitting at the interface between simple and complex genetic conditions, these diseases provide clues to the future direction of human genetics.	[Novarino, Gaia; Akizu, Naiara; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Neurosci & Pediat,Inst Genom Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego	Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Neurosci & Pediat,Inst Genom Med, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu			California Institute for Regenerative Medicine; Deutsche Forschungsgemeinschaft (DFG); NIH [R01NS041537, P01HD070494, R01NS052455, P30NS047101, R01NS048453]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, R01NS041537, P30NS047101, R01NS052455] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	N.A. is supported by a training grant from the California Institute for Regenerative Medicine. G.N. is supported by a grant from the Deutsche Forschungsgemeinschaft (DFG). Work in the Gleeson lab is supported by grants from the NIH (R01NS041537, P01HD070494, R01NS052455, P30NS047101, and R01NS048453). J.G.G. is an Investigator of the Simons Foundation Autism Research Initiative (SFARI) and the Howard Hughes Medical Institute.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Arnaiz O, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap022; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; BRANCATI F, 1967, HUM MUTAT, V30, pE432; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chen YH, 2010, MOL INTERV, V10, P271, DOI 10.1124/mi.10.5.4; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Coppieters F, 2010, HUM MUTAT, V31, pE1709, DOI 10.1002/humu.21336; Coppieters F, 2010, HUM MUTAT, V31, P1097, DOI 10.1002/humu.21337; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Edery P, 2011, SCIENCE, V332, P240, DOI 10.1126/science.1202205; Eichers ER, 2004, ANN MED, V36, P262, DOI 10.1080/07853890410026214; Eley L, 2008, KIDNEY INT, V74, P1139, DOI 10.1038/ki.2008.377; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Gorden NT, 2008, AM J HUM GENET, V83, P559, DOI 10.1016/j.ajhg.2008.10.002; Gu YY, 2009, NATURE, V458, P1039, DOI 10.1038/nature07811; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; He HL, 2011, SCIENCE, V332, P238, DOI 10.1126/science.1200587; Hoefele J, 2007, J AM SOC NEPHROL, V18, P2789, DOI 10.1681/ASN.2007020243; Hopp K, 2011, HUM MOL GENET, V20, P2524, DOI 10.1093/hmg/ddr151; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Iannicelli M, 2010, HUM MUTAT, V31, pE1319, DOI 10.1002/humu.21239; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Jacob LS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001225; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Jiang ST, 2008, HUM MOL GENET, V17, P3368, DOI 10.1093/hmg/ddn231; Jiang ST, 2009, HUM MOL GENET, V18, P1566, DOI 10.1093/hmg/ddp068; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Kyttala M, 2006, NAT GENET, V38, P155, DOI 10.1038/ng1714; Lai CK, 2011, MOL BIOL CELL, V22, P1104, DOI 10.1091/mbc.E10-07-0596; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Louie CM, 2010, NAT GENET, V42, P175, DOI 10.1038/ng.519; Mykytyn K, 2003, AM J HUM GENET, V72, P429, DOI 10.1086/346172; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Piasecki BP, 2010, P NATL ACAD SCI USA, V107, P12969, DOI 10.1073/pnas.0914241107; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; Tobin JL, 2008, PEDIATR NEPHROL, V23, P2095, DOI 10.1007/s00467-008-0898-7; Tory K, 2007, J AM SOC NEPHROL, V18, P1566, DOI 10.1681/ASN.2006101164; Williams CL, 2008, MOL BIOL CELL, V19, P2154, DOI 10.1091/mbc.E07-10-1070; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Wiszniewski W, 2011, HUM GENET, V129, P319, DOI 10.1007/s00439-010-0928-y; Yen HJ, 2006, HUM MOL GENET, V15, P667, DOI 10.1093/hmg/ddi468	68	126	132	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2011	147	1					70	79		10.1016/j.cell.2011.09.014	http://dx.doi.org/10.1016/j.cell.2011.09.014			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962508	Green Accepted, Bronze			2022-12-28	WOS:000295396700016
J	Sellers, WR				Sellers, William R.			A Blueprint for Advancing Genetics-Based Cancer Therapy	CELL			English	Article							RESISTANT PROSTATE-CANCER; FACTOR-H POLYMORPHISM; CHRONIC-PHASE; INHIBITOR; IMATINIB; MUTATION; PATHWAY	In the era of next-generation sequencing, there are significant challenges to harnessing cancer genome information to develop novel therapies. Key research thrusts in both academia and industry will speed this transition, and lessons learned for cancer will more broadly shape the process for genetic contributions to the therapy of disease more broadly.	Novartis Inst Biomed Res, Cambridge, MA 02139 USA	Novartis	Sellers, WR (corresponding author), Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	william.sellers@novartis.com						Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Brough R, 2011, CANCER DISCOV, V1, P260, DOI 10.1158/2159-8290.CD-11-0107; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Haber DA, 2011, CELL, V145, P19, DOI 10.1016/j.cell.2011.03.026; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Infante JR, 2011, J CLIN ONCOL, V29; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shim MS, 2010, FEBS J, V277, P4814, DOI 10.1111/j.1742-4658.2010.07904.x; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sun HY, 2004, J MED CHEM, V47, P4147, DOI 10.1021/jm0499108; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	33	54	55	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2011	147	1					26	31		10.1016/j.cell.2011.09.016	http://dx.doi.org/10.1016/j.cell.2011.09.016			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962504	Bronze			2022-12-28	WOS:000295396700012
J	Zhu, H; Shyh-Chang, N; Segre, AV; Shinoda, G; Shah, SP; Einhorn, WS; Takeuchi, A; Engreitz, JM; Hagan, JP; Kharas, MG; Urbach, A; Thornton, JE; Triboulet, R; Gregory, RI; Altshuler, D; Daley, GQ				Zhu, Hao; Shyh-Chang, Ng; Segre, Ayellet V.; Shinoda, Gen; Shah, Samar P.; Einhorn, William S.; Takeuchi, Ayumu; Engreitz, Jesse M.; Hagan, John P.; Kharas, Michael G.; Urbach, Achia; Thornton, James E.; Triboulet, Robinson; Gregory, Richard I.; Altshuler, David; Daley, George Q.		DIAGRAM Consortium; MAGIC Investigators	The Lin28/let-7 Axis Regulates Glucose Metabolism	CELL			English	Article							LET-7 MICRORNA FAMILY; HUMAN HEPATOCELLULAR-CARCINOMA; CAENORHABDITIS-ELEGANS; PROMOTES TRANSFORMATION; INSULIN-RESISTANCE; TRANSGENIC MICE; MESSENGER-RNA; STEM-CELLS; LIN-28; LIN28	The let-7 tumor suppressor microRNAs are known for their regulation of oncogenes, while the RNA-binding proteins Lin28a/b promote malignancy by inhibiting let-7 biogenesis. We have uncovered unexpected roles for the Lin28/let-7 pathway in regulating-metabolism. When overexpressed in mice, both Lin28a and LIN28B promote an insulin-sensitized state that resists high-fat-diet induced diabetes. Conversely, muscle-specific loss of Lin28a or overexpression of let-7 results in insulin resistance and impaired glucose tolerance. These phenomena occur, in part, through the let-7-mediated repression of multiple components of the insulin-PI3K-mTOR pathway, including IGF1R, INSR, and IRS2. In addition, them TOR inhibitor, rapamycin, abrogates Lin28a-mediated insulin sensitivity and enhanced glucose uptake. Moreover, let-7 targets are enriched for genes containing SNPs associated with type 2 diabetes and control of fasting glucose in human genome-wide association studies. These data establish the Lin28/let-7 pathway as a central regulator of mammalian glucose metabolism.	[Zhu, Hao; Shyh-Chang, Ng; Shinoda, Gen; Shah, Samar P.; Einhorn, William S.; Takeuchi, Ayumu; Hagan, John P.; Kharas, Michael G.; Urbach, Achia; Thornton, James E.; Triboulet, Robinson; Gregory, Richard I.; Daley, George Q.] Childrens Hosp, Stem Cell Transplantat Program, Stem Cell Program, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Zhu, Hao; Shyh-Chang, Ng; Shinoda, Gen; Shah, Samar P.; Einhorn, William S.; Takeuchi, Ayumu; Hagan, John P.; Kharas, Michael G.; Urbach, Achia; Thornton, James E.; Triboulet, Robinson; Gregory, Richard I.; Daley, George Q.] Harvard Stem Cell Inst, Boston, MA USA; [Zhu, Hao] Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02115 USA; [Zhu, Hao; Einhorn, William S.; Kharas, Michael G.; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Segre, Ayellet V.; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Diabet Unit, Dept Med, Boston, MA 02114 USA; [Segre, Ayellet V.; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Segre, Ayellet V.; Altshuler, David] Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Engreitz, Jesse M.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Shyh-Chang, Ng; Hagan, John P.; Thornton, James E.; Triboulet, Robinson; Gregory, Richard I.; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Hagan, John P.] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Daley, George Q.] Howard Hughes Med Inst, Boston, MA USA; [Daley, George Q.] Manton Ctr Orphan Dis Res, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; University System of Ohio; Ohio State University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Daley, GQ (corresponding author), Childrens Hosp, Stem Cell Transplantat Program, Stem Cell Program, Div Pediat Hematol Oncol, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Altshuler, David M/A-4476-2009; Roden, Michael/AAD-3843-2019; Segre, Ayellet V/E-9800-2010; Bonnefond, Amélie/O-2784-2017; FROGUEL, Philippe/O-6799-2017; Boehm, Bernhard Otto/F-8750-2015; Colaus, PsyColaus/K-6607-2013; Ripatti, Samuli/H-9446-2014; Palmer, Lyle John/N-1948-2019; Kanoni, Stavroula/AAN-7161-2021; Visvikis-Siest, Sophie/H-2324-2014; Uda, Manuela/AAC-2645-2019; Hide, Winston Hide/C-7217-2009; Singleton, Andrew B/C-3010-2009; Benediktsson, Rafn/R-2457-2018; Walters, G. Bragi/L-4215-2013; Zhu, Hao/L-5114-2013; Naitza, Silvia/D-5620-2017; Crisponi, Laura/AAC-2642-2019; Hide, Winston A/V-2727-2017; Rudan, Igor/I-1467-2012; de Geus, Eco J.C./M-9318-2015; Kyvik, Kirsten O/K-5680-2016; /GLR-9975-2022; Meitinger, Thomas/O-1318-2015; Mukherjee, Sutapa/U-7262-2017; Kaprio, Jaakko/A-1820-2008; Langenberg, Claudia/ABG-9067-2021; Pattou, Francois/O-6151-2017; Palmer, Lyle John/K-3196-2014; Hide, Winston/R-3815-2019; Polasek, Ozren/B-6002-2011; Aulchenko, Yurii/M-8270-2013; Willems van Dijk, Ko/A-1798-2008	Altshuler, David M/0000-0002-7250-4107; Bonnefond, Amélie/0000-0001-9976-3005; FROGUEL, Philippe/0000-0003-2972-0784; Ripatti, Samuli/0000-0002-0504-1202; Palmer, Lyle John/0000-0002-1628-3055; Kanoni, Stavroula/0000-0002-1691-9615; Visvikis-Siest, Sophie/0000-0001-8104-8425; Uda, Manuela/0000-0002-4890-6456; Hide, Winston Hide/0000-0002-8621-3271; Benediktsson, Rafn/0000-0002-2954-9801; Walters, G. Bragi/0000-0002-5415-6487; Zhu, Hao/0000-0002-8417-9698; Crisponi, Laura/0000-0001-9128-8537; Hide, Winston A/0000-0002-8621-3271; Rudan, Igor/0000-0001-6993-6884; de Geus, Eco J.C./0000-0001-6022-2666; Kyvik, Kirsten O/0000-0003-2981-0245; Mukherjee, Sutapa/0000-0001-5021-1648; Kaprio, Jaakko/0000-0002-3716-2455; Langenberg, Claudia/0000-0002-5017-7344; Pattou, Francois/0000-0001-8388-3766; Palmer, Lyle John/0000-0002-1628-3055; Hide, Winston/0000-0002-8621-3271; Polasek, Ozren/0000-0002-5765-1862; Van Duijn, Cornelia/0000-0002-2374-9204; bennett, amanda/0000-0003-2140-8710; Willemsen, Gonneke/0000-0003-3755-0236; Kivimaki, Mika/0000-0002-4699-5627; Jorgensen, Torben/0000-0001-9453-2830; Lindgren, Cecilia/0000-0002-4903-9374; Couper, David/0000-0002-4313-9235; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Aulchenko, Yurii/0000-0002-7899-1575; Weedon, Michael/0000-0002-6174-6135; Pattaro, Cristian/0000-0002-4119-0109; Zeggini, Eleftheria/0000-0003-4238-659X; Kumari, Meena/0000-0001-9716-1035; Hagan, John/0000-0003-0295-4898; Shyh-Chang, Ng/0000-0003-3138-9525; Meitinger, Thomas/0000-0002-8838-8403; Magi, Reedik/0000-0002-2964-6011; Willems van Dijk, Ko/0000-0002-2172-7394; Pichler, Irene/0000-0001-8251-0757; Gloyn, Anna/0000-0003-1205-1844; Posthuma, Danielle/0000-0001-7582-2365; Seedorf, Udo/0000-0003-4652-5358; Bergman, Richard/0000-0003-1539-4471; Stumvoll, Michael/0000-0001-6225-8240; Hattersley, Andrew/0000-0001-5620-473X; Urbach, Achia/0000-0001-9393-4504; Dina, Christian/0000-0002-7722-7348	US NIH; Graduate Training in Cancer Research Grant; American Cancer Society; Agency for Science, Technology and Research, Singapore; NIH NIDDK; American Diabetes Association; National Human Genome Research Institute (NHGRI); US National Institute of General Medical Sciences (NIGMS); Burroughs Wellcome Fund; Leukemia and Lymphoma Society; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [MC_UP_A100_1003, G8802774, G0902037, G19/35, G0100222, MC_U127561128, MC_PC_U127561128, MC_UP_A620_1015, U1475000002] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [T32CA009172, K08CA157727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, R01DK070055] Funding Source: NIH RePORTER; MRC [MC_UP_A620_1015, MC_U127561128, MC_PC_U127561128, G0902037, MC_UP_A100_1003] Funding Source: UKRI	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate Training in Cancer Research Grant; American Cancer Society(American Cancer Society); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank John Powers, Harith Rajagopalan, Jason Locasale, Abdel Saci, Akash Patnaik, Charles Kaufman, Christian Mosimann and Lewis Cantley for invaluable discussions and advice, Roderick Bronson and the Harvard Medical School Rodent Histopathology Core for mouse tissue pathology, and the Harvard Neurobehavior Laboratory for CLAMS experiments. This work was supported by grants from the US NIH to G. Q. D., a Graduate Training in Cancer Research Grant and a American Cancer Society Postdoctoral Fellowship to H.Z., the NSS Scholarship from the Agency for Science, Technology and Research, Singapore for N.S.C, an NIH NIDDK Diseases Career Development Award to M. G. K, and an American Diabetes Association Postdoctoral Fellowship for A. V. S. J.M.E. was supported by the National Human Genome Research Institute (NHGRI). R. I. G. was supported by US National Institute of General Medical Sciences (NIGMS) and is a Pew Research Scholar. D. A. is a Distinguished Clinical Scholar of the Doris Duke Charitable Foundation. G. Q. D. is a recipient of Clinical Scientist Awards in Translational Research from the Burroughs Wellcome Fund and the Leukemia and Lymphoma Society, and an investigator of the Howard Hughes Medical Institute and the Manton Center for Orphan Disease Research. H.Z. and N.S.C designed and performed the experiments, and wrote the manuscript. A. V. S. and D. A. performed bioinformatic analysis on let-7 targets in GWAS. G. S. and S. P. S. performed expression analysis, metabolic assays and mouse husbandry. G. S., W. S. E. and A. T. generated the mouse strains. J.E.T, R. T. and R. I. G. assisted with the luciferase assays. J.P.H., R. I. G., G. S., and A. T generated the conditional knockout mice. M. G. K. helped to design the experiments. G. Q. D. designed and supervised experiments, and wrote the manuscript. The authors declare no competing financial interests.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Berti L, 1999, MOL CELL ENDOCRINOL, V157, P121, DOI 10.1016/S0303-7207(99)00154-9; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Chiefari E, 2011, JAMA-J AM MED ASSOC, V305, P903, DOI 10.1001/jama.2011.207; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Lu L, 2007, CANCER RES, V67, P10117, DOI 10.1158/0008-5472.CAN-07-2544; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nimmo RA, 2009, CHROMOSOMA, V118, P405, DOI 10.1007/s00412-009-0210-z; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; Xu BS, 2009, NUCLEIC ACIDS RES, V37, P4256, DOI 10.1093/nar/gkp372; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	55	647	679	2	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2011	147	1					81	94		10.1016/j.cell.2011.08.033	http://dx.doi.org/10.1016/j.cell.2011.08.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962509	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000295396700017
J	Davies, E				Davies, Edward			NHS REFORMS The Health and Social Care Bill: 10 things for the Lords to consider	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ Careers, London WC1H 9JR, England		Davies, E (corresponding author), BMJ Careers, London WC1H 9JR, England.	edavies@bmj.com						38 Degrees, NHS EXP LEG ADV; *DEP HLTH, 2011, QUEST WILL AN QUAL P; *DEP HLTH, 2011, TOP 10 FREQ AS UNPUB; GERADA C, 2011, COMMUNICATION   0506; LANSLEY A, 2011, HANSARD         0404; *LIB DEM, 2011, MOT CARR AM UPD NHS; Peedell C, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2996; RAMESH R, 2011, GUARDIAN        0901; SELL S, 2011, GP              0606; TOYNBEE P, 2011, GUARDIAN        0902; *UN, 2011, NHS PRIV BILL HANGS; WHITELAW B, 2011, GUARDIAN        0907	12	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 28	2011	343								d6082	10.1136/bmj.d6082	http://dx.doi.org/10.1136/bmj.d6082			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829JZ	21957212				2022-12-28	WOS:000295577100008
J	Sokol, D				Sokol, Daniel			ETHICS MAN Manners maketh the doctor	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Sokol, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	daniel.sokol@talk21.com						GIBBS D, 2007, ADVICE YOUNG PHYS OT, P62; *GMC, 2009, MOR 218000 DOCT NOW; Penfield W, 1949, CMAJ, V61, P69; PERCIVAL T, 1985, MED ETHICS, P125; Sokol DK, 2004, BRIT MED J, V328, P471, DOI 10.1136/bmj.328.7437.471; Swick HM, 2006, PERSPECT BIOL MED, V49, P263, DOI 10.1353/pbm.2006.0026	6	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 28	2011	343								d6073	10.1136/bmj.d6073	http://dx.doi.org/10.1136/bmj.d6073			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829JZ	21957210				2022-12-28	WOS:000295577100006
J	Choi, GB; Stettler, DD; Kallman, BR; Bhaskar, ST; Fleischmann, A; Axel, R				Choi, Gloria B.; Stettler, Dan D.; Kallman, Benjamin R.; Bhaskar, Shakthi T.; Fleischmann, Alexander; Axel, Richard			Driving Opposing Behaviors with Ensembles of Piriform Neurons	CELL			English	Article							MOUSE OLFACTORY-BULB; IN-VIVO; NEURAL ACTIVITY; EVOKED ACTIVITY; CORTEX; ODOR; MAP; MICE; REPRESENTATIONS; EXPRESSION	Anatomic and physiologic studies have suggested a model in which neurons of the piriform cortex receive convergent input from random collections of glomeruli. In this model, odor representations can only be afforded behavioral significance upon experience. We have devised an experimental strategy that permits us to ask whether the activation of an arbitrarily chosen subpopulation of neurons in piriform cortex can elicit different behavioral responses dependent upon learning. Activation of a small subpopulation of piriform neurons expressing channelr-hodopsin at multiple loci in the piriform cortex, when paired with reward or shock, elicits either appetitive or aversive behavior. Moreover, we demonstrate that different subpopulations of piriform neurons expressing ChR2 can be discriminated and independently entrained to elicit distinct behaviors. These observations demonstrate that the piriform cortex is sufficient to elicit learned behavioral outputs in the absence of sensory input. These data imply that the piriform does not use spatial order to map odorant identity or behavioral output.	[Choi, Gloria B.; Stettler, Dan D.; Kallman, Benjamin R.; Bhaskar, Shakthi T.; Fleischmann, Alexander; Axel, Richard] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Choi, Gloria B.; Stettler, Dan D.; Kallman, Benjamin R.; Bhaskar, Shakthi T.; Fleischmann, Alexander; Axel, Richard] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA.	ra27@columbia.edu		Axel, Richard/0000-0002-3141-4076	Howard Hughes Medical Institute; Mathers Foundation; Damon Runyon Cancer Research Foundation; EMBO; Human Frontiers Science Program	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Mathers Foundation; Damon Runyon Cancer Research Foundation; EMBO(European Molecular Biology Organization (EMBO)); Human Frontiers Science Program(Human Frontier Science Program)	We thank Karl Deisseroth for ChR2 reagents; Nadia Propp for setting up lentiviral production method; Meredith Glinka, Justin Schwarz, and Dan Feng Mei for help with behavioral assays; Monica Mendelsohn, Jennifer Kirkland, and Nataliya Zabello for help with the mice; Anmo Kim for help with laser and olfactometer machines; Phyllis Kisloff for assistance in preparation of the manuscript; David J. Anderson, Larry Abbott, Thomas Jessell, Eric R. Kandel, and members of the Axel lab for critical reading of the manuscript and discussions; and Miriam Gutierrez for general laboratory support. This work was supported by the Howard Hughes Medical Institute and the Mathers Foundation. G.B.C. was supported by the Damon Runyon Cancer Research Foundation Postdoctoral Fellowship. A.F. was supported by long-term postdoctoral fellowships from EMBO and the Human Frontiers Science Program.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; [Anonymous], 1941, AM J OPHTHALMOL, DOI [10.1016/S0002-9394(41)91363-6, DOI 10.1016/S0002-9394(41)91363-6]; Araneda RC, 2004, J PHYSIOL-LONDON, V555, P743, DOI 10.1113/jphysiol.2003.058040; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHANGEUX JP, 1973, P NATL ACAD SCI USA, V70, P2974, DOI 10.1073/pnas.70.10.2974; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Davison IG, 2011, NEURON, V70, P82, DOI 10.1016/j.neuron.2011.02.047; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Doty R W, 1969, Annu Rev Psychol, V20, P289, DOI 10.1146/annurev.ps.20.020169.001445; Edelman GM, 1987, NEURAL DARWINISM THE; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Gorski JA, 2002, J NEUROSCI, V22, P6309; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Illig KR, 2003, J COMP NEUROL, V457, P361, DOI 10.1002/cne.10557; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Kugler S, 2003, GENE THER, V10, P337, DOI 10.1038/sj.gt.3301905; Llinas R.R., 2004, SYNAPTIC ORG BRAIN; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Marshall WH, 1941, J NEUROPHYSIOL, V4, P1; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P374, DOI 10.1152/jn.1957.20.4.374; Murphey DK, 2007, CURR BIOL, V17, P862, DOI 10.1016/j.cub.2007.03.066; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; O'Keefe J, 1998, PHILOS T ROY SOC B, V353, P1333, DOI 10.1098/rstb.1998.0287; Oka Y, 2006, NEURON, V52, P857, DOI 10.1016/j.neuron.2006.10.019; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; PRICE JL, 1970, J CELL SCI, V7, P631; Redish AD, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-05-j0004.2001; Rennaker RL, 2007, J NEUROSCI, V27, P1534, DOI 10.1523/JNEUROSCI.4072-06.2007; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Schwabe K, 2004, NEUROSCIENCE, V126, P727, DOI 10.1016/j.neuroscience.2004.04.022; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Sugai T, 2005, NEUROSCIENCE, V130, P769, DOI 10.1016/j.neuroscience.2004.09.059; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Woolsey CN, 1942, B JOHNS HOPKINS HOSP, V71, P315; Yan ZQ, 2008, NEURON, V58, P613, DOI 10.1016/j.neuron.2008.03.012; Yang Y, 2008, NAT NEUROSCI, V11, P1262, DOI 10.1038/nn.2211; Zhan C, 2010, J NEUROSCI, V30, P16662, DOI 10.1523/JNEUROSCI.4400-10.2010; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	54	158	162	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2011	146	6					1003	1014		10.1016/j.cell.2011.07.041	http://dx.doi.org/10.1016/j.cell.2011.07.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925321	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000295258100021
J	Cole, ST				Cole, Stewart T.			Pyrazinamide-Old TB Drug Finds New Target	SCIENCE			English	Editorial Material							TUBERCULOSIS		Ecole Polytech Fed Lausanne, Global Hlth Inst, Stn 15, CH-1015 Lausanne, Switzerland	Ecole Polytechnique Federale de Lausanne	Cole, ST (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, Stn 15, CH-1015 Lausanne, Switzerland.	stewart.cole@epfl.ch						Barends S, 2001, J MOL BIOL, V314, P9, DOI 10.1006/jmbi.2001.5114; CHORINE V, 1945, CR HEBD ACAD SCI, V220, P150; Keiler KC, 2008, ANNU REV MICROBIOL, V62, P133, DOI 10.1146/annurev.micro.62.081307.162948; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Lamichhane G, 2011, TRENDS MOL MED, V17, P25, DOI 10.1016/j.molmed.2010.10.004; MCDERMOTT W, 1954, AM REV TUBERC PULM, V70, P748; Sala C, 2011, FUTURE MICROBIOL, V6, P617, DOI [10.2217/FMB.11.46, 10.2217/fmb.11.46]; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Shi WL, 2011, SCIENCE, V333, P1630, DOI 10.1126/science.1208813; Thibonnier M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003810; Zhang Y, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P115	11	12	12	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1583	1584		10.1126/science.1212450	http://dx.doi.org/10.1126/science.1212450			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921185				2022-12-28	WOS:000294900900027
J	Adashi, EY; Wyden, R				Adashi, Eli Y.; Wyden, Ron			Public Reporting of Clinical Outcomes of Assisted Reproductive Technology Programs Implications for Other Medical and Surgical Procedures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							REPORT CARDS		Brown Univ, Warren Alpert Med Schl, Providence, RI 02905 USA	Brown University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Schl, Providence, RI 02905 USA.	eli_adashi@brown.edu						Centers for Disease Control and Prevention, ASS REPR TECHN ART; Centers for Disease Control and Prevention, 2008, 2008 ART SUCC RAT; Dranove D, 2008, J HEALTH ECON, V27, P1201, DOI 10.1016/j.jhealeco.2008.03.001; Ferris TG, 2010, NEW ENGL J MED, V363, P1593, DOI 10.1056/NEJMp1009423; Herbert MA, 2004, ANN THORAC SURG, V77, P1960, DOI 10.1016/j.athoracsur.2003.12.018; Lee TH, 2004, NEW ENGL J MED, V350, P2409, DOI 10.1056/NEJMsb041193; Marshall MN, 2005, QUAL SAF HEALTH CARE, V14, P77, DOI 10.1136/qshc.2005.013730; New York State Department of Health, 2010, AD CARD SURG NEW YOR; Steinbrook R, 2006, NEW ENGL J MED, V355, P1847, DOI 10.1056/NEJMp068222	9	31	32	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2011	306	10					1135	1136		10.1001/jama.2011.1249	http://dx.doi.org/10.1001/jama.2011.1249			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819DS	21917583				2022-12-28	WOS:000294806200030
J	Sokol, DK; McFadzean, WA; Dickson, WA; Whitaker, IS				Sokol, Daniel K.; McFadzean, William A.; Dickson, William A.; Whitaker, Iain S.			Ethical dilemmas in the acute setting: a framework for clinicians	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sokol, Daniel K.] Univ London Imperial Coll Sci Technol & Med, Dept Publ Hlth & Primary Care, London W6 8RF, England; [Dickson, William A.; Whitaker, Iain S.] Morriston Hosp, Welsh Ctr Burns & Plast Surg, Swansea SA6 6NL, W Glam, Wales	Imperial College London; Morriston Hospital	Sokol, DK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Publ Hlth & Primary Care, Charing Cross Campus, London W6 8RF, England.	daniel.sokol@talk21.com	Whitaker, Iain/O-5896-2019	Whitaker, Iain/0000-0002-3922-2079				Beauchamp Tom L., 2019, PRINCIPLES BIOMEDICA, V8th; JONSEN AR, 2006, CLIN ETHICS PRACTICA; Sokol DK, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2007.021212	3	9	9	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 13	2011	343								d5528	10.1136/bmj.d5528	http://dx.doi.org/10.1136/bmj.d5528			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822VI	21914736				2022-12-28	WOS:000295077500015
J	Walter, MJ; Kohn, SC; Araujo, D; Bulanova, GP; Smith, CB; Gaillou, E; Wang, J; Steele, A; Shirey, SB				Walter, M. J.; Kohn, S. C.; Araujo, D.; Bulanova, G. P.; Smith, C. B.; Gaillou, E.; Wang, J.; Steele, A.; Shirey, S. B.			Deep Mantle Cycling of Oceanic Crust: Evidence from Diamonds and Their Mineral Inclusions	SCIENCE			English	Article							TRANSITION ZONE; PHASE; TRANSFORMATIONS; RECORD; SLAB; MORB	A primary consequence of plate tectonics is that basaltic oceanic crust subducts with lithospheric slabs into the mantle. Seismological studies extend this process to the lower mantle, and geochemical observations indicate return of oceanic crust to the upper mantle in plumes. There has been no direct petrologic evidence, however, of the return of subducted oceanic crustal components from the lower mantle. We analyzed superdeep diamonds from Juina-5 kimberlite, Brazil, which host inclusions with compositions comprising the entire phase assemblage expected to crystallize from basalt under lower-mantle conditions. The inclusion mineralogies require exhumation from the lower to upper mantle. Because the diamond hosts have carbon isotope signatures consistent with surface-derived carbon, we conclude that the deep carbon cycle extends into the lower mantle.	[Walter, M. J.; Kohn, S. C.; Bulanova, G. P.; Smith, C. B.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [Araujo, D.] Univ Brasilia, Inst Geociencias, BR-70910900 Brasilia, DF, Brazil; [Gaillou, E.; Wang, J.; Shirey, S. B.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; [Steele, A.] Carnegie Inst Washington, Geophys Lab, Washington, DC 20015 USA	University of Bristol; Universidade de Brasilia; Carnegie Institution for Science; Carnegie Institution for Science	Walter, MJ (corresponding author), Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England.	m.j.walter@bristol.ac.uk	Wang, Jianhua/D-6500-2011; Gaillou, Eloise/Y-4502-2019; Kohn, simon c/C-5150-2012; Steele, Andrew/A-3573-2013; Gaillou, Eloise/D-1753-2009	Wang, Jianhua/0000-0002-7671-2413; Gaillou, Eloise/0000-0002-7949-268X; Steele, Andrew/0000-0001-9643-2841; Gaillou, Eloise/0000-0002-7949-268X; Kohn, Simon/0000-0001-6415-8518	UK Natural Environment Research Council [NE/H011242/1]; NSF [EAR-1049992]; Natural Environment Research Council [NE/E010466/1] Funding Source: researchfish; NERC [NE/E010466/1] Funding Source: UKRI	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NSF(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank I. Buisman and S. Kearns for assisting in the collection of electron microprobe data and L. Gobbo on behalf of Rio Tinto for providing samples. Supported by UK Natural Environment Research Council grant NE/H011242/1 (M.J.W.) and NSF grant EAR-1049992 (S. B. S. and J.W.). See (20) for additional compositional data on inclusion phases, experimental run products, and Raman spectroscopy.	Akaogi M, 2002, PHYS EARTH PLANET IN, V130, P49, DOI 10.1016/S0031-9201(01)00305-3; Brenker FE, 2005, EARTH PLANET SC LETT, V236, P579, DOI 10.1016/j.epsl.2005.05.021; Brenker FE, 2002, EARTH PLANET SC LETT, V198, P1, DOI 10.1016/S0012-821X(02)00514-9; Bulanova GP, 2010, CONTRIB MINERAL PETR, V160, P489, DOI 10.1007/s00410-010-0490-6; Cartigny P, 2005, ELEMENTS, V1, P79, DOI 10.2113/gselements.1.2.79; Fukao Y, 2009, ANNU REV EARTH PL SC, V37, P19, DOI 10.1146/annurev.earth.36.031207.124224; Gibson S. A., 1995, J PETROL, V36, P89; Goes S, 2008, NATURE, V451, P981, DOI 10.1038/nature06691; Harte B, 2010, MINERAL MAG, V74, P189, DOI 10.1180/minmag.2010.074.2.189; Harte B, 1999, MANTLE PETROLOGY FIE, P125, DOI [10.1007/978-81-322-1170-9_15, DOI 10.1007/978-81-322-1170-9_15]; Harte B, 2007, PHYS CHEM MINER, V34, P647, DOI 10.1007/s00269-007-0178-2; Hayman P. C., 2005, CONTRIB MINERAL PETR, V140, P734; Heaman L., 1998, 7 INT KIMB C CAP TOW, V7, P322; Hirose K, 2005, EARTH PLANET SC LETT, V237, P239, DOI 10.1016/j.epsl.2005.06.035; Kaminsky FV, 2001, CONTRIB MINERAL PETR, V140, P734, DOI 10.1007/s004100000221; KIRKLEY MB, 1991, APPL GEOCHEM, V6, P477, DOI 10.1016/0883-2927(91)90048-T; Ono S, 2001, EARTH PLANET SC LETT, V190, P57, DOI 10.1016/S0012-821X(01)00375-2; Palyanov YN, 2006, EARTH PLANET SC LETT, V250, P269, DOI 10.1016/j.epsl.2006.06.049; Poli S, 2009, EARTH PLANET SC LETT, V278, P350, DOI 10.1016/j.epsl.2008.12.022; Ricolleau A, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006709; Rohrbach A, 2011, NATURE, V472, P209, DOI 10.1038/nature09899; Shilobreeva S, 2011, GEOCHIM COSMOCHIM AC, V75, P2237, DOI 10.1016/j.gca.2010.11.027; Stachel T, 2005, ELEMENTS, V1, P73, DOI 10.2113/gselements.1.2.73; Stachel T, 2000, CONTRIB MINERAL PETR, V140, P16, DOI 10.1007/s004100000174; Stachel T, 2000, CONTRIB MINERAL PETR, V140, P1, DOI 10.1007/s004100000173; Tappert R, 2005, GEOLOGY, V33, P565, DOI 10.1130/G21637.1; Tappert R, 2009, GEOLOGY, V37, P43, DOI 10.1130/G25055A.1; Torsvik TH, 2010, NATURE, V466, P352, DOI 10.1038/nature09216; VANDECAR JC, 1995, NATURE, V378, P25, DOI 10.1038/378025a0; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0; Walter MJ, 2008, NATURE, V454, P622, DOI 10.1038/nature07132; Wood BJ, 2000, EARTH PLANET SC LETT, V174, P341, DOI 10.1016/S0012-821X(99)00273-3	32	256	287	6	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 7	2011	334	6052					54	57		10.1126/science.1209300	http://dx.doi.org/10.1126/science.1209300			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21921159				2022-12-28	WOS:000295580300036
J	Nakar, E; Piran, T				Nakar, Ehud; Piran, Tsvi			Detectable radio flares following gravitational waves from mergers of binary neutron stars	NATURE			English	Article							GAMMA-RAY BURSTS; COMPACT OBJECT MERGERS; NUCLEOSYNTHESIS; CALORIMETRY; TRANSIENTS; SUPERNOVAE; SIGNATURES; RADIATION; MODELS	Mergers of neutron-star/neutron-star binaries are strong sources of gravitational waves(1-3). They can also launch subrelativistic and mildly relativistic outflows(4-8) and are often assumed to be the sources of short gamma-ray bursts(9). An electromagnetic signature that persisted for weeks to months after the event would strengthen any future claim of a detection of gravitational waves(10). Here we present results of calculations showing that the interaction of mildly relativistic outflows with the surrounding medium produces radio flares with peak emission at 1.4 gigahertz that persist at detectable (submillijansky) levels for weeks, out to a redshift of 0.1. Slower subrelativistic outflows produce flares detectable for years at 150 megahertz, as well as at 1.4 gigahertz, from slightly shorter distances. The radio transient RT 19870422 (ref. 11) has the properties predicted by our model, and its most probable origin is the merger of a compact neutron-star/neutron-star binary. The lack of radio detections usually associated with short gamma-ray bursts does not constrain the radio transients that we discuss here (from mildly relativistic and subrelativistic outflows) because short gamma-ray burst redshifts are typically >0.1 and the appropriate timescales (longer than weeks) have not been sampled.	[Piran, Tsvi] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Nakar, Ehud] Tel Aviv Univ, Raymond & Beverly Sackler Sch Phys & Astron, IL-69978 Tel Aviv, Israel	Hebrew University of Jerusalem; Tel Aviv University	Piran, T (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.	udini@wise.tau.ac.il; tsvi@phys.huji.ac.il		Nakar, Ehud/0000-0002-4534-7089	ERC; Israeli Center for Excellence for High Energy Astrophysics; ISF [174/08]; IRG grant	ERC(European Research Council (ERC)European Commission); Israeli Center for Excellence for High Energy Astrophysics; ISF(Israel Science Foundation); IRG grant	We thank D. Frail, S. Kulkarni, A. Levinson, A. MacFadyen, E. Ofek and S. Rosswog for discussions. This research was supported by an ERC advanced research grant, by the Israeli Center for Excellence for High Energy Astrophysics, by the ISF (grant No. 174/08) and by an IRG grant.	Bower GC, 2007, ASTROPHYS J, V666, P346, DOI 10.1086/519831; Chevalier RA, 1998, ASTROPHYS J, V499, P810, DOI 10.1086/305676; Chevalier RA, 2006, ASTROPHYS J, V651, P381, DOI 10.1086/507606; Dessart L, 2009, ASTROPHYS J, V690, P1681, DOI 10.1088/0004-637X/690/2/1681; EICHLER D, 1989, NATURE, V340, P126, DOI 10.1038/340126a0; ESPOSITO LW, 1975, ASTROPHYS J, V196, pL1, DOI 10.1086/181729; Frail DA, 2000, ASTROPHYS J, V537, P191, DOI 10.1086/309024; Frail DA, 2005, ASTROPHYS J, V619, P994, DOI 10.1086/426680; Hansen BMS, 2001, MON NOT R ASTRON SOC, V322, P695, DOI 10.1046/j.1365-8711.2001.04103.x; Kiuchi K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.141101; KOCHANEK CS, 1993, ASTROPHYS J, V417, pL17, DOI 10.1086/187083; Levinson A, 2006, ASTROPHYS J, V648, P510, DOI 10.1086/505635; Li LX, 1998, ASTROPHYS J, V507, pL59, DOI 10.1086/311680; Metzger BD, 2008, MON NOT R ASTRON SOC, V390, P781, DOI 10.1111/j.1365-2966.2008.13789.x; Metzger BD, 2010, MON NOT R ASTRON SOC, V406, P2650, DOI 10.1111/j.1365-2966.2010.16864.x; Moortgat J, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.023001; Pshirkov MS, 2010, ASTROPHYS SPACE SCI, V330, P13, DOI 10.1007/s10509-010-0395-x; Rezzolla L, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/11/114105; Rhoads JE, 1997, ASTROPHYS J, V487, pL1, DOI 10.1086/310876; Rosswog S, 2005, ASTROPHYS J, V634, P1202, DOI 10.1086/497062; Rosswog S, 2000, ASTRON ASTROPHYS, V360, P171; Smith JR, 2009, CLASSICAL QUANT GRAV, V26, DOI 10.1088/0264-9381/26/11/114013; SODERBERG AM, 2006, 4884 GCN; TAYLOR JH, 1982, ASTROPHYS J, V253, P908, DOI 10.1086/159690; VANDERHORST AJ, 2006, 5390 GCN; WAGONER RV, 1975, ASTROPHYS J, V196, pL63, DOI 10.1086/181745; Wen LQ, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.082001; WIERINGA MH, 2007, 7095 GCN; Yamamoto T, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.064054	30	281	285	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2011	478	7367					82	84		10.1038/nature10365	http://dx.doi.org/10.1038/nature10365			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21964342	Green Submitted			2022-12-28	WOS:000295575400038
J	Peplowski, PN; Evans, LG; Hauck, SA; McCoy, TJ; Boynton, WV; Gillis-Davis, JJ; Ebel, DS; Goldsten, JO; Hamara, DK; Lawrence, DJ; McNutt, RL; Nittler, LR; Solomon, SC; Rhodes, EA; Sprague, AL; Starr, RD; Stockstill-Cahill, KR				Peplowski, Patrick N.; Evans, Larry G.; Hauck, Steven A., II; McCoy, Timothy J.; Boynton, William V.; Gillis-Davis, Jeffery J.; Ebel, Denton S.; Goldsten, John O.; Hamara, David K.; Lawrence, David J.; McNutt, Ralph L., Jr.; Nittler, Larry R.; Solomon, Sean C.; Rhodes, Edgar A.; Sprague, Ann L.; Starr, Richard D.; Stockstill-Cahill, Karen R.			Radioactive Elements on Mercury's Surface from MESSENGER: Implications for the Planet's Formation and Evolution	SCIENCE			English	Article							MAGNETIC-FIELD; RAY	The MESSENGER Gamma-Ray Spectrometer measured the average surface abundances of the radioactive elements potassium (K, 1150 +/- 220 parts per million), thorium (Th, 220 +/- 60 parts per billion), and uranium (U, 90 +/- 20 parts per billion) in Mercury's northern hemisphere. The abundance of the moderately volatile element K, relative to Th and U, is inconsistent with physical models for the formation of Mercury requiring extreme heating of the planet or its precursor materials, and supports formation from volatile-containing material comparable to chondritic meteorites. Abundances of K, Th, and U indicate that internal heat production has declined substantially since Mercury's formation, consistent with widespread volcanism shortly after the end of late heavy bombardment 3.8 billion years ago and limited, isolated volcanic activity since.	[Peplowski, Patrick N.; Goldsten, John O.; Lawrence, David J.; McNutt, Ralph L., Jr.; Rhodes, Edgar A.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Evans, Larry G.] Comp Sci Corp, Lanham, MD 20706 USA; [Hauck, Steven A., II] Case Western Reserve Univ, Dept Geol Sci, Cleveland, OH 44106 USA; [McCoy, Timothy J.; Stockstill-Cahill, Karen R.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20013 USA; [Boynton, William V.; Hamara, David K.; Sprague, Ann L.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Gillis-Davis, Jeffery J.] Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Ebel, Denton S.] Amer Museum Nat Hist, Dept Earth & Planetary Sci, New York, NY 10024 USA; [Nittler, Larry R.; Solomon, Sean C.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Starr, Richard D.] Catholic Univ Amer, Dept Phys, Washington, DC 20064 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Case Western Reserve University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Arizona; University of Hawaii System; American Museum of Natural History (AMNH); Carnegie Institution for Science; Catholic University of America	Peplowski, PN (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	patrick.peplowski@jhuapl.edu	Cahill, Karen/A-6601-2019; Lawrence, David J/E-7463-2015; Hauck, Steven A/A-7865-2008; McNutt, Ralph L/E-8006-2010; Peplowski, Patrick N/I-7254-2012	Cahill, Karen/0000-0002-9017-3110; Lawrence, David J/0000-0002-7696-6667; Hauck, Steven A/0000-0001-8245-146X; McNutt, Ralph L/0000-0002-4722-9166; Peplowski, Patrick N/0000-0001-7154-8143; McCoy, Timothy/0000-0002-4573-3553	NASA [NAS5-97271, NASW-00002]	NASA(National Aeronautics & Space Administration (NASA))	We thank the entire MESSENGER team for their invaluable contributions to the development and operation of the spacecraft. The MESSENGER project is supported by the NASA Discovery Program under contract NAS5-97271 to The Johns Hopkins University Applied Physics Laboratory and NASW-00002 to the Carnegie Institution of Washington. Several authors are supported by NASA's MESSENGER Participating Scientist Program. All original data reported in this paper are archived by the NASA Planetary Data System.	Anderson BJ, 2011, SCIENCE, V333, P1859, DOI 10.1126/science.1211001; Arndt N, 2008, KOMATIITE, P1, DOI 10.1017/CBO9780511535550; Benz W, 2007, SPACE SCI REV, V132, P189, DOI 10.1007/s11214-007-9284-1; CAMERON AGW, 1985, ICARUS, V64, P285, DOI 10.1016/0019-1035(85)90091-0; Denevi BW, 2009, SCIENCE, V324, P613, DOI 10.1126/science.1172226; FEGLEY B, 1987, EARTH PLANET SC LETT, V82, P207, DOI 10.1016/0012-821X(87)90196-8; Goldsten JO, 2007, SPACE SCI REV, V131, P339, DOI 10.1007/s11214-007-9262-7; HAPKE B, 1975, J GEOPHYS RES, V80, P2431, DOI 10.1029/JB080i017p02431; Hauck SA, 2004, EARTH PLANET SC LETT, V222, P713, DOI 10.1016/j.epsl.2004.03.037; Head JW, 2011, SCIENCE, V333, P1853, DOI 10.1126/science.1211997; HOWARD HT, 1974, SCIENCE, V185, P179, DOI 10.1126/science.185.4146.179; Krot AN, 2001, SCIENCE, V291, P1776, DOI 10.1126/science.291.5509.1776; LEWIS JS, 1973, ANNU REV PHYS CHEM, V24, P339, DOI 10.1146/annurev.pc.24.100173.002011; Lodders K., 1998, PLANETARY SCI COMPAN; Malavergne V, 2010, ICARUS, V206, P199, DOI 10.1016/j.icarus.2009.09.001; Margot JL, 2007, SCIENCE, V316, P710, DOI 10.1126/science.1140514; MORGAN JW, 1980, P NATL ACAD SCI USA, V77, P6973, DOI 10.1073/pnas.77.12.6973; NESS NF, 1974, SCIENCE, V185, P151, DOI 10.1126/science.185.4146.151; Nittler LR, 2011, SCIENCE, V333, P1847, DOI 10.1126/science.1211567; Prettyman TH, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002656; Taylor GJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002645; Taylor GJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002676; Taylor GJ, 2005, TREATISE GEOCHEM, V1, P477; Warell J, 2004, ICARUS, V168, P257, DOI 10.1016/j.icarus.2003.10.020; Watters TR, 2009, EARTH PLANET SC LETT, V285, P283, DOI 10.1016/j.epsl.2009.01.025	26	169	171	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051					1850	1852		10.1126/science.1211576	http://dx.doi.org/10.1126/science.1211576			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960624				2022-12-28	WOS:000295365800044
J	Monack, DM				Monack, Denise M.			IMMUNOLOGY Recognition of a unique partner	NATURE			English	Editorial Material							INFLAMMASOME ACTIVATION		[Monack, Denise M.] Stanford Univ, Dept Microbiol & Immunol, Stanford Sch Med, Stanford, CA 94305 USA	Stanford University	Monack, DM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford Sch Med, Stanford, CA 94305 USA.	dmonack@stanford.edu		Monack, Denise/0000-0003-3804-2209				Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	5	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2011	477	7366					543	544		10.1038/477543a	http://dx.doi.org/10.1038/477543a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21956324				2022-12-28	WOS:000295320900027
J	Rodrigues, LC; Mangtani, P; Abubakar, I				Rodrigues, Laura Cunha; Mangtani, Punam; Abubakar, Ibrahim			UNCERTAINTIES PAGE How does the level of BCG vaccine protection against tuberculosis fall over time?	BRITISH MEDICAL JOURNAL			English	Editorial Material							METAANALYSIS; MENINGITIS; EFFICACY	This is one of a series of occasional articles that highlight areas of practice where management lacks convincing supporting evidence. The series adviser is David Tovey, editor in chief, the Cochrane Library. This paper is based on a research priority identified and commissioned by the National Institute for Health Research's Health Technology Assessment programme on an important clinical uncertainty. To suggest a topic for this series, please email us at uncertainties@bmj.com	[Rodrigues, Laura Cunha] London Sch Hyg & Trop Med, Dept Infect Dis, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Abubakar, Ibrahim] Hlth Protect Agcy, TB Sect, London, England; [Abubakar, Ibrahim] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	University of London; London School of Hygiene & Tropical Medicine; Health Protection Agency; University of East Anglia	Rodrigues, LC (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England.	laura.rodrigues@lshtm.ac.uk	RODRIGUES, LAURA CUNHA/AAO-4130-2021	Rodrigues, Laura Cunha/0000-0001-9008-660X; Abubakar, Ibrahim/0000-0002-0370-1430; Mangtani, Punam/0000-0001-7074-2999	National Institute for Health Research [08/17/01, 08/16/01] Funding Source: researchfish; Department of Health [08/17/01, 08/16/01, HTA/08/17/01] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Abubakar I, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4281; Aronson NE, 2004, JAMA-J AM MED ASSOC, V291, P2086, DOI 10.1001/jama.291.17.2086; Barreto ML, 2005, INT J TUBERC LUNG D, V9, P1171; Department of Health, 2011, IMM INF DIS; Fine PE, 1995, LANCET, V46, P1339; FRIMODT-MOLLER J, 1960, Bull World Health Organ, V22, P61; HART PD, 1977, BRIT MED J, V2, P293, DOI 10.1136/bmj.2.6082.293; *INT UN TUB LUNG D, 1994, TUBERCLE LUNG DIS, V75, P179; Joint Committee for Vaccination and Immunisation, 2005, WORK GROUP BCG VACC; Kaufmann SHE, 2011, NAT MED, V17, P159, DOI 10.1038/nm0211-159; *MRC, 1956, BRIT MED J, V1, P413; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Rodrigues LC, 1996, LANCET, V348, P611, DOI 10.1016/S0140-6736(05)64823-4; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Sterne JAC, 1998, INT J TUBERC LUNG D, V2, P200; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; *WHO, 2010, GLOB TUB REP	17	29	31	2	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 29	2011	343								d5974	10.1136/bmj.d5974	http://dx.doi.org/10.1136/bmj.d5974			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829KC	21964347	Green Accepted			2022-12-28	WOS:000295577500002
J	Hermelin, S; Takada, S; Yamamoto, M; Tarucha, S; Wieck, AD; Saminadayar, L; Bauerle, C; Meunier, T				Hermelin, Sylvain; Takada, Shintaro; Yamamoto, Michihisa; Tarucha, Seigo; Wieck, Andreas D.; Saminadayar, Laurent; Baeuerle, Christopher; Meunier, Tristan			Electrons surfing on a sound wave as a platform for quantum optics with flying electrons	NATURE			English	Article							TELEPORTATION; INTERFERENCE; TRANSPORT; SPIN; DOTS	Electrons in a metal are indistinguishable particles that interact strongly with other electrons and their environment. Isolating and detecting a single flying electron after propagation, in a similar manner to quantum optics experiments with single photons(1,2), is therefore a challenging task. So far only a few experiments have been performed in a high-mobility two-dimensional electron gas in which the electron propagates almost ballistically(3-5). In these previous works, flying electrons were detected by means of the current generated by an ensemble of electrons, and electron correlations were encrypted in the current noise. Here we demonstrate the experimental realization of high-efficiency single-electron source and detector for a single electron propagating isolated from the other electrons through a one-dimensional channel. The moving potential is excited by a surface acoustic wave, which carries the single electron along the one-dimensional channel at a speed of 3 mu m ns(-1). When this quantum channel is placed between two quantum dots several micrometres apart, a single electron can be transported from one quantum dot to the other with quantum efficiencies of emission and detection of 96% and 92%, respectively. Furthermore, the transfer of the electron can be triggered on a timescale shorter than the coherence time T-2* of GaAs spin qubits(6). Our work opens new avenues with which to study the teleportation of a single electron spin and the distant interaction between spatially separated qubits in a condensed-matter system.	[Hermelin, Sylvain; Saminadayar, Laurent; Baeuerle, Christopher; Meunier, Tristan] CNRS, Inst Neel, F-38042 Grenoble, France; [Hermelin, Sylvain; Saminadayar, Laurent; Baeuerle, Christopher; Meunier, Tristan] Univ Grenoble 1, F-38042 Grenoble, France; [Takada, Shintaro; Yamamoto, Michihisa; Tarucha, Seigo] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; [Yamamoto, Michihisa] ERATO JST, Kawaguchi, Saitama 3310012, Japan; [Tarucha, Seigo] ICORP Int Cooperat Res Project Quantum Spin Infor, Atsugi, Kanagawa 2430198, Japan; [Wieck, Andreas D.] Ruhr Univ Bochum, Lehrstuhl Angew Festkorperphys, D-44780 Bochum, Germany; [Saminadayar, Laurent] Inst Univ France, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Tokyo; Japan Science & Technology Agency (JST); Ruhr University Bochum; Institut Universitaire de France	Bauerle, C (corresponding author), CNRS, Inst Neel, F-38042 Grenoble, France.	bauerle@grenoble.cnrs.fr; tristan.meunier@grenoble.cnrs.fr	Yamamoto, Michihisa/E-6850-2017; Bäuerle, Christopher/S-8973-2016; Bauerle, Christopher/A-3972-2012; Takada, Shintaro/L-9336-2018; TARUCHA, SEIGO/I-7030-2012; Wieck, Andreas Dirk D/C-5129-2009	Yamamoto, Michihisa/0000-0001-9113-6461; Bäuerle, Christopher/0000-0001-7393-0346; Takada, Shintaro/0000-0002-7831-585X; Wieck, Andreas Dirk D/0000-0001-9776-2922	ERATO-JST [080300000477]; Special Coordination Funds for Promoting Science and Technology (NanoQuine); Japan Science and Technology Agency Strategic International Cooperative Program; Japanese Ministry of Education, Culture, Sports, Science, and Technology; Harvard University; Deutsche Forschungsgemeinschaft [SPP1285]; Bundesministerium fur Bildung und Forschung [QuaHLRep 01BQ1035]; Centre National de la Recherche Scientifique (DREI) - Japan Society for the Promotion of Science [PRC 424, L08519]; Marie-Curie European Reintegration Grant [224786]; Nanoscience Foundation of Grenoble;  [20684011]	ERATO-JST(Japan Science & Technology Agency (JST)); Special Coordination Funds for Promoting Science and Technology (NanoQuine); Japan Science and Technology Agency Strategic International Cooperative Program; Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Harvard University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Centre National de la Recherche Scientifique (DREI) - Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceCentre National de la Recherche Scientifique (CNRS)); Marie-Curie European Reintegration Grant(European Commission); Nanoscience Foundation of Grenoble; 	We thank Y. Launay and P. Perrier for technical support. We acknowledge technical support from the 'Poles E'lectroniques' of the 'Department Nano et MCBT' from the Institut Neel. M. Y. acknowledges financial support by Grant-in-Aid for Young Scientists A (no. 20684011) and ERATO-JST (080300000477). S. T. acknowledges financial support from Special Coordination Funds for Promoting Science and Technology (NanoQuine), Japan Science and Technology Agency Strategic International Cooperative Program, Japanese Ministry of Education, Culture, Sports, Science, and Technology KAKENHI 'Quantum Cybernetics', and Intelligence Advanced Research Projects Activity project 'Multi-Qubit Coherent Operations' through Harvard University. A. D. W. acknowledges expert help from D. Reuter and support of the Deutsche Forschungsgemeinschaft (SPP1285) and the Bundesministerium fur Bildung und Forschung (QuaHLRep 01BQ1035). C. B. acknowledges financial support from Centre National de la Recherche Scientifique (DREI) - Japan Society for the Promotion of Science (nos PRC 424 and L08519). T. M. acknowledges financial support from Marie-Curie European Reintegration Grant 224786. We are grateful to the Nanoscience Foundation of Grenoble for partial financial support of this work.	ASPECT A, 1981, PHYS REV LETT, V47, P460, DOI 10.1103/PhysRevLett.47.460; Bluhm H, 2011, NAT PHYS, V7, P109, DOI 10.1038/NPHYS1856; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Buks E, 1998, NATURE, V391, P871, DOI 10.1038/36057; DELALAMO JA, 1990, APPL PHYS LETT, V56, P78, DOI 10.1063/1.102657; Feve G, 2007, SCIENCE, V316, P1169, DOI 10.1126/science.1141243; FIELD M, 1993, PHYS REV LETT, V70, P1311, DOI 10.1103/PhysRevLett.70.1311; Gustavsson S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.076605; Henny M, 1999, SCIENCE, V284, P296, DOI 10.1126/science.284.5412.296; Ji Y, 2003, NATURE, V422, P415, DOI 10.1038/nature01503; Koppens FHL, 2006, NATURE, V442, P766, DOI 10.1038/nature05065; Liu RC, 1998, NATURE, V391, P263, DOI 10.1038/34611; Meunier T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.126601; Neder I, 2007, NATURE, V448, P333, DOI 10.1038/nature05955; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Roulleau P, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.126802; Splettstoesser J, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.205110; Stevenson RM, 2006, NATURE, V439, P179, DOI 10.1038/nature04446; Stotz JAH, 2005, NAT MATER, V4, P585, DOI 10.1038/nmat1430; Talyanskii VI, 1997, PHYS REV B, V56, P15180, DOI 10.1103/PhysRevB.56.15180; TSUKADA N, 1990, APPL PHYS LETT, V56, P2527, DOI 10.1063/1.102877	24	219	220	4	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2011	477	7365					435	438		10.1038/nature10416	http://dx.doi.org/10.1038/nature10416			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21938064	Green Submitted			2022-12-28	WOS:000295080500034
J	Gross, DM				Gross, Dawn M.			Yitgadal	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Calif San Francisco, Div Hosp Med, Palliat Care Serv, VITAS Innovat Hosp Care, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Gross, DM (corresponding author), Univ Calif San Francisco, Div Hosp Med, Palliat Care Serv, VITAS Innovat Hosp Care, San Francisco, CA 94143 USA.	ajgross@massemd.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2011	306	11					1177	1178		10.1001/jama.2011.1335	http://dx.doi.org/10.1001/jama.2011.1335			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HB	21934044				2022-12-28	WOS:000295033500001
J	Armstrong, PW; Boden, WE				Armstrong, Paul W.; Boden, William E.			Reperfusion Paradox in ST-Segment Elevation Myocardial Infarction	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; IN-HOSPITAL MORTALITY; PRIMARY ANGIOPLASTY; NATIONAL-REGISTRY; SYMPTOM ONSET; THERAPY; TIME; OUTCOMES; RISK; TIMELINESS	A transformation in ST-segment elevation myocardial infarction (STEMI) care in the United States has unfolded. It asserts superior reperfusion with primary percutaneous coronary intervention (PPCI) over fibrinolysis on the basis of studies showing the former method to be superior for reperfusion of patients with STEMI. Although clear benefit has resulted from national programs directed toward achieving shorter times to PPCI in facilities with around-the-clock access, most patients present to non-PPCI hospitals. Because delay to PPCI for most patients with STEMI presenting to non-PPCI centers remains outside current guidelines, many are denied benefit from pharmacologic therapy. This article describes why this approach creates a treatment paradox in which more effort to improve treatment for patients with PPCI for acute STEMI often leads to unnecessary avoidance and delay in the use of fibrinolysis. Recent evidence confirms the unfavorable consequences of delay to PPCI and that early prehospital fibrinolysis combined with strategic mechanical co-interventions affords excellent outcomes. The authors believe it is time to embrace an integrated dual reperfusion strategy to best serve all patients with STEMI.	[Armstrong, Paul W.] Univ Alberta, Edmonton, AB T6G 2H7, Canada; Buffalo Gen Hosp, Buffalo, NY 14203 USA	University of Alberta; Buffalo General Medical Center	Armstrong, PW (corresponding author), Univ Alberta, 2-51 MSB, Edmonton, AB T6G 2H7, Canada.	paul.armstrong@ualberta.ca		Armstrong, Paul/0000-0002-0460-3445				Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; ANTMAN EM, 2004, ACC AHA GUIDELINES M; Armstrong PW, 2009, J AM COLL CARDIOL, V53, P1503, DOI 10.1016/j.jacc.2009.01.046; Armstrong PW, 2009, CIRCULATION, V119, P1293, DOI 10.1161/CIRCULATIONAHA.108.796383; Bates ER, 2008, CIRCULATION, V118, P567, DOI 10.1161/CIRCULATIONAHA.108.788620; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Henry TD, 2007, CIRCULATION, V116, P721, DOI 10.1161/CIRCULATIONAHA.107.694141; Kadakia MB, 2010, JACC-CARDIOVASC INTE, V3, P1166, DOI 10.1016/j.jcin.2010.08.015; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Lambert L, 2010, JAMA-J AM MED ASSOC, V303, P2148, DOI 10.1001/jama.2010.712; Magid DJ, 2005, JAMA-J AM MED ASSOC, V294, P803, DOI 10.1001/jama.294.7.803; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P1356, DOI 10.1001/jama.286.11.1356; Nallamothu BK, 2005, CIRCULATION, V111, P761, DOI 10.1161/01.CIR.0000155258.44268.F8; Peterson ED, 2007, CIRCULATION, V116, pE64, DOI 10.1161/CIRCULATIONAHA.107.184051; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Stone GW, 2008, CIRCULATION, V118, P538, DOI 10.1161/CIRCULATIONAHA.107.756494; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; Thune JJ, 2005, CIRCULATION, V112, P2017, DOI 10.1161/CIRCULATIONAHA.105.558676; Verheugt FWA, 2006, EUR HEART J, V27, P901, DOI 10.1093/eurheartj/ehi829; Westerhout CM, 2011, AM HEART J, V161, P283, DOI 10.1016/j.ahj.2010.10.033; Williams DO, 2004, CIRCULATION, V109, P1806, DOI 10.1161/01.CIR.0000126892.17646.83	22	36	40	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6					389	391		10.7326/0003-4819-155-6-201109200-00008	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-00008			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930857				2022-12-28	WOS:000295033400019
J	Ning, G; Bi, YF; Wang, TG; Xu, M; Xu, Y; Huang, Y; Li, MA; Li, XY; Wang, WQ; Chen, YH; Wu, YH; Hou, JN; Song, AY; Liu, Y; Lai, SH				Ning, Guang; Bi, Yufang; Wang, Tiange; Xu, Min; Xu, Yu; Huang, Yun; Li, Mian; Li, Xiaoying; Wang, Weiqing; Chen, Yuhong; Wu, Yaohua; Hou, Jianing; Song, Aiyun; Liu, Yu; Lai, Shenghan			Relationship of Urinary Bisphenol A Concentration to Risk for Prevalent Type 2 Diabetes in Chinese Adults A Cross-sectional Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							ESTROGEN-RECEPTOR; POPULATION; EXPOSURE; ALPHA	Background: Greater bisphenol A exposure has been shown to be associated with a higher risk for self-reported adverse health outcomes, including diabetes. Objective: To examine the association between bisphenol A exposure and type 2 diabetes in adults. Design: Cross-sectional study. Setting: Songnan, Baoshan District, Shanghai, China. Participants: 3423 local residents aged 40 years or older who were enrolled from 27 June 2008 to 10 August 2009. Measurements: Urinary concentrations of bisphenol A from morning spot urine samples (exposure) and fasting plasma glucose concentration, plasma glucose concentration 2 hours after an oral glucose tolerance test, and serum insulin concentration (outcomes). Results: Median age of the participants was 59.0 years (interquartile range, 53.0 to 68.7 years), 40% were men, and 1087 had type 2 diabetes. The median urinary bisphenol A level was 0.81 ng/mL (interquartile range, 0.47 to 1.43 ng/mL). Clinical characteristics differed between participants with normal glucose regulation and those with impaired glucose regulation and by bisphenol A quartile, but in multivariable analyses, there was no clear association between bisphenol A levels and type 2 diabetes. The adjusted odds ratio (OR) of type 2 diabetes was slightly increased for participants in the second bisphenol A quartile (0.48 to 0.81 ng/mL) (adjusted OR, 1.30 [95% CI, 1.03 to 1.64]) and the fourth quartile (>1.43 ng/mL) (adjusted OR, 1.37 [CI, 1.08 to 1.74]) but not the third quartile (0.82 to 1.43 ng/mL) (adjusted OR, 1.09 [CI, 0.86 to 1.39]), and a test of the trend of the association was not statistically significant. Limitations: The cross-sectional study design and nonrandom sample of participants limit the conclusions that can be drawn. Many patients in the study already had diabetes, successful treatment of which could have obscured apparent associations. Dietary variables were not measured; however, this is necessary in observational studies of bisphenol A and diabetes because the presence of the chemical in the body may reflect consumption of sugared drinks in plastic bottles. Conclusion: These findings do not confirm a previously reported association between urinary bisphenol A levels and self-reported type 2 diabetes.	[Ning, Guang] Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Dept Endocrinol & Metab,Rui Jin Hosp,Sch Med, Shanghai 200025, Peoples R China; Shanghai Jiao Tong Univ, Key Lab Endocrine & Metab Dis, Minist Hlth, Rui Jin Hosp,Sch Med,E Inst Shanghai Univ, Shanghai 200025, Peoples R China; Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Johns Hopkins University	Ning, G (corresponding author), Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Dept Endocrinol & Metab,Rui Jin Hosp,Sch Med, 197 Rui Jin 2nd Rd, Shanghai 200025, Peoples R China.	gning@sibs.ac.cn	Li, Mian/HGE-6038-2022	Li, Xiaoying/0000-0002-9383-5757	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health [1994DP131044]; Ministry of Science and Technology [2008ZX09312-019, 2008BAI52B03]; Ministry of Health [201002002]; Creative Research Group of Ministry of Education [IRT0932]; Shanghai Committee of Science and Technology [09DZ1950200]; National Natural Science Foundation of China [30725037]	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health; Creative Research Group of Ministry of Education; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health, National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology, Sector Funds of Ministry of Health, Creative Research Group of Ministry of Education, Major Project of Shanghai Committee of Science and Technology, National Key Technologies Research and Development Program of Ministry of Science and Technology, and the National Natural Science Foundation of China.; By Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health (1994DP131044), National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology (2008ZX09312-019), Sector Funds of Ministry of Health (201002002), Creative Research Group of Ministry of Education (IRT0932), Major Project of Shanghai Committee of Science and Technology (09DZ1950200), National Key Technologies Research and Development Program of Ministry of Science and Technology (2008BAI52B03), and the National Natural Science Foundation of China (30725037).	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Alonso-Magdalena P, 2005, ENVIRON HEALTH PERSP, V113, P969, DOI 10.1289/ehp.8002; Alonso-Magdalena P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002069; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Dekant W, 2008, TOXICOL APPL PHARM, V228, P114, DOI 10.1016/j.taap.2007.12.008; Hastie TJ., 2017, GEN ADDITIVE MODELS; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hugo ER, 2008, ENVIRON HEALTH PERSP, V116, P1642, DOI 10.1289/ehp.11537; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Nadal A, 2009, MOL CELL ENDOCRINOL, V304, P63, DOI 10.1016/j.mce.2009.02.016; Ropero AB, 2008, INT J ANDROL, V31, P194, DOI 10.1111/j.1365-2605.2007.00832.x; Rosenberg PS, 2003, STAT MED, V22, P3369, DOI 10.1002/sim.1638; US FDA, 2010, UPD BISPH BPA US FOO; Vogel Sarah A, 2009, Am J Public Health, V99 Suppl 3, pS559, DOI 10.2105/AJPH.2008.159228; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010	18	102	114	3	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6					368	U62		10.7326/0003-4819-155-6-201109200-00005	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930854				2022-12-28	WOS:000295033400016
J	Ferreira, MAR; Matheson, MC; Duffy, DL; Marks, GB; Hui, JN; Le Souef, P; Danoy, P; Baltic, S; Nyholt, DR; Jenkins, M; Hayden, C; Willemsen, G; Ang, W; Kuokkanen, M; Beilby, J; Cheah, F; de Geus, EJC; Ramasamy, A; Vedantam, S; Salomaa, V; Madden, PA; Heath, AC; Hopper, JL; Visscher, PM; Musk, B; Leeder, SR; Jarvelin, MR; Pennell, C; Boomsma, DI; Hirschhorn, JN; Walters, H; Martin, NG; James, A; Jones, G; Abramson, MJ; Robertson, CF; Dharmage, SC; Brown, MA; Montgomery, GW; Thompson, PJ				Ferreira, Manuel A. R.; Matheson, Melanie C.; Duffy, David L.; Marks, Guy B.; Hui, Jennie; Le Souef, Peter; Danoy, Patrick; Baltic, Svetlana; Nyholt, Dale R.; Jenkins, Mark; Hayden, Catherine; Willemsen, Gonneke; Ang, Wei; Kuokkanen, Mikko; Beilby, John; Cheah, Faang; de Geus, Eco J. C.; Ramasamy, Adaikalavan; Vedantam, Sailaja; Salomaa, Veikko; Madden, Pamela A.; Heath, Andrew C.; Hopper, John L.; Visscher, Peter M.; Musk, Bill; Leeder, Stephen R.; Jarvelin, Marjo-Riitta; Pennell, Craig; Boomsma, Dorret I.; Hirschhorn, Joel N.; Walters, Haydn; Martin, Nicholas G.; James, Alan; Jones, Graham; Abramson, Michael J.; Robertson, Colin F.; Dharmage, Shyamali C.; Brown, Matthew A.; Montgomery, Grant W.; Thompson, Philip J.		Australian Asthma Genetics Consort	Identification of IL6R and chromosome 11q13.5 as risk loci for asthma	LANCET			English	Article							GENOME-WIDE ASSOCIATION; GENETIC RISK; DISEASE; VARIANTS; ECZEMA; HERITABILITY; METAANALYSIS; EXPRESSION; PREDICTION; CHILDHOOD	Background We aimed to identify novel genetic variants affecting asthma risk, since these might provide novel insights into molecular mechanisms underlying the disease. Methods We did a genome-wide association study (GWAS) in 2669 physician-diagnosed asthmatics and 4528 controls from Australia. Seven loci were prioritised for replication after combining our results with those from the GABRIEL consortium (n=26 475), and these were tested in an additional 25 358 independent samples from four in-silico cohorts. Quantitative multi-marker scores of genetic load were constructed on the basis of results from the GABRIEL study and tested for association with asthma in our Australian GWAS dataset. Findings Two loci were confirmed to associate with asthma risk in the replication cohorts and reached genome-wide significance in the combined analysis of all available studies (n=57 800): rs4129267 (OR 1.09, combined p=2.4x10(-8)) in the interleukin-6 receptor (IL6R) gene and rs7130588 (OR 1.09, p=1.8x10(-8)) on chromosome 11q13.5 near the leucine-rich repeat containing 32 gene (LRRC32, also known as GARP). The 11q13.5 locus was significantly associated with atopic status among asthmatics (OR 1.33, p=7x10(-4)), suggesting that it is a risk factor for allergic but not non-allergic asthma. Multi-marker association results are consistent with a highly polygenic contribution to asthma risk, including loci with weak effects that might be shared with other immune-related diseases, such as NDFIP1, HLA-B, LPP, and BACH2. Interpretation The IL6R association further supports the hypothesis that cytokine signalling dysregulation affects asthma risk, and raises the possibility that an IL6R antagonist (tocilizumab) may be effective to treat the disease, perhaps in a genotype-dependent manner. Results for the 11q13.5 locus suggest that it directly increases the risk of allergic sensitisation which, in turn, increases the risk of subsequent development of asthma. Larger or more functionally focused studies are needed to characterise the many loci with modest effects that remain to be identified for asthma.	[Ferreira, Manuel A. R.; Duffy, David L.; Nyholt, Dale R.; Visscher, Peter M.; Martin, Nicholas G.; Montgomery, Grant W.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Matheson, Melanie C.; Jenkins, Mark; Hopper, John L.; Dharmage, Shyamali C.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Hui, Jennie; Beilby, John] Univ Western Australia, PathW Lab Med Western Australia, Nedlands, WA 6009, Australia; [Hui, Jennie; Musk, Bill] Univ Western Australia, Sch Populat Hlth, Nedlands, WA 6009, Australia; [Hui, Jennie; Beilby, John] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Hui, Jennie; Beilby, John; Musk, Bill; James, Alan] Sir Charles Gairdner Hosp, Busselton Populat Med Res Fdn, Perth, WA, Australia; [Le Souef, Peter; Hayden, Catherine] Princess Margaret Hosp Children, Sch Paediat & Child Hlth, Perth, WA, Australia; [Danoy, Patrick; Brown, Matthew A.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld, Australia; [Baltic, Svetlana; Cheah, Faang; Thompson, Philip J.] Univ Western Australia, Lung Inst Western Australia, Perth, WA 6009, Australia; [Baltic, Svetlana; Cheah, Faang; Thompson, Philip J.] Univ Western Australia, Ctr Asthma Allergy & Resp Res, Perth, WA 6009, Australia; [Willemsen, Gonneke; de Geus, Eco J. C.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, EMGO & NCA Inst, Amsterdam, Netherlands; [Ang, Wei; Pennell, Craig] Univ Western Australia, Sch Womens & Infants Hlth, Subiaco, WA, Australia; [Kuokkanen, Mikko; Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Ramasamy, Adaikalavan] Univ London Imperial Coll Sci Technol & Med, London, England; [Vedantam, Sailaja; Hirschhorn, Joel N.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Vedantam, Sailaja; Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Vedantam, Sailaja; Hirschhorn, Joel N.] Broad Inst, Cambridge, MA USA; [Madden, Pamela A.; Heath, Andrew C.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Musk, Bill] Sir Charles Gairdner Hosp, Dept Resp Med, Perth, WA, Australia; [Musk, Bill; James, Alan] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Leeder, Stephen R.] Univ Sydney, Australian Hlth Policy Inst, Sydney, NSW 2006, Australia; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Walters, Haydn] Menzies Res Inst, Hobart, Tas, Australia; [James, Alan] W Australian Sleep Disorders Res Inst, Dept Pulm Physiol, Nedlands, WA, Australia; [Jones, Graham] Univ Western Sydney, Penrith, NSW 1797, Australia; [Abramson, Michael J.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Robertson, Colin F.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia	QIMR Berghofer Medical Research Institute; University of Melbourne; University of Sydney; Woolcock Institute of Medical Research; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Queensland; University of Western Australia; University of Western Australia; Vrije Universiteit Amsterdam; University of Western Australia; Finland National Institute for Health & Welfare; Imperial College London; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Washington University (WUSTL); University of Western Australia; University of Western Australia; University of Sydney; Imperial College London; Harvard University; Harvard Medical School; University of Tasmania; Menzies Institute for Medical Research; Western Sydney University; Monash University; Murdoch Children's Research Institute	Ferreira, MAR (corresponding author), Royal Brisbane Hosp, Queensland Inst Med Res, Locked Bag 2000, Herston, Qld 4029, Australia.	manuel.ferreira@qimr.edu.au	de Geus, Eco J.C./M-9318-2015; Mitrpant, Chalermchai/AAX-6699-2021; Visscher, Peter/ABB-6151-2020; Palmer, Lyle John/K-3196-2014; Abramson, Michael/AAQ-2671-2020; Hui, Jennie/A-9543-2013; Kuokkanen, Mikko/M-8247-2016; Wright, Margaret J/H-3308-2014; Marks, Guy B./F-5058-2013; Nyholt, Dale Robert/J-3174-2017; WALTERS, Eugene/AAL-2264-2021; Baltic, Svetlana/C-2313-2014; Boomsma, Dorret I/AAX-4470-2020; Matheson, Melanie C/O-4721-2015; Warrington, Nicole/P-4868-2014; Study, Raine/K-4517-2013; Wright, Margaret Jane/A-4560-2016; Le Souef, Peter N/H-5256-2014; Martin, Nicholas/R-9235-2019; Montgomery, Grant W/B-7148-2008; Ferreira, Manuel A R/D-3609-2013; Pennell, Craig/ABD-6902-2020; Ramasamy, Adaikalavan/G-2632-2010; Duffy, David L/B-7392-2013; Brown, Matthew A/E-5749-2010; Sly, Peter D/F-1486-2010; Jenkins, Mark/P-7803-2015	de Geus, Eco J.C./0000-0001-6022-2666; Mitrpant, Chalermchai/0000-0001-9311-7977; Visscher, Peter/0000-0002-2143-8760; Palmer, Lyle John/0000-0002-1628-3055; Abramson, Michael/0000-0002-9954-0538; Hui, Jennie/0000-0002-1653-2496; Kuokkanen, Mikko/0000-0003-4375-9327; Marks, Guy B./0000-0002-8976-8053; Nyholt, Dale Robert/0000-0001-7159-3040; Matheson, Melanie C/0000-0002-5822-3499; Warrington, Nicole/0000-0003-4195-775X; Wright, Margaret Jane/0000-0001-7133-4970; Martin, Nicholas/0000-0003-4069-8020; Montgomery, Grant W/0000-0002-4140-8139; Ferreira, Manuel A R/0000-0001-9059-1825; Pennell, Craig/0000-0002-0937-6165; Ramasamy, Adaikalavan/0000-0002-7598-2892; Duffy, David L/0000-0001-7227-632X; Brown, Matthew A/0000-0003-0538-8211; Sly, Peter D/0000-0001-6305-2201; Dharmage, Shyamali/0000-0001-6063-1937; Whitfield, John/0000-0002-1103-0876; Willemsen, Gonneke/0000-0003-3755-0236; Jenkins, Mark/0000-0002-8964-6160; Walters, Eugene/0000-0002-0993-4374; Le Souef, Peter/0000-0003-0930-1654; Britton, Warwick/0000-0001-6721-9646; Flynn, Loren/0000-0001-5249-547X; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Baltic, Svetlana/0000-0002-3428-940X	GlaxoSmithKline; Novartis; Sunovion Inc; Boehringer Ingelheim; AstraZeneca; Merck; Australian National Health and Medical Research Council [613627]; Medical Research Council [G0801056B] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042157] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679, R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268, R01MH066206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS062691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010249, R01AA013321, R01AA014041, R37AA007728, R01AA007728, R01AA013320, K05AA017688, P60AA011998, R01AA007535, R01AA013326, P50AA011998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA012854, R01DA012854] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Sunovion Inc; Boehringer Ingelheim(Boehringer Ingelheim); AstraZeneca(AstraZeneca); Merck(Merck & Company); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	MAF owns stock in Illumina, Roche, and Complete Genomics. PST's institution has received consulting fees from GlaxoSmithKline as a result of activities outside this work. PST has received lecture fees from GlaxoSmithKline and Novartis. GTO has received consulting fees from Novartis and Sunovion Inc, as a result of work unrelated to this study. G BM was a board member of Novartis; GBM's institution received fees for lectures and preparation of educational presentations from Boehringer Ingelheim and AstraZeneca. CFR received consulting fees from GlaxoSmithKline and Merck as a result of activities outside this work. ASK's institution received speaker's fees from Nutricia. All other authors declare that they have no conflicts of interest.; The Australian Asthma Genetics Consortium was supported by the Australian National Health and Medical Research Council (613627). Detailed acknowledgments and funding sources are provided in the webappendix (pp 27-30).	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Burgess JA, 2008, J ALLERGY CLIN IMMUN, V122, P280, DOI 10.1016/j.jaci.2008.05.018; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Doganci A, 2005, J CLIN INVEST, V115, P313, DOI 10.1172/JCI200522433; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Evans DM, 2009, HUM MOL GENET, V18, P3525, DOI 10.1093/hmg/ddp295; Ferreira MAR, 2011, EUR J HUM GENET, V19, P458, DOI 10.1038/ejhg.2010.191; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hindorff LA, CATALOG PUBLISHED GE; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Lowe AJ, 2007, CLIN EXP ALLERGY, V37, P1624, DOI 10.1111/j.1365-2222.2007.02822.x; Lowe AJ, 2008, J ALLERGY CLIN IMMUN, V121, P1190, DOI 10.1016/j.jaci.2008.01.034; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marenholz I, 2011, HUM MOL GENET, V20, P2443, DOI 10.1093/hmg/ddr117; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Oliver PM, 2006, IMMUNITY, V25, P929, DOI 10.1016/j.immuni.2006.10.012; Patel AM, 2010, DRUG DES DEV THER, V4, P263, DOI 10.2147/DDDT.S14099; Paynter NP, 2010, JAMA-J AM MED ASSOC, V303, P631, DOI 10.1001/jama.2010.119; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Schuttelaar MLA, 2009, ALLERGY, V64, P1758, DOI 10.1111/j.1398-9995.2009.02080.x; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yokoyama A, 1997, AM J RESP CRIT CARE, V156, P1688, DOI 10.1164/ajrccm.156.5.9610070	36	279	290	1	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2011	378	9795					1006	1014		10.1016/S0140-6736(11)60874-X	http://dx.doi.org/10.1016/S0140-6736(11)60874-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HO	21907864	Green Accepted, Green Submitted			2022-12-28	WOS:000295193200026
J	Franzen, D; Bloch, KE				Franzen, Daniel; Bloch, Konrad E.			Something in the air	LANCET			English	Editorial Material							UNKNOWN ORIGIN; FEVER		[Franzen, Daniel; Bloch, Konrad E.] Univ Zurich Hosp, Dept Pneumol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Franzen, D (corresponding author), Univ Zurich Hosp, Dept Pneumol, CH-8091 Zurich, Switzerland.	daniel.franzen@usz.ch						Arnow PM, 1997, LANCET, V350, P575, DOI 10.1016/S0140-6736(97)07061-X; Cunha BA, 2007, INFECT DIS CLIN N AM, V21, P1137, DOI 10.1016/j.idc.2007.09.004; Mohr LC, 2004, CURR OPIN PULM MED, V10, P401, DOI 10.1097/01.mcp.0000135675.95674.29; Mourad O, 2003, ARCH INTERN MED, V163, P545, DOI 10.1001/archinte.163.5.545; PETERSDORF RG, 1992, ARCH INTERN MED, V152, P21, DOI 10.1001/archinte.152.1.21	5	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 10	2011	378	9795					1048	1048		10.1016/S0140-6736(11)60922-7	http://dx.doi.org/10.1016/S0140-6736(11)60922-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HO	21907868				2022-12-28	WOS:000295193200030
J	Meredith, RW; Janecka, JE; Gatesy, J; Ryder, OA; Fisher, CA; Teeling, EC; Goodbla, A; Eizirik, E; Simao, TLL; Stadler, T; Rabosky, DL; Honeycutt, RL; Flynn, JJ; Ingram, CM; Steiner, C; Williams, TL; Robinson, TJ; Burk-Herrick, A; Westerman, M; Ayoub, NA; Springer, MS; Murphy, WJ				Meredith, Robert W.; Janecka, Jan E.; Gatesy, John; Ryder, Oliver A.; Fisher, Colleen A.; Teeling, Emma C.; Goodbla, Alisha; Eizirik, Eduardo; Simao, Taiz L. L.; Stadler, Tanja; Rabosky, Daniel L.; Honeycutt, Rodney L.; Flynn, John J.; Ingram, Colleen M.; Steiner, Cynthia; Williams, Tiffani L.; Robinson, Terence J.; Burk-Herrick, Angela; Westerman, Michael; Ayoub, Nadia A.; Springer, Mark S.; Murphy, William J.			Impacts of the Cretaceous Terrestrial Revolution and KPg Extinction on Mammal Diversification	SCIENCE			English	Article							PHYLOGENY; EVOLUTION; DIVERGENCE	Previous analyses of relations, divergence times, and diversification patterns among extant mammalian families have relied on supertree methods and local molecular clocks. We constructed a molecular supermatrix for mammalian families and analyzed these data with likelihood-based methods and relaxed molecular clocks. Phylogenetic analyses resulted in a robust phylogeny with better resolution than phylogenies from supertree methods. Relaxed clock analyses support the long-fuse model of diversification and highlight the importance of including multiple fossil calibrations that are spread across the tree. Molecular time trees and diversification analyses suggest important roles for the Cretaceous Terrestrial Revolution and Cretaceous-Paleogene (KPg) mass extinction in opening up ecospace that promoted interordinal and intraordinal diversification, respectively. By contrast, diversification analyses provide no support for the hypothesis concerning the delayed rise of present-day mammals during the Eocene Period.	[Meredith, Robert W.; Gatesy, John; Burk-Herrick, Angela; Ayoub, Nadia A.; Springer, Mark S.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Janecka, Jan E.; Fisher, Colleen A.; Murphy, William J.] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Ryder, Oliver A.; Steiner, Cynthia] San Diego Zoo, Inst Conservat Res, Escondido, CA 92027 USA; [Teeling, Emma C.; Goodbla, Alisha] Univ Coll Dublin, UCD Sch Biol & Environm Sci, Dublin 4, Ireland; [Eizirik, Eduardo; Simao, Taiz L. L.] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, BR-90619900 Porto Alegre, RS, Brazil; [Stadler, Tanja] ETH, Inst Integrat Biol, CH-8092 Zurich, Switzerland; [Rabosky, Daniel L.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Honeycutt, Rodney L.] Pepperdine Univ, Div Nat Sci, Malibu, CA 90263 USA; [Flynn, John J.; Ingram, Colleen M.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Flynn, John J.; Ingram, Colleen M.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Flynn, John J.] Amer Museum Nat Hist, Richard Glider Grad Sch, New York, NY 10024 USA; [Williams, Tiffani L.] Texas A&M Univ, Dept Comp Sci, College Stn, TX 77843 USA; [Robinson, Terence J.] Univ Stellenbosch, Dept Bot & Zool, ZA-7602 Matieland, South Africa; [Burk-Herrick, Angela] Chaffey Coll, Rancho Cucamonga, CA 91737 USA; [Westerman, Michael] La Trobe Univ, Dept Genet, Bundoora, Vic 3086, Australia; [Ayoub, Nadia A.] Washington & Lee Univ, Dept Biol, Lexington, VA 24450 USA	University of California System; University of California Riverside; Texas A&M University System; Texas A&M University College Station; Zoological Society of San Diego; University College Dublin; Pontificia Universidade Catolica Do Rio Grande Do Sul; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Berkeley; Pepperdine University; American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); Texas A&M University System; Texas A&M University College Station; Stellenbosch University; La Trobe University; Washington & Lee University	Springer, MS (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	mark.springer@ucr.edu; wmurphy@cvm.tamu.edu	Eizirik, Eduardo/K-8034-2012; Rabosky, Daniel L/G-4530-2015; Stadler, Tanja/J-4742-2013; Robinson, Terence J./K-7342-2017	Eizirik, Eduardo/0000-0002-9658-0999; Stadler, Tanja/0000-0001-6431-535X; Goodbla, Alisha/0000-0003-0416-2069; Teeling, Emma/0000-0002-3309-1346; Ayoub, Nadia/0000-0003-4404-1472; Robinson, Terence J./0000-0002-4298-4891	NSF [EF0629860, EF0629849]; Science Foundation Ireland [06/YI3/B932]; CNPq-Brazil; South African National Research Foundation	NSF(National Science Foundation (NSF)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); South African National Research Foundation(National Research Foundation - South Africa)	Supported by NSF (EF0629860 to M. S. S. and J.G.; EF0629849 to W.J.M., R.L.H and T.L.W.), Science Foundation Ireland PIYRA 06/YI3/B932 to E.C.T., CNPq-Brazil to E.E., and South African National Research Foundation to T.J.R. New GenBank accession numbers: JN413803 to JN415086 and JN632710 to JN633870. TreeBase ID: S11872. The Zoological Society of San Diego provided samples for this project under materials transfer agreements as indicated in Materials and Methods. Requests for materials should be directed to authors and/or institutions as stipulated in Materials and Methods.	ADKINS RM, 1991, P NATL ACAD SCI USA, V88, P10317, DOI 10.1073/pnas.88.22.10317; [Anonymous], 1999, WALKERS MAMMALS WORL; Archibald J. David, 2001, Journal of Mammalian Evolution, V8, P107, DOI 10.1023/A:1011317930838; Benton MJ, 2010, PHILOS T R SOC B, V365, P3667, DOI 10.1098/rstb.2010.0269; Benton Michael J., 2009, P35; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Cooper N, 2010, AM NAT, V175, P727, DOI 10.1086/652466; Davies TJ, 2008, P NATL ACAD SCI USA, V105, P11556, DOI 10.1073/pnas.0801917105; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; Hou ZC, 2009, MOL PHYLOGENET EVOL, V52, P660, DOI 10.1016/j.ympev.2009.05.002; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Liu L, 2009, MOL PHYLOGENET EVOL, V53, P320, DOI 10.1016/j.ympev.2009.05.033; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; MARSHALL CR, 1994, P NATL ACAD SCI USA, V91, P12283, DOI 10.1073/pnas.91.25.12283; Meredith RW, 2008, J MAMM EVOL, V15, P1, DOI 10.1007/s10914-007-9062-6; Meredith RW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000634; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Nishihara H, 2009, P NATL ACAD SCI USA, V106, P5235, DOI 10.1073/pnas.0809297106; PETTIGREW JD, 1986, SCIENCE, V231, P1304, DOI 10.1126/science.3945827; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Springer MS, 1997, NATURE, V388, P61, DOI 10.1038/40386; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; VANVALEN L, 1971, EVOLUTION, V25, P420, DOI 10.1111/j.1558-5646.1971.tb01898.x; Wible JR, 2007, NATURE, V447, P1003, DOI 10.1038/nature05854; Wildman DE, 2007, P NATL ACAD SCI USA, V104, P14395, DOI 10.1073/pnas.0704342104; Wilson D. E., 2005, MAMMAL SPECIES WORLD; [No title captured]	32	968	990	6	437	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2011	334	6055					521	524		10.1126/science.1211028	http://dx.doi.org/10.1126/science.1211028			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	21940861				2022-12-28	WOS:000296230500049
J	Schmidt, MWI; Torn, MS; Abiven, S; Dittmar, T; Guggenberger, G; Janssens, IA; Kleber, M; Kogel-Knabner, I; Lehmann, J; Manning, DAC; Nannipieri, P; Rasse, DP; Weiner, S; Trumbore, SE				Schmidt, Michael W. I.; Torn, Margaret S.; Abiven, Samuel; Dittmar, Thorsten; Guggenberger, Georg; Janssens, Ivan A.; Kleber, Markus; Koegel-Knabner, Ingrid; Lehmann, Johannes; Manning, David A. C.; Nannipieri, Paolo; Rasse, Daniel P.; Weiner, Steve; Trumbore, Susan E.			Persistence of soil organic matter as an ecosystem property	NATURE			English	Article							BLACK CARBON; TEMPERATURE SENSITIVITY; MOLECULAR-STRUCTURE; MICROBIAL COMMUNITIES; LITTER DECOMPOSITION; PERMAFROST CARBON; HUMIC SUBSTANCES; NITROGEN; STABILIZATION; DYNAMICS	Globally, soil organic matter (SOM) contains more than three times as much carbon as either the atmosphere or terrestrial vegetation. Yet it remains largely unknown why some SOM persists for millennia whereas other SOM decomposes readily-and this limits our ability to predict how soils will respond to climate change. Recent analytical and experimental advances have demonstrated that molecular structure alone does not control SOM stability: in fact, environmental and biological controls predominate. Here we propose ways to include this understanding in a new generation of experiments and soil carbon models, thereby improving predictions of the SOM response to global warming.	[Schmidt, Michael W. I.; Abiven, Samuel] Univ Zurich, Dept Geog, CH-8050 Zurich, Switzerland; [Torn, Margaret S.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Torn, Margaret S.] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Max Planck Res Grp Marine Geochem, Inst Chem & Biol Marine Environm, D-26129 Oldenburg, Germany; [Dittmar, Thorsten] Max Planck Inst Marine Microbiol, Max Planck Res Grp Marine Geochem, D-28359 Bremen, Germany; [Guggenberger, Georg] Leibniz Univ Hannover, Inst Soil Sci, D-30419 Hannover, Germany; [Janssens, Ivan A.] Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium; [Kleber, Markus] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA; [Koegel-Knabner, Ingrid] Tech Univ Munich, Lehrstuhl Bodenkunde, D-85354 Freising Weihenstephan, Germany; [Lehmann, Johannes] Cornell Univ, Dept Crop & Soil Sci, Atkinson Ctr Sustainable Future, Ithaca, NY 14853 USA; [Manning, David A. C.] Newcastle Univ, Sch Civil Engn & Geosci, Inst Res Environm & Sustainabil, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Nannipieri, Paolo] Univ Florence, Dept Plant Soil & Environm Sci, I-50144 Florence, Italy; [Rasse, Daniel P.] Norwegian Inst Agr & Environm Res, N-1432 As, Norway; [Weiner, Steve] Weizmann Inst Sci, IL-76100 Rehovot, Israel; [Trumbore, Susan E.] Max Planck Inst Biogeochem, D-07745 Jena, Germany	University of Zurich; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Carl von Ossietzky Universitat Oldenburg; Max Planck Society; Max Planck Society; Leibniz University Hannover; University of Antwerp; Oregon State University; Technical University of Munich; Cornell University; Newcastle University - UK; University of Florence; Bioforsk; Weizmann Institute of Science; Max Planck Society	Schmidt, MWI (corresponding author), Univ Zurich, Dept Geog, CH-8050 Zurich, Switzerland.	Michael.Schmidt@geo.uzh.ch; mstorn@lbl.gov	Abiven, Samuel/J-5328-2013; Janssens, Ivan A/P-1331-2014; Trumbore, Susan/B-1948-2013; Manning, David/P-3471-2019; Kleber, Markus/M-1381-2019; Schmidt, Michael/G-5186-2012; Lehmann, Johannes/H-2682-2014; Torn, Margaret/CAF-8960-2022; Guggenberger, Georg/C-8423-2013; Rasse, Daniel/H-7279-2019; Manning, David A C/I-3771-2012; Torn, Margaret S/D-2305-2015; Dittmar, Thorsten/L-7796-2013; Kögel-Knabner, Ingrid/A-7905-2008	Abiven, Samuel/0000-0002-5663-0912; Janssens, Ivan A/0000-0002-5705-1787; Manning, David/0000-0003-3473-120X; Kleber, Markus/0000-0002-5681-2361; Schmidt, Michael/0000-0002-7227-0646; Lehmann, Johannes/0000-0002-4701-2936; Torn, Margaret/0000-0002-8174-0099; Guggenberger, Georg/0000-0002-6962-8264; Rasse, Daniel/0000-0002-5977-3863; Torn, Margaret S/0000-0002-8174-0099; Dittmar, Thorsten/0000-0002-3462-0107; Kögel-Knabner, Ingrid/0000-0002-7216-8326; NANNIPIERI, PAOLO/0000-0002-5488-2593	European Science Foundation Network MOLTER; US Department of Energy [DE-AC02-05CH11231]	European Science Foundation Network MOLTER; US Department of Energy(United States Department of Energy (DOE))	The European Science Foundation Network MOLTER sponsored the workshop at which the idea for this Perspective was conceived. Support for M. W. I. S. and M. S. T. was also provided by the US Department of Energy (contract no. DE-AC02-05CH11231).	Agren GI, 2001, OECOLOGIA, V128, P94, DOI 10.1007/s004420100646; Amelung W, 2008, ADV AGRON, V100, P155, DOI 10.1016/S0065-2113(08)00606-8; AMUNDSON R, 1991, SOIL SCI, V151, P99, DOI 10.1097/00010694-199101000-00012; Arrhenius S., 1889, Z PHYS CHEM, V4U, P226, DOI [10.1515/zpch-1889-0416, DOI 10.1515/ZPCH-1889-0416]; Balesdent J, 1996, SOIL BIOL BIOCHEM, V28, P1261, DOI 10.1016/0038-0717(96)00112-5; Bird JA, 2008, ORG GEOCHEM, V39, P465, DOI 10.1016/j.orggeochem.2007.12.003; Bird JA, 2006, BIOGEOCHEMISTRY, V79, P361, DOI 10.1007/s10533-005-5632-y; Brodowski S, 2006, EUR J SOIL SCI, V57, P539, DOI 10.1111/j.1365-2389.2006.00807.x; Chabbi A, 2009, SOIL BIOL BIOCHEM, V41, P256, DOI 10.1016/j.soilbio.2008.10.033; Cheng CH, 2009, CHEMOSPHERE, V75, P1021, DOI 10.1016/j.chemosphere.2009.01.045; Cohen-Ofri I, 2006, J ARCHAEOL SCI, V33, P428, DOI 10.1016/j.jas.2005.08.008; Craine JM, 2010, NAT GEOSCI, V3, P854, DOI [10.1038/ngeo1009, 10.1038/NGEO1009]; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Dittmar T, 2009, NAT GEOSCI, V2, P175, DOI 10.1038/NGEO440; Ekschmitt K, 2008, J PLANT NUTR SOIL SC, V171, P27, DOI 10.1002/jpln.200700051; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Fierer N, 2003, GLOBAL CHANGE BIOL, V9, P1322, DOI 10.1046/j.1365-2486.2003.00663.x; Fischlin A., 2007, CONTRIBUTION WORKING, P211; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Godbold DL, 2006, PLANT SOIL, V281, P15, DOI 10.1007/s11104-005-3701-6; Grandy AS, 2008, SCI TOTAL ENVIRON, V404, P297, DOI 10.1016/j.scitotenv.2007.11.013; Hammes K, 2008, BIOGEOSCIENCES, V5, P1339, DOI 10.5194/bg-5-1339-2008; HAUMAIER L, 1995, ORG GEOCHEM, V23, P191, DOI 10.1016/0146-6380(95)00003-W; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; Hedges JI, 1997, ORG GEOCHEM, V27, P319, DOI 10.1016/S0146-6380(97)00056-9; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Herrmann AM, 2007, SOIL BIOL BIOCHEM, V39, P1835, DOI 10.1016/j.soilbio.2007.03.011; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/NGEO844, 10.1038/ngeo844]; JENKINSON DS, 1990, PHILOS T R SOC B, V329, P361, DOI 10.1098/rstb.1990.0177; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kalbitz K, 2005, SOIL BIOL BIOCHEM, V37, P1319, DOI 10.1016/j.soilbio.2004.11.028; Kawahigashi M, 2006, GLOBAL CHANGE BIOL, V12, P1868, DOI 10.1111/j.1365-2486.2006.01203.x; Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419; Kelleher BP, 2006, ENVIRON SCI TECHNOL, V40, P4605, DOI 10.1021/es0608085; Khvorostyanov DV, 2008, TELLUS B, V60, P250, DOI 10.1111/j.1600-0889.2007.00333.x; Kim SW, 2004, MAR CHEM, V92, P225, DOI 10.1016/j.marchem.2004.06.042; Kirschbaum MUF, 2010, GLOBAL CHANGE BIOL, V16, P2117, DOI 10.1111/j.1365-2486.2009.02093.x; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; Kleber M, 2010, ENVIRON CHEM, V7, P320, DOI 10.1071/EN10006; Kleber M, 2010, ADV AGRON, V106, P77, DOI 10.1016/S0065-2113(10)06003-7; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Kogel-Knabner I, 2002, SOIL BIOL BIOCHEM, V34, P139, DOI 10.1016/S0038-0717(01)00158-4; Kong AYY, 2010, SOIL SCI SOC AM J, V74, P1201, DOI 10.2136/sssaj2009.0346; Kramer C, 2008, SOIL BIOL BIOCHEM, V40, P425, DOI 10.1016/j.soilbio.2007.09.016; Kramer C, 2010, SOIL BIOL BIOCHEM, V42, P1028, DOI 10.1016/j.soilbio.2010.02.021; Kucharik CJ, 2001, ECOSYSTEMS, V4, P237, DOI 10.1007/s10021\N001\N0007-2; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Lehmann J, 2008, NAT GEOSCI, V1, P238, DOI 10.1038/ngeo155; Lehmann J, 2007, NATURE, V447, P143, DOI 10.1038/447143a; Lehmann J, 2008, NAT GEOSCI, V1, P832, DOI 10.1038/ngeo358; Liang B, 2008, GEOCHIM COSMOCHIM AC, V72, P6069, DOI 10.1016/j.gca.2008.09.028; Lorenz K, 2007, GEODERMA, V142, P1, DOI 10.1016/j.geoderma.2007.07.013; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Major J, 2010, GLOBAL CHANGE BIOL, V16, P1366, DOI 10.1111/j.1365-2486.2009.02044.x; Manzoni S, 2009, SOIL BIOL BIOCHEM, V41, P1355, DOI 10.1016/j.soilbio.2009.02.031; Marschner B, 2008, J PLANT NUTR SOIL SC, V171, P91, DOI 10.1002/jpln.200700049; McGuire KL, 2010, SOIL BIOL BIOCHEM, V42, P529, DOI 10.1016/j.soilbio.2009.11.016; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Mendez-Millan M, 2010, SOIL BIOL BIOCHEM, V42, P169, DOI 10.1016/j.soilbio.2009.10.010; Morales SE, 2011, FEMS MICROBIOL ECOL, V75, P2, DOI 10.1111/j.1574-6941.2010.00938.x; Nguyen BT, 2010, ENVIRON SCI TECHNOL, V44, P3324, DOI 10.1021/es903016y; Nowinski NS, 2008, ECOSYSTEMS, V11, P16, DOI 10.1007/s10021-007-9104-1; Nowinski NS, 2010, OECOLOGIA, V163, P785, DOI 10.1007/s00442-009-1556-x; OADES JM, 1988, BIOGEOCHEMISTRY, V5, P35, DOI 10.1007/BF02180317; Olk DC, 2006, SOIL SCI SOC AM J, V70, P967, DOI 10.2136/sssaj2005.0111; PARTON WJ, 1994, SSSA SPEC PUBL, P147; Pascault N, 2010, MICROB ECOL, V60, P816, DOI 10.1007/s00248-010-9705-7; Preston CM, 2006, BIOGEOSCIENCES, V3, P397, DOI 10.5194/bg-3-397-2006; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; Ranjard L, 2010, AGRON SUSTAIN DEV, V30, P359, DOI 10.1051/agro/2009033; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Richter DD, 2007, SOIL SCI SOC AM J, V71, P266, DOI 10.2136/sssaj2006.0181; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; Sachs J, 2010, NATURE, V466, P558, DOI 10.1038/466558a; Schmidt MWI, 2000, GLOBAL BIOGEOCHEM CY, V14, P777, DOI 10.1029/1999GB001208; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; Sollins P, 1996, GEODERMA, V74, P65, DOI 10.1016/S0016-7061(96)00036-5; Sollins P, 2007, BIOGEOCHEMISTRY, V85, P1, DOI 10.1007/s10533-007-9099-x; STEVENSON F. J, 1994, HUMUS CHEM; Striegl RG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024413; Sutton R, 2005, ENVIRON SCI TECHNOL, V39, P9009, DOI 10.1021/es050778q; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Thevenot M, 2010, SOIL BIOL BIOCHEM, V42, P1200, DOI 10.1016/j.soilbio.2010.03.017; Thornton PE, 2005, ECOL MODEL, V189, P25, DOI 10.1016/j.ecolmodel.2005.04.008; Torn MS, 1997, NATURE, V389, P170, DOI 10.1038/38260; Torn MS, 2002, GLOBAL CHANGE BIOL, V8, P941, DOI 10.1046/j.1365-2486.2002.00477.x; Totsche KU, 2010, J PLANT NUTR SOIL SC, V173, P88, DOI 10.1002/jpln.200900105; Trompowsky PM, 2005, ORG GEOCHEM, V36, P1480, DOI 10.1016/j.orggeochem.2005.08.001; TRUMBORE SE, 1995, GLOBAL BIOGEOCHEM CY, V9, P515, DOI 10.1029/95GB02148; Trumbore SE, 2008, SCIENCE, V321, P1455, DOI 10.1126/science.1160232; van Hove ERA, 2010, J CHROMATOGR A, V1217, P3946, DOI 10.1016/j.chroma.2010.01.033; von Lutzow M, 2006, EUR J SOIL SCI, V57, P426, DOI 10.1111/j.1365-2389.2006.00809.x; von Lutzow M, 2009, BIOL FERT SOILS, V46, P1, DOI 10.1007/s00374-009-0413-8; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Xu TF, 2008, VADOSE ZONE J, V7, P305, DOI 10.2136/vzj2006.0130; Ziolkowski LA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043963	100	3258	3446	337	4496	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 6	2011	478	7367					49	56		10.1038/nature10386	http://dx.doi.org/10.1038/nature10386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21979045	Green Submitted			2022-12-28	WOS:000295575400033
J	Weismann, D; Hartvigsen, K; Lauer, N; Bennett, KL; Scholl, HPN; Issa, PC; Cano, M; Brandstatter, H; Tsimikas, S; Skerka, C; Superti-Furga, G; Handa, JT; Zipfel, PF; Witztum, JL; Binder, CJ				Weismann, David; Hartvigsen, Karsten; Lauer, Nadine; Bennett, Keiryn L.; Scholl, Hendrik P. N.; Issa, Peter Charbel; Cano, Marisol; Brandstaetter, Hubert; Tsimikas, Sotirios; Skerka, Christine; Superti-Furga, Giulio; Handa, James T.; Zipfel, Peter F.; Witztum, Joseph L.; Binder, Christoph J.			Complement factor H binds malondialdehyde epitopes and protects from oxidative stress	NATURE			English	Article							RETINAL-PIGMENT EPITHELIUM; MACULAR DEGENERATION; APOPTOTIC CELLS; INNATE IMMUNITY; END-PRODUCTS; AGE; PHAGOCYTOSIS; PROTEINS; RISK; PHOSPHOLIPIDS	Oxidative stress and enhanced lipid peroxidation are linked to many chronic inflammatory diseases, including age-related macular degeneration (AMD). AMD is the leading cause of blindness in Western societies, but its aetiology remains largely unknown. Malondialdehyde (MDA) is a common lipid peroxidation product that accumulates in many pathophysiological processes, including AMD. Here we identify complement factor H (CFH) as a major MDA-binding protein that can block both the uptake of MDA-modified proteins by macrophages and MDA-induced proinflammatory effects in vivo in mice. The CFH polymorphism H402, which is strongly associated with AMD, markedly reduces the ability of CFH to bind MDA, indicating a causal link to disease aetiology. Our findings provide important mechanistic insights into innate immune responses to oxidative stress, which may be exploited in the prevention of and therapy for AMD and other chronic inflammatory diseases.	[Weismann, David; Hartvigsen, Karsten; Bennett, Keiryn L.; Superti-Furga, Giulio; Binder, Christoph J.] Austrian Acad Sci, CeMM, A-1090 Vienna, Austria; [Weismann, David; Hartvigsen, Karsten; Brandstaetter, Hubert; Binder, Christoph J.] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria; [Hartvigsen, Karsten; Tsimikas, Sotirios; Witztum, Joseph L.; Binder, Christoph J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lauer, Nadine; Skerka, Christine; Zipfel, Peter F.] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, D-07745 Jena, Germany; [Lauer, Nadine; Skerka, Christine; Zipfel, Peter F.] Univ Jena, D-07745 Jena, Germany; [Scholl, Hendrik P. N.; Cano, Marisol; Handa, James T.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA; [Issa, Peter Charbel] Univ Oxford, Nuffield Lab Ophthalmol, Oxford OX3 9DU, England; [Brandstaetter, Hubert] Octapharma PPGmbH, Res & Dev, A-1100 Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; University of California System; University of California San Diego; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Johns Hopkins University; Johns Hopkins Medicine; University of Oxford; Octapharma	Binder, CJ (corresponding author), Austrian Acad Sci, CeMM, A-1090 Vienna, Austria.	christoph.binder@meduniwien.ac.at	Superti-Furga, Giulio/F-4755-2015; Superti-Furga, Giulio/AAE-5681-2019; Issa, Peter Charbel/E-8935-2018; Issa, Peter Charbel/O-2580-2019	Superti-Furga, Giulio/0000-0002-0570-1768; Issa, Peter Charbel/0000-0002-0351-6673; Issa, Peter Charbel/0000-0002-0351-6673; Bennett, Keiryn L./0000-0001-9356-7708; Binder, Christoph J./0000-0001-8313-7050	Austrian Academy of Sciences; Austrian Research Promotion Agency; SFB Lipotox F30 of the Austrian Science Fund; NIH [HL088093, RO1 HL086599, EY14005, EY019044]; Edward N. & Della L. Thome Memorial Foundation; Research to Prevent Blindness (Wilmer Eye institute); Deutsche Forschungsgemeinschaft; ProRetina Foundation; Fondation Leducq; Wynn-Gund Translational Research Acceleration Program Enhanced Research and Clinical Training Award; National Neurovision Research Institute - Foundation Fighting Blindness; Macular Degeneration Research Award; American Health Assistance Foundation; European Commission; European Community; American Heart Association [0630228N]; NATIONAL EYE INSTITUTE [R01EY014005, R01EY019904] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088093] Funding Source: NIH RePORTER	Austrian Academy of Sciences; Austrian Research Promotion Agency; SFB Lipotox F30 of the Austrian Science Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward N. & Della L. Thome Memorial Foundation; Research to Prevent Blindness (Wilmer Eye institute)(Research to Prevent Blindness (RPB)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ProRetina Foundation; Fondation Leducq(Leducq Foundation); Wynn-Gund Translational Research Acceleration Program Enhanced Research and Clinical Training Award; National Neurovision Research Institute - Foundation Fighting Blindness; Macular Degeneration Research Award(BrightFocus Foundation); American Health Assistance Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); European Community(European Commission); American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are indebted to M. Ozsvar-Kozma for technical assistance, S. Halbich for performing the surface plasmon resonance analysis, A. Hartmann for purification of CFH variants from patient plasma, C. Mannhalter for help with genotyping, and E. N. Montano. This work was supported by the Austrian Academy of Sciences, a BRIDGE grant from the Austrian Research Promotion Agency, the SFB Lipotox F30 of the Austrian Science Fund (C.J.B.); NIH grants HL088093 (C.J.B., S. T., J.L.W.), RO1 HL086599 (K. H., J.L.W.), EY14005, EY019044 (J.T.H.); the Edward N. & Della L. Thome Memorial Foundation Awards Program in AMD Research, Research to Prevent Blindness (Wilmer Eye institute) (J.T.H.); the Deutsche Forschungsgemeinschaft (P.F.Z., C. S.); the ProRetina Foundation (N. L., P.F.Z., C. S.); the Fondation Leducq (C.J.B., S. T., J.L.W.); the Wynn-Gund Translational Research Acceleration Program Enhanced Research and Clinical Training Award, National Neurovision Research Institute - Foundation Fighting Blindness, Macular Degeneration Research Award, American Health Assistance Foundation (H. P. N. S.); European Commission and the Seventh European Community Framework Program, Marie Curie Intra-European Fellowship (P. C. I.). K. H. was supported by the Scientist Development Grant 0630228N of the American Heart Association. J. T. H. is the Robert Bond Welch Professor. We thank all patients for participation.	Amarilyo G, 2010, EUR J IMMUNOL, V40, P699, DOI 10.1002/eji.200838951; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Chou MY, 2008, J INTERN MED, V263, P479, DOI 10.1111/j.1365-2796.2008.01968.x; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Clark SJ, 2006, J BIOL CHEM, V281, P24713, DOI 10.1074/jbc.M605083200; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Donoso LA, 2010, SURV OPHTHALMOL, V55, P227, DOI 10.1016/j.survophthal.2009.11.001; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Flierman R, 2007, IMMUNOBIOLOGY, V212, P363, DOI 10.1016/j.imbio.2006.11.005; Goverdhan SV, 2008, BRIT J OPHTHALMOL, V92, P537, DOI 10.1136/bjo.2007.123190; GREEN WR, 1993, OPHTHALMOLOGY, V100, P1519; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Higgins GT, 2003, INVEST OPHTH VIS SCI, V44, P1775, DOI 10.1167/iovs.02-0742; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Kaemmerer E, 2007, INVEST OPHTH VIS SCI, V48, P1342, DOI 10.1167/iovs.06-0549; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Leffler J, 2010, J BIOL CHEM, V285, P3766, DOI 10.1074/jbc.M109.045427; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Mihlan M, 2009, CELL DEATH DIFFER, V16, P1630, DOI 10.1038/cdd.2009.103; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Schutt F, 2003, INVEST OPHTH VIS SCI, V44, P3663, DOI 10.1167/iovs.03-0172; Shanmugam N, 2008, DIABETES, V57, P879, DOI 10.2337/db07-1204; SHECHTER I, 1981, J LIPID RES, V22, P63; Sofat R, 2010, ATHEROSCLEROSIS, V213, P184, DOI 10.1016/j.atherosclerosis.2010.07.021; Sun MJ, 2006, J BIOL CHEM, V281, P4222, DOI 10.1074/jbc.M509769200; Suzuki M, 2007, MOL VIS, V13, P772; Takizawa F, 1996, FEBS LETT, V397, P269, DOI 10.1016/S0014-5793(96)01197-0; Thakkinstian A, 2006, HUM MOL GENET, V15, P2784, DOI 10.1093/hmg/ddl220; Thiele Geoffrey M, 2004, Comp Hepatol, V3 Suppl 1, pS25, DOI 10.1186/1476-5926-2-S1-S25; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; Xu DS, 1997, CHEM RES TOXICOL, V10, P978, DOI 10.1021/tx970069t; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	42	395	413	4	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2011	478	7367					76	81		10.1038/nature10449	http://dx.doi.org/10.1038/nature10449			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21979047	Green Accepted			2022-12-28	WOS:000295575400037
J	Greenhalgh, T				Greenhalgh, Trisha			OUTSIDE THE BOX Walkabout	BRITISH MEDICAL JOURNAL			English	Editorial Material									Barts & London Queen Marys Sch Med & Dent, London, England	University of London; Queen Mary University London	Greenhalgh, T (corresponding author), Barts & London Queen Marys Sch Med & Dent, London, England.	p.greenhalgh@qmul.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088					0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 5	2011	343								d6198	10.1136/bmj.d6198	http://dx.doi.org/10.1136/bmj.d6198			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	832CS	21976693				2022-12-28	WOS:000295779400003
J	Steinmann, AF				Steinmann, Alwin F.			Threats to Graduate Medical Education Funding and the Need for a Rational Approach: A Statement From the Alliance for Academic Internal Medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RESIDENTS; COSTS	With the current focus on reducing the federal budget deficit, funding for graduate medical education (GME) has come under scrutiny, particularly those monies labeled as indirect medical education payments; these are intended to cover ill-defined costs inherent to training programs, such as increased lengths of stay, additional testing, and patients with more complex conditions. Although there are cogent arguments that indirect medical education expenses have decreased over the past 25 years, there is also a reasonable expectation that direct medical education expenses, such as those related to resident salaries, faculty involvement, administration of programs, and overhead costs, have increased. Our current system of GME financing is complex and cumbersome and relies almost exclusively on government support. This article examines the adequacy of current funding, focusing on the economics of the entire system rather than individual hospitals, states, or regions. It also recommends reexamining GME financing and considering options that ensure appropriate levels of government support and participation of other health care insurers to adequately fund GME. Ann Intern Med. 2011; 155: 461-464.	[Steinmann, Alwin F.] Exempla St Joseph Hosp, Denver, CO 80218 USA; Alliance Acad Med, Arlington, VA USA		Steinmann, AF (corresponding author), Exempla St Joseph Hosp, 1835 Franklin St,Midtown 2,Suite 500, Denver, CO 80218 USA.	steinmanna@exempla.org			Alliance for Academic Internal Medicine	Alliance for Academic Internal Medicine	The author thanks the leadership and staff of the Alliance for Academic Internal Medicine for their help and support.	[Anonymous], GME TABL; [Anonymous], 2010, MED PAYM ADV COMM RE; [Anonymous], 2010, ASS AM MED COLL SURV; Kane GC, 2009, AM J MED, V122, P1156, DOI 10.1016/j.amjmed.2009.07.010; Larch Martin., 2020, NUMERICAL COMPLIANCE; Nasca TJ, 2001, ARCH INTERN MED, V161, P760, DOI 10.1001/archinte.161.5.760; Nuckols TK, 2009, NEW ENGL J MED, V360, P2202, DOI 10.1056/NEJMsa0810251; Pauwels J, 2006, FAM MED, V38, P408; Rich EO, 2002, J GEN INTERN MED, V17, P283, DOI 10.1046/j.1525-1497.2002.10804.x; Tucker L, 2010, 2010 ABIM FDN FORUM; Zeidel ML, 2005, AM J MED, V118, P557, DOI 10.1016/j.amjmed.2005.02.025	11	13	13	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2011	155	7					461	464		10.7326/0003-4819-155-7-201110040-00008	http://dx.doi.org/10.7326/0003-4819-155-7-201110040-00008			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	833OC	21969344				2022-12-28	WOS:000295893800006
J	Wiest, O; Helquist, P				Wiest, Olaf; Helquist, Paul			Striking a Balance to Control Stereochemistry	SCIENCE			English	Editorial Material							PREDICTION; ENANTIOSELECTIVITY; PRINCIPLES; CATALYSTS; DESIGN		[Wiest, Olaf; Helquist, Paul] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Wiest, Olaf] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Shenzhen 518055, Peoples R China; [Helquist, Paul] Univ Gothenburg, Dept Chem, SE-41296 Gothenburg, Sweden	University of Notre Dame; Peking University; University Town of Shenzhen; University of Gothenburg	Wiest, O (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.							Cintas P, 2007, ANGEW CHEM INT EDIT, V46, P4016, DOI 10.1002/anie.200603714; Corbeil CR, 2008, ANGEW CHEM INT EDIT, V47, P2635, DOI 10.1002/anie.200704774; Donoghue PJ, 2009, J AM CHEM SOC, V131, P410, DOI 10.1021/ja806246h; Harper KC, 2011, SCIENCE, V333, P1875, DOI 10.1126/science.1206997; Harper KC, 2011, P NATL ACAD SCI USA, V108, P2179, DOI 10.1073/pnas.1013331108; Houk KN, 2008, NATURE, V455, P309, DOI 10.1038/nature07368; Ianni JC, 2006, ANGEW CHEM INT EDIT, V45, P5502, DOI 10.1002/anie.200600329; Jenkins AL, 2005, CHIRALITY, V17, pS24, DOI 10.1002/chir.20104; Palucki M, 1998, J AM CHEM SOC, V120, P948, DOI 10.1021/ja973468j	9	2	2	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 30	2011	333	6051					1831	1832		10.1126/science.1211195	http://dx.doi.org/10.1126/science.1211195			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960616				2022-12-28	WOS:000295365800036
J	Kulmala, M; Petaja, T				Kulmala, Markku; Petaja, Tuukka			Soil Nitrites Influence Atmospheric Chemistry	SCIENCE			English	Editorial Material							CLIMATE; AEROSOLS; FORESTS; ACID		[Kulmala, Markku; Petaja, Tuukka] Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland	University of Helsinki	Kulmala, M (corresponding author), Univ Helsinki, Dept Phys, Gustaf Hallstromin Katu 2A,POB 64, FI-00014 Helsinki, Finland.	markku.kulmala@helsinki.fi	Petäjä, Tuukka/A-8009-2008; Kulmala, Markku T/I-7671-2016	Petäjä, Tuukka/0000-0002-1881-9044; Kulmala, Markku T/0000-0003-3464-7825				Acker K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024643; [Anonymous], 2007, IPCC 4 ASS REP CLIM; Arneth A, 2010, NAT GEOSCI, V3, P525, DOI [10.1038/NGEO905, 10.1038/ngeo905]; Arneth A, 2009, SCIENCE, V326, P672, DOI 10.1126/science.1181568; Hari P, 2008, BOREAL FOREST CLIMAT; Hari P, 2009, BOREAL ENVIRON RES, V14, P442; Kiendler-Scharr A, 2009, NATURE, V461, P381, DOI 10.1038/nature08292; Kulmala M, 2004, ATMOS CHEM PHYS, V4, P557, DOI 10.5194/acp-4-557-2004; Kulmala M, 2003, SCIENCE, V302, P1000, DOI 10.1126/science.1090848; Kulmala M, 2008, ATMOS RES, V90, P132, DOI 10.1016/j.atmosres.2008.01.005; Kurten T, 2008, ATMOS CHEM PHYS, V8, P4095, DOI 10.5194/acp-8-4095-2008; Lelieveld J, 2008, NATURE, V452, P737, DOI 10.1038/nature06870; Rosenfeld D, 2008, SCIENCE, V321, P1309, DOI 10.1126/science.1160606; Su H, 2011, SCIENCE, V333, P1616, DOI 10.1126/science.1207687; Sutton M.A., EUROPEAN NITROGEN AS; Zhou XL, 2011, NAT GEOSCI, V4, P440, DOI [10.1038/ngeo1164, 10.1038/NGEO1164]	16	30	35	5	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2011	333	6049					1586	1587		10.1126/science.1211872	http://dx.doi.org/10.1126/science.1211872			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921187				2022-12-28	WOS:000294900900029
J	Sherman, KE; Flamm, SL; Afdhal, NH; Nelson, DR; Sulkowski, MS; Everson, GT; Fried, MW; Adler, M; Reesink, HW; Martin, M; Sankoh, AJ; Adda, N; Kauffman, RS; George, S; Wright, CI; Poordad, F				Sherman, Kenneth E.; Flamm, Steven L.; Afdhal, Nezam H.; Nelson, David R.; Sulkowski, Mark S.; Everson, Gregory T.; Fried, Michael W.; Adler, Michael; Reesink, Hendrik W.; Martin, Marie; Sankoh, Abdul J.; Adda, Nathalie; Kauffman, Robert S.; George, Shelley; Wright, Christopher I.; Poordad, Fred		ILLUMINATE Study Team	Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PEGINTERFERON ALPHA-2A; PLUS RIBAVIRIN; GENOTYPE-1	Background Patients with chronic infection with hepatitis C virus (HCV) genotype 1 often need 48 weeks of peginterferon-ribavirin treatment for a sustained virologic response. We designed a noninferiority trial (noninferiority margin, -10.5%) to compare rates of sustained virologic response among patients receiving two treatment durations. Methods We enrolled patients with chronic infection with HCV genotype 1 who had not previously received treatment. All patients received telaprevir at a dose of 750 mg every 8 hours, peginterferon alfa-2a at a dose of 180 mu g per week, and ribavirin at a dose of 1000 to 1200 mg per day, for 12 weeks (T12PR12), followed by peginterferon-ribavirin. Patients who had an extended rapid virologic response (undetectable HCV RNA levels at weeks 4 and 12) were randomly assigned after week 20 to receive the dual therapy for 4 more weeks (T12PR24) or 28 more weeks (T12PR48). Patients without an extended rapid virologic response were assigned to T12PR48. Results Of the 540 patients, a total of 352 (65%) had an extended rapid virologic response. The overall rate of sustained virologic response was 72%. Among the 322 patients with an extended rapid virologic response who were randomly assigned to a study group, 149 (92%) in the T12PR24 group and 140 (88%) in the T12PR48 group had a sustained virologic response (absolute difference, 4 percentage points; 95% confidence interval, -2 to 11), establishing noninferiority. Adverse events included rash (in 37% of patients, severe in 5%) and anemia (in 39%, severe in 6%). Discontinuation of all the study drugs was based on adverse events in 18% of patients overall, as well as in 1% of patients (all of whom were randomly assigned) in the T12PR24 group and 12% of the patients randomly assigned to the T12PR48 group (P<0.001). Conclusions In this study, among patients with chronic HCV infection who had not received treatment previously, a regimen of peginterferon-ribavirin for 24 weeks, with telaprevir for the first 12 weeks, was noninferior to the same regimen for 48 weeks in patients with undetectable HCV RNA at weeks 4 and 12, with an extended rapid virologic response achieved in nearly two thirds of patients. (Funded by Vertex Pharmaceuticals and Tibotec; ILLUMINATE ClinicalTrials.gov number, NCT00758043.)	[Sherman, Kenneth E.] Univ Cincinnati, Coll Med, Div Digest Dis, Cincinnati, OH 45267 USA; [Flamm, Steven L.] Northwestern Univ, Sch Med, Div Hepatol, Chicago, IL USA; [Afdhal, Nezam H.] Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Boston, MA 02215 USA; [Nelson, David R.] Univ Florida, Sect Hepatol, Gainesville, FL USA; [Sulkowski, Mark S.] Johns Hopkins Univ, Sch Med, Viral Hepatitis Ctr, Baltimore, MD USA; [Everson, Gregory T.] Univ Colorado, Sch Med Denver, Div Gastroenterol & Hepatol, Sect Hepatol, Aurora, CO USA; [Fried, Michael W.] Univ N Carolina, UNC Liver Ctr, Chapel Hill, NC USA; [Adler, Michael] Erasme Hosp Brussels, Dept Gastroenterol & Hepatopancreatol, Brussels, Belgium; [Reesink, Hendrik W.] Univ Amsterdam, Acad Med Ctr, Dept Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Martin, Marie; Sankoh, Abdul J.; Adda, Nathalie; Kauffman, Robert S.; George, Shelley; Wright, Christopher I.] Vertex Pharmaceut, Cambridge, MA USA; [Poordad, Fred] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA	University System of Ohio; University of Cincinnati; Northwestern University; Harvard University; Beth Israel Deaconess Medical Center; State University System of Florida; University of Florida; Johns Hopkins University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of North Carolina; University of North Carolina Chapel Hill; Universite Libre de Bruxelles; University of Amsterdam; Academic Medical Center Amsterdam; Vertex Pharmaceuticals; Cedars Sinai Medical Center	Sherman, KE (corresponding author), Univ Cincinnati, Coll Med, Div Digest Dis, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	shermake@ucmail.uc.edu		Van Vlierberghe, Hans/0000-0003-0647-9238; Afdhal, Nezam/0000-0002-7342-6593	Vertex Pharmaceuticals; Tibotec; NATIONAL CANCER INSTITUTE [K24CA139570] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK070528, K24DK066144] Funding Source: NIH RePORTER	Vertex Pharmaceuticals(Vertex Pharmaceuticals); Tibotec; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by Vertex Pharmaceuticals and Tibotec; ILLUMINATE ClinicalTrials.gov number, NCT00758043.	[Anonymous], 2011, HEP C; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2009, NEW ENGL J MED, V361, P1516; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Zeuzem S, 2010, HEPATOLOGY, V52, p436A	11	585	624	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2011	365	11					1014	1024		10.1056/NEJMoa1014463	http://dx.doi.org/10.1056/NEJMoa1014463			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819UR	21916639	Green Published, Green Accepted			2022-12-28	WOS:000294857300009
J	Thera, MA; Doumbo, OK; Coulibaly, D; Laurens, MB; Ouattara, A; Kone, AK; Guindo, AB; Traore, K; Traore, I; Kouriba, B; Diallo, DA; Diarra, I; Daou, M; Dolo, A; Tolo, Y; Sissoko, MS; Niangaly, A; Sissoko, M; Takala-Harrison, S; Lyke, KE; Wu, YK; Blackwelder, WC; Godeaux, O; Vekemans, J; Dubois, MC; Ballou, WR; Cohen, J; Thompson, D; Dube, T; Soisson, L; Diggs, CL; House, B; Lanar, DE; Dutta, S; Heppner, DG; Plowe, CV				Thera, Mahamadou A.; Doumbo, Ogobara K.; Coulibaly, Drissa; Laurens, Matthew B.; Ouattara, Amed; Kone, Abdoulaye K.; Guindo, Ando B.; Traore, Karim; Traore, Idrissa; Kouriba, Bourema; Diallo, Dapa A.; Diarra, Issa; Daou, Modibo; Dolo, Amagana; Tolo, Youssouf; Sissoko, Mahamadou S.; Niangaly, Amadou; Sissoko, Mady; Takala-Harrison, Shannon; Lyke, Kirsten E.; Wu, Yukun; Blackwelder, William C.; Godeaux, Olivier; Vekemans, Johan; Dubois, Marie-Claude; Ballou, W. Ripley; Cohen, Joe; Thompson, Darby; Dube, Tina; Soisson, Lorraine; Diggs, Carter L.; House, Brent; Lanar, David E.; Dutta, Sheetij; Heppner, D. Gray, Jr.; Plowe, Christopher V.			A Field Trial to Assess a Blood-Stage Malaria Vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CIRCUMSPOROZOITE PROTEIN VACCINE; FALCIPARUM-MALARIA; EFFICACY; IMMUNOGENICITY; CHILDREN; SAFETY; ADULTS	Background Blood-stage malaria vaccines are intended to prevent clinical disease. The malaria vaccine FMP2.1/AS02(A), a recombinant protein based on apical membrane antigen 1 (AMA1) from the 3D7 strain of Plasmodium falciparum, has previously been shown to have immunogenicity and acceptable safety in Malian adults and children. Methods In a double-blind, randomized trial, we immunized 400 Malian children with either the malaria vaccine or a control (rabies) vaccine and followed them for 6 months. The primary end point was clinical malaria, defined as fever and at least 2500 parasites per cubic millimeter of blood. A secondary end point was clinical malaria caused by parasites with the AMA1 DNA sequence found in the vaccine strain. Results The cumulative incidence of the primary end point was 48.4% in the malaria-vaccine group and 54.4% in the control group; efficacy against the primary end point was 17.4% (hazard ratio for the primary end point, 0.83; 95% confidence interval [CI], 0.63 to 1.09; P=0.18). Efficacy against the first and subsequent episodes of clinical malaria, as defined on the basis of various parasite-density thresholds, was approximately 20%. Efficacy against clinical malaria caused by parasites with AMA1 corresponding to that of the vaccine strain was 64.3% (hazard ratio, 0.36; 95% CI, 0.08 to 0.86; P=0.03). Local reactions and fever after vaccination were more frequent with the malaria vaccine. Conclusions On the basis of the primary end point, the malaria vaccine did not provide significant protection against clinical malaria, but on the basis of secondary results, it may have strain-specific efficacy. If this finding is confirmed, AMA1 might be useful in a multicomponent malaria vaccine. (Funded by the National Institute of Allergy and Infectious Diseases and others; ClinicalTrials.gov number, NCT00460525.)	[Laurens, Matthew B.; Ouattara, Amed; Takala-Harrison, Shannon; Lyke, Kirsten E.; Wu, Yukun; Blackwelder, William C.; Plowe, Christopher V.] Univ Maryland, Sch Med, Howard Hughes Med Inst, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Thera, Mahamadou A.; Doumbo, Ogobara K.; Coulibaly, Drissa; Ouattara, Amed; Kone, Abdoulaye K.; Guindo, Ando B.; Traore, Karim; Traore, Idrissa; Kouriba, Bourema; Diallo, Dapa A.; Diarra, Issa; Daou, Modibo; Dolo, Amagana; Tolo, Youssouf; Sissoko, Mahamadou S.; Niangaly, Amadou; Sissoko, Mady] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Godeaux, Olivier; Vekemans, Johan; Dubois, Marie-Claude; Ballou, W. Ripley; Cohen, Joe] GlaxoSmithKline Biol, Rixensart, Belgium; [Thompson, Darby; Dube, Tina] EMMES, Rockville, MD USA; [Soisson, Lorraine; Diggs, Carter L.] US Agcy Int Dev, Malaria Vaccine Dev Program, Washington, DC 20523 USA; [House, Brent; Lanar, David E.; Dutta, Sheetij; Heppner, D. Gray, Jr.] Walter Reed Army Inst Res, Silver Spring, MD USA	Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore; University of Bamako; GlaxoSmithKline; United States Agency for International Development (USAID); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Plowe, CV (corresponding author), Univ Maryland, Sch Med, Howard Hughes Med Inst, Ctr Vaccine Dev, 685 W Baltimore St,HSF1-480, Baltimore, MD 21201 USA.	cplowe@medicine.umaryland.edu	Laurens, Matthew/E-7293-2013; Wu, Yukun/G-4292-2012	Laurens, Matthew/0000-0003-3874-581X; Ouattara, Amed/0000-0003-1964-7130; Thera, Mahamadou A/0000-0002-2679-035X; Takala-Harrison, Shannon/0000-0003-4674-8500; Traore, Karim/0000-0002-9553-6611	National Institute of Allergy and Infectious Diseases [NCT00460525, N01AI85346, U19AI065683, HH-SN272200800013C]; Fogarty International Center, National Institutes of Health [D43TW001589]; Department of Defense [W81XWH-06-1-0427]; U.S. Agency for International Development for site development; U.S. Agency for International Development; Military Infectious Diseases Research Program; Doris Duke Charitable Foundation; Howard Hughes Medical Institute; FOGARTY INTERNATIONAL CENTER [D43TW001589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI085346, U19AI065683] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Department of Defense(United States Department of Defense); U.S. Agency for International Development for site development; U.S. Agency for International Development(United States Agency for International Development (USAID)); Military Infectious Diseases Research Program; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institute of Allergy and Infectious Diseases and others; ClinicalTrials.gov number, NCT00460525.; Supported by a contract (N01AI85346) and a cooperative agreement (U19AI065683) from the National Institute of Allergy and Infectious Diseases, a grant (D43TW001589) from the Fogarty International Center, National Institutes of Health, and a contract (W81XWH-06-1-0427) from the Department of Defense and the U.S. Agency for International Development for site development and the conduct of the trial; by a contract (HH-SN272200800013C) from the National Institute of Allergy and Infectious Diseases for data management and statistical support; by grants from the U.S. Agency for International Development and the Military Infectious Diseases Research Program, Fort Detrick, MD, for vaccine production and laboratory assays; and by the Doris Duke Charitable Foundation Distinguished Clinical Scientist Award and an award from the Howard Hughes Medical Institute (to Dr. Plowe).; We thank Steven Rosenthal, Walter Jones, Abdollah Naficy, and Lee Hall of the National Institute of Allergy and Infectious Diseases for support and advice; Mariam Traore Guindo and Boubacar Kouyate for serving as local medical monitors; the study monitors, Norbert Tamm (of PPD) and Denise McKinney (of the U. S. Army Medical Materiel and Development Activity); Valerie Brown and the malaria team at EMMES; Mirjana Nesin, medical monitor, National Institute of Allergy and Infectious Diseases, and members of the data and safety monitoring board (Anna Durbin, Kathryn Edwards, Cristina Sison, Elissa Malkin, Mariam Traore Guindo, and David Diemert); Amanda Leach and the GlaxoSmithKline Malaria Vaccine Project Team (in particular, Marie-Ange Demoitie, Yannick Vanloubbeeck, and Marc Lievens); Mahamadou Traore, Bourama Kane, Mamadou Dembele, and the Bandiagara District Hospital staff for clinical assistance; Danzele Coulibaly, Sekouba Mariko, and Moctar Traore for administrative support; Nicole Eddington, Carey Martin, and Lisa Ware for technical and administrative support; Karen Ball for regulatory support; the team of the Bandiagara Malaria Project in Bandiagara for their dedication; and the community of Bandiagara, Mali.	Alloueche A, 2003, AM J TROP MED HYG, V68, P97, DOI 10.4269/ajtmh.2003.68.97; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Dutta S, 2002, INFECT IMMUN, V70, P3101, DOI 10.1128/IAI.70.6.3101-3110.2002; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Enosse S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010005; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; Heppner DG, 2005, VACCINE, V23, P2243, DOI 10.1016/j.vaccine.2005.01.042; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Lyke KE, 2009, VACCINE, V27, P2171, DOI 10.1016/j.vaccine.2009.01.097; malERA Consultative Group on Vaccines, 2011, PLOS MED, V8; Ogutu BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004708; Ouattara A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-175; Plowe CV, 2009, J INFECT DIS, V200, P1646, DOI 10.1086/646613; Polhemus ME, 2007, VACCINE, V25, P4203, DOI 10.1016/j.vaccine.2007.03.012; Sagara I, 2009, VACCINE, V27, P3090, DOI 10.1016/j.vaccine.2009.03.014; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Takala SL, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000257; Thera MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001465; Thera MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009041; Waitumbi JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007849	24	254	258	2	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2011	365	11					1004	1013		10.1056/NEJMoa1008115	http://dx.doi.org/10.1056/NEJMoa1008115			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819UR	21916638	Green Accepted, Bronze			2022-12-28	WOS:000294857300008
J	Shaw, A; Smith, B; Inglis, C; Howlett, D				Shaw, A.; Smith, B.; Inglis, C.; Howlett, D.			PICTURE QUIZ A man with intra-abdominal calcification	BRITISH MEDICAL JOURNAL			English	Editorial Material							PORCELAIN GALLBLADDER; CARCINOMA		[Shaw, A.; Smith, B.; Inglis, C.; Howlett, D.] E Sussex Hosp Trust, Eastbourne Dist Gen Hosp, Eastbourne BN21 2UD, England		Shaw, A (corresponding author), E Sussex Hosp Trust, Eastbourne Dist Gen Hosp, Eastbourne BN21 2UD, England.	aidanshaw1@gmail.com						ASHUR H, 1978, ARCH SURG-CHICAGO, V113, P594; BERK RN, 1973, RADIOLOGY, V106, P29, DOI 10.1148/106.1.29; DAHNERT W, 2006, RADIOLOGY REV MANUAL, P743; Kim JH, 2009, HEPATO-GASTROENTEROL, V56, P943; Lacaine F, 2003, J CHIR-PARIS, V140, P115; POLK HC, 1966, GASTROENTEROLOGY, V50, P582; Puia I C, 2005, Chirurgia (Bucur), V100, P187; Stephen AE, 2001, SURGERY, V129, P699, DOI 10.1067/msy.2001.113888; Towfigh S, 2001, AM SURGEON, V67, P7	9	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2011	343								d5322	10.1136/bmj.d5322	http://dx.doi.org/10.1136/bmj.d5322			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822VM	21917841				2022-12-28	WOS:000295078100003
J	Brusselle, GG; Joos, GF; Bracke, KR				Brusselle, Guy G.; Joos, Guy F.; Bracke, Ken R.			Chronic Obstructive Pulmonary Disease 1 New insights into the immunology of chronic obstructive pulmonary disease	LANCET			English	Article							HISTONE DEACETYLASE ACTIVITY; DENDRITIC CELLS; INDUCED SPUTUM; AIRWAY INFLAMMATION; SYSTEMIC INFLAMMATION; EXTRACELLULAR-MATRIX; PERIPHERAL AIRWAYS; LYMPHOID FOLLICLES; ADAPTIVE IMMUNITY; NATURAL-HISTORY	Chronic obstructive pulmonary disease (COPD) is a heterogeneous syndrome associated with abnormal inflammatory immune responses of the lung to noxious particles and gases. Cigarette smoke activates innate immune cells such as epithelial cells and macrophages by triggering pattern recognition receptors, either directly or indirectly via the release of damage-associated molecular patterns from stressed or dying cells. Activated dendritic cells induce adaptive immune responses encompassing T helper (Th1 and Th17) CD4+ T cells, CD8+ cytotoxicity, and B-cell responses, which lead to the development of lymphoid follicles on chronic inflammation. Viral and bacterial infections not only cause acute exacerbations of COPD, but also amplify and perpetuate chronic inflammation in stable COPD via pathogen-associated molecular patterns. We discuss the role of autoimmunity (autoantibodies), remodelling, extracellular matrix-derived fragments, impaired innate lung defences, oxidative stress, hypoxia, and dysregulation of microRNAs in the persistence of the pulmonary inflammation despite smoking cessation.	[Brusselle, Guy G.; Joos, Guy F.; Bracke, Ken R.] Ghent Univ Hosp, Lab Translat Res Obstruct Pulm Dis, Dept Resp Med, B-9000 Ghent, Belgium; [Brusselle, Guy G.; Joos, Guy F.; Bracke, Ken R.] Univ Ghent, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University	Brusselle, GG (corresponding author), Ghent Univ Hosp, Dept Resp Med 7K12, B-9000 Ghent, Belgium.	guy.brusselle@ugent.be	Bracke, Ken R/GSN-7630-2022	Bracke, Ken R/0000-0001-5906-4605; Brusselle, Guy/0000-0001-7021-8505	AstraZeneca; Boehringer-Ingelheim; Chiesi; GlaxoSmitliKline; Merck; Novartis; Pfizer; UCB; Almirall; Merk Novartis; Interuniversity Attraction Poles Program (Belgian State, Belgian Science Policy) [P6/35]; Fund for Scientific Research Flanders; Ghent University	AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); Chiesi(Chiesi Pharmaceuticals Inc); GlaxoSmitliKline; Merck(Merck & Company); Novartis(Novartis); Pfizer(Pfizer); UCB(UCB Pharma SA); Almirall(Almirall); Merk Novartis; Interuniversity Attraction Poles Program (Belgian State, Belgian Science Policy)(Belgian Federal Science Policy Office); Fund for Scientific Research Flanders(FWO); Ghent University(Ghent University)	GGB is a member of advisory boards for AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, and Novartis; has been a consultant for Amakem; and has received speaker's fees from AstraZeneca, Boehringer-Ingelheim, Chiesi, GlaxoSmitliKline, Merck, Novartis, Pfizer, and UCB. GFJ is a member of advisory boards for AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck, Novartis, and Nycomed; has received grants or has grants pending from AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Novartis, and UCB; and has received speaker's fees from Almirall, AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merk Novartis, Pfizer, and UCB. KRB declares that he has no conflicts of interest.; We thank all collaborators at the Laboratory for Translational Research of Obstructive Pulmonary Disease, Department of Respiratory Medicine, Ghent University Hospital and Ghent University, Ghent, Belgium; Professor Patrick Venables for helpful insights into autoantibodies; and the Interuniversity Attraction Poles Program (Belgian State, Belgian Science Policy, Project P6/35), the Fund for Scientific Research Flanders and the Concerted Research Action of Ghent University for funding.	Adcock IM, 2008, CHEST, V134, P394, DOI 10.1378/chest.08-0440; Adcock IM, 2007, CURR OPIN IMMUNOL, V19, P694, DOI 10.1016/j.coi.2007.07.016; Andersson CK, 2010, AM J RESP CRIT CARE, V181, P206, DOI 10.1164/rccm.200906-0932OC; Barcelo B, 2008, EUR RESPIR J, V31, P555, DOI 10.1183/09031936.00010407; Barnes NC, 2006, AM J RESP CRIT CARE, V173, P736, DOI 10.1164/rccm.200508-1321OC; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Berenson CS, 2006, J INFECT DIS, V194, P1375, DOI 10.1086/508428; Bonarius HPJ, 2011, THORAX, V66, P101, DOI 10.1136/thx.2009.134171; Botelho FM, 2010, AM J RESP CELL MOL, V42, P394, DOI 10.1165/rcmb.2008-0301OC; Brusselle GG, 2009, EUR RESPIR J, V34, P219, DOI 10.1183/09031936.00150208; Calverley PMA, 2009, LANCET, V374, P685, DOI 10.1016/S0140-6736(09)61255-1; Chen ZH, 2010, P NATL ACAD SCI USA, V107, P18880, DOI 10.1073/pnas.1005574107; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Churg A, 2009, AM J RESP CELL MOL, V40, P482, DOI 10.1165/rcmb.2008-0038OC; Cicko S, 2010, J IMMUNOL, V185, P688, DOI 10.4049/jimmunol.0904042; Cosio BG, 2004, J EXP MED, V200, P689, DOI 10.1084/jem.20040416; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; D'hulst AI, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-147; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Demedts IK, 2006, THORAX, V61, P196, DOI 10.1136/thx.2005.042432; Demedts IK, 2007, AM J RESP CRIT CARE, V175, P998, DOI 10.1164/rccm.200608-1113OC; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Di Stefano A, 2009, CLIN EXP IMMUNOL, V157, P316, DOI 10.1111/j.1365-2249.2009.03965.x; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; Ferhani N, 2010, AM J RESP CRIT CARE, V181, P917, DOI 10.1164/rccm.200903-0340OC; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Ford PA, 2010, CHEST, V137, P1338, DOI 10.1378/chest.09-2363; Freeman CM, 2009, AM J RESP CRIT CARE, V180, P1179, DOI 10.1164/rccm.200904-0552OC; Gamble E, 2007, EUR RESPIR J, V30, P467, DOI 10.1183/09031936.00013006; Greene CM, 2010, AM J RESP CRIT CARE, V181, P31, DOI 10.1164/rccm.200904-0545OC; Grootendorst DC, 2007, THORAX, V62, P1081, DOI 10.1136/thx.2006.075937; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Guerassimov A, 2004, AM J RESP CRIT CARE, V170, P974, DOI 10.1164/rccm.200309-1270oc; Hattotuwa KL, 2002, AM J RESP CRIT CARE, V165, P1592, DOI 10.1164/rccm.2105025; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hodge S, 2008, AM J RESP CRIT CARE, V178, P139, DOI 10.1164/rccm.200711-1666OC; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Imaoka H, 2008, EUR RESPIR J, V31, P287, DOI 10.1183/09031936.00019207; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Kunz LIZ, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-34; Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lommatzsch M, 2010, EUR RESPIR J, V35, P1130, DOI 10.1183/09031936.00090109; Lommatzsch M, 2010, AM J RESP CRIT CARE, V181, P928, DOI 10.1164/rccm.200910-1506OC; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; Mercado N, 2011, BIOCHEM BIOPH RES CO, V406, P292, DOI 10.1016/j.bbrc.2011.02.035; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; Murphy TF, 2005, AM J RESP CRIT CARE, V172, P195, DOI 10.1164/rccm.200412-1747OC; Nunez B, 2011, AM J RESP CRIT CARE, V183, P1025, DOI 10.1164/rccm.201001-0029OC; Opitz B, 2010, AM J RESP CRIT CARE, V181, P1294, DOI 10.1164/rccm.200909-1427SO; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Plumb J, 2009, EUR RESPIR J, V34, P89, DOI 10.1183/09031936.00100708; Polverino F, 2010, AM J RESP CRIT CARE, V182, P1011, DOI 10.1164/rccm.200911-1700OC; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Randall TD, 2010, ADV IMMUNOL, V107, P187, DOI [10.1016/S0065-2776(10)07002-1, 10.1016/B978-0-12-381300-8.00007-1]; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; Rennard SI, 2007, AM J RESP CRIT CARE, V175, P926, DOI 10.1164/rccm.200607-995OC; Richens TR, 2009, AM J RESP CRIT CARE, V179, P1011, DOI 10.1164/rccm.200807-1148OC; Rosell A, 2005, ARCH INTERN MED, V165, P891, DOI 10.1001/archinte.165.8.891; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; Saetta M, 2002, AM J RESP CRIT CARE, V165, P1404, DOI 10.1164/rccm.2107139; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Seemungal TAR, 2008, AM J RESP CRIT CARE, V178, P1139, DOI 10.1164/rccm.200801-145OC; Sethi S, 2006, AM J RESP CRIT CARE, V173, P991, DOI 10.1164/rccm.200509-1525OC; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Shapiro SD, 2007, EUR RESPIR J, V29, P375, DOI 10.1183/09031936.00087606; Sinden NJ, 2010, THORAX, V65, P930, DOI 10.1136/thx.2009.130260; Singh M, 2010, J ALLERGY CLIN IMMUN, V125, P1369, DOI 10.1016/j.jaci.2010.02.035; Smyth LJC, 2007, CHEST, V132, P156, DOI 10.1378/chest.07-0083; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Taylor AE, 2010, EUR RESPIR J, V35, P1039, DOI 10.1183/09031936.00036709; Tsuji T, 2004, AM J RESP CELL MOL, V31, P643, DOI 10.1165/rcmb.2003-0290OC; Urbanowicz RA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-76; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; Van Pottelberge GR, 2010, EUR RESPIR J, V36, P781, DOI 10.1183/09031936.00140409; Van Pottelberge GR, 2011, AM J RESP CRIT CARE, V183, P898, DOI 10.1164/rccm.201002-0304OC; Vanaudenaerde BM, 2011, AM J RESP CRIT CARE, V183, P977, DOI 10.1164/rccm.201007-1196PP; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; Wood AM, 2011, EUR RESPIR J, V37, P32, DOI 10.1183/09031936.00033710; Wouters Emiel F M, 2007, Proc Am Thorac Soc, V4, P626, DOI 10.1513/pats.200706-071TH; Wouters Emiel F M, 2009, Proc Am Thorac Soc, V6, P638, DOI 10.1513/pats.200907-073DP	103	496	523	8	133	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2011	378	9795					1015	1026		10.1016/S0140-6736(11)60988-4	http://dx.doi.org/10.1016/S0140-6736(11)60988-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HO	21907865				2022-12-28	WOS:000295193200027
J	Sarewitz, D				Sarewitz, Daniel			The voice of science: let's agree to disagree	NATURE			English	Editorial Material									Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA.	daniel.sarewitz@gmail.com							0	22	22	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2011	478	7367					7	7		10.1038/478007a	http://dx.doi.org/10.1038/478007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	829JN	21979007	Bronze			2022-12-28	WOS:000295575400004
J	O'Flynn, N; Potter, J				O'Flynn, Norma; Potter, Jonathan			Commissioning Health Care in England: An Evolving Story	ANNALS OF INTERNAL MEDICINE			English	Article								The general election in the United Kingdom in May 2010 resulted in the election of a new government, a coalition between Conservative and Liberal Democrat parties. Six weeks after the election, a white paper, "Equity and Excellence: Liberating the NHS," that proposed profound changes to the structure and organization of the health service was published. The change that generated the most discussion was the proposal that general practitioners be placed at the center of the system and given control of about 80% of the National Health Service's 100 pound billion budget. The proposals were greeted with considerable concern by many health care professionals, patient representatives, and the media. In response, the government organized an independent review, and proposals have been altered in response. This article outlines the current organization of the National Health Service, the rationale for change, and government proposals. Ann Intern Med. 2011; 155: 465-469.	[O'Flynn, Norma] Royal Coll Physicians, Natl Clin Guideline Ctr Acute & Chron Condit, London NW1 4LE, England	Royal College of Physicians	O'Flynn, N (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr Acute & Chron Condit, 11 St Andrews Pl,Regents Pk, London NW1 4LE, England.							[Anonymous], 2011, REF NHS CHANG HLTH S; [Anonymous], 2011, RCGP RESP FUT FOR RE; [Anonymous], 2011, BMJ, V342, pd3995; Delamothe T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d4050; Department of Health, 2011, GOV CHANG RESP NHS F; Department of Health, 2010, EQ EXC LIB NHS; Department of Health, 2010, NHS OUTC FRAM 2011 1; Jones R, 2010, BRIT J GEN PRACT, V60, P635, DOI 10.3399/bjgp10X515322; NHS Future Forum, 2011, NHS FUT FOR REC GOV; Nicholson D., 2010, LIBERATING NHS MANAG; Royal College of General Practitioners, 2011, GOV HLTH REF AN NEED; Thorlby R, 2010, HIGH PERFORMING NHS; Walshe K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3843	13	5	5	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2011	155	7					465	U105		10.7326/0003-4819-155-7-201110040-00009	http://dx.doi.org/10.7326/0003-4819-155-7-201110040-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	833OC	21969345				2022-12-28	WOS:000295893800007
J	Faelber, K; Posor, Y; Gao, S; Held, M; Roske, Y; Schulze, D; Haucke, V; Noe, F; Daumke, O				Faelber, Katja; Posor, York; Gao, Song; Held, Martin; Roske, Yvette; Schulze, Dennis; Haucke, Volker; Noe, Frank; Daumke, Oliver			Crystal structure of nucleotide-free dynamin	NATURE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; PARTICLE MESH EWALD; GTPASE DOMAIN; MIDDLE DOMAIN; PH DOMAIN; MODEL; PHOSPHORYLATION; IDENTIFICATION; RESOLUTION; MECHANISM	Dynamin is a mechanochemical GTPase that oligomerizes around the neck of clathrin-coated pits and catalyses vesicle scission in a GTP-hydrolysis-dependent manner. The molecular details of oligomerization and the mechanism of the mechanochemical coupling are currently unknown. Here we present the crystal structure of human dynamin 1 in the nucleotide-free state with a four-domain architecture comprising the GTPase domain, the bundle signalling element, the stalk and the pleckstrin homology domain. Dynamin 1 oligomerized in the crystals via the stalks, which assemble in a criss-cross fashion. The stalks further interact via conserved surfaces with the pleckstrin homology domain and the bundle signalling element of the neighbouring dynamin molecule. This intricate domain interaction rationalizes a number of disease-related mutations in dynamin 2 and suggests a structural model for the mechanochemical coupling that reconciles previous models of dynamin function.	[Faelber, Katja; Gao, Song; Roske, Yvette; Schulze, Dennis; Daumke, Oliver] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Posor, York; Gao, Song; Haucke, Volker] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Held, Martin; Noe, Frank] Free Univ Berlin, Inst Math, D-14195 Berlin, Germany; [Daumke, Oliver] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Daumke, O (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	katja.faelber@mdc-berlin.de; oliver.daumke@mdc-berlin.de	Noe, Frank/Y-2766-2019	Haucke, Volker/0000-0003-3119-6993; Gao, Song/0000-0001-7427-6681	Deutsche Forschungsgemeinschaft [SFB 740/C7, SFB958/A12, SFB740/D7, SFB958/A04, SFB740/C8, SFB 958/A7]; International Human Frontier Science Program Organization; EMBO	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Human Frontier Science Program Organization(Human Frontier Science Program); EMBO(European Molecular Biology Organization (EMBO))	This project was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 740/C7 and SFB958/A12 to O.D., SFB740/D7 and SFB958/A04 to F.N., SFB740/C8 and SFB 958/A7 to V. H.), by a Career Development Fellowship of The International Human Frontier Science Program Organization and by the EMBO Young Investigator Program to O.D. We would like to thank S. Werner, M. Papst and S. Kraft for technical assistance, the BESSY staff at BL14.1 for help during data collection, G. Schroder for advice in DEN refinement and U. Heinemann for discussions.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano WL, 2011, PYMOL MOL GRAPHICS S; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Graham ME, 2007, J BIOL CHEM, V282, P14695, DOI 10.1074/jbc.M609713200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; Klockow B, 2002, EMBO J, V21, P240, DOI 10.1093/emboj/21.3.240; Kochs G, 2005, METHOD ENZYMOL, V404, P632, DOI 10.1016/S0076-6879(05)04055-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Low HH, 2010, CURR OPIN STRUC BIOL, V20, P791, DOI 10.1016/j.sbi.2010.09.011; Low HH, 2009, CELL, V139, P1342, DOI 10.1016/j.cell.2009.11.003; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Morlot S, 2010, BIOPHYS J, V99, P3580, DOI 10.1016/j.bpj.2010.10.015; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prinz JH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3565032; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Reubold TF, 2005, P NATL ACAD SCI USA, V102, P13093, DOI 10.1073/pnas.0506491102; ROBINSON PJ, 1993, NATURE, V365, P163, DOI 10.1038/365163a0; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIMM D, 1994, NAT STRUCT BIOL, V1, P782, DOI 10.1038/nsb1194-782; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang L, 2010, J BIOL CHEM, V285, P22751, DOI 10.1074/jbc.C110.130013; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002	57	212	216	3	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2011	477	7366					556	U318		10.1038/nature10369	http://dx.doi.org/10.1038/nature10369			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21927000				2022-12-28	WOS:000295320900032
J	Barry, MJ; Meleth, S; Lee, JY; Kreder, KJ; Avins, AL; Nickel, JC; Roehrborn, CG; Crawford, ED; Foster, HE; Kaplan, SA; McCullough, A; Andriole, GL; Naslund, MJ; Williams, OD; Kusek, JW; Meyers, CM; Betz, JM; Cantor, A; McVary, KT				Barry, Michael J.; Meleth, Sreelatha; Lee, Jeannette Y.; Kreder, Karl J.; Avins, Andrew L.; Nickel, J. Curtis; Roehrborn, Claus G.; Crawford, E. David; Foster, Harris E., Jr.; Kaplan, Steven A.; McCullough, Andrew; Andriole, Gerald L.; Naslund, Michael J.; Williams, O. Dale; Kusek, John W.; Meyers, Catherine M.; Betz, Joseph M.; Cantor, Alan; McVary, Kevin T.		Complementary Alternative Med Urol	Effect of Increasing Doses of Saw Palmetto Extract on Lower Urinary Tract Symptoms A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BENIGN PROSTATIC HYPERPLASIA; CLINICAL-TRIAL; HEALTH-STATUS; IMPACT INDEX; SCALE; MEN; PHYTOTHERAPY; VALIDATION; THERAPY	Context Saw palmetto fruit extracts are widely used for treating lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH); however, recent clinical trials have questioned their efficacy, at least at standard doses (320 mg/d). Objective To determine the effect of saw palmetto extract (Serenoa repens, from saw palmetto berries) at up to 3 times the standard dose on lower urinary tract symptoms attributed to BPH. Design, Setting, and Participants A double-blind, multicenter, placebo-controlled randomized trial at 11 North American clinical sites conducted between June 5, 2008, and October 10, 2010, of 369 men aged 45 years or older, with a peak urinary flow rate of at least 4 mL/s, an American Urological Association Symptom Index (AUASI) score of between 8 and 24 at 2 screening visits, and no exclusions. Interventions One, 2, and then 3 doses (320 mg/d) of saw palmetto extract or placebo, with dose increases at 24 and 48 weeks. Main Outcome Measures Difference in AUASI score between baseline and 72 weeks. Secondary outcomes included measures of urinary bother, nocturia, peak uroflow, post-void residual volume, prostate-specific antigen level, participants' global assessments, and indices of sexual function, continence, sleep quality, and prostatitis symptoms. Results Between baseline and 72 weeks, mean AUASI scores decreased from 14.42 to 12.22 points (-2.20 points; 95% CI, -3.04 to -0.36) with saw palmetto extract and from 14.69 to 11.70 points (-2.99 points; 95% CI, -3.81 to -2.17) with placebo. The group mean difference in AUASI score change from baseline to 72 weeks between the saw palmetto extract and placebo groups was 0.79 points favoring placebo (upper bound of the 1-sided 95% CI most favorable to saw palmetto extract was 1.77 points, 1-sided P=.91). Saw palmetto extract was no more effective than placebo for any secondary outcome. No clearly attributable adverse effects were identified. Conclusion Increasing doses of a saw palmetto fruit extract did not reduce lower urinary tract symptoms more than placebo.	[Barry, Michael J.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Meleth, Sreelatha; Williams, O. Dale; Cantor, Alan] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; [Lee, Jeannette Y.] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA; [Kreder, Karl J.] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA; [Avins, Andrew L.] No Calif Kaiser Permanente, Div Res, Oakland, CA USA; [Nickel, J. Curtis] Queens Univ, Dept Urol, Kingston, ON, Canada; [Roehrborn, Claus G.] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Crawford, E. David] Univ Colorado, Sect Urol Oncol, Denver, CO 80202 USA; [Foster, Harris E., Jr.] Yale Univ, Sch Med, Urol Sect, New Haven, CT USA; [Kaplan, Steven A.] Weill Cornell Med Coll, Dept Urol, New York, NY USA; [McCullough, Andrew] NYU, Urol Associates, New York, NY USA; [Andriole, Gerald L.] Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63110 USA; [Naslund, Michael J.] Univ Maryland, Maryland Prostate Ctr, Baltimore, MD 21201 USA; [Kusek, John W.] NIDDK, Bethesda, MD USA; [Meyers, Catherine M.] Natl Ctr Complementary & Alternat Med, Bethesda, MD USA; [Betz, Joseph M.] NIH, Off Dietary Supplements, Bethesda, MD 20892 USA; [McVary, Kevin T.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Harvard University; Massachusetts General Hospital; University of Alabama System; University of Alabama Birmingham; University of Arkansas System; University of Arkansas Medical Sciences; University of Iowa; Kaiser Permanente; Queens University - Canada; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Colorado System; University of Colorado Denver; Yale University; Cornell University; New York University; Washington University (WUSTL); University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine; National Institutes of Health (NIH) - USA; Northwestern University; Feinberg School of Medicine	Barry, MJ (corresponding author), Massachusetts Gen Hosp, Dept Med, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	mbarry@partners.org		Kreder, Karl/0000-0002-8981-5286	GlaxoSmithKline; Pfizer; Watson; Astellas; Ferring; Taris; Triton; Farr Labs; Trillium; Cernelle; Johnson Johnson; Amgen; Bayer; Caris; France Foundation; GenProbe; Steba Biotech; Ortho-Clinical Diagnostics; Ferring Pharmaceuticals; Lilly/ICOS; Allergan; National Institute of Diabetes and Digestive and Kidney Diseases; Watson Pharm; Neotract; National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases [U01 DK63795, U01 DK63797, U01 DK63825, U01 DK63835, U01 DK63866, U01 DK63833, U01 DK63862, U01 DK63840, U01 DK63883, U01 DK63831, U01 DK63778, U01 DK63788]; National Center for Complementary and Alternative Medicine; Office of Dietary Supplements, NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK063788, U01DK063862, U01DK063840, U01DK063825, U01DK063833, U01DK063795, U01DK063866, U01DK063883, U01DK063797, U01DK063778, U01DK063835, U01DK063831] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Watson; Astellas(Astellas Pharmaceuticals); Ferring(Ferring Pharmaceuticals); Taris; Triton; Farr Labs; Trillium(University of Toronto); Cernelle; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Amgen(Amgen); Bayer(Bayer AG); Caris; France Foundation; GenProbe; Steba Biotech; Ortho-Clinical Diagnostics; Ferring Pharmaceuticals(Ferring Pharmaceuticals); Lilly/ICOS(Eli Lilly); Allergan(AbbVieAllergan); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Watson Pharm; Neotract; National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Office of Dietary Supplements, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Barry reported serving on the board of and receiving salary support as president of the not-for-profit (501[3]c) Foundation for Informed Medical Decision Making (http://www.fimdm.org), which develops content for patient education programs. The foundation has an arrangement with a for-profit company, Health Dialog, to coproduce and market these programs to health care organizations. Dr Lee reported that funds were paid to her institution for consultancy to Merck. Dr Nickel reported receiving consultation funds from GlaxoSmithKline, Pfizer, Watson, Astellas, Ferring, Taris, Triton, Farr Labs, Trillium, Cernelle, and Johnson & Johnson; having provided expert testimony for GlaxoSmithKline; and having received payment for development of educational presentations from the Canadian Urological Association. Dr Crawford reported receiving payment for lectures from Ferring Pharmaceuticals and GlaxoSmithKline. Dr Andriole reported receiving consultation funds from Amgen, Bayer, Caris, France Foundation, GenProbe, GlaxoSmithKline, Steba Biotech, Ortho-Clinical Diagnostics, and Ferring Pharmaceuticals; having received royalties from Up to Date; receiving payment for development of educational presentations from Amgen; having stock and/or stock options in Envisioneering Medical, Viking Medical, Augmenix, and Cambridge Endo; and receiving travel, accommodations, and meeting expenses from Amgen, Augmenix, Bayer, Cambridge Endo, Caris, France Foundation, GenProbe, Myriad Genetics, Steba Biotech, and Ortho Clinical Diagnostics. Dr Naslund reported receiving payment for lectures from GlaxoSmithKline and sanofi-aventis, as well as payment for development of educational presentations for France Foundation. Dr McVary reported receiving consultancy funds from Lilly/ICOS, Allergan, National Institute of Diabetes and Digestive and Kidney Diseases, Watson Pharm, and Neotract, as well as payment for lectures from GlaxoSmithKline. No other disclosures were reported.; This study was funded by cooperative agreements U01 DK63795, U01 DK63797, U01 DK63825, U01 DK63835, U01 DK63866, U01 DK63833, U01 DK63862, U01 DK63840, U01 DK63883, U01 DK63831, U01 DK63778, and U01 DK63788 from the National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases. Support was also provided by the National Center for Complementary and Alternative Medicine and the Office of Dietary Supplements, NIH. Saw palmetto fruit extract and matching placebo were donated by Rottapharm/Madaus, Cologne, Germany. This study was conducted under an Investigational New Drug Application from the US Food and Drug Administration.	AUA Practise Guidelines Committee, 2003, J UROLOGY, V170, P530, DOI 10.1097/01.ju.0000078083.38675.79; Avins AL, 2008, COMPLEMENT THER MED, V16, P147, DOI 10.1016/j.ctim.2007.10.005; Barnes P. M., 2007, COMPLEMENTARY ALTERN; BARRY MJ, 1995, MED CARE, V33, pAS145; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; BARRY MJ, 1995, J UROLOGY, V154, P1770, DOI 10.1016/S0022-5347(01)66780-6; Bent S, 2006, NEW ENGL J MED, V354, P557, DOI 10.1056/NEJMoa053085; Buck AC, 2004, J UROLOGY, V172, P1792, DOI 10.1097/01.ju.0000140503.11467.8e; Chapple CR, 2006, EUR UROL, V49, P651, DOI 10.1016/j.eururo.2006.02.018; Dedhia RC, 2008, J UROLOGY, V179, P2119, DOI 10.1016/j.juro.2008.01.094; Donovan JL, 2000, J UROLOGY, V164, P1948, DOI 10.1016/S0022-5347(05)66926-1; Gerber GS, 2000, J UROLOGY, V163, P1408, DOI 10.1016/S0022-5347(05)67631-8; JACOBSEN SJ, 1995, ARCH INTERN MED, V155, P477, DOI 10.1001/archinte.155.5.477; JENKINS CD, 1988, J CLIN EPIDEMIOL, V41, P313, DOI 10.1016/0895-4356(88)90138-2; Knottnerus JA, 2001, J CLIN EPIDEMIOL, V54, P109, DOI 10.1016/S0895-4356(00)00276-6; Lee J, 2009, CLIN TRIALS, V6, P628, DOI 10.1177/1740774509352199; Lee JY, 2011, J ALTERN COMPLEM MED, V17, P469, DOI 10.1089/acm.2010.0300; Litwin MS, 1999, J UROLOGY, V162, P369, DOI 10.1016/S0022-5347(05)68562-X; Maccagnano C, 2006, EUR UROL SUPPL, V5, P430, DOI 10.1016/j.eursup.2006.02.006; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Nickel JC, 2006, CURR OPIN UROL, V16, P5, DOI 10.1097/01.mou.0000193365.46081.cd; O'Leary MP, 2008, BJU INT, V101, P1531, DOI 10.1111/j.1464-410X.2008.07574.x; Pais P, 2010, ADV THER, V27, P555, DOI 10.1007/s12325-010-0041-6; Rosen RC, 2007, UROLOGY, V69, P805, DOI 10.1016/j.urology.2007.02.036; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Tacklind J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001423.pub2; *US PHARM CONV, 2010, US PHARM SAW PALM EX; Wilt T, 2002, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001423	28	101	104	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 28	2011	306	12					1344	1351		10.1001/jama.2011.1364	http://dx.doi.org/10.1001/jama.2011.1364			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825FQ	21954478	Bronze, Green Accepted			2022-12-28	WOS:000295257000023
J	Maher, AR; Maglione, M; Bagley, S; Suttorp, M; Hu, JH; Ewing, B; Wang, Z; Timmer, M; Sultzer, D; Shekelle, PG				Maher, Alicia Ruelaz; Maglione, Margaret; Bagley, Steven; Suttorp, Marika; Hu, Jian-Hui; Ewing, Brett; Wang, Zhen; Timmer, Martha; Sultzer, David; Shekelle, Paul G.			Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							OBSESSIVE-COMPULSIVE DISORDER; GENERALIZED ANXIETY DISORDER; SEROTONIN REUPTAKE INHIBITORS; PLACEBO-CONTROLLED TRIAL; NURSING-HOME RESIDENTS; FUMARATE QUETIAPINE XR; A-DOUBLE-BLIND; ALZHEIMERS-DISEASE; BEHAVIORAL DISTURBANCES; PSYCHOLOGICAL SYMPTOMS	Context Atypical antipsychotic medications are commonly used for off-label conditions such as agitation in dementia, anxiety, and obsessive-compulsive disorder. Objective To perform a systematic review on the efficacy and safety of atypical antipsychotic medications for use in conditions lacking approval for labeling and marketing by the US Food and Drug Administration. Data Sources and Study Selection Relevant studies published in the English language were identified by searches of 6 databases (PubMed, EMBASE, CINAHL, PsycInfo, Cochrane DARE, and CENTRAL) from inception through May 2011. Controlled trials comparing an atypical antipsychotic medication (risperidone, olanzapine, quetiapine, aripiprazole, ziprasidone, asenapine, iloperidone, or paliperidone) with placebo, another atypical antipsychotic medication, or other pharmacotherapy for adult off-label conditions were included. Observational studies with sample sizes of greater than 1000 patients were included to assess adverse events. Data Extraction Independent article review and study quality assessment by 2 investigators. Data Synthesis Of 12 228 citations identified, 162 contributed data to the efficacy review. Among 14 placebo-controlled trials of elderly patients with dementia reporting a total global outcome score that includes symptoms such as psychosis, mood alterations, and aggression, small but statistically significant effects sizes ranging from 0.12 and 0.20 were observed for aripiprazole, olanzapine, and risperidone. For generalized anxiety disorder, a pooled analysis of 3 trials showed that quetiapine was associated with a 26% greater likelihood of a favorable response (defined as at least 50% improvement on the Hamilton Anxiety Scale) compared with placebo. For obsessive-compulsive disorder, risperidone was associated with a 3.9-fold greater likelihood of a favorable response (defined as a 25% improvement on the Yale-Brown Obsessive Compulsive Scale) compared with placebo. In elderly patients, adverse events included an increased risk of death (number needed to harm [NNH]=87), stroke (NNH=53 for risperidone), extrapyramidal symptoms (NNH=10 for olanzapine; NNH=20 for risperidone), and urinary tract symptoms (NNH range=16-36). In nonelderly adults, adverse events included weight gain (particularly with olanzapine), fatigue, sedation, akathisia (for aripiprazole), and extrapyramidal symptoms. Conclusions Benefits and harms vary among atypical antipsychotic medications for off-label use. For global behavioral symptom scores associated with dementia in elderly patients, small but statistically significant benefits were observed for aripiprazole, olanzapine, and risperidone. Quetiapine was associated with benefits in the treatment of generalized anxiety disorder, and risperidone was associated with benefits in the treatment of obsessive-compulsive disorder; however, adverse events were common. JAMA. 2011;306(12):1359-1369	[Maher, Alicia Ruelaz; Maglione, Margaret; Suttorp, Marika; Hu, Jian-Hui; Ewing, Brett; Wang, Zhen; Timmer, Martha; Shekelle, Paul G.] So Calif Evidence Based Practice Ctr, RAND Hlth, Santa Monica, CA 90401 USA; [Bagley, Steven] VA Palo Alto Healthcare Syst, Palo Alto, CA USA; [Sultzer, David; Shekelle, Paul G.] W Los Angeles VA Med Ctr, Los Angeles, CA USA; [Sultzer, David] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA	RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Maher, AR (corresponding author), So Calif Evidence Based Practice Ctr, RAND Hlth, 1776 Main St, Santa Monica, CA 90401 USA.	Alicia.Ruelaz@cshs.org	Zhen, Wang/S-7244-2019; Hug, Balthasar L./G-1568-2010; Wang, Zhen/D-5991-2013	Wang, Zhen/0000-0002-9368-6149; Bagley, Steven/0000-0003-2187-7955	Eli Lilly; RAND Corporation; Agency for Healthcare Research and Quality [HHSA2902007100621]; Department of Veterans Affairs	Eli Lilly(Eli Lilly); RAND Corporation; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Department of Veterans Affairs(US Department of Veterans Affairs)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Sultzer reported that he received research support for an Alzheimer disease study from Eli Lilly (no direct or indirect salary was paid to him) and consulting fees from RAND Corporation for his work as member of a technical expert panel for the Agency for Healthcare Research and Quality that performed the initial analysis. No other disclosures were reported.; This article is based on research conducted by the Southern California Evidence-Based Practice Center under contract HHSA2902007100621 with the Agency for Healthcare Research and Quality. This work was commissioned by the Agency for Healthcare Research and Quality as an update to an earlier report. Drs Sultzer and Shekelle are also supported by the Department of Veterans Affairs.	*AHRQ, EFF COMP EFF OFF LAB; Alexander GC, 2011, PHARMACOEPIDEM DR S, V20, P177, DOI 10.1002/pds.2082; Altamura AC, 2011, INT CLIN PSYCHOPHARM, V26, P201, DOI 10.1097/YIC.0b013e3283457d73; [Anonymous], 14 ANN M AM ASS GER; Atmaca M, 2002, INT CLIN PSYCHOPHARM, V17, P115, DOI 10.1097/00004850-200205000-00004; Ballard C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003476.pub2; Ballard C, 2005, BMJ-BRIT MED J, V330, P874, DOI 10.1136/bmj.38369.459988.8F; Ballard CG, 2004, J CLIN PSYCHIAT, V65, P114; Bandelow B, 2010, INT J NEUROPSYCHOPH, V13, P305, DOI 10.1017/S1461145709990423; Brawman-Mintzer O, 2005, J CLIN PSYCHIAT, V66, P1321, DOI 10.4088/JCP.v66n1016; Brodaty H, 2005, INT J GERIATR PSYCH, V20, P1153, DOI 10.1002/gps.1409; Brodaty H, 2003, J CLIN PSYCHIAT, V64, P134, DOI 10.4088/JCP.v64n0205; Bystritsky A, 2004, J CLIN PSYCHIAT, V65, P565; Carey PD, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-5; Cavedini P, 2004, J CLIN PSYCHOPHARM, V24, P628, DOI 10.1097/01.jcp.0000144889.51072.03; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; CUMMINGS JL, NEUROPSYCHIATRIC INV; De Deyn PP, 1999, NEUROLOGY, V53, P946, DOI 10.1212/WNL.53.5.946; De Deyn PP, 2005, CLIN NEUROL NEUROSUR, V107, P497, DOI 10.1016/j.clineuro.2005.03.013; De Deyn PP, 2004, INT J GERIATR PSYCH, V19, P115, DOI 10.1002/gps.1032; Deberdt WG, 2005, AM J GERIAT PSYCHIAT, V13, P722, DOI 10.1176/appi.ajgp.13.8.722; DEDEYN PPJ, 2003, 16 ANN M AM ASS GER; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Denys D, 2004, J CLIN PSYCHIAT, V65, P1040; Denys D, 2006, NEUROPSYCHOPHARMACOL, V31, pS104; Depping AM, 2010, COCHRANE DB SYST REV, V12; Diniz JB, 2010, J PSYCHOPHARMACOL, V24, P297, DOI 10.1177/0269881108099423; Erzegovesi S, 2005, EUR NEUROPSYCHOPHARM, V15, P69, DOI 10.1016/j.euroneuro.2004.04.004; Fineberg NA, 2005, INT CLIN PSYCHOPHARM, V20, P223, DOI 10.1097/00004850-200507000-00005; Gareri P, 2004, ARCH GERONTOL GERIAT, P207; Gill SS, 2007, ANN INTERN MED, V146, P775, DOI 10.7326/0003-4819-146-11-200706050-00006; Herz LR, 2002, J CLIN PSYCHIAT, V63, P1065; Hirschfeld RMA, 2006, J CLIN PSYCHIAT, V67, P355, DOI 10.4088/JCP.v67n0304; Hollander E, 2003, INT J NEUROPSYCHOPH, V6, P397, DOI 10.1017/S1461145703003730; Holmes C, 2007, INT J GERIATR PSYCH, V22, P380, DOI 10.1002/gps.1667; Huybrechts KF, 2011, CAN MED ASSOC J, V183, pE411, DOI 10.1503/cmaj.101406; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JOYCE M, 2008, 161 ANN M AM PSYCH A; Kales HC, 2007, AM J PSYCHIAT, V164, P1568, DOI 10.1176/appi.ajp.2007.06101710; Kales HC, 2011, ARCH GEN PSYCHIAT, V68, P190, DOI 10.1001/archgenpsychiatry.2010.200; Katz IR, 1999, J CLIN PSYCHIAT, V60, P107, DOI 10.4088/JCP.v60n0207; Katzman MA, 2011, INT CLIN PSYCHOPHARM, V26, P11, DOI 10.1097/YIC.0b013e32833e34d9; Kennedy J, 2005, INT J GERIATR PSYCH, V20, P1020, DOI 10.1002/gps.1397; Khan A, 2009, 49 ANN NEW CLIN DRUG; KINON BJL, 2005, INT C SCHIZ RES APR; Kordon A, 2008, J CLIN PSYCHOPHARM, V28, P550, DOI 10.1097/JCP.0b013e318185e735; Krystal JH, 2011, JAMA-J AM MED ASSOC, V306, P493, DOI 10.1001/jama.2011.1080; Liperoti R, 2009, J CLIN PSYCHIAT, V70, P1340, DOI 10.4088/JCP.08m04597yel; Lohoff FW, 2010, J CLIN PSYCHOPHARM, V30, P185, DOI 10.1097/JCP.0b013e3181d21951; MAGLIONE M, EFFICACY COMP EFFECT; Maina G, 2008, EUR NEUROPSYCHOPHARM, V18, P364, DOI 10.1016/j.euroneuro.2008.01.001; Matsunaga H, 2009, J CLIN PSYCHIAT, V70, P863, DOI 10.4088/JCP.08m04369; McDougle CJ, 2000, ARCH GEN PSYCHIAT, V57, P794, DOI 10.1001/archpsyc.57.8.794; McIntyre A, 2007, DEPRESS ANXIETY, V24, P487, DOI 10.1002/da.20275; Merideth C, 2008, EUR NEUROPSYCHOPHARM, V18, pS499, DOI 10.1016/S0924-977X(08)70749-1; Mintzer J, 2006, AM J GERIAT PSYCHIAT, V14, P280, DOI 10.1097/01.JGP.0000194643.63245.8c; MINTZER J, 2004, 4 ANN M INT COLL GER; Mintzer JE, 2007, AM J GERIAT PSYCHIAT, V15, P918, DOI 10.1097/JGP.0b013e3181557b47; Moretti R, 2005, J NEUROL, V252, P1186, DOI 10.1007/s00415-005-0830-z; Mowla A, 2010, J CLIN PSYCHOPHARM, V30, P40, DOI 10.1097/JCP.0b013e3181ca0c59; Mulsant BH, 2004, J CLIN PSYCHIAT, V65, P1708, DOI 10.4088/JCP.v65n1217; Naber D, 2007, PSYCHOPHARMACOLOGY, V191, P1027, DOI 10.1007/s00213-007-0747-6; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Paleacu D, 2008, INT J GERIATR PSYCH, V23, P393, DOI 10.1002/gps.1892; Pandina GJ, 2007, PSYCHOPHARMACOL BULL, V40, P41; Parker C, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4245; Pollack MH, 2006, BIOL PSYCHIAT, V59, P211, DOI 10.1016/j.biopsych.2005.07.005; Pollock BG, 2007, AM J GERIAT PSYCHIAT, V15, P942, DOI 10.1097/JGP.0b013e3180cc1ff5; Rainer M, 2007, EUR PSYCHIAT, V22, P395, DOI 10.1016/j.eurpsy.2007.03.001; Rappaport SA, 2009, J AM MED DIR ASSOC, V10, P21, DOI 10.1016/j.jamda.2008.06.006; Ray WA, 2009, NEW ENGL J MED, V360, P225, DOI 10.1056/NEJMoa0806994; Satterlee Winston G., 1995, Psychopharmacology Bulletin, V31, P534; Savaskan E, 2006, INT J NEUROPSYCHOPH, V9, P507, DOI 10.1017/S1461145705006036; Schneeweiss S, 2007, CAN MED ASSOC J, V176, P627, DOI 10.1503/cmaj.061250; Schneider LS, 2006, NEW ENGL J MED, V355, P1525, DOI 10.1056/NEJMoa061240; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Schneider LS, 2006, AM J GERIAT PSYCHIAT, V14, P191, DOI 10.1097/01.JGP.0000200589.01396.6d; Shapira NA, 2004, BIOL PSYCHIAT, V55, P553, DOI 10.1016/j.biopsych.2003.11.010; Sheehan DV, 2009, J AFFECT DISORDERS, V115, P376, DOI 10.1016/j.jad.2008.10.005; Simon NM, 2008, PSYCHOPHARMACOLOGY, V197, P675, DOI 10.1007/s00213-008-1087-x; Street JS, 2000, ARCH GEN PSYCHIAT, V57, P968, DOI 10.1001/archpsyc.57.10.968; Street JS, 2000, PSYCHIAT ANN, V30, P191, DOI 10.3928/0048-5713-20000301-12; STREET JS, 2000, OLANZAPINE ZYPREXA N, P416; STREIM JE, 2004, AM PSYCH ASS ANN M M; STREIM JE, 2004, ANN M AM ASS GER PSY; Streim JE, 2008, AM J GERIAT PSYCHIAT, V16, P537, DOI 10.1097/JGP.0b013e318165db77; Suh GH, 2007, INT J GERIATR PSYCH, V22, P494, DOI 10.1002/gps.1693; Sultzer DL, 2008, AM J PSYCHIAT, V165, P844, DOI 10.1176/appi.ajp.2008.07111779; Tariot PN, 2006, AM J GERIAT PSYCHIAT, V14, P767, DOI 10.1097/01.JGP.0000196628.12010.35; TARIOT PS, 2002, ANN M AM ASS GER PSY; TODD MS, 2002, 155 ANN M AM PSYCH A; van Reekum R, 2002, INT PSYCHOGERIATR, V14, P197, DOI 10.1017/S1041610202008396; Verhey FRJ, 2006, DEMENT GERIATR COGN, V21, P1, DOI 10.1159/000089136; Vigen CLP, 2011, AM J PSYCHIAT, V168, P831, DOI 10.1176/appi.ajp.2011.08121844; Vulink NCC, 2009, J CLIN PSYCHIAT, V70, P1001, DOI 10.4088/JCP.08m04269; Wells G., NEWCASTLE OTTAWA SCA; Yury CA, 2007, PSYCHOTHER PSYCHOSOM, V76, P213, DOI 10.1159/000101499; Zhong KX, 2007, CURR ALZHEIMER RES, V4, P81, DOI 10.2174/156720507779939805; ZHONG XT, 2004, 56 I PSYCH SERV OCT	99	354	368	0	74	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 28	2011	306	12					1359	1369		10.1001/jama.2011.1360	http://dx.doi.org/10.1001/jama.2011.1360			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825FQ	21954480	Bronze			2022-12-28	WOS:000295257000025
J	Jit, M; Chapman, R; Hughes, O; Choi, YH				Jit, Mark; Chapman, Ruth; Hughes, Owain; Choi, Yoon Hong			Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RECURRENT RESPIRATORY PAPILLOMATOSIS; QUALITY-OF-LIFE; CERVICAL-CANCER; HPV VACCINE; PARTICLE VACCINE; UNITED-KINGDOM; INTRAEPITHELIAL NEOPLASIA; GENITAL WARTS; WOMEN; COST	Objectives To compare the effect and cost effectiveness of bivalent and quadrivalent human papillomavirus (HPV) vaccination, taking into account differences in licensure indications, protection against non-vaccine type disease, protection against disease related to HPV types 6 and 11, and reported long term immunogenicity. Design A model of HPV transmission and disease previously used to inform UK vaccination policy, updated with recent evidence and expanded to include scenarios where the two vaccines differ in duration of protection, cross protection, and end points prevented. Setting United Kingdom. Population Males and females aged 12-75 years. Main outcome measure Incremental cost effectiveness ratios for both vaccines and additional cost per dose for the quadrivalent vaccine to be equally cost effective as the bivalent vaccine. Results The bivalent vaccine needs to be cheaper than the quadrivalent vaccine to be equally cost effective, mainly because of its lack of protection against anogenital warts. The price difference per dose ranges from a median of 19 pound (interquartile range 12- pound 27) pound to 35 pound (27- pound 44) pound across scenarios about vaccine duration, cross protection, and end points prevented (assuming one quality adjusted life year (QALY) is valued at 30 pound 000 and both vaccines can prevent all types of HPV related cancers). Conclusions The quadrivalent vaccine may have an advantage over the bivalent vaccine in reducing healthcare costs and QALYs lost. The bivalent vaccine may have an advantage in preventing death due to cancer. However, considerable uncertainty remains about the differential benefit of the two vaccines.	[Jit, Mark; Chapman, Ruth; Choi, Yoon Hong] Hlth Protect Agcy, London NW9 6BT, England; [Hughes, Owain] Inst Child Hlth, London WC1N 1EH, England	Health Protection Agency; University of London; University College London	Jit, M (corresponding author), Hlth Protect Agcy, London NW9 6BT, England.	mark.jit@hpa.org.uk	Jit, Mark/HDM-7797-2022; Choi, Yoon Hong/AAY-1740-2020	Choi, Yoon Hong/0000-0001-5561-4366; Jit, Mark/0000-0001-6658-8255	Department of Health, England [DOH 039/0031]; Medical Research Council [G0900348]; Sanofi Pasteur; MRC [G0900348] Funding Source: UKRI	Department of Health, England; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sanofi Pasteur; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RC was funded by a grant from the Policy Research Programme of the Department of Health, England (reference DOH 039/0031). OH was funded by a Medical Research Council Clinical Research Training Fellowship (reference G0900348). The authors' work was independent of the funders, who had no role in the study design, analysis of data, writing of the manuscript, or decision to submit for publication.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author). OH has received unrestricted funding from Sanofi Pasteur to investigate the potential benefits of the quadrivalent L1 vaccine as therapy for recurrent respiratory papillomatoses. The other authors declare no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	[Anonymous], 2008, GUID METH TECHN APPR; Bishai D, 2000, ARCH OTOLARYNGOL, V126, P935, DOI 10.1001/archotol.126.8.935; Bosch F Xavier, 2003, J Natl Cancer Inst Monogr, P3; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Brisson M, 2007, VACCINE, V25, P5399, DOI 10.1016/j.vaccine.2007.04.086; [British Medical Association Royal Pharmaceutical Society of Great Britain], 2010, BRIT NAT FORM; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Brown DR, 1999, J CLIN MICROBIOL, V37, P3316, DOI 10.1128/JCM.37.10.3316-3322.1999; Brown RE, 2006, CURR MED RES OPIN, V22, P663, DOI 10.1185/030079906X99972; Chadha NK, 2010, OTOLARYNG HEAD NECK, V143, P685, DOI 10.1016/j.otohns.2010.08.005; Chapman R, 2011, VACCINE, V29, P2881, DOI 10.1016/j.vaccine.2011.02.008; Choi Y, 2009, INT PAP C MALM SWED; Choi YH, 2010, VACCINE, V28, P4091, DOI 10.1016/j.vaccine.2009.09.125; Clifford G, 2010, EUROGIN 2010 MONT CA; Curtis L., 2009, UNIT COSTS HLTH SOCI; David MP, 2009, GYNECOL ONCOL, V115, pS1, DOI 10.1016/j.ygyno.2009.01.011; De Carvalho N, 2010, VACCINE, V28, P6247, DOI 10.1016/j.vaccine.2010.07.007; de Kok IMCM, 2011, EUR J CANCER, V47, P428, DOI 10.1016/j.ejca.2010.09.030; de Rijke JM, 2002, EUR J CANCER, V38, P2041, DOI 10.1016/S0959-8049(02)00315-5; Dee A, 2010, EUR J PUBLIC HEALTH, V20, P213, DOI 10.1093/eurpub/ckp141; Demarteau Nadia, 2010, J Med Econ, V13, P324, DOI 10.3111/13696998.2010.490481; Department of Health, KEY VACC INF HPV; Desai S, SEX TRANSM IN PRESS; Dillner J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3493; Franco E, 2010, EUROGIN 2010 MONT CA; GISSMANN L, 1982, J VIROL, V44, P393, DOI 10.1128/JVI.44.1.393-400.1982; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; GREER CE, 1995, J CLIN MICROBIOL, V33, P2058, DOI 10.1128/JCM.33.8.2058-2063.1995; Haas M, 2009, HEALTH POLICY, V92, P288, DOI 10.1016/j.healthpol.2009.05.002; Hawkes N, 2008, TIMES           0718; Howell-Jones R, 2010, BRIT J CANCER, V103, P209, DOI 10.1038/sj.bjc.6605747; Hu D, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.03.064; Hughes OR, CLIN OTOLAR IN PRESS; Ilmarinen T, 2011, LARYNGOSCOPE, V121, P846, DOI 10.1002/lary.21332; Institute of Medicine, 2000, VACC 21 CENT TOOL DE; Jeffreys M, 2006, EUR J CANCER, V42, P1434, DOI 10.1016/j.ejca.2006.01.019; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Karnon J, 2004, Health Technol Assess, V8, P1; Karnon J, 2004, HEALTH TECHNOL ASSES, V8, P1; Kim JJ, 2008, NEW ENGL J MED, V359, P821, DOI 10.1056/NEJMsa0707052; Kim JJ, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a842; Kitchener HC, 2006, BRIT J CANCER, V95, P56, DOI 10.1038/sj.bjc.6603210; Klee M, 2000, GYNECOL ONCOL, V76, P5, DOI 10.1006/gyno.1999.5644; Klee M, 2000, GYNECOL ONCOL, V76, P14, DOI 10.1006/gyno.1999.5642; Korfage IJ, 2009, INT J RADIAT ONCOL, V73, P1501, DOI 10.1016/j.ijrobp.2008.06.1905; Kreimer AR, 2011, LANCET ONCOL, V12, P862, DOI 10.1016/S1470-2045(11)70213-3; Martin-Hirsch P, 2007, BJOG-INT J OBSTET GY, V114, P408, DOI 10.1111/j.1471-0528.2007.01261.x; Morris SR, 2009, SEX TRANSM INFECT, V85, P315, DOI 10.1136/sti.2008.034793; Myers ER, 21 INT PAP C CLIN WO; Office for National Statistics, ON 5 YEAR SUR PAT DI; Office for National Statistics, CANC STAT 2007 REG S; Office for National Statistics, CANC SURV ENGL PAT D; Olsson SE, 2007, VACCINE, V25, P4931, DOI 10.1016/j.vaccine.2007.03.049; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2006, VACCINE S3, V24, pS3/11; Quint W, 2009, 25 INT PAP C MALM SW; Reeves WC, 2003, ARCH OTOLARYNGOL, V129, P976, DOI 10.1001/archotol.129.9.976; Rogers SN, 2006, INT J ORAL MAX SURG, V35, P913, DOI 10.1016/j.ijom.2006.07.017; Romanowski B, 2011, HUM VACCIN, V7; Schiller JT, 2008, VACCINE, V26, pK53, DOI 10.1016/j.vaccine.2008.06.002; Sheridan A, ANN HPV VACCINE COVE; Steben M, 2010, EUROGIN 2010 MONT CA; Stern PL, 2010, SEX HEALTH, V7, P238, DOI 10.1071/SH09131; Sturegard Erik, 2008, Lakartidningen, V105, P3648; Tjalma W, 2009, INT J GYNECOL CANCER, V19, P1; Van de Velde N, 2010, VACCINE, V28, P5473, DOI 10.1016/j.vaccine.2010.05.056; Wain G, 2010, SEX HEALTH, V7, P235, DOI 10.1071/SH09129; Wheeler CM, 2009, JNCI-J NATL CANCER I, V101, P475, DOI 10.1093/jnci/djn510; Wolstenholme JL, 1998, EUR J CANCER, V34, P1889, DOI 10.1016/S0959-8049(98)00232-9; Woodhall SC, 2011, SEX TRANSM INFECT	72	69	71	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 27	2011	343								d5775	10.1136/bmj.d5775	http://dx.doi.org/10.1136/bmj.d5775			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829JV	21951758	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000295576600003
J	Acuna, JL; Lopez-Urrutia, A; Colin, S				Luis Acuna, Jose; Lopez-Urrutia, Angel; Colin, Sean			Faking Giants: The Evolution of High Prey Clearance Rates in Jellyfishes	SCIENCE			English	Article							PELAGIC FISH; ECOSYSTEM; SEA; ZOOPLANKTON; OVERLAP	Jellyfishes have functionally replaced several overexploited commercial stocks of planktivorous fishes. This is paradoxical, because they use a primitive prey capture mechanism requiring direct contact with the prey, whereas fishes use more efficient visual detection. We have compiled published data to show that, in spite of their primitive life-style, jellyfishes exhibit similar instantaneous prey clearance and respiration rates as their fish competitors and similar potential for growth and reproduction. To achieve this production, they have evolved large, water-laden bodies that increase prey contact rates. Although larger bodies are less efficient for swimming, optimization analysis reveals that large collectors are advantageous if they move through the water sufficiently slowly.	[Luis Acuna, Jose] Univ Oviedo, Dept Biol Organismos & Sistemas, E-33071 Oviedo, Spain; [Lopez-Urrutia, Angel] Ctr Oceanog Gijon, Inst Espanol Oceanog, Gijon 33212, Spain; [Colin, Sean] Roger Williams Univ, Dept Marine Biol & Environm Sci, Bristol, RI 02809 USA	University of Oviedo; Spanish Institute of Oceanography	Acuna, JL (corresponding author), Univ Oviedo, Dept Biol Organismos & Sistemas, Calle Catedrat Rodrigo Uria, E-33071 Oviedo, Spain.	acuna@uniovi.es	Lopez-Urrutia, Angel/R-9475-2019; Fernández, José Luis Acuña/I-7482-2016; Lopez-Urrutia, Angel/L-2636-2014	Fernández, José Luis Acuña/0000-0003-3306-7212; Colin, Sean/0000-0003-4463-5588	Spanish Ministry of Science [MICINN-08-CSD2008-00077]; Administration of the Principality of Asturias to the University of Oviedo; European Commission [212085]; NSF [OCE-0623534, -0727544]; Office of Naval Research [N000140810654]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Administration of the Principality of Asturias to the University of Oviedo; European Commission(European CommissionEuropean Commission Joint Research Centre); NSF(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research)	We thank A. Bochdansky for fish respiration data and F. Gonzalez-Taboada for help with statistics. This research has been financed by project MALASPINA 2010 (MICINN-08-CSD2008-00077, Spanish Ministry of Science) to J.L.A. and A.L.-U., partially funded by a Campus of International Excellence grant from the Administration of the Principality of Asturias to the University of Oviedo, by Theme 6 of the European Commission Seventh Framework Programme through the Marine Ecosystem Evolution in a Changing Environment (MEECE No 212085) Collaborative Project to A.L.-U., and by awards from NSF to S. C. (OCE-0623534 and -0727544) and from the Office of Naval Research (N000140810654). The present data compilation is available in the form of tables in the SOM.	Arai MN, 1997, FUNCTIONAL BIOL SCYP; Brodeur RD, 2008, MAR BIOL, V154, P649, DOI 10.1007/s00227-008-0958-3; Brodeur RD, 2002, MAR ECOL PROG SER, V233, P89, DOI 10.3354/meps233089; Dabiri JO, 2005, J EXP BIOL, V208, P1257, DOI 10.1242/jeb.01519; DANIEL TL, 1983, CAN J ZOOL, V61, P1406, DOI 10.1139/z83-190; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; Huntley ME, 2004, MAR ECOL PROG SER, V273, P65, DOI 10.3354/meps273065; Kawasaki T., 1993, Fisheries Oceanography, V2, P244, DOI 10.1111/j.1365-2419.1993.tb00139.x; Kiorboe T., 2008, MECH APPROACH PLANKT; Lynam CP, 2006, CURR BIOL, V16, pR492, DOI 10.1016/j.cub.2006.06.018; Parsons T. R., 2002, Mer (Tokyo), V40, P111; PURCELL JE, 1990, CAN J FISH AQUAT SCI, V47, P505, DOI 10.1139/f90-056; Purcell JE, 2001, MAR ECOL PROG SER, V210, P67, DOI 10.3354/meps210067; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; SCHNEIDER G, 1992, HELGOLANDER MEERESUN, V46, P377, DOI 10.1007/BF02367205; Shadden SC, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2189885; Shiganova TA, 1998, FISH OCEANOGR, V7, P305, DOI 10.1046/j.1365-2419.1998.00080.x; Sornes TA, 2004, LIMNOL OCEANOGR, V49, P69, DOI 10.4319/lo.2004.49.1.0069; Vinogradov A., 1953, ELEMENTARY COMPOSITI; WARE DM, 1978, J FISH RES BOARD CAN, V35, P220, DOI 10.1139/f78-036	21	75	76	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2011	333	6049					1627	1629		10.1126/science.1205134	http://dx.doi.org/10.1126/science.1205134			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921197	Green Published			2022-12-28	WOS:000294900900042
J	Mair, W; Steffen, KK; Dillin, A				Mair, William; Steffen, Kristan K.; Dillin, Andrew			SIP-ing the Elixir of Youth	CELL			English	Editorial Material							LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; C-ELEGANS; KINASE; AMPK	AMP-activated protein kinase (AMPK) is a conserved cellular fuel gauge previously implicated in aging. In this issue, Lu et al. (2011) describe how age-related deacetylation of Sip2, a subunit of the AMPK homolog in yeast, acts as a life span clock that can be wound backward or forward to modulate longevity.	[Mair, William; Steffen, Kristan K.; Dillin, Andrew] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Mair, William; Steffen, Kristan K.; Dillin, Andrew] Glenn Fdn Med Res, La Jolla, CA 92037 USA; [Mair, William] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Howard Hughes Medical Institute; Salk Institute; Harvard University; Harvard T.H. Chan School of Public Health	Mair, W (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wmair@hsph.harvard.edu; dillin@salk.edu		Mair, William/0000-0002-0661-1342	NATIONAL INSTITUTE ON AGING [R01AG042679] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Ashrafi K, 2000, GENE DEV, V14, P1872; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Lu JY, 2011, CELL, V146, P968, DOI 10.1016/j.cell.2011.07.044; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Taliaferro-Smith L, 2009, ONCOGENE, V28, P2621, DOI 10.1038/onc.2009.129; Tohyama D, 2010, BIOCHEM BIOPH RES CO, V394, P112, DOI 10.1016/j.bbrc.2010.02.126; Zhang J, 2010, MOL MICROBIOL, V77, P371, DOI 10.1111/j.1365-2958.2010.07209.x	10	0	0	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 16	2011	146	6					859	860		10.1016/j.cell.2011.08.026	http://dx.doi.org/10.1016/j.cell.2011.08.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925309	Bronze			2022-12-28	WOS:000295258100007
J	Norell, MA				Norell, Mark A.			Fossilized Feathers	SCIENCE			English	Editorial Material							COLOR; EVOLUTION; DINOSAUR; ORIGIN		Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	American Museum of Natural History (AMNH)	Norell, MA (corresponding author), Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA.	norell@amnh.org						Brusatte SL, 2010, EARTH-SCI REV, V101, P68, DOI 10.1016/j.earscirev.2010.04.001; Clarke JA, 2010, SCIENCE, V330, P954, DOI 10.1126/science.1193604; DARWIN F, 1887, LIFE LETT C DARWIN, V2, P296; Grimaldi David, 1995, American Museum Novitates, V3126, P1; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; McKellar RC, 2011, SCIENCE, V333, P1619, DOI 10.1126/science.1203344; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Prum RO, 2005, J EXP ZOOL PART B, V304B, P570, DOI 10.1002/jez.b.21073; Prum RO, 2002, Q REV BIOL, V77, P261, DOI 10.1086/341993; Wogelius RA, 2011, SCIENCE, V333, P1622, DOI 10.1126/science.1205748; Xu Xing, 2009, Vertebrata Palasiatica, V47, P311; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740; Zheng XT, 2009, NATURE, V458, P333, DOI 10.1038/nature07856	14	5	5	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2011	333	6049					1590	1591		10.1126/science.1212049	http://dx.doi.org/10.1126/science.1212049			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921190				2022-12-28	WOS:000294900900032
J	Rothman, JE; Schekman, R				Rothman, James E.; Schekman, Randy			Molecular Mechanism of Protein Folding in the Cell	CELL			English	Editorial Material							RIBULOSE-BISPHOSPHATE CARBOXYLASE; CHAPERONIN GROEL; HEAT-SHOCK; CRYSTAL-STRUCTURE; STRESS PROTEINS; BINDING; MITOCHONDRIA; RELEASE; COMPLEX; HSP60	F.-Ulrich Hartl and Arthur Horwich will share this year's Lasker Basic Medical Science Award for the discovery of the cell's protein-folding machinery, exemplified by cage-like structures that convert newly synthesized proteins into their biologically active forms. Their fundamental findings reveal mechanisms that operate in normal physiologic processes and help to explain the problems that arise in diseases of protein folding.	[Rothman, James E.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Schekman, Randy] Univ Calif Berkeley, Dept Cell & Mol Biol, HHMI, Berkeley, CA 94720 USA	Yale University; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Rothman, JE (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	james.rothman@yale.edu; schekman@berkeley.edu						BARRACLOUGH R, 1980, BIOCHIM BIOPHYS ACTA, V608, P19, DOI 10.1016/0005-2787(80)90129-X; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRAIG K, 1993, P NATL ACAD SCI USA, V90, P3978, DOI 10.1073/pnas.90.9.3978; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; DAHLMANN B, 1986, BIOMED BIOCHIM ACTA, V45, P1493; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Georgopoulos C., 1971, BACTERIOPHAGE LAMBDA, P553; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; HENDRIX RW, 1979, J MOL BIOL, V129, P375, DOI 10.1016/0022-2836(79)90502-3; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Langer T., 1992, EMBO J, V11, P4767; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	23	25	30	0	85	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 16	2011	146	6					851	854		10.1016/j.cell.2011.08.041	http://dx.doi.org/10.1016/j.cell.2011.08.041			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21907398	Bronze			2022-12-28	WOS:000295258100005
J	Michelena, HI; Khanna, AD; Mahoney, D; Margaryan, E; Topilsky, Y; Suri, RM; Eidem, B; Edwards, WD; Sundt, TM; Enriquez-Sarano, M				Michelena, Hector I.; Khanna, Amber D.; Mahoney, Douglas; Margaryan, Edit; Topilsky, Yan; Suri, Rakesh M.; Eidem, Ben; Edwards, William D.; Sundt, Thoralf M., III; Enriquez-Sarano, Maurice			Incidence of Aortic Complications in Patients With Bicuspid Aortic Valves	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASCENDING AORTA; INTERNATIONAL REGISTRY; EJECTION FRACTION; DISSECTION IRAD; MARFAN-SYNDROME; HEART-DISEASE; RISK-FACTORS; ECHOCARDIOGRAPHY; ANEURYSMS; DILATATION	Context Bicuspid aortic valve (BAV), the most common congenital heart defect, has been thought to cause frequent and severe aortic complications; however, long-term, population-based data are lacking. Objective To determine the incidence of aortic complications in patients with BAV in a community cohort and in the general population. Design, Setting, and Participants In this retrospective cohort study, we conducted comprehensive assessment of aortic complications of patients with BAV living in a population-based setting in Olmsted County, Minnesota. We analyzed long-term follow-up of a cohort of all Olmsted County residents diagnosed with definite BAV by echocardiography from 1980 to 1999 and searched for aortic complications of patients whose bicuspid valves had gone undiagnosed. The last year of follow-up was 2008-2009. Main Outcome Measure Thoracic aortic dissection, ascending aortic aneurysm, and aortic surgery. Results The cohort included 416 consecutive patients with definite BAV diagnosed by echocardiography, mean (SD) follow-up of 16 (7) years (6530 patient-years). Aortic dissection occurred in 2 of 416 patients; incidence of 3.1 (95% CI, 0.5-9.5) cases per 10 000 patient-years, age-adjusted relative-risk 8.4 (95% CI, 2.1-33.5; P=.003) compared with the county's general population. Aortic dissection incidences for patients 50 years or older at baseline and bearers of aortic aneurysms at baseline were 17.4 (95% CI, 2.9-53.6) and 44.9(95% CI, 7.5-138.5) cases per 10 000 patient-years, respectively. Comprehensive search for aortic dissections in undiagnosed bicuspid valves revealed 2 additional patients, allowing estimation of aortic dissection incidence in bicuspid valve patients irrespective of diagnosis status (1.5; 95% CI, 0.4-3.8 cases per 10 000 patient-years), which was similar to the diagnosed cohort. Of 384 patients without baseline aneurysms, 49 developed aneurysms at follow-up, incidence of 84.9 (95% CI, 63.3-110.9) cases per 10 000 patient-years and an age-adjusted relative risk 86.2 (95% CI, 65.1-114; P<.001 compared with the general population). The 25-year rate of aortic surgery was 25% (95% CI, 17.2%-32.8%). Conclusions In the population of patients with BAV, the incidence of aortic dissection over a mean of 16 years of follow-up was low but significantly higher than in the general population. JAMA. 2011;306(10):1104-1113 www.jama.com	[Michelena, Hector I.; Khanna, Amber D.; Margaryan, Edit; Topilsky, Yan; Eidem, Ben; Enriquez-Sarano, Maurice] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Mahoney, Douglas] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Suri, Rakesh M.] Mayo Clin, Div Cardiovasc Surg, Rochester, MN 55905 USA; [Edwards, William D.] Mayo Clin, Div Anat Pathol, Rochester, MN 55905 USA; [Sundt, Thoralf M., III] Massachusetts Gen Hosp, Div Cardiac Surg, Boston, MA 02114 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Harvard University; Massachusetts General Hospital	Michelena, HI (corresponding author), Mayo Clin, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.	michelena.hector@mayo.edu	Topilsky, Yan/AFK-7827-2022	Enriquez-Sarano, Maurice/0000-0003-0910-5450	Department of Internal Medicine of the Mayo Clinic, Rochester, Minnesot; Division of Cardiovascular Diseases of the Mayo Clinic	Department of Internal Medicine of the Mayo Clinic, Rochester, Minnesot; Division of Cardiovascular Diseases of the Mayo Clinic	Partially funded by a faculty development grant awarded to Dr Michelena by the Department of Internal Medicine of the Mayo Clinic, Rochester, Minnesot. The Division of Cardiovascular Diseases of the Mayo Clinic supported the costs of survey creation and mailings, as well as statistical analysis costs.	Beaton AZ, 2009, AM J CARDIOL, V103, P266, DOI 10.1016/j.amjcard.2008.09.062; BICKERSTAFF LK, 1982, SURGERY, V92, P1103; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Clouse WD, 1998, JAMA-J AM MED ASSOC, V280, P1926, DOI 10.1001/jama.280.22.1926; Coady MA, 1997, J THORAC CARDIOV SUR, V113, P476, DOI 10.1016/S0022-5223(97)70360-X; Coady MA, 1999, ANN THORAC SURG, V67, P1922, DOI 10.1016/S0003-4975(99)00431-2; Coady MA, 2010, CARDIOL CLIN, V28, P299, DOI 10.1016/j.ccl.2010.02.003; CURRIE PJ, 1985, CIRCULATION, V71, P1162, DOI 10.1161/01.CIR.71.6.1162; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R; Duran A C, 1995, J Heart Valve Dis, V4, P581; EDWARDS WD, 1978, CIRCULATION, V57, P1022, DOI 10.1161/01.CIR.57.5.1022; Fedak PWM, 2003, J THORAC CARDIOV SUR, V126, P797, DOI 10.1016/S0022-5223(03)00398-2; Fedak PWM, 2002, CIRCULATION, V106, P900, DOI 10.1161/01.CIR.0000027905.26586.E8; Fernandes SM, 2004, J AM COLL CARDIOL, V44, P1648, DOI 10.1016/j.jacc.2004.05.063; Guntheroth WG, 2008, AM J CARDIOL, V102, P107, DOI 10.1016/j.amjcard.2008.02.106; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LARSON EW, 1984, AM J CARDIOL, V53, P849, DOI 10.1016/0002-9149(84)90418-1; Oliver JM, 2009, AM J CARDIOL, V104, P1001, DOI 10.1016/j.amjcard.2009.05.045; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Meszaros I, 2000, CHEST, V117, P1271, DOI 10.1378/chest.117.5.1271; Michelena HI, 2008, CIRCULATION, V117, P2776, DOI 10.1161/CIRCULATIONAHA.107.740878; MURDOCH JL, 1972, NEW ENGL J MED, V286, P804, DOI 10.1056/NEJM197204132861502; NISHIMURA RA, 1985, MAYO CLIN PROC, V60, P321, DOI 10.1016/S0025-6196(12)60540-0; Nkomo VT, 2003, ARTERIOSCL THROM VAS, V23, P351, DOI 10.1161/01.ATV.0000055441.28842.0A; Pape LA, 2007, CIRCULATION, V116, P1120, DOI 10.1161/CIRCULATIONAHA.107.702720; PATE JW, 1976, AM SURGEON, V42, P395; PERRY GJ, 1987, J AM COLL CARDIOL, V9, P952, DOI 10.1016/S0735-1097(87)80254-1; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; RICH S, 1982, AM HEART J, V104, P603, DOI 10.1016/0002-8703(82)90233-2; ROBERTS CS, 1991, J AM COLL CARDIOL, V17, P712, DOI 10.1016/S0735-1097(10)80188-3; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; ROMAN MJ, 1989, AM J CARDIOL, V64, P507, DOI 10.1016/0002-9149(89)90430-X; Sabet HY, 1999, MAYO CLIN PROC, V74, P14, DOI 10.4065/74.1.14; Schaefer BM, 2008, HEART, V94, P1634, DOI 10.1136/hrt.2007.132092; TAJIK AJ, 1978, MAYO CLIN PROC, V53, P271; Tzemos N, 2008, JAMA-J AM MED ASSOC, V300, P1317, DOI 10.1001/jama.300.11.1317; Ward C, 2000, HEART, V83, P81, DOI 10.1136/heart.83.1.81; Warren AE, 2006, HEART, V92, P1496, DOI 10.1136/hrt.2005.081539	40	520	531	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2011	306	10					1104	1112		10.1001/jama.2011.1286	http://dx.doi.org/10.1001/jama.2011.1286			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819DS	21917581	Bronze			2022-12-28	WOS:000294806200024
J	Powell, H; Murphy, VE; Taylor, DR; Hensley, MJ; McCaffery, K; Giles, W; Clifton, VL; Gibson, PG				Powell, Heather; Murphy, Vanessa E.; Taylor, D. Robin; Hensley, Michael J.; McCaffery, Kirsten; Giles, Warwick; Clifton, Vicki L.; Gibson, Peter G.			Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial	LANCET			English	Article							SPUTUM CELL COUNTS; AIRWAY INFLAMMATION; EXACERBATIONS; ADULTS; BUDESONIDE; CHILDREN; WOMEN	Background Asthma exacerbations during pregnancy are common and can be associated with substantial maternal and fetal morbidity. Treatment decisions based on sputum eosinophil counts reduce exacerbations in non-pregnant women with asthma, but results with the fraction of exhaled nitric oxide (F(E)NO) to guide management are equivocal. We tested the hypothesis that a management algorithm for asthma in pregnancy based on F(E)NO and symptoms would reduce asthma exacerbations. Methods We undertook a double-blind, parallel-group, controlled trial in two antenatal clinics in Australia. 220 pregnant, non-smoking women with asthma were randomly assigned, by a computer-generated random number list, before 22 weeks' gestation to treatment adjustment at monthly visits by an algorithm using clinical symptoms (control group) or F(E)NO concentrations (active intervention group) used to uptitrate (F(E)NO >29 ppb) or downtitrate (F(E)NO <16 ppb) inhaled corticosteroid dose. Participants, caregivers, and outcome assessors were masked to group assignment. Longacting beta 2 agonist and minimum dose inhaled corticosteroid were used to treat symptoms when F(E)NO was not increased. The primary outcome was total asthma exacerbations (moderate and severe). Analysis was by intention to treat. This study is registered with the Australian and New Zealand Clinical Trials Registry, number 12607000561482. Findings 111 women were randomly assigned to the F(E)NO group (100 completed) and 109 to the control group (103 completed). The exacerbation rate was lower in the F(E)NO group than in the control group (0.288 vs 0.615 exacerbations per pregnancy; incidence rate ratio 0.496,95% CI 0.325-0.755; p=0.001). The number needed to treat was 6. In the F(E)NO group, quality of life was improved (score on short form 12 mental summary was 56.9 [95% CI 50.2-59.3] in F(E)NO group vs 54.2 [46.1-57.6] in control group; p=0.037) and neonatal hospitalisations were reduced (eight [8%] vs 18 [17%]; p=0.046). Interpretation Asthma exacerbations during pregnancy can be significantly reduced with a validated F(E)NO-based treatment algorithm.	[Powell, Heather; Murphy, Vanessa E.; Hensley, Michael J.; Gibson, Peter G.] Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2310, Australia; [Powell, Heather; Murphy, Vanessa E.; Hensley, Michael J.; Gibson, Peter G.] Hunter Med Res Inst, Newcastle, NSW 2310, Australia; [Powell, Heather; Hensley, Michael J.; Gibson, Peter G.] John Hunter Hosp, Dept Resp & Sleep Med, Newcastle, NSW, Australia; [Taylor, D. Robin] Univ Otago, Dunedin Sch Med, Dunedin, New Zealand; [McCaffery, Kirsten; Giles, Warwick] Univ Sydney, Sydney, NSW 2006, Australia; [Giles, Warwick] Royal N Shore Hosp, Sydney, NSW, Australia; [Clifton, Vicki L.] Univ Adelaide, Dept Obstet & Gynaecol, Robinson Inst, Adelaide, SA 5005, Australia; [Gibson, Peter G.] Woolcock Inst Med Res, Sydney, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; John Hunter Hospital; University of Otago; University of Sydney; Royal North Shore Hospital; University of Sydney; Robinson Research Institute; University of Adelaide; University of Sydney; Woolcock Institute of Medical Research	Powell, H (corresponding author), Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2310, Australia.	heather.powell@hnehealth.nsw.gov.au	Clifton, Vicki/A-1445-2012; McCaffery, Kirsten/K-7945-2019; Clifton, Vicki/AAV-2749-2021; gibson, peter/G-6194-2014	Clifton, Vicki/0000-0002-4892-6748; McCaffery, Kirsten/0000-0003-2696-5006; Clifton, Vicki/0000-0002-4892-6748; gibson, peter/0000-0001-5865-489X	National Health and Medical Research Council of Australia [455626, 510703]; Aerocrine AB	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Aerocrine AB(HOGANAS ABStatisticon AB)	National Health and Medical Research Council of Australia.; PGG has received payment for reimbursement of meeting/travel expenses from GlaxoSmithKline, AstraZeneca, Novartis, and Boehringer Ingelheim. DRT has received lecture fees from Aerocrine AB. MJH, KMcC, WG, HP, VEM, and VLC declare that they have no conflicts of interest.; This study was funded by the National Health and Medical Research Council of Australia. VEM was the recipient of a National Health and Medical Research Council (NHMRC) Australian Research Training Fellowship (part time, 455626). VLC was the recipient of an NHMRC Senior Research Fellowship (510703). PGG was an NHMRC Practitioner Fellowship recipient. We thank Patrick McElduff, Kelly Steel, Karen McLaughlin, Linda Howell, Rebecca Oldham, Sandra Dowley, and Katie Baines for assistance; the midwives and staff of the antenatal clinics; and the women who participated in the study.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P912; Berry MA, 2005, CLIN EXP ALLERGY, V35, P1175, DOI 10.1111/j.1365-2222.2005.02314.x; Gibson PG, 2009, CLIN EXP ALLERGY, V39, P478, DOI 10.1111/j.1365-2222.2009.03226.x; Gibson PG, 2007, J ALLERGY CLIN IMMUN, V119, P344, DOI 10.1016/j.jaci.2006.10.043; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Grunewald C, 1998, GYNECOL OBSTET INVES, V46, P232, DOI 10.1159/000010040; Harkins MS, 2004, J ASTHMA, V41, P471, DOI 10.1081/JAS-120033990; Jayaram L, 2006, EUR RESPIR J, V27, P483, DOI 10.1183/09031936.06.00137704; Juniper EF, 2006, RESP MED, V100, P616, DOI 10.1016/j.rmed.2005.08.012; Kharitonov SA, 2002, THORAX, V57, P889, DOI 10.1136/thorax.57.10.889; MARKS GB, 1992, J CLIN EPIDEMIOL, V45, P461, DOI 10.1016/0895-4356(92)90095-5; MORRIS NH, 1995, EUR J CLIN INVEST, V25, P138, DOI 10.1111/j.1365-2362.1995.tb01539.x; MURPHY V, 2007, AM J RESP CRIT CARE, V175, pA207; Murphy VE, 2011, BJOG-INT J OBSTET GY, V118, P1314, DOI 10.1111/j.1471-0528.2011.03055.x; Murphy VE, 2010, THORAX, V65, P739, DOI 10.1136/thx.2009.124941; Murphy VE, 2006, THORAX, V61, P169, DOI 10.1136/thx.2005.049718; Murphy VE, 2005, OBSTET GYNECOL, V106, P1046, DOI 10.1097/01.AOG.0000185281.21716.02; Murphy VE, 2005, EUR RESPIR J, V26, P435, DOI 10.1183/09031936.05.00135604; Murphy VE, 2003, AM J RESP CRIT CARE, V168, P1317, DOI 10.1164/rccm.200303-374OC; *NAT ASTHM ED PREV, 2005, J ALLERGY CLIN IMMUN, V115, P36; Parameswaran K, 2000, EUR RESPIR J, V15, P486, DOI 10.1034/j.1399-3003.2000.15.10.x; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Pavord ID, 2008, LANCET, V372, P1017, DOI 10.1016/S0140-6736(08)61421-X; PETSKY HL, 2008, COCHRANE DB SYST REV, V2, P6340; Pijnenburg MW, 2005, AM J RESP CRIT CARE, V172, P831, DOI 10.1164/rccm.200503-458OC; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Smith AD, 2005, NEW ENGL J MED, V352, P2163, DOI 10.1056/NEJMoa043596; Szefler S, 2008, LANCET, V372, P1065, DOI 10.1016/S0140-6736(08)61448-8; Tamasi L, 2009, J ASTHMA, V46, P786, DOI 10.3109/02770900903090004; Taylor DR, 2006, THORAX, V61, P817, DOI 10.1136/thx.2005.056093; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Zacharasiewicz A, 2005, AM J RESP CRIT CARE, V171, P1077, DOI 10.1164/rccm.200409-1242OC	32	222	229	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 10	2011	378	9795					983	990		10.1016/S0140-6736(11)60971-9	http://dx.doi.org/10.1016/S0140-6736(11)60971-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HO	21907861				2022-12-28	WOS:000295193200023
J	Harker, JA; Lewis, GM; Mack, L; Zuniga, EI				Harker, James A.; Lewis, Gavin M.; Mack, Lauren; Zuniga, Elina I.			Late Interleukin-6 Escalates T Follicular Helper Cell Responses and Controls a Chronic Viral Infection	SCIENCE			English	Article							DENDRITIC CELLS; SERUM LEVELS; IN-VIVO; VIRUS; MICE; IL-6; INDUCTION; IMMUNE; BCL6; DIFFERENTIATION	Multiple inhibitory molecules create a profoundly immunuosuppressive environment during chronic viral infections in humans and mice. Therefore, eliciting effective immunity in this context represents a challenge. Here, we report that during a murine chronic viral infection, interleukin-6 (IL-6) was produced by irradiation-resistant cells in a biphasic manner, with late IL-6 being absolutely essential for viral control. The underlying mechanism involved IL-6 signaling on virus-specific CD4 T cells that caused up-regulation of the transcription factor Bcl6 and enhanced T follicular helper cell responses at late, but not early, stages of chronic viral infection. This resulted in escalation of germinal center reactions and improved antibody responses. Our results uncover an antiviral strategy that helps to safely resolve a persistent infection in vivo.	[Harker, James A.; Lewis, Gavin M.; Mack, Lauren; Zuniga, Elina I.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Zuniga, EI (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	eizuniga@ucsd.edu		Harker, James/0000-0002-0301-6898	NIH [AI072752, AI081923, AI09484]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI009484, R21AI072752, R01AI081923, R01AI009484] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The data reported in this paper are tabulated in the supporting online material. The authors thank A. Drew (University of Cincinnati), P. Schwartzberg (NIH), M. David (University of California, San Diego), and S. Crotty (La Jolla Institute of Allergy and Immunology) for providing IL-6R ko, SAP ko, stat3 ko, and CD45.1<SUP>+</SUP> Smarta mice, respectively; S. Crotty for insightful discussion; L.-Y. Liou for technical help with initial experiment; and A. Dolgoter for technical assistance throughout. This work was supported by grants from the NIH (AI072752 and AI081923 to E.I.Z. and AI09484). J.A.H. and E.I.Z. have a provisional patent (no. 61/475,511) relating in part to methods of treating chronic viral infections by administering compounds that boost IL-6 signaling and/or T<INF>FH</INF> responses.	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bergthaler A, 2009, PLOS BIOL, V7, P789, DOI 10.1371/journal.pbio.1000080; BIRX DL, 1990, BLOOD, V76, P2303; Brooks DG, 2005, J VIROL, V79, P10514, DOI 10.1128/JVI.79.16.10514-10527.2005; Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796; Chevalier MF, 2011, J VIROL, V85, P733, DOI 10.1128/JVI.02030-10; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Conry SJ, 2009, J VIROL, V83, P11175, DOI 10.1128/JVI.00753-09; Crotty S, 2006, BLOOD, V108, P3085, DOI 10.1182/blood-2006-04-018929; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Huber C, 2005, J IMMUNOL, V174, P5526, DOI 10.4049/jimmunol.174.9.5526; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Kranich J, 2008, J EXP MED, V205, P1293, DOI 10.1084/jem.20071019; Letvin NL, 2003, NAT MED, V9, P861, DOI 10.1038/nm0703-861; McFarland-Mancini MM, 2010, J IMMUNOL, V184, P7219, DOI 10.4049/jimmunol.0901929; Netski DM, 2005, CLIN INFECT DIS, V41, P667, DOI 10.1086/432478; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Spanakis NE, 2002, J CLIN LAB ANAL, V16, P40, DOI 10.1002/jcla.2060; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; TORRE D, 1994, CLIN INFECT DIS, V18, P194, DOI 10.1093/clinids/18.2.194; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wu YZ, 2009, INT IMMUNOL, V21, P745, DOI 10.1093/intimm/dxp041; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yue FY, 2010, J IMMUNOL, V185, P498, DOI 10.4049/jimmunol.0903915; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016	45	250	255	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 11	2011	334	6057					825	829		10.1126/science.1208421	http://dx.doi.org/10.1126/science.1208421			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845US	21960530	Green Accepted			2022-12-28	WOS:000296849600052
J	Gopel, W; Kribs, A; Ziegler, A; Laux, R; Hoehn, T; Wieg, C; Siegel, J; Avenarius, S; von der Wense, A; Vochem, M; Groneck, P; Weller, U; Moller, J; Haertel, C; Haller, S; Roth, B; Herting, E				Goepel, Wolfgang; Kribs, Angela; Ziegler, Andreas; Laux, Reinhard; Hoehn, Thomas; Wieg, Christian; Siegel, Jens; Avenarius, Stefan; von der Wense, Axel; Vochem, Matthias; Groneck, Peter; Weller, Ursula; Moeller, Jens; Haertel, Christoph; Haller, Sebastian; Roth, Bernhard; Herting, Egbert		German Neonatal Network	Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial	LANCET			English	Article							RESPIRATORY-DISTRESS-SYNDROME; POSITIVE AIRWAY PRESSURE; LARYNGEAL MASK AIRWAY; BIRTH-WEIGHT INFANTS; BRONCHOPULMONARY DYSPLASIA; ENDOTRACHEAL INTUBATION; NASAL CPAP; THERAPY; MULTICENTER; FAILURE	Background Surfactant is usually given to mechanically ventilated preterm infants via an endotracheal tube to treat respiratory distress syndrome. We tested a new method of surfactant application to spontaneously breathing preterm infants to avoid mechanical ventilation. Method In a parallel-group, randomised controlled trial, 220 preterm infants with a gestational age between 26 and 28 weeks and a birthweight less than 1.5 kg were enrolled in 12 German neonatal intensive care units. Infants were independently randomised in a 1:1 ratio with variable block sizes, to standard treatment or intervention, and randomisation was stratified according to centre and multiple birth status. Masking was not possible. Infants were stabilised with continuous positive airway pressure and received rescue intubation if necessary. In the intervention group, infants received surfactant treatment during spontaneous breathing via a thin catheter inserted into the trachea by laryngoscopy if they needed a fraction of inspired oxygen more than 0.30. The primary endpoint was need for any mechanical ventilation, or being not ventilated but having a partial pressure of carbon dioxide more than 65 mm Hg (8.6 kPa) or a fraction of inspired oxygen more than 0.60, or both, for more than 2 h between 25 h and 72 h of age. Analysis was by intention to treat. This study is registered, number ISRCTN05025922. Findings 108 infants were assigned to the intervention group and 112 infants to the standard treatment group. All infants were analysed. On day 2 or 3 after birth, 30 (28%) infants in the intervention group were mechanically ventilated versus 51 (46%) in the standard treatment group (number needed to treat 6, 95% CI 3-20, absolute risk reduction 0.18, 95% CI 0.30-0.05, p=0.008). 36 (33%) infants in the intervention group were mechanically ventilated during their stay in the hospital compared with 82 (73%) in the standard treatment group (number needed to treat: 3, 95% CI 2-4, p<0.0001). The intervention group had significantly fewer median days on mechanical ventilation, (0 days. IQR 0-3 vs 2 days, 0-5) and a lower need for oxygen therapy at 28 days (30 infants [30%] vs 49 infants [45%], p=0.032) compared with the standard treatment group. We recorded no differences between groups for mortality (seven deaths in the intervention group vs five in the standard treatment group) and serious adverse events (21 vs 28). Interpretation The application of surfactant via a thin catheter to spontaneously breathing preterm infants receiving continuous positive airway pressure reduces the need for mechanical ventilation.	[Goepel, Wolfgang; Ziegler, Andreas; Haertel, Christoph; Haller, Sebastian; Herting, Egbert] Univ Lubeck, D-23538 Lubeck, Germany; [Kribs, Angela; Roth, Bernhard] Univ Cologne, Cologne, Germany; [Laux, Reinhard] Asklepios Klin Barmbek, Hamburg, Germany; [Hoehn, Thomas] Univ Dusseldorf, Dusseldorf, Germany; [Wieg, Christian] Klin Kinder & Jugendmed, Aschaffenburg, Germany; [Siegel, Jens] Kinderkrankenhaus Bult, Hannover, Germany; [Avenarius, Stefan] Univ Magdeburg, D-39106 Magdeburg, Germany; [von der Wense, Axel] Altonaer Kinderkrankenhaus, Hamburg, Germany; [Vochem, Matthias] Olga Hosp, Stuttgart, Germany; [Groneck, Peter] Klin Kinder & Jugendliche, Leverkusen, Germany; [Weller, Ursula] Evangel Krankenhaus, Bielefeld, Germany; [Moeller, Jens] Klin Kinder & Jugendmed, Saarbrucken, Germany	University of Lubeck; University of Cologne; Heinrich Heine University Dusseldorf; Otto von Guericke University; University of Hamburg; University Medical Center Hamburg-Eppendorf; General Hospital of N. Ionia Agia Olga; Klinikum Stuttgart	Herting, E (corresponding author), Univ Lubeck, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	herting@paedia.ukl.mu-luebeck.de	Möller, Jens/H-1204-2017; Haller, Sebastian/P-1634-2014; Ziegler, Andreas/G-4246-2012	Möller, Jens/0000-0003-1767-5859; Haller, Sebastian/0000-0001-8242-711X; Ziegler, Andreas/0000-0002-8386-5397	German Ministry of Research and Technology [01ER0805]; Lubeck University; Chiesi Pharmaceuticals; Abbot; Chiesi; Nycomed; Boehringer; Altana; Byk Gulden	German Ministry of Research and Technology; Lubeck University; Chiesi Pharmaceuticals(Chiesi Pharmaceuticals Inc); Abbot; Chiesi(Chiesi Pharmaceuticals Inc); Nycomed; Boehringer(Boehringer Ingelheim); Altana; Byk Gulden	EH has received speaking fees and travel grants from the surfactant-producing companies Abbot, Chiesi, Nycomed, Boehringer, and Altana. EH has participated in clinical trials sponsored by Abbott, Boehringer, Chiesi, Byk Gulden, Altana, and Nycomed. EH has worked on advisory boards for Chiesi, Nycomed, and Draeger Medical, a company working in the field of neonatal ventilation, monitoring, and thermal care. EH received no money personally for this study, the support was institutional to cover insurance and other regulatory costs of the trial.; The trial was supported by grants from Chiesi Pharmaceuticals, Lubeck University, and the German Ministry of Research and Technology (grant number 01ER0805, The German Neonatal Network). Chiesi Pharmaceuticals is a manufacturer of surfactant. We thank all the staff in participating hospitals and especially the parents and infants who participated in the trial.	Ammari A, 2005, J PEDIATR-US, V147, P341, DOI 10.1016/j.jpeds.2005.04.062; Berggren E, 2000, ACTA PAEDIATR, V89, P460, DOI 10.1080/080352500750028195; Dahmen G, 2004, BIOMETRICAL J, V46, P214, DOI 10.1002/bimj.200310018; Dani C, 2004, PEDIATRICS, V113, pE560, DOI 10.1542/peds.113.6.e560; Dargaville PA, 2011, ARCH DIS CHILD-FETAL, V96, pF243, DOI 10.1136/adc.2010.192518; Escobedo MB, 2004, J PEDIATR-US, V144, P804, DOI 10.1016/j.jpeds.2004.03.024; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; Gandini D, 2003, PAEDIATR ANAESTH, V13, P181, DOI 10.1046/j.1460-9592.2003.01019_4.x; Halliday HL, 2008, J PERINATOL, V28, pS47, DOI 10.1038/jp.2008.50; Jung SH, 2001, STAT MED, V20, P2149, DOI 10.1002/sim.857; Kattwinkel John, 2004, J Perinatol, V24, P360, DOI 10.1038/sj.jp.7211103; Kribs A, 2010, KLIN PADIATR, V222, P13, DOI 10.1055/s-0029-1241867; Kribs A, 2008, ACTA PAEDIATR, V97, P293, DOI 10.1111/j.1651-2227.2007.00617.x; Kribs A, 2007, PEDIATR ANESTH, V17, P364, DOI 10.1111/j.1460-9592.2006.02126.x; Lindner W, 1999, PEDIATRICS, V103, P961, DOI 10.1542/peds.103.5.961; Mercier JC, 2010, LANCET, V376, P346, DOI 10.1016/S0140-6736(10)60664-2; Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788; Nava S, 2009, LANCET, V374, P250, DOI 10.1016/S0140-6736(09)60496-7; O'Donnell CPF, 2006, PEDIATRICS, V117, pE16, DOI 10.1542/peds.2005-0901; Reininger Ann, 2005, J Perinatol, V25, P703, DOI 10.1038/sj.jp.7211381; Rojas MA, 2009, PEDIATRICS, V123, P137, DOI 10.1542/peds.2007-3501; Sandri F, 2010, PEDIATRICS, V125, pE1402, DOI 10.1542/peds.2009-2131; Seger N, 2009, COCHRANE DB SYST REV, V2; Soll Roger F, 2009, Neonatology, V95, P368, DOI 10.1159/000209303; Stevens TP, 2007, COCHRANE DB SYST REV, V4; Trevisanuto D, 2005, BIOL NEONATE, V87, P217, DOI 10.1159/000083370; van den Berg E, 2010, ARCH DIS CHILD-FETAL, V95, pF53, DOI 10.1136/adc.2008.156414; VERDER H, 1994, NEW ENGL J MED, V331, P1051, DOI 10.1056/NEJM199410203311603; Verder H, 1992, Ugeskr Laeger, V154, P2136; Walsh MC, 2004, PEDIATRICS, V114, P1305, DOI 10.1542/peds.2004-0204; Welzing L, 2010, PEDIATR ANESTH, V20, P605, DOI 10.1111/j.1460-9592.2010.03330.x	31	282	301	0	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2011	378	9803					1627	1634		10.1016/S0140-6736(11)60986-0	http://dx.doi.org/10.1016/S0140-6736(11)60986-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844ST	21963186				2022-12-28	WOS:000296768300027
J	Wang, F; Zhu, J; Zhu, H; Zhang, Q; Lin, ZM; Hu, HL				Wang, Fei; Zhu, Jun; Zhu, Hong; Zhang, Qi; Lin, Zhanmin; Hu, Hailan			Bidirectional Control of Social Hierarchy by Synaptic Efficacy in Medial Prefrontal Cortex	SCIENCE			English	Article							AMPA RECEPTOR TRAFFICKING; DOMINANCE; MICE; PLASTICITY; RATS; ENVIRONMENT; MODULATION; BEHAVIOR; MOUSE; RAS	Dominance hierarchy has a profound impact on animals' survival, health, and reproductive success, but its neural circuit mechanism is virtually unknown. We found that dominance ranking in mice is transitive, relatively stable, and highly correlates among multiple behavior measures. Recording from layer V pyramidal neurons of the medial prefrontal cortex (mPFC) showed higher strength of excitatory synaptic inputs in mice with higher ranking, as compared with their subordinate cage mates. Furthermore, molecular manipulations that resulted in an increase and decrease in the synaptic efficacy in dorsal mPFC neurons caused an upward and downward movement in the social rank, respectively. These results provide direct evidence for mPFC's involvement in social hierarchy and suggest that social rank is plastic and can be tuned by altering synaptic strength in mPFC pyramidal cells.	[Wang, Fei; Zhu, Jun; Zhu, Hong; Zhang, Qi; Lin, Zhanmin; Hu, Hailan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Wang, Fei; Zhu, Jun; Zhu, Hong; Zhang, Qi; Lin, Zhanmin; Hu, Hailan] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Wang, Fei; Zhu, Hong] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Hu, HL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	hailan@ion.ac.cn		Hu, Hailan/0000-0002-0425-5057; Wang, Fei/0000-0002-8646-2411; zhang, qi/0000-0001-7622-1393	Chinese 973 Program [2011CBA00400]; Scientific Research Foundation; Hundreds of Talents Program; Shanghai Pujiang Talent Program	Chinese 973 Program(National Basic Research Program of China); Scientific Research Foundation; Hundreds of Talents Program(Chinese Academy of Sciences); Shanghai Pujiang Talent Program	We thank J. Zhu for the gifts of pSindbis GluR4 and R4Ct constructs and discussion on GluR4; R. Malinow for support of the initial exploration of the tube test in his laboratory; M. Poo, H. Kessels, J. Feldman, and R. Sapolsky for discussion and critical reading of the manuscript; J. Yan for help with statistics; B. Lu for the idea of agonistic behavior test; B. Zhang, K. Zhang, and M. Streets for technical help; Y. Yanagawa for the Gad67-GFP mouse; and X. Yu for ultrasound equipment. The work was supported by Chinese 973 Program (2011CBA00400), Projects of the Scientific Research Foundation, the Hundreds of Talents Program, and the Shanghai Pujiang Talent Program to H. H. Author contributions: F. W. performed most experiments. J.Z. participated in the behavioral and viral injection experiments. F. W., J.Z., and H. H. analyzed data and prepared the figures. H.Z, Q.Z., and Z.L. assisted in experiments. H. H. designed the study and wrote the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Arakawa H, 2007, BEHAV BRAIN RES, V176, P27, DOI 10.1016/j.bbr.2006.07.027; BENTON D, 1980, ANIM BEHAV, V28, P1274, DOI 10.1016/S0003-3472(80)80115-1; BERNSTEIN IS, 1981, BEHAV BRAIN SCI, V4, P419, DOI 10.1017/S0140525X00009614; Chiao JY, 2010, CURR OPIN NEUROBIOL, V20, P803, DOI 10.1016/j.conb.2010.08.006; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Cummins DD, 2000, SYNTHESE, V122, P3, DOI 10.1023/A:1005263825428; DEWSBURY DA, 1990, ANIM BEHAV, V39, P284, DOI 10.1016/S0003-3472(05)80872-3; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; Drickamer LC, 2001, BEHAV PROCESS, V53, P113, DOI 10.1016/S0376-6357(00)00152-2; FRANKEL DG, 1980, INT J BEHAV DEV, V3, P287, DOI 10.1177/016502548000300305; Garfield AS, 2011, NATURE, V469, P534, DOI 10.1038/nature09651; Guillem K, 2011, SCIENCE, V333, P888, DOI 10.1126/science.1207079; HOLSON RR, 1986, PHYSIOL BEHAV, V37, P239, DOI 10.1016/0031-9384(86)90226-X; Hu HL, 2008, J NEUROSCI, V28, P7847, DOI 10.1523/JNEUROSCI.1496-08.2008; Kushner SA, 2005, J NEUROSCI, V25, P9721, DOI 10.1523/JNEUROSCI.2836-05.2005; LINDZEY G, 1961, NATURE, V191, P474, DOI 10.1038/191474a0; LONG SY, 1972, ANIM BEHAV, V20, P10, DOI 10.1016/S0003-3472(72)80167-2; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; MASUR J, 1974, NATURE, V249, P284, DOI 10.1038/249284a0; McCormack SG, 2006, NEURON, V50, P75, DOI 10.1016/j.neuron.2006.02.027; Mehrabian A, 1996, CURR PSYCHOL, V14, P261, DOI 10.1007/BF02686918; NYBY J, 1976, BEHAV BIOL, V18, P285, DOI 10.1016/S0091-6773(76)92198-2; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Tse D, 2011, SCIENCE, V333, P891, DOI 10.1126/science.1205274; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Wilson E.O., 1975, P1; Yeh SR, 1996, SCIENCE, V271, P366, DOI 10.1126/science.271.5247.366; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhu JJ, 2009, J NEUROSCI, V29, P6320, DOI 10.1523/JNEUROSCI.4630-08.2009; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025	34	260	264	23	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2011	334	6056					693	697		10.1126/science.1209951	http://dx.doi.org/10.1126/science.1209951			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	21960531				2022-12-28	WOS:000296494700061
J	Duderstadt, KE; Chuang, K; Berger, JM				Duderstadt, Karl E.; Chuang, Kevin; Berger, James M.			DNA stretching by bacterial initiators promotes replication origin opening	NATURE			English	Article							ESCHERICHIA-COLI CHROMOSOME; AAA PLUS ATPASES; RECA PROTEIN; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; COMPLEX; RECOGNITION; MECHANISM; HELICASE; BINDING	Many replication initiators form higher-order oligomers that process host replication origins to promote replisome formation. In addition to dedicated duplex-DNA-binding domains, cellular initiators possess AAA+ (ATPases associated with various cellular activities) elements that drive functions ranging from protein assembly to origin recognition. In bacteria, the AAA+ domain of the initiator DnaA has been proposed to assist in single-stranded DNA formation during origin melting. Here we show crystallographically and in solution that the ATP-dependent assembly of Aquifex aeolicus DnaA into a spiral oligomer creates a continuous surface that allows successive AAA+ domains to bind and extend single-stranded DNA segments. The mechanism of binding is unexpectedly similar to that of RecA, a homologous recombination factor, but it differs in that DnaA promotes a nucleic acid conformation that prevents pairing of a complementary strand. These findings, combined with strand-displacement assays, indicate that DnaA opens replication origins by a direct ATP-dependent stretching mechanism. Comparative studies reveal notable commonalities between the approach used by DnaA to engage DNA substrates and other, nucleic-acid-dependent, AAA+ systems.	[Duderstadt, Karl E.; Berger, James M.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Chuang, Kevin; Berger, James M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Calif Inst Quantitat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Berger, JM (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.	jmberger@berkeley.edu		Duderstadt, Karl/0000-0002-1279-7841	NIGMS [GM071747]; National Institute of Health [T32 GM008295]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008295, R01GM071747] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank K. Drlica, J. Keck, T. Murray and the Berger laboratory for helpful comments, and M. M. Cox for his contribution of RecA protein. This work was supported by the NIGMS (GM071747) and the National Institute of Health Molecular Biophysics Training Grant T32 GM008295.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BIANCHI M, 1985, EMBO J, V4, P3025, DOI 10.1002/j.1460-2075.1985.tb04039.x; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CANTOR CR, 1980, BIOPHYSICAL CHEM 2, P846; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Clarey MG, 2006, NAT STRUCT MOL BIOL, V13, P684, DOI 10.1038/nsmb1121; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Crisona NJ, 2006, J BIOL CHEM, V281, P18927, DOI 10.1074/jbc.M603068200; CROOKE E, 1993, J MOL BIOL, V233, P16, DOI 10.1006/jmbi.1993.1481; DeLano W.L, PYMOL MOL GRAPHICS S; Duderstadt KE, 2008, CRIT REV BIOCHEM MOL, V43, P163, DOI [10.1080/10409230802058296, 10.1080/10409230802058296 ]; Duderstadt KE, 2010, J BIOL CHEM, V285, P28229, DOI 10.1074/jbc.M110.147975; Dueber ELC, 2007, SCIENCE, V317, P1210, DOI 10.1126/science.1143690; Egelman E, 2000, Trends Biochem Sci, V25, P179, DOI 10.1016/S0968-0004(00)01555-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Ennifar E, 2002, ACTA CRYSTALLOGR D, V58, P1262, DOI 10.1107/S0907444902009526; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Felczak MM, 2004, J BIOL CHEM, V279, P51156, DOI 10.1074/jbc.M409695200; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; FUNNELL BE, 1987, J BIOL CHEM, V262, P10327; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Gaudier M, 2007, SCIENCE, V317, P1213, DOI 10.1126/science.1143664; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; Kornberg A., 1992, DNA REPLICATION; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; KOWALSKI D, 1989, EMBO J, V8, P4335, DOI 10.1002/j.1460-2075.1989.tb08620.x; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lee DG, 2000, CURR OPIN CELL BIOL, V12, P280, DOI 10.1016/S0955-0674(00)00089-2; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Leonard AC, 2010, CURR OPIN MICROBIOL, V13, P766, DOI 10.1016/j.mib.2010.10.001; Liu XF, 2007, MOL CELL, V25, P825, DOI 10.1016/j.molcel.2007.02.009; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Magde D, 2002, PHOTOCHEM PHOTOBIOL, V75, P327, DOI 10.1562/0031-8655(2002)075<0327:FQYATR>2.0.CO;2; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; MUJUMDAR RB, 1993, BIOCONJUGATE CHEM, V4, P105, DOI 10.1021/bc00020a001; Neuwald AF, 1999, GENOME RES, V9, P27; Nishinaka T, 1997, P NATL ACAD SCI USA, V94, P6623, DOI 10.1073/pnas.94.13.6623; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Petsko CA, 2000, P NATL ACAD SCI USA, V97, P538, DOI 10.1073/pnas.97.2.538; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; STASIAK A, 1982, NATURE, V299, P185, DOI 10.1038/299185a0; Stillman B, 2005, FEBS LETT, V579, P877, DOI 10.1016/j.febslet.2004.12.011; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; WEBER K, 1969, J BIOL CHEM, V244, P4406	60	139	140	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2011	478	7368					209	U91		10.1038/nature10455	http://dx.doi.org/10.1038/nature10455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21964332	Green Accepted			2022-12-28	WOS:000295782800042
J	McDermott-Roe, C; Ye, JM; Ahmed, R; Sun, XM; Serafin, A; Ware, J; Bottolo, L; Muckett, P; Canas, X; Zhang, JS; Rowe, GC; Buchan, R; Lu, H; Braithwaite, A; Mancini, M; Hauton, D; Marti, R; Garcia-Arumi, E; Hubner, N; Jacob, H; Serikawa, T; Zidek, V; Papousek, F; Kolar, F; Cardona, M; Ruiz-Meana, M; Garcia-Dorado, D; Comella, JX; Felkin, LE; Barton, PJR; Arany, Z; Pravenec, M; Petretto, E; Sanchis, D; Cook, SA				McDermott-Roe, Chris; Ye, Junmei; Ahmed, Rizwan; Sun, Xi-Ming; Serafin, Anna; Ware, James; Bottolo, Leonardo; Muckett, Phil; Canas, Xavier; Zhang, Jisheng; Rowe, Glenn C.; Buchan, Rachel; Lu, Han; Braithwaite, Adam; Mancini, Massimiliano; Hauton, David; Marti, Ramon; Garcia-Arumi, Elena; Hubner, Norbert; Jacob, Howard; Serikawa, Tadao; Zidek, Vaclav; Papousek, Frantisek; Kolar, Frantisek; Cardona, Maria; Ruiz-Meana, Marisol; Garcia-Dorado, David; Comella, Joan X.; Felkin, Leanne E.; Barton, Paul J. R.; Arany, Zoltan; Pravenec, Michal; Petretto, Enrico; Sanchis, Daniel; Cook, Stuart A.			Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function	NATURE			English	Article							LEFT-VENTRICULAR MASS; OXIDATIVE STRESS; CARDIOMYOPATHY; DISEASE; DEATH; PATHOGENESIS; REPLICATION; BIOGENESIS; MECHANISMS; EXPRESSION	Left ventricular mass (LVM) is a highly heritable trait(1) and an independent risk factor for all-cause mortality(2). So far, genome-wide association studies have not identified the genetic factors that underlie LVM variation(3), and the regulatory mechanisms for blood-pressure-independent cardiac hypertrophy remain poorly understood(4,5). Unbiased systems genetics approaches in the rat(6,7) now provide a powerful complementary tool to genome-wide association studies, and we applied integrative genomics to dissect a highly replicated, blood-pressure-independent LVM locus on rat chromosome 3p. Here we identified endonuclease G (Endog), which previously was implicated in apoptosis(8) but not hypertrophy, as the gene at the locus, and we found a loss-of-function mutation in Endog that is associated with increased LVM and impaired cardiac function. Inhibition of Endog in cultured cardiomyocytes resulted in an increase in cell size and hypertrophic biomarkers in the absence of pro-hypertrophic stimulation. Genome-wide network analysis unexpectedly implicated ENDOG in fundamental mitochondrial processes that are unrelated to apoptosis. We showed direct regulation of ENDOG by ERR-alpha and PGC1 alpha (which are master regulators of mitochondrial and cardiac function)(9-11), interaction of ENDOG with the mitochondrial genome and ENDOG-mediated regulation of mitochondrial mass. At baseline, the Endog-deleted mouse heart had depleted mitochondria, mitochondrial dysfunction and elevated levels of reactive oxygen species, which were associated with enlarged and steatotic cardiomyocytes. Our study has further established the link between mitochondrial dysfunction, reactive oxygen species and heart disease and has uncovered a role for Endog in maladaptive cardiac hypertrophy.	[McDermott-Roe, Chris; Ahmed, Rizwan; Sun, Xi-Ming; Ware, James; Bottolo, Leonardo; Muckett, Phil; Buchan, Rachel; Lu, Han; Braithwaite, Adam; Petretto, Enrico; Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Med Res Council Clin Sci Ctr, London W12 0NN, England; [Ye, Junmei; Zhang, Jisheng; Cardona, Maria; Sanchis, Daniel] Univ Lleida, Biomed Res Inst Lleida IRBLLEIDA, Cell Signaling & Apoptosis Grp, Lleida 25198, Spain; [Serafin, Anna; Canas, Xavier] Platform Appl Res Lab Anim, Barcelona 08028, Spain; [Rowe, Glenn C.; Arany, Zoltan] Beth Israel Deaconess Med Inst, Cardiovasc Inst, Boston, MA 02215 USA; [Mancini, Massimiliano] Univ Rome, Dept Radiol Oncol & Anatomopathol Sci, I-00161 Sapienza, Italy; [Hauton, David] Univ Birmingham, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Marti, Ramon; Garcia-Arumi, Elena] Univ Autonoma Barcelona, Inst Recerca Hosp Univ Vall dHebron, Unitat Patol Mitocondrial & Neuromuscular CIBERER, Barcelona 08035, Spain; [Hubner, Norbert] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Hubner, Norbert] Charite Univ Med Berlin, Campus Charite Mitte, CC4, D-10117 Berlin, Germany; [Jacob, Howard] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Serikawa, Tadao] Kyoto Univ, Grad Sch Med, Inst Lab Anim, Sakyo Ku, Kyoto 6068501, Japan; [Zidek, Vaclav; Papousek, Frantisek; Kolar, Frantisek; Pravenec, Michal] Acad Sci Czech Republic, Inst Physiol, CR-14220 Prague 4, Czech Republic; [Ruiz-Meana, Marisol; Garcia-Dorado, David] Univ Autonoma Barcelona, Inst Recerca Hosp Univ Vall dHebron, Grp Patol Cardiovasc, Barcelona 08035, Spain; [Comella, Joan X.] CIBERNED, Cell Signaling & Apoptosis Grp, Barcelona 08035, Spain; [Comella, Joan X.] VHIR, Barcelona 08035, Spain; [Comella, Joan X.] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Barcelona 08035, Spain; [Comella, Joan X.] Univ Autonoma Barcelona, Inst Neurociencies, Barcelona 08035, Spain; [Felkin, Leanne E.; Barton, Paul J. R.] Harefield Hosp, Imperial Coll London, Natl Heart & Lung Inst, Heart Sci Ctr, Harefield UB9 6JH, Middx, England; [Barton, Paul J. R.; Cook, Stuart A.] Royal Brompton & Harefield NHS Trust, Cardiovasc Biomed Res Unit, London SW3 6NP, England; [Petretto, Enrico] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Epidemiol & Biostat, London W2 1PG, England	Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Universitat de Lleida; Harvard University; Beth Israel Deaconess Medical Center; Sapienza University Rome; University of Birmingham; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Medical College of Wisconsin; Kyoto University; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Autonomous University of Barcelona; CIBERNED; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Autonomous University of Barcelona; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Imperial College London	Cook, SA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Med Res Council Clin Sci Ctr, Du Cane Rd, London W12 0NN, England.	daniel.sanchis@cmb.udl.cat; stuart.cook@imperial.ac.uk	Rowe, Glenn/N-5314-2019; Sanchis, Daniel/C-8077-2009; MANCINI, MASSIMILIANO/GWC-9347-2022; Ahmed, Rizwan/P-3581-2019; MANCINI, MASSIMILIANO/AAC-1583-2022; Garcia-Arumi, Elena/ABH-4229-2020; Pravenec, Michal/B-1666-2012; Martí, Ramon/Q-3442-2016; Zidek, Vaclav/C-6685-2012; Cook, Stuart/G-9567-2011; Zhang, Jisheng/AAT-6495-2020; Zhang, Jisheng/A-1928-2010; Kolar, Frantisek/A-7852-2012; Cañas, Xavier/D-7656-2015; Comella, Joan/GQA-4279-2022; Ware, James S/G-5139-2012; Comella, Joan X/D-7333-2012; Braithwaite, Adam/R-4099-2016	Sanchis, Daniel/0000-0003-0047-8533; MANCINI, MASSIMILIANO/0000-0001-7465-2229; MANCINI, MASSIMILIANO/0000-0001-7465-2229; Pravenec, Michal/0000-0001-9197-5871; Martí, Ramon/0000-0002-8273-9540; Kolar, Frantisek/0000-0002-8723-1826; Cañas, Xavier/0000-0002-0512-2248; Ware, James S/0000-0002-6110-5880; Comella, Joan X/0000-0002-6218-0786; Braithwaite, Adam/0000-0003-3228-2172; Barton, Paul/0000-0002-1165-7767; Serafin, Anna/0000-0002-9486-8948; Felkin, Leanne/0000-0003-1402-8314; Buchan, Rachel/0000-0003-2490-9289; Cook, Stuart/0000-0001-6628-194X; Bottolo, Leonardo/0000-0002-6381-2327; Rowe, Glenn/0000-0002-8195-9605	Medical Research Council (UK); National Institute for Health Research (UK); Royal Brompton and Harefield Cardiovascular Biomedical Research Unit; Imperial College Healthcare Biomedical Research Centre; British Heart Foundation; Fondation Leducq; Wellcome Trust; Grant Agency of the Czech Republic [301/08/0166]; Ministry of Education of the Czech Republic [1M0520]; Ministerio de Ciencia e Innovacion (Spain) [PTQ-08-03-07880, SAF2008-02271, SAF2008-03067, SAF2010-19125]; Agencia de Gestio d'Ajuts Universitaris i Recerca (Spain) [2009-SGR-346]; Fondo de Investigaciones Sanitarias (Spain) [PS09/02034, PS09/01602, PS09/01591]; European Community [HEALTH-F4-2010-241504]; German National Genome Research Network (NGFN-Plus) Heart Failure; MRC [MC_U120097112, MC_U120085815] Funding Source: UKRI; British Heart Foundation [SP/10/10/28431] Funding Source: researchfish; Medical Research Council [MC_U120085815, MC_U120097112] Funding Source: researchfish; National Institute for Health Research [ACF-2007-21-004] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (UK)(National Institute for Health Research (NIHR)); Royal Brompton and Harefield Cardiovascular Biomedical Research Unit; Imperial College Healthcare Biomedical Research Centre; British Heart Foundation(British Heart Foundation); Fondation Leducq(Leducq Foundation); Wellcome Trust(Wellcome Trust); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia de Gestio d'Ajuts Universitaris i Recerca (Spain); Fondo de Investigaciones Sanitarias (Spain)(Instituto de Salud Carlos III); European Community(European Commission); German National Genome Research Network (NGFN-Plus) Heart Failure; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We acknowledge funding from the Medical Research Council (UK), the National Institute for Health Research (UK), the Royal Brompton and Harefield Cardiovascular Biomedical Research Unit, the Imperial College Healthcare Biomedical Research Centre, the British Heart Foundation, Fondation Leducq, the Wellcome Trust, the Grant Agency of the Czech Republic (301/08/0166), the Ministry of Education of the Czech Republic (1M0520), the Ministerio de Ciencia e Innovacion (Spain; PTQ-08-03-07880, SAF2008-02271, SAF2008-03067 and SAF2010-19125), the Agencia de Gestio d'Ajuts Universitaris i Recerca (Spain; 2009-SGR-346), the Fondo de Investigaciones Sanitarias (Spain; PS09/02034, PS09/01602 and PS09/01591), the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. HEALTH-F4-2010-241504 (EURATRANS), and the German National Genome Research Network (NGFN-Plus) Heart Failure. We thank M. R. Lieber for providing the Endog deleted mice and E. Wahle for providing the CG4930 expression plasmid. We thank the National BioResource Project for the Rat (http://www.anim.med.kyoto-u.ac.jp/NBR/) for providing rat strains.	Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; Bahi N, 2006, J BIOL CHEM, V281, P22943, DOI 10.1074/jbc.M601025200; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306; David KK, 2006, CELL DEATH DIFFER, V13, P1147, DOI 10.1038/sj.cdd.4401787; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Inomata H, 2005, HYPERTENS RES, V28, P273, DOI 10.1291/hypres.28.273; Irvine RA, 2005, MOL CELL BIOL, V25, P294, DOI 10.1128/MCB.25.1.294-302.2005; Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Lorell BH, 2000, CIRCULATION, V102, P470; McGavock JM, 2006, ANN INTERN MED, V144, P517, DOI 10.7326/0003-4819-144-7-200604040-00011; Petretto E, 2008, NAT GENET, V40, P546, DOI 10.1038/ng.134; Post WS, 1997, HYPERTENSION, V30, P1025, DOI 10.1161/01.HYP.30.5.1025; Rothfuss O, 2009, HUM MOL GENET, V18, P3832, DOI 10.1093/hmg/ddp327; Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270; Siegel AK, 2003, ARTERIOSCL THROM VAS, V23, P1211, DOI 10.1161/01.ATV.0000079509.20542.C9; Spiegelman Bruce M, 2007, Novartis Found Symp, V287, P60; Temme C, 2009, J BIOL CHEM, V284, P8337, DOI 10.1074/jbc.M808319200; TIRANTI V, 1995, GENOMICS, V25, P559, DOI 10.1016/0888-7543(95)80058-T; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Vasan RS, 2009, JAMA-J AM MED ASSOC, V302, P168, DOI 10.1001/jama.2009.978-a; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Wong C, 2007, NAT CLIN PRACT CARD, V4, P436, DOI 10.1038/ncpcardio0943; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	30	112	116	1	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2011	478	7367					114	118		10.1038/nature10490	http://dx.doi.org/10.1038/nature10490			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21979051	Green Accepted			2022-12-28	WOS:000295575400045
J	Golder, SA; Macy, MW				Golder, Scott A.; Macy, Michael W.			Diurnal and Seasonal Mood Vary with Work, Sleep, and Daylength Across Diverse Cultures	SCIENCE			English	Article							AFFECTIVE-DISORDER; EXPRESSION; RHYTHMS; DIARY	We identified individual-level diurnal and seasonal mood rhythms in cultures across the globe, using data from millions of public Twitter messages. We found that individuals awaken in a good mood that deteriorates as the day progresses-which is consistent with the effects of sleep and circadian rhythm-and that seasonal change in baseline positive affect varies with change in daylength. People are happier on weekends, but the morning peak in positive affect is delayed by 2 hours, which suggests that people awaken later on weekends.	[Golder, Scott A.; Macy, Michael W.] Cornell Univ, Dept Sociol, Ithaca, NY 14853 USA	Cornell University	Golder, SA (corresponding author), Cornell Univ, Dept Sociol, Uris Hall, Ithaca, NY 14853 USA.	sag262@cornell.edu			NSF [BCS-0537606, IIS-0705774, IIS-0910664]	NSF(National Science Foundation (NSF))	We thank V. Barash for assistance in data collection. Supported by NSF grants BCS-0537606, IIS-0705774, and IIS-0910664 and conducted using the resources of the Cornell University Center for Advanced Computing. Data are available at www.redlog.net/timeuse.	*AB DHAB GOV PORT, 2010, WORK HOURS POL; Ashby F. G., 2002, EMOTIONAL COGNITION, P245, DOI [DOI 10.1075/AICR.44.11ASH, 10.1075/aicr.44.11ash]; Bantum EO, 2009, PSYCHOL ASSESSMENT, V21, P79, DOI 10.1037/a0014643; Boivin DB, 1997, ARCH GEN PSYCHIAT, V54, P145; Bolger N, 2003, ANNU REV PSYCHOL, V54, P579, DOI 10.1146/annurev.psych.54.101601.145030; Bollen J., 2011, INT AAAI C WEBL SOC; CLARK LA, 1989, MOTIV EMOTION, V13, P205, DOI 10.1007/BF00995536; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; Dodds PS, 2010, J HAPPINESS STUD, V11, P441, DOI 10.1007/s10902-009-9150-9; FORSYTHE WC, 1995, ECOL MODEL, V80, P87, DOI 10.1016/0304-3800(94)00034-F; Hasler BP, 2008, J RES PERS, V42, P1537, DOI 10.1016/j.jrp.2008.07.012; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Kramer ADI, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P287; Lam RW, 2000, J PSYCHIATR NEUROSCI, V25, P469; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Murray G, 2001, CHRONOBIOL INT, V18, P875, DOI 10.1081/CBI-100107522; OConnor B, 2010, P ICWSM C; Pennebaker J. W., 2001, LING INQ WORD COUNT; Rosenthal N. E., 2006, WINTER BLUES; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; Segerstrom SC, 2010, PSYCHOL SCI, V21, P448, DOI 10.1177/0956797610362061; Terman M., 2005, PRINCIPLES PRACTICE, V4, P1424, DOI [10.1016/B0-72-160797-7/50128-2, DOI 10.1016/B0-72-160797-7/50128-2, 10.1016/B0-72-160797-7/50128-2.]; Vittengl JR, 1998, MOTIV EMOTION, V22, P255, DOI 10.1023/A:1022388123550	25	559	585	11	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051					1878	1881		10.1126/science.1202775	http://dx.doi.org/10.1126/science.1202775			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	826PJ	21960633				2022-12-28	WOS:000295365800053
J	Haque, A; Andersen, JN; Salmeen, A; Barford, D; Tonks, NK				Haque, Aftabul; Andersen, Jannik N.; Salmeen, Annette; Barford, David; Tonks, Nicholas K.			Conformation-Sensing Antibodies Stabilize the Oxidized Form of PTP1B and Inhibit Its Phosphatase Activity	CELL			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SIGNAL-TRANSDUCTION; INSULIN-RECEPTOR; IN-VIVO; REVERSIBLE OXIDATION; HYDROGEN-PEROXIDE; REDOX REGULATION; 1B; DEPHOSPHORYLATION; MICE	Protein tyrosine phosphatase 1B (PTP1B) plays important roles in downregulation of insulin and leptin signaling and is an established therapeutic target for diabetes and obesity. PTP1B is regulated by reactive oxygen species (ROS) produced in response to various stimuli, including insulin. The reversibly oxidized form of the enzyme (PTP1B-OX) is inactive and undergoes profound conformational changes at the active site. We generated conformation-sensor antibodies, in the form of single-chain variable fragments (scFvs), that stabilize PTP1B-OX and thereby inhibit its phosphatase function. Expression of conformation-sensor scFvs as intracellular antibodies (intrabodies) enhanced insulin-induced tyrosyl phosphorylation of the beta subunit of the insulin receptor and its substrate IRS-1 and increased insulin-induced phosphorylation of PKB/AKT. Our data suggest that stabilization of the oxidized, inactive form of PTP1B with appropriate therapeutic molecules may offer a paradigm for phosphatase drug development.	[Haque, Aftabul; Andersen, Jannik N.; Tonks, Nicholas K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Haque, Aftabul] SUNY Stony Brook, Mol & Cellular Biol Grad Program, Stony Brook, NY 11790 USA; [Salmeen, Annette; Barford, David] Inst Canc Res, Chester Beatty Labs, Div Struct Biol, London SW3 6JB, England	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Tonks, NK (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	tonks@cshl.edu		Andersen, Jannik/0000-0003-4528-2120	NIH [CA53840, GM55989]; Cancer Research UK; NATIONAL CANCER INSTITUTE [R01CA053840, R37CA053840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants CA53840 and GM55989 to N.K.T. The work in D.B.'s lab was supported by a grant from Cancer Research UK.	Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bandyopadhyay D, 1997, J BIOL CHEM, V272, P1639, DOI 10.1074/jbc.272.3.1639; BARFORD D, 1994, J MOL BIOL, V239, P726, DOI 10.1006/jmbi.1994.1409; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Bokoch GM, 2006, ANTIOXID REDOX SIGN, V8, P1533, DOI 10.1089/ars.2006.8.1533; BRANDT TA, 2010, AM DIAB ASS CARLSB C; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Cardinale A, 2008, TRENDS MOL MED, V14, P373, DOI 10.1016/j.molmed.2008.07.004; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Iversen LF, 2002, J BIOL CHEM, V277, P19982, DOI 10.1074/jbc.M200567200; Johnson TO, 2002, NAT REV DRUG DISCOV, V1, P696, DOI 10.1038/nrd895; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Lohse DL, 1997, BIOCHEMISTRY-US, V36, P4568, DOI 10.1021/bi963094r; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Marasco WA, 1997, GENE THER, V4, P11, DOI 10.1038/sj.gt.3300346; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Nievergall E, 2010, J CELL BIOL, V191, P1189, DOI 10.1083/jcb.201005035; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Romsicki Y, 2004, J BIOL CHEM, V279, P12868, DOI 10.1074/jbc.M309600200; Rondinone CM, 2002, DIABETES, V51, P2405, DOI 10.2337/diabetes.51.8.2405; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Savitsky PA, 2002, J BIOL CHEM, V277, P20535, DOI 10.1074/jbc.M201589200; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tjernberg A, 2004, BIOORG MED CHEM LETT, V14, P891, DOI 10.1016/j.bmcl.2003.12.014; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; TONKS NK, 1988, J BIOL CHEM, V263, P6722; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; WHO, 2009, DIAB FACT SHEET; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683; Yudushkin IA, 2007, SCIENCE, V315, P115, DOI 10.1126/science.1134966; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zhang S, 2007, DRUG DISCOV TODAY, V12, P373, DOI 10.1016/j.drudis.2007.03.011; Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199	55	108	112	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					185	198		10.1016/j.cell.2011.08.036	http://dx.doi.org/10.1016/j.cell.2011.08.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962515	Green Accepted, Bronze			2022-12-28	WOS:000295396700025
J	Kawaguchi, S; Ng, DTW				Kawaguchi, Shinichi; Ng, Davis T. W.			Sensing ER Stress	SCIENCE			English	Editorial Material							UNFOLDED-PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; SENSOR IRE1; DISSOCIATION; ACTIVATION; REVEALS; YEAST; BIP		[Kawaguchi, Shinichi; Ng, Davis T. W.] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; [Ng, Davis T. W.] Natl Univ Singapore, Dept Biol Sci, Singapore 117604, Singapore	National University of Singapore; National University of Singapore	Kawaguchi, S (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore.	davis@tll.org.sg						Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Oikawa D, 2007, J CELL SCI, V120, P1681, DOI 10.1242/jcs.002808; Okamura K, 2000, BIOCHEM BIOPH RES CO, V279, P445, DOI 10.1006/bbrc.2000.3987; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	12	23	23	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 30	2011	333	6051					1830	1831		10.1126/science.1212840	http://dx.doi.org/10.1126/science.1212840			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	826PJ	21960615				2022-12-28	WOS:000295365800035
J	Larson, RG				Larson, Ronald G.			Predicting the Flow of Real Polymers	SCIENCE			English	Editorial Material							LIGHT-SCATTERING; RHEOLOGY; DYNAMICS		Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Larson, RG (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	rlarson@umich.edu						Chang T, 2005, J POLYM SCI POL PHYS, V43, P1591, DOI 10.1002/polb.20440; Costeux S, 2002, MACROMOLECULES, V35, P2514, DOI 10.1021/ma011432c; Daniels DR, 2001, MACROMOLECULES, V34, P7025, DOI 10.1021/ma010712p; Das C, 2006, J RHEOL, V50, P207, DOI 10.1122/1.2167487; DEGENNES PG, 1971, J CHEM PHYS, V55, P572, DOI 10.1063/1.1675789; Doi M., 1988, THEORY POLYM DYNAMIC; Flory PJ., 1953, PRINCIPLES POLYM CHE, V672; Hutchings LR, 2009, MACROMOLECULES, V42, P8675, DOI 10.1021/ma901819f; Larson RG, 2001, MACROMOLECULES, V34, P4556, DOI 10.1021/ma000700o; McLeish TCB, 1999, MACROMOLECULES, V32, P6734, DOI 10.1021/ma990323j; McLeish TCB, 1998, J RHEOL, V42, P81, DOI 10.1122/1.550933; Milner ST, 1997, MACROMOLECULES, V30, P2159, DOI 10.1021/ma961559f; Radke W, 2005, MACROMOLECULES, V38, P3949, DOI 10.1021/ma047799+; Read DJ, 2011, SCIENCE, V333, P1871, DOI 10.1126/science.1207060; ROOVERS J, 1981, MACROMOLECULES, V14, P766, DOI 10.1021/ma50004a057; ROOVERS J, 1981, MACROMOLECULES, V14, P1174, DOI 10.1021/ma50006a007; Soares JBP, 1996, MACROMOL THEOR SIMUL, V5, P547, DOI 10.1002/mats.1996.040050310; Tobita H, 2001, J POLYM SCI POL PHYS, V39, P391, DOI 10.1002/1099-0488(20010115)39:4<391::AID-POLB1011>3.0.CO;2-3; WINTERMANTEL M, 1993, APPL POLYM SYMP SER, V52, P91; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S	20	10	10	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051					1834	1835		10.1126/science.1211863	http://dx.doi.org/10.1126/science.1211863			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960619				2022-12-28	WOS:000295365800039
J	Lupski, JR; Belmont, JW; Boerwinkle, E; Gibbs, RA				Lupski, James R.; Belmont, John W.; Boerwinkle, Eric; Gibbs, Richard A.			Clan Genomics and the Complex Architecture of Human Disease	CELL			English	Article							MARIE-TOOTH-DISEASE; CASSETTE TRANSPORTER GENE; SEVERE MENTAL-RETARDATION; CYSTIC-FIBROSIS GENE; COPY NUMBER; DENSITY-LIPOPROTEIN; STARGARDT-DISEASE; CHRONIC RHINOSINUSITIS; TREMOR/ATAXIA SYNDROME; HEREDITARY NEUROPATHY	Human diseases are caused by alleles that encompass the full range of variant types, from single-nucleotide changes to copy-number variants, and these variations span a broad frequency spectrum, from the very rare to the common. The picture emerging from analysis of whole-genome sequences, the 1000 Genomes Project pilot studies, and targeted genomic sequencing derived from very large sample sizes reveals an abundance of rare and private variants. One implication of this realization is that recent mutation may have a greater influence on disease susceptibility or protection than is conferred by variations that arose in distant ancestors.	[Lupski, James R.; Belmont, John W.; Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.; Belmont, John W.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Univ Texas Hlth Sci Ctr Houston, Texas Childrens Hosp, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jlupski@bcm.edu; agibbs@bcm.edu	Belmont, John W/AAI-2494-2019; Belmont, John/AAH-6084-2021	Belmont, John W/0000-0001-7409-3578; 	National Human Genome Research Institute [5 U54 HG003273]; National Institute of Neurological Disorders and Stroke [R01NS058529]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529, R01NS027042] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the National Human Genome Research Institute (5 U54 HG003273) to R. A. G. and the National Institute of Neurological Disorders and Stroke (R01NS058529) to J.R.L. J.R.L. is a consultant for Athena Diagnostics, has stock ownership in 23andMe and Ion Torrent Systems, and is a coinventor on multiple United States and European patents for DNA diagnostics. R. A. G. and J.W.B. are founding shareholders in Seq-Wright, Inc. The Department of Molecular and Human Genetics derives revenue from clinical testing by high-resolution human genome analyses.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Athma P, 1996, CANCER GENET CYTOGEN, V92, P130, DOI 10.1016/S0165-4608(96)00328-7; Bacq Y, 2009, J MED GENET, V46, P711, DOI 10.1136/jmg.2009.067397; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; Chung KW, 2005, NEUROGENETICS, V6, P159, DOI 10.1007/s10048-005-0217-4; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; CONSORTIUM LS, 2008, NATURE, V455, P237; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Crow JF, 2008, J GENET, V87, P349, DOI 10.1007/s12041-008-0057-8; Del Colle R, 2003, NEUROL SCI, V24, P57, DOI 10.1007/s100720300073; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Divac Aleksandra, 2004, J Cyst Fibros, V3, P189, DOI 10.1016/j.jcf.2004.05.049; Douros K, 2008, INT J CLIN EXP MED, V1, P345; El-Hattab AW, 2010, GENET MED, V12, P573, DOI 10.1097/GIM.0b013e3181eb9b4a; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Fellermann K, 2003, EUR J GASTROEN HEPAT, V15, P627, DOI 10.1097/00042737-200306000-00008; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friez MJ, 2006, PEDIATRICS, V118, pE1687, DOI 10.1542/peds.2006-0395; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; GOLDSTEIN JL, 1987, CIRCULATION, V76, P504, DOI 10.1161/01.CIR.76.3.504; Goldstein JL, 2001, SCIENCE, V292, P1310, DOI 10.1126/science.1061815; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Greeley SAW, 2010, CURR OPIN ENDOCRINOL, V17, P13, DOI 10.1097/MED.0b013e328334f158; Guardamagna O, 2009, J PEDIATR-US, V155, P199, DOI 10.1016/j.jpeds.2009.02.022; Hagerman RJ, 2004, AM J HUM GENET, V74, P1051, DOI 10.1086/420700; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HEIM RA, 1992, MUTAT RES, V284, P25, DOI 10.1016/0027-5107(92)90022-T; Hersh CP, 2004, THORAX, V59, P843, DOI 10.1136/thx.2004.022541; Hodapp JA, 2006, ARCH NEUROL-CHICAGO, V63, P112, DOI 10.1001/archneur.63.1.112; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Jacquemont S, 2004, JAMA-J AM MED ASSOC, V291, P460, DOI 10.1001/jama.291.4.460; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Kurotaki N, 2005, GENET MED, V7, P479, DOI 10.1097/01.GIM.0000177419.43309.37; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Lu XY, 2008, PEDIATRICS, V122, P1310, DOI 10.1542/peds.2008-0297; Lupski JR, 2008, NATURE, V455, P178, DOI 10.1038/455178a; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Lupski JR, 2010, NAT GENET, V42, P1036, DOI 10.1038/ng1210-1036; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Meggouh F, 2005, ANN NEUROL, V57, P589, DOI 10.1002/ana.20434; Meins M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023804; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; MULLER HJ, 1950, AM J HUM GENET, V2, P111; POLLER W, 1990, EUR J CLIN INVEST, V20, P1; Potocki L, 1999, AM J HUM GENET, V64, P471, DOI 10.1086/302240; Ramocki MB, 2009, ANN NEUROL, V66, P771, DOI 10.1002/ana.21715; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Roa BB, 1996, HUM GENET, V97, P642; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Schaaf CP, 2011, HUM MOL GENET, V20, P3366, DOI 10.1093/hmg/ddr243; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Shroyer NF, 1999, VISION RES, V39, P2537, DOI 10.1016/S0042-6989(99)00037-1; Shroyer NF, 2001, HUM MOL GENET, V10, P2671, DOI 10.1093/hmg/10.23.2671; Shroyer NF, 2001, INVEST OPHTH VIS SCI, V42, P2757; Shy ME, 2006, ANN NEUROL, V59, P358, DOI 10.1002/ana.20777; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Stankiewicz P, 2007, CURR OPIN GENET DEV, V17, P182, DOI 10.1016/j.gde.2007.04.009; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Vernimmen D, 2009, BLOOD, V114, P4253, DOI 10.1182/blood-2009-03-213439; Verny C, 2004, NEUROLOGY, V63, P1527; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wagner CA, 2008, J NEPHROL, V21, P632; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang XJ, 2000, JAMA-J AM MED ASSOC, V284, P1814, DOI 10.1001/jama.284.14.1814; Wang XJ, 2005, ARCH OTOLARYNGOL, V131, P237, DOI 10.1001/archotol.131.3.237; Weiss FU, 2005, GUT, V54, P1456, DOI 10.1136/gut.2005.064808; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wittrup HH, 2006, J CLIN ENDOCR METAB, V91, P1438, DOI 10.1210/jc.2005-1725; Wittrup HH, 1997, J CLIN INVEST, V99, P1606, DOI 10.1172/JCI119323	119	259	261	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2011	147	1					32	43		10.1016/j.cell.2011.09.008	http://dx.doi.org/10.1016/j.cell.2011.09.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962505	Bronze, Green Accepted			2022-12-28	WOS:000295396700013
J	Read, DJ; Auhl, D; Das, C; den Doelder, J; Kapnistos, M; Vittorias, I; McLeish, TCB				Read, Daniel J.; Auhl, Dietmar; Das, Chinmay; den Doelder, Jaap; Kapnistos, Michael; Vittorias, Iakovos; McLeish, Tom C. B.			Linking Models of Polymerization and Dynamics to Predict Branched Polymer Structure and Flow	SCIENCE			English	Article							RHEOLOGY; BEHAVIOR	We present a predictive scheme connecting the topological structure of highly branched entangled polymers, with industrial-level complexity, to the emergent viscoelasticity of the polymer melt. The scheme is able to calculate the linear and nonlinear viscoelasticity of a stochastically branched "high-pressure free radical" polymer melt as a function of the chemical kinetics of its formation. The method combines numerical simulation of polymerization with the tube/entanglement physics of polymer dynamics extended to fully nonlinear response. We compare calculations for a series of low-density polyethylenes with experiments on structural and viscoelastic properties. The method provides a window onto the molecular processes responsible for the optimized rheology of these melts, connecting fundamental science to process in complex flow, and opens up the in silico design of new materials.	[McLeish, Tom C. B.] Univ Durham, Dept Phys, Durham DH1 3LE, England; [McLeish, Tom C. B.] Univ Durham, Dept Chem, Durham DH1 3LE, England; [Vittorias, Iakovos] LyondellBasell Polyolefine GmbH, R&D Polymer Phys & Characterizat, Frankfurt, Germany; [den Doelder, Jaap] Dow Benelux BV, Polyethylene Prod Res, NL-4530 AA Terneuzen, Netherlands; [Auhl, Dietmar; Das, Chinmay; Kapnistos, Michael] Univ Leeds, Dept Phys & Astron, Leeds LS2 9JT, W Yorkshire, England; [Read, Daniel J.] Univ Leeds, Dept Appl Math, Leeds LS2 9JT, W Yorkshire, England	Durham University; Durham University; LyondellBasell; Dow Chemical Company; Dow Benelux BV; University of Leeds; University of Leeds	McLeish, TCB (corresponding author), Univ Durham, Dept Phys, Durham DH1 3LE, England.	t.c.b.mcleish@durham.ac.uk	Read, Daniel J/F-8318-2014; Auhl, Dietmar/B-6585-2009; Read, Daniel/O-6450-2019	Read, Daniel/0000-0003-1194-9273; McLeish, Tom/0000-0002-2025-0299; Auhl, Dietmar/0000-0002-4705-4941	Engineering and Physical Sciences Research Council (UK) under the "Microscale Polymer Processing" (MuPP) consortium; European Union under the Marie Curie Initial Training Network Dynamics of Architecturally Complex Polymers; Engineering and Physical Sciences Research Council [GR/T11807/01, EP/D06631X/1] Funding Source: researchfish; EPSRC [EP/D06631X/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (UK) under the "Microscale Polymer Processing" (MuPP) consortium(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union under the Marie Curie Initial Training Network Dynamics of Architecturally Complex Polymers; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the Engineering and Physical Sciences Research Council (UK) for funding under the "Microscale Polymer Processing" (MuPP) consortium and the European Union Framework Programme 7 People Programme for funding under the Marie Curie Initial Training Network Dynamics of Architecturally Complex Polymers. The data described in this work are archived on the MuPP project online materials database at www.irc.leeds.ac.uk/mupp2.	Archer LA, 2002, MACROMOLECULES, V35, P10216, DOI [10.1021/ma021286q, 10.1021/ma0208436]; Bick DK, 1996, PHYS REV LETT, V76, P2587, DOI 10.1103/PhysRevLett.76.2587; Blackwell RJ, 2000, J RHEOL, V44, P121, DOI 10.1122/1.551081; Das C, 2006, J RHEOL, V50, P207, DOI 10.1122/1.2167487; Dealy J. M., 2018, STRUCTURE RHEOLOGY M, DOI DOI 10.3139/9781569906125; DEGENNES PG, 1971, J CHEM PHYS, V55, P572, DOI 10.1063/1.1675789; DEGENNES PG, 1975, J PHYS-PARIS, V36, P1199, DOI 10.1051/jphys:0197500360120119900; Doi M., 1988, THEORY POLYM DYNAMIC; Gennes P.G., 1980, SCALING CONCEPTS POL; Inkson NJ, 2006, MACROMOLECULES, V39, P4217, DOI 10.1021/ma060018f; KLEIN J, 1983, NATURE, V304, P526, DOI 10.1038/304526a0; McLeish TCB, 2002, ADV PHYS, V51, P1379, DOI 10.1080/00018730210153216; McLeish TCB, 1999, MACROMOLECULES, V32, P6734, DOI 10.1021/ma990323j; McLeish TCB, 1998, J RHEOL, V42, P81, DOI 10.1122/1.550933; PEARSON DS, 1984, MACROMOLECULES, V17, P888, DOI 10.1021/ma00134a060; SHULL KR, 1990, NATURE, V345, P790, DOI 10.1038/345790a0; Small P.A., 1975, ADV POLYM SCI, V18, P1; Stanescu P, 2005, J POLYM SCI POL PHYS, V43, P1973, DOI 10.1002/polb.20477; Tobita H, 2001, J POLYM SCI POL PHYS, V39, P391, DOI 10.1002/1099-0488(20010115)39:4<391::AID-POLB1011>3.0.CO;2-3; van Ruymbeke E, 2007, MACROMOLECULES, V40, P5941, DOI 10.1021/ma0706024	20	130	131	3	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051					1871	1874		10.1126/science.1207060	http://dx.doi.org/10.1126/science.1207060			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960631	Green Accepted			2022-12-28	WOS:000295365800051
J	Swaminathan, K; Wilson, J				Swaminathan, Krishnan; Wilson, John			PICTURE QUIZ Elusive cause of hypomagnesaemia	BRITISH MEDICAL JOURNAL			English	Editorial Material							PROTON-PUMP INHIBITORS; RISK; PNEUMONIA		[Swaminathan, Krishnan] Victoria Hosp, Dept Endocrinol, Kirkcaldy KY2 5AH, England; [Wilson, John] Victoria Hosp, Dept Gastroenterol, Kirkcaldy KY2 5AH, England		Swaminathan, K (corresponding author), Victoria Hosp, Dept Endocrinol, Kirkcaldy KY2 5AH, England.	k_swaminathan@hotmail.com						Cundy T, 2008, CLIN ENDOCRINOL, V69, P338, DOI 10.1111/j.1365-2265.2008.03194.x; Doorduyn Y, 2010, EPIDEMIOL INFECT, V138, P1391, DOI 10.1017/S095026881000052X; Dublin S, 2010, PHARMACOEPIDEM DR S, V19, P792, DOI 10.1002/pds.1978; Epstein M, 2006, NEW ENGL J MED, V355, P1834, DOI 10.1056/NEJMc066308; Eurich DT, 2010, AM J MED, V123, P47, DOI 10.1016/j.amjmed.2009.05.032; Forgacs I, 2008, BMJ-BRIT MED J, V336, P2, DOI 10.1136/bmj.39406.449456.BE; Hoorn EJ, 2010, AM J KIDNEY DIS, V56, P112, DOI 10.1053/j.ajkd.2009.11.019; Howell MD, 2010, ARCH INTERN MED, V170, P784, DOI 10.1001/archinternmed.2010.89; Kuipers MT, 2009, NETH J MED, V67, P169; McGowan B, 2010, PHARMACOEPIDEM DR S, V19, P763, DOI 10.1002/pds.1972; *NHS, 2006, PACT CTR PAG DRUGS D; Quamme GA, 2008, CURR OPIN GASTROEN, V24, P230, DOI 10.1097/MOG.0b013e3282f37b59; Regolisti G, 2010, AM J KIDNEY DIS, V56, P168, DOI 10.1053/j.ajkd.2010.03.013; Shabajee N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.39505.738981.BE	14	7	7	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 30	2011	343								d5087	10.1136/bmj.d5087	http://dx.doi.org/10.1136/bmj.d5087			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829KD	21964544				2022-12-28	WOS:000295577600001
J	Vesper, O; Amitai, S; Belitsky, M; Byrgazov, K; Kaberdina, AC; Engelberg-Kulka, H; Moll, I				Vesper, Oliver; Amitai, Shahar; Belitsky, Maria; Byrgazov, Konstantin; Kaberdina, Anna Chao; Engelberg-Kulka, Hanna; Moll, Isabella			Selective Translation of Leaderless mRNAs by Specialized Ribosomes Generated by MazF in Escherichia coli	CELL			English	Article							PROGRAMMED CELL-DEATH; TOXIN-ANTITOXIN LOCI; ADDICTION MODULE; INITIATION; SEQUENCE; MAINTENANCE; ANTIBIOTICS; EXPRESSION; MECHANISM; SUBUNIT	Escherichia coli (E. coli) mazEF is a stress-induced toxin-antitoxin (TA) module. The toxin MazF is an endoribonuclease that cleaves single-stranded mRNAs at ACA sequences. Here, we show that MazF cleaves at ACA sites at or closely upstream of the AUG start codon of some specific mRNAs and thereby generates leaderless mRNAs. Moreover, we provide evidence that MazF also targets 16S rRNA within 30S ribosomal subunits at the decoding center, thereby removing 43 nucleotides from the 30 terminus. As this region comprises the anti-Shine-Dalgarno (aSD) sequence that is required for translation initiation on canonical mRNAs, a subpopulation of ribosomes is formed that selectively translates the described leaderless mRNAs both in vivo and in vitro. Thus, we have discovered a modified translation machinery that is generated in response to MazF induction and that probably serves for stress adaptation in Escherichia coli.	[Amitai, Shahar; Belitsky, Maria; Engelberg-Kulka, Hanna] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, IMRIC, IL-91120 Jerusalem, Israel; [Vesper, Oliver; Byrgazov, Konstantin; Kaberdina, Anna Chao; Moll, Isabella] Univ Vienna, Max F Perutz Labs, Ctr Mol Biol, Dept Microbiol Immunobiol & Genet, A-1030 Vienna, Austria	Hebrew University of Jerusalem; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Engelberg-Kulka, H (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, IMRIC, IL-91120 Jerusalem, Israel.	hanita@cc.huji.ac.il; isabella.moll@univie.ac.at	Moll, Isabella/E-8665-2012; Byrgazov, Konstantin/G-9358-2016	Moll, Isabella/0000-0002-3210-4336; Byrgazov, Konstantin/0000-0002-8924-9536	Austrian Science Fund [P20112-B03, P22249-B20]; Israel Science Foundation (ISF) [66/10]; USA Army [W911NF0910212]; NIH [GM069509]; Austrian Science Fund (FWF) [P 22249] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069509] Funding Source: NIH RePORTER	Austrian Science Fund(Austrian Science Fund (FWF)); Israel Science Foundation (ISF)(Israel Science Foundation); USA Army; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants P20112-B03 and P22249-B20 from the Austrian Science Fund to I. M., by grant number 66/10 from the Israel Science Foundation (ISF) administrated by the Israel Academy of Science and Humanities, by the USA Army grant W911NF0910212, and by NIH grant GM069509 to H.E.-K.	Agarwal S, 2007, FEBS LETT, V581, P1727, DOI 10.1016/j.febslet.2007.03.051; Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Amitai S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000390; Baik S, 2009, J BACTERIOL, V191, P6157, DOI 10.1128/JB.00699-09; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BROSIUS J, 1981, PLASMID, V6, P112, DOI 10.1016/0147-619X(81)90058-5; CALOGERO RA, 1988, P NATL ACAD SCI USA, V85, P6427, DOI 10.1073/pnas.85.17.6427; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Cochella L, 2004, P NATL ACAD SCI USA, V101, P3786, DOI 10.1073/pnas.0307596101; DELANO WL, 2002, PYMOL MOL SYSTEM; Engelberg-Kulka H, 1998, P NATL ACAD SCI USA, V95, P15481, DOI 10.1073/pnas.95.26.15481; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GIBSON T, 1984, THESIS U CAMBRIDGE U; Green J, 1998, MOL MICROBIOL, V29, P1113, DOI 10.1046/j.1365-2958.1998.01002.x; Grill S, 2000, EMBO J, V19, P4101, DOI 10.1093/emboj/19.15.4101; HAMMERJE, 1971, EUR J BIOCHEM, V19, P533; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; HUI A, 1987, P NATL ACAD SCI USA, V84, P4762, DOI 10.1073/pnas.84.14.4762; Kaberdina AC, 2009, MOL CELL, V33, P227, DOI 10.1016/j.molcel.2008.12.014; Kaminishi T, 2007, STRUCTURE, V15, P289, DOI 10.1016/j.str.2006.12.008; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kolodkin-Gal I, 2006, J BACTERIOL, V188, P3420, DOI 10.1128/JB.188.9.3420-3423.2006; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Kolodkin-Gal I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006785; LUPSKI JR, 1984, MOL GEN GENET, V195, P391, DOI 10.1007/BF00341439; Marianovsky I, 2001, J BIOL CHEM, V276, P5975, DOI 10.1074/jbc.M008832200; MASUDA YJ, 1993, J BACTERIOL, V175, P6850, DOI 10.1128/jb.175.21.6850-6856.1993; Mawn MV, 2002, J BACTERIOL, V184, P494, DOI 10.1128/JB.184.2.494-502.2002; METZGER S, 1988, J BIOL CHEM, V263, P15699; Mittenhuber Gerhard, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P295; MOAZED D, 1987, BIOCHIMIE, V69, P879, DOI 10.1016/0300-9084(87)90215-X; Moll I, 2004, NUCLEIC ACIDS RES, V32, P3354, DOI 10.1093/nar/gkh663; Moll I, 2002, MOL MICROBIOL, V44, P1387, DOI 10.1046/j.1365-2958.2002.02971.x; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Porollo A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-316; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; Schmidt O, 2007, J MOL BIOL, V372, P894, DOI 10.1016/j.jmb.2007.07.016; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; SENIOR BW, 1971, P NATL ACAD SCI USA, V68, P959, DOI 10.1073/pnas.68.5.959; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; Vila-Sanjurjo A, 2001, J MOL BIOL, V308, P457, DOI 10.1006/jmbi.2001.4576; Wagner AFV, 2001, BIOCHEM BIOPH RES CO, V285, P456, DOI 10.1006/bbrc.2001.5186; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1; WOODCOCK J, 1991, EMBO J, V10, P3099, DOI 10.1002/j.1460-2075.1991.tb07863.x; WRZESINSKI J, 1995, BIOCHEMISTRY-US, V34, P8904, DOI 10.1021/bi00027a043; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zhang JJ, 2004, J BIOL CHEM, V279, P20678, DOI 10.1074/jbc.M314284200; Zhang JJ, 2003, J BIOL CHEM, V278, P32300, DOI 10.1074/jbc.M304767200; Zhu L, 2008, MOL MICROBIOL, V69, P559, DOI 10.1111/j.1365-2958.2008.06284.x	58	214	219	0	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2011	147	1					147	157		10.1016/j.cell.2011.07.047	http://dx.doi.org/10.1016/j.cell.2011.07.047			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21944167	Green Accepted, Bronze			2022-12-28	WOS:000295396700022
J	Ferlitsch, M; Reinhart, K; Pramhas, S; Wiener, C; Gal, O; Bannert, C; Hassler, M; Kozbial, K; Dunkler, D; Trauner, M; Weiss, W				Ferlitsch, Monika; Reinhart, Karoline; Pramhas, Sibylle; Wiener, Caspar; Gal, Orsolya; Bannert, Christina; Hassler, Michaela; Kozbial, Karin; Dunkler, Daniela; Trauner, Michael; Weiss, Werner			Sex-Specific Prevalence of Adenomas, Advanced Adenomas, and Colorectal Cancer in Individuals Undergoing Screening Colonoscopy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASYMPTOMATIC ADULTS; AMERICAN-COLLEGE; RISK; GUIDELINES; NEOPLASIA; AGE; SURVEILLANCE; RATIONALE; SOCIETY; POLYPS	Context Although some studies have shown that men are at greater age-specific risk for advanced colorectal neoplasia than women, the age for referring patients to screening colonoscopy is independent of sex and usually recommended to be 50 years. Objective To determine and compare the prevalence and number needed to screen (NNS) for adenomas, advanced adenomas (AAs), and colorectal carcinomas (CRCs) for different age groups in men and women. Design, Setting, and Patients Cohort study of 44 350 participants in a national screening colonoscopy program over a 4-year period (2007 to 2010) in Austria. Main Outcome Measures Prevalence and NNS of adenomas, AAs, and CRCs in different age groups for men and women. Results The median ages were 60.7 years (interquartile range [IQR], 54.5-67.5 years) for women and 60.6 years (IQR, 54.3-67.6 years) for men, and the sex ratio was nearly identical (51.0% [22 598] vs 49.0% [21 572]). Adenomas were found in 19.7% of individuals screened (95% CI, 19.3%-20.1%; n=8743), AAs in 6.3% (95% CI, 6.1%-6.5%; n=2781), and CRCs in 1.1% (95% CI, 1.0%-1.2%; n=491); NNS were 5.1 (95% CI, 5.0-5.2), 15.9 (95% CI, 15.4-16.5), and 90.9 (95% CI, 83.3-100.0), respectively. Male sex was significantly associated with a higher prevalence of adenomas (24.9% [95% CI, 24.3%-25.4%] vs 14.8% [95% CI, 14.3%-15.2%]; P<.001; unadjusted odds ratio [OR], 1.9 [95% CI, 1.8-2.0]), AAs (8.0% [95% CI, 7.6%-8.3%] vs 4.7% [95% CI, 4.4%-4.9%]; P<.001; unadjusted OR, 1.8 [95% CI, 1.6-1.9]), and CRCs (1.5% [95% CI, 1.3%-1.7%] vs 0.7% [95% CI, 0.6%-0.9%]; P<.001; unadjusted OR, 2.1 [95% CI, 1.7-2.5]). The prevalence of AAs in 50- to 54-year-old individuals was 5.0% (95% CI, 4.4%-5.6%) in men but 2.9% (95% CI, 2.5%-3.4%) in women (adjusted P=.001); the NNS in men was 20 (95% CI, 17.8-22.6) vs 34 in women (95% CI, 29.1-40; adjusted P=.001). There was no statistical significance between the prevalence and NNS of AAs in men aged 45 to 49 years compared with women aged 55 to 59 years (3.8% [95% CI, 2.3%-6.1%] vs 3.9% [95% CI, 3.3%-4.5%] and 26.1 [95% CI, 16.5-44.4] vs 26 [95% CI, 22.5-30.2]; P=.99). Conclusion Among a cohort of Austrian individuals undergoing screening colonoscopy, the prevalence and NNS of AAs were comparable between men aged 45 to 49 years and women aged 55 to 59 years. JAMA. 2011;306(12):1352-1358	[Ferlitsch, Monika; Reinhart, Karoline; Pramhas, Sibylle; Wiener, Caspar; Gal, Orsolya; Bannert, Christina; Kozbial, Karin; Trauner, Michael] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, A-1090 Vienna, Austria; [Ferlitsch, Monika; Reinhart, Karoline; Pramhas, Sibylle; Wiener, Caspar; Gal, Orsolya; Bannert, Christina; Hassler, Michaela; Weiss, Werner] Austrian Soc Gastroenterol & Hepatol, Qual Assurance Working Grp, Vienna, Austria; [Dunkler, Daniela] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, A-1090 Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Ferlitsch, M (corresponding author), Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	monika.ferlitsch@meduniwien.ac.at	Dunkler, Daniela/B-2733-2018	Dunkler, Daniela/0000-0003-1339-0311; Trauner, Michael/0000-0002-1275-6425	Fund for Preventive Check-ups and Health Promotion	Fund for Preventive Check-ups and Health Promotion	The Quality Certificate for Screening Colonoscopy project was conducted in cooperation with the Main Association of Austrian Social Security Institutions and funded by the Fund for Preventive Check-ups and Health Promotion (fund 447h ASVG).	Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Berg AO, 2002, ANN INTERN MED, V137, P129, DOI 10.7326/0003-4819-137-2-200207160-00014; Brenner H, 2007, BRIT J CANCER, V96, P828, DOI 10.1038/sj.bjc.6603628; Brenner H, 2007, GUT, V56, P1585, DOI 10.1136/gut.2007.122739; Hoffmeister M, 2010, CLIN GASTROENTEROL H, V8, P870, DOI 10.1016/j.cgh.2010.07.004; Imperiale TF, 2002, NEW ENGL J MED, V346, P1781, DOI 10.1056/NEJM200206063462304; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Imperiale TF, 2003, ANN INTERN MED, V139, P959, DOI 10.7326/0003-4819-139-12-200312160-00005; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2008, JAMA-J AM MED ASSOC, V300, P1417, DOI 10.1001/jama.300.12.1417; Nguyen SP, 2009, CLIN GASTROENTEROL H, V7, P676, DOI 10.1016/j.cgh.2009.01.008; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Rundle AG, 2008, GASTROENTEROLOGY, V134, P1311, DOI 10.1053/j.gastro.2008.02.032; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Smith RA, 2004, CA-CANCER J CLIN, V54, P41, DOI 10.3322/canjclin.54.1.41; *STAT AUSTR, MAL NEOPL COL TIM; Sung JJY, 2008, GUT, V57, P1166, DOI 10.1136/gut.2007.146316; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Weiss W, 2008, J GASTROEN HEPATOL, V6, P19; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044	23	195	200	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 28	2011	306	12					1352	1358		10.1001/jama.2011.1362	http://dx.doi.org/10.1001/jama.2011.1362			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825FQ	21954479	Bronze			2022-12-28	WOS:000295257000024
J	Iwasaki, A; Medzhitov, R				Iwasaki, Akiko; Medzhitov, Ruslan			A New Shield for a Cytokine Storm	CELL			English	Editorial Material							INFLUENZA-VIRUS INFECTION; ENDOTHELIAL-CELLS; MICE	Highly virulent influenza virus infection results in excessive cytokine production, recruitment of leukocytes, and immune-mediated pulmonary injury. Teijaro et al. (2011) now demonstrate that sphingosine-1-phosphate receptor 1 ligands suppress all features of flu-inflicted pathological inflammation and place the endothelium at the center of this regulatory network.	[Iwasaki, Akiko; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu; ruslan.medzhitov@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856	NIAID NIH HHS [R01 AI064705, U54 AI057160] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057160, R01AI064705] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cahalan SM, 2011, NAT CHEM BIOL, V7, P254, DOI 10.1038/nchembio.547; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Feldmann A, 2000, J VIROL, V74, P8018, DOI 10.1128/JVI.74.17.8018-8027.2000; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Marsolais D, 2008, MOL PHARMACOL, V74, P896, DOI 10.1124/mol.108.048769; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Tscherne DM, 2011, J CLIN INVEST, V121, P6, DOI 10.1172/JCI44947; Walsh KB, 2011, P NATL ACAD SCI USA, V108, P12018, DOI 10.1073/pnas.1107024108	10	30	30	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2011	146	6					861	862		10.1016/j.cell.2011.08.027	http://dx.doi.org/10.1016/j.cell.2011.08.027			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925310	Green Accepted, Bronze			2022-12-28	WOS:000295258100008
J	Kastor, JA; Adashi, EY				Kastor, John A.; Adashi, Eli Y.			Maryland's Hospital Cost Review Commission at 40 A Model for the Country	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kastor, John A.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	University System of Maryland; University of Maryland Baltimore; Brown University	Kastor, JA (corresponding author), Univ Maryland Med Syst, Baltimore, MD 21201 USA.	jkastor@medicine.umaryland.edu						Adashi EY, 2009, WASHINGTON POST 1002, pA21; McDonough E, 1997, HEALTH AFFAIR, V16, P142, DOI 10.1377/hlthaff.16.1.142; Murray R, 2009, HEALTH AFFAIR, V28, P1395, DOI 10.1377/hlthaff.28.5.1395; State of Maryland Health Services Cost Review Commission, REP GOV FISC YEAR 20	4	22	22	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2011	306	10					1137	1138		10.1001/jama.2011.1311	http://dx.doi.org/10.1001/jama.2011.1311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	819DS	21917584				2022-12-28	WOS:000294806200031
J	Saavedra, S; Stouffer, DB; Uzzi, B; Bascompte, J				Saavedra, Serguei; Stouffer, Daniel B.; Uzzi, Brian; Bascompte, Jordi			Strong contributors to network persistence are the most vulnerable to extinction	NATURE			English	Article							MUTUALISTIC NETWORKS; ARCHITECTURE; SYSTEMS	The architecture of mutualistic networks facilitates coexistence of individual participants by minimizing competition relative to facilitation(1,2). However, it is not known whether this benefit is received by each participant node in proportion to its overall contribution to network persistence. This issue is critical to understanding the trade-offs faced by individual nodes in a network(3-5). We address this question by applying a suite of structural and dynamic methods to an ensemble of flowering plant/insect pollinator networks. Here we report two main results. First, nodes contribute heterogeneously to the overall nested architecture of the network. From simulations, we confirm that the removal of a strong contributor tends to decrease overall network persistence more than the removal of a weak contributor. Second, strong contributors to collective persistence do not gain individual survival benefits but are in fact the nodes most vulnerable to extinction. We explore the generality of these results to other cooperative networks by analysing a 15-year time series of the interactions between designer and contractor firms in the New York City garment industry. As with the ecological networks, a firm's survival probability decreases as its individual nestedness contribution increases. Our results, therefore, introduce a new paradox into the study of the persistence of cooperative networks, and potentially address questions about the impact of invasive species in ecological systems and new competitors in economic systems.	[Stouffer, Daniel B.; Bascompte, Jordi] CSIC, Estn Biol Donana, Integrat Ecol Grp, E-41092 Seville, Spain; [Saavedra, Serguei; Uzzi, Brian] Northwestern Univ, NW Inst Complex Syst, Evanston, IL 60208 USA; [Saavedra, Serguei; Uzzi, Brian] Northwestern Univ, Kellogg Sch Management, Evanston, IL 60208 USA; [Saavedra, Serguei] Northwestern Univ, Clin & Translat Sci Inst, Chicago, IL 60611 USA; [Stouffer, Daniel B.] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Northwestern University; Northwestern University; Northwestern University; University of Canterbury	Bascompte, J (corresponding author), CSIC, Estn Biol Donana, Integrat Ecol Grp, Calle Americo Vespucio S-N, E-41092 Seville, Spain.	bascompte@ebd.csic.es	Bascompte, Jordi/B-7596-2008; Stouffer, Daniel/C-2223-2008	Bascompte, Jordi/0000-0002-0108-6411; Stouffer, Daniel/0000-0001-9436-9674	Kellogg School of Management, Northwestern University; Northwestern University Institute on Complex Systems; NUCATS [UL1RR025741]; CSIC-JAE postdoctoral fellowship; Army Research Laboratory [W911NF-09-2-0053]; European Research Council under the European Community [268543]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER	Kellogg School of Management, Northwestern University; Northwestern University Institute on Complex Systems; NUCATS; CSIC-JAE postdoctoral fellowship; Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); European Research Council under the European Community(European Research Council (ERC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was provided by the Kellogg School of Management, Northwestern University, the Northwestern University Institute on Complex Systems (NICO; to S. S. and B. U.), NUCATS grant UL1RR025741 (to S. S.), a CSIC-JAE postdoctoral fellowship (to D. B. S.), the Army Research Laboratory (under cooperative agreement W911NF-09-2-0053 to B. U.), and the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013) through an Advanced Grant (grant agreement 268543 to J.B.). Figures were generated with PyGrace (http://pygrace.sourceforge.net).	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; DETONI A, 1995, OMEGA-INT J MANAGE S, V23, P403, DOI 10.1016/0305-0483(95)00024-I; Doeringer J., 1996, SOCIO-ECON REV, V4, P353; Falster DS, 2003, TRENDS ECOL EVOL, V18, P337, DOI 10.1016/S0169-5347(03)00061-2; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Gintis H., 2005, MORAL SENTIMENTS MAT; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; LEIGH EG, 1977, P NATL ACAD SCI USA, V74, P4542, DOI 10.1073/pnas.74.10.4542; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Saavedra S, 2008, P NATL ACAD SCI USA, V105, P16466, DOI 10.1073/pnas.0804740105; Saavedra S, 2010, PHYSICA A, V389, P1131, DOI 10.1016/j.physa.2009.10.038; Sugihara G, 2009, NATURE, V458, P979, DOI 10.1038/458979a; Uzzi B, 1996, AM SOCIOL REV, V61, P674, DOI 10.2307/2096399; Weyl EG, 2010, P NATL ACAD SCI USA, V107, P15712, DOI 10.1073/pnas.1005294107	22	205	211	1	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2011	478	7368					233	235		10.1038/nature10433	http://dx.doi.org/10.1038/nature10433			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21918515	Green Submitted			2022-12-28	WOS:000295782800048
J	Noggle, S; Fung, HL; Gore, A; Martinez, H; Satriani, KC; Prosser, R; Oum, K; Paull, D; Druckenmiller, S; Freeby, M; Greenberg, E; Zhang, K; Goland, R; Sauer, MV; Leibel, RL; Egli, D				Noggle, Scott; Fung, Ho-Lim; Gore, Athurva; Martinez, Hector; Satriani, Kathleen Crumm; Prosser, Robert; Oum, Kiboong; Paull, Daniel; Druckenmiller, Sarah; Freeby, Matthew; Greenberg, Ellen; Zhang, Kun; Goland, Robin; Sauer, Mark V.; Leibel, Rudolph L.; Egli, Dieter			Human oocytes reprogram somatic cells to a pluripotent state	NATURE			English	Article							EMBRYONIC STEM-CELLS; NUCLEAR TRANSFER; GENE-EXPRESSION; DEVELOPMENTAL COMPETENCE; DERIVATION; LINES	The exchange of the oocyte's genome with the genome of a somatic cell, followed by the derivation of pluripotent stem cells, could enable the generation of specific cells affected in degenerative human diseases. Such cells, carrying the patient's genome, might be useful for cell replacement. Here we report that the development of human oocytes after genome exchange arrests at late cleavage stages in association with transcriptional abnormalities. In contrast, if the oocyte genome is not removed and the somatic cell genome is merely added, the resultant triploid cells develop to the blastocyst stage. Stem cell lines derived from these blastocysts differentiate into cell types of all three germ layers, and a pluripotent gene expression program is established on the genome derived from the somatic cell. This result demonstrates the feasibility of reprogramming human cells using oocytes and identifies removal of the oocyte genome as the primary cause of developmental failure after genome exchange.	[Noggle, Scott; Martinez, Hector; Paull, Daniel; Druckenmiller, Sarah; Egli, Dieter] New York Stem Cell Fdn Lab, New York, NY USA; [Fung, Ho-Lim; Gore, Athurva; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Satriani, Kathleen Crumm; Prosser, Robert; Oum, Kiboong; Sauer, Mark V.] Columbia Univ, Coll Phys & Surg, Ctr Womens Reprod Care, New York, NY USA; [Satriani, Kathleen Crumm; Prosser, Robert; Oum, Kiboong; Sauer, Mark V.] Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY USA; [Freeby, Matthew; Greenberg, Ellen; Goland, Robin; Leibel, Rudolph L.] Columbia Univ, Coll Phys & Surg, Naomi Berrie Diabet Ctr, New York, NY USA; [Freeby, Matthew; Greenberg, Ellen; Goland, Robin; Leibel, Rudolph L.] Columbia Univ, Dept Pediat, Coll Phys & Surg, New York, NY 10027 USA	The New York Stem Cell Foundation; University of California System; University of California San Diego; Columbia University; Columbia University; Columbia University; Columbia University	Egli, D (corresponding author), New York Stem Cell Fdn Lab, New York, NY USA.	d.egli@nyscf.org	Egli, Dieter/C-3566-2013; Zhang, Kun/ABE-6349-2020	Zhang, Kun/0000-0002-7596-5224; Noggle, Scott/0000-0002-0374-2240	UCSD; New York Stem Cell Foundation; Russell Berrie Foundation	UCSD; New York Stem Cell Foundation; Russell Berrie Foundation	We thank our research subjects for participating. We thank S. Solomon and K. Eggan for discussions and support, L. Bauer for help with blastocyst thawing, D. Kahler for cell sorting, M. Verbitsky and S. Kisselev for microarray hybridization, V. Miljkovic for Affymetrix SNP chip hybridization, C. LeDuc and Y. Ravussin for help with data analysis and mouse work, R. Maehr for DiPS H.1.5, C. Marshall and J. Safran for administrative support, S. Paull for cover art, Z. Hall and S. Chang for critical reading of the manuscript. This research was supported by a UCSD startup fund to K. Z., the New York Stem Cell Foundation primarily, and the Russell Berrie Foundation.	BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Chung Y, 2009, CLONING STEM CELLS, V11, P213, DOI 10.1089/clo.2009.0004; Cibelli J.B., 2001, J REGEN MED, V2, P25, DOI [10.1089/152489001753262168, DOI 10.1089/152489001753262168]; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Daley GQ, 2007, SCIENCE, V315, P603, DOI 10.1126/science.1139337; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Egli D, 2011, CELL STEM CELL, V9, P293, DOI 10.1016/j.stem.2011.08.002; Egli D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1503; Ethics Comm Amer Soc Reprod Med, 2007, FERTIL STERIL, V88, P305, DOI 10.1016/j.fertnstert2007.01.104; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; French AJ, 2008, STEM CELLS, V26, P485, DOI 10.1634/stemcells.2007-0252; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hall VJ, 2007, HUM REPROD, V22, P52, DOI 10.1093/humrep/del345; Heindryckx B, 2007, HUM REPROD, V22, P1982, DOI 10.1093/humrep/dem106; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Kennedy Donald, 2006, Science, V311, P335; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Klitzman R, 2009, REPROD BIOMED ONLINE, V18, P603, DOI 10.1016/S1472-6483(10)60002-8; Kornafel KL, 2007, FERTIL STERIL, V87, P1253, DOI 10.1016/j.fertnstert.2006.11.056; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; McElroy SL, 2008, REPROD BIOMED ONLINE, V16, P684, DOI 10.1016/S1472-6483(10)60483-X; Mitalipov SM, 2007, HUM REPROD, V22, P2232, DOI 10.1093/humrep/dem136; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Revazova ES, 2007, CLONING STEM CELLS, V9, P432, DOI 10.1089/clo.2007.0033; Stojkovic M, 2005, REPROD BIOMED ONLINE, V11, P226; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357	38	149	165	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2011	478	7367					70	U81		10.1038/nature10397	http://dx.doi.org/10.1038/nature10397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21979046				2022-12-28	WOS:000295575400036
J	Tobian, AAR; Gray, RH				Tobian, Aaron A. R.; Gray, Ronald H.			The Medical Benefits of Male Circumcision	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SEXUAL SATISFACTION; RANDOMIZED-TRIAL; MEN; TRANSMISSION; UGANDA; WOMEN; RAKAI; RISK		[Tobian, Aaron A. R.] Johns Hopkins Univ, Dept Pathol, Sch Med, Baltimore, MD 21287 USA; [Tobian, Aaron A. R.; Gray, Ronald H.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Tobian, AAR (corresponding author), Johns Hopkins Univ, Dept Pathol, Sch Med, Carnegie 667,600 N Wolfe St, Baltimore, MD 21287 USA.	atobian1@jhmi.edu	Hug, Balthasar L./G-1568-2010		NIAID NIH HHS [1K23AI093152-01A1, K23 AI093152-01A1, K23 AI093152, K23 AI093152-02] Funding Source: Medline; NICHD NIH HHS [R24 HD042854] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI093152] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*DC DEP HLTH, HIV AIDS; Kigozi G, 2009, BJU INT, V104, P1698, DOI 10.1111/j.1464-410X.2009.08683.x; Krieger JN, 2008, J SEX MED, V5, P2610, DOI 10.1111/j.1743-6109.2008.00979.x; Lannon CM, 1999, PEDIATRICS, V103, P686; Leibowitz AA, 2009, AM J PUBLIC HEALTH, V99, P138, DOI 10.2105/AJPH.2008.134403; Sansom SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008723; Tobian AAR, 2010, ARCH PEDIAT ADOL MED, V164, P78, DOI 10.1001/archpediatrics.2009.232; *UNAIDS, SAF VOL INF MAL CIRC; Warner L, 2009, J INFECT DIS, V199, P59, DOI 10.1086/595569; Wawer MJ, 2011, LANCET, V377, P209, DOI 10.1016/S0140-6736(10)61967-8	10	71	71	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 5	2011	306	13					1479	1480		10.1001/jama.2011.1431	http://dx.doi.org/10.1001/jama.2011.1431			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	828MZ	21972310	Green Accepted			2022-12-28	WOS:000295506900027
J	Ziperstein, JC				Ziperstein, Joshua C.			Je Vais le Faire	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Massachusetts Gen Hosp, Dept Internal Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Ziperstein, JC (corresponding author), Massachusetts Gen Hosp, Dept Internal Med, Boston, MA 02114 USA.	jziperstein@partners.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 5	2011	306	13					1418	1419		10.1001/jama.2011.1411	http://dx.doi.org/10.1001/jama.2011.1411			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	828MZ	21972298				2022-12-28	WOS:000295506900001
J	Dagna, L; Salvo, F; Tiraboschi, M; Bozzolo, EP; Franchini, S; Doglioni, C; Manfredi, AA; Baldissera, E; Sabbadini, MG				Dagna, Lorenzo; Salvo, Fulvio; Tiraboschi, Mirta; Bozzolo, Enrica P.; Franchini, Stefano; Doglioni, Claudio; Manfredi, Angelo A.; Baldissera, Elena; Sabbadini, Maria Grazia			Pentraxin-3 as a Marker of Disease Activity in Takayasu Arteritis	ANNALS OF INTERNAL MEDICINE			English	Article							C-REACTIVE PROTEIN; RECOGNITION RECEPTOR PTX3; REGULATES TISSUE FACTOR; AMYLOID-P COMPONENT; LONG PENTRAXIN; CLOTTING ACTIVATION; ENDOTHELIAL-CELLS; DENDRITIC CELLS; INNATE IMMUNITY; IN-VIVO	Background: Because pentraxin-3 (PTX3) is produced by immune and vascular cells in response to proinflammatory signals, it may be a useful biomarker for defining disease activity in patients with Takayasu arteritis. Objective: To compare PTX3 levels in patients who have Takayasu arteritis with those in healthy and infected controls, and to compare accuracy of PTX3 levels with that of C-reactive protein (CRP) levels and erythrocyte sedimentation rate (ESR) for distinguishing active and inactive disease. Design: Cross-sectional, noninterventional study conducted between September 2005 and October 2008. Setting: Immunology and rheumatology clinic at a university hospital in Italy. Patients: 57 consecutive patients with Takayasu arteritis and known disease activity, 57 healthy blood donor controls, and 15 patients with acute infection. Measurements: Disease activity by clinical criteria; plasma PTX3 and CRP levels and ESR. Results: 27 patients had active Takayasu arteritis; 30 had inactive disease. Levels of PTX3 were higher in patients with active disease(median, >2.14 ng/mL [range, 0.57 to 48.18 ng/mL]) than in those with inactive disease (median, 0.63 ng/mL [range, 0.00 to 1.64 ng/mL]) and were higher than in healthy patients (median, 0.11 ng/mL [range, 0 to 1.20 ng/mL]) or those with acute infection (median, 0.26 ng/mL [range, 0 to 0.75 ng/mL]). A plasma PTX3 level greater than 1 ng/mL was more accurate than normal thresholds of CRP or ESR for distinguishing active from inactive disease. Limitation: The study excluded patients with unknown or equivocal disease status. Conclusion: Plasma levels of PTX3 could help distinguish active from inactive Takayasu arteritis but should not be adopted for clinical use until the findings are confirmed in a broader spectrum of patients whose disease activity is unknown or equivocal before testing.	[Dagna, Lorenzo] Ist Sci San Raffaele, Unit Med & Clin Immunol, I-20132 Milan, Italy; Univ Vita Salute San Raffaele, Sch Med, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Dagna, L (corresponding author), Ist Sci San Raffaele, Unit Med & Clin Immunol, Via Olgettina 60, I-20132 Milan, Italy.	lorenzo.dagna@unisr.it	Manfredi, Angelo A./C-7018-2014; Dagna, Lorenzo/AAB-2790-2019; Franchini, Stefano/AAV-8416-2021	Manfredi, Angelo A./0000-0001-8370-6970; DOGLIONI, Claudio/0000-0002-4969-5216; Dagna, Lorenzo/0000-0002-7428-315X				Abderrahim-Ferkoune A, 2003, J LIPID RES, V44, P994, DOI 10.1194/jlr.M200382-JLR200; ALLES VV, 1994, BLOOD, V84, P3483; AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129; Aubert S, 2005, J THORAC CARDIOV SUR, V130, P573, DOI 10.1016/j.jtcvs.2005.02.006; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; Camozzi M, 2005, ARTERIOSCL THROM VAS, V25, P1837, DOI 10.1161/01.ATV.0000177807.54959.7d; Canas CA, 1998, INT J CARDIOL, V66, pS73, DOI 10.1016/S0167-5273(98)00153-3; Deng JS, 2009, CIRC RES, V104, P488, DOI 10.1161/CIRCRESAHA.108.185777; Dhingra R, 2007, AM J MED, V120, P1054, DOI 10.1016/j.amjmed.2007.08.037; Doni A, 2003, EUR J IMMUNOL, V33, P2886, DOI 10.1002/eji.200324390; Fazzini F, 2001, ARTHRITIS RHEUM, V44, P2841, DOI 10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gotway MB, 2005, AM J ROENTGENOL, V184, P1945, DOI 10.2214/ajr.184.6.01841945; Gravanis MB, 2000, INT J CARDIOL, V75, pS21, DOI 10.1016/S0167-5273(00)00184-4; Hoffman GS, 2004, ARTHRITIS RHEUM, V50, P2296, DOI 10.1002/art.20300; Hoffman GS, 1998, INT J CARDIOL, V66, pS191, DOI 10.1016/S0167-5273(98)00181-8; Hoffman GS, 1996, INT J CARDIOL S, V54, pS99; Holley L, 1999, BIORHEOLOGY, V36, P287; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; KAMENEVA MV, 1994, BIORHEOLOGY, V31, P297; KERR GS, 1995, RHEUM DIS CLIN N AM, V21, P1041; KERR GS, 1994, ANN INTERN MED, V120, P919, DOI 10.7326/0003-4819-120-11-199406010-00004; Koga T, 2010, RHEUMATOL INT, V30, P561, DOI 10.1007/s00296-009-1296-6; Koide K, 1992, Heart Vessels Suppl, V7, P48, DOI 10.1007/BF01744544; Legouffe E, 1998, LEUKEMIA LYMPHOMA, V31, P351, DOI 10.3109/10428199809059228; Luchetti MM, 2004, CLIN EXP RHEUMATOL, V22, pS66; Luchetti MM, 2000, CLIN EXP IMMUNOL, V119, P196, DOI 10.1046/j.1365-2249.2000.01110.x; LUPIHERRERA E, 1977, AM HEART J, V93, P94, DOI 10.1016/S0002-8703(77)80178-6; Maksimowicz-McKinnon K, 2007, ARTHRITIS RHEUM, V56, P1000, DOI 10.1002/art.22404; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Mantovani A, 2006, VASC PHARMACOL, V45, P326, DOI 10.1016/j.vph.2006.08.011; Matsuyama A, 2003, CIRCULATION, V108, P1469, DOI 10.1161/01.CIR.0000090689.69973.B1; MORLEY JJ, 1982, ANN NY ACAD SCI, V389, P406, DOI 10.1111/j.1749-6632.1982.tb22153.x; Mwipatayi BP, 2005, ANZ J SURG, V75, P110, DOI 10.1111/j.1445-2197.2005.03312.x; Napoleone E, 2004, J LEUKOCYTE BIOL, V76, P203, DOI 10.1189/jlb.1003528; Napoleone E, 2002, ARTERIOSCL THROM VAS, V22, P782, DOI 10.1161/01.ATV.0000012282.39306.64; Norata GD, 2010, TRENDS CARDIOVAS MED, V20, P35, DOI 10.1016/j.tcm.2010.03.005; Noris M, 1999, CIRCULATION, V100, P55, DOI 10.1161/01.CIR.100.1.55; Nozoe T, 1998, AM J SURG, V176, P335, DOI 10.1016/S0002-9610(98)00204-9; Numano F, 1996, Vasc Med, V1, P227; Numano F, 1999, INTERNAL MED, V38, P226, DOI 10.2169/internalmedicine.38.226; Park MC, 2006, RHEUMATOLOGY, V45, P545, DOI 10.1093/rheumatology/kei266; Park Y B, 1992, Heart Vessels Suppl, V7, P55, DOI 10.1007/BF01744545; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Pipitone N, 2008, RHEUMATOLOGY, V47, P403, DOI 10.1093/rheumatology/kem379; Presta M, 2007, J CELL MOL MED, V11, P723, DOI 10.1111/j.1582-4934.2007.00061.x; Pryshchep O, 2008, CIRCULATION, V118, P1276, DOI 10.1161/CIRCULATIONAHA.108.789172; ROBLES M, 1994, CLIN EXP RHEUMATOL, V12, P381; Rosenthal T, 1992, Heart Vessels Suppl, V7, P44, DOI 10.1007/BF01744543; Rovere P, 2000, BLOOD, V96, P4300; Rusnati M, 2004, BLOOD, V104, P92, DOI 10.1182/blood-2003-10-3433; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Sato EI, 1998, INT J CARDIOL, V66, pS67, DOI 10.1016/S0167-5273(98)00152-1; Savchenko AS, 2008, J PATHOL, V215, P48, DOI 10.1002/path.2314; Sharma BK, 1998, INT J CARDIOL, V66, pS85, DOI 10.1016/S0167-5273(98)00155-7; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Tripathy NK, 2003, J RHEUMATOL, V30, P2023; Tripathy NK, 2004, CLIN EXP RHEUMATOL, V22, pS27; Tripathy NK, 2003, CLIN EXP IMMUNOL, V134, P360, DOI 10.1046/j.1365-2249.2003.02282.x; Tso E, 2002, ARTHRITIS RHEUM-US, V46, P1634, DOI 10.1002/art.10251; Turkoglu C, 1996, INT J CARDIOL, V54, pS135; Vanoli M, 2005, ARTHRIT RHEUM-ARTHR, V53, P100, DOI 10.1002/art.20922; Vergara IA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-265; VouretCraviari V, 1997, INFECT IMMUN, V65, P1345, DOI 10.1128/IAI.65.4.1345-1350.1997	64	109	117	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2011	155	7					425	U51		10.7326/0003-4819-155-7-201110040-00005	http://dx.doi.org/10.7326/0003-4819-155-7-201110040-00005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	833OC	21969341				2022-12-28	WOS:000295893800003
J	Gkikopoulos, T; Schofield, P; Singh, V; Pinskaya, M; Mellor, J; Smolle, M; Workman, JL; Barton, GJ; Owen-Hughes, T				Gkikopoulos, Triantaffyllos; Schofield, Pieta; Singh, Vijender; Pinskaya, Marina; Mellor, Jane; Smolle, Michaela; Workman, Jerry L.; Barton, Geoffrey J.; Owen-Hughes, Tom			A Role for Snf2-Related Nucleosome-Spacing Enzymes in Genome-Wide Nucleosome Organization	SCIENCE			English	Article							CHROMATIN-REMODELING ENZYME; HISTONE-DNA INTERACTIONS; IN-VIVO; SACCHAROMYCES-CEREVISIAE; YEAST ISWI; CHD1; TRANSCRIPTION; IDENTIFICATION; MECHANISMS; POSITIONS	The positioning of nucleosomes within the coding regions of eukaryotic genes is aligned with respect to transcriptional start sites. This organization is likely to influence many genetic processes, requiring access to the underlying DNA. Here, we show that the combined action of Isw1 and Chd1 nucleosome-spacing enzymes is required to maintain this organization. In the absence of these enzymes, regular positioning of the majority of nucleosomes is lost. Exceptions include the region upstream of the promoter, the +1 nucleosome, and a subset of locations distributed throughout coding regions where other factors are likely to be involved. These observations indicate that adenosine triphosphate-dependent remodeling enzymes are responsible for directing the positioning of the majority of nucleosomes within the Saccharomyces cerevisiae genome.	[Gkikopoulos, Triantaffyllos; Schofield, Pieta; Singh, Vijender; Owen-Hughes, Tom] Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Coll Life Sci, Dundee DD1 5EH, Scotland; [Schofield, Pieta; Barton, Geoffrey J.] Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee DD1 5EH, Scotland; [Pinskaya, Marina; Mellor, Jane] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Smolle, Michaela; Workman, Jerry L.] Stowers Inst Med Res, Kansas City, MO 64110 USA	University of Dundee; University of Dundee; University of Oxford; Stowers Institute for Medical Research	Owen-Hughes, T (corresponding author), Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Coll Life Sci, Dundee DD1 5EH, Scotland.	t.a.owenhughes@dundee.ac.uk	Barton, Geoffrey/N-1037-2019; GenePool, The/D-8812-2012; Barton, Geoffrey J/C-6267-2011; Schofield, Pieta/Q-4847-2019	Barton, Geoffrey/0000-0002-9014-5355; Schofield, Pieta/0000-0002-6398-2537; Owen-Hughes, Tom/0000-0002-0618-8185; Smolle, Michaela/0000-0001-8900-1541; Pinskaya, Marina/0000-0003-1992-0264	Wellcome Trust [064414]; Stowers Institute; MRC [G0900740] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047867] Funding Source: NIH RePORTER; Medical Research Council [G0900740] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Stowers Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Sequence data were generated at the Genepool Facility at the University of Edinburgh and Genotypic Technology Ltd, Bangalore. T. G., V. S., and T.O.H. were supported by Wellcome Trust Senior Fellowship 064414. M. S. and J.L.W. were supported by the Stowers Institute. We thank A. Nair for useful advice and sending strains, and J. Allan and members of the T.O.H. laboratory and Welcome Trust Centre for Gene Regulation and Expression for useful discussions. Sequence and microarray data sets are accessible at the National Center for Biotechnology Information Gene Expresssion Omnibus repository (www.ncbi.nlm.nih.gov/geo) under accession numbers GSE31015, GSE31301, and GSE31833.	Biswas D, 2007, MOL CELL BIOL, V27, P6279, DOI 10.1128/MCB.00978-07; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Fraser RM, 2006, J MOL BIOL, V364, P582, DOI 10.1016/j.jmb.2006.08.092; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Kent NA, 2001, GENE DEV, V15, P619, DOI 10.1101/gad.190301; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Quan TK, 2010, GENETICS, V184, P321, DOI 10.1534/genetics.109.111526; Robinson KM, 2003, MOL CELL BIOL, V23, P7937, DOI 10.1128/MCB.23.22.7937-7946.2003; Ryan DP, 2011, EMBO J, V30, P2596, DOI 10.1038/emboj.2011.166; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; SIMPSON RT, 1990, NATURE, V343, P387, DOI 10.1038/343387a0; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Tirosh I, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r49; Travers A, 2010, J BIOMOL STRUCT DYN, V27, P713, DOI 10.1080/073911010010524942; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wippo CJ, 2011, EMBO J, V30, P1277, DOI 10.1038/emboj.2011.43; Xella B, 2006, MOL MICROBIOL, V59, P1531, DOI 10.1111/j.1365-2958.2005.05031.x; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508; Zhang ZH, 2011, CELL, V144, P175, DOI 10.1016/j.cell.2011.01.003	30	197	199	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1758	1760		10.1126/science.1206097	http://dx.doi.org/10.1126/science.1206097			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940898	Green Accepted			2022-12-28	WOS:000295121500046
J	Dymond, JS; Richardson, SM; Coombes, CE; Babatz, T; Muller, H; Annaluru, N; Blake, WJ; Schwerzmann, JW; Dai, JB; Lindstrom, DL; Boeke, AC; Gottschling, DE; Chandrasegaran, S; Bader, JS; Boeke, JD				Dymond, Jessica S.; Richardson, Sarah M.; Coombes, Candice E.; Babatz, Timothy; Muller, Heloise; Annaluru, Narayana; Blake, William J.; Schwerzmann, Joy W.; Dai, Junbiao; Lindstrom, Derek L.; Boeke, Annabel C.; Gottschling, Daniel E.; Chandrasegaran, Srinivasan; Bader, Joel S.; Boeke, Jef D.			Synthetic chromosome arms function in yeast and generate phenotypic diversity by design	NATURE			English	Article							DNA; SELECTION; SEQUENCE; GENES; SITE	Recent advances in DNA synthesis technology have enabled the construction of novel genetic pathways and genomic elements, furthering our understanding of system-level phenomena(1-7). The ability to synthesize large segments of DNA allows the engineering of pathways and genomes according to arbitrary sets of design principles. Here we describe a synthetic yeast genome project, Sc2.0, and the first partially synthetic eukaryotic chromosomes, Saccharomyces cerevisiae chromosome synIXR, and semi-synVIL. We defined three design principles for a synthetic genome as follows: first, it should result in a (near) wild-type phenotype and fitness; second, it should lack destabilizing elements such as tRNA genes or transposons(8,9); and third, it should have genetic flexibility to facilitate future studies. The synthetic genome features several systemic modifications complying with the design principles, including an inducible evolution system, SCRaMbLE (synthetic chromosome rearrangement and modification by loxP-mediated evolution). We show the utility of SCRaMbLE as a novel method of combinatorial mutagenesis, capable of generating complex genotypes and a broad variety of phenotypes. When complete, the fully synthetic genome will allow massive restructuring of the yeast genome, and may open the door to a new type of combinatorial genetics based entirely on variations in gene content and copy number.	[Dymond, Jessica S.; Richardson, Sarah M.; Coombes, Candice E.; Babatz, Timothy; Dai, Junbiao; Boeke, Annabel C.; Bader, Joel S.; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Dymond, Jessica S.; Coombes, Candice E.; Dai, Junbiao; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Richardson, Sarah M.; Babatz, Timothy] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Muller, Heloise; Annaluru, Narayana; Schwerzmann, Joy W.; Chandrasegaran, Srinivasan] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Blake, William J.] Codon Devices, Cambridge, MA 02139 USA; [Lindstrom, Derek L.; Gottschling, Daniel E.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Bader, Joel S.] Johns Hopkins Univ, Dept Biomed Engn, Whiting Sch Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Fred Hutchinson Cancer Center; Johns Hopkins University	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, 733 North Broadway, Baltimore, MD 21205 USA.	jboeke@jhmi.edu	Dai, Junbiao/AAB-8328-2021; Bader, Joel/A-1818-2009	Dai, Junbiao/0000-0002-5299-4700; Bader, Joel/0000-0002-6020-4625; Richardson, Sarah/0000-0002-9820-9421; Boeke, Jef/0000-0001-5322-4946	National Science Foundation [MCB0718846]; Microsoft; Department of Energy [DE-FG02097ER25308]; National Institutes of Health [AG023779]; Fondation pour la Recherche Medicale; NATIONAL INSTITUTE ON AGING [R01AG023779, R37AG023779] Funding Source: NIH RePORTER; Direct For Biological Sciences [1443299] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Microsoft(Microsoft); Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank G. Church for suggesting the global substitution of TAG codons with TAA codons, C. Connelly for sharing technical expertise and V. Huang for generating a sequence visualizer. We are grateful to B. Cormack, G. Seydoux and J. Nathans for offering helpful advice, to Y. Cai and J. Peccoud for suggesting methods to validate the sequence data, and to E. Louis for providing expert advice on telomeres. The work was supported by National Science Foundation grant MCB0718846 to J. D. B., J. S. B. and S. C.; by a grant from Microsoft to J. S. B. and J. D. B.; by Department of Energy Fellowship DE-FG02097ER25308 to S. M. R.; by National Institutes of Health grant AG023779 to D. E. G.; and by a fellowship from Fondation pour la Recherche Medicale to H.M.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Admire A, 2006, GENE DEV, V20, P159, DOI 10.1101/gad.1392506; Blake WJ, 2010, NUCLEIC ACIDS RES, V38, P2594, DOI 10.1093/nar/gkq123; BOEKE JD, 1985, CELL, V40, P491, DOI 10.1016/0092-8674(85)90197-7; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Churcher C, 1997, NATURE, V387, P84, DOI 10.1038/387s084; Dymond JS, 2009, GENETICS, V181, P13, DOI 10.1534/genetics.108.096784; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; Han JS, 2004, NATURE, V429, P314, DOI 10.1038/nature02535; HOESS RH, 1986, NUCLEIC ACIDS RES, V14, P2287, DOI 10.1093/nar/14.5.2287; Hoffman C. S., 2001, CURR PROTOC MOL BIOL; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; JI H, 1993, CELL, V73, P1007, DOI 10.1016/0092-8674(93)90278-X; Kuras L, 1996, EMBO J, V15, P2519, DOI 10.1002/j.1460-2075.1996.tb00609.x; Lartigue C, 2009, SCIENCE, V325, P1693, DOI 10.1126/science.1173759; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Lindstrom DL, 2009, GENETICS, V183, P413, DOI 10.1534/genetics.109.106229; Louis EJ, 1995, YEAST, V11, P1553, DOI 10.1002/yea.320111604; OGAWA H, 1978, J BIOL CHEM, V253, P3666; Parenteau J, 2008, MOL BIOL CELL, V19, P1932, DOI 10.1091/mbc.E07-12-1254; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; Percudani R, 1997, J MOL BIOL, V268, P322, DOI 10.1006/jmbi.1997.0942; Richardson SM, 2006, GENOME RES, V16, P550, DOI 10.1101/gr.4431306; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4006; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; VOLLRATH D, 1988, P NATL ACAD SCI USA, V85, P6027, DOI 10.1073/pnas.85.16.6027	29	278	323	10	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2011	477	7365					471	U124		10.1038/nature10403	http://dx.doi.org/10.1038/nature10403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21918511	Green Accepted			2022-12-28	WOS:000295080500042
J	Lombard, DB; Pletcher, SD				Lombard, David B.; Pletcher, Scott D.			Longevity hits a roadblock	NATURE			English	Editorial Material									[Lombard, David B.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Lombard, David B.; Pletcher, Scott D.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; [Pletcher, Scott D.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lombard, DB (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	davidlom@umich.edu; spletch@umich.edu		Auwerx, Johan/0000-0002-5065-5393; Lombard, David/0000-0002-4292-0185	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101171] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM101171] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	39	44	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2011	477	7365					410	410		10.1038/477410a	http://dx.doi.org/10.1038/477410a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21938058				2022-12-28	WOS:000295080500024
J	Mohrenschlager, M; Arbogast, HP; Henkel, V				Moehrenschlager, Matthias; Arbogast, Helmut P.; Henkel, Verena			CASE REPORT An umbilical nodule with cyclical changes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ABDOMINAL-WALL; PELVIC PAIN; ENDOMETRIOSIS; TUMORS; DEPRESSION		[Moehrenschlager, Matthias] Hochgebirgsklin Davos Wolfgang, Dept Dermatol & Allergol, Davos, Switzerland; [Arbogast, Helmut P.] Univ Munich, Dept Surg, Grosshadern Med Ctr, Munich, Germany; [Henkel, Verena] Univ Munich, Dept Psychiat, D-8000 Munich, Germany	University of Munich; University of Munich	Mohrenschlager, M (corresponding author), Hochgebirgsklin Davos Wolfgang, Dept Dermatol & Allergol, Davos, Switzerland.	matthias.moehrenschlager@hgk.ch						Agarwal A, 2008, SINGAP MED J, V49, P704; AMATO M, 1984, J COMPUT ASSIST TOMO, V8, P1213, DOI 10.1097/00004728-198412000-00040; Bagade Pallavi V, 2009, J Med Case Rep, V3, P9326, DOI 10.1186/1752-1947-3-9326; Chatzikokkinou P, 2009, ACTA DERMATOVEN ALP, V18, P126; Chene G, 2007, INT J GYNECOL CANCER, V17, p709A, DOI 10.1111/j.1525-1438.2007.00822.x; DADWHAL V, 2010, ARCH GYNECOL OBSTE S, V283, P119; De Giorgi V, 2003, CLIN EXP DERMATOL, V28, P315, DOI 10.1046/j.1365-2230.2003.01194.x; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Henkel V, 2003, BRIT MED J, V326, P200, DOI 10.1136/bmj.326.7382.200; Ilica AT, 2007, EMERG RADIOL, V13, P333, DOI 10.1007/s10140-006-0560-2; Jackson B, 2006, CAN FAM PHYSICIAN, V52, P1420; Khaled A, 2008, PATHOLOGICA, V100, P473; Lalor PF, 2005, GYNECOL ONCOL, V97, P719, DOI 10.1016/j.ygyno.2005.01.050; Lee Arnold, 2008, Dermatol Online J, V14, P23; Lorencatto C, 2006, ACTA OBSTET GYN SCAN, V85, P88, DOI 10.1080/00016340500456118; Mechsner S, 2009, ARCH GYNECOL OBSTET, V280, P235, DOI 10.1007/s00404-008-0900-4; MICHOWITZ M, 1983, DERMATOLOGICA, V167, P326, DOI 10.1159/000249810; Nirula R, 2000, J AM COLL SURGEONS, V190, P404, DOI 10.1016/S1072-7515(99)00286-0; PURVIS RS, 1994, J DERMATOL SURG ONC, V20, P693, DOI 10.1111/j.1524-4725.1994.tb00456.x; SHETTY MR, 1990, J SURG ONCOL, V45, P212, DOI 10.1002/jso.2930450316; Sidani M S, 2002, Clin Exp Obstet Gynecol, V29, P40; SINGH KK, 1995, BRIT J SURG, V82, P1349, DOI 10.1002/bjs.1800821017; Socolov R, 2011, EUR J OBSTET GYN R B, V154, P215, DOI 10.1016/j.ejogrb.2010.10.008; Spaziani E, 2009, CLIN EXP OBSTET GYN, V36, P263; STECK WD, 1965, CANCER, V18, P907, DOI 10.1002/1097-0142(196507)18:7<907::AID-CNCR2820180721>3.0.CO;2-U; Van Gorp T, 2004, BEST PRACT RES CL OB, V18, P349, DOI 10.1016/j.bpobgyn.2003.03.001; Victory R, 2007, J MINIM INVAS GYN, V14, P23, DOI 10.1016/j.jmig.2006.07.014; WALLER KG, 1995, FERTIL STERIL, V63, P796, DOI 10.1016/S0015-0282(16)57484-6; World Health Organization, 1998, INF PACK MAST DEPR P	29	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	2011	343								d5855	10.1136/bmj.d5855	http://dx.doi.org/10.1136/bmj.d5855			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	826AJ	21940744	Green Submitted			2022-12-28	WOS:000295323400003
J	Cameron, ID; Aggar, C; Robinson, AL; Kurrle, SE				Cameron, I. D.; Aggar, C.; Robinson, A. L.; Kurrle, S. E.			Assessing and helping carers of older people	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CAREGIVERS; INTERVENTIONS; DEMENTIA; BURDEN; PRACTITIONERS; METAANALYSIS; COMMUNITY; RESPITE		[Cameron, I. D.] Univ Sydney, Fac Med, Rehabil Studies Unit, Ryde, NSW 1680, Australia; [Aggar, C.] Univ Sydney, Sydney Nursing Sch, Ryde, NSW 1680, Australia; [Robinson, A. L.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Kurrle, S. E.] Hornsby Ku Ring Gai Hlth Serv, Curran Ageing Res Unit, Hornsby, NSW, Australia	University of Sydney; University of Sydney; Newcastle University - UK	Cameron, ID (corresponding author), Univ Sydney, Fac Med, Rehabil Studies Unit, Ryde, NSW 1680, Australia.	ian.cameron@sydney.edu.au	Aggar, Christina/ABD-7762-2021	Aggar, Christina/0000-0002-0137-7796; Robinson, Louise/0000-0003-0209-2503	Australian National Health and Medical Research Council [402791, 1002488]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Preparation of the paper was supported by an Australian National Health and Medical Research Council Health Services Research Grant ID 402791. CA's salary is funded by a scholarship from the above grant, and IDC's salary is supported by an Australian National Health and Medical Research Council Practitioner Fellowship (ID 1002488).	*AM MED ASS, CAR SELF ASS QUEST A; Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652; Bertrand RM, 2006, J AGING HEALTH, V18, P534, DOI 10.1177/0898264306289620; *BMA, 2009, WORK CAR GUID GOOD P; Brodaty H, 2003, J AM GERIATR SOC, V51, P657, DOI 10.1034/j.1600-0579.2003.00210.x; CAMERON M, 2008, RES BASED RECOMMENDA; Chappell NL, 2008, CAN J AGING, V27, P169, DOI 10.3138/cja.27.2.169; Deeken JF, 2003, J PAIN SYMPTOM MANAG, V26, P922, DOI 10.1016/S0885-3924(03)00327-0; *DEP HLTH, 2011, CAR; Eagar K., 2007, 27 CHSD; *FAM CAR ALL, 2006, CAR COUNT TOO TOOL K; *FAM CAR ALL, 2002, SEL CAR ASS MEAS RES; Family Caregiver Alliance, 2006, NAT CONS DEV C SAN F, VI; Greenwood N, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-100; Guberman N, 2003, HEALTH SOC CARE COMM, V11, P345, DOI 10.1046/j.1365-2524.2003.00434.x; Higginson IJ, 2010, J CLIN EPIDEMIOL, V63, P535, DOI 10.1016/j.jclinepi.2009.06.014; Horner B, 2008, AUST HEALTH REV, V32, P356, DOI 10.1071/AH080356; *I MED SOC, 2006, EUR; Lam LCW, 2010, INT J GERIATR PSYCH, V25, P395, DOI 10.1002/gps.2352; LEE H, 2004, COCHRANE DB SYST REV, V2; Lee JH, 2007, WESTERN J NURS RES, V29, P344, DOI 10.1177/0193945906296564; Liu K, 2000, J GERONTOL B-PSYCHOL, V55, pS245, DOI 10.1093/geronb/55.4.S245; Long Sharon K, 2005, J Aging Soc Policy, V17, P19; Mason A, 2007, J AM GERIATR SOC, V55, P290, DOI 10.1111/j.1532-5415.2006.01037.x; *NAT COLL CTR MENT, 2011, NICE SCIE GUID SUPP; OYEBODE J, 2003, ADV PSYCHIAT TREATME, V9, P45; Parker D, 2008, INT J EVID-BASED HEA, V6, P137, DOI 10.1111/j.1479-6988.2008.00090.x; Pimouguet C, 2010, J NUTR HEALTH AGING, V14, P669, DOI 10.1007/s12603-010-0314-4; Pinquart M, 2006, INT PSYCHOGERIATR, V18, P577, DOI 10.1017/S1041610206003462; *PRINC ROYAL TRUST, SUPP CAR ACT GUID GE; Schulz R, 2005, PSYCHIAT CLIN N AM, V28, P1007, DOI 10.1016/j.psc.2005.09.003; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Shaw C, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13200; Specht J, 2009, AM J ALZHEIMERS DIS, V24, P193, DOI 10.1177/1533317508330466; Sussman T, 2009, J GERONTOL SOC WORK, V52, P406, DOI 10.1080/01634370802609205; Zarit SH, 2010, AGING MENT HEALTH, V14, P220, DOI 10.1080/13607860903167861; ZARIT BURDEN INTERVI	37	17	17	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2011	343								d5202	10.1136/bmj.d5202	http://dx.doi.org/10.1136/bmj.d5202			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	826AE	21930805				2022-12-28	WOS:000295322900002
J	Fu, YV; Yardimci, H; Long, DT; Ho, TV; Guainazzi, A; Bermudez, VP; Hurwitz, J; van Oijen, A; Scharer, OD; Walter, JC				Fu, Yu V.; Yardimci, Hasan; Long, David T.; The Vinh Ho; Guainazzi, Angelo; Bermudez, Vladimir P.; Hurwitz, Jerard; van Oijen, Antoine; Schaerer, Orlando D.; Walter, Johannes C.			Selective Bypass of a Lagging Strand Roadblock by the Eukaryotic Replicative DNA Helicase	CELL			English	Article							MCM2-7 HELICASE; STRUCTURAL BASIS; INITIATION; MECHANISM; COMPLEX; ORIGIN; CDC45; PROTEIN; GINS; ASSOCIATION	The eukaryotic replicative DNA helicase, CMG, unwinds DNA by an unknown mechanism. In some models, CMG encircles and translocates along one strand of DNA while excluding the other strand. In others, CMG encircles and translocates along duplex DNA. To distinguish between these models, replisomes were confronted with strand-specific DNA roadblocks in Xenopus egg extracts. An ssDNA translocase should stall at an obstruction on the translocation strand but not the excluded strand, whereas a dsDNA translocase should stall at obstructions on either strand. We found that replisomes bypass large roadblocks on the lagging strand template much more readily than on the leading strand template. Our results indicate that CMG is a 3' to 5' ssDNA translocase, consistent with unwinding via "steric exclusion." Given that MCM2-7 encircles dsDNA in G1, the data imply that formation of CMG in S phase involves remodeling of MCM2-7 from a dsDNA to a ssDNA binding mode.	[Fu, Yu V.; Yardimci, Hasan; Long, David T.; van Oijen, Antoine; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [The Vinh Ho; Guainazzi, Angelo; Schaerer, Orlando D.] SUNY Stony Brook, Dept Pharmacol Sci & Chem, Stony Brook, NY 11794 USA; [Bermudez, Vladimir P.; Hurwitz, Jerard] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Harvard University; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Memorial Sloan Kettering Cancer Center	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu	Scharer, Orlando/B-8908-2008; van Oijen, Antoine/I-3167-2014; Schärer, Orlando D./AAF-8613-2021; Classen, Scott/AAY-8176-2020; FU, YU Vincent/AAX-4936-2021	Scharer, Orlando/0000-0003-2425-2715; van Oijen, Antoine/0000-0002-1794-5161; FU, YU Vincent/0000-0001-8251-2306; Long, David/0000-0001-9232-0316; Yardimci, Hasan/0000-0001-5009-1391; Walter, Johannes/0000-0002-4186-7570	National Institutes of Health (NIH) [GM62267, GM08454, CA092584, GM034559]; Leukemia and Lymphoma Scholar Award; American Cancer Society [RSG-08-234-01-GMC, PF-10-146-01-DMC, RSG-08-234-01]; Human Frontier Science Program [LT000307/2009]; New York State Office of Science and Technology and Academic Research NYSTAR [C040069]; Searle Scholarship [05-L-104]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034559, R01GM034559, R01GM062267] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Scholar Award(Leukemia and Lymphoma Society); American Cancer Society(American Cancer Society); Human Frontier Science Program(Human Frontier Science Program); New York State Office of Science and Technology and Academic Research NYSTAR; Searle Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Milica Enoiu for the gift of pICL<SUP>Intra</SUP>, Anna Loveland, Puck Knipscheer, and Tatsuro Takahashi for helpful discussions, and the members of our laboratory for valuable feedback on the manuscript. J.C.W was supported by National Institutes of Health (NIH) grant GM62267, by a Leukemia and Lymphoma Scholar Award, and by the American Cancer Society grant RSG-08-234-01-GMC. Y.V.F. was supported by a Human Frontier Science Program Long-Term Fellowship (LT000307/2009). D.T.L was supported by a postdoctoral fellowship (PF-10-146-01-DMC) from the American Cancer Society. O.D.S. was supported by grants from the New York State Office of Science and Technology and Academic Research NYSTAR (C040069) and the NIH (GM08454 and CA092584). A.M.v.O. acknowledges support from the American Cancer Society grant RSG-08-234-01 and Searle Scholarship 05-L-104. J.H. was supported by NIH grant GM034559 and American Cancer Society grant RSG-08-234-01-GMC.	Angelov T, 2009, ORG LETT, V11, P661, DOI 10.1021/ol802719a; Arias EE, 2004, FRONT BIOSCI-LANDMRK, V9, P3029, DOI 10.2741/1457; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Brewster AS, 2008, P NATL ACAD SCI USA, V105, P20191, DOI 10.1073/pnas.0808037105; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2011, J BIOL CHEM, V286, P11855, DOI 10.1074/jbc.M110.199521; Geraghty DS, 2000, J BIOL CHEM, V275, P18011, DOI 10.1074/jbc.M909787199; Guainazzi A, 2010, CHEM-EUR J, V16, P12100, DOI 10.1002/chem.201002041; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Kanter DM, 2011, NUCLEIC ACIDS RES, V39, P2580, DOI 10.1093/nar/gkq1222; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kochaniak AB, 2009, J BIOL CHEM, V284, P17700, DOI 10.1074/jbc.M109.008706; Kuhn H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn107; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Lucas I, 2000, J MOL BIOL, V296, P769, DOI 10.1006/jmbi.2000.3500; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Pape T, 2003, EMBO REP, V4, P1079, DOI 10.1038/sj.embor.7400010; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Shechter DF, 2000, J BIOL CHEM, V275, P15049, DOI 10.1074/jbc.M000398200; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Takahashi TS, 2005, GENE DEV, V19, P2295, DOI 10.1101/gad.1339805; Tremeau-Bravard A, 2004, J BIOL CHEM, V279, P7751, DOI 10.1074/jbc.M309853200; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; van Oijen AM, 2007, BIOPOLYMERS, V85, P144, DOI 10.1002/bip.20624; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Warren EM, 2008, STRUCTURE, V16, P1892, DOI 10.1016/j.str.2008.10.005; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Yardimci H, 2010, MOL CELL, V40, P834, DOI 10.1016/j.molcel.2010.11.027	48	259	265	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2011	146	6					930	940		10.1016/j.cell.2011.07.045	http://dx.doi.org/10.1016/j.cell.2011.07.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925316	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000295258100015
J	Purcell, CW; Bullock, JS; Tollerud, EJ; Rocha, M; Chakrabarti, S				Purcell, Chris W.; Bullock, James S.; Tollerud, Erik J.; Rocha, Miguel; Chakrabarti, Sukanya			The Sagittarius impact as an architect of spirality and outer rings in the Milky Way	NATURE			English	Article							SKY SURVEY VIEW; DWARF GALAXY; SUBSTRUCTURE; STARS	Like many galaxies of its size, the Milky Way is a disk with prominent spiral arms rooted in a central bar(1), although our knowledge of its structure and origin is incomplete. Traditional attempts to understand our Galaxy's morphology assume that it has been unperturbed by major external forces. Here we report simulations of the response of the Milky Way to the infall of the Sagittarius(2) dwarf galaxy (Sgr), which results in the formation of spiral arms, influences the central bar and produces a flared outer disk. Two ring-like wrappings emerge towards the Galactic anti-Centre in our model that are reminiscent of the low-latitude arcs observed in the same area of the Milky Way. Previous models have focused on Sgr itself(3,4) to reproduce the dwarf's orbital history and place associated constraints on the shape of the Milky Way gravitational potential, treating the Sgr impact event as a trivial influence on the Galactic disk. Our results show that the Milky Way's morphology is not purely secular in origin and that low-mass minor mergers predicted to be common throughout the Universe(5) probably have a similarly important role in shaping galactic structure.	[Purcell, Chris W.] Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA; [Purcell, Chris W.; Bullock, James S.; Tollerud, Erik J.; Rocha, Miguel] Univ Calif Irvine, Dept Phys & Astron, Ctr Cosmol, Irvine, CA 92697 USA; [Chakrabarti, Sukanya] Florida Atlantic Univ, Dept Phys, Boca Raton, FL 33431 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Irvine; State University System of Florida; Florida Atlantic University	Purcell, CW (corresponding author), Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA.	cpurcell@pitt.edu	Bullock, James/K-1928-2015	Bullock, James/0000-0003-4298-5082; Tollerud, Erik/0000-0002-9599-310X	Direct For Mathematical & Physical Scien [1009973] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Behroozi PS, 2010, ASTROPHYS J, V717, P379, DOI 10.1088/0004-637X/717/1/379; Bissantz N, 2002, MON NOT R ASTRON SOC, V330, P591, DOI 10.1046/j.1365-8711.2002.05116.x; Conroy C, 2009, ASTROPHYS J, V696, P620, DOI 10.1088/0004-637X/696/1/620; Correnti M, 2010, ASTROPHYS J, V721, P329, DOI 10.1088/0004-637X/721/1/329; Dinescu DI, 2005, ASTROPHYS J, V618, pL25, DOI 10.1086/427731; Grillmair CJ, 2006, ASTROPHYS J, V651, pL29, DOI 10.1086/509255; IBATA RA, 1994, NATURE, V370, P194, DOI 10.1038/370194a0; Ibata RA, 2003, MON NOT R ASTRON SOC, V340, pL21, DOI 10.1046/j.1365-8711.2003.06545.x; JOHNSTON KV, 1995, ASTROPHYS J, V451, P598, DOI 10.1086/176247; Kazantzidis S, 2008, ASTROPHYS J, V688, P254, DOI 10.1086/591958; Keselman JA, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.063517; KING IR, 1971, PUBL ASTRON SOC PAC, V83, P199, DOI 10.1086/129100; Kunder A, 2009, ASTRON J, V137, P4478, DOI 10.1088/0004-6256/137/5/4478; Law DR, 2010, ASTROPHYS J, V714, P229, DOI 10.1088/0004-637X/714/1/229; Law DR, 2005, ASTROPHYS J, V619, P807, DOI 10.1086/426779; Levine ES, 2006, SCIENCE, V312, P1773, DOI 10.1126/science.1128455; Lokas EL, 2010, ASTROPHYS J, V725, P1516, DOI 10.1088/0004-637X/725/2/1516; Majewski SR, 2004, ASTRON J, V128, P245, DOI 10.1086/421372; Majewski SR, 2003, ASTROPHYS J, V599, P1082, DOI 10.1086/379504; Momany Y, 2006, ASTRON ASTROPHYS, V451, P515, DOI 10.1051/0004-6361:20054081; Navarro JF, 1996, ASTROPHYS J, V462, P563, DOI 10.1086/177173; Niederste-Ostholt M, 2010, ASTROPHYS J, V712, P516, DOI 10.1088/0004-637X/712/1/516; Nordstrom B, 2004, ASTRON ASTROPHYS, V418, P989, DOI 10.1051/0004-6361:20035959; Penarrubia J, 2005, ASTROPHYS J, V626, P128, DOI 10.1086/429903; Pohl M, 2008, ASTROPHYS J, V677, P283, DOI 10.1086/529004; Reid MJ, 2009, ASTROPHYS J, V700, P137, DOI 10.1088/0004-637X/700/1/137; Sellwood JA, 2011, MON NOT R ASTRON SOC, V410, P1637, DOI 10.1111/j.1365-2966.2010.17545.x; Struck C, 2011, MON NOT R ASTRON SOC, V414, P2498, DOI 10.1111/j.1365-2966.2011.18568.x; Widrow LM, 2008, ASTROPHYS J, V679, P1239, DOI 10.1086/587636; Zemp M, 2008, MON NOT R ASTRON SOC, V386, P1543, DOI 10.1111/j.1365-2966.2008.13126.x	30	179	179	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2011	477	7364					301	303		10.1038/nature10417	http://dx.doi.org/10.1038/nature10417			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21921911	Green Submitted			2022-12-28	WOS:000294852400024
J	Spence, D				Spence, Des			FROM THE FRONTLINE Herd mentality	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						2009, BRIT MED J, V339, pB2587, DOI DOI 10.1136/BMJ.B2587	1	2	2	0	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2011	343								d5820	10.1136/bmj.d5820	http://dx.doi.org/10.1136/bmj.d5820			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822VM	21917844				2022-12-28	WOS:000295078100012
J	Thorpe, LE; Friedman, S				Thorpe, Lorna E.; Friedman, Stephen			Health Consequences of the World Trade Center Disaster A 10th Anniversary Perspective	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RESCUE WORKERS; SYMPTOMS; DISEASE		[Thorpe, Lorna E.] CUNY Sch Publ Hlth, New York, NY 10035 USA; [Friedman, Stephen] New York City Dept Hlth & Mental Hyg, New York, NY USA	City University of New York (CUNY) System; New York City Department of Health & Mental Hygiene	Thorpe, LE (corresponding author), CUNY Sch Publ Hlth, 2180 3rd Ave,Room 537, New York, NY 10035 USA.	lthor@hunter.cuny.edu			NIOSH CDC HHS [U50 OH009739] Funding Source: Medline; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U50OH009739] Funding Source: NIH RePORTER; ALLCDC [5U50OH009739-07, 5U50OH009739-05] Funding Source: Federal RePORTER	NIOSH CDC HHS; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); ALLCDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)		Aldrich TK, 2010, NEW ENGL J MED, V362, P1263, DOI 10.1056/NEJMoa0910087; Brackbill RM, 2009, JAMA-J AM MED ASSOC, V302, P502, DOI 10.1001/jama.2009.1121; Friedman S, 2008, CLIN GUIDELINES ADUL; FRIEDMAN SM, AM J RESP CRIT CARE; Herbert R, 2006, ENVIRON HEALTH PERSP, V114, P1853, DOI 10.1289/ehp.9592; Izbicki G, 2007, CHEST, V131, P1414, DOI 10.1378/chest.06-2114; Lin S, 2007, J ASTHMA, V44, P325, DOI 10.1080/02770900701344181; Stellman JM, 2008, ENVIRON HEALTH PERSP, V116, P1248, DOI 10.1289/ehp.11164; Webber MP, 2009, ENVIRON HEALTH PERSP, V117, P975, DOI 10.1289/ehp.0800291; Weiden MD, 2010, CHEST, V137, P566, DOI 10.1378/chest.09-1580	10	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2011	306	10					1133	1134		10.1001/jama.2011.1289	http://dx.doi.org/10.1001/jama.2011.1289			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819DS	21903819				2022-12-28	WOS:000294806200029
J	Carthey, J; Walker, S; Deelchand, V; Vincent, C; Griffiths, WH				Carthey, Jane; Walker, Susannah; Deelchand, Vashist; Vincent, Charles; Griffiths, William Harrop			Breaking the rules: understanding non-compliance with policies and guidelines	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VIOLATIONS		[Carthey, Jane; Walker, Susannah; Deelchand, Vashist; Vincent, Charles] Univ London Imperial Coll Sci Technol & Med, Dept Biosurg & Technol, London, England; [Griffiths, William Harrop] Imperial Coll Healthcare NHS Trust, Dept Anaesthesia, London, England	Imperial College London; Imperial College London	Carthey, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biosurg & Technol, London, England.	jcarthey_gosh@yahoo.com	Vincent, Charles A/D-1134-2010	Vincent, Charles A/0000-0003-0270-0222	National Institute of Health Research; Health Foundation	National Institute of Health Research(National Institute for Health Research (NIHR)); Health Foundation	The Imperial Centre for Patient Safety and Service Quality is funded by the National Institute of Health Research. We thank staff from the orthopaedic department at Imperial College Hospitals NHS Trust and NHS Lothian for their help.; All authors have completed the ICJME unified declaration form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare the Imperial Centre for Patient Safety and Service Quality is funded by the National Institute of Health Research. CV has received funding from The Health Foundation and receives royalties from his book on patient safety.	Amalberti R, 2006, QUAL SAF HEALTH CARE, V15, pI66, DOI 10.1136/qshc.2005.015982; Amalberti R, 2005, ANN INTERN MED, V142, P756, DOI 10.7326/0003-4819-142-9-200505030-00012; Glasziou Paul, 2005, ACP J Club, V142, pA8; HM Government, 2010, WORK TOG SAF CHILDR; Lawton R, 1998, SAFETY SCI, V28, P77, DOI 10.1016/S0925-7535(97)00073-8; National Institute for Health and Clinical Excellence, 2002, GUID US ULTR LOC DEV; *NIH CLIN EXC, 2009, CG81 NIH CLIN EXC NA; *NIH CLIN EXC, 2008, CG63 NIH CLIN EXC NA; PARTON N, 1974, INCREASING LENGTH CO; Reason J, 1998, J OCCUP ORGAN PSYCH, V71, P289, DOI 10.1111/j.2044-8325.1998.tb00678.x; Toft B., 2001, EXTERNAL INQUIRY ADV	11	75	75	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2011	343								d5283	10.1136/bmj.d5283	http://dx.doi.org/10.1136/bmj.d5283			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822VI	21914756	Green Submitted			2022-12-28	WOS:000295077500010
J	Emery, EC; Young, GT; Berrocoso, EM; Chen, LB; McNaughton, PA				Emery, Edward C.; Young, Gareth T.; Berrocoso, Esther M.; Chen, Lubin; McNaughton, Peter A.			HCN2 Ion Channels Play a Central Role in Inflammatory and Neuropathic Pain	SCIENCE			English	Article							RESISTANT SODIUM-CHANNEL; ACTIVATED PACEMAKER CHANNELS; GATED CATION CHANNELS; CURRENT I-H; MECHANICAL ALLODYNIA; MICE LACKING; EXPRESSION; HYPERALGESIA; INHIBITION; RESPONSES	The rate of action potential firing in nociceptors is a major determinant of the intensity of pain. Possible modulators of action potential firing include the HCN ion channels, which generate an inward current, I-h, after hyperpolarization of the membrane. We found that genetic deletion of HCN2 removed the cyclic adenosine monophosphate (cAMP)-sensitive component of Ih and abolished action potential firing caused by an elevation of cAMP in nociceptors. Mice in which HCN2 was specifically deleted in nociceptors expressing Na(V)1.8 had normal pain thresholds, but inflammation did not cause hyperalgesia to heat stimuli. After a nerve lesion, these mice showed no neuropathic pain in response to thermal or mechanical stimuli. Neuropathic pain is therefore initiated by HCN2-driven action potential firing in Na(V)1.8-expressing nociceptors.	[Emery, Edward C.; Young, Gareth T.; Berrocoso, Esther M.; Chen, Lubin; McNaughton, Peter A.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Berrocoso, Esther M.] Univ Cadiz, Dept Neurosci, Ctr Invest Biomed Red Salud Mental CIBERSAM, Sch Med, Cadiz 11003, Spain	University of Cambridge; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Universidad de Cadiz	McNaughton, PA (corresponding author), Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England.	pam42@cam.ac.uk	Berrocoso, Esther/H-9958-2015	Berrocoso, Esther/0000-0003-0208-7472; McNaughton, Peter/0000-0003-1946-9610; Emery, Edward/0000-0001-9723-8661	UK Biotechnology and Biological Sciences Research Council (BBSRC); EU; Organon Inc.; Cambridge Gates Foundation; BBSRC [BB/F009860/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F009860/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU(European Commission); Organon Inc.; Cambridge Gates Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by a grant from the UK Biotechnology and Biological Sciences Research Council (BBSRC) (P.A.M.), an EU Marie Curie fellowship (E.M.B.), a BBSRC CASE Ph.D. studentship (part-funded by Organon Inc.) (E.C.E.), and a Cambridge Gates Foundation studentship (L.C.). We thank colleagues in Organon Inc., Newhouse, Scotland (now Merck Sharp & Dohme Inc.), and in particular A. Mason and S. Neale, for making available to us floxed HCN2 mice created by Organon in collaboration with Lexicon Pharmaceuticals Inc.; T. Lii for help with experiments in figs. S3 and S4; J. Wood for giving us the Na<INF>V</INF>1.8-Cre mice created in his lab; M. J. Fischer for help with statistical analysis; I. Sandovici and M. Constancia for providing us with the ROSA26-YFP mouse; and J. Wood and X. Zhang for their comments on the manuscript.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Ali Z, 1999, J NEUROPHYSIOL, V81, P455, DOI 10.1152/jn.1999.81.2.455; Baruscotti M, 2011, P NATL ACAD SCI USA, V108, P1705, DOI 10.1073/pnas.1010122108; Biel M, 2002, TRENDS CARDIOVAS MED, V12, P206, DOI 10.1016/S1050-1738(02)00162-7; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Chaplan SR, 2003, J NEUROSCI, V23, P1169, DOI 10.1523/JNEUROSCI.23-04-01169.2003; Cho HJ, 2009, NEUROSCIENCE, V162, P453, DOI 10.1016/j.neuroscience.2009.04.063; Cho HJ, 2009, CELL TISSUE RES, V338, P171, DOI 10.1007/s00441-009-0869-8; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006; Doan TN, 2004, J NEUROSCI, V24, P3335, DOI 10.1523/JNEUROSCI.5156-03.2004; Dong XW, 2007, NEUROSCIENCE, V146, P812, DOI 10.1016/j.neuroscience.2007.01.054; Ekberg J, 2006, P NATL ACAD SCI USA, V103, P17030, DOI 10.1073/pnas.0601819103; INGRAM SL, 1994, NEURON, V13, P179, DOI 10.1016/0896-6273(94)90468-5; Ingram SL, 1996, J PHYSIOL-LONDON, V492, P97, DOI 10.1113/jphysiol.1996.sp021292; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Jiang YQ, 2008, PAIN, V137, P495, DOI 10.1016/j.pain.2007.10.011; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Kerr BJ, 2001, NEUROREPORT, V12, P3077, DOI 10.1097/00001756-200110080-00019; Kim KS, 2007, GENES BRAIN BEHAV, V6, P120, DOI 10.1111/j.1601-183X.2006.00238.x; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Lawson JJ, 2008, J PAIN, V9, P298, DOI 10.1016/j.jpain.2007.12.001; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Luo L, 2007, NEUROSCIENCE, V144, P1477, DOI 10.1016/j.neuroscience.2006.10.048; Ma WY, 2008, NEUROSCI LETT, V437, P165, DOI 10.1016/j.neulet.2008.02.072; Mabuchi T, 2004, NEUROREPORT, V15, P1395, DOI 10.1097/01.wnr.0000129372.89000.31; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Momin A, 2009, EXP BRAIN RES, V196, P45, DOI 10.1007/s00221-009-1744-2; Momin A, 2008, J PHYSIOL-LONDON, V586, P5911, DOI 10.1113/jphysiol.2008.163154; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Orio P, 2009, J PHYSIOL-LONDON, V587, P1961, DOI 10.1113/jphysiol.2008.165738; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; Shields SD, 2010, PAIN, V151, P422, DOI 10.1016/j.pain.2010.08.001; Stirling LC, 2005, PAIN, V113, P27, DOI 10.1016/j.pain.2004.08.015; Takasu K, 2010, PAIN, V151, P87, DOI 10.1016/j.pain.2010.06.020; Tu HY, 2004, J NEUROSCI RES, V76, P713, DOI 10.1002/jnr.20109; Wang Y, 2010, NEUROSCI LETT, V478, P77, DOI 10.1016/j.neulet.2010.04.069; Yao H, 2003, J NEUROSCI, V23, P2069	43	229	250	3	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2011	333	6048					1462	1466		10.1126/science.1206243	http://dx.doi.org/10.1126/science.1206243			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21903816				2022-12-28	WOS:000294672200047
J	Psaki, SR; OlaOlorun, F				Psaki, Stephanie R.; OlaOlorun, Funmilola			More than mothers: aligning indicators with women's lives	LANCET			English	Editorial Material							HEALTH; MORTALITY		[Psaki, Stephanie R.; OlaOlorun, Funmilola] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA; [OlaOlorun, Funmilola] Univ Ibadan, Coll Med, Dept Prevent Med & Primary Care, Ibadan, Nigeria	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Ibadan	Psaki, SR (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.	spsaki@jhsph.edu	OlaOlorun, Funmilola/ABN-6506-2022	OlaOlorun, Funmilola/0000-0001-5544-2875				Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; [Anonymous], KEEP PROM MEAS RES C; [Anonymous], 1946, CONST WHO AD INT HLT; Betancourt Theresa S, 2010, J Int AIDS Soc, V13 Suppl 2, pS2, DOI 10.1186/1758-2652-13-S2-S2; Eyakuze C, 2008, DEV WORLD BIOETH, V8, P33, DOI 10.1111/j.1471-8847.2008.00230.x; Gupta R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014252; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Lee J, 2011, J CROSS-CULT GERONTO, V26, P121, DOI 10.1007/s10823-011-9142-1; Mackenbach JP, 2002, INT J EPIDEMIOL, V31, P1162, DOI 10.1093/ije/31.6.1162; Rani M, 2009, J INTERPERS VIOLENCE, V24, P1371, DOI 10.1177/0886260508322182; United Nations Development Programme, HUM DEV REP HUM DEV; World Health Organization, 2008, The global burden of disease: 2004 update; Zavalaa Diego E, 2008, Med Confl Surviv, V24, P260, DOI 10.1080/13623690802373884	16	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 25	2012	380	9843					711	713		10.1016/S0140-6736(11)60757-5	http://dx.doi.org/10.1016/S0140-6736(11)60757-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	995IK	21975365				2022-12-28	WOS:000308001300008
J	Bassani, DG; Roth, DE				Bassani, Diego G.; Roth, Daniel E.			China's progress in neonatal mortality	LANCET			English	Editorial Material							SYSTEMATIC ANALYSIS; COUNTRIES; SURVIVAL; NEWBORN; DEATHS; IMPACT		[Bassani, Diego G.] Hosp Sick Children, Dept Paediat, Toronto, ON M5G 1X8, Canada; Univ Toronto, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Bassani, DG (corresponding author), Hosp Sick Children, Dept Paediat, Toronto, ON M5G 1X8, Canada.	diego.bassani@sickkids.ca	Bassani, Diego/G-2827-2015	Bassani, Diego/0000-0001-6704-3820				Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Feng XL, 2011, LANCET, V378, P1493, DOI 10.1016/S0140-6736(11)61096-9; Gao Y, 2009, INT J GYNECOL OBSTET, V104, P128, DOI 10.1016/j.ijgo.2008.10.004; Kumar V, 2010, SEMIN PERINATOL, V34, P446, DOI 10.1053/j.semperi.2010.09.006; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0; Wall SN, 2010, SEMIN PERINATOL, V34, P395, DOI 10.1053/j.semperi.2010.09.009	11	3	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2011	378	9801					1446	1447		10.1016/S0140-6736(11)61257-9	http://dx.doi.org/10.1016/S0140-6736(11)61257-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	838VC	21924765				2022-12-28	WOS:000296319600007
J	Gibson, L; Lee, TM; Koh, LP; Brook, BW; Gardner, TA; Barlow, J; Peres, CA; Bradshaw, CJA; Laurance, WF; Lovejoy, TE; Sodhi, NS				Gibson, Luke; Lee, Tien Ming; Koh, Lian Pin; Brook, Barry W.; Gardner, Toby A.; Barlow, Jos; Peres, Carlos A.; Bradshaw, Corey J. A.; Laurance, William F.; Lovejoy, Thomas E.; Sodhi, Navjot S.			Primary forests are irreplaceable for sustaining tropical biodiversity	NATURE			English	Article							COUNTRYSIDE BIOGEOGRAPHY; GLOBAL BIODIVERSITY; CONSERVATION; OPPORTUNITIES; DISTURBANCE; SCENARIOS	Human-driven land-use changes increasingly threaten biodiversity, particularly in tropical forests where both species diversity and human pressures on natural environments are high(1). The rapid conversion of tropical forests for agriculture, timber production and other uses has generated vast, human-dominated landscapes with potentially dire consequences for tropical biodiversity(2-5). Today, few truly undisturbed tropical forests exist, whereas those degraded by repeated logging and fires, as well as secondary and plantation forests, are rapidly expanding(6,7). Here we provide a global assessment of the impact of disturbance and land conversion on biodiversity in tropical forests using a meta-analysis of 138 studies. We analysed 2,220 pairwise comparisons of biodiversity values in primary forests (with little or no human disturbance) and disturbed forests. We found that biodiversity values were substantially lower in degraded forests, but that this varied considerably by geographic region, taxonomic group, ecological metric and disturbance type. Even after partly accounting for confounding colonization and succession effects due to the composition of surrounding habitats, isolation and time since disturbance, we find that most forms of forest degradation have an overwhelmingly detrimental effect on tropical biodiversity. Our results clearly indicate that when it comes to maintaining tropical biodiversity, there is no substitute for primary forests.	[Gibson, Luke; Koh, Lian Pin; Sodhi, Navjot S.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Lee, Tien Ming] Univ Calif San Diego, Ecol Behav & Evolut Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Lee, Tien Ming] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Koh, Lian Pin] ETH, Dept Environm Sci, CH-8092 Zurich, Switzerland; [Brook, Barry W.; Bradshaw, Corey J. A.] Univ Adelaide, Inst Environm, Adelaide, SA 5005, Australia; [Brook, Barry W.; Bradshaw, Corey J. A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Gardner, Toby A.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Barlow, Jos] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; [Peres, Carlos A.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Bradshaw, Corey J. A.] S Australian Res & Dev Inst, Henley Beach, SA 5022, Australia; [Laurance, William F.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci TESS, Cairns, Qld 4870, Australia; [Laurance, William F.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld 4870, Australia; [Lovejoy, Thomas E.] Natl Inst Amazonian Res INPA, Biol Dynam Forest Fragments Project, BR-69011970 Manaus, AM, Brazil; [Lovejoy, Thomas E.] H John Heinz III Ctr Sci Econ & Environm, Washington, DC 20004 USA	National University of Singapore; University of California System; University of California San Diego; Yale University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Adelaide; University of Adelaide; University of Cambridge; Lancaster University; University of East Anglia; James Cook University; James Cook University; Institute Nacional de Pesquisas da Amazonia	Gibson, L (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	lggibson@nus.edu.sg; tmlee@ucsd.edu	Gardner, Toby/B-7516-2008; Laurance, William F/B-2709-2012; Barlow, Jos/HGE-9486-2022; Brook, Barry W./G-2686-2011; Peres, Carlos Augusto/N-8275-2019; Barlow, Jos/E-7861-2014; Koh, Lian Pin/A-5794-2010; Peres, Carlos A./ABE-8361-2020; Bradshaw, Corey J.A./A-1311-2008; Peres, Carlos A./B-1276-2013; /Y-6615-2018	Laurance, William F/0000-0003-4430-9408; Brook, Barry W./0000-0002-2491-1517; Koh, Lian Pin/0000-0001-8152-3871; Peres, Carlos A./0000-0002-1588-8765; Bradshaw, Corey J.A./0000-0002-5328-7741; Peres, Carlos A./0000-0002-1588-8765; /0000-0002-7706-3355	National University of Singapore [R-154-000-479-112]; Singapore International; Swiss National Science Foundation; ETH North-South Centre; Natural Environmental Research Council [NE/F01614X/1]; Instituto Nacional de Ciencia e Tecnologia - Biodiversidade e Uso da Terra na Amazonia [CNPq 574008/2008-0]; NERC [NE/F01614X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E500811/1] Funding Source: researchfish; Natural Environment Research Council [NE/F01614X/1, ceh010010] Funding Source: researchfish	National University of Singapore(National University of Singapore); Singapore International; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH North-South Centre; Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Instituto Nacional de Ciencia e Tecnologia - Biodiversidade e Uso da Terra na Amazonia; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the tropical conservation scientists whose efforts helped to make our study possible. L.G., T.M.L. and N.S.S. were supported by grant R-154-000-479-112 from the National University of Singapore and L.G. was also supported by the Singapore International Graduate Award. L.P.K. was supported by the Swiss National Science Foundation and the ETH North-South Centre. T.A.G. thanks the Natural Environmental Research Council (NE/F01614X/1), and T.A.G. and J.B. thank the Instituto Nacional de Ciencia e Tecnologia - Biodiversidade e Uso da Terra na Amazonia (CNPq 574008/2008-0) for funding. Wededicate this paper to the memory of N.S.S., who died while the manuscript was being reviewed.	Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Borenstein M., 2009, INTRO METAANALYSIS; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x; Dent DH, 2009, BIOL CONSERV, V142, P2833, DOI 10.1016/j.biocon.2009.05.035; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Edwards DP, 2011, P ROY SOC B-BIOL SCI, V278, P82, DOI 10.1098/rspb.2010.1062; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gardner TA, 2007, BIOTROPICA, V39, P25, DOI 10.1111/j.1744-7429.2006.00228.x; Gardner TA, 2010, BIOL CONSERV, V143, P2293, DOI 10.1016/j.biocon.2010.05.017; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Harvey CA, 2010, CONSERV LETT, V3, P53, DOI 10.1111/j.1755-263X.2009.00086.x; Horner-Devine MC, 2003, CONSERV BIOL, V17, P168, DOI 10.1046/j.1523-1739.2003.01310.x; Hughes JB, 2002, ECOL LETT, V5, P121, DOI 10.1046/j.1461-0248.2002.00294.x; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Koh LP, 2010, P NATL ACAD SCI USA, V107, P11140, DOI 10.1073/pnas.1000530107; Laurance WF, 2007, TRENDS ECOL EVOL, V22, P65, DOI 10.1016/j.tree.2006.09.014; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Peres CA, 2006, TRENDS ECOL EVOL, V21, P227, DOI 10.1016/j.tree.2006.03.007; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; R Development Core Team, 2011, R PROJ STAT COMP VER; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sodhi NS, 2009, BIOTROPICA, V41, P103, DOI 10.1111/j.1744-7429.2008.00460.x; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Stork NE, 2009, CONSERV BIOL, V23, P1438, DOI 10.1111/j.1523-1739.2009.01335.x; Strassburg BBN, 2010, CONSERV LETT, V3, P98, DOI 10.1111/j.1755-263X.2009.00092.x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Walpole M, 2009, SCIENCE, V325, P1503, DOI 10.1126/science.1175466; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009	34	1243	1284	44	938	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 20	2011	478	7369					378	+		10.1038/nature10425	http://dx.doi.org/10.1038/nature10425			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	21918513				2022-12-28	WOS:000296021100044
J	Opitz, CA; Litzenburger, UM; Sahm, F; Ott, M; Tritschler, I; Trump, S; Schumacher, T; Jestaedt, L; Schrenk, D; Weller, M; Jugold, M; Guillemin, GJ; Miller, CL; Lutz, C; Radlwimmer, B; Lehmann, I; von Deimling, A; Wick, W; Platten, M				Opitz, Christiane A.; Litzenburger, Ulrike M.; Sahm, Felix; Ott, Martina; Tritschler, Isabel; Trump, Saskia; Schumacher, Theresa; Jestaedt, Leonie; Schrenk, Dieter; Weller, Michael; Jugold, Manfred; Guillemin, Gilles J.; Miller, Christine L.; Lutz, Christian; Radlwimmer, Bernhard; Lehmann, Irina; von Deimling, Andreas; Wick, Wolfgang; Platten, Michael			An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor	NATURE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE; TRYPTOPHAN 2,3-DIOXYGENASE; T-CELLS; INHIBITION; KYNURENINE; DIFFERENTIATION; INFLAMMATION; DEGRADATION; SUPPRESSION; PATHWAY	Activation of the aryl hydrocarbon receptor (AHR) by environmental xenobiotic toxic chemicals, for instance 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin), has been implicated in a variety of cellular processes such as embryogenesis, transformation, tumorigenesis and inflammation. But the identity of an endogenous ligand activating the AHR under physiological conditions in the absence of environmental toxic chemicals is still unknown. Here we identify the tryptophan (Trp) catabolite kynurenine (Kyn) as an endogenous ligand of the human AHR that is constitutively generated by human tumour cells via tryptophan-2,3-dioxygenase (TDO), a liver-and neuron-derived Trp-degrading enzyme not yet implicated in cancer biology. TDO-derived Kyn suppresses antitumour immune responses and promotes tumour-cell survival and motility through the AHR in an autocrine/paracrine fashion. The TDO-AHR pathway is active in human brain tumours and is associated with malignant progression and poor survival. Because Kyn is produced during cancer progression and inflammation in the local microenvironment in amounts sufficient for activating the human AHR, these results provide evidence for a previously unidentified pathophysiological function of the AHR with profound implications for cancer and immune biology.	[Opitz, Christiane A.; Litzenburger, Ulrike M.; Ott, Martina; Schumacher, Theresa; Wick, Wolfgang; Platten, Michael] Univ Heidelberg Hosp, Neurol Clin, Dept Neurooncol, D-69120 Heidelberg, Germany; [Opitz, Christiane A.; Litzenburger, Ulrike M.; Ott, Martina; Schumacher, Theresa; Wick, Wolfgang; Platten, Michael] Univ Heidelberg Hosp, Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [Opitz, Christiane A.; Litzenburger, Ulrike M.; Ott, Martina; Schumacher, Theresa; Platten, Michael] German Canc Res Ctr, Expt Neuroimmunol Unit, D-69120 Heidelberg, Germany; [Sahm, Felix; von Deimling, Andreas] Univ Heidelberg Hosp, Inst Pathol, Dept Neuropathol, D-69120 Heidelberg, Germany; [Sahm, Felix; von Deimling, Andreas] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, D-69120 Heidelberg, Germany; [Tritschler, Isabel; Weller, Michael] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Trump, Saskia; Lehmann, Irina] UFZ Helmholtz Ctr Environm Res, Dept Environm Immunol, D-04318 Leipzig, Germany; [Jestaedt, Leonie] Univ Heidelberg Hosp, Dept Neuroradiol, D-69120 Heidelberg, Germany; [Schrenk, Dieter] Univ Kaiserslautern, D-67663 Kaiserslautern, Germany; [Jugold, Manfred] German Canc Res Ctr, Small Anim Imaging Ctr, D-69120 Heidelberg, Germany; [Guillemin, Gilles J.] Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW 2052, Australia; [Miller, Christine L.] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21287 USA; [Lutz, Christian] Heidelberg Pharma AG, D-68526 Ladenburg, Germany; [Radlwimmer, Bernhard] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Wick, Wolfgang] German Canc Res Ctr, Clin Cooperat Unit Neurooncol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Zurich; University Zurich Hospital; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Ruprecht Karls University Heidelberg; University of Kaiserslautern; Helmholtz Association; German Cancer Research Center (DKFZ); University of New South Wales Sydney; Johns Hopkins University; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Platten, M (corresponding author), Univ Heidelberg Hosp, Neurol Clin, Dept Neurooncol, D-69120 Heidelberg, Germany.	m.platten@dkfz-heidelberg.de	Wick, Wolfgang/AAA-2545-2020; Bunse, Theresa/AAD-1719-2019; Radlwimmer, Bernhard F/I-3229-2013; Guillemin, Gilles J/C-3878-2015; Platten, Michael/F-2902-2013; von Deimling, Andreas/F-7774-2013; Trump, Saskia/ABG-5182-2021; Opitz, Christiane A/I-9507-2012; Sahm, Felix/GQY-8202-2022	Wick, Wolfgang/0000-0002-6171-634X; Radlwimmer, Bernhard F/0000-0002-4553-7800; Guillemin, Gilles J/0000-0001-8105-4470; Platten, Michael/0000-0002-4746-887X; von Deimling, Andreas/0000-0002-5863-540X; Opitz, Christiane A/0000-0001-5575-9821; Sahm, Felix/0000-0001-5441-1962; Weller, Michael/0000-0002-1748-174X; Trump, Saskia/0000-0002-9894-1807; Lehmann, Irina/0000-0001-8875-5587	Helmholtz Association [VH-NG-306]; German Research Foundation [SFB 938 TP K]; Hertie Foundation; Helmholtz Alliance on Systems Biology; DKFZ PhD Program stipend; Heidelberg University Medical Faculty	Helmholtz Association(Helmholtz Association); German Research Foundation(German Research Foundation (DFG)); Hertie Foundation; Helmholtz Alliance on Systems Biology; DKFZ PhD Program stipend; Heidelberg University Medical Faculty	We thank K. Rauschenbach, J. Reiert, S. Koch and A. Mlitzko for technical assistance, P.-N. Pfenning for help with the invasion assays, J. Blaes for help generating genetically modified cells, T. V. Lanz and I. Oezen for help with animal experiments, C. Esser for providing Ahr<SUP>-/-</SUP> mice, M. Schwarz for providing the human DRE-luciferase construct, D. Lemke for generating GICs, K. Ochs for providing human umbilical-vein endothelial cell cDNA, A. Hertenstein for generation of CD4<SUP>+</SUP> and CD8<SUP>+</SUP> T cells, M. Betts and R. B. Russel for modelling of the binding of Kyn to the AHR, R. Koch for performing quantitative reverse transcriptase polymerase chain reaction analyses, R. Tudoran for generation of GL261 cells overexpressing murine TDO, M. Deponte for help with the radioligand binding assay, D. Schemmer for collecting and banking serum samples, W. Roth for providing tissue specimens, M. Remke for suggestions regarding data analysis, and G. Hammerling, B. Arnold and M. Feuerer for discussions. This work was supported by grants from the Helmholtz Association (VH-NG-306) to M. P., the German Research Foundation to M. P. and W. W. (Deutsche Forschungsgemeinschaft SFB 938 TP K), the Hertie Foundation to W. W. and the Helmholtz Alliance on Systems Biology to S. T. and I. L. T. S. is supported by a DKFZ PhD Program stipend. C.A.O. is supported by a Heidelberg University Medical Faculty Postdoctoral Fellowship.	Andersson P, 2002, P NATL ACAD SCI USA, V99, P9990, DOI 10.1073/pnas.152706299; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Ball HJ, 2007, GENE, V396, P203, DOI 10.1016/j.gene.2007.04.010; Bui LC, 2009, ONCOGENE, V28, P3642, DOI 10.1038/onc.2009.224; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Dolusic E, 2011, J MED CHEM, V54, P5320, DOI 10.1021/jm2006782; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Frericks M, 2008, TOXICOL APPL PHARM, V232, P268, DOI 10.1016/j.taap.2008.07.009; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Gramatzki D, 2009, ONCOGENE, V28, P2593, DOI 10.1038/onc.2009.104; Lob S, 2009, NAT REV CANCER, V9, P445, DOI 10.1038/nrc2639; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Miller CL, 2004, NEUROBIOL DIS, V15, P618, DOI 10.1016/j.nbd.2003.12.015; Moennikes O, 2004, CANCER RES, V64, P4707, DOI 10.1158/0008-5472.CAN-03-0875; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Muller AJ, 2008, P NATL ACAD SCI USA, V105, P17073, DOI 10.1073/pnas.0806173105; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; NewLink Genetics Corporation, 2008, IDO INH STUD REL REF; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Opitz CA, 2007, CELL MOL LIFE SCI, V64, P2542, DOI 10.1007/s00018-007-7140-9; Opitz CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019823; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Zudaire E, 2008, J CLIN INVEST, V118, P640, DOI 10.1172/JCI30024	33	1205	1290	7	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2011	478	7368					197	203		10.1038/nature10491	http://dx.doi.org/10.1038/nature10491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21976023	Green Accepted, Bronze			2022-12-28	WOS:000295782800040
J	Nicholas, LH; Langa, KM; Iwashyna, TJ; Weir, DR				Nicholas, Lauren Hersch; Langa, Kenneth M.; Iwashyna, Theodore J.; Weir, David R.			Regional Variation in the Association Between Advance Directives and End-of-Life Medicare Expenditures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PATIENT PREFERENCES; HEALTH-CARE; OUTCOMES; QUALITY; VALIDATION; DEATH	Context It is unclear if advance directives (living wills) are associated with end-of-life expenditures and treatments. Objective To examine regional variation in the associations between treatment-limiting advance directive use, end-of-life Medicare expenditures, and use of palliative and intensive treatments. Design, Setting, and Patients Prospectively collected survey data from the Health and Retirement Study for 3302 Medicare beneficiaries who died between 1998 and 2007 linked to Medicare claims and the National Death Index. Multivariable regression models examined associations between advance directives, end-of-life Medicare expenditures, and treatments by level of Medicare spending in the decedent's hospital referral region. Main Outcome Measures Medicare expenditures, life-sustaining treatments, hospice care, and in-hospital death over the last 6 months of life. Results Advance directives specifying limits in care were associated with lower spending in hospital referral regions with high average levels of end-of-life expenditures (-$5585 per decedent; 95% CI, -$10 903 to -$267), but there was no difference in spending in hospital referral regions with low or medium levels of end-of-life expenditures. Directives were associated with lower adjusted probabilities of in-hospital death in high-and medium-spending regions (-9.8%; 95% CI, -16% to -3% in high-spending regions; -5.3%; 95% CI, -10% to -0.4% in medium-spending regions). Advance directives were associated with higher adjusted probabilities of hospice use in high-and medium-spending regions (17%; 95% CI, 11% to 23% in high-spending regions, 11%; 95% CI, 6% to 16% in medium-spending regions), but not in low-spending regions. Conclusion Advance directives specifying limitations in end-of-life care were associated with significantly lower levels of Medicare spending, lower likelihood of in-hospital death, and higher use of hospice care in regions characterized by higher levels of end-of-life spending. JAMA. 2011;306(13):1447-1453	[Nicholas, Lauren Hersch; Langa, Kenneth M.; Iwashyna, Theodore J.; Weir, David R.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Langa, Kenneth M.; Iwashyna, Theodore J.] Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48104 USA; [Langa, Kenneth M.; Iwashyna, Theodore J.] Vet Affairs Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nicholas, LH (corresponding author), 3005 Inst Social Res, 426 Thompson St, Ann Arbor, MI 48104 USA.	lnichola@umich.edu		Iwashyna, Theodore/0000-0002-4226-9310; Langa, Kenneth/0000-0002-2798-1836	National Institutes of Health [U01 AG09740, R01 AG030155, K08 HL091249]; Michigan Institute for Clinical and Health Research [UL1RR024986]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041028] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL091249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000221, U01AG009740, P30AG012846, R01AG030155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Institute for Clinical and Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants U01 AG09740, R01 AG030155, K08 HL091249 from the National Institutes of Health and Clinical and Translational Science Award grant UL1RR024986 from the Michigan Institute for Clinical and Health Research.	Bach PB, 2004, JAMA-J AM MED ASSOC, V292, P2765, DOI 10.1001/jama.292.22.2765; Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Barnato AE, 2009, MED CARE, V47, P1098, DOI 10.1097/MLR.0b013e3181993191; Barnato AE, 2009, J GEN INTERN MED, V24, P695, DOI 10.1007/s11606-009-0952-6; Christakis NA, 2003, SOC SCI MED, V57, P465, DOI 10.1016/S0277-9536(02)00370-2; Curtis JR, 2002, J PAIN SYMPTOM MANAG, V24, P17, DOI 10.1016/S0885-3924(02)00419-0; *DARTM, DARTM ATL HLTH CAR D; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fried TR, 2011, J AM GERIATR SOC, V59, P1105, DOI 10.1111/j.1532-5415.2011.03412.x; Greene W.H., 2012, ECONOMETRIC ANAL, V7th; Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277; Kelley AS, 2011, ANN INTERN MED, V154, P235, DOI 10.7326/0003-4819-154-4-201102150-00004; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; McPherson CJ, 2003, SOC SCI MED, V56, P95, DOI 10.1016/S0277-9536(02)00011-4; Pritchard RS, 1998, J AM GERIATR SOC, V46, P1242, DOI 10.1111/j.1532-5415.1998.tb04540.x; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Silveira MJ, 2010, NEW ENGL J MED, V362, P1211, DOI 10.1056/NEJMsa0907901; Sudore RL, 2010, ANN INTERN MED, V153, P256, DOI 10.7326/0003-4819-153-4-201008170-00008; Taylor JS, 1999, CAN FAM PHYSICIAN, V45, P2408; Teno J, 1997, J AM GERIATR SOC, V45, P513, DOI 10.1111/j.1532-5415.1997.tb05180.x; Teno J, 1997, J AM GERIATR SOC, V45, P500, DOI 10.1111/j.1532-5415.1997.tb05178.x; Teno JM, 2007, J AM GERIATR SOC, V55, P189, DOI 10.1111/j.1532-5415.2007.01045.x; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Xu Jiaquan, 2010, Natl Vital Stat Rep, V58, P1; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587	28	212	213	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 5	2011	306	13					1447	1453		10.1001/jama.2011.1410	http://dx.doi.org/10.1001/jama.2011.1410			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	828MZ	21972306	Green Accepted			2022-12-28	WOS:000295506900023
J	Quill, TE; Holloway, R				Quill, Timothy E.; Holloway, Robert			Time-Limited Trials Near the End of Life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMMUNICATION; PREFERENCES; CARE		[Quill, Timothy E.] Univ Rochester, Med Ctr, Palliat Care Program, Ctr Eth Humanities & Palliat Care, Rochester, NY 14642 USA; [Quill, Timothy E.] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; [Holloway, Robert] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Quill, TE (corresponding author), Univ Rochester, Med Ctr, Palliat Care Program, Ctr Eth Humanities & Palliat Care, 601 Elmwood Ave,Box 687, Rochester, NY 14642 USA.	timothy_quill@urmc.rochester.edu						Berwick DM, 1998, ANN INTERN MED, V128, P651, DOI 10.7326/0003-4819-128-8-199804150-00009; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Chung GS, 2012, J MED ETHICS, V38, P77, DOI 10.1136/jme.2010.040618; Hagerty RG, 2004, J CLIN ONCOL, V22, P1721, DOI 10.1200/JCO.2004.04.095; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Quill TE, 1996, ANN INTERN MED, V125, P763, DOI 10.7326/0003-4819-125-9-199611010-00010; Quill TE, 2009, ANN INTERN MED, V151, P345, DOI 10.7326/0003-4819-151-5-200909010-00010; Tulsky JA, 2005, JAMA-J AM MED ASSOC, V294, P359, DOI 10.1001/jama.294.3.359; Ubel PA, 2005, HEALTH PSYCHOL, V24, pS57, DOI 10.1037/0278-6133.24.4.S57; Wendler D, 2011, ANN INTERN MED, V154, P336, DOI 10.7326/0003-4819-154-5-201103010-00008	10	132	134	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 5	2011	306	13					1483	1484		10.1001/jama.2011.1413	http://dx.doi.org/10.1001/jama.2011.1413			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	828MZ	21972312				2022-12-28	WOS:000295506900029
J	Lucassen, W; Geersing, GJ; Erkens, PMG; Reitsma, JB; Moons, KGM; Buller, H; van Weert, HC				Lucassen, Wim; Geersing, Geert-Jan; Erkens, Petra M. G.; Reitsma, Johannes B.; Moons, Karel G. M.; Buller, Harry; van Weert, Henk C.			Clinical Decision Rules for Excluding Pulmonary Embolism: A Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							QUANTITATIVE D-DIMER; HELICAL COMPUTED-TOMOGRAPHY; REVISED GENEVA SCORE; C-REACTIVE PROTEIN; EMERGENCY-DEPARTMENT; PRETEST PROBABILITY; PREDICTION RULES; VENOUS ULTRASONOGRAPHY; DIAGNOSTIC MANAGEMENT; WELLS RULE	Background: Clinical probability assessment is combined with D-dimer testing to exclude pulmonary embolism (PE). Purpose: To compare the test characteristics of gestalt (a physician's unstructured estimate) and clinical decision rules for evaluating adults with suspected PE and assess the failure rate of gestalt and rules when used in combination with D-dimer testing. Data Sources: Articles in MEDLINE and EMBASE in English, French, German, Italian, Spanish, or Dutch that were published between 1966 and June 2011. Study Selection: 3 reviewers, working in pairs, selected prospective studies in consecutive patients suspected of having PE. Studies had to estimate the probability of PE by using gestalt or a decision rule and verify the diagnosis by using an appropriate reference standard. Data Extraction: Data on study characteristics, test performance, and prevalence were extracted. Reviewers constructed 2 x 2 tables and assessed the methodological quality of the studies. Data Synthesis: 52 studies, comprising 55 268 patients, were selected. Meta-analysis was performed on studies that used gestalt (15 studies; sensitivity, 0.85; specificity, 0.51), the Wells rule with a cutoff value less than 2 (19 studies; sensitivity, 0.84; specificity, 0.58) or 4 or less (11 studies; sensitivity, 0.60; specificity, 0.80), the Geneva rule (5 studies; sensitivity, 0.84; specificity, 0.50), and the revised Geneva rule (4 studies; sensitivity, 0.91; specificity, 0.37). An increased prevalence of PE was associated with higher sensitivity and lower specificity. Combining a decision rule or gestalt with D-dimer testing seemed safe for all strategies, except when the less-sensitive Wells rule (cutoff value <= 4) was combined with less-sensitive qualitative D-dimer testing. Limitations: Studies had substantial heterogeneity due to prevalence of PE and differences in threshold. Many studies (63%) had potential bias due to differential disease verification. Conclusion: Clinical decision rules and gestalt can safely exclude PE when combined with sensitive D-dimer testing. The authors recommend standardized rules because gestalt has lower specificity, but the choice of a particular rule and D-dimer test depend on both prevalence and setting.	[Lucassen, Wim] Acad Med Ctr, Dept Gen Practice, NL-1100 DD Amsterdam, Netherlands; Univ Med Ctr Utrecht, Utrecht, Netherlands; Univ Maastricht, Maastricht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Maastricht University	Lucassen, W (corresponding author), Acad Med Ctr, Dept Gen Practice, J2-128,Box 22660, NL-1100 DD Amsterdam, Netherlands.	w.a.lucassen@amc.uva.nl	Geersing, Geert-Jan/AAY-1119-2021	Reitsma, Johannes/0000-0003-4026-4345	Dutch Heart Foundation [2006B237]	Dutch Heart Foundation(Netherlands Heart Foundation)	By the Dutch Heart Foundation (project 2006B237).	Anderson DR, 2008, SEMIN NUCL MED, V38, P412, DOI 10.1053/j.semnuclmed.2008.07.003; Anderson DR, 2005, J EMERG MED, V29, P399, DOI 10.1016/j.jemermed.2005.05.010; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Aujesky D, 2003, THROMB HAEMOSTASIS, V90, P1198, DOI 10.1160/TH03-03-0175; Barghouth G, 2000, EUR J NUCL MED, V27, P1280, DOI 10.1007/s002590000284; Calisir C, 2009, EUR J EMERG MED, V16, P49, DOI 10.1097/MEJ.0b013e328304ae6d; Carrier M, 2010, J THROMB HAEMOST, V8, P1716, DOI 10.1111/j.1538-7836.2010.03938.x; Ceriani E, 2010, J THROMB HAEMOST, V8, P957, DOI 10.1111/j.1538-7836.2010.03801.x; Chagnon I, 2002, AM J MED, V113, P269, DOI 10.1016/S0002-9343(02)01212-3; Cross JJL, 1998, CLIN RADIOL, V53, P177, DOI 10.1016/S0009-9260(98)80097-4; Douma RA, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00002; Douma RA, 2009, THROMB HAEMOSTASIS, V101, P197, DOI 10.1160/TH08-07-0444; Elias A, 2005, THROMB HAEMOSTASIS, V93, P982, DOI 10.1160/TH04-11-0734; Geersing GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2990; Gibson NS, 2008, THROMB HAEMOSTASIS, V99, P229, DOI 10.1160/TH07-05-0321; Goekoop RJ, 2007, THROMB HAEMOSTASIS, V97, P146, DOI 10.1160/TH06-09-0529; Hamza TH, 2008, J CLIN EPIDEMIOL, V61, P41, DOI 10.1016/j.jclinepi.2007.03.016; Hugli O, 2011, J THROMB HAEMOST, V9, P300, DOI 10.1111/j.1538-7836.2010.04147.x; Kabrhel C, 2005, ACAD EMERG MED, V12, P915, DOI 10.1197/j.aem.2005.05.030; Kabrhel C, 2005, CHEST, V127, P1627, DOI 10.1378/chest.127.5.1627; Kabrhel C, 2009, ACAD EMERG MED, V16, P325, DOI 10.1111/j.1553-2712.2009.00368.x; Kearon C, 2006, ANN INTERN MED, V144, P812, DOI 10.7326/0003-4819-144-11-200606060-00007; Kline JA, 2008, J THROMB HAEMOST, V6, P772, DOI 10.1111/j.1538-7836.2008.02944.x; Kline JA, 2006, CLIN PHYSIOL FUNCT I, V26, P212, DOI 10.1111/j.1475-097X.2006.00672.x; Kline JA, 2004, J THROMB HAEMOST, V2, P1247, DOI 10.1111/j.1538-7836.2004.00790.x; Kline JA, 2002, ANN EMERG MED, V39, P144, DOI 10.1067/mem.2002.121398; Kline JA, 2006, CHEST, V129, P1417, DOI 10.1378/chest.129.6.1417; Klok FA, 2008, J THROMB HAEMOST, V6, P40, DOI 10.1111/j.1538-7836.2007.02820.x; Klok FA, 2008, ARCH INTERN MED, V168, P2131, DOI 10.1001/archinte.168.19.2131; Kruip MJHA, 2003, ANN INTERN MED, V138, P941, DOI 10.7326/0003-4819-138-12-200306170-00005; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Leeflang MMG, 2009, J CLIN EPIDEMIOL, V62, P5, DOI 10.1016/j.jclinepi.2008.04.007; Legnani C, 2010, THROMB RES, V125, P398, DOI 10.1016/j.thromres.2009.07.013; Miniati M, 2005, MEDICINE, V84, P107, DOI 10.1097/01.md.0000158793.32512.37; Miniati M, 2003, EUR J NUCL MED MOL I, V30, P1450, DOI 10.1007/s00259-003-1253-7; Miniati M, 2003, AM J MED, V114, P173, DOI 10.1016/S0002-9343(02)01478-X; Miniati M, 1996, AM J RESP CRIT CARE, V154, P1387, DOI 10.1164/ajrccm.154.5.8912753; Miniati M, 2008, AM J RESP CRIT CARE, V178, P290, DOI 10.1164/rccm.200802-207OC; Miron MJ, 1999, EUR RESPIR J, V13, P1365, DOI 10.1183/09031936.99.13613719; Moons KGM, 1997, EPIDEMIOLOGY, V8, P12, DOI 10.1097/00001648-199701000-00002; MOSER KM, 1990, AM REV RESPIR DIS, V141, P235, DOI 10.1164/ajrccm/141.1.235; Musset D, 2002, LANCET, V360, P1914, DOI 10.1016/S0140-6736(02)11914-3; Nilsson T, 2001, J INTERN MED, V250, P213, DOI 10.1046/j.1365-2796.2001.00880.x; Parent F, 2007, THROMB RES, V120, P195, DOI 10.1016/j.thromres.2006.09.012; Pasha SM, 2010, THROMB RES, V125, pE123, DOI 10.1016/j.thromres.2009.11.009; Penaloza A, 2011, THROMB RES, V127, P81, DOI 10.1016/j.thromres.2010.10.026; Perrier A, 2000, ARCH INTERN MED, V160, P512, DOI 10.1001/archinte.160.4.512; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Perrier A, 2004, AM J MED, V116, P291, DOI 10.1016/j.amjmed.2003.09.041; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Righini M, 2008, LANCET, V371, P1343, DOI 10.1016/S0140-6736(08)60594-2; Runyon MS, 2008, EMERG MED J, V25, P70, DOI 10.1136/emj.2007.048918; Runyon MS, 2005, ACAD EMERG MED, V12, P587, DOI 10.1197/j.aem.2005.02.010; Sanson BJ, 2000, THROMB HAEMOSTASIS, V83, P199; Siragusa S, 2007, HAEMATOLOGICA, V92, P410, DOI 10.3324/haematol.09899; Steeghs N, 2005, BRIT J HAEMATOL, V130, P614, DOI 10.1111/j.1365-2141.2005.05652.x; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Ten Wolde M, 2004, J THROMB HAEMOST, V2, P1110, DOI 10.1111/j.1538-7836.2004.00769.x; van Beek EJR, 2001, CLIN RADIOL, V56, P838, DOI 10.1053/crad.2001.0778; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92; Wolf SJ, 2004, ANN EMERG MED, V44, P503, DOI 10.1016/j.annemergmed.2004.04.002; Wolf SJ, 2008, AM J EMERG MED, V26, P181, DOI 10.1016/j.ajem.2007.04.026; Yap KSK, 2007, MED J AUSTRALIA, V187, P333, DOI 10.5694/j.1326-5377.2007.tb01274.x	69	189	201	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2011	155	7					448	U94		10.7326/0003-4819-155-7-201110040-00007	http://dx.doi.org/10.7326/0003-4819-155-7-201110040-00007			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	833OC	21969343				2022-12-28	WOS:000295893800005
J	Chappie, JS; Mears, JA; Fang, SM; Leonard, M; Schmid, SL; Milligan, RA; Hinshaw, JE; Dyda, F				Chappie, Joshua S.; Mears, Jason A.; Fang, Shunming; Leonard, Marilyn; Schmid, Sandra L.; Milligan, Ronald A.; Hinshaw, Jenny E.; Dyda, Fred			A Pseudoatomic Model of the Dynamin Polymer Identifies a Hydrolysis-Dependent Powerstroke	CELL			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PLECKSTRIN HOMOLOGY DOMAIN; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; GTPASE ACTIVITY; STALK REGION; IN-VIVO; MEMBRANE; CONSTRICTION; MECHANISM	The GTPase dynamin catalyzes membrane fission by forming a collar around the necks of clathrin-coated pits, but the specific structural interactions and conformational changes that drive this process remain a mystery. We present the GMPPCP-bound structures of the truncated human dynamin 1 helical polymer at 12.2 angstrom and a fusion protein, GG, linking human dynamin 1's catalytic G domain to its GTPase effector domain (GED) at 2.2 angstrom. The structures reveal the position and connectivity of dynamin fragments in the assembled structure, showing that G domain dimers only form between tetramers in sequential rungs of the dynamin helix. Using chemical crosslinking, we demonstrate that dynamin tetramers are made of two dimers, in which the G domain of one molecule interacts in trans with the GED of another. Structural comparison of GG(GMPPCP) to the GG transition-state complex identifies a hydrolysis-dependent powerstroke that may play a role in membrane-remodeling events necessary for fission.	[Mears, Jason A.; Fang, Shunming; Hinshaw, Jenny E.] NIDDKD, Lab Cell Biochem & Biol, Bethesda, MD 20892 USA; [Chappie, Joshua S.; Dyda, Fred] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Mears, Jason A.] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Leonard, Marilyn; Schmid, Sandra L.; Milligan, Ronald A.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Case Western Reserve University; Scripps Research Institute	Hinshaw, JE (corresponding author), NIDDKD, Lab Cell Biochem & Biol, Bethesda, MD 20892 USA.	jennyh@helix.nih.gov; dyda@helix.nih.gov	Chappie, Joshua S./AAV-6076-2021	Chappie, Joshua S./0000-0002-5733-7275; Schmid, Sandra/0000-0002-1690-7024; Mears, Jason/0000-0002-5199-4872	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH [GM52468, GM75820, GM42455]; National Institutes of Health through the National Center for Research Resources [RR017573]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060100, ZIADK075049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075820, R01GM052468, R37GM052468, R01GM042455] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Vasyl Lukiyanchuk and Sharmistha Acharya for assistance in cloning and purification, Rodolfo Ghirlando for assistance with sedimentation velocity experiments, Juha-Pekka Mattila for communication of unpublished data, Joshua Zimmerberg for insightful discussions, Alison B. Hickman for technical advice and critical reading of the manuscript, and Yihong Ye for critical reading of the manuscript. We especially thank Marijn Ford and Jodi Nunnari for the ongoing open dialogue regarding the intricacies of dynamin structure and assembly. This work was supported by the Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and NIH grants GM52468 and GM75820 (to R.A.M.) and GM42455 (to S.L.S.). J.S.C. was supported by a Nancy Nossal Fellowship award from NIDDK. A portion of the work presented here was conducted at the National Resource for Automated Molecular Microscopy, which is supported by the National Institutes of Health through the National Center for Research Resources' P41 program (RR017573).	Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Colombo Marina, ANNU REV CELL DEV BI, V30, P255, DOI [DOI 10.1146/ANNUREV-CELLBIO-100109-104016, 10.1146/annurev-cellbio-101512-122326, DOI 10.1146/ANNUREV-CELLBIO-101512-122326]; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Egelman EH, 2007, J STRUCT BIOL, V157, P83, DOI 10.1016/j.jsb.2006.05.015; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Low HH, 2006, NATURE, V444, P766, DOI 10.1038/nature05312; Low HH, 2009, CELL, V139, P1342, DOI 10.1016/j.cell.2009.11.003; Mallick SP, 2005, ULTRAMICROSCOPY, V104, P8, DOI 10.1016/j.ultramic.2005.02.004; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; Potter CS, 1999, ULTRAMICROSCOPY, V77, P153, DOI 10.1016/S0304-3991(99)00043-1; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Ramachandran R, 2009, MOL BIOL CELL, V20, P4630, DOI 10.1091/mbc.E09-08-0683; Reubold TF, 2005, P NATL ACAD SCI USA, V102, P13093, DOI 10.1073/pnas.0506491102; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Sever S, 2006, EMBO J, V25, P4163, DOI 10.1038/sj.emboj.7601298; Solomaha E, 2005, BIOCHEM J, V391, P601, DOI 10.1042/BJ20050707; Song BD, 2004, MOL BIOL CELL, V15, P2243, DOI 10.1091/mbc.E04-01-0015; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Tan RKZ, 2008, J STRUCT BIOL, V163, P163, DOI 10.1016/j.jsb.2008.05.001; Tan RKZ, 2006, J CHEM THEORY COMPUT, V2, P529, DOI 10.1021/ct050323r; TIMM D, 1994, NAT STRUCT BIOL, V1, P782, DOI 10.1038/nsb1194-782; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Wilson-Kubalek EM, 2010, METHOD ENZYMOL, V481, P45, DOI 10.1016/S0076-6879(10)81002-X; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	49	153	155	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					209	222		10.1016/j.cell.2011.09.003	http://dx.doi.org/10.1016/j.cell.2011.09.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962517	Green Accepted, Bronze			2022-12-28	WOS:000295396700027
J	Lord, C				Lord, Catherine			Unweaving the Autism Spectrum	CELL			English	Editorial Material							MOUSE MODELS	Although genes associated with human autism spectrum disorders have been identified, bridging the gap between genetics and the patchwork of behavioral deficits associated with the disease remains an enormous challenge. Penagarikano et al. (2011) now show that mice lacking CNTNAP2, a gene that causes a rare form of epilepsy associated with autistic features and language impairment, display similar phenotypes to their human counterparts, raising hopes that such models may speed the identification of neuronal circuitries underlying the core features of autism.	Weill Cornell Med Coll, Dept Psychiat, White Plains, NY 10605 USA	Cornell University	Lord, C (corresponding author), Weill Cornell Med Coll, Dept Psychiat, White Plains, NY 10605 USA.	cal2028@med.cornell.edu						Bishop DVM, 2010, BEHAV GENET, V40, P618, DOI 10.1007/s10519-010-9381-x; Gotham K, 2007, J AUTISM DEV DISORD, V37, P613, DOI 10.1007/s10803-006-0280-1; Hus V, 2007, BIOL PSYCHIAT, V61, P438, DOI 10.1016/j.biopsych.2006.08.044; Minshew N, 2011, AUTISM RES, V4, P1, DOI 10.1002/aur.185; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Richler J, 2007, J AUTISM DEV DISORD, V37, P73, DOI 10.1007/s10803-006-0332-6; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828	10	7	7	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					24	25		10.1016/j.cell.2011.09.017	http://dx.doi.org/10.1016/j.cell.2011.09.017			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962503	Bronze			2022-12-28	WOS:000295396700011
J	Baulch, HM; Stanley, EH; Bernhardt, ES				Baulch, Helen M.; Stanley, Emily H.; Bernhardt, Emily S.			Can algal uptake stop NO3- pollution?	NATURE			English	Letter							FOREST STREAM; DENITRIFICATION		[Baulch, Helen M.; Stanley, Emily H.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Bernhardt, Emily S.] Duke Univ, Dept Biol, Durham, NC 27708 USA	University of Wisconsin System; University of Wisconsin Madison; Duke University	Baulch, HM (corresponding author), Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA.	helenmbaulch@gmail.com	Bernhardt, Emily/B-4541-2010; Bernhardt, Emily S/D-9940-2011	Bernhardt, Emily S/0000-0003-3031-621X; Baulch, Helen/0000-0001-9018-4998; Stanley, Emily/0000-0003-4922-8121				Cardinale BJ, 2011, NATURE, V472, P86, DOI 10.1038/nature09904; Ishida CK, 2008, MICROB ECOL, V56, P140, DOI 10.1007/s00248-007-9332-0; McMillan SK, 2010, J ENVIRON QUAL, V39, P274, DOI 10.2134/jeq2008.0438; Merriam JL, 2002, FRESHWATER BIOL, V47, P143, DOI 10.1046/j.1365-2427.2002.00785.x; Mulholland PJ, 2008, NATURE, V452, P202, DOI 10.1038/nature06686; Mulholland PJ, 2000, ECOL MONOGR, V70, P471, DOI 10.1890/0012-9615(2000)070[0471:NCIAFS]2.0.CO;2; Tank JL, 2000, LIMNOL OCEANOGR, V45, P1013, DOI 10.4319/lo.2000.45.5.1013	7	9	10	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 29	2011	477	7366					E3	E3		10.1038/nature10418	http://dx.doi.org/10.1038/nature10418			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21956333	Bronze			2022-12-28	WOS:000295320900001
J	Spence, D				Spence, Des			FROM THE FRONTLINE If and butts about smoking cessation	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						[Anonymous], MOTIVATIONAL INTERVI; *NHS STOP SMOK SER, STAT NHS STOP SMOK S; NICOTINE REPLACEMENT	3	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 27	2011	343								d6171	10.1136/bmj.d6171	http://dx.doi.org/10.1136/bmj.d6171			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829JV	21952460				2022-12-28	WOS:000295576600021
J	Byass, P; Graham, WJ				Byass, Peter; Graham, Wendy J.			Grappling with uncertainties along the MDG trail	LANCET			English	Editorial Material							MORTALITY		[Byass, Peter; Graham, Wendy J.] Univ Aberdeen, Sch Med & Dent, Aberdeen AB25 2ZD, Scotland; [Byass, Peter] Umea Univ, Umea Ctr Global Hlth Res, Umea, Sweden; [Byass, Peter] Univ Witwatersrand, Sch Publ Hlth, MRC, Wits Rural Publ Hlth & Hlth Transit Res Unit Agin, Johannesburg, South Africa	University of Aberdeen; Umea University; University of Witwatersrand	Byass, P (corresponding author), Univ Aberdeen, Sch Med & Dent, Aberdeen AB25 2ZD, Scotland.	peter.byass@epiph.umu.se		Byass, Peter/0000-0001-5474-4361; Graham, Wendy/0000-0003-1473-5342				AbouZahr C, 2011, REPROD HEALTH MATTER, V19, P117, DOI 10.1016/S0968-8080(11)37550-7; Byass P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001006; Byass P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000155; Commission on Information and Accountability for Women's and Children's Health, 2010, KEEP PROM MEAS RES; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; WHO, 2010, TRENDS MAT MORT 1990	10	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2011	378	9797					1119	1120		10.1016/S0140-6736(11)61419-0	http://dx.doi.org/10.1016/S0140-6736(11)61419-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829RH	21937101				2022-12-28	WOS:000295601500004
J	Atkinson, K; Bradshaw, DM; Nwokolo, N				Atkinson, Kate; Bradshaw, Daniel M.; Nwokolo, Nneka			CASE REPORT A patient with rectal discharge and fever	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Atkinson, Kate; Bradshaw, Daniel M.; Nwokolo, Nneka] Chelsea & Westminster NHS Fdn Trust, London SW10 9NH, England	Imperial College London	Atkinson, K (corresponding author), Chelsea & Westminster NHS Fdn Trust, London SW10 9NH, England.	kateatkinson@doctors.org.uk						*CLIN EFF GROUP BR, 2006, NAT GUID MAN LYMPH V; French P, 2005, SEX TRANSM INFECT, V81, P97, DOI 10.1136/sti.2005.015263; Health Protection Agency, 2009, SYPH LYMPH VEN RES S; Herring A, 2006, SEX TRANSM INFECT, V82, P23, DOI 10.1136/sti.2006.023143; RADCLIFFE K, 2010, BRIT ASS SEXUAL HLTH; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; SIMMS I, 2004, EUROSURVEILLANCE, V8, P41	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2011	343								d5981	10.1136/bmj.d5981	http://dx.doi.org/10.1136/bmj.d5981			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	826AK	21948590				2022-12-28	WOS:000295323500004
J	Kraft, NJB; Comita, LS; Chase, JM; Sanders, NJ; Swenson, NG; Crist, TO; Stegen, JC; Vellend, M; Boyle, B; Anderson, MJ; Cornell, HV; Davies, KF; Freestone, AL; Inouye, BD; Harrison, SP; Myers, JA				Kraft, Nathan J. B.; Comita, Liza S.; Chase, Jonathan M.; Sanders, Nathan J.; Swenson, Nathan G.; Crist, Thomas O.; Stegen, James C.; Vellend, Mark; Boyle, Brad; Anderson, Marti J.; Cornell, Howard V.; Davies, Kendi F.; Freestone, Amy L.; Inouye, Brian D.; Harrison, Susan P.; Myers, Jonathan A.			Disentangling the Drivers of beta Diversity Along Latitudinal and Elevational Gradients	SCIENCE			English	Article							GAMMA-DIVERSITY; COMMUNITY DIVERSITY; SPECIES-DIVERSITY; AMAZONIAN FOREST; ALPHA-DIVERSITY; TREE COMMUNITY; SCALE; ENVIRONMENTS; BIODIVERSITY; RICHNESS	Understanding spatial variation in biodiversity along environmental gradients is a central theme in ecology. Differences in species compositional turnover among sites (beta diversity) occurring along gradients are often used to infer variation in the processes structuring communities. Here, we show that sampling alone predicts changes in beta diversity caused simply by changes in the sizes of species pools. For example, forest inventories sampled along latitudinal and elevational gradients show the well-documented pattern that beta diversity is higher in the tropics and at low elevations. However, after correcting for variation in pooled species richness (gamma diversity), these differences in beta diversity disappear. Therefore, there is no need to invoke differences in the mechanisms of community assembly in temperate versus tropical systems to explain these global-scale patterns of beta diversity.	[Kraft, Nathan J. B.; Vellend, Mark] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Kraft, Nathan J. B.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Comita, Liza S.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Comita, Liza S.] Smithsonian Trop Res Inst, Balboa Ancon, Panama; [Chase, Jonathan M.; Myers, Jonathan A.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Sanders, Nathan J.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Sanders, Nathan J.] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen O, Denmark; [Swenson, Nathan G.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Crist, Thomas O.] Miami Univ, Inst Environm & Sustainabil, Oxford, OH 45056 USA; [Crist, Thomas O.] Miami Univ, Dept Zool, Oxford, OH 45056 USA; [Stegen, James C.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Stegen, James C.] Pacific NW Natl Lab, Fundamental & Computat Sci Directorate, Div Biol Sci, Richland, WA 99352 USA; [Vellend, Mark] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Boyle, Brad] Univ Arizona, Dept Ecol & Evolut, Tucson, AZ 85719 USA; [Anderson, Marti J.] Massey Univ, New Zealand Inst Adv Study, Auckland 0745, New Zealand; [Cornell, Howard V.; Harrison, Susan P.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Davies, Kendi F.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Freestone, Amy L.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Inouye, Brian D.] Florida State Univ, Tallahassee, FL 32306 USA	University of British Columbia; University System of Maryland; University of Maryland College Park; National Center for Ecological Analysis & Synthesis; Smithsonian Institution; Smithsonian Tropical Research Institute; Washington University (WUSTL); University of Tennessee System; University of Tennessee Knoxville; University of Copenhagen; Michigan State University; University System of Ohio; Miami University; University System of Ohio; Miami University; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Sherbrooke; University of Arizona; Massey University; University of California System; University of California Davis; University of Colorado System; University of Colorado Boulder; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; State University System of Florida; Florida State University	Kraft, NJB (corresponding author), Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada.	nkraft@biodiversity.ubc.ca	B, A/AHB-5155-2022; Swenson, Nathan/A-3514-2012; Anderson, Marti J./AAQ-9038-2021; Sanders, Nathan/A-6945-2009; Stegen, James/Q-3078-2016; Kraft, Nathan J. B./A-2817-2012; Sanders, Nathan/ABE-4335-2020	Swenson, Nathan/0000-0003-3819-9767; Anderson, Marti J./0000-0002-4018-4049; Sanders, Nathan/0000-0001-6220-6731; Stegen, James/0000-0001-9135-7424; Kraft, Nathan J. B./0000-0001-8867-7806; Comita, Liza/0000-0002-9169-1331	National Center for Ecological Analysis and Synthesis (NCEAS); NSF [EF-0553768, DBI-0906005]; University of California, Santa Barbara; state of California; National Science and Engineering Research Council of Canada; U.S. Department of Energy [DE-FG02-08ER64510]; Veterans Affairs [IK6RX002477] Funding Source: NIH RePORTER	National Center for Ecological Analysis and Synthesis (NCEAS); NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); state of California; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); U.S. Department of Energy(United States Department of Energy (DOE)); Veterans Affairs(US Department of Veterans Affairs)	We are grateful to A. H. Gentry, the Missouri Botanical Garden, and numerous additional collectors who contributed to the latitudinal data set. The data sets are available in the original publications or electronically from SALVIAS (www.salvias.net). This work was conducted as part of the Gradients of beta-diversity Working Group supported by the National Center for Ecological Analysis and Synthesis (NCEAS), a center funded by NSF (grant EF-0553768); the University of California, Santa Barbara; and the state of California. N.J.B.K. was supported by the National Science and Engineering Research Council of Canada CREATE Training Program in Biodiversity Research. L. S. C. was supported by an NCEAS postdoctoral fellowship. N.J.S. was supported by U.S. Department of Energy Program for Ecosystem Research DE-FG02-08ER64510. J.C.S. was supported by an NSF Postdoctoral Fellowship in Bioinformatics (DBI-0906005).	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Boyle B. L., 1996, THESIS WASHINGTON U; Caley MJ, 1997, ECOLOGY, V78, P70; Canham CD, 2004, CAN J FOREST RES, V34, P778, DOI [10.1139/x03-232, 10.1139/X03-232]; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Cornell HV, 2007, ECOLOGY, V88, P1707, DOI 10.1890/06-0742.1; Crist TO, 2006, ECOL LETT, V9, P923, DOI 10.1111/j.1461-0248.2006.00941.x; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Dahl C, 2009, J BIOGEOGR, V36, P896, DOI 10.1111/j.1365-2699.2008.02042.x; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Phillips O, 2002, GLOBAL PATTERNS PLAN; Qian H, 2007, ECOL LETT, V10, P737, DOI 10.1111/j.1461-0248.2007.01066.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Ricotta C, 2010, ECOLOGY, V91, P1981, DOI 10.1890/09-0126.1; Rodriguez P, 2004, ECOGRAPHY, V27, P547, DOI 10.1111/j.0906-7590.2004.03788.x; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Soininen J, 2007, ECOLOGY, V88, P2830, DOI 10.1890/06-1730.1; Svenning JC, 1999, J ECOL, V87, P55, DOI 10.1046/j.1365-2745.1999.00329.x; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715	34	488	518	25	677	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1755	1758		10.1126/science.1208584	http://dx.doi.org/10.1126/science.1208584			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940897				2022-12-28	WOS:000295121500045
J	Kenealy, T; Sheridan, N				Kenealy, Timothy; Sheridan, Nicolette			Protocol-based nurse management of type 2 diabetes did not differ from usual GP care for HbA(1c) levels	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kenealy, Timothy; Sheridan, Nicolette] Univ Auckland, Auckland 1, New Zealand	University of Auckland	Kenealy, T (corresponding author), Univ Auckland, Auckland 1, New Zealand.			Sheridan, Nicolette/0000-0002-8098-2918; Kenealy, Timothy/0000-0001-6002-4766				Griffin S, 2000, COCHRANE DB SYST REV; Kenealy TW, 2010, DIABETES RES CLIN PR, V89, P256, DOI 10.1016/j.diabres.2010.05.003; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015	3	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6							JC3-7	10.7326/0003-4819-155-6-201109200-02007	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930844				2022-12-28	WOS:000295033400006
J	Abubakar, I; Dara, M; Manissero, D; Zumla, A				Abubakar, Ibrahim; Dara, Masoud; Manissero, Davide; Zumla, Alimuddin			Tackling the spread of drug-resistant tuberculosis in Europe	LANCET			English	Editorial Material									[Abubakar, Ibrahim] Hlth Protect Agcy, TB Sect, London NW9 5EQ, England; [Abubakar, Ibrahim] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Dara, Masoud] WHO Reg Off Europe, Copenhagen, Denmark; [Manissero, Davide] European Ctr Dis Control & Prevent, Stockholm, Sweden; [Zumla, Alimuddin] UCL, Sch Med, Div Infect & Immun, London W1N 8AA, England	Health Protection Agency; University of East Anglia; World Health Organization; University of London; University College London; UCL Medical School	Abubakar, I (corresponding author), Hlth Protect Agcy, TB Sect, London NW9 5EQ, England.	ibrahim.abubakar@hpa.org.uk	ZUMLA, Alimuddin/ABA-8208-2020; Manissero, Davide/HGU-6178-2022	ZUMLA, Alimuddin/0000-0002-5111-5735; Manissero, Davide/0000-0002-8887-8795; Abubakar, Ibrahim/0000-0002-0370-1430				[Anonymous], 2009, 62 WORLD HLTH ASS PR; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; *DEP HLTH, 2004, STOPP TUB ENGL CHIEF; European Centre for Disease Prevention and Control/WHO, TUB SURV EUR 2009; Fears R, 2010, TUBERCULOSIS, V90, P182, DOI 10.1016/j.tube.2010.03.008; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Kruijshaar ME, 2008, BRIT MED J, V336, P1231, DOI 10.1136/bmj.39546.573067.25; Veen J, 2010, REV NATL TUBERCULOSI; WHO, GLOB TUB CONTR 2010; WHO European Region, 2011, EURRC61INFDOC3 WHO E; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	12	16	17	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 28	2012	379	9813					E21	E23		10.1016/S0140-6736(11)61428-1	http://dx.doi.org/10.1016/S0140-6736(11)61428-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889BA	21924489				2022-12-28	WOS:000300047300002
J	Forouzanfar, MH; Foreman, KJ; Delossantos, AM; Lozano, R; Lopez, AD; Murray, CJL; Naghavi, M				Forouzanfar, Mohammad H.; Foreman, Kyle J.; Delossantos, Allyne M.; Lozano, Rafael; Lopez, Alan D.; Murray, Christopher J. L.; Naghavi, Mohsen			Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis	LANCET			English	Article							HUMAN-PAPILLOMAVIRUS; RECENT TRENDS; TIME TRENDS; MORTALITY; SURVIVAL; VALIDATION; DEATHS; WOMEN; EPIDEMIOLOGY; POPULATIONS	Background Breast and cervical cancer are important causes of mortality in women aged >= 15 years. We undertook annual age-specific assessments of breast and cervical cancer in 187 countries. Methods We systematically collected cancer registry data on mortality and incidence, vital registration, and verbal autopsy data for the period 1980-2010. We modelled the mortality-to-incidence (MI) ratio using a hierarchical model. Vital registration and verbal autopsy were supplemented with incidence multiplied by the MI ratio to yield a comprehensive database of mortality rates. We used Gaussian process regression to develop estimates of mortality with uncertainty by age, sex, country, and year. We used out-of-sample predictive validity to select the final model. Estimates of incidence with uncertainty were also generated with mortality and MI ratios. Findings Global breast cancer incidence increased from 641 000 (95% uncertainty intervals 610 000-750 000) cases in 1980 to 1 643 000 (1 421 000-1 782 000) cases in 2010, an annual rate of increase of 3.1%. Global cervical cancer incidence increased from 378 000 (256 000-489 000) cases per year in 1980 to 454 000 (318 000-620 000) cases per year in 2010-a 0.6% annual rate of increase. Breast cancer killed 425 000 (359 000-453 000) women in 2010, of whom 68 000 (62 000-74 000) were aged 15-49 years in developing countries. Cervical cancer death rates have been decreasing but the disease still killed 200 000 (139 000-276 000) women in 2010, of whom 46 000 (33 000-64 000) were aged 15-49 years in developing countries. We recorded pronounced variation in the trend in breast cancer mortality across regions and countries. Interpretation More policy attention is needed to strengthen established health-system responses to reduce breast and cervical cancer, especially in developing countries.	[Forouzanfar, Mohammad H.; Foreman, Kyle J.; Delossantos, Allyne M.; Lozano, Rafael; Murray, Christopher J. L.; Naghavi, Mohsen] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Lopez, Alan D.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Queensland	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@u.washington.edu	Lopez, Alan D/F-1487-2010; Lozano, Rafael/T-5352-2018; Lopez, Alan/AAA-2734-2022	Lopez, Alan D/0000-0001-5818-6512; Lozano, Rafael/0000-0002-7356-8823; 	Susan G Komen for the Cure; Bill & Melinda Gates Foundation	Susan G Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding Susan G Komen for the Cure and the Bill & Melinda Gates Foundation.	Altekruse S. F., 1975, SEER CANC STAT REV 1; Althuis MD, 2005, INT J EPIDEMIOL, V34, P405, DOI 10.1093/ije/dyh414; [Anonymous], 2021, CANC INCIDENCE 5 CON; [Anonymous], GLOBAL ACTION PLAN M; [Anonymous], ENHANCING GLOBAL FUN; Arbyn M, 2011, INT J CANCER, V128, P1899, DOI 10.1002/ijc.25525; Arbyn M, 2009, EUR J CANCER, V45, P2640, DOI 10.1016/j.ejca.2009.07.018; Baili P, 2008, TUMORI J, V94, P658; Barnabas RV, 2006, PLOS MED, V3, P624, DOI 10.1371/journal.pmed.0030138; Baum M, 2000, BMJ-BRIT MED J, V321, P1470, DOI 10.1136/bmj.321.7274.1470/a; Blanks RG, 2000, BRIT MED J, V321, P665, DOI 10.1136/bmj.321.7262.665; Botha JL, 2003, EUR J CANCER, V39, P1718, DOI 10.1016/S0959-8049(03)00118-7; Brown P, 2000, BRIT MED J, V321, P849, DOI 10.1136/bmj.321.7265.849; Chu KC, 1996, JNCI-J NATL CANCER I, V88, P1571, DOI 10.1093/jnci/88.21.1571; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Curado MP, 2009, CANCER CAUSE CONTROL, V20, P751, DOI 10.1007/s10552-008-9288-5; de Vries E, 2010, NAT REV CLIN ONCOL, V7, P60, DOI 10.1038/nrclinonc.2009.184; Doll R., 1966, CANC INCIDENCE 5 CON, VI; Doll R, 1970, CANC INCIDENCE 5 CON, VII; Engholm G, NORDCAN CANC INCIDEN; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Flaxman AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-29; Franco EL, 2001, CAN MED ASSOC J, V164, P1017; Frenk J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000089; Fryback D.G., 2006, OBSTET GYNECOL SURV, V61, P179, DOI [10.1097/01.ogx.0000201966.23445.91, DOI 10.1097/01.OGX.0000201966.23445.91]; Gates Melinda, COMMUNICATION; Gondos A, 2009, ANN ONCOL, V20, P564, DOI 10.1093/annonc/mdn639; Gondos A, 2007, INT J CANCER, V121, P395, DOI 10.1002/ijc.22683; Green J, 1944, BRIT J CANCER, V2078-86; Hermon C, 1996, BRIT J CANCER, V73, P955, DOI 10.1038/bjc.1996.171; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Holleczek B, 2011, CANCER EPIDEMIOL, V35, P399, DOI 10.1016/j.canep.2011.01.008; Holmes RS, 2009, CANCER EPIDEM BIOMAR, V18, P2442, DOI 10.1158/1055-9965.EPI-08-0956; International Agency for Research on Cancer, GLOBOCAN 2008 CANC I; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jatoi I, 1999, AM J SURG, V177, P518, DOI 10.1016/S0002-9610(99)00096-3; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; LAARA E, 1987, LANCET, V1, P1247; Lee JH, 2007, J KOREAN MED SCI, V22, pS11, DOI 10.3346/jkms.2007.22.S.S11; Levi F, 2007, ANN ONCOL, V18, P593, DOI 10.1093/annonc/mdl437; Loos AH, 2004, EUR J CANCER, V40, P2794, DOI 10.1016/j.ejca.2004.09.007; Lopez A, 1998, HLTH DIMENSIONS SEX; Lozano R, LANCET IN PRESS; Lozano R, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-32; Lozano-Ascencio R, 2009, SALUD PUBLICA MEXICO, V51, pS147, DOI 10.1590/S0036-36342009000800004; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; MUIR CS, 1987, IARC SCI PUBLICATION, V88; MUNOZ N, 1992, INT J CANCER, V52, P743, DOI 10.1002/ijc.2910520513; Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-30; Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-27; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; National Cancer Institute, SEER SURV STAT; Ngo Anh D, 2010, BMC Res Notes, V3, P78, DOI 10.1186/1756-0500-3-78; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; PARKIN DM, 1992, IARC SCI PUBLICATION, V120; PARKIN DM, 1997, IARC SCI PUBLICATION, V143; Parkin DM, 2002, IARC SCI PUBLICATION, VVIII; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Peto R, 1998, BRIT MED J, V317, P476; Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7; Porapakkham Y, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-14; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rajaratnam JK, 2010, LANCET, V375, P1704, DOI 10.1016/S0140-6736(10)60517-X; Reynolds T, 1999, J NATL CANCER I, V91, P750, DOI 10.1093/jnci/91.9.750; Sankaranarayanan R, 2011, IARC SCI PUBLICATION, V162; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Shin HR, 2010, CANCER SCI, V101, P1241, DOI 10.1111/j.1349-7006.2010.01519.x; Survival of cancer patients in Europe, 2015, SURV CANC PAT EUR; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4; The NCD Alliance, PROP OUTC DOC UN HIG; Tyczynski JE, 2004, INT J CANCER, V112, P1056, DOI 10.1002/ijc.20514; UNFPA, 1995, INT C POP DEV; Valsecchi MG, 2008, LANCET ONCOL, V9, P159, DOI 10.1016/S1470-2045(08)70028-7; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; Wabinga HR, 2000, BRIT J CANCER, V82, P1585, DOI 10.1054/bjoc.1999.1071; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Waterhouse J., 1976, IARC SCI PUBLICATION, V15; Waterhouse JA, 1982, IARC SCI PUBLICATION, VIV; WHO, 2008 2013 ACT PLAN G; WHO, 2011, UN ACC REPR HLTH ACC; WHO, STRENGTH CERV CANC P; World Health Organization, 1 GLOB MIN C HLTH LI; World Health Organization, WORLD HLTH REP 2000; World Vision, CHILD HLTH NOW; Yang GH, 2006, INT J EPIDEMIOL, V35, P741, DOI 10.1093/ije/dyi181	86	680	740	2	80	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2011	378	9801					1461	1484		10.1016/S0140-6736(11)61351-2	http://dx.doi.org/10.1016/S0140-6736(11)61351-2			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838VC	21924486				2022-12-28	WOS:000296319600021
J	Yun, BW; Feechan, A; Yin, MH; Saidi, NBB; Le Bihan, T; Yu, M; Moore, JW; Kang, JG; Kwon, E; Spoel, SH; Pallas, JA; Loake, GJ				Yun, Byung-Wook; Feechan, Angela; Yin, Minghui; Saidi, Noor B. B.; Le Bihan, Thierry; Yu, Manda; Moore, John W.; Kang, Jeong-Gu; Kwon, Eunjung; Spoel, Steven H.; Pallas, Jacqueline A.; Loake, Gary J.			S-nitrosylation of NADPH oxidase regulates cell death in plant immunity	NATURE			English	Article							NITRIC-OXIDE; DISEASE-RESISTANCE; SALICYLIC-ACID; HYPERSENSITIVE RESPONSE; SUPEROXIDE-PRODUCTION; ARABIDOPSIS-THALIANA; STRUCTURE PREDICTION; DEFENSE; TOBACCO; GENE	Changes in redox status are a conspicuous feature of immune responses in a variety of eukaryotes(1,2), but the associated signalling mechanisms are not well understood. In plants, attempted microbial infection triggers the rapid synthesis of nitric oxide(3,4) and a parallel accumulation of reactive oxygen intermediates, the latter generated by NADPH oxidases related to those responsible for the pathogen-activated respiratory burst in phagocytes(5). Both nitric oxide and reactive oxygen intermediates have been implicated in controlling the hypersensitive response, a programmed execution of plant cells at sites of attempted infection(3,5,6). However, the molecular mechanisms that underpin their function and coordinate their synthesis are unknown. Here we show genetic evidence that increases in cysteine thiols modified using nitric oxide, termed S-nitrosothiols, facilitate the hypersensitive response in the absence of the cell death agonist salicylic acid and the synthesis of reactive oxygen intermediates. Surprisingly, when concentrations of S-nitrosothiols were high, nitric oxide function also governed a negative feedback loop limiting the hypersensitive response, mediated by S-nitrosylation of the NADPH oxidase, AtRBOHD, at Cys 890, abolishing its ability to synthesize reactive oxygen intermediates. Accordingly, mutation of Cys 890 compromised S-nitrosothiol-mediated control of AtRBOHD activity, perturbing the magnitude of cell death development. This cysteine is evolutionarily conserved and specifically S-nitrosylated in both human and fly NADPH oxidase, suggesting that this mechanism may govern immune responses in both plants and animals.	[Yun, Byung-Wook; Feechan, Angela; Yin, Minghui; Saidi, Noor B. B.; Yu, Manda; Moore, John W.; Kang, Jeong-Gu; Kwon, Eunjung; Spoel, Steven H.; Loake, Gary J.] Univ Edinburgh, Sch Biol Sci, Inst Mol Plant Sci, Edinburgh EH9 3JH, Midlothian, Scotland; [Saidi, Noor B. B.] Univ Putra, Dept Cell & Mol Biol, Serdang 43400, Malaysia; [Le Bihan, Thierry] Univ Edinburgh, Ctr Syst Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Pallas, Jacqueline A.] Syngenta, Trait Res, Bracknell RG42 6EY, Berks, England	University of Edinburgh; Universiti Putra Malaysia; University of Edinburgh; Syngenta	Loake, GJ (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Mol Plant Sci, Kings Bldg, Edinburgh EH9 3JH, Midlothian, Scotland.	gloake@ed.ac.uk	Feechan, Angela/A-1296-2010; Le Bihan, Thierry/AAN-2534-2020; Saidi, Noor Baity/A-8423-2017; Yu, Manda/AAB-2472-2020	Saidi, Noor Baity/0000-0002-0715-2133; Yu, Manda/0000-0001-5932-9597; Feechan, Angela/0000-0002-4954-5613; Pallas, Jacqueline/0000-0002-2207-3185; Spoel, Steven/0000-0003-4340-7591; Loake, Gary/0000-0002-7989-9180; Le Bihan, Thierry/0000-0003-0498-8063; Yin, Minghui/0000-0003-3468-225X	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D011809/1]; Physical Sciences Research Council (EPSRC); Darwin Trust; EPSRC [BB/D019621/1]; Ministry of Education Malaysia; Torrance Scholarship; BBSRC [BB/H000984/1, BB/D019621/1, BB/D011809/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D019621/1, BB/H000984/1, BB/D011809/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Darwin Trust; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Ministry of Education Malaysia(Ministry of Education, Malaysia); Torrance Scholarship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We would like to acknowledge R. Innes and W. Gassmann for Pst DC3000 strains expressing either avrB or avrRps4, respectively. Arabidopsis transfer DNA insertion mutants were obtained from SAIL (Syngeneta) populations. We thank M. Tor for the H. arabidopsidis isolate Emwa1, and K. Kanchanawatee for the Drosophila cDNA clone and associated mutant. A. F. was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) CASE studentship. B.-W.Y. and E.K. were funded by BBSRC grant BB/D011809/1 awarded to G.J.L. J.W.M. received a grant from the Physical Sciences Research Council (EPSRC). M. Yu was the recipient of a Darwin Trust Scholarship. T. L. B. was supported by BBSRC and EPSRC grant BB/D019621/1. N.B.B.S. and M. Yin were funded by a Ministry of Education Malaysia scholarship and a Torrance Scholarship, respectively.	Aboul-Soud MAM, 2004, CHROMATOGRAPHIA, V59, P129, DOI 10.1365/s10337-003-0136-1; Chen YY, 2007, METHODS, V42, P243, DOI 10.1016/j.ymeth.2007.03.002; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Dellagi A, 1998, MOL PLANT MICROBE IN, V11, P734, DOI 10.1094/MPMI.1998.11.8.734; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Delledonne M, 2001, P NATL ACAD SCI USA, V98, P13454, DOI 10.1073/pnas.231178298; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; Feechan A, 2005, P NATL ACAD SCI USA, V102, P8054, DOI 10.1073/pnas.0501456102; Foissner I, 2000, PLANT J, V23, P817, DOI 10.1046/j.1365-313X.2000.00835.x; Gassmann W, 1999, PLANT J, V20, P265, DOI 10.1046/j.1365-313X.1999.t01-1-00600.x; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; He YK, 2004, SCIENCE, V305, P1968, DOI 10.1126/science.1098837; HOLUB EB, 1994, MOL PLANT MICROBE IN, V7, P223, DOI 10.1094/MPMI-7-0223; Ingelman M, 1997, J MOL BIOL, V268, P147, DOI 10.1006/jmbi.1997.0957; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Keller H, 1999, PLANT CELL, V11, P223, DOI 10.1105/tpc.11.2.223; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lindermayr C, 2010, PLANT CELL, V22, P2894, DOI 10.1105/tpc.109.066464; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Romero-Puertas MC, 2007, PLANT CELL, V19, P4120, DOI 10.1105/tpc.107.055061; Sagi M, 2001, PLANT PHYSIOL, V126, P1281, DOI 10.1104/pp.126.3.1281; Selemidis S, 2007, CARDIOVASC RES, V75, P349, DOI 10.1016/j.cardiores.2007.03.030; Shen AL, 2000, J BIOL CHEM, V275, P41087, DOI 10.1074/jbc.M008380200; Shirasu K, 1997, PLANT CELL, V9, P261, DOI 10.1105/tpc.9.2.261; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Wang YQ, 2009, J BIOL CHEM, V284, P2131, DOI 10.1074/jbc.M806782200; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yu IC, 1998, P NATL ACAD SCI USA, V95, P7819, DOI 10.1073/pnas.95.13.7819; Yun BW, 2003, PLANT J, V34, P768, DOI 10.1046/j.1365-313X.2003.01773.x; Zhen L, 1998, J BIOL CHEM, V273, P6575, DOI 10.1074/jbc.273.11.6575	39	445	458	4	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					264	U161		10.1038/nature10427	http://dx.doi.org/10.1038/nature10427			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21964330	Green Accepted			2022-12-28	WOS:000295782800055
J	Coombes, R				Coombes, Rebecca			NHS REFORM Shirley Williams: still a rebel	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Coombes, R (corresponding author), BMJ, London WC1H 9JR, England.	rcoombes@bmjgroup.com						2011, BRIT MED J, V342, pD4050, DOI DOI 10.1136/BMJ.D4050	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 4	2011	343								d6359	10.1136/bmj.d6359	http://dx.doi.org/10.1136/bmj.d6359			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	832CR	21971430				2022-12-28	WOS:000295779300014
J	Esmail, A				Esmail, Aneez			MEDICINE AND THE MEDIA Secret filming shows fundamental problems in general practice	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Manchester, Manchester M13 9PL, Lancs, England	University of Manchester	Esmail, A (corresponding author), Univ Manchester, Manchester M13 9PL, Lancs, England.		Esmail, Aneez/I-6903-2013	Esmail, Aneez/0000-0001-7061-7434					0	2	2	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 4	2011	343								d6392	10.1136/bmj.d6392	http://dx.doi.org/10.1136/bmj.d6392			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	832CR	21971432				2022-12-28	WOS:000295779300025
J	Graveley, BR				Graveley, Brenton R.			Splicing up Pluripotency	CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; TRANSCRIPTIONAL NETWORK; FOXP1	In this issue of Cell, Gabut and colleagues (2011) identify a new splice variant of FOXP1 that directly regulates the expression of pluripotency genes. It endows human embryonic stem cells with their pluripotent nature and is required for the reprogramming of somatic cells to induced pluripotent stem cells.	Univ Connecticut, Ctr Hlth, Stem Cell Inst, Dept Genet & Dev Biol, Farmington, CT 06030 USA	University of Connecticut	Graveley, BR (corresponding author), Univ Connecticut, Ctr Hlth, Stem Cell Inst, Dept Genet & Dev Biol, 400 Farmington Ave, Farmington, CT 06030 USA.	graveley@neuron.uchc.edu	Graveley, Brenton R/C-3108-2013	Graveley, Brenton/0000-0001-5777-5892				Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Salz HK, 2011, CURR OPIN GENET DEV, V21, P395, DOI 10.1016/j.gde.2011.03.001; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287	10	6	7	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					22	24		10.1016/j.cell.2011.09.004	http://dx.doi.org/10.1016/j.cell.2011.09.004			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962502	Bronze			2022-12-28	WOS:000295396700010
J	Farrell, L				Farrell, Liam			THE BEST MEDICINE Co-lumbo	BRITISH MEDICAL JOURNAL			English	Editorial Material												drfarrell@hotmail.co.uk						2000, MEREC BULLETIN, V11, P1	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 28	2011	343								d6080	10.1136/bmj.d6080	http://dx.doi.org/10.1136/bmj.d6080			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829JZ	21957211				2022-12-28	WOS:000295577100007
J	Lozano, R; Wang, HD; Foreman, KJ; Rajaratnam, JK; Naghavi, M; Marcus, JR; Dwyer-Lindgren, L; Lofgren, KT; Phillips, D; Atkinson, C; Lopez, AD; Murray, CJL				Lozano, Rafael; Wang, Haidong; Foreman, Kyle J.; Rajaratnam, Julie Knoll; Naghavi, Mohsen; Marcus, Jake R.; Dwyer-Lindgren, Laura; Lofgren, Katherine T.; Phillips, David; Atkinson, Charles; Lopez, Alan D.; Murray, Christopher J. L.			Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis	LANCET			English	Article							DEVELOPMENT ASSISTANCE; H1N1 INFLUENZA; HEALTH; CHALLENGES; COUNTRIES; WORLDWIDE; COUNTDOWN; NEWBORN; TRENDS; WOMEN	Background With 4 years until 2015, it is essential to monitor progress towards Millennium Development Goals (MDGs) 4 and 5. Although estimates of maternal and child mortality were published in 2010, an update of estimates is timely in view of additional data sources that have become available and new methods developed. Our aim was to update previous estimates of maternal and child mortality using better data and more robust methods to provide the best available evidence for tracking progress on MDGs 4 and 5. Methods We update the analyses of the progress towards MDGs 4 and 5 from 2010 with additional surveys, censuses, vital registration, and verbal autopsy data. For children, we estimate early neonatal (0-6 days), late neonatal (7-28 days), postneonatal (29-364 days), childhood (ages 1-4 years), and under-5 mortality. We use an improved model for estimating mortality by age under 5 years. For maternal mortality, our updated analysis includes greater than 1000 additional site-years of data. We tested a large set of alternative models for maternal mortality; we used an ensemble model based on the models with the best out-of-sample predictive validity to generate new estimates from 1990 to 2011. Findings Under-5 deaths have continued to decline, reaching 7.2 million in 2011 of which 2.2 million were early neonatal, 0.7 million late neonatal, 2.1 million postneonatal, and 2.2 million during childhood (ages 1-4 years). Comparing rates of decline from 1990 to 2000 with 2000 to 2011 shows that 106 countries have accelerated declines in the child mortality rate in the past decade. Maternal mortality has also continued to decline from 409 100 (uncertainty interval 382 900-437 900) in 1990 to 273 500 (256 300-291 700) deaths in 2011. We estimate that 56 100 maternal deaths in 2011 were HIV-related deaths during pregnancy. Based on recent trends in developing countries, 31 countries will achieve MDG 4, 13 countries MDG 5, and nine countries will achieve both. Interpretation Even though progress on reducing maternal and child mortality in most countries is accelerating, most developing countries will take many years past 2015 to achieve the targets of the MDGs 4 and 5. Similarly, although there continues to be progress on maternal mortality the pace is slow, without any overall evidence of acceleration. Immediate concerted action is needed for a large number of countries to achieve MDG 4 and MDG 5.	[Lozano, Rafael; Wang, Haidong; Foreman, Kyle J.; Rajaratnam, Julie Knoll; Naghavi, Mohsen; Marcus, Jake R.; Dwyer-Lindgren, Laura; Lofgren, Katherine T.; Phillips, David; Atkinson, Charles; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Lopez, Alan D.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Queensland	Lozano, R (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	rlozano@u.washington.edu	Lozano, Rafael/T-5352-2018; Lopez, Alan D/F-1487-2010; Lopez, Alan/AAA-2734-2022	Lozano, Rafael/0000-0002-7356-8823; Lopez, Alan D/0000-0001-5818-6512; Dwyer-Lindgren, Laura/0000-0002-3872-6451; Phillips, David/0000-0003-2569-1015	Bill & Melinda Gates Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Bill & Melinda Gates Foundation.	Abdool Karim Q, 2010, LANCET, V375, P1948, DOI 10.1016/S0140-6736(10)60747-7; AbouZahr C, 2011, REPROD HEALTH MATTER, V19, P117, DOI 10.1016/S0968-8080(11)37550-7; Althabe F, 2010, LANCET, V375, P1966, DOI 10.1016/S0140-6736(10)60923-3; [Anonymous], GLOBAL STRATEGY WOME; Bhutan, 2006, BHUT POP HOUS CENS 2; Bhutta ZA, 2011, LANCET, V377, P403, DOI 10.1016/S0140-6736(10)62274-X; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Byass P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001006; Colbourn T, 2010, LANCET, V376, P1390, DOI 10.1016/S0140-6736(10)61953-8; Commission on Information and Accountability for Women's and Children's Health, 2011, KEEP PROM MEAS RES H; Dede FS, 2011, BJOG-INT J OBSTET GY, V118, P1216, DOI 10.1111/j.1471-0528.2011.03002.x; Melgar JD, 2010, LANCET, V375, P1963, DOI 10.1016/S0140-6736(10)60919-1; Diallo AH, 2010, LANCET, V376, P1223, DOI 10.1016/S0140-6736(10)61880-6; Dubar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013112; Family Health Bureau Sri Lanka Ministry of Health Nutrition and Welfare Sri Lanka United Nations Children's Fund, 2008, MAT MORT DECL SRI LA; Family Health Bureau Sri Lanka Ministry of Health Nutrition and Welfare Sri Lanka United Nations Children's Fund, 2003, MAT MORT DECL SRI LA; Frisancho A, 2010, LANCET, V375, P1966, DOI 10.1016/S0140-6736(10)60922-1; Garenne M, 2010, LANCET, V376, P1389, DOI 10.1016/S0140-6736(10)61950-2; Gneiting T, 2005, SCIENCE, V310, P248, DOI 10.1126/science.1115255; Graham WJ, 2010, LANCET, V375, P1963, DOI 10.1016/S0140-6736(10)60918-X; Greco G, 2008, LANCET, V371, P1268, DOI 10.1016/S0140-6736(08)60561-9; Hakkert R, 2001, STAT MED, V20, P3505, DOI 10.1002/sim.1075; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Horton R, 2010, LANCET, V375, P1581, DOI 10.1016/S0140-6736(10)60547-8; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; MacKay AP, 2011, OBSTET GYNECOL, V118, P104, DOI 10.1097/AOG.0b013e31821fd49d; MacKay AP, 2000, AM J PREV MED, V19, P35, DOI 10.1016/S0749-3797(00)00171-9; McCaw-Binns A, 2007, INT J GYNECOL OBSTET, V96, P226, DOI 10.1016/j.ijgo.2006.12.002; McCaw-Binns A, 2009, W INDIAN MED J, V58, P518; McCaw-Binns A, 2010, LANCET, V375, P1967, DOI 10.1016/S0140-6736(10)60924-5; McKee M, 2010, LANCET, V376, P1389, DOI 10.1016/S0140-6736(10)61951-4; Meda N, 2010, LANCET, V375, P1965, DOI 10.1016/S0140-6736(10)60921-X; Mosby LG, 2011, AM J OBSTET GYNECOL, V205, P10, DOI 10.1016/j.ajog.2010.12.033; Murray CJL, 2007, LANCET, V369, P862, DOI 10.1016/S0140-6736(07)60415-2; Murray CJL, 2011, LANCET, V378, P8, DOI 10.1016/S0140-6736(10)62356-2; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; National Institute of Statistics Cambodia United Nations Population Fund Japan International Cooperation Agency, 2008, CAMB GEN POP CENS 20; Office of the Registrar General & Census Commissioner (India), 2009, COMP IND FERT MORT I; Qomariyah SN, 2010, LANCET, V375, P1964, DOI 10.1016/S0140-6736(10)60920-8; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rajaratnam JK, 2010, LANCET, V375, P1704, DOI 10.1016/S0140-6736(10)60517-X; Rajaratnam JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000253; Rasmussen C.E, 2006, MODEL SELECTION ADAP; Ravishankar N, 2009, FINANCING GLOBAL HLT; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; UN Development Group, 2003, IND MON MILL DEV GOA; *UN SECR GEN, 2001, ROAD MAP IMPL UN MIL; UN Secretary General, GLOB STRAT WOM CHILD; UNAIDS, 2010, GLOB REP UNAIDS REP; UNICEF, CHILD MON SIT CHILDR; United Nations, 2000, UN MILL DECL GEN ASS; United Nations Population Division, WORLD POP PROSP 2010; WHO, 2010, TRENDS MAT MORT 1990; World Health Organization, 2004, INT STAT CLASS DIS R; YOU D., 2010, LEVELS TRENDS CHILD; You DZ, 2010, LANCET, V376, P931, DOI 10.1016/S0140-6736(10)61429-8; Zureick S, LEVELS TRENDS MATERN	59	586	601	2	53	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2011	378	9797					1139	1165		10.1016/S0140-6736(11)61337-8	http://dx.doi.org/10.1016/S0140-6736(11)61337-8			27	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829RH	21937100				2022-12-28	WOS:000295601500023
J	Armon, S; Efrati, E; Kupferman, R; Sharon, E				Armon, Shahaf; Efrati, Efi; Kupferman, Raz; Sharon, Eran			Geometry and Mechanics in the Opening of Chiral Seed Pods	SCIENCE			English	Article							HELICAL RIBBONS; NANOBELTS	We studied the mechanical process of seed pods opening in Bauhinia variegate and found a chirality-creating mechanism, which turns an initially flat pod valve into a helix. We studied configurations of strips cut from pod valve tissue and from composite elastic materials that mimic its structure. The experiments reveal various helical configurations with sharp morphological transitions between them. Using the mathematical framework of "incompatible elasticity," we modeled the pod as a thin strip with a flat intrinsic metric and a saddle-like intrinsic curvature. Our theoretical analysis quantitatively predicts all observed configurations, thus linking the pod's microscopic structure and macroscopic conformation. We suggest that this type of incompatible strip is likely to play a role in the self-assembly of chiral macromolecules and could be used for the engineering of synthetic self-shaping devices.	[Armon, Shahaf; Efrati, Efi; Sharon, Eran] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Kupferman, Raz] Hebrew Univ Jerusalem, Inst Math, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Sharon, E (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.	erans@vms.huji.ac.il			Israeli Science Foundation; European Research Council; Eshkol Scholarship; Israeli Ministry of Science	Israeli Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission); Eshkol Scholarship; Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel)	We are grateful to Y. Abraham and U. Raviv for performing the small-angle x-ray scattering measurements. R. K. was partially supported by the Israeli Science Foundation. E. S. was partially supported by the European Research Council SoftGrowth project. S. A. was supported by the Eshkol Scholarship sponsored by the Israeli Ministry of Science.	Efrati E, 2009, J MECH PHYS SOLIDS, V57, P762, DOI 10.1016/j.jmps.2008.12.004; Efrati E, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016602; Elbaum R, 2007, SCIENCE, V316, P884, DOI 10.1126/science.1140097; FAHN A., 1955, PHYTOMORPHOLOGY [DELHI], V5, P99; Fahn A, 1972, SEED BIOL IMPORTANCE, P151; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Gao PX, 2005, SCIENCE, V309, P1700, DOI 10.1126/science.1116495; Ghafouri R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.138101; Kong XY, 2004, SCIENCE, V303, P1348, DOI 10.1126/science.1092356; Kroner E., 1981, LESS HOUCHES SESSION, P282; Oda R, 1999, NATURE, V399, P566, DOI 10.1038/21154; Reyssat E, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/54001; Reyssat E, 2009, J R SOC INTERFACE, V6, P951, DOI 10.1098/rsif.2009.0184; Seffen KA, 1999, P ROY SOC A-MATH PHY, V455, P1003, DOI 10.1098/rspa.1999.0347; Selinger JV, 2001, J PHYS CHEM B, V105, P7157, DOI 10.1021/jp010452d; Selinger RLB, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.158103; Skotheim JM, 2005, SCIENCE, V308, P1308, DOI 10.1126/science.1107976; Struik Dirk Jan, 1961, LECT CLASSICAL DIFFE, P7; WANG CC, 1967, ARCH RATION MECH AN, V27, P33, DOI 10.1007/BF00276434; Zastavker YV, 1999, P NATL ACAD SCI USA, V96, P7883, DOI 10.1073/pnas.96.14.7883; Zhang L, 2005, NANOTECHNOLOGY, V16, P655, DOI 10.1088/0957-4484/16/6/006	21	484	498	28	394	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1726	1730		10.1126/science.1203874	http://dx.doi.org/10.1126/science.1203874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940888				2022-12-28	WOS:000295121500036
J	Ramirez, SR; Eltz, T; Fujiwara, MK; Gerlach, G; Goldman-Huertas, B; Tsutsui, ND; Pierce, NE				Ramirez, Santiago R.; Eltz, Thomas; Fujiwara, Mikiko K.; Gerlach, Guenter; Goldman-Huertas, Benjamin; Tsutsui, Neil D.; Pierce, Naomi E.			Asynchronous Diversification in a Specialized Plant-Pollinator Mutualism	SCIENCE			English	Article							EUGLOSSINE BEES; ORCHID; EVOLUTION; MODELS	Most flowering plants establish mutualistic associations with insect pollinators to facilitate sexual reproduction. However, the evolutionary processes that gave rise to these associations remain poorly understood. We reconstructed the times of divergence, diversification patterns, and interaction networks of a diverse group of specialized orchids and their bee pollinators. In contrast to a scenario of coevolution by race formation, we show that fragrance-producing orchids originated at least three times independently after their fragrance-collecting bee mutualists. Whereas orchid diversification has apparently tracked the diversification of orchids' bee pollinators, bees appear to have depended on the diverse chemical environment of neotropical forests. We corroborated this apparent asymmetrical dependency by simulating co-extinction cascades in real interaction networks that lacked reciprocal specialization. These results suggest that the diversification of insect-pollinated angiosperms may have been facilitated by the exploitation of preexisting sensory biases of insect pollinators.	[Ramirez, Santiago R.; Fujiwara, Mikiko K.; Goldman-Huertas, Benjamin; Pierce, Naomi E.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Ramirez, Santiago R.; Tsutsui, Neil D.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Eltz, Thomas] Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, D-44780 Bochum, Germany; [Gerlach, Guenter] Bot Garten Munchen Nymphenburg, D-80638 Munich, Germany	Harvard University; University of California System; University of California Berkeley; Ruhr University Bochum	Ramirez, SR (corresponding author), Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA.	sramirez@post.harvard.edu	Ramirez, Santiago/B-4948-2012	Goldman-Huertas, Benjamin/0000-0002-6741-5193; Eltz, Thomas/0000-0002-8465-7944; Gerlach, Gunter/0000-0002-2819-7218	NSF [DEB-0608409, SES-0750480, DGE-0646147]; Society of Systematic Biologists, Fundacion Alejandro Angel Escobar (Colombia Biodiversa); Putnam (Harvard); German Science Foundation [EL 249/6]	NSF(National Science Foundation (NSF)); Society of Systematic Biologists, Fundacion Alejandro Angel Escobar (Colombia Biodiversa); Putnam (Harvard); German Science Foundation(German Research Foundation (DFG))	We thank M. Blanco, R. L. Dressler, F. Pupulin, G. Romero, and M. W. Whitten for pollinaria identification; A. Link, M. Lopez, and C. Hernandez for assistance during field work; R. Kaiser for chemical data; and B. Pringle, C. C. Davis, S. V. Edwards, B. D. Farrell, B. Gravendeel, M. Patten, T. B. Quental, E. L. Rezende, D. L. Roberts, and F. Zapata for useful comments. Supported by NSF Doctoral Dissertation Improvement Grant DEB-0608409, NSF grants SES-0750480 and DGE-0646147, and grants from the Society of Systematic Biologists, Fundacion Alejandro Angel Escobar (Colombia Biodiversa), and Putnam (Harvard) (S. R. R., B. G. H., and N.E.P.) and by German Science Foundation grant EL 249/6 (T. E.). DNA sequences are deposited in GenBank (JF691905 to JF692160; EU421211 to EU421711). Matrices and trees are deposited in treebase.org (S11737).	ACKERMAN JD, 1983, BIOL J LINN SOC, V20, P301, DOI 10.1111/j.1095-8312.1983.tb01878.x; [Anonymous], 1862, VARIOUS CONTRIVANCES; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Cardinal S, 2010, P NATL ACAD SCI USA, V107, P16207, DOI 10.1073/pnas.1006299107; Chase M.W., 2003, ORCHID CONSERV, P69; Conran JG, 2009, AM J BOT, V96, P466, DOI 10.3732/ajb.0800269; Courtois EA, 2009, J CHEM ECOL, V35, P1349, DOI 10.1007/s10886-009-9718-1; Dodson C.H., 1975, P91; DODSON CH, 1969, SCIENCE, V164, P1243, DOI 10.1126/science.164.3885.1243; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eltz T, 2005, J COMP PHYSIOL A, V191, P575, DOI 10.1007/s00359-005-0603-2; Grimaldi D, 1999, ANN MO BOT GARD, V86, P373, DOI 10.2307/2666181; Gustafsson ALS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-177; JANZEN DH, 1971, SCIENCE, V171, P203, DOI 10.1126/science.171.3967.203; KIESTER AR, 1984, AM NAT, V124, P220, DOI 10.1086/284265; Labandeira CC, 2010, ANN MO BOT GARD, V97, P469, DOI 10.3417/2010037; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Pemberton RW, 2006, ECOLOGY, V87, P1995, DOI 10.1890/0012-9658(2006)87[1995:OBDNOE]2.0.CO;2; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Ramirez SR, 2007, NATURE, V448, P1042, DOI 10.1038/nature06039; Ramirez SR, 2010, BIOL J LINN SOC, V100, P552, DOI 10.1111/j.1095-8312.2010.01440.x; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Ronsted N, 2005, P ROY SOC B-BIOL SCI, V272, P2593, DOI 10.1098/rspb.2005.3249; Roubik D. W., 2004, ORCHID BEES TROPICAL; Schiestl FP, 2010, ECOL LETT, V13, P643, DOI 10.1111/j.1461-0248.2010.01451.x; Thompson J. N., 2005, GEOGRAHIC MOSAIC COE; Whitten WM, 2000, AM J BOT, V87, P1842, DOI 10.2307/2656837; WHITTEN WM, 1993, J CHEM ECOL, V19, P3017, DOI 10.1007/BF00980599; Zimmermann Y, 2009, ECOLOGY, V90, P2994, DOI 10.1890/08-1858.1	29	108	115	3	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2011	333	6050					1742	1746		10.1126/science.1209175	http://dx.doi.org/10.1126/science.1209175			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940893	Green Submitted			2022-12-28	WOS:000295121500041
J	Burnett, C; Valentini, S; Cabreiro, F; Goss, M; Somogyvari, M; Piper, MD; Hoddinott, M; Sutphin, GL; Leko, V; McElwee, JJ; Vazquez-Manrique, RP; Orfila, AM; Ackerman, D; Au, C; Vinti, G; Riesen, M; Howard, K; Neri, C; Bedalov, A; Kaeberlein, M; Soti, C; Partridge, L; Gems, D				Burnett, Camilla; Valentini, Sara; Cabreiro, Filipe; Goss, Martin; Somogyvari, Milan; Piper, Matthew D.; Hoddinott, Matthew; Sutphin, George L.; Leko, Vid; McElwee, Joshua J.; Vazquez-Manrique, Rafael P.; Orfila, Anne-Marie; Ackerman, Daniel; Au, Catherine; Vinti, Giovanna; Riesen, Michele; Howard, Ken; Neri, Christian; Bedalov, Antonio; Kaeberlein, Matt; Soti, Csaba; Partridge, Linda; Gems, David			Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila	NATURE			English	Article							SMALL-MOLECULE ACTIVATORS; SACCHAROMYCES-CEREVISIAE; RESVERATROL; LONGEVITY; SIRTUINS; RESTRICTION; GENETICS; EXTENSION	Overexpression of sirtuins(NAD(+)-dependent protein deacetylases) has been reported to increase lifespan in budding yeast (Saccharomyces cerevisiae), Caenorhabditis elegans and Drosophila melanogaster(1-3). Studies of the effects of genes on ageing are vulnerable to confounding effects of genetic background(4). Here were-examined the reported effects of sirtuin overexpression on ageing and found that standardization of genetic background and the use of appropriate controls abolished the apparent effects in both C. elegans and Drosophila. In C. elegans, outcrossing of a line with high-level sir-2.1 overexpression(1) abrogated the longevity increase, but did not abrogate sir-2.1 overexpression. Instead, longevity co-segregated with a second-site mutation affecting sensory neurons. Outcrossing of a line with low-copy-number sir-2.1 overexpression(2) also abrogated longevity. A Drosophila strain with ubiquitous overexpression of dSir2 using the UAS-GAL4 system was long-lived relative to wild-type controls, as previously reported(3), but was not long-lived relative to the appropriate transgenic controls, and nor was a new line with stronger overexpression of dSir2. These findings underscore the importance of controlling for genetic background and for the mutagenic effects of transgene insertions in studies of genetic effects on lifespan. The life-extending effect of dietary restriction on ageing in Drosophila has also been reported to be dSir2 dependent(3). We found that dietary restriction increased fly lifespan independently of dSir2. Our findings do not rule out a role for sirtuins in determination of metazoan lifespan, but they do cast doubt on the robustness of the previously reported effects of sirtuins on lifespan in C. elegans and Drosophila.	[Burnett, Camilla; Valentini, Sara; Cabreiro, Filipe; Goss, Martin; Piper, Matthew D.; Hoddinott, Matthew; McElwee, Joshua J.; Ackerman, Daniel; Au, Catherine; Vinti, Giovanna; Riesen, Michele; Partridge, Linda; Gems, David] UCL, Inst Hlth Ageing, London WC1E 6BT, England; [Burnett, Camilla; Valentini, Sara; Cabreiro, Filipe; Goss, Martin; Piper, Matthew D.; Hoddinott, Matthew; McElwee, Joshua J.; Ackerman, Daniel; Au, Catherine; Vinti, Giovanna; Riesen, Michele; Partridge, Linda; Gems, David] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Somogyvari, Milan; Soti, Csaba] Semmelweis Univ, Dept Med Chem, H-1094 Budapest, Hungary; [Sutphin, George L.; Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Sutphin, George L.; Kaeberlein, Matt] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Leko, Vid; Bedalov, Antonio] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Vazquez-Manrique, Rafael P.; Orfila, Anne-Marie; Neri, Christian] INSERM, Lab Neuronal Cell Biol & Pathol, U894, F-75014 Paris, France; [Vazquez-Manrique, Rafael P.; Orfila, Anne-Marie; Neri, Christian] Univ Paris 05, F-75014 Paris, France; [Howard, Ken] UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England; [Partridge, Linda] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany	University of London; University College London; University of London; University College London; Semmelweis University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; MRC Laboratory Molecular Biology; University of London; University College London; Max Planck Society	Gems, D (corresponding author), UCL, Inst Hlth Ageing, Gower St, London WC1E 6BT, England.	david.gems@ucl.ac.uk	Sutphin, George L./AAE-6151-2020; Partridge, Linda/E-7342-2015; Piper, Matthew/C-1714-2008; Sőti, Csaba/O-6070-2017; Neri, Christian/F-6729-2013; Partridge, Linda/A-5501-2010; Vázquez-Manrique, Rafael/K-7882-2014	Piper, Matthew/0000-0003-3245-7219; Sőti, Csaba/0000-0002-4057-7678; Neri, Christian/0000-0002-3790-2978; Vázquez-Manrique, Rafael/0000-0002-1594-0033; Gems, David/0000-0002-6653-4676; Sutphin, George/0000-0002-3659-4678; Partridge, Linda/0000-0001-9615-0094; Cabreiro, Filipe/0000-0002-3696-4843; Ackerman, Daniel/0000-0002-3466-5444; Somogyvari, Milan/0000-0002-6257-4849; Au, Catherine/0000-0002-1923-9121; Kaeberlein, Matt/0000-0002-1311-3421	National Institutes of Health National Center for Research Resources; European Union [FP6-036894, FP6-518230]; Hungarian Science Foundation and Norway Grants [NNF-78794]; INSERM; ANR, Paris; National Institutes of Health [CA129132, R01AG031108, T32AG000057]; Wellcome Trust; Medical Research Council [G0700729B] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA129132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057, R01AG031108] Funding Source: NIH RePORTER	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); European Union(European Commission); Hungarian Science Foundation and Norway Grants; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR, Paris(French National Research Agency (ANR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Gartner for providing an antibody against C. elegans SIR-2.1; D. Chen, P. Kapahi, S. Pletcher and D. Skorupa for providing data; S. S. Lee for permission to cite unpublished results; S. Helfand and J. Rine for providing fly strains; W. Mair for performing preliminary trials and R. Baumeister for useful discussion. Some nematode strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources. We acknowledge funding from the European Union (FP6-036894 to C. B., D. G., L. P. and S. V. and FP6-518230 to D. G. and C. S.), the Hungarian Science Foundation and Norway Grants (NNF-78794 to C. S.), INSERM and ANR, Paris (R. V., A.-M.O. and C.N.), the National Institutes of Health (CA129132 to A. B., R01AG031108 to M. K. and T32AG000057 to G. L. S.) and the Wellcome Trust (Strategic Award to C. A., F. C., D. G., L. P. and M. R.). C. S. is a Bolyai Research Scholar of the Hungarian Academy of Sciences and M. K. is an Ellison Medical Foundation New Scholar in Aging.	Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Astrom SU, 2003, GENETICS, V163, P931; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Borra MT, 2004, METHOD ENZYMOL, V376, P171; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRENNER S, 1974, GENETICS, V77, P71; Garber K, 2008, NAT BIOTECHNOL, V26, P371, DOI 10.1038/nbt0408-371; Gems D, 1998, GENETICS, V150, P129; Grandison RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004067; Greiss S, 2008, GENE DEV, V22, P2831, DOI 10.1101/gad.482608; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Newman BL, 2002, GENETICS, V162, P1675; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Partridge L, 2007, NATURE, V450, P165, DOI 10.1038/450165a; Patel DS, 2008, GENETICS, V178, P931, DOI 10.1534/genetics.107.070813; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Wang YM, 2006, MECH AGEING DEV, V127, P48, DOI 10.1016/j.mad.2005.09.005; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	36	460	488	0	174	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 22	2011	477	7365					482	U136		10.1038/nature10296	http://dx.doi.org/10.1038/nature10296			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21938067	Green Accepted, Green Submitted			2022-12-28	WOS:000295080500044
J	Singer, PW				Singer, P. W.			A world of killer apps	NATURE			English	Editorial Material									Brookings Inst, 21st Century Def Initiat, Washington, DC 20036 USA	Brookings Institution	Singer, PW (corresponding author), Brookings Inst, 21st Century Def Initiat, Washington, DC 20036 USA.								0	9	9	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2011	477	7365					399	401		10.1038/477399a	http://dx.doi.org/10.1038/477399a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	822WH	21938049				2022-12-28	WOS:000295080500016
J	Wong, TS; Kang, SH; Tang, SKY; Smythe, EJ; Hatton, BD; Grinthal, A; Aizenberg, J				Wong, Tak-Sing; Kang, Sung Hoon; Tang, Sindy K. Y.; Smythe, Elizabeth J.; Hatton, Benjamin D.; Grinthal, Alison; Aizenberg, Joanna			Bioinspired self-repairing slippery surfaces with pressure-stable omniphobicity	NATURE			English	Article							SOLID-SURFACES; WATER; RESISTANCE; DROPS	Creating a robust synthetic surface that repels various liquids would have broad technological implications for areas ranging from biomedical devices and fuel transport to architecture but has proved extremely challenging(1). Inspirations from natural non-wetting structures(2-6), particularly the leaves of the lotus, have led to the development of liquid-repellent microtextured surfaces that rely on the formation of a stable air-liquid interface(7-9). Despite over a decade of intense research, these surfaces are, however, still plagued with problems that restrict their practical applications: limited oleophobicity with high contact angle hysteresis(9), failure under pressure(10-12) and upon physical damage(1,7,11), inability to self-heal and high production cost(1,11). To address these challenges, here we report a strategy to create self-healing, slippery liquid-infused porous surface(s) (SLIPS) with exceptional liquid- and ice-repellency, pressure stability and enhanced optical transparency. Our approach-inspired by Nepenthes pitcher plants(13)-is conceptually different from the lotus effect, because we use nano/microstructured substrates to lock in place the infused lubricating fluid. We define the requirements for which the lubricant forms a stable, defect-free and inert 'slippery' interface. This surface outperforms its natural counterparts(2-6) and state-of-the-art synthetic liquid-repellent surfaces(8,9,14-16) in its capability to repel various simple and complex liquids (water, hydrocarbons, crude oil and blood), maintain low contact angle hysteresis (<2.5 degrees), quickly restore liquid-repellency after physical damage (within 0.1-1 s), resist ice adhesion, and function at high pressures (up to about 680 atm). We show that these properties are insensitive to the precise geometry of the underlying substrate, making our approach applicable to various inexpensive, low-surface-energy structured materials (such as porous Teflon membrane). We envision that these slippery surfaces will be useful in fluid handling and transportation, optical sensing, medicine, and as self-cleaning and antifouling materials operating in extreme environments.	[Wong, Tak-Sing; Kang, Sung Hoon; Tang, Sindy K. Y.; Hatton, Benjamin D.; Grinthal, Alison; Aizenberg, Joanna] Harvard Univ, Wyss Inst Biol Inspired Engn, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Wong, Tak-Sing; Kang, Sung Hoon; Tang, Sindy K. Y.; Hatton, Benjamin D.; Grinthal, Alison; Aizenberg, Joanna] Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA; [Smythe, Elizabeth J.] Schlumberger Doll Res Ctr, Cambridge, MA 02139 USA	Harvard University; Harvard University; Schlumberger	Aizenberg, J (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	jaiz@seas.harvard.edu	Hatton, Benjamin D/I-4239-2012; Wong, Tak Sing/L-9488-2013; Kang, Sung H/B-1084-2010; Kang, Sung Hoon/AAA-9959-2020; Im, Hwon/B-5659-2012	Wong, Tak Sing/0000-0001-5500-0575; Kang, Sung H/0000-0002-9156-3348; Kang, Sung Hoon/0000-0002-9156-3348; 	Croucher Foundation; AFOSR MURI [FA9550-09-1-0669-DOD35CAP]; ARO MURI [W911NF-09-1-0476]; NSF [ECS-0335765]	Croucher Foundation; AFOSR MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); ARO MURI(MURI); NSF(National Science Foundation (NSF))	T.-S.W. acknowledges funding support from the Croucher Foundation Postdoctoral Fellowship. We thank K. E. Martin for help with the drop impact test. We also thank J. C. Weaver and P. Allen for help in manuscript preparation. The work was supported partially by the AFOSR MURI award FA9550-09-1-0669-DOD35CAP (optical properties), and ARO MURI award W911NF-09-1-0476 (robustness and self-repair). We acknowledge the use of the facilities at the Harvard Center for Nanoscale Systems supported by the NSF under award ECS-0335765.	Ahuja A, 2008, LANGMUIR, V24, P9, DOI 10.1021/la702327z; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Bauer U, 2009, PLANT SIGNAL BEHAV, V4, P1019, DOI 10.4161/psb.4.11.9664; Bocquet L, 2011, NAT MATER, V10, P334, DOI 10.1038/nmat2994; Bohn HF, 2004, P NATL ACAD SCI USA, V101, P14138, DOI 10.1073/pnas.0405885101; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; CASSIE ABD, 1945, NATURE, V155, P21, DOI 10.1038/155021a0; Chen W, 1999, LANGMUIR, V15, P3395, DOI 10.1021/la990074s; Courbin L, 2007, NAT MATER, V6, P661, DOI 10.1038/nmat1978; de Gennes P.-G., 2003, CAPILLARITY WETTING, P15; Delmas M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.136102; Epstein AK, 2011, P NATL ACAD SCI USA, V108, P995, DOI 10.1073/pnas.1011033108; Federle W, 2002, INTEGR COMP BIOL, V42, P1100, DOI 10.1093/icb/42.6.1100; FURMIDGE CG, 1962, J COLL SCI IMP U TOK, V17, P309, DOI 10.1016/0095-8522(62)90011-9; Gao XF, 2004, NATURE, V432, P36, DOI 10.1038/432036a; Gao XF, 2007, ADV MATER, V19, P2213, DOI 10.1002/adma.200601946; Hansen WR, 2005, P NATL ACAD SCI USA, V102, P385, DOI 10.1073/pnas.0408304102; Ishino C, 2007, EPL-EUROPHYS LETT, V79, DOI 10.1209/0295-5075/79/56005; Lee C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.014502; Li Y, 2010, ANGEW CHEM INT EDIT, V49, P6129, DOI 10.1002/anie.201001258; Nakajima A, 1999, ADV MATER, V11, P1365, DOI 10.1002/(SICI)1521-4095(199911)11:16<1365::AID-ADMA1365>3.3.CO;2-6; Nguyen TPN, 2010, LANGMUIR, V26, P18369, DOI 10.1021/la103097y; Poetes R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.166104; Pokroy B, 2009, ADV MATER, V21, P463, DOI 10.1002/adma.200801432; Quere D, 2005, REP PROG PHYS, V68, P2495, DOI 10.1088/0034-4885/68/11/R01; Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434; SHAFRIN EG, 1960, J PHYS CHEM-US, V64, P519, DOI 10.1021/j100834a002; Tuteja A, 2007, SCIENCE, V318, P1618, DOI 10.1126/science.1148326; Tuteja A, 2008, P NATL ACAD SCI USA, V105, P18200, DOI 10.1073/pnas.0804872105; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024	30	2479	2625	198	3539	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2011	477	7365					443	447		10.1038/nature10447	http://dx.doi.org/10.1038/nature10447			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21938066	Green Submitted			2022-12-28	WOS:000295080500036
J	Navathe, AS; Clancy, C; Glied, S				Navathe, Amol S.; Clancy, Carolyn; Glied, Sherry			Advancing Research Data Infrastructure for Patient-Centered Outcomes Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Navathe, Amol S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Navathe, Amol S.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Navathe, Amol S.; Clancy, Carolyn; Glied, Sherry] US Dept HHS, Washington, DC 20201 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Pennsylvania	Navathe, AS (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, PBB-B4,75 Francis St, Boston, MA 02115 USA.	anavathe@partners.org		Navathe, Amol/0000-0001-7182-4988				FDA'sSentinel Initiative, FDAS SENT IN	1	11	11	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2011	306	11					1254	1255		10.1001/jama.2011.1341	http://dx.doi.org/10.1001/jama.2011.1341			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HB	21934060				2022-12-28	WOS:000295033500028
J	Parodi, G; Marcucci, R; Valenti, R; Gori, AM; Migliorini, A; Giusti, B; Buonamici, P; Gensini, GF; Abbate, R; Abbate, R; Antoniucci, D				Parodi, Guido; Marcucci, Rossella; Valenti, Renato; Gori, Anna Maria; Migliorini, Angela; Giusti, Betti; Buonamici, Piergiovanni; Gensini, Gian Franco; Abbate, Rosanna; Abbate, Rosanna; Antoniucci, David			High Residual Platelet Reactivity After Clopidogrel Loading and Long-term Cardiovascular Events Among Patients With Acute Coronary Syndromes Undergoing PCI	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-CARE ASSAY; MYOCARDIAL-INFARCTION; STENT THROMBOSIS; RESISTANCE; INTERVENTION; IMPACT; INDEX; NONRESPONDERS; AGGREGATION; INHIBITION	Context High residual platelet reactivity (HRPR) in patients receiving clopidogrel has been associated with high risk of ischemic events after percutaneous coronary intervention (PCI). Objective To test the hypothesis that HRPR after clopidogrel loading is an independent prognostic marker of risk of long-term thrombotic events in patients with acute coronary syndromes (ACS) undergoing an invasive procedure and antithrombotic treatment adjusted according to the results of platelet function tests. Design, Setting, and Patients Prospective, observational, referral center cohort study of 1789 consecutive patients with ACS undergoing PCI from April 2005 to April 2009 at the Division of Cardiology of Careggi Hospital, Florence, Italy, in whom platelet reactivity was prospectively assessed by light transmittance aggregometry. Interventions All patients received 325 mg of aspirin and a loading dose of 600 mg of clopidogrel followed by a maintenance dosage of 325 mg/d of aspirin and 75 mg/d of clopidogrel for at least 6 months. Patients with HRPR as assessed by adenosine diphosphate test (>= 70% platelet aggregation) received an increased dose of clopidogrel (150-300 mg/d) or switched to ticlopidine (500-1000 mg/d) under adenosine diphosphate test guidance. Main Outcome Measures The primary end point was a composite of cardiac death, myocardial infarction, any urgent coronary revascularization, and stroke at 2-year follow-up. Secondary end points were stent thrombosis and each component of the primary end point. Results The primary end point event rate was 14.6% (36/247) in patients with HRPR and 8.7% (132/1525) in patients with low residual platelet reactivity (absolute risk increase, 5.9%; 95% CI, 1.6%-11.1%; P=.003). Stent thrombosis was higher in the HRPR group compared with the low residual platelet reactivity group (6.1% [15/247] vs 2.9% [44/1525]; absolute risk increase, 3.2%; 95% CI, 0.4%-6.7%; P=.01). By multivariable analysis, HRPR was independently associated with the primary end point (hazard ratio, 1.49; 95% CI, 1.08-2.05; P=.02) and with cardiac mortality (hazard ratio, 1.81; 95% CI, 1.18-2.76; P=.006). Conclusion Among patients receiving platelet reactivity-guided antithrombotic medication after PCI, HRPR status was significantly associated with increased risk of ischemic events at short-and long-term follow-up.	[Antoniucci, David] Careggi Hosp, Div Cardiol, Dept Cardiol, I-50134 Florence, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi	Antoniucci, D (corresponding author), Careggi Hosp, Div Cardiol, Dept Cardiol, Viale Pieraccini 17, I-50134 Florence, Italy.	david.antoniucci@virgilio.it	Marcucci, Rossella/K-8471-2016; Giusti, Betti/K-6978-2016; 刘, 李陆/H-8469-2015; Parodi, Guido/R-9346-2016; Gori, annamaria.gori@unifi.it/K-6077-2016	Giusti, Betti/0000-0002-8708-9444; Parodi, Guido/0000-0002-9718-9107; Gori, annamaria.gori@unifi.it/0000-0001-6857-5861; Marcucci, Rossella/0000-0001-9549-7176	Bayer; Boehringer Ingelheim; Eli Lilly; AstraZeneca; GlaxoSmithKline; Instrumentation Laboratory; Menarini; Sigma Tau; Novo Nordisk; Merck Sharp Dohme; Pfizer; Pierrel; sanofi-aventis; Servier; Daiichi Sankyo/Eli Lilly; Medicines Company; Italian Health Ministry	Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Eli Lilly(Eli Lilly); AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Instrumentation Laboratory; Menarini(Menarini Group); Sigma Tau; Novo Nordisk(Novo Nordisk); Merck Sharp Dohme(Merck & Company); Pfizer(Pfizer); Pierrel; sanofi-aventis(Sanofi-Aventis); Servier(Servier); Daiichi Sankyo/Eli Lilly(Daiichi Sankyo Company LimitedEli Lilly); Medicines Company; Italian Health Ministry(Ministry of Health, Italy)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Parodi reported receiving consulting fees from Daiichi Sankyo/Eli Lilly. Dr Marcucci reported receiving honoraria for lectures from Daiichi Sankyo/Eli Lilly and Merck Sharp & Dohme. Dr Gensini reported receiving consulting fees from Bayer, Boehringer Ingelheim, and Eli Lilly; lecture fees from AstraZeneca, GlaxoSmithKline, Instrumentation Laboratory, Menarini, and Sigma Tau; and research grant funding from Novo Nordisk, Merck Sharp & Dohme, Pfizer, Pierrel, sanofi-aventis, and Servier. Dr Abbate reported receiving consulting fees from Eli Lilly; lecture fees from Instrumentation Laboratory and Sigma Tau; and research grant funding from Bayer, Boehringer Ingelheim, and Pfizer. Dr Antoniucci reported receiving consulting fees from Daiichi Sankyo/Eli Lilly and The Medicines Company and serving on the advisory boards of Cordis and CID. No other disclosures were reported.; This study was supported by an unrestricted grant from the Italian Health Ministry to the Tuscany Region for the Finalized Medical Research Program 2007.	Angiolillo DJ, 2007, J AM COLL CARDIOL, V50, P1541, DOI 10.1016/j.jacc.2007.05.049; Barragan P, 2003, CATHETER CARDIO INTE, V59, P295, DOI 10.1002/ccd.10497; Bonello L, 2007, J THROMB HAEMOST, V5, P1630, DOI 10.1111/j.1538-7836.2007.02609.x; Bonello L, 2008, J AM COLL CARDIOL, V51, P1404, DOI 10.1016/j.jacc.2007.12.044; Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047; Bonello L, 2009, AM J CARDIOL, V103, P5, DOI 10.1016/j.amjcard.2008.08.048; Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181; Buonamici P, 2007, J AM COLL CARDIOL, V49, P2312, DOI 10.1016/j.jacc.2007.01.094; Chin CT, 2010, AM HEART J, V160, P16, DOI 10.1016/j.ahj.2010.04.022; Cuisset T, 2009, AM J CARDIOL, V104, P1078, DOI 10.1016/j.amjcard.2009.06.007; Cuisset T, 2008, JACC-CARDIOVASC INTE, V1, P649, DOI 10.1016/j.jcin.2008.08.018; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Frere C, 2007, THROMB HAEMOSTASIS, V98, P838, DOI 10.1160/TH07-04-0296; Gori AM, 2008, J AM COLL CARDIOL, V52, P734, DOI 10.1016/j.jacc.2008.05.032; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1820, DOI 10.1016/j.jacc.2005.07.041; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Gurbel PA, 2007, J AM COLL CARDIOL, V50, P1822, DOI 10.1016/j.jacc.2007.07.051; Gurbel PA, 2010, CIRCULATION, V121, P1188, DOI 10.1161/CIRCULATIONAHA.109.919456; Marcucci R, 2009, CIRCULATION, V119, P237, DOI 10.1161/CIRCULATIONAHA.108.812636; Matetzky S, 2004, CIRCULATION, V109, P3171, DOI 10.1161/01.CIR.0000130846.46168.03; Migliorini A, 2009, CIRCULATION, V120, P2214, DOI 10.1161/CIRCULATIONAHA.109.883454; Price MJ, 2008, EUR HEART J, V29, P992, DOI 10.1093/eurheartj/ehn046; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Sibbing D, 2007, BLOOD COAGUL FIBRIN, V18, P335, DOI 10.1097/MBC.0b013e3280d21aed; Valgimigli M, 2009, CIRCULATION, V119, P3215, DOI 10.1161/CIRCULATIONAHA.108.833236	25	331	342	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2011	306	11					1215	1223		10.1001/jama.2011.1332	http://dx.doi.org/10.1001/jama.2011.1332			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HB	21934054	Green Published, Bronze			2022-12-28	WOS:000295033500022
J	Sharfstein, JM				Sharfstein, Joshua M.			The FDA-A Misunderstood Agency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Maryland Dept Hlth & Mental Hyg, Baltimore, MD 21202 USA	Maryland Department of Health & Mental Hygiene	Sharfstein, JM (corresponding author), Maryland Dept Hlth & Mental Hyg, 201 W Preston St, Baltimore, MD 21202 USA.	JSharfstein@DHMH.state.md.us						[Anonymous], AB FDA; Hamburg MA, 2009, NEW ENGL J MED, V360, P2493, DOI 10.1056/NEJMp0903764; Sharfstein JM, 2007, NEW ENGL J MED, V357, P2321, DOI 10.1056/NEJMp0707400; *US FDA, FDA TRACK AG WID PRO; *US FDA, FDA BAS PROV INF FDA; US Food and Drug Administration, ADV REG SCI PUBL HLT	6	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2011	306	11					1250	1251		10.1001/jama.2011.1345	http://dx.doi.org/10.1001/jama.2011.1345			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HB	21934058				2022-12-28	WOS:000295033500026
J	Ram, FSF				Ram, Felix S. F.			Review: Oral phosphodiesterase 4 inhibitors reduce exacerbations but increase adverse events in COPD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Massey Univ, Auckland, New Zealand	Massey University	Ram, FSF (corresponding author), Massey Univ, Auckland, New Zealand.			Ram, Felix Simon Francis/0000-0002-5437-4089				Jones Paul W, 2005, COPD, V2, P75; Robichaud A, 2002, J CLIN INVEST, V110, P1045, DOI 10.1172/JCI200215506	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6							JC3-2	10.7326/0003-4819-155-6-201109200-02002	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930839				2022-12-28	WOS:000295033400001
J	Pincock, S				Pincock, Stephen			Baruj Benacerraf Obituary	LANCET			English	Biographical-Item														Pincock, Stephen/0000-0003-1655-2902					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 17	2011	378	9796					1066	1066		10.1016/S0140-6736(11)61468-2	http://dx.doi.org/10.1016/S0140-6736(11)61468-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829BE	21936065				2022-12-28	WOS:000295548900014
J	Mannino, DM; Martinez, FJ				Mannino, David M.; Martinez, Fernando J.			Lifetime risk of COPD: what will the future bring?	LANCET			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; PREVALENCE		[Martinez, Fernando J.] Univ Michigan Hlth Syst, Dept Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Mannino, David M.] Univ Kentucky, Coll Publ Hlth, Dept Prevent Med & Environm Hlth, Lexington, KY USA	University of Michigan System; University of Michigan; University of Kentucky	Martinez, FJ (corresponding author), Univ Michigan Hlth Syst, Dept Pulm & Crit Care Med, Ann Arbor, MI 48109 USA.	fmartine@umich.edu		Mannino, David/0000-0003-3646-7828				FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Ford ES, 2012, CHEST, V141, P101, DOI 10.1378/chest.11-0472; Gershon AS, 2011, LANCET, V378, P991, DOI 10.1016/S0140-6736(11)60990-2; Gillum LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016837; Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419; Lundback B, 2003, RESP MED, V97, P115, DOI 10.1053/rmed.2003.1446; Mannino David M, 2007, Proc Am Thorac Soc, V4, P502, DOI 10.1513/pats.200701-001FM; Rennard SI, 2006, LANCET, V367, P1216, DOI 10.1016/S0140-6736(06)68516-4; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Soriano JB, 2010, EUR RESPIR J, V36, P758, DOI 10.1183/09031936.00138409; Svanes C, 2010, THORAX, V65, P14, DOI 10.1136/thx.2008.112136; Vasankari TM, 2010, EUR RESPIR J, V36, P766, DOI 10.1183/09031936.00178109	12	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2011	378	9795					964	965		10.1016/S0140-6736(11)61188-4	http://dx.doi.org/10.1016/S0140-6736(11)61188-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	824HO	21907847				2022-12-28	WOS:000295193200005
J	Martinez, FJ; Donohue, JF; Rennard, SI				Martinez, Fernando J.; Donohue, James F.; Rennard, Stephen I.			Chronic Obstructive Pulmonary Disease 2 The future of chronic obstructive pulmonary disease treatment-difficulties of and barriers to drug development	LANCET			English	Article							6-MINUTE WALK DISTANCE; AIR-FLOW OBSTRUCTION; COPD EXACERBATIONS; BODE INDEX; SALMETEROL/FLUTICASONE PROPIONATE; AUGMENTATION THERAPY; PROGENITOR CELLS; CT DENSITOMETRY; CLINICAL-TRIALS; SMALL AIRWAYS	Although chronic obstructive pulmonary disease (COPD) is a major global health problem with a rising incidence and morbidity, few pharmacotherapeutic advances have been made over the past several decades. The challenges of development of such agents are multifactorial and include rudimentary understanding of the biological genesis of human disease, inadequate in-vitro and in-vivo models, unvalidated biomarkers, inefficient physiological and clinical endpoints, and variable regulatory review worldwide. Blockade of various inflammatory pathways and mediators is a reasonable therapeutic strategy to alter the natural history of COPD. Substantial heterogeneity is evident with respect to clinical presentation, physiology, imaging, response to therapy, decline in lung function, and survival. Numerous endpoints have been proposed for clinical studies in COPD, with new approaches under study. The novel strategy that seems most promising is the use of biomarkers. We hope that with these approaches novel pharmacotherapies will be developed in the near future.	[Martinez, Fernando J.] Univ Michigan, Dept Internal Med & Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Donohue, James F.] Univ N Carolina, Sch Med, Div Pulm & Crit Care Med, Chapel Hill, NC USA; [Rennard, Stephen I.] Univ Nebraska Med Ctr, Dept Internal Med, Pulm & Crit Care Med Sect, Omaha, NE USA	University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Nebraska System; University of Nebraska Medical Center	Martinez, FJ (corresponding author), Univ Michigan, Dept Internal Med & Pulm & Crit Care Med, Ann Arbor, MI 48109 USA.	fmartine@umich.edu			Boehringer Ingelheim; Gilead; Johnson and Johnson; Centocor; Actelion; GlaxoSmithKline; National Association for Continuing Education; MedEd; Potomac Center for Medical Education; Pfizer; CME Incite; Schering; Vox Medic; American Lung Association; WebMD; AstraZenca; France Foundation; Altana; Nycomed; HIT Global; UpToDate; American Academy of Allergy, Asthma, and Immunology; American College of Osteopathic Physicians; Asan medical centre; American Thoracic Society; AstraZeneca; California Society of Allergy; Convergent Health Solutions for Reviews and Trends in COPD; COPDFoundation; Creative Education Concepts; Dey; Duke; Information TV; University of California; Network for Continuing Education; Novartis; Ostuka; Sarasota Memorial Hospital; Spanish Thoracic Society; University of Washington; University of Alabama; University of Pittsburgh; University of British Columbia; VA Sioux Falls; Biomarck; Mpex; Nabi; National Institutes of Health, National Heart, Lung and Blood Institute	Boehringer Ingelheim(Boehringer Ingelheim); Gilead(Gilead Sciences); Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Centocor; Actelion; GlaxoSmithKline(GlaxoSmithKline); National Association for Continuing Education; MedEd; Potomac Center for Medical Education; Pfizer(Pfizer); CME Incite; Schering; Vox Medic; American Lung Association; WebMD; AstraZenca; France Foundation; Altana; Nycomed; HIT Global; UpToDate; American Academy of Allergy, Asthma, and Immunology; American College of Osteopathic Physicians; Asan medical centre; American Thoracic Society; AstraZeneca(AstraZeneca); California Society of Allergy; Convergent Health Solutions for Reviews and Trends in COPD; COPDFoundation; Creative Education Concepts; Dey; Duke; Information TV; University of California(University of California System); Network for Continuing Education; Novartis(Novartis); Ostuka; Sarasota Memorial Hospital; Spanish Thoracic Society; University of Washington(University of Washington); University of Alabama; University of Pittsburgh(University of Pittsburgh); University of British Columbia; VA Sioux Falls; Biomarck; Mpex; Nabi; National Institutes of Health, National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	FJM has served on advisory boards or steering committees for GlaxoSmithKline, MedImmune, AstraZeneca, Merck, Pearl, Novartis, UBC, MPex, and Ikaria; served as a consultant for Forest Laboratories, Almirall, Boehringer Ingelheim, Nycomed, Roche, Bayer, Schering, Health Learning Systems, Talecris, Comgenix, FB Communications, BoomCom, Actelion, Elan, Genzyme, Quark, Merck, Pfizer, and Sanofi-Aventis; received grants from Boehringer Ingelheim, Gilead, Johnson and Johnson, Centocor, and Actelion; received speaker's fees from GlaxoSmithKline, National Association for Continuing Education, MedEd, Potomac Center for Medical Education, Pfizer, Boehringer Ingelheim, CME Incite, Schering, Vox Medic, American Lung Association, WebMD, AstraZenca, France Foundation, Altana, and Nycomed; received book royalties from Associates in Medical Marketing, Assan Medical Center, and Castle Connolly; received payment for development of educational presentations from France Foundation, HIT Global, and UpToDate. JFD has served as a consultant for Novartis, GlaxoSmithKline, Boehringer Ingelheim, Forest Laboratories, Pfizer, Almirall, Sunouim, Talecris, ePocrates, and Elevation. SR has served as a consultant or participated in advisory boards for American Board of Internal Medicine, Able Associates, Adelphi Research, Almirall, APT Pharamceuticals, Aradigm, Argenta, AstraZeneca, Boehringer Ingelheim (American College of Chest Physicians), Biostrategies, BoomCom, Britnall and Nicolini, Capital Research, Chiesi, Clinical Advisors, CommonHealth, Complete Medical Group, Consult Complete, COPDForum, DataMonitor, Decision Resources, Defined Health, Dey, Dunn Croup, Easton Associates, Enterprise Analysis, Equinox, Forest, Fulcrum, Gerson Lehman, GlaxoSmithKline, Guidepoint, Hoffman LaRoche, IMS Health, Informed, Inspire, Insyght, KOL Connection, Leerink Swan, M Pankove, MDRx Financial, MedaCorp, Medimmune, Mpex, Novartis, Nycomed, Oriel, Ostuka, Pearl, Pennside Partners, Pfizer, Pharma Ventures, Pharmaxis, Pick Research, Prescott, Price Waterhouse, Propagate, Pulmatrix, Pulmonary Reviews, Quadrant, Reckner Associates, Recruiting Resource, Reviews and Trends in COPD, Convergent Health Solutions, Roche, Sacoor, Schering, Schlesinger Medical, Scimed, Smith Research, Sudler and Hennessey, Talecris, Theravance, United BioSource, Uptake Medical, and Vantage Point; received lecture fees from American Academy of Allergy, Asthma, and Immunology, American College of Osteopathic Physicians, Asan medical centre, American Thoracic Society, AstraZeneca, California Society of Allergy, Convergent Health Solutions for Reviews and Trends in COPD, COPDFoundation, Creative Education Concepts, Dey, Duke, France Foundation, Information TV, University of California, Network for Continuing Education, Novartis, Nycomed, Ostuka, Pfizer, Sarasota Memorial Hospital, Spanish Thoracic Society, University of Washington, University of Alabama, University of Pittsburgh, University of British Columbia, University of California, VA Sioux Falls; and received grants from AstraZeneca, Biomarck, Centocor, GlaxoSmithKline, Mpex, Nabi, Novartis, Ostuka, and Pfizer.; FJM's contribution was supported by funding from the National Institutes of Health, National Heart, Lung and Blood Institute.	Adams CP, 2006, HEALTH AFFAIR, V25, P420, DOI 10.1377/hlthaff.25.2.420; Agusti AGN, 2003, EUR RESPIR J, V21, P347, DOI 10.1183/09031936.03.00405703; Agusti A, 2011, AM J RESP CRIT CARE, V183, P1129, DOI 10.1164/rccm.201009-1414PP; Aliverti A, 2007, RESPIROLOGY, V12, P478, DOI 10.1111/j.1440-1843.2007.01106.x; [Anonymous], 2010, GUID CLIN INV MED PR; Anthonisen N, 1991, Ann N Y Acad Sci, V624 Suppl, P31, DOI 10.1111/j.1749-6632.1991.tb55336.x; Anzueto Antonio, 2007, Proc Am Thorac Soc, V4, P554, DOI 10.1513/pats.200701-003FM; Anzueto A, 2009, COPD, V6, P320, DOI 10.1080/15412550903140881; Azarisman MS, 2007, POSTGRAD MED J, V83, P492, DOI 10.1136/pgmj.2006.052399; Balmes J, 2003, AM J RESP CRIT CARE, V167, P787, DOI 10.1164/rccm.167.5.787; Barbera JA, 2003, EUR RESPIR J, V21, P892, DOI 10.1183/09031936.03.00115402; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Barnes PJ, 2008, CHEST, V134, P1278, DOI 10.1378/chest.08-1385; Barnes PJ, 2004, LANCET, V364, P985, DOI 10.1016/S0140-6736(04)17025-6; Beeh KM, 2010, ADV THER, V27, P150, DOI 10.1007/s12325-010-0017-6; Briggs A, 2008, ARCH INTERN MED, V168, P71, DOI 10.1001/archinternmed.2007.37; Burgel PR, 2010, EUR RESPIR J, V36, P531, DOI 10.1183/09031936.00175109; Calverley PMA, 2009, LANCET, V374, P685, DOI 10.1016/S0140-6736(09)61255-1; Casanova C, 2005, AM J RESP CRIT CARE, V171, P591, DOI 10.1164/rccm.200407-867OC; CAZZOLA M, 2008, EUR RESPIR J, V31, P1; Cazzola M, 2010, PULM PHARMACOL THER, V23, P493, DOI 10.1016/j.pupt.2010.05.001; Celli B, 2009, AM J RESP CRIT CARE, V180, P948, DOI 10.1164/rccm.200906-0876OC; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Center for Research on Environmental Decisions, 2009, POL INS, P1; Cho MH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-30; Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074; *CLINCALTRIALS GOV, 2011, TERSA TREATM EMPH GA; Cote CG, 2008, EUR RESPIR J, V32, P1269, DOI 10.1183/09031936.00138507; Crim C, 2011, RESP MED, V105, P1069, DOI 10.1016/j.rmed.2011.01.010; *CTR DRUG EV RES, 2010, QUAL PROC DRUG DEV T, P1; D'silva L, 2007, RESP MED, V101, P2217, DOI 10.1016/j.rmed.2007.05.010; da Costa GM, 2009, J BRAS PNEUMOL, V35, P325, DOI 10.1590/S1806-37132009000400006; Daudey L, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-98; Diba C, 2011, RESP MED, V105, P1345, DOI 10.1016/j.rmed.2011.03.013; Dodd JW, 2011, THORAX, V66, P425, DOI 10.1136/thx.2010.156372; Effing TW, 2009, CHEST, V136, P918, DOI 10.1378/chest.08-1680; Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST; Fishman A, 2001, NEW ENGL J MED, V345, P1075; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; *FOOD DRUG ADM, 2007, CHRON OBSTR PULM DIS, P1; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Garcia-Aymerich J, 2011, THORAX, V66, P585, DOI 10.1136/thx.2010.152876; Gelb AF, 1996, CHEST, V109, P353, DOI 10.1378/chest.109.2.353; Glaab T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-79; Grydeland TB, 2010, AM J RESP CRIT CARE, V181, P353, DOI 10.1164/rccm.200907-1008OC; HALBERT R, 2006, EUR RESPIR J, V28, P423; Han MK, 2010, EUR RESPIR J, V35, P1048, DOI 10.1183/09031936.00052509; Han MK, 2007, AM J RESP CRIT CARE, V176, P1179, DOI 10.1164/rccm.200704-553CC; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Han MK, 2009, COPD, V6, P459, DOI 10.3109/15412550903341513; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; Hegab AE, 2008, MOL THER, V16, P1417, DOI 10.1038/mt.2008.137; Hnizdo E, 2004, AM J IND MED, V46, P126, DOI 10.1002/ajim.20042; Hoesein FAAM, 2011, THORAX, V66, P782, DOI 10.1136/thx.2010.145995; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Holland AE, 2010, ARCH PHYS MED REHAB, V91, P221, DOI 10.1016/j.apmr.2009.10.017; Hurst JR, 2007, CLIN CHEST MED, V28, P525, DOI 10.1016/j.ccm.2007.05.003; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Hurst JR, 2009, AM J RESP CRIT CARE, V179, P369, DOI 10.1164/rccm.200807-1067OC; Hurst JR, 2006, AM J RESP CRIT CARE, V173, P71, DOI 10.1164/rccm.200505-704OC; Inst Med, 2010, EVALUATION OF BIOMARKERS AND SURROGATE ENDPOINTS IN CHRONIC DISEASE, P1; Ishizawa K, 2004, FEBS LETT, V556, P249, DOI 10.1016/S0014-5793(03)01399-1; Jenkins CR, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-59; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Jones PW, 2011, CHEST, V139, P1388, DOI 10.1378/chest.10-1240; Jones RC, 2009, AM J RESP CRIT CARE, V180, P1189, DOI 10.1164/rccm.200902-0271OC; Soler-Cataluna JJ, 2009, RESP MED, V103, P692, DOI 10.1016/j.rmed.2008.12.005; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Keene ON, 2008, EUR RESPIR J, V32, P17, DOI 10.1183/09031936.00161507; Keene ON, 2007, PHARM STAT, V6, P89, DOI 10.1002/pst.250; KESTEN S, 1994, CHEST, V105, P1042, DOI 10.1378/chest.105.4.1042; KUWANO K, 1993, AM REV RESPIR DIS, V148, P1220, DOI 10.1164/ajrccm/148.5.1220; Langsetmo L, 2008, AM J RESP CRIT CARE, V177, P396, DOI 10.1164/rccm.200708-1290OC; Lee JH, 2010, RESP MED, V104, P542, DOI 10.1016/j.rmed.2009.10.024; LEIDY N, AM J RESP CRIT CARE, V183, P323; Leidy NK, 2010, VALUE HEALTH, V13, P965, DOI 10.1111/j.1524-4733.2010.00772.x; Lynch DA, 2009, J THORAC IMAG, V24, P189, DOI 10.1097/RTI.0b013e3181b31cf0; Macario Ciro Casanova, 2010, Arch Bronconeumol, V46 Suppl 4, P9, DOI 10.1016/S0300-2896(10)70027-2; Mahler DA, 2004, CHEST, V126, P926, DOI 10.1378/chest.126.3.926; Mair G, 2010, RESP MED, V104, P1683, DOI 10.1016/j.rmed.2010.04.021; Make Barry, 2007, COPD, V4, P191; Martinez FJ, 2006, AM J RESP CRIT CARE, V173, P1326, DOI 10.1164/rccm.200510-1677OC; Massaro Donald, 2006, Proc Am Thorac Soc, V3, P709, DOI 10.1513/pats.200605-127SF; Massaro GD, 1997, NAT MED, V3, P675, DOI 10.1038/nm0697-675; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Meguro M, 2007, CHEST, V132, P456, DOI 10.1378/chest.06-0702; Morjaria JB, 2010, DRUG DISCOV TODAY, V15, P396, DOI 10.1016/j.drudis.2010.03.001; Murakami S, 2005, AM J RESP CRIT CARE, V172, P581, DOI 10.1164/rccm.200409-1280OC; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Newell J D Jr, 2004, Eur Respir J, V23, P769, DOI 10.1183/09031936.04.00026504; Newell John D Jr, 2008, Proc Am Thorac Soc, V5, P915, DOI 10.1513/pats.200804-034QC; Niewoehner D, 2007, CHRONIC OBSTRUCTIVE, P3; Niewoehner DE, 2005, ANN INTERN MED, V143, P317, DOI 10.7326/0003-4819-143-5-200509060-00007; Nussbaumer-Ochsner Y, 2011, CHEST, V139, P165, DOI 10.1378/chest.10-1252; O'Donnell DE, 1999, AM J RESP CRIT CARE, V160, P542, DOI 10.1164/ajrccm.160.2.9901038; O'Donnell DE, 2001, AM J RESP CRIT CARE, V164, P770, DOI 10.1164/ajrccm.164.5.2012122; O'Donnell Denis E, 2007, Proc Am Thorac Soc, V4, P145, DOI 10.1513/pats.200611-159CC; OShaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852, DOI 10.1164/ajrccm.155.3.9117016; OWENS GR, 1984, NEW ENGL J MED, V310, P1218, DOI 10.1056/NEJM198405103101903; Palange P, 2006, EUR RESPIR J, V27, P529, DOI 10.1183/09031936.06.00120604; Parr DG, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-75; Parr DG, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-21; Partridge MR, 2010, EUR RESPIR J, V36, P96, DOI 10.1183/09031936.00123709; Peinado VI, 2006, AM J RESP CELL MOL, V34, P257, DOI 10.1165/rcmb.2005-0255OC; Peinado VI, 2008, CHEST, V134, P808, DOI 10.1378/chest.08-0820; Pepin V, 2011, THORAX, V66, P115, DOI 10.1136/thx.2010.146159; Puhan MA, 2008, EUR RESPIR J, V32, P637, DOI 10.1183/09031936.00140507; Puhan MA, 2009, LANCET, V374, P704, DOI 10.1016/S0140-6736(09)61301-5; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Renard D, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-54; RENNARD SI, 2011, RESP RES, V12, P38; Rennard SI, 2008, CHEST, V134, P623, DOI 10.1378/chest.07-3059; Rennard SI, 2007, AM J RESP CRIT CARE, V175, P926, DOI 10.1164/rccm.200607-995OC; Rice JP, 2001, ADV GENET, V42, P69, DOI 10.1016/S0065-2660(01)42015-3; Rodriguez-Roisin R, 2000, CHEST, V117, p398S, DOI 10.1378/chest.117.5_suppl_2.398S; Rodriguez-Roisin R, 2009, J APPL PHYSIOL, V106, P1902, DOI 10.1152/japplphysiol.00085.2009; Saeta M, 1999, AM J RESP CRIT CARE, V160, P711, DOI 10.1164/ajrccm.160.2.9812020; SAETTA M, 1985, AM REV RESPIR DIS, V131, P764; Shapiro SD, 2010, TXB RESP MED, P919; Shigemura N, 2005, CIRCULATION, V111, P1407, DOI 10.1161/01.CIR.0000158433.89103.85; Singh SJ, 2008, THORAX, V63, P775, DOI 10.1136/thx.2007.081208; Stockley RA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-136; Stull DE, 2007, CURR MED RES OPIN, V23, P2655, DOI 10.1185/030079907X233133; Suissa S, 2006, AM J RESP CRIT CARE, V173, P842, DOI 10.1164/rccm.200508-1338PP; Taraseviciene-Stewart Laima, 2006, Proc Am Thorac Soc, V3, P687, DOI 10.1513/pats.200605-105SF; TASHKIN DP, 1992, AM REV RESPIR DIS, V145, P301, DOI 10.1164/ajrccm/145.2_Pt_1.301; Vadivel A, 2010, AM J RESP CELL MOL, V43, P152, DOI 10.1165/rcmb.2009-0004OC; Vestbo J, 2010, AM J RESP CRIT CARE, V182, P863, DOI 10.1164/rccm.201004-0602ED; Vogelmeier C, 2011, NEW ENGL J MED, V364, P1093, DOI 10.1056/NEJMoa1008378; Washko GR, 2010, SEMIN RESP CRIT CARE, V31, P276, DOI 10.1055/s-0030-1254068; Weatherall M, 2009, EUR RESPIR J, V34, P812, DOI 10.1183/09031936.00174408; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wise RA, 2006, AM J MED, V119, pS4, DOI 10.1016/j.amjmed.2006.08.002; Xu W, 2010, EUR RESPIR J, V35, P1022, DOI 10.1183/09031936.00079409; Yildirim AO, 2010, AM J RESP CRIT CARE, V181, P705, DOI 10.1164/rccm.200804-573OC	136	76	79	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2011	378	9795					1027	1037		10.1016/S0140-6736(11)61047-7	http://dx.doi.org/10.1016/S0140-6736(11)61047-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HO	21907866				2022-12-28	WOS:000295193200028
J	Glantz, S; Gonzalez, M				Glantz, Stanton; Gonzalez, Mariaelena			Effective tobacco control is key to rapid progress in reduction of non-communicable diseases	LANCET			English	Editorial Material							SMOKE-FREE LEGISLATION; ACUTE MYOCARDIAL-INFARCTION; LUNG-CANCER; HOSPITAL ADMISSIONS; CIGARETTE-SMOKING; EXPENDITURE; HEALTH; ASSOCIATION; IMPACT; RATES		[Glantz, Stanton; Gonzalez, Mariaelena] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, Cardiovasc Res Inst, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA; [Glantz, Stanton; Gonzalez, Mariaelena] Univ Calif San Francisco, Dept Med, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Glantz, S (corresponding author), Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, Cardiovasc Res Inst, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA.	glantz@medicine.ucsf.edu			NCI NIH HHS [R25 CA113710, R25 CA113710-05, T32 CA113710, R01 CA061021-18, CA-61021, R01 CA061021, CA-113710] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R25CA113710, T32CA113710, R01CA061021] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		American Cancer Society, 2010, CANC FACTS FIG 2010; Barnoya J, 2004, CANCER CAUSE CONTROL, V15, P689, DOI 10.1023/B:CACO.0000036187.13805.30; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Busch Susan H, 2004, Appl Health Econ Health Policy, V3, P263, DOI 10.2165/00148365-200403040-00009; Efroymson D, 2001, TOB CONTROL, V10, P212, DOI 10.1136/tc.10.3.212; Eisner MD, 1998, JAMA-J AM MED ASSOC, V280, P1909, DOI 10.1001/jama.280.22.1909; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferrante D, 2011, TOB CONTROL, DOI [10.1136/tc.2010.04.2325, DOI 10.1136/TC.2010.04.2325]; Fichtenberg CM, 2000, NEW ENGL J MED, V343, P1772, DOI 10.1056/NEJM200012143432406; Herman PM, 2011, AM J PUBLIC HEALTH, V101, P491, DOI 10.2105/AJPH.2009.179572; Institute of Medicine, 2009, SEC SMOK EXP CARD EF; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; John RM, 2008, SOC SCI MED, V66, P1356, DOI 10.1016/j.socscimed.2007.11.020; Lightwood J, 2011, SOC SCI MED, V72, P166, DOI 10.1016/j.socscimed.2010.11.015; Lightwood JM, 2009, CIRCULATION, V120, P1373, DOI 10.1161/CIRCULATIONAHA.109.870691; Lightwood JM, 2008, PLOS MED, V5, P1214, DOI 10.1371/journal.pmed.0050178; Lightwood JM, 1997, CIRCULATION, V96, P1089, DOI 10.1161/01.CIR.96.4.1089; Mackay DF, 2010, HEART, V96, P1525, DOI 10.1136/hrt.2010.199026; Mackay D, 2010, NEW ENGL J MED, V363, P1139, DOI 10.1056/NEJMoa1002861; Mamudu HM, 2011, 36 MAMUDU HM HAMMOND, V20, pe3; McAlister AL, 2010, AM J PUBLIC HEALTH, V100, P2391, DOI 10.2105/AJPH.2010.192211; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; Naiman A, 2010, CAN MED ASSOC J, V182, P761, DOI 10.1503/cmaj.091130; Office of the Surgeon General, 2010, TOB SMOK CAUS DIS BI; Pierce JP, 2010, CANCER EPIDEM BIOMAR, V19, P2801, DOI 10.1158/1055-9965.EPI-10-0563; Pu CY, 2008, SOC SCI MED, V66, P1979, DOI 10.1016/j.socscimed.2008.01.007; Rappange DR, 2008, PHARMACOECONOMICS, V26, P815, DOI 10.2165/00019053-200826100-00003; Siahpush M, 2003, J EPIDEMIOL COMMUN H, V57, P798, DOI 10.1136/jech.57.10.798; Sims M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2161; Thomson GW, 2002, TOB CONTROL, V11, P372, DOI 10.1136/tc.11.4.372; Thun MJ, 2006, TOB CONTROL, V15, P345, DOI 10.1136/tc.2006.017749; van Baal PHM, 2011, HEALTH ECON, V20, P432, DOI 10.1002/hec.1599; WARNER KE, 1987, JAMA-J AM MED ASSOC, V258, P2080, DOI 10.1001/jama.258.15.2080; World Health Organization, 2008, 2008 2013 ACT PLAN G; Xin Y, 2009, TOB CONTROL, V18, P150, DOI 10.1136/tc.2008.026955	36	67	69	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 31	2012	379	9822					1269	1271		10.1016/S0140-6736(11)60615-6	http://dx.doi.org/10.1016/S0140-6736(11)60615-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	918DV	21963004	Green Accepted			2022-12-28	WOS:000302230400039
J	Hussain, K; Challis, B; Rocha, N; Payne, F; Minic, M; Thompson, A; Daly, A; Scott, C; Harris, J; Smillie, BJL; Savage, DB; Ramaswami, U; De Lonlay, P; O'Rahilly, S; Barroso, I; Semple, RK				Hussain, K.; Challis, B.; Rocha, N.; Payne, F.; Minic, M.; Thompson, A.; Daly, A.; Scott, C.; Harris, J.; Smillie, B. J. L.; Savage, D. B.; Ramaswami, U.; De Lonlay, P.; O'Rahilly, S.; Barroso, I.; Semple, R. K.			An Activating Mutation of AKT2 and Human Hypoglycemia	SCIENCE			English	Article							INSULIN-RESISTANCE		[Challis, B.; Rocha, N.; Minic, M.; Harris, J.; Smillie, B. J. L.; Savage, D. B.; O'Rahilly, S.; Barroso, I.; Semple, R. K.] Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England; [Challis, B.; Rocha, N.; Minic, M.; Harris, J.; Smillie, B. J. L.; Savage, D. B.; O'Rahilly, S.; Barroso, I.; Semple, R. K.] Addenbrookes Hosp, Inst Metab Sci, Natl Inst Hlth Res, Cambridge Biomed Res Ctr, Cambridge CB2 0QQ, England; [Hussain, K.] UCL, Inst Child Hlth, Clin & Mol Genet Unit, Dev Endocrinol Res Grp, London WC1N 1EH, England; [Payne, F.; Thompson, A.; Daly, A.; Scott, C.; Barroso, I.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Ramaswami, U.] Addenbrookes Hosp, Dept Paediat Endocrinol Diabet & Metab, Cambridge CB2 2QQ, England; [De Lonlay, P.] Univ Paris 05, Hop Necker Enfants Malad, Dept Pediat, F-75743 Paris 15, France	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	O'Rahilly, S (corresponding author), Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England.	so104@medschl.cam.ac.uk; ib1@sanger.ac.uk; rks16@cam.ac.uk	O'Rahilly, Stephen/ABF-6509-2020; Semple, Robert/AAB-2948-2019; Payne, Felicity/GKF-2573-2022	O'Rahilly, Stephen/0000-0003-2199-4449; Payne, Felicity/0000-0003-4228-581X; Barroso, Ines/0000-0001-5800-4520; Semple, Robert Kenneth/0000-0001-6539-3069	Wellcome Trust [080952/Z/06/Z, 078986/Z/06/Z, 077016/Z/05/Z, 091551/Z/10/Z]; Medical Research Council Centre for Obesity and Related Disorders; UK NIHR Cambridge Biomedical Research Centre; NIHR; MRC [G0502115] Funding Source: UKRI; Medical Research Council [G0502115, G0600717B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Centre for Obesity and Related Disorders(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	R.K.S., S.O'R., I.B., and D.B.S. are supported by the Wellcome Trust (grants 080952/Z/06/Z, 078986/Z/06/Z, 077016/Z/05/Z, and 091551/Z/10/Z), the Medical Research Council Centre for Obesity and Related Disorders, and the UK NIHR Cambridge Biomedical Research Centre. B.C. is supported by NIHR and Wellcome Trust, and M.M. by the Gates Cambridge Trust. We thank L. Boyle for confocal microscopy assistance.	Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Gonzalez E, 2009, P NATL ACAD SCI USA, V106, P7004, DOI 10.1073/pnas.0901933106; Hussain K, 2004, Horm Res, V61, P222, DOI 10.1159/000076553; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822	8	113	116	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 28	2011	334	6055					474	474		10.1126/science.1210878	http://dx.doi.org/10.1126/science.1210878			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	21979934	Green Accepted			2022-12-28	WOS:000296230500036
J	Kim, TW; Lee, K; Najjar, RG; Jeong, HD; Jeong, HJ				Kim, Tae-Wook; Lee, Kitack; Najjar, Raymond G.; Jeong, Hee-Dong; Jeong, Hae Jin			Increasing N Abundance in the Northwestern Pacific Ocean Due to Atmospheric Nitrogen Deposition	SCIENCE			English	Article							EAST CHINA SEA; NUTRIENT LIMITATION; DINITROGEN FIXATION; YELLOW SEA; CYCLES; JAPAN; STOICHIOMETRY; COASTAL; RATIOS; SYSTEM	The relative abundance of nitrate (N) over phosphorus (P) has increased over the period since 1980 in the marginal seas bordering the northwestern Pacific Ocean, located downstream of the populated and industrialized Asian continent. The increase in N availability within the study area was mainly driven by increasing N concentrations and was most likely due to deposition of pollutant nitrogen from atmospheric sources. Atmospheric nitrogen deposition had a high temporal correlation with N availability in the study area (r = 0.74 to 0.88), except in selected areas wherein riverine nitrogen load may be of equal importance. The increase in N availability caused by atmospheric deposition and riverine input has switched extensive parts of the study area from being N-limited to P-limited.	[Kim, Tae-Wook; Lee, Kitack] Pohang Univ Sci & Technol, Sch Environm Sci & Engn, Pohang 790784, South Korea; [Najjar, Raymond G.] Penn State Univ, Dept Meteorol, University Pk, PA 16802 USA; [Jeong, Hee-Dong] Natl Fisheries Res & Dev Inst, E Sea Fisheries Res Inst, Kangnung 210861, South Korea; [Jeong, Hae Jin] Seoul Natl Univ, Sch Earth & Environm Sci, Seoul 151747, South Korea	Pohang University of Science & Technology (POSTECH); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Seoul National University (SNU)	Lee, K (corresponding author), Pohang Univ Sci & Technol, Sch Environm Sci & Engn, Pohang 790784, South Korea.	ktl@postech.ac.kr	Lee, Kitack/G-7184-2015; Kim, Tae-Wook/E-9611-2011; Jeong, hae jin/B-8908-2009	Kim, Tae-Wook/0000-0002-4236-0720; Lee, Kitack/0000-0002-4226-2303; Jeong, Hae Jin/0000-0003-3310-4335	Korea National Research Foundation [2009-0084756]; Korea Meteorological Administration [RACS_2010-1006]; Ministry of Land, Transport, and Maritime Affairs; NASA [NNX08AO25G]	Korea National Research Foundation(National Research Foundation of Korea); Korea Meteorological Administration(Korea Meteorological Administration (KMA)); Ministry of Land, Transport, and Maritime Affairs(Ministry of Land, Transport and Maritime Affairs (MLTM), Republic of Korea); NASA(National Aeronautics & Space Administration (NASA))	This work would not have been possible without the efforts of many scientists who contributed data to National Fisheries Research and Development Institute and Japan Meteorological Agency for the seawater nutrient data and to Acid Deposition Monitoring Network in East Asia and Korea Meteorological Administration (Climate Change Information Center) for the atmospheric deposition data. The preparation of the manuscript was supported by the Mid-career Researcher Program (2009-0084756) of the Korea National Research Foundation (K.L.). Partial support was provided by the Korea Meteorological Administration Research and Development Program under grant RACS_2010-1006 (K.L.). Support for H.J.J. was provided by the Ministry of Land, Transport, and Maritime Affairs' Ecological Disturbance Program. Support for R.G.N. was provided by NASA's Ocean Biology and Biogeochemistry Program (contract NNX08AO25G).	AKIMOTO H, 1994, ATMOS ENVIRON, V28, P213, DOI 10.1016/1352-2310(94)90096-5; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Chen CTA, 2004, J OCEANOGR, V60, P17, DOI 10.1023/B:JOCE.0000038316.56018.d4; Dai ZJ, 2011, ENVIRON SCI TECHNOL, V45, P223, DOI 10.1021/es103026a; Davis CS, 2006, SCIENCE, V312, P1517, DOI 10.1126/science.1123570; Doney SC, 2007, P NATL ACAD SCI USA, V104, P14580, DOI 10.1073/pnas.0702218104; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; FANNING KA, 1989, NATURE, V339, P460, DOI 10.1038/339460a0; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Ichikawa H, 2002, J OCEANOGR, V58, P77, DOI 10.1023/A:1015876701363; Kang J, 2010, SCI TOTAL ENVIRON, V408, P2369, DOI 10.1016/j.scitotenv.2010.02.022; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Kim K, 2008, J OCEANOGR, V64, P721, DOI 10.1007/s10872-008-0061-x; Klausmeier CA, 2004, NATURE, V429, P171, DOI 10.1038/nature02454; Lie HJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001194; Moisander PH, 2010, SCIENCE, V327, P1512, DOI 10.1126/science.1185468; Nakamura T, 2005, ATMOS ENVIRON, V39, P1749, DOI 10.1016/j.atmosenv.2004.11.037; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419, DOI 10.5194/acp-7-4419-2007; Onitsuka G, 2009, J OCEANOGR, V65, P433, DOI 10.1007/s10872-009-0038-4; OWENS NJP, 1992, NATURE, V357, P397, DOI 10.1038/357397a0; Paerl HW, 2002, ENVIRON SCI TECHNOL, V36, p323A, DOI 10.1021/es022392a; Pahlow M, 2000, SCIENCE, V287, P831, DOI 10.1126/science.287.5454.831; Park GH, 2008, LIMNOL OCEANOGR, V53, P1697, DOI 10.4319/lo.2008.53.5.1697; Wang BD, 2003, ESTUAR COAST SHELF S, V58, P127, DOI 10.1016/S0272-7714(03)00067-2; Watanabe YW, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032188; Weber TS, 2010, NATURE, V467, P550, DOI 10.1038/nature09403; Zhang GS, 2007, J ATMOS CHEM, V57, P41, DOI 10.1007/s10874-007-9060-3	32	178	195	8	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 28	2011	334	6055					505	509		10.1126/science.1206583	http://dx.doi.org/10.1126/science.1206583			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	21940860				2022-12-28	WOS:000296230500045
J	Dawson, MA; Prinjha, RK; Dittmann, A; Giotopoulos, G; Bantscheff, M; Chan, WI; Robson, SC; Chung, CW; Hopf, C; Savitski, MM; Huthmacher, C; Gudgin, E; Lugo, D; Beinke, S; Chapman, TD; Roberts, EJ; Soden, PE; Auger, KR; Mirguet, O; Doehner, K; Delwel, R; Burnett, AK; Jeffrey, P; Drewes, G; Lee, K; Huntly, BJP; Kouzarides, T				Dawson, Mark A.; Prinjha, Rab K.; Dittmann, Antje; Giotopoulos, George; Bantscheff, Marcus; Chan, Wai-In; Robson, Samuel C.; Chung, Chun-wa; Hopf, Carsten; Savitski, Mikhail M.; Huthmacher, Carola; Gudgin, Emma; Lugo, Dave; Beinke, Soren; Chapman, Trevor D.; Roberts, Emma J.; Soden, Peter E.; Auger, Kurt R.; Mirguet, Olivier; Doehner, Konstanze; Delwel, Ruud; Burnett, Alan K.; Jeffrey, Phillip; Drewes, Gerard; Lee, Kevin; Huntly, Brian J. P.; Kouzarides, Tony			Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia	NATURE			English	Article							BROMODOMAIN PROTEIN BRD4; P-TEFB; TRANSCRIPTION; ELONGATION; COMPONENT; TARGET; CELLS	Recurrent chromosomal translocations involving the mixed lineage leukaemia (MLL) gene initiate aggressive forms of leukaemia, which are often refractory to conventional therapies(1). Many MLL-fusion partners are members of the super elongation complex (SEC), a critical regulator of transcriptional elongation, suggesting that aberrant control of this process has an important role in leukaemia induction(2,3). Here we use a global proteomic strategy to demonstrate that MLL fusions, as part of SEC(2,3) and the polymerase-associated factor complex (PAFc)(4,5), are associated with the BET family of acetyl-lysine recognizing, chromatin 'adaptor' proteins. These data provided the basis for therapeutic intervention in MLL-fusion leukaemia, via the displacement of the BET family of proteins from chromatin. We show that a novel small molecule inhibitor of the BET family, GSK1210151A (I-BET151), has profound efficacy against human and murine MLL-fusion leukaemic cell lines, through the induction of early cell cycle arrest and apoptosis. I-BET151 treatment in two human leukaemia cell lines with different MLL fusions alters the expression of a common set of genes whose function may account for these phenotypic changes. The mode of action of I-BET151 is, at least in part, due to the inhibition of transcription at key genes (BCL2, C-MYC and CDK6) through the displacement of BRD3/4, PAFc and SEC components from chromatin. In vivo studies indicate that I-BET151 has significant therapeutic value, providing survival benefit in two distinct mouse models of murine MLL-AF9 and human MLL-AF4 leukaemia. Finally, the efficacy of I-BET151 against human leukaemia stem cells is demonstrated, providing further evidence of its potent therapeutic potential. These findings establish the displacement of BET proteins from chromatin as a promising epigenetic therapy for these aggressive leukaemias.	[Dawson, Mark A.; Giotopoulos, George; Chan, Wai-In; Gudgin, Emma; Huntly, Brian J. P.] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England; [Dawson, Mark A.; Giotopoulos, George; Chan, Wai-In; Gudgin, Emma; Huntly, Brian J. P.] Univ Cambridge, Addenbrookes Hosp, Cambridge CB2 0XY, England; [Dawson, Mark A.; Robson, Samuel C.; Kouzarides, Tony] Gurdon Inst, Cambridge CB2 1QN, England; [Dawson, Mark A.; Robson, Samuel C.; Kouzarides, Tony] Dept Pathol, Cambridge CB2 1QN, England; [Prinjha, Rab K.; Lugo, Dave; Beinke, Soren; Chapman, Trevor D.; Roberts, Emma J.; Soden, Peter E.; Jeffrey, Phillip; Lee, Kevin] GlaxoSmithKline Inc, Med Res Ctr, Immunoinflammat Ctr Excellence Drug Discovery, Epinova DPU, Stevenage SG1 2NY, Herts, England; [Dittmann, Antje; Bantscheff, Marcus; Hopf, Carsten; Savitski, Mikhail M.; Huthmacher, Carola; Drewes, Gerard] Cellzome AG, D-69117 Heidelberg, Germany; [Chung, Chun-wa] GlaxoSmithKline R&D, Mol Discovery Res, Stevenage SG1 2NY, Herts, England; [Auger, Kurt R.] GlaxoSmithKline Inc, Oncol R&D, Canc Epigenet DPU, Collegeville, PA 19426 USA; [Mirguet, Olivier] GlaxoSmithKline Res & Dev Ltd, Lipid Metab Discovery Performance Unit, F-91951 Les Ulis, France; [Doehner, Konstanze] Univ Hosp Ulm Internal Med 3, D-89081 Ulm, Germany; [Delwel, Ruud] Erasmus Univ, Med Ctr, Dept Hematol, NL-3015 GE Rotterdam, Netherlands; [Burnett, Alan K.] Cardiff Univ, Sch Med, Dept Hematol, Cardiff CF14 4XN, S Glam, Wales	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; GlaxoSmithKline; GlaxoSmithKline; Cellzome GmbH; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Erasmus University Rotterdam; Erasmus MC; Cardiff University	Huntly, BJP (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England.	mafd2@cam.ac.uk; bjph2@cam.ac.uk; t.kouzarides@gurdon.cam.ac.uk	Bantscheff, Marcus/AAQ-2903-2021; Dawson, Mark A/B-9317-2017; Mirguet, Olivier/Q-1682-2018; huntly, brian JP/E-6725-2014; Hopf, Carsten/A-3275-2015	Bantscheff, Marcus/0000-0002-8343-8977; Dawson, Mark A/0000-0002-5464-5029; Mirguet, Olivier/0000-0002-5486-0386; huntly, brian JP/0000-0003-0312-161X; Kouzarides, Tony/0000-0002-8918-4162; Hopf, Carsten/0000-0003-0802-6451; Giotopoulos, George/0000-0003-1390-6592; Drewes, Gerard/0000-0003-0575-6766	Wellcome-Beit Intermediate Clinical Fellowship; Medical Research Council (UK); Leukaemia Lymphoma Research (UK); Wellcome Trust; Leukemia & Lymphoma Society of America; Cancer Research UK (CRUK); NIHR Cambridge Biomedical Research Centre; Medical Research Council [G0800784B, G0800784, G116/187] Funding Source: researchfish; MRC [G0800784, G116/187] Funding Source: UKRI	Wellcome-Beit Intermediate Clinical Fellowship; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia Lymphoma Research (UK); Wellcome Trust(Wellcome TrustEuropean Commission); Leukemia & Lymphoma Society of America(Leukemia and Lymphoma Society); Cancer Research UK (CRUK)(Cancer Research UK); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. J. Dawson, A. Bannister, S. Anand and all members of the Huntly and Kouzarides laboratories. We are grateful to H. Doehner, the NCRI AML trials biobank and A. Giles for the provision of patient samples. We acknowledge D. Huang for the BCL2 expression plasmid, L. Gordon for supplying fluorescence resonance energy transfer data and R. Woodward, C. Delves, E. Jones and P. Holmes for protein production. J. Witherington, N. Parr, S. Baddeley and J. Seal provided compound selectivity data. We thank N. Deeks and L. Cutler for providing sample and PK data analysis. We acknowledge K. Smitheman and A. Wyce for help with the cellular analysis of the BET inhibitors, P. Grandi for suggestions and discussion, S. Chan for biophysical assay data, and members of the Epinova team for discussion and suggestions. We thank staff at the ESRF at Grenoble for beamline assistance. We thank T. Werner for assistance with mass spectrometry experiments and data analysis, and the members of the Cellzome Biochemistry, Mass Spectrometry, and IT teams for outstanding expertise and diligence. This work was supported by a Wellcome-Beit Intermediate Clinical Fellowship to M. A. D. The Huntly lab is funded by the Medical Research Council (UK), Leukaemia Lymphoma Research (UK), the Wellcome Trust, The Leukemia & Lymphoma Society of America, Cancer Research UK (CRUK) and the NIHR Cambridge Biomedical Research Centre. This work in the Kouzarides laboratory was funded by a programme grant from Cancer Research UK (CRUK).	Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Chung CW, 2011, J MED CHEM, V54, P3827, DOI 10.1021/jm200108t; Dawson MA, 2009, NATURE, V461, P819, DOI 10.1038/nature08448; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; Milne TA, 2010, MOL CELL, V38, P853, DOI 10.1016/j.molcel.2010.05.011; Muntean AG, 2010, CANCER CELL, V17, P609, DOI 10.1016/j.ccr.2010.04.012; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Robinson BW, 2008, BRIT J HAEMATOL, V141, P827, DOI 10.1111/j.1365-2141.2008.07100.x; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Wang J, 2005, EMBO J, V24, P368, DOI 10.1038/sj.emboj.7600521; Wang QF, 2011, BLOOD, V117, P6895, DOI 10.1182/blood-2010-12-324699; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040	20	1134	1269	3	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2011	478	7370					529	533		10.1038/nature10509	http://dx.doi.org/10.1038/nature10509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	21964340	Green Accepted			2022-12-28	WOS:000296194200046
J	Vladeck, BC				Vladeck, Bruce C.			The Continuing Paradoxes of Nursing Home Policy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Nexera Inc, New York, NY 10019 USA		Vladeck, BC (corresponding author), Nexera Inc, 555 W 57th St,15th Floor, New York, NY 10019 USA.	bvladeck@nexeraconsulting.com						*ADAPT, ADAPTS DEF OUR FREED; *HJ KAIS FAM FDN K, 2011, POL BRIEF PROP MOD I; *HJ KAIS FAM FDN K, 2011, ISS PAP MED HOM COMM; *MED PAY ADV COMM, REP C MED PAYM POL, pCH7; Mor V, 2007, HEALTH AFFAIR, V26, P1762, DOI 10.1377/hlthaff.26.6.1762; Vladeck BC, 2003, HEALTH AFFAIR, V22, P90, DOI 10.1377/hlthaff.22.1.90; Zweig SC, 2011, JAMA-J AM MED ASSOC, V306, P1468, DOI 10.1001/jama.2011.1420; LONG TERM CARE	8	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 26	2011	306	16					1802	1803		10.1001/jama.2011.1527	http://dx.doi.org/10.1001/jama.2011.1527			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HH	21972271				2022-12-28	WOS:000296181600028
J	Isogai, Y; Si, S; Pont-Lezica, L; Tan, T; Kapoor, V; Murthy, VN; Dulac, C				Isogai, Yoh; Si, Sheng; Pont-Lezica, Lorena; Tan, Taralyn; Kapoor, Vikrant; Murthy, Venkatesh N.; Dulac, Catherine			Molecular organization of vomeronasal chemoreception	NATURE			English	Article							ACCESSORY OLFACTORY-BULB; PUTATIVE PHEROMONE RECEPTORS; GENETIC-ANALYSIS; SENSORY NEURONS; ORGAN; MICE; BEHAVIOR; EXPRESSION; FAMILY; AGGRESSION	The vomeronasal organ (VNO) has a key role in mediating the social and defensive responses of many terrestrial vertebrates to species- and sex-specific chemosignals(1). More than 250 putative pheromone receptors have been identified in the mouse VNO(2,3), but the nature of the signals detected by individual VNO receptors has not yet been elucidated. To gain insight into the molecular logic of VNO detection leading to mating, aggression or defensive responses, we sought to uncover the response profiles of individual vomeronasal receptors to a wide range of animal cues. Here we describe the repertoire of behaviourally and physiologically relevant stimuli detected by a large number of individual vomeronasal receptors in mice, and define a global map of vomeronasal signal detection. We demonstrate that the two classes (V1R and V2R) of vomeronasal receptors use fundamentally different strategies to encode chemosensory information, and that distinct receptor subfamilies have evolved towards the specific recognition of certain animal groups or chemical structures. The association of large subsets of vomeronasal receptors with cognate, ethologically and physiologically relevant stimuli establishes the molecular foundation of vomeronasal information coding, and opens new avenues for further investigating the neural mechanisms underlying behaviour specificity.	[Isogai, Yoh; Dulac, Catherine] Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Dulac, C (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	dulac@fas.harvard.edu	Grieshaber-Bouyer, Ricardo/R-7512-2016	Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135; Si, Sheng/0000-0001-5825-7712; Tan, Taralyn/0000-0002-4917-3047; Dulac, Catherine/0000-0001-5024-5418; Murthy, Venkatesh/0000-0003-2443-4252	NIDCD at the National Institute of Health; Howard Hughes Medical Institute; Damon Runyon Cancer Research Foundation [DRG-1981-08]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009019, R01DC003903] Funding Source: NIH RePORTER	NIDCD at the National Institute of Health; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We acknowledge H. Fisher, H. Hoekstra, E. Kay, M. Kirchgessner, N. Uchida, A. Wang, X.-D. Wang, B. Watson, W. Tong, Harvard Museum of Natural History, Harvard Concord Field Station, Museum of Science, Boston, and New England Wildlife Center, for providing stimulus materials used in this study, L. Looger for the G-CaMP3 construct, M. Wienisch, F. Markopoulos and D. Mak for help with electrophysiology and imaging experiments, and B. Goetze and the Harvard Center for Biological Imaging for help with microscopy. We also thank members of the Dulac laboratory for critical reading of the manuscript, S. Andreeva for technical support and R. Hellmiss for help with figure artwork. This work was supported by the NIDCD at the National Institute of Health, the Howard Hughes Medical Institute and the Damon Runyon Cancer Research Foundation (Y.I., DRG-1981-08).	Ben-Shaul Y, 2010, P NATL ACAD SCI USA, V107, P5172, DOI 10.1073/pnas.0915147107; Berghard A, 1996, J NEUROSCI, V16, P909; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; BROWN JS, 1988, OECOLOGIA, V76, P408, DOI 10.1007/BF00377036; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chevret P, 2005, BIOL J LINN SOC, V84, P417, DOI 10.1111/j.1095-8312.2005.00444.x; DANCIGER E, 1989, P NATL ACAD SCI USA, V86, P8565, DOI 10.1073/pnas.86.21.8565; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Guenet JL, 2003, TRENDS GENET, V19, P24, DOI 10.1016/S0168-9525(02)00007-0; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; He J, 2008, SCIENCE, V320, P535, DOI 10.1126/science.1154476; Holekamp TF, 2008, NEURON, V57, P661, DOI 10.1016/j.neuron.2008.01.011; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leinders-Zufall T, 2009, NAT NEUROSCI, V12, P1551, DOI 10.1038/nn.2452; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Martini S, 2001, J NEUROSCI, V21, P843, DOI 10.1523/JNEUROSCI.21-03-00843.2001; Miller RA, 2000, J ZOOL, V250, P95, DOI 10.1111/j.1469-7998.2000.tb00580.x; Nodari F, 2008, J NEUROSCI, V28, P6407, DOI 10.1523/JNEUROSCI.1425-08.2008; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Samuelsen CL, 2009, NEUROSCIENCE, V164, P1468, DOI 10.1016/j.neuroscience.2009.09.030; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Stewart R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-253; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Sundell J, 2004, OECOLOGIA, V139, P157, DOI 10.1007/s00442-004-1490-x; Taha M, 2009, PHYSIOL BEHAV, V98, P147, DOI 10.1016/j.physbeh.2009.05.006; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wagner S, 2006, NEURON, V50, P697, DOI 10.1016/j.neuron.2006.04.033; ZHANG X, 2010, NEUROSCIENCE, V4, P164	33	211	215	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					241	U130		10.1038/nature10437	http://dx.doi.org/10.1038/nature10437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21937988	Green Accepted, Green Submitted			2022-12-28	WOS:000295782800050
J	Spence, D				Spence, Des			FROM THE FRONTLINE Bad medicine: rheumatoid arthritis	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						[Anonymous], PRESCRIPTION COST AN; GRANT LH, 2010, ANN RHEUM DIS, V69, P868; Houssien DA, 1998, SCAND J RHEUMATOL, V27, P300; Jordan KP, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-144; Myasoedova E, 2010, ARTHRITIS RHEUM-US, V62, P1576, DOI 10.1002/art.27425; National Institute for Health and Clinical Excellence (NICE), 2009, RHEUMATOID ARTHRITIS; Pollard LC, 2010, RHEUMATOLOGY, V49, P924, DOI 10.1093/rheumatology/kep458; Weiss RJ, 2008, RHEUMATOLOGY, V47, P491, DOI 10.1093/rheumatology/ken009	8	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 5	2011	343								d6357	10.1136/bmj.d6357	http://dx.doi.org/10.1136/bmj.d6357			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	832CS	21976694				2022-12-28	WOS:000295779400006
J	Hawkes, N				Hawkes, Nigel			BODY POLITIC Choice-a love Labour's lost	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						2011, BRIT MED J, V343, pD6179, DOI DOI 10.1136/BMJ.D6179	1	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 3	2011	343								d6319	10.1136/bmj.d6319	http://dx.doi.org/10.1136/bmj.d6319			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	832CQ	21968127				2022-12-28	WOS:000295779200003
J	Anderson, BJ; Johnson, CL; Korth, H; Purucker, ME; Winslow, RM; Slavin, JA; Solomon, SC; McNutt, RL; Raines, JM; Zurbuchen, TH				Anderson, Brian J.; Johnson, Catherine L.; Korth, Haje; Purucker, Michael E.; Winslow, Reka M.; Slavin, James A.; Solomon, Sean C.; McNutt, Ralph L., Jr.; Raines, Jim M.; Zurbuchen, Thomas H.			The Global Magnetic Field of Mercury from MESSENGER Orbital Observations	SCIENCE			English	Article							MISSION; DYNAMO	Magnetometer data acquired by the MESSENGER spacecraft in orbit about Mercury permit the separation of internal and external magnetic field contributions. The global planetary field is represented as a southward-directed, spin-aligned, offset dipole centered on the spin axis. Positions where the cylindrical radial magnetic field component vanishes were used to map the magnetic equator and reveal an offset of 484 +/- 11 kilometers northward of the geographic equator. The magnetic axis is tilted by less than 3 degrees from the rotation axis. A magnetopause and tail-current model was defined by using 332 magnetopause crossing locations. Residuals of the net external and offset-dipole fields from observations north of 30 degrees N yield a best-fit planetary moment of 195 +/- 10 nanotesla-R-M(3), where R-M is Mercury's mean radius.	[Anderson, Brian J.; Korth, Haje; McNutt, Ralph L., Jr.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Johnson, Catherine L.; Winslow, Reka M.] Univ British Columbia, Vancouver, BC V6T 1Z4, Canada; [Johnson, Catherine L.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Purucker, Michael E.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Slavin, James A.; Raines, Jim M.; Zurbuchen, Thomas H.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Solomon, Sean C.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of British Columbia; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Michigan System; University of Michigan; Carnegie Institution for Science	Anderson, BJ (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	brian.anderson@jhuapl.edu	Korth, Haje/C-3182-2016; Anderson, Brian J/I-8615-2012; Slavin, James A/H-3170-2012; Raines, Jim M./O-5649-2016; Johnson, Catherine L./AAZ-7295-2020; McNutt, Ralph L/E-8006-2010	Korth, Haje/0000-0001-7394-7439; Slavin, James A/0000-0002-9206-724X; McNutt, Ralph L/0000-0002-4722-9166	NASA; MESSENGER Participating Scientist Program; Natural Sciences and Engineering Research Council of Canada	NASA(National Aeronautics & Space Administration (NASA)); MESSENGER Participating Scientist Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank the MESSENGER operations and engineering teams. The MESSENGER mission is supported by the NASA Discovery Program and the MESSENGER Participating Scientist Program. C.L.J. and R. M. W. acknowledge support from the Natural Sciences and Engineering Research Council of Canada.	Alexeev II, 2010, ICARUS, V209, P23, DOI 10.1016/j.icarus.2010.01.024; Anderson BJ, 2007, SPACE SCI REV, V131, P417, DOI 10.1007/s11214-007-9246-7; Anderson BJ, 2010, SPACE SCI REV, V152, P307, DOI 10.1007/s11214-009-9544-3; BACKUS G, 1986, REV GEOPHYS, V24, P75, DOI 10.1029/RG024i001p00075; Baumjohann W., 1997, BASIC SPACE PLASMA P; CONNERNEY JEP, 1988, MERCURY, P494; Killen R, 2007, SPACE SCI REV, V132, P433, DOI 10.1007/s11214-007-9232-0; Kivelson M., 1995, INTRO SPACE PHYS; Korth H, 2004, PLANET SPACE SCI, V52, P733, DOI 10.1016/j.pss.2003.12.008; Manglik A, 2010, EARTH PLANET SC LETT, V289, P619, DOI 10.1016/j.epsl.2009.12.007; NESS NF, 1975, J GEOPHYS RES-SPACE, V80, P2708, DOI 10.1029/JA080i019p02708; Russell CT, 2010, SPACE SCI REV, V152, P251, DOI 10.1007/s11214-009-9621-7; Solomon SC, 2007, SPACE SCI REV, V131, P3, DOI 10.1007/s11214-007-9247-6; Stanley S, 2010, SPACE SCI REV, V152, P617, DOI 10.1007/s11214-009-9573-y; Travnicek P, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028518; Uno H, 2009, EARTH PLANET SC LETT, V285, P328, DOI 10.1016/j.epsl.2009.02.032; Vilim R, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003528; Zurbuchen TH, 2011, SCIENCE, V333, P1862, DOI 10.1126/science.1211302	19	220	222	5	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051					1859	1862		10.1126/science.1211001	http://dx.doi.org/10.1126/science.1211001			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960627				2022-12-28	WOS:000295365800047
J	DiTacchio, L; Le, HD; Vollmers, C; Hatori, M; Witcher, M; Secombe, J; Panda, S				DiTacchio, Luciano; Le, Hiep D.; Vollmers, Christopher; Hatori, Megumi; Witcher, Michael; Secombe, Julie; Panda, Satchidananda			Histone Lysine Demethylase JARID1a Activates CLOCK-BMAL1 and Influences the Circadian Clock	SCIENCE			English	Article							DISTINCT	In animals, circadian oscillators are based on a transcription-translation circuit that revolves around the transcription factors CLOCK and BMAL1. We found that the JumonjiC (JmjC) and ARID domain-containing histone lysine demethylase 1a (JARID1a) formed a complex with CLOCK-BMAL1, which was recruited to the Per2 promoter. JARID1a increased histone acetylation by inhibiting histone deacetylase 1 function and enhanced transcription by CLOCK-BMAL1 in a demethylase-independent manner. Depletion of JARID1a in mammalian cells reduced Per promoter histone acetylation, dampened expression of canonical circadian genes, and shortened the period of circadian rhythms. Drosophila lines with reduced expression of the Jarid1a homolog, lid, had lowered Per expression and similarly altered circadian rhythms. JARID1a thus has a nonredundant role in circadian oscillator function.	[DiTacchio, Luciano; Le, Hiep D.; Vollmers, Christopher; Hatori, Megumi; Panda, Satchidananda] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA; [Witcher, Michael] McGill Univ, Dept Oncol, Montreal, PQ H2W 1S6, Canada; [Secombe, Julie] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA	Salk Institute; McGill University; Yeshiva University; Albert Einstein College of Medicine	Panda, S (corresponding author), Salk Inst Biol Studies, Regulatory Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	satchin@salk.edu	DiTacchio, Luciano/D-6341-2011; Panda, Satchidananda/J-6891-2012; Hatori, Megumi/GTY-3770-2022	DiTacchio, Luciano/0000-0001-9570-7348; Hatori, Megumi/0000-0001-7888-158X	NIH [EY 16807, DK 091618, S10 RR027450, F32GM082083]; Pew Scholars Program; Dana Foundation; Japan Society for the Promotion of Science; Blasker Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027450] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM082083] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Program; Dana Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Blasker Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Kaelin for JARID1a antibodies, and Jarid1a<SUP>-/-</SUP> and Jarid1a<SUP>+/+</SUP> fibroblasts; and R. Janknecht for JARID1b and JARID1c cDNAs. Supported by NIH grants (EY 16807, DK 091618, and S10 RR027450), the Pew Scholars Program, and a Dana Foundation award to S. P.; a Japan Society for the Promotion of Science fellowship to M. H.; NIH grant F32GM082083 to L.D.; and a Blasker Foundation award to C.V.	Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Lee N, 2009, MOL CELL BIOL, V29, P1401, DOI 10.1128/MCB.01643-08; Li L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001221; Naruse Y, 2004, MOL CELL BIOL, V24, P6278, DOI 10.1128/MCB.24.14.6278-6287.2004; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102	9	163	182	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051					1881	1885		10.1126/science.1206022	http://dx.doi.org/10.1126/science.1206022			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960634	Green Accepted			2022-12-28	WOS:000295365800054
J	Ford, MGJ; Jenni, S; Nunnari, J				Ford, Marijn G. J.; Jenni, Simon; Nunnari, Jodi			The crystal structure of dynamin	NATURE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; CLATHRIN-MEDIATED ENDOCYTOSIS; GTPASE ACTIVITY; IN-VIVO; CONFORMATIONAL-CHANGES; BINDING PROTEINS; MECHANISM; FISSION; MITOCHONDRIAL; CONSTRICTION	Dynamin-related proteins (DRPs) are multi-domain GTPases that function via oligomerization and GTP-dependent conformational changes to play central roles in regulating membrane structure across phylogenetic kingdoms. How DRPs harness self-assembly and GTP-dependent conformational changes to remodel membranes is not understood. Here we present the crystal structure of an assembly-deficient mammalian endocytic DRP, dynamin 1, lacking the proline-rich domain, in its nucleotide-free state. The dynamin 1 monomer is an extended structure with the GTPase domain and bundle signalling element positioned on top of a long helical stalk with the pleckstrin homology domain flexibly attached on its opposing end. Dynamin 1 dimer and higher order dimer multimers form via interfaces located in the stalk. Analysis of these interfaces provides insight into DRP family member specificity and regulation and provides a framework for understanding the biogenesis of higher order DRP structures and the mechanism of DRP-mediated membrane scission events.	[Ford, Marijn G. J.; Nunnari, Jodi] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Jenni, Simon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of California System; University of California Davis; Harvard University; Harvard Medical School	Nunnari, J (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	jmnunnari@ucdavis.edu			Howard Hughes Medical Institute [DRG-2004-09]; American Heart Innovator Award; NIH [R01GM062942S1, R01GM097432]; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062942, R01GM097432] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Heart Innovator Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to express thanks to I. Stokes-Rees for assistance with the Wide Space Molecular Replacement, J. Holton for advice and assistance with data collection and H. McMahon for the kind gift of the dynamin clone. We would also like to thank J. Al-Bassam, J. Chappie, A. McCoy, S. Harrison, D. Owen, A. Fisher, E. Baldwin, L. Lackner, G. Adamson, N. Varlakhanova and members of the Nunnari lab for extensive discussions. S. J. is a Damon Runyon Cancer Research Foundation Fellow supported by the Howard Hughes Medical Institute (DRG-2004-09). This work was supported by an American Heart Innovator Award and NIH grants (R01GM062942S1 and R01GM097432) to J. N. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under Contract No. DE-AC02-05CH11231.	Achiriloaie M, 1999, MOL CELL BIOL, V19, P1410; Barylko B, 2010, BIOCHEMISTRY-US, V49, P10592, DOI 10.1021/bi101343p; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Ingerman E, 2005, METHOD ENZYMOL, V404, P611, DOI 10.1016/S0076-6879(05)04053-X; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; Lackner LL, 2009, SCIENCE, V325, P874, DOI 10.1126/science.1176921; Low HH, 2006, NATURE, V444, P766, DOI 10.1038/nature05312; Low HH, 2009, CELL, V139, P1342, DOI 10.1016/j.cell.2009.11.003; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Narayanan R, 2005, J CELL BIOL, V169, P117, DOI 10.1083/jcb.200502042; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Ramachandran R, 2009, MOL BIOL CELL, V20, P4630, DOI 10.1091/mbc.E09-08-0683; RAMASWAMI M, 1993, J NEUROGENET, V9, P73, DOI 10.3109/01677069309083451; Reubold TF, 2005, P NATL ACAD SCI USA, V102, P13093, DOI 10.1073/pnas.0506491102; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Song BD, 2004, MOL BIOL CELL, V15, P2243, DOI 10.1091/mbc.E04-01-0015; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TIMM D, 1994, NAT STRUCT BIOL, V1, P782, DOI 10.1038/nsb1194-782; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	42	191	197	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 29	2011	477	7366					561	566		10.1038/nature10441	http://dx.doi.org/10.1038/nature10441			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21927001	Green Accepted			2022-12-28	WOS:000295320900033
J	Nallamothu, BK; Gurm, HS; Ting, HH; Goodney, PP; Rogers, MAM; Curtis, JP; Dimick, JB; Bates, ER; Krumholz, HM; Birkmeyer, JD				Nallamothu, Brahmajee K.; Gurm, Hitinder S.; Ting, Henry H.; Goodney, Philip P.; Rogers, Mary A. M.; Curtis, Jeptha P.; Dimick, Justin B.; Bates, Eric R.; Krumholz, Harlan M.; Birkmeyer, John D.			Operator Experience and Carotid Stenting Outcomes in Medicare Beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEARNING-CURVE; ENDARTERECTOMY; COMPLICATIONS; COMPETENCE; STATEMENT; COMMITTEE; SKILLS	Context Although the efficacy of carotid stenting has been established in clinical trials, outcomes of the procedure based on operator experience are less certain in clinical practice. Objective To assess association between outcomes and 2 measures of operator experience: annual volume and experience at the time of the procedure among new operators who first performed carotid stenting after a national coverage decision by the Centers for Medicare & Medicaid Services (CMS). Design, Setting, and Patients Observational study using administrative data on fee-for-service Medicare beneficiaries aged 65 years or older undergoing carotid stenting between 2005 and 2007. Main Outcome Measure Thirty-day mortality stratified by very low, low, medium, and high annual operator volumes (<6, 6-11, 12-23, and >24 procedures per year, respectively) and treatment early vs late during a new operator's experience (1st to 11th procedure and 12th procedure or higher). Results During the study period, 24 701 procedures were performed by 2339 operators. Of these, 11 846 were performed by 1792 new operators who first performed carotid stenting after the CMS national coverage decision. Overall, 30-day mortality was 1.9% (n= 461) and rate of failure to use an embolic protection device was 4.8% (n= 1173). The median annual operator volume among Medicare beneficiaries was 3.0 per year (interquartile range, 1.4-6.5) and 11.6% of operators performed 12 or more procedures per year during the study period. Observed 30-day mortality was higher among patients treated by operators with lower annual volumes (2.5% [95% CI, 2.1%-2.9%], 1.9% [95% CI, 1.6%-2.3%], 1.6% [95% CI, 1.3%-1.9%], and 1.4% [95% CI, 1.1%-1.7%] across the 4 categories; P<.001) and among patients treated early (2.3%; 95% CI, 2.0%-2.7%) vs late (1.4%; 95% CI, 1.1%-1.9%; P<.001) during a new operator's experience. After multivariable adjustment, patients treated by very low-volume operators had a higher risk of 30-day mortality compared with patients treated by high-volume operators (adjusted odds ratio, 1.9; 95% CI, 1.4-2.7; P<.001). Similarly, we found a higher risk of 30-day mortality in patients treated early vs late during a new operator's experience (adjusted odds ratio, 1.7; 95% CI, 1.2-2.4; P=.001). Conclusion Among older patients undergoing carotid stenting, lower annual operator volume and early experience are associated with increased 30-day mortality. JAMA. 2011;306(12):1338-1343	[Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; [Dimick, Justin B.; Birkmeyer, John D.] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.; Gurm, Hitinder S.; Dimick, Justin B.; Birkmeyer, John D.] Univ Michigan, Sch Med, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.] Vet Affairs Ann Arbor Hlth Serv Res & Dev Ctr Exc, Ann Arbor, MI USA; [Ting, Henry H.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Goodney, Philip P.] Dartmouth Hitchcock Med Ctr, Vasc Surg Sect, Lebanon, NH 03766 USA; [Curtis, Jeptha P.; Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Mayo Clinic; Dartmouth College; Yale University	Nallamothu, BK (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Ctr Cardiovasc, SPC 5869, Ann Arbor, MI 48109 USA.	bnallamo@umich.edu	, Harlan/AAI-2875-2020	Gurm, Hitinder/0000-0002-1646-0218; Rogers, Mary/0000-0001-5519-3223	National Institutes of Health [5R21AG032155-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL105676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by grant 5R21AG032155-02 from the National Institutes of Health.	*AG HEALTH RES QUA, HCUPNET HEALTHC COST; *AM MED ASS, 2009, CPT 2010 PROF ED; Anderson HV, 2010, CATHETER CARDIO INTE, V75, P519, DOI 10.1002/ccd.22333; Bates ER, 2007, J AM COLL CARDIOL, V49, P126, DOI 10.1016/j.jacc.2006.10.021; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Cates CU, 2007, JAMA-J AM MED ASSOC, V297, P265, DOI 10.1001/jama.297.3.265-b; Centers for Medicare and Medicaid Services, 2005, CMS MAN SYST PUB; Clair DG, 2008, SEMIN VASC SURG, V21, P64, DOI 10.1053/j.semvascsurg.2008.03.006; Connors JJ, 2005, NEUROLOGY, V64, P190, DOI 10.1212/01.WNL.0000148958.34025.09; *CTR MED MED SERV, UN PHYS ID NUMB UPIN; *CTR MED MED SERV, 2010, CMS MAN SYST PUB; Davis SM, 2010, NEW ENGL J MED, V363, P80, DOI 10.1056/NEJMe1005220; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gallagher AG, 2004, JAMA-J AM MED ASSOC, V292, P3024, DOI 10.1001/jama.292.24.3024; Goodney PP, 2010, CIRC-CARDIOVASC QUAL, V3, P15, DOI 10.1161/CIRCOUTCOMES.109.864736; Grantcharov TP, 2008, BRIT MED J, V336, P1129, DOI 10.1136/bmj.39517.686956.47; Halm EA, 2010, ARCH INTERN MED, V170, P1225, DOI 10.1001/archinternmed.2010.223; Kastrup A, 2003, STROKE, V34, P813, DOI 10.1161/01.STR.0000058160.53040.5F; Lin PH, 2005, AM J SURG, V190, P850, DOI 10.1016/j.amsjurg.2005.08.008; Nallamothu BK, 2011, ARCH INTERN MED, V171, P1804, DOI 10.1001/archinternmed.2011.354; Ramsay C R, 2001, Health Technol Assess, V5, P1; Ramsay CR, 2000, INT J TECHNOL ASSESS, V16, P1095, DOI 10.1017/S0266462300103149; Reznick RK, 2006, NEW ENGL J MED, V355, P2664, DOI 10.1056/NEJMra054785; Rosenfield K, 2005, J AM COLL CARDIOL, V45, P165, DOI 10.1016/j.jacc.2004.11.016; Schreiber TL, 2010, J AM COLL CARDIOL, V56, P49, DOI 10.1016/j.jacc.2010.02.045; SEE WA, 1993, JAMA-J AM MED ASSOC, V270, P2689, DOI 10.1001/jama.270.22.2689; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Verzini F, 2006, J VASC SURG, V44, P1205, DOI 10.1016/j.jvs.2006.08.027; Wholey MH, 2000, CATHETER CARDIO INTE, V50, P160, DOI 10.1002/(SICI)1522-726X(200006)50:2<160::AID-CCD2>3.0.CO;2-E; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127	30	139	140	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 28	2011	306	12					1338	1343		10.1001/jama.2011.1357	http://dx.doi.org/10.1001/jama.2011.1357			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825FQ	21954477	Green Accepted, Bronze			2022-12-28	WOS:000295257000022
J	Adler, PB; Seabloom, EW; Borer, ET; Hillebrand, H; Hautier, Y; Hector, A; Harpole, WS; O'Halloran, LR; Grace, JB; Anderson, TM; Bakker, JD; Biederman, LA; Brown, CS; Buckley, YM; Calabrese, LB; Chu, CJ; Cleland, EE; Collins, SL; Cottingham, KL; Crawley, MJ; Damschen, EI; Davies, KF; DeCrappeo, NM; Fay, PA; Firn, J; Frater, P; Gasarch, EI; Gruner, DS; Hagenah, N; Lambers, JHR; Humphries, H; Jin, VL; Kay, AD; Kirkman, KP; Klein, JA; Knops, JMH; La Pierre, KJ; Lambrinos, JG; Li, W; MacDougall, AS; McCulley, RL; Melbourne, BA; Mitchell, CE; Moore, JL; Morgan, JW; Mortensen, B; Orrock, JL; Prober, SM; Pyke, DA; Risch, AC; Schuetz, M; Smith, MD; Stevens, CJ; Sullivan, LL; Wang, G; Wragg, PD; Wright, JP; Yang, LH				Adler, Peter B.; Seabloom, Eric W.; Borer, Elizabeth T.; Hillebrand, Helmut; Hautier, Yann; Hector, Andy; Harpole, W. Stanley; O'Halloran, Lydia R.; Grace, James B.; Anderson, T. Michael; Bakker, Jonathan D.; Biederman, Lori A.; Brown, Cynthia S.; Buckley, Yvonne M.; Calabrese, Laura B.; Chu, Cheng-Jin; Cleland, Elsa E.; Collins, Scott L.; Cottingham, Kathryn L.; Crawley, Michael J.; Damschen, Ellen I.; Davies, Kendi F.; DeCrappeo, Nicole M.; Fay, Philip A.; Firn, Jennifer; Frater, Paul; Gasarch, Eve I.; Gruner, Daniel S.; Hagenah, Nicole; Lambers, Janneke Hille Ris; Humphries, Hope; Jin, Virginia L.; Kay, Adam D.; Kirkman, Kevin P.; Klein, Julia A.; Knops, Johannes M. H.; La Pierre, Kimberly J.; Lambrinos, John G.; Li, Wei; MacDougall, Andrew S.; McCulley, Rebecca L.; Melbourne, Brett A.; Mitchell, Charles E.; Moore, Joslin L.; Morgan, John W.; Mortensen, Brent; Orrock, John L.; Prober, Suzanne M.; Pyke, David A.; Risch, Anita C.; Schuetz, Martin; Smith, Melinda D.; Stevens, Carly J.; Sullivan, Lauren L.; Wang, Gang; Wragg, Peter D.; Wright, Justin P.; Yang, Louie H.			Productivity Is a Poor Predictor of Plant Species Richness	SCIENCE			English	Article							DIVERSITY; BIODIVERSITY; HYPOTHESIS	For more than 30 years, the relationship between net primary productivity and species richness has generated intense debate in ecology about the processes regulating local diversity. The original view, which is still widely accepted, holds that the relationship is hump-shaped, with richness first rising and then declining with increasing productivity. Although recent meta-analyses questioned the generality of hump-shaped patterns, these syntheses have been criticized for failing to account for methodological differences among studies. We addressed such concerns by conducting standardized sampling in 48 herbaceous-dominated plant communities on five continents. We found no clear relationship between productivity and fine-scale (meters(-2)) richness within sites, within regions, or across the globe. Ecologists should focus on fresh, mechanistic approaches to understanding the multivariate links between productivity and richness.	[Adler, Peter B.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Adler, Peter B.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Seabloom, Eric W.; Borer, Elizabeth T.; Wragg, Peter D.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Hillebrand, Helmut] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, D-26381 Wilhelmshaven, Germany; [Hautier, Yann; Hector, Andy] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Harpole, W. Stanley; Biederman, Lori A.; Frater, Paul; Li, Wei; Mortensen, Brent; Sullivan, Lauren L.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [O'Halloran, Lydia R.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Grace, James B.] US Geol Survey, Natl Wetlands Res Ctr, Lafayette, LA 70506 USA; [Anderson, T. Michael] Wake Forest Univ, Dept Biol, Reynolda Stn 7325, Winston Salem, NC 27109 USA; [Bakker, Jonathan D.] Univ Washington, Sch Forest Resources, Seattle, WA 98195 USA; [Brown, Cynthia S.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Buckley, Yvonne M.; Collins, Scott L.] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia; [Calabrese, Laura B.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Chu, Cheng-Jin; Wang, Gang] Lanzhou Univ, Minist Educ, Key Lab Arid & Grassland Ecol, Lanzhou 730000, Gansu, Peoples R China; [Cleland, Elsa E.] Univ Calif San Diego, Ecol Behav & Evolut Sect, La Jolla, CA 92093 USA; [Cottingham, Kathryn L.] Dartmouth Coll, Dept Biol Sci, Gilman Lab 6044, Hanover, NH 03755 USA; [Crawley, Michael J.] Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Ascot SL5 7PY, Berks, England; [Damschen, Ellen I.; Orrock, John L.] Univ Wisconsin, Dept Zool, Madison, WI 53704 USA; [Davies, Kendi F.; Gasarch, Eve I.; Humphries, Hope; Melbourne, Brett A.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [DeCrappeo, Nicole M.; Pyke, David A.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR 97331 USA; [Fay, Philip A.] USDA ARS, Grassland Soil & Water Res Lab, Temple, TX 76502 USA; [Firn, Jennifer] Queensland Univ Technol, Sch Biogeosci, Brisbane, Qld 4001, Australia; [Gruner, Daniel S.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Hagenah, Nicole; Kirkman, Kevin P.; La Pierre, Kimberly J.] Univ KwaZulu Natal, Sch Biol & Conservat Sci, ZA-3209 Kwa Zulu, South Africa; [Hagenah, Nicole; Smith, Melinda D.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Lambers, Janneke Hille Ris] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Jin, Virginia L.] USDA ARS, Agroecosyst Management Res Unit, Lincoln, NE 68583 USA; [Kay, Adam D.] Univ St Thomas, Dept Biol, St Paul, MN 55105 USA; [Klein, Julia A.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Knops, Johannes M. H.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Lambrinos, John G.] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [MacDougall, Andrew S.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [McCulley, Rebecca L.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40546 USA; [Mitchell, Charles E.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Moore, Joslin L.] Univ Melbourne, Sch Bot, Parkville, Vic 3010, Australia; [Morgan, John W.] La Trobe Univ, Dept Bot, Bundoora, Vic 3086, Australia; [Prober, Suzanne M.] Commonwealth Sci & Ind Res Org Ecosyst Sci, Wembley, WA 6913, Australia; [Risch, Anita C.; Schuetz, Martin] Swiss Fed Inst Forest Snow & Landscape Res, CH-8903 Birmensdorf ZH, Switzerland; [Stevens, Carly J.] Open Univ, Dept Life Sci, Milton Keynes MK7 6AA, Bucks, England; [Stevens, Carly J.] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; [Wright, Justin P.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Yang, Louie H.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; University of Minnesota System; University of Minnesota Twin Cities; Carl von Ossietzky Universitat Oldenburg; University of Zurich; Iowa State University; Oregon State University; United States Department of the Interior; United States Geological Survey; Wake Forest University; University of Washington; University of Washington Seattle; Colorado State University; University of Queensland; University of New Mexico; Lanzhou University; University of California System; University of California San Diego; Dartmouth College; Imperial College London; University of Wisconsin System; University of Wisconsin Madison; University of Colorado System; University of Colorado Boulder; United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA); Queensland University of Technology (QUT); University System of Maryland; University of Maryland College Park; University of Kwazulu Natal; Yale University; University of Washington; University of Washington Seattle; United States Department of Agriculture (USDA); University of St Thomas Minnesota; Colorado State University; University of Nebraska System; University of Nebraska Lincoln; Oregon State University; University of Guelph; University of Kentucky; University of North Carolina; University of North Carolina Chapel Hill; University of Melbourne; La Trobe University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Open University - UK; Lancaster University; Duke University; University of California System; University of California Davis	Adler, PB (corresponding author), Utah State Univ, Dept Wildland Resources, 5230 Old Main, Logan, UT 84322 USA.	peter.adler@usu.edu	Fay, Philip A./I-1853-2012; Cottingham, Kathryn L./AAV-3934-2021; Brown, Cynthia/K-5814-2012; Gruner, Daniel Stephen/A-5166-2010; Wright, Justin/AAG-6461-2019; Cottingham, Kathryn/H-1593-2012; Grace, James/B-8472-2009; Knops, Johannes/AAA-8546-2020; Mortensen, Brent/AAD-2092-2021; Mitchell, Charles E/I-3709-2014; Chu, Chu/T-6038-2019; Pyke, David A./AAW-8291-2020; Moore, Joslin/AAE-3819-2020; Damschen, Ellen/E-4919-2011; Harpole, W Stanley/C-2814-2013; Wragg, Peter/C-8385-2009; Hillebrand, Helmut/I-1717-2014; Collins, Scott/P-7742-2014; Hautier, Yann/D-5426-2015; Prober, Suzanne/G-6465-2010; Kirkman, Kevin/F-4160-2010; Risch, Anita C./A-9836-2012; Buckley, Yvonne/B-1281-2008	Fay, Philip A./0000-0002-8291-6316; Cottingham, Kathryn L./0000-0003-3169-5047; Gruner, Daniel Stephen/0000-0002-3153-4297; Wright, Justin/0000-0002-9102-5347; Grace, James/0000-0001-6374-4726; Mortensen, Brent/0000-0002-4873-6127; Mitchell, Charles E/0000-0002-1633-1993; Pyke, David A./0000-0002-4578-8335; Moore, Joslin/0000-0001-9809-5092; Damschen, Ellen/0000-0001-7435-0669; Harpole, W Stanley/0000-0002-3404-9174; Wragg, Peter/0000-0003-2361-4286; Seabloom, Eric/0000-0001-6780-9259; Firn, Jennifer/0000-0001-6026-8912; Hillebrand, Helmut/0000-0001-7449-1613; Collins, Scott/0000-0002-0193-2892; Komatsu, Kimberly/0000-0001-7056-4547; Yang, Louie/0000-0002-9237-5357; Hautier, Yann/0000-0003-4347-7741; Borer, Elizabeth/0000-0003-2259-5853; Stevens, Carly/0000-0002-2390-1763; Frater, Paul/0000-0002-7237-6563; Prober, Suzanne/0000-0002-6518-239X; Kirkman, Kevin/0000-0001-9580-5191; Bakker, Jonathan/0000-0002-8973-2771; Chu, Chengjin/0000-0002-0606-449X; MELBOURNE, BRETT/0000-0002-8843-4131; Brown, Cynthia/0000-0001-8486-7119; Risch, Anita C./0000-0003-0531-8336; Biederman, Lori/0000-0003-2171-7898; Buckley, Yvonne/0000-0001-7599-3201	NSF [DEB-0741952]; Natural Environment Research Council [ceh010010] Funding Source: researchfish	NSF(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was generated using data from the Nutrient Network collaborative experiment, funded at the site-scale by individual researchers and coordinated through Research Coordination Network funding from NSF to E. Borer and E. Seabloom (grant DEB-0741952). The authors declare no competing interests. The data used in the primary analyses are available in the Supporting Online Material. We thank B. Enquist, A. Leakey, and three anonymous reviewers for suggestions that improved the manuscript.	ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; ALMUFTI MM, 1977, J ECOL, V65, P759, DOI 10.2307/2259378; Cardinale BJ, 2009, ECOLOGY, V90, P1227, DOI 10.1890/08-1038.1; Cardinale BJ, 2009, ECOL LETT, V12, P475, DOI 10.1111/j.1461-0248.2009.01317.x; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Fukami T, 2003, NATURE, V424, P423, DOI 10.1038/nature01785; Gillman LN, 2006, ECOLOGY, V87, P1234, DOI 10.1890/0012-9658(2006)87[1234:TIOPOT]2.0.CO;2; GOLDBERG DE, 1990, ECOLOGY, V71, P213, DOI 10.2307/1940261; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grace JB, 2007, ECOL LETT, V10, P680, DOI 10.1111/j.1461-0248.2007.01058.x; Grace JB, 1999, OIKOS, V85, P398, DOI 10.2307/3546689; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Huston M. A., 1994, BIOL DIVERSITY; Huston MA, 1999, OIKOS, V86, P393, DOI 10.2307/3546645; Kondoh M, 2001, P ROY SOC B-BIOL SCI, V268, P269, DOI 10.1098/rspb.2000.1384; Ma WH, 2010, GLOBAL ECOL BIOGEOGR, V19, P233, DOI 10.1111/j.1466-8238.2009.00508.x; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Oesterheld M, 2000, METHODS IN ECOSYSTEM SCIENCE, P151; Rosenzweig Michael L., 1993, P52; Scheiner SM, 2000, EVOL ECOL RES, V2, P791; Tilman D., 1982, Monographs in Population Biology, pi; Tilman David, 1993, P13; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Whittaker RJ, 2003, ECOLOGY, V84, P3384, DOI 10.1890/02-3128; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1; Zobel M, 2008, GLOBAL ECOL BIOGEOGR, V17, P679, DOI 10.1111/j.1466-8238.2008.00400.x	30	397	437	23	709	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2011	333	6050					1750	1753		10.1126/science.1204498	http://dx.doi.org/10.1126/science.1204498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940895	Green Accepted			2022-12-28	WOS:000295121500043
J	Frisch, RL; Rosenberg, SM				Frisch, Ryan L.; Rosenberg, Susan M.			Antibiotic Resistance, Not Shaken or Stirred	SCIENCE			English	Editorial Material							POPULATION; MUTATION		[Frisch, Ryan L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Frisch, RL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	smr@bcm.edu		Rosenberg, Susan M./0000-0003-1444-473X	NCI NIH HHS [DP1 CA174424, R01 CA085777] Funding Source: Medline; NIGMS NIH HHS [R01 GM053158] Funding Source: Medline; NIH HHS [DP1 OD006429] Funding Source: Medline; NATIONAL CANCER INSTITUTE [DP1CA174424, R01CA085777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053158] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006429] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Hermsen R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.248104; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Pena MI, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.43; Torkelson J, 1997, EMBO J, V16, P3303, DOI 10.1093/emboj/16.11.3303; Yeiser B, 2002, P NATL ACAD SCI USA, V99, P8737, DOI 10.1073/pnas.092269199; Zhang QC, 2011, SCIENCE, V333, P1764, DOI 10.1126/science.1208747	9	5	5	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1713	1714		10.1126/science.1212449	http://dx.doi.org/10.1126/science.1212449			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940884	Green Accepted			2022-12-28	WOS:000295121500030
J	Johnson, DDP; Fowler, JH				Johnson, Dominic D. P.; Fowler, James H.			The evolution of overconfidence	NATURE			English	Article							FIGHTING BEHAVIOR; BIASES; WAR	Confidence is an essential ingredient of success in a wide range of domains ranging from job performance and mental health to sports, business and combat(1-4). Some authors have suggested that not just confidence but overconfidence-believing you are better than you are in reality-is advantageous because it serves to increase ambition, morale, resolve, persistence or the credibility of bluffing, generating a self-fulfilling prophecy in which exaggerated confidence actually increases the probability of success(3-8). However, overconfidence also leads to faulty assessments, unrealistic expectations and hazardous decisions, so it remains a puzzle how such a false belief could evolve or remain stable in a population of competing strategies that include accurate, unbiased beliefs. Here we present an evolutionary model showing that, counterintuitively, overconfidence maximizes individual fitness and populations tend to become overconfident, as long as benefits from contested resources are sufficiently large compared with the cost of competition. In contrast, unbiased strategies are only stable under limited conditions. The fact that overconfident populations are evolutionarily stable in a wide range of environments may help to explain why overconfidence remains prevalent today, even if it contributes to hubris, market bubbles, financial collapses, policy failures, disasters and costly wars(9-13).	[Johnson, Dominic D. P.] Univ Edinburgh, Edinburgh EH8 9LD, Midlothian, Scotland; [Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA; [Fowler, James H.] Univ Calif San Diego, Div Med Genet, La Jolla, CA 92093 USA	University of Edinburgh; University of California System; University of California San Diego; University of California System; University of California San Diego	Johnson, DDP (corresponding author), Univ Edinburgh, Edinburgh EH8 9LD, Midlothian, Scotland.	dominic.johnson@ed.ac.uk	Johnson, Dominic/GXH-1117-2022; Fowler, James H/C-2750-2008	Fowler, James H/0000-0001-7795-1638				Akerlof George, 2009, ANIMAL SPIRITS HUMAN; Camerer C, 1999, AM ECON REV, V89, P306, DOI 10.1257/aer.89.1.306; COSMIDES L, 1994, AM ECON REV, V84, P327; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; ENQUIST M, 1990, ANIM BEHAV, V39, P1, DOI 10.1016/S0003-3472(05)80721-3; FAMA EF, 1968, J AM STAT ASSOC, V63, P817, DOI 10.2307/2283875; FEARON JD, 1995, INT ORGAN, V49, P379, DOI 10.1017/S0020818300033324; FUDENBERG D, 1991, J ECON THEORY, V53, P236, DOI 10.1016/0022-0531(91)90155-W; Gigerenzer G, 2002, ADAPTIVE THINKING RA; Haselton MG, 2006, PERS SOC PSYCHOL REV, V10, P47, DOI 10.1207/s15327957pspr1001_3; Johnson DDP., 2004, OVERCONFIDENCE WAR H; Johnson D, 2009, CURR SCI INDIA, V97, P1593; Johnson DDP, 2011, INT SECURITY, V36, P7, DOI 10.1162/ISEC_a_00043; Johnson DDP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020851; Kanter RM, 2004, CONFIDENCE WINNING S; Malmendier U, 2005, J FINANC, V60, P2661, DOI 10.1111/j.1540-6261.2005.00813.x; McDermott R, 2008, J POLIT, V70, P335, DOI 10.1017/S0022381608080341; McKay RT, 2009, BEHAV BRAIN SCI, V32, P493, DOI 10.1017/S0140525X09990975; Nettle D., 2004, EMOTION EVOLUTION RA, P193, DOI 10.1093/acprof:oso/9780198528975.003.0010; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Peterson C., 2006, PRIMER POSITIVE PSYC, DOI DOI 10.1016/j.compedu.2004.08.013; Sharot T., 2011, OPTIMISM BIAS TOUR I; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Taylor S. E., 1989, POSITIVE ILLUSIONS C; TAYLOR SE, 1994, PSYCHOL BULL, V116, P21, DOI 10.1037/0033-2909.116.1.21; Trivers R, 2000, ANN NY ACAD SCI, V907, P114; Trivers Robert, 2011, DECEIT SELF DECEPTIO; Tuchman B., 1984, MARCH FOLLY TROY VIE; Wrangham R, 1999, EVOL HUM BEHAV, V20, P3, DOI 10.1016/S1090-5138(98)00040-3	30	270	279	11	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 15	2011	477	7364					317	320		10.1038/nature10384	http://dx.doi.org/10.1038/nature10384			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	819TD	21921915	Green Submitted			2022-12-28	WOS:000294852400028
J	Beasley, R; Patel, M; Perrin, K; O'Driscoll, BR				Beasley, Richard; Patel, Mitesh; Perrin, Kyle; O'Driscoll, B. Ronan			High-concentration oxygen therapy in COPD	LANCET			English	Editorial Material							MORTALITY		[Beasley, Richard; Patel, Mitesh; Perrin, Kyle] Med Res Inst New Zealand, Wellington 6242, New Zealand; [Beasley, Richard; Perrin, Kyle] Capital & Coast Dist Hlth Board, Wellington, New Zealand; [O'Driscoll, B. Ronan] Univ Manchester, Salford Royal Univ Hosp, Manchester Acad Hlth Sci Ctr, Salford, Lancs, England	Medical Research Institute Of New Zealand; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester	Beasley, R (corresponding author), Med Res Inst New Zealand, Wellington 6242, New Zealand.	richard.beasley@mrinz.ac.nz	Beasley, Richard/AAH-3908-2019	Beasley, Richard/0000-0003-0337-406X				Austin MA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5462; *BRIT THOR SOC, 2004, THORAX, V59, P131; CAMPBELL EJM, 1960, LANCET, V2, P10; GUNAWARDENA KA, 1984, BRIT MED J, V288, P272, DOI 10.1136/bmj.288.6413.272; Kane B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1557; MASSARO D J, 1962, Br Med J, V2, P627; Murphy R, 2001, EMERG MED J, V18, P333, DOI 10.1136/emj.18.5.333; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; Price LC, 2006, THORAX, V61, P837, DOI 10.1136/thx.2005.049940; Roberts CM, 2011, THORAX, V66, P43, DOI 10.1136/thx.2010.153114; Wijesinghe M, 2011, INTERN MED J, V41, P618, DOI 10.1111/j.1445-5994.2010.02207.x	11	17	17	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2011	378	9795					969	970		10.1016/S0140-6736(11)61431-1	http://dx.doi.org/10.1016/S0140-6736(11)61431-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	824HO	21907850				2022-12-28	WOS:000295193200008
J	Sandel, B; Arge, L; Dalsgaard, B; Davies, RG; Gaston, KJ; Sutherland, WJ; Svenning, JC				Sandel, B.; Arge, L.; Dalsgaard, B.; Davies, R. G.; Gaston, K. J.; Sutherland, W. J.; Svenning, J. -C.			The Influence of Late Quaternary Climate-Change Velocity on Species Endemism	SCIENCE			English	Article							RANGE SHIFTS; DIVERSITY; DISTRIBUTIONS; SCALE	The effects of climate change on biodiversity should depend in part on climate displacement rate (climate-change velocity) and its interaction with species' capacity to migrate. We estimated Late Quaternary glacial-interglacial climate-change velocity by integrating macroclimatic shifts since the Last Glacial Maximum with topoclimatic gradients. Globally, areas with high velocities were associated with marked absences of small-ranged amphibians, mammals, and birds. The association between endemism and velocity was weakest in the highly vagile birds and strongest in the weakly dispersing amphibians, linking dispersal ability to extinction risk due to climate change. High velocity was also associated with low endemism at regional scales, especially in wet and aseasonal regions. Overall, we show that low-velocity areas are essential refuges for Earth's many small-ranged species.	[Sandel, B.; Svenning, J. -C.] Aarhus Univ, Dept Biosci, Ecoinformat & Biodivers Grp, DK-8000 Aarhus C, Denmark; [Sandel, B.; Arge, L.] Aarhus Univ, Dept Comp Sci, Ctr Mass Data Algorithm MADALGO, DK-8000 Aarhus C, Denmark; [Dalsgaard, B.; Sutherland, W. J.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge CB2 3EJ, England; [Davies, R. G.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	Aarhus University; Aarhus University; University of Cambridge; University of East Anglia	Sandel, B (corresponding author), Aarhus Univ, Dept Biosci, Ecoinformat & Biodivers Grp, DK-8000 Aarhus C, Denmark.	brody.sandel@biology.au.dk	Davies, Richard/H-7447-2019; Sandel, Brody/I-8009-2013; Svenning, Jens-Christian/C-8977-2012; Sutherland, William/B-1291-2013	Svenning, Jens-Christian/0000-0002-3415-0862; Gaston, Kevin J./0000-0002-7235-7928; Dalsgaard, Bo/0000-0003-2867-2805; Sutherland, William/0000-0002-6498-0437	Aarhus University Research Foundation; MADALGO-Center for Massive Data Algorithmics, a Center of the Danish National Research Foundation; Danish Council for Independent Research-Natural Sciences; Arcadia; Natural Environment Research Council [NER/O/S/2001/01230]	Aarhus University Research Foundation; MADALGO-Center for Massive Data Algorithmics, a Center of the Danish National Research Foundation; Danish Council for Independent Research-Natural Sciences(Det Frie Forskningsrad (DFF)); Arcadia; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the Aarhus University Research Foundation for financial support. This study was also supported in part by MADALGO-Center for Massive Data Algorithmics, a Center of the Danish National Research Foundation. B. D. is supported by the Danish Council for Independent Research-Natural Sciences, and W.J.S. is funded by Arcadia. We thank international climate modeling groups for providing their data for analysis, the Laboratoire des Sciences du Climat et de l'Environnement for collecting and archiving the paleoclimate model data, the International Union for Conservation of Nature and Natural Resources for making the amphibian and mammal range data available, and the Natural Environment Research Council-funded Avian Diversity Hotspots Consortium (NER/O/S/2001/01230) for the use of the bird range data. We thank four anonymous reviewers whose constructive comments improved this manuscript. Data are archived at Dryad (http://dx.doi.org/10.5061/dryad.b13j1).	Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Davies TJ, 2009, AM NAT, V174, P297, DOI 10.1086/603614; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Gaston K.J., 2003, STRUCTURE DYNAMICS G; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; HUNTLEY B, 1989, J BIOGEOGR, V16, P5, DOI 10.2307/2845307; Jansson R, 2003, P ROY SOC B-BIOL SCI, V270, P583, DOI 10.1098/rspb.2002.2283; Jansson R, 2008, ECOL LETT, V11, P173, DOI 10.1111/j.1461-0248.2007.01138.x; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; McGlone MS, 1996, GLOBAL ECOL BIOGEOGR, V5, P309, DOI 10.2307/2997586; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Nogues-Bravo D, 2010, EVOLUTION, V64, P2442, DOI 10.1111/j.1558-5646.2010.01009.x; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Ruddiman WF, 2001, EARTHS CLIMATE FUTUR; Scherrer D, 2011, J BIOGEOGR, V38, P406, DOI 10.1111/j.1365-2699.2010.02407.x; SCHOONMAKER PK, 1991, BOT REV, V57, P204, DOI 10.1007/BF02858563; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Svenning JC, 2003, ECOL LETT, V6, P646, DOI 10.1046/j.1461-0248.2003.00477.x; Svenning JC, 2008, ECOGRAPHY, V31, P316, DOI 10.1111/j.0906-7590.2008.05206.x; Svenning JC, 2007, ECOL LETT, V10, P453, DOI 10.1111/j.1461-0248.2007.01038.x; Svenning JC, 2007, GLOBAL ECOL BIOGEOGR, V16, P234, DOI 10.1111/j.1466-8238.2006.00280.x	29	538	559	15	352	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2011	334	6056					660	664		10.1126/science.1210173	http://dx.doi.org/10.1126/science.1210173			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	21979937				2022-12-28	WOS:000296494700052
J	Locke, JCW; Young, JW; Fontes, M; Jimenez, MJH; Elowitz, MB				Locke, James C. W.; Young, Jonathan W.; Fontes, Michelle; Jimenez, Maria Jesus Hernandez; Elowitz, Michael B.			Stochastic Pulse Regulation in Bacterial Stress Response	SCIENCE			English	Article							BACILLUS-SUBTILIS; TRANSCRIPTION FACTOR; GENE-REGULATION; SIGMA(B); EXPRESSION; GROWTH; DIFFERENTIATION; ACTIVATION; VIRULENCE; DYNAMICS	Gene regulatory circuits can use dynamic, and even stochastic, strategies to respond to environmental conditions. We examined activation of the general stress response mediated by the alternative sigma factor, sigma(B), in individual Bacillus subtilis cells. We observed that energy stress activates sigma(B) in discrete stochastic pulses, with increasing levels of stress leading to higher pulse frequencies. By perturbing and rewiring the endogenous system, we found that this behavior results from three key features of the sigma(B) circuit: an ultrasensitive phosphorylation switch; stochasticity ("noise"), which activates that switch; and a mixed (positive and negative) transcriptional feedback, which can both amplify a pulse and switch it off. Together, these results show how prokaryotes encode signals using stochastic pulse frequency modulation through a compact regulatory architecture.	[Locke, James C. W.; Young, Jonathan W.; Fontes, Michelle; Jimenez, Maria Jesus Hernandez; Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Div Biol & Bioengn, Broad Ctr, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Elowitz, MB (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol & Bioengn, Broad Ctr, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	melowitz@caltech.edu		Locke, James/0000-0003-0670-1943	NIH [R01GM079771, P50 GM068763]; U.S. National Science Foundation [0644463]; Packard Foundation; International Human Frontier Science Program Organization; European Molecular Biology Organization; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763, R01GM079771] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Science Foundation(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation); International Human Frontier Science Program Organization(Human Frontier Science Program); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Price and D. Rudner for providing strains. We thank A. Eldar, R. Kishony, C. Price, N. Wingreen, J. Levine, and other members of M. B. E's laboratory for helpful discussions. Work in M. B. E's laboratory was supported by NIH grants R01GM079771 and P50 GM068763, U.S. National Science Foundation CAREER Award 0644463, and the Packard Foundation. J.C.W.L was supported by the International Human Frontier Science Program Organization and the European Molecular Biology Organization.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; ALPER S, 1994, CELL, V77, P195, DOI 10.1016/0092-8674(94)90312-3; Brody MS, 2001, J BACTERIOL, V183, P6422, DOI 10.1128/JB.183.21.6422-6428.2001; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Cheng Z, 2009, BIOPHYS J, V97, P2867, DOI 10.1016/j.bpj.2009.09.008; DUFOUR A, 1994, J BACTERIOL, V176, P1813, DOI 10.1128/jb.176.7.1813-1820.1994; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; HALDENWANG WG, 1979, NATURE, V282, P256, DOI 10.1038/282256a0; Hecker M, 1998, MOL MICROBIOL, V29, P1129, DOI 10.1046/j.1365-2958.1998.00977.x; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Igoshin OA, 2007, J MOL BIOL, V369, P1333, DOI 10.1016/j.jmb.2007.04.021; Kazmierczak MJ, 2003, J BACTERIOL, V185, P5722, DOI 10.1128/JB.185.19.5722-5734.2003; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Lorenz U, 2008, MICROBES INFECT, V10, P217, DOI 10.1016/j.micinf.2007.11.006; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Melen GJ, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100036; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Ray JCJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000676; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Schweder T, 1999, ARCH MICROBIOL, V171, P439, DOI 10.1007/s002030050731; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; WISE AA, 1995, J BACTERIOL, V177, P123, DOI 10.1128/jb.177.1.123-133.1995; Zhang SY, 2005, J BACTERIOL, V187, P7554, DOI 10.1128/JB.187.22.7554-7560.2005	30	139	142	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054					366	369		10.1126/science.1208144	http://dx.doi.org/10.1126/science.1208144			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	21979936	Green Accepted			2022-12-28	WOS:000296052500050
J	Hu, NJ; Iwata, S; Cameron, AD; Drew, D				Hu, Nien-Jen; Iwata, So; Cameron, Alexander D.; Drew, David			Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT	NATURE			English	Article							MEMBRANE-PROTEIN OVEREXPRESSION; NHAA NA+/H+ ANTIPORTER; ESCHERICHIA-COLI; MAXIMUM-LIKELIHOOD; ALTERNATING ACCESS; HUMAN ILEAL; TRANSPORT; MODEL; IDENTIFICATION; COTRANSPORTER	High cholesterol levels greatly increase the risk of cardiovascular disease. About 50 per cent of cholesterol is eliminated from the body by its conversion into bile acids. However, bile acids released from the bile duct are constantly recycled, being reabsorbed in the intestine by the apical sodium-dependent bile acid transporter (ASBT, also known as SLC10A2). It has been shown in animal models that plasma cholesterol levels are considerably lowered by specific inhibitors of ASBT(1,2), and ASBT is thus a target for hypercholesterolaemia drugs. Here we report the crystal structure of a bacterial homologue of ASBT from Neisseria meningitidis (ASBT(NM)) at 2.2 angstrom. ASBT(NM) contains two inverted structural repeats of five transmembrane helices. A core domain of six helices harbours two sodium ions, and the remaining four helices pack in a row to form a flat, 'panel'-like domain. Overall, the architecture of the protein is remarkably similar to the sodium/proton antiporter NhaA(3), despite having no detectable sequence homology. The ASBT(NM) structure was captured with the substrate taurocholate present, bound between the core and panel domains in a large, inward-facing, hydrophobic cavity. Residues near this cavity have been shown to affect the binding of specific inhibitors of human ASBT(4). The position of the taurocholate molecule, together with the molecular architecture, suggests the rudiments of a possible transport mechanism.	[Hu, Nien-Jen; Iwata, So; Cameron, Alexander D.; Drew, David] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Hu, Nien-Jen; Iwata, So; Cameron, Alexander D.] Diamond Light Source, Membrane Prot Lab, Chilton OX11 0DE, England; [Hu, Nien-Jen; Iwata, So; Cameron, Alexander D.] Appleton Lab, Didcot OX11 0FA, Oxon, England; [Iwata, So; Cameron, Alexander D.] Japan Sci & Technol Agcy, ERATO, Human Crystallog Project, Sakyo Ku, Kyoto 606851, Japan; [Iwata, So] Kyoto Univ, Dept Cell Biol, Sch Med, Sakyo Ku, Kyoto 6068501, Japan	Imperial College London; Diamond Light Source; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Japan Science & Technology Agency (JST); Kyoto University	Drew, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England.	s.iwata@imperial.ac.uk; a.cameron@imperial.ac.uk; d.drew@imperial.ac.uk	Drew, David/AAY-3455-2020; Drew, David/D-3243-2018; Cameron, Alexander/L-7288-2013	Hu, Nien-Jen/0000-0002-0917-0677; Drew, David/0000-0001-8866-6349; Cameron, Alexander/0000-0001-8776-3518	Medical Research Council [MRC_G0900990(91997)]; European Union [LSHG-CT-2004-504601]; Biotechnology and Biological Sciences Research Council [BB/G023425/1]; MEXT, Japan; Japan Science and Technology Agency; Wellcome Trust [WT089809]; BBSRC [BB/G023425/1] Funding Source: UKRI; MRC [G0900990] Funding Source: UKRI; Medical Research Council [G0900990] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to C. Lee and Y. Sekiguchi for assistance with cloning and expression screening of ASBT<INF>NM</INF> mutants, and to S. van de Graaf for donating fluorescently labelled bile acid, which was used in the initial functional characterization of ASBTNM. Data were collected at the European Synchrotron Radiation Facility, France, and the Diamond Light Source, UK, with assistance from beamline scientists; in particular, we would like to thank J. Sanchez-Weatherby for help with the HCl. We are also grateful to K. Beis and G. von Heijne for reading the manuscript. This work was funded by the Medical Research Council (MRC_G0900990(91997), to A.D.C. and D.D.), the European Union (EMeP grant LSHG-CT-2004-504601, to S.I.) and the Biotechnology and Biological Sciences Research Council (BB/G023425/1, to S.I.). Part of this work was also supported by a grant from the Targeted Proteins Research Program of MEXT, Japan, and the ERATO Iwata Human Receptor Crystallography Project, Japan Science and Technology Agency. The authors are grateful for the use of the Membrane Protein Laboratory funded by the Wellcome Trust (WT089809) at the Diamond Light Source. D.D. acknowledges personal support from The Royal Society through the University Research Fellow scheme.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Appel M, 2009, J MOL BIOL, V388, P659, DOI 10.1016/j.jmb.2009.03.010; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee A, 2006, BIOCHEMISTRY-US, V45, P943, DOI 10.1021/bi052202j; Bhat BG, 2003, J LIPID RES, V44, P1614, DOI 10.1194/jlr.M200469-JLR200; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; Chignard N, 2001, HEPATOLOGY, V33, P496, DOI 10.1053/jhep.2001.22345; Craddock AL, 1998, AM J PHYSIOL-GASTR L, V274, pG157, DOI 10.1152/ajpgi.1998.274.1.G157; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L., 2002, PYMOL MOL VIEWER; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Geyer J, 2006, N-S ARCH PHARMACOL, V372, P413, DOI 10.1007/s00210-006-0043-8; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P566, DOI 10.1007/s00424-003-1130-z; Hagenbuch B, 1996, SEMIN LIVER DIS, V16, P129, DOI 10.1055/s-2007-1007226; Hallen S, 1999, BIOCHEMISTRY-US, V38, P11379, DOI 10.1021/bi990554i; Hallen S, 2002, BIOCHEMISTRY-US, V41, P14916, DOI 10.1021/bi0205404; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Hussainzada N, 2006, MOL PHARMACOL, V70, P1565, DOI 10.1124/mol.106.028647; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kleywegt G.J., 1994, PROTEIN CRYSTALLOGR, V31, P9; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Knight SD, 2000, ACTA CRYSTALLOGR D, V56, P42, DOI 10.1107/S0907444999012913; Kramer W, 1996, EUR J CLIN INVEST, V26, P715, DOI 10.1111/j.1365-2362.1996.tb02383.x; Leslie A. G. W., 1992, JOINT CCP4 ESF EACBM, V26; LEWIS MC, 1995, J LIPID RES, V36, P1098; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Oelkers P, 1997, J CLIN INVEST, V99, P1880, DOI 10.1172/JCI119355; Olkhova E, 2006, P NATL ACAD SCI USA, V103, P2629, DOI 10.1073/pnas.0510914103; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Sanchez-Weatherby J, 2009, ACTA CRYSTALLOGR D, V65, P1237, DOI 10.1107/S0907444909037822; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Sonoda Y, 2011, STRUCTURE, V19, P17, DOI 10.1016/j.str.2010.12.001; Sun AQ, 2006, J BIOL CHEM, V281, P16410, DOI 10.1074/jbc.M600034200; Tzubery T, 2008, J BIOL CHEM, V283, P15975, DOI 10.1074/jbc.M800482200; Weinman SA, 1998, J BIOL CHEM, V273, P34691, DOI 10.1074/jbc.273.52.34691; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; WONG MH, 1994, J BIOL CHEM, V269, P1340; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zahner D, 2003, EUR J BIOCHEM, V270, P1117, DOI 10.1046/j.1432-1033.2003.03463.x; Zheng XW, 2009, MOL PHARMACEUT, V6, P1591, DOI 10.1021/mp900163d	55	183	189	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2011	478	7369					408	+		10.1038/nature10450	http://dx.doi.org/10.1038/nature10450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	21976025	Green Accepted			2022-12-28	WOS:000296021100051
J	Taniguchi-Ikeda, M; Kobayashi, K; Kanagawa, M; Yu, C; Mori, K; Oda, T; Kuga, A; Kurahashi, H; Akman, HO; DiMauro, S; Kaji, R; Yokota, T; Takeda, S; Toda, T				Taniguchi-Ikeda, Mariko; Kobayashi, Kazuhiro; Kanagawa, Motoi; Yu, Chih-chieh; Mori, Kouhei; Oda, Tetsuya; Kuga, Atsushi; Kurahashi, Hiroki; Akman, Hasan O.; DiMauro, Salvatore; Kaji, Ryuji; Yokota, Toshifumi; Takeda, Shin'ichi; Toda, Tatsushi			Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy	NATURE			English	Article							DYSTROGLYCAN GLYCOSYLATION; TRANSPOSABLE ELEMENTS; GENOME EVOLUTION; GENE; INSERTION; EXPRESSION; DISEASE; PATHOLOGY; HUMANS; FAMILY	Fukuyama muscular dystrophy (FCMD; MIM253800), one of the most common autosomal recessive disorders in Japan, was the first human disease found to result from ancestral insertion of a SINE-VNTR-Alu (SVA) retrotransposon into a causative gene(1-3). In FCMD, the SVA insertion occurs in the 3' untranslated region (UTR) of the fukutin gene. The pathogenic mechanism for FCMD is unknown, and no effective clinical treatments exist. Here we show that aberrant messenger RNA (mRNA) splicing, induced by SVA exon-trapping, underlies the molecular pathogenesis of FCMD. Quantitative mRNA analysis pinpointed a region that was missing from transcripts in patients with FCMD. This region spans part of the 3' end of the fukutin coding region, a proximal part of the 3' UTR and the SVA insertion. Correspondingly, fukutin mRNA transcripts in patients with FCMD and SVA knock-in model mice were shorter than the expected length. Sequence analysis revealed an abnormal splicing event, provoked by a strong acceptor site in SVA and a rare alternative donor site in fukutin exon 10. The resulting product truncates the fukutin carboxy (C) terminus and adds 129 amino acids encoded by the SVA. Introduction of antisense oligonucleotides (AONs) targeting the splice acceptor, the predicted exonic splicing enhancer and the intronic splicing enhancer prevented pathogenic exon-trapping by SVA in cells of patients with FCMD and model mice, rescuing normal fukutin mRNA expression and protein production. AON treatment also restored fukutin functions, including O-glycosylation of alpha-dystroglycan (alpha-DG) and laminin binding by alpha-DG. Moreover, we observe exon-trapping in other SVA insertions associated with disease (hypercholesterolemia(4), neutral lipid storage disease(5)) and human-specific SVA insertion in a novel gene. Thus, although splicing into SVA is known(6-8), we have discovered in human disease a role for SVA-mediated exon-trapping and demonstrated the promise of splicing modulation therapy as the first radical clinical treatment for FCMD and other SVA-mediated diseases.	[Taniguchi-Ikeda, Mariko; Kobayashi, Kazuhiro; Kanagawa, Motoi; Yu, Chih-chieh; Mori, Kouhei; Oda, Tetsuya; Kuga, Atsushi; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 6500017, Japan; [Taniguchi-Ikeda, Mariko] Kobe Univ, Grad Sch Med, Div Gen Pediat, Kobe, Hyogo 6500017, Japan; [Kurahashi, Hiroki] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Mol Genet, Aichi 4701192, Japan; [Akman, Hasan O.; DiMauro, Salvatore] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Kaji, Ryuji] Univ Tokushima, Grad Sch, Dept Clin Neurosci, Tokushima 7708503, Japan; [Yokota, Toshifumi] Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB T6G 2H7, Canada; [Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo 1878502, Japan	Kobe University; Kobe University; Fujita Health University; Columbia University; Tokushima University; University of Alberta; National Center for Neurology & Psychiatry - Japan	Toda, T (corresponding author), Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 6500017, Japan.	toda@med.kobe-u.ac.jp	Kobayashi, Kazuhiro/AAH-8638-2021; Taniguchi-Ikeda, Mariko/GPP-1368-2022; Taniguchi-Ikeda, Mariko/AGE-3152-2022	Kobayashi, Kazuhiro/0000-0001-7801-147X; Taniguchi-Ikeda, Mariko/0000-0002-1607-400X; Kanagawa, Motoi/0000-0003-0984-6398; , toshifumi/0000-0001-6672-6742; Yokota, Toshifumi/0000-0001-7316-3546; Toda, Tatsushi/0000-0002-0717-1123	National Center of Neurology and Psychiatry [20B-13]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science [23249049, 21689030, 20790980]; Takeda Science Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR056993] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21390101, 23013019, 21689030, 23659182, 22790980] Funding Source: KAKEN	National Center of Neurology and Psychiatry(National Center for Neurology & Psychiatry - Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Nakagawa, K. Ohno, S. Tsujino, N. Taniguchi, and I. Nonaka for comments; M. Okabe and A. Kawai for generating the ES cell line from knock-in model mice; Y. Motoyoshi and J. C. Cohen for providing patients' samples; W. Sako and Y. Izumi for sending patients' samples; I. Mizuta, T. Mure, M. Furukawa, K. Kaneshiro, Y. Dainin and all laboratory members for technical support; and J. Logan for editing the manuscript. We thank the GAIN for providing chimpanzee brain samples. This work was supported by an Intramural Research Grant (20B-13) for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry (to T. T.), the Global COE Program (Frontier Biomedical Science Underlying Organelle Network Biology) (to T. T., M.T.-I. and M. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grants-in-Aid for Scientific Research (A) (23249049 to T. T.), and Young Scientists (A) (21689030 to K. K.) and (B) (20790980 to M.T.-I.) from the Japan Society for the Promotion of Science, and the Takeda Science Foundation (to K.K.).	Akman HO, 2010, NEUROMUSCULAR DISORD, V20, P397, DOI 10.1016/j.nmd.2010.04.004; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Bantysh OB, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1393, DOI 10.1134/S0006297909120153; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Bennettt EA, 2004, GENETICS, V168, P933, DOI 10.1534/genetics.104.031757; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Crooke ST, 1998, ANTISENSE NUCLEIC A, V8, pVII, DOI 10.1089/oli.1.1998.8.vii; Damert A, 2009, GENOME RES, V19, P1992, DOI 10.1101/gr.093435.109; Hancks DC, 2011, HUM MOL GENET, V20, P3386, DOI 10.1093/hmg/ddr245; Hancks DC, 2010, SEMIN CANCER BIOL, V20, P234, DOI 10.1016/j.semcancer.2010.04.001; Hancks DC, 2009, GENOME RES, V19, P1983, DOI 10.1101/gr.093153.109; HASSOUN H, 1994, J CLIN INVEST, V94, P643, DOI 10.1172/JCI117380; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kanagawa M, 2009, HUM MOL GENET, V18, P621, DOI 10.1093/hmg/ddn387; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Legoix P, 2000, GENOMICS, V65, P62, DOI 10.1006/geno.2000.6139; Lu QL, 2003, NAT MED, V9, P1009, DOI 10.1038/nm897; Makino S, 2007, AM J HUM GENET, V80, P393, DOI 10.1086/512129; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; O'Brien S, 2007, J CLIN ONCOL, V25, P1114, DOI 10.1200/JCO.2006.07.1191; Ostertag EM, 2003, AM J HUM GENET, V73, P1444, DOI 10.1086/380207; Rohrer J, 1999, CLIN IMMUNOL, V90, P28, DOI 10.1006/clim.1998.4629; Strichman-Almashanu LZ, 2003, GENOME RES, V13, P800, DOI 10.1101/gr.893803; Takeda S, 2003, HUM MOL GENET, V12, P1449, DOI 10.1093/hmg/ddg153; TODA T, 1993, NAT GENET, V5, P283, DOI 10.1038/ng1193-283; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Watanabe M, 2005, AM J MED GENET A, V138A, P344, DOI 10.1002/ajmg.a.30978; Wilund KR, 2002, HUM MOL GENET, V11, P3019, DOI 10.1093/hmg/11.24.3019; Wu B, 2009, MOL THER, V17, P864, DOI 10.1038/mt.2009.38; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627	33	119	129	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2011	478	7367					127	U143		10.1038/nature10456	http://dx.doi.org/10.1038/nature10456			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21979053	Green Accepted			2022-12-28	WOS:000295575400048
J	Liu, JL; Xia, HG; Kim, M; Xu, LH; Li, Y; Zhang, LH; Cai, Y; Norberg, HV; Zhang, T; Furuya, T; Jin, MZ; Zhu, ZM; Wang, HC; Yu, J; Li, YX; Hao, Y; Choi, A; Ke, HM; Ma, DW; Yuan, JY				Liu, Junli; Xia, Hongguang; Kim, Minsu; Xu, Lihua; Li, Ying; Zhang, Lihong; Cai, Yu; Norberg, Helin Vakifahmetoglu; Zhang, Tao; Furuya, Tsuyoshi; Jin, Minzhi; Zhu, Zhimin; Wang, Huanchen; Yu, Jia; Li, Yanxia; Hao, Yan; Choi, Augustine; Ke, Hengming; Ma, Dawei; Yuan, Junying			Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13	CELL			English	Article							TUMOR-SUPPRESSOR; AUTOPHAGY GENE; TUMORIGENESIS; PROTEINS; INHIBITION; COMPLEXES; RUBICON; SCREEN; ATG14L; VPS34	Autophagy is an important intracellular catabolic mechanism that mediates the degradation of cytoplasmic proteins and organelles. We report a potent small molecule inhibitor of autophagy named "spautin-1" for specific and potent autophagy inhibitor-1. Spautin-1 promotes the degradation of Vps34 PI3 kinase complexes by inhibiting two ubiquitin-specific peptidases, USP10 and USP13, that target the Beclin1 subunit of Vps34 complexes. Beclin1 is a tumor suppressor and frequently monoallelically lost in human cancers. Interestingly, Beclin1 also controls the protein stabilities of USP10 and USP13 by regulating their deubiquitinating activities. Since USP10 mediates the deubiquitination of p53, regulating deubiquitination activity of USP10 and USP13 by Beclin1 provides a mechanism for Beclin1 to control the levels of p53. Our study provides a molecular mechanism involving protein deubiquitination that connects two important tumor suppressors, p53 and Beclin1, and a potent small molecule inhibitor of autophagy as a possible lead compound for developing anticancer drugs.	[Liu, Junli; Xia, Hongguang; Xu, Lihua; Li, Ying; Zhang, Lihong; Cai, Yu; Zhang, Tao; Jin, Minzhi; Yu, Jia; Li, Yanxia; Hao, Yan; Ma, Dawei] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Kim, Minsu; Li, Ying; Norberg, Helin Vakifahmetoglu; Furuya, Tsuyoshi; Zhu, Zhimin; Yuan, Junying] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Wang, Huanchen; Ke, Hengming] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Choi, Augustine] Brigham & Womens Hosp, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Brigham & Women's Hospital	Ma, DW (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 354 Fenglin Lu, Shanghai 200032, Peoples R China.	madw@mail.sioc.ac.cn; jyuan@hms.harvard.edu	xu, li/GNH-3667-2022	Xia, hongguang/0000-0003-3044-9282; Wang, Huanchen/0000-0003-2701-7155; Liu, Junli/0000-0001-8861-3706; Li, Ying/0000-0002-3506-1255	NIH US; Chinese Academy of Sciences [KGCX2-SW-209, KJCX2-YW-H08]; National Natural Science Foundation of China [21020102037, 90813007]; National Institute on Aging US [R37 AG012859, PO1 AG027916]; Samsung Scholarship from South Korea; Swedish Society for Medical Research (SSMF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG012859, P01AG027916] Funding Source: NIH RePORTER	NIH US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute on Aging US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Samsung Scholarship from South Korea(Samsung); Swedish Society for Medical Research (SSMF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dan Finley, Bruce Yankner, Zhujun Yao, Dana Christofferson, Dimitry Ofengeim, and Benedicte Py for comments on the manuscript; Dr. Xin Xie of the National Center for Drug Screening in Shanghai for help with the original compound screen for autophagy regulators; Dr. Wade Harper for providing expression vectors of USP10 and USP13; Dr. Zhenkun Lou for mutant expression vector for USP10; Dr. Caroline Shamu (the director of the ICCB screening facility); and David Wrobel and Stewart Rudnicki for helps with siRNA screening. This work was supported in part by a NIH Director's Pioneer Award US (to J.Y.), grants from the Chinese Academy of Sciences (KGCX2-SW-209 and KJCX2-YW-H08 [to D.M.]), the National Natural Science Foundation of China (21020102037 [to D.M.], and 90813007 [to L.Z.]) and the National Institute on Aging US (R37 AG012859 and PO1 AG027916 [to J.Y.]). M.K. is a recipient of Samsung Scholarship from South Korea. H.V.N. is supported in part by a fellowship form the Swedish Society for Medical Research (SSMF).	Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; DOWLER S, 2002, SCI STKE, pPL6, DOI DOI 10.1126/STKE.2002.129.PL6; Furuya T, 2010, MOL CELL, V38, P500, DOI 10.1016/j.molcel.2010.05.009; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Komander D, 2010, SUBCELL BIOCHEM, V54, P69, DOI 10.1007/978-1-4419-6676-6_6; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; MacPherson JD, 2006, J PHARMACOL EXP THER, V317, P188, DOI 10.1124/jpet.105.094763; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Wang HC, 2008, BIOCHEMISTRY-US, V47, P12760, DOI 10.1021/bi801487x; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	29	534	570	7	125	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					223	234		10.1016/j.cell.2011.08.037	http://dx.doi.org/10.1016/j.cell.2011.08.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962518	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000295396700028
J	Manolio, TA; Green, ED				Manolio, Teri A.; Green, Eric D.			Genomics Reaches the Clinic: From Basic Discoveries to Clinical Impact	CELL			English	Editorial Material							MEDICINE	Today, more than ever, basic science research provides significant opportunities to advance our understanding about the genetic basis of human disease. Close interactions among laboratory, computational, and clinical research communities will be crucial to ensure that genomic discoveries advance medical science and, ultimately, improve human health.	[Manolio, Teri A.; Green, Eric D.] NHGRI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Green, ED (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	egreen@nhgri.nih.gov						Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Collins FS, 1999, ANN NY ACAD SCI, V882, P42, DOI 10.1111/j.1749-6632.1999.tb08532.x; COLLINS FS, 1999, ANN NY ACAD SCI, V882, P56; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Roden DM, 2010, CIRCULATION, V122, P445, DOI 10.1161/CIRCULATIONAHA.110.973362; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; Varmus H, 2010, NEW ENGL J MED, V362, P2028, DOI 10.1056/NEJMe0911933; Wilke RA, 2011, JAMA-J AM MED ASSOC, V306, P306, DOI 10.1001/jama.2011.998; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158	11	22	22	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					14	16		10.1016/j.cell.2011.09.012	http://dx.doi.org/10.1016/j.cell.2011.09.012			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962499	Bronze			2022-12-28	WOS:000295396700007
J	Raychaudhuri, S				Raychaudhuri, Soumya			Mapping Rare and Common Causal Alleles for Complex Human Diseases	CELL			English	Article							GENOME-WIDE ASSOCIATION; CHROMATIN SIGNATURES; GENE-EXPRESSION; LARGE-SCALE; VARIANTS; POPULATION; SEQUENCE; LOCI; RISK; IMPUTATION	Advances in genotyping and sequencing technologies have revolutionized the genetics of complex disease by locating rare and common variants that influence an individual's risk for diseases, such as diabetes, cancers, and psychiatric disorders. However, to capitalize on these data for prevention and therapies requires the identification of causal alleles and a mechanistic understanding for how these variants contribute to the disease. After discussing the strategies currently used to map variants for complex diseases, this Primer explores how variants may be prioritized for follow-up functional studies and the challenges and approaches for assessing the contributions of rare and common variants to disease phenotypes.	[Raychaudhuri, Soumya] Harvard Univ, Sch Med, Div Genet, Brigham & Womens Hosp, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Partners HealthCare Ctr Personalized Genet Med, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Raychaudhuri, Soumya] MIT, Cambridge, MA 02142 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Partners Healthcare System; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Raychaudhuri, S (corresponding author), Harvard Univ, Sch Med, Div Genet, Brigham & Womens Hosp, Boston, MA 02115 USA.	soumya@broadinstitute.org		Raychaudhuri, Soumya/0000-0002-1901-8265	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055688] Funding Source: NIH RePORTER; NIAMS NIH HHS [K08 AR055688, K08 AR055688-05, K08 AR055688-04, K08 AR055688-01A1S1] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alexander RP, 2010, NAT REV GENET, V11, P559, DOI 10.1038/nrg2814; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000580; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bhangale TR, 2008, NAT GENET, V40, P841, DOI 10.1038/ng.180; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Browning SR, 2008, HUM GENET, V124, P439, DOI 10.1007/s00439-008-0568-7; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Cardon LR, 2003, TRENDS GENET, V19, P135, DOI 10.1016/S0168-9525(03)00022-2; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Gusev A, 2011, AM J HUM GENET, V88, P706, DOI 10.1016/j.ajhg.2011.04.023; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hicks S, 2011, HUM MUTAT, V32, P661, DOI 10.1002/humu.21490; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Maxmen A, 2011, CELL, V144, P635, DOI 10.1016/j.cell.2011.02.033; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Montgomery SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002144; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Raychaudhuri S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001097; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	91	73	79	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					57	69		10.1016/j.cell.2011.09.011	http://dx.doi.org/10.1016/j.cell.2011.09.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962507	Green Accepted, Bronze			2022-12-28	WOS:000295396700015
J	Shenoy, SK; Rockman, HA				Shenoy, Sudha K.; Rockman, Howard A.			CARDIOVASCULAR BIOLOGY Heart fails without pump partner	NATURE			English	Editorial Material							SUMO; SUMOYLATION		[Shenoy, Sudha K.; Rockman, Howard A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Shenoy, Sudha K.; Rockman, Howard A.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Shenoy, Sudha K.; Rockman, Howard A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Shenoy, SK (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	sudha@receptor-biol.duke.edu; h.rockman@duke.edu	Shenoy, Sudha/AAN-4075-2021	Shenoy, Sudha/0000-0002-2565-4663	NHLBI NIH HHS [R01 HL080525] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080525] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407; Matunis MJ, 2005, NAT STRUCT MOL BIOL, V12, P565, DOI 10.1038/nsmb0705-565; Plant LD, 2010, P NATL ACAD SCI USA, V107, P10743, DOI 10.1073/pnas.1004712107; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Shah AM, 2011, LANCET, V378, P704, DOI 10.1016/S0140-6736(11)60894-5; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Stade K, 2002, J BIOL CHEM, V277, P49554, DOI 10.1074/jbc.M207991200; Wang J, 2010, CIRC RES, V107, P19, DOI 10.1161/CIRCRESAHA.110.220491; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200	13	4	4	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 29	2011	477	7366					546	547		10.1038/477546a	http://dx.doi.org/10.1038/477546a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21956327				2022-12-28	WOS:000295320900029
J	Visintin, C; Mugglestone, MA; James, D; Kilby, MD				Visintin, Cristina; Mugglestone, Moira A.; James, David; Kilby, Mark D.		Guideline Dev Grp	GUIDELINES Antenatal care for twin and triplet pregnancies: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material							GESTATIONS		[Visintin, Cristina; Mugglestone, Moira A.; James, David] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England; [Kilby, Mark D.] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Kilby, Mark D.] Birmingham Womens Fdn Trust, Birmingham B15 2TG, W Midlands, England	University of Birmingham	Mugglestone, MA (corresponding author), Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England.	mmugglestone@ncc-wch.org.uk	FRCPI, Mark D Kilby MB BS DSc MD FRCOG/AAW-9704-2020; Nherera, Leo/P-1567-2018	FRCPI, Mark D Kilby MB BS DSc MD FRCOG/0000-0001-9987-4223; Bricker, Leanne/0000-0001-7713-2771; Nherera, Leo/0000-0003-1758-9504; Thilaganathan, Basky/0000-0002-5531-4301				[Anonymous], 2008, ANT CAR ROUT CAR HLT; CHAN A, 2008, PREGNANCY OUTCOME S; Department of Health, 2010, EQ EXC LIB NHS; EDWARDS MS, 1995, ULTRASOUND OBST GYN, V6, P43, DOI 10.1046/j.1469-0705.1995.06010043.x; Elliott JP, 2005, SEMIN PERINATOL, V29, P305, DOI 10.1053/j.semperi.2005.08.001; Laws PJ., 2008, AUSTR MOTHERS BABIES; LIPITZ S, 1994, AM J OBSTET GYNECOL, V170, P874, DOI 10.1016/S0002-9378(94)70301-9; Luke B, 2003, AM J OBSTET GYNECOL, V189, P934, DOI 10.1067/S0002-9378(03)01054-8; *NAT I HLTH CLIN E, 2006, SEPT AMN TREATM TWIN; *NAT I HLTH CLIN E, 2006, INTR LAS ABL PLAC VE; National Institute for Health and Clinical Excellence, 2011, MULT PREGN MAN TWIN; Roberts CL, 2002, INT J GYNECOL OBSTET, V78, P213, DOI 10.1016/S0020-7292(02)00147-9; *SEMACH, 2009, CONF ENQ MAT CHILD H; Tucker J, 2004, BRIT MED J, V329, P675, DOI 10.1136/bmj.329.7467.675	14	32	35	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 28	2011	343								d5714	10.1136/bmj.d5714	http://dx.doi.org/10.1136/bmj.d5714			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829JZ	21957208				2022-12-28	WOS:000295577100003
J	Michalczyk, L; Millard, AL; Martin, OY; Lumley, AJ; Emerson, BC; Chapman, T; Gage, MJG				Michalczyk, Lukasz; Millard, Anna L.; Martin, Oliver Y.; Lumley, Alyson J.; Emerson, Brent C.; Chapman, Tracey; Gage, Matthew J. G.			Inbreeding Promotes Female Promiscuity	SCIENCE			English	Article							POLYANDROUS FEMALES; SEXUAL SELECTION; SPERM SELECTION; EVOLUTION; FITNESS; SUCCESS; BEETLE	The widespread phenomenon of polyandry (mating by females with multiple males) is an evolutionary puzzle, because females can sustain costs from promiscuity, whereas full fertility can be provided by a single male. Using the red flour beetle, Tribolium castaneum, we identify major fitness benefits of polyandry to females under inbreeding, when the risks of fertilization by incompatible male haplotypes are especially high. Fifteen generations after inbred populations had passed through genetic bottlenecks, we recorded increased levels of female promiscuity compared with noninbred controls, most likely due to selection from prospective fitness gains through polyandry. These data illustrate how this common mating pattern can evolve if population genetic bottlenecks increase the risks of fitness depression due to fertilization by sperm carrying genetically incompatible haplotypes.	[Michalczyk, Lukasz; Millard, Anna L.; Martin, Oliver Y.; Lumley, Alyson J.; Emerson, Brent C.; Chapman, Tracey; Gage, Matthew J. G.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Martin, Oliver Y.] ETH, Inst Integrat Biol, CH-8092 Zurich, Switzerland; [Emerson, Brent C.] Isl Ecol & Evolut Res Grp IPNA CSIC, Tenerife, Spain	University of East Anglia; Swiss Federal Institutes of Technology Domain; ETH Zurich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA)	Gage, MJG (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	m.gage@uea.ac.uk	Gage, Matthew/E-5539-2011; Chapman, Tracey/E-5100-2011; MARTIN, OLIVER Y/A-4534-2009; Michalczyk, Łukasz/D-1362-2009	MARTIN, OLIVER Y/0000-0002-8601-7131; Michalczyk, Łukasz/0000-0002-2912-4870; Emerson, Brent/0000-0003-4067-9858	Natural Environment Research Council; University of East Anglia; Swiss National Science Foundation; NERC [NE/G006881/1] Funding Source: UKRI; Natural Environment Research Council [NE/C004639/1, NE/G006881/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of East Anglia; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank R. Beeman and the Stored Product Insect Research Unit for providing Tribolium stocks, and C. Fricke, A. Bretman, and the referees and editors for manuscript improvements. Funded by the Natural Environment Research Council, the University of East Anglia, and the Swiss National Science Foundation. Data sets for all assays described in this paper are available in the DRYAD data repository under http://dx.doi.org/10.5061/dryad.2cn83.	Arnqvist Goran, 2005, pUnpaginated; Birkhead TR, 1998, SPERM COMPETITION SE; Bloch MC, 1996, ANN ENTOMOL SOC AM, V89, P892, DOI 10.1093/aesa/89.6.892; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; COCKBURN A, 1985, ANIM BEHAV, V33, P908, DOI 10.1016/S0003-3472(85)80025-7; Cornell SJ, 2007, P ROY SOC B-BIOL SCI, V274, P2873, DOI 10.1098/rspb.2007.0926; Drury DW, 2009, J HERED, V100, P732, DOI 10.1093/jhered/esp077; Edvardsson M, 2000, P ROY SOC B-BIOL SCI, V267, P559, DOI 10.1098/rspb.2000.1037; Fisher DO, 2006, NATURE, V444, P89, DOI 10.1038/nature05206; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Frankham R, 2005, J EVOLUTION BIOL, V18, P750, DOI 10.1111/j.1420-9101.2005.00885.x; Hunt J, 2004, TRENDS ECOL EVOL, V19, P329, DOI 10.1016/j.tree.2004.03.035; Michalczyk L, 2011, EVOLUTION, V65, P713, DOI 10.1111/j.1558-5646.2010.01174.x; Michalczyk L, 2010, P ROY SOC B-BIOL SCI, V277, P3483, DOI 10.1098/rspb.2010.0514; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; Pai A, 2003, CAN J ZOOL, V81, P888, DOI [10.1139/z03-070, 10.1139/Z03-070]; Parker G.A., 1979, SEXUAL SELECTION REP, P123, DOI DOI 10.1016/B978-0-12-108750-0.50010-0; Price TAR, 2008, SCIENCE, V322, P1241, DOI 10.1126/science.1163766; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Wade MJ, 1996, EVOLUTION, V50, P723, DOI 10.1111/j.1558-5646.1996.tb03882.x; Wright S, 1921, GENETICS, V6, P111; Yasui Y, 1997, AM NAT, V149, P573, DOI 10.1086/286006; Zeh JA, 1997, BEHAV ECOL SOCIOBIOL, V40, P111, DOI 10.1007/s002650050323; Zeh JA, 2001, ANIM BEHAV, V61, P1051, DOI 10.1006/anbe.2000.1705	30	77	77	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2011	333	6050					1739	1742		10.1126/science.1207314	http://dx.doi.org/10.1126/science.1207314			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940892				2022-12-28	WOS:000295121500040
J	Spence, D				Spence, Des			FROM THE FRONTLINE Ethics committees: an ethical dilemma	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 21	2011	343								d6002	10.1136/bmj.d6002	http://dx.doi.org/10.1136/bmj.d6002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	826AG	21937564				2022-12-28	WOS:000295323100021
J	Fine, AM; Nizet, V; Mandl, KD				Fine, Andrew M.; Nizet, Victor; Mandl, Kenneth D.			Improved Diagnostic Accuracy of Group A Streptococcal Pharyngitis With Use of Real-Time Biosurveillance	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; RETAIL CLINICS; DECISION RULE; STREP THROAT; SORE THROAT; SURVEILLANCE; CHILDREN; INFLUENZA; HEALTH; ADULTS	Background: Clinical prediction rules do not incorporate real-time incidence data to adjust estimates of disease risk in symptomatic patients. Objective: To measure the value of integrating local incidence data into a clinical decision rule for diagnosing group A streptococcal (GAS) pharyngitis in patients aged 15 years or older. Design: Retrospective analysis of clinical and biosurveillance predictors of GAS pharyngitis. Setting: Large U. S.-based retail health chain. Patients: 82 062 patient visits for pharyngitis. Measurements: Accuracy of the Centor score was compared with that of a biosurveillance-responsive score, which was essentially an adjusted Centor score based on real-time GAS pharyngitis information from the 14 days before a patient's visit: the recent local proportion positive (RLPP). Results: Increased RLPP correlated with the likelihood of GAS pharyngitis (r(2) = 0.79; P < 0.001). Local incidence data enhanced diagnostic models. For example, when the RLPP was greater than 0.30, managing patients with Centor scores of 1 as if the scores were 2 would identify 62 537 previously missed patients annually while misclassifying 18 446 patients without GAS pharyngitis. Decreasing the score of patients with Centor values of 3 by 1 point for an RLPP less than 0.20 would spare unnecessary antibiotics for 166 616 patients while missing 18 812 true-positive cases. Limitations: Analyses were conducted retrospectively. Real-time regional data on GAS pharyngitis are generally not yet available to clinicians. Conclusion: Incorporating live biosurveillance data into clinical guidelines for GAS pharyngitis and other communicable diseases should be considered for reducing missed cases when the contemporaneous incidence is elevated and for sparing unnecessary antibiotics when the contemporaneous incidence is low. Delivering epidemiologic data to the point of care will enable the use of real-time pretest probabilities in medical decision making.	[Fine, Andrew M.] Harvard Univ, Sch Med, Childrens Hosp Boston, Harvard MIT Hlth Sci & Technol, Boston, MA 02115 USA; Univ Calif San Diego, La Jolla, CA 92093 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California San Diego	Fine, AM (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Harvard MIT Hlth Sci & Technol, 300 Longwood Ave, Boston, MA 02115 USA.		Nizet, Victor/AAF-3190-2019	Nizet, Victor/0000-0003-3847-0422	Centers for Disease Control and Prevention (CDC) [K01HK000055, P01HK000088]; National Library of Medicine, National Institutes of Health [1G08LM009778, R01 LM007677]; NATIONAL LIBRARY OF MEDICINE [G08LM009778, R01LM007677] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Centers for Disease Control and Prevention and the National Library of Medicine, National Institutes of Health.; By the Mentored Public Health Research Scientist Development Award K01HK000055 from the Centers for Disease Control and Prevention (CDC), by Public Health Informatics Center of Excellence Award P01HK000088 from CDC, and by grants 1G08LM009778 and R01 LM007677 from the National Library of Medicine, National Institutes of Health.	[Anonymous], 2005, MMWR MORB MORTAL W S, V54, P1; Asteberg I, 2006, SCAND J INFECT DIS, V38, P988, DOI 10.1080/00365540600868370; Bisno AL, 2002, CLIN INFECT DIS, V35, P126, DOI 10.1086/342056; Bisno AL, 2001, NEW ENGL J MED, V344, P205, DOI 10.1056/NEJM200101183440308; Blumenthal D, 2010, NEW ENGL J MED, V362, P382, DOI 10.1056/NEJMp0912825; Brownstein JS, 2010, NEW ENGL J MED, V362, P1731, DOI 10.1056/NEJMsr1002707; Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; Corneli HM, 2001, PEDIATR EMERG CARE, V17, P272, DOI 10.1097/00006565-200108000-00014; CORNFELD D, 1961, AM J PUBLIC HEALTH N, V51, P242, DOI 10.2105/AJPH.51.2.242; Costello D, 2008, HEALTH AFFAIR, V27, P1299, DOI 10.1377/hlthaff.27.5.1299; Croskerry P, 2003, ACAD MED, V78, P775, DOI 10.1097/00001888-200308000-00003; Danchin MH, 2007, PEDIATRICS, V120, P950, DOI 10.1542/peds.2006-3368; Ebell MH, 2000, JAMA-J AM MED ASSOC, V284, P2912, DOI 10.1001/jama.284.22.2912; Fine AM, 2007, J AM MED INFORM ASSN, V14, P206, DOI 10.1197/jamia.M2253; Fine AM, 2011, ARCH PEDIAT ADOL MED, V165, P61, DOI 10.1001/archpediatrics.2010.250; Fine AM, 2010, J AM MED INFORM ASSN, V17, P85, DOI 10.1197/jamia.M3061; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Friedman CP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001456; Institute for Clinical Systems Improvement, STREP PHAR ALG; Kahneman D., 1982, JUDGEMENT UNCERTAINT; Kaplan EL, 2001, LANCET, V358, P1334, DOI 10.1016/S0140-6736(01)06415-7; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Mandl KD, 2004, J AM MED INFORM ASSN, V11, P141, DOI 10.1197/jamia.M1356; Martin JM, 2002, NEW ENGL J MED, V346, P1200, DOI 10.1056/NEJMoa013169; McIsaac WJ, 2004, JAMA-J AM MED ASSOC, V291, P1587, DOI 10.1001/jama.291.13.1587; Mehrotra A, 2009, ANN INTERN MED, V151, P321, DOI 10.7326/0003-4819-151-5-200909010-00006; Middleton Kimberly, 2007, Adv Data, P1; Pollack CE, 2009, ARCH INTERN MED, V169, P945, DOI 10.1001/archinternmed.2009.69; Rudavsky R, 2009, ANN INTERN MED, V151, P315, DOI 10.7326/0003-4819-151-5-200909010-00005; Snow V, 2001, ANN INTERN MED, V134, P506, DOI 10.7326/0003-4819-134-6-200103200-00018; Snyderman R, 2010, JAMA-J AM MED ASSOC, V303, P363, DOI 10.1001/jama.2010.34; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; WIGTON RS, 1986, ARCH INTERN MED, V146, P81, DOI 10.1001/archinte.146.1.81; Woodburn JA, 2007, AM J MED QUAL, V22, P457, DOI 10.1177/1062860607309626	37	14	15	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6					345	U37		10.7326/0003-4819-155-6-201109200-00002	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-00002			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930851	Green Accepted			2022-12-28	WOS:000295033400013
J	Robbins, J				Robbins, John			Raloxifene increased bone mineral density in the spine and hips of postmenopausal women using long-term glucocorticoids	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calif Davis, Sacramento, CA 95817 USA	University of California System; University of California Davis	Robbins, J (corresponding author), Univ Calif Davis, Sacramento, CA 95817 USA.							Delmas PD, 2002, J CLIN ENDOCR METAB, V87, P3609, DOI 10.1210/jc.87.8.3609; Van Staa TP, 2005, J BONE MINER RES, V20, P1486, DOI 10.1359/jbmr.2005.20.8.1486	2	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6							JC3-4	10.7326/0003-4819-155-6-201109200-02004	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930841				2022-12-28	WOS:000295033400003
J	Sacks, HS				Sacks, Henry S.			Dexamethasone reduced length of hospital stay in patients with community-acquired pneumonia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CORTICOSTEROIDS; TRIAL		Mt Sinai Sch Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Sacks, HS (corresponding author), Mt Sinai Sch Med, New York, NY 10029 USA.							Annane D, 2009, JAMA-J AM MED ASSOC, V301, P2362, DOI 10.1001/jama.2009.815; Chen YJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007720.pub2; Fernandez-Serrano S, 2011, CRIT CARE, V15, DOI 10.1186/cc10103; Snijders D, 2010, AM J RESP CRIT CARE, V181, P975, DOI 10.1164/rccm.200905-0808OC	4	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6							JC3-6	10.7326/0003-4819-155-6-201109200-02006	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930843				2022-12-28	WOS:000295033400005
J	Araque, A; Navarrete, M				Araque, Alfonso; Navarrete, Marta			Electrically Driven Insulation in the Central Nervous System	SCIENCE			English	Editorial Material							MYELINATION		[Araque, Alfonso; Navarrete, Marta] CSIC, Inst Cajal, E-28002 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Araque, A (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	araque@cajal.csic.es	Navarrete, Marta/E-9266-2013	Navarrete, Marta/0000-0003-2097-4788; Araque, Alfonso/0000-0003-3840-1144				BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Karadottir R, 2007, NEUROSCIENCE, V145, P1426, DOI 10.1016/j.neuroscience.2006.08.070; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Simons M, 2007, CURR OPIN NEUROBIOL, V17, P533, DOI 10.1016/j.conb.2007.08.003; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998	10	5	5	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1587	1588		10.1126/science.1212525	http://dx.doi.org/10.1126/science.1212525			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921188				2022-12-28	WOS:000294900900030
J	Drinnenberg, IA; Fink, GR; Bartel, DP				Drinnenberg, Ines A.; Fink, Gerald R.; Bartel, David P.			Compatibility with Killer Explains the Rise of RNAi-Deficient Fungi	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST		[Drinnenberg, Ines A.; Fink, Gerald R.; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Drinnenberg, Ines A.; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Fink, Gerald R.; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu			Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM040266, R01 GM040266, GM0305010, R01 GM061835, GM061835, R37 GM061835] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040266, R37GM061835, R01GM061835] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Ivannikova YV, 2007, RES MICROBIOL, V158, P638, DOI 10.1016/j.resmic.2007.07.008; Naumov G. A., 2005, Molekulyarnaya Genetika Mikrobiologiya i Virusologiya, P38; Schmitt MJ, 2006, NAT REV MICROBIOL, V4, P212, DOI 10.1038/nrmicro1347; VALLE RPC, 1993, J VIROL, V67, P2764, DOI 10.1128/JVI.67.5.2764-2771.1993; Wickner RB, 1996, MICROBIOL REV, V60, P250, DOI 10.1128/MMBR.60.1.250-265.1996	7	148	151	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1592	1592		10.1126/science.1209575	http://dx.doi.org/10.1126/science.1209575			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921191	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000294900900033
J	Korber, B; Gnanakaran, S				Korber, Bette; Gnanakaran, S.			Converging on an HIV Vaccine	SCIENCE			English	Editorial Material							NEUTRALIZING ANTIBODIES; SHIV CHALLENGE; PROTECTION; EVOLUTION; MACAQUES; BINDING; VRC01; BROAD		[Korber, Bette; Gnanakaran, S.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Korber, Bette] Santa Fe Inst, Santa Fe, NM 87501 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute	Korber, B (corresponding author), Los Alamos Natl Lab, T6, Los Alamos, NM 87545 USA.	btk@lanl.gov		Gnanakaran, S/0000-0002-9368-3044; Korber, Bette/0000-0002-2026-5757				Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Ma BJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002200; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Ojikutu B., 2008, Current HIV/AIDS Reports, V5, P94, DOI 10.1007/s11904-008-0015-3; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, VIRUSES-BASEL, V1, P802, DOI 10.3390/v1030802; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zimmermann J, 2006, P NATL ACAD SCI USA, V103, P13722, DOI 10.1073/pnas.0603282103	16	15	16	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2011	333	6049					1589	1590		10.1126/science.1211919	http://dx.doi.org/10.1126/science.1211919			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	820JE	21921189				2022-12-28	WOS:000294900900031
J	Naidu, S; Friedrich, JK; Russell, J; Zomerdijk, JCBM				Naidu, Srivatsava; Friedrich, J. Karsten; Russell, Jackie; Zomerdijk, Joost C. B. M.			TAF1B Is a TFIIB-Like Component of the Basal Transcription Machinery for RNA Polymerase I	SCIENCE			English	Article							PREINITIATION COMPLEX; RDNA TRANSCRIPTION; ZINC RIBBON; FACTOR SL1; INITIATION; PROMOTER; SUBUNITS; RECRUITMENT; BINDING; TBP	Transcription by eukaryotic RNA polymerases (Pols) II and III and archaeal Pol requires structurally related general transcription factors TFIIB, Brf1, and TFB, respectively, which are essential for polymerase recruitment and initiation events. A TFIIB-like protein was not evident in the Pol I basal transcription machinery. We report that TAF1B, a subunit of human Pol I basal transcription factor SL1, is structurally related to TFIIB/TFIIB-like proteins, through predicted amino-terminal zinc ribbon and cyclin-like fold domains. SL1, essential for Pol I recruitment to the ribosomal RNA gene promoter, also has an essential postpolymerase recruitment role, operating through TAF1B. Therefore, a TFIIB-related protein is implicated in preinitiation complex assembly and postpolymerase recruitment events in Pol I transcription, underscoring the parallels between eukaryotic Pol I, II, and III and archaeal transcription machineries.	[Naidu, Srivatsava; Friedrich, J. Karsten; Russell, Jackie; Zomerdijk, Joost C. B. M.] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland	University of Dundee	Zomerdijk, JCBM (corresponding author), Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland.	j.zomerdijk@dundee.ac.uk		Zomerdijk, Joost/0000-0003-1865-729X	Medical Research Council; Wellcome Trust [085441/Z/08/Z]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)	We thank S. Hahn and B. Knutson (Fred Hutchinson Cancer Center, Seattle, WA) for sharing findings with us before publication; B. Knutson for insights regarding connecting region alignments; and S. Hahn, B. Knutson, T. Owen-Hughes (University of Dundee), and J.C.B.M.Z. lab members for advice and critique. This work was supported by a Medical Research Council-funded Ph.D. studentship (J.K.F.) and Wellcome Trust Programme Grant (085441/Z/08/Z) (J.C.B.M.Z.).	BELL SP, 1990, GENE DEV, V4, P943, DOI 10.1101/gad.4.6.943; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; COMAI L, 1994, SCIENCE, V266, P1966, DOI 10.1126/science.7801123; Deng WS, 2007, CHROMOSOMA, V116, P417, DOI 10.1007/s00412-007-0113-9; Elsby LM, 2008, BIOCHEM SOC T, V36, P595, DOI 10.1042/BST0360595; Friedrich JK, 2005, J BIOL CHEM, V280, P29551, DOI 10.1074/jbc.M501595200; Gorski JJ, 2007, EMBO J, V26, P1560, DOI 10.1038/sj.emboj.7601601; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hahn S, 2000, GENE DEV, V14, P719; Imamura S, 2008, EMBO J, V27, P2317, DOI 10.1038/emboj.2008.151; Kassavetis GA, 2006, BIOCHEM SOC T, V34, P1082, DOI 10.1042/BST0341082; Kassavetis GA, 1998, P NATL ACAD SCI USA, V95, P9196, DOI 10.1073/pnas.95.16.9196; Kassavetis GA, 2001, EMBO J, V20, P2823, DOI 10.1093/emboj/20.11.2823; KEYS DA, 1994, GENE DEV, V8, P2349, DOI 10.1101/gad.8.19.2349; Kosa PF, 1997, P NATL ACAD SCI USA, V94, P6042, DOI 10.1073/pnas.94.12.6042; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Miller G, 2001, EMBO J, V20, P1373, DOI 10.1093/emboj/20.6.1373; Muth V, 2001, EMBO J, V20, P1353, DOI 10.1093/emboj/20.6.1353; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Tran K, 2008, J BIOL CHEM, V283, P15665, DOI 10.1074/jbc.M801439200; Werner F, 2005, MOL CELL BIOL, V25, P8344, DOI 10.1128/MCB.25.18.8344-8355.2005; Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507; Yuan XJ, 2002, EMBO REP, V3, P1082, DOI 10.1093/embo-reports/kvf212; ZOMERDIJK JCBM, 1994, SCIENCE, V266, P2015, DOI 10.1126/science.7801130	29	40	41	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1640	1642		10.1126/science.1207656	http://dx.doi.org/10.1126/science.1207656			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921199	Green Accepted			2022-12-28	WOS:000294900900046
J	Dasanu, CA; Codreanu, I				Dasanu, Constantin A.; Codreanu, Ion			Splenic Calcification	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dasanu, Constantin A.] Univ Connecticut, Farmington, CT 06032 USA; [Codreanu, Ion] Hosp Univ Penn, Philadelphia, PA 19104 USA	University of Connecticut; University of Pennsylvania	Dasanu, CA (corresponding author), Univ Connecticut, Farmington, CT 06032 USA.		Codreanu, Ion/AAS-4378-2020	Codreanu, Ion/0000-0002-2644-5572					0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2011	365	11					1042	1042		10.1056/NEJMicm1100222	http://dx.doi.org/10.1056/NEJMicm1100222			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819UR	21916642				2022-12-28	WOS:000294857300012
J	Hudson, KL				Hudson, Kathy L.			GENOMIC MEDICINE Genomics, Health Care, and Society	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GENETICS; CANCER; CETUXIMAB; PRIVACY; LEGAL; HYPERSENSITIVITY; CONFIDENTIALITY; ASSOCIATION; ATTITUDES; BIOBANKS		NIH, Off Director, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Hudson, KL (corresponding author), NIH, Off Director, 9000 Rockville Pike,Bldg 1, Bethesda, MD 20892 USA.	hudsonkl@od.nih.gov						Alonso-Zaldivar R, 2008, LOS ANGELES TIM 0425; [Anonymous], 2000, FED REG, V65, P82661; [Anonymous], 2010, GENE PATENTS LICENSI; [Anonymous], 2009, FED REGIST, V74, P51698; Baruch S, 2008, AM J HUM GENET, V83, P435, DOI 10.1016/j.ajhg.2008.09.003; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bonham VL, 2010, NEW ENGL J MED, V363, P997, DOI 10.1056/NEJMp1007639; Carlton J, 2011, TEXAN DECLARED INNOC; Clayton EW, 2006, JAMA-J AM MED ASSOC, V295, P37, DOI 10.1001/jama.295.1.37-a; Cook-Deegan R, 2010, ANNU REV GENOM HUM G, V11, P383, DOI 10.1146/annurev-genom-082509-141811; Cooper ZN, 2004, GENET TEST, V8, P214, DOI 10.1089/gte.2004.8.214; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; *DEP HLTH HUM SERV, 2008, US SYST OV GEN TEST; Department of Health and Human Services, 2011, FED REG, V76, P44512; Department of Health and Human Services, UND HIPPA PRIV COV E; Department of Justice, 2010, 20101406 DEP JUST; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; Dietz HC, 2010, NEW ENGL J MED, V363, P852, DOI 10.1056/NEJMra0907180; Duster T., 2004, DNA CRIMINAL JUSTICE, P315; Emanuel EJ, 2011, NEW ENGL J MED, V365, P1145, DOI 10.1056/NEJMsb1106942; Feero WG, 2010, NEW ENGL J MED, V362, P2001, DOI 10.1056/NEJMra0907175; Fernandez CV, 2009, J CLIN ONCOL, V27, P878, DOI 10.1200/JCO.2008.18.5223; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Food and Drug Administration, TABL PHARM BIOM DRUG; GeneTests, 1993, GENETESTS MED GEN IN; Gold ER, 2010, GENET MED, V12, pS39, DOI 10.1097/GIM.0b013e3181d72661; Greely HT, 2007, ANNU REV GENOM HUM G, V8, P343, DOI 10.1146/annurev.genom.7.080505.115721; Greenbaum D, 2008, AM J BIOETHICS, V8, P71, DOI 10.1080/15265160802478560; Haga SB, 2008, ADV GENET, V60, P505, DOI 10.1016/S0065-2660(07)00418-X; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Huys I, 2009, NAT BIOTECHNOL, V27, P903, DOI 10.1038/nbt1009-903; Innocence Project, FACTS POSTCONV DNA E; Kaufman D, 2008, GENET MED, V10, P331, DOI 10.1097/GIM.0b013e31818bb3ab; Kaufman DJ, 2009, AM J HUM GENET, V85, P643, DOI 10.1016/j.ajhg.2009.10.002; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Lin Z, 2004, SCIENCE, V305, P183, DOI 10.1126/science.1095019; Lunshof JE, 2008, NAT REV GENET, V9, P406, DOI 10.1038/nrg2360; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McGuire AL, 2008, GENET MED, V10, P495, DOI [10.1097/GIM.0b013e31817a8aaa, 10.1097GIM.0b013e31817a8aaa]; National Center for Biotechnology Information, GEN TEST REG; Office for human research protections, 2008, GUID RES INV COD PRI; Scheuner MT, 2009, GENET MED, V11, P510, DOI 10.1097/GIM.0b013e3181a53331; Shalowitz DI, 2008, PLOS MED, V5, P714, DOI 10.1371/journal.pmed.0050091; Skloot R., 2011, IMMORTAL LIFE HENRIE; The Federal Bureau of Investigation, COMB DNA IND SYST CO; Valle-Mansilla JI, 2010, CANCER INVEST, V28, P726, DOI 10.3109/07357907.2010.494320; Wolf Leslie E, 2004, IRB, V26, P1, DOI 10.2307/3563696	52	95	95	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2011	365	11					1033	1041		10.1056/NEJMra1010517	http://dx.doi.org/10.1056/NEJMra1010517			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819UR	21916641	Bronze			2022-12-28	WOS:000294857300011
J	Trivedi, NS; Ship, AN				Trivedi, Neha S.; Ship, Amy N.			Update: A 24-Year-Old Woman With Intractable Seizures Review of Surgery for Epilepsy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material														Trivedi, Neha/0000-0003-1006-1408				Schomer DL, 2008, JAMA-J AM MED ASSOC, V300, P2527, DOI 10.1001/jama.2008.709	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2011	306	10					1130	1130		10.1001/jama.2011.1328	http://dx.doi.org/10.1001/jama.2011.1328			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819DS	21917582				2022-12-28	WOS:000294806200027
J	Wellesley, H				Wellesley, Hugo			A nudge in the right direction for organ donation-but is it enough?	BRITISH MEDICAL JOURNAL			English	Editorial Material							PRESUMED CONSENT; TRANSPLANTATION		Great Ormond St Hosp Sick Children, London WC1N 3JH, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Wellesley, H (corresponding author), Great Ormond St Hosp Sick Children, London WC1N 3JH, England.	hugowellesley@yahoo.com						Backman L, 2002, TRANSPLANT P, V34, P2560, DOI 10.1016/S0041-1345(02)03424-3; Barber K, 2006, BMJ-BRIT MED J, V332, P1124, DOI 10.1136/bmj.38804.658183.55; Behavioural Insights Team, 2010, APPL BEH INS HLTH; Bird SM, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2188; Bosch X, 1999, JAMA-J AM MED ASSOC, V282, P17, DOI 10.1001/jama.282.1.17; *COMM INCR RAT ORG, 2006, ORG DON OPP ACT, P178; EVANS G, 2011, PROMPTED CHOICE; Feeley TH, 2007, HEALTH COMMUN, V21, P125, DOI 10.1080/10410230701307022; GORE SM, 1989, BRIT MED J, V299, P1193, DOI 10.1136/bmj.299.6709.1193; Hippen B., 2008, ORGAN SALES MORAL TR; *HL SCI TECHN SEL, 2011, 2 REP SESS 2010 11 B; Landry DW, 2006, KIDNEY INT, V69, P957, DOI 10.1038/sj.ki.5000280; Morgan SE, 2007, HEALTH COMMUN, V22, P143, DOI 10.1080/10410230701454114; *NAT ASS WAL, 2011, REC P; *NHS BLOOD TRANSPL, 2009, WILL THEY RESP MY BO; Organ Donation Taskforce, 2008, POT IMP OPT OUT SYST; Rithalia A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3162; Rodrigue JR, 2009, PROG TRANSPLANT, V19, P173; Tuppin P, 1997, TRANSPL P, V29, P996, DOI 10.1016/S0041-1345(96)00341-7; Wright L, 2010, LANCET, V375, P1233, DOI 10.1016/S0140-6736(09)61520-8; *YOUGOV, 2007, ORG DON	21	11	11	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2011	343								d5726	10.1136/bmj.d5726	http://dx.doi.org/10.1136/bmj.d5726			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822VM	21917830				2022-12-28	WOS:000295078100005
J	Fogo, A; Kemp, N; Morris-Jones, R				Fogo, A.; Kemp, N.; Morris-Jones, R.			EASILY MISSED? PVL positive Staphylococcus aureus skin infections	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PANTON-VALENTINE LEUKOCIDIN; ENGLAND; DISEASE; ANTIBIOTICS; GENES; WALES		[Fogo, A.; Morris-Jones, R.] Kings Coll Hosp London, Dept Dermatol, London SE5 9RS, England; [Kemp, N.] Elm Lodge Surg, London SE24 9HJ, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Fogo, A (corresponding author), Kings Coll Hosp London, Dept Dermatol, London SE5 9RS, England.	abigailfogo@nhs.net						[Anonymous], J INTENSIVE CARE SOC; Dumitrescu O, 2007, ANTIMICROB AGENTS CH, V51, P1515, DOI 10.1128/AAC.01201-06; Ellington MJ, 2010, CLIN MICROBIOL INFEC, V16, P86, DOI 10.1111/j.1469-0691.2009.02887.x; Hawkes M, 2007, CAN MED ASSOC J, V176, P54; Health Protection Agency, 2008, GUID DIAGN MAN PVL A; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P1157, DOI 10.1111/j.1469-0691.2007.01833.x; Shallcross LJ, 2010, CLIN MICROBIOL INFEC, V16, P1644, DOI 10.1111/j.1469-0691.2010.03153.x; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396	9	16	16	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2011	343								d5343	10.1136/bmj.d5343	http://dx.doi.org/10.1136/bmj.d5343			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819SJ	21908525				2022-12-28	WOS:000294850000001
J	Osotimehin, B				Osotimehin, Babatunde			Is there enough investment in young people?	LANCET			English	Editorial Material									UN Populat Fund, New York, NY 10158 USA	United Nations Population Fund	Osotimehin, B (corresponding author), UN Populat Fund, New York, NY 10158 USA.	osotimehin@unfpa.org						International Labour Office, 2010, GLOB EMPL TRENDS YOU; Joint United Nations Programme on HIV/AIDS, 2010, UNAIDS REP GLOB EC C; UN, 2011, INT YOUTH DAY CHANG; UN Populations Programme, 2007, GIV GIRLS TOD TOM BR; UNESCO Institute for Statistics, 2010, REG LIT RAT YOUTHS 1; United Nations Population Fund, 2010, CAS INV YOUNG PEOPL; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1	7	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 21	2012	379	9812					202	203		10.1016/S0140-6736(11)61312-3	http://dx.doi.org/10.1016/S0140-6736(11)61312-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879FW	21920597				2022-12-28	WOS:000299316100016
J	Scott, DC; Monda, JK; Bennett, EJ; Harper, JW; Schulman, BA				Scott, Daniel C.; Monda, Julie K.; Bennett, Eric J.; Harper, J. Wade; Schulman, Brenda A.			N-Terminal Acetylation Acts as an Avidity Enhancer Within an Interconnected Multiprotein Complex	SCIENCE			English	Article							MEMBRANE-PROTEIN SYS1P; SACCHAROMYCES-CEREVISIAE; CULLIN NEDDYLATION; ALPHA-ACETYLATION; GTPASE ARL3P; YEAST; ACETYLTRANSFERASES; CONSERVATION; SUBUNITS; REQUIRES	Although many eukaryotic proteins are amino (N)-terminally acetylated, structural mechanisms by which N-terminal acetylation mediates protein interactions are largely unknown. Here, we found that N-terminal acetylation of the E2 enzyme, Ubc12, dictates distinctive E3-dependent ligation of the ubiquitin-like protein Nedd8 to Cul1. Structural, biochemical, biophysical, and genetic analyses revealed how complete burial of Ubc12's N-acetyl-methionine in a hydrophobic pocket in the E3, Dcn1, promotes cullin neddylation. The results suggest that the N-terminal acetyl both directs Ubc12's interactions with Dcn1 and prevents repulsion of a charged N terminus. Our data provide a link between acetylation and ubiquitin-like protein conjugation and define a mechanism for N-terminal acetylation-dependent recognition.	[Scott, Daniel C.; Monda, Julie K.; Schulman, Brenda A.] St Jude Childrens Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Scott, Daniel C.; Schulman, Brenda A.] St Jude Childrens Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; [Bennett, Eric J.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	St Jude Children's Research Hospital; Howard Hughes Medical Institute; St Jude Children's Research Hospital; Harvard University; Harvard Medical School	Schulman, BA (corresponding author), St Jude Childrens Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.	brenda.schulman@stjude.org		Harper, Jeffrey/0000-0002-6944-7236	American Lebanese Syrian Associated Charities-St. Jude; NIH; Howard Hughes Medical Institute; Millennium Pharmaceuticals; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069530, R01GM070565, R01GM054137] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities-St. Jude; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This was supported by American Lebanese Syrian Associated Charities-St. Jude, NIH, and Howard Hughes Medical Institute (B. A. S.), grants from NIH and Millennium Pharmaceuticals (J.W.H.), and Damon Runyon Cancer Research Foundation (E.J.B.). We thank S. Gygi, I. Kurinov, C. Ralston, R. Cassell, P. Rodrigues, K. Kodali, V. Pagala, R. Schekman, D. W. Miller, S. Bozeman, D. J. Miller, J. Bollinger, and C. Rock for assistance, reagents, and/or discussions. D. C. S., J. K. M., B. A. S., and St. Jude Children's Research Hospital have applied for a patent on uses of Ubc12 N-terminal acetylation for inhibiting neddylation. Research Collaboratory for Structural Bioinformatics structural accession codes: 3TDI, 3TDU, 3TDZ. Author contributions: D. C. S., J. K. M., and E. J. B. designed, performed, and analyzed experiments; D. C. S. and B. A. S. wrote the manuscript, with all authors contributing; J. W. H. and B. A. S. advised and assisted on all aspects.	Arnesen T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001074; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Bird GH, 2008, METHOD ENZYMOL, V446, P369, DOI 10.1016/S0076-6879(08)01622-4; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Huang GC, 2011, J BIOL CHEM, V286, P10297, DOI 10.1074/jbc.M110.203729; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Polevoda B, 2003, BIOCHEM BIOPH RES CO, V308, P1, DOI 10.1016/S0006-291X(03)01316-0; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Polevoda B, 2001, J BIOL CHEM, V276, P20154, DOI 10.1074/jbc.M011440200; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Setty SRG, 2004, NAT CELL BIOL, V6, P414, DOI 10.1038/ncb1121; Van Damme P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002169; Yang XY, 2007, J BIOL CHEM, V282, P24490, DOI 10.1074/jbc.C700038200; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yi CH, 2011, CELL, V146, P607, DOI 10.1016/j.cell.2011.06.050	25	195	209	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 4	2011	334	6056					674	678		10.1126/science.1209307	http://dx.doi.org/10.1126/science.1209307			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	21940857	Green Accepted			2022-12-28	WOS:000296494700056
J	Jani, IV; Sitoe, NE; Alfai, ER; Chongo, PL; Quevedo, JI; Rocha, BM; Lehe, JD; Peter, TF				Jani, Ilesh V.; Sitoe, Nadia E.; Alfai, Eunice R.; Chongo, Patrina L.; Quevedo, Jorge I.; Rocha, Beatriz M.; Lehe, Jonathan D.; Peter, Trevor F.			Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study	LANCET			English	Article							RESOURCE-LIMITED SETTINGS; SUB-SAHARAN AFRICA; SOUTH-AFRICA; FOLLOW-UP; HIV TREATMENT; HIV-1-INFECTED PATIENTS; TREATMENT PROGRAMS; TREATMENT SERVICE; MORTALITY; DURBAN	Background Loss to follow-up of HIV-positive patients before initiation of antiretroviral therapy can exceed 50% in low-income settings and is a challenge to the scale-up of treatment. We implemented point-of-care counting of CD4 cells in Mozambique and assessed the effect on loss to follow-up before immunological staging and treatment initiation. Methods In this observational cohort study, data for enrolment into HIV management and initiation of antiretroviral therapy were extracted retrospectively from patients' records at four primary health clinics providing HIV treatment and point-of-care CD4 services. Loss to follow-up and the duration of each preparatory step before treatment initiation were measured and compared with baseline data from before the introduction of point-of-care CD4 testing. Findings After the introduction of point-of-care CD4 the proportion of patients lost to follow-up before completion of CD4 staging dropped from 57% (278 of 492) to 21% (92 of 437) (adjusted odds ratio [OR] 0.2, 95% CI 0.15-0.27). Total loss to follow-up before initiation of antiretroviral treatment fell from 64% (314 of 492) to 33% (142 of 437) (OR 0.27, 95% CI 0.21-0.36) and the proportion of enrolled patients initiating antiretroviral therapy increased from 12% (57 of 492) to 22% (94 of 437) (OR 2.05, 95% CI 1.42-2.96). The median time from enrolment to antiretroviral therapy initiation reduced from 48 days to 20 days (p<0.0001), primarily because of a reduction in the median time taken to complete CD4 staging, which decreased from 32 days to 3 days (p<0.0001). Loss to follow-up between staging and antiretroviral therapy initiation did not change significantly (OR 0.84, 95% CI 0.49-1.45). Interpretation Point-of-care CD4 testing enabled clinics to stage patients rapidly on-site after enrolment, which reduced opportunities for pretreatment loss to follow-up. As a result, more patients were identified as eligible for and initiated antiretroviral treatment. Point-of-care testing might therefore be an effective intervention to reduce pretreatment loss to follow-up.	[Jani, Ilesh V.; Sitoe, Nadia E.; Alfai, Eunice R.; Chongo, Patrina L.] Inst Nacl Saude, Maputo, Mozambique; [Quevedo, Jorge I.; Rocha, Beatriz M.; Lehe, Jonathan D.; Peter, Trevor F.] Clinton Hlth Access Initiat, Maputo, Mozambique		Jani, IV (corresponding author), Inst Nacl Saude, Av Eduardo Mondlane 1008,2nd Floor, Maputo, Mozambique.	ilesh.jani@gmail.com		Sitoe, Nadia/0000-0001-7310-8221; Jani, Ilesh/0000-0002-6880-6655	Absolute Return for Kids; UNITAID	Absolute Return for Kids; UNITAID	Absolute Return for Kids and UNITAID.	Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; [Anonymous], 2009, LANCET, V373, P1352; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Bekker LG, 2006, SAMJ S AFR MED J, V96, P315; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Cleary SM, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327621.24232.71; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng EH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014098; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Holmes CB, 2010, JAMA-J AM MED ASSOC, V304, P313, DOI 10.1001/jama.2010.993; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; Mccoy D, 2009, HEALTH POLICY PLANN, V24, P407, DOI 10.1093/heapol/czp026; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Mossdorf E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-98; Mulissa Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013268; Nash D, 2011, AIDS, V25, P1523, DOI 10.1097/QAD.0b013e32834811b2; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; UNAIDS, UNAIDS OUTL REP 2010; *UNAIDS, UNAIDS UPD GLOB AIDS; van Oosterhout JJ, 2005, TROP MED INT HEALTH, V10, P464, DOI 10.1111/j.1365-3156.2005.01409.x; Walensky RP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000382; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; World Health Organization, 2010, ANT THER HIV INF INF; Zachariah R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000121	32	220	222	0	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 29	2011	378	9802					1572	1579		10.1016/S0140-6736(11)61052-0	http://dx.doi.org/10.1016/S0140-6736(11)61052-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844SL	21951656				2022-12-28	WOS:000296767500022
J	Brown, SA				Brown, Steven A.			A New Histone Code for Clocks?	SCIENCE			English	Editorial Material							TRANSCRIPTION; CLOCK-BMAL1; ACETYLATION		Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland	University of Zurich	Brown, SA (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland.	steven.brown@pharma.uzh.ch						Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; DiTacchio L, 2011, SCIENCE, V333, P1881, DOI 10.1126/science.1206022; Duong HA, 2011, SCIENCE, V332, P1436, DOI 10.1126/science.1196766; Etchegaray JP, 2006, J BIOL CHEM, V281, P21209, DOI 10.1074/jbc.M603722200; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tao WW, 2011, HEPATOLOGY, V54, P1410, DOI 10.1002/hep.24514; Yang J, 2009, ANN NY ACAD SCI, V1177, P185, DOI 10.1111/j.1749-6632.2009.05027.x	16	11	13	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051					1833	1834		10.1126/science.1212842	http://dx.doi.org/10.1126/science.1212842			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960618				2022-12-28	WOS:000295365800038
J	Zhao, Y; Yang, JL; Shi, JJ; Gong, YN; Lu, QH; Xu, H; Liu, LP; Shao, F				Zhao, Yue; Yang, Jieling; Shi, Jianjin; Gong, Yi-Nan; Lu, Qiuhe; Xu, Hao; Liu, Liping; Shao, Feng			The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus	NATURE			English	Article							INDUCED CELL-DEATH; PHAGOSOME MATURATION; ACTIVATES CASPASE-1; LEGIONELLA; RECOGNITION; DOMAIN; INTERLEUKIN-1-BETA; SUSCEPTIBILITY; IL-1-BETA; INFECTION	Inflammasomes are large cytoplasmic complexes that sense microbial infections/danger molecules and induce caspase-1 activation-dependent cytokine production and macrophage inflammatory death(1,2). The inflammasome assembled by the NOD-like receptor (NLR) protein NLRC4 responds to bacterial flagellin and a conserved type III secretion system (TTSS) rod component(3-5). How the NLRC4 inflammasome detects the two bacterial products and the molecular mechanism of NLRC4 inflammasome activation are not understood. Here we show that NAIP5, a BIR-domain NLR protein required for Legionella pneumophila replication in mouse macrophages(6), is a universal component of the flagellin-NLRC4 pathway. NAIP5 directly and specifically interacted with flagellin, which determined the inflammasome-stimulation activities of different bacterial flagellins. NAIP5 engagement by flagellin promoted a physical NAIP5-NLRC4 association, rendering full reconstitution of a flagellin-responsive NLRC4 inflammasome in non-macrophage cells. The related NAIP2 functioned analogously to NAIP5, serving as a specific inflammasome receptor for TTSS rod proteins such as Salmonella PrgJ and Burkholderia BsaK. Genetic analysis of Chromobacterium violaceum infection revealed that the TTSS needle protein CprI can stimulate NLRC4 inflammasome activation in human macrophages. Similarly, CprI is specifically recognized by human NAIP, the sole NAIP family member in human. The finding that NAIP proteins are inflammasome receptors for bacterial flagellin and TTSS apparatus components further predicts that the remaining NAIP family members may recognize other unidentified microbial products to activate NLRC4 inflammasome-mediated innate immunity.	[Zhao, Yue; Yang, Jieling; Shi, Jianjin; Gong, Yi-Nan; Lu, Qiuhe; Xu, Hao; Liu, Liping; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Zhao, Yue; Yang, Jieling] Peking Union Med Coll, Beijing 100730, Peoples R China; [Zhao, Yue; Yang, Jieling] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Shao, F (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	shaofeng@nibs.ac.cn	Zhao, Yue/A-5285-2018; liu, li/HGC-0900-2022	Zhao, Yue/0000-0003-1509-9261; Lu, Qiuhe/0000-0002-0202-7448; Shi, Jianjin/0000-0001-8048-5180	National Basic Research Program of China (973 Programs) [2010CB835400, 2012CB518700]	National Basic Research Program of China (973 Programs)(National Basic Research Program of China)	We thank V. Dixit for providing Nlrc4 and Asc knockout mice, K. Fitzgerald, D. Radzioch and A. Ding for immortalized macrophages, R. Vance for Naip5<SUP>A/J</SUP> cDNA, M. Donnenberg and J. Giron for EPEC strains, E. Miao for flagellin-deficient S. typhimurium strain, D. Milton and T. Hoang for bacterial vectors and T. Miki for C. violaceum strains. We are grateful to C. Yao for helping with flow cytometry, and Y. Xu and the NIBS animal facility for handling mouse lines. We thank members of the F. S. laboratory for helpful discussions and technical assistance. This work was supported by the National Basic Research Program of China (973 Programs, 2010CB835400 and 2012CB518700).	Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Barrett AR, 2008, APPL ENVIRON MICROB, V74, P4498, DOI 10.1128/AEM.00531-08; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Cui JX, 2010, SCIENCE, V329, P1215, DOI 10.1126/science.1193844; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Diez E, 2003, NAT GENET, V33, P55, DOI 10.1038/ng1065; Dong N, 2010, EMBO J, V29, P1363, DOI 10.1038/emboj.2010.33; Fortier A, 2007, CELL MICROBIOL, V9, P910, DOI 10.1111/j.1462-5822.2006.00839.x; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Lamkanfi M, 2007, J IMMUNOL, V178, P8022, DOI 10.4049/jimmunol.178.12.8022; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Lightfield KL, 2011, INFECT IMMUN, V79, P1606, DOI 10.1128/IAI.01187-10; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Miki T, 2010, MOL MICROBIOL, V77, P855, DOI 10.1111/j.1365-2958.2010.07248.x; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Poyraz O, 2010, NAT STRUCT MOL BIOL, V17, P788, DOI 10.1038/nsmb.1822; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; VOJTEK AB, 1995, CELL, V82, P527, DOI 10.1016/0092-8674(95)90023-3; Worrall LJ, 2011, CURR OPIN MICROBIOL, V14, P3, DOI 10.1016/j.mib.2010.10.009; Wright EK, 2003, CURR BIOL, V13, P27, DOI 10.1016/S0960-9822(02)01359-3; Yao Q, 2009, P NATL ACAD SCI USA, V106, P3716, DOI 10.1073/pnas.0900212106; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	37	826	862	4	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2011	477	7366					596	U257		10.1038/nature10510	http://dx.doi.org/10.1038/nature10510			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21918512				2022-12-28	WOS:000295320900041
J	Beitelshees, AL; Veenstra, DL				Beitelshees, Amber L.; Veenstra, David L.			Evolving Research and Stakeholder Perspectives on Pharmacogenomics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RESEARCH NETWORK		[Veenstra, David L.] Univ Washington, Dept Pharm, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA; [Beitelshees, Amber L.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland Baltimore	Veenstra, DL (corresponding author), Univ Washington, Dept Pharm, Pharmaceut Outcomes Res & Policy Program, Box 357630,Hlth Sci Bldg,Room H-375P, Seattle, WA 98195 USA.	veenstra@uw.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105198, K23HL091120] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092676, U01GM074492] Funding Source: NIH RePORTER; NCI NIH HHS [RC2 CA148570, RC2CA148570] Funding Source: Medline; NHGRI NIH HHS [P50HG003374, P50 HG003374] Funding Source: Medline; NHLBI NIH HHS [K23 HL091120, U01HL105198, U01 HL105198, K23HL091120] Funding Source: Medline; NIGMS NIH HHS [UO1GM092676, U01GM074492, U01 GM092676, U01 GM074492] Funding Source: Medline; OGDP CDC HHS [U18 GD000005, U18GD000005, GD000005] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OGDP CDC HHS		Alfirevic A, 2011, PHARMACEUTICALS, V4, P69, DOI 10.3390/ph4010069; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; Dimou A, 2011, PATHOLOG RES INT; Holmes DR, 2010, CIRCULATION, V122, P537, DOI 10.1161/CIR.0b013e3181ee08ed; Long RM, 2011, CLIN PHARMACOL THER, V89, P339, DOI 10.1038/clpt.2010.293; Payne K, 2011, VALUE HEALTH, V14, P121, DOI 10.1016/j.jval.2010.10.007; Relling MV, 2011, CLIN PHARMACOL THER, V89, P464, DOI 10.1038/clpt.2010.279; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Teutsch SM, 2009, GENET MED, V11, P3, DOI 10.1097/GIM.0b013e318184137c	10	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2011	306	11					1252	1253		10.1001/jama.2011.1343	http://dx.doi.org/10.1001/jama.2011.1343			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HB	21934059	Green Accepted			2022-12-28	WOS:000295033500027
J	Crump, C; Sundquist, K; Sundquist, J; Winkleby, MA				Crump, Casey; Sundquist, Kristina; Sundquist, Jan; Winkleby, Marilyn A.			Gestational Age at Birth and Mortality in Young Adulthood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; DANISH MEN BORN; PRETERM BIRTH; PRENATAL EXPOSURE; RISK-FACTORS; FOLLOW-UP; WEIGHT; ASSOCIATION; COHORT; SURVIVAL	Context Preterm birth is the leading cause of infant mortality in developed countries, but the association between gestational age at birth and mortality in adulthood remains unknown. Objective To examine the association between gestational age at birth and mortality in young adulthood. Design, Setting, and Participants National cohort study of 674 820 individuals born as singletons in Sweden in 1973 through 1979 who survived to age 1 year, including 27 979 born preterm (gestational age <37 weeks), followed up to 2008 (ages 29-36 years). Main Outcome Measures All-cause and cause-specific mortality. Results A total of 7095 deaths occurred in 20.8 million person-years of follow-up. Among individuals still alive at the beginning of each age range, a strong inverse association was found between gestational age at birth and mortality in early childhood (ages 1-5 years: adjusted hazard ratio [aHR] for each additional week of gestation, 0.92; 95% CI, 0.89-0.94; P<.001), which disappeared in late childhood (ages 6-12 years: aHR, 0.99; 95% CI, 0.95-1.03; P=.61) and adolescence (ages 13-17 years: aHR, 0.99; 95% CI, 0.95-1.03; P=.64) and then reappeared in young adulthood (ages 18-36 years: aHR, 0.96; 95% CI, 0.94-0.97; P<.001). In young adulthood, mortality rates (per 1000 person-years) by gestational age at birth were 0.94 for 22 to 27 weeks, 0.86 for 28 to 33 weeks, 0.65 for 34 to 36 weeks, 0.46 for 37 to 42 weeks (full-term), and 0.54 for 43 or more weeks. Preterm birth was associated with increased mortality in young adulthood even among individuals born late preterm (34-36 weeks, aHR, 1.31; 95% CI, 1.13-1.50; P<.001), relative to those born full-term. In young adulthood, gestational age at birth had the strongest inverse association with mortality from congenital anomalies and respiratory, endocrine, and cardiovascular disorders and was not associated with mortality from neurological disorders, cancer, or injury. Conclusion After excluding earlier deaths, low gestational age at birth was independently associated with increased mortality in early childhood and young adulthood. JAMA. 2011;306(11):1233-1240 www.jama.com	[Crump, Casey] Stanford Univ, Dept Med, Stanford, CA 94304 USA; [Sundquist, Kristina; Sundquist, Jan] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden; [Sundquist, Jan; Winkleby, Marilyn A.] Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA	Stanford University; Lund University; Stanford University	Crump, C (corresponding author), Stanford Univ, Dept Med, 900 Blake Wilbur Dr, Stanford, CA 94304 USA.	kccrump@stanford.edu	Crump, Casey/AAO-8802-2021	Crump, Casey/0000-0002-2990-1166	National Institute of Child Health and Human Development [1R01HD052848-01]; Swedish Research Council [2008-3110, 2008-2638]; Swedish Council for Working Life and Social Research [2006-0386, 2007-1754, 2007-1962]; Avtal om Lakarutbildning och Forskning, Lund, Sweden; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052848] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Avtal om Lakarutbildning och Forskning, Lund, Sweden; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grants from the National Institute of Child Health and Human Development (1R01HD052848-01), the Swedish Research Council (2008-3110 and 2008-2638), the Swedish Council for Working Life and Social Research (2006-0386, 2007-1754, and 2007-1962), and an ALF project grant (Avtal om Lakarutbildning och Forskning, or Agreement on Medical Training and Research), Lund, Sweden.	Ananth CV, 2005, OBSTET GYNECOL, V105, P1084, DOI 10.1097/01.AOG.0000158124.96300.c7; Andersen AMN, 2004, INT J EPIDEMIOL, V33, P92, DOI 10.1093/ije/dyg195; Archer JM, 2011, PEDIATRICS, V127, P293, DOI 10.1542/peds.2010-0418; Astolfi P, 1999, HUM REPROD, V14, P2891, DOI 10.1093/humrep/14.11.2891; Baker JL, 2008, EPIDEMIOLOGY, V19, P197, DOI 10.1097/EDE.0b013e31816339c6; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Behrman RE, 2007, PRETERM BIRTH CAUSES; Crump C, 2011, CLIN ENDOCRINOL, V75, P255, DOI 10.1111/j.1365-2265.2011.04034.x; Crump C, 2011, DIABETES CARE, V34, P1109, DOI 10.2337/dc10-2108; Crump C, 2011, AM J EPIDEMIOL, V173, P797, DOI 10.1093/aje/kwq440; Crump C, 2011, PEDIATRICS, V127, pE913, DOI 10.1542/peds.2010-2603; Crump C, 2010, INT J EPIDEMIOL, V39, P1522, DOI 10.1093/ije/dyq103; David R, 2001, INT J EPIDEMIOL, V30, P1241, DOI 10.1093/ije/30.6.1241; Doyle LW, 2003, PEDIATRICS, V112, P565, DOI 10.1542/peds.112.3.565; Frankel S, 1996, PUBLIC HEALTH, V110, P139, DOI 10.1016/S0033-3506(96)80066-7; Friedlander Y, 2003, PAEDIATR PERINAT EP, V17, P398, DOI 10.1046/j.1365-3016.2003.00522.x; Furberg H, 2006, ADDICTION, V101, P1509, DOI 10.1111/j.1360-0443.2006.01550.x; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Honein MA, 2009, MATERN CHILD HLTH J, V13, P164, DOI 10.1007/s10995-008-0348-y; Ijzerman RG, 2005, PAEDIATR PERINAT EP, V19, P10, DOI 10.1111/j.1365-3016.2005.00614.x; Jokela M, 2009, PEDIATRICS, V124, pE380, DOI 10.1542/peds.2009-0334; Kajantie E, 2005, INT J EPIDEMIOL, V34, P655, DOI 10.1093/ije/dyi048; Kase JS, 2007, J PERINAT MED, V35, P538, DOI 10.1515/JPM.2007.132; Lapidus Leif, 2008, Prim Care Diabetes, V2, P127, DOI 10.1016/j.pcd.2008.05.002; Lawlor DA, 2005, CIRCULATION, V112, P1414, DOI 10.1161/CIRCULATIONAHA.104.528356; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; March of Dimes, PERISTATS; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; McCalman J, 2008, SOC SCI MED, V66, P1070, DOI 10.1016/j.socscimed.2007.11.040; Modin B, 2002, SOC SCI MED, V54, P1051, DOI 10.1016/S0277-9536(01)00080-6; Nilsson PM, 2006, SCAND J PUBLIC HEALT, V34, P660, DOI 10.1080/14034940600607509; Osler M, 2003, J EPIDEMIOL COMMUN H, V57, P681, DOI 10.1136/jech.57.9.681; Painter RC, 2005, EUR J EPIDEMIOL, V20, P673, DOI 10.1007/s10654-005-7921-0; Power C, 2000, BRIT MED J, V320, P840, DOI 10.1136/bmj.320.7238.840; Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267; Roseboom TJ, 2001, PAEDIATR PERINAT EP, V15, P220, DOI 10.1046/j.1365-3016.2001.00336.x; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049; SHIONO PH, 1986, JAMA-J AM MED ASSOC, V255, P82; StataCorp, 2010, STAT STAT SOFTW REL; Swamy GK, 2008, JAMA-J AM MED ASSOC, V299, P1429, DOI 10.1001/jama.299.12.1429; Syddall HE, 2005, AM J EPIDEMIOL, V161, P1074, DOI 10.1093/aje/kwi137; Tanner K, 2005, PEDIATRICS, V116, pE833, DOI 10.1542/peds.2005-0397; Wang Y, 2010, BIRTH DEFECTS RES A, V88, P1023, DOI 10.1002/bdra.20711; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233	49	241	246	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2011	306	11					1233	1240		10.1001/jama.2011.1331	http://dx.doi.org/10.1001/jama.2011.1331			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HB	21934056				2022-12-28	WOS:000295033500024
J	Leipzig, RM				Leipzig, Rosanne M.			Inability to correctly identify year or month was accurate for detecting cognitive impairment in older patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Mt Sinai Sch Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Leipzig, RM (corresponding author), Mt Sinai Sch Med, New York, NY 10029 USA.							BENTON AL, 1964, J NERV MENT DIS, V139, P110, DOI 10.1097/00005053-196408000-00003; Mitchell AJ, 2011, ACTA PSYCHIAT SCAND; Wong CL, 2010, JAMA-J AM MED ASSOC, V304, P779, DOI 10.1001/jama.2010.1182	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6							JC3-9	10.7326/0003-4819-155-6-201109200-02009	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930846				2022-12-28	WOS:000295033400008
J	McKellar, RC; Chatterton, BDE; Wolfe, AP; Currie, PJ				McKellar, Ryan C.; Chatterton, Brian D. E.; Wolfe, Alexander P.; Currie, Philip J.			A Diverse Assemblage of Late Cretaceous Dinosaur and Bird Feathers from Canadian Amber	SCIENCE			English	Article							EVOLUTIONARY ORIGIN; TRANSPORT; ALBERTA; WATER	The fossil record of early feathers has relied on carbonized compressions that lack fine structural detail. Specimens in amber are preserved in greater detail, but they are rare. Late Cretaceous coal-rich strata from western Canada provide the richest and most diverse Mesozoic feather assemblage yet reported from amber. The fossils include primitive structures closely matching the protofeathers of nonavian dinosaurs, offering new insights into their structure and function. Additional derived morphologies confirm that plumage specialized for flight and underwater diving had evolved in Late Cretaceous birds. Because amber preserves feather structure and pigmentation in unmatched detail, these fossils provide novel insights regarding feather evolution.	[McKellar, Ryan C.; Chatterton, Brian D. E.; Wolfe, Alexander P.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	University of Alberta; University of Alberta	McKellar, RC (corresponding author), Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada.	rcm1@ualberta.ca	Currie, Philip J/A-2628-2014; Wolfe, Alexander P/G-6867-2011	Currie, Philip J/0000-0001-6857-3161; 	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC; Alberta Ingenuity Fund	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Ingenuity Fund	We thank the Leuck family and M. Schmidt (donated specimens); M. Caldwell, S. Ogg and M. Srayko (microscopy); E. Koppelhus and H. Proctor (discussions); and J. Gardner, B. Strilisky, A. Howell, and J. Hudon (TMP, Redpath Museum, and Royal Alberta Museum collections). Research was funded by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grants to B. D. E. C., A. P. W., and P. J. C. and NSERC and Alberta Ingenuity Fund support to R.C.M.	Alonso J, 2000, J PALEONTOL, V74, P158, DOI 10.1666/0022-3360(2000)074<0158:ANFRWB>2.0.CO;2; Brush AH, 2000, AM ZOOL, V40, P631, DOI 10.1668/0003-1569(2000)040[0631:EAPAFD]2.0.CO;2; Buffetaut E, 2010, GEOL MAG, V147, P469, DOI 10.1017/S0016756810000129; CADE TJ, 1967, CONDOR, V69, P323, DOI 10.2307/1366197; Chandler A. C., 1916, U CALIFORNIA PUBLICA, V13, P243; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Currie PJ, 2005, LIFE O PAST, P367; Currie PJ, 2001, CAN J EARTH SCI, V38, P1705, DOI 10.1139/e01-050; DAVIS PG, 1995, GEOLOGY, V23, P783, DOI 10.1130/0091-7613(1995)023<0783:FOF>2.3.CO;2; Dove Carla J., 2000, Ornithological Monographs, V51, P1; Fjeldsa J., 2004, GREBES PODICIPEDIDAE; Grimaldi David, 1995, American Museum Novitates, V3126, P1; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Kellner AWA, 2010, P ROY SOC B-BIOL SCI, V277, P321, DOI 10.1098/rspb.2009.0846; Longrich N, 2009, CRETACEOUS RES, V30, P161, DOI 10.1016/j.cretres.2008.06.007; Lucas A., 1972, AVIAN ANATOMY INTEGU; MACLEAN GL, 1983, BIOSCIENCE, V33, P365, DOI 10.2307/1309104; McKellar Ryan C., 2010, P149; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Perrichot V, 2008, P ROY SOC B-BIOL SCI, V275, P1197, DOI 10.1098/rspb.2008.0003; Prum RO, 1999, J EXP ZOOL, V285, P291; Prum RO, 2002, Q REV BIOL, V77, P261, DOI 10.1086/341993; Schlee D., 1978, STUTTGARTER BEITRA C, V8, P1; STETTENHEIM P, 1973, Living Bird, V12, P201; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589; Xu X, 2010, NATURE, V464, P1338, DOI 10.1038/nature08965; Xu Xing, 2009, Vertebrata Palasiatica, V47, P311	27	49	53	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2011	333	6049					1619	1622		10.1126/science.1203344	http://dx.doi.org/10.1126/science.1203344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921196	Green Submitted			2022-12-28	WOS:000294900900040
J	Cohen, D				Cohen, Deborah			NON-COMMUNICABLE DISEASES The prickly problem of access to insulin	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIABETES CARE		BMJ, London WC1H 9JR, England		Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.	dcohen@bmj.com						Abdraimova A, 2009, REPORT RAPID ASSESSM; BENNETT S, 2011, BLOOMBERG BUSIN 0906; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Beran D, 2010, DIABETES RES CLIN PR, V88, P217, DOI 10.1016/j.diabres.2010.03.029; Bliss M., 1984, DISCOVERY INSULIN; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; COHEN D, 2011, FINAL DECLARATION UN; *DIAB LEAD FOR AFR, 2010, DIAB HIDD PAND ITS I; *EUR MED AG, WITHDR ASS REP INS H; GHANGURDE A, 2011, SCRIP           0816; GHANGURDE A, 2010, SCRIP           1201; Hemmingsen B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub2; Holden SE, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000258; *I QUAL EFF HLTH C, 2011, IQWIG; *INT DIAB FED, ANN REP 2010 INT DIA; *INT DIAB FED, INT DIAB FED GLOB GU; International Diabetes Federation, LIF CHILD; International Diabetes Federation, DIAB ATL; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; National Institute for Health and Clinical Excellence, 2008, TYP 2 DIAB MAN TYP 2; *NCD ALL, ACC ESS MED TECHN NC; PAGODA PR, WHO WE ARE; PAGODA PR, OUR CLIENTS; SAWACKI PT, 2011, BRIT MED J, V343, pD5858; STRUMELLO S, 2007, COULD GENERIC INSULI; *WHO, 2011, EXP COMM SEL US ESS; Yudkin JS, 2010, DIABETOLOGIA, V53, P2079, DOI 10.1007/s00125-010-1864-z; 2009, SHARE           1112	29	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2011	343								d5782	10.1136/bmj.d5782	http://dx.doi.org/10.1136/bmj.d5782			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822VM	21917833				2022-12-28	WOS:000295078100009
J	Rice, TW; Wheeler, AP; Thompson, BT; DeBoisblanc, BP; Steingrub, J; Rock, P				Rice, Todd W.; Wheeler, Arthur P.; Thompson, B. Taylor; DeBoisblanc, Bennett P.; Steingrub, Jay; Rock, Peter		NHLBI ARDS Clinical Trials Network	Enteral Omega-3 Fatty Acid, gamma-Linolenic Acid, and Antioxidant Supplementation in Acute Lung Injury	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MECHANICALLY VENTILATED PATIENTS; EICOSAPENTAENOIC ACID; FATTY-ACIDS; FISH-OIL; PLASMA; INFLAMMATION; NUTRITION; OUTCOMES; MARKERS; BENEFIT	Context The omega-3 (n-3) fatty acids docosahexaenoic acid and eicosapentaenoic acid, along with gamma-linolenic acid and antioxidants, may modulate systemic inflammatory response and improve oxygenation and outcomes in patients with acute lung injury. Objective To determine if dietary supplementation of these substances to patients with acute lung injury would increase ventilator-free days to study day 28. Design, Setting, and Participants The OMEGA study, a randomized, double-blind, placebo-controlled, multicenter trial conducted from January 2, 2008, through February 21, 2009. Participants were 272 adults within 48 hours of developing acute lung injury requiring mechanical ventilation whose physicians intended to start enteral nutrition at 44 hospitals in the National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. All participants had complete follow-up. Interventions Twice-daily enteral supplementation of n-3 fatty acids, gamma-linolenic acid, and antioxidants compared with an isocaloric control. Enteral nutrition, directed by a protocol, was delivered separately from the study supplement. Main Outcome Measure Ventilator-free days to study day 28. Results The study was stopped early for futility after 143 and 129 patients were enrolled in the n-3 and control groups. Despite an 8-fold increase in plasma eicosapentaenoic acid levels, patients receiving the n-3 supplement had fewer ventilator-free days (14.0 vs 17.2; P=.02) (difference, -3.2 [95% CI, -5.8 to -0.7]) and intensive care unit-free days (14.0 vs 16.7; P=.04). Patients in the n-3 group also had fewer nonpulmonary organ failure-free days (12.3 vs 15.5; P=.02). Sixty-day hospital mortality was 26.6% in the n-3 group vs 16.3% in the control group (P=.054), and adjusted 60-day mortality was 25.1% and 17.6% in the n-3 and control groups, respectively (P=.11). Use of the n-3 supplement resulted in more days with diarrhea (29% vs 21%; P=.001). Conclusions Twice-daily enteral supplementation of n-3 fatty acids, gamma-linolenic acid, and antioxidants did not improve the primary end point of ventilator-free days or other clinical outcomes in patients with acute lung injury and may be harmful.	[Rice, Todd W.] Vanderbilt Univ, Div Allergy Pulm & Crit Care Med, Vanderbilt Med Ctr, Sch Med, Nashville, TN 37232 USA; [Thompson, B. Taylor] Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; [DeBoisblanc, Bennett P.] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA; [Steingrub, Jay] Baystate Med Ctr, Springfield, MA USA; [Rock, Peter] Univ Maryland, Dept Anesthesiol, Sch Med, Baltimore, MD 21201 USA	Vanderbilt University; Harvard University; Massachusetts General Hospital; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Baystate Medical Center; University System of Maryland; University of Maryland Baltimore	Rice, TW (corresponding author), Vanderbilt Univ, Div Allergy Pulm & Crit Care Med, Vanderbilt Med Ctr, Sch Med, T-1218 MCN, Nashville, TN 37232 USA.	todd.rice@vanderbilt.edu	Rice, Todd/X-7853-2019	Rice, Todd/0000-0002-7136-5408	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268200536165C, HHSN268200536176C, HHSN268200536179C]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056176, R01HL056169] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Heart, Lung, and Blood Institute (NHLBI) contracts HHSN268200536165C, HHSN268200536176C, and HHSN268200536179C. Abbott Nutrition, Columbus, Ohio, provided the omega-3 fatty acid, gamma-linolenic acid, antioxidant, and control supplements used in the study.	Abraham E, 2000, AM J RESP CELL MOL, V22, P401, DOI 10.1165/ajrcmb.22.4.f184; ALSAADY NM, 1989, INTENS CARE MED, V15, P290; Barbosa VM, 2010, CRIT CARE, V14, DOI 10.1186/cc8844; Barham JB, 2000, J NUTR, V130, P1925, DOI 10.1093/jn/130.8.1925; Bernard GR, 2005, AM J RESP CRIT CARE, V172, P798, DOI 10.1164/rccm.200504-663OE; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Caironi P, 2005, AM J RESP CRIT CARE, V172, P334, DOI 10.1164/rccm.200501-034OC; Calder PC, 2004, LIPIDS, V39, P1147, DOI 10.1007/s11745-004-1342-z; Cao J, 2006, CLIN CHEM, V52, P2265, DOI 10.1373/clinchem.2006.072322; CHILTON FH, 1993, J CLIN INVEST, V91, P115, DOI 10.1172/JCI116159; DEMETS DL, 1982, BIOMETRIKA, V69, P661; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Friesecke S, 2008, INTENS CARE MED, V34, P1411, DOI 10.1007/s00134-008-1072-1; Gadek JE, 1999, CRIT CARE MED, V27, P1409, DOI 10.1097/00003246-199908000-00001; Gust R, 1999, AM J RESP CRIT CARE, V160, P1165, DOI 10.1164/ajrccm.160.4.9811073; Johnson MM, 1997, J NUTR, V127, P1435, DOI 10.1093/jn/127.8.1435; Kumar KV, 2000, CLIN CHIM ACTA, V298, P111, DOI 10.1016/S0009-8981(00)00264-3; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; National Heart Lung and Blood Institute (NHLBI), EARL VERS DEL ENT FE; Pacht ER, 2003, CRIT CARE MED, V31, P491, DOI 10.1097/01.CCM.0000049952.96496.3E; Parsons PE, 2005, CRIT CARE MED, V33, P1, DOI 10.1097/01.CCM.0000149854.61192.DC; Pontes-Arruda A, 2006, CRIT CARE MED, V34, P2325, DOI 10.1097/01.CCM.0000234033.65657.B6; Prescott SM, 2005, NAT MED, V11, P596, DOI 10.1038/nm0605-596; Singer P, 2006, CRIT CARE MED, V34, P1033, DOI 10.1097/01.CCM.0000206111.23629.0A; Skeaff CM, 2006, J NUTR, V136, P565, DOI 10.1093/jn/136.3.565; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564	30	357	383	0	44	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2011	306	14					1574	1581		10.1001/jama.2011.1435	http://dx.doi.org/10.1001/jama.2011.1435			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831FS	21976613	Green Accepted, Bronze			2022-12-28	WOS:000295714700023
J	Lee, SJ; Walter, LC				Lee, Sei J.; Walter, Louise C.			Quality Indicators for Older Adults Preventing Unintended Harms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRACTICE GUIDELINES; OF-CARE; CANCER; PERFORMANCE; LESSONS		[Lee, Sei J.] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94121 USA; Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Lee, SJ (corresponding author), Univ Calif San Francisco, Div Geriatr, 4150 Clement St,Bldg 1,Room 211A, San Francisco, CA 94121 USA.	sei.lee@ucsf.edu			NATIONAL CANCER INSTITUTE [R01CA134425] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG040779] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA134425, 1R01CA134425] Funding Source: Medline; NCRR NIH HHS [KL2 RR024130, KL2 RR024130-02] Funding Source: Medline; NIA NIH HHS [K23 AG040779] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Min LC, 2007, J AM GERIATR SOC, V55, pS359, DOI 10.1111/j.1532-5415.2007.01343.x; Quanstrum KH, 2010, NEW ENGL J MED, V363, P1076, DOI 10.1056/NEJMsb1002538; Reuben DB, 2003, J AM GERIATR SOC, V51, pS346, DOI 10.1046/j.1365-2389.2003.51346.x; Sima CS, 2010, JAMA-J AM MED ASSOC, V304, P1584, DOI 10.1001/jama.2010.1449; Vincent G. K., 2010, CURRENT POPULATION R, VP25, P1; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Wenger NS, 2007, J AM GERIATR SOC, V55, pS457, DOI 10.1111/j.1532-5415.2007.01375.x	10	27	27	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 5	2011	306	13					1481	1482		10.1001/jama.2011.1418	http://dx.doi.org/10.1001/jama.2011.1418			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	828MZ	21972311	Green Accepted			2022-12-28	WOS:000295506900028
J	Rodda, J; Walker, Z; Carter, J				Rodda, Joanne; Walker, Zuzana; Carter, Janet			Depression in older adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LATE-LIFE DEPRESSION; POSTSTROKE DEPRESSION; PUBLIC-HEALTH; RISK; PEOPLE; INTERVENTIONS; PSYCHOTHERAPY; METAANALYSIS; DEMENTIA; ANXIETY		[Rodda, Joanne; Walker, Zuzana; Carter, Janet] UCL, Dept Mental Hlth Sci, London W1W 7EJ, England	University of London; University College London	Carter, J (corresponding author), UCL, Dept Mental Hlth Sci, London W1W 7EJ, England.	j.carter@ucl.ac.uk	Vieira, Edgar Ramos/I-7609-2013; Walker, Zuzana/B-8339-2009	Vieira, Edgar Ramos/0000-0002-1011-5077; Walker, Zuzana/0000-0001-7346-8200				Alexopoulos GS, 2005, BIOL PSYCHIAT, V58, P204, DOI 10.1016/j.biopsych.2005.04.024; Alvarez P, 2011, INT J GERIATR PSYCH, V26, P615, DOI 10.1002/gps.2571; Azar AR, 2011, INT J GERIATR PSYCH, V26, P48, DOI 10.1002/gps.2485; Banerjee S, 2011, LANCET, V378, P403, DOI 10.1016/S0140-6736(11)60830-1; Beekman ATF, 2000, AM J PSYCHIAT, V157, P89, DOI 10.1176/ajp.157.1.89; Blake H, 2009, CLIN REHABIL, V23, P873, DOI 10.1177/0269215509337449; Byers AL, 2011, NAT REV NEUROL, V7, P323, DOI 10.1038/nrneurol.2011.60; Chen Y, 2007, INT CLIN PSYCHOPHARM, V22, P159, DOI 10.1097/YIC.0b013e32807fb028; Colasanti V, 2010, ARCH GERONTOL GERIAT, V50, P227, DOI 10.1016/j.archger.2009.04.001; Cooper C, 2011, AM J PSYCHIAT; Cuijpers P, 2009, DEPRESS ANXIETY, V26, P279, DOI 10.1002/da.20519; Cuijpers P, 2009, INT PSYCHOGERIATR, V21, P16, DOI 10.1017/S1041610208008089; Green LA, 2009, ANN FAM MED, V7, P71, DOI 10.1370/afm.918; Jorm AF, 2001, AUST NZ J PSYCHIAT, V35, P776, DOI 10.1046/j.1440-1614.2001.00967.x; Klug G, 2010, BRIT J PSYCHIAT, V197, P463, DOI 10.1192/bjp.bp.110.083121; Kok RM, 2011, AM J GERIAT PSYCHIAT, V19, P249, DOI 10.1097/JGP.0b013e3181ec8085; Licht-Strunk E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3079; Manthorpe J, 2010, INT J GERIATR PSYCH, V25, P1230, DOI 10.1002/gps.2473; Meeks TW, 2011, J AFFECT DISORDERS, V129, P126, DOI 10.1016/j.jad.2010.09.015; Mitchell AJ, 2005, AM J PSYCHIAT, V162, P1588, DOI 10.1176/appi.ajp.162.9.1588; Mottram P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003491.pub2; Nelson JC, 2008, AM J GERIAT PSYCHIAT, V16, P558, DOI 10.1097/JGP.0b013e3181693288; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Robinson RG, 2010, CAN J PSYCHIAT, V55, P341, DOI 10.1177/070674371005500602; Sneed JR, 2011, AM J GERIAT PSYCHIAT, V19, P99, DOI 10.1097/JGP.0b013e318202fc8a; Stek ML, 2006, COCHRANE DB SYST REV, V2; Taylor D, 2011, BRIT J PSYCHIAT, V198, P179, DOI 10.1192/bjp.bp.110.077610; Tsopelas C, 2011, BRIT J PSYCHIAT, V198, P109, DOI 10.1192/bjp.bp.110.078816; van't Veer-Tazelaar PJ, 2009, ARCH GEN PSYCHIAT, V66, P297, DOI 10.1001/archgenpsychiatry.2008.555; Vilalta-Franch J, 2012, INT J GERIATR PSYCH, V27, P67, DOI 10.1002/gps.2691	30	197	197	2	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 28	2011	343								d5219	10.1136/bmj.d5219	http://dx.doi.org/10.1136/bmj.d5219			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829JZ	21957206				2022-12-28	WOS:000295577100001
J	Nolan, JP; Soar, J				Nolan, Jerry P.; Soar, Jasmeet			Does the evidence support the use of mild hypothermia after cardiac arrest? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							THERAPEUTIC HYPOTHERMIA; CARDIOPULMONARY-RESUSCITATION; COMATOSE SURVIVORS		[Nolan, Jerry P.] Royal United Hosp NHS Trust, Bath BA2 7AJ, Avon, England; [Soar, Jasmeet] N Bristol NHS Trust, Southmead Hosp, Bristol, Avon, England	North Bristol NHS Trust; Southmead Hospital	Nolan, JP (corresponding author), Royal United Hosp NHS Trust, Bath BA2 7AJ, Avon, England.	jerry.nolan@nhs.net	Nolan, Jerry P./ABF-2561-2020; Soar, Jasmeet/HGA-2279-2022	Soar, Jasmeet/0000-0001-5970-6073; Nolan, Jerry/0000-0003-3141-3812				Arrich J, 2007, CRIT CARE MED, V35, P1041, DOI 10.1097/01.CCM.0000259383.48324.35; Bernard SA, 1997, ANN EMERG MED, V30, P146, DOI 10.1016/S0196-0644(97)70133-1; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Binks AC, 2010, ANAESTHESIA, V65, P260, DOI 10.1111/j.1365-2044.2009.06227.x; Deakin CD, 2010, RESUSCITATION, V81, pE93, DOI 10.1016/j.resuscitation.2010.08.027; Holzer M, 2002, NEW ENGL J MED, V346, P549; Holzer M, 2006, STROKE, V37, P1792, DOI 10.1161/01.STR.0000227265.52763.16; Kern KB, 2010, CATHETER CARDIO INTE, V75, P616, DOI 10.1002/ccd.22192; Mongardon N, 2011, CRIT CARE MED, V39, P1359, DOI 10.1097/CCM.0b013e3182120b56; Nolan JP, 2003, RESUSCITATION, V57, P231, DOI 10.1016/S0300-9572(03)00184-9; Nunnally ME, 2011, CRIT CARE MED, V39, P1113, DOI 10.1097/CCM.0b013e318206bab2; STERZ F, 1991, CRIT CARE MED, V19, P379, DOI 10.1097/00003246-199103000-00017; Tomte O, 2011, RESUSCITATION, V82, P1186, DOI 10.1016/j.resuscitation.2011.05.003; van der Wal G, 2011, CRIT CARE MED, V39, P84, DOI 10.1097/CCM.0b013e3181fd6aef; Walters JH, 2011, RESUSCITATION, V82, P508, DOI 10.1016/j.resuscitation.2011.01.021	15	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 23	2011	343								d5830	10.1136/bmj.d5830	http://dx.doi.org/10.1136/bmj.d5830			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	826AK	21948587				2022-12-28	WOS:000295323500001
J	Viswanathan, M; Guarente, L				Viswanathan, Mohan; Guarente, Leonard			Regulation of Caenorhabditis elegans lifespan by sir-2.1 transgenes	NATURE			English	News Item									[Viswanathan, Mohan; Guarente, Leonard] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Viswanathan, M (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu			SAB of Sirtris/GSK	SAB of Sirtris/GSK(GlaxoSmithKline)	LG is co-chair of the SAB of Sirtris/GSK.	Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Bamps S, 2009, MECH AGEING DEV, V130, P762, DOI 10.1016/j.mad.2009.10.001; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Rizki G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002235; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017	6	149	162	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2011	477	7365					E1	E2		10.1038/nature10440	http://dx.doi.org/10.1038/nature10440			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21938026				2022-12-28	WOS:000295080500001
J	Tan, MJ; Luo, H; Lee, S; Jin, FL; Yang, JS; Montellier, E; Buchou, T; Cheng, ZY; Rousseaux, S; Rajagopal, N; Lu, ZK; Ye, Z; Zhu, Q; Wysocka, J; Ye, Y; Khochbin, S; Ren, B; Zhao, YM				Tan, Minjia; Luo, Hao; Lee, Sangkyu; Jin, Fulai; Yang, Jeong Soo; Montellier, Emilie; Buchou, Thierry; Cheng, Zhongyi; Rousseaux, Sophie; Rajagopal, Nisha; Lu, Zhike; Ye, Zhen; Zhu, Qin; Wysocka, Joanna; Ye, Yang; Khochbin, Saadi; Ren, Bing; Zhao, Yingming			Identification of 67 Histone Marks and Histone Lysine Crotonylation as a New Type of Histone Modification	CELL			English	Article							MASS-SPECTROMETRY; POSTTRANSLATIONAL MODIFICATIONS; CHROMATIN MODIFICATIONS; HUMAN-CELLS; CODE; DISTINCT; H3; PHOSPHORYLATION; ACETYLATION; METHYLATION	We report the identification of 67 previously undescribed histone modifications, increasing the current number of known histone marks by about 70%. We further investigated one of the marks, lysine crotonylation (Kcr), confirming that it represents an evolutionarily-conserved histone posttranslational modification. The unique structure and genomic localization of histone Kcr suggest that it is mechanistically and functionally different from histone lysine acetylation (Kac). Specifically, in both human somatic and mouse male germ cell genomes, histone Kcr marks either active promoters or potential enhancers. In male germinal cells immediately following meiosis, Kcr is enriched on sex chromosomes and specifically marks testis-specific genes, including a significant proportion of X-linked genes that escape sex chromosome inactivation in haploid cells. These results therefore dramatically extend the repertoire of histone PTM sites and designate Kcr as a specific mark of active sex chromosome-linked genes in postmeiotic male germ cells.	[Tan, Minjia; Luo, Hao; Lee, Sangkyu; Yang, Jeong Soo; Cheng, Zhongyi; Lu, Zhike; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Jin, Fulai; Rajagopal, Nisha; Ye, Zhen; Ren, Bing] Univ Calif San Diego, Ludwig Inst Canc Res, Sch Med, La Jolla, CA 92093 USA; [Jin, Fulai; Rajagopal, Nisha; Ye, Zhen; Ren, Bing] Univ Calif San Diego, Dept Cellular & Mol Med, Sch Med, La Jolla, CA 92093 USA; [Zhu, Qin; Ye, Yang] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Wysocka, Joanna] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA; [Montellier, Emilie; Buchou, Thierry; Rousseaux, Sophie; Khochbin, Saadi] INSERM, U823, F-38706 La Tronche, France; [Montellier, Emilie; Buchou, Thierry; Rousseaux, Sophie; Khochbin, Saadi] Univ Grenoble 1, F-38706 La Tronche, France; [Montellier, Emilie; Buchou, Thierry; Rousseaux, Sophie; Khochbin, Saadi] Fac Med, Inst Albert Bonniot, F-38706 La Tronche, France	University of Chicago; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Stanford University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Zhao, YM (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	yingming.zhao@uchicago.edu	BUCHOU, Thierry/F-3136-2019; Rousseaux, Sophie/G-1697-2013; Khochbin, Saadi/M-8090-2013; Montellier, Emilie/ABE-9802-2020; Montellier, Emilie/N-4071-2017; BUCHOU, THIERRY/N-2553-2013; Tan, Minjia/C-4491-2014; zhu, qin/G-3520-2016	BUCHOU, Thierry/0000-0002-9206-2377; Rousseaux, Sophie/0000-0001-5246-5350; Khochbin, Saadi/0000-0002-0455-0857; Montellier, Emilie/0000-0001-5069-3536; Tan, Minjia/0000-0002-6784-9653; zhu, qin/0000-0003-4093-9517; Jin, Fulai/0000-0003-0025-4337	National Institute of Health; INCa-DHOS; ANR blanche "EpiSperm"; ARC; NATIONAL CANCER INSTITUTE [R01CA126832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082664] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INCa-DHOS; ANR blanche "EpiSperm"(French National Research Agency (ANR)); ARC(Australian Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health grants to B.R., J.W., and Y.Z., by INCa-DHOS, ANR blanche "EpiSperm," and ARC research programs to S.K. Z.C. is a shareholder of PTM BioLab, Co., Ltd (Chicago, IL); Y.Z. is a member of the scientific advisory board of PTM BioLab, Co., Ltd (Chicago, IL).	ALLIS CD, 1985, P NATL ACAD SCI USA, V82, P8048, DOI 10.1073/pnas.82.23.8048; ARENTS G, 1993, P NATL ACAD SCI USA, V90, P10489, DOI 10.1073/pnas.90.22.10489; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Boussouar F, 2008, CELL CYCLE, V7, P3499, DOI 10.4161/cc.7.22.6975; Chen Y, 2005, J PROTEOME RES, V4, P998, DOI 10.1021/pr049754t; Chen Y, 2009, P NATL ACAD SCI USA, V106, P761, DOI 10.1073/pnas.0811739106; Chu FX, 2006, MOL CELL PROTEOMICS, V5, P194, DOI 10.1074/mcp.M500285-MCP200; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Fullgrabe J., 2011, HISTONE ONCO MODIFIC; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Garcia BA, 2007, CURR OPIN CHEM BIOL, V11, P66, DOI 10.1016/j.cbpa.2006.11.022; Gaucher J, 2010, FEBS J, V277, P599, DOI 10.1111/j.1742-4658.2009.07504.x; Govin J, 2004, EUR J BIOCHEM, V271, P3459, DOI 10.1111/j.1432-1033.2004.04266.x; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Johnson L, 2004, NUCLEIC ACIDS RES, V32, P6511, DOI 10.1093/nar/gkh992; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luo H, 2008, J BIOL CHEM, V283, P19176, DOI 10.1074/jbc.M802299200; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2007, CURR OPIN CELL BIOL, V19, P266, DOI 10.1016/j.ceb.2007.04.002; MCGHEE JD, 1980, ANNU REV BIOCHEM, V49, P1115, DOI 10.1146/annurev.bi.49.070180.005343; Mersfelder EL, 2006, NUCLEIC ACIDS RES, V34, P2653, DOI 10.1093/nar/gkl338; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zhao M, 2004, GENESIS, V38, P200, DOI 10.1002/gene.20019	37	1104	1201	20	291	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 16	2011	146	6					1015	1027		10.1016/j.cell.2011.08.008	http://dx.doi.org/10.1016/j.cell.2011.08.008			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925322	Green Accepted, Bronze			2022-12-28	WOS:000295258100022
J	Shallcross, LJ; Mbeledogu, CN; Hayward, AC				Shallcross, L. J.; Mbeledogu, C. N.; Hayward, A. C.			UNCERTAINTIES PAGE Should we screen and decolonise contacts of patients with Panton Valentine leukocidin associated Staphylococcus aureus infection?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Shallcross, L. J.] UCL, Res Dept Infect & Populat Hlth, London WC1E 6JB, England; [Mbeledogu, C. N.] Springfield Univ Hosp, SW London Hlth Protect Unit, London SW17 7DJ, England; [Hayward, A. C.] Royal Free Hosp, Univ Coll London, Res Dept Infect & Populat Hlth, London NW3 2PF, England	University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Shallcross, LJ (corresponding author), UCL, Res Dept Infect & Populat Hlth, London WC1E 6JB, England.	l.shallcross@ucl.ac.uk	Hayward, Andrew C/C-3268-2013	Hayward, Andrew C/0000-0002-3549-6232; Shallcross, Laura/0000-0003-1713-2555	MRC [G0501879] Funding Source: UKRI; Medical Research Council [G0501879] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		del Giudice P, 2009, DERMATOLOGY, V219, P299, DOI 10.1159/000232391; Gorwitz RJ., 2006, STRATEGIES CLIN MANA; Health Protection Agency, 2008, GUID DIAGN MAN PVL A; *HLTH PROT AG LOC, 2010, MAN PVL STAPH AUR RE; Jappe U, 2008, J INVEST DERMATOL, V128, P2655, DOI 10.1038/jid.2008.133; Laupland KB, 2003, J INFECT DIS, V187, P1452, DOI 10.1086/374621; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Shallcross LJ, 2010, CLIN MICROBIOL INFEC, V16, P1644, DOI 10.1111/j.1469-0691.2010.03153.x; VANRIJEN M, 2008, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD006216.PUB2	9	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 9	2011	343								d5479	10.1136/bmj.d5479	http://dx.doi.org/10.1136/bmj.d5479			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819SJ	21908526				2022-12-28	WOS:000294850000003
J	Shukla, S; Kavak, E; Gregory, M; Imashimizu, M; Shutinoski, B; Kashlev, M; Oberdoerffer, P; Sandberg, R; Oberdoerffer, S				Shukla, Sanjeev; Kavak, Ersen; Gregory, Melissa; Imashimizu, Masahiko; Shutinoski, Bojan; Kashlev, Mikhail; Oberdoerffer, Philipp; Sandberg, Rickard; Oberdoerffer, Shalini			CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing	NATURE			English	Article							INSULATOR PROTEIN CTCF; BINDING-SITES; ZINC FINGERS; CD45; TRANSCRIPTION; IDENTIFICATION; ELONGATION; EXPRESSION; REPRESSOR; SEQUENCES	Alternative splicing of pre-messenger RNA is a key feature of transcriptome expansion in eukaryotic cells, yet its regulation is poorly understood. Spliceosome assembly occurs co-transcriptionally, raising the possibility that DNA structure may directly influence alternative splicing. Supporting such an association, recent reports have identified distinct histone methylation patterns, elevated nucleosome occupancy and enriched DNA methylation at exons relative to introns. Moreover, the rate of transcription elongation has been linked to alternative splicing. Here we provide the first evidence that a DNA-binding protein, CCCTC-binding factor (CTCF), can promote inclusion of weak upstream exons by mediating local RNA polymerase II pausing both in a mammalian model system for alternative splicing, CD45, and genome-wide. We further show that CTCF binding to CD45 exon 5 is inhibited by DNA methylation, leading to reciprocal effects on exon 5 inclusion. These findings provide a mechanistic basis for developmental regulation of splicing outcome through heritable epigenetic marks.	[Shukla, Sanjeev; Gregory, Melissa; Shutinoski, Bojan; Oberdoerffer, Philipp; Oberdoerffer, Shalini] Natl Canc Inst Frederick, Ctr Canc Res, Mouse Canc Genet Program, Frederick, MD 21702 USA; [Kavak, Ersen; Sandberg, Rickard] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Kavak, Ersen; Sandberg, Rickard] Ludwig Inst Canc Res, SE-17177 Stockholm, Sweden; [Imashimizu, Masahiko; Kashlev, Mikhail] Natl Canc Inst Frederick, Ctr Canc Res, Gene Regulat & Chromosome Biol Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Karolinska Institutet; Ludwig Institute for Cancer Research; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Oberdoerffer, S (corresponding author), Natl Canc Inst Frederick, Ctr Canc Res, Mouse Canc Genet Program, Frederick, MD 21702 USA.	shalini.oberdoerffer@nih.gov	Imashimizu, Masahiko/M-4278-2018; Shukla, Sanjeev/L-8391-2018; Shutinoski, Bojan/M-5260-2016	Imashimizu, Masahiko/0000-0003-4891-5034; Shukla, Sanjeev/0000-0003-3361-0588; Shutinoski, Bojan/0000-0003-4669-5656; Sandberg, Rickard/0000-0001-6473-1740	NIH, the National Cancer Institute, The Center for Cancer Research; Swedish Research Council Foundation; Foundation for Strategic Research; NATIONAL CANCER INSTITUTE [ZIABC010795] Funding Source: NIH RePORTER	NIH, the National Cancer Institute, The Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Research Council Foundation; Foundation for Strategic Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Rao, C. Burge and K. Lynch for critical reading of this manuscript. We also thank A. Rao for reagents and K. Nyswaner and M. Prigge for technical assistance. This work is supported by the Intramural Research Program of NIH, the National Cancer Institute, The Center for Cancer Research (S.O., P.O., M. K.), and the Swedish Research Council Foundation and the Foundation for Strategic Research (R.S.).	Allo M, 2010, COLD SH Q B, V75, P103, DOI 10.1101/sqb.2010.75.023; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Han JH, 2011, TRENDS CELL BIOL, V21, P336, DOI 10.1016/j.tcb.2011.03.003; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hodges E, 2009, GENOME RES, V19, P1593, DOI 10.1101/gr.095190.109; HORGAN KJ, 1994, EUR J IMMUNOL, V24, P1240, DOI 10.1002/eji.1830240536; Huff JT, 2010, NAT STRUCT MOL BIOL, V17, P1495, DOI 10.1038/nsmb.1924; Jelinic P, 2007, J PATHOL, V211, P261, DOI 10.1002/path.2116; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kireeva ML, 2008, MOL CELL, V30, P557, DOI 10.1016/j.molcel.2008.04.017; Kireeva ML, 2003, METHOD ENZYMOL, V370, P138; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Komissarova N, 2003, METHOD ENZYMOL, V371, P233; Kornblihtt AR, 2007, ADV EXP MED BIOL, V623, P175, DOI 10.1007/978-0-387-77374-2_11; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mohn Fabio, 2009, V507, P55, DOI 10.1007/978-1-59745-522-0_5; Motta-Mena LB, 2010, MOL CELL, V37, P223, DOI 10.1016/j.molcel.2009.12.027; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Ohlsson R, 2010, CHROMOSOMA, V119, P351, DOI 10.1007/s00412-010-0262-0; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Tong A, 2005, J BIOL CHEM, V280, P38297, DOI 10.1074/jbc.M508123200; Topp JD, 2008, RNA, V14, P2038, DOI 10.1261/rna.1212008; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; UCSC Genome Browser, UCSC GEN BROWS GRC37; Wada Y, 2009, P NATL ACAD SCI USA, V106, P18357, DOI 10.1073/pnas.0902573106; Wall ME, 2001, BIOINFORMATICS, V17, P566, DOI 10.1093/bioinformatics/17.6.566; Wall ME, 2003, PRACTICAL APPROACH M, P91, DOI DOI 10.1007/0-306-47815-3_5; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	54	670	692	3	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2011	479	7371					74	U99		10.1038/nature10442	http://dx.doi.org/10.1038/nature10442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840FA	21964334	Green Accepted, Green Published			2022-12-28	WOS:000296422600034
J	Rosas-Ballina, M; Olofsson, PS; Ochani, M; Valdes-Ferrer, SI; Levine, YA; Reardon, C; Tusche, MW; Pavlov, VA; Andersson, U; Chavan, S; Mak, TW; Tracey, KJ				Rosas-Ballina, Mauricio; Olofsson, Peder S.; Ochani, Mahendar; Valdes-Ferrer, Sergio I.; Levine, Yaakov A.; Reardon, Colin; Tusche, Michael W.; Pavlov, Valentin A.; Andersson, Ulf; Chavan, Sangeeta; Mak, Tak W.; Tracey, Kevin J.			Acetylcholine-Synthesizing T Cells Relay Neural Signals in a Vagus Nerve Circuit	SCIENCE			English	Article							NORADRENERGIC SYMPATHETIC INNERVATION; CHOLINE-ACETYLTRANSFERASE ACTIVITY; IMPROVES SURVIVAL; RAT SPLEEN; STIMULATION; LYMPHOCYTES; TNF; ENDOTOXEMIA; RELEASE; SEPSIS	Neural circuits regulate cytokine production to prevent potentially damaging inflammation. A prototypical vagus nerve circuit, the inflammatory reflex, inhibits tumor necrosis factor-alpha production in spleen by a mechanism requiring acetylcholine signaling through the alpha 7 nicotinic acetylcholine receptor expressed on cytokine-producing macrophages. Nerve fibers in spleen lack the enzymatic machinery necessary for acetylcholine production; therefore, how does this neural circuit terminate in cholinergic signaling? We identified an acetylcholine-producing, memory phenotype T cell population in mice that is integral to the inflammatory reflex. These acetylcholine-producing T cells are required for inhibition of cytokine production by vagus nerve stimulation. Thus, action potentials originating in the vagus nerve regulate T cells, which in turn produce the neurotransmitter, acetylcholine, required to control innate immune responses.	[Rosas-Ballina, Mauricio; Olofsson, Peder S.; Ochani, Mahendar; Valdes-Ferrer, Sergio I.; Levine, Yaakov A.; Pavlov, Valentin A.; Chavan, Sangeeta; Tracey, Kevin J.] Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY 11030 USA; [Valdes-Ferrer, Sergio I.] Feinstein Inst Med Res, Elmezzi Grad Sch Mol Med, Manhasset, NY 11030 USA; [Reardon, Colin; Tusche, Michael W.; Mak, Tak W.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada; [Andersson, Ulf] Karolinska Inst, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden	Northwell Health; Northwell Health; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Karolinska Institutet	Tracey, KJ (corresponding author), Feinstein Inst Med Res, Lab Biomed Sci, 350 Community Dr, Manhasset, NY 11030 USA.	kjtracey@nshs.edu	Levine, Yaakov/AAA-2578-2020; Valdés-Ferrer, Sergio Iván/ABD-1057-2020; Andersson, Ulf/ABD-5162-2021	Valdés-Ferrer, Sergio Iván/0000-0002-4863-6484; Andersson, Ulf/0000-0003-0316-3860; Pavlov, Valentin/0000-0002-1994-2853; Levine, Yaakov/0000-0002-3313-6858; Chavan, Sangeeta S./0000-0002-4822-3356; Tracey, Kevin J/0000-0003-1884-6314; Reardon, Colin/0000-0003-2204-8091	National Institute of General Medical Sciences, NIH; Wenner-Gren Foundations in Stockholm; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057226] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wenner-Gren Foundations in Stockholm; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from National Institute of General Medical Sciences, NIH, to K.J.T. and from the Wenner-Gren Foundations in Stockholm to P.S.O. We thank B. Diamond for helpful discussions, and H. Borrero and S. Matheravidathu for technical support. The data reported in this paper are tabulated in the main text and supporting online material.	BELLINGER D L, 1989, Brain Behavior and Immunity, V3, P291, DOI 10.1016/0889-1591(89)90029-9; BELLINGER DL, 1987, J NEUROSCI RES, V18, P55, DOI 10.1002/jnr.490180110; BELLINGER DL, 1993, BRAIN BEHAV IMMUN, V7, P191, DOI 10.1006/brbi.1993.1021; BERTHOUD HR, 1993, J AUTONOM NERV SYST, V42, P153, DOI 10.1016/0165-1838(93)90046-W; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; BRANDON KW, 1961, J PHYSIOL-LONDON, V157, P18, DOI 10.1113/jphysiol.1961.sp006702; Bulloch K, 1994, Int J Neurosci, V76, P141; Dale HH, 1929, J PHYSIOL-LONDON, V68, P97, DOI 10.1113/jphysiol.1929.sp002598; FELDMAN RD, 1987, J IMMUNOL, V139, P3355; FELTEN DL, 1985, J IMMUNOL, V135, P755; FELTEN SY, 1987, J NEUROSCI RES, V18, P37, DOI 10.1002/jnr.490180108; Fujii T, 1998, J NEUROIMMUNOL, V82, P101, DOI 10.1016/S0165-5728(97)00195-1; Giebelen IAJ, 2007, SHOCK, V28, P700, DOI 10.1097/shk.0b013e318054dd89; Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED; Huston JM, 2007, CRIT CARE MED, V35, P2762, DOI 10.1097/01.CCM.0000288102.15975.BA; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Huston JM, 2009, J IMMUNOL, V183, P552, DOI 10.4049/jimmunol.0802684; KAWASHIMA K, 1989, NEUROSCI LETT, V104, P336, DOI 10.1016/0304-3940(89)90599-5; Kees MG, 2003, J NEUROIMMUNOL, V145, P77, DOI 10.1016/j.jneuroim.2003.09.011; Kohm AP, 2001, PHARMACOL REV, V53, P487; Kox M, 2009, BIOCHEM PHARMACOL, V78, P863, DOI 10.1016/j.bcp.2009.06.096; LEADERS FE, 1965, J PHARMACOL EXP THER, V147, P145; Parrish WR, 2008, MOL MED, V14, P567, DOI 10.2119/2008-00079.Parrish; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; Riether C, 2011, BRAIN BEHAV IMMUN, V25, P59, DOI 10.1016/j.bbi.2010.07.248; RINNER I, 1993, J NEUROSCI RES, V35, P188, DOI 10.1002/jnr.490350209; Rinner I, 1998, J NEUROIMMUNOL, V81, P31, DOI 10.1016/S0165-5728(97)00155-0; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2009, MOL MED, V15, P195, DOI 10.2119/molmed.2009.00039; STEPHENSNEWSHAM LG, 1979, GEN PHARMACOL-VASC S, V10, P385, DOI 10.1016/0306-3623(79)90076-4; Tallini YN, 2006, PHYSIOL GENOMICS, V27, P391, DOI 10.1152/physiolgenomics.00092.2006; Todman D, 2008, EUR NEUROL, V60, P162, DOI 10.1159/000145336; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Yeboah MM, 2008, KIDNEY INT, V74, P62, DOI 10.1038/ki.2008.94	35	836	871	10	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 7	2011	334	6052					98	101		10.1126/science.1209985	http://dx.doi.org/10.1126/science.1209985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21921156	Green Accepted			2022-12-28	WOS:000295580300048
J	Wong, CHY; Jenne, CN; Lee, WY; Leger, C; Kubes, P				Wong, Connie H. Y.; Jenne, Craig N.; Lee, Woo-Yong; Leger, Caroline; Kubes, Paul			Functional Innervation of Hepatic iNKT Cells Is Immunosuppressive Following Stroke	SCIENCE			English	Article							KILLER T-CELLS; ISCHEMIC-STROKE; NKT CELLS; ACTIVATION; IMMUNE; INFECTION; ANTIGENS; BRAIN	Systemic immunosuppression has been associated with stroke for many years, but the underlying mechanisms are poorly understood. In this study, we demonstrated that stroke induced profound behavioral changes in hepatic invariant NKT (iNKT) cells in mice. Unexpectedly, these effects were mediated by a noradrenergic neurotransmitter rather than a CD1d ligand or other well-characterized danger signals. Blockade of this innervation was protective in wild-type mice after stroke but had no effect in mice deficient in iNKT cells. Selective immunomodulation of iNKT cells with a specific activator (a-galactosylceramide) promoted proinflammatory cytokine production and prevented infections after stroke. Our results therefore identify a molecular mechanism that leads to immunosuppression after stroke and suggest an attractive potential therapeutic alternative to antibiotics, namely, immunomodulation of iNKT cells to prevent stroke-associated infections.	[Wong, Connie H. Y.; Jenne, Craig N.; Lee, Woo-Yong; Kubes, Paul] Univ Calgary, Calvin Phoebe & Joan Snyder Inst Infect Immun & I, Calgary, AB, Canada; [Jenne, Craig N.; Leger, Caroline; Kubes, Paul] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Kubes, Paul] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Kubes, P (corresponding author), Univ Calgary, Calvin Phoebe & Joan Snyder Inst Infect Immun & I, Calgary, AB, Canada.	pkubes@ucalgary.ca	Jenne, Craig/HCH-3413-2022	Wong, Connie/0000-0002-9020-1847	Canada Foundation for Innovation; Canadian Association of Gastroenterology; Canadian Institutes of Health Research; Canada Research Chairs Program; Alberta Innovates Health Solutions; Calvin, Phoebe, and Joan Snyder Chair for Translational Research in Critical Care Medicine	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Association of Gastroenterology; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Alberta Innovates Health Solutions; Calvin, Phoebe, and Joan Snyder Chair for Translational Research in Critical Care Medicine	We thank D. R. Littman (New York University School of Medicine) for the Cxcr6<SUP>gfp/+</SUP> knock-in mice, and the Live Cell Imaging Facility funded by the Canada Foundation for Innovation and P. Colarusso for training and assistance related to microscopy. We thank C. Badick for excellent technical support. The NIH Tetramer Core Facility provided mouse PBS57-loaded CD1d-tetramer for identification of iNKT cells by flow cytometry. We also thank the University of Calgary Flow Cytometry Facility and L. Kennedy for their assistance with the flow cytometric analysis. The work is supported by the Canadian Association of Gastroenterology (C.H.Y.W), the Canadian Institutes of Health Research (C.H.Y.W., W-Y.L., and P. K.), the Canada Research Chairs Program (P. K.), the Alberta Innovates Health Solutions (C.N.J and P. K.), and the Calvin, Phoebe, and Joan Snyder Chair for Translational Research in Critical Care Medicine (C. L.). The data reported in this paper are tabulated in the supporting online material. The authors declare no competing financial interests. C.H.Y.W designed and did most of the experiments, analyzed the results, and prepared the manuscript; C.N.J. did some flow cytometry experiments; W-Y.L. isolated iNKT cells for the in vitro experiments; C. L. performed the multiplex mouse cytokine/chemokine assay; and P. K. provided overall supervision, helped design all of the experiments, and prepared the manuscript.	Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Chamorro A, 2006, J NEUROL NEUROSUR PS, V77, P1279, DOI 10.1136/jnnp.2006.100800; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; HOWARD RJ, 1974, SURG GYNECOL OBSTET, V139, P771; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kimura K, 2005, CEREBROVASC DIS, V19, P171, DOI 10.1159/000083252; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Lichtman JH, 2011, NEUROLOGY, V76, P1976, DOI 10.1212/WNL.0b013e31821e54f3; Liesz A, 2011, BRAIN, V134, P704, DOI 10.1093/brain/awr008; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Meisel C, 2004, STROKE, V35, P2, DOI 10.1161/01.STR.0000109041.89959.4C; Minagawa M, 2000, HEPATOLOGY, V31, P907, DOI 10.1053/he.2000.5850; Offner H, 2009, NEUROSCIENCE, V158, P1098, DOI 10.1016/j.neuroscience.2008.05.033; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Offner H, 2006, J IMMUNOL, V176, P6523, DOI 10.4049/jimmunol.176.11.6523; Oya H, 2000, CLIN EXP IMMUNOL, V121, P384, DOI 10.1046/j.1365-2249.2000.01310.x; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Velazquez P, 2008, J IMMUNOL, V180, P2024, DOI 10.4049/jimmunol.180.4.2024	26	287	296	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2011	334	6052					101	105		10.1126/science.1210301	http://dx.doi.org/10.1126/science.1210301			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21921158				2022-12-28	WOS:000295580300049
J	Navarro, C; Abelenda, JA; Cruz-Oro, E; Cuellar, CA; Tamaki, S; Silva, J; Shimamoto, K; Prat, S				Navarro, Cristina; Abelenda, Jose A.; Cruz-Oro, Eduard; Cuellar, Carlos A.; Tamaki, Shojiro; Silva, Javier; Shimamoto, Ko; Prat, Salome			Control of flowering and storage organ formation in potato by FLOWERING LOCUS T	NATURE			English	Article							FLORAL INDUCTION; FT PROTEIN; PHOTOPERIODIC CONTROL; REGULATE GROWTH; TUBER FORMATION; TIME; GENE; SIGNALS; HD3A; TUBERIZATION	Seasonal fluctuations in day length regulate important aspects of plant development such as the flowering transition or, in potato (Solanum tuberosum), the formation of tubers. Day length is sensed by the leaves, which produce a mobile signal transported to the shoot apex or underground stems to induce a flowering transition or, respectively, a tuberization transition. Work in Arabidopsis, tomato and rice (Oryza sativa) identified the mobile FLOWERING LOCUS T (FT) protein as a main component of the long-range 'florigen', or flowering hormone, signal(1-3). Here we show that expression of the Hd3a gene, the FT orthologue in rice, induces strict short-day potato types(4) to tuberize in long days. Tuber induction is graft transmissible and the Hd3a-GFP protein is detected in the stolons of grafted plants, transport of the fusion protein thus correlating with tuber formation. We provide evidence showing that the potato floral and tuberization transitions are controlled by two different FT-like paralogues (StSP3D and StSP6A) that respond to independent environmental cues, and show that an autorelay mechanism involving CONSTANS modulates expression of the tuberization-control StSP6A gene.	[Navarro, Cristina; Abelenda, Jose A.; Cruz-Oro, Eduard; Cuellar, Carlos A.; Silva, Javier; Prat, Salome] CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Madrid 28049, Spain; [Tamaki, Shojiro; Shimamoto, Ko] Nara Inst Sci & Technol, Plant Mol Genet Lab, Ikoma 6300101, Japan	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Nara Institute of Science & Technology	Prat, S (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Calle Darwin 3, Madrid 28049, Spain.	sprat@cnb.csic.es	Abelenda, Jose A/L-8315-2017; Prat, Salome/L-9240-2014; Navarro, Cristina/L-5967-2014	Abelenda, Jose A/0000-0001-7952-4891; Prat, Salome/0000-0003-2684-5485; Navarro, Cristina/0000-0001-9876-2174	Spanish MCyT; EU-SOL European Union; JSPS; CSIC; MEXT of Japan	Spanish MCyT(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); EU-SOL European Union; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CSIC; MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank J. Paz-Ares, G. Bryan and C. Bachem for their comments on the manuscript. We also thank S. Yokoi for his help in this work. This research was supported by grants from the Spanish MCyT and the EU-SOL European Union Integrated Project. Support by the JSPS and CSIC under the Japan-Spain research cooperative programme and Grants-in-Aid for Scientific Research on Priority Areas of the MEXT of Japan are also acknowledged. C.N. was recipient of an I3P postdoctoral contract from the CSIC.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Carmel-Goren L, 2003, PLANT MOL BIOL, V52, P1215, DOI 10.1023/B:PLAN.0000004333.96451.11; CHAILAKHIAN MK, 1981, DOKL AKAD NAUK SSSR+, V257, P1276; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Ewing E. E., 1992, Horticultural Reviews, V14, P89; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Ishikawa R, 2005, PLANT CELL, V17, P3326, DOI 10.1105/tpc.105.037028; Jackson SD, 1999, PLANT PHYSIOL, V119, P1, DOI 10.1104/pp.119.1.1; Jackson SD, 1996, PLANT J, V9, P159, DOI 10.1046/j.1365-313X.1996.09020159.x; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Kloosterman B, 2008, FUNCT INTEGR GENOMIC, V8, P329, DOI 10.1007/s10142-008-0083-x; Kloosterman B, 2007, PLANT J, V52, P362, DOI 10.1111/j.1365-313X.2007.03245.x; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Lagercrantz U, 2009, J EXP BOT, V60, P2501, DOI 10.1093/jxb/erp139; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lifschitz E, 2006, J EXP BOT, V57, P3405, DOI 10.1093/jxb/erl106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Garcia JF, 2002, P NATL ACAD SCI USA, V99, P15211, DOI 10.1073/pnas.222390599; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Rodriguez-Falcon M, 2006, ANNU REV PLANT BIOL, V57, P151, DOI 10.1146/annurev.arplant.57.032905.105224; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Zeevaart JAD, 2008, CURR OPIN PLANT BIOL, V11, P541, DOI 10.1016/j.pbi.2008.06.009	39	393	439	14	342	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 6	2011	478	7367					119	U132		10.1038/nature10431	http://dx.doi.org/10.1038/nature10431			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21947007				2022-12-28	WOS:000295575400046
J	Nazarian, S; Hansford, R; Roguin, A; Goldsher, D; Zviman, MM; Lardo, AC; Caffo, BS; Frick, KD; Kraut, MA; Kamel, IR; Calkins, H; Berger, RD; Bluemke, DA; Halperin, HR				Nazarian, Saman; Hansford, Rozann; Roguin, Ariel; Goldsher, Dorith; Zviman, Menekhem M.; Lardo, Albert C.; Caffo, Brian S.; Frick, Kevin D.; Kraut, Michael A.; Kamel, Ihab R.; Calkins, Hugh; Berger, Ronald D.; Bluemke, David A.; Halperin, Henry R.			A Prospective Evaluation of a Protocol for Magnetic Resonance Imaging of Patients With Implanted Cardiac Devices	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIOVERTER-DEFIBRILLATORS; INDUSTRY VIEWPOINT; 1.5 TESLA; IN-VIVO; PERMANENT PACEMAKERS; SAFE PERFORMANCE; ABSORPTION RATE; MRI; ICDS; LEADS	Background: Magnetic resonance imaging (MRI) is avoided in most patients with implanted cardiac devices because of safety concerns. Objective: To define the safety of a protocol for MRI at the commonly used magnetic strength of 1.5 T in patients with implanted cardiac devices. Design: Prospective nonrandomized trial. (ClinicalTrials.gov registration number: NCT01130896) Setting: One center in the United States (94% of examinations) and one in Israel. Patients: 438 patients with devices (54% with pacemakers and 46% with defibrillators) who underwent 555 MRI studies. Intervention: Pacing mode was changed to asynchronous for pacemaker-dependent patients and to demand for others. Tachyarrhythmia functions were disabled. Blood pressure, electrocardiography, oximetry, and symptoms were monitored by a nurse with experience in cardiac life support and device programming who had immediate backup from an electrophysiologist. Measurements: Activation or inhibition of pacing, symptoms, and device variables. Results: In 3 patients (0.7% [95% CI, 0% to 1.5%]), the device reverted to a transient back-up programming mode without long-term effects. Right ventricular (RV) sensing (median change, 0 mV [interquartile range {IQR}, -0.7 to 0 V]) and atrial and right and left ventricular lead impedances (median change, -2 Omega [IQR, -13 to 0 Omega], -4 Omega [IQR, -16 to 0 Omega], and -11 Omega [IQR, -40 to 0 Omega], respectively) were reduced immediately after MRI. At long-term follow-up (61% of patients), decreased RV sensing (median, 0 mV, [IQR, -1.1 to 0.3 mV]), decreased RV lead impedance (median, -3 Omega, [IQR, -29 to 15 Omega]), increased RV capture threshold (median, 0 V, IQR, [0 to 0.2 Omega]), and decreased battery voltage (median, -0.01 V, IQR, -0.04 to 0 V) were noted. The observed changes did not require device revision or reprogramming. Limitations: Not all available cardiac devices have been tested. Long-term in-person or telephone follow-up was unavailable in 43 patients (10%), and some data were missing. Those with missing long-term capture threshold data had higher baseline right atrial and right ventricular capture thresholds and were more likely to have undergone thoracic imaging. Defibrillation threshold testing and random assignment to a control group were not performed. Conclusion: With appropriate precautions, MRI can be done safely in patients with selected cardiac devices. Because changes in device variables and programming may occur, electrophysiologic monitoring during MRI is essential.	Johns Hopkins Univ, Baltimore, MD USA; Technion Israel Inst Technol, Rambam Med Ctr, Haifa, Israel; Natl Inst Biomed Imaging & Bioengn, Bethesda, MD USA	Johns Hopkins University; Rambam Health Care Campus; Technion Israel Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Nazarian, S (corresponding author), Johns Hopkins Univ Hosp, 600 N Wolfe St, Baltimore, MD 21287 USA.	snazarian@jhmi.edu	Nazarian, Saman/ABC-8000-2020; Bluemke, David/GYU-8169-2022	Frick, Kevin/0000-0002-0178-5319; Bluemke, David/0000-0002-8323-8086; Nazarian, Saman/0000-0002-8369-0259	National Institutes of Health [R01-HL64795, R01-HL094610, K23-HL089333]; PJ Schafer Memorial Research Award; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL089333, R01HL094610, R01HL064795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000072] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090019] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PJ Schafer Memorial Research Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); CLINICAL CENTER	By National Institutes of Health grants R01-HL64795 and R01-HL094610 to Dr. Halperin and K23-HL089333 to Dr. Nazarian, and a PJ Schafer Memorial Research Award.	Baker KB, 2004, J MAGN RESON IMAGING, V20, P315, DOI 10.1002/jmri.20103; Burke PT, 2010, J INTERV CARD ELECTR, V28, P59, DOI 10.1007/s10840-009-9463-y; CALLANS DJ, 1993, J AM COLL CARDIOL, V22, P746, DOI 10.1016/0735-1097(93)90186-5; CHAN CC, 1994, PACE, V17, P1873, DOI 10.1111/j.1540-8159.1994.tb03766.x; Coman JA, 2004, J AM COLL CARDIOL, V43, p138A, DOI 10.1016/S0735-1097(04)90585-2; Danilovic D, 1998, PACE, V21, P1356, DOI 10.1111/j.1540-8159.1998.tb00205.x; Danilovic D, 1999, PACE, V22, P567, DOI 10.1111/j.1540-8159.1999.tb00498.x; Del Ojo JL, 2005, PACE, V28, P274, DOI 10.1111/j.1540-8159.2005.50033.x; Faris OP, 2005, PACE, V28, P268, DOI 10.1111/j.1540-8159.2005.50035.x; Faris OP, 2006, CIRCULATION, V114, P1232, DOI 10.1161/CIRCULATIONAHA.106.647800; FRAME R, 1992, PACE, V15, P870, DOI 10.1111/j.1540-8159.1992.tb03077.x; Gelblum DY, 2009, INT J RADIAT ONCOL, V73, P1525, DOI 10.1016/j.ijrobp.2008.06.1903; Gimbel JR, 2009, EUROPACE, V11, P1241, DOI 10.1093/europace/eup162; Gimbel JR, 2004, J AM COLL CARDIOL, V43, P1325, DOI 10.1016/j.jacc.2004.02.009; Gimbel JR, 2005, PACE, V28, P270, DOI 10.1111/j.1540-8159.2005.09520.x; Gimbel JR, 1996, PACE, V19, P913, DOI 10.1111/j.1540-8159.1996.tb03387.x; Glikson M, 2000, J CARDIOVASC ELECTR, V11, P127, DOI 10.1111/j.1540-8167.2000.tb00311.x; Halshtok O, 2010, ISR MED ASSOC J, V12, P391; Kalin R, 2005, PACE, V28, P326, DOI 10.1111/j.1540-8159.2005.50024.x; Levine GN, 2007, CIRCULATION, V116, P2878, DOI 10.1161/CIRCULATIONAHA.107.187256; Levine PA, 2005, PACE, V28, P266, DOI 10.1111/j.1540-8159.2005.50027.x; Luechinger R, 2005, EUR HEART J, V26, P376, DOI 10.1093/eurheartj/ehi009; Martin ET, 2004, J AM COLL CARDIOL, V43, P1315, DOI 10.1016/j.jacc.2003.12.016; Mollerus M, 2008, PACE, V31, P1241, DOI 10.1111/j.1540-8159.2008.01172.x; Mollerus M, 2010, EUROPACE, V12, P947, DOI 10.1093/europace/euq092; Naehle CP, 2009, PACE, V32, P1526, DOI 10.1111/j.1540-8159.2009.02570.x; Naehle CP, 2009, J AM COLL CARDIOL, V54, P549, DOI 10.1016/j.jacc.2009.04.050; Naehle CP, 2008, RADIOLOGY, V249, P991, DOI 10.1148/radiol.2493072195; Nazarian S, 2009, HEART RHYTHM, V6, P138, DOI 10.1016/j.hrthm.2008.10.021; Nazarian S, 2006, CIRCULATION, V114, P1277, DOI 10.1161/CIRCULATIONAHA.105.607655; Roguin A, 2004, CIRCULATION, V110, P475, DOI 10.1161/01.CIR.0000137121.28722.33; Sharif MN, 1998, AM J CARDIOL, V82, P600, DOI 10.1016/S0002-9149(98)00414-7; Smith JM, 2005, PACE, V28, P264, DOI 10.1111/j.1540-8159.2005.09591.x; Sommer T, 2000, RADIOLOGY, V215, P869, DOI 10.1148/radiology.215.3.r00jn08869; Sommer T, 2006, CIRCULATION, V114, P1285, DOI 10.1161/CIRCULATIONAHA.105.597013; Stanton MS, 2005, PACE, V28, P265, DOI 10.1111/j.1540-8159.2005.50025.x; Strach K, 2010, EUROPACE, V12, P952, DOI 10.1093/europace/euq081; Vahlhaus C, 2001, PACE, V24, P489, DOI 10.1046/j.1460-9592.2001.00489.x; Wilkoff BL, 2011, HEART RHYTHM, V8, P65, DOI 10.1016/j.hrthm.2010.10.002	39	202	206	0	27	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2011	155	7					415	U39		10.7326/0003-4819-155-7-201110040-00004	http://dx.doi.org/10.7326/0003-4819-155-7-201110040-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	833OC	21969340	Green Accepted			2022-12-28	WOS:000295893800002
J	Dorresteijn, JAN; Visseren, FLJ; Ridker, PM; Wassink, AMJ; Paynter, NP; Steyerberg, EW; van der Graaf, Y; Cook, NR				Dorresteijn, Johannes A. N.; Visseren, Frank L. J.; Ridker, Paul M.; Wassink, Annemarie M. J.; Paynter, Nina P.; Steyerberg, Ewout W.; van der Graaf, Yolanda; Cook, Nancy R.			Estimating treatment effects for individual patients based on the results of randomised clinical trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							C-REACTIVE PROTEIN; DENSITY-LIPOPROTEIN CHOLESTEROL; GLOBAL CARDIOVASCULAR RISK; PRIMARY PREVENTION; JUPITER TRIAL; MYOCARDIAL-INFARCTION; ROSUVASTATIN; THERAPY; PREDICTION; WOMEN	Objectives To predict treatment effects for individual patients based on data from randomised trials, taking rosuvastatin treatment in the primary prevention of cardiovascular disease as an example, and to evaluate the net benefit of making treatment decisions for individual patients based on a predicted absolute treatment effect. Setting As an example, data were used from the Justification for the Use of Statins in Prevention (JUPITER) trial, a randomised controlled trial evaluating the effect of rosuvastatin 20 mg daily versus placebo on the occurrence of cardiovascular events (myocardial infarction, stroke, arterial revascularisation, admission to hospital for unstable angina, or death from cardiovascular causes). Population 17 802 healthy men and women who had low density lipoprotein cholesterol levels of less than 3.4 mmol/L and high sensitivity C reactive protein levels of 2.0 mg/L or more. Methods Data from the Justification for the Use of Statins in Prevention trial were used to predict rosuvastatin treatment effect for individual patients based on existing risk scores (Framingham and Reynolds) and on a newly developed prediction model. We compared the net benefit of prediction based rosuvastatin treatment (selective treatment of patients whose predicted treatment effect exceeds a decision threshold) with the net benefit of treating either everyone or no one. Results The median predicted 10 year absolute risk reduction for cardiovascular events was 4.4% (interquartile range 2.6-7.0%) based on the Framingham risk score, 4.2% (2.5-7.1%) based on the Reynolds score, and 3.9% (2.5-6.1%) based on the newly developed model (optimal fit model). Prediction based treatment was associated with more net benefit than treating everyone or no one, provided that the decision threshold was between 2% and 7%, and thus that the number willing to treat (NWT) to prevent one cardiovascular event over 10 years was between 15 and 50. Conclusions Data from randomised trials can be used to predict treatment effect in terms of absolute risk reduction for individual patients, based on a newly developed model or, if available, existing risk scores. The value of such prediction of treatment effect for medical decision making is conditional on the NWT to prevent one outcome event.	[Dorresteijn, Johannes A. N.; Visseren, Frank L. J.; Wassink, Annemarie M. J.] Univ Med Ctr Utrecht, Dept Vasc Med, NL-3508 GA Utrecht, Netherlands; [Ridker, Paul M.; Paynter, Nina P.; Cook, Nancy R.] Harvard Univ, Brigham & Womens Hosp, Div Prevent Med, Sch Med, Boston, MA 02115 USA; [Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [van der Graaf, Yolanda] Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC	Visseren, FLJ (corresponding author), Univ Med Ctr Utrecht, Dept Vasc Med, POB 85500, NL-3508 GA Utrecht, Netherlands.	F.L.J.Visseren@umcutrecht.nl	Visseren, Frank LJ/I-4855-2013; Steyerberg, Ewout/C-1509-2018	Venkatasubramanian, Siddharth/0000-0002-5860-0768; Steyerberg, Ewout/0000-0002-7787-0122; Visseren, Frank/0000-0003-3951-5223	AstraZeneca (Wilmington, Delaware); Novartis; Roche; Siemens Medical Systems; ISIS; Vascular Biogenetics; Merck; Netherlands Organisation for Health Research and Development; Catharijne Foundation Utrecht; AstraZeneca	AstraZeneca (Wilmington, Delaware)(AstraZeneca); Novartis(Novartis); Roche(Roche Holding); Siemens Medical Systems(Siemens AG); ISIS; Vascular Biogenetics; Merck(Merck & Company); Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Catharijne Foundation Utrecht; AstraZeneca(AstraZeneca)	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: PMR is the principal investigator of the investigator initiated Justification for the Use of Statins in Prevention trial, which was funded by AstraZeneca (Wilmington, Delaware). PMR received grant support from Novartis and Roche; consulting fees from Siemens Medical Systems, ISIS, and Vascular Biogenetics; and is listed as a co-inventor on patents held by the Brigham and Women's Hospital that relate to the use of inflammatory biomarkers in cardiovascular disease that have been licensed to Siemens Medical Systems (Erlangen, Germany) and AstraZeneca. FLJV's department receives grant support from Merck, the Netherlands Organisation for Health Research and Development, and the Catharijne Foundation Utrecht; and speaker fees from Merck and AstraZeneca. JAND, AMJW, NPP, EWS, YvdG, and NRC have no relationships with industry that might have an interest in the submitted work in the previous three years. All authors have no non-financial interests that may be relevant to the submitted work.	Califf RM, 1997, AM HEART J, V133, P630, DOI 10.1016/S0002-8703(97)70164-9; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Gill S, 2004, J CLIN ONCOL, V22, P1797, DOI 10.1200/JCO.2004.09.059; GLASZIOU PP, 1995, BMJ-BRIT MED J, V311, P1356, DOI 10.1136/bmj.311.7016.1356; Hayward Rodney A, 2006, BMC Med Res Methodol, V6, P18, DOI 10.1186/1471-2288-6-18; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Kent DM, 2002, AM J MED, V113, P104, DOI 10.1016/S0002-9343(02)01160-9; Koenig W, 2011, EUR HEART J, V32, P75, DOI 10.1093/eurheartj/ehq370; Kravitz RL, 2004, MILBANK Q, V82, P661, DOI 10.1111/j.0887-378X.2004.00327.x; Loprinzi CL, 2001, J CLIN ONCOL, V19, P972, DOI 10.1200/JCO.2001.19.4.972; National Institute for Health and Clinical Excellence, 2006, TECHN APPR 94 STAT P; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2007, AM J CARDIOL, V100, P1659, DOI 10.1016/j.amjcard.2007.09.072; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2010, CIRC-CARDIOVASC QUAL, V3, P447, DOI 10.1161/CIRCOUTCOMES.110.938118; Ridker PM, 2009, CIRC-CARDIOVASC QUAL, V2, P616, DOI 10.1161/CIRCOUTCOMES.109.848473; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Ridker PM, 2003, CIRCULATION, V108, P2292, DOI 10.1161/01.CIR.0000100688.17280.E6; Rothwell PM, 1999, LANCET, V353, P2105, DOI 10.1016/S0140-6736(98)11415-0; ROTHWELL PM, 1995, LANCET, V345, P1616, DOI 10.1016/S0140-6736(95)90120-5; Selker HP, 2002, ANN INTERN MED, V137, P87, DOI 10.7326/0003-4819-137-2-200207160-00006; Steyerberg EW, 2005, GASTROINTEST ENDOSC, V62, P333, DOI 10.1016/S0016-5107(05)01587-7; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Vickers AJ, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-14; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361	26	95	93	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 3	2011	343								d5888	10.1136/bmj.d5888	http://dx.doi.org/10.1136/bmj.d5888			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832CQ	21968126	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000295779200002
J	Bogdanove, AJ; Voytas, DF				Bogdanove, Adam J.; Voytas, Daniel F.			TAL Effectors: Customizable Proteins for DNA Targeting	SCIENCE			English	Review							ZINC-FINGER NUCLEASES; DOUBLE-STRAND BREAKS; TRANSCRIPTION FACTORS; BINDING SPECIFICITY; BACTERIAL-BLIGHT; RESISTANCE GENE; III EFFECTORS; ONE-POT; CELLS; RECOGNITION	Generating and applying new knowledge from the wealth of available genomic information is hindered, in part, by the difficulty of altering nucleotide sequences and expression of genes in living cells in a targeted fashion. Progress has been made in engineering DNA binding domains to direct proteins to particular sequences for mutagenesis or manipulation of transcription; however, achieving the requisite specificities has been challenging. Transcription activator-like (TAL) effectors of plant pathogenic bacteria contain a modular DNA binding domain that appears to overcome this challenge. Comprising tandem, polymorphic amino acid repeats that individually specify contiguous nucleotides in DNA, this domain is being deployed in DNA targeting for applications ranging from understanding gene function in model organisms to improving traits in crop plants to treating genetic disorders in people.	[Bogdanove, Adam J.] Iowa State Univ, Dept Plant Pathol, Ames, IA 50011 USA; [Voytas, Daniel F.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Voytas, Daniel F.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Voytas, Daniel F.] Cellectis Plant Sci, St Paul, MN 55114 USA	Iowa State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bogdanove, AJ (corresponding author), Iowa State Univ, Dept Plant Pathol, 351 Bessey Hall, Ames, IA 50011 USA.	ajbog@iastate.edu	Bogdanove, Adam/ABE-6252-2020	Voytas, Daniel/0000-0002-4944-1224	NSF	NSF(National Science Foundation (NSF))	TAL effector and DNA targeting research in the Bogdanove and Voytas laboratories is funded by the NSF. D. F. V. serves as Chief Scientific Officer of Cellectis Plant Sciences (a consulting appointment), a subsidiary of Cellectis, a European biotechnology company that is a vendor of custom TAL effector nucleases, one of the subjects of this Review. A.J.B. and D. F. V. are listed inventors on a patent application titled "TAL effector-mediated DNA modification" (US-2011/0145940-A1 and PCT/US2010/059932). This intellectual property, co-owned by Iowa State Univ. and the Univ. of Minnesota, has been licensed to Cellectis.	Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Handel EM, 2009, MOL THER, V17, P104, DOI 10.1038/mt.2008.233; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Romer P, 2010, NEW PHYTOL, V187, P1048, DOI 10.1111/j.1469-8137.2010.03217.x; Romer P, 2009, P NATL ACAD SCI USA, V106, P20526, DOI 10.1073/pnas.0908812106; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Urnov FD, 2002, BIOCHEM PHARMACOL, V64, P919, DOI 10.1016/S0006-2952(02)01150-4; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Wulff BBH, 2011, CURR OPIN PLANT BIOL, V14, P468, DOI 10.1016/j.pbi.2011.04.002; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	36	677	824	2	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051					1843	1846		10.1126/science.1204094	http://dx.doi.org/10.1126/science.1204094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960622				2022-12-28	WOS:000295365800042
J	Ginsburg, D				Ginsburg, David			Genetics and Genomics to the Clinic: A Long Road ahead	CELL			English	Editorial Material								Advances in genomic technology have produced an explosion of new information about the genetic basis for human disease, fueling extraordinarily high expectations for improved treatments. This perspective will take brief stock of what genetics/genomics have brought to clinical practice to date and what we might expect for the future.	[Ginsburg, David] Univ Michigan, Dept Internal Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ginsburg, D (corresponding author), Univ Michigan, Dept Internal Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.	ginsburg@umich.edu			Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [P01HL057346, R01 HL039693, P01 HL057346, R01HL039693] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057346, R01HL039693] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; KORF BR, 2007, EMERY RIMOINS PRINCI, P49; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Middeldorp S, 2011, J THROMB THROMBOLYS, V31, P275, DOI 10.1007/s11239-011-0572-y; Ng PC, 2009, NATURE, V461, P724, DOI 10.1038/461724a; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; Rosove MH, 2009, ANN INTERN MED, V151, P270, DOI 10.7326/0003-4819-151-4-200908180-00009; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Zlotogora J, 2009, HUM GENET, V126, P247, DOI 10.1007/s00439-009-0669-y	10	10	10	1	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					17	19		10.1016/j.cell.2011.09.013	http://dx.doi.org/10.1016/j.cell.2011.09.013			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962500	Bronze			2022-12-28	WOS:000295396700008
J	Whorton, MR; MacKinnon, R				Whorton, Matthew R.; MacKinnon, Roderick			Crystal Structure of the Mammalian GIRK2 K+ Channel and Gating Regulation by G Proteins, PIP2, and Sodium	CELL			English	Article							BETA-GAMMA-SUBUNITS; MUSCARINIC POTASSIUM CHANNEL; DEPENDENT ACTIVATION; ANGSTROM RESOLUTION; ANDERSEN-SYNDROME; RECTIFICATION; MECHANISM; BINDING; KIR2.1; MUTATIONS	G protein-gated K+ channels (Kir3.1-Kir3.4) control electrical excitability in many different cells. Among their functions relevant to human physiology and disease, they regulate the heart rate and govern a wide range of neuronal activities. Here, we present the first crystal structures of a G protein-gated K+ channel. By comparing the wild-type structure to that of a constitutively active mutant, we identify a global conformational change through which G proteins could open a G loop gate in the cytoplasmic domain. The structures of both channels in the absence and presence of PIP2 suggest that G proteins open only the G loop gate in the absence of PIP2, but in the presence of PIP2 the G loop gate and a second inner helix gate become coupled, so that both gates open. We also identify a strategically located Na+ ion-binding site, which would allow intracellular Na+ to modulate GIRK channel activity. These data provide a structural basis for understanding multiligand regulation of GIRK channel gating.	[Whorton, Matthew R.; MacKinnon, Roderick] Rockefeller Univ, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA; [Whorton, Matthew R.; MacKinnon, Roderick] Howard Hughes Med Inst, Chevy Chase, MD USA	Rockefeller University; Howard Hughes Medical Institute	MacKinnon, R (corresponding author), Rockefeller Univ, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu			Howard Hughes Medical Institute Funding Source: Medline; NIBIB NIH HHS [P30 EB009998] Funding Source: Medline; NIGMS NIH HHS [R01 GM043949-21, R01 GM043949] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Decher N, 2007, CARDIOVASC RES, V75, P748, DOI 10.1016/j.cardiores.2007.05.010; Donaldson MR, 2003, NEUROLOGY, V60, P1811, DOI 10.1212/01.WNL.0000072261.14060.47; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finley M, 2004, J PHYSIOL-LONDON, V555, P643, DOI 10.1113/jphysiol.2003.056101; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Ho IHM, 1999, J PHYSIOL-LONDON, V520, P645, DOI 10.1111/j.1469-7793.1999.00645.x; Ho IHM, 1999, J BIOL CHEM, V274, P8639, DOI 10.1074/jbc.274.13.8639; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14286, DOI 10.1021/bi991205r; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; Lin YW, 2006, J BIOL CHEM, V281, P3006, DOI 10.1074/jbc.M511875200; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Spassova MA, 1998, J GEN PHYSIOL, V112, P211, DOI 10.1085/jgp.112.2.211; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Sui JL, 1996, J GEN PHYSIOL, V108, P381, DOI 10.1085/jgp.108.5.381; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yokogawa M, 2011, J BIOL CHEM, V286, P2215, DOI 10.1074/jbc.M110.160754; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	47	312	315	0	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2011	147	1					199	208		10.1016/j.cell.2011.07.046	http://dx.doi.org/10.1016/j.cell.2011.07.046			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962516	Green Accepted, Bronze			2022-12-28	WOS:000295396700026
J	du Toit, JT				du Toit, Johan T.			Coexisting with Cattle	SCIENCE			English	Editorial Material							UNGULATE DIVERSITY; BODY-SIZE; AFRICAN; HERBIVORES; SAVANNAS; PATTERNS		Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	du Toit, JT (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	johan.dutoit@usu.edu	du Toit, Johan T./D-3390-2009	du Toit, Johan T./0000-0003-0705-7117				Bell R.H.V., 1970, ANIMAL POPULATIONS R, P111; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; Cameron EZ, 2007, AM NAT, V169, P130, DOI 10.1086/509940; Cerling TE, 2003, J MAMMAL, V84, P456, DOI 10.1644/1545-1542(2003)084&lt;0456:DOEABB&gt;2.0.CO;2; Cromsigt JPGM, 2009, DIVERS DISTRIB, V15, P513, DOI 10.1111/j.1472-4642.2008.00554.x; DeGabriel JL, 2011, J APPL ECOL, V48, P1269, DOI 10.1111/j.1365-2664.2011.02032.x; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; Du Toit JT, 1999, BIODIVERS CONSERV, V8, P1643, DOI 10.1023/A:1008959721342; DUTOIT JT, 1989, AM NAT, V133, P736, DOI 10.1086/284949; ILLIUS AW, 1987, J ANIM ECOL, V56, P989, DOI 10.2307/4961; MCNAUGHTON SJ, 1986, ANNU REV ECOL SYST, V17, P39, DOI 10.1146/annurev.es.17.110186.000351; Odadi WO, 2011, SCIENCE, V333, P1753, DOI 10.1126/science.1208468; Ogutu JO, 2010, ECOL MONOGR, V80, P241, DOI 10.1890/09-0439.1; Redfern JV, 2006, OECOLOGIA, V146, P632, DOI 10.1007/s00442-005-0235-9; Wrobel ML, 2010, WILD RANGELANDS CONS, P1, DOI [10.1002/9781444317091.ch1, DOI 10.1002/9781444317091.CH1]	15	23	27	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1710	1711		10.1126/science.1212452	http://dx.doi.org/10.1126/science.1212452			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	823KQ	21940882				2022-12-28	WOS:000295121500028
J	Ott, S				Ott, Sascha			Ironing Out Hydrogen Storage	SCIENCE			English	Editorial Material							HOMOGENEOUS HYDROGENATION; FORMIC-ACID; ACTIVE-SITE; CONVERSION; CATALYST; CO2		Uppsala Univ, Dept Photochem & Mol Sci, S-75120 Uppsala, Sweden	Uppsala University	Ott, S (corresponding author), Uppsala Univ, Dept Photochem & Mol Sci, S-75120 Uppsala, Sweden.	sascha.ott@fotomol.uu.se						Angamuthu R, 2010, SCIENCE, V327, P313, DOI 10.1126/science.1177981; Benson EE, 2009, CHEM SOC REV, V38, P89, DOI 10.1039/b804323j; Boddien A, 2011, SCIENCE, V333, P1733, DOI 10.1126/science.1206613; Boddien A, 2010, J AM CHEM SOC, V132, P8924, DOI 10.1021/ja100925n; COFFEY RS, 1967, CHEM COMMUN, P923; Enthaler S, 2010, ENERG ENVIRON SCI, V3, P1207, DOI 10.1039/b907569k; Frey M, 2002, CHEMBIOCHEM, V3, P153, DOI 10.1002/1439-7633(20020301)3:2/3<153::AID-CBIC153>3.0.CO;2-B; Gust D, 2009, ACCOUNTS CHEM RES, V42, P1890, DOI 10.1021/ar900209b; Jessop PG, 2004, COORDIN CHEM REV, V248, P2425, DOI 10.1016/j.ccr.2004.05.019; Johnson TC, 2010, CHEM SOC REV, V39, P81, DOI 10.1039/b904495g; Kaur-Ghumaan S, 2010, ANGEW CHEM INT EDIT, V49, P8033, DOI 10.1002/anie.201002719; Le Goff A, 2009, SCIENCE, V326, P1384, DOI 10.1126/science.1179773; Magnuson A, 2009, ACCOUNTS CHEM RES, V42, P1899, DOI 10.1021/ar900127h; Shima S, 2008, SCIENCE, V321, P572, DOI 10.1126/science.1158978; Tard C, 2005, NATURE, V433, P610, DOI 10.1038/nature03298; Tard C, 2009, CHEM REV, V109, P2245, DOI 10.1021/cr800542q; Z?ttel A., 2008, HYDROGEN FUTURE ENER	17	39	39	2	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2011	333	6050					1714	1715		10.1126/science.1211021	http://dx.doi.org/10.1126/science.1211021			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940885				2022-12-28	WOS:000295121500031
J	Willig, MR				Willig, Michael R.			Biodiversity and Productivity	SCIENCE			English	Editorial Material							SPECIES RICHNESS; DIVERSITY		[Willig, Michael R.] Univ Connecticut, Ctr Environm Sci & Engn, Storrs, CT 06269 USA; [Willig, Michael R.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Willig, MR (corresponding author), Univ Connecticut, Ctr Environm Sci & Engn, Storrs, CT 06269 USA.	michael.willig@uconn.edu						Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Andelman SJ, 2004, BIOSCIENCE, V54, P240, DOI 10.1641/0006-3568(2004)054[0240:UECTAD]2.0.CO;2; Andelman SJ, 2004, SCIENCE, V305, P1565; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Chalcraft DR, 2009, BIODIVERS CONSERV, V18, P91, DOI 10.1007/s10531-008-9457-6; Climate Change and Biodiversity, 2002, CLIM CHANG BIOD; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Fox G. A., 2011, THEORY ECOLOGY, P283; Gillman LN, 2006, ECOLOGY, V87, P1234, DOI 10.1890/0012-9658(2006)87[1234:TIOPOT]2.0.CO;2; Grace JB, 2007, ECOL LETT, V10, P680, DOI 10.1111/j.1461-0248.2007.01058.x; Haines-Young R, 2009, LAND USE POLICY, V26, pS178, DOI 10.1016/j.landusepol.2009.08.009; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Rosenzweig M. L., 1993, SPECIES DIVERSITY EC, P13; Scheiner SM, 2005, AM NAT, V166, P458, DOI 10.1086/444402; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Whittaker RJ, 2003, ECOLOGY, V84, P3384, DOI 10.1890/02-3128; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1	19	42	48	15	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2011	333	6050					1709	1710		10.1126/science.1212453	http://dx.doi.org/10.1126/science.1212453			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940881				2022-12-28	WOS:000295121500027
J	Bhaskaran, K; Hajat, S; Armstrong, B; Haines, A; Herrett, E; Wilkinson, P; Smeeth, L				Bhaskaran, Krishnan; Hajat, Shakoor; Armstrong, Ben; Haines, Andy; Herrett, Emily; Wilkinson, Paul; Smeeth, Liam			The effects of hourly differences in air pollution on the risk of myocardial infarction: case crossover analysis of the MINAP database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FINE-PARTICULATE MATTER; HEART-RATE-VARIABILITY; TIME-SERIES; HOSPITAL ADMISSIONS; EXPOSURE; MORTALITY; INFLAMMATION; TEMPERATURE; PARTICLES; COEFFICIENTS	Objectives To investigate associations between air pollution levels and myocardial infarction (MI) on short timescales, with data at an hourly temporal resolution. Design Time stratified case crossover study linking clinical data from the Myocardial Ischaemia National Audit Project (MINAP) with PM10, ozone, CO, NO2, and SO2 data from the UK National Air Quality Archive. Pollution effects were investigated with delays (lags) of 1-6, 7-12, 13-18, 19-24, and 25-72 hours in both single and multi-pollutant models, adjusted for ambient temperature, relative humidity, circulating levels of influenza and respiratory syncytial virus, day of week, holidays, and residual seasonality within calendar month strata. Setting Population based study in 15 conurbations in England and Wales. Subjects 79 288 diagnoses of myocardial infarction recorded over the period 2003-6. Main outcome measures Excess risk of myocardial infarction per 10 mu g/m(3) increase in pollutant level. Results In single pollutant models, PM10 and NO2 levels were associated with a very short term increase in risk of myocardial infarction 1-6 hours later (excess risks 1.2% (95% confidence interval 0.3 to 2.1) and 1.1% (0.3 to 1.8) respectively per 10 mu g/m(3) increase); the effects persisted in multi-pollutant models, though with only weak evidence of an independent PM10 effect (P=0.05). The immediate risk increases were followed by reductions in risk at longer lags: we found no evidence of any net excess risk associated with the five pollutants studied over a 72 hour period after exposure. Conclusions Higher levels of PM10 and NO2, which are typically markers of traffic related pollution, seem to be associated with transiently increased risk of myocardial infarction 1-6 hours after exposure, but later reductions in risk suggest that air pollution may be associated with bringing events forward in time ("short-term displacement") rather than increasing overall risk. The well established effect of air pollution on cardiorespiratory mortality may not be mediated through increasing the acute risk of myocardial infarction, but through another mechanism.	London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Bhaskaran, K (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England.	krishnan.bhaskaran@lshtm.ac.uk	; Smeeth, Liam/X-5862-2018	Bhaskaran, Krishnan/0000-0001-5364-8757; Smeeth, Liam/0000-0002-9168-6022; armstrong, benedict/0000-0003-4407-0409; Haines, Andy/0000-0002-8053-4605; Wilkinson, Paul/0000-0001-7456-259X	British Heart Foundation [FS/04/045]; Garfield Weston Foundation; Wellcome Trust [082178, 076583/Z/05/Z]; Garfield Weston Trust; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Garfield Weston Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Garfield Weston Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the British Heart Foundation (grant number FS/04/045) and the Garfield Weston Foundation. LS is supported by a Wellcome Trust Senior Research Fellowship in Clinical Science (grant number 082178). SH is funded by a Wellcome Trust Research Career Development Fellowship (grant number 076583/Z/05/Z). The funding bodies had no role in the design or conduct of this study or in the preparation, review, approval, or decision to submit the manuscript. All authors carried out this research independently of the funding bodies.; All authors have completed the unified competing interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: KB, EH, and LS had support for the submitted work from the British Heart Foundation, the Garfield Weston Trust, and the Wellcome Trust respectively; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work	Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; Bhaskaran K, 2009, HEART, V95, P1746, DOI 10.1136/hrt.2009.175018; Bhaskaran K, 2011, HEART, V97, P519, DOI 10.1136/hrt.2010.212183; Bhaskaran K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3823; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; Burgan O, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-26; Committee on the Medical Effects of Air Pollutants, 2006, CARD DIS AIR POLL; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Doherty RM, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-S1-S8; Dominici F, 2010, EPIDEMIOLOGY, V21, P187, DOI 10.1097/EDE.0b013e3181cc86e8; Ghio AJ, 2000, AM J RESP CRIT CARE, V162, P981, DOI 10.1164/ajrccm.162.3.9911115; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Janssen NAH, 2000, J AIR WASTE MANAGE, V50, P1133, DOI 10.1080/10473289.2000.10464159; Joseph PM, 2007, ENVIRON INT, V33, P1090, DOI 10.1016/j.envint.2007.07.001; Katsouyanni K, 1997, BMJ-BRIT MED J, V314, P1658, DOI 10.1136/bmj.314.7095.1658; Koken PJM, 2003, ENVIRON HEALTH PERSP, V111, P1312, DOI 10.1289/ehp.5957; Lumley T, 2000, ENVIRONMETRICS, V11, P689, DOI 10.1002/1099-095X(200011/12)11:6<689::AID-ENV439>3.0.CO;2-N; Maheswaran R, 2005, EUR HEART J, V26, P2543, DOI 10.1093/eurheartj/ehi457; Mann JK, 2002, ENVIRON HEALTH PERSP, V110, P1247, DOI 10.1289/ehp.021101247; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mills NL, 2007, NEW ENGL J MED, V357, P1075, DOI 10.1056/NEJMoa066314; Murakami Y, 2006, J EPIDEMIOL COMMUN H, V60, P262, DOI 10.1136/jech.2005.038315; Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203; Peters A, 2001, CIRCULATION, V103, P2810; Peters A, 1997, LANCET, V349, P1582, DOI 10.1016/S0140-6736(97)01211-7; Peters A, 2005, RES REP HLTH EFF I, P141; Peters A, 2005, RES REP HLTH EFF I, P67; Peters Annette, 2005, Res Rep Health Eff Inst, P1; Pope CA, 1999, AM HEART J, V138, P890, DOI 10.1016/S0002-8703(99)70014-1; Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588; POPE CA, 1992, ARCH ENVIRON HEALTH, V47, P211, DOI 10.1080/00039896.1992.9938351; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Ruckerl R, 2007, ENVIRON HEALTH PERSP, V115, P1072, DOI 10.1289/ehp.10021; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Schwartz J, 2001, EPIDEMIOLOGY, V12, P55, DOI 10.1097/00001648-200101000-00010; Smith KR, 2009, LANCET, V374, P2091, DOI 10.1016/S0140-6736(09)61716-5; Sullivan J, 2005, EPIDEMIOLOGY, V16, P41, DOI 10.1097/01.ede.0000147116.34813.56; WOOLHISER DA, 1979, J APPL METEOROL, V18, P34, DOI 10.1175/1520-0450(1979)018<0034:MLEOFC>2.0.CO;2; Zanobetti A, 2004, CIRCULATION, V110, P2184, DOI 10.1161/01.CIR.0000143831.33243.D8; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382; Zeger SL, 1999, EPIDEMIOLOGY, V10, P171, DOI 10.1097/00001648-199903000-00015	41	107	107	3	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2011	343								d5531	10.1136/bmj.d5531	http://dx.doi.org/10.1136/bmj.d5531			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	826AF	21933824	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000295323000001
J	Chou, R; Arora, B; Dana, T; Fu, RW; Walker, M; Humphrey, L				Chou, Roger; Arora, Bhaskar; Dana, Tracy; Fu, Rongwei; Walker, Miranda; Humphrey, Linda			Screening Asymptomatic Adults With Resting or Exercise Electrocardiography: A Review of the Evidence for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							CORONARY-HEART-DISEASE; MIDDLE-AGED MEN; LEFT-VENTRICULAR HYPERTROPHY; FACTOR INTERVENTION TRIAL; ST-SEGMENT DEPRESSION; ALL-CAUSE MORTALITY; APPARENTLY HEALTHY-MEN; CARDIOVASCULAR RISK-FACTORS; SILENT-MYOCARDIAL-ISCHEMIA; T-WAVE ABNORMALITIES	Background: Coronary heart disease is the leading cause of death in adults. Screening for abnormalities by using resting or exercise electrocardiography (ECG) might help identify persons who would benefit from interventions to reduce cardiovascular risk. Purpose: To update the 2004 U. S. Preventive Services Task Force evidence review on screening for resting or exercise ECG abnormalities in asymptomatic adults. Data Sources: MEDLINE (2002 through January 2011), the Cochrane Library database (through the fourth quarter of 2010), and reference lists. Study Selection: Randomized, controlled trials and prospective cohort studies. Data Extraction: Investigators abstracted details about the study population, study design, data analysis, follow-up, and results and assessed quality by using predefined criteria. Data Synthesis: No study evaluated clinical outcomes or use of risk-reducing therapies after screening versus no screening. No study estimated how accurately resting or exercise electrocardiography classified participants into high-, intermediate-, or low-risk groups, compared with traditional risk factor assessment alone. Sixty-three prospective cohort studies evaluated abnormalities on resting or exercise ECG as predictors of cardiovascular events after adjustment for traditional risk factors. Abnormalities on resting ECG (ST-segment or T-wave abnormalities, left ventricular hypertrophy, bundle branch block, or left-axis deviation) or exercise ECG (ST-segment depression with exercise, chronotropic incompetence, abnormal heart rate recovery, or decreased exercise capacity) were associated with increased risk (pooled hazard ratio estimates, 1.4 to 2.1). Evidence on harms was limited, but direct harms seemed minimal (for resting ECG) or small (for exercise ECG). No study estimated harms from subsequent testing or interventions, although rates of angiography after exercise ECG ranged from 0.6% to 2.9%. Limitations: Only English-language studies were included. Statistical heterogeneity was present in several of the pooled analyses. Conclusion: Abnormalities on resting or exercise ECG are associated with an increased risk for subsequent cardiovascular events after adjustment for traditional risk factors, but the clinical implications of these findings are unclear.	[Chou, Roger] Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, Mailcode BICC, Portland, OR 97239 USA; Portland VA Med Ctr, Portland, OR USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, Mailcode BICC, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610	Agency for Healthcare Research and Quality [HHSA-290-2007-10057-I-EPC3]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By contract number HHSA-290-2007-10057-I-EPC3, Task Order No. 3, from the Agency for Healthcare Research and Quality.	Adabag AS, 2008, AM J CARDIOL, V101, P1437, DOI 10.1016/j.amjcard.2008.01.021; Aktas MK, 2004, JAMA-J AM MED ASSOC, V292, P1462, DOI 10.1001/jama.292.12.1462; Balady GJ, 2004, CIRCULATION, V110, P1920, DOI 10.1161/01.CIR.0000143226.40607.71; Berg AO, 2004, ANN INTERN MED, V140, P569, DOI 10.7326/0003-4819-140-7-200404060-00001; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; Blumenthal RS, 2003, CIRCULATION, V107, P702, DOI 10.1161/01.CIR.0000048127.93169.88; Bodegard J, 2004, EUR J CARDIOV PREV R, V11, P320, DOI 10.1097/01.hjr.0000136460.57921.46; BOYLE RM, 1987, J ELECTROCARDIOL, V20, P128; Brown DW, 2000, AM HEART J, V140, P848, DOI 10.1067/mhj.2000.111112; Centers for Disease Control and Prevention, 2010, HEART DIS ATL CDCP; Chou R, 2011, AHRQ PUBLICATION; Cole CR, 2000, ANN INTERN MED, V132, P552, DOI 10.7326/0003-4819-132-7-200004040-00007; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Cournot M, 2006, EUR J CARDIOV PREV R, V13, P37, DOI 10.1097/00149831-200602000-00006; Crow RS, 2003, CIRCULATION, V108, P1985, DOI 10.1161/01.CIR.0000095027.28753.9D; Cuddy TE, 2006, CAN J CARDIOL, V22, P205; Davies B, 1996, CLIN CARDIOL, V19, P303, DOI 10.1002/clc.4960190405; Daviglus ML, 1999, JAMA-J AM MED ASSOC, V281, P530, DOI 10.1001/jama.281.6.530; De Bacquer D, 1998, HEART, V80, P570, DOI 10.1136/hrt.80.6.570; Denes P, 2007, JAMA-J AM MED ASSOC, V297, P978, DOI 10.1001/jama.297.9.978; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dhingra R, 2006, HYPERTENSION, V47, P861, DOI 10.1161/01.HYP.0000217141.20163.23; Diercks GFH, 2002, J AM COLL CARDIOL, V40, P1401, DOI 10.1016/S0735-1097(02)02165-4; DUNN RL, 1991, AM J PREV MED, V7, P255, DOI 10.1016/S0749-3797(18)30896-1; EKELUND LG, 1989, J AM COLL CARDIOL, V14, P556, DOI 10.1016/0735-1097(89)90092-2; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Ferdinand KC, 2006, AM J CARDIOL, V97, p12A, DOI 10.1016/j.amjcard.2005.11.011; FLEG JL, 1990, CIRCULATION, V81, P428, DOI 10.1161/01.CIR.81.2.428; Fowler-Brown Angela, 2004, Ann Intern Med, V140, pW9; GIAGNONI E, 1983, NEW ENGL J MED, V309, P1085, DOI 10.1056/NEJM198311033091803; GORDON DJ, 1986, CIRCULATION, V74, P252, DOI 10.1161/01.CIR.74.2.252; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Greenland P, 2003, AM J CARDIOL, V91, P1068, DOI 10.1016/S0002-9149(03)00150-4; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Gulati M, 2005, AM J CARDIOL, V96, P369, DOI 10.1016/j.amjcard.2005.03.078; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOLLENBERG M, 1985, NEW ENGL J MED, V313, P600, DOI 10.1056/NEJM198509053131003; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Jones RC, 2004, AM J MED, V117, P380, DOI 10.1016/j.amjmed.2004.06.004; JOSEPHSON RA, 1990, CIRCULATION, V81, P20, DOI 10.1161/01.CIR.81.1.20; Jouven X, 2000, NEW ENGL J MED, V343, P826, DOI 10.1056/NEJM200009213431201; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Kahn S, 1996, J AM GERIATR SOC, V44, P524, DOI 10.1111/j.1532-5415.1996.tb01437.x; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Kurl S, 2009, J INTERN MED, V265, P229, DOI 10.1111/j.1365-2796.2008.02006.x; Kurl S, 2003, STROKE, V34, P1760, DOI 10.1161/01.STR.0000078564.46376.0A; Larsen CT, 2002, EUR HEART J, V23, P315, DOI 10.1053/euhj.2001.2774; Lauer MS, 1996, CIRCULATION, V93, P1520, DOI 10.1161/01.CIR.93.8.1520; Laukkanen JA, 2001, J AM COLL CARDIOL, V38, P72, DOI 10.1016/S0735-1097(01)01311-0; Laukkanen JA, 2008, EUR J CARDIOV PREV R, V15, P285, DOI 10.1097/HJR.0b013e3282f37a33; Laukkanen JA, 2006, EUR J CARDIOV PREV R, V13, P421, DOI 10.1097/00149831-200606000-00019; LIAO YL, 1988, J AM COLL CARDIOL, V12, P1494, DOI 10.1016/S0735-1097(88)80016-0; Livschitz S, 2000, AM J CARDIOL, V86, P462, DOI 10.1016/S0002-9149(00)00968-1; Lyerly GW, 2008, CIRCULATION, V117, P2734, DOI 10.1161/CIRCULATIONAHA.107.729277; Lyerly GW, 2009, MAYO CLIN PROC, V84, P780, DOI 10.1016/S0025-6196(11)60487-4; Macfarlane PW, 2007, J ELECTROCARDIOL, V40, P101, DOI 10.1016/j.jelectrocard.2006.05.003; Machado DB, 2006, AM J CARDIOL, V97, P1176, DOI 10.1016/j.amjcard.2005.11.036; MASSIE BM, 1993, J AM COLL CARDIOL, V22, P1598, DOI 10.1016/0735-1097(93)90583-M; Massing MW, 2006, AM J CARDIOL, V98, P1609, DOI 10.1016/j.amjcard.2006.06.061; Menotti A, 2001, ACTA CARDIOL, V56, P27, DOI 10.2143/AC.56.1.2005590; Menotti A, 1997, G Ital Cardiol, V27, P40; Moller CS, 2007, J EPIDEMIOL COMMUN H, V61, P704, DOI 10.1136/jech.2006.048074; Moller Christina Strom, 2006, BMC Cardiovasc Disord, V6, P10, DOI 10.1186/1471-2261-6-10; Mora S, 2005, CIRCULATION, V112, P1566, DOI 10.1161/CIRCULATIONAHA.105.542993; Mora S, 2003, JAMA-J AM MED ASSOC, V290, P1600, DOI 10.1001/jama.290.12.1600; Morshedi-Meibodi A, 2002, AM J CARDIOL, V90, P848, DOI 10.1016/S0002-9149(02)02706-6; Myers J, 2009, CIRCULATION, V119, P3144, DOI 10.1161/CIRCULATIONAHA.109.192520; NOTO TJ, 1991, CATHETER CARDIO DIAG, V24, P75, DOI 10.1002/ccd.1810240202; O'Malley PG, 2010, ARCH INTERN MED, V170, P1602, DOI 10.1001/archinternmed.2010.327; Ohman EM, 2000, JAMA-J AM MED ASSOC, V284, P876, DOI 10.1001/jama.284.7.876; Okin PM, 1996, J AM COLL CARDIOL, V27, P1437, DOI 10.1016/0735-1097(96)00030-7; OKIN PM, 1991, CIRCULATION, V83, P866, DOI 10.1161/01.CIR.83.3.866; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; PETERS RK, 1983, JAMA-J AM MED ASSOC, V249, P3052, DOI 10.1001/jama.249.22.3052; PIEPGRASS SR, 1982, AVIAT SPACE ENVIR MD, V53, P379; Pignone M, 2003, SCREENING ASYMPTOMAT; Pignone MP, 2001, AM J PREV MED, V20, P77, DOI 10.1016/S0749-3797(01)00255-0; Pilote L, 1998, AM J CARDIOL, V81, P219, DOI 10.1016/S0002-9149(97)00871-0; Prineas RJ, 2002, AM J CARDIOL, V90, P1391, DOI 10.1016/S0002-9149(02)02881-3; Prineas RJ, 2001, J ELECTROCARDIOL, V34, P91, DOI 10.1054/jelc.2001.23360; RAUTAHARJU PM, 1986, J AM COLL CARDIOL, V8, P1, DOI 10.1016/S0735-1097(86)80084-5; Rautaharju PM, 2006, AM J CARDIOL, V97, P309, DOI 10.1016/j.amjcard.2005.08.046; Rautaharju PM, 2006, CIRCULATION, V113, P481, DOI 10.1161/CIRCULATIONAHA.105.537415; Rautaharju PM, 2006, CIRCULATION, V113, P473, DOI 10.1161/CIRCULATIONAHA.104.496091; Rutter MK, 2002, J AM COLL CARDIOL, V40, P56, DOI 10.1016/S0735-1097(02)01910-1; Rywik TM, 1998, CIRCULATION, V97, P2117, DOI 10.1161/01.CIR.97.21.2117; Rywik TM, 2002, CIRCULATION, V106, P2787, DOI 10.1161/01.CIR.0000039329.47437.3B; Savonen KP, 2007, AM J CARDIOL, V100, P563, DOI 10.1016/j.amjcard.2007.03.061; Scott IA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.a2844; Sigurdsson E, 1996, J AM COLL CARDIOL, V27, P1140, DOI 10.1016/0735-1097(95)00614-1; SISCOVICK DS, 1991, ARCH INTERN MED, V151, P325, DOI 10.1001/archinte.151.2.325; SLATTERY ML, 1988, AM J EPIDEMIOL, V127, P571, DOI 10.1093/oxfordjournals.aje.a114832; Stern RH, 2008, J CLIN HYPERTENS, V10, P485, DOI 10.1111/j.1751-7176.2008.07814.x; Sui XM, 2007, AM J EPIDEMIOL, V165, P1413, DOI 10.1093/aje/kwm031; SUTHERLAND SE, 1993, CIRCULATION, V88, P2685, DOI 10.1161/01.CIR.88.6.2685; Wolff T, 2009, ANN INTERN MED, V150, P405, DOI 10.7326/0003-4819-150-6-200903170-00009	100	96	97	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6					375	U74		10.7326/0003-4819-155-6-201109200-00006	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-00006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930855				2022-12-28	WOS:000295033400017
J	Gatrad, AR; Sheikh, A				Gatrad, A. R.; Sheikh, A.			10 MINUTE CONSULTATION The Hajj	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gatrad, A. R.] Manor Hosp, Walsall, W Midlands, England; [Gatrad, A. R.] Univ Kentucky, Lexington, KY 40506 USA; [Sheikh, A.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9DX, Midlothian, Scotland	University of Kentucky; University of Edinburgh	Gatrad, AR (corresponding author), Manor Hosp, Walsall, W Midlands, England.	abdul.gatrad@walsallhospitals.nhs.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056				Ahmed QA, 2006, LANCET, V367, P1008, DOI 10.1016/S0140-6736(06)68429-8; Gatrad AR, 2006, BMJ-BRIT MED J, V333, P1182, DOI 10.1136/bmj.39052.628958.BE; Gatrad AR, 2001, ARCH DIS CHILD, V84, P375; Gatrad AR, 2005, BRIT MED J, V330, P133, DOI 10.1136/bmj.330.7483.133; *NHS SCOTL, TIM ZON INS; PICKUP J, 1997, TXB DIABETES, V2, P14; SALISBURY D, 2011, MENINGOCOCCAL MENING, V22, P235; *SAUD MIN HLTH, HLTH STAT SAUD MIN H; Shafi S, 2006, J R SOC PROMO HEALTH, V126, P68, DOI 10.1177/146642400612600207	9	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2011	343								d5593	10.1136/bmj.d5593	http://dx.doi.org/10.1136/bmj.d5593			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822VP	21920879	Green Submitted			2022-12-28	WOS:000295078400003
J	Howarth, RW; Ingraffea, A; Engelder, T				Howarth, Robert W.; Ingraffea, Anthony; Engelder, Terry			Natural gas: Should fracking stop?	NATURE			English	Editorial Material									[Howarth, Robert W.] Cornell Univ, Dept Ecology & Evolutionary Biol, Ithaca, NY 14853 USA; [Ingraffea, Anthony] Cornell Univ, Sch Civil & Environm Engn, Ithaca, NY 14853 USA; [Engelder, Terry] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Cornell University; Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Howarth, RW (corresponding author), Cornell Univ, Dept Ecology & Evolutionary Biol, Ithaca, NY 14853 USA.		ingraffea, anthony/AAU-6221-2021	Howarth, Robert/0000-0001-9531-4288					0	399	416	4	951	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 15	2011	477	7364					271	275		10.1038/477271a	http://dx.doi.org/10.1038/477271a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21921896	Bronze			2022-12-28	WOS:000294852400038
J	Schreiner, PR; Chernish, LV; Gunchenko, PA; Tikhonchuk, EY; Hausmann, H; Serafin, M; Schlecht, S; Dahl, JEP; Carlson, RMK; Fokin, AA				Schreiner, Peter R.; Chernish, Lesya V.; Gunchenko, Pavel A.; Tikhonchuk, Evgeniya Yu.; Hausmann, Heike; Serafin, Michael; Schlecht, Sabine; Dahl, Jeremy E. P.; Carlson, Robert M. K.; Fokin, Andrey A.			Overcoming lability of extremely long alkane carbon-carbon bonds through dispersion forces	NATURE			English	Article							DENSITY-FUNCTIONAL THERMOCHEMISTRY; VAN-DER-WAALS; THERMOLABILE HYDROCARBONS; HEXAPHENYLETHANE; ENERGY; CHEMISTRY; LENGTHS; STRAIN	Steric effects in chemistry are a consequence of the space required to accommodate the atoms and groups within a molecule, and are often thought to be dominated by repulsive forces arising from overlapping electron densities (Pauli repulsion). An appreciation of attractive interactions such as van der Waals forces (which include London dispersion forces) is necessary to understand chemical bonding and reactivity fully. This is evident from, for example, the strongly debated origin of the higher stability of branched alkanes relative to linear alkanes(1,2) and the possibility of constructing hydrocarbons with extraordinarily long C-C single bonds through steric crowding(3). Although empirical bond distance/bond strength relationships have been established for C-C bonds(4) (longer C-C bonds have smaller bond dissociation energies), these have no present theoretical basis(5). Nevertheless, these empirical considerations are fundamental to structural and energetic evaluations in chemistry(6,7), as summarized by Pauling(8) as early as 1960 and confirmed more recently(4). Here we report the preparation of hydrocarbons with extremely long C-C bonds (up to 1.704 angstrom), the longest such bonds observed so far in alkanes. The prepared compounds are unexpectedly stable-noticeable decomposition occurs only above 200 degrees C. We prepared the alkanes by coupling nanometre-sized, diamond-like, highly rigid structures known as diamondoids(9). The extraordinary stability of the coupling products is due to overall attractive dispersion interactions between the intramolecular H center dot center dot center dot H contact surfaces, as is evident from density functional theory computations with(10) and without inclusion of dispersion corrections.	[Schreiner, Peter R.; Hausmann, Heike; Fokin, Andrey A.] Univ Giessen, Inst Organ Chem, D-35392 Giessen, Germany; [Chernish, Lesya V.; Gunchenko, Pavel A.; Tikhonchuk, Evgeniya Yu.; Fokin, Andrey A.] Kiev Polytech Inst, Dept Organ Chem, UA-03056 Kiev, Ukraine; [Serafin, Michael; Schlecht, Sabine] Univ Giessen, Inst Anorgan Chem, D-35392 Giessen, Germany; [Dahl, Jeremy E. P.; Carlson, Robert M. K.] Stanford Univ, Stanford Inst Mat & Energy Sci, Stanford, CA 94305 USA	Justus Liebig University Giessen; Ministry of Education & Science of Ukraine; Igor Sikorsky Kyiv Polytechnic Institute; Justus Liebig University Giessen; Stanford University	Schreiner, PR (corresponding author), Univ Giessen, Inst Organ Chem, Heinrich Buff Ring 58, D-35392 Giessen, Germany.	prs@org.chemie.uni-giessen.de; aaf@xtf.ntu-kpi.kiev.ua	Gunchenko, Pavel/B-2475-2017; Schreiner, Peter Richard R/A-4084-2008; Fokin, Andrey A/I-3146-2018; Chernysh, Lesia/M-4363-2018	Gunchenko, Pavel/0000-0002-7366-1809; Schreiner, Peter Richard R/0000-0002-3608-5515; Fokin, Andrey A/0000-0002-6381-8948; Chernysh, Lesia/0000-0001-8005-7661	Deutsche Forschungsgemeinschaft; National Science Foundation of the USA; Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering [DE-AC02-76SF00515]; Ministry of Science and Education of Ukraine; Ukrainian State Basic Research Fund	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation of the USA(National Science Foundation (NSF)); Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering(United States Department of Energy (DOE)); Ministry of Science and Education of Ukraine; Ukrainian State Basic Research Fund(State Fund for Fundamental Research (SFFR))	We thank S. Grimme for providing an implementation of his dispersion correction technique and for discussions. We are grateful for support from the Deutsche Forschungsgemeinschaft and the National Science Foundation of the USA, and in part from the Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering, under contract DE-AC02-76SF00515; the Ministry of Science and Education of Ukraine; and the Ukrainian State Basic Research Fund.	Becke AD, 1997, J CHEM PHYS, V107, P8554, DOI 10.1063/1.475007; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BINKLEY JS, 1980, J AM CHEM SOC, V102, P939, DOI 10.1021/ja00523a008; Boese R, 1999, ANGEW CHEM INT EDIT, V38, P988, DOI 10.1002/(SICI)1521-3773(19990401)38:7<988::AID-ANIE988>3.0.CO;2-0; de Silva KMN, 2005, J CHEM INF MODEL, V45, P81, DOI 10.1021/ci0497657; DONOHUE J, 1967, ACTA CRYSTALLOGR, V22, P352; Dyker CA, 2008, SCIENCE, V321, P1050, DOI 10.1126/science.1162926; FLAMMTERMEER MA, 1985, CHEM BER-RECL, V118, P4665; Frisch M. J, 2009, GAUSSIAN09 V B 01; Frisch M. J, 2003, GAUSSIAN 03 V D 02; FRITZ G, 1981, Z ANORG ALLG CHEM, V475, P87, DOI 10.1002/zaac.19814750412; GORDY W, 1946, J CHEM PHYS, V14, P305, DOI 10.1063/1.1724138; Grimme S, 2004, J COMPUT CHEM, V25, P1463, DOI 10.1002/jcc.20078; Grimme S, 2006, ANGEW CHEM INT EDIT, V45, P4460, DOI 10.1002/anie.200600448; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; Grimme S, 2009, ANGEW CHEM INT EDIT, V48, P2592, DOI 10.1002/anie.200805751; Gronert S, 2009, CHEM-EUR J, V15, P5372, DOI 10.1002/chem.200800282; HUGGINS ML, 1953, J AM CHEM SOC, V75, P4126, DOI 10.1021/ja01113a002; KAHR B, 1986, J AM CHEM SOC, V108, P8305, DOI 10.1021/ja00286a053; Kammermeier S, 1997, ANGEW CHEM INT EDIT, V36, P1757, DOI 10.1002/anie.199717571; Kaupp M, 2000, ANGEW CHEM INT EDIT, V39, P4607, DOI 10.1002/1521-3773(20001215)39:24<4607::AID-ANIE4607>3.0.CO;2-L; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; MAIER G, 1978, ANGEW CHEM INT EDIT, V17, P520, DOI 10.1002/anie.197805201; MCBRIDE JM, 1974, TETRAHEDRON, V30, P2009, DOI 10.1016/S0040-4020(01)97332-6; Pauling L., 1960, NATURE CHEM BOND; RUCHARDT C, 1980, ANGEW CHEM INT EDIT, V19, P429, DOI 10.1002/anie.198004291; RUCHARDT C, 1985, ANGEW CHEM INT EDIT, V24, P529, DOI 10.1002/anie.198505293; Schwabe T, 2006, PHYS CHEM CHEM PHYS, V8, P4398, DOI 10.1039/b608478h; Schwertfeger H, 2008, ANGEW CHEM INT EDIT, V47, P1022, DOI 10.1002/anie.200701684; Suzuki T, 2008, PURE APPL CHEM, V80, P547, DOI 10.1351/pac200880030547; Takatani T, 2007, PHYS CHEM CHEM PHYS, V9, P6106, DOI 10.1039/b709669k; Tang KT, 2010, ANGEW CHEM INT EDIT, V49, P9574, DOI 10.1002/anie.201002332; Vreven T, 2002, J PHYS CHEM A, V106, P6167, DOI 10.1021/jp014588n; Wang YZ, 2009, CHEM COMMUN, P5201, DOI 10.1039/b908048a; WINIKER R, 1980, CHEM BER-RECL, V113, P3456, DOI 10.1002/cber.19801131105; Wodrich MD, 2007, CHEM-EUR J, V13, P7731, DOI 10.1002/chem.200700602; Zavitsas AA, 2003, J PHYS CHEM A, V107, P897, DOI 10.1021/jp0269367; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	38	295	293	2	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2011	477	7364					308	U73		10.1038/nature10367	http://dx.doi.org/10.1038/nature10367			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21921913				2022-12-28	WOS:000294852400026
J	Glynn, KP				Glynn, Kevin P.			Piano Lessons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Scripps Mercy Hosp, San Diego, CA USA		Glynn, KP (corresponding author), Scripps Mercy Hosp, San Diego, CA USA.	kevpglynn@san.rr.com							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2011	306	10					1063	1064		10.1001/jama.2011.1225	http://dx.doi.org/10.1001/jama.2011.1225			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819DS	21917567				2022-12-28	WOS:000294806200001
J	Gerson, AR; Guglielmo, CG				Gerson, Alexander R.; Guglielmo, Christopher G.			Flight at Low Ambient Humidity Increases Protein Catabolism in Migratory Birds	SCIENCE			English	Article							METABOLIC CONSTRAINTS; WATER; FLEXIBILITY; BALANCE; COSTS; SIZE	Although fat is the primary fuel for migratory flight in birds, protein is also used. Catabolism of tissue protein yields five times as much water per kilojoule as fat, and so one proposed function of protein catabolism is to maintain water balance during nonstop flights. To test the protein-for-water hypothesis, we flew Swainson's thrushes (Catharus ustulatus) in a climatic wind tunnel under high- and low-humidity conditions at 18 degrees C for up to 5 hours. Flight under dry conditions increased the rates of lean mass loss and endogenous water production and also increased plasma uric acid concentration. These data demonstrate that atmospheric humidity influences fuel composition in flight and suggest that protein deposition and catabolism during migration are, in part, a metabolic strategy to maintain osmotic homeostasis during flight.	[Gerson, Alexander R.; Guglielmo, Christopher G.] Univ Western Ontario, Dept Biol, Adv Facil Avian Res, London, ON N6A 5B7, Canada	Western University (University of Western Ontario)	Gerson, AR (corresponding author), Univ Western Ontario, Dept Biol, Adv Facil Avian Res, London, ON N6A 5B7, Canada.	agerson2@uwo.ca	Gerson, Alexander/E-3313-2010		Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation and Ontario Research	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation and Ontario Research(Canada Foundation for Innovation)	We thank W. Bezner-Kerr for technical assistance with wind tunnel operations; M. Rebuli, T. Farrell, B. Kriengwatana, and A. Macmillan for assistance with animal care; Y. Morbey and L. McGuire for expert statistical advice; A. Boyle, T. Crewe, L. Kennedy, B. McCabe, S. Nebel, E. Price, B. Thurber, and M. Gerson for assistance or advice during this project; and P. Taylor, J. McCracken, S. Mackenzie, M. Burrell, and the volunteers at the Long Point Bird Observatory for their assistance. A.R.G. was supported by an Natural Sciences and Engineering Research Council of Canada (NSERC) Alexander Graham Bell Canada Graduate Scholarship. This study was funded by an NSERC Discovery Grant and by Leaders Opportunity and New Initiatives grants from the Canada Foundation for Innovation and Ontario Research Fund to C.G.G. and colleagues.	Battley PF, 2000, P ROY SOC B-BIOL SCI, V267, P191, DOI 10.1098/rspb.2000.0986; Bauchinger U, 2005, ZOOLOGY, V108, P97, DOI 10.1016/j.zool.2005.03.003; Bauchinger U, 2009, PHYSIOL BIOCHEM ZOOL, V82, P787, DOI 10.1086/605548; Biebach H., 1990, P352; Biebach H, 1998, J AVIAN BIOL, V29, P529, DOI 10.2307/3677172; CARMI N, 1992, AUK, V109, P268; Engel S, 2006, PHYSIOL BIOCHEM ZOOL, V79, P763, DOI 10.1086/504610; Gerson AR, 2011, AM J PHYSIOL-REG I, V300, pR925, DOI 10.1152/ajpregu.00701.2010; Giladi I, 1997, J EXP BIOL, V200, P3203; Giladi I, 1999, J COMP PHYSIOL B, V169, P311, DOI 10.1007/s003600050226; Gill RE, 2005, CONDOR, V107, P1, DOI 10.1650/7613; Guglielmo CG, 2011, J ORNITHOL, V152, P75, DOI 10.1007/s10336-011-0724-z; HOLMES RT, 1975, COMP BIOCHEM PHYSIOL, V50, P527, DOI 10.1016/0300-9629(75)90310-2; Jenni L, 1998, J AVIAN BIOL, V29, P521, DOI 10.2307/3677171; Klaassen M, 2000, CONDOR, V102, P444, DOI 10.1650/0010-5422(2000)102[0444:FCAFCO]2.0.CO;2; Klaassen M, 2004, J AVIAN BIOL, V35, P4; Klaassen M, 1996, J EXP BIOL, V199, P57; Landys MM, 2000, CONDOR, V102, P645, DOI 10.1650/0010-5422(2000)102[0645:WBDRAS]2.0.CO;2; Lighton J. R., 2008, MEASURING METABOLIC, P105; Lindstrom A, 2000, J EXP BIOL, V203, P913; McWilliams SR, 2001, COMP BIOCHEM PHYS A, V128, P579, DOI 10.1016/S1095-6433(00)00336-6; Pennycuick CJ, 1998, J THEOR BIOL, V191, P47, DOI 10.1006/jtbi.1997.0572; Schmaljohann H, 2008, ANIM BEHAV, V76, P1133, DOI 10.1016/j.anbehav.2008.05.024; Schmaljohann H, 2009, BEHAV ECOL SOCIOBIOL, V63, P1609, DOI 10.1007/s00265-009-0758-x; Schwilch R, 2002, J EXP BIOL, V205, P687; Seewagen CL, 2011, J COMP PHYSIOL B, V181, P413, DOI 10.1007/s00360-010-0534-2; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a	28	101	104	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2011	333	6048					1434	1436		10.1126/science.1210449	http://dx.doi.org/10.1126/science.1210449			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21903811				2022-12-28	WOS:000294672200039
J	Coebergh, JW				Coebergh, Jan W.			What global protection against women's cancers?	LANCET			English	Editorial Material									[Coebergh, Jan W.] Erasmus Univ, Dept Publ Hlth, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Coebergh, Jan W.] Comprehens Canc Ctr S, Eindhoven, Netherlands	Erasmus University Rotterdam; Erasmus MC	Coebergh, JW (corresponding author), Erasmus Univ, Dept Publ Hlth, Med Ctr, NL-3000 DR Rotterdam, Netherlands.	j.coebergh@erasmusmc.nl		Coebergh, Jan Willem/0000-0002-2419-3930				Brewster DH, 2005, LANCET ONCOL, V6, P193, DOI 10.1016/S1470-2045(05)70071-1; Coebergh JW, 2010, EUR J CANCER, V46, P2660, DOI 10.1016/j.ejca.2010.07.037; Davis DL, 2007, FEAR SELLS SECRET HI; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Michels KB, 2009, LANCET, V374, P268, DOI 10.1016/S0140-6736(09)61247-2; Soerjomataram I, 2008, BREAST CANCER RES TR, V111, P297, DOI 10.1007/s10549-007-9778-2; Terracini B, 2010, EPIDEMIOL PREV, V34, P1; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	8	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2011	378	9801					1442	1444		10.1016/S0140-6736(11)61459-1	http://dx.doi.org/10.1016/S0140-6736(11)61459-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	838VC	21924488				2022-12-28	WOS:000296319600005
J	Jebb, SA; Ahern, AL; Olson, AD; Aston, LM; Holzapfel, C; Stoll, J; Amann-Gassner, U; Simpson, AE; Fuller, NR; Pearson, S; Lau, NS; Mander, AP; Hauner, H; Caterson, ID				Jebb, Susan A.; Ahern, Amy L.; Olson, Ashley D.; Aston, Louise M.; Holzapfel, Christina; Stoll, Julia; Amann-Gassner, Ulrike; Simpson, Annie E.; Fuller, Nicholas R.; Pearson, Suzanne; Lau, Namson S.; Mander, Adrian P.; Hauner, Hans; Caterson, Ian D.			Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial	LANCET			English	Article							PHYSICAL-ACTIVITY; BLOOD-PRESSURE; LOSS PROGRAMS; QUESTIONNAIRE; INTERVENTION; SIBUTRAMINE; REDUCTION; OBESITY; LIFE	Background The increasing prevalence of overweight and obesity needs effective approaches for weight loss in primary care and community settings. We compared weight loss with standard treatment in primary care with that achieved after referral by the primary care team to a commercial provider in the community. Methods In this parallel group, non-blinded, randomised controlled trial, 772 overweight and obese adults were recruited by primary care practices in Australia, Germany, and the UK. Participants were randomly assigned with a computer-generated simple randomisation sequence to receive either 12 months of standard care as defined by national treatment guidelines, or 12 months of free membership to a commercial programme (Weight Watchers), and followed up for 12 months. The primary outcome was weight change over 12 months. Analysis was by intention to treat (last observation carried forward [LOCF] and baseline observation carried forward [BOCF]) and in the population who completed the 12-month assessment. This trial is registered, number ISRCTN85485463. Findings 377 participants were assigned to the commercial programme, of whom 230 (61%) completed the 12-month assessment; and 395 were assigned to standard care, of whom 214 (54%) completed the 12-month assessment. In all analyses, participants in the commercial programme group lost twice as much weight as did those in the standard care group. Mean weight change at 12 months was -5.06 kg (SE 0.31) for those in the commercial programme versus -2.25 kg (0.21) for those receiving standard care (adjusted difference -2.77 kg, 95% CI -3.50 to -2.03) with LOCF; -4.06 kg (0.31) versus -1.77 kg (0.19; adjusted difference -2.29 kg, -2.99 to -1.58) with BOCF; and -6.65 kg (0.43) versus -3.26 kg (0.33; adjusted difference -3.16 kg, -4.23 to -2.11) for those who completed the 12-month assessment. Participants reported no adverse events related to trial participation. Interpretation Referral by a primary health-care professional to a commercial weight loss programme that provides regular weighing, advice about diet and physical activity, motivation, and group support can off er a clinically useful early intervention for weight management in overweight and obese people that can be delivered at large scale.	[Jebb, Susan A.] MRC Human Nutr Res, Elsie Widdowson Lab, Cambridge CB1 9NL, England; [Holzapfel, Christina; Stoll, Julia; Amann-Gassner, Ulrike; Hauner, Hans] Tech Univ Munich, Else Kroener Fresenius Ctr Nutr Med, Fac Med, Munich, Germany; [Simpson, Annie E.; Fuller, Nicholas R.; Pearson, Suzanne; Lau, Namson S.; Caterson, Ian D.] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia; [Mander, Adrian P.] MRC Biostat Unit, Cambridge, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Technical University of Munich; University of Sydney; MRC Biostatistics Unit	Jebb, SA (corresponding author), MRC Human Nutr Res, Elsie Widdowson Lab, Fulbourn Rd, Cambridge CB1 9NL, England.	susan.jebb@mrc-hnr.cam.ac.uk	Holzapfel, Christina/AAO-5928-2020; Mander, Adrian Paul/E-5261-2010	Holzapfel, Christina/0000-0002-0155-9338; Mander, Adrian Paul/0000-0002-0742-9040; Lau, Namson/0000-0002-9400-8470; Jebb, Susan/0000-0001-9190-2920; Ahern, Amy/0000-0001-5069-4758	Sanofi-Aventis; Coca Cola; Allergan; Roche products; MSD; GlaxoSmithKline; Roche; Tanita Medical Advisory Board; Sara Lee; Lilly; Novartis; Bristol-Myers Squibb; iNova Pharmaceuticals; Eisai Pharmaceuticals; Pfizer Australia; Servier Laboratories (Australia); Weight Watchers International; MRC [MC_U105960389, MC_EX_G0800860, MC_U105960384] Funding Source: UKRI; Medical Research Council [MC_U105960384, MC_U105960389, MC_EX_G0800860] Funding Source: researchfish	Sanofi-Aventis(Sanofi-Aventis); Coca Cola; Allergan(AbbVieAllergan); Roche products; MSD; GlaxoSmithKline(GlaxoSmithKline); Roche(Roche Holding); Tanita Medical Advisory Board; Sara Lee; Lilly(Eli Lilly); Novartis(Novartis); Bristol-Myers Squibb(Bristol-Myers Squibb); iNova Pharmaceuticals; Eisai Pharmaceuticals(Eisai Co Ltd); Pfizer Australia(PfizerPfizer Australia); Servier Laboratories (Australia); Weight Watchers International; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	All authors declare financial support to their institutions for the submitted work from Weight Watchers. SAJ has received research grants for other clinical trials from Sanofi-Aventis and Coca Cola. IDC, NSL, AES, and NRF have received research grants for other clinical trials funded by Sanofi-Aventis, Allergan, Roche products, MSD, and GlaxoSmithKline. NRF has received conference travel expenses from Allergan. HH has received a travel grant from Roche. SAJ is a member of the Tanita Medical Advisory Board and has received payment for nutrition articles and lectures for Rosemary Conley Enterprises. HH is on the Advisory Board for Weight Watchers International and has received payment for lectures from Sara Lee, Lilly, Novartis, Sanofi-Aventis, and Bristol-Myers Squibb. IDC was a board member for the SCOUT trial and has received payment for lectures from iNova Pharmaceuticals, Eisai Pharmaceuticals, Pfizer Australia, and Servier Laboratories (Australia).; This trial was funded by Weight Watchers International, through a grant to the UK Medical Research Council. We thank participants and the staff of participating primary care practices for their contribution to the trial.	Ahern AL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-434; Clark VL, 2010, CLIN OBESITY ADULTS; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Ebrahim S, 1998, J PUBLIC HEALTH MED, V20, P441, DOI 10.1093/oxfordjournals.pubmed.a024800; Flodgren G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000984.pub2; Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017; Hauner H, 2004, EXP CLIN ENDOCR DIAB, V112, P201, DOI 10.1055/s-2004-817934; Heshka S, 2003, JAMA-J AM MED ASSOC, V289, P1792, DOI 10.1001/jama.289.14.1792; Jacobs EJ, 2010, ARCH INTERN MED, V170, P1293, DOI 10.1001/archinternmed.2010.201; Jordan J, 2005, INT J OBESITY, V29, P509, DOI 10.1038/sj.ijo.0802887; Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kolotkin RL, 2001, OBES RES, V9, P102, DOI 10.1038/oby.2001.13; Lavin JH, 2006, PUBLIC HEALTH, V120, P872, DOI 10.1016/j.puhe.2006.05.008; Miyazaki Y, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-44; Nanchahal K, 2009, BRIT J GEN PRACT, V59, P349, DOI 10.3399/bjgp09X420617; Organization WH, 2009, GLOB HLTH RISKS MORT; Renjilian DA, 2001, J CONSULT CLIN PSYCH, V69, P717, DOI 10.1037//0022-006X.69.4.717; Rock CL, 2007, OBESITY, V15, P939, DOI 10.1038/oby.2007.614; Rock CL, 2010, JAMA-J AM MED ASSOC, V304, P1803, DOI 10.1001/jama.2010.1503; Ross HM, 2008, BRIT J GEN PRACT, V58, P548, DOI 10.3399/bjgp08X319710; Steinbeck K S, 1997, Asia Pac J Clin Nutr, V6, P119; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Truby H, 2006, BMJ-BRIT MED J, V332, P1309, DOI 10.1136/bmj.38833.411204.80; Tsai AG, 2010, OBESITY, V18, P1614, DOI 10.1038/oby.2009.457; Tsai AG, 2005, ANN INTERN MED, V142, P56, DOI 10.7326/0003-4819-142-1-200501040-00012; Wadden TA, 2009, OBESITY, V17, P713, DOI 10.1038/oby.2008.637	27	275	277	3	71	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2011	378	9801					1485	1492		10.1016/S0140-6736(11)61344-5	http://dx.doi.org/10.1016/S0140-6736(11)61344-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	838VC	21906798	Green Published			2022-12-28	WOS:000296319600022
J	Schmitz, RJ; Schultz, MD; Lewsey, MG; O'Malley, RC; Urich, MA; Libiger, O; Schork, NJ; Ecker, JR				Schmitz, Robert J.; Schultz, Matthew D.; Lewsey, Mathew G.; O'Malley, Ronan C.; Urich, Mark A.; Libiger, Ondrej; Schork, Nicholas J.; Ecker, Joseph R.			Transgenerational Epigenetic Instability Is a Source of Novel Methylation Variants	SCIENCE			English	Article							DNA METHYLATION; NATURAL VARIATION; GENE; MUTATION; EXPRESSION; TRANSPOSON; PATTERNS; ALLELES; SIRNAS	Epigenetic information, which may affect an organism's phenotype, can be stored and stably inherited in the form of cytosine DNA methylation. Changes in DNA methylation can produce meiotically stable epialleles that affect transcription and morphology, but the rates of spontaneous gain or loss of DNA methylation are unknown. We examined spontaneously occurring variation in DNA methylation in Arabidopsis thaliana plants propagated by single-seed descent for 30 generations. We identified 114,287 CG single methylation polymorphisms and 2485 CG differentially methylated regions (DMRs), both of which show patterns of divergence compared with the ancestral state. Thus, transgenerational epigenetic variation in DNA methylation may generate new allelic states that alter transcription, providing a mechanism for phenotypic diversity in the absence of genetic mutation.	[Schmitz, Robert J.; Schultz, Matthew D.; Lewsey, Mathew G.; Urich, Mark A.; Ecker, Joseph R.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Schmitz, Robert J.; Schultz, Matthew D.; Lewsey, Mathew G.; O'Malley, Ronan C.; Urich, Mark A.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Schultz, Matthew D.] Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA; [Libiger, Ondrej; Schork, Nicholas J.] Scripps Res Inst, Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Libiger, Ondrej; Schork, Nicholas J.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; University of California System; University of California San Diego; Scripps Research Institute; Scripps Research Institute; Howard Hughes Medical Institute; Salk Institute	Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	ecker@salk.edu	Ecker, Joseph R/B-9144-2008; Lewsey, Mathew G/AAE-8530-2019; Schmitz, Robert/AAY-7659-2020	Ecker, Joseph R/0000-0001-5799-5895; Schmitz, Robert/0000-0001-7538-6663; Schork, Nicholas/0000-0003-0920-5013; Lewsey, Mathew/0000-0002-2631-4337; omalley, ronan/0000-0002-4907-0339	NIH [F32-HG004830]; NSF [DGE-0504645, MCB-0929402, MCB1122246]; European Union [252475]; NIH/National Center for Research Resources [UL1 RR025774]; Mary K. Chapman Foundation; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation (GBMF); NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG004830, R01HG003523] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); European Union(European Commission); NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Mary K. Chapman Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation (GBMF)(Gordon and Betty Moore Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank M. White, R. Lister, M. Galli, and R. Amasino for discussions; R. Shaw and E. Darmo for seeds; J. Nery for sequencing operations; and M. Axtell for Southern blot protocol. R.J.S. was supported by an NIH National Research Service Award postdoctoral fellowship (F32-HG004830). M.D.S. was supported by a NSF Integrative Graduate Education and Research Traineeship grant (DGE-0504645). M.G.L. was supported by an European Union Framework Programme 7 Marie Curie International Outgoing Fellowship (project 252475). O.L. and N.J.S. are supported by NIH/National Center for Research Resources grant number UL1 RR025774. This work was supported by the Mary K. Chapman Foundation, the NSF (grants MCB-0929402 and MCB1122246), the Howard Hughes Medical Institute, and the Gordon and Betty Moore Foundation (GBMF) to J.R.E. J.R.E. is a HHMI-GBMF Investigator. Analyzed data sets can be viewed at http://neomorph.salk.edu/30_generations/browser.html. Sequence data can be downloaded from National Center for Biotechnology Information Sequence Read Archive (SRA035939). Correspondence and requests for materials should be addressed to J.R.E. (ecker@salk.edu).	BENDER J, 1995, CELL, V83, P725, DOI 10.1016/0092-8674(95)90185-X; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu J, 2004, GENE DEV, V18, P2873, DOI 10.1101/gad.1217304; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Melquist S, 1999, GENETICS, V153, P401; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Nievergelt CM, 2006, AM J MED GENET B, V141B, P234, DOI 10.1002/ajmg.b.30252; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Paszkowski J, 2011, CURR OPIN PLANT BIOL, V14, P195, DOI 10.1016/j.pbi.2011.01.002; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Saze H, 2007, EMBO J, V26, P3641, DOI 10.1038/sj.emboj.7601788; Shaw RG, 2000, GENETICS, V155, P369; Shibuya K, 2009, P NATL ACAD SCI USA, V106, P1660, DOI 10.1073/pnas.0809294106; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Thompson AJ, 1999, PLANT PHYSIOL, V120, P383, DOI 10.1104/pp.120.2.383; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Zapala MA, 2006, P NATL ACAD SCI USA, V103, P19430, DOI 10.1073/pnas.0609333103; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	29	421	434	3	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2011	334	6054					369	373		10.1126/science.1212959	http://dx.doi.org/10.1126/science.1212959			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	21921155	Green Accepted			2022-12-28	WOS:000296052500051
J	Chan, J; Alegre, TPM; Safavi-Naeini, AH; Hill, JT; Krause, A; Groblacher, S; Aspelmeyer, M; Painter, O				Chan, Jasper; Mayer Alegre, T. P.; Safavi-Naeini, Amir H.; Hill, Jeff T.; Krause, Alex; Groeblacher, Simon; Aspelmeyer, Markus; Painter, Oskar			Laser cooling of a nanomechanical oscillator into its quantum ground state	NATURE			English	Article							RADIATION-PRESSURE; OPTOMECHANICAL CRYSTALS; MECHANICAL RESONATOR; CAVITY; MOTION; MICROMIRROR	The simple mechanical oscillator, canonically consisting of a coupled mass-spring system, is used in a wide variety of sensitive measurements, including the detection of weak forces(1) and small masses(2). On the one hand, a classical oscillator has a well-defined amplitude of motion; a quantum oscillator, on the other hand, has a lowest-energy state, or ground state, with a finite-amplitude uncertainty corresponding to zero-point motion. On the macroscopic scale of our everyday experience, owing to interactions with its highly fluctuating thermal environment a mechanical oscillator is filled with many energy quanta and its quantum nature is all but hidden. Recently, in experiments performed at temperatures of a few hundredths of a kelvin, engineered nanomechanical resonators coupled to electrical circuits have been measured to be oscillating in their quantum ground state(3,4). These experiments, in addition to providing a glimpse into the underlying quantum behaviour of mesoscopic systems consisting of billions of atoms, represent the initial steps towards the use of mechanical devices as tools for quantum metrology(5,6) or as a means of coupling hybrid quantum systems(7-9). Here we report the development of a coupled, nanoscale optical and mechanical resonator(10) formed in a silicon microchip, in which radiation pressure from a laser is used to cool the mechanical motion down to its quantum ground state (reaching an average phonon occupancy number of 0.85 +/- 0.08). This cooling is realized at an environmental temperature of 20 K, roughly one thousand times larger than in previous experiments and paves the way for optical control of mesoscale mechanical oscillators in the quantum regime.	[Chan, Jasper; Mayer Alegre, T. P.; Safavi-Naeini, Amir H.; Hill, Jeff T.; Krause, Alex; Groeblacher, Simon; Painter, Oskar] CALTECH, Thomas J Watson Sr Lab Appl Phys, Pasadena, CA 91125 USA; [Groeblacher, Simon; Aspelmeyer, Markus] Univ Vienna, Fac Phys, Vienna Ctr Quantum Sci & Technol VCQ, A-1090 Vienna, Austria	California Institute of Technology; University of Vienna	Painter, O (corresponding author), CALTECH, Thomas J Watson Sr Lab Appl Phys, Pasadena, CA 91125 USA.	opainter@caltech.edu	Groeblacher, Simon/O-2455-2014; Alegre, Thiago/B-1505-2012; Aspelmeyer, Markus/C-4098-2017; Hill, Jeffrey T/A-5027-2013; Chan, Jasper/E-6801-2011	Groeblacher, Simon/0000-0003-3932-7820; Alegre, Thiago/0000-0002-8999-8369; Aspelmeyer, Markus/0000-0003-4499-7335; Hill, Jeffrey T/0000-0001-6330-2354; Safavi-Naeini, Amir H./0000-0001-6176-1274; Painter, Oskar/0000-0002-1581-9209	DARPA/MTO through the AFOSR; European Commission (MINOS, QUESSENCE); European Research Council (ERC QOM); Austrian Science Fund (CoQuS, FOQUS, START); Kavli Nanoscience Institute at the California Institute of Technology; NSERC; Austrian Science Fund (FWF) [Y 414] Funding Source: researchfish	DARPA/MTO through the AFOSR(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); European Commission (MINOS, QUESSENCE)(European CommissionEuropean Commission Joint Research Centre); European Research Council (ERC QOM)(European Research Council (ERC)); Austrian Science Fund (CoQuS, FOQUS, START)(Austrian Science Fund (FWF)); Kavli Nanoscience Institute at the California Institute of Technology; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the DARPA/MTO ORCHID program through a grant from the AFOSR, the European Commission (MINOS, QUESSENCE), the European Research Council (ERC QOM), the Austrian Science Fund (CoQuS, FOQUS, START) and the Kavli Nanoscience Institute at the California Institute of Technology. The authors thank B. Baker for help with the cryostat set-up, J.C. thanks R. Li, and J.C. and A.H.S.-N. acknowledge support from NSERC.	Akram U, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083030; Alegre TPM, 2011, OPT EXPRESS, V19, P5658, DOI 10.1364/OE.19.005658; Arcizet O, 2006, NATURE, V444, P71, DOI 10.1038/nature05244; Braginsky V. B., 1977, MEASUREMENT WEAK FOR; CAVES CM, 1980, REV MOD PHYS, V52, P341, DOI 10.1103/RevModPhys.52.341; Chang DE, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/023003; Cohadon PF, 1999, PHYS REV LETT, V83, P3174, DOI 10.1103/PhysRevLett.83.3174; COHENTANNOUDJI CN, 1990, PHYS TODAY, V43, P33, DOI 10.1063/1.881239; DIEDRICH F, 1989, PHYS REV LETT, V62, P403, DOI 10.1103/PhysRevLett.62.403; Eichenfield M, 2009, NATURE, V462, P78, DOI 10.1038/nature08524; Gigan S, 2006, NATURE, V444, P67, DOI 10.1038/nature05273; Groblacher S, 2009, NAT PHYS, V5, P485, DOI 10.1038/NPHYS1301; Jensen K, 2008, NAT NANOTECHNOL, V3, P533, DOI 10.1038/nnano.2008.200; Kippenberg TJ, 2008, SCIENCE, V321, P1172, DOI 10.1126/science.1156032; Marquardt F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093902; Metzger CH, 2004, NATURE, V432, P1002, DOI 10.1038/nature03118; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Rabl P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.063601; Regal CA, 2008, NAT PHYS, V4, P555, DOI 10.1038/nphys974; Riviere R, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.063835; Rocheleau T, 2010, NATURE, V463, P72, DOI 10.1038/nature08681; Safavi-Naeini AH, 2011, NATURE, V472, P69, DOI 10.1038/nature09933; Safavi-Naeini AH, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013017; Stannigel K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.220501; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Teufel JD, 2011, NATURE, V471, P204, DOI 10.1038/nature09898; Thompson JD, 2008, NATURE, V452, P72, DOI 10.1038/nature06715; Vitali D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.030405; Wallquist M, 2009, PHYS SCRIPTA, VT137, DOI 10.1088/0031-8949/2009/T137/014001; Wiseman H. M., 2010, QUANTUM MEASUREMENT	30	1617	1632	11	423	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2011	478	7367					89	92		10.1038/nature10461	http://dx.doi.org/10.1038/nature10461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21979049	Green Submitted			2022-12-28	WOS:000295575400040
J	Yoshida, K; Sanada, M; Shiraishi, Y; Nowak, D; Nagata, Y; Yamamoto, R; Sato, Y; Sato-Otsubo, A; Kon, A; Nagasaki, M; Chalkidis, G; Suzuki, Y; Shiosaka, M; Kawahata, R; Yamaguchi, T; Otsu, M; Obara, N; Sakata-Yanagimoto, M; Ishiyama, K; Mori, H; Nolte, F; Hofmann, WK; Miyawaki, S; Sugano, S; Haferlach, C; Koeffler, HP; Shih, LY; Haferlach, T; Chiba, S; Nakauchi, H; Miyano, S; Ogawa, S				Yoshida, Kenichi; Sanada, Masashi; Shiraishi, Yuichi; Nowak, Daniel; Nagata, Yasunobu; Yamamoto, Ryo; Sato, Yusuke; Sato-Otsubo, Aiko; Kon, Ayana; Nagasaki, Masao; Chalkidis, George; Suzuki, Yutaka; Shiosaka, Masashi; Kawahata, Ryoichiro; Yamaguchi, Tomoyuki; Otsu, Makoto; Obara, Naoshi; Sakata-Yanagimoto, Mamiko; Ishiyama, Ken; Mori, Hiraku; Nolte, Florian; Hofmann, Wolf-Karsten; Miyawaki, Shuichi; Sugano, Sumio; Haferlach, Claudia; Koeffler, H. Phillip; Shih, Lee-Yung; Haferlach, Torsten; Chiba, Shigeru; Nakauchi, Hiromitsu; Miyano, Satoru; Ogawa, Seishi			Frequent pathway mutations of splicing machinery in myelodysplasia	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; PRE-MESSENGER-RNA; DEVELOPMENTAL DISORDER; SOMATIC MUTATIONS; U4ATAC SNRNA; GENOME; GENE; IDENTIFICATION; SPLICEOSOME; COMPONENT	Myelodysplastic syndromes and related disorders (myelodysplasia) are a heterogeneous group of myeloid neoplasms showing deregulated blood cell production with evidence of myeloid dysplasia and a predisposition to acute myeloid leukaemia, whose pathogenesis is only incompletely understood. Here we report whole-exome sequencing of 29 myelodysplasia specimens, which unexpectedly revealed novel pathway mutations involving multiple components of the RNA splicing machinery, including U2AF35, ZRSR2, SRSF2 and SF3B1. In a large series analysis, these splicing pathway mutations were frequent (similar to 45 to similar to 85%) in, and highly specific to, myeloid neoplasms showing features of myelodysplasia. Conspicuously, most of the mutations, which occurred in a mutually exclusive manner, affected genes involved in the 3'-splice site recognition during pre-mRNA processing, inducing abnormal RNA splicing and compromised haematopoiesis. Our results provide the first evidence indicating that genetic alterations of the major splicing components could be involved inhuman pathogenesis, also implicating a novel therapeutic possibility for myelodysplasia.	[Yoshida, Kenichi; Sanada, Masashi; Nagata, Yasunobu; Sato, Yusuke; Sato-Otsubo, Aiko; Kon, Ayana; Shiosaka, Masashi; Kawahata, Ryoichiro; Ogawa, Seishi] Univ Tokyo, Grad Sch Med, Canc Genom Project, Bunkyo Ku, Tokyo 1138655, Japan; [Shiraishi, Yuichi; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal,Minato Ku, Tokyo 1088639, Japan; [Nowak, Daniel; Nolte, Florian; Hofmann, Wolf-Karsten] Univ Heidelberg, Dept Hematol & Oncol, Med Fac Manheim, D-68167 Mannheim, Germany; [Yamamoto, Ryo; Otsu, Makoto; Nakauchi, Hiromitsu] Univ Tokyo, Div Stem Cell Therapy, Ctr Stem Cell Biol & Regenerat Med, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Nagasaki, Masao] Univ Tokyo, Lab Funct Genom, Ctr Human Genome, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Chalkidis, George; Miyano, Satoru] Univ Tokyo, Lab Sequence Data Anal, Ctr Human Genome, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Div Syst Biomed Technol, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Yamaguchi, Tomoyuki; Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, Nakauchi Stem Cell & Organ Regenerat Project, Minato Ku, Tokyo 1088639, Japan; [Obara, Naoshi; Sakata-Yanagimoto, Mamiko; Chiba, Shigeru] Univ Tsukuba, Dept Hematol, Inst Clin Med, Tsukuba, Ibaraki 3058571, Japan; [Ishiyama, Ken; Miyawaki, Shuichi] Tokyo Metropolitan Otsuka Hosp, Div Hematol, Toshima Ku, Tokyo 1700005, Japan; [Mori, Hiraku] Showa Univ, Fujigaoka Hosp, Div Hematol, Aoba Ku, Kanagawa 2278501, Japan; [Haferlach, Claudia; Haferlach, Torsten] Munich Leukemia Lab, D-81377 Munich, Germany; [Koeffler, H. Phillip] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117456, Singapore; [Shih, Lee-Yung] Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Taipei 105, Taiwan	University of Tokyo; University of Tokyo; Ruprecht Karls University Heidelberg; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Tsukuba; Showa University; MLL Munich Leukemia Laboratory; Cedars Sinai Medical Center; National University of Singapore; Chang Gung Memorial Hospital; Chang Gung University	Ogawa, S (corresponding author), Univ Tokyo, Grad Sch Med, Canc Genom Project, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	sogawa-tky@umin.ac.jp	Mamiko, Sakata-yanagimoto/AAP-3298-2020; Ogawa, Seishi/AAE-7088-2019	Miyano, Satoru/0000-0002-1753-6616; Nowak, Daniel/0000-0001-7130-7921; Nagasaki, Masao/0000-0002-4292-8785; Otsu, Makoto/0000-0002-9769-0217; Yoshida, Kenichi/0000-0003-4612-2778	Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [22790895, 23791068] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R01CA026038] Funding Source: NIH RePORTER	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grant-in-Aids from the Ministry of Health, Labor and Welfare of Japan and from the Ministry of Education, Culture, Sports, Science and Technology, and also by the Japan Society for the Promotion of Science (JSPS) through the 'Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)', initiated by the Council for Science and Technology Policy (CSTP). pGCDNsamIRESEGFP vector was a gift from M. Onodera. We thank Y. Mori, O. Hagiwara, M. Nakamura and N. Mizota for their technical assistance. We are also grateful to K. Ikeuchi and M. Ueda for their continuous encouragement throughout the study.	Barlow JL, 2010, NAT MED, V16, P59, DOI 10.1038/nm.2063; Bejar R, 2011, J CLIN ONCOL, V29, P504, DOI 10.1200/JCO.2010.31.1175; Bevilacqua L, 2010, NATURE, V468, P1061, DOI 10.1038/nature09629; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Edery P, 2011, SCIENCE, V332, P240, DOI 10.1126/science.1202205; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; He HL, 2011, SCIENCE, V332, P238, DOI 10.1126/science.1200587; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Ma X, 2007, CANCER-AM CANCER SOC, V109, P1536, DOI 10.1002/cncr.22570; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shen HH, 2010, GENE DEV, V24, P2389, DOI 10.1101/gad.1974810; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tronchere H, 1997, NATURE, V388, P397, DOI 10.1038/41137; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788	37	1246	1300	2	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2011	478	7367					64	69		10.1038/nature10496	http://dx.doi.org/10.1038/nature10496			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21909114				2022-12-28	WOS:000295575400035
J	Forsberg, JS; Hansson, MG; Eriksson, S				Forsberg, Joanna Stjernschantz; Hansson, Mats G.; Eriksson, Stefan			Biobank research: who benefits from individual consent?	BRITISH MEDICAL JOURNAL			English	Editorial Material							GENETIC RESEARCH; SAMPLES; BIAS; SPECIMEN; CANCER		[Forsberg, Joanna Stjernschantz; Hansson, Mats G.; Eriksson, Stefan] Uppsala Univ, Ctr Res Eth & Bioeth, S-75122 Uppsala, Sweden	Uppsala University	Forsberg, JS (corresponding author), Uppsala Univ, Ctr Res Eth & Bioeth, Box 564, S-75122 Uppsala, Sweden.	joanna.forsberg@crb.uu.se		Eriksson, Stefan/0000-0001-7486-4678				Aagaard-Tillery K, 2006, OBSTET GYNECOL, V108, P1115, DOI 10.1097/01.AOG.0000241536.19539.14; Arnason V, 2004, BIOETHICS, V18, P27, DOI 10.1111/j.1467-8519.2004.00377.x; Arruda-Olson AM, 2007, MAYO CLIN PROC, V82, P1185, DOI 10.4065/82.10.1185; Caulfield T, 2007, KINGS LAW J, V18, P209, DOI DOI 10.1080/09615768.2007.11427674; Council for International Organizations of Medical Sciences, 2009, INT ETH GUID EP STUD; Couzin-Frankel J, 2009, SCIENCE, V324, P166, DOI 10.1126/science.324.5924.166; Duque CG, 2010, REV ASSOC MED BRAS, V56, P563, DOI 10.1590/S0104-42302010000500018; Forsberg JS, 2010, EUR J EPIDEMIOL, V25, P65, DOI 10.1007/s10654-009-9413-0; Furness PN, 2004, J MED ETHICS, V30, P561, DOI 10.1136/jme.2003.003368; Greely H T, 1999, Wake Forest Law Rev, V34, P737; Greely HT, 2007, ANNU REV GENOM HUM G, V8, P343, DOI 10.1146/annurev.genom.7.080505.115721; Hansson MG, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2335; Hofmann B, 2009, J MED ETHICS, V35, P125, DOI 10.1136/jme.2008.024851; Kanovitch B, 1998, ETHICS CODES MED FDN; Mezuk B, 2008, COMMUNITY GENET, V11, P171, DOI 10.1159/000113880; Ness KK, 2010, PEDIATR BLOOD CANCER, V55, P165, DOI 10.1002/pbc.22513; O'Neill O, 2003, J MED ETHICS, V29, P4, DOI 10.1136/jme.29.1.4; Ransohoff DF, 2010, J CLIN ONCOL, V28, P698, DOI 10.1200/JCO.2009.25.6065; Reverby Susan M., 2009, EXAMINING TUSKEGEE I; The Royal Liverpool Children's Inquiry, 2001, REP; UN Educ. Sci. Cult. Organ, 2003, INT DECL HUM GEN DAT; Vermeulen E, 2009, EUR J CANCER, V45, P1168, DOI 10.1016/j.ejca.2008.11.022; Weir RF, 2004, STORED TISSUE ISSUE	23	21	21	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 4	2011	343								d5647	10.1136/bmj.d5647	http://dx.doi.org/10.1136/bmj.d5647			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	832CR	21972296				2022-12-28	WOS:000295779300002
J	Guo, CG; Yoon, HS; Franklin, A; Jain, S; Ebert, A; Cheng, HL; Hansen, E; Despo, O; Bossen, C; Vettermann, C; Bates, JG; Richards, N; Myers, D; Patel, H; Gallagher, M; Schlissel, MS; Murre, C; Busslinger, M; Giallourakis, CC; Alt, FW				Guo, Chunguang; Yoon, Hye Suk; Franklin, Andrew; Jain, Suvi; Ebert, Anja; Cheng, Hwei-Ling; Hansen, Erica; Despo, Orion; Bossen, Claudia; Vettermann, Christian; Bates, Jamie G.; Richards, Nicholas; Myers, Darienne; Patel, Harin; Gallagher, Michael; Schlissel, Mark S.; Murre, Cornelis; Busslinger, Meinrad; Giallourakis, Cosmas C.; Alt, Frederick W.			CTCF-binding elements mediate control of V(D)J recombination	NATURE			English	Article							B-CELL DEVELOPMENT; HEAVY-CHAIN LOCUS; VH GENE SEGMENTS; IGH LOCUS; REGULATORY ELEMENTS; INTRONIC ENHANCER; ANTISENSE TRANSCRIPTION; LYMPHOCYTE DEVELOPMENT; NUCLEAR-ORGANIZATION; REGION	Immunoglobulin heavy chain (IgH) variable region exons are assembled from V-H, D and J(H) gene segments in developing B lymphocytes. Within the 2.7-megabase mouse Igh locus, V(D)J recombination is regulated to ensure specific and diverse antibody repertoires. Here we report in mice a key Igh V(D)J recombination regulatory region, termed intergenic control region 1 (IGCR1), which lies between the V-H and D clusters. Functionally, IGCR1 uses CTCF looping/insulator factor-binding elements and, correspondingly, mediates Igh loops containing distant enhancers. IGCR1 promotes normal B-cell development and balances antibody repertoires by inhibiting transcription and rearrangement of D-H-proximal V-H gene segments and promoting rearrangement of distal V-H segments. IGCR1 maintains ordered and lineage-specific V-H(D)J(H) recombination by suppressing V-H joining to D segments not joined to J(H) segments, and V-H to DJ(H) joins in thymocytes, respectively. IGCR1 is also required for feedback regulation and allelic exclusion of proximal V-H-to-DJ(H) recombination. Our studies elucidate a long-sought Igh V(D) J recombination control region and indicate a new role for the generally expressed CTCF protein.	[Guo, Chunguang; Yoon, Hye Suk; Franklin, Andrew; Jain, Suvi; Cheng, Hwei-Ling; Hansen, Erica; Despo, Orion; Richards, Nicholas; Myers, Darienne; Patel, Harin; Gallagher, Michael; Giallourakis, Cosmas C.; Alt, Frederick W.] Childrens Hosp, Howard Hughes Med Inst, Immune Dis Inst, Boston, MA 02115 USA; [Guo, Chunguang; Yoon, Hye Suk; Franklin, Andrew; Jain, Suvi; Cheng, Hwei-Ling; Hansen, Erica; Despo, Orion; Richards, Nicholas; Myers, Darienne; Patel, Harin; Gallagher, Michael; Giallourakis, Cosmas C.; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Ebert, Anja; Busslinger, Meinrad] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Bossen, Claudia; Murre, Cornelis] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Vettermann, Christian; Bates, Jamie G.; Schlissel, Mark S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Giallourakis, Cosmas C.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of California System; University of California San Diego; University of California System; University of California Berkeley; Harvard University; Massachusetts General Hospital	Alt, FW (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Immune Dis Inst, 300 Longwood Ave, Boston, MA 02115 USA.	cgiallourakis@partners.org; alt@enders.tch.harvard.edu	Busslinger, Meinrad J./J-1249-2016	Busslinger, Meinrad J./0000-0002-9111-9351; Vettermann, Christian/0000-0003-3794-6441	NIH [RO1 AI20047, RO1 HL48702, RO1 AI40227, CA054198-20, K08 AI070839]; Austrian GEN-AU initiative; Boehringer Ingelheim; Cancer Research Institute; Marie Curie Fellowship; EMBO; NATIONAL CANCER INSTITUTE [T32CA009151, R37CA054198, R01CA054198] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020047, R37AI040227, K08AI070839, R01AI040227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian GEN-AU initiative; Boehringer Ingelheim(Boehringer Ingelheim); Cancer Research Institute; Marie Curie Fellowship(European Commission); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Y. Fujiwara and P.-Y. Huang for generating chimaeric mice. This work was supported by NIH grants RO1 AI20047 (to F. W. A.), RO1 HL48702 and AI40227 (to M. S. S.), CA054198-20 (to C. M.) and K08 AI070839 (to C. C. G.). M. B. was supported by the Austrian GEN-AU initiative and Boehringer Ingelheim. C. G. is supported by an Irvington Institute Postdoctoral Fellowship from the Cancer Research Institute. C. V. is supported by a Marie Curie Fellowship. C. B. is supported by an EMBO fellowship. F. W. A. is an Investigator of the Howard Hughes Medical Institute.	Abarrategui I, 2009, ADV EXP MED BIOL, V650, P93; Afshar R, 2006, J IMMUNOL, V176, P2439, DOI 10.4049/jimmunol.176.4.2439; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; Barreto V, 2000, J IMMUNOL, V164, P893, DOI 10.4049/jimmunol.164.2.893; Bates JG, 2007, J EXP MED, V204, P3247, DOI 10.1084/jem.20071787; Bergman Y, 2010, SEMIN IMMUNOL, V22, P323, DOI 10.1016/j.smim.2010.07.003; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; CHEN JZ, 1993, EMBO J, V12, P4635, DOI 10.1002/j.1460-2075.1993.tb06152.x; Corcoran AE, 2010, SEMIN IMMUNOL, V22, P353, DOI 10.1016/j.smim.2010.08.001; DECKER DJ, 1991, J IMMUNOL, V147, P1406; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Degner-Leisso SC, 2010, SEMIN IMMUNOL, V22, P346, DOI 10.1016/j.smim.2010.08.002; Dudley DD, 2003, J EXP MED, V198, P1439, DOI 10.1084/jem.20030627; Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Featherstone K, 2010, J BIOL CHEM, V285, P9327, DOI 10.1074/jbc.M109.098251; Feeney A, 2010, SEMIN IMMUNOL, V22, P311, DOI 10.1016/j.smim.2010.09.002; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Giallourakis CC, 2010, P NATL ACAD SCI USA, V107, P22207, DOI 10.1073/pnas.1015954107; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hirano SL, 2001, IMMUNOGENETICS, V53, P54, DOI 10.1007/s002510000287; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jhunjhunwala S, 2009, CELL, V138, P435, DOI 10.1016/j.cell.2009.07.016; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kyrchanova O, 2008, NUCLEIC ACIDS RES, V36, P7019, DOI 10.1093/nar/gkn781; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; MacPherson MJ, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-101; MALYNN BA, 1990, J EXP MED, V171, P843, DOI 10.1084/jem.171.3.843; McManus S, 2011, EMBO J, V30, P2388, DOI 10.1038/emboj.2011.140; Melchers F, 2000, IMMUNOL REV, V175, P33, DOI 10.1111/j.1600-065X.2000.imr017510.x; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; Perlot T, 2008, ADV IMMUNOL, V99, P1, DOI 10.1016/S0065-2776(08)00601-9; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pinaud E, 2011, ADV IMMUNOL, V110, P27, DOI 10.1016/B978-0-12-387663-8.00002-8; RETH MG, 1985, NATURE, V317, P353, DOI 10.1038/317353a0; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Sakai E, 1999, P NATL ACAD SCI USA, V96, P1526, DOI 10.1073/pnas.96.4.1526; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Schatz DG, 2004, SEMIN IMMUNOL, V16, P245, DOI 10.1016/j.smim.2004.08.004; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Subrahmanyam R, 2010, SEMIN IMMUNOL, V22, P337, DOI 10.1016/j.smim.2010.08.003; tenBoekel E, 1997, IMMUNITY, V7, P357; Williams A, 2008, J EXP MED, V205, P747, DOI 10.1084/jem.20080066; Wuerffe R, 2007, IMMUNITY, V27, P711, DOI 10.1016/j.immuni.2007.09.007; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0; Zhang Y, 2010, ADV IMMUNOL, V106, P93, DOI 10.1016/S0065-2776(10)06004-9	53	193	202	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2011	477	7365					424	U182		10.1038/nature10495	http://dx.doi.org/10.1038/nature10495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21909113	Green Accepted			2022-12-28	WOS:000295080500032
J	Moore, W				Moore, Wendy			PAST CARING Rubber love	BRITISH MEDICAL JOURNAL			English	Editorial Material												wendymoore@ntlworld.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 20	2011	343								d5915	10.1136/bmj.d5915	http://dx.doi.org/10.1136/bmj.d5915			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	826AF	21933828				2022-12-28	WOS:000295323000006
J	Summerskill, W				Summerskill, William			Museum Hope after Hiroshima	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Summerskill, W (corresponding author), The Lancet, London NW1 7BY, England.								0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 17	2011	378	9796					1063	1063		10.1016/S0140-6736(11)61467-0	http://dx.doi.org/10.1016/S0140-6736(11)61467-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829BE	21936111	Bronze			2022-12-28	WOS:000295548900011
J	Barbash, DA				Barbash, Daniel A.			Comment on "A Test of the Snowball Theory for the Rate of Evolution of Hybrid Incompatibilities"	SCIENCE			English	Editorial Material							DROSOPHILA; PROTEIN	Matute et al. (Reports, 17 September 2010, p. 1518) tested the theory that the number of genes involved in hybrid incompatibility increases faster than linearly. However, the method they used is inappropriate because it detects genes that are haploinsufficient in a hybrid background but that would not contribute to lethality in wild-type hybrids, thus overestimating the frequency of hybrid inviability.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Barbash, DA (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	dab87@cornell.edu						Aruna S, 2009, GENETICS, V181, P1437, DOI 10.1534/genetics.108.100057; Ashburner M., 2004, DROSOPHILA LAB HDB; Barbash DA, 2003, P NATL ACAD SCI USA, V100, P5302, DOI 10.1073/pnas.0836927100; Barbash DA, 2010, GENETICS, V186, P1, DOI 10.1534/genetics.110.121459; Bayes JJ, 2009, SCIENCE, V326, P1538, DOI 10.1126/science.1181756; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Ferree PM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000234; Llopart A, 2005, GENETICS, V171, P197, DOI 10.1534/genetics.104.033597; Masly JP, 2007, PLOS BIOL, V5, P1890, DOI 10.1371/journal.pbio.0050243; Matute DR, 2010, SCIENCE, V329, P1518, DOI 10.1126/science.1193440; McManus CJ, 2010, GENOME RES, V20, P816, DOI 10.1101/gr.102491.109; Moyle LC, 2010, SCIENCE, V329, P1521, DOI 10.1126/science.1193063; Salz HK, 2010, FLY, V4, P60, DOI 10.4161/fly.4.1.11277; Sanchez L, 1997, GENETICS, V147, P231; Walker M.Y., 2003, ADV GENETIC ANAL FIN	15	6	6	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1576B	U30		10.1126/science.1202876	http://dx.doi.org/10.1126/science.1202876			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921181				2022-12-28	WOS:000294900900021
J	Aspinall, W				Aspinall, Willy			Check your legal position before advising others	NATURE			English	Editorial Material									Univ Bristol, Bristol BS8 1TH, Avon, England	University of Bristol	Aspinall, W (corresponding author), Univ Bristol, Bristol BS8 1TH, Avon, England.	willy@aspinall.demon.co.uk	Aspinall, Willy/AAW-1022-2020	Aspinall, Willy/0000-0001-6014-6042					0	10	10	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 15	2011	477	7364					251	251		10.1038/477251a	http://dx.doi.org/10.1038/477251a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	819TD	21921877	Bronze			2022-12-28	WOS:000294852400004
J	Cheema, U				Cheema, Usman			Gout Nodulosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									So Illinois Univ, Sch Med, Springfield, IL 62702 USA	Southern Illinois University System; Southern Illinois University	Cheema, U (corresponding author), So Illinois Univ, Sch Med, Springfield, IL 62702 USA.								0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2011	365	11					E23	E23		10.1056/NEJMicm1014335	http://dx.doi.org/10.1056/NEJMicm1014335			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819UR	21916637				2022-12-28	WOS:000294857300013
J	Keane, TM; Goodstadt, L; Danecek, P; White, MA; Wong, K; Yalcin, B; Heger, A; Agam, A; Slater, G; Goodson, M; Furlotte, NA; Eskin, E; Nellaker, C; Whitley, H; Cleak, J; Janowitz, D; Hernandez-Pliego, P; Edwards, A; Belgard, TG; Oliver, PL; McIntyre, RE; Bhomra, A; Nicod, J; Gan, XC; Yuan, W; van der Weyden, L; Steward, CA; Bala, S; Stalker, J; Mott, R; Durbin, R; Jackson, IJ; Czechanski, A; Guerra-Assuncao, JA; Donahue, LR; Reinholdt, LG; Payseur, BA; Ponting, CP; Birney, E; Flint, J; Adams, DJ				Keane, Thomas M.; Goodstadt, Leo; Danecek, Petr; White, Michael A.; Wong, Kim; Yalcin, Binnaz; Heger, Andreas; Agam, Avigail; Slater, Guy; Goodson, Martin; Furlotte, Nicholas A.; Eskin, Eleazar; Nellaker, Christoffer; Whitley, Helen; Cleak, James; Janowitz, Deborah; Hernandez-Pliego, Polinka; Edwards, Andrew; Belgard, T. Grant; Oliver, Peter L.; McIntyre, Rebecca E.; Bhomra, Amarjit; Nicod, Jerome; Gan, Xiangchao; Yuan, Wei; van der Weyden, Louise; Steward, Charles A.; Bala, Sendu; Stalker, Jim; Mott, Richard; Durbin, Richard; Jackson, Ian J.; Czechanski, Anne; Guerra-Assuncao, Jose Afonso; Donahue, Leah Rae; Reinholdt, Laura G.; Payseur, Bret A.; Ponting, Chris P.; Birney, Ewan; Flint, Jonathan; Adams, David J.			Mouse genomic variation and its effect on phenotypes and gene regulation	NATURE			English	Article							COMPLEX TRAITS; INTELLECTUAL HISTORY; MICE; STRAINS; WIDE; ASSOCIATION; CONCORDANCE; TREES; ARCHITECTURE; DISSECTION	We report genome sequences of 17 inbred strains of laboratory mice and identify almost ten times more variants than previously known. We use these genomes to explore the phylogenetic history of the laboratory mouse and to examine the functional consequences of allele-specific variation on transcript abundance, revealing that at least 12% of transcripts show a significant tissue-specific expression bias. By identifying candidate functional variants at 718 quantitative trait loci we show that the molecular nature of functional variants and their position relative to genes vary according to the effect size of the locus. These sequences provide a starting point for a new era in the functional analysis of a key model organism.	[Goodstadt, Leo; Yalcin, Binnaz; Agam, Avigail; Goodson, Martin; Whitley, Helen; Cleak, James; Janowitz, Deborah; Hernandez-Pliego, Polinka; Edwards, Andrew; Bhomra, Amarjit; Nicod, Jerome; Gan, Xiangchao; Yuan, Wei; Mott, Richard; Flint, Jonathan] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Keane, Thomas M.; Danecek, Petr; Wong, Kim; Slater, Guy; McIntyre, Rebecca E.; van der Weyden, Louise; Steward, Charles A.; Bala, Sendu; Stalker, Jim; Durbin, Richard; Adams, David J.] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [White, Michael A.; Payseur, Bret A.] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Heger, Andreas; Agam, Avigail; Nellaker, Christoffer; Belgard, T. Grant; Oliver, Peter L.; Ponting, Chris P.] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford OX1 3QX, England; [Furlotte, Nicholas A.; Eskin, Eleazar] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Janowitz, Deborah] Ernst Moritz Arndt Univ Greifswald, Greifswald Klinikum Hansestadt Stralsund, Dept Psychiat & Psychotherapy, D-18437 Stralsund, Germany; [Jackson, Ian J.] MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Czechanski, Anne; Donahue, Leah Rae; Reinholdt, Laura G.] Jackson Lab, Bar Harbor, ME 04609 USA; [Guerra-Assuncao, Jose Afonso; Birney, Ewan] European Bioinformat Inst, Cambridge CB10 1SD, England	University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; University of Wisconsin System; University of Wisconsin Madison; University of Oxford; University of California System; University of California Los Angeles; Ernst Moritz Arndt Universitat Greifswald; University of Edinburgh; Jackson Laboratory; European Molecular Biology Laboratory (EMBL)	Flint, J (corresponding author), Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	jf@well.ox.ac.uk; da1@sanger.ac.uk	Durbin, Richard/AAE-7178-2019; van der Weyden, Louise/AAV-5711-2021; Ponting, Chris/AAV-2621-2021; Yalcin, Binnaz/ABB-7735-2020; Oliver, Peter/AAS-4022-2020; Eskin, Eleazar/J-9187-2012; Yalcin, Binnaz/P-5482-2016; Guerra-Assuncao, Jose Afonso/F-3887-2011	Durbin, Richard/0000-0002-9130-1006; van der Weyden, Louise/0000-0002-0645-1879; Yalcin, Binnaz/0000-0002-1924-6807; Eskin, Eleazar/0000-0003-1149-4758; Yalcin, Binnaz/0000-0002-1924-6807; Nellaker, Christoffer/0000-0002-2887-2068; Guerra-Assuncao, Jose Afonso/0000-0001-6593-403X; Gan, Xiangchao/0000-0001-6398-5191; Bala, Senduran/0000-0003-4509-8307; Wong, Kim/0000-0002-0984-1477; Flint, Jonathan/0000-0002-9427-4429; Keane, Thomas/0000-0001-7532-6898; Adams, David/0000-0001-9490-0306; Slater, Guy/0000-0002-4202-8285; Steward, Charles/0000-0001-8829-5349; BHOMRA, AMARJIT/0000-0002-0439-0128; Jackson, Ian/0000-0001-6526-0688; Heger, Andreas/0000-0001-7720-0447; Oliver, Peter/0000-0003-3347-2461; Belgard, Tildon/0000-0002-6962-7894; Ponting, Chris/0000-0003-0202-7816; Mott, Richard/0000-0002-1022-9330; Birney, Ewan/0000-0001-8314-8497; Czechanski, Anne/0000-0003-3210-4210	Medical Research Council, UK; Wellcome Trust; Cancer Research UK; Jackson Laboratory; NSF [DEB 0918000]; NLM [NLM 2T15LM007359]; Wellcome Trust [085906/Z/08/Z, 083573/Z/07/Z]; BBSRC [BB/F022697/1]; Immune Tolerance Network [AI 15416]; National Institute of Allergy and Infectious Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; Juvenile Diabetes Research Foundation International; MRC [MC_U137761446, G0800024, MC_U127561112, MC_EX_G0802457] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL080079] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI015416] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007359] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F022697/1] Funding Source: researchfish; Medical Research Council [MC_EX_G0802457, MC_U137761446, G0800024, MC_U127561112] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Jackson Laboratory; NSF(National Science Foundation (NSF)); NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Immune Tolerance Network; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was supported by The Medical Research Council, UK, and the Wellcome Trust. D.J.A. is supported by Cancer Research UK and L. R., L.R.-D. and A. C. were supported by the Jackson Laboratory. B. A. P. was supported by NSF Grant DEB 0918000 and M. A. W. was supported by an NLM training grant in Computation and Informatics in Biology and Medicine to the University of Wisconsin (NLM 2T15LM007359). R. M., L. G. were supported by Wellcome Trust Grants 085906/Z/08/Z and 083573/Z/07/Z and BBSRC grant BB/F022697/1. The NOD/ShiLtJ BAC sequencing and the next generation Illumina sequencing was funded by Immune Tolerance Network Contract AI 15416, which was sponsored by the National Institute of Allergy and Infectious Diseases, the National Institute of Diabetes and Digestive and Kidney Diseases, and Juvenile Diabetes Research Foundation International. We thank staff in the Sanger Institute sequencing and informatics teams for making this project possible.	Ane C, 2007, MOL BIOL EVOL, V24, P412; Baum DA, 2007, TAXON, V56, P417, DOI 10.1002/tax.562013; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Davis RC, 2005, GENOMICS, V86, P259, DOI 10.1016/j.ygeno.2005.05.010; Deem A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000594; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gale GD, 2009, MOL PSYCHIATR, V14, P631, DOI 10.1038/mp.2008.4; Guan CM, 2010, GENESIS, V48, P73, DOI 10.1002/dvg.20594; HUANG DW, 2009, CURR PROTOC BIOINFOR, V13; Hunter KW, 2008, ANNU REV GENET, V42, P131, DOI 10.1146/annurev.genet.42.110807.091659; Iakoubova OA, 2001, GENOMICS, V74, P89, DOI 10.1006/geno.2000.6497; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Laurie CC, 2007, PLOS GENET, V3, P1487, DOI 10.1371/journal.pgen.0030144; Lutzmann M, 2009, CELL CYCLE, V8, P1309, DOI 10.4161/cc.8.9.8216; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; McDonald JP, 2003, J EXP MED, V198, P635, DOI 10.1084/jem.20030767; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; Paigen K, 2003, GENETICS, V163, P1227; Paigen K, 2003, GENETICS, V163, P1; PAMILO P, 1987, GENET RES, V49, P135, DOI 10.1017/S0016672300026938; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Ringwald M, 2011, NUCLEIC ACIDS RES, V39, pD849, DOI 10.1093/nar/gkq879; Rosenberg NA, 2002, THEOR POPUL BIOL, V61, P225, DOI 10.1006/tpbi.2001.1568; Rozmahel R, 1996, NAT GENET, V12, P280, DOI 10.1038/ng0396-280; Shao HF, 2010, MAMM GENOME, V21, P276, DOI 10.1007/s00335-010-9267-5; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; Sherry ST, 1999, GENOME RES, V9, P677; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Solberg LC, 2006, MAMM GENOME, V17, P129, DOI 10.1007/s00335-005-0112-1; Steward CA, 2010, GENOMICS, V95, P105, DOI 10.1016/j.ygeno.2009.10.004; Turner DJ, 2009, MAMM GENOME, V20, P327, DOI 10.1007/s00335-009-9187-4; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Van der Weyden L, 2002, PHYSIOL GENOMICS, V11, P133, DOI 10.1152/physiolgenomics.00074.2002; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; White MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000729; Yalcin B, 2005, GENETICS, V171, P673, DOI 10.1534/genetics.104.028902	44	1027	1036	6	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 15	2011	477	7364					289	294		10.1038/nature10413	http://dx.doi.org/10.1038/nature10413			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21921910	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000294852400022
J	Cassidy, J				Cassidy, Jane			LOBBY WATCH Jewish Medical Association UK	BRITISH MEDICAL JOURNAL			English	Editorial Material												janecassi2@googlemail.com						2003, BRIT MED J, V327, P1107, DOI DOI 10.1136/BMJ.327.7423.1107; 2009, BRIT MED J, V338, pB2556, DOI DOI 10.1136/BMJ.B2556	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2011	343								d5730	10.1136/bmj.d5730	http://dx.doi.org/10.1136/bmj.d5730			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822VM	21917831				2022-12-28	WOS:000295078100006
J	Sadiq, A; Hershman, M; Luke, D; Durrans, D; Wells, D				Sadiq, Ambreen; Hershman, Michael; Luke, David; Durrans, David; Wells, David			CASE REPORT Abdominal pain	BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE APPENDICITIS; DIAGNOSIS; ULTRASONOGRAPHY; ACCURACY; DETECT; SCORE		[Sadiq, Ambreen; Hershman, Michael; Luke, David; Durrans, David; Wells, David] Stafford Hosp, Stafford ST16 3SA, England		Sadiq, A (corresponding author), Stafford Hosp, Weston Rd, Stafford ST16 3SA, England.	ambreen.sadiq@doctors.org.uk	Luke, David/GWC-3264-2022					ALVARADO A, 1986, ANN EMERG MED, V15, P557, DOI 10.1016/S0196-0644(86)80993-3; Bijnen CL, 2003, DIGEST SURG, V20, P115, DOI 10.1159/000069386; Hardin DM, 1999, AM FAM PHYSICIAN, V60, P2027; Lee JH, 2005, AM J ROENTGENOL, V184, P91, DOI 10.2214/ajr.184.1.01840091; Longmore M, 2007, OXFORD HDB CLIN MED, P294; Malik AA, 1998, AUST NZ J SURG, V68, P504, DOI 10.1111/j.1445-2197.1998.tb04811.x; OOMS HWA, 1991, BRIT J SURG, V78, P315, DOI 10.1002/bjs.1800780316; Stephens P L, 1999, Conn Med, V63, P137; Terasawa T, 2004, ANN INTERN MED, V141, P537, DOI 10.7326/0003-4819-141-7-200410050-00011; WADE DS, 1993, ARCH SURG-CHICAGO, V128, P1039; WALKER SJ, 1995, ANN ROY COLL SURG, V77, P358	11	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2011	343								d4444	10.1136/bmj.d4444	http://dx.doi.org/10.1136/bmj.d4444			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822VM	21917840				2022-12-28	WOS:000295078100002
J	Holmes, D				Holmes, David			Profile Klaus Rabe: incoming President of the ERS	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 10	2011	378	9795					977	977		10.1016/S0140-6736(11)61437-2	http://dx.doi.org/10.1016/S0140-6736(11)61437-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HO	21907852	Bronze			2022-12-28	WOS:000295193200013
J	Ehrlicher, AJ; Nakamura, F; Hartwig, JH; Weitz, DA; Stossel, TP				Ehrlicher, A. J.; Nakamura, F.; Hartwig, J. H.; Weitz, D. A.; Stossel, T. P.			Mechanical strain in actin networks regulates FilGAP and integrin binding to filamin A	NATURE			English	Article							MOLECULAR MOTORS; AUTO-INHIBITION; CROSS-LINKING; LIVING CELLS; MECHANOTRANSDUCTION; PROTEINS	Mechanical stresses elicit cellular reactions mediated by chemical signals. Defective responses to forces underlie human medical disorders(1-4) such as cardiac failure(5) and pulmonary injury(6). The actin cytoskeleton's connectivity enables it to transmit forces rapidly over large distances(7), implicating it in these physiological and pathological responses. Despite detailed knowledge of the cytoskeletal structure, the specific molecular switches that convert mechanical stimuli into chemical signals have remained elusive. Here we identify the actin-binding protein filamin A (FLNA)(8,9) as a central mechanotransduction element of the cytoskeleton. We reconstituted a minimal system consisting of actin filaments, FLNA and two FLNA-binding partners: the cytoplasmic tail of beta-integrin, and FilGAP. Integrins form an essential mechanical linkage between extracellular and intracellular environments, with beta-integrin tails connecting to the actin cytoskeleton by binding directly to filamin(4). FilGAP is an FLNA-binding GTPase-activating protein specific for RAC, which in vivo regulates cell spreading and bleb formation(10). Using fluorescence loss after photoconversion, a novel, high-speed alternative to fluorescence recovery after photobleaching(11), we demonstrate that both externally imposed bulk shear and myosin-II-driven forces differentially regulate the binding of these partners to FLNA. Consistent with structural predictions, strain increases beta-integrin binding to FLNA, whereas it causes FilGAP to dissociate from FLNA, providing a direct and specific molecular basis for cellular mechanotransduction. These results identify a molecular mechanotransduction element within the actin cytoskeleton, revealing that mechanical strain of key proteins regulates the binding of signalling molecules.	[Ehrlicher, A. J.; Nakamura, F.; Hartwig, J. H.; Stossel, T. P.] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp,Translat Med Div, Boston, MA 02115 USA; [Ehrlicher, A. J.; Weitz, D. A.] Harvard Univ, Dept Phys, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University	Nakamura, F (corresponding author), Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp,Translat Med Div, Boston, MA 02115 USA.	aje@seas.harvard.edu; fnakamura@rics.bwh.harvard.edu	Nakamura, Fumihiko/N-5476-2016	Ehrlicher, Allen/0000-0003-3030-979X; Nakamura, Fumihiko/0000-0002-6872-4246	NIH [R01 HL19429, T32 HL07680]; Harvard University Science and Engineering Committee; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL019429, T32HL007680] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University Science and Engineering Committee; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge the Harvard Materials Research and Engineering Center (DMR-0820484) for confocal imaging, and M. Ginsberg, J. Lippincott-Schwartz and V. Verkhusha for providing complementary DNA for PA-GFP and PA-mCherry constructs. We thank T. Collins for technical assistance, L. Jawerth and V. Zaburdaev for discussions, and J. Wilking and K. Guenthner for help with the manuscript. This work was supported by grants NIH R01 HL19429 (T. P. S.) and NIH T32 HL07680 (A. J. E.) and by the Harvard University Science and Engineering Committee Seed Fund for Interdisciplinary Science (D.A.W., T.P.S., F.N.).	Birukov KG, 2009, MICROVASC RES, V77, P46, DOI 10.1016/j.mvr.2008.09.006; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Chen HS, 2009, BIOPHYS J, V97, P3095, DOI 10.1016/j.bpj.2009.08.059; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Heikkinen OK, 2009, J BIOL CHEM, V284, P25450, DOI 10.1074/jbc.M109.019661; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Humphrey D, 2002, NATURE, V416, P413, DOI 10.1038/416413; Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Koenderink GH, 2009, P NATL ACAD SCI USA, V106, P15192, DOI 10.1073/pnas.0903974106; Krieger CC, 2011, P NATL ACAD SCI USA, V108, P8269, DOI 10.1073/pnas.1018887108; Kruger M, 2009, J MOL CELL CARDIOL, V46, P490, DOI 10.1016/j.yjmcc.2009.01.004; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Nakamura F, 2002, J BIOL CHEM, V277, P9148, DOI 10.1074/jbc.M111297200; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Pentikainen U, 2009, J MOL BIOL, V393, P644, DOI 10.1016/j.jmb.2009.08.035; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Shifrin Y, 2009, MOL BIOL CELL, V20, P1269, DOI 10.1091/mbc.E08-08-0872; Smith D, 2007, BIOPHYS J, V93, P4445, DOI 10.1529/biophysj.106.095919; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Weissmann C, 2009, TRAFFIC, V10, P1655, DOI 10.1111/j.1600-0854.2009.00977.x	34	252	257	3	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					260	U154		10.1038/nature10430	http://dx.doi.org/10.1038/nature10430			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21926999	Green Accepted			2022-12-28	WOS:000295782800054
J	Walker, SP; Wachs, TD; Grantham-McGregor, S; Black, MM; Nelson, CA; Huffman, SL; Baker-Henningham, H; Chang, SM; Hamadani, JD; Lozoff, B; Gardner, JMM; Powell, CA; Rahman, A; Richter, L				Walker, Susan P.; Wachs, Theodore D.; Grantham-McGregor, Sally; Black, Maureen M.; Nelson, Charles A.; Huffman, Sandra L.; Baker-Henningham, Helen; Chang, Susan M.; Hamadani, Jena D.; Lozoff, Betsy; Gardner, Julie M. Meeks; Powell, Christine A.; Rahman, Atif; Richter, Linda			Child Development 1 Inequality in early childhood: risk and protective factors for early child development	LANCET			English	Article							RANDOMIZED-CONTROLLED-TRIAL; LOW-BIRTH-WEIGHT; IRON-DEFICIENCY ANEMIA; EARLY INSTITUTIONAL DEPRIVATION; ACTIVE ANTIRETROVIRAL THERAPY; 1ST 5 YEARS; YOUNG-CHILDREN; COGNITIVE-DEVELOPMENT; PRENATAL EXPOSURE; PSYCHOSOCIAL STIMULATION	Inequality between and within populations has origins in adverse early experiences. Developmental neuroscience shows how early biological and psychosocial experiences affect brain development. We previously identified inadequate cognitive stimulation, stunting, iodine deficiency, and iron-deficiency anaemia as key risks that prevent millions of young children from attaining their developmental potential. Recent research emphasises the importance of these risks, strengthens the evidence for other risk factors including intrauterine growth restriction, malaria, lead exposure, HIV infection, maternal depression, institutionalisation, and exposure to societal violence, and identifies protective factors such as breastfeeding and maternal education. Evidence on risks resulting from prenatal maternal nutrition, maternal stress, and families affected with HIV is emerging. Interventions are urgently needed to reduce children's risk exposure and to promote development in affected children. Our goal is to provide information to help the setting of priorities for early child development programmes and policies to benefit the world's poorest children and reduce persistent inequalities.	[Walker, Susan P.] Univ W Indies, Res Inst Trop Med, Epidemiol Res Unit, Kingston 7, Jamaica; [Wachs, Theodore D.] Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA; [Grantham-McGregor, Sally] Inst Child Hlth, London, England; [Black, Maureen M.] Univ Maryland, Dept Pediat, College Pk, MD 20742 USA; [Nelson, Charles A.] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA; [Huffman, Sandra L.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Hamadani, Jena D.] ICDDR B, Child Dev Unit, Dhaka B, Bangladesh; [Lozoff, Betsy] Univ Michigan, Ctr Human Growth & Dev, Dept Pediat, Ann Arbor, MI 48109 USA; [Gardner, Julie M. Meeks] Univ W Indies, Caribbean Child Dev Ctr, Kingston 7, Jamaica; [Rahman, Atif] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England; [Richter, Linda] Univ Witwatersrand, ZA-2050 Johannesburg, South Africa	University West Indies Mona Jamaica; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of London; University College London; University System of Maryland; University of Maryland College Park; Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California Davis; International Centre for Diarrhoeal Disease Research (ICDDR); University of Michigan System; University of Michigan; University West Indies Mona Jamaica; University of Liverpool; University of Witwatersrand	Walker, SP (corresponding author), Univ W Indies, Res Inst Trop Med, Epidemiol Res Unit, Kingston 7, Jamaica.	susan.walker@uwimona.edu.jm	Hamadani, Jena/Z-1429-2018	Hamadani, Jena/0000-0003-0733-6829; Baker-Henningham, Helen/0000-0001-5697-155X; Black, Maureen/0000-0002-6427-4639	Wellcome Trust [080534/Z/06/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank Amika Wright for assistance with referencing and Anna Quigg for assistance with figure 2. A meeting of all authors to discuss review findings and coordinate the report was held in Jamaica in December, 2009, with the support of the Global Alliance for Improved Nutrition (GAIN), UNICEF, the Bernard van Leer Foundation, and the University of the West Indies. A follow-up steering committee meeting was held in May, 2010, with the support of UNICEF, the Bernard van Leer Foundation, and the Child Health and Nutrition Research Initiative. The sponsors had no role in the design and conduct of the review, interpretation and writing or the decision to submit for publication. HBH was supported by a Wellcome Trust Fellowship (# 080534/Z/06/Z). We thank the Global Child Development Group Secretariat for coordinating the meetings.	Adu-Afarwuah S, 2007, AM J CLIN NUTR, V86, P412, DOI 10.1093/ajcn/86.2.412; Alderman H, 2006, OXFORD ECON PAP, V58, P450, DOI 10.1093/oep/gpl008; Almqvist Kjerstin, 2003, Attach Hum Dev, V5, P367; Baker-Henningham H, 2009, W INDIAN MED J, V58, P460; Bangirana P, 2009, J DEV BEHAV PEDIATR, V30, P310, DOI 10.1097/DBP.0b013e3181b0f01b; Barros AJD, 2010, INT J EPIDEMIOL, V39, P285, DOI 10.1093/ije/dyp272; Black MM, 2008, LANCET, V371, P454, DOI 10.1016/S0140-6736(08)60215-9; Black MM, 2009, AM J CLIN NUTR, V89, p951S, DOI 10.3945/ajcn.2008.26692E; Black MM, 2004, AM J CLIN NUTR, V80, P903, DOI 10.1093/ajcn/80.4.903; Boris NW, 2006, INFANT MENT HEALTH J, V27, P584, DOI 10.1002/imhj.20116; Boyle MH, 2006, SOC SCI MED, V63, P2242, DOI 10.1016/j.socscimed.2006.04.034; Carba DB, 2009, ECON HUM BIOL, V7, P7, DOI 10.1016/j.ehb.2009.01.010; Castro DC, 2002, INT J BEHAV DEV, V26, P334, DOI 10.1080/01650250143000229; Caulfield LE, 2010, AM J CLIN NUTR, V92, P130, DOI 10.3945/ajcn.2010.29407; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; Chen CM, 2010, BIOMED ENVIRON SCI, V23, P83, DOI 10.1016/S0895-3988(10)60036-0; Chiriboga CA, 2005, J PEDIATR-US, V146, P402, DOI 10.1016/j.jpeds.2004.10.021; Christian P, 2010, JAMA-J AM MED ASSOC, V304, P2716, DOI 10.1001/jama.2010.1861; Clarke SE, 2008, LANCET, V372, P127, DOI 10.1016/S0140-6736(08)61034-X; Cluver L, 2007, J CHILD ADOLESC MENT, V19, P1, DOI 10.2989/17280580709486631; Colombo J, 2004, CHILD DEV, V75, P1254, DOI 10.1111/j.1467-8624.2004.00737.x; Cooper PJ, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b974; Corapci F, 2010, J PEDIATR PSYCHOL, V35, P296, DOI 10.1093/jpepsy/jsp065; Crookston BT, 2010, J NUTR, V140, P1996, DOI 10.3945/jn.109.118927; Davidson PW, 2008, NEUROTOXICOLOGY, V29, P453, DOI 10.1016/j.neuro.2008.02.009; Dawson G, 2000, DEV PSYCHOPATHOL, V12, P695, DOI 10.1017/S0954579400004089; DHINGRA P, 2004, 2 WORLD C PED GASTR; Dowd JB, 2009, INT J EPIDEMIOL, V38, P1297, DOI 10.1093/ije/dyp277; Edwards SC, 2010, ENVIRON HEALTH PERSP, V118, P1326, DOI 10.1289/ehp.0901070; Emond AM, 2006, ACTA PAEDIATR, V95, P1249, DOI 10.1080/08035250600615127; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Fernald LCH, 2009, SOC SCI MED, V68, P2180, DOI 10.1016/j.socscimed.2009.03.032; Fernando D, 2006, AM J TROP MED HYG, V74, P386, DOI 10.4269/ajtmh.2006.74.386; Fernando D, 2003, T ROY SOC TROP MED H, V97, P161, DOI 10.1016/S0035-9203(03)90107-6; Floyd S, 2007, AIDS CARE, V19, P781, DOI 10.1080/09540120601163227; Friedman J, 2011, NO SMALL MATTER IMPA, P51; Fries ABW, 2008, DEV PSYCHOBIOL, V50, P588, DOI 10.1002/dev.20319; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Gray GE, 2006, VULNERABLE CHILD YOU, V1, P15, DOI 10.1080/17450120600659051; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Hamadani JD, 2010, INT J EPIDEMIOL, V39, P1206, DOI 10.1093/ije/dyp369; Handal AJ, 2007, ENVIRON HEALTH PERSP, V115, P128, DOI 10.1289/ehp.9261; Hertzman C, 2010, ANNU REV PUBL HEALTH, V31, P329, DOI 10.1146/annurev.publhealth.012809.103538; Hoddinott J, 2008, LANCET, V371, P411, DOI 10.1016/S0140-6736(08)60205-6; Innis SM, 2008, AM J CLIN NUTR, V87, P548, DOI 10.1093/ajcn/87.3.548; Jedrychowski W, 2009, NEUROEPIDEMIOLOGY, V32, P270, DOI 10.1159/000203075; Jin XM, 2007, J DEV BEHAV PEDIATR, V28, P213, DOI 10.1097/dbp.0b013e31802d410b; Judge MP, 2007, AM J CLIN NUTR, V85, P1572, DOI 10.1093/ajcn/85.6.1572; Jukes MCH, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010019; Kagitcibasi C, 2009, J APPL DEV PSYCHOL, V30, P764, DOI 10.1016/j.appdev.2009.05.003; Kihara M, 2006, TROP MED INT HEALTH, V11, P386, DOI 10.1111/j.1365-3156.2006.01579.x; Kithakye M, 2010, CHILD DEV, V81, P1114, DOI 10.1111/j.1467-8624.2010.01457.x; Kordas K, 2009, J DEV BEHAV PEDIATR, V30, P131, DOI 10.1097/DBP.0b013e31819e6a48; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Kramer MS, 2008, PEDIATRICS, V121, pE435, DOI 10.1542/peds.2007-1248; Kuklina EV, 2006, EARLY HUM DEV, V82, P425, DOI 10.1016/j.earlhumdev.2005.10.018; Li Q, 2009, PEDIATRICS, V123, pE685, DOI 10.1542/peds.2008-3007; Lindsey JC, 2007, PEDIATRICS, V119, pE681, DOI 10.1542/peds.2006-1145; Lorntz B, 2006, PEDIATR INFECT DIS J, V25, P513, DOI 10.1097/01.inf.0000219524.64448.90; Lozoff B, 2010, PEDIATRICS, V126, pE884, DOI 10.1542/peds.2009-3535; Lukowski AF, 2010, NUTR NEUROSCI, V13, P54, DOI 10.1179/147683010X12611460763689; LUSK D, 2003, COMMUNITY CARE ORPHA; Lustig S. L., 2010, CHAOS ITS INFLUENCE, DOI DOI 10.1037/12057-015; Marques RC, 2009, COGN BEHAV NEUROL, V22, P134, DOI 10.1097/WNN.0b013e3181a72248; Marshall PJ, 2008, DEV PSYCHOPATHOL, V20, P861, DOI 10.1017/S0954579408000412; Martorell R, 2010, J NUTR, V140, P348, DOI 10.3945/jn.109.112300; McConachie H, 2000, J PEDIATR-US, V137, P769, DOI 10.1067/mpd.2000.110135; McGrath N, 2006, PEDIATRICS, V117, pE216, DOI 10.1542/peds.2004-1668; Mehta MA, 2009, J CHILD PSYCHOL PSYC, V50, P943, DOI 10.1111/j.1469-7610.2009.02084.x; Mirza I, 2009, J INTELL DISABIL RES, V53, P559, DOI 10.1111/j.1365-2788.2009.01176.x; Murray-Kolb LE, 2009, AM J CLIN NUTR, V89, p946S, DOI 10.3945/ajcn.2008.26692D; Myers GJ, 2009, NEUROTOXICOLOGY, V30, P338, DOI 10.1016/j.neuro.2009.01.005; Nahar B, 2009, EUR J CLIN NUTR, V63, P725, DOI 10.1038/ejcn.2008.44; Nair MKC, 2009, INDIAN PEDIATR, V46, pS20; Nelson CA, 2009, AM SCI, V97, P222, DOI 10.1511/2009.78.222; Nores M., 2009, ECON EDUC REV, V29, P271; Olney DK, 2007, J NUTR, V137, P2756, DOI 10.1093/jn/137.12.2756; Pal DK, 2002, SOC SCI MED, V54, P1867, DOI 10.1016/S0277-9536(01)00154-X; Patrick PD, 2005, CHILD NEUROPSYCHOL, V11, P233, DOI 10.1080/092970490911252; Paxson C, 2007, J HUM RESOUR, V42, P49, DOI 10.3368/jhr.XLII.1.49; Peirano PD, 2007, PEDIATR RES, V62, P715, DOI 10.1203/PDR.0b013e3181586aef; Perez EM, 2005, J NUTR, V135, P850, DOI 10.1093/jn/135.4.850; Potterton J, 2010, DEV MED CHILD NEUROL, V52, P547, DOI 10.1111/j.1469-8749.2009.03534.x; Qouta S, 2008, INT J BEHAV DEV, V32, P310, DOI 10.1177/0165025408090973; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Russell PSS, 1999, BRIT J PSYCHIAT, V174, P254, DOI 10.1192/bjp.174.3.254; Rutter M, 2010, MONOGR SOC RES CHILD, V75, P1, DOI 10.1111/j.1540-5834.2010.00548.x; Sabet F, 2009, INT J EPIDEMIOL, V38, P944, DOI 10.1093/ije/dyp204; Sadeh A, 2008, PEDIATRICS, V121, P46, DOI 10.1542/peds.2007-1348; Saloojee G, 2007, CHILD CARE HLTH DEV, V33, P230, DOI 10.1111/j.1365-2214.2006.00645.x; Sanmaneechai Oranee, 2005, J Med Assoc Thai, V88, P1873; Santos DN, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-202; Shafir T, 2006, HUM MOVEMENT SCI, V25, P821, DOI 10.1016/j.humov.2006.06.006; Sheffield PE, 2011, ENVIRON HEALTH PERSP, V119, P291, DOI 10.1289/ehp.1002233; Sherr L, 2009, PSYCHOL HEALTH MED, V14, P387, DOI 10.1080/13548500903012897; Shin JY, 2009, J INTELL DISABIL RES, V53, P339, DOI 10.1111/j.1365-2788.2008.01151.x; Smith L, 2008, S AFR J CHILD HEALTH, V2, P108; St Petersburg USA Orphanage Res Team, 2008, MONOGR SOC RES CHILD, V73, P1, DOI 10.1111/j.1540-5834.2008.00483.x; Stein AD, 2008, ARCH PEDIAT ADOL MED, V162, P612, DOI 10.1001/archpedi.162.7.612; Stiles J., 2008, FUNDAMENTALS BRAIN D; Stith AY, 2003, APPL PSYCHOL-INT REV, V52, P614, DOI 10.1111/1464-0597.00154; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Tang DL, 2008, ENVIRON HEALTH PERSP, V116, P674, DOI 10.1289/ehp.10471; Thabet AAM, 2006, BRIT J PSYCHIAT, V188, P154, DOI 10.1192/bjp.188.2.154; Thuilliez Josselin, 2009, REV EC DEV REV EC DEV, V2, P127; Tofail F, 2008, AM J CLIN NUTR, V87, P704, DOI 10.1093/ajcn/87.3.704; Torres-Sanchez L, 2009, NEUROTOXICOLOGY, V30, P1162, DOI 10.1016/j.neuro.2009.08.010; Tottenham N, 2010, DEVELOPMENTAL SCI, V13, P46, DOI 10.1111/j.1467-7687.2009.00852.x; Unay B, 2004, ARCH DIS CHILD-FETAL, V89, P177, DOI 10.1136/adc.2002.021014; van Ijzendoorn MH, 2008, MERRILL PALMER QUART, V54, P341; van IJzendoorn MH, 2006, J CHILD PSYCHOL PSYC, V47, P1228, DOI 10.1111/j.1469-7610.2006.01675.x; Van Rie A, 2008, PEDIATRICS, V122, pE123, DOI 10.1542/peds.2007-2558; Van Rie A, 2007, EUR J PAEDIATR NEURO, V11, P1, DOI 10.1016/j.ejpn.2006.10.006; Van Rie A, 2009, JAIDS-J ACQ IMM DEF, V52, P636, DOI 10.1097/QAI.0b013e3181b32646; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2005, ACTA PAEDIATR, V94, P1656, DOI 10.1080/08035250500252658; Wachs TD, 2008, DEV PSYCHOBIOL, V50, P217, DOI 10.1002/dev.20284; Wachs TD, 2009, CHILD DEV PERSPECT, V3, P51, DOI 10.1111/j.1750-8606.2008.00077.x; Walker SP, 2007, J NUTR, V137, P2464, DOI 10.1093/jn/137.11.2464; Walker SP, 2007, EARLY HUM DEV, V83, P355, DOI 10.1016/j.earlhumdev.2006.07.006; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Walker SP, 2006, BRIT MED J, V333, P472, DOI 10.1136/bmj.38897.555208.2F; Walker SP, 2010, DEV MED CHILD NEUROL, V52, pe148, DOI 10.1111/j.1469-8749.2010.03637.x; Wang LW, 2008, ACTA PAEDIATR, V97, P568, DOI 10.1111/j.1651-2227.2008.00738.x; Wang SX, 2007, ENVIRON HEALTH PERSP, V115, P643, DOI 10.1289/ehp.9270; Wang WL, 2008, J PEDIATR-US, V153, P333, DOI 10.1016/j.jpeds.2008.04.017; Zabina H, 2009, REPROD HEALTH MATTER, V17, P162, DOI 10.1016/S0968-8080(09)33438-2	127	839	860	9	212	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 8	2011	378	9799					1325	1338		10.1016/S0140-6736(11)60555-2	http://dx.doi.org/10.1016/S0140-6736(11)60555-2			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	831IU	21944375				2022-12-28	WOS:000295724300028
J	Arner, P; Bernard, S; Salehpour, M; Possnert, G; Liebl, J; Steier, P; Buchholz, BA; Eriksson, M; Arner, E; Hauner, H; Skurk, T; Ryden, M; Frayn, KN; Spalding, KL				Arner, Peter; Bernard, Samuel; Salehpour, Mehran; Possnert, Goran; Liebl, Jakob; Steier, Peter; Buchholz, Bruce A.; Eriksson, Mats; Arner, Erik; Hauner, Hans; Skurk, Thomas; Ryden, Mikael; Frayn, Keith N.; Spalding, Kirsty L.			Dynamics of human adipose lipid turnover in health and metabolic disease	NATURE			English	Article							FAMILIAL COMBINED HYPERLIPIDEMIA; CELL TURNOVER; FATTY-ACIDS; IN-VIVO; TISSUE; ASSIMILATION; RADIOCARBON; OXIDATION; LIPOLYSIS	Adipose tissue mass is determined by the storage and removal of triglycerides in adipocytes(1). Little is known, however, about adipose lipid turnover in humans in health and pathology. To study this in vivo, here we determined lipid age by measuring C-14 derived from above ground nuclear bomb tests in adipocyte lipids. We report that during the average ten-year lifespan of human adipocytes, triglycerides are renewed six times. Lipid age is independent of adipocyte size, is very stable across a wide range of adult ages and does not differ between genders. Adipocyte lipid turnover, however, is strongly related to conditions with disturbed lipid metabolism. In obesity, triglyceride removal rate (lipolysis followed by oxidation) is decreased and the amount of triglycerides stored each year is increased. In contrast, both lipid removal and storage rates are decreased in non-obese patients diagnosed with the most common hereditary form of dyslipidaemia, familial combined hyperlipidaemia. Lipid removal rate is positively correlated with the capacity of adipocytes to break down triglycerides, as assessed through lipolysis, and is inversely related to insulin resistance. Our data support a mechanism in which adipocyte lipid storage and removal have different roles in health and pathology. High storage but low triglyceride removal promotes fat tissue accumulation and obesity. Reduction of both triglyceride storage and removal decreases lipid shunting through adipose tissue and thus promotes dyslipidaemia. We identify adipocyte lipid turnover as a novel target for prevention and treatment of metabolic disease.	[Arner, Peter; Eriksson, Mats; Arner, Erik; Ryden, Mikael] Karolinska Univ Hosp, Dept Med, SE-14186 Stockholm, Sweden; [Bernard, Samuel] Univ Lyon, CNRS UMR 5208, Inst Camille Jordan, F-69622 Villeurbanne, France; [Salehpour, Mehran; Possnert, Goran] Uppsala Univ, Dept Phys & Astron, SE-75120 Uppsala, Sweden; [Liebl, Jakob; Steier, Peter] Univ Vienna, Fac Phys Isotope Res, A-1090 Vienna, Austria; [Buchholz, Bruce A.] Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94551 USA; [Hauner, Hans; Skurk, Thomas] Tech Univ Munich, Else Kroner Fresenius Ctr Nutr Med, D-85350 Weihenstephan, Germany; [Frayn, Keith N.] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Spalding, Kirsty L.] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Uppsala University; University of Vienna; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Technical University of Munich; University of Oxford; Karolinska Institutet	Arner, P (corresponding author), Karolinska Univ Hosp, Dept Med, SE-14186 Stockholm, Sweden.	peter.arner@ki.se; kirsty.spalding@ki.se	Spalding, Kirsty/CAF-4248-2022; Buchholz, Bruce A/G-1356-2011; Arner, Erik/A-1895-2010; Steier, Peter/AAZ-6043-2020; Bernard, Samuel/A-5623-2009; spalding, kirsty/I-6046-2017	Spalding, Kirsty/0000-0002-5189-7028; Buchholz, Bruce A/0000-0002-9531-551X; Arner, Erik/0000-0003-1225-4908; Bernard, Samuel/0000-0002-8442-9968; Eriksson, Mats/0000-0001-6481-5549; Skurk, Thomas/0000-0002-6875-1658; Arner, Peter/0000-0002-6208-6220	Swedish Research Council; Swedish Foundation for Strategic Research; Swedish Heart and Lung Foundation; Novo Nordic Foundation; Swedish Diabetes Foundation; Karolinska Institutet; Swedish Cancer Society; Uppsala BIO, Sweden; NIH/NCRR [RR13461]; ERC [261258-HUFATREG]; European Commission [LSHM-CT-2005-018734, HEALTH-F2-2008-201100]; US Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103483] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Novo Nordic Foundation(Novo Nordisk Foundation); Swedish Diabetes Foundation; Karolinska Institutet(Karolinska Institutet); Swedish Cancer Society(Swedish Cancer Society); Uppsala BIO, Sweden; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ERC(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); US Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Swedish Research Council, Swedish Foundation for Strategic Research, Swedish Heart and Lung Foundation, Novo Nordic Foundation, Swedish Diabetes Foundation, Strategic Research Program in Diabetes at the Karolinska Institutet, Swedish Cancer Society, Uppsala BIO, Sweden, NIH/NCRR Grant RR13461, ERC grant 261258-HUFATREG and by the projects 'Hepatic and adipose tissue and functions in the metabolic syndrome' (HEPADIP, http://www.hepadip.org/) and 'Adipokines as drug targets to combat adverse effects of excess adipose tissue' (ADAPT, http://www.adapt-eu.net), which were supported by the European Commission as an Integrated Project under the 6th and the 7th Framework Programmes (contract LSHM-CT-2005-018734 and contract HEALTH-F2-2008-201100). This work was performed in part under the auspices of the US Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. The authors would like to acknowledge E. Sjolin, K. Wahlen, B.-M. Leijonhufvud, K. Hertel and Y. Widlund for technical assistance. We would like to thank F. Barnabe-Heider and J. Frisen for useful comments on the manuscript.	Arner P, 1997, CURR OPIN LIPIDOL, V8, P89, DOI 10.1097/00041433-199704000-00006; Ayyobi AF, 2003, AM J CARDIOL, V92, p27J, DOI 10.1016/S0002-9149(03)00613-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bernard S, 2010, NUCL INSTRUM METH B, V268, P1295, DOI 10.1016/j.nimb.2009.10.156; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; BJORNTORP P, 1974, METABOLISM, V23, P1091, DOI 10.1016/0026-0495(74)90076-6; Blaak EE, 2006, J CLIN ENDOCR METAB, V91, P1462, DOI 10.1210/jc.2005-1598; de Graaf J, 2002, J ROY SOC MED, V95, P46; EKSTEDT B, 1970, LIPIDS, V5, P858, DOI 10.1007/BF02531981; GRUNDY SM, 1987, ARTERIOSCLEROSIS, V7, P203; Houmard JA, 2008, AM J PHYSIOL-REG I, V294, pR1111, DOI 10.1152/ajpregu.00396.2007; KERPEL S, 1961, BIOCHIM BIOPHYS ACTA, V46, P495, DOI 10.1016/0006-3002(61)90580-7; KLEIN RA, 1980, LIPIDS, V15, P572, DOI 10.1007/BF02534181; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; MARIN P, 1995, J CLIN ENDOCR METAB, V80, P239, DOI 10.1210/jc.80.1.239; MARIN P, 1990, EUR J CLIN INVEST, V20, P158, DOI 10.1111/j.1365-2362.1990.tb02263.x; NYDAL R, 1965, NATURE, V206, P1029, DOI 10.1038/2061029a0; Perl S, 2010, J CLIN ENDOCR METAB, V95, pE234, DOI 10.1210/jc.2010-0932; REYNISDOTTIR S, 1995, J CLIN INVEST, V95, P2161, DOI 10.1172/JCI117905; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; van der Kallen CJH, 2002, ATHEROSCLEROSIS, V164, P337, DOI 10.1016/S0021-9150(02)00109-0	24	244	250	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2011	478	7367					110	113		10.1038/nature10426	http://dx.doi.org/10.1038/nature10426			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21947005	Green Accepted, Green Submitted			2022-12-28	WOS:000295575400044
J	Virgin, HW; Todd, JA				Virgin, Herbert W.; Todd, John A.			Metagenomics and Personalized Medicine	CELL			English	Article							INFLAMMATORY-BOWEL-DISEASE; TYPE-1 DIABETES-MELLITUS; DIABETOGENIC T-CELLS; GUT MICROBIOTA; INTESTINAL MICROBIOTA; CROHNS-DISEASE; IMMUNE-SYSTEM; ENTEROVIRUS INFECTION; COMMENSAL BACTERIA; VIRAL-INFECTION	The microbiome is a complex community of Bacteria, Archaea, Eukarya, and viruses that infect humans and live in our tissues. It contributes the majority of genetic information to our metagenome and, consequently, influences our resistance and susceptibility to diseases, especially common inflammatory diseases, such as type 1 diabetes, ulcerative colitis, and Crohn's disease. Here we discuss how host-gene-microbial interactions are major determinants for the development of these multifactorial chronic disorders and, thus, for the relationship between genotype and phenotype. We also explore how genome-wide association studies (GWAS) on autoimmune and inflammatory diseases are uncovering mechanism-based subtypes for these disorders. Applying these emerging concepts will permit a more complete understanding of the etiologies of complex diseases and underpin the development of both next-generation animal models and new therapeutic strategies for targeting personalized disease phenotypes.	[Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, Dept Mol Microbiol, St Louis, MO 63110 USA; [Virgin, Herbert W.] Washington Univ, Sch Med, Midwest Reg Ctr Excellence Biodef & Emerging Infe, St Louis, MO 63110 USA; [Todd, John A.] Univ Cambridge, Addenbrookes Hosp, Juvenile Diabet Res Fdn,Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab,Dept Med Ge, Cambridge CB2 0XY, England	Washington University (WUSTL); Washington University (WUSTL); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Dept Mol Microbiol, St Louis, MO 63110 USA.	virgin@wustl.edu; john.todd@cimr.cam.ac.uk	; Todd, John/A-3542-2010	Virgin, Herbert/0000-0001-8580-7628; Todd, John/0000-0003-2740-8148	NCI; NIAID; NCRR; Crohn's and Colitis Foundation of America; Broad Medical Foundation; NIDDK; NIHR; Wellcome Trust; Juvenile Diabetes Research Foundation International; European Union; National Institute for Health Research [NF-SI-0508-10275] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA074730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065982, R01AI084887, R01AI054483] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011170] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Crohn's and Colitis Foundation of America; Broad Medical Foundation; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIHR(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); European Union(European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to acknowledge helpful conversations with Thad Stappenbeck, Ramnik Xavier, Emil Unanue, Jeff Gordon, Balfour Sartor, Adolfo Garcia-Sastre, and Dermot McGovern. We thank Tom Smith for providing the images of noroviruses used in Figure 4. H. W. V. is supported by the NCI, NIAID, NCRR, the Crohn's and Colitis Foundation of America, and the Broad Medical Foundation. J.A.T. is supported by the NIDDK, NIHR, the Wellcome Trust, the Juvenile Diabetes Research Foundation International, and the European Union.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Bottini N, 2006, SEMIN IMMUNOL, V18, P207, DOI 10.1016/j.smim.2006.03.008; Brehm MA, 2010, DIABETES, V59, P2265, DOI 10.2337/db10-0323; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Calderon B, 2011, P NATL ACAD SCI USA, V108, P1561, DOI 10.1073/pnas.1018973108; Calderon B, 2011, P NATL ACAD SCI USA, V108, P1567, DOI 10.1073/pnas.1018975108; Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z; Cardwell CR, 2010, DIABETOLOGIA, V53, P641, DOI 10.1007/s00125-009-1648-5; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; Cooper JD, 2011, DIABETES, V60, P1624, DOI 10.2337/db10-1656; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Ehlers S, 2010, TRENDS IMMUNOL, V31, P184, DOI 10.1016/j.it.2010.02.003; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Foxman EF, 2011, NAT REV MICROBIOL, V9, P254, DOI 10.1038/nrmicro2541; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Gianani R, 2010, DIABETOLOGIA, V53, P690, DOI 10.1007/s00125-009-1642-y; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Hansen EE, 2011, P NATL ACAD SCI USA, V108, P4599, DOI 10.1073/pnas.1000071108; Hansen J, 2010, CURR OPIN GASTROEN, V26, P564, DOI 10.1097/MOG.0b013e32833f1195; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326; Kang SS, 2008, PLOS MED, V5, P424, DOI 10.1371/journal.pmed.0050041; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim YG, 2011, CELL HOST MICROBE, V9, P496, DOI 10.1016/j.chom.2011.05.006; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Long SA, 2011, GENES IMMUN, V12, P116, DOI 10.1038/gene.2010.54; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McCartney SA, 2011, J CLIN INVEST, V121, P1497, DOI 10.1172/JCI44005; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Melmed GY, 2010, NAT REV GASTRO HEPAT, V7, P110, DOI 10.1038/nrgastro.2009.218; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Odze R, 2003, MODERN PATHOL, V16, P347, DOI 10.1097/01.MP.0000064746.82024.D1; Oikarinen S, 2011, DIABETES, V60, P276, DOI 10.2337/db10-0186; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Pfluger M, 2010, HORM METAB RES, V42, P143, DOI 10.1055/s-0029-1241830; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Robinson T, 2011, J IMMUNOL, V187, P1298, DOI 10.4049/jimmunol.1100857; Roesch LFW, 2009, ISME J, V3, P536, DOI 10.1038/ismej.2009.5; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sczesnak A, 2011, CELL HOST MICROBE, V10, P260, DOI 10.1016/j.chom.2011.08.005; Smyth DJ, 2011, DIABETES, V60, P3081, DOI 10.2337/db11-0638; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Stappenbeck TS, 2011, AUTOPHAGY, V7, P355, DOI 10.4161/auto.7.2.13074; Stene LC, 2010, DIABETES, V59, P3174, DOI 10.2337/db10-0866; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Turley SJ, 2005, P NATL ACAD SCI USA, V102, P17729, DOI 10.1073/pnas.0509006102; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vehik K, 2011, DIABETES-METAB RES, V27, P3, DOI 10.1002/dmrr.1141; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; White DW, 2010, BLOOD, V115, P4377, DOI 10.1182/blood-2009-09-245464; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yeung WCG, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d35	88	151	158	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2011	147	1					44	56		10.1016/j.cell.2011.09.009	http://dx.doi.org/10.1016/j.cell.2011.09.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962506	Green Accepted, Bronze			2022-12-28	WOS:000295396700014
J	Laxon, S; Ranganath, L; Timmis, O				Laxon, Simon; Ranganath, Lakshminarayan; Timmis, Oliver			A PATIENT'S JOURNEY Living with alkaptonuria	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ranganath, Lakshminarayan] Royal Liverpool & Broadgreen Univ Hosp, Dept Clin Biochem & Metab Med, Liverpool L7 8XP, Merseyside, England; [Timmis, Oliver] AKU Soc, Cambridge CB2 9JG, England	Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital	Laxon, S (corresponding author), 66 Northfield Rd, Coventry CV1 2BP, W Midlands, England.	laxon66@ntlworld.com							0	6	6	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 29	2011	343								d5155	10.1136/bmj.d5155	http://dx.doi.org/10.1136/bmj.d5155			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829KC	21964346	Bronze			2022-12-28	WOS:000295577500001
J	Kontos, T				Kontos, Takis			QUANTUM PHYSICS Single electrons take the bus	NATURE			English	Editorial Material							DOTS		Ecole Normale Super, Lab Pierre Aigrain, F-75231 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite	Kontos, T (corresponding author), Ecole Normale Super, Lab Pierre Aigrain, F-75231 Paris 05, France.	kontos@lpa.ens.fr						Bluhm H, 2011, NAT PHYS, V7, P109, DOI 10.1038/NPHYS1856; Feve G, 2007, SCIENCE, V316, P1169, DOI 10.1126/science.1141243; Foletti S, 2009, NAT PHYS, V5, P903, DOI 10.1038/NPHYS1424; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Hermelin S, 2011, NATURE, V477, P435, DOI 10.1038/nature10416; McNeil RPG, 2011, NATURE, V477, P439, DOI 10.1038/nature10444	6	2	2	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2011	477	7365					414	414		10.1038/477414a	http://dx.doi.org/10.1038/477414a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21938061				2022-12-28	WOS:000295080500028
J	Wiedenheft, B; Lander, GC; Zhou, KH; Jore, MM; Brouns, SJJ; van der Oost, J; Doudna, JA; Nogales, E				Wiedenheft, Blake; Lander, Gabriel C.; Zhou, Kaihong; Jore, Matthijs M.; Brouns, Stan J. J.; van der Oost, John; Doudna, Jennifer A.; Nogales, Eva			Structures of the RNA-guided surveillance complex from a bacterial immune system	NATURE			English	Article							CRISPR RNA; ELECTRON-MICROSCOPY; TARGET RECOGNITION; SEED SEQUENCE; PROKARYOTES; INTERFERENCE; REPEATS; DNA; ENDORIBONUCLEASE; MATURATION	Bacteria and archaea acquire resistance to viruses and plasmids by integrating short fragments of foreign DNA into clustered regularly interspaced short palindromic repeats (CRISPRs). These repetitive loci maintain a genetic record of all prior encounters with foreign transgressors(1-6). CRISPRs are transcribed and the long primary transcript is processed into a library of short CRISPR-derived RNAs (crRNAs) that contain a unique sequence complementary to a foreign nucleic-acid challenger(7-12). In Escherichia coli, crRNAs are incorporated into a multisubunit surveillance complex called Cascade (CRISPR-associated complex for antiviral defence), which is required for protection against bacteriophages(13,14). Here we use cryo-electron microscopy to determine the subnanometre structures of Cascade before and after binding to a target sequence. These structures reveal a sea-horse-shaped architecture in which the crRNA is displayed along a helical arrangement of protein subunits that protect the crRNA from degradation while maintaining its availability for base pairing. Cascade engages invading nucleic acids through high-affinity base-pairing interactions near the 5' end of the crRNA. Base pairing extends along the crRNA, resulting in a series of short helical segments that trigger a concerted conformational change. This conformational rearrangement may serve as a signal that recruits a trans-acting nuclease (Cas3) for destruction of invading nucleic-acid sequences.	[Wiedenheft, Blake; Zhou, Kaihong; Doudna, Jennifer A.; Nogales, Eva] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Wiedenheft, Blake; Zhou, Kaihong; Doudna, Jennifer A.; Nogales, Eva] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Lander, Gabriel C.; Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Jore, Matthijs M.; Brouns, Stan J. J.; van der Oost, John] Wageningen Univ, Dept Agrotechnol & Food Sci, Microbiol Lab, NL-6703 HB Wageningen, Netherlands; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Wageningen University & Research; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	doudna@berkeley.edu; enogales@lbl.gov	Jore, Matthijs/F-7852-2018; van+der+Oost, John/Y-2548-2019	Jore, Matthijs/0000-0002-0686-370X; Brouns, Stan/0000-0002-9573-1724; Lander, Gabriel C./0000-0003-4921-1135	National Science Foundation; Veni grant [863.08.014]; NWO [865.05.001]; Damon Runyon Cancer Research Foundation	National Science Foundation(National Science Foundation (NSF)); Veni grant; NWO(Netherlands Organization for Scientific Research (NWO)); Damon Runyon Cancer Research Foundation	We are grateful to the Doudna and Nogales lab members for their reading of this manuscript, and to P. Grob, S. Hill, R. Hall and T. Houweling for technical support. This project was funded by a National Science Foundation grant to J.A.D., a Veni grant to S.J.J.B. (863.08.014) and a NWO Vici grant to J.v.d.O. (865.05.001). G. C. L. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation. B. W. is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation. E.N. and J.A.D. are Howard Hughes Medical Institute investigators.	Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Egelman EH, 2007, CURR OPIN STRUC BIOL, V17, P556, DOI 10.1016/j.sbi.2007.07.006; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Parker JS, 2009, MOL CELL, V33, P204, DOI 10.1016/j.molcel.2008.12.012; Roseman AM, 2004, J STRUCT BIOL, V145, P91, DOI 10.1016/j.jsb.2003.11.007; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108	31	273	314	4	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2011	477	7365					486	U141		10.1038/nature10402	http://dx.doi.org/10.1038/nature10402			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21938068	Green Accepted			2022-12-28	WOS:000295080500045
J	Sobolev, SV; Sobolev, AV; Kuzmin, DV; Krivolutskaya, NA; Petrunin, AG; Arndt, NT; Radko, VA; Vasiliev, YR				Sobolev, Stephan V.; Sobolev, Alexander V.; Kuzmin, Dmitry V.; Krivolutskaya, Nadezhda A.; Petrunin, Alexey G.; Arndt, Nicholas T.; Radko, Viktor A.; Vasiliev, Yuri R.			Linking mantle plumes, large igneous provinces and environmental catastrophes	NATURE			English	Article							CARBON-ISOTOPE FLUCTUATIONS; FLOOD-BASALT EVENTS; MASS EXTINCTION; PERMIAN EXTINCTION; SIBERIAN TRAPS; MELT; VOLCANISM; CONSTRAINTS; ERUPTION; HAWAIIAN	Large igneous provinces (LIPs) are known for their rapid production of enormous volumes of magma (up to several million cubic kilometres in less than a million years)(1), for marked thinning of the lithosphere(2,3), often ending with a continental break-up, and for their links to global environmental catastrophes(4,5). Despite the importance of LIPs, controversy surrounds even the basic idea that they form through melting in the heads of thermal mantle plumes(2,3,6-10). The Permo-Triassic Siberian Traps(11)-the type example and the largest continental LIP1,12-is located on thick cratonic lithosphere(1,12) and was synchronous with the largest known mass-extinction event(1). However, there is no evidence of pre-magmatic uplift or of a large lithospheric stretching(7), as predicted above a plume head(2,6,9). Moreover, estimates of magmatic CO2 degassing from the Siberian Traps are considered insufficient to trigger climatic crises(13-15), leading to the hypothesis that the release of thermogenic gases from the sediment pile caused the mass extinction(15,16). Here we present petrological evidence for a large amount (15 wt%) of dense recycled oceanic crust in the head of the plume and develop a thermomechanical model that predicts no pre-magmatic uplift and requires no lithospheric extension. The model implies extensive plume melting and heterogeneous erosion of the thick cratonic lithosphere over the course of a few hundred thousand years. The model suggests that massive degassing of CO2 and HCl, mostly from the recycled crust in the plume head, could alone trigger a mass extinction and predicts it happening before the main volcanic phase, in agreement with stratigraphic and geochronological data for the Siberian Traps and other LIPs(5).	[Sobolev, Stephan V.; Petrunin, Alexey G.] Deutsch GeoForschungsZentrum GFZ, D-14473 Potsdam, Germany; [Sobolev, Stephan V.; Petrunin, Alexey G.] Russian Acad Sci, O Yu Schmidt Inst Phys Earth, Moscow 123995, Russia; [Sobolev, Alexander V.; Arndt, Nicholas T.] Univ Grenoble 1, CNRS, ISTerre, F-38041 Grenoble 9, France; [Sobolev, Alexander V.; Kuzmin, Dmitry V.] Max Planck Inst Chem, D-55128 Mainz, Germany; [Sobolev, Alexander V.; Krivolutskaya, Nadezhda A.] Russian Acad Sci, VI Vernadsky Inst Geochem & Analyt Chem, Moscow 119991, Russia; [Kuzmin, Dmitry V.; Vasiliev, Yuri R.] Russian Acad Sci, Siberian Branch, VS Sobolev Inst Geol & Mineral, Novosibirsk 630090, Russia; [Radko, Viktor A.] Ltd Liabil Co Norilskgeologiya Norilsk, Norilsk 663330, Russia	Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Russian Academy of Sciences; Schmidt Institute of Physics of the Earth of the Russian Academy of Sciences; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie; Max Planck Society; Russian Academy of Sciences; Vernadsky Institute of Geochemistry & Analytical Chemistry; Russian Academy of Sciences; Sobolev Institute of Geology & Mineralogy of the Russian Academy of Sciences	Sobolev, SV (corresponding author), Deutsch GeoForschungsZentrum GFZ, D-14473 Potsdam, Germany.	stephan@gfz-potsdam.de; alexander.sobolev@ujf-grenoble.fr	Petrunin, Alexey/N-4247-2018; Sobolev, Stephan V/G-3813-2011; Sobolev, Alexander/AAQ-6001-2021; Sobolev, Alexander/E-6367-2010; Krivolutskaya, Nadezhda A./C-3554-2015; Vasiliev, Yurii/A-5374-2014; Petrunin, Alexey/AAD-6186-2020; Kuzmin, Dmitry/A-3809-2014; Sobolev, Alexander/AAB-4269-2021	Petrunin, Alexey/0000-0002-5439-4178; Sobolev, Stephan V/0000-0002-3382-4028; Sobolev, Alexander/0000-0002-1997-2032; Krivolutskaya, Nadezhda A./0000-0002-5709-7785; Petrunin, Alexey/0000-0002-5439-4178; Vasiliev, Yurii/0000-0002-9843-2412	Deutsche Forschungsgemeinschaft (DFG) [SPP 1375 SAMPLE (SO 425/4)]; Agence Nationale de la Recherche, France [ANR-09-CEXC-003-01]; Gottingen University, Germany; Russian Foundation for Basic Research [09-05-01193a]; Russian President [HIII-3919.2010.5]; Earth Sciences Department of Russian Academy	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Agence Nationale de la Recherche, France(French National Research Agency (ANR)); Gottingen University, Germany; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian President; Earth Sciences Department of Russian Academy	S.V.S. and A. V. S. are especially grateful to Vladimir Stepanovich Sobolev, who excited their interest in the origin of the Siberian Traps. We thank G. A. Fedorenko for providing data on the Norilsk lavas and for discussions; N. Groschopf for help in managing the electron probe microanalyser; O. Kuzmina, N. Svirskaya and T. Shlichkova for sample preparation; P. Cardin, N. Dobretsov, E. Galimov, C. Herzberg, A. Hofmann, L. Kogarko, H.-C. Nataf, J. Payne, Y. Podladchikov, I. Ryabchikov, A. Turchyn and G. Worner for discussions; and P. Kelemen for comments. S. V. S. thanks the Deutsche Forschungsgemeinschaft (DFG) SPP 1375 SAMPLE (SO 425/4) for support. The study by A. V. S. was funded by the Agence Nationale de la Recherche, France (Chair of Excellence Grant ANR-09-CEXC-003-01) and partly supported by a Gauss Professorship in Gottingen University, Germany, the Russian Foundation for Basic Research (09-05-01193a), a Russian President grant for leading Russian scientific schools (HIII-3919.2010.5) and an Earth Sciences Department of Russian Academy Grants.	Babeyko AY, 2002, EARTH PLANET SC LETT, V199, P373, DOI 10.1016/S0012-821X(02)00597-6; BEATTIE P, 1991, CONTRIB MINERAL PETR, V109, P212, DOI 10.1007/BF00306480; Beerling DJ, 2007, PHILOS T R SOC A, V365, P1843, DOI 10.1098/rsta.2007.2046; CAMPBELL IH, 1990, EARTH PLANET SC LETT, V99, P79, DOI 10.1016/0012-821X(90)90072-6; Cordery MJ, 1997, J GEOPHYS RES-SOL EA, V102, P20179, DOI 10.1029/97JB00648; Courtillot VE, 2003, CR GEOSCI, V335, P113, DOI 10.1016/S1631-0713(03)00006-3; Czamanske GK, 1998, INT GEOL REV, V40, P95, DOI 10.1080/00206819809465200; Dasgupta R, 2007, AM MINERAL, V92, P370, DOI 10.2138/am.2007.2201; Dasgupta R, 2010, EARTH PLANET SC LETT, V298, P1, DOI 10.1016/j.epsl.2010.06.039; Dobretsov NL, 2008, LITHOS, V100, P66, DOI 10.1016/j.lithos.2007.06.025; Elkins-Tanton LT, 2000, GEOPHYS RES LETT, V27, P3937, DOI 10.1029/2000GL011751; FARNETANI CG, 1994, J GEOPHYS RES-SOL EA, V99, P13813, DOI 10.1029/94JB00649; Fedorenko V.A., 1996, INT GEOL REV, V38, P99, DOI DOI 10.1080/00206819709465327; Ganino C, 2009, GEOLOGY, V37, P323, DOI 10.1130/G25325A.1; Garfunkel Z, 2008, LITHOS, V100, P49, DOI 10.1016/j.lithos.2007.06.015; Grasby SE, 2011, NAT GEOSCI, V4, P104, DOI [10.1038/ngeo1069, 10.1038/NGEO1069]; Hauri E, 2002, CHEM GEOL, V183, P115, DOI 10.1016/S0009-2541(01)00374-6; Herzberg C, 2011, J PETROL, V52, P113, DOI 10.1093/petrology/egq075; Holzapfel C, 2007, PHYS EARTH PLANET IN, V162, P186, DOI 10.1016/j.pepi.2007.04.009; Humayun M, 2004, SCIENCE, V306, P91, DOI 10.1126/science.1101050; Jarosewich E., 1980, GEOSTANDARD NEWSLETT, V4, P43, DOI [10.1111/j.1751-908X.1980.tb00273.x, DOI 10.1111/J.1751-908X.1980.TB00273.X]; Jochum KP, 2000, GEOSTANDARD NEWSLETT, V24, P87, DOI 10.1111/j.1751-908X.2000.tb00590.x; Kamo SL, 2003, EARTH PLANET SC LETT, V214, P75, DOI 10.1016/S0012-821X(03)00347-9; Katz RF, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000433; Kelemen PB, 1997, PHILOS T R SOC A, V355, P283, DOI 10.1098/rsta.1997.0010; Kelemen PB, 1998, EARTH PLANET SC LETT, V164, P387, DOI 10.1016/S0012-821X(98)00233-7; Leng W, 2010, EARTH PLANET SC LETT, V291, P207, DOI 10.1016/j.epsl.2010.01.015; Manglik A, 2006, GEOPHYS J INT, V164, P259, DOI [10.1111/j.1365-246X.2005.02811.X, 10.1111/J.1365-246X.2005.02811.x]; Masaitis V.L., 1983, ZAP VSEROSS MINER OV, V112, P412; Mundil R, 2010, GEOL SOC SPEC PUBL, V334, P41, DOI 10.1144/SP334.3; Payne JL, 2007, EARTH PLANET SC LETT, V256, P264, DOI 10.1016/j.epsl.2007.01.034; Payne JL, 2010, P NATL ACAD SCI USA, V107, P8543, DOI 10.1073/pnas.0914065107; POLIAKOV ANB, 1993, NATO ADV SCI INST SE, V391, P175; Reichow MK, 2009, EARTH PLANET SC LETT, V277, P9, DOI 10.1016/j.epsl.2008.09.030; Retallack GJ, 2008, J GEOL, V116, P1, DOI 10.1086/524120; RICHARDS MA, 1989, SCIENCE, V246, P103, DOI 10.1126/science.246.4926.103; Ridgwell A, 2005, MAR GEOL, V217, P339, DOI 10.1016/j.margeo.2004.10.036; Ryabchikov ID, 2003, DOKL EARTH SCI, V389, P437; Ryabchikov ID, 2001, GEOCHEM INT+, V39, P432; Safonov OG, 2011, J PETROL, V52, P1307, DOI 10.1093/petrology/egq034; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Self S, 2006, EARTH PLANET SC LETT, V248, P518, DOI 10.1016/j.epsl.2006.05.041; Sobolev AV, 2009, RUSS GEOL GEOPHYS+, V50, P999, DOI 10.1016/j.rgg.2009.11.002; Sobolev AV, 2009, PETROLOGY+, V17, P253, DOI 10.1134/S0869591109030047; Sobolev AV, 2008, SCIENCE, V321, P536, DOI 10.1126/science.1158452; Sobolev AV, 2007, SCIENCE, V316, P412, DOI 10.1126/science.1138113; Sobolev AV, 2005, NATURE, V434, P590, DOI 10.1038/nature03411; Sobolev SV, 2005, GEOLOGY, V33, P617, DOI 10.1130/G21557.1; Sobolev V. S., 1936, T ALL UNION ARCTIC I, V43; Spandler C, 2008, J PETROL, V49, P771, DOI 10.1093/petrology/egm039; Stoll B, 2008, GEOSTAND GEOANAL RES, V32, P5; Svensen H, 2009, EARTH PLANET SC LETT, V277, P490, DOI 10.1016/j.epsl.2008.11.015; WHITE R, 1989, J GEOPHYS RES-SOLID, V94, P7685, DOI 10.1029/JB094iB06p07685; White RV, 2005, LITHOS, V79, P299, DOI 10.1016/j.lithos.2004.09.016; Wignall PB, 2009, SCIENCE, V324, P1179, DOI 10.1126/science.1171956; Wignall PB, 2001, EARTH-SCI REV, V53, P1, DOI 10.1016/S0012-8252(00)00037-4; WOODEN JL, 1993, GEOCHIM COSMOCHIM AC, V57, P3677, DOI 10.1016/0016-7037(93)90149-Q	57	386	412	10	272	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2011	477	7364					312	316		10.1038/nature10385	http://dx.doi.org/10.1038/nature10385			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21921914	Green Submitted			2022-12-28	WOS:000294852400027
J	Langer, A; Frenk, J; Horton, R				Langer, Ana; Frenk, Julio; Horton, Richard			Women and Health Initiative: integrating needs and response	LANCET			English	Editorial Material									[Langer, Ana; Frenk, Julio] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Horton, Richard] The Lancet, London NW1 7BY, England	Harvard University; Harvard T.H. Chan School of Public Health	Langer, A (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.	alanger@hsph.harvard.edu						Buvinic M, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P195; Disease Control Priorities Project, 2008, SEX GEND WOM HLTH WH; Frenk J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000089; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Graham WJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P499; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Levine R, 2006, DIS CONTROL PRIORITI, P1193; Morrison A, 2007, WORLD BANK RES OBSER, V22, P25, DOI 10.1093/wbro/lkm003; UN Secretary-General Ban Ki-moon, 2010, GLOBAL STRATEGY WOME; UN Women, 2010, UN CREAT NEW STRUCT; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1	11	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 18	2012	380	9842					631	632		10.1016/S0140-6736(11)60742-3	http://dx.doi.org/10.1016/S0140-6736(11)60742-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	991SE	21955577				2022-12-28	WOS:000307721000009
J	Hill, JC; Whitehurst, DGT; Lewis, M; Bryan, S; Dunn, KM; Foster, NE; Konstantinou, K; Main, CJ; Mason, E; Somerville, S; Sowden, G; Vohora, K; Hay, EM				Hill, Jonathan C.; Whitehurst, David G. T.; Lewis, Martyn; Bryan, Stirling; Dunn, Kate M.; Foster, Nadine E.; Konstantinou, Kika; Main, Chris J.; Mason, Elizabeth; Somerville, Simon; Sowden, Gail; Vohora, Kanchan; Hay, Elaine M.			Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial	LANCET			English	Article							CLINICAL-TRIAL; DISABILITY; INTERVENTIONS; LESSONS; PROGRAM	Background Back pain remains a challenge for primary care internationally. One model that has not been tested is stratification of the management according to the patient's prognosis (low, medium, or high risk). We compared the clinical effectiveness and cost-effectiveness of stratified primary care (intervention) with non-stratified current best practice (control). Methods 1573 adults (aged >= 18 years) with back pain (with or without radiculopathy) consultations at ten general practices in England responded to invitations to attend an assessment clinic. Eligible participants were randomly assigned by use of computer-generated stratified blocks with a 2:1 ratio to intervention or control group. Primary outcome was the effect of treatment on the Roland Morris Disability Questionnaire (RMDQ) score at 12 months. In the economic evaluation, we focused on estimating incremental quality-adjusted life years (QALYs) and health-care costs related to back pain. Analysis was by intention to treat. This study is registered, number ISRCTN37113406. Findings 851 patients were assigned to the intervention (n=568) and control groups (n=283). Overall, adjusted mean changes in RMDQ scores were significantly higher in the intervention group than in the control group at 4 months (4.7 [SD 5.9] vs 3.0 [5.9], between-group difference 1.81 [95% CI 1.06-2.57]) and at 12 months (4.3 [6.4] vs 3.3 [6.2], 1.06 [0.25-1.86]), equating to effect sizes of 0.32 (0.19-0.45) and 0.19 (0.04-0.33), respectively. At 12 months, stratified care was associated with a mean increase in generic health benefit (0.039 additional QALYs) and cost savings (240.01 pound vs 274.40) pound compared with the control group. Interpretation The results show that a stratified approach, by use of prognostic screening with matched pathways, will have important implications for the future management of back pain in primary care.	[Hill, Jonathan C.; Whitehurst, David G. T.; Lewis, Martyn; Dunn, Kate M.; Foster, Nadine E.; Konstantinou, Kika; Main, Chris J.; Mason, Elizabeth; Somerville, Simon; Sowden, Gail; Vohora, Kanchan; Hay, Elaine M.] Keele Univ, Arthrit Res UK Primary Care Ctr, Stoke On Trent, Staffs, England; [Whitehurst, David G. T.; Bryan, Stirling] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Whitehurst, David G. T.; Bryan, Stirling] Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada	Keele University; University of British Columbia; Vancouver Coastal Health Research Institute	Hill, JC (corresponding author), Keele Univ, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England.	j.hill@cphc.keele.ac.uk	Hill, Jonathan/AAT-2744-2020; Rajendran, Devan/A-3251-2011	Whitehurst, David/0000-0002-7890-6756; Foster, Nadine/0000-0003-4429-9756	Arthritis Research UK [17741]; North Staffordshire Primary Care Research Consortium; West Midlands North Comprehensive Local Research Network; National Institute for Health Research [RP-PG-0707-10131] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); North Staffordshire Primary Care Research Consortium; West Midlands North Comprehensive Local Research Network; National Institute for Health Research(National Institute for Health Research (NIHR))	Arthritis Research UK funded the study (grant code 17741). We thank all the participants and general practices who participated in the STarT Back trial; and NHS Stoke-on-Trent and North Staffordshire for hosting the conduct of the study, and the North Staffordshire Primary Care Research Consortium and the primary care delivery arm of West Midlands North Comprehensive Local Research Network for their service support funding.	[Anonymous], 2008, ANN SURV HOURS EARN; Beattie P, 2000, PHYS THER, V80, P499; Beurskens AJHM, 1996, PAIN, V65, P71, DOI 10.1016/0304-3959(95)00149-2; Brundtland GH, 2003, WHO TECH REP SER, V919, P1; Costa-Black KM, 2010, BEST PRACT RES CL RH, V24, P227, DOI 10.1016/j.berh.2009.11.007; Department of Health (UK), 2006, MUSC SERV FRAM JOINT; Deyo RA, 2009, J AM BOARD FAM MED, V22, P62, DOI 10.3122/jabfm.2009.01.080102; Dolan P., 1995, SOCIAL TARIFF EUROQO; Dunn KM, 2005, SPINE, V30, P1887, DOI 10.1097/01.brs.0000173900.46863.02; Foster NE, 2011, MANUAL THER, V16, P3, DOI 10.1016/j.math.2010.05.013; Foster NE, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-186; Hay EM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-58; Hay EM, 2005, LANCET, V365, P2024, DOI 10.1016/S0140-6736(05)66696-2; Hestbaek L, 2003, EUR SPINE J, V12, P149, DOI 10.1007/s00586-002-0508-5; Hill JC, 2008, ARTHRIT RHEUM-ARTHR, V59, P632, DOI 10.1002/art.23563; Hill JC, 2010, CLIN J PAIN, V26, P783, DOI 10.1097/AJP.0b013e3181f18aac; Hill JC, 2010, EUR J PAIN, V14, P83, DOI 10.1016/j.ejpain.2009.01.003; Hollinghurst S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2656; Imison Candace, 2010, REFERRAL MANAGEMENT; Jordan K, 2006, J CLIN EPIDEMIOL, V59, P45, DOI 10.1016/j.jclinepi.2005.03.018; Kori SH., 1990, PAIN MANAG, P35; Lamb SE, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14410; Lewis M, 2010, EUR J PAIN, V14, P1033, DOI 10.1016/j.ejpain.2010.04.002; Little R, 1981, STAT ANAL MISSING DA, P97; McGrail MP, 2001, AM FAM PHYSICIAN, V63, P679; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Office for National Statistics, 2000, STAND OCC CLASS 2000, V2; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Royal College of General Practitioners and NHS Executive, 2002, GET BACK ACT BACK BO; Royal College of General Practitioners and NHS Executive, 2002, BACK BOOK; Savigny P., 2009, LOND NATL COLLAB CEN; Stang A, 2010, J CLIN EPIDEMIOL, V63, P820, DOI 10.1016/j.jclinepi.2009.08.006; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Underwood M, 2004, BMJ-BRIT MED J, V329, P1377, DOI 10.1136/bmj.38282.669225AE; van der Windt D, 2008, SPINE, V33, P81, DOI 10.1097/BRS.0b013e31815e39f9; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	38	820	827	2	81	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 29	2011	378	9802					1560	1571		10.1016/S0140-6736(11)60937-9	http://dx.doi.org/10.1016/S0140-6736(11)60937-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844SL	21963002	Green Published			2022-12-28	WOS:000296767500021
J	Sattur, AP; Goyal, M				Sattur, Atul P.; Goyal, Megha			Sturge-Weber angiomatosis	LANCET			English	Editorial Material									[Sattur, Atul P.; Goyal, Megha] SDM Coll Dent Sci & Hosp, Dept Oral Med & Radiog, Dharwad 580009, Karnataka, India		Sattur, AP (corresponding author), SDM Coll Dent Sci & Hosp, Dept Oral Med & Radiog, Dharwad 580009, Karnataka, India.	dratulomr@yahoo.com	Sattur, Atul/AAF-3158-2021	Sattur, Atul/0000-0003-3252-3773					0	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 29	2011	378	9802					1580	1580		10.1016/S0140-6736(11)60249-3	http://dx.doi.org/10.1016/S0140-6736(11)60249-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844SL	21907403				2022-12-28	WOS:000296767500023
J	Hua, YM; Sahashi, K; Rigo, F; Hung, G; Horev, G; Bennett, CF; Krainer, AR				Hua, Yimin; Sahashi, Kentaro; Rigo, Frank; Hung, Gene; Horev, Guy; Bennett, C. Frank; Krainer, Adrian R.			Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model	NATURE			English	Article							IGF-I; CARDIAC DEFECTS; MICE; DELIVERY; PHENOTYPE; GROWTH; SURVIVAL; DISEASES	Spinal muscular atrophy (SMA) is a motor neuron disease and the leading genetic cause of infant mortality; it results from loss-of-function mutations in the survival motor neuron 1 (SMN1) gene(1). Humans have a paralogue, SMN2, whose exon 7 is predominantly skipped(2), but the limited amount of functional, full-length SMN protein expressed from SMN2 cannot fully compensate for a lack of SMN1. SMN is important for the biogenesis of spliceosomal small nuclear ribonucleoprotein particles(3), but downstream splicing targets involved in pathogenesis remain elusive. There is no effective SMA treatment, but SMN restoration in spinal cord motor neurons is thought to be necessary and sufficient(4). Non-central nervous system (CNS) pathologies, including cardiovascular defects, were recently reported in severe SMA mouse models and patients(5-8), reflecting autonomic dysfunction or direct effects in cardiac tissues. Here we compared systemic versus CNS restoration of SMN in a severe mouse model(9,10). We used an antisense oligonucleotide (ASO), ASO-10-27, that effectively corrects SMN2 splicing and restores SMN expression in motor neurons after intracerebroventricular injection(11,12). Systemic administration of ASO-10-27 to neonates robustly rescued severe SMA mice, much more effectively than intracerebroventricular administration; subcutaneous injections extended the median lifespan by 25 fold. Furthermore, neonatal SMA mice had decreased hepatic Igfals expression, leading to a pronounced reduction in circulating insulin-like growth factor 1 (IGF1), and ASO-10-27 treatment restored IGF1 to normal levels. These results suggest that the liver is important in SMA pathogenesis, underscoring the importance of SMN in peripheral tissues, and demonstrate the efficacy of a promising drug candidate.	[Hua, Yimin; Sahashi, Kentaro; Horev, Guy; Krainer, Adrian R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Rigo, Frank; Hung, Gene; Bennett, C. Frank] ISIS Pharmaceut, Carlsbad, CA 92010 USA	Cold Spring Harbor Laboratory; Isis Pharmaceuticals Inc	Krainer, AR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	Krainer@cshl.edu	; Hua, Yimin/U-6911-2018	Krainer, Adrian/0000-0001-9024-9501; Hua, Yimin/0000-0003-0905-7989	Muscular Dystrophy Association; National Institute of General Medical Sciences; St. Giles Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042699, R37GM042699] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); St. Giles Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge support from the Muscular Dystrophy Association, the National Institute of General Medical Sciences and St. Giles Foundation. We thank J. Bu and M. Passini for protocols and advice on NMJ staining, and S. Hearn for assistance with microscope imaging.	Bevan AK, 2010, HUM MOL GENET, V19, P3895, DOI 10.1093/hmg/ddq300; Bosch-Marce M, 2011, HUM MOL GENET, V20, P1844, DOI 10.1093/hmg/ddr067; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Colao A, 2008, CLIN ENDOCRINOL, V69, P347, DOI 10.1111/j.1365-2265.2008.03292.x; Domene HM, 2009, HORM RES, V72, P129, DOI 10.1159/000232486; Dominguez E, 2011, HUM MOL GENET, V20, P681, DOI 10.1093/hmg/ddq514; Ek CJ, 2003, J COMP NEUROL, V460, P451, DOI 10.1002/cne.10661; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Gavrilina TO, 2008, HUM MOL GENET, V17, P1063, DOI 10.1093/hmg/ddm379; Gogliotti RG, 2010, BIOCHEM BIOPH RES CO, V391, P517, DOI 10.1016/j.bbrc.2009.11.090; Heier CR, 2010, HUM MOL GENET, V19, P3906, DOI 10.1093/hmg/ddq330; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 2010, HUM MOL GENET, V19, pR111, DOI 10.1093/hmg/ddq147; Millino C, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-14; Park GH, 2010, CURR NEUROL NEUROSCI, V10, P108, DOI 10.1007/s11910-010-0095-5; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Riessland M, 2010, HUM MOL GENET, V19, P1492, DOI 10.1093/hmg/ddq023; Rudnik-Schoneborn S, 2008, J MED GENET, V45, P635, DOI 10.1136/jmg.2008.057950; Shababi M, 2011, HUM GENE THER, V22, P135, DOI 10.1089/hum.2010.114; Shababi M, 2010, HUM MOL GENET, V19, P4059, DOI 10.1093/hmg/ddq329; Sorenson EJ, 2008, NEUROLOGY, V71, P1770, DOI 10.1212/01.wnl.0000335970.78664.36; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; Trejo JL, 2004, J MOL MED, V82, P156, DOI 10.1007/s00109-003-0499-7; Wu YJ, 2009, ENDOCRINOLOGY, V150, P4395, DOI 10.1210/en.2009-0272	30	497	533	3	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2011	478	7367					123	126		10.1038/nature10485	http://dx.doi.org/10.1038/nature10485			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21979052	Green Accepted			2022-12-28	WOS:000295575400047
J	Hajjaji, IM				Hajjaji, Issam M.			PERSONAL VIEW An elected Libyan government should restore order to the health system	BRITISH MEDICAL JOURNAL			English	Editorial Material													Hajjaji, Issam/S-6077-2019	Hajjaji, Issam/0000-0001-8497-0749					0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 5	2011	343								d6385	10.1136/bmj.d6385	http://dx.doi.org/10.1136/bmj.d6385			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	832CS	21976695				2022-12-28	WOS:000295779400008
J	Kenny, EE; Bustamante, CD				Kenny, Eimear E.; Bustamante, Carlos D.			SnapShot: Human Biomedical Genomics	CELL			English	Editorial Material							ASSOCIATION		[Kenny, Eimear E.; Bustamante, Carlos D.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University	Kenny, EE (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.			Kenny, Eimear/0000-0001-9198-759X				Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; FREERO GW, 2010, NEW ENGL J MED, V362, P2001; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hindorff LA, CATALOG PUBLISHED GE; Lynch M., 1998, GENETICS ANAL QUANTI; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718	8	0	0	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					248	U262		10.1016/j.cell.2011.09.020	http://dx.doi.org/10.1016/j.cell.2011.09.020			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962520	Bronze			2022-12-28	WOS:000295396700031
J	Frieden, TR; Berwick, DM				Frieden, Thomas R.; Berwick, Donald M.			The "Million Hearts" Initiative - Preventing Heart Attacks and Strokes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEATHS; US		[Frieden, Thomas R.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Berwick, Donald M.] Ctr Medicare & Medicaid Serv, Baltimore, MD USA	Centers for Disease Control & Prevention - USA; Centers for Medicare & Medicaid Services	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.			Frieden, Thomas/0000-0002-4759-2256				Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Farley TA, 2010, AM J PREV MED, V38, P600, DOI 10.1016/j.amepre.2010.02.016; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Mehta RH, 2007, AM J MED, V120, P398, DOI 10.1016/j.amjmed.2006.12.018	5	236	243	2	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2011	365	13							e27	10.1056/NEJMP1110421	http://dx.doi.org/10.1056/NEJMP1110421			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	825YO	21913835				2022-12-28	WOS:000295318400004
J	Robledo, L; Childress, L; Bernien, H; Hensen, B; Alkemade, PFA; Hanson, R				Robledo, Lucio; Childress, Lilian; Bernien, Hannes; Hensen, Bas; Alkemade, Paul F. A.; Hanson, Ronald			High-fidelity projective read-out of a solid-state spin quantum register	NATURE			English	Article							SINGLE-SHOT READOUT; NUCLEAR-SPIN; ELECTRON-SPIN; DIAMOND; DOT; ENTANGLEMENT; COHERENCE	Initialization and read-out of coupled quantum systems are essential ingredients for the implementation of quantum algorithms(1,2). Single-shot read-out of the state of a multi-quantum-bit (multi-qubit) register would allow direct investigation of quantum correlations (entanglement), and would give access to further key resources such as quantum error correction and deterministic quantum teleportation(1). Although spins in solids are attractive candidates for scalable quantum information processing, their single-shot detection has been achieved only for isolated qubits(3-6). Here we demonstrate the preparation and measurement of a multi-spin quantum register in a low-temperature solid-state system by implementing resonant optical excitation techniques originally developed in atomic physics. We achieve high-fidelity read-out of the electronic spin associated with a single nitrogen-vacancy centre in diamond, and use this read-out to project up to three nearby nuclear spin qubits onto a well-defined state(7). Conversely, we can distinguish the state of the nuclear spins in a single shot by mapping it onto, and subsequently measuring, the electronic spin(5,8). Finally, we show compatibility with qubit control: we demonstrate initialization, coherent manipulation and single-shot read-out in a single experiment on a two-qubit register, using techniques suitable for extension to larger registers. These results pave the way for a test of Bell's inequalities on solid-state spins and the implementation of measurement-based quantum information protocols.	[Robledo, Lucio; Bernien, Hannes; Hensen, Bas; Alkemade, Paul F. A.; Hanson, Ronald] Delft Univ Technol, Kavli Inst Nanosci Delft, NL-2600 GA Delft, Netherlands; [Childress, Lilian] Bates Coll, Dept Phys & Astron, Lewiston, ME 04240 USA	Delft University of Technology	Hanson, R (corresponding author), Delft Univ Technol, Kavli Inst Nanosci Delft, POB 5046, NL-2600 GA Delft, Netherlands.	r.hanson@tudelft.nl	Childress, Lilian/H-1359-2012; Hanson, Ronald/B-9555-2008; Robledo, Lucio M/F-3120-2011; Bernien, Hannes/E-6197-2012; Bernien, Hannes/AAM-5598-2020	Childress, Lilian/0000-0002-0507-6392; Bernien, Hannes/0000-0002-1950-7368	European Community; Dutch Organization for Fundamental Research on Matter (FOM); European Commission (SOLID); Research Corporation for Science Advancement (RCSA)	European Community(European Commission); Dutch Organization for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); European Commission (SOLID)(European CommissionEuropean Commission Joint Research Centre); Research Corporation for Science Advancement (RCSA)(Research Corporation for Science Advancement)	L.R. acknowledges support by a Marie Curie Intra European Fellowship within the 7th European Community Framework Programme. L. R., H. B., B. H. and R. H. acknowledge support from the Dutch Organization for Fundamental Research on Matter (FOM) and the European Commission (SOLID). L. C. acknowledges support from Research Corporation for Science Advancement (RCSA).	Atature M, 2006, SCIENCE, V312, P551, DOI 10.1126/science.1126074; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Barrett SD, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.060310; Batalov A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.077401; Blatt R., 1988, European Journal of Physics, V9, P250, DOI 10.1088/0143-0807/9/4/002; Buckley BB, 2010, SCIENCE, V330, P1212, DOI 10.1126/science.1196436; Childress L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.070504; de Lange G, 2010, SCIENCE, V330, P60, DOI 10.1126/science.1192739; Degen CL, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2943282; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Fu KMC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.256404; Fuchs GD, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.117601; Giedke G, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.032316; Dutt MVG, 2007, SCIENCE, V316, P1312, DOI 10.1126/science.1139831; Hadden JP, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3519847; HAPPER W, 1972, REV MOD PHYS, V44, P169, DOI 10.1103/RevModPhys.44.169; Jacques V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.057403; Jiang L, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.012301; Jiang L, 2009, SCIENCE, V326, P267, DOI 10.1126/science.1176496; Manson NB, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.104303; Morello A, 2010, NATURE, V467, P687, DOI 10.1038/nature09392; Neumann P, 2008, SCIENCE, V320, P1326, DOI 10.1126/science.1157233; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Raussendorf R, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.022312; Robledo L, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.177403; Ryan CA, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.200402; Tamarat P, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/045004; Taylor JM, 2008, NAT PHYS, V4, P810, DOI 10.1038/nphys1075; Togan E, 2010, NATURE, V466, P730, DOI 10.1038/nature09256; Vamivakas AN, 2010, NATURE, V467, P297, DOI 10.1038/nature09359	32	474	481	6	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2011	477	7366					574	578		10.1038/nature10401	http://dx.doi.org/10.1038/nature10401			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21937989	Green Submitted			2022-12-28	WOS:000295320900036
J	Brownell, KD; Ludwig, DS				Brownell, Kelly D.; Ludwig, David S.			The Supplemental Nutrition Assistance Program, Soda, and USDA Policy Who Benefits?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brownell, Kelly D.] Yale Univ, Rudd Ctr Food Policy & Obes, New Haven, CT 06520 USA; [Ludwig, David S.] Childrens Hosp, Dept Med, Optimal Weight Life Program, Boston, MA 02115 USA	Yale University; Harvard University; Boston Children's Hospital	Brownell, KD (corresponding author), Yale Univ, Rudd Ctr Food Policy & Obes, POB 208369, New Haven, CT 06520 USA.	kelly.brownell@yale.edu		Ludwig, David/0000-0003-3307-8544	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER; NIDDK NIH HHS [K24DK082730] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barnhill A, 2011, AM J PUBLIC HEALTH, V101, P2037, DOI 10.2105/AJPH.2011.300225; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; DIMSDALE J, 2010, MARKETPLACE     1007; MCGEEHAN P, 2011, NY TIMES        0819; *NY CIT DEP HLTH M, REM SNAP SUBS SUG SW; POLHEMUS B, 2011, PEDIAT NUTR SURVEILL; SCOTTTHOMAS C, 2011, FOOD NAVIGATOR  0505; Shahn J., 2011, SUPPLEMENTAL NUTR AS; Shenkin JD, 2010, AM J PUBLIC HEALTH, V100, P1562, DOI 10.2105/AJPH.2010.198549	9	43	43	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 28	2011	306	12					1370	1371		10.1001/jama.2011.1382	http://dx.doi.org/10.1001/jama.2011.1382			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	825FQ	21954481				2022-12-28	WOS:000295257000026
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA GMTV's Dr Steele is wrong to promote cervical screening in under 25s	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				2009, OBSTET GYNECOLOGY, V114, P504, DOI DOI 10.1097/AOG.0B013E3181B052DE; 2009, BRIT MED J, V339, pB2968, DOI DOI 10.1136/BMJ.B2968	2	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 28	2011	343								d6167	10.1136/bmj.d6167	http://dx.doi.org/10.1136/bmj.d6167			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829JZ	21957213				2022-12-28	WOS:000295577100009
J	Franklin, ME; Sapyta, J; Freeman, JB; Khanna, M; Compton, S; Almirall, D; Moore, P; Choate-Summers, M; Garcia, A; Edson, AL; Foa, EB; March, JS				Franklin, Martin E.; Sapyta, Jeffrey; Freeman, Jennifer B.; Khanna, Muniya; Compton, Scott; Almirall, Daniel; Moore, Phoebe; Choate-Summers, Molly; Garcia, Abbe; Edson, Aubrey L.; Foa, Edna B.; March, John S.			Cognitive Behavior Therapy Augmentation of Pharmacotherapy in Pediatric Obsessive-Compulsive Disorder The Pediatric OCD Treatment Study II (POTS II) Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHILDREN; ADOLESCENTS; RELIABILITY; SCALE	Context The extant literature on the treatment of pediatric obsessive-compulsive disorder (OCD) indicates that partial response to serotonin reuptake inhibitors (SRIs) is the norm and that augmentation with short-term OCD-specific cognitive behavior therapy (CBT) may provide additional benefit. Objective To examine the effects of augmenting SRIs with CBT or a brief form of CBT, instructions in CBT delivered in the context of medication management. Design, Setting, and Participants A 12-week randomized controlled trial conducted at 3 academic medical centers between 2004 and 2009, involving 124 pediatric outpatients between the ages of 7 and 17 years with OCD as a primary diagnosis and a Children's Yale-Brown Obsessive Compulsive Scale score of 16 or higher despite an adequate SRI trial. Interventions Participants were randomly assigned to 1 of 3 treatment strategies that included 7 sessions over 12 weeks: 42 in the medication management only, 42 in the medication management plus instructions in CBT, and 42 in the medication management plus CBT; the last included 14 concurrent CBT sessions. Main Outcome Measures Whether patients responded positively to treatment by improving their baseline obsessive-compulsive scale score by 30% or more and demonstrating a change in their continuous scores over 12 weeks. Results The medication management plus CBT strategy was superior to the other 2 strategies on all outcome measures. In the primary intention-to-treat analysis, 68.6% (95% CI, 53.9%-83.3%) in the plus CBT group were considered responders, which was significantly better than the 34.0% (95% CI, 18.0%-50.0%) in the plus instructions in CBT group, and 30.0% (95% CI, 14.9%-45.1%) in the medication management only group. The results were similar in pairwise comparisons with the plus CBT strategy being superior to the other 2 strategies (P<.01 for both). The plus instructions in CBT strategy was not statistically superior to medication management only (P=.72). The number needed-to-treat analysis with the plus CBT vs medication management only in order to see 1 additional patient at week 12, on average, was estimated as 3; for the plus CBT vs the plus instructions in CBT strategy, the number needed to treat was also estimated as 3; for the plus instructions in CBT vs medication management only the number needed to treat was estimated as 25. Conclusions Among patients aged 7 to 17 years with OCD and partial response to SRI use, the addition of CBT to medication management compared with medication management alone resulted in a significantly greater response rate, whereas augmentation of medication management with the addition of instructions in CBT did not.	[Franklin, Martin E.; Khanna, Muniya; Edson, Aubrey L.; Foa, Edna B.] Univ Penn, Dept Psychiat, Sch Med, Philadelphia, PA 19104 USA; [Sapyta, Jeffrey; Compton, Scott; March, John S.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Freeman, Jennifer B.; Choate-Summers, Molly; Garcia, Abbe] Brown Univ, Sch Med, Dept Psychiat, Providence, RI 02912 USA; [Almirall, Daniel] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Moore, Phoebe] Univ Massachusetts, Med Ctr, Dept Psychiat, Worcester, MA 01655 USA	University of Pennsylvania; Duke University; Brown University; University of Michigan System; University of Michigan; University of Massachusetts System; University of Massachusetts Worcester	Franklin, ME (corresponding author), Univ Penn, Dept Psychiat, Sch Med, 3535 Market St,Ste 600, Philadelphia, PA 19104 USA.	marty@mail.med.upenn.edu	Compton, Scott/A-6656-2011		Pfizer; Wyeth; Lilly; National Institute of Mental Health [2R01MH055126-08A2, 2R01MH055121-06A2, 1R01MH064188-01A2]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064188, R01MH055121, R01MH055126] Funding Source: NIH RePORTER	Pfizer(Pfizer); Wyeth(Wyeth); Lilly(Eli Lilly); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr March has received speaker fees from Pfizer, consulting fees from Pfizer and Wyeth, and research support from Pfizer and Lilly, and has served as a scientific advisor for Pfizer and on the data and safety monitoring board for Organon, AstraZeneca, and Pfizer. Ms Edson and Drs Franklin, Sapyta, Freeman, Khanna, Compton, Almirall, Moore, Choate-Summers, Garcia and Foa did not report any financial conflicts of interest.; The Pediatric OCD Treatment Study II was supported by grants 2R01MH055126-08A2 (Penn), 2R01MH055121-06A2 (Duke), and 1R01MH064188-01A2 (Brown) from the National Institute of Mental Health.	Abramowitz JS, 2005, BEHAV THER, V36, P55, DOI 10.1016/S0005-7894(05)80054-1; ALLISON PD, SAS MACROS; Barnard J, 1999, BIOMETRIKA, V86, P948, DOI 10.1093/biomet/86.4.948; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Conners CK, 1996, CONNERS MARCH DEV QU; Franklin ME, 2000, J CONSULT CLIN PSYCH, V68, P594, DOI 10.1037//0022-006X.68.4.594; Freeman JB, 2009, CHILD ADOLESC PSYCHI, V3, P1; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Guy W, 1970, MANUAL ECDEU ASSESSM; *I STAT MATH RES, R LANG ENV STAT COMP; MARCH J, 2007, SCI P 2007 ANN M AM; March JS, 2004, JAMA-J AM MED ASSOC, V292, P1969; March JS, 1998, JAMA-J AM MED ASSOC, V280, P1752, DOI 10.1001/jama.280.20.1752; March JS, 1998, OCD CHILDREN ADOLESC; Miller RG., 1966, SIMULTANEOUS STAT IN; Nakatani E, 2009, CHILD ADOL MENT H-UK, V14, P133, DOI 10.1111/j.1475-3588.2008.00509.x; Piacentini J, 2000, PSYCHIAT CLIN N AM, V23, P519, DOI 10.1016/S0193-953X(05)70178-7; Piacentini J, 2003, J CHILD ADOL PSYCHOP, V13, pS61, DOI 10.1089/104454603322126359; Raghunathan T.E., 2001, SURV METHODOL, V27, P85; Riddle MA, 2001, J AM ACAD CHILD PSY, V40, P222, DOI 10.1097/00004583-200102000-00017; Rothbaum BO, 2000, COGN BEHAV PRACT, V7, P262, DOI 10.1016/S1077-7229(00)80082-6; Rubin DB, 1987, MULTIPLE IMPUTATION, p[xxix, 258], DOI DOI 10.1002/9780470316696; Ruscio AM, 2010, MOL PSYCHIATR, V15, P53, DOI 10.1038/mp.2008.94; Scahill L, 1997, J AM ACAD CHILD PSY, V36, P844, DOI 10.1097/00004583-199706000-00023; Silverman W, 1996, ANXIETY DISORDERS IN; Silverman WK, 2001, J AM ACAD CHILD PSY, V40, P937, DOI 10.1097/00004583-200108000-00016; Simpson HB, 2008, AM J PSYCHIAT, V165, P621, DOI 10.1176/appi.ajp.2007.07091440; SWEDO SE, 1989, ARCH GEN PSYCHIAT, V46, P335; Tenneij NH, 2005, J CLIN PSYCHIAT, V66, P1169, DOI 10.4088/JCP.v66n0913; Tolin DE, 2005, J CLIN PSYCHIAT, V66, P1549, DOI 10.4088/JCP.v66n1209; Valderhaug R, 2007, BEHAV RES THER, V45, P577, DOI 10.1016/j.brat.2006.04.011; Warren R, 2001, J ANXIETY DISORD, V15, P277, DOI 10.1016/S0887-6185(01)00063-9; Watson HJ, 2008, J CHILD PSYCHOL PSYC, V49, P489, DOI 10.1111/j.1469-7610.2007.01875.x; Williams M, 2010, J ANXIETY DISORD, V24, P171, DOI 10.1016/j.janxdis.2009.11.004	34	143	143	1	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2011	306	11					1224	1232		10.1001/jama.2011.1344	http://dx.doi.org/10.1001/jama.2011.1344			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822HB	21934055	Green Accepted			2022-12-28	WOS:000295033500023
J	Teijaro, JR; Walsh, KB; Cahalan, S; Fremgen, DM; Roberts, E; Scott, F; Martinborough, E; Peach, R; Oldstone, MBA; Rosen, H				Teijaro, John R.; Walsh, Kevin B.; Cahalan, Stuart; Fremgen, Daniel M.; Roberts, Edward; Scott, Fiona; Martinborough, Esther; Peach, Robert; Oldstone, Michael B. A.; Rosen, Hugh			Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection	CELL			English	Article							IMMUNE-RESPONSE; S1P(1) AGONIST; RECEPTORS; VIRULENCE	Cytokine storm during viral infection is a prospective predictor of morbidity and mortality, yet the cellular sources remain undefined. Here, using genetic and chemical tools to probe functions of the S1P(1) receptor, we elucidate cellular and signaling mechanisms that are important in initiating cytokine storm. Whereas S1P(1) receptor is expressed on endothelial cells and lymphocytes within lung tissue, S1P(1) agonism suppresses cytokines and innate immune cell recruitment in wild-type and lymphocyte-deficient mice, identifying endothelial cells as central regulators of cytokine storm. Furthermore, our data reveal immune cell infiltration and cytokine production as distinct events that are both orchestrated by endothelial cells. Moreover, we demonstrate that suppression of early innate immune responses through S1P(1) signaling results in reduced mortality during infection with a human pathogenic strain of influenza virus. Modulation of endothelium with a specific agonist suggests that diseases in which amplification of cytokine storm is a significant pathological component could be chemically tractable.	[Teijaro, John R.; Walsh, Kevin B.; Fremgen, Daniel M.; Oldstone, Michael B. A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Cahalan, Stuart; Rosen, Hugh] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Roberts, Edward] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Scott, Fiona; Martinborough, Esther; Peach, Robert] Receptos Inc, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Oldstone, MBA (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	mbaobo@scripps.edu; hrosen@scripps.edu			USPHS [AI074564, AI009484, AI05509, MH084512]; NIH [NS041219, AI007244, AI007364]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055509, T32AI007244, R37AI009484, U01AI074564, R01AI009484, T32AI007364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS041219] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This is Publication Number 21112 from the Department of Immunology and Microbial Science and the Department of Chemical Physiology and The Scripps Research Institute Molecular Screening Center, The Scripps Research Institute (TSRI). This work was supported, in part, by USPHS grants AI074564 (M.B.A.O., H.R., K.B.W., and J.R.T.), AI009484 (M.B.A.O.), AI05509 (H.R.), MH084512 (H.R.), and NIH training grants NS041219 (K.B.W.), AI007244 (K.B.W.), and AI007364 (J.R.T). We thank Marcus Boehm, Li-ming Huang, and Bryan Clemons (Receptos, Inc.) for helping provide RP-002 as a chemical tool. Hugh Rosen is a founder of Receptos. Edward Roberts is a consultant to Receptos. Fiona Scott, Esther Martinborough, and Robert Peach are employees of Receptos.	Bergeron Y, 1998, INFECT IMMUN, V66, P912, DOI 10.1128/IAI.66.3.912-922.1998; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Borges AA, 2006, MICROBES INFECT, V8, P2324, DOI 10.1016/j.micinf.2006.04.019; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Cahalan SM, 2011, NAT CHEM BIOL, V7, P254, DOI 10.1038/nchembio.547; Cilloniz C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000604; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Garcia-Sastre A, 2010, AM J PATHOL, V176, P1584, DOI 10.2353/ajpath.2010.100066; Gonzalez-Cabrera PJ, 2008, MOL PHARMACOL, V74, P1308, DOI 10.1124/mol.108.049783; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Kawane K, 2010, P NATL ACAD SCI USA, V107, P19432, DOI 10.1073/pnas.1010603107; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Link H, 1998, MULT SCLER, V4, P12, DOI 10.1191/135245898678909141; Marsolais D, 2008, MOL PHARMACOL, V74, P896, DOI 10.1124/mol.108.048769; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; Martinborough M.F., 2011, Patent No. [wo 2011060392, 2011060392]; Openshaw PJM, 2010, MUCOSAL IMMUNOL, V3, P422, DOI 10.1038/mi.2010.34; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rosen H, 2003, CURR OPIN CHEM BIOL, V7, P461, DOI 10.1016/S1367-5931(03)00085-1; ROSEN H, 1987, J EXP MED, V166, P1685, DOI 10.1084/jem.166.6.1685; Rosen H, 2008, IMMUNOL REV, V223, P221, DOI 10.1111/j.1600-065X.2008.00645.x; Rosen H, 2007, TRENDS IMMUNOL, V28, P102, DOI 10.1016/j.it.2007.01.007; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Thiel V, 2008, CYTOKINE GROWTH F R, V19, P121, DOI 10.1016/j.cytogfr.2008.01.001; Tscherne DM, 2011, J CLIN INVEST, V121, P6, DOI 10.1172/JCI44947	35	474	512	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2011	146	6					980	991		10.1016/j.cell.2011.08.015	http://dx.doi.org/10.1016/j.cell.2011.08.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925319	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000295258100019
J	Burdette, DL; Monroe, KM; Sotelo-Troha, K; Iwig, JS; Eckert, B; Hyodo, M; Hayakawa, Y; Vance, RE				Burdette, Dara L.; Monroe, Kathryn M.; Sotelo-Troha, Katia; Iwig, Jeff S.; Eckert, Barbara; Hyodo, Mamoru; Hayakawa, Yoshihiro; Vance, Russell E.			STING is a direct innate immune sensor of cyclic di-GMP	NATURE			English	Article							I INTERFERON RESPONSE; CYTOSOLIC DNA; PSEUDOMONAS-AERUGINOSA; INTRACELLULAR DNA; BIS-(3'-5')-CYCLIC-GMP; DIGUANYLATE; REVEALS; ADAPTER	The innate immune system detects infection by using germline-encoded receptors that are specific for conserved microbial molecules. The recognition of microbial ligands leads to the production of cytokines, such as type I interferons (IFNs), that are essential for successful pathogen elimination. Cytosolic detection of pathogen-derived DNA is one major mechanism of inducing IFN production(1,2), and this process requires signalling through TANK binding kinase 1 (TBK1) and its downstream transcription factor, IFN-regulatory factor 3 (IRF3). In addition, a transmembrane protein called STING (stimulator of IFN genes; also known as MITA, ERIS, MPYS and TMEM173) functions as an essential signalling adaptor, linking the cytosolic detection of DNA to the TBK1-IRF3 signalling axis(3-7). Recently, unique nucleic acids called cyclic dinucleotides, which function as conserved signalling molecules in bacteria(8), have also been shown to induce a STING-dependent type I IFN response(9-12). However, a mammalian sensor of cyclic dinucleotides has not been identified. Here we report evidence that STING itself is an innate immune sensor of cyclic dinucleotides. We demonstrate that STING binds directly to radiolabelled cyclic diguanylate monophosphate (c-di-GMP), and we show that unlabelled cyclic dinucleotides, but not other nucleotides or nucleic acids, compete with c-di-GMP for binding to STING. Furthermore, we identify mutations in STING that selectively affect the response to cyclic dinucleotides without affecting the response to DNA. Thus, STING seems to function as a direct sensor of cyclic dinucleotides, in addition to its established role as a signalling adaptor in the IFN response to cytosolic DNA. Cyclic dinucleotides have shown promise as novel vaccine adjuvants and immunotherapeutics(9,13), and our results provide insight into the mechanism by which cyclic dinucleotides are sensed by the innate immune system.	[Burdette, Dara L.; Monroe, Kathryn M.; Sotelo-Troha, Katia; Iwig, Jeff S.; Eckert, Barbara; Vance, Russell E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Iwig, Jeff S.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA; [Hyodo, Mamoru] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Hayakawa, Yoshihiro] Aichi Inst Technol, Fac Engn, Dept Appl Chem, Toyota 4700392, Japan	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Hokkaido University	Vance, RE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	rvance@berkeley.edu	Hyodo, Mamoru/D-5496-2012	Hyodo, Mamoru/0000-0002-1766-3949; Troha, Katia/0000-0001-9389-4952	Burroughs Wellcome Fund; Cancer Research Institute; National Institutes of Health (NIH) [AI075039, AI080749, AI063302, F32 (AI091100)]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063302, R01AI075039, R01AI080749, F32AI091100] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23700552] Funding Source: KAKEN	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Cancer Research Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Carlson, K. Collins, S. McWhirter, D. Raulet, K. Sjolander and members of the Vance, Barton and Portnoy laboratories at the University of California, Berkeley, for advice and discussions. We thank J. Woodward and D. Portnoy for their gift of purified c-di-AMP. Work in R.E.V.'s laboratory is supported by investigator awards from the Burroughs Wellcome Fund and the Cancer Research Institute and by National Institutes of Health (NIH) grants AI075039, AI080749 and AI063302. D. L. B. is supported by an NIH National Research Service Award fellowship F32 (AI091100).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Chen WX, 2010, VACCINE, V28, P3080, DOI 10.1016/j.vaccine.2010.02.081; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Chodosh L A, 2001, Curr Protoc Mol Biol, VChapter 12, DOI 10.1002/0471142727.mb1205s36; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; Hyodo M, 2004, B CHEM SOC JPN, V77, P2089, DOI 10.1246/bcsj.77.2089; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Karaolis DKR, 2007, J IMMUNOL, V178, P2171, DOI 10.4049/jimmunol.178.4.2171; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Simm R, 2009, J BACTERIOL, V191, P3928, DOI 10.1128/JB.00290-09; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	26	935	1006	11	238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2011	478	7370					515	U111		10.1038/nature10429	http://dx.doi.org/10.1038/nature10429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	21947006	Green Accepted			2022-12-28	WOS:000296194200043
J	Grosjean, Y; Rytz, R; Farine, JP; Abuin, L; Cortot, J; Jefferis, GSXE; Benton, R				Grosjean, Yael; Rytz, Raphael; Farine, Jean-Pierre; Abuin, Liliane; Cortot, Jerome; Jefferis, Gregory S. X. E.; Benton, Richard			An olfactory receptor for food-derived odours promotes male courtship in Drosophila	NATURE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; PHENYLACETIC ACID; SEX-PHEROMONE; BEHAVIOR; MELANOGASTER; NEURONS; REPRESENTATION; ARCHITECTURE; ALGORITHM; RESPONSES	Many animals attract mating partners through the release of volatile sex pheromones, which can convey information on the species, gender and receptivity of the sender to induce innate courtship and mating behaviours by the receiver(1). Male Drosophila melanogaster fruitflies display stereotyped reproductive behaviours towards females, and these behaviours are controlled by the neural circuitry expressing male-specific isoforms of the transcription factor Fruitless (FRUM)(2-5). However, the volatile pheromone ligands, receptors and olfactory sensory neurons (OSNs) that promote male courtship have not been identified in this important model organism. Here we describe a novel courtship function of Ionotropic receptor 84a (IR84a), which is a member of the chemosensory ionotropic glutamate receptor family(6), in a previously uncharacterized population of FRUM-positive OSNs. IR84a-expressing neurons are activated not by fly-derived chemicals but by the aromatic odours phenylacetic acid and phenylacetaldehyde, which are widely found in fruit and other plant tissues(7) that serve as food sources and oviposition sites for drosophilid flies(8). Mutation of Ir84a abolishes both odour-evoked and spontaneous electrophysiological activity in these neurons and markedly reduces male courtship behaviour. Conversely, male courtship is increased-in an IR84a-dependent manner-in the presence of phenylacetic acid but not in the presence of another fruit odour that does not activate IR84a. Interneurons downstream of IR84a-expressing OSNs innervate a pheromone-processing centre in the brain. Whereas IR84a orthologues and phenylacetic-acid-responsive neurons are present in diverse drosophilid species, IR84a is absent from insects that rely on long-range sex pheromones. Our results suggest a model in which IR84a couples food presence to the activation of the fru(M) courtship circuitry in fruitflies. These findings reveal an unusual but effective evolutionary solution to coordinate feeding and oviposition site selection with reproductive behaviours through a specific sensory pathway.	[Grosjean, Yael; Rytz, Raphael; Abuin, Liliane; Benton, Richard] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Grosjean, Yael; Farine, Jean-Pierre; Cortot, Jerome] Univ Bourgogne, INRA, UMR 1324, Ctr Sci Gout & Alimentat,CNRS,UMR 6265, F-21000 Dijon, France; [Jefferis, Gregory S. X. E.] MRC, Mol Biol Lab, Div Neurobiol, Cambridge CB2 0QH, England	University of Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; MRC Laboratory Molecular Biology	Benton, R (corresponding author), Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.	Richard.Benton@unil.ch	Grosjean, Yael/E-2634-2017; Jefferis, Gregory/C-6386-2012	Grosjean, Yael/0000-0003-0689-8344; Jefferis, Gregory/0000-0002-0587-9355; Benton, Richard/0000-0003-4305-8301	Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche (ANR) [GGCB-2010]; Conseil Regional de Bourgogne (FABER); Roche Research Foundation; Medical Research Council; European Research Council; University of Lausanne; Swiss National Science Foundation; MRC [MC_U105188491] Funding Source: UKRI; Medical Research Council [MC_U105188491] Funding Source: researchfish	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Conseil Regional de Bourgogne (FABER)(Region Bourgogne-Franche-Comte); Roche Research Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); University of Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to B. Dickson, A. Hofbauer, T. Lee, the Bloomington Drosophila Stock Center, the Drosophila Species Stock Center and the Developmental Studies Hybridoma Bank for provision of plasmid vectors, Drosophila strains and antibodies. We are also grateful to A. Wong, J. Wang, R. Axel, H.-H. Yu and T. Lee for sharing raw image data. We thank D. Featherstone, J.-F. Ferveur, T. Kawecki, L. Keller, S. Martin and members of the Benton laboratory for comments on the manuscript. Y.G., J.-P. F. and J. C. are supported by the Centre National de la Recherche Scientifique (CNRS), the Agence Nationale de la Recherche (ANR; JCJC, GGCB-2010) and the Conseil Regional de Bourgogne (FABER). R. R. was supported by a Roche Research Foundation fellowship. G. S. X. E. J. is supported by the Medical Research Council and a European Research Council Starting Investigator Grant. Research in R.B.'s laboratory is supported by the University of Lausanne, a European Research Council Starting Independent Researcher Grant and the Swiss National Science Foundation.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; ALCORTA E, 1989, BEHAV GENET, V19, P285, DOI 10.1007/BF01065911; [Anonymous], 2014, PHEROMONES ANIMAL BE; Barata A, 2011, J AGR FOOD CHEM, V59, P2543, DOI 10.1021/jf104141f; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evers JF, 2005, J NEUROPHYSIOL, V93, P2331, DOI 10.1152/jn.00761.2004; EWING ARTHUR W., 1963, ANIMAL BEHAVIOUR, V11, P596, DOI 10.1016/0003-3472(63)90283-5; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Han DD, 2000, DEVELOPMENT, V127, P573; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Kim J, 2007, J MICROBIOL BIOTECHN, V17, P1727; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Markow TA, 2008, FUNCT ECOL, V22, P747, DOI 10.1111/j.1365-2435.2008.01457.x; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; SHOREY HH, 1970, ANIM BEHAV, V18, P159, DOI 10.1016/0003-3472(70)90085-0; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang LM, 2011, NAT NEUROSCI, V14, P757, DOI 10.1038/nn.2800; WIGHTMAN F, 1982, PHYSIOL PLANTARUM, V55, P17, DOI 10.1111/j.1399-3054.1982.tb00278.x; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; Yu HH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000461; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025	44	223	230	9	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2011	478	7368					236	U123		10.1038/nature10428	http://dx.doi.org/10.1038/nature10428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21964331				2022-12-28	WOS:000295782800049
J	Hartogh, P; Lis, DC; Bockelee-Morvan, D; de Val-Borro, M; Biver, N; Kuppers, M; Emprechtinger, M; Bergin, EA; Crovisier, J; Rengel, M; Moreno, R; Szutowicz, S; Blake, GA				Hartogh, Paul; Lis, Dariusz C.; Bockelee-Morvan, Dominique; de Val-Borro, Miguel; Biver, Nicolas; Kueppers, Michael; Emprechtinger, Martin; Bergin, Edwin A.; Crovisier, Jacques; Rengel, Miriam; Moreno, Raphael; Szutowicz, Slawomira; Blake, Geoffrey A.			Ocean-like water in the Jupiter-family comet 103P/Hartley 2	NATURE			English	Article							HEAVY BOMBARDMENT PERIOD; GIANT PLANETS; ORIGIN; DEUTERIUM; RATIOS; EARTH; CONSTRAINTS; DELIVERY; SYSTEM; GASES	For decades, the source of Earth's volatiles, especially water with a deuterium-to-hydrogen ratio (D/H) of (1.558 +/- 0.001) x 10(-4), has been a subject of debate. The similarity of Earth's bulk composition to that of meteorites known as enstatite chondrites(1) suggests a dry proto-Earth(2) with subsequent delivery of volatiles(3) by local accretion(4) or impacts of asteroids or comets(5,6). Previous measurements in six comets from the Oort cloud yielded a mean D/H ratio of (2.96 +/- 0.25) x 10(-4). The D/H value in carbonaceous chondrites, (1.4 +/- 0.1) x 10(-4), together with dynamical simulations, led to models in which asteroids were the main source of Earth's water(7), with <= 10 per cent being delivered by comets. Here we report that the D/H ratio in the Jupiter-family comet 103P/Hartley 2, which originated in the Kuiper belt, is (1.61 +/- 0.24) x 10(-4). This result substantially expands the reservoir of Earth ocean-like water to include some comets, and is consistent with the emerging picture of a complex dynamical evolution of the early Solar System(8,9).	[Hartogh, Paul; de Val-Borro, Miguel; Rengel, Miriam] Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; [Lis, Dariusz C.; Emprechtinger, Martin; Blake, Geoffrey A.] CALTECH, Pasadena, CA 91125 USA; [Bockelee-Morvan, Dominique; Biver, Nicolas; Crovisier, Jacques; Moreno, Raphael] Univ Paris Diderot, UPMC, CNRS, Observ Paris,LESIA, F-92195 Meudon, France; [Kueppers, Michael] European Space Astron Ctr, Rosetta Sci Operat Ctr, Madrid 28691, Spain; [Bergin, Edwin A.] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Szutowicz, Slawomira] Polish Acad Sci, Space Res Ctr, PL-00716 Warsaw, Poland	Max Planck Society; California Institute of Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; European Space Agency; University of Michigan System; University of Michigan; Centrum Badan Kosmicznych, Polish Academy of Sciences; Polish Academy of Sciences; Space Research Centre of the Polish Academy of Sciences	Hartogh, P (corresponding author), Max Planck Inst Sonnensyst Forsch, Max Planck Str 2, D-37191 Katlenburg Lindau, Germany.	hartogh@mps.mpg.de	; de Val-Borro, Miguel/H-1319-2013	Lis, Dariusz/0000-0002-0500-4700; de Val-Borro, Miguel/0000-0002-0455-9384; Rengel, Miriam/0000-0001-6419-4893	CEA (France); CNES (France); CNRS (France); ASI (Italy); DLR (Germany); ESA; NASA; JPL/Caltech; NSF	CEA (France)(French Atomic Energy Commission); CNES (France)(Centre National D'etudes Spatiales); CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); ASI (Italy)(Agenzia Spaziale Italiana (ASI)); DLR (Germany)(Helmholtz AssociationGerman Aerospace Centre (DLR)); ESA(European Space Agency); NASA(National Aeronautics & Space Administration (NASA)); JPL/Caltech; NSF(National Science Foundation (NSF))	Herschel is an ESA space observatory with science instruments provided by European-led Principal Investigator consortia and with important participation by NASA. The Heterodyne Instrument for the Far Infrared (HIFI) has been designed and built by a consortium of institutes and university departments from across Europe, Canada and the United States under the leadership of SRON, the Netherlands Institute for Space Research, and with major contributions from Germany, France and the USA. This development has been supported by national funding agencies: CEA, CNES, CNRS (France); ASI (Italy); and DLR (Germany). Additional funding support for some instrument activities has been provided by ESA. Support for this work was also provided by NASA through an award issued by JPL/Caltech. D. C. L. is supported by an NSF award to the Caltech Submillimeter Observatory. We thank R. Lorente, P. Garcia-Lario, M. Kidger and G. Pilbratt for helping with the scheduling of these observations, and I. Avruch for the assistance with HIFI specific software issues.	Aikawa Y, 2001, ASTRON ASTROPHYS, V371, P1107, DOI 10.1051/0004-6361:20010416; Bensch F, 2004, ASTROPHYS J, V615, P531, DOI 10.1086/424439; Biver N, 2007, PLANET SPACE SCI, V55, P1058, DOI 10.1016/j.pss.2006.11.010; Butner HM, 2007, ASTROPHYS J, V659, pL137, DOI 10.1086/517883; Delsemme AH, 1999, PLANET SPACE SCI, V47, P125, DOI 10.1016/S0032-0633(98)00093-2; Dones L., 2005, COMETS, P153; Drake MJ, 2002, NATURE, V416, P39, DOI 10.1038/416039a; Drouart A, 1999, ICARUS, V140, P129, DOI 10.1006/icar.1999.6137; Emel'yanenko VV, 2005, MON NOT R ASTRON SOC, V361, P1345, DOI 10.1111/j.1365-2966.2005.09267.x; GEISS J, 1972, ASTRON ASTROPHYS, V18, P126; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; Greenwood JP, 2011, NAT GEOSCI, V4, P79, DOI 10.1038/NGEO1050; Hartogh P, 2009, PLANET SPACE SCI, V57, P1596, DOI 10.1016/j.pss.2009.07.009; Javoy M, 2010, EARTH PLANET SC LETT, V293, P259, DOI 10.1016/j.epsl.2010.02.033; Jorgensen UG, 2009, ICARUS, V204, P368, DOI 10.1016/j.icarus.2009.07.015; Levison HF, 1997, ICARUS, V127, P13, DOI 10.1006/icar.1996.5637; Linsky JL, 2006, ASTROPHYS J, V647, P1106, DOI 10.1086/505556; MARZARI F, 1995, ASTRON ASTROPHYS, V299, P267; Meech KJ, 2011, ASTROPHYS J LETT, V734, DOI 10.1088/2041-8205/734/1/L1; Mousis O, 2000, ICARUS, V148, P513, DOI 10.1006/icar.2000.6499; ORO J, 1961, NATURE, V190, P389, DOI 10.1038/190389a0; OWEN T, 1992, NATURE, V358, P43, DOI 10.1038/358043a0; Robert F, 2011, NAT GEOSCI, V4, P74, DOI 10.1038/ngeo1066; Thi WF, 2010, MON NOT R ASTRON SOC, V407, P232, DOI 10.1111/j.1365-2966.2009.16162.x; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; Walsh KJ, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/201015277; WANKE H, 1981, PHILOS T R SOC A, V303, P287, DOI 10.1098/rsta.1981.0203; WATSON WD, 1974, ASTROPHYS J, V188, P35, DOI 10.1086/152681; Zakharov V, 2007, ASTRON ASTROPHYS, V473, P303, DOI 10.1051/0004-6361:20066715	30	301	304	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2011	478	7368					218	220		10.1038/nature10519	http://dx.doi.org/10.1038/nature10519			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21976024				2022-12-28	WOS:000295782800044
J	Engle, PL; Fernald, LCH; Alderman, H; Behrman, J; O'Gara, C; Yousafzai, A; de Mello, MC; Hidrobo, M; Ulkuer, N; Ertem, I; Iltus, S				Engle, Patrice L.; Fernald, Lia C. H.; Alderman, Harold; Behrman, Jere; O'Gara, Chloe; Yousafzai, Aisha; de Mello, Meena Cabral; Hidrobo, Melissa; Ulkuer, Nurper; Ertem, Ilgi; Iltus, Selim		Global Child Dev Steering Grp	Child Development 2 Strategies for reducing inequalities and improving developmental outcomes for young children in low-income and middle-income countries	LANCET			English	Article							POSITIVE PARENTING PROGRAM; CASH TRANSFER PROGRAMS; LOW-BIRTH-WEIGHT; PSYCHOSOCIAL STIMULATION; EARLY INTERVENTION; PRESCHOOL PROGRAM; PROVIDING CARE; COMMUNITY; RISK; PARTICIPATION	This report is the second in a Series on early child development in low-income and middle-income countries and assesses the effectiveness of early child development interventions, such as parenting support and preschool enrolment. The evidence reviewed suggests that early child development can be improved through these interventions, with effects greater for programmes of higher quality and for the most vulnerable children. Other promising interventions for the promotion of early child development include children's educational media, interventions with children at high risk, and combining the promotion of early child development with conditional cash transfer programmes. Effective investments in early child development have the potential to reduce inequalities perpetuated by poverty, poor nutrition, and restricted learning opportunities. A simulation model of the potential long-term economic effects of increasing preschool enrolment to 25% or 50% in every low-income and middle-income country showed a benefit-to-cost ratio ranging from 6.4 to 17.6, depending on preschool enrolment rate and discount rate.	[Engle, Patrice L.] Calif Polytech State Univ San Luis Obispo, San Luis Obispo, CA 94307 USA; [Fernald, Lia C. H.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Alderman, Harold] World Bank, Dev Res Grp, Washington, DC 20433 USA; [Behrman, Jere] Univ Penn, Dept Econ, Philadelphia, PA 19104 USA; [Behrman, Jere] Univ Penn, Dept Sociol, Philadelphia, PA 19104 USA; [O'Gara, Chloe] William & Flora Hewlett Fdn, Menlo Pk, CA USA; [Yousafzai, Aisha] Aga Khan Univ, Dept Paediat & Hlth, Div Women & Child Hlth, Karachi, Pakistan; [de Mello, Meena Cabral] WHO, CH-1211 Geneva, Switzerland; [Hidrobo, Melissa] Int Food Policy Res Inst, Washington, DC 20036 USA; [Ulkuer, Nurper] United Nations Childrens Fund, New York, NY USA; [Ertem, Ilgi] Ankara Univ, Dept Pediat, Fac Med, TR-06100 Ankara, Turkey; [Iltus, Selim] Bernard van Leer Fdn, The Hague, Netherlands	California State University System; California Polytechnic State University San Luis Obispo; University of California System; University of California Berkeley; The World Bank; University of Pennsylvania; University of Pennsylvania; Hewlett-Packard; Aga Khan University; World Health Organization; CGIAR; International Food Policy Research Institute (IFPRI); UNICEF; Ankara University	Engle, PL (corresponding author), Calif Polytech State Univ San Luis Obispo, 1 Grand Ave, San Luis Obispo, CA 94307 USA.	pengle@calpoly.edu	Behrman, Jere R/A-9734-2009	Fernald, Lia C.H./0000-0003-1555-4607				Aboud FE, 2008, RES COMP INT EDUC, V3, P295, DOI 10.2304/rcie.2008.3.3.295; Aboud FE, 2011, EARLY CHILD RES Q, V26, P237, DOI 10.1016/j.ecresq.2010.07.001; Aboud FE, 2011, PEDIATRICS, V127, pE1191, DOI 10.1542/peds.2010-2160; Al-Hassan SM, 2011, EARLY CHILD DEV CARE, V181, P587, DOI 10.1080/03004431003654925; Anderson DR, 2005, AM BEHAV SCI, V48, P505, DOI 10.1177/0002764204271506; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; Ashworth A., 2003, GUIDELINES INPATIENT; Baker-Henningham H, 2009, CHILD CARE HLTH DEV, V35, P624, DOI 10.1111/j.1365-2214.2009.00964.x; Bakermans-Kranenburg MJ, 2003, PSYCHOL BULL, V129, P195, DOI 10.1037/0033-2909.129.2.195; Baydar N, 2008, J APPL DEV PSYCHOL, V29, P349, DOI 10.1016/j.appdev.2008.06.005; BENTLEY ME, 2010, FASEB J S, V24; Berlinski S, 2008, J PUBLIC ECON, V92, P1416, DOI 10.1016/j.jpubeco.2007.10.007; Berlinski S, 2009, J PUBLIC ECON, V93, P219, DOI 10.1016/j.jpubeco.2008.09.002; BERNAL R, 2009, EVALUACION IMPACTO P; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; BIERSTEKER L, 2010, SCALING UP EARLY CHI; Bradley RH, 2005, INT J BEHAV DEV, V29, P468, DOI 10.1080/01650250500146925; Cole CF, 2008, INT J BEHAV DEV, V32, P359, DOI 10.1177/0165025408090977; Cooper PJ, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b974; CUETO S, 2009, 15 DEP INT DEV; Das J, 2005, WORLD BANK RES OBSER, V20, P57, DOI 10.1093/wbro/lki005; de Janvry A, 2006, WORLD BANK ECON REV, V20, P1, DOI 10.1093/wber/lhj002; Dunn L. M., 1986, TEST VOCABULARIO IM; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; ENGLE PL, CARE DEV 3 CENTRAL A; Ertem IO, 2006, PEDIATRICS, V118, pE124, DOI 10.1542/peds.2005-2704; Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7; Fernald LCH, 2009, LANCET, V374, P1997, DOI 10.1016/S0140-6736(09)61676-7; Fernald LCH, 2011, SOC SCI MED, V72, P1437, DOI 10.1016/j.socscimed.2011.03.005; Filmer, 2010, ED ATTAINMENT ENROLL; FILMER D, ED ATTAINMENT ENROLL; Finkenflugel H, 2005, INT J REHABIL RES, V28, P187, DOI 10.1097/00004356-200509000-00001; Fisch S.M., 2004, CHILDRENS LEARNING E; Fiszbein A, 2009, CONDITIONAL CASH TRA; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Handa S, 2006, DEV POLICY REV, V24, P513, DOI 10.1111/j.1467-7679.2006.00345.x; Ho J., 2009, J ED INT DEV, V4, P34; Horton S, 2009, SCALING UP NUTR WHAT; Jain S, 2009, J CHILD MEDIA, V3, P95; Janssens W., 2011, IMPACT HOME VISITING; Jin XM, 2007, J DEV BEHAV PEDIATR, V28, P213, DOI 10.1097/dbp.0b013e31802d410b; JONES L, AM J ORTHOP IN PRESS; Kagitcibasi C, 2009, J APPL DEV PSYCHOL, V30, P764, DOI 10.1016/j.appdev.2009.05.003; KAYTAZ M, COST BENEFIT ANAL PR; KILBURN MR, 2008, EC EARLY CHILDHOOD P; King E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006733.pub2; Klebanov P, 2006, ANN NY ACAD SCI, V1094, P63, DOI 10.1196/annals.1376.007; Klein PS, 2004, INFANT YOUNG CHILD, V17, P340, DOI 10.1097/00001163-200410000-00007; Korfmacher J, 2007, INFANT MENT HEALTH J, V28, P459, DOI 10.1002/imhj.20148; LEE J, ED IMPACT SISIMPUR R; Leung C, 2003, FAM PROCESS, V42, P531, DOI 10.1111/j.1545-5300.2003.00531.x; LUSK D, 2005, BUNGOMA VIHIGA ANN A; MACOURS K, AM EC J APP IN PRESS; Malmberg LE, 2011, EARLY CHILD RES Q, V26, P124, DOI 10.1016/j.ecresq.2010.04.003; Maulik PK, 2009, J PERINATOL, V29, P531, DOI 10.1038/jp.2009.42; McConachie H, 2000, J PEDIATR-US, V137, P769, DOI 10.1067/mpd.2000.110135; *MCMAST U SCH NURS, EFF PUBL HLTH PRACT; Mirza I, 2009, J INTELL DISABIL RES, V53, P559, DOI 10.1111/j.1365-2788.2009.01176.x; Moore AC, 2008, INT J EDUC DEV, V28, P118, DOI 10.1016/j.ijedudev.2007.05.003; Moran P., 2005, CHILDREN SOC, V19, P329, DOI [10.1002/chi.878, DOI 10.1002/CHI.878]; MORRIS E, 2009, RADIO INSTRUCTION ST; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Mwaura PAM, 2008, INT J EARLY YEARS ED, V16, P237, DOI 10.1080/09669760802357121; NADEAU S, 2010, INVESTING YOUNG CHIL; Nahar B, 2009, EUR J CLIN NUTR, V63, P725, DOI 10.1038/ejcn.2008.44; Nair MKC, 2009, INDIAN PEDIATR, V46, pS20; NODIRA A, 2009, IMPACT ASSESSMENT FA; Nores M, 2010, ECON EDUC REV, V29, P271, DOI 10.1016/j.econedurev.2009.09.001; Nowak C, 2008, CLIN CHILD FAM PSYCH, V11, P114, DOI 10.1007/s10567-008-0033-0; Nyesigomwe L, 2006, J INTERGENER RELATSH, V4, P55, DOI 10.1300/J194v04n01_07; Opel A., 2009, INT J EDUC RES, V48, P12, DOI [DOI 10.1016/J.IJER.2009.02.008, 10.1016/j.ijer.2009.02.008]; ORAZEM P, COPENHAGEN CONSENSUS; *ORG AM STAT INT C, 2007, 5 M MIN ED IN PRESS; Palti H, 1982, Community Med, V4, P302; PAUL D, 2005, REPORT PRETEST STUDY; Paxson C, 2010, ECON DEV CULT CHANGE, V59, P187, DOI 10.1086/655458; Potterton J, 2010, DEV MED CHILD NEUROL, V52, P547, DOI 10.1111/j.1469-8749.2009.03534.x; Raine A, 2003, AM J PSYCHIAT, V160, P1627, DOI 10.1176/appi.ajp.160.9.1627; RAMEY CT, 1992, PEDIATRICS, V89, P454; RAO N, CHILD DEV IN PRESS; RAO N, EARLY CHILD IN PRESS; Rawlings LB, 2005, WORLD BANK RES OBSER, V20, P29, DOI 10.1093/wbro/lki001; Reynolds AJ, 2008, ANNU REV CLIN PSYCHO, V4, P109, DOI 10.1146/annurev.clinpsy.3.022806.091411; Schenk KD, 2009, AIDS CARE, V21, P918, DOI 10.1080/09540120802537831; SIDIBEH L, EVALUATION PARENTAL; Spittle AJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005495.pub2; TAYLER C, 2006, STARTING STRONG, V2; Tinajero A.R., 2010, SCALING UP EARLY CHI; *UN SECR GEN, 2010, STAT CONV RIGHTS CHI, P2; UNAIDS, 2010, REP GLOB AIDS EP; UNESCO, 2006, ED ALL GLOB MON REP; Urzua S, 2010, IMPACT OUT OF HOME C; Vegas E, 2010, LATIN AMER DEVELOP, P1, DOI 10.1596/978-0-8213-7759-8; Villers R, 2006, INT J EDUC RES, V45, P188, DOI [DOI 10.1016/j.ijer.2006.11.002, DOI 10.1016/J.IJER.2006.11.002]; Walker S. P., 2011, NO SMALL MATTER IMPA, P115, DOI DOI 10.1596/9780821386774_CH04; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; Walker SP, 2010, DEV MED CHILD NEUROL, V52, pe148, DOI 10.1111/j.1469-8749.2010.03637.x; Wallander JL, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-27; *WHO, 2010, DOC INT MAN CHILDH I; *WOLF CTR DEV BROO, 2009, SCAL EARL CHILD DEV; *WORLD BANK, ED STAT; World Bank, WORLD DEV IND; Yarbrough D. B., 2011, PROGRAM EVALUATION S; YOSIKAWA H, 2007, EARLY CHILDHOOD ED M	105	455	458	2	121	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 8	2011	378	9799					1339	1353		10.1016/S0140-6736(11)60889-1	http://dx.doi.org/10.1016/S0140-6736(11)60889-1			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	831IU	21944378	Green Submitted			2022-12-28	WOS:000295724300029
J	Reynolds, MR; Zimetbaum, P				Reynolds, Matthew R.; Zimetbaum, Peter			Magnetic Resonance Imaging and Cardiac Devices: How Safe Is Safe Enough?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; 1.5 TESLA; PACEMAKER; PERFORMANCE; PATIENT		[Zimetbaum, Peter] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Cardiol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Zimetbaum, P (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Cardiol, 185 Pilgrim Rd, Boston, MA 02215 USA.							Anfinsen OG, 2002, PACE, V25, P1400, DOI 10.1046/j.1460-9592.2002.01400.x; Fontaine JM, 1998, PACE, V21, P1336, DOI 10.1111/j.1540-8159.1998.tb00202.x; Hammill SC, 2010, HEART RHYTHM, V7, P1340, DOI 10.1016/j.hrthm.2010.07.015; Hauser RG, 2005, J AM COLL CARDIOL, V45, P2022, DOI 10.1016/j.jacc.2005.02.077; HAYES DL, 1987, J AM COLL CARDIOL, V10, P782, DOI 10.1016/S0735-1097(87)80270-X; Kalin R, 2005, PACE, V28, P326, DOI 10.1111/j.1540-8159.2005.50024.x; Luechinger R, 2005, EUR HEART J, V26, P376, DOI 10.1093/eurheartj/ehi009; Martin ET, 2004, J AM COLL CARDIOL, V43, P1315, DOI 10.1016/j.jacc.2003.12.016; Mollerus M, 2010, EUROPACE, V12, P947, DOI 10.1093/europace/euq092; Nazarian S, 2011, ANN INTERN MED, V155, P415, DOI 10.7326/0003-4819-155-7-201110040-00004; Roguin A, 2004, CIRCULATION, V110, P475, DOI 10.1161/01.CIR.0000137121.28722.33; Sommer T, 2006, CIRCULATION, V114, P1285, DOI 10.1161/CIRCULATIONAHA.105.597013; Strach K, 2010, EUROPACE, V12, P952, DOI 10.1093/europace/euq081; Wilkoff BL, 2011, HEART RHYTHM, V8, P65, DOI 10.1016/j.hrthm.2010.10.002	14	6	6	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2011	155	7					470	U109		10.7326/0003-4819-155-7-201110040-00010	http://dx.doi.org/10.7326/0003-4819-155-7-201110040-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	833OC	21969346				2022-12-28	WOS:000295893800008
J	Fong, YW; Inouye, C; Yamaguchi, T; Cattoglio, C; Grubisic, I; Tjian, R				Fong, Yick W.; Inouye, Carla; Yamaguchi, Teppei; Cattoglio, Claudia; Grubisic, Ivan; Tjian, Robert			A DNA Repair Complex Functions as an Oct4/Sox2 Coactivator in Embryonic Stem Cells	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; TRANSCRIPTIONAL REGULATORY CIRCUITRY; PROTEIN-INTERACTION NETWORK; NANOG GENE-EXPRESSION; GROUP-C PROTEIN; SELF-RENEWAL; TARGET GENES; XPC PROTEIN; IN-VITRO; PLURIPOTENCY	The transcriptional activators Oct4, Sox2, and Nanog cooperate with a wide array of cofactors to orchestrate an embryonic stem (ES) cell-specific gene expression program that forms the molecular basis of pluripotency. Here, we report using an unbiased in vitro transcription-biochemical complementation assay to discover a multisubunit stem cell coactivator complex (SCC) that is selectively required for the synergistic activation of the Nanog gene by Oct4 and Sox2. Purification, identification, and reconstitution of SCC revealed this coactivator to be the trimeric XPC-nucleotide excision repair complex. SCC interacts directly with Oct4 and Sox2 and is recruited to the Nanog and Oct4 promoters as well as a majority of genomic regions that are occupied by Oct4 and Sox2. Depletion of SCC/XPC compromised both pluripotency in ES cells and somatic cell reprogramming of fibroblasts to induced pluripotent stem (iPS) cells. This study identifies a transcriptional coactivator with diversified functions in maintaining ES cell pluripotency and safeguarding genome integrity.	[Fong, Yick W.; Inouye, Carla; Yamaguchi, Teppei; Cattoglio, Claudia; Tjian, Robert] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Grubisic, Ivan] Univ Calif Berkeley, UC Berkeley UCSF Grad Program Bioengn, Berkeley, CA 94720 USA; [Tjian, Robert] Univ Calif Berkeley, Li Ka Shing Ctr Biomed & Hlth Sci, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Stanford University; Li Ka Shing Center; University of California System; University of California Berkeley	Tjian, R (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	jmlim@berkeley.edu		Grubisic, Ivan/0000-0002-4200-0653	California Institute for Regenerative Medicine (CIRM) [T1-00007]; Swiss National Science Foundation; Siebel Stem Cell Institute; NATIONAL CANCER INSTITUTE [R37CA025417] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Siebel Stem Cell Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors wish to thank A. Fischer and M. Richner at the Tissue Culture Facility (University of California, Berkeley); S. Zheng, G. Dailey, M. Haggart, and E. Bourbon for technical assistance; S. Chen at National Institute of Biological Sciences (Beijing, China) for mass spectrometry analysis; S. Zhou for initial mass spectrometry analysis; J. Hoeijmakers for knockout MEFs; G. Mostoslavsky for STEMCCA; O. Puig for pGL3-CAT plasmid; S. Ryu for purified rTBP and G3BCAT plasmid; K. Hochedlinger, M. Stadtfeld, J. de Wit, and M. Holmes for technical advice; and M. Botchan, M. Holmes, M. Levine, S. Martin, M. Rape, D. Rio, and all members of our laboratory for critical reading of the manuscript. Y.W.F. was a California Institute for Regenerative Medicine Scholar (CIRM training grant T1-00007). T.Y. was supported by the Swiss National Science Foundation and the Siebel Stem Cell Institute and is a Jane Coffin Childs fellow.	Araki M, 2001, J BIOL CHEM, V276, P18665, DOI 10.1074/jbc.M100855200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Camenisch U, 2009, EMBO J, V28, P2387, DOI 10.1038/emboj.2009.187; Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199; Chakravarthy H, 2008, J CELL PHYSIOL, V216, P651, DOI 10.1002/jcp.21440; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; de Jesus BMB, 2008, MOL CELL BIOL, V28, P7225, DOI 10.1128/MCB.00781-08; Engelen E, 2011, NAT GENET, V43, P607, DOI 10.1038/ng.825; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Le May N, 2010, MOL CELL, V38, P54, DOI 10.1016/j.molcel.2010.03.004; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maillard O, 2007, PLOS BIOL, V5, P717, DOI 10.1371/journal.pbio.0050079; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Naar AM, 1998, GENE DEV, V12, P3020, DOI 10.1101/gad.12.19.3020; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; Pal R, 2006, CELL PROLIFERAT, V39, P585, DOI 10.1111/j.1365-2184.2006.00400.x; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; SANDS AT, 1995, NATURE, V377, P162, DOI 10.1038/377162a0; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; Schwartz CM, 2005, STEM CELLS DEV, V14, P517, DOI 10.1089/scd.2005.14.517; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Sugasawa K, 1996, MOL CELL BIOL, V16, P4852; Taatjes DJ, 2004, NAT REV MOL CELL BIO, V5, P403, DOI 10.1038/nrm1369; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Tutter AV, 2009, J BIOL CHEM, V284, P3709, DOI 10.1074/jbc.M805677200; Uchida A, 2002, DNA REPAIR, V1, P449, DOI 10.1016/S1568-7864(02)00031-9; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; VENEMA J, 1990, NUCLEIC ACIDS RES, V18, P443, DOI 10.1093/nar/18.3.443; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yasuda G, 2007, MOL CELL BIOL, V27, P6606, DOI 10.1128/MCB.02166-06; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200	53	124	128	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					120	131		10.1016/j.cell.2011.08.038	http://dx.doi.org/10.1016/j.cell.2011.08.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962512	Bronze, Green Accepted			2022-12-28	WOS:000295396700020
J	Matos, J; Blanco, MG; Maslen, S; Skehel, JM; West, SC				Matos, Joao; Blanco, Miguel G.; Maslen, Sarah; Skehel, J. Mark; West, Stephen C.			Regulatory Control of the Resolution of DNA Recombination Intermediates during Meiosis and Mitosis	CELL			English	Article							HOLLIDAY JUNCTION RESOLUTION; DOUBLE-STRAND BREAK; MEIOTIC RECOMBINATION; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; CROSSING-OVER; KINASE CDC5; FUNCTIONAL OVERLAP; JOINT MOLECULES; ENDONUCLEASE	The efficient and timely resolution of DNA recombination intermediates is essential for bipolar chromosome segregation. Here, we show that the specialized chromosome segregation patterns of meiosis and mitosis, which require the coordination of recombination with cell-cycle progression, are achieved by regulating the timing of activation of two crossover-promoting endonucleases. In yeast meiosis, Mus81-Mms4 and Yen1 are controlled by phosphorylation events that lead to their sequential activation. Mus81-Mms4 is hyperactivated by Cdc5-mediated phosphorylation in meiosis I, generating the crossovers necessary for chromosome segregation. Yen1 is also tightly regulated and is activated in meiosis II to resolve persistent Holliday junctions. In yeast and human mitotic cells, a similar regulatory network restrains these nuclease activities until mitosis, biasing the outcome of recombination toward noncrossover products while also ensuring the elimination of any persistent joint molecules. Mitotic regulation thereby facilitates chromosome segregation while limiting the potential for loss of heterozygosity and sister-chromatid exchanges.	[Matos, Joao; Blanco, Miguel G.; Maslen, Sarah; Skehel, J. Mark; West, Stephen C.] Canc Res UK, Clare Hall Labs, London Res Inst, S Mimms EN6 3LD, Herts, England	Cancer Research UK	West, SC (corresponding author), Canc Res UK, Clare Hall Labs, London Res Inst, S Mimms EN6 3LD, Herts, England.	stephen.west@cancer.org.uk	Blanco, Miguel González/R-5754-2017; Matos, Joao/C-1488-2014; Blanco, Miguel González/J-6424-2012	Blanco, Miguel González/0000-0002-2883-7326; Matos, Joao/0000-0002-3754-3709; Blanco, Miguel González/0000-0002-2883-7326; West, Stephen/0000-0001-8848-9418	Cancer Research UK; European Research Council; Louis-Jeantet Foundation; Swiss Bridge Foundation; Breast Cancer Campaign; Human Frontiers Science Program long-term Fellowship; Xunta de Galicia (Spain); Cancer Research UK [11582] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); Louis-Jeantet Foundation; Swiss Bridge Foundation; Breast Cancer Campaign; Human Frontiers Science Program long-term Fellowship; Xunta de Galicia (Spain)(Xunta de Galicia); Cancer Research UK(Cancer Research UK)	We thank Wolfgang Zachariae and Nancy Kleckner for strains and plasmids, Tony Hyman for the BAC tagging cassettes, Keun Kim for help with the physical analysis of recombination, and members of our laboratory for comments and criticisms. This work was supported by Cancer Research UK, the European Research Council, the Louis-Jeantet Foundation, the Swiss Bridge Foundation, and the Breast Cancer Campaign. J.M. was a recipient of a Human Frontiers Science Program long-term Fellowship, and M. G. B. by the Angeles Alvarino program of the Xunta de Galicia (Spain).	Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Blanco MG, 2010, DNA REPAIR, V9, P394, DOI 10.1016/j.dnarep.2009.12.017; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; de los Santos T, 2003, GENETICS, V164, P81; de los Santos T, 2001, GENETICS, V159, P1511; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Fricke WM, 2003, GENE DEV, V17, P1768, DOI 10.1101/gad.1105203; Fu Y, 2003, DNA REPAIR, V2, P1435, DOI 10.1016/j.dnarep.2003.08.013; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Haber JE, 2001, CELL, V107, P551, DOI 10.1016/S0092-8674(01)00593-1; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Ho CK, 2010, MOL CELL, V40, P988, DOI 10.1016/j.molcel.2010.11.016; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Mullen JR, 2001, GENETICS, V157, P103; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; Oh SD, 2008, MOL CELL, V31, P324, DOI 10.1016/j.molcel.2008.07.006; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Rass U, 2010, GENE DEV, V24, P1559, DOI 10.1101/gad.585310; Rockmill B, 2003, CURR BIOL, V13, P1954, DOI 10.1016/j.cub.2003.10.059; Schoffski P, 2009, ONCOLOGIST, V14, P559, DOI 10.1634/theoncologist.2009-0010; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Sourirajan A, 2008, GENE DEV, V22, P2627, DOI 10.1101/gad.1711408; Tay YD, 2010, J BIOL CHEM, V285, P11427, DOI 10.1074/jbc.M110.108399; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	40	212	213	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					158	172		10.1016/j.cell.2011.08.032	http://dx.doi.org/10.1016/j.cell.2011.08.032			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962513	Bronze, Green Accepted			2022-12-28	WOS:000295396700023
J	Boyce, N				Boyce, Niall			Profile Alice Roberts: the skull beneath the skin	LANCET			English	Biographical-Item												niall.boyce@lancet.com							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 24	2011	378	9797					1132	1132		10.1016/S0140-6736(11)61495-5	http://dx.doi.org/10.1016/S0140-6736(11)61495-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829RH	21943693				2022-12-28	WOS:000295601500013
J	Clapham, PR; Lu, S				Clapham, Paul R.; Lu, Shan			VACCINOLOGY Precisely tuned antibodies nab HIV	NATURE			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; NEUTRALIZING ANTIBODIES; INDIVIDUALS; TARGET; BROAD		[Clapham, Paul R.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Clapham, Paul R.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA; [Lu, Shan] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Lu, Shan] Nanjing Med Univ, China US Vaccine Res Ctr, Nanjing, Peoples R China	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Nanjing Medical University	Clapham, PR (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	paul.clapham@umassmed.edu; shan.lu@umassmed.edu		Lu, Shan/0000-0002-8417-7588				BARBAS CF, 1994, P NATL ACAD SCI USA, V91, P3809, DOI 10.1073/pnas.91.9.3809; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659	12	19	21	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2011	477	7365					416	417		10.1038/477416a	http://dx.doi.org/10.1038/477416a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21938063				2022-12-28	WOS:000295080500030
J	McNeil, RPG; Kataoka, M; Ford, CJB; Barnes, CHW; Anderson, D; Jones, GAC; Farrer, I; Ritchie, DA				McNeil, R. P. G.; Kataoka, M.; Ford, C. J. B.; Barnes, C. H. W.; Anderson, D.; Jones, G. A. C.; Farrer, I.; Ritchie, D. A.			On-demand single-electron transfer between distant quantum dots	NATURE			English	Article							SPIN; COMPUTATION	Single-electron circuits of the future, consisting of a network of quantum dots, will require a mechanism to transport electrons from one functional part of the circuit to another. For example, in a quantum computer(1) decoherence and circuit complexity can be reduced by separating quantum bit (qubit) manipulation from measurement and by providing a means of transporting electrons between the corresponding parts of the circuit(2). Highly controlled tunnelling between neighbouring dots has been demonstrated(3,4), and our ability to manipulate electrons in single-and double-dot systems is improving rapidly(5-8). For distances greater than a few hundred nanometres, neither free propagation nor tunnelling is viable while maintaining confinement of single electrons. Here we show how a single electron may be captured in a surface acoustic wave minimum and transferred from one quantum dot to a second, unoccupied, dot along a long, empty channel. The transfer direction may be reversed and the same electron moved back and forth more than sixty times-a cumulative distance of 0.25 mm-without error. Such on-chip transfer extends communication between quantum dots to a range that may allow the integration of discrete quantum information processing components and devices.	[McNeil, R. P. G.; Kataoka, M.; Ford, C. J. B.; Barnes, C. H. W.; Anderson, D.; Jones, G. A. C.; Farrer, I.; Ritchie, D. A.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Kataoka, M.] Natl Phys Lab, Teddington TW11 0LW, Middx, England	University of Cambridge; National Physical Laboratory - UK	Ford, CJB (corresponding author), Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	cjbf@cam.ac.uk	Ford, Christopher JB/G-5690-2017; Farrer, Ian/A-7671-2009; Barnes, Crispin H. W./X-7093-2019; Ritchie, David/K-2206-2014; Kataoka, Masaya/Q-1168-2018	Ford, Christopher JB/0000-0002-4557-3721; Farrer, Ian/0000-0002-3033-4306; Barnes, Crispin H. W./0000-0001-7337-7245; Ritchie, David/0000-0002-9844-8350; Kataoka, Masaya/0000-0001-5780-6871	UK EPSRC; Toshiba Research Europe Limited; QIPIRC	UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Toshiba Research Europe Limited; QIPIRC	The authors acknowledge funding from the UK EPSRC, Toshiba Research Europe Limited and QIPIRC.	Barnes CHW, 2000, PHYS REV B, V62, P8410, DOI 10.1103/PhysRevB.62.8410; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; FIELD M, 1993, PHYS REV LETT, V70, P1311, DOI 10.1103/PhysRevLett.70.1311; Fujisawa T, 1998, SCIENCE, V282, P932, DOI 10.1126/science.282.5390.932; Gell JR, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2405419; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Hanson R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.196802; Kataoka M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.046801; Kataoka M, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.085302; Kataoka M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.156801; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Morello A, 2010, NATURE, V467, P687, DOI 10.1038/nature09392; Morgan D., 2007, SURFACE ACOUSTIC WAV, P9; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Pioro-Ladriere M, 2008, NAT PHYS, V4, P776, DOI 10.1038/nphys1053; Rahman S, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.035308; Stotz JAH, 2005, NAT MATER, V4, P585, DOI 10.1038/nmat1430; Taubert D, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.235404	18	216	220	6	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2011	477	7365					439	442		10.1038/nature10444	http://dx.doi.org/10.1038/nature10444			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21938065	Green Submitted			2022-12-28	WOS:000295080500035
J	Knutson, BA; Hahn, S				Knutson, Bruce A.; Hahn, Steven			Yeast Rrn7 and Human TAF1B Are TFIIB-Related RNA Polymerase I General Transcription Factors	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; RDNA TRANSCRIPTION; INITIATION-FACTOR; BDP1 SUBUNITS; COMPLEX; BINDING; PROTEIN; SL1; TBP; RECRUITMENT	Eukaryotic and archaeal multisubunit RNA polymerases (Pols) are structurally related and require several similar components for transcription initiation. However, none of the Pol I factors were known to share homology with transcription factor IIB (TFIIB) or TFIIB-related proteins, key factors in the initiation mechanisms of the other Pols. Here we show that Rrn7, a subunit of the yeast Pol I core factor, and its human ortholog TAF1B are TFIIB-like factors. Although distantly related, Rrn7 shares many activities associated with TFIIB-like factors. Domain swaps between TFIIB-related factors show that Rrn7 is most closely related to the Pol III general factor Brf1. Our results point to the conservation of initiation mechanisms among multisubunit Pols and reveal a key function of yeast core factor/human SL1 in Pol I transcription.	[Knutson, Bruce A.; Hahn, Steven] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Hahn, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N,POB 19024,Mailstop A1-162, Seattle, WA 98109 USA.	shahn@fhcrc.org			NIH [GM053451, T32 CA09657]; NATIONAL CANCER INSTITUTE [T32CA009657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053451] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Moorefield for yeast strains and plasmids, J. Zomerdijk for comments and sharing results, and members of the Hahn laboratory, B. Moorefield, and E. Young for their comments and encouragement. Supported by NIH grants GM053451 (to S. H.) and T32 CA09657 (to B.A.K.).	Aprikian P, 2001, MOL CELL BIOL, V21, P4847, DOI 10.1128/MCB.21.15.4847-4855.2001; Boukhgalter B, 2002, GENE, V291, P187, DOI 10.1016/S0378-1119(02)00597-8; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Carter R, 2009, MOL BIOL EVOL, V26, P2515, DOI 10.1093/molbev/msp164; Cavel E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017216; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; Friedrich JK, 2005, J BIOL CHEM, V280, P29551, DOI 10.1074/jbc.M501595200; Gorski JJ, 2007, EMBO J, V26, P1560, DOI 10.1038/sj.emboj.7601601; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hahn S, 2009, NATURE, V462, P292, DOI 10.1038/462292a; Imamura S, 2008, EMBO J, V27, P2317, DOI 10.1038/emboj.2008.151; Kassavetis GA, 2006, J BIOL CHEM, V281, P14321, DOI 10.1074/jbc.M601702200; KHOO B, 1994, GENE DEV, V8, P2879, DOI 10.1101/gad.8.23.2879; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Lalo D, 1996, J BIOL CHEM, V271, P21062, DOI 10.1074/jbc.271.35.21062; Liao YL, 2003, J BIOL CHEM, V278, P44467, DOI 10.1074/jbc.M308354200; Lin CW, 1996, MOL CELL BIOL, V16, P6436; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P3962, DOI 10.1073/pnas.88.9.3962; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Steffan JS, 1996, GENE DEV, V10, P2551, DOI 10.1101/gad.10.20.2551; ZOMERDIJK JCBM, 1994, SCIENCE, V266, P2015, DOI 10.1126/science.7801130	23	50	52	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1637	1640		10.1126/science.1207699	http://dx.doi.org/10.1126/science.1207699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921198	Green Accepted			2022-12-28	WOS:000294900900045
J	Molaro, A; Hodges, E; Fang, F; Song, Q; McCombie, WR; Hannon, GJ; Smith, AD				Molaro, Antoine; Hodges, Emily; Fang, Fang; Song, Qiang; McCombie, W. Richard; Hannon, Gregory J.; Smith, Andrew D.			Sperm Methylation Profiles Reveal Features of Epigenetic Inheritance and Evolution in Primates	CELL			English	Article							DE-NOVO METHYLATION; DNA METHYLATION; CYTOSINE METHYLATION; HUMAN GENOME; CPG ISLANDS; VERTEBRATE GENOMES; BINDING-PROTEIN; SVA ELEMENTS; STEM-CELLS; GERM-CELLS	During germ cell and preimplantation development, mammalian cells undergo nearly complete reprogramming of DNA methylation patterns. We profiled the methylomes of human and chimp sperm as a basis for comparison to methylation patterns of ESCs. Although the majority of promoters escape methylation in both ESCs and sperm, the corresponding hypomethylated regions show substantial structural differences. Repeat elements are heavily methylated in both germ and somatic cells; however, retrotransposons from several subfamilies evade methylation more effectively during male germ cell development, whereas other subfamilies show the opposite trend. Comparing methylomes of human and chimp sperm revealed a subset of differentially methylated promoters and strikingly divergent methylation in retrotransposon subfamilies, with an evolutionary impact that is apparent in the underlying genomic sequence. Thus, the features that determine DNA methylation patterns differ between male germ cells and somatic cells, and elements of these features have diverged between humans and chimpanzees.	[Molaro, Antoine; Hodges, Emily; McCombie, W. Richard; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Fang, Fang; Song, Qiang; Smith, Andrew D.] Univ So Calif, Los Angeles, CA 90089 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Southern California	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu; andrewds@usc.edu	Hannon, Gregory/AAB-3568-2019; Song, Qiang/I-7887-2013; Smith, Andrew D./G-4104-2013	Song, Qiang/0000-0002-5923-0842; Smith, Andrew D./0000-0002-3337-1970; FANG, FANG/0000-0001-9829-2934; Hodges, Emily/0000-0001-6513-610X; Molaro, Antoine/0000-0002-3756-3793; McCombie, W. Richard/0000-0003-1899-0682	NIH [R01HG005238, 1RC2HD064459]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [RC2HD064459] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005238] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Michelle Rooks, Pramod Thekkat, and Colin Malone for help with experimental procedures and Assaf Gordon, Luigi Manna, and the CSHL and USC High Performance Computing Centers for computational support. We thank Babette Fontenot (New Iberia Research Center) and Jerilyn Pecotte (Southwest National Primate Center) for help with chimp sperm collection. We thank Sergey Nuzhdin, Ed Green, Peter Calabrese, Maren Friesen, Magnus Norborg, and Marie-Stanislas Remigereau for helpful discussions. This work was supported in part by grants from the NIH (R01HG005238 and 1RC2HD064459) and by a kind gift from Kathryn W. Davis.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Aravin AA, 2008, COLD SH Q B, V73, P283, DOI 10.1101/sqb.2008.73.058; Bantysh OB, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1393, DOI 10.1134/S0006297909120153; Bestor TH, 1998, AM J HUM GENET, V62, P1269, DOI 10.1086/301891; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; CHESNOKOV IN, 1995, J BIOL CHEM, V270, P18539, DOI 10.1074/jbc.270.31.18539; Cohen NM, 2011, CELL, V145, P773, DOI 10.1016/j.cell.2011.04.024; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; Curley JP, 2011, HORM BEHAV, V59, P306, DOI 10.1016/j.yhbeh.2010.06.018; Dalal Y, 2009, BIOCHEM CELL BIOL, V87, P273, DOI 10.1139/O08-135; Damert A, 2009, GENOME RES, V19, P1992, DOI 10.1101/gr.093435.109; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; Edwards JR, 2010, GENOME RES, V20, P972, DOI 10.1101/gr.101535.109; EHRLICH M, 1990, MUTAT RES, V238, P277, DOI 10.1016/0165-1110(90)90019-8; Enard W, 2004, CURR BIOL, V14, pR148, DOI 10.1016/j.cub.2004.01.042; Frescas D, 2008, CELL CYCLE, V7, P3539, DOI 10.4161/cc.7.22.7062; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hodges E., 2011, MOL CELL, DOI [10.1016/j.cell.2008.06.028, DOI 10.1016/J.CELL.2008.06.028]; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; KOCHANEK S, 1993, EMBO J, V12, P1141, DOI 10.1002/j.1460-2075.1993.tb05755.x; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lee SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011353; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LIU WM, 1994, NUCLEIC ACIDS RES, V22, P1087, DOI 10.1093/nar/22.6.1087; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mills RE, 2006, AM J HUM GENET, V78, P671, DOI 10.1086/501028; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Ostertag EM, 2003, AM J HUM GENET, V73, P1444, DOI 10.1086/380207; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Probst AV, 2010, DEV CELL, V19, P625, DOI 10.1016/j.devcel.2010.09.002; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; SCHMID CW, 1991, NUCLEIC ACIDS RES, V19, P5613, DOI 10.1093/nar/19.20.5613; SHEN LM, 1994, J BIOL CHEM, V269, P8466; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yamagata K, 2007, DEV BIOL, V312, P419, DOI 10.1016/j.ydbio.2007.09.041; Yu XP, 2005, J BIOL CHEM, V280, P35184, DOI 10.1074/jbc.M508138200; Zaidi SK, 2010, NAT REV GENET, V11, P583, DOI 10.1038/nrg2827; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147	55	261	269	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 16	2011	146	6					1028	1040		10.1016/j.cell.2011.08.016	http://dx.doi.org/10.1016/j.cell.2011.08.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925323	Bronze, Green Accepted			2022-12-28	WOS:000295258100023
J	Hoang, U; Stewart, R; Goldacre, MJ				Hoang, Uy; Stewart, Robert; Goldacre, Michael J.			Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999-2006	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SERIOUS MENTAL-ILLNESS; PSYCHIATRIC-DISORDERS; UNNATURAL CAUSES; FOLLOW-UP; SUICIDE; DEATH; ENGLAND; POPULATION; DATABASE; COHORT	Objective To investigate whether the mortality gap has reduced in recent years between people with schizophrenia or bipolar disorder and the general population. Design Record linkage study. Setting English hospital episode statistics and death registration data for patients discharged 1999-2006. Participants People discharged from inpatient care with a diagnosis of schizophrenia or bipolar disorder, followed for a year after discharge. Main outcome measures Age standardised mortality ratios at each time, comparing the mortality in people with schizophrenia or bipolar disorder with mortality in the general population. Poisson test of trend was used to investigate trend in ratios over time. Results By 2006 standardised mortality ratios in the psychiatric cohorts were about double the population average. The mortality gap widened over time. For people discharged with schizophrenia, the ratio was 1.6 (95% confidence interval 1.5 to 1.8) in 1999 and 2.2 (2.0 to 2.4) in 2006 (P<0.001 for trend). For bipolar disorder, the ratios were 1.3 (1.1 to 1.6) in 1999 and 1.9 (1.6 to 2.2) in 2006 (P=0.06 for trend). Ratios were higher for unnatural than for natural causes. About three quarters of all deaths, however, were certified as natural, and increases in ratios for natural causes, especially circulatory disease and respiratory diseases, were the main components of the increase in all cause mortality. Conclusions The total burden of premature deaths from natural causes in people with schizophrenia or bipolar disorder is substantial. There is a need for better understanding of the reasons for the persistent and increasing gap in mortality between discharged psychiatric patients and the general population, and for continued action to target risk factors for both natural and unnatural causes of death in people with serious mental illness.	[Hoang, Uy; Goldacre, Michael J.] Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England; [Stewart, Robert] Kings Coll London, Inst Psychiat, London SE5 8AF, England	University of Oxford; University of London; King's College London	Hoang, U (corresponding author), Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England.	uy.hoang@dphpc.ox.ac.uk	Stewart, Robert/B-1667-2010; Hoang, Uy/G-3012-2011; Hoang, Uy/AAD-9445-2022	Stewart, Robert/0000-0002-4435-6397; Hoang, Uy/0000-0002-8428-5140; Hoang, Uy/0000-0002-8428-5140	English National Institute for Health Research; NIHR Specialist Biomedical Research Centre for Mental Health at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London	English National Institute for Health Research; NIHR Specialist Biomedical Research Centre for Mental Health at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London	This work was funded in part by the English National Institute for Health Research. RS is funded by the NIHR Specialist Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King's College London. UH is an academic clinical fellow at the Oxford University Clinical Academic Graduate School and the Oxford School of Public Health. The work of the authors is independent from the funders of this research. The funders were not involved in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	ALLEBECK P, 1989, SCHIZOPHRENIA BULL, V15, P81, DOI 10.1093/schbul/15.1.81; Bean J, 2010, STRENGTH POWER TRAIN; Biddle L, 2008, BRIT MED J, V336, P539, DOI 10.1136/bmj.39475.603935.25; Breslow NE., 1987, STAT METHODS CANC RE, P81; Brown S, 2010, BRIT J PSYCHIAT, V196, P116, DOI 10.1192/bjp.bp.109.067512; Bushe CJ, 2010, J PSYCHOPHARMACOL, V24, P17, DOI 10.1177/1359786810382468; Byrne N, 2005, ACTA PSYCHIAT SCAND, V112, P409, DOI 10.1111/j.1600-0447.2005.00663.x; Chang CK, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-77; Chwastiak LA, 2009, LANCET, V374, P590, DOI 10.1016/S0140-6736(09)61072-2; Davidson M, 2002, J CLIN PSYCHIAT, V63, P5; *DEP HLTH, 2009, HLTH BILL; *DEP HLTH, 2008, LIF EXP ALL AG ALL C; *DEP HLTH, 2009, PUBL HLTH WHIT PAP; Department of Health, 1999, NAT SERV FRAM MENT H; Department of Health, 2002, NAT SUIC PREV STRAT; Department of Health, 2004, CHOOS HLTH MAK HLTH; Dutta R, 2011, SCHIZOPHR RES, V126, P11, DOI 10.1016/j.schres.2010.11.021; Gau SSF, 2004, BRIT J PSYCHIAT, V185, P422, DOI 10.1192/bjp.185.5.422; Gelder M. G., 2009, NEW OXFORD TXB PSYCH; GOLDACRE M, 1994, J EPIDEMIOL COMMUN H, V48, P318, DOI 10.1136/jech.48.3.318; GOLDACRE M, 1993, LANCET, V342, P283, DOI 10.1016/0140-6736(93)91822-4; Goldacre MJ, 2006, SOC PSYCH PSYCH EPID, V41, P409, DOI 10.1007/s00127-006-0035-5; Griffiths C, 2006, HLTH STAT Q, V32, P5; Hall DJ, 1998, BRIT J PSYCHIAT, V172, P239, DOI 10.1192/bjp.172.3.239; Hall P., 2005, STANDARDISATION; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; HASSALL C, 1988, J EPIDEMIOL COMMUN H, V42, P286, DOI 10.1136/jech.42.3.286; Higgins N, 2005, EUR J PSYCHIAT, V19, P19; Hiroeh U, 2001, LANCET, V358, P2110, DOI 10.1016/S0140-6736(01)07216-6; Kapur N, 2006, PSYCHOL MED, V36, P1485, DOI 10.1017/S0033291706008373; Keown P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1837; Leucht S., 2007, PHYS ILLNESS SCHIZOP; National Institute for Health and Clinical Excellence, 2007, DRUG MIS PSYCH INT; National Institute for Health and Clinical Excellence, 2008, SMOK CESS SERV PRIM; *NHS HLTH SCOTL, 2008, MOV SMOK FREE MENT H; *NIH CLIN EXC, 2007, DRUG MIS OP DET; NORDENTOFT M, 1993, BRIT MED J, V306, P1637, DOI 10.1136/bmj.306.6893.1637; *OFF NAT STAT, 2005, MORT STAT INJ POS SE, V26; Osborn DPJ, 2007, ARCH GEN PSYCHIAT, V64, P242, DOI 10.1001/archpsyc.64.2.242; Robson D, 2007, INT J NURS STUD, V44, P457, DOI 10.1016/j.ijnurstu.2006.07.013; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; *SCOTT EX, 2002, NAT FRAM PREV SUIC D; Sicouri S, 2008, EXPERT OPIN DRUG SAF, V7, P181, DOI [10.1517/14740338.7.2.181, 10.1517/14740338.7.2.181 ]; Tiihonen J, 2009, LANCET, V374, P620, DOI 10.1016/S0140-6736(09)60742-X; Wildgust HJ, 2010, J PSYCHOPHARMACOL, V24, P9, DOI 10.1177/1359786810382149	45	150	154	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2011	343								d5422	10.1136/bmj.d5422	http://dx.doi.org/10.1136/bmj.d5422			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822VI	21914766	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000295077500014
J	Jiang, FG; Ramanathan, A; Miller, MT; Tang, GQ; Gale, M; Patel, SS; Marcotrigiano, J				Jiang, Fuguo; Ramanathan, Anand; Miller, Matthew T.; Tang, Guo-Qing; Gale, Michael, Jr.; Patel, Smita S.; Marcotrigiano, Joseph			Structural basis of RNA recognition and activation by innate immune receptor RIG-I	NATURE			English	Article							COOPERATIVE BINDING; ADAPTER PROTEIN; NUCLEOTIDE; MECHANISM; HELICASES; LIGAND; DOMAIN; ATP	Retinoic-acid-inducible gene-I (RIG-I; also known as DDX58) is a cytoplasmic pathogen recognition receptor that recognizes pathogen-associated molecular pattern (PAMP) motifs to differentiate between viral and cellular RNAs. RIG-I is activated by blunt-ended double-stranded (ds)RNA with or without a 5'-triphosphate (ppp), by single-stranded RNA marked by a 5'-ppp(1) and by polyuridine sequences(2,3). Upon binding to such PAMP motifs, RIG-I initiates a signalling cascade that induces innate immune defences and inflammatory cytokines to establish an antiviral state. The RIG-I pathway is highly regulated and aberrant signalling leads to apoptosis, altered cell differentiation, inflammation, autoimmune diseases and cancer(4,5). The helicase and repressor domains (RD) of RIG-I recognize dsRNA and 5'-ppp RNA to activate the two amino-terminal caspase recruitment domains (CARDs) for signalling. Here, to understand the synergy between the helicase and the RD for RNA binding, and the contribution of ATP hydrolysis to RIG-I activation, we determined the structure of human RIG-I helicase-RD in complex with dsRNA and an ATP analogue. The helicase-RD organizes into a ring around dsRNA, capping one end, while contacting both strands using previously uncharacterized motifs to recognize dsRNA. Small-angle X-ray scattering, limited proteolysis and differential scanning fluorimetry indicate that RIG-I is in an extended and flexible conformation that compacts upon binding RNA. These results provide a detailed view of the role of helicase in dsRNA recognition, the synergy between the RD and the helicase for RNA binding and the organization of full-length RIG-I bound to dsRNA, and provide evidence of a conformational change upon RNA binding. The RIG-I helicase-RD structure is consistent with dsRNA translocation without unwinding and cooperative binding to RNA. The structure yields unprecedented insight into innate immunity and has a broader impact on other areas of biology, including RNA interference and DNA repair, which utilize homologous helicase domains within DICER and FANCM.	[Jiang, Fuguo; Miller, Matthew T.; Marcotrigiano, Joseph] Rutgers State Univ, Dept Chem & Chem Biol, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Ramanathan, Anand; Tang, Guo-Qing; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Gale, Michael, Jr.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Washington; University of Washington Seattle	Marcotrigiano, J (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Ctr Adv Biotechnol & Med, 679 Hoes Lane W, Piscataway, NJ 08854 USA.	patelss@umdnj.edu; jmarco@cabm.rutgers.edu	Marcotrigiano, Joseph/K-6697-2016; JIANG, FUGUO/G-6581-2012	Marcotrigiano, Joseph/0000-0003-0346-3353; JIANG, FUGUO/0000-0003-4469-1803; Gale, Michael/0000-0002-6332-7436	US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886, DE-AC02-06CH11357]; NSF; NIH/NIGMS through NSF [DMR-0936384]; NIH/NCRR [RR-01646]; NIH [GM55310, AI080659]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080659, R01AI060389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055310] Funding Source: NIH RePORTER	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); NIH/NIGMS through NSF(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge access to beamlines X29 at the NSLS (National Synchrotron Light Source), LRL-CAT at APS (Advanced Photon Source), and G1 and F1 at CHESS (Cornell High Energy Synchrotron Source) and thank the NSLS, APS and CHESS staff. NSLS and APS are supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-98CH10886 and DE-AC02-06CH11357, respectively. CHESS is supported by the NSF and NIH/NIGMS through NSF award DMR-0936384, and the MacCHESS resource is supported by NIH/NCRR award RR-01646. Use of the LRL-CAT beamline facilities at Sector 31 was provided by Eli Lilly & Company. We would like to thank V. Rajagopal for initiating the biochemical experiments and guiding the project in the early stages. We thank E. Arnold, H. Berman, S. K. Burley, R. Gillilian, L. Morisco, W. Olson, T. Saito, A. Shatkin, A. Stock, H. Yang and M. Zhuravieva for providing helpful comments and assistance. This work was supported by NIH grants GM55310 to S.S.P. and AI080659 to J.M.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Binder M., 2011, J BIOL CHEM; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lam AMI, 2003, J BIOL CHEM, V278, P44514, DOI 10.1074/jbc.M306444200; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2194, DOI 10.1021/bi9724319; Lu C, 2011, NUCLEIC ACIDS RES, V39, P1565, DOI 10.1093/nar/gkq974; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Matsumiya T, 2010, CRIT REV IMMUNOL, V30, P489, DOI 10.1615/CritRevImmunol.v30.i6.10; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Polach KJ, 2002, BIOCHEMISTRY-US, V41, P3693, DOI 10.1021/bi012062n; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schlee M, 2009, IMMUNOL REV, V227, P66, DOI 10.1111/j.1600-065X.2008.00724.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sun ZG, 2011, J VIROL, V85, P1036, DOI 10.1128/JVI.01734-10; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Tang GQ, 2005, J BIOL CHEM, V280, P40707, DOI 10.1074/jbc.M508013200; Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014	41	302	324	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2011	479	7373					423	U184		10.1038/nature10537	http://dx.doi.org/10.1038/nature10537			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	848OA	21947008	Green Accepted			2022-12-28	WOS:000297059700051
J	Lekic, V; French, SW; Fischer, KM				Lekic, Vedran; French, Scott W.; Fischer, Karen M.			Lithospheric Thinning Beneath Rifted Regions of Southern California	SCIENCE			English	Article							GULF-OF-CALIFORNIA; LOS-ANGELES BASIN; SALTON TROUGH; RELATIVE IMPORTANCE; TECTONIC EVOLUTION; VELOCITY STRUCTURE; REFLECTION DATA; NORTH-AMERICA; EXTENSION; CRUSTAL	The stretching and break-up of tectonic plates by rifting control the evolution of continents and oceans, but the processes by which lithosphere deforms and accommodates strain during rifting remain enigmatic. Using scattering of teleseismic shear waves beneath rifted zones and adjacent areas in Southern California, we resolve the lithosphere-asthenosphere boundary and lithospheric thickness variations to directly constrain this deformation. Substantial and laterally abrupt lithospheric thinning beneath rifted regions suggests efficient strain localization. In the Salton Trough, either the mantle lithosphere has experienced more thinning than the crust, or large volumes of new lithosphere have been created. Lack of a systematic offset between surface and deep lithospheric deformation rules out simple shear along throughgoing unidirectional shallow-dipping shear zones, but is consistent with symmetric extension of the lithosphere.	[Lekic, Vedran; French, Scott W.; Fischer, Karen M.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Brown University	Lekic, V (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	vedran_lekic@brown.edu	Lekic, Vedran/I-8121-2012	Lekic, Vedran/0000-0002-3548-272X	National Science Foundation [EAR-0641772]; EAR [EAR-0948303]	National Science Foundation(National Science Foundation (NSF)); EAR	This work was supported by the National Science Foundation EarthScope Program (EAR-0641772) and an EAR Postdoctoral Fellowship to V.L. (EAR-0948303). We thank the IRIS Data Management Center and the Southern California Earthquake Data Center for the waveform data used in this study. We thank H. Yuan, D. Forsyth, C. Rau, B. Schmandt, H. Ford, and D. Brothers for assistance with methods and interpretation.	Abt DL, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006914; BASSI G, 1995, GEOPHYS J INT, V122, P195, DOI 10.1111/j.1365-246X.1995.tb03547.x; Bialas RW, 2010, EARTH PLANET SC LETT, V292, P68, DOI 10.1016/j.epsl.2010.01.021; Bialas RW, 2009, TECTONICS, V28, DOI 10.1029/2008TC002394; Bohannon RG, 1998, GEOL SOC AM BULL, V110, P779, DOI 10.1130/0016-7606(1998)110<0779:UCSANT>2.3.CO;2; Brothers DS, 2009, NAT GEOSCI, V2, P581, DOI 10.1038/NGEO590; BUCK WR, 1991, J GEOPHYS RES-SOL EA, V96, P20161, DOI 10.1029/91JB01485; BUCK WR, 1988, TECTONICS, V7, P213, DOI 10.1029/TC007i002p00213; CROUCH JK, 1993, GEOL SOC AM BULL, V105, P1415, DOI 10.1130/0016-7606(1993)105<1415:LCTEOT>2.3.CO;2; Evans RL, 2005, NATURE, V437, P249, DOI 10.1038/nature04014; FUIS GS, 1984, J GEOPHYS RES, V89, P1165, DOI 10.1029/JB089iB02p01165; Hansen SE, 2009, S AFR J GEOL, V112, P229, DOI 10.2113/gssajg.112.3-4.229; HERZIG CT, 1994, GEOLOGY, V22, P991, DOI 10.1130/0091-7613(1994)022<0991:CVATSE>2.3.CO;2; Huismans RS, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002026; Huismans RS, 2001, J GEOPHYS RES-SOL EA, V106, P11271, DOI 10.1029/2000JB900424; Li XQ, 2007, GEOPHYS J INT, V170, P700, DOI [10.1111/j.1365-246X.2007.03428.x, 10.1111/J.1365-246X.2007.03428.x]; Lizarralde D, 2007, NATURE, V448, P466, DOI 10.1038/nature06035; LUYENDYK BP, 1991, GEOL SOC AM BULL, V103, P1528, DOI 10.1130/0016-7606(1991)103<1528:AMFNCR>2.3.CO;2; MCKENZIE D, 1978, EARTH PLANET SC LETT, V40, P25, DOI 10.1016/0012-821X(78)90071-7; McQuarrie N, 2005, GEOSPHERE, V1, P147, DOI 10.1130/GES00016.1; MILLER MS, 2009, EARTHSCOPE ONSITE NE, V4, P2; NICOLAS A, 1985, NATURE, V315, P112, DOI 10.1038/315112a0; Oskin M, 2001, GEOLOGY, V29, P459, DOI 10.1130/0091-7613(2001)029<0459:RLOPNA>2.0.CO;2; Parsons T, 1996, TECTONICS, V15, P456, DOI 10.1029/95TC02616; Rau CJ, 2011, GEOLOGY, V39, P975, DOI 10.1130/G32179.1; Schmandt B, 2010, EARTH PLANET SC LETT, V297, P435, DOI 10.1016/j.epsl.2010.06.047; Schmitt AK, 2006, EARTH PLANET SC LETT, V252, P260, DOI 10.1016/j.epsl.2006.09.041; Suss MP, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001628; Wilson D, 2005, NATURE, V433, P851, DOI 10.1038/nature03297	29	95	96	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 11	2011	334	6057					783	787		10.1126/science.1208898	http://dx.doi.org/10.1126/science.1208898			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845US	21979933				2022-12-28	WOS:000296849600040
J	Kartal, B; Maalcke, WJ; de Almeida, NM; Cirpus, I; Gloerich, J; Geerts, W; den Camp, HJMO; Harhangi, HR; Janssen-Megens, EM; Francoijs, KJ; Stunnenberg, HG; Keltjens, JT; Jetten, MSM; Strous, M				Kartal, Boran; Maalcke, Wouter J.; de Almeida, Naomi M.; Cirpus, Irina; Gloerich, Jolein; Geerts, Wim; den Camp, Huub J. M. Op; Harhangi, Harry R.; Janssen-Megens, Eva M.; Francoijs, Kees-Jan; Stunnenberg, Hendrik G.; Keltjens, Jan T.; Jetten, Mike S. M.; Strous, Marc			Molecular mechanism of anaerobic ammonium oxidation	NATURE			English	Article							ASSISTED-LASER-DESORPTION/IONIZATION; HYDRAZINE-OXIDIZING ENZYME; NITRIC-OXIDE; NITROSOMONAS-EUROPAEA; ANAMMOX BACTERIUM; POLYACRYLAMIDE-GELS; MASS-SPECTROMETRY; MULTIHEME PROTEIN; MICROORGANISMS; MONOOXYGENASE	Two distinct microbial processes, denitrification and anaerobic ammonium oxidation (anammox), are responsible for the release of fixed nitrogen as dinitrogen gas (N(2)) to the atmosphere(1-4). Denitrification has been studied for over 100 years and its intermediates and enzymes are well known(5). Even though anammox is a key biogeochemical process of equal importance, its molecular mechanism is unknown, but it was proposed to proceed through hydrazine (N(2)H(4))(6,7). Here we show that N(2)H(4) is produced from the anammox substrates ammonium and nitrite and that nitric oxide (NO) is the direct precursor of N(2)H(4). We resolved the genes and proteins central to anammox metabolism and purified the key enzymes that catalyse N(2)H(4) synthesis and its oxidation to N(2). These results present a new biochemical reaction forging an N-N bond and fill a lacuna in our understanding of the biochemical synthesis of the N(2) in the atmosphere. Furthermore, they reinforce the role of nitric oxide in the evolution of the nitrogen cycle.	[Kartal, Boran; Maalcke, Wouter J.; de Almeida, Naomi M.; Cirpus, Irina; Geerts, Wim; den Camp, Huub J. M. Op; Harhangi, Harry R.; Keltjens, Jan T.; Jetten, Mike S. M.; Strous, Marc] Radboud Univ Nijmegen, Dept Microbiol, Inst Water & Wetland Res, NL-6525 AJ Nijmegen, Netherlands; [Gloerich, Jolein] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Nijmegen Prote Facil,Dept Lab Med, NL-6500 HB Nijmegen, Netherlands; [Janssen-Megens, Eva M.; Francoijs, Kees-Jan; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Jetten, Mike S. M.] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands; [Strous, Marc] Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Delft University of Technology; Max Planck Society	Kartal, B (corresponding author), Radboud Univ Nijmegen, Dept Microbiol, Inst Water & Wetland Res, Heyendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands.	kartal@science.ru.nl	Strous, Marc/B-4064-2017; Camp, Huub J.M. Op den/F-5114-2011; Gloerich, Jolein/L-4327-2015; Kartal, Boran/ABD-5400-2021; Keltjens, Jan/M-3002-2013; Jetten, Mike/B-8834-2011; Kartal, Boran/D-2488-2014; Stunnenberg, Hendrik G./D-6875-2012	Strous, Marc/0000-0001-9600-3828; Camp, Huub J.M. Op den/0000-0003-1990-9030; Gloerich, Jolein/0000-0001-5976-8426; Jetten, Mike/0000-0002-4691-7039; Stunnenberg, Hendrik G./0000-0002-0066-1576; Kartal, Boran/0000-0003-4199-952X	Dutch Foundation for Applied Research [05987]; Darwin Center for Biogeosciences [142161201]; Netherlands Organization for Scientific Research [81802015]; European Research Council [242635]; ERC [232987]	Dutch Foundation for Applied Research; Darwin Center for Biogeosciences; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); ERC(European Research Council (ERC)European Commission)	B.K. was supported by a grant (05987) from the Dutch Foundation for Applied Research. W.J.M. was supported by a grant (142161201) from the Darwin Center for Biogeosciences. N.M.d.A. and I. C. were supported by a grant (81802015) from the Netherlands Organization for Scientific Research. M. S. was supported by a VIDI grant from the Netherlands Organization for Scientific Research and a European Research Council grant MASEM (242635). The anammox research of M.S.M.J. is supported by an advanced grant (232987) from the ERC. The authors acknowledge R. Klefoth for the initial tests for protein purification procedures.	Akaike T, 1996, METHOD ENZYMOL, V268, P211; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Audrieth L. F., 1951, CHEM HYDRAZINE; Brandes JA, 2007, CHEM REV, V107, P577, DOI 10.1021/cr050377t; Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Ducluzeau AL, 2009, TRENDS BIOCHEM SCI, V34, P9, DOI 10.1016/j.tibs.2008.10.005; Farhoud MH, 2005, MOL CELL PROTEOMICS, V4, P1653, DOI 10.1074/mcp.M500171-MCP200; Gilch S, 2009, MICROBIOL-SGM, V155, P279, DOI 10.1099/mic.0.023721-0; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Hooper AB, 1997, ANTON LEEUW INT J G, V71, P59, DOI 10.1023/A:1000133919203; HOOPER AB, 1965, J BIOL CHEM, V240, P4044; HYMAN MR, 1985, BIOCHEM J, V227, P719, DOI 10.1042/bj2270719; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Kartal B, 2008, FEMS MICROBIOL ECOL, V63, P46, DOI 10.1111/j.1574-6941.2007.00408.x; Kartal B, 2011, METHOD ENZYMOL, V486, P89, DOI [10.1016/S0076-6879(11)86004-0, 10.1016/B978-0-12-381294-0.00004-3]; Kartal B, 2010, APPL ENVIRON MICROB, V76, P6304, DOI 10.1128/AEM.00991-10; Keller M, 2009, MICROBIOL MOL BIOL R, V73, P62, DOI 10.1128/MMBR.00028-08; Klotz MG, 2008, ENVIRON MICROBIOL, V10, P3150, DOI 10.1111/j.1462-2920.2008.01733.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MCTAVISH H, 1993, J BACTERIOL, V175, P2436, DOI 10.1128/JB.175.8.2436-2444.1993; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Nagano T, 1999, LUMINESCENCE, V14, P283, DOI 10.1002/(SICI)1522-7243(199911/12)14:6<283::AID-BIO572>3.0.CO;2-G; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; PAYNE WJ, 1973, BACTERIOL REV, V37, P409, DOI 10.1128/MMBR.37.4.409-452.1973; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Schmid M, 2000, SYST APPL MICROBIOL, V23, P93, DOI 10.1016/S0723-2020(00)80050-8; Schmid MC, 2005, APPL ENVIRON MICROB, V71, P1677, DOI 10.1128/AEM.71.4.1677-1684.2005; Shimamura M, 2008, J BIOSCI BIOENG, V105, P243, DOI 10.1263/jbb.105.243; Shimamura M, 2007, APPL ENVIRON MICROB, V73, P1065, DOI 10.1128/AEM.01978-06; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; Strous M, 1998, APPL MICROBIOL BIOT, V50, P589, DOI 10.1007/s002530051340; Van De Graaf Astrid A., 1996, Microbiology (Reading), V142, P2187; van der Star WRL, 2008, BIOTECHNOL BIOENG, V101, P286, DOI 10.1002/bit.21891; van Niftrik L, 2010, MOL MICROBIOL, V77, P701, DOI 10.1111/j.1365-2958.2010.07242.x; vandeGraaf AA, 1997, MICROBIOL-SGM, V143, P2415, DOI 10.1099/00221287-143-7-2415; WATT GW, 1952, ANAL CHEM, V24, P2006, DOI 10.1021/ac60072a044; Weatherly DB, 2005, MOL CELL PROTEOMICS, V4, P762, DOI 10.1074/mcp.M400215-MCP200; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	41	529	605	80	1176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 3	2011	479	7371					127	U159		10.1038/nature10453	http://dx.doi.org/10.1038/nature10453			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840FA	21964329				2022-12-28	WOS:000296422600045
J	Wilensky, GR				Wilensky, Gail R.			Lessons from the Physician Group Practice Demonstration - A Sobering Reflection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Project HOPE, Bethesda, MD USA		Wilensky, GR (corresponding author), Project HOPE, Bethesda, MD USA.							CMS HHS, 2011, FED REGISTER, V76, P19528; Iglehart JK, 2011, NEW ENGL J MED, V364, P198, DOI 10.1056/NEJMp1013896	2	26	26	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2011	365	18					1659	1661		10.1056/NEJMp1110185	http://dx.doi.org/10.1056/NEJMp1110185			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	840FL	21916636				2022-12-28	WOS:000296424200004
J	Tian, H; Biehs, B; Warming, S; Leong, KG; Rangell, L; Klein, OD; de Sauvage, FJ				Tian, Hua; Biehs, Brian; Warming, Soren; Leong, Kevin G.; Rangell, Linda; Klein, Ophir D.; de Sauvage, Frederic J.			A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable	NATURE			English	Article							TRANSGENIC MICE; HAIR FOLLICLE; IN-VIVO; DIFFERENTIATION; EXPRESSION; RENEWAL; MARKS; LGR5; HOMEOSTASIS; DYNAMICS	The small intestine epithelium renews every 2 to 5 days, making it one of the most regenerative mammalian tissues. Genetic inducible fate mapping studies have identified two principal epithelial stem cell pools in this tissue. One pool consists of columnar Lgr5-expressing cells that cycle rapidly and are present predominantly at the crypt base(1). The other pool consists of Bmi1-expressing cells that largely reside above the crypt base(2). However, the relative functions of these two pools and their interrelationship are not understood. Here we specifically ablated Lgr5-expressing cells in mice using a human diphtheria toxin receptor (DTR) gene knocked into the Lgr5 locus. We found that complete loss of the Lgr5-expressing cells did not perturb homeostasis of the epithelium, indicating that other cell types can compensate for the elimination of this population. After ablation of Lgr5-expressing cells, progeny production by Bmi1-expressing cells increased, indicating that Bmi1-expressing stem cells compensate for the loss of Lgr5-expressing cells. Indeed, lineage tracing showed that Bmi1-expressing cells gave rise to Lgr5-expressing cells, pointing to a hierarchy of stem cells in the intestinal epithelium. Our results demonstrate that Lgr5-expressing cells are dispensable for normal intestinal homeostasis, and that in the absence of these cells, Bmi1-expressing cells can serve as an alternative stem cell pool. These data provide the first experimental evidence for the interrelationship between these populations. The Bmi1-expressing stem cells may represent both a reserve stem cell pool in case of injury to the small intestine epithelium and a source for replenishment of the Lgr5-expressing cells under non-pathological conditions.	[Tian, Hua; Warming, Soren; de Sauvage, Frederic J.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Biehs, Brian; Klein, Ophir D.] Univ Calif San Francisco, Inst Human Genet, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Biehs, Brian; Klein, Ophir D.] Univ Calif San Francisco, Inst Human Genet, Dept Pediat, San Francisco, CA 94143 USA; [Biehs, Brian; Klein, Ophir D.] Univ Calif San Francisco, Program Craniofacial & Mesenchymal Biol, San Francisco, CA 94143 USA; [Leong, Kevin G.] Genentech Inc, Dept Res Oncol, San Francisco, CA 94080 USA; [Rangell, Linda] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Roche Holding; Genentech; Roche Holding; Genentech	de Sauvage, FJ (corresponding author), Genentech Inc, Dept Mol Biol, 1 DNA Way, San Francisco, CA 94080 USA.	ophir.klein@ucsf.edu; desauvage.fred@gene.com	Warming, Soren/ABD-5729-2021; Parry, Lee/A-9623-2011; de Sauvage, Frederic/ABE-8400-2020	Parry, Lee/0000-0002-4467-9196; de Sauvage, Frederic/0000-0002-5275-2584; Klein, Ophir/0000-0002-6254-7082; Warming, Soren/0000-0002-5721-0741	National Institutes of Health [1-DP2-OD007191];  [R01-DE021420]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021420] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007191] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We gratefully acknowledge efforts by all the members of the Genentech mouse facility, in particular R. Ybarra and G. Morrow. We are grateful to N. Strauli, D.-K. Tran and A. Rathnayake for assistance with mouse breeding. We thank M. Roose-Girma, X. Rairdan and the members of the embryonic stem cell and microinjection groups for embryonic stem cell work and transgenic line generation and members of the F.J.d.S. laboratory for discussions and ideas. This work was funded in part by the National Institutes of Health through the NIH Director's New Innovator Award Program, 1-DP2-OD007191 and by R01-DE021420, both to O.D.K.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Buske P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001045; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Gregorieff A, 2010, CURR PROTOC STEM CEL; Hosen N, 2007, STEM CELLS, V25, P1635, DOI 10.1634/stemcells.2006-0229; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lobachevsky PN, 2006, CELL PROLIFERAT, V39, P379, DOI 10.1111/j.1365-2184.2006.00395.x; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Van Keuren ML, 2009, TRANSGENIC RES, V18, P769, DOI 10.1007/s11248-009-9271-2; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Warming S, 2006, MOL CELL BIOL, V26, P6913, DOI 10.1128/MCB.02255-05; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	31	795	823	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2011	478	7368					255	U148		10.1038/nature10408	http://dx.doi.org/10.1038/nature10408			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21927002	Green Accepted			2022-12-28	WOS:000295782800053
J	Robotham, JV; Graves, N; Cookson, BD; Barnett, AG; Wilson, JA; Edgeworth, JD; Batra, R; Cuthbertson, BH; Cooper, BS				Robotham, Julie V.; Graves, Nicholas; Cookson, Barry D.; Barnett, Adrian G.; Wilson, Jennie A.; Edgeworth, Jonathan D.; Batra, Rahul; Cuthbertson, Brian H.; Cooper, Ben S.			Screening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus in intensive care units: cost effectiveness evaluation	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SURGICAL-SITE INFECTIONS; BLOOD-STREAM INFECTIONS; MRSA PCR ASSAY; LENGTH-OF-STAY; CHROMAGAR MRSA; NASAL CARRIAGE; HOSPITALIZED-PATIENTS; IMPACT; COLONIZATION; CHLORHEXIDINE	Objective To assess the cost effectiveness of screening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus (MRSA) in intensive care units. Design Economic evaluation based on a dynamic transmission model. Setting England and Wales. Population Theoretical population of patients on an intensive care unit. Main outcome measures Infections, deaths, costs, quality adjusted life years (QALYs), incremental cost effectiveness ratios for alternative strategies, and net monetary benefits. Results All decolonisation strategies improved health outcomes and reduced costs. Although universal decolonisation (regardless of MRSA status) was the most cost effective in the short term, strategies using screening to target MRSA carriers may be preferred owing to the reduced risk of selecting for resistance. Among such targeted strategies, universal admission and weekly screening with polymerase chain reaction coupled with decolonisation using nasal mupirocin was the most cost effective. This finding was robust to the size of intensive care units, prevalence of MRSA on admission, proportion of patients classified as high risk, and precise value of willingness to pay for health benefits. All strategies using isolation but not decolonisation improved health outcomes but costs were increased. When the prevalence of MRSA on admission to the intensive care unit was 5% and the willingness to pay per QALY gained was between 20 pound 000 ((sic)23 000; $32 000) and 30 pound 000, the best such strategy was to isolate only those patients at high risk of carrying MRSA (either pre-emptively or after identification by admission and weekly screening for MRSA using chromogenic agar). Universal admission and weekly screening using polymerase chain reaction based detection of MRSA coupled with isolation was unlikely to be cost effective unless prevalence was high (10% of patients colonised with MRSA on admission). Conclusions MRSA control strategies that use decolonisation are likely to be cost saving in an intensive care unit setting provided resistance is lacking, and combining universal screening using polymerase chain reaction with decolonisation is likely to represent good value for money if untargeted decolonisation is considered unacceptable. In intensive care units where decolonisation is not implemented, evidence is insufficient to support universal screening for MRSA outside high prevalence settings.	[Robotham, Julie V.] Hlth Protect Agcy, London NW9 5EQ, England; [Graves, Nicholas; Barnett, Adrian G.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Cookson, Barry D.] Hlth Protect Agcy, Lab Healthcare Associated Infect, London NW9 5EQ, England; [Wilson, Jennie A.] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, London, England; [Edgeworth, Jonathan D.] Kings Coll London, Dept Infect Dis, Sch Med, Guys Hosp, London WC2R 2LS, England; [Edgeworth, Jonathan D.; Batra, Rahul] Guys & St Thomas NHS Fdn Trust, Directorate Infect, London, England; [Cuthbertson, Brian H.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Cooper, Ben S.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Cooper, Ben S.] Univ Oxford, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford, England	Health Protection Agency; Queensland University of Technology (QUT); Health Protection Agency; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Robotham, JV (corresponding author), Hlth Protect Agcy, London NW9 5EQ, England.	julie.robotham@hpa.org.uk	Barnett, Adrian/I-9850-2012; Cooper, Ben/HGC-7082-2022	Barnett, Adrian/0000-0001-6339-0374; Robotham, Julie/0000-0003-2515-4084; Wilson, Jennie/0000-0002-4713-9662; Graves, Nicholas/0000-0002-5559-3267; Cooper, Ben/0000-0002-9445-7217	Department of Health Policy Research [PR-IP-0807-0410026]; Mastering Hospital Antimicrobial Resistance in Europe consortium; Oak Foundation; Wellcome Trust	Department of Health Policy Research; Mastering Hospital Antimicrobial Resistance in Europe consortium; Oak Foundation; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a grant from the Department of Health Policy Research Programme (PR-IP-0807-0410026). The views expressed are not necessarily those of the department. The authors' work was independent of the funders, who had no role in the study design, analysis of data, writing of the manuscript, or decision to submit for publication. We acknowledge support from the Mastering Hospital Antimicrobial Resistance in Europe consortium. BSC acknowledges support from the Oak Foundation. The Mahidol Oxford Research Unit is supported by the Wellcome Trust.	Apfalter P, 2002, DIAGN MICR INFEC DIS, V44, P209, DOI 10.1016/S0732-8893(02)00435-2; Barnett AG, 2009, AM J EPIDEMIOL, V170, P1186, DOI 10.1093/aje/kwp249; Barton GR, 2008, VALUE HEALTH, V11, P886, DOI 10.1111/j.1524-4733.2008.00358.x; Batra R, 2010, CLIN INFECT DIS, V50, P210, DOI 10.1086/648717; Ben Nsira S, 2006, INT J ANTIMICROB AG, V27, P561, DOI 10.1016/j.ijantimicag.2006.03.011; Beyersmann J, 2008, J CLIN EPIDEMIOL, V61, P1216, DOI 10.1016/j.jclinepi.2008.02.008; Bishop EJ, 2006, J CLIN MICROBIOL, V44, P2904, DOI 10.1128/JCM.02211-05; Bleasdale SC, 2007, ARCH INTERN MED, V167, P2073, DOI 10.1001/archinte.167.19.2073; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Brown J, 2010, PHARMACOECONOMICS, V28, P567, DOI 10.2165/11533020-000000000-00000; Cepeda JA, 2005, LANCET, V365, P295, DOI 10.1016/S0140-6736(05)17783-6; Claxton K, 2005, HEALTH ECON, V14, P339, DOI 10.1002/hec.985; Climo MW, 2009, CRIT CARE MED, V37, P1858, DOI 10.1097/CCM.0b013e31819ffe6d; Coia JE, 2006, J HOSP INFECT, V63, pS1, DOI 10.1016/j.jhin.2006.01.001; Compernolle V, 2007, J CLIN MICROBIOL, V45, P154, DOI 10.1128/JCM.01115-06; Cookson BD, 1998, J ANTIMICROB CHEMOTH, V41, P11, DOI 10.1093/jac/41.1.11; Cooper BS, 2004, BMJ-BRIT MED J, V329, P533, DOI 10.1136/bmj.329.7465.533; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Cunningham R, 2007, J HOSP INFECT, V65, P24, DOI 10.1016/j.jhin.2006.09.019; Cuthbertson BH, 2010, CRIT CARE, V14, DOI 10.1186/cc8848; Dancer SJ, 2006, AM J INFECT CONTROL, V34, P10, DOI 10.1016/j.ajic.2005.08.009; de Vries R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013392; Evans HL, 2010, ARCH SURG-CHICAGO, V145, P240, DOI 10.1001/archsurg.2010.5; Eveillard M, 2006, AM J INFECT CONTROL, V34, P108, DOI 10.1016/j.ajic.2006.01.001; Girou E, 2004, J HOSP INFECT, V57, P162, DOI 10.1016/j.jhin.2004.03.010; Graves N, 2008, J HOSP INFECT, V69, P274, DOI 10.1016/j.jhin.2008.04.022; Graves N, 2006, EMERG INFECT DIS, V12, P831; Graves N, 2004, EMERG INFECT DIS, V10, P561, DOI 10.3201/eid1004.020754; Graves N, 2007, INFECT CONT HOSP EP, V28, P178, DOI 10.1086/510787; Harbarth S, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.04.042; Harbarth S, 2006, CRIT CARE, V10, DOI 10.1186/cc3982; Hardy K, 2010, CLIN MICROBIOL INFEC, V16, P333, DOI 10.1111/j.1469-0691.2009.02899.x; Health Protection Scotland, 2011, PATHF IMPL STUD; Huletsky A, 2005, CLIN INFECT DIS, V40, P976, DOI 10.1086/428579; Jain R, 2011, NEW ENGL J MED, V364, P1419, DOI 10.1056/NEJMoa1007474; Jeyaratnam D, 2008, BMJ-BRIT MED J, V336, P927, DOI 10.1136/bmj.39525.579063.BE; Keshtgar MRS, 2008, BRIT J SURG, V95, P381, DOI 10.1002/bjs.6013; Kypraios T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-29; Lagace-Wiens PRS, 2008, J CLIN MICROBIOL, V46, P1174, DOI 10.1128/JCM.01253-07; Lee AS, 2011, CLIN INFECT DIS, V52, P1422, DOI 10.1093/cid/cir233; Lee BY, 2010, INFECT CONT HOSP EP, V31, P1130, DOI 10.1086/656591; Meyer B, 2010, J HOSP INFECT, V76, P200, DOI 10.1016/j.jhin.2010.05.020; Nahimana I, 2006, CLIN MICROBIOL INFEC, V12, P1168, DOI 10.1111/j.1469-0691.2006.01534.x; National Health Service, 2011, CLEAN SAF CAR RED MR; Nelson RE, 2010, CLIN MICROBIOL INFEC, V16, P1740, DOI 10.1111/j.1469-0691.2010.03324.x; O'Hagan A., 2006, UNCERTAIN JUDGEMENTS; Paule SM, 2007, J CLIN MICROBIOL, V45, P2993, DOI 10.1128/JCM.00670-07; Perry JD, 2004, J CLIN MICROBIOL, V42, P4519, DOI 10.1128/JCM.42.10.4519-4523.2004; Popovich KJ, 2009, INFECT CONT HOSP EP, V30, P959, DOI 10.1086/605925; Porter R, 2003, INTENS CARE MED, V29, P655, DOI 10.1007/s00134-003-1679-1; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; RITCHIE K, 2006, CONSULTATION REPORT; Roberts T, 2004, SEX TRANSM INFECT, V80, P324, DOI 10.1136/sti.2003.008458; Rohr U, 2003, J HOSP INFECT, V54, P305, DOI 10.1016/S0195-6701(03)00140-3; Rossney AS, 2007, EUR J CLIN MICROBIOL, V26, P459, DOI 10.1007/s10096-007-0303-7; Safdar N, 2003, J CLIN MICROBIOL, V41, P3163, DOI 10.1128/JCM.41.7.3163-3166.2003; Samad A, 2002, J HOSP INFECT, V51, P43, DOI 10.1053/jhin.2002.1182; Theaker C, 2001, J HOSP INFECT, V48, P98, DOI 10.1053/jhin.2001.0960; Thompson DS, 2004, J ROY SOC MED, V97, P521, DOI 10.1258/jrsm.97.11.521; Turner K, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7250; van Hal SJ, 2007, J CLIN MICROBIOL, V45, P2486, DOI 10.1128/JCM.00139-07; van Hal S, 2009, EUR J CLIN MICROBIOL, V28, P47, DOI 10.1007/s10096-008-0593-4; van Rijen M, 2008, COCHRANE DB SYST REV, V8; Warren DK, 2007, CRIT CARE MED, V35, P430, DOI 10.1097/01.CCM.0000253813.98431.28; Zhang SX, 2007, J CLIN MICROBIOL, V45, P2278, DOI 10.1128/JCM.00469-07	65	54	55	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2011	343								d5694	10.1136/bmj.d5694	http://dx.doi.org/10.1136/bmj.d5694			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832CT	21980062	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000295779600001
J	Cockman, P; Dawson, L; Mathur, R; Hull, S				Cockman, Philippa; Dawson, Luise; Mathur, Rohini; Hull, Sally			QUALITY IMPROVEMENT REPORT Improving MMR vaccination rates: herd immunity is a realistic goal	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POPULATION; AUTISM	Problem As measles is a highly infectious disease, the United Kingdom recommendation is for at least 95% of children to receive a first vaccination with the measles, mumps, and rubella (MMR) vaccine before age 2 years and a booster before age 5 years to achieve herd immunity and prevent outbreaks. Reported vaccination rates for England have improved since a low level in 2003-4. Coverage for London is consistently lower than for England, however, and concerns have been expressed that there could be an epidemic of measles in the capital. Design Observational time series study. Setting London Borough of Tower Hamlets. Key measurements for improvement Uptake rates for childhood vaccinations. The key target was to reach 95% coverage for the first MMR vaccine before age 2 years. Strategies for change Financial support for the development of geographically based networks of general practices. Commissioning of care packages, incentivising delivery of high quality integrated care with network level vaccination targets of 95%. Innovative use of information technology to enable robust call and recall processes, active follow-up of defaulters, and increased knowledge about the demography of the children most difficult to reach. Effects of change The development of networks of practices facilitated collaborative working among primary care clinicians and other stakeholders; peer review of achievements; and an element of healthy competition. Uptake improved for all childhood vaccinations, and to herd immunity levels for most. Uptake of the first MMR vaccine before age 2 years rose from 80% in September 2009 to 94% in March 2011. Lessons learnt Achieving herd immunity for childhood vaccinations is an achievable target in an ethnically mixed, socially deprived inner city borough. The ability to identify characteristics of the difficult to reach groups, including significant differences in uptake across different ethnicities, will allow targeted interventions that may further improve overall coverage. Vaccination programmes are cost effective and have been shown to reduce health inequality worldwide. 1 As measles is a highly contagious disease(2) it requires vaccination levels to be at least 95% to maintain herd immunity and prevent outbreaks.(3) These levels of vaccination will also be needed to achieve the World Health Organization's goal of elimination of measles worldwide. The measles, mumps, and rubella (MMR) vaccine was introduced in the United Kingdom in 1988 and the booster dose was added to the programme in 1996.(4) Current recommendations are that every child should receive a first dose of MMR vaccine before the age of 2 years and a booster dose before the age of 5 years.(4) Uptake for the first dose of MMR vaccine (MMR1) in England reached 92% in 1992, and stayed above 90% until 1998 when rates started falling, down to 79% by 2003.(5) The decline in uptake of the MMR vaccine is thought to be caused partly by safety concerns but also, ironically, by the success of vaccination programmes leading to the impression that these childhood diseases are mild and uncommon.(6) MMR vaccination uptake rates are now increasing in England. However, the effects of the vaccine scare in the UK that followed Andrew Wakefield and colleagues' now discredited 1998 article (which had raised the possibility of a link between MMR vaccine and autism) are still present over a decade later.(7) Reported rates of uptake of all childhood vaccinations in London remain below those for England.(8) Ongoing low levels of MMR vaccination in London have raised concerns of the possibility of a serious outbreak of measles in the city.(9) The year 2008 saw the highest number of recorded confirmed cases of measles (1370) in England and Wales since the introduction of disease monitoring in 1995.(10) Most of the cases were concentrated in London.(11) Between 2006 and 2008 the inner London borough of Tower Hamlets had the highest rates of confirmed measles,(12) with 24.6 cases per 100 000 (46 confirmed cases) compared with a national figure of 2 per 100 000.	[Cockman, Philippa] St Stephens Hlth Ctr, London E3 5ED, England; [Dawson, Luise] NHS Tower Hamlets, London E1 1RD, England; [Mathur, Rohini; Hull, Sally] Queen Mary Univ London, Blizard Inst, London E1 2AT, England	University of London; Queen Mary University London	Cockman, P (corresponding author), St Stephens Hlth Ctr, London E3 5ED, England.	Philippa.Cockman@nhs.net	Mathur, Rohini/C-7788-2013	Mathur, Rohini/0000-0002-3817-8790; hull, Sally/0000-0002-8691-7519				Andre FE, 2006, B WHO, V86; Barnevik-Olsson M, 2010, DEV MED CHILD NEUROL, V52, P1167, DOI 10.1111/j.1469-8749.2010.03812.x; Berger A, 1999, BRIT MED J, V319, P1466; Bhatti N, 2011, DIV C U BRADF; Brown KF, 2010, VACCINE, V28, P4235, DOI 10.1016/j.vaccine.2010.04.052; Crowcroft NS, 2009, ARCH DIS CHILD, V94, P829, DOI 10.1136/adc.2008.138776; Department of Health, 2009, INT CAR PIL INTR GUI; Department of Health, 2007, MEASL IMM INF DIS; Gardner B, 2008, CAN MMR UPTAKE BE IN; Godlee Fiona, 2011, BMJ, V342, pc7452, DOI 10.1136/bmj.c7452; Health Protection Agency, 2011, VACC COV COVER COV V; Health Protection Agency, CONF CAS MEASL MUMPS; Health Protection Agency, ANN VACC COV STAT EN; HEATHCOCK R, 2008, EURO SURVEILL, V13; Hull SA, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X572544; London Assembly, 2007, STILL MISS POINT INF; Minnesota Department of Health, 2009, AUT SOM COMM REP STU; National Institute for Health and Clinical Excellence, 2009, RED DIFF UPT IMM INC, V21; Nelson J, WORKING SMARTER IMPR; Schickler P, 2010, IDENTIFYING BARRIERS; Tower Hamlets Council, ETHN; Vann JCJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003941.pub2; World Health Organization, 2009, MEASL FACT SHEET	24	31	31	0	62	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 4	2011	343								d5703	10.1136/bmj.d5703	http://dx.doi.org/10.1136/bmj.d5703			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832CR	21971162				2022-12-28	WOS:000295779300003
J	Heavens, NG				Heavens, Nicholas G.			Sunshine on a Cloudy Forecast	SCIENCE			English	Editorial Material							WATER-ICE CLOUDS; MARS		Cornell Univ, Ithaca, NY 14853 USA	Cornell University	Heavens, NG (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.	heavens@cornell.edu		Heavens, Nicholas/0000-0001-7654-503X				HABERLE RM, 2011, P 4 INT WORKSH MARS; Heavens NG, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003692; Iraci LT, 2010, ICARUS, V210, P985, DOI 10.1016/j.icarus.2010.07.020; Kleinbohl A, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003358; Maattanen A, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002308; Maltagliati L, 2011, SCIENCE, V333, P1868, DOI 10.1126/science.1207957; MICHELANGELI DV, 1993, ICARUS, V102, P261, DOI 10.1006/icar.1993.1048; Montmessin F, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002284; Rafkin SCR, 2012, PLANET SPACE SCI, V60, P147, DOI 10.1016/j.pss.2011.07.015; Richardson MI, 2002, NATURE, V416, P298, DOI 10.1038/416298a; SPINRAD H, 1963, ASTROPHYS J, V137, P1319, DOI 10.1086/147613; Whiteway JA, 2009, SCIENCE, V325, P68, DOI 10.1126/science.1172344; Wilson RJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032405; WILSON RJ, 2011, P 4 INT WORKSH MARS; Zurek R.W., 1992, MARS, P835	15	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 30	2011	333	6051					1832	1833		10.1126/science.1212490	http://dx.doi.org/10.1126/science.1212490			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960617				2022-12-28	WOS:000295365800037
J	Janssen, A; van der Burg, M; Szuhai, K; Kops, GJPL; Medema, RH				Janssen, Aniek; van der Burg, Marja; Szuhai, Karoly; Kops, Geert J. P. L.; Medema, Rene H.			Chromosome Segregation Errors as a Cause of DNA Damage and Structural Chromosome Aberrations	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; HUMAN-CELLS; CELLULAR-RESPONSE; MITOTIC ARREST; IN-VIVO; INSTABILITY; KINASE; ANEUPLOIDY; CANCER; INHIBITORS	Various types of chromosomal aberrations, including numerical (aneuploidy) and structural (e. g., translocations, deletions), are commonly found in human tumors and are linked to tumorigenesis. Aneuploidy is a direct consequence of chromosome segregation errors in mitosis, whereas structural aberrations are caused by improperly repaired DNA breaks. Here, we demonstrate that chromosome segregation errors can also result in structural chromosome aberrations. Chromosomes that missegregate are frequently damaged during cytokinesis, triggering a DNA double-strand break response in the respective daughter cells involving ATM, Chk2, and p53. We show that these double-strand breaks can lead to unbalanced translocations in the daughter cells. Our data show that segregation errors can cause translocations and provide insights into the role of whole-chromosome instability in tumorigenesis.	[Kops, Geert J. P. L.] Univ Med Ctr Utrecht, Dept Mol Canc Res, NL-3584 CG Utrecht, Netherlands; [Janssen, Aniek; Kops, Geert J. P. L.; Medema, Rene H.] Univ Med Ctr Utrecht, Canc Genom Ctr, NL-3584 CG Utrecht, Netherlands; [Janssen, Aniek; Medema, Rene H.] Univ Med Ctr Utrecht, Dept Med Oncol, NL-3584 CG Utrecht, Netherlands; [van der Burg, Marja; Szuhai, Karoly] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kops, GJPL (corresponding author), Univ Med Ctr Utrecht, Dept Mol Canc Res, Univ Sweg 100, NL-3584 CG Utrecht, Netherlands.	g.j.p.l.kops@umcutrecht.nl; rh.medema@nki.nl	Szuhai, Karoly/A-1100-2008; Medema, Rene H/E-2981-2013	Szuhai, Karoly/0000-0002-1228-4245; Janssen, Aniek/0000-0001-6731-6657; Medema, Rene/0000-0002-6754-0381; Kops, Geert/0000-0003-3555-5295	Netherlands Organisation for Scientific Research (NWO) [ZonMw 918.46.616, VIDI-91776336]; TI Pharma [T3-105]; European Research Council; Netherlands Genomic Initiative of NWO	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); TI Pharma; European Research Council(European Research Council (ERC)European Commission); Netherlands Genomic Initiative of NWO	We thank L. Kleij for technical assistance and the Medema, Lens, and Kops laboratories for discussions. We thank J. Raaijmakers, M. Tanenbaum, A. Maia, and S. Suijkerbuijk for critically reading the manuscript. We are grateful to M. van Vugt and R. Beijersbergen for sharing plasmids and cell lines. This work was supported by the Netherlands Organisation for Scientific Research (NWO) (R. H. M. and A. J.: ZonMw 918.46.616; G. J. P. L. K.: VIDI-91776336), TI Pharma (R. H. M and A. J.: T3-105) and the European Research Council (G. J. P. L. K.: ERC-StG KINSIGN). R. H. M. was additionally funded by the Netherlands Genomic Initiative of NWO.	Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; Dalton WB, 2010, ONCOGENE, V29, P1929, DOI 10.1038/onc.2009.477; Dalton WB, 2007, CANCER RES, V67, P11487, DOI 10.1158/0008-5472.CAN-07-5162; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Mortlock AA, 2007, J MED CHEM, V50, P2213, DOI 10.1021/jm061335f; Obe G, 2010, CYTOGENET GENOME RES, V128, P8, DOI 10.1159/000303328; Petrini JHJ, 2003, TRENDS CELL BIOL, V13, P458, DOI 10.1016/S0962-8924(03)00170-3; Quignon F, 2007, ONCOGENE, V26, P165, DOI 10.1038/sj.onc.1209787; Ricke RM, 2008, TRENDS GENET, V24, P457, DOI 10.1016/j.tig.2008.07.002; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Szuhai K, 2006, NAT PROTOC, V1, P264, DOI 10.1038/nprot.2006.41; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Thompson SL, 2011, CHROMOSOME RES, V19, P433, DOI 10.1007/s10577-010-9179-y; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287	25	390	397	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 30	2011	333	6051					1895	1898		10.1126/science.1210214	http://dx.doi.org/10.1126/science.1210214			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960636				2022-12-28	WOS:000295365800058
J	Ledley, TS; Dahlman, L; McAuliffe, C; Haddad, N; Taber, MR; Domenico, B; Lynds, S; Grogan, M				Ledley, Tamara Shapiro; Dahlman, Luann; McAuliffe, Carla; Haddad, Nick; Taber, Michael R.; Domenico, Ben; Lynds, Susan; Grogan, Marian			Making Earth Science Data Accessible and Usable in Education	SCIENCE			English	Editorial Material									[Ledley, Tamara Shapiro; McAuliffe, Carla; Haddad, Nick; Grogan, Marian] TERC, Cambridge, MA 02140 USA; [Dahlman, Luann] NOAA, Climate Program Off, Silver Spring, MD 20910 USA; [Taber, Michael R.] Colorado Coll, Dept Educ, Colorado Springs, CO 80903 USA; [Domenico, Ben] UCAR, Unidata Program Ctr, Boulder, CO 80307 USA; [Lynds, Susan] Univ Colorado Boulder, CIRES, Boulder, CO 80309 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Colorado College; National Center Atmospheric Research (NCAR) - USA; University of Colorado System; University of Colorado Boulder	Ledley, TS (corresponding author), TERC, Cambridge, MA 02140 USA.	tamara_ledley@terc.edu			Div Atmospheric & Geospace Sciences [0833450] Funding Source: National Science Foundation	Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		HADDAD N, 2008, EOS S, V89; Ledley T. S., 2006, J GEOSCIENCE ED, V54, P223, DOI DOI 10.5408/1089-9995-54.3.223; LEDLEY TS, 2005, COMM DIGIT LIB B, V2; LYNDS S, 2010, LONG IMP SURV RES DL; MCAULIFFE C, 2008, EOS S, V89	5	10	11	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 30	2011	333	6051					1838	1839		10.1126/science.1199348	http://dx.doi.org/10.1126/science.1199348			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	826PJ	21960621				2022-12-28	WOS:000295365800041
J	Potente, M; Gerhardt, H; Carmeliet, P				Potente, Michael; Gerhardt, Holger; Carmeliet, Peter			Basic and Therapeutic Aspects of Angiogenesis	CELL			English	Review							VASCULAR MORPHOGENESIS; EXTRACELLULAR-MATRIX; MOLECULAR-MECHANISMS; TUMOR VASCULATURE; ENDOTHELIAL NOTCH; METASTASIS; CANCER; GROWTH; PERICYTES; NORMALIZATION	Blood vessels form extensive networks that nurture all tissues in the body. Abnormal vessel growth and function are hallmarks of cancer and ischemic and inflammatory diseases, and they contribute to disease progression. Therapeutic approaches to block vascular supply have reached the clinic, but limited efficacy and resistance pose unresolved challenges. Recent insights establish how endothelial cells communicate with each other and with their environment to form a branched vascular network. The emerging principles of vascular growth provide exciting new perspectives, the translation of which might overcome the current limitations of pro- and antiangiogenic medicine.	[Carmeliet, Peter] Katholieke Univ Leuven, Lab Angiogenesis & Neurovasc Link, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Carmeliet, Peter] VIB, Lab Angiogenesis & Neurovasc Link, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Potente, Michael] Goethe Univ Frankfurt, Vasc Epigenet Grp, Inst Cardiovasc Regenerat, Ctr Mol Med, D-60590 Frankfurt, Germany; [Potente, Michael] Goethe Univ Frankfurt, Dept Cardiol, D-60590 Frankfurt, Germany; [Gerhardt, Holger] Canc Res UK, Vasc Biol Lab, London Res Inst, London WC2A 3LY, England; [Gerhardt, Holger] VIB, Vasc Patterning Lab, Vesalius Res Ctr, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); Goethe University Frankfurt; Goethe University Frankfurt; Cancer Research UK; Flanders Institute for Biotechnology (VIB)	Carmeliet, P (corresponding author), Katholieke Univ Leuven, Lab Angiogenesis & Neurovasc Link, Vesalius Res Ctr, B-3000 Louvain, Belgium.	peter.carmeliet@vib-kuleuven.be	Gerhardt, Holger/G-4610-2011; Carmeliet, Peter/AAQ-5140-2020; Gerhardt, Holger/G-4610-2011	Gerhardt, Holger/0000-0002-3030-0384; Carmeliet, Peter/0000-0001-7961-1821; Gerhardt, Holger/0000-0001-9228-7472; Potente, Michael/0000-0002-5689-0036	Federal Government Belgium [IUAP06/30]; Flemish Government, a Concerted Research Activities Belgium [GOA2006/11]; The Research Foundation-Flanders [FWO G.0673.08]; Foundation Leducq Transatlantic Network ARTEMIS; Deutsche Forschungsgemeinschaft (DFG) [SFB 834/A6, Exc 147/1]; Cancer Research UK; Lister Institute of Preventive Medicine; EMBO	Federal Government Belgium; Flemish Government, a Concerted Research Activities Belgium; The Research Foundation-Flanders(FWO); Foundation Leducq Transatlantic Network ARTEMIS; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cancer Research UK(Cancer Research UK); Lister Institute of Preventive Medicine; EMBO(European Molecular Biology Organization (EMBO))	We acknowledge L. Notebaert and A. Truyens for help with the illustrations. We apologize to authors whose work we could not cite because of the limit on the number of references and therefore mostly cited overview articles. The work of P.C. is supported by a Federal Government Belgium grant (IUAP06/30), long-term structural Methusalem funding by the Flemish Government, a Concerted Research Activities Belgium grant (GOA2006/11), a grant from The Research Foundation-Flanders (FWO G.0673.08), and the Foundation Leducq Transatlantic Network ARTEMIS. The research of M.P. is supported by grants from the Deutsche Forschungsgemeinschaft (DFG - SFB 834/A6 and Exc 147/1). The research of H.G. is supported by Cancer Research UK, the Lister Institute of Preventive Medicine, the EMBO Young Investigator Programme, and the Foundation Leducq Transatlantic Network ARTEMIS.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Arroyo AG, 2010, CARDIOVASC RES, V86, P226, DOI 10.1093/cvr/cvq049; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bagri A, 2010, TRENDS MOL MED, V16, P122, DOI 10.1016/j.molmed.2010.01.004; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bentley K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000549; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bonauer A, 2010, CURR DRUG TARGETS, V11, P943, DOI 10.2174/138945010791591313; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Castets M, 2010, CELL CYCLE, V9, P1466, DOI 10.4161/cc.9.8.11197; Cavallaro U, 2011, NAT REV MOL CELL BIO, V12, P189, DOI 10.1038/nrm3068; Chappell JC, 2010, CURR TOP DEV BIOL, V90, P43, DOI 10.1016/S0070-2153(10)90002-1; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; Crawford Y, 2009, TRENDS PHARMACOL SCI, V30, P624, DOI 10.1016/j.tips.2009.09.004; Crawford Y, 2009, CELL TISSUE RES, V335, P261, DOI 10.1007/s00441-008-0675-8; De Palma M, 2009, BBA-REV CANCER, V1796, P5, DOI 10.1016/j.bbcan.2009.04.001; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Dyer LA, 2010, SEMIN THROMB HEMOST, V36, P227, DOI 10.1055/s-0030-1253446; Eble JA, 2009, CURR PHARM DESIGN, V15, P1385, DOI 10.2174/138161209787846757; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Falk MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-34; Fang ST, 2011, J MOL CELL CARDIOL, V50, P290, DOI 10.1016/j.yjmcc.2010.10.024; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Fantin A, 2009, BIOCHEM SOC T, V37, P1228, DOI 10.1042/BST0371228; Ferrara N, 2010, CURR OPIN HEMATOL, V17, P219, DOI 10.1097/MOH.0b013e3283386660; Ferrara N, 2010, CYTOKINE GROWTH F R, V21, P21, DOI 10.1016/j.cytogfr.2009.11.003; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Franco CA, 2009, CURR OPIN GENET DEV, V19, P476, DOI 10.1016/j.gde.2009.09.004; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gerhardt H, 2008, J MOL MED, V86, P135, DOI 10.1007/s00109-007-0258-2; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guarani V, 2011, NATURE, V473, P234, DOI 10.1038/nature09917; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Herbert SP, 2009, SCIENCE, V326, P294, DOI 10.1126/science.1178577; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Jones EAV, 2006, PHYSIOLOGY, V21, P388, DOI 10.1152/physiol.00020.2006; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim J, 2011, GENE DEV, V25, P1399, DOI 10.1101/gad.2042011; Koch AW, 2011, DEV CELL, V20, P33, DOI 10.1016/j.devcel.2010.12.001; Leblanc GG, 2009, STROKE, V40, pE694, DOI 10.1161/STROKEAHA.109.563692; Liu ZY, 2011, J CLIN INVEST, V121, P800, DOI 10.1172/JCI43114; London NR, 2009, J THROMB HAEMOST, V7, P57, DOI 10.1111/j.1538-7836.2009.03421.x; Lucke S, 2010, CELL PHYSIOL BIOCHEM, V26, P87, DOI 10.1159/000315109; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Makanya AN, 2009, ANGIOGENESIS, V12, P113, DOI 10.1007/s10456-009-9129-5; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Miles D, 2011, J CLIN ONCOL, V29, P83, DOI 10.1200/JCO.2010.30.2794; Murakami M, 2008, J CLIN INVEST, V118, P3355, DOI 10.1172/JCI35298; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Nisancioglu MH, 2010, CANCER RES, V70, P5109, DOI 10.1158/0008-5472.CAN-09-4245; Norden AD, 2009, NAT REV NEUROL, V5, P610, DOI 10.1038/nrneurol.2009.159; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Nyberg P, 2008, FRONT BIOSCI, V13, P6537, DOI 10.2741/3173; Padera TP, 2008, MOL CANCER THER, V7, P2272, DOI 10.1158/1535-7163.MCT-08-0182; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Pitulescu ME, 2010, GENE DEV, V24, P2480, DOI 10.1101/gad.1973910; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quaegebeur A, 2010, NEURON, V68, P321, DOI 10.1016/j.neuron.2010.10.024; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Roukens MG, 2010, NAT CELL BIOL, V12, P933, DOI 10.1038/ncb2096; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Schaper W, 2009, BASIC RES CARDIOL, V104, P5, DOI 10.1007/s00395-008-0760-x; Schmidt T, 2011, CANCER CELL, V19, P740, DOI 10.1016/j.ccr.2011.05.007; Serini G, 2009, ANGIOGENESIS, V12, P187, DOI 10.1007/s10456-009-9138-4; Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2004, DOI 10.1200/JCO.2010.29.5436; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Warren CM, 2010, CURR OPIN HEMATOL, V17, P213, DOI 10.1097/MOH.0b013e32833865d1; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Xu K, 2011, DEV CELL, V20, P526, DOI 10.1016/j.devcel.2011.02.010; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751; Zeeb M, 2010, CURR OPIN CELL BIOL, V22, P626, DOI 10.1016/j.ceb.2010.07.003	100	1794	1878	8	351	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2011	146	6					873	887		10.1016/j.cell.2011.08.039	http://dx.doi.org/10.1016/j.cell.2011.08.039			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925313	Bronze			2022-12-28	WOS:000295258100011
J	Richards, T				Richards, Tessa			BORDER CROSSING Enlist the patients' help	BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com						2011, BRIT MED J, V343, pD5836, DOI DOI 10.1136/BMJ.D5836; 2011, BRIT MED J, V343, pD5336, DOI DOI 10.1136/BMJ.D5336; 2011, BRIT MED J, V342, pD3823, DOI DOI 10.1136/BMJ.D3823; 2011, JAMA-J AM MED ASSOC, V305, P1800, DOI DOI 10.1001/JAMA.2011.547; 2011, BRIT MED J, V343, pD5762, DOI DOI 10.1136/BMJ.D5762; 2011, BRIT MED J, V343, pD5623, DOI DOI 10.1136/BMJ.D5623; 2011, BRIT MED J, V342, pD1513, DOI DOI 10.1136/BMJ.D1513	7	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2011	343								d5827	10.1136/bmj.d5827	http://dx.doi.org/10.1136/bmj.d5827			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822VM	21917834				2022-12-28	WOS:000295078100013
J	Szefler, SJ				Szefler, Stanley J.			Personalised medicine for asthma management in pregnancy	LANCET			English	Editorial Material							EXHALED NITRIC-OXIDE; RANDOMIZED CONTROLLED-TRIAL; ISSUES		[Szefler, Stanley J.] Natl Jewish Hlth, Dept Pediat, Div Pediat Clin Pharmacol, Denver, CO 80206 USA; [Szefler, Stanley J.] Natl Jewish Hlth, Dept Pediat, Div Allergy & Immunol, Denver, CO 80206 USA; [Szefler, Stanley J.] Univ Colorado, Sch Med, Denver, CO USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Szefler, SJ (corresponding author), Natl Jewish Hlth, Dept Pediat, Div Pediat Clin Pharmacol, Denver, CO 80206 USA.	szeflers@njhealth.org		Szefler, Stanley/0000-0002-6911-3199				Chowdhury BA, 2011, NEW ENGL J MED, V364, P2473, DOI 10.1056/NEJMp1104375; Gibson PG, 2009, CLIN EXP ALLERGY, V39, P478, DOI 10.1111/j.1365-2222.2009.03226.x; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Juniper EF, 2006, RESP MED, V100, P616, DOI 10.1016/j.rmed.2005.08.012; *NAT ASTHM ED PREV, 2005, J ALLERGY CLIN IMMUN, V115, P36; Powell H, 2011, LANCET, V378, P983, DOI 10.1016/S0140-6736(11)60971-9; Smith AD, 2005, NEW ENGL J MED, V352, P2163, DOI 10.1056/NEJMoa043596; Szefler S, 2008, LANCET, V372, P1065, DOI 10.1016/S0140-6736(08)61448-8; Szefler SJ, 2011, J ALLERGY CLIN IMMUN, V127, P102, DOI 10.1016/j.jaci.2010.11.018	10	3	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 10	2011	378	9795					963	964		10.1016/S0140-6736(11)61131-8	http://dx.doi.org/10.1016/S0140-6736(11)61131-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HO	21907846				2022-12-28	WOS:000295193200004
J	Affolder, R				Affolder, Rebecca			Keeping women's and children's health at the forefront	LANCET			English	Editorial Material									UN, Execut Off Secretary Gen, New York, NY 10017 USA		Affolder, R (corresponding author), UN, Execut Off Secretary Gen, New York, NY 10017 USA.	affolder@un.org						[Anonymous], 2010, KEEP PROM UN ACH MIL; Commission on Information and Accountability for Women's and Children's Health, 2010, KEEP PROM MEAS RES; *EV WOM EV CHILD, COMM; *INT HLTH PARTN RE, STRENGTH ACC ACH HLT; United Nations, 2010, GLOB STRAT WOM CHILD	5	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 3	2011	378	9807					E13	E15		10.1016/S0140-6736(11)61462-1	http://dx.doi.org/10.1016/S0140-6736(11)61462-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	863AW	21933746				2022-12-28	WOS:000298136200002
J	Emanuele, MJ; Elia, AEH; Xu, QK; Thoma, CR; Izhar, L; Leng, YM; Guo, AL; Chen, YN; Rush, J; Hsu, PWC; Yen, HCS; Elledge, SJ				Emanuele, Michael J.; Elia, Andrew E. H.; Xu, Qikai; Thoma, Claudio R.; Izhar, Lior; Leng, Yumei; Guo, Ailan; Chen, Yi-Ning; Rush, John; Hsu, Paul Wei-Che; Yen, Hsueh-Chi Sherry; Elledge, Stephen J.			Global Identification of Modular Cullin-RING Ligase Substrates	CELL			English	Article							CUL3-BASED E3 LIGASE; UBIQUITIN-LIGASE; PROTEIN; SCF; INHIBITOR; NUSAP; DEGRADATION; ACTIVATION; EXPRESSION; CATALYZES	Cullin-RING ligases (CRLs) represent the largest E3 ubiquitin ligase family in eukaryotes, and the identification of their substrates is critical to understanding regulation of the proteome. Using genetic and pharmacologic Cullin inactivation coupled with genetic (GPS) and proteomic (QUAINT) assays, we have identified hundreds of proteins whose stabilities or ubiquitylation status are regulated by CRLs. Together, these approaches yielded many known CRL substrates as well as a multitude of previously unknown putative substrates. We demonstrate that one substrate, NUSAP1, is an SCFCyclin F substrate during S and G2 phases of the cell cycle and is also degraded in response to DNA damage. This collection of regulated substrates is highly enriched for nodes in protein interaction networks, representing critical connections between regulatory pathways. This demonstrates the broad role of CRL ubiquitylation in all aspects of cellular biology and provides a set of proteins likely to be key indicators of cellular physiology.	[Emanuele, Michael J.; Elia, Andrew E. H.; Xu, Qikai; Thoma, Claudio R.; Izhar, Lior; Leng, Yumei; Yen, Hsueh-Chi Sherry; Elledge, Stephen J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Emanuele, Michael J.; Elia, Andrew E. H.; Xu, Qikai; Thoma, Claudio R.; Izhar, Lior; Leng, Yumei; Yen, Hsueh-Chi Sherry; Elledge, Stephen J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Elia, Andrew E. H.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Guo, Ailan; Rush, John] Cell Signaling Technol, Danvers, MA 01923 USA; [Chen, Yi-Ning; Hsu, Paul Wei-Che; Yen, Hsueh-Chi Sherry] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Emanuele, Michael J.; Elia, Andrew E. H.; Xu, Qikai; Thoma, Claudio R.; Izhar, Lior; Leng, Yumei; Yen, Hsueh-Chi Sherry; Elledge, Stephen J.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Academia Sinica - Taiwan; Howard Hughes Medical Institute	Yen, HCS (corresponding author), Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA.	hyen@imb.sinica.edu.tw; selledge@genetics.med.harvard.edu	Yen, Hsueh-Chi Sherry/AAA-3907-2021	Yen, Hsueh-Chi Sherry/0000-0003-3511-4414	The Jane Coffin Childs Foundation; The American Society for Radiation Oncology; EMBO and HFSP fellowship; American Cancer Society; NSC [NSC100-2628-B-001-014-MY3]; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	The Jane Coffin Childs Foundation; The American Society for Radiation Oncology; EMBO and HFSP fellowship; American Cancer Society(American Cancer Society); NSC(Ministry of Science and Technology, Taiwan); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the members of the Elledge lab for helpful discussions. We thank W. Harper for the Cul3 and Cul4 dominant-negative clones and F box siRNA; S. Gygi for access to and assistance with MS/MS analysis software; the IMB Bioinformatics Services Core of Academia Sinica for technical support; and Michele Pagano for cyclin F plasmids. We thank Marc Vidal and David Hill for the ORFeome library. M.J.E. is the Philip O'Bryan Montgomery Jr., MD fellow of the Damon Runyon Cancer Research Foundation (DRG-1996-08). A.E.H.E. is supported by fellowships from The Jane Coffin Childs Foundation and The American Society for Radiation Oncology. C.R.T. is funded by an EMBO and HFSP fellowship. Q.X. is supported by a fellowship from the American Cancer Society. H.-C.S.Y. was supported by an NSC grant (NSC100-2628-B-001-014-MY3). This work was supported by an NIH grant to S.J.E. S.J.E. is an Investigator with the Howard Hughes Medical Institute.	Abbas T, 2011, CELL CYCLE, V10, P241, DOI 10.4161/cc.10.2.14530; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Benanti JA, 2007, NAT CELL BIOL, V9, P1184, DOI 10.1038/ncb1639; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Cheng IH, 2002, J BIOL CHEM, V277, P41706, DOI 10.1074/jbc.M205793200; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Deshaies RJ, 2010, SUBCELL BIOCHEM, V54, P41, DOI 10.1007/978-1-4419-6676-6_4; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Emanuele MJ, 2011, P NATL ACAD SCI USA, V108, P9845, DOI 10.1073/pnas.1106136108; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Jun L, 2002, DEV DYNAM, V224, P116, DOI 10.1002/dvdy.10090; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Munera J, 2011, STEM CELLS, V29, P430, DOI 10.1002/stem.599; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ou YY, 2002, J CELL SCI, V115, P1825; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Ribbeck K, 2007, CURR BIOL, V17, P230, DOI 10.1016/j.cub.2006.11.050; Ribbeck K, 2006, MOL BIOL CELL, V17, P2646, DOI 10.1091/mbc.E05-12-1178; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Wen F, 2007, DEV BIOL, V312, P284, DOI 10.1016/j.ydbio.2007.09.024; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Xie P, 2011, BIOCHEM BIOPH RES CO, V404, P413, DOI 10.1016/j.bbrc.2010.11.135; Xu DK, 2008, J BIOL CHEM, V283, P23567, DOI 10.1074/jbc.M800790200; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489	49	310	318	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					459	474		10.1016/j.cell.2011.09.019	http://dx.doi.org/10.1016/j.cell.2011.09.019			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	21963094	Green Accepted, Bronze			2022-12-28	WOS:000296199300022
J	LeBlanc, ES; O'Connor, E; Whitlock, EP; Patnode, CD; Kapka, T				LeBlanc, Erin S.; O'Connor, Elizabeth; Whitlock, Evelyn P.; Patnode, Carrie D.; Kapka, Tanya			Effectiveness of Primary Care-Relevant Treatments for Obesity in Adults: A Systematic Evidence Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							BODY-MASS INDEX; CARDIOVASCULAR RISK-FACTORS; LIFE-STYLE INTERVENTION; RANDOMIZED CONTROLLED-TRIAL; INTENTIONAL WEIGHT-LOSS; X-RAY ABSORPTIOMETRY; POLYCYSTIC-OVARY-SYNDROME; TYPE-2 DIABETES-MELLITUS; LONG-TERM MORTALITY; TO-HIP RATIO	Background: Overweight and obesity in adults are common and adversely affect health. Purpose: To summarize effectiveness and harms of primary care-relevant weight-loss interventions for overweight and obese adults. Data Sources: MEDLINE, Cochrane Central Register of Controlled Trials, and PsycINFO from January 2005 to September 2010; systematic reviews for identifying trials before 2005. Study Selection: Two investigators appraised 6498 abstracts and 648 articles. Clinical trials were included if control groups received minimal interventions. Articles were rated as good, fair, or poor by using design-specific criteria. Data Extraction: One investigator abstracted study characteristics and findings for good- and fair-quality studies; a second checked them. Data Synthesis: Behaviorally based treatment resulted in 3-kg (6.6-lb) greater weight loss in intervention than control participants after 12 to 18 months, with more treatment sessions associated with greater loss. Limited data suggest weight-loss maintenance for 1 year or more. Orlistat plus behavioral intervention resulted in 3-kg (6.6-lb) more weight loss than did placebo after 12 months. Met-formin resulted in less weight loss. Data on effects of weight-loss treatment on long-term health outcomes (for example, death and cardiovascular disease) were insufficient. Weight-loss treatment reduced diabetes incidence in participants with prediabetes. Effects on intermediate outcomes (for example, lipids and blood pressure) were mixed and small. Data on serious medication harms were insufficient. Medications commonly caused withdrawals due to gastrointestinal symptoms. Limitations: Few studies reported health outcomes. Behaviorally based treatments were heterogeneous and specific elements were not well-described. Many studies could not be pooled because of insufficient reporting of variance data. Medication trials had high attrition, lacked postdiscontinuation data, and were inadequately powered for rare adverse effects. Conclusion: Behaviorally based treatments are safe and effective for weight loss and maintenance.	[LeBlanc, Erin S.; O'Connor, Elizabeth; Whitlock, Evelyn P.; Patnode, Carrie D.; Kapka, Tanya] Kaiser Permanente NW, Ctr Hlth Res, Portland, OR USA	Kaiser Permanente	LeBlanc, ES (corresponding author), Kaiser Permanente NW, Ctr Hlth Res, Portland, OR USA.				Agency for Healthcare Research and Quality; Oregon Evidence-based Practice Center; Agency for Healthcare Research and Quality, Rockville, Maryland [HHS-290-2007-10057-I]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Oregon Evidence-based Practice Center; Agency for Healthcare Research and Quality, Rockville, Maryland(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.; Grant Support: By the Oregon Evidence-based Practice Center under contract to the Agency for Healthcare Research and Quality, Rockville, Maryland (contract HHS-290-2007-10057-I, task order no. 3).	Acharya NV, 2006, INT J OBESITY, V30, P1645, DOI 10.1038/sj.ijo.0803323; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Anderssen Sigmund, 1995, Blood Pressure, V4, P343, DOI 10.3109/08037059509077619; [Anonymous], 1990, Arch Intern Med, V150, P153, DOI 10.1001/archinte.150.1.153; [Anonymous], [No title captured]; Ardern CI, 2004, OBES RES, V12, P1094, DOI 10.1038/oby.2004.137; Bakris G, 2002, J HYPERTENS, V20, P2257, DOI 10.1097/00004872-200211000-00026; Berne C, 2005, DIABETIC MED, V22, P612, DOI 10.1111/j.1464-5491.2004.01474.x; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Bray GA, 1999, DIABETES CARE, V22, P623; Broom I, 2002, INT J CLIN PRACT, V56, P494; Broom I, 2002, BR J CARDIOL, V9, P460; Burke V, 2005, J HYPERTENS, V23, P1241, DOI 10.1097/01.hjh.0000170388.61579.4f; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Christian JG, 2008, ARCH INTERN MED, V168, P141, DOI 10.1001/archinternmed.2007.13; Christou NV, 2004, ANN SURG, V240, P416, DOI 10.1097/01.sla.0000137343.63376.19; Cohen M D, 1991, Fam Med, V23, P25; COLLINS R, 1994, BRIT MED BULL, V50, P272, DOI 10.1093/oxfordjournals.bmb.a072892; Cornell JE, 2008, ANN INTERN MED, V148, P786, DOI 10.7326/0003-4819-148-10-200805200-00012; Crandall J, 2006, J GERONTOL A-BIOL, V61, P1075; Cussler EC, 2008, OBESITY, V16, P1052, DOI 10.1038/oby.2008.19; Davidson MH, 1999, JAMA-J AM MED ASSOC, V281, P235, DOI 10.1001/jama.281.3.235; DAVIS BR, 1992, HYPERTENSION, V19, P393, DOI 10.1161/01.HYP.19.4.393; Derosa G, 2003, CLIN THER, V25, P1107, DOI 10.1016/S0149-2918(03)80070-X; Derosa G, 2010, EXPERT OPIN PHARMACO, V11, P1971, DOI 10.1517/14656566.2010.493557; Desilets AR, 2008, ANN PHARMACOTHER, V42, P817, DOI 10.1345/aph.1K656; EGGER M, 2005, J CLIN EPIDEMIOL, V58, P894; *EV BAS PRACT CTR, PROJ TITL COMP EFF B; Finer N, 2000, INT J OBESITY, V24, P306, DOI 10.1038/sj.ijo.0801128; Finer N, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1346; Fitzgibbon ML, 2010, OBESITY, V18, P2317, DOI 10.1038/oby.2010.47; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Fontbonne A, 1996, DIABETES CARE, V19, P920, DOI 10.2337/diacare.19.9.920; Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x; FREYHEWITT B, 1990, INT J OBESITY, V14, P327; Gambineri A, 2006, J CLIN ENDOCR METAB, V91, P3970, DOI 10.1210/jc.2005-2250; Gokcel A, 2002, DIABETES OBES METAB, V4, P49, DOI 10.1046/j.1463-1326.2002.00181.x; Gregg EW, 2004, DIABETES CARE, V27, P657, DOI 10.2337/diacare.27.3.657; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Haapala I, 2009, PUBLIC HEALTH NUTR, V12, P2382, DOI 10.1017/S1368980009005230; Haffner S, 2005, DIABETES, V54, pA1; Hanefeld M, 2002, DIABETES OBES METAB, V4, P415, DOI 10.1046/j.1463-1326.2002.00237.x; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hauptman J, 2000, ARCH FAM MED, V9, P160, DOI 10.1001/archfami.9.2.160; HEALY M, 2010, LOS ANGELES TIM 0715; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hill JO, 1999, AM J CLIN NUTR, V69, P1108; Hollander PA, 1998, DIABETES CARE, V21, P1288, DOI 10.2337/diacare.21.8.1288; Irwin ML, 2003, JAMA-J AM MED ASSOC, V289, P323, DOI 10.1001/jama.289.3.323; Janssen I, 2004, AM J CLIN NUTR, V79, P379; JEFFERY RW, 1993, J CONSULT CLIN PSYCH, V61, P1038, DOI 10.1037/0022-006X.61.6.1038; Jones DW, 1999, AM J HYPERTENS, V12, P1175, DOI 10.1016/S0895-7061(99)00123-5; Kastarinen MJ, 2002, J HYPERTENS, V20, P2505, DOI 10.1097/00004872-200212000-00031; Kelley DE, 2002, DIABETES CARE, V25, P1033, DOI 10.2337/diacare.25.6.1033; Kirk EP, 2003, INT J OBESITY, V27, P912, DOI 10.1038/sj.ijo.0802317; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Knudtson MD, 2005, ANN EPIDEMIOL, V15, P483, DOI 10.1016/j.annepidem.2004.12.003; Koster A, 2008, AM J EPIDEMIOL, V167, P1465, DOI 10.1093/aje/kwn079; Krempf M, 2003, INT J OBESITY, V27, P591, DOI 10.1038/sj.ijo.0802281; Kulzer B, 2009, DIABETES CARE, V32, P1143, DOI 10.2337/dc08-2141; LANGFORD HG, 1985, JAMA-J AM MED ASSOC, V253, P657, DOI 10.1001/jama.253.5.657; Lear SA, 2010, EUR J CLIN NUTR, V64, P42, DOI 10.1038/ejcn.2009.70; Lear SA, 2009, J CLIN ENDOCR METAB, V94, P4696, DOI 10.1210/jc.2009-1030; LeBlanc E, 2011, SCREENING MANAGEMENT; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Lenz M, 2009, DTSCH ARZTEBL INT, V106, P641, DOI 10.3238/arztebl.2009.0641; Lindgarde F, 2000, J INTERN MED, V248, P245, DOI 10.1046/j.1365-2796.2000.00720.x; Martin PD, 2008, OBESITY, V16, P2462, DOI 10.1038/oby.2008.399; Mayer-Davis EJ, 2004, AM J PUBLIC HEALTH, V94, P1736, DOI 10.2105/AJPH.94.10.1736; McTigue K., 2003, SCREENING INTERVENTI; Mensink M, 2003, OBES RES, V11, P1588, DOI 10.1038/oby.2003.211; Miles JM, 2002, DIABETES CARE, V25, P1123, DOI 10.2337/diacare.25.7.1123; Mitsui T, 2008, TOHOKU J EXP MED, V215, P355, DOI 10.1620/tjem.215.355; Moore H, 2003, BRIT MED J, V327, P1085, DOI 10.1136/bmj.327.7423.1085; Muls E, 2001, INT J OBESITY, V25, P1713, DOI 10.1038/sj.ijo.0801814; Narayan KMV, 1998, DIABETIC MED, V15, P66; *NAT I HLTH CLIN E, 2006, CLIN GUIDELINE, V43, P1; National Heart Lung and Blood Institute Division of blood diseases and resources, 2002, NIH PUBL; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; Parikh P, 2010, AM J PUBLIC HEALTH, V100, pS232, DOI 10.2105/AJPH.2009.170910; Patel MR, 2006, AM HEART J, V151, P633, DOI 10.1016/j.ahj.2005.03.006; Peeters A, 2007, ANN SURG, V246, P1028, DOI 10.1097/SLA.0b013e31814a6929; PERRI MG, 1988, J CONSULT CLIN PSYCH, V56, P529, DOI 10.1037/0022-006X.56.4.529; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Pritchard DA, 1999, J EPIDEMIOL COMMUN H, V53, P311, DOI 10.1136/jech.53.5.311; Qiao Q, 2010, EUR J CLIN NUTR, V64, P23, DOI 10.1038/ejcn.2009.92; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Richelsen B, 2007, DIABETES CARE, V30, P27, DOI 10.2337/dc06-0210; Rossner S, 2000, OBES RES, V8, P49, DOI 10.1038/oby.2000.8; Rubin RR, 2005, DIABETES CARE, V28, P830; Sanchez-Castillo CP, 2003, OBES RES, V11, P442, DOI 10.1038/oby.2003.60; Sarwer DB, 2006, J WOMENS HEALTH, V15, P720, DOI 10.1089/jwh.2006.15.720; Silva MN, 2010, J BEHAV MED, V33, P110, DOI 10.1007/s10865-009-9239-y; Simkin-Silverman LR, 2003, ANN BEHAV MED, V26, P212, DOI 10.1207/S15324796ABM2603_06; Sjostrom CD, 1997, OBES RES, V5, P519; Sjostrom L, 1998, LANCET, V352, P167, DOI 10.1016/S0140-6736(97)11509-4; Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288; Stevens J, 2002, AM J CLIN NUTR, V75, P986, DOI 10.1093/ajcn/75.6.986; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; STEVENS VJ, 1993, ARCH INTERN MED, V153, P849, DOI 10.1001/archinte.153.7.849; Svetkey LP, 2008, JAMA-J AM MED ASSOC, V299, P1139, DOI 10.1001/jama.299.10.1139; Swinburn BA, 2005, DIABETES OBES METAB, V7, P254, DOI 10.1111/j.1463-1326.2004.00467.x; ter Bogt NCW, 2009, AM J PREV MED, V37, P270, DOI 10.1016/j.amepre.2009.06.011; TONSTAD S, 1994, EUR J CLIN PHARMACOL, V46, P405, DOI 10.1007/BF00191901; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Tothill P, 1997, J BONE MINER RES, V12, P1908, DOI 10.1359/jbmr.1997.12.11.1908; Tothill P, 2005, J CLIN DENSITOM, V8, P31, DOI 10.1385/JCD:8:1:031; Tothill P, 1999, BRIT J RADIOL, V72, P661, DOI 10.1259/bjr.72.859.10624323; Trolle B, 2007, HUM REPROD, V22, P2967, DOI 10.1093/humrep/dem271; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; U.S. Food and Drug Administration, 2010, MER SIB MARK WITHDR; *US DEP HHS, 2004, NIH PUBL; *US FDA, 2010, FDA DRUG B; Van Gaal LF, 1998, EUR J CLIN PHARMACOL, V54, P125, DOI 10.1007/s002280050433; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Vetter ML, 2010, NAT REV ENDOCRINOL, V6, P578, DOI 10.1038/nrendo.2010.121; Villareal DT, 2008, J CLIN ENDOCR METAB, V93, P2181, DOI 10.1210/jc.2007-1473; Warren M, 2009, AM J HEALTH PROMOT, V23, P309, DOI 10.4278/ajhp.07081584; Weir MA, 2011, ARCH INTERN MED, V171, P703, DOI 10.1001/archinternmed.2011.103; Werkman A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-110; West DS, 2008, OBESITY, V16, P1413, DOI 10.1038/oby.2008.224; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Williamson DF, 2000, DIABETES CARE, V23, P1499, DOI 10.2337/diacare.23.10.1499; WILLIAMSON DF, 1995, AM J EPIDEMIOL, V141, P1128, DOI 10.1093/oxfordjournals.aje.a117386; Williamson DA, 2008, HEALTH PSYCHOL, V27, pS32, DOI 10.1037/0278-6133.27.1.S32; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334; WOOD PD, 1988, NEW ENGL J MED, V319, P1173, DOI 10.1056/NEJM198811033191801; WOOD PD, 1991, NEW ENGL J MED, V325, P461, DOI 10.1056/NEJM199108153250703; Woollard J, 2003, J CARDIOVASC RISK, V10, P31, DOI 10.1097/00043798-200302000-00007; Yaari S, 1998, AM J EPIDEMIOL, V148, P546, DOI 10.1093/oxfordjournals.aje.a009680	135	276	283	0	36	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2011	155	7					434	U71		10.7326/0003-4819-155-7-201110040-00006	http://dx.doi.org/10.7326/0003-4819-155-7-201110040-00006			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	833OC	21969342				2022-12-28	WOS:000295893800004
J	Roux, C; Guey, S; Crassard, I; Hautefort, C; Liote, F; Jouvent, E				Roux, Charles; Guey, Stephanie; Crassard, Isabelle; Hautefort, Charlotte; Liote, Frederic; Jouvent, Eric			A rare cause of gait ataxia	LANCET			English	Editorial Material							RELAPSING POLYCHONDRITIS		[Jouvent, Eric] Hop Lariboisiere, Serv Neurol, Dept Neurol, F-75010 Paris, France; [Hautefort, Charlotte] Hop Lariboisiere, Dept Otorhinolaryngol, F-75010 Paris, France; [Liote, Frederic] Hop Lariboisiere, Dept Rheumatol, F-75010 Paris, France; [Liote, Frederic; Jouvent, Eric] Univ Paris Diderot, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Jouvent, E (corresponding author), Hop Lariboisiere, Serv Neurol, Dept Neurol, 2 Rue Ambroise Pare, F-75010 Paris, France.	eric.jouvent@lrb.aphp.fr	Jouvent, Eric/B-4320-2014; Jouvent, Eric/I-6635-2012; Liote, Frederic/AAD-6926-2020	Jouvent, Eric/0000-0001-7797-2236; Liote, Frederic/0000-0003-4419-0726; Hautefort, Charlotte/0000-0002-5056-5136				Gluth MB, 2006, MAYO CLIN PROC, V81, P483, DOI 10.4065/81.4.483; Kent Peter D., 2004, Current Opinion in Rheumatology, V16, P56, DOI 10.1097/00002281-200401000-00011; MCADAM LP, 1976, MEDICINE, V55, P193, DOI 10.1097/00005792-197605000-00001; MICHET CJ, 1986, ANN INTERN MED, V104, P74, DOI 10.7326/0003-4819-104-1-74; Trentham DE, 1998, ANN INTERN MED, V129, P114, DOI 10.7326/0003-4819-129-2-199807150-00011	5	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 1	2011	378	9798					1274	1274		10.1016/S0140-6736(11)61024-6	http://dx.doi.org/10.1016/S0140-6736(11)61024-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831IO	21962557				2022-12-28	WOS:000295723600030
J	Zurbuchen, TH; Raines, JM; Slavin, JA; Gershman, DJ; Gilbert, JA; Gloeckler, G; Anderson, BJ; Baker, DN; Korth, H; Krimigis, SM; Sarantos, M; Schriver, D; McNutt, RL; Solomon, SC				Zurbuchen, Thomas H.; Raines, Jim M.; Slavin, James A.; Gershman, Daniel J.; Gilbert, Jason A.; Gloeckler, George; Anderson, Brian J.; Baker, Daniel N.; Korth, Haje; Krimigis, Stamatios M.; Sarantos, Menelaos; Schriver, David; McNutt, Ralph L., Jr.; Solomon, Sean C.			MESSENGER Observations of the Spatial Distribution of Planetary Ions Near Mercury	SCIENCE			English	Article							MAGNETOSPHERE; EXOSPHERE; PLASMA	Global measurements by MESSENGER of the fluxes of heavy ions at Mercury, particularly sodium (Na(+)) and oxygen (O(+)), exhibit distinct maxima in the northern magnetic-cusp region, indicating that polar regions are important sources of Mercury's ionized exosphere, presumably through solar-wind sputtering near the poles. The observed fluxes of helium (He(+)) are more evenly distributed, indicating a more uniform source such as that expected from evaporation from a helium-saturated surface. In some regions near Mercury, especially the nightside equatorial region, the Na(+) pressure can be a substantial fraction of the proton pressure.	[Zurbuchen, Thomas H.; Raines, Jim M.; Slavin, James A.; Gershman, Daniel J.; Gilbert, Jason A.; Gloeckler, George] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Slavin, James A.; Sarantos, Menelaos] NASA Goddard Space Flight Ctr, Heliophys Sci Div, Greenbelt, MD 20771 USA; [Anderson, Brian J.; Korth, Haje; Krimigis, Stamatios M.; McNutt, Ralph L., Jr.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Baker, Daniel N.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Krimigis, Stamatios M.] Acad Athens, Off Space Res & Technol, Athens 11527, Greece; [Sarantos, Menelaos] Univ Maryland Baltimore Cty, Goddard Planetary Heliophys Inst, Baltimore, MD 21228 USA; [Schriver, David] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; [Solomon, Sean C.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA	University of Michigan System; University of Michigan; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Colorado System; University of Colorado Boulder; Academy of Athens; University System of Maryland; University of Maryland Baltimore County; University of California System; University of California Los Angeles; Carnegie Institution for Science	Zurbuchen, TH (corresponding author), Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA.	thomasz@umich.edu	Sarantos, Menelaos/O-6644-2019; Gilbert, Jason A/I-9020-2012; Sarantos, Menelaos/H-8136-2013; Krimigis, Stamatios/G-4591-2019; Korth, Haje/C-3182-2016; Anderson, Brian J/I-8615-2012; Raines, Jim M./O-5649-2016; McNutt, Ralph L/E-8006-2010; Slavin, James A/H-3170-2012	Sarantos, Menelaos/0000-0003-0728-2971; Gilbert, Jason A/0000-0002-3182-7014; Krimigis, Stamatios/0000-0003-2781-2386; Korth, Haje/0000-0001-7394-7439; McNutt, Ralph L/0000-0002-4722-9166; Slavin, James A/0000-0002-9206-724X	NASA [NAS5-97271, NASW-00002]	NASA(National Aeronautics & Space Administration (NASA))	The MESSENGER project is supported by the NASA Discovery Program under contracts NAS5-97271 to The Johns Hopkins University Applied Physics Laboratory and NASW-00002 to the Carnegie Institution of Washington.	Anderson BJ, 2011, SCIENCE, V333, P1859, DOI 10.1126/science.1211001; Andrews GB, 2007, SPACE SCI REV, V131, P523, DOI 10.1007/s11214-007-9272-5; Baker DN, 2011, PLANET SPACE SCI, V59, P2066, DOI 10.1016/j.pss.2011.01.018; Delcourt DC, 2007, PLANET SPACE SCI, V55, P1502, DOI 10.1016/j.pss.2006.11.026; FRANK LA, 1971, J GEOPHYS RES, V76, P5202, DOI 10.1029/JA076i022p05202; HAERENDEL G, 1978, J GEOPHYS RES-SPACE, V83, P3195, DOI 10.1029/JA083iA07p03195; HARTLE RE, 1975, J GEOPHYS RES, V80, P3689, DOI 10.1029/JA080i025p03689; Kabin K, 2000, ICARUS, V143, P397, DOI 10.1006/icar.1999.6252; Killen R, 2007, SPACE SCI REV, V132, P433, DOI 10.1007/s11214-007-9232-0; Lukyanov A, 2004, ADV SPACE RES-SERIES, V33, P1890, DOI 10.1016/j.asr.2003.05.035; Mobius E, 2004, ASTRON ASTROPHYS, V426, P897, DOI 10.1051/0004-6361:20035834; Raines JM, 2011, PLANET SPACE SCI, V59, P2004, DOI 10.1016/j.pss.2011.02.004; Sarantos M, 2001, PLANET SPACE SCI, V49, P1629, DOI 10.1016/S0032-0633(01)00100-3; Slavin JA, 2008, SCIENCE, V321, P85, DOI 10.1126/science.1159040; Slavin JA, 2010, SCIENCE, V329, P665, DOI 10.1126/science.1188067; Wurz P, 2010, PLANET SPACE SCI, V58, P1599, DOI 10.1016/j.pss.2010.08.003; Zurbuchen TH, 2008, SCIENCE, V321, P90, DOI 10.1126/science.1159314	17	85	86	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 30	2011	333	6051					1862	1865		10.1126/science.1211302	http://dx.doi.org/10.1126/science.1211302			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960628				2022-12-28	WOS:000295365800048
J	Ioannidis, JPA				Ioannidis, John P. A.			Fund people not projects	NATURE			English	Editorial Material									[Ioannidis, John P. A.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Humanities & Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011					[Anonymous], 2011, SCI AM, V304, P10; Azoulay P., 2009, 15466 NBER; Baggerly K, 2010, NATURE, V467, P401, DOI 10.1038/467401b; Contopoulos-Ioannidis DG, 2008, SCIENCE, V321, P1298, DOI 10.1126/science.1160622; Graves N, 2011, NATURE, V469, P299, DOI 10.1038/469299c; Simera I, 2010, EUR J CLIN INVEST, V40, P35, DOI 10.1111/j.1365-2362.2009.02234.x; Tatsioni A, 2010, FASEB J, V24, P1335, DOI 10.1096/fj.09-148239	7	83	88	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 29	2011	477	7366					529	531		10.1038/477529a	http://dx.doi.org/10.1038/477529a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825ZM	21956312	Bronze			2022-12-28	WOS:000295320900015
J	Schwartz, TW; Sakmar, TP				Schwartz, Thue W.; Sakmar, Thomas P.			STRUCTURAL BIOLOGY Snapshot of a signalling complex	NATURE			English	Editorial Material							RECEPTOR		[Schwartz, Thue W.] Univ Copenhagen, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Schwartz, Thue W.] Univ Copenhagen, NNF Ctr Basic Metab Res, Fac Hlth Sci, DK-2200 Copenhagen, Denmark; [Sakmar, Thomas P.] Rockefeller Univ, Lab Mol Biol & Biochem, New York, NY 10065 USA	University of Copenhagen; University of Copenhagen; Rockefeller University	Schwartz, TW (corresponding author), Univ Copenhagen, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark.		Sakmar, Thomas P/D-1833-2015	Sakmar, Thomas P/0000-0002-2836-8953; Schwartz, Thue W./0000-0002-0261-6904				Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Huber T, 2011, TRENDS PHARMACOL SCI, V32, P410, DOI 10.1016/j.tips.2011.03.004; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; RODBELL M, 1980, NATURE, V284, P17, DOI 10.1038/284017a0; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108	12	11	11	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2011	477	7366					540	541		10.1038/477540a	http://dx.doi.org/10.1038/477540a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21956322				2022-12-28	WOS:000295320900025
J	Seaford, C				Seaford, Charles			Time to legislate for the good life	NATURE			English	Editorial Material							WELL		[Seaford, Charles] New Econ Fdn, Ctr Well Being, London SE11 5NH, England		Seaford, C (corresponding author), New Econ Fdn, Ctr Well Being, 3 Jonathan St, London SE11 5NH, England.	Charles.Seaford@neweconomics.org						[Anonymous], 2009, REPORT COMMISSION ME; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; *NEW EC FDN, 2011, WELL BEING IN PRESS; Ryan RM, 2008, J HAPPINESS STUD, V9, P139, DOI 10.1007/s10902-006-9023-4	4	25	25	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 29	2011	477	7366					532	533		10.1038/477532a	http://dx.doi.org/10.1038/477532a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825ZM	21956313				2022-12-28	WOS:000295320900016
J	Heath, I				Heath, Iona			LIFE AND DEATH The politics of drug industry sponsorship	BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Coll Gen Practitioners, London, England		Heath, I (corresponding author), Royal Coll Gen Practitioners, London, England.	iona.heath22@yahoo.co.uk						2001, AM J MED, V110, P551	1	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 28	2011	343								d6060	10.1136/bmj.d6060	http://dx.doi.org/10.1136/bmj.d6060			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829JZ	21957209				2022-12-28	WOS:000295577100004
J	Boddien, A; Mellmann, D; Gartner, F; Jackstell, R; Junge, H; Dyson, PJ; Laurenczy, G; Ludwig, R; Beller, M				Boddien, Albert; Mellmann, Doerthe; Gaertner, Felix; Jackstell, Ralf; Junge, Henrik; Dyson, Paul J.; Laurenczy, Gabor; Ludwig, Ralf; Beller, Matthias			Efficient Dehydrogenation of Formic Acid Using an Iron Catalyst	SCIENCE			English	Article							HYDROGEN-PRODUCTION; COMPLEXES; GENERATION; DIHYDRIDE; DECOMPOSITION; PRINCIPLES; DIHYDROGEN; STORAGE; WATER	Hydrogen is one of the essential reactants in the chemical industry, though its generation from renewable sources and storage in a safe and reversible manner remain challenging. Formic acid (HCO(2)H or FA) is a promising source and storage material in this respect. Here, we present a highly active iron catalyst system for the liberation of H(2) from FA. Applying 0.005 mole percent of Fe(BF(4))(2)center dot 6H(2)O and tris[(2-diphenylphosphino)ethyl]phosphine [P(CH(2)CH(2)PPh(2))(3), PP(3)] to a solution of FA in environmentally benign propylene carbonate, with no further additives or base, affords turnover frequencies up to 9425 per hour and a turnover number of more than 92,000 at 80 degrees C. We used in situ nuclear magnetic resonance spectroscopy, kinetic studies, and density functional theory calculations to explain possible reaction mechanisms.	[Boddien, Albert; Dyson, Paul J.; Laurenczy, Gabor] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, CH-1015 Lausanne, Switzerland; [Boddien, Albert; Mellmann, Doerthe; Gaertner, Felix; Jackstell, Ralf; Junge, Henrik; Beller, Matthias] Univ Rostock, Leibniz Inst Katalyse eV, D-18059 Rostock, Germany; [Ludwig, Ralf] Univ Rostock, Inst Chem, Phys Chem Abt, D-18059 Rostock, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Leibniz Institut fur Katalyse e.V. an der Universitat Rostock (LIKAT); University of Rostock; University of Rostock	Laurenczy, G (corresponding author), Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, CH-1015 Lausanne, Switzerland.	gabor.laurenczy@epfl.ch; ralf.ludwig@uni-rostock.de; matthias.beller@catalysis.de	Junge, Henrik/C-4652-2016; Dyson, Paul/AAB-9075-2019; Ludwig, Ralf/B-7939-2015; , 000/AAG-9847-2019; Jackstell, Ralf/A-1619-2015	Junge, Henrik/0000-0002-7603-1984; Dyson, Paul/0000-0003-3117-3249; Ludwig, Ralf/0000-0002-8549-071X; Mellmann, Dorthe/0000-0001-8564-7409	Mecklenburg-Vorpommern, Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie; Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie (FCI); Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation	Mecklenburg-Vorpommern, Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie (FCI)(Fonds der Chemischen Industrie); Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work has been supported by the state of Mecklenburg-Vorpommern, Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie, and Deutsche Forschungsgemeinschaft (Leibniz Prize). We thank A. Koch, S. Buchholz, C. Fischer, A. Lehmann, and A. Kammer for their excellent analytical and technical support. F. G. thanks the Fonds der Chemischen Industrie (FCI) for a Kekule grant. We also thank Ecole Polytechnique Federale de Lausanne and Swiss National Science Foundation for financial support. R. L. thanks the University of Rostock for continuous support. Parts of this work have been filed as a German patent application (DE 10 2011 007 661.1, submitted on 19 April 2011 by the Leibniz-Institute for Catalysis). All the data described in the paper are available in the supporting online material or from the authors.	Armaroli N, 2007, ANGEW CHEM INT EDIT, V46, P52, DOI 10.1002/anie.200602373; Armstrong FA, 2008, SCIENCE, V321, P498, DOI 10.1126/science.1161326; Artero V, 2005, COORDIN CHEM REV, V249, P1518, DOI 10.1016/j.ccr.2005.01.014; BIANCHINI C, 1990, INORG CHEM, V29, P3394, DOI 10.1021/ic00343a025; Bianchini C, 1997, INORG CHIM ACTA, V259, P61, DOI 10.1016/S0020-1693(96)05585-5; BIANCHINI C, 1988, J ORGANOMET CHEM, V354, pC19, DOI 10.1016/0022-328X(88)87057-8; Blackmond DG, 2005, ANGEW CHEM INT EDIT, V44, P4302, DOI 10.1002/anie.200462544; Boddien A, 2010, ANGEW CHEM INT EDIT, V49, P8993, DOI 10.1002/anie.201004621; Boddien A, 2010, J AM CHEM SOC, V132, P8924, DOI 10.1021/ja100925n; Boddien A, 2008, CHEMSUSCHEM, V1, P751, DOI 10.1002/cssc.200800093; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; Enthaler S, 2010, ENERG ENVIRON SCI, V3, P1207, DOI 10.1039/b907569k; Federsel C, 2010, ANGEW CHEM INT EDIT, V49, P9777, DOI 10.1002/anie.201004263; Fellay C, 2009, CHEM-EUR J, V15, P3752, DOI 10.1002/chem.200801824; Fukuzumi S, 2010, J AM CHEM SOC, V132, P1496, DOI 10.1021/ja910349w; Haszeldine RS, 2009, SCIENCE, V325, P1647, DOI 10.1126/science.1172246; Hauwert P, 2010, J AM CHEM SOC, V132, P16900, DOI 10.1021/ja1062407; Heinekey DM, 1996, J AM CHEM SOC, V118, P12134, DOI 10.1021/ja962702n; Johnson TC, 2010, CHEM SOC REV, V39, P81, DOI 10.1039/b904495g; Loges B, 2010, TOP CATAL, V53, P902, DOI 10.1007/s11244-010-9522-8; Lubitz W, 2008, ENERG ENVIRON SCI, V1, P15, DOI 10.1039/b808792j; Morris RH, 2008, COORDIN CHEM REV, V252, P2381, DOI 10.1016/j.ccr.2008.01.010; Pershad HR, 1999, BIOCHEMISTRY-US, V38, P8992, DOI 10.1021/bi990108v; Rauchfuss TB, 2007, SCIENCE, V316, P553, DOI 10.1126/science.1140733; Schaffner B, 2010, CHEM REV, V110, P4554, DOI 10.1021/cr900393d; Schlapbach L, 2001, NATURE, V414, P353, DOI 10.1038/35104634; Shima S, 2008, SCIENCE, V321, P572, DOI 10.1126/science.1158978; Stephenson M, 1932, BIOCHEM J, V26, P712, DOI 10.1042/bj0260712; STOPPIONI P, 1974, INORG CHIM ACTA, V11, P227, DOI 10.1016/S0020-1693(00)93713-7; Turner JA, 2004, SCIENCE, V305, P972, DOI 10.1126/science.1103197; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Wang M, 2010, CHEMSUSCHEM, V3, P551, DOI 10.1002/cssc.201000062	32	626	642	11	625	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1733	1736		10.1126/science.1206613	http://dx.doi.org/10.1126/science.1206613			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940890				2022-12-28	WOS:000295121500038
J	Luo, J; Cheng, HK; Asl, KM; Kiely, CJ; Harmer, MP				Luo, Jian; Cheng, Huikai; Asl, Kaveh Meshinchi; Kiely, Christopher J.; Harmer, Martin P.			The Role of a Bilayer Interfacial Phase on Liquid Metal Embrittlement	SCIENCE			English	Article							GRAIN-BOUNDARY SEGREGATION; INTERGRANULAR PENETRATION; TEMPERATURE-DEPENDENCE; BISMUTH; COPPER; FILMS; NICKEL; POLYCRYSTALS; THICKNESS; BI	Intrinsically ductile metals are prone to catastrophic failure when exposed to certain liquid metals, but the atomic-level mechanism for this effect is not fully understood. We characterized a model system, a nickel sample infused with bismuth atoms, by using aberration-corrected scanning transmission electron microscopy and observed a bilayer interfacial phase that is the underlying cause of embrittlement. This finding provides a new perspective for understanding the atomic-scale embrittlement mechanism and for developing strategies to control the practically important liquid metal embrittlement and the more general grain boundary embrittlement phenomena in alloys. This study further demonstrates that adsorption can induce a coupled grain boundary structural and chemical phase transition that causes drastic changes in properties.	[Luo, Jian; Asl, Kaveh Meshinchi] Clemson Univ, Sch Mat Sci & Engn, Ctr Opt Mat Sci & Engn Technol, Clemson, SC 29634 USA; [Cheng, Huikai; Kiely, Christopher J.; Harmer, Martin P.] Lehigh Univ, Dept Mat Sci & Engn, Ctr Adv Mat & Nanotechnol, Bethlehem, PA 18015 USA	Clemson University; Lehigh University	Luo, J (corresponding author), Clemson Univ, Sch Mat Sci & Engn, Ctr Opt Mat Sci & Engn Technol, Clemson, SC 29634 USA.	jluo@alum.mit.edu; mph2@lehigh.edu	Cheng, Huikai/I-2933-2013; Luo, jian/HGE-7331-2022; Luo, Jian/A-4777-2008	Cheng, Huikai/0000-0003-0131-3298; Luo, Jian/0000-0002-5424-0216; Kiely, Christopher/0000-0001-5412-0970	Department of Energy Office of Basic Energy Sciences [DE-FG02-08ER46511]; Office of Naval Research [N00014-09-1-0942, N00014-11-1-0678]	Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); Office of Naval Research(Office of Naval Research)	J. L. and K. M. A. acknowledge the support from Department of Energy Office of Basic Energy Sciences under grant no. DE-FG02-08ER46511. M. P. H. and H. C. acknowledge the support from the Office of Naval Research under grant nos. N00014-09-1-0942 and N00014-11-1-0678.	Alber U, 1999, ACTA MATER, V47, P4047, DOI 10.1016/S1359-6454(99)00265-7; Baram M, 2011, SCIENCE, V332, P206, DOI 10.1126/science.1201596; CAHN JW, 1977, J CHEM PHYS, V66, P3667, DOI 10.1063/1.434402; Chang LS, 1997, SCRIPTA MATER, V37, P729, DOI 10.1016/S1359-6462(97)00171-1; Chang LS, 2004, SCRIPTA MATER, V51, P551, DOI 10.1016/j.scriptamat.2004.05.036; Chen HP, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.155502; Chiang YM, 1998, J MICROSC-OXFORD, V191, P275, DOI 10.1046/j.1365-2818.1998.00377.x; CLARKE DR, 1987, J AM CERAM SOC, V70, P15, DOI 10.1111/j.1151-2916.1987.tb04846.x; Dash JG, 2006, REV MOD PHYS, V78, P695, DOI 10.1103/RevModPhys.78.695; Dillon SJ, 2007, ACTA MATER, V55, P6208, DOI 10.1016/j.actamat.2007.07.029; Duscher G, 2004, NAT MATER, V3, P621, DOI 10.1038/nmat1191; Gupta VK, 2007, ACTA MATER, V55, P3131, DOI 10.1016/j.actamat.2007.01.017; Harmer MP, 2011, SCIENCE, V332, P182, DOI 10.1126/science.1204204; Harmer MP, 2010, J AM CERAM SOC, V93, P301, DOI 10.1111/j.1551-2916.2009.03545.x; Hashibon A, 2002, COMP MATER SCI, V24, P443, DOI 10.1016/S0927-0256(01)00265-8; HONDROS ED, 1977, METALL TRANS A, V8, P1363, DOI 10.1007/BF02642850; IKEDA JAS, 1993, J AM CERAM SOC, V76, P2447, DOI 10.1111/j.1151-2916.1993.tb03965.x; Joseph B, 1999, EUR PHYS J-APPL PHYS, V5, P19, DOI 10.1051/epjap:1999108; Kauffmann Y, 2011, ACTA MATER, V59, P4378, DOI 10.1016/j.actamat.2011.03.061; Keast VJ, 2007, ACTA MATER, V55, P5149, DOI 10.1016/j.actamat.2007.05.034; Klinger L, 2010, SCRIPTA MATER, V62, P918, DOI 10.1016/j.scriptamat.2010.02.029; Luo J, 2007, CRIT REV SOLID STATE, V32, P67, DOI 10.1080/10408430701364388; Luo J, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3212733; Marie N, 2000, SCRIPTA MATER, V43, P943, DOI 10.1016/S1359-6462(00)00518-2; PANDIT R, 1982, PHYS REV B, V26, P5112, DOI 10.1103/PhysRevB.26.5112; RICE JR, 1989, MAT SCI ENG A-STRUCT, V107, P23, DOI 10.1016/0921-5093(89)90372-9; Schweinfest R, 2004, NATURE, V432, P1008, DOI 10.1038/nature03198; Shi XM, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3155443; Sigle W, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2356322; Tang M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.075502; Wolski K, 2008, MAT SCI ENG A-STRUCT, V495, P138, DOI 10.1016/j.msea.2007.10.107; Wolski K, 2001, INTERFACE SCI, V9, P183, DOI 10.1023/A:1015142324557; Yamaguchi M, 2005, SCIENCE, V307, P393, DOI 10.1126/science.1104624	33	206	216	10	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1730	1733		10.1126/science.1208774	http://dx.doi.org/10.1126/science.1208774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940889				2022-12-28	WOS:000295121500037
J	Walden, AP; Nielsen, N; Wise, MP				Walden, Andrew P.; Nielsen, Niklas; Wise, Matt P.			Does the evidence support the use of mild hypothermia after cardiac arrest? No	BRITISH MEDICAL JOURNAL			English	Editorial Material							THERAPEUTIC HYPOTHERMIA; SURVIVORS		[Wise, Matt P.] Univ Wales Hosp, Cardiff CF14 4XW, S Glam, Wales; [Walden, Andrew P.] Royal Berkshire Hosp, Reading RG1 5AN, Berks, England; [Nielsen, Niklas] Helsingborg Hosp, Dept Anaesthesiol & Intens Care, Helsingborg, Sweden	Cardiff University; Royal Berkshire Hospital; Helsingborgs Hospital	Wise, MP (corresponding author), Univ Wales Hosp, Cardiff CF14 4XW, S Glam, Wales.	mattwise@doctors.org.uk		Wise, Matt/0000-0002-2763-4316				Arrich J, 2009, COCHRANE DB SYST REV, V4; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Carr BG, 2009, RESUSCITATION, V80, P30, DOI 10.1016/j.resuscitation.2008.09.001; Hachimi-Idrissi S, 2001, RESUSCITATION, V51, P275, DOI 10.1016/S0300-9572(01)00412-9; Holzer M, 2002, NEW ENGL J MED, V346, P549; Laurent I, 2005, J AM COLL CARDIOL, V46, P432, DOI 10.1016/j.jacc.2005.04.039; Mori K, 2000, CRIT CARE MED, V28, pA168; Nielsen N, 2011, INT J CARDIOL, V151, P333, DOI 10.1016/j.ijcard.2010.06.008; Nielsen N, 2011, CRIT CARE MED, V39, P57, DOI 10.1097/CCM.0b013e3181fa4301; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; STERZ F, 1991, CRIT CARE MED, V19, P379, DOI 10.1097/00003246-199103000-00017; *TTM TRIAL INV, TARG TEMP MAN OUT OF	14	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 23	2011	343								d5889	10.1136/bmj.d5889	http://dx.doi.org/10.1136/bmj.d5889			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	826AK	21948589				2022-12-28	WOS:000295323500003
J	Wassarman, PM				Wassarman, Paul M.			The Sperm's Sweet Tooth	SCIENCE			English	Editorial Material							MOUSE SPERM; BINDING; ZP3; OLIGOSACCHARIDE		Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Wassarman, PM (corresponding author), Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	paul.wassarman@mssm.edu						CARVER JP, 1989, CIBA F SYMP, V145, P6; CARVER JP, 1989, CIBA F S, V145, P18; FLORMAN HM, 1985, CELL, V41, P313, DOI 10.1016/0092-8674(85)90084-4; FLORMAN HM, 2006, PHYSL REPROD, V1, P55; FUKUDA M, 1985, J BIOL CHEM, V260, P2957; Han L, 2010, CELL, V143, P404, DOI 10.1016/j.cell.2010.09.041; Johnston DS, 1998, J BIOL CHEM, V273, P1888, DOI 10.1074/jbc.273.4.1888; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Kerr CL, 2004, BIOL REPROD, V71, P770, DOI 10.1095/biolreprod.103.023812; LITSCHER ES, 1995, BIOCHEMISTRY-US, V34, P4662, DOI 10.1021/bi00014a020; Pang PC, 2011, SCIENCE, V333, P1761, DOI 10.1126/science.1207438; Shur BD, 2008, INT J DEV BIOL, V52, P703, DOI 10.1387/ijdb.082571bs; Varki A., 2008, ESSENTIALS GLYCOBIOL; Wassarman PM, 2008, J BIOL CHEM, V283, P24285, DOI 10.1074/jbc.R800027200; Yanagimachi R., 1994, P189	15	8	9	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2011	333	6050					1708	1709		10.1126/science.1212841	http://dx.doi.org/10.1126/science.1212841			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940880				2022-12-28	WOS:000295121500026
J	Terkelsen, CJ; Jensen, LO; Tilsted, HH; Trautner, S; Johnsen, SP; Vach, W; Botker, HE; Thuesen, L; Lassen, JF				Terkelsen, Christian Juhl; Jensen, Lisette Okkels; Tilsted, Hans-Henrik; Trautner, Sven; Johnsen, Soren Paaske; Vach, Werner; Botker, Hans Erik; Thuesen, Leif; Lassen, Jens Flensted			Health Care System Delay and Heart Failure in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Follow-up of Population-Based Medical Registry Data	ANNALS OF INTERNAL MEDICINE			English	Article							REPERFUSION THERAPY; TIME; DIAGNOSIS; COHORT; MATTER; STEMI	Background: In patients with ST-segment elevation myocardial infarction (STEMI), delay between contact with the health care system and initiation of reperfusion therapy (system delay) is associated with mortality, but data on the associated risk for congestive heart failure (CHF) among survivors are limited. Objective: To evaluate the association between system delay and the risk for readmissions or outpatient contacts due to CHF after primary percutaneous coronary intervention (PPCI) in patients with STEMI. Design: Historical follow-up study using population-based medical registries. Setting: Western Denmark. Patients: Patients with STEMI who were transported by emergency medical service from 1 January 1999 to 7 February 2010 and treated with PPCI within 12 hours of symptom onset and who had a system delay of 6 hours or less (n = 7952). The median duration of follow-up was 3.1 years. Measurements: Cumulative incidence of readmissions or outpatient contacts due to CHF was determined by using competing-risk regression analysis, with death as the competing risk. Crude and adjusted cause-specific hazard ratios for readmissions or outpatient contacts due to CHF were determined for system delay and other covariates. Results: System delays of 60 minutes or less (n = 451), 61 to 120 minutes (n = 3457), 121 to 180 minutes (n = 2655), and 181 to 360 minutes (n = 1389) corresponded with long-term risks for readmissions or outpatient contacts due to CHF of 10.1%, 10.6%, 12.3%, and 14.1%, respectively (P < 0.001). In multivariable analysis, system delay was an independent predictor of readmissions or outpatient contacts due to CHF (adjusted hazard ratio per hour increase in delay, 1.10 [95% CI, 1.02 to 1.17]). Limitation: In any nonrandomized study, there are risks for selection bias and residual confounding. Conclusion: In patients with STEMI, shorter delay to PPCI is associated with lower risk for readmissions or outpatient contacts due to CHF during follow-up.	[Terkelsen, Christian Juhl] Aarhus Univ Hosp, Dept Cardiol B, DK-8200 Aarhus, Denmark; Odense Univ Hosp, DK-5000 Odense, Denmark; Aalborg Univ Hosp, Aalborg, Denmark; Falck Emergency Med Serv, Copenhagen, Denmark; Univ Med Ctr, Freiburg, Germany	Aarhus University; University of Southern Denmark; Odense University Hospital; Aalborg University; Aalborg University Hospital; University of Freiburg	Terkelsen, CJ (corresponding author), Aarhus Univ Hosp, Dept Cardiol B, DK-8200 Aarhus, Denmark.	Christian_Juhl_Terkelsen@hotmail.com	Vach, Werner/F-2512-2011; Lassen, Jens Flensted/AAY-2127-2021; terkelsen, christian/ABD-6294-2021	Vach, Werner/0000-0003-1865-8399; Lassen, Jens Flensted/0000-0001-7972-9192; terkelsen, christian juhl/0000-0003-0205-9551; Botker, Hans Erik/0000-0001-6358-8962; Jensen, Lisette Okkels/0000-0002-4838-2429	Karl G. Andersen Foundation; Helga and Peter Korning Foundation; Health Research Fund of Central Denmark Region; Research Foundation at Skejby University Hospital; Riisfort Foundation; Arvid Nilsson Foundation	Karl G. Andersen Foundation; Helga and Peter Korning Foundation; Health Research Fund of Central Denmark Region; Research Foundation at Skejby University Hospital; Riisfort Foundation; Arvid Nilsson Foundation	The Karl G. Andersen Foundation, the Helga and Peter Korning Foundation, the Health Research Fund of Central Denmark Region, the Research Foundation at Skejby University Hospital, the Riisfort Foundation, and the Arvid Nilsson Foundation.	Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; Andersen TF, 1999, DAN MED BULL, V46, P263; Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]; Aquaro GD, 2007, AM J CARDIOL, V100, P28, DOI 10.1016/j.amjcard.2007.02.050; Boersma E, 2006, EUR HEART J, V27, P779, DOI 10.1093/eurheartj/ehi810; Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Lambert L, 2010, JAMA-J AM MED ASSOC, V303, P2148, DOI 10.1001/jama.2010.712; Pedersen CB, 2006, DAN MED BULL, V53, P441; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Schmidt Morten, 2010, Clin Epidemiol, V2, P137; Sorensen H T, 1997, Int J Risk Saf Med, V10, P1, DOI 10.3233/JRS-1997-10101; Terkelsen CJ, 2009, HEART, V95, P362, DOI 10.1136/hrt.2007.139493; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; Terkelsen CJ, 2005, EUR HEART J, V26, P770, DOI 10.1093/eurheartj/ehi100; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618	19	73	73	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6					361	U54		10.7326/0003-4819-155-6-201109200-00004	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930853				2022-12-28	WOS:000295033400015
J	Yalcin, B; Wong, K; Agam, A; Goodson, M; Keane, TM; Gan, XC; Nellaker, C; Goodstadt, L; Nicod, J; Bhomra, A; Hernandez-Pliego, P; Whitley, H; Cleak, J; Dutton, R; Janowitz, D; Mott, R; Adams, DJ; Flint, J				Yalcin, Binnaz; Wong, Kim; Agam, Avigail; Goodson, Martin; Keane, Thomas M.; Gan, Xiangchao; Nellaker, Christoffer; Goodstadt, Leo; Nicod, Jerome; Bhomra, Amarjit; Hernandez-Pliego, Polinka; Whitley, Helen; Cleak, James; Dutton, Rebekah; Janowitz, Deborah; Mott, Richard; Adams, David J.; Flint, Jonathan			Sequence-based characterization of structural variation in the mouse genome	NATURE			English	Article							COPY NUMBER VARIATION; HETEROGENEOUS STOCK MICE; GENE-EXPRESSION; T-CELLS; DISEASE; REARRANGEMENTS; MECHANISM	Structural variation is widespread in mammalian genomes(1,2) and is an important cause of disease(3), but just how abundant and important structural variants (SVs) are in shaping phenotypic variation remains unclear(4,5). Without knowing how many SVs there are, and how they arise, it is difficult to discover what they do. Combining experimental with automated analyses, we identified 711,920 SVs at 281,243 sites in the genomes of thirteen classical and four wild-derived inbred mouse strains. The majority of SVs are less than 1 kilobase in size and 98% are deletions or insertions. The breakpoints of 160,000 SVs were mapped to base pair resolution, allowing us to infer that insertion of retrotransposons causes more than half of SVs. Yet, despite their prevalence, SVs are less likely than other sequence variants to cause gene expression or quantitative phenotypic variation. We identified 24 SVs that disrupt coding exons, acting as rare variants of large effect on gene function. One-third of the genes so affected have immunological functions.	[Yalcin, Binnaz; Agam, Avigail; Goodson, Martin; Gan, Xiangchao; Goodstadt, Leo; Nicod, Jerome; Bhomra, Amarjit; Hernandez-Pliego, Polinka; Whitley, Helen; Cleak, James; Dutton, Rebekah; Janowitz, Deborah; Mott, Richard; Flint, Jonathan] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Wong, Kim; Keane, Thomas M.; Adams, David J.] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Agam, Avigail; Nellaker, Christoffer] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford OX1 3QX, England; [Janowitz, Deborah] Ernst Moritz Arndt Univ Greifswald, Klinikum Hansestadt Stralsund, Dept Psychiat & Psychotherapy, D-18437 Stralsund, Germany	University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; University of Oxford; Ernst Moritz Arndt Universitat Greifswald	Flint, J (corresponding author), Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	da1@sanger.ac.uk; jf@well.ox.ac.uk	Yalcin, Binnaz/P-5482-2016; Yalcin, Binnaz/ABB-7735-2020	Yalcin, Binnaz/0000-0002-1924-6807; Yalcin, Binnaz/0000-0002-1924-6807; Gan, Xiangchao/0000-0001-6398-5191; Wong, Kim/0000-0002-0984-1477; Flint, Jonathan/0000-0002-9427-4429; Adams, David/0000-0001-9490-0306; Keane, Thomas/0000-0001-7532-6898; Dutton, Rebekah/0000-0001-7539-2633; BHOMRA, AMARJIT/0000-0002-0439-0128; Mott, Richard/0000-0002-1022-9330; Nellaker, Christoffer/0000-0002-2887-2068	Medical Research Council, UK; Wellcome Trust; Cancer Research UK; MRC [MC_EX_G0802457, MC_U137761446, G0800024] Funding Source: UKRI; Medical Research Council [MC_U137761446, MC_EX_G0802457, G0800024] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Whitley, G. Durrant, A. M. Hammond, D. J. Fabrigar, L. Chen, M. Johannesson, E. Cong and G. Blazquez for helping B.Y. with various laboratory-based work. We also thank C. P. Ponting for comments on the manuscript. This project was supported by The Medical Research Council, UK, and the Wellcome Trust. D. J. A. is supported by Cancer Research UK.	Agam A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012839; Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Cahan P, 2009, NAT GENET, V41, P430, DOI 10.1038/ng.350; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Huang GJ, 2009, GENOME RES, V19, P1133, DOI 10.1101/gr.088120.108; Ma JL, 2003, MOL CELL BIOL, V23, P8820, DOI 10.1128/MCB.23.23.8820-8828.2003; Manske HM, 2009, GENOME RES, V19, P2125, DOI 10.1101/gr.093443.109; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nelson TM, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-32; Persson K, 1999, MAMM GENOME, V10, P784, DOI 10.1007/s003359901092; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Simpson JT, 2010, BIOINFORMATICS, V26, P565, DOI 10.1093/bioinformatics/btp693; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tareen SU, 2009, VIROLOGY, V385, P473, DOI 10.1016/j.virol.2008.12.018; Taylor K, 2009, EUR J IMMUNOL, V39, P1353, DOI 10.1002/eji.200838566; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Wu BJ, 2010, J INVEST DERMATOL, V130, P2666, DOI 10.1038/jid.2010.168; Yalcin B, 2005, GENETICS, V171, P673, DOI 10.1534/genetics.104.028902; Yalcin B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001085; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	29	219	219	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 15	2011	477	7364					326	329		10.1038/nature10432	http://dx.doi.org/10.1038/nature10432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21921916	Green Accepted, Green Published			2022-12-28	WOS:000294852400030
J	Sawicki, PT				Sawicki, Peter T.			Commentary: Does additional benefit justify additional costs of insulin analogues?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Cologne, Inst Hlth Econ & Clin Epidemiol, Cologne, Germany	University of Cologne	Sawicki, PT (corresponding author), Univ Cologne, Inst Hlth Econ & Clin Epidemiol, Cologne, Germany.	peter.sawicki@uk-koeln.de						*G BA, VERF GEM BUND; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; *IQWIG, METH PAP IQWIG; *IQWIG, LONG ACT INS AN TREA; *IQWIG, RAP ACT INS AN CHILD; *IQWIG, RAP ACT INS AN TREAT; KNIEPS F, USE SCI EVIDENCE POL	7	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2011	343								d5858	10.1136/bmj.d5858	http://dx.doi.org/10.1136/bmj.d5858			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822VM	21917837				2022-12-28	WOS:000295078100016
J	Ham, C; Zollinger-Read, P				Ham, Chris; Zollinger-Read, Paul			What are the lessons from the USA for clinical commissioning groups in the English National Health Service?	LANCET			English	Editorial Material									[Ham, Chris; Zollinger-Read, Paul] Kings Fund, London W1G 0AN, England		Ham, C (corresponding author), Kings Fund, 11-13 Cavendish Sq, London W1G 0AN, England.	c.ham@kingsfund.org.uk						[Anonymous], 2011, ECONOMIST       0625, P47; BCBSMA, 2011, ALT QUAL CONTR YEAR; Casalino L., 2011, GP COMMISSIONING 10; Chernew ME, 2011, HEALTH AFFAIR, V30, P51, DOI 10.1377/hlthaff.2010.0980; Fisher ES, 2010, JAMA-J AM MED ASSOC, V304, P1715, DOI 10.1001/jama.2010.1513; Kirwan L. A., 2009, RECOMMENDATIONS SPEC; Roland M, 2010, BRIT MED J, V341, P211; Thorlby R., 2011, GP COMMISSIONING INS; Werner RM, 2011, HEALTH AFFAIR, V30, P690, DOI 10.1377/hlthaff.2010.1277	9	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2012	379	9811					189	191		10.1016/S0140-6736(11)61088-X	http://dx.doi.org/10.1016/S0140-6736(11)61088-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879GM	21920598				2022-12-28	WOS:000299317700041
J	Jezek, K; Henriksen, EJ; Treves, A; Moser, EI; Moser, MB				Jezek, Karel; Henriksen, Espen J.; Treves, Alessandro; Moser, Edvard I.; Moser, May-Britt			Theta-paced flickering between place-cell maps in the hippocampus	NATURE			English	Article							PATH-INTEGRATION; ATTRACTOR DYNAMICS; NEURAL NETWORKS; ENVIRONMENT; CA1; MODEL; REPRESENTATIONS; INFORMATION; ASSEMBLIES; DISCHARGE	The ability to recall discrete memories is thought to depend on the formation of attractor states in recurrent neural networks(1-4). In such networks, representations can be reactivated reliably from subsets of the cues that were present when the memory was encoded, at the same time as interference from competing representations is minimized. Theoretical studies have pointed to the recurrent CA3 system of the hippocampus as a possible attractor network(3,4). Consistent with predictions from these studies, experiments have shown that place representations in CA3 and downstream CA1 tolerate small changes in the configuration of the environment but switch to uncorrelated representations when dissimilarities become larger(5-9). However, the kinetics supporting such network transitions, at the subsecond timescale, is poorly understood. Here we show in rats that instantaneous transformation of the spatial context does not change the hippocampal representation all at once but is followed by temporary bistability in the discharge activity of CA3 ensembles. Rather than sliding through a continuum of intermediate activity states, the CA3 network undergoes a short period of competitive flickering between preformed representations of the past and present environment before settling on the latter. Network flickers are extremely fast, often with complete replacement of the active ensemble from one theta cycle to the next. Within individual cycles, segregation is stronger towards the end, when firing starts to decline, pointing to the theta cycle as a temporal unit for expression of attractor states in the hippocampus. Repetition of pattern-completion processes across successive theta cycles may facilitate error correction and enhance discriminative power in the presence of weak and ambiguous input cues.	[Jezek, Karel; Henriksen, Espen J.; Treves, Alessandro; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, MTFS, N-7489 Trondheim, Norway; [Jezek, Karel; Henriksen, Espen J.; Treves, Alessandro; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, Ctr Biol Memory, MTFS, N-7489 Trondheim, Norway; [Jezek, Karel] Acad Sci Czech Republic, Inst Physiol, Dept Physiol Memory, CR-14220 Prague 4, Krc, Czech Republic; [Treves, Alessandro] SISSA Int Sch Adv Studies, Cognit Neurosci Sect, I-34136 Trieste, Italy	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; International School for Advanced Studies (SISSA)	Jezek, K (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, MTFS, Olav Kyrres Gate 9, N-7489 Trondheim, Norway.	karel.jezek@biomed.cas.cz; edvard.moser@ntnu.no	Jezek, Karel/A-9581-2012	Jezek, Karel/0000-0001-7559-3689; TREVES, Alessandro/0000-0001-7246-5673	European Commission [200873]; European Research Council ('ENSEMBLE'); Kavli Foundation; Norwegian Research Council; Academy of Sciences of the Czech Republic [MSMT CR LC554, 1M0517, AV0Z50110509]	European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council ('ENSEMBLE')(European Research Council (ERC)); Kavli Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	We thank R. Skjerpeng, A. M. Amundsgard, K. Haugen, K. Jenssen, E. Krakvik and H. Waade for technical assistance. The work was supported by the 7th Framework Programme of the European Commission ('SPACEBRAIN', grant agreement no. 200873), an Advanced Investigator Grant to M.-B.M. from the European Research Council ('ENSEMBLE'), the Kavli Foundation, a Centre of Excellence grant from the Norwegian Research Council, and research projects MSMT CR LC554, 1M0517 and AV0Z50110509 at the Academy of Sciences of the Czech Republic.	Akrami A, 2009, CEREB CORTEX, V19, P760, DOI 10.1093/cercor/bhn125; AMIT DJ, 1985, PHYS REV LETT, V55, P1530, DOI 10.1103/PhysRevLett.55.1530; Blumenfeld B, 2006, NEURON, V52, P383, DOI 10.1016/j.neuron.2006.08.016; Colgin LL, 2010, J NEUROPHYSIOL, V104, P35, DOI 10.1152/jn.00202.2010; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Derdikman D, 2009, NAT NEUROSCI, V12, P1325, DOI 10.1038/nn.2396; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; Gothard KM, 1996, J NEUROSCI, V16, P8027; Gothard KM, 1996, J NEUROSCI, V16, P823; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Jackson J, 2007, HIPPOCAMPUS, V17, P1209, DOI 10.1002/hipo.20359; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Kelemen E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000403; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; Olypher AV, 2002, NEUROSCIENCE, V111, P553, DOI 10.1016/S0306-4522(01)00586-3; Romani S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000869; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Skaggs WE, 1998, J NEUROSCI, V18, P8455; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Tsodyks M, 1995, INT J NEURAL SYS S, V6, P81; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905	30	192	193	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					246	U136		10.1038/nature10439	http://dx.doi.org/10.1038/nature10439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21964339				2022-12-28	WOS:000295782800051
J	Lake, A				Lake, Anthony			Early childhood development-global action is overdue	LANCET			English	Editorial Material							DEVELOPING-COUNTRIES; CHILDREN		UNICEF, New York, NY 10017 USA	UNICEF	Lake, A (corresponding author), UNICEF, New York, NY 10017 USA.	alake@unicef.org						Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Engle PL, 2011, LANCET, V378, P1339, DOI 10.1016/S0140-6736(11)60889-1; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Jolly R, 2007, LANCET, V369, P8, DOI 10.1016/S0140-6736(07)60007-5; Naudeau S, 2011, DIR DEV, P1, DOI 10.1596/978-0-8213-8526-5; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2	7	22	22	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 8	2011	378	9799					1277	1278		10.1016/S0140-6736(11)61450-5	http://dx.doi.org/10.1016/S0140-6736(11)61450-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	831IU	21944376				2022-12-28	WOS:000295724300004
J	Blewett, DT; Chabot, NL; Denevi, BW; Ernst, CM; Head, JW; Izenberg, NR; Murchie, SL; Solomon, SC; Nittler, LR; McCoy, TJ; Xiao, ZY; Baker, DMH; Fassett, CI; Braden, SE; Oberst, J; Scholten, F; Preusker, F; Hurwitz, DM				Blewett, David T.; Chabot, Nancy L.; Denevi, Brett W.; Ernst, Carolyn M.; Head, James W.; Izenberg, Noam R.; Murchie, Scott L.; Solomon, Sean C.; Nittler, Larry R.; McCoy, Timothy J.; Xiao, Zhiyong; Baker, David M. H.; Fassett, Caleb I.; Braden, Sarah E.; Oberst, Juergen; Scholten, Frank; Preusker, Frank; Hurwitz, Debra M.			Hollows on Mercury: MESSENGER Evidence for Geologically Recent Volatile-Related Activity	SCIENCE			English	Article							VOLCANISM; FLYBY; EROS; CRATERS	High-resolution images of Mercury's surface from orbit reveal that many bright deposits within impact craters exhibit fresh-appearing, irregular, shallow, rimless depressions. The depressions, or hollows, range from tens of meters to a few kilometers across, and many have high-reflectance interiors and halos. The host rocks, which are associated with crater central peaks, peak rings, floors, and walls, are interpreted to have been excavated from depth by the crater-forming process. The most likely formation mechanisms for the hollows involve recent loss of volatiles through some combination of sublimation, space weathering, outgassing, or pyroclastic volcanism. These features support the inference that Mercury's interior contains higher abundances of volatile materials than predicted by most scenarios for the formation of the solar system's innermost planet.	[Blewett, David T.; Chabot, Nancy L.; Denevi, Brett W.; Ernst, Carolyn M.; Izenberg, Noam R.; Murchie, Scott L.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Head, James W.; Baker, David M. H.; Fassett, Caleb I.; Hurwitz, Debra M.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Solomon, Sean C.; Nittler, Larry R.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; [McCoy, Timothy J.] Smithsonian Inst, Washington, DC 20013 USA; [Xiao, Zhiyong] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Xiao, Zhiyong] China Univ Geosci, Fac Earth Sci, Wuhan 430074, Hubei, Peoples R China; [Braden, Sarah E.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85251 USA; [Oberst, Juergen; Scholten, Frank; Preusker, Frank] German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Brown University; Carnegie Institution for Science; Smithsonian Institution; University of Arizona; China University of Geosciences; Arizona State University; Arizona State University-Tempe; Helmholtz Association; German Aerospace Centre (DLR)	Blewett, DT (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	david.blewett@jhuapl.edu	Ernst, Carolyn M/I-4902-2012; Chabot, Nancy L/F-5384-2015; Izenberg, Noam R/F-3952-2015; Murchie, Scott L/E-8030-2015; Denevi, Brett W./I-6502-2012; Blewett, David T/I-4904-2012	Ernst, Carolyn M/0000-0002-9434-7886; Chabot, Nancy L/0000-0001-8628-3176; Izenberg, Noam R/0000-0003-1629-6478; Murchie, Scott L/0000-0002-1616-8751; Denevi, Brett W./0000-0001-7837-6663; Blewett, David T/0000-0002-9241-6358; Hollibaugh Baker, David/0000-0002-1284-0715; Fassett, Caleb/0000-0001-9155-3804; McCoy, Timothy/0000-0002-4573-3553	NASA; Participating Scientist grant	NASA(National Aeronautics & Space Administration (NASA)); Participating Scientist grant	This work was supported by NASA through the MESSENGER project and by a Participating Scientist grant to D. T. B. M. Robinson offered helpful comments on the manuscript. We thank N. Fontanella, S. Peel, E. Zhong, P. Pashai, and E. Coman for assistance with data processing and compilation. MESSENGER data are archived with the NASA Planetary Data System.	ASHWORTH DG, 1977, COSMIC DUST, P427; Blewett DT, 2010, ICARUS, V209, P239, DOI 10.1016/j.icarus.2010.03.008; Blewett DT, 2009, EARTH PLANET SC LETT, V285, P272, DOI 10.1016/j.epsl.2009.02.021; Denevi BW, 2009, SCIENCE, V324, P613, DOI 10.1126/science.1172226; DZURISIN D, 1977, GEOPHYS RES LETT, V4, P383, DOI 10.1029/GL004i010p00383; Ernst CM, 2010, ICARUS, V209, P210, DOI 10.1016/j.icarus.2010.05.022; FEGLEY B, 1987, EARTH PLANET SC LETT, V82, P207, DOI 10.1016/0012-821X(87)90196-8; Gillis-Davis JJ, 2009, EARTH PLANET SC LETT, V285, P243, DOI 10.1016/j.epsl.2009.05.023; Hawkins SE, 2007, SPACE SCI REV, V131, P247, DOI 10.1007/sl11214-007-9266-3; Head JW, 2008, SCIENCE, V321, P69, DOI 10.1126/science.1159256; Head JW, 2011, SCIENCE, V333, P1853, DOI 10.1126/science.1211997; Head JW, 2009, EARTH PLANET SC LETT, V285, P227, DOI 10.1016/j.epsl.2009.03.007; Kerber L, 2011, PLANET SPACE SCI, V59, P1895, DOI 10.1016/j.pss.2011.03.020; Kerber L, 2009, EARTH PLANET SC LETT, V285, P263, DOI 10.1016/j.epsl.2009.04.037; Kracher A, 2005, ICARUS, V174, P36, DOI 10.1016/j.icarus.2004.10.010; LEWIS JS, 1973, ANNU REV PHYS CHEM, V24, P339, DOI 10.1146/annurev.pc.24.100173.002011; Loeffler MJ, 2008, ICARUS, V195, P622, DOI 10.1016/j.icarus.2008.02.002; Malin MC, 2001, SCIENCE, V294, P2146, DOI 10.1126/science.1066416; Murchie SL, 2008, SCIENCE, V321, P73, DOI 10.1126/science.1159261; Nittler LR, 2011, SCIENCE, V333, P1847, DOI 10.1126/science.1211567; Nittler LR, 2001, METEORIT PLANET SCI, V36, P1673, DOI 10.1111/j.1945-5100.2001.tb01856.x; Peplowski PN, 2011, SCIENCE, V333, P1850, DOI 10.1126/science.1211576; Preusker F, 2011, PLANET SPACE SCI, V59, P1910, DOI 10.1016/j.pss.2011.07.005; RAVA B, 1987, ICARUS, V71, P397, DOI 10.1016/0019-1035(87)90037-6; Robinson MS, 2008, SCIENCE, V321, P66, DOI 10.1126/science.1160080; Robinson MS, 1997, SCIENCE, V275, P197, DOI 10.1126/science.275.5297.197; Schultz PH, 2006, NATURE, V444, P184, DOI 10.1038/nature05303; Spudis P.D., 1988, MERCURY, P118; STROM RG, 1975, J GEOPHYS RES, V80, P2478, DOI 10.1029/JB080i017p02478; Strom RG, 2008, SCIENCE, V321, P79, DOI 10.1126/science.1159317	31	99	99	4	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 30	2011	333	6051					1856	1859		10.1126/science.1211681	http://dx.doi.org/10.1126/science.1211681			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960626				2022-12-28	WOS:000295365800046
J	Head, JW; Chapman, CR; Strom, RG; Fassett, CI; Denevi, BW; Blewett, DT; Ernst, CM; Watters, TR; Solomon, SC; Murchie, SL; Prockter, LM; Chabot, NL; Gillis-Davis, JJ; Whitten, JL; Goudge, TA; Baker, DMH; Hurwitz, DM; Ostrach, LR; Xiao, ZY; Merline, WJ; Kerber, L; Dickson, JL; Oberst, J; Byrne, PK; Klimczak, C; Nittler, LR				Head, James W.; Chapman, Clark R.; Strom, Robert G.; Fassett, Caleb I.; Denevi, Brett W.; Blewett, David T.; Ernst, Carolyn M.; Watters, Thomas R.; Solomon, Sean C.; Murchie, Scott L.; Prockter, Louise M.; Chabot, Nancy L.; Gillis-Davis, Jeffrey J.; Whitten, Jennifer L.; Goudge, Timothy A.; Baker, David M. H.; Hurwitz, Debra M.; Ostrach, Lillian R.; Xiao, Zhiyong; Merline, William J.; Kerber, Laura; Dickson, James L.; Oberst, Juergen; Byrne, Paul K.; Klimczak, Christian; Nittler, Larry R.			Flood Volcanism in the Northern High Latitudes of Mercury Revealed by MESSENGER	SCIENCE			English	Article							SMOOTH PLAINS; CALORIS BASIN; EMPLACEMENT; SURFACE; STRATIGRAPHY; EVOLUTION	MESSENGER observations from Mercury orbit reveal that a large contiguous expanse of smooth plains covers much of Mercury's high northern latitudes and occupies more than 6% of the planet's surface area. These plains are smooth, embay other landforms, are distinct in color, show several flow features, and partially or completely bury impact craters, the sizes of which indicate plains thicknesses of more than 1 kilometer and multiple phases of emplacement. These characteristics, as well as associated features, interpreted to have formed by thermal erosion, indicate emplacement in a flood-basalt style, consistent with x-ray spectrometric data indicating surface compositions intermediate between those of basalts and komatiites. The plains formed after the Caloris impact basin, confirming that volcanism was a globally extensive process in Mercury's post-heavy bombardment era.	[Head, James W.; Fassett, Caleb I.; Whitten, Jennifer L.; Goudge, Timothy A.; Baker, David M. H.; Hurwitz, Debra M.; Kerber, Laura; Dickson, James L.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Chapman, Clark R.; Merline, William J.] SW Res Inst, Boulder, CO 80302 USA; [Strom, Robert G.; Xiao, Zhiyong] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Denevi, Brett W.; Blewett, David T.; Ernst, Carolyn M.; Murchie, Scott L.; Prockter, Louise M.; Chabot, Nancy L.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Watters, Thomas R.] Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; [Solomon, Sean C.; Byrne, Paul K.; Klimczak, Christian; Nittler, Larry R.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Gillis-Davis, Jeffrey J.] Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Ostrach, Lillian R.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85251 USA; [Xiao, Zhiyong] China Univ Geosci, Fac Earth Sci, Wuhan 430074, Hubei, Peoples R China; [Oberst, Juergen] German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany	Brown University; University of Arizona; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Smithsonian Institution; Carnegie Institution for Science; University of Hawaii System; Arizona State University; Arizona State University-Tempe; China University of Geosciences; Helmholtz Association; German Aerospace Centre (DLR)	Head, JW (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	james_head@brown.edu	Murchie, Scott L/E-8030-2015; Kerber, Laura/AAP-1707-2021; Chabot, Nancy L/F-5384-2015; Byrne, Paul k/N-8606-2017; Blewett, David T/I-4904-2012; Denevi, Brett W./I-6502-2012; Ernst, Carolyn M/I-4902-2012	Murchie, Scott L/0000-0002-1616-8751; Chabot, Nancy L/0000-0001-8628-3176; Byrne, Paul k/0000-0002-5644-7069; Blewett, David T/0000-0002-9241-6358; Denevi, Brett W./0000-0001-7837-6663; Ernst, Carolyn M/0000-0002-9434-7886; Hollibaugh Baker, David/0000-0002-1284-0715; Fassett, Caleb/0000-0001-9155-3804; Goudge, Timothy/0000-0003-4297-9838	NASA [NAS5-97271, NASW-00002]	NASA(National Aeronautics & Space Administration (NASA))	We thank the MESSENGER team for development and flight operations. The NASA Discovery Program supports the MESSENGER mission through contract NAS5-97271 to The Johns Hopkins University Applied Physics Laboratory and NASW-00002 to the Carnegie Institution of Washington.	Arndt N, 2008, KOMATIITE, P1, DOI 10.1017/CBO9780511535550; Carr MH, 2010, EARTH PLANET SC LETT, V294, P185, DOI 10.1016/j.epsl.2009.06.042; COFFIN MF, 1993, GEOLOGY, V21, P515, DOI 10.1130/0091-7613(1993)021<0515:STSEDO>2.3.CO;2; Denevi BW, 2009, SCIENCE, V324, P613, DOI 10.1126/science.1172226; Fassett CI, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047294; Fassett CI, 2009, EARTH PLANET SC LETT, V285, P297, DOI 10.1016/j.epsl.2009.05.022; GROLIER MJ, 1984, MISC INVEST SER US G; Hawkins SE, 2007, SPACE SCI REV, V131, P247, DOI 10.1007/sl11214-007-9266-3; Head JW, 2008, SCIENCE, V321, P69, DOI 10.1126/science.1159256; Head JW, 2009, EARTH PLANET SC LETT, V285, P227, DOI 10.1016/j.epsl.2009.03.007; HEAD JW, 1992, GEOCHIM COSMOCHIM AC, V56, P2155, DOI 10.1016/0016-7037(92)90183-J; Hiesinger H, 2011, GEOL SOC AM SPEC PAP, V477, P1, DOI 10.1130/2011.2477(01); HON K, 1994, GEOL SOC AM BULL, V106, P351, DOI 10.1130/0016-7606(1994)106<0351:EAIOPS>2.3.CO;2; Hunten D.M., 1988, MERCURY, P562; HUPPERT HE, 1984, NATURE, V309, P19, DOI 10.1038/309019a0; Kerber L, 2011, PLANET SPACE SCI, V59, P1895, DOI 10.1016/j.pss.2011.03.020; Milkovich SM, 2002, METEORIT PLANET SCI, V37, P1209, DOI 10.1111/j.1945-5100.2002.tb00890.x; Murchie SL, 2008, SCIENCE, V321, P73, DOI 10.1126/science.1159261; MURRAY BC, 1975, J GEOPHYS RES, V80, P2508, DOI 10.1029/JB080i017p02508; Nittler LR, 2011, SCIENCE, V333, P1847, DOI 10.1126/science.1211567; PIKE RJ, 1988, MERCURY, P165; Robinson MS, 2008, SCIENCE, V321, P66, DOI 10.1126/science.1160080; Robinson MS, 1997, SCIENCE, V275, P197, DOI 10.1126/science.275.5297.197; Spudis P.D., 1988, MERCURY, P118; Strom RG, 2011, PLANET SPACE SCI, V59, P1960, DOI 10.1016/j.pss.2011.03.018; Thordarson T, 1998, J GEOPHYS RES-SOL EA, V103, P27411, DOI 10.1029/98JB01355; Watters TR, 2009, EARTH PLANET SC LETT, V285, P309, DOI 10.1016/j.epsl.2009.03.040; WILHELMS DE, 1976, ICARUS, V28, P551, DOI 10.1016/0019-1035(76)90128-7; WILHELMS DE, 1987, PROF PUB US GEOLOGIC, V1348; Williams DA, 2001, J VOLCANOL GEOTH RES, V110, P27, DOI 10.1016/S0377-0273(01)00206-2; Wilson L, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035620	31	176	178	3	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051					1853	1856		10.1126/science.1211997	http://dx.doi.org/10.1126/science.1211997			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960625				2022-12-28	WOS:000295365800045
J	Holzer, RG; Park, EJ; Li, N; Tran, H; Chen, M; Choi, C; Solinas, G; Karin, M				Holzer, Ryan G.; Park, Eek-Joong; Li, Ning; Tran, Helen; Chen, Monica; Choi, Crystal; Solinas, Giovanni; Karin, Michael			Saturated Fatty Acids Induce c-Src Clustering within Membrane Subdomains, Leading to JNK Activation	CELL			English	Article							ENDOPLASMIC-RETICULUM STRESS; INDUCED INSULIN-RESISTANCE; MIXED-LINEAGE KINASES; LIPID RAFTS; ADIPOSE-TISSUE; PLASMA-MEMBRANE; FISH OIL; OBESITY; INFLAMMATION; RECEPTOR	Saturated fatty acids (FA) exert adverse health effects and are more likely to cause insulin resistance and type 2 diabetes than unsaturated FA, some of which exert protective and beneficial effects. Saturated FA, but not unsaturated FA, activate Jun N-terminal kinase (JNK), which has been linked to obesity and insulin resistance in mice and humans. However, it is unknown how saturated and unsaturated FA are discriminated. We now demonstrate that saturated FA activate JNK and inhibit insulin signaling through c-Src activation. FA alter the membrane distribution of c-Src, causing it to partition into intracellular membrane subdomains, where it likely becomes activated. Conversely, unsaturated FA with known beneficial effects on glucose metabolism prevent c-Src membrane partitioning and activation, which are dependent on its myristoylation, and block JNK activation. Consumption of a diabetogenic high-fat diet causes the partitioning and activation of c-Src within detergent insoluble membrane subdomains of murine adipocytes.	[Holzer, Ryan G.; Park, Eek-Joong; Li, Ning; Tran, Helen; Chen, Monica; Choi, Crystal; Karin, Michael] Univ Calif San Diego, Dept Pharmacol, Sch Med, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Solinas, Giovanni] Univ Fribourg, Lab Metab Stress Biol, Dept Med, CH-1700 Fribourg, Switzerland	University of California System; University of California San Diego; University of Fribourg	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Sch Med, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Solinas, Giovanni/P-6596-2017; Solinas, Giovanni/R-4777-2019	Solinas, Giovanni/0000-0002-0140-2621; Solinas, Giovanni/0000-0002-0140-2621	National Institutes of Health [ES006376, ES0100337]; American Diabetes Association (ADA) [7-08-MN-29]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337, R01ES006376, R37ES004151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association (ADA)(American Diabetes Association); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the individuals mentioned in the Extended Experimental Procedures who provided us with essential reagents. Research was supported by grants from the National Institutes of Health (ES006376, ES0100337) and the American Diabetes Association (ADA 7-08-MN-29) to M. K., who is an American Cancer Society Research Professor.	Agostino Nicole M, 2011, J Oncol Pharm Pract, V17, P197, DOI 10.1177/1078155210378913; Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; Arcaro A, 2007, CELL SIGNAL, V19, P1081, DOI 10.1016/j.cellsig.2006.12.003; Breccia M, 2008, LEUKEMIA RES, V32, P1626, DOI 10.1016/j.leukres.2008.01.015; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Browning LM, 2007, DIABETES OBES METAB, V9, P70, DOI 10.1111/j.1463-1326.2006.00576.x; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Charruyer A, 2005, J BIOL CHEM, V280, P19196, DOI 10.1074/jbc.M412867200; Clamp AG, 1997, LIPIDS, V32, P179, DOI 10.1007/s11745-997-0022-3; CLANDININ MT, 1991, FASEB J, V5, P2761, DOI 10.1096/fasebj.5.13.1916101; CULP BR, 1980, PROSTAG OTH LIPID M, V20, P1021, DOI 10.1016/0090-6980(80)90056-8; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Faloia E, 1999, EUR J CLIN INVEST, V29, P432, DOI 10.1046/j.1365-2362.1999.00458.x; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Handley ME, 2007, INT J EXP PATHOL, V88, P111, DOI 10.1111/j.1365-2613.2007.00531.x; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jaeschke A, 2004, GENE DEV, V18, P1976, DOI 10.1101/gad.1216504; Jaeschke A, 2007, MOL CELL, V27, P498, DOI 10.1016/j.molcel.2007.07.008; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Jorgensen ME, 2006, AM J CLIN NUTR, V84, P29, DOI 10.1093/ajcn/84.1.29; KAGAWA Y, 1982, J NUTR SCI VITAMINOL, V28, P441, DOI 10.3177/jnsv.28.441; Kahn CR, 1996, ANNU REV MED, V47, P509; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; KARNOVSKY MJ, 1982, J CELL BIOL, V94, P1, DOI 10.1083/jcb.94.1.1; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; KROMANN N, 1980, ACTA MED SCAND, V208, P401; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Liu GM, 2001, P NATL ACAD SCI USA, V98, P7510, DOI 10.1073/pnas.131195198; Luo J, 1996, J NUTR, V126, P1951; Mukherjee A, 2003, J BIOL CHEM, V278, P40806, DOI 10.1074/jbc.M306440200; Neschen S, 2007, DIABETES, V56, P1034, DOI 10.2337/db06-1206; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; OKADA M, 1991, J BIOL CHEM, V266, P24249; Ostrom Rennolds S., 2006, V332, P181; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Patwardhan P, 2010, MOL CELL BIOL, V30, P4094, DOI 10.1128/MCB.00246-10; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Rajendran L, 2007, BIOL CHEM, V388, P307, DOI 10.1515/BC.2007.034; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; RINTOUL DA, 1978, J BIOL CHEM, V253, P7447; Robinson LE, 2007, APPL PHYSIOL NUTR ME, V32, P1008, DOI 10.1139/H07-087; Ryan M, 2000, QJM-MON J ASSOC PHYS, V93, P85, DOI 10.1093/qjmed/93.2.85; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sabio G, 2010, GENE DEV, V24, P256, DOI 10.1101/gad.1878510; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Seong JH, 2009, CHEM BIOL, V16, P48, DOI 10.1016/j.chembiol.2008.11.007; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; Stulnig TM, 1998, J CELL BIOL, V143, P637, DOI 10.1083/jcb.143.3.637; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; Taniguchi CM, 2007, MOL CELL BIOL, V27, P2830, DOI 10.1128/MCB.00079-07; Thorsdottir I, 2004, PREV MED, V39, P630, DOI 10.1016/j.ypmed.2004.02.031; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vallerie SN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003151; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; WATALA C, 1992, EUR J CLIN CHEM CLIN, V30, P513; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Wu YT, 2008, CELL DEATH DIFFER, V15, P386, DOI 10.1038/sj.cdd.4402273	71	200	209	2	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					173	184		10.1016/j.cell.2011.08.034	http://dx.doi.org/10.1016/j.cell.2011.08.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962514	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000295396700024
J	Punyasena, SW; Dalling, JW; Jaramillo, C; Turner, BL				Punyasena, Surangi W.; Dalling, James W.; Jaramillo, Carlos; Turner, Benjamin L.			Comment on "The Response of Vegetation on the Andean Flank in Western Amazonia to Pleistocene Climate Change"	SCIENCE			English	Editorial Material							MAXIMUM		[Punyasena, Surangi W.; Dalling, James W.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Dalling, James W.; Jaramillo, Carlos; Turner, Benjamin L.] Smithsonian Trop Res Inst, Ancon, Panama	University of Illinois System; University of Illinois Urbana-Champaign; Smithsonian Institution; Smithsonian Tropical Research Institute	Punyasena, SW (corresponding author), Univ Illinois, Dept Plant Biol, 505 S Goodwin Ave, Urbana, IL 61801 USA.	punyasena@life.illinois.edu	Turner, Benjamin L/E-5940-2011; Punyasena, Surangi/C-9134-2011	Turner, Benjamin L/0000-0002-6585-0722; Punyasena, Surangi/0000-0003-2110-5840; Dalling, James/0000-0002-6488-9895; jaramillo, carlos/0000-0002-2616-5079				Andersen KM, 2010, J BIOGEOGR, V37, P278, DOI 10.1111/j.1365-2699.2009.02192.x; Berendse F, 2009, ECOL LETT, V12, P865, DOI 10.1111/j.1461-0248.2009.01342.x; BOND WJ, 1989, BIOL J LINN SOC, V36, P227, DOI 10.1111/j.1095-8312.1989.tb00492.x; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; Brodribb TJ, 2010, ECOL LETT, V13, P175, DOI 10.1111/j.1461-0248.2009.01410.x; Cardenas ML, 2011, SCIENCE, V331, P1055, DOI 10.1126/science.1197947; Colinvaux PA, 1996, CLIMATIC CHANGE, V32, P19, DOI 10.1007/BF00141276; Farjon A., 1998, WORLD CHECKLIST BIBL; HENDERSON A, 1995, FIELD GUIDE PALMS AM; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; LIU KB, 1985, NATURE, V318, P556, DOI 10.1038/318556a0; Neill D., 2008, BOT INVENTORY CORDIL; Niinemets U, 2011, TRENDS ECOL EVOL, V26, P136, DOI 10.1016/j.tree.2010.12.012; Peppe DJ, 2011, NEW PHYTOL, V190, P724, DOI 10.1111/j.1469-8137.2010.03615.x	14	23	24	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051								10.1126/science.1207525	http://dx.doi.org/10.1126/science.1207525			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960612				2022-12-28	WOS:000295365800030
J	Odadi, WO; Karachi, MK; Abdulrazak, SA; Young, TP				Odadi, Wilfred O.; Karachi, Moses K.; Abdulrazak, Shaukat A.; Young, Truman P.			African Wild Ungulates Compete with or Facilitate Cattle Depending on Season	SCIENCE			English	Article							SEMIARID SAVANNA; ELEPHANTS; SERENGETI; RANGELAND; SELECTION; LIVESTOCK; LAIKIPIA; KENYA	Savannas worldwide are vital for both socioeconomic and biodiversity values. In these ecosystems, management decisions are based on the perception that wildlife and livestock compete for food, yet there are virtually no experimental data to support this assumption. We examined the effects of wild African ungulates on cattle performance, food intake, and diet quality. Wild ungulates depressed cattle food intake and performance during the dry season (competition) but enhanced cattle diet quality and performance during the wet season (facilitation). These results extend our understanding of the context-dependent-competition-facilitation balance, in general, and are critical for better understanding and managing wildlife-livestock coexistence in human-occupied savanna landscapes.	[Odadi, Wilfred O.; Young, Truman P.] Mpala Res Ctr, Nanyuki 10400, Kenya; [Karachi, Moses K.] Egerton Univ, Dept Nat Resources, Egerton 20115, Kenya; [Abdulrazak, Shaukat A.] Natl Council Sci & Technol, Nairobi 00100, Kenya; [Young, Truman P.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Egerton University; University of California System; University of California Davis	Odadi, WO (corresponding author), Mpala Res Ctr, POB 555, Nanyuki 10400, Kenya.	woodadie@yahoo.com; tpyoung@ucdavis.edu			Smithsonian Institution; National Geographic Society; National Science Foundation [08-16453]; U.S. Fish and Wildlife Service; International Foundation for Science [B/4182-1]	Smithsonian Institution(Smithsonian Institution); National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); U.S. Fish and Wildlife Service(US Fish & Wildlife Service); International Foundation for Science(International Foundation for Science)	This research was supported by grants from the James Smithson Fund (Smithsonian Institution), the National Geographic Society, the National Science Foundation (grant 08-16453 to T.P.Y.), the African Elephant Program (U.S. Fish and Wildlife Service), and the International Foundation for Science (grant B/4182-1 to W.O.O.). We thank M. Kinnaird, M. Littlewood, and the Mpala Board of Trustees; K. Veblen, C. Riginos, and G. Aike for logistical support; and F. Erii, M. Namoni, R. Kibet, and P. Ekai for field assistance. We appreciate comments and suggestions by T. Palmer.	Arsenault R, 2002, OIKOS, V97, P313, DOI 10.1034/j.1600-0706.2002.970301.x; Beck JL, 2005, RANGELAND ECOL MANAG, V58, P135, DOI 10.2111/03-13.1; Bell R.H.V., 1970, ANIMAL POPULATIONS R, P111; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; CASEBEER R L, 1970, East African Wildlife Journal, V8, P25; Cerling TE, 2009, P NATL ACAD SCI USA, V106, P8093, DOI 10.1073/pnas.0902192106; Du Toit JT, 1999, BIODIVERS CONSERV, V8, P1643, DOI 10.1023/A:1008959721342; DUNCAN P, 1990, OECOLOGIA, V84, P411, DOI 10.1007/BF00329768; Georgiadis NJ, 2007, BIOL CONSERV, V137, P461, DOI 10.1016/j.biocon.2007.03.005; GWYNNE MD, 1968, NATURE, V220, P390, DOI 10.1038/220390a0; Hogan J. P., 1982, Nutritional limits to animal production from pastures., P245; Lima GFD, 1999, CROP SCI, V39, P1853, DOI 10.2135/cropsci1999.3961853x; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; McNaughton SJ, 1997, SCIENCE, V278, P1798, DOI 10.1126/science.278.5344.1798; Odadi WO, 2007, RANGELAND ECOL MANAG, V60, P179, DOI 10.2111/05-044R3.1; Odadi WO, 2011, EVOL ECOL RES, V13, P237; Odadi WO, 2009, APPL ANIM BEHAV SCI, V116, P120, DOI 10.1016/j.applanim.2008.08.010; OWAGA ML, 1975, THESIS U NAIROBI; POPPI DP, 1995, J ANIM SCI, V73, P278; Pringle RM, 2007, P NATL ACAD SCI USA, V104, P193, DOI 10.1073/pnas.0609840104; Prins HHT, 2000, WILDLIFE CONSERVATIO, P51, DOI DOI 10.1007/978-94-011-4012-6_5; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Veblen KE, 2008, ECOLOGY, V89, P1532, DOI 10.1890/07-0973.1; Young TP, 2005, BIOL CONSERV, V122, P351, DOI 10.1016/j.biocon.2004.08.007	24	160	164	1	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1753	1755		10.1126/science.1208468	http://dx.doi.org/10.1126/science.1208468			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940896				2022-12-28	WOS:000295121500044
J	Weinberger, SE				Weinberger, Steven E.			Providing High-Value, Cost-Conscious Care: A Critical Seventh General Competency for Physicians	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CONTAINMENT; EDUCATION	There is general agreement that the U.S. economy cannot sustain the staggering economic burden imposed by the current and projected costs of health care. Whereas governmental approaches are focused primarily on decreasing spending for medical care, it is the responsibility of the medical profession to become cost-conscious and decrease unnecessary care that does not benefit patients but represents a substantial percentage of health care costs. At present, the 6 general competencies of the Accreditation Council for Graduate Medical Education (ACGME) and the American Board of Medical Specialties (ABMS) that drive residency training place relatively little emphasis on residents' understanding of the need for stewardship of resources or for practicing in a cost-conscious fashion. Given the importance in today's health care system, the author proposes that cost-consciousness and stewardship of resources be elevated by the ACGME and the ABMS to the level of a new, seventh general competency. This will hopefully provide the necessary impetus to change the culture of the training environment and the practice patterns of both residents and their supervising faculty.	Amer Coll Physicians, Philadelphia, PA 19106 USA	American College of Physicians	Weinberger, SE (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	sweinberger@acponline.org						Accreditation Council for Graduate Medical Education, OUTC PROJ; Cooke M, 2010, NEW ENGL J MED, V362, P1253, DOI 10.1056/NEJMp0911502; EISENBERG JM, 1981, JAMA-J AM MED ASSOC, V246, P2195, DOI 10.1001/jama.246.19.2195; Institute of Medicine, 2001, CROSS QUAL CHASM; Institute of Medicine, 2010, HEALTHC IMP LOW COST; Institute of Medicine, 2000, ERR IS HUM BUILD SAF; Reinhardt UE, 2010, FEES VOLUME SPENDING; SCHROEDER SA, 1984, JAMA-J AM MED ASSOC, V252, P225, DOI 10.1001/jama.252.2.225; Schroeder SA, 2011, ARCH INTERN MED, V171, P722, DOI 10.1001/archinternmed.2011.149; Weinberger SE, 2010, ANN INTERN MED, V153, P751, DOI 10.7326/0003-4819-153-11-201012070-00009	10	146	145	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6					386	388		10.7326/0003-4819-155-6-201109200-00007	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-00007			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930856				2022-12-28	WOS:000295033400018
J	Bhutani, N; Burns, DM; Blau, HM				Bhutani, Nidhi; Burns, David M.; Blau, Helen M.			DNA Demethylation Dynamics	CELL			English	Article							EMBRYONIC STEM-CELLS; BASE EXCISION-REPAIR; METHYLATION PATTERNS; PATERNAL GENOME; PREIMPLANTATION DEVELOPMENT; SOMATIC HYPERMUTATION; GENE-EXPRESSION; 5-HYDROXYMETHYLCYTOSINE; MOUSE; TET1	The discovery of cytosine hydroxymethylation (5hmC) suggested a simple means of demethylating DNA and activating genes. Further experiments, however, unearthed an unexpectedly complex process, entailing both passive and active mechanisms of DNA demethylation by the ten-eleven translocation (TET) and AID/APOBEC families of enzymes. The consensus emerging from these studies is that removal of cytosine methylation in mammalian cells can occur by DNA repair. These reports highlight that in certain contexts, DNA methylation is not fixed but dynamic, requiring continuous regulation.	[Bhutani, Nidhi; Burns, David M.; Blau, Helen M.] Stanford Univ, Baxter Lab Stem Cell Biol, Inst Stem Cell Biol & Regenerat Med, Dept Microbiol & Immunol,Sch Med, Stanford, CA 94305 USA	Stanford University	Blau, HM (corresponding author), Stanford Univ, Baxter Lab Stem Cell Biol, Inst Stem Cell Biol & Regenerat Med, Dept Microbiol & Immunol,Sch Med, Stanford, CA 94305 USA.	hblau@stanford.edu			PHS [5T32CA09151]; NIH [HL096113, HL100397, AG020961, AG009521]; JDRF [34-2008-623]; CIRM [RT1-01001, RB1-01292]; Baxter Foundation; NCI; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397, R01HL096113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG009521, R01AG009521, R01AG020961] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); CIRM(California Institute for Regenerative Medicine); Baxter Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Steve Hennikoff, Mary Goll, Mark Ptashne, Peter Jones, Jason Pomerantz, and members of our laboratory for critical reading of the manuscript and constructive suggestions and Stephane Corbel for expert artwork. This work was funded by a PHS grant 5T32CA09151 awarded by NCI to D.M.B. and funding from NIH grants HL096113, HL100397, AG020961, and AG009521; JDRF grant 34-2008-623; CIRM grants RT1-01001 and RB1-01292; and the Baxter Foundation to H.M.B.	Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BLAU HM, 1991, J CELL BIOL, V112, P781, DOI 10.1083/jcb.112.5.781; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BLAU HM, 1992, ANNU REV BIOCHEM, V61, P1213, DOI 10.1146/annurev.bi.61.070192.010025; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; De Carvalho DD, 2010, TRENDS CELL BIOL, V20, P609, DOI 10.1016/j.tcb.2010.08.003; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Delker RK, 2009, NAT IMMUNOL, V10, P1147, DOI 10.1038/ni.1799; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; FRANK D, 1990, PHILOS T ROY SOC B, V326, P241, DOI 10.1098/rstb.1990.0008; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; He Y-F, 2011, SCIENCE; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jullien J, 2011, NAT REV MOL CELL BIO, V12, P453, DOI 10.1038/nrm3140; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Maul RW, 2010, ADV IMMUNOL, V105, P159, DOI 10.1016/S0065-2776(10)05006-6; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; MONK M, 1991, DEVELOPMENT, V112, P189; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Ono R, 2002, CANCER RES, V62, P4075; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; PAROUSH Z, 1990, CELL, V63, P1229, DOI 10.1016/0092-8674(90)90418-E; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Ptashne M, 2009, CURR BIOL, V19, pR234, DOI 10.1016/j.cub.2009.02.015; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; to S, 2011, SCIENCE; Weiss A, 1996, CELL, V86, P709, DOI 10.1016/S0092-8674(00)80146-4; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; WYATT GR, 1952, NATURE, V170, P1072, DOI 10.1038/1701072a0; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Zhang F, 2007, P NATL ACAD SCI USA, V104, P4395, DOI 10.1073/pnas.0700181104	62	473	501	1	92	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2011	146	6					866	872		10.1016/j.cell.2011.08.042	http://dx.doi.org/10.1016/j.cell.2011.08.042			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925312	Green Accepted, Bronze			2022-12-28	WOS:000295258100010
J	Lee, DH; Kwon, KH; Yi, CS				Lee, Dong-Hwan; Kwon, Ki-Hyeok; Yi, Chae S.			Selective Catalytic C-H Alkylation of Alkenes with Alcohols	SCIENCE			English	Article							RUTHENIUM-HYDRIDE COMPLEX; CARBON-HYDROGEN; COUPLING REACTION; BOND; DEHYDROGENATION; REACTIVITY; MECHANISM; IRIDIUM; OXYGEN	Alkenes and alcohols are among the most abundant and commonly used organic feedstock in industrial processes. We report a selective catalytic alkylation reaction of alkenes with alcohols that forms a carbon-carbon bond between vinyl carbon-hydrogen (C-H) and carbon-hydroxy centers with the concomitant loss of water. The cationic ruthenium complex [(C6H6)(PCy3)(CO)RuH]+BF4- (Cy, cyclohexyl) catalyzes the alkylation in solution within 2 to 8 hours at temperatures ranging from 75 degrees to 110 degrees C and tolerates a broad range of substrate functionality, including amines and carbonyls. Preliminary mechanistic studies are inconsistent with Friedel-Crafts-type electrophilic activation of the alcohols, suggesting instead a vinyl C-H activation pathway with opposite electronic polarization.	[Lee, Dong-Hwan; Kwon, Ki-Hyeok; Yi, Chae S.] Marquette Univ, Dept Chem, Milwaukee, WI 53201 USA	Marquette University	Yi, CS (corresponding author), Marquette Univ, Dept Chem, Milwaukee, WI 53201 USA.	chae.yi@marquette.edu			NSF [CHE-1011891]	NSF(National Science Foundation (NSF))	We thank the NSF for financial support (grant CHE-1011891).	Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Courchay FC, 2006, ORGANOMETALLICS, V25, P6074, DOI 10.1021/om0509894; Dobereiner GE, 2010, CHEM REV, V110, P681, DOI 10.1021/cr900202j; Feng Y, 2005, J AM CHEM SOC, V127, P14174, DOI 10.1021/ja054101e; Frantz DE, 1997, J AM CHEM SOC, V119, P3383, DOI 10.1021/ja9636348; Gao RL, 2010, J ORG CHEM, V75, P3144, DOI 10.1021/jo100269y; Grotjahn DB, 1996, ORGANOMETALLICS, V15, P2860, DOI 10.1021/om9603171; HECK RF, 1979, ACCOUNTS CHEM RES, V12, P146, DOI 10.1021/ar50136a006; Kakiuchi F, 2002, ACCOUNTS CHEM RES, V35, P826, DOI 10.1021/ar960318p; KARPLUS M, 1959, J CHEM PHYS, V30, P11, DOI 10.1063/1.1729860; Lee DW, 2010, ORGANOMETALLICS, V29, P3413, DOI 10.1021/om100468q; Li CJ, 2009, ACCOUNTS CHEM RES, V42, P335, DOI 10.1021/ar800164n; Liu ZQ, 2011, ORG LETT, V13, P2208, DOI 10.1021/ol200372y; Matsumoto T, 2008, J AM CHEM SOC, V130, P2458, DOI 10.1021/ja711325f; MCGRATH DV, 1994, ORGANOMETALLICS, V13, P224, DOI 10.1021/om00013a035; MURAI S, 1993, NATURE, V366, P529, DOI 10.1038/366529a0; Olah G. A., 2003, HYDROCARBON CHEM; OLAH GA, 1991, ADV SILIC C, V1, P1; Renkema KB, 2003, J AM CHEM SOC, V125, P7770, DOI 10.1021/ja0289200; Roberts R. M., 1984, FRIEDELCRAFTS ALKYLA; RONDON D, 1991, J AM CHEM SOC, V113, P5671, DOI 10.1021/ja00015a022; Smith M.B., 2007, ADV ORGANIC CHEM REA, V6th ed, DOI 10.1002/9780470084960.ch15; STOUTLAND PO, 1985, J AM CHEM SOC, V107, P4581, DOI 10.1021/ja00301a052; Stuart DR, 2007, SCIENCE, V316, P1172, DOI 10.1126/science.1141956; Ueno S, 2006, J AM CHEM SOC, V128, P16516, DOI 10.1021/ja067612p; Wang DH, 2010, SCIENCE, V327, P315, DOI 10.1126/science.1182512; Yeung CS, 2011, CHEM REV, V111, P1215, DOI 10.1021/cr100280d; Yi CS, 2010, ORGANOMETALLICS, V29, P1883, DOI 10.1021/om100051h; Yi CS, 2009, ORGANOMETALLICS, V28, P4266, DOI 10.1021/om900416k; Yu J.-Q., 2010, C H ACTIVATION	30	138	139	1	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2011	333	6049					1613	1616		10.1126/science.1208839	http://dx.doi.org/10.1126/science.1208839			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921195				2022-12-28	WOS:000294900900038
J	Lu, JY; Lin, YY; Sheu, JC; Wu, JT; Lee, FJ; Chen, Y; Lin, MI; Chiang, FT; Tai, TY; Berger, SL; Zhao, YM; Tsai, KS; Zhu, H; Chuang, LM; Boeke, JD				Lu, Jin-Ying; Lin, Yu-Yi; Sheu, Jin-Chuan; Wu, June-Tai; Lee, Fang-Jen; Chen, Yue; Lin, Min-I; Chiang, Fu-Tien; Tai, Tong-Yuan; Berger, Shelley L.; Zhao, Yingming; Tsai, Keh-Sung; Zhu, Heng; Chuang, Lee-Ming; Boeke, Jef D.			Acetylation of Yeast AMPK Controls Intrinsic Aging Independently of Caloric Restriction	CELL			English	Article							SNF1 PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; CAENORHABDITIS-ELEGANS; SCH9; SENESCENCE; EXTENSION; LONGEVITY; TARGET; STRESS	Acetylation of histone and nonhistone proteins is an important posttranslational modification affecting many cellular processes. Here, we report that NuA4 acetylation of Sip2, a regulatory beta subunit of the Snf1 complex (yeast AMP-activated protein kinase), decreases as cells age. Sip2 acetylation, controlled by antagonizing NuA4 acetyltransferase and Rpd3 deacetylase, enhances interaction with Snf1, the catalytic subunit of Snf1 complex. Sip2-Snf1 interaction inhibits Snf1 activity, thus decreasing phosphorylation of a downstream target, Sch9 (homolog of Akt/S6K), and ultimately leading to slower growth but extended replicative life span. Sip2 acetylation mimetics are more resistant to oxidative stress. We further demonstrate that the anti-aging effect of Sip2 acetylation is independent of extrinsic nutrient availability and TORC1 activity. We propose a protein acetylation-phosphorylation cascade that regulates Sch9 activity, controls intrinsic aging, and extends replicative life span in yeast.	[Zhu, Heng] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Boeke, Jef D.] Johns Hopkins Univ, Sch Med, Dept Mol Biol, Baltimore, MD 21205 USA; [Zhu, Heng; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Boeke, Jef D.] Johns Hopkins Univ, Sch Med, Dept Genet, Baltimore, MD 21205 USA; [Berger, Shelley L.] Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA; [Chen, Yue; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Lu, Jin-Ying; Lin, Min-I; Chiang, Fu-Tien; Tsai, Keh-Sung] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan; [Lu, Jin-Ying; Tsai, Keh-Sung; Chuang, Lee-Ming] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 100, Taiwan; [Lin, Yu-Yi] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 100, Taiwan; [Sheu, Jin-Chuan; Chiang, Fu-Tien; Tai, Tong-Yuan; Tsai, Keh-Sung; Chuang, Lee-Ming] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Wu, June-Tai; Lee, Fang-Jen] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 100, Taiwan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; The Wistar Institute; University of Chicago; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Zhu, H (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	heng.zhu@jhmi.edu; leeming@ntu.edu.tw; jboeke@jhmi.edu	Chuang, Lee-Ming/AAF-3324-2019	CHUANG, LEE-MING/0000-0003-0978-2662; Boeke, Jef/0000-0001-5322-4946; LEE, FANG-JEN/0000-0002-2167-2426; SHEU, JIN-CHUAN/0000-0002-2503-7139; CHIANG, FU-TIEN/0000-0003-4936-8968; WU, JUNE-TAI/0000-0002-4023-7315; TSAI, KEH-SUNG/0000-0001-8528-1566; Berger, Shelley/0000-0001-5398-4400	National Science Council (NSC) [98-2314-B-002-031-MY3]; National Taiwan University Hospital [099-001376]; National Taiwan University [99C101-603]; Liver Disease Prevention & Treatment Research Foundation (Taiwan); NIH (USA) [U54-RR020839]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University); National Taiwan University(National Taiwan University); Liver Disease Prevention & Treatment Research Foundation (Taiwan); NIH (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Sheng-Ce Tao and Chien-Sheng Chen for their early contribution to this work. We are grateful to Dr. Brian K. Kennedy for providing sch9 Delta strain, Dr. Robbie Loewith for providing SCH9 phosphorylation mutants, and Dr. Marian B. Carlson for providing snf1-K84R construct. We thank Dr. Fang-Jen Lee for kindly sharing the laboratory space and reagents. We thank Department of Medical Science, National Taiwan University for technical help with sequencing. We thank Dr. Yi-Juang Chern for critical suggestions on this work. Work was supported by National Science Council (NSC 98-2314-B-002-031-MY3 to J.-Y.L.), National Taiwan University Hospital (099-001376, to J.-Y.L.), National Taiwan University (99C101-603 to J.-Y.L., Y.-Y.L., and L.-M.C.), Liver Disease Prevention & Treatment Research Foundation (Taiwan) (to J.-Y.L. and Y.-Y.L.), and NIH Common Fund grant (USA) (U54-RR020839 to H.Z. and J.D.B.).	Amodeo GA, 2007, NATURE, V449, P492, DOI 10.1038/nature06127; Ashrafi K, 2000, GENE DEV, V14, P1872; Barker MG, 1999, FEMS MICROBIOL LETT, V177, P199, DOI 10.1016/S0378-1097(99)00308-0; Bitterman KJ, 2003, MICROBIOL MOL BIOL R, V67, P376, DOI 10.1128/MMBR.67.3.376-399.2003; Chang CS, 2009, GENETICS, V183, P149, DOI 10.1534/genetics.109.103846; Chang KT, 2002, AGEING RES REV, V1, P313, DOI 10.1016/S1568-1637(02)00003-X; Chiocchetti A, 2007, EXP GERONTOL, V42, P275, DOI 10.1016/j.exger.2006.11.002; Close P, 2010, CELL MOL LIFE SCI, V67, P1255, DOI 10.1007/s00018-009-0252-7; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Colman RJ, 2011, ANTIOXID REDOX SIGN, V14, P229, DOI 10.1089/ars.2010.3224; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Dirks AJ, 2006, MECH AGEING DEV, V127, P1, DOI 10.1016/j.mad.2005.09.001; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Ehrentraut S, 2010, P NATL ACAD SCI USA, V107, P5522, DOI 10.1073/pnas.0909169107; Evans DS, 2011, AGEING RES REV, V10, P225, DOI 10.1016/j.arr.2010.04.001; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jablonowski D, 2004, MOL BIOL CELL, V15, P1459, DOI 10.1091/mbc.E03-10-0750; JAMIESON DJ, 1992, J BACTERIOL, V174, P6678, DOI 10.1128/JB.174.20.6678-6681.1992; Jiang JC, 2002, EXP GERONTOL, V37, P1023, DOI 10.1016/S0531-5565(02)00064-5; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kim MD, 2005, EUKARYOT CELL, V4, P861, DOI 10.1128/EC.4.5.861-866.2005; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lin SS, 2003, J BIOL CHEM, V278, P13390, DOI 10.1074/jbc.M212818200; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Liu FD, 2012, AGE, V34, P157, DOI 10.1007/s11357-011-9214-8; Madia F, 2009, J CELL BIOL, V186, P509, DOI 10.1083/jcb.200906011; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Marino G, 2008, HUM MOL GENET, V17, P2196, DOI 10.1093/hmg/ddn120; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nakamura A, 2010, ANN NY ACAD SCI, V1197, P33, DOI 10.1111/j.1749-6632.2009.05374.x; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x; Powers T, 2007, CELL METAB, V6, P1, DOI 10.1016/j.cmet.2007.06.009; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Sanz P, 2003, BIOCHEM SOC T, V31, P178; Sanz P, 2008, CURR PROTEIN PEPT SC, V9, P478, DOI 10.2174/138920308785915254; Schmidt MC, 2000, EMBO J, V19, P4936, DOI 10.1093/emboj/19.18.4936; Scott JW, 2009, FRONT BIOSCI-LANDMRK, V14, P596, DOI 10.2741/3266; Shi L, 2010, MOL BIOL CELL, V21, P1982, DOI 10.1091/mbc.E10-01-0056; Silva H., 2008, AGING STEM CELL RENE; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7; Thomson DM, 2009, J PHYSIOL-LONDON, V587, P2077, DOI 10.1113/jphysiol.2008.166512; Toulmay A, 2006, YEAST, V23, P825, DOI 10.1002/yea.1397; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wang JQ, 2010, EXP GERONTOL, V45, P621, DOI 10.1016/j.exger.2010.02.008; Wang WG, 2003, J BIOL CHEM, V278, P27016, DOI 10.1074/jbc.M300318200; Wang Y, 2011, FEBS LETT, V585, P986, DOI 10.1016/j.febslet.2010.11.047; Williams DS, 2009, AGING CELL, V8, P765, DOI 10.1111/j.1474-9726.2009.00527.x; Willis-Martinez D, 2010, EXP GERONTOL, V45, P279, DOI 10.1016/j.exger.2009.10.001; Zhou J, 2009, NUCLEIC ACIDS RES, V37, P3699, DOI 10.1093/nar/gkp233; Zu Y, 2010, CIRC RES, V106, P1384, DOI 10.1161/CIRCRESAHA.109.215483	66	108	112	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2011	146	6					968	978		10.1016/j.cell.2011.07.044	http://dx.doi.org/10.1016/j.cell.2011.07.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21906795	Bronze, Green Accepted			2022-12-28	WOS:000295258100018
J	Close, JCT; Lord, SR				Close, Jacqueline C. T.; Lord, Stephen R.			Clinical Review Fall assessment in older people	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RISK-ASSESSMENT TOOL; NURSING-HOME; CARE; PROBABILITY; PREDICTION; GO; PREVENTION; VALIDATION		[Close, Jacqueline C. T.] Univ New S Wales, Falls & Injury Prevent Grp, Sydney, NSW 2031, Australia; [Close, Jacqueline C. T.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW 2031, Australia; [Close, Jacqueline C. T.; Lord, Stephen R.] Univ New S Wales, Falls & Balance Res Grp, Sydney, NSW 2031, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Close, JCT (corresponding author), Univ New S Wales, Falls & Injury Prevent Grp, Sydney, NSW 2031, Australia.	j.close@neura.edu.au	Lord, Stephen R/C-9612-2011; Close, Jacqueline CT/C-9803-2011	Close, Jacqueline CT/0000-0003-2908-9507; Lord, Stephen R/0000-0002-7111-8802				*AUSTR COMM SAF QU, 2009, FALLS PREV GUID PREV; Close J, 1999, LANCET, V353, P93, DOI 10.1016/S0140-6736(98)06119-4; Close JCT, 2003, EMERG MED J, V20, P421, DOI 10.1136/emj.20.5.421; Delbaere K, 2008, MED J AUSTRALIA, V189, P193, DOI 10.5694/j.1326-5377.2008.tb01980.x; Gillespie L. D., 2012, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD007146; Gunter KB, 2000, J GERONTOL A-BIOL, V55, pM672, DOI 10.1093/gerona/55.11.M672; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Lord SR, 2003, PHYS THER, V83, P237, DOI 10.1093/ptj/83.3.237; Lord SR, 2003, J AM GERIATR SOC, V51, P1645, DOI 10.1046/j.1532-5415.2003.51518.x; Moseley AM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.cd002840.pub2; Nandy S, 2004, J PUBLIC HEALTH-UK, V26, P138, DOI 10.1093/pubmed/fdh132; National Institute for Health and Clinical Excellence, 2004, FALLS ASS PREV FALLS; Oliver D, 1997, BMJ-BRIT MED J, V315, P1049, DOI 10.1136/bmj.315.7115.1049; Papaioannou A, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-1; Rose DJ, 2002, J AGING PHYS ACTIV, V10, P466, DOI 10.1123/japa.10.4.466; Russell MA, 2008, AGE AGEING, V37, P634, DOI 10.1093/ageing/afn129; Salter AE, 2006, OSTEOPOROSIS INT, V17, P672, DOI 10.1007/s00198-005-0032-7; Sherrington C, 2010, J REHABIL MED, V42, P482, DOI 10.2340/16501977-0550; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; ShumwayCook A, 1997, PHYS THER, V77, P812, DOI 10.1093/ptj/77.8.812; Tiedemann A, 2008, AGE AGEING, V37, P430, DOI 10.1093/ageing/afn100; Tiedemann A, 2010, J GERONTOL A-BIOL, V65, P893, DOI 10.1093/gerona/glq067; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Whitney JC, 2005, AGE AGEING, V34, P567, DOI 10.1093/ageing/afi178	25	27	29	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2011	343								d5153	10.1136/bmj.d5153	http://dx.doi.org/10.1136/bmj.d5153			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822VM	21917828				2022-12-28	WOS:000295078100019
J	Barnes, KC				Barnes, Kathleen C.			Successfully mapping novel asthma loci by GWAS	LANCET			English	Editorial Material							GENOME-WIDE ASSOCIATION; HUMAN-DISEASE; ETIOLOGY; TRAITS		Johns Hopkins Univ, Dept Med, Baltimore, MD 21224 USA	Johns Hopkins University	Barnes, KC (corresponding author), Johns Hopkins Univ, Dept Med, Baltimore, MD 21224 USA.	kbarnes@jhmi.edu						Barnes Kathleen C, 2011, Proc Am Thorac Soc, V8, P143, DOI 10.1513/pats.201103-030MS; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; Corvol H, 2009, PHARMACOGENET GENOM, V19, P489, DOI 10.1097/FPC.0b013e32832c440e; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gorlov IP, 2011, CLIN GENET, V79, P199, DOI 10.1111/j.1399-0004.2010.01535.x; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Hindorff LA, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; O'Regan GM, 2010, J ALLERGY CLIN IMMUN, V125, P170, DOI 10.1016/j.jaci.2009.10.046; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888	16	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 10	2011	378	9795					967	968		10.1016/S0140-6736(11)61422-0	http://dx.doi.org/10.1016/S0140-6736(11)61422-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HO	21907849				2022-12-28	WOS:000295193200007
J	Stroes, ESG; van Wijk, DF				Stroes, Erik S. G.; van Wijk, Diederik F.			Dalcetrapib: turning the tide for CETP inhibition?	LANCET			English	Editorial Material							OFF-TARGET TOXICITY; HIGH-RISK; TORCETRAPIB; ATHEROSCLEROSIS; ALDOSTERONE; DISEASE; SAFETY		[Stroes, Erik S. G.; van Wijk, Diederik F.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Stroes, ESG (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.s.stroes@amc.uva.nl						Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Camont L, 2011, TRENDS MOL MED, V17, P594, DOI 10.1016/j.molmed.2011.05.013; Cannon CP, 2010, NEW ENGL J MED, V363, P2406, DOI 10.1056/NEJMoa1009744; Fayad ZA, 2011, LANCET, V378, P1547, DOI 10.1016/S0140-6736(11)61383-4; Hu X, 2009, ENDOCRINOLOGY, V150, P2211, DOI 10.1210/en.2008-1512; Kastelein JJP, 2007, NEW ENGL J MED, V356, P1620, DOI 10.1056/NEJMoa071359; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Rader DJ, 2007, NEW ENGL J MED, V357, P2180, DOI 10.1056/NEJMe0707210; Rudd JHF, 2009, ARTERIOSCL THROM VAS, V29, P1009, DOI 10.1161/ATVBAHA.108.165563; Sofat R, 2010, CIRCULATION, V121, P52, DOI 10.1161/CIRCULATIONAHA.109.865444; Stein EA, 2009, AM J CARDIOL, V104, P82, DOI 10.1016/j.amjcard.2009.02.061; Stroes ESG, 2009, BRIT J PHARMACOL, V158, P1763, DOI 10.1111/j.1476-5381.2009.00460.x; Vergeer M, 2008, CIRCULATION, V118, P2515, DOI 10.1161/CIRCULATIONAHA.108.772665	13	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 29	2011	378	9802					1529	1530		10.1016/S0140-6736(11)61421-9	http://dx.doi.org/10.1016/S0140-6736(11)61421-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844SL	21908039				2022-12-28	WOS:000296767500007
J	Kesselheim, AS; Murtagh, L; Mello, MM				Kesselheim, Aaron S.; Murtagh, Lindsey; Mello, Michelle M.			"Pay for Delay" Settlements of Disputes over Pharmaceutical Patents	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GENERIC DRUGS; COMPETITION; RIGHTS		[Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA; [Murtagh, Lindsey; Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Mello, Michelle/0000-0003-2877-4270				[Anonymous], 2010, OR BOOK APPR DRUG PR; Anton JJ, 2006, INNOV POLICY ECON, V6, P1; BELIAN D, 2010, GENERIC LINE, V27, P4; BELIAN D, 2010, GENERIC LINE, V27, P1; Bernard Kent S., 2005, FED CIRCUIT BAR J, V15, P617; Berndt ER, 2007, HEALTH AFFAIR, V26, P790, DOI 10.1377/hlthaff.26.3.790; Bhaven N.Sampat, 2011, EVERGREENING PATENT; Bigelow JP., 2004, ANTITRUST B, V49, P655, DOI 10.1177/0003603X0404900306; Carrier MA, 2009, MICH LAW REV, V108, P37; CRANE DA, 2002, FLA L REV, V54, P747; DICKEY B, 2010, PRELIMINARY EC ANAL; Engelberg A., 1999, IDEA, V39, P389; *FED TRAD COMM, 2002, GEN DRUG ENTR PRIOR; Federal Trade Commission, 2010, PAY FOR DEL DRUG CO; Federal Trade Commission, 2009, AUTH GEN INT REP AUTH GEN INT REP; *FTC, 2009, PAY FOR DEL SETTL MA; Haas JS, 2005, ANN INTERN MED, V142, P891, DOI 10.7326/0003-4819-142-11-200506070-00006; Hemphill CS, 2009, COLUMBIA LAW REV, V109, P629; Higgins MJ, 2009, SCIENCE, V326, P370, DOI 10.1126/science.1176116; HOVENKAMP H, 2005, ANTITRUST ENTERPRISE; Kesselheim AS, 2006, HEALTH AFFAIR, V25, P1637, DOI 10.1377/hlthaff.25.6.1637; PERITZ RJR, 2011, RES PAPER SERIES NEW, V1011; Roin BN, 2009, TEX LAW REV, V87, P503; ROSCH JT, 2010, REMARKS FTC COMMISSI; Shrank WH, 2006, ARCH INTERN MED, V166, P332, DOI 10.1001/archinte.166.3.332; Shuchman M, 2006, NEW ENGL J MED, V355, P1297, DOI 10.1056/NEJMp068193; STOLBERG SG, 2000, NY TIMES        0723; Voet Martin A., 2005, GENERIC CHALLENGE UN	28	17	17	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2011	365	15					1439	1445		10.1056/NEJMhle1102235	http://dx.doi.org/10.1056/NEJMhle1102235			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	832DQ	21916635				2022-12-28	WOS:000295782500014
J	Rao, SV; Kaltenbach, LA; Weintraub, WS; Roe, MT; Brindis, RG; Rumsfeld, JS; Peterson, ED				Rao, Sunil V.; Kaltenbach, Lisa A.; Weintraub, William S.; Roe, Matthew T.; Brindis, Ralph G.; Rumsfeld, John S.; Peterson, Eric D.			Prevalence and Outcomes of Same-Day Discharge After Elective Percutaneous Coronary Intervention Among Older Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SINGLE-CENTER EXPERIENCE; DAY HOME DISCHARGE; STENT IMPLANTATION; ANGIOPLASTY; OUTPATIENT; FEASIBILITY; SAFETY; STAY; TRENDS; BOLUS	Context Patients undergoing elective percutaneous coronary intervention (PCI) are generally observed overnight in the hospital. The association between same-day discharge of older patients and death or readmission is unclear. Objective To evaluate the prevalence and outcomes of same-day discharge among older patients undergoing elective PCI in the United States. Design, Setting, and Participants Multicenter cohort study. Data were from 107 018 patients 65 years or older undergoing elective PCI procedures at 903 sites participating in the CathPCI Registry between November 2004 and December 2008 and were linked with Medicare Part A claims. Patients were divided into 2 groups based on their length of stay after PCI: same-day discharge or overnight stay. Main Outcome Measures Death or rehospitalization occurring within 2 days and by 30 days after PCI. Results The prevalence of same-day discharge was 1.25% (95% CI, 1.19%-1.32%; n = 1339 patients) with significant variation across facilities. Patient characteristics were similar between the 2 groups, although same-day discharge patients underwent shorter procedures with less multivessel intervention. There were no significant differences in the rates of death or rehospitalization at 2 days (same-day discharge, 0.37% [95% CI, 0.16%-0.87%] vs overnight stay, 0.50% [95% CI, 0.46%-0.54%]; P = .51) or at 30 days (same-day discharge, 9.63% [95% CI, 8.17%-11.33%] vs overnight stay, 9.70% [95% CI, 9.52%-9.88%]; P = .94). Among patients with adverse outcomes, the median time to death or rehospitalization did not differ significantly between the groups (same-day discharge, 13 days [interquartile range, 7.0-21.0] vs overnight stay, 14 days [interquartile range, 7.0-21.0]; P = .96). After adjustment for patient and procedure characteristics, same-day discharge was not significantly associated with 30-day death or rehospitalization (adjusted odds ratio, 0.95 [95% CI, 0.78-1.16]). Conclusion Among selected low-risk Medicare patients undergoing elective PCI, same-day discharge is rarely implemented but is not associated with death or rehospitalization compared with overnight observation. JAMA. 2011;306(13):1461-1467	[Rao, Sunil V.; Kaltenbach, Lisa A.; Roe, Matthew T.; Peterson, Eric D.] Duke Clin Res Inst, Durham, NC 27705 USA; [Weintraub, William S.] Christiana Care Hosp, Newark, DE USA; [Brindis, Ralph G.] No Calif Kaiser Permanente, Oakland, CA USA; [Rumsfeld, John S.] Denver VA Med Ctr, Denver, CO USA	Duke University; Christiana Care Health System; Kaiser Permanente; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Rao, SV (corresponding author), Duke Clin Res Inst, 508 Fulton St 111A, Durham, NC 27705 USA.	sunil.rao@duke.edu	Peterson, Eric David/ABF-5033-2021		Terumo Medical; Medicines Company; AstraZeneca; Zoll; Ikaria; sanofi-aventis; Otsuka; Bristol-Myers Squibb; Abbott; Eli Lilly; Shionogi; Cardionet; Daiichi-Sankyo; Roche; Novartis; Merck-Schering Plough; American College of Cardiology; American Heart Association; GlaxoSmithKline; KAI Pharmaceuticals; Orexigen; Helsinn Pharmaceuticals; Regeneron; Schering Plough/Merck; Johnson Johnson; St Jude Inc; Bayer; Pfizer; American College of Cardiology Foundation National Cardiovascular Data Registry (NCDR)	Terumo Medical; Medicines Company; AstraZeneca(AstraZeneca); Zoll; Ikaria; sanofi-aventis(Sanofi-Aventis); Otsuka(Otsuka Pharmaceutical); Bristol-Myers Squibb(Bristol-Myers Squibb); Abbott(Abbott Laboratories); Eli Lilly(Eli Lilly); Shionogi; Cardionet; Daiichi-Sankyo(Daiichi Sankyo Company Limited); Roche(Roche Holding); Novartis(Novartis); Merck-Schering Plough(Merck & CompanySchering Plough Corporation); American College of Cardiology(General Electric); American Heart Association(American Heart Association); GlaxoSmithKline(GlaxoSmithKline); KAI Pharmaceuticals; Orexigen; Helsinn Pharmaceuticals; Regeneron(Regeneron); Schering Plough/Merck(Merck & CompanySchering Plough Corporation); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); St Jude Inc; Bayer(Bayer AG); Pfizer(Pfizer); American College of Cardiology Foundation National Cardiovascular Data Registry (NCDR)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Rao reported receiving consulting fees from Terumo Medical, The Medicines Company, AstraZeneca, and Zoll and research funding from Ikaria, sanofi-aventis, and Terumo Medical. Dr Weintraub reported receiving research grants from Otsuka, AstraZeneca, Bristol-Myers Squibb, sanofi-aventis, and Abbott; receiving consultant fees from Eli Lilly, Bristol-Myers Squibb, Shionogi, sanofi-aventis, Cardionet, and Daiichi-Sankyo; and providing expert testimony in cases involving Bayer and Pfizer. Dr Roe reported receiving research funding from Eli Lilly, Roche, Novartis, Merck-Schering Plough, Bristol-Myers Squibb, the American College of Cardiology, and the American Heart Association and consulting fees/honoraria from GlaxoSmithKline, KAI Pharmaceuticals, Novartis, Eli Lilly, Bristol-Myers Squibb, sanofi-aventis, Merck, Orexigen, Helsinn Pharmaceuticals, Regeneron, and AstraZeneca. Dr Rumsfeld reported being chief science officer for the National Cardiovascular Data Registry. Dr Peterson reported receiving research grants from Bristol-Myers Squibb, sanofi-aventis, Eli Lilly, Schering Plough/Merck, Johnson & Johnson, and St Jude Inc and consultant fees from Bayer and Pfizer. No other disclosures were reported.; This analysis was funded by the American College of Cardiology. This research was supported by the American College of Cardiology Foundation National Cardiovascular Data Registry (NCDR).	Banning AP, 2003, HEART, V89, P665, DOI 10.1136/heart.89.6.665; Bertrand OF, 2006, CIRCULATION, V114, P2636, DOI 10.1161/CIRCULATIONAHA.106.638627; Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9; Carere RG, 2000, AM HEART J, V139, P52, DOI 10.1016/S0002-8703(00)90308-9; Chambers CE, 2009, CATHETER CARDIO INTE, V73, P847, DOI 10.1002/ccd.22100; Dalby M, 2003, CATHETER CARDIO INTE, V60, P18, DOI 10.1002/ccd.10618; Gilchrist IC, 2002, CATHETER CARDIO INTE, V56, P10, DOI 10.1002/ccd.10093; Heyde GS, 2007, CIRCULATION, V115, P2299, DOI 10.1161/CIRCULATIONAHA.105.591495; Jabara R, 2008, AM HEART J, V156, P1141, DOI 10.1016/j.ahj.2008.07.018; Kiemeneij F, 1997, J AM COLL CARDIOL, V29, P323, DOI 10.1016/S0735-1097(96)00486-X; Koch KT, 2000, HEART, V83, P557, DOI 10.1136/heart.83.5.557; Kugelmass AD, 2006, AM J CARDIOL, V97, P322, DOI 10.1016/j.amjcard.2005.08.047; Lasevitch R, 2005, AM J CARDIOL, V96, P766, DOI 10.1016/j.amjcard.2005.04.058; Ormiston JA, 2002, CATHETER CARDIO INTE, V55, P289, DOI 10.1002/ccd.10125; Patel M, 2010, JACC-CARDIOVASC INTE, V3, P851, DOI 10.1016/j.jcin.2010.05.010; Popescu AM, 2010, JACC-CARDIOVASC INTE, V3, P1020, DOI 10.1016/j.jcin.2010.09.001; Rao SV, 2010, CIRC-CARDIOVASC INTE, V3, P80, DOI 10.1161/CIRCINTERVENTIONS.109.884478; Rinfret S, 2010, JACC-CARDIOVASC INTE, V3, P1011, DOI 10.1016/j.jcin.2010.07.011; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Singh M, 2007, CIRCULATION, V115, P2835, DOI 10.1161/CIRCULATIONAHA.106.632679; Slagboom T, 2001, CATHETER CARDIO INTE, V53, P204, DOI 10.1002/ccd.1149; Small A, 2007, CATHETER CARDIO INTE, V70, P907, DOI 10.1002/ccd.21277; Smith SC, 2001, J AM COLL CARDIOL, V37, P2215, DOI 10.1016/S0735-1097(01)01344-4; Wiper A, 2006, CATHETER CARDIO INTE, V68, P549, DOI 10.1002/ccd.20743; Ziakas AA, 2003, AM HEART J, V146, P699, DOI 10.1016/S0002-8703(03)00258-8	25	87	91	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 5	2011	306	13					1461	1467		10.1001/jama.2011.1409	http://dx.doi.org/10.1001/jama.2011.1409			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	828MZ	21972308				2022-12-28	WOS:000295506900025
J	Bruskotter, JT; Enzler, SA; Treves, A				Bruskotter, Jeremy T.; Enzler, Sherry A.; Treves, Adrian			Rescuing Wolves from Politics: Wildlife as a Public Trust Resource	SCIENCE			English	Editorial Material							NORTHERN ROCKY-MOUNTAINS; WOLF		[Bruskotter, Jeremy T.] Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA; [Enzler, Sherry A.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Enzler, Sherry A.] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA; [Treves, Adrian] Univ Wisconsin Madison, Nelson Inst Environm Studies, Madison, WI 53706 USA	University System of Ohio; Ohio State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison	Bruskotter, JT (corresponding author), Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA.	bruskotter.9@osu.edu	Treves, Adrian/P-3707-2018; Bruskotter, Jeremy T/B-3240-2012	Treves, Adrian/0000-0002-3052-4708; Bruskotter, Jeremy T/0000-0002-1782-7835				Babcock Hope M., 2009, SC L REV, V61, P393; Bergstrom BJ, 2009, BIOSCIENCE, V59, P991, DOI 10.1525/bio.2009.59.11.11; BLUMM MC, 2005, ENV L, V35, P673; Bruskotter JT, 2010, BIOSCIENCE, V60, P941, DOI 10.1525/bio.2010.60.11.10; Carroll C, 2006, BIOSCIENCE, V56, P25, DOI 10.1641/0006-3568(2006)056[0025:DRGASF]2.0.CO;2; Enzler Sherry A., 2011, WILLIAMMARY ENV LAW, V35, P413; Feldman James W., 2007, Human-Wildlife Conflicts, V1, P112; GEHRKE R, 2011, SALT LAKE TRIBU 0208; Houston M. J., 2010, Human Dimensions of Wildlife, V15, P389, DOI 10.1080/10871209.2010.507563; HUDSON B, 2009, COLUMBIA J ENV LAW, V34, P99; Jacobson CA, 2010, J WILDLIFE MANAGE, V74, P203, DOI 10.2193/2008-485; Mech D., 2003, WOLVES BEHAV ECOLOGY; MUSIKER DG, 1995, LAW REV, V16, P87; Redmond P, 2009, NAT RESOUR J, V49, P249; SAX JL, 1970, MICH LAW REV, V68, P473; Treves A, 2011, SOC NATUR RESOUR, V24, P984, DOI 10.1080/08941920.2011.559654; US Fish and Wildlife Service Montana Fish Wildlife and Parks Nez Perce Tribe National Park Service Blackfeet Nation Confederated Salish and Kootenai Tribes Wind River Tribes Washington Department of Wildlife Oregon Department of Wildlife Utah Department of Natural Resources USDA Wildlife Services, 2011, ROCK MOUNT WOLF REC; Wood Mary Christina, 2004, ENV L, V34, P605, DOI DOI 10.1111/J.1752-1688.2007.00038.X	18	32	32	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051					1828	1829		10.1126/science.1207803	http://dx.doi.org/10.1126/science.1207803			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	826PJ	21960614				2022-12-28	WOS:000295365800034
J	Neria, Y; Sullivan, GM				Neria, Yuval; Sullivan, Gregory M.			Understanding the Mental Health Effects of Indirect Exposure to Mass Trauma Through the Media	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSTTRAUMATIC-STRESS-DISORDER; TERRORIST ATTACKS; SEPTEMBER-11		[Neria, Yuval; Sullivan, Gregory M.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Neria, Yuval] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Neria, Yuval] New York State Psychiat Inst & Hosp, Div Clin Therapeut, New York, NY 10032 USA; [Sullivan, Gregory M.] New York State Psychiat Inst & Hosp, Div Mol Imaging & Neuropathol, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute; New York State Psychiatry Institute	Neria, Y (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Psychiat, 1051 Riverside Dr,Unit 69, New York, NY 10032 USA.	ny126@columbia.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072833] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH072833] Funding Source: Medline; PHS HHS [2R01-MHO72833] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Brackbill RM, 2009, JAMA-J AM MED ASSOC, V302, P502, DOI 10.1001/jama.2009.1121; Galea S, 2003, AM J EPIDEMIOL, V158, P514, DOI 10.1093/aje/kwg187; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Neria Y, 2006, GEN HOSP PSYCHIAT, V28, P213, DOI 10.1016/j.genhosppsych.2006.02.002; Neria Y, 2010, J TRAUMA STRESS, V23, P322, DOI 10.1002/jts.20522; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; Schlenger WE, 2002, JAMA-J AM MED ASSOC, V288, P581, DOI 10.1001/jama.288.5.581	10	102	104	3	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 28	2011	306	12					1374	1375		10.1001/jama.2011.1358	http://dx.doi.org/10.1001/jama.2011.1358			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	825FQ	21903818	Green Accepted			2022-12-28	WOS:000295257000028
J	Zhang, QC; Lambert, G; Liao, D; Kim, H; Robin, K; Tung, CK; Pourmand, N; Austin, RH				Zhang, Qiucen; Lambert, Guillaume; Liao, David; Kim, Hyunsung; Robin, Kristelle; Tung, Chih-kuan; Pourmand, Nader; Austin, Robert H.			Acceleration of Emergence of Bacterial Antibiotic Resistance in Connected Microenvironments	SCIENCE			English	Article							ESCHERICHIA-COLI; FLUOROQUINOLONE RESISTANCE; EVOLUTION; INFECTIONS; MUTATION	The emergence of bacterial antibiotic resistance is a growing problem, yet the variables that influence the rate of emergence of resistance are not well understood. In a microfluidic device designed to mimic naturally occurring bacterial niches, resistance of Escherichia coli to the antibiotic ciprofloxacin developed within 10 hours. Resistance emerged with as few as 100 bacteria in the initial inoculation. Whole-genome sequencing of the resistant organisms revealed that four functional single-nucleotide polymorphisms attained fixation. Knowledge about the rapid emergence of antibiotic resistance in the heterogeneous conditions within the mammalian body may be helpful in understanding the emergence of drug resistance during cancer chemotherapy.	[Zhang, Qiucen; Lambert, Guillaume; Austin, Robert H.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Liao, David] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Kim, Hyunsung; Pourmand, Nader] Univ Calif Santa Cruz, Santa Cruz Genome Sequencing Ctr, Santa Cruz, CA 95064 USA; [Robin, Kristelle; Austin, Robert H.] Hong Kong Univ Sci & Technol, Inst Adv Study, Kowloon, Hong Kong, Peoples R China; [Tung, Chih-kuan] Univ Pittsburgh, Dept Phys, Pittsburgh, PA 15260 USA	Princeton University; University of California System; University of California San Francisco; University of California System; University of California Santa Cruz; Hong Kong University of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Austin, RH (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	austin@princeton.edu	Bougot-Robin, Kristelle/J-9926-2012; Zhang, Qiucen/G-4130-2013	Lambert, Guillaume/0000-0003-4779-287X; Pourmand, Nader/0000-0003-0251-9060; Tung, Chih-kuan/0000-0002-0017-7880	NSF [NSF0750323]; National Cancer Institute [U54CA143803]; NATIONAL CANCER INSTITUTE [U54CA143803] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by NSF grant NSF0750323 and National Cancer Institute grant U54CA143803. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. We thank T. Cox, T. Hwa, N. Goldenfeld, J. Pedersen, S. J. Rahi, S. Rosenberg, and S. Vyawahare for useful discussions, and the referees for useful comments. The reference sequence for the E. coli strain K-12 was obtained from GenBank (accession no. NC000913.2). The sequence of the E. coli mutant strain was uploaded on the National Center for Biotechnology Information Sequence Read Archive (accession no. SRP007391.10).	Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Drlica K, 2003, CURR TOP MED CHEM, V3, P249, DOI 10.2174/1568026033452537; FATH MJ, 1993, MICROBIOL REV, V57, P995, DOI 10.1128/MMBR.57.4.995-1017.1993; Hermsen R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.248104; Keymer JE, 2008, P NATL ACAD SCI USA, V105, P20269, DOI 10.1073/pnas.0810792105; Klaus W, 2000, J BIOMOL NMR, V16, P357, DOI 10.1023/A:1008383508219; Lambert G, 2011, NAT REV CANCER, V11, P375, DOI 10.1038/nrc3039; Lautcnbach E, 2002, ARCH INTERN MED, V162, P2469, DOI 10.1001/archinte.162.21.2469; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lindgren PK, 2003, ANTIMICROB AGENTS CH, V47, P3222, DOI 10.1128/AAC.47.10.3222-3232.2003; May R., 2007, THEORETICAL ECOLOGY, V3rd; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Park S, 2003, SCIENCE, V301, P188, DOI 10.1126/science.1079805; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wright S, 1931, J AM STAT ASSOC, V26, P201, DOI 10.2307/2277618	23	350	354	5	302	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1764	1767		10.1126/science.1208747	http://dx.doi.org/10.1126/science.1208747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940899				2022-12-28	WOS:000295121500048
J	Alemozaffar, M; Regan, MM; Cooperberg, MR; Wei, JT; Michalski, JM; Sandler, HM; Hembroff, L; Sadetsky, N; Saigal, CS; Litwin, MS; Klein, E; Kibel, AS; Hamstra, DA; Pisters, LL; Kuban, DA; Kaplan, ID; Wood, DP; Ciezki, J; Dunn, RL; Carroll, PR; Sanda, MG				Alemozaffar, Mehrdad; Regan, Meredith M.; Cooperberg, Matthew R.; Wei, John T.; Michalski, Jeff M.; Sandler, Howard M.; Hembroff, Larry; Sadetsky, Natalia; Saigal, Christopher S.; Litwin, Mark S.; Klein, Eric; Kibel, Adam S.; Hamstra, Daniel A.; Pisters, Louis L.; Kuban, Deborah A.; Kaplan, Irving D.; Wood, David P.; Ciezki, Jay; Dunn, Rodney L.; Carroll, Peter R.; Sanda, Martin G.			Prediction of Erectile Function Following Treatment for Prostate Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; RADICAL RETROPUBIC PROSTATECTOMY; EXTERNAL-BEAM RADIOTHERAPY; SEXUAL FUNCTION; INDEX COMPOSITE; UNITED-STATES; OUTCOMES; SURVIVORS; THERAPY; URINARY	Context Sexual function is the health-related quality of life (HRQOL) domain most commonly impaired after prostate cancer treatment; however, validated tools to enable personalized prediction of erectile dysfunction after prostate cancer treatment are lacking. Objective To predict long-term erectile function following prostate cancer treatment based on individual patient and treatment characteristics. Design Pretreatment patient characteristics, sexual HRQOL, and treatment details measured in a longitudinal academic multicenter cohort (Prostate Cancer Outcomes and Satisfaction With Treatment Quality Assessment; enrolled from 2003 through 2006), were used to develop models predicting erectile function 2 years after treatment. A community-based cohort (community-based Cancer of the Prostate Strategic Urologic Research Endeavor [CaPSURE]; enrolled 1995 through 2007) externally validated model performance. Patients in US academic and community-based practices whose HRQOL was measured pretreatment (N=1201) underwent follow-up after prostatectomy, external radiotherapy, or brachytherapy for prostate cancer. Sexual outcomes among men completing 2 years' follow-up (n=1027) were used to develop models predicting erectile function that were externally validated among 1913 patients in a community-based cohort. Main Outcome Measures Patient-reported functional erections suitable for intercourse 2 years following prostate cancer treatment. Results Two years after prostate cancer treatment, 368 (37% [95% CI, 34%-40%]) of all patients and 335 (48% [95% CI, 45%-52%]) of those with functional erections prior to treatment reported functional erections; 531 (53% [95% CI, 50%-56%]) of patients without penile prostheses reported use of medications or other devices for erectile dysfunction. Pretreatment sexual HRQOL score, age, serum prostate-specific antigen level, race/ethnicity, body mass index, and intended treatment details were associated with functional erections 2 years after treatment. Multivariable logistic regression models predicting erectile function estimated 2-year function probabilities from as low as 10% or less to as high as 70% or greater depending on the individual's pretreatment patient characteristics and treatment details. The models performed well in predicting erections in external validation among CaPSURE cohort patients (areas under the receiver operating characteristic curve, 0.77 [95% CI, 0.74-0.80] for prostatectomy; 0.87 [95% CI, 0.80-0.94] for external radiotherapy; and 0.90 [95% CI, 0.85-0.95] for brachytherapy). Conclusion Stratification by pretreatment patient characteristics and treatment details enables prediction of erectile function 2 years after prostatectomy, external radiotherapy, or brachytherapy for prostate cancer. JAMA. 2011;306(11):1205-1214 www.jama.com	[Alemozaffar, Mehrdad; Sanda, Martin G.] Beth Israel Deaconess Med Ctr, Div Urol, Boston, MA 02215 USA; [Kaplan, Irving D.] Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; [Regan, Meredith M.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA USA; [Regan, Meredith M.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Cooperberg, Matthew R.; Sadetsky, Natalia; Carroll, Peter R.] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA; [Wei, John T.; Wood, David P.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA; [Hamstra, Daniel A.] Univ Michigan, Dept Radiat Oncol, Sch Med, Ann Arbor, MI 48109 USA; [Dunn, Rodney L.] Univ Michigan, Sch Med, Dept Biostat Core, Ann Arbor, MI USA; [Michalski, Jeff M.] Washington Univ, Dept Radiat Oncol, St Louis, MO USA; [Kibel, Adam S.] Washington Univ, Dept Surg, St Louis, MO USA; [Sandler, Howard M.] Cedars Sinai Med Ctr, Dept Radiat Oncol, Los Angeles, CA 90048 USA; [Hembroff, Larry] Michigan State Univ, Off Survey Res, Inst Publ Policy & Social Res, E Lansing, MI 48824 USA; [Saigal, Christopher S.; Litwin, Mark S.] UCLA Ctr Hlth Sci, Dept Urol, Los Angeles, CA USA; [Litwin, Mark S.] UCLA Ctr Hlth Sci, Dept Hlth Serv, Los Angeles, CA USA; [Klein, Eric] Cleveland Clin Hosp, Glickman Urol & Kidney Inst, Cleveland, OH USA; [Ciezki, Jay] Cleveland Clin Hosp, Dept Radiat Oncol, Cleveland, OH USA; [Pisters, Louis L.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Kuban, Deborah A.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Washington University (WUSTL); Washington University (WUSTL); Cedars Sinai Medical Center; Michigan State University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Sanda, MG (corresponding author), Beth Israel Deaconess Med Ctr, Div Urol, 330 Brookline Ave,Rabb 440, Boston, MA 02215 USA.	msanda@bidmc.harvard.edu	Cooperberg, Matthew R/G-6249-2017; Wei, John T/E-8967-2012; Sanda, Martin G/B-2023-2015; Sanda, Martin G/A-6202-2013	Cooperberg, Matthew R/0000-0003-4339-6685; Litwin, Mark/0000-0002-2318-344X	National Institutes of Health (NIH) [R01 CA 95662, 1RC1CA146596]; Takeda; Abbott; Amgen; sanofi-aventis; Dendreon; Radiation Oncology Institute; NATIONAL CANCER INSTITUTE [RC1CA146596, R01CA095662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [RC1EB011001] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takeda(Takeda Pharmaceutical Company Ltd); Abbott(Abbott Laboratories); Amgen(Amgen); sanofi-aventis(Sanofi-Aventis); Dendreon; Radiation Oncology Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. None of the coauthors have been compensated specifically for work related to this manuscript other than having received research support from the National Institutes of Health (NIH) to cover costs of conducting the study. Dr Cooperberg reported serving as a consultant for Denreon and Ortho-Centocor and receiving payment for lectures from Takeda, Abbott, and Amgen. Dr Wei reported serving as a consultant for Envisioneering Inc and sanofi-aventis; serving as an expert witness for Genprobe; serving as a proctor for American Medical Systems; and receiving research funding from sanofi-aventis. Dr Michaliski reported making donations to charity in lieu of honoraria for his role as a board member for Elekta Inc, Augmenix Inc, and Viewray. Dr Sandler reported serving as a consultant for Varian, Calypso Medical, Millennium-Takeda, and Centocor-Ortho Biotech. Dr Kibel reported serving as a consultant for Myraid, Caris, Dendreon, sanofi-aventis, Cougar, and Ferring; receiving payment for lectures from Dendreon; and holding stock in Myriad. Dr Kuban serving as a consultant for Ferring Pharmaceuticals and bioTheranostics and as a lecturer supported by the Radiation Oncology Institute. Dr Wood reported serving as a consultant for Intuitive Surgical and holding stock in that company. Dr Carroll reported receiving an institutional research grant from Abbott. Dr Sanda reported receiving a lecture honnorarium from Eli Lily. No other authors reported financial disclosures.; The study was supported by NIH grants R01 CA 95662 and 1RC1CA146596	Ahlering TE, 2008, UROLOGY, V72, P1263, DOI 10.1016/j.urology.2008.05.055; Ayyathurai R, 2008, BJU INT, V101, P833, DOI 10.1111/j.1464-410X.2007.07409.x; Bergman J, 2009, J UROLOGY, V182, P649, DOI 10.1016/j.juro.2009.04.001; Bolla M, 2009, NEW ENGL J MED, V360, P2516, DOI 10.1056/NEJMoa0810095; Briganti A, 2009, CANCER-AM CANCER SOC, V115, P3150, DOI 10.1002/cncr.24349; Chang P, 2011, J UROLOGY, V186, P865, DOI 10.1016/j.juro.2011.04.085; Chen RC, 2009, J CLIN ONCOL, V27, P3916, DOI 10.1200/JCO.2008.18.6486; Cooperberg MR, 2004, J UROLOGY, V171, P1393, DOI 10.1097/01.ju.0000107247.81471.06; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Ferrer M, 2008, INT J RADIAT ONCOL, V72, P421, DOI 10.1016/j.ijrobp.2007.12.024; Giberti C, 2009, WORLD J UROL, V27, P607, DOI 10.1007/s00345-009-0418-9; Gore JL, 2009, J NATL CANCER I, V101, P888, DOI 10.1093/jnci/djp114; Hoffman RM, 2003, CANCER, V97, P1653, DOI 10.1002/cncr.11233; Hollenbeck BK, 2003, J UROLOGY, V169, P1453, DOI 10.1097/01.ju.0000056737.40872.56; Hu JC, 2004, J UROLOGY, V171, P703, DOI 10.1097/01.ju.0000107964.61300.f6; Karakiewicz PI, 2008, J SEX MED, V5, P919, DOI 10.1111/j.1743-6109.2007.00741.x; Krupski TL, 2003, J UROLOGY, V170, P1291, DOI 10.1097/01.ju.0000085341.63407.46; Levinson AW, 2010, UROLOGY, V76, P380, DOI 10.1016/j.urology.2010.04.033; Litwin MS, 1998, MED CARE, V36, P1002, DOI 10.1097/00005650-199807000-00007; LITWIN MS, 1995, JAMA-J AM MED ASSOC, V273, P129, DOI 10.1001/jama.273.2.129; Lubeck DP, 1996, UROLOGY, V48, P773, DOI 10.1016/S0090-4295(96)00226-9; Madalinska JB, 2001, J CLIN ONCOL, V19, P1619, DOI 10.1200/JCO.2001.19.6.1619; Michl UHG, 2006, J UROLOGY, V176, P227, DOI 10.1016/S0022-5347(06)00632-X; Miller DC, 2006, JNCI-J NATL CANCER I, V98, P1134, DOI 10.1093/jnci/djj308; Miller DC, 2006, UROLOGY, V68, P166, DOI 10.1016/j.urology.2006.01.077; Nelson CJ, 2007, J SEX MED, V4, P1422, DOI 10.1111/j.1743-6109.2007.00547.x; Penson DF, 2005, J UROLOGY, V173, P1701, DOI 10.1097/01.ju.0000154637.38262.3a; Pinkawa M, 2008, INT J RADIAT ONCOL, V70, P83, DOI 10.1016/j.ijrobp.2007.05.051; Potosky AL, 2000, JNCI-J NATL CANCER I, V92, P1582, DOI 10.1093/jnci/92.19.1582; Prasad MM, 2010, J SEX MED, V7, P1062, DOI 10.1111/j.1743-6109.2009.01644.x; QUINLAN DM, 1991, J UROLOGY, V145, P998, DOI 10.1016/S0022-5347(17)38512-9; Rabbani F, 2000, J UROLOGY, V164, P1929, DOI 10.1016/S0022-5347(05)66921-2; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Schover LR, 2002, CANCER, V95, P2397, DOI 10.1002/cncr.10970; Schroeck FR, 2008, CANCER, V113, P2687, DOI 10.1002/cncr.23887; Smith DP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4817; Stanford JL, 2000, JAMA-J AM MED ASSOC, V283, P354, DOI 10.1001/jama.283.3.354; Szymanski KM, 2010, UROLOGY, V76, P1245, DOI 10.1016/j.urology.2010.01.027; Talcott JA, 2003, J CLIN ONCOL, V21, P3979, DOI 10.1200/JCO.2003.01.199; Wu AK, 2008, J UROLOGY, V180, P2415, DOI 10.1016/j.juro.2008.08.015	40	211	220	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2011	306	11					1205	1214		10.1001/jama.2011.1333	http://dx.doi.org/10.1001/jama.2011.1333			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HB	21934053	Green Accepted, Green Published			2022-12-28	WOS:000295033500021
J	Dong, GB; Teo, PL; Wickens, ZK; Grubbs, RH				Dong, Guangbin; Teo, Peili; Wickens, Zachary K.; Grubbs, Robert H.			Primary Alcohols from Terminal Olefins: Formal Anti-Markovnikov Hydration via Triple Relay Catalysis	SCIENCE			English	Article							WACKER REACTION; ALKENES; OXIDATION; ALKYNES; ALDEHYDES; WATER; REGIOSELECTIVITY; STYRENES; AMINES; BOND	Alcohol synthesis is critical to the chemical and pharmaceutical industries. The addition of water across olefins to form primary alcohols (anti-Markovnikov olefin hydration) would be a broadly useful reaction but has largely proven elusive; an indirect hydroboration/oxidation sequence requiring stoichiometric borane and oxidant is currently the most practical methodology. Here, we report a more direct approach with the use of a triple relay catalysis system that couples palladium-catalyzed oxidation, acid-catalyzed hydrolysis, and ruthenium-catalyzed reduction cycles. Aryl-substituted terminal olefins are converted to primary alcohols by net reaction with water in good yield and excellent regioselectivity.	[Dong, Guangbin; Teo, Peili; Wickens, Zachary K.; Grubbs, Robert H.] CALTECH, Div Chem & Chem Engn, Arnold & Mabel Beckman Labs Chem Synth, Pasadena, CA 91125 USA; [Teo, Peili] Inst Chem & Engn Sci, Singapore 627833, Singapore	California Institute of Technology; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Sustainability for Chemicals, Energy & Environment (ISCE2)	Grubbs, RH (corresponding author), King Fahd Univ Petr & Minerals, Dhahran 31261, Saudi Arabia.	rhg@caltech.edu	teo, peili/B-2786-2009; grubbs, robert h/D-4293-2009; Teo, Peili/GYA-3817-2022	grubbs, robert h/0000-0002-0057-7817; Teo, Peili/0000-0002-6944-5345; Wickens, Zachary/0000-0002-5733-5288	King Abdullah University of Science and Technology Center in Development; King Fahd University of Petroleum and Minerals; NSF; Camille and Henry Dreyfus Foundation; A*STAR (Agency for Science, Technology and Research)	King Abdullah University of Science and Technology Center in Development; King Fahd University of Petroleum and Minerals; NSF(National Science Foundation (NSF)); Camille and Henry Dreyfus Foundation; A*STAR (Agency for Science, Technology and Research)(Agency for Science Technology & Research (A*STAR))	We gratefully acknowledge financial support from the King Abdullah University of Science and Technology Center in Development, King Fahd University of Petroleum and Minerals, and the NSF. G. D. thanks the Camille and Henry Dreyfus Foundation for a postdoctoral fellowship. P. T. thanks A*STAR (Agency for Science, Technology and Research) for a postdoctoral fellowship (2009 to 2011). P. T. and Z.K.W. contributed equally to this paper. We also thank V. Lavallo and B. K. Keitz for proofreading the manuscript. A provisional patent was filed for work described in this Report.	Backvall JE, 2002, J ORGANOMET CHEM, V652, P105, DOI 10.1016/S0022-328X(02)01316-5; Beller M, 2004, ANGEW CHEM INT EDIT, V43, P3368, DOI 10.1002/anie.200300616; Boersma AJ, 2010, NAT CHEM, V2, P991, DOI [10.1038/nchem.819, 10.1038/NCHEM.819]; BROWN HC, 1975, J AM CHEM SOC, V97, P5249, DOI 10.1021/ja00851a038; BUDAVARI S, 1989, MERCK INDEX ENCY CHE, P7185; Campbell AN, 2010, J AM CHEM SOC, V132, P15116, DOI 10.1021/ja105829t; Eilbracht P, 1999, CHEM REV, V99, P3329, DOI 10.1021/cr970413r; FERINGA BL, 1986, J CHEM SOC CHEM COMM, P909, DOI 10.1039/c39860000909; HAGGIN J, 1993, CHEM ENG NEWS, V71, P23, DOI 10.1021/cen-v071n022.p023; Hintermann L, 2010, TOP ORGANOMETAL CHEM, V31, P123, DOI 10.1007/978-3-642-12073-2_6; Itami K, 1998, J ORG CHEM, V63, P6466, DOI 10.1021/jo980561x; JENSEN CM, 1986, SCIENCE, V233, P1069, DOI 10.1126/science.233.4768.1069; Kim S, 2009, ADV SYNTH CATAL, V351, P2573, DOI 10.1002/adsc.200900347; Koch HF, 1999, POLYHEDRON, V18, P2275, DOI 10.1016/S0277-5387(99)00122-9; KRESGE AJ, 1987, ACCOUNTS CHEM RES, V20, P364, DOI 10.1021/ar00142a002; Krische MJ, 2007, ACCOUNTS CHEM RES, V40, P1237, DOI 10.1021/ar700250e; Muller TE, 2008, CHEM REV, V108, P3795, DOI 10.1021/cr0306788; Muzart J, 2007, TETRAHEDRON, V63, P7505, DOI 10.1016/j.tet.2007.04.001; Ogura T, 2005, B CHEM SOC JPN, V78, P1555, DOI 10.1246/bcsj.78.1555; RAMPRASAD D, 1988, INORG CHEM, V27, P3151, DOI 10.1021/ic00291a021; SCHUBERT WM, 1972, J AM CHEM SOC, V94, P559, DOI 10.1021/ja00757a039; SHVO Y, 1986, J ORGANOMET CHEM, V315, pC25, DOI 10.1016/0022-328X(86)80425-9; Smith M.B., 2007, ADV ORGANIC CHEM REA, V6th ed, DOI 10.1002/9780470084960.ch15; Stewart IC, 2003, J AM CHEM SOC, V125, P8696, DOI 10.1021/ja035232n; Takacs JM, 2003, CURR ORG CHEM, V7, P369, DOI 10.2174/1385272033372851; Takahashi K, 2010, ANGEW CHEM INT EDIT, V49, P4488, DOI 10.1002/anie.201001327; Vora HU, 2007, J AM CHEM SOC, V129, P13796, DOI 10.1021/ja0764052; Weissermel K., 2003, IND ORGANIC CHEM, V4th; WENZEL TT, 1993, J CHEM SOC CHEM COMM, P862, DOI 10.1039/c39930000862; Wiseman P, 1979, INTRO IND ORGANIC CH; Wright JA, 2006, CHEM-EUR J, V12, P949, DOI 10.1002/chem.200400644; YANG TK, 2009, ENCY REAGENTS ORGANI, P544	32	150	154	6	256	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1609	1612		10.1126/science.1208685	http://dx.doi.org/10.1126/science.1208685			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921194				2022-12-28	WOS:000294900900037
J	Weder, W; Russi, EW				Weder, Walter; Russi, Erich W.			Lung-volume reduction by airway bypass	LANCET			English	Editorial Material							PULMONARY-EMPHYSEMA; SURGERY; TRIAL; COPD		[Weder, Walter] Univ Zurich Hosp, Div Thorac Surg, CH-8091 Zurich, Switzerland; [Russi, Erich W.] Univ Zurich Hosp, Div Pulm Med, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Weder, W (corresponding author), Univ Zurich Hosp, Div Thorac Surg, CH-8091 Zurich, Switzerland.	walter.weder@usz.ch	Russi, Erich/AGN-8387-2022					Bingisser R, 1996, J THORAC CARDIOV SUR, V112, P875, DOI 10.1016/S0022-5223(96)70086-7; BRANTIGAN OC, 1959, AM REV RESPIR DIS, V80, P194; Choong CK, 2008, AM J RESP CRIT CARE, V178, P902, DOI 10.1164/rccm.200712-1832OC; COOPER JD, 1995, J THORAC CARDIOV SUR, V109, P106, DOI 10.1016/S0022-5223(95)70426-4; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Ingenito EP, 2003, AM J RESP CRIT CARE, V167, P771, DOI 10.1164/rccm.200208-842OC; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Pompeo E, 2000, ANN THORAC SURG, V70, P948, DOI 10.1016/S0003-4975(00)01646-5; Shah PL, 2011, LANCET, V378, P997, DOI 10.1016/S0140-6736(11)61050-7; Wan IYP, 2006, CHEST, V129, P518, DOI 10.1378/chest.129.3.518; Weder W, 2009, ANN THORAC SURG, V87, P229, DOI 10.1016/j.athoracsur.2008.10.012; Wouters EFM, 2004, LANCET, V364, P883, DOI 10.1016/S0140-6736(04)16984-5	12	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 10	2011	378	9795					966	967		10.1016/S0140-6736(11)61394-9	http://dx.doi.org/10.1016/S0140-6736(11)61394-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HO	21907848				2022-12-28	WOS:000295193200006
J	Fayad, ZA; Mani, V; Woodward, M; Kallend, D; Abt, M; Burgess, T; Fuster, V; Ballantyne, CM; Stein, EA; Tardif, JC; Rudd, JHF; Farkouh, ME; Tawakol, A				Fayad, Zahi A.; Mani, Venkatesh; Woodward, Mark; Kallend, David; Abt, Markus; Burgess, Tracy; Fuster, Valentin; Ballantyne, Christie M.; Stein, Evan A.; Tardif, Jean-Claude; Rudd, James H. F.; Farkouh, Michael E.; Tawakol, Ahmed		Dal-PLAQUE Investigators	Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial	LANCET			English	Article							ESTER TRANSFER PROTEIN; HIGH-DENSITY-LIPOPROTEIN; POSITRON-EMISSION-TOMOGRAPHY; CORONARY-HEART-DISEASE; RAPID EXTENDED COVERAGE; CARDIOVASCULAR EVENTS; CHOLESTEROL LEVELS; HIGH-RESOLUTION; STATIN THERAPY; BLOOD-PRESSURE	Background Dalcetrapib modulates cholesteryl ester transfer protein (CETP) activity to raise high-density lipoprotein cholesterol (HDL-C). After the failure of torcetrapib it was unknown if HDL produced by interaction with CETP had pro-atherogenic or pro-inflammatory properties. dal-PLAQUE is the first multicentre study using novel non-invasive multimodality imaging to assess structural and inflammatory indices of atherosclerosis as primary endpoints. Methods In this phase 2b, double-blind, multicentre trial, patients (aged 18-75 years) with, or with high risk of, coronary heart disease were randomly assigned (1:1) to dalcetrapib 600 mg/day or placebo for 24 months. Randomisation was done with a computer-generated randomisation code and was stratified by centre. Patients and investigators were masked to treatment. Coprimary endpoints were MRI-assessed indices (total vessel area, wall area, wall thickness, and normalised wall index [average carotid]) after 24 months and F-18-fluorodeoxyglucose (F-18-FDG) PET/CT assessment of arterial inflammation within an index vessel (right carotid, left carotid, or ascending thoracic aorta) after 6 months, with no-harm boundaries established before unblinding of the trial. Analysis was by intention to treat. This trial is registered at ClinicalTrials.gov, NCT00655473. Findings 189 patients were screened and 130 randomly assigned to placebo (66 patients) or dalcetrapib (64 patients). For the coprimary MRI and PET/CT endpoints, CIs were below the no-harm boundary or the adverse change was numerically lower in the dalcetrapib group than in the placebo group. MRI-derived change in total vessel area was reduced in patients given dalcetrapib compared with those given placebo after 24 months; absolute change from baseline relative to placebo was -4.01 mm(2) (90% CI -7.23 to -0.80; nominal p=0.04). The PET/CT measure of index vessel most-diseased-segment target-to-background ratio (TBR) was not different between groups, but carotid artery analysis showed a 7% reduction in most-diseased-segment TBR in the dalcetrapib group compared with the placebo group (-7.3 [90% CI -13.5 to -0.8]; nominal p=0.07). Dalcetrapib did not increase office blood pressure and the frequency of adverse events was similar between groups. Interpretation Dalcetrapib showed no evidence of a pathological effect related to the arterial wall over 24 months. Moreover, this trial suggests possible beneficial vascular effects of dalcetrapib, including the reduction in total vessel enlargement over 24 months, but long-term safety and clinical outcomes efficacy of dalcetrapib need to be analysed.	[Fayad, Zahi A.; Mani, Venkatesh] Mt Sinai Sch Med, Dept Radiol, Translat & Mol Imaging Inst, 1 Gustave L Levy Pl,Box 1234, New York, NY 10029 USA; [Fayad, Zahi A.; Fuster, Valentin; Farkouh, Michael E.] Mt Sinai Sch Med, Cardiovasc Inst, New York, NY 10029 USA; [Woodward, Mark] Univ Sydney, George Inst, Sydney, NSW 2006, Australia; [Kallend, David] F Hoffmann La Roche Ltd, Basel, Switzerland; [Burgess, Tracy] Hoffmann La Roche Inc, Nutley, NJ 07110 USA; [Fuster, Valentin] CNIC, Madrid, Spain; [Ballantyne, Christie M.] Baylor Coll Med, Methodist DeBakey Heart & Vasc Ctr, Houston, TX 77030 USA; [Stein, Evan A.] Metab & Atherosclerosis Res Ctr, Cincinnati, OH USA; [Tardif, Jean-Claude] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Rudd, James H. F.] Univ Cambridge, Div Cardiovasc Med, Cambridge, England; [Farkouh, Michael E.] Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Farkouh, Michael E.] Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Tawakol, Ahmed] Harvard Univ, Sch Med, Boston, MA USA; [Tawakol, Ahmed] Massachusetts Gen Hosp, Boston, MA 02114 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Sydney; Roche Holding; Roche Holding; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Universite de Montreal; University of Cambridge; University of Toronto; Peter Munk Cardiac Centre; University of Toronto; Li Ka Shing Knowledge Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Fayad, ZA (corresponding author), Mt Sinai Sch Med, Dept Radiol, Translat & Mol Imaging Inst, 1 Gustave L Levy Pl,Box 1234, New York, NY 10029 USA.	zahi.fayad@mssm.edu	Woodward, Mark/L-6817-2017; Fuster, Valentin/H-4319-2015; Ballantyne, Christie/A-6599-2008; Fayad, Zahi/Z-3272-2019; Mani, Venkatesh/B-8939-2011; Woodward, Mark/D-8492-2015	Fuster, Valentin/0000-0002-9043-9986; Fayad, Zahi/0000-0002-3439-7347; Mani, Venkatesh/0000-0002-0432-2918; Rudd, James/0000-0003-2243-3117; Woodward, Mark/0000-0001-9800-5296; Ballantyne, Christie/0000-0002-6432-1730	F Hoffmann-La Roche Ltd.; Roche; GlaxoSmithKline; Merck; VBL Therapeutics; Novartis; Bristol-Myers Squibb; Via Pharmaceuticals; Abbott; AstraZeneca; diaDexus; Kowa; Sanofi-Synthelabo; Takeda; National Institutes of Health; American Diabetes Association; American Heart Association; Amarin; F Hoffmann-La Roche Inc; Sanofi-Aventis; Schering-Plough; National Institute for Health Research Cambridge Biomedical Research Centre; BMS; Genentech; VBL; Academy of Medical Sciences (AMS) [AMS-SGCL1-Rudd] Funding Source: researchfish; British Heart Foundation [PG/09/083/27667] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071021, R01HL092989] Funding Source: NIH RePORTER	F Hoffmann-La Roche Ltd.(Hoffmann-La Roche); Roche(Roche Holding); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); VBL Therapeutics; Novartis(Novartis); Bristol-Myers Squibb(Bristol-Myers Squibb); Via Pharmaceuticals; Abbott(Abbott Laboratories); AstraZeneca(AstraZeneca); diaDexus; Kowa; Sanofi-Synthelabo; Takeda(Takeda Pharmaceutical Company Ltd); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); Amarin; F Hoffmann-La Roche Inc(Hoffmann-La Roche); Sanofi-Aventis(Sanofi-Aventis); Schering-Plough(Merck & CompanySchering Plough Corporation); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); BMS(Bristol-Myers Squibb); Genentech(Roche HoldingGenentech); VBL; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	F Hoffmann-La Roche Ltd.r ZAF has received research grants from Roche, GlaxoSmithKline, Merck, VBL Therapeutics, Novartis, Bristol-Myers Squibb, and Via Pharmaceuticals, and honoraria from Roche. MW has received honoraria from Roche. DK and MA are employees of F Hoffmann-La Roche Ltd and receive share options. TB is an employee of F Hoffmann-La Roche Inc. CMB has received grant or research support (paid to institution, not individual) from Abbott, AstraZeneca, Bristol-Myers Squibb, diaDexus, GlaxoSmithKline, Kowa, Merck, Novartis, Roche, Sanofi-Synthelabo, Takeda, National Institutes of Health, American Diabetes Association, and American Heart Association; is a consultant for Abbott, Adnexus, Amylin, AstraZeneca, Bristol-Myers Squibb, Esperion, Genentech, GlaxoSmithKline, Idera Pharma, Kowa, Merck, Novartis, Omthera, Resverlogix, Roche, Sanofi-Synthelabo, and Takeda; serves on the speaker's bureau of Abbott, AstraZeneca, GlaxoSmithKline, and Merck; and has received honoraria from Abbott, AstraZeneca, GlaxoSmithKline, Merck, Sanofi-Synthelabo, and Takeda. EAS has received grant support (paid to institution, not individual) from AstraZeneca, Abbott, GlaxoSmithKline, Amarin, F Hoffmann-La Roche Inc, Sanofi-Aventis, Schering-Plough; serves on the speakers' bureau of AstraZeneca; is a consultant or served on advisory board for F Hoffmann-La Roche Inc, Sanofi-Aventis, and Schering-Plough. J-CT has received research grants and honoraria from Roche. JHFR has received honoraria from Roche and is part-supported by the National Institute for Health Research Cambridge Biomedical Research Centre. MEF has received honoraria from Roche. AT has received honoraria from Roche, BMS, and Novartis; and research grants from Merck, BMS, Genentech, GlaxoSmithKline, and VBL. VM and VF declare that they have no conflicts of interest.	Arsenault Benoit J, 2011, J Am Coll Cardiol, V57, P63, DOI 10.1016/j.jacc.2010.06.052; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2006, J AM COLL CARDIOL, V47, P492, DOI 10.1016/j.jacc.2005.09.042; Boden WE, 2000, AM J CARDIOL, V86, p19L; Boekholdt SM, 2005, CIRCULATION, V111, P278, DOI 10.1161/01.CIR.0000153341.46271.40; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Chapman MJ, 2010, EUR HEART J, V31, P149, DOI 10.1093/eurheartj/ehp399; Corsetti JP, 2010, ARTERIOSCL THROM VAS, V30, P1657, DOI 10.1161/ATVBAHA.110.207977; Corti R, 2001, CIRCULATION, V104, P249, DOI 10.1161/01.CIR.104.3.249; Corti R, 2002, CIRCULATION, V106, P2884, DOI 10.1161/01.CIR.0000041255.88750.F0; Curb JD, 2004, J LIPID RES, V45, P948, DOI 10.1194/jlr.M300520-JLR200; Duivenvoorden R, 2009, CIRC-CARDIOVASC IMAG, V2, P235, DOI 10.1161/CIRCIMAGING.108.788059; El Aidi H, 2009, NAT CLIN PRACT CARD, V6, P219, DOI 10.1038/ncpcardio1444; Fayad ZA, 2011, AM HEART J, V162, P214, DOI 10.1016/j.ahj.2011.05.006; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hayashi K, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-10; HIRANO K, 1995, ARTERIOSCL THROM VAS, V15, P1849, DOI 10.1161/01.ATV.15.11.1849; Jafri H, 2010, ANN INTERN MED, V153, P800, DOI 10.7326/0003-4819-153-12-201012210-00006; Johnsen SH, 2005, CIRCULATION, V112, P498, DOI 10.1161/CIRCULATIONAHA.104.522706; Kastelein JJP, 2011, CURR MED RES OPIN, V27, P141, DOI 10.1185/03007995.2010.536207; Lee SJ, 2008, J NUCL MED, V49, P1277, DOI 10.2967/jnumed.108.052233; Mani V, 2004, RADIOLOGY, V232, P281, DOI 10.1148/radiol.2321031022; Mani V, 2005, J MAGN RESON IMAGING, V22, P628, DOI 10.1002/jmri.20428; Mani V, 2006, J CARDIOVASC MAGN R, V8, P529, DOI 10.1080/10976640600675245; Mani V, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-10; Martin-Ventura JL, 2005, STROKE, V36, P1796, DOI 10.1161/01.STR.0000174289.34110.b0; Naghavi M, 2006, AM J CARDIOL, V98, p2H, DOI 10.1016/j.amjcard.2006.03.002; Niesor EJ, 2010, J LIPID RES, V51, P3443, DOI 10.1194/jlr.M008706; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Okamoto H, 2000, NATURE, V406, P203, DOI 10.1038/35018119; Pasterkamp G, 1997, ARTERIOSCL THROM VAS, V17, P3057, DOI 10.1161/01.ATV.17.11.3057; Paulmier B, 2008, J NUCL CARDIOL, V15, P209, DOI 10.1016/j.nuclcard.2007.10.009; PEDERSEN TR, 1994, LANCET, V344, P1383; Rader DJ, 2007, NEW ENGL J MED, V357, P2180, DOI 10.1056/NEJMe0707210; Robinson JG, 2010, EXPERT OPIN INV DRUG, V19, P795, DOI 10.1517/13543784.2010.488219; Rudd JHF, 2008, J NUCL MED, V49, P871, DOI 10.2967/jnumed.107.050294; Rudd JHF, 2007, J AM COLL CARDIOL, V50, P892, DOI 10.1016/j.jacc.2007.05.024; Rudd JHF, 2010, J AM COLL CARDIOL, V55, P2527, DOI 10.1016/j.jacc.2009.12.061; Rudd JHF, 2009, CIRC-CARDIOVASC IMAG, V2, P107, DOI 10.1161/CIRCIMAGING.108.811752; Rudd JHF, 2002, CIRCULATION, V105, P2708, DOI 10.1161/01.CIR.0000020548.60110.76; Rye KA, 2009, J LIPID RES, V50, pS195, DOI 10.1194/jlr.R800034-JLR200; Schoenhagen P, 2000, CIRCULATION, V101, P598, DOI 10.1161/01.CIR.101.6.598; Schwartz GG, 2009, AM HEART J, V158, P896, DOI 10.1016/j.ahj.2009.09.017; Shah PK, 2010, J AM COLL CARDIOL, V56, P98, DOI 10.1016/j.jacc.2009.09.081; Stein EA, 2010, EUR HEART J, V31, P480, DOI 10.1093/eurheartj/ehp601; Stein EA, 2009, AM J CARDIOL, V104, P82, DOI 10.1016/j.amjcard.2009.02.061; Stroes ESG, 2009, BRIT J PHARMACOL, V158, P1763, DOI 10.1111/j.1476-5381.2009.00460.x; Tahara N, 2007, J AM COLL CARDIOL, V49, P1533, DOI 10.1016/j.jacc.2006.11.046; Tahara N, 2006, J AM COLL CARDIOL, V48, P1825, DOI 10.1016/j.jacc.2006.03.069; Tardif JC, 2004, CIRCULATION, V110, P3372, DOI 10.1161/01.CIR.0000147777.12010.EF; Tardif JC, 2011, CIRC-CARDIOVASC IMAG, V4, P319, DOI 10.1161/CIRCIMAGING.110.962001; Tawakol A, 2006, J AM COLL CARDIOL, V48, P1818, DOI 10.1016/j.jacc.2006.05.076; Tellis CC, 2009, BBA-MOL CELL BIOL L, V1791, P327, DOI 10.1016/j.bbalip.2009.02.015; Underhill HR, 2008, AM HEART J, V155, DOI 10.1016/j.ahj.2007.11.018; Vasan RS, 2009, CIRCULATION, V120, P2414, DOI 10.1161/CIRCULATIONAHA.109.872705; Wei L, 2006, HEART, V92, P746, DOI 10.1136/hrt.2005.068411; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751	64	407	411	0	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 29	2011	378	9802					1547	1559		10.1016/S0140-6736(11)61383-4	http://dx.doi.org/10.1016/S0140-6736(11)61383-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844SL	21908036	Green Accepted			2022-12-28	WOS:000296767500020
J	Bollasina, MA; Ming, Y; Ramaswamy, V				Bollasina, Massimo A.; Ming, Yi; Ramaswamy, V.			Anthropogenic Aerosols and the Weakening of the South Asian Summer Monsoon	SCIENCE			English	Article							HYDROLOGICAL CYCLE; CLIMATE; RESPONSES; RAINFALL; TREND; INDIA	Observations show that South Asia underwent a widespread summertime drying during the second half of the 20th century, but it is unclear whether this trend was due to natural variations or human activities. We used a series of climate model experiments to investigate the South Asian monsoon response to natural and anthropogenic forcings. We find that the observed precipitation decrease can be attributed mainly to human-influenced aerosol emissions. The drying is a robust outcome of a slowdown of the tropical meridional overturning circulation, which compensates for the aerosol-induced energy imbalance between the Northern and Southern Hemispheres. These results provide compelling evidence of the prominent role of aerosols in shaping regional climate change over South Asia.	[Ming, Yi; Ramaswamy, V.] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA; [Bollasina, Massimo A.] Princeton Univ, Program Atmospher & Ocean Sci, Princeton, NJ 08542 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University	Ming, Y (corresponding author), NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA.	Yi.Ming@noaa.gov	Ramaswamy, Venkatachalam/AAJ-6265-2021; Ming, Yi/F-3023-2012	Ramaswamy, Venkatachalam/0000-0002-1984-6423; Bollasina, Massimo/0000-0001-7509-7650				Allan R, 2006, J CLIMATE, V19, P5816, DOI 10.1175/JCLI3937.1; Chen CT, 1996, J CLIMATE, V9, P2788, DOI 10.1175/1520-0442(1996)009<2788:SOSGCT>2.0.CO;2; Chen MY, 2002, J HYDROMETEOROL, V3, P249, DOI 10.1175/1525-7541(2002)003<0249:GLPAYM>2.0.CO;2; Chung CE, 2006, J CLIMATE, V19, P2036, DOI 10.1175/JCLI3820.1; Donner LJ, 2011, J CLIMATE, V24, P3484, DOI 10.1175/2011JCLI3955.1; Gadgil S, 2006, ASIAN MONSOON, P651; Goswami BN, 2006, SCIENCE, V314, P1442, DOI 10.1126/science.1132027; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Lau KM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027546; Lau WKM, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043255; Meehl GA, 2008, J CLIMATE, V21, P2869, DOI 10.1175/2007JCLI1777.1; Ming Y, 2011, J CLIMATE, V24, P5125, DOI 10.1175/2011JCLI4108.1; Ming Y, 2009, J CLIMATE, V22, P1329, DOI [10.1175/2008JCLI2362.1, 10.1175/2008JCL12362.1]; Mitchell JFB, 1997, J CLIMATE, V10, P245, DOI 10.1175/1520-0442(1997)010&lt;0245:OMOGWB&gt;2.0.CO;2; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Peiqun Z., 2005, ADV ATMOS SCI, V22, P915; Rajeevan M, 2006, CURR SCI INDIA, V91, P296; Ramanathan V, 2005, P NATL ACAD SCI USA, V102, P5326, DOI 10.1073/pnas.0500656102; Seager R, 2010, J CLIMATE, V23, P4651, DOI 10.1175/2010JCLI3655.1; Trenberth K.E., 2005, S-P BKS ENVIRONM SCI, P67, DOI 10.1007/3-540-37722-0_2; Ueda H, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025336; Vecchi GA, 2006, NATURE, V441, P73, DOI 10.1038/nature04744; Vecchi GA, 2007, J CLIMATE, V20, P4316, DOI 10.1175/JCLI4258.1; Wang B, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025347; Wang C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040114; Webster PJ, 1998, J GEOPHYS RES-OCEANS, V103, P14451, DOI 10.1029/97JC02719; WOODWARD WA, 1993, J CLIMATE, V6, P953, DOI 10.1175/1520-0442(1993)006&lt;0953:GWATPO&gt;2.0.CO;2; Zhang LX, 2011, CLIM DYNAM, V37, P279, DOI 10.1007/s00382-011-0993-5; Zhang MH, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025942	29	713	730	10	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2011	334	6055					502	505		10.1126/science.1204994	http://dx.doi.org/10.1126/science.1204994			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	21960529	Green Accepted			2022-12-28	WOS:000296230500044
J	Sanai, N; Nguyen, T; Ihrie, RA; Mirzadeh, Z; Tsai, HH; Wong, M; Gupta, N; Berger, MS; Huang, E; Garcia-Verdugo, JM; Rowitch, DH; Alvarez-Buylla, A				Sanai, Nader; Thuhien Nguyen; Ihrie, Rebecca A.; Mirzadeh, Zaman; Tsai, Hui-Hsin; Wong, Michael; Gupta, Nalin; Berger, Mitchel S.; Huang, Eric; Garcia-Verdugo, Jose-Manuel; Rowitch, David H.; Alvarez-Buylla, Arturo			Corridors of migrating neurons in the human brain and their decline during infancy	NATURE			English	Article							NEURAL STEM-CELLS; VENTROMEDIAL PREFRONTAL CORTEX; SUBVENTRICULAR ZONE; OLFACTORY-BULB; ADULT NEUROGENESIS; LATERAL VENTRICLE; PLASTICITY; FOREBRAIN; NEUROBLASTS; EPENDYMA	The subventricular zone of many adult non-human mammals generates large numbers of new neurons destined for the olfactory bulb(1-6). Along the walls of the lateral ventricles, immature neuronal progeny migrate in tangentially oriented chains that coalesce into a rostral migratory stream (RMS) connecting the subventricular zone to the olfactory bulb. The adult human subventricular zone, in contrast, contains a hypocellular gap layer separating the ependymal lining from a periventricular ribbon of astrocytes(7). Some of these subventricular zone astrocytes can function as neural stem cells in vitro, but their function in vivo remains controversial. An initial report found few subventricular zone proliferating cells and rare migrating immature neurons in the RMS of adult humans(7). In contrast, a subsequent study indicated robust proliferation and migration in the human subventricular zone and RMS8,9. Here we find that the infant human subventricular zone and RMS contain an extensive corridor of migrating immature neurons before 18 months of age but, contrary to previous reports(8), this germinal activity subsides in older children and is nearly extinct by adulthood. Surprisingly, during this limited window of neurogenesis, not all new neurons in the human subventricular zone are destined for the olfactory bulb-we describe a major migratory pathway that targets the prefrontal cortex in humans. Together, these findings reveal robust streams of tangentially migrating immature neurons in human early postnatal subventricular zone and cortex. These pathways represent potential targets of neurological injuries affecting neonates.	[Sanai, Nader; Thuhien Nguyen; Ihrie, Rebecca A.; Mirzadeh, Zaman; Tsai, Hui-Hsin; Wong, Michael; Rowitch, David H.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Eli & Edythe Broad Inst Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Sanai, Nader; Thuhien Nguyen; Ihrie, Rebecca A.; Mirzadeh, Zaman; Tsai, Hui-Hsin; Wong, Michael; Rowitch, David H.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Sanai, Nader; Gupta, Nalin; Berger, Mitchel S.; Rowitch, David H.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Sanai, Nader; Mirzadeh, Zaman] Barrow Neurol Inst, Barrow Brain Tumor Res Ctr, Phoenix, AZ 85013 USA; [Huang, Eric] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Garcia-Verdugo, Jose-Manuel] CIBERNED, Unidad Mixta CIPF UVEG, Lab Morfol Celular, Valencia 46012, Spain; [Rowitch, David H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Barrow Neurological Institute; University of California System; University of California San Francisco; CIBERNED; Prince Felipe Research Center; University of California System; University of California San Francisco	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Inst Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	rowitchd@peds.ucsf.edu; abuylla@stemcell.ucsf.edu	Huang, Eric J./AAH-7997-2019; García-Verdugo, José Manuel/L-8421-2017	Huang, Eric J./0000-0002-5381-3801; García-Verdugo, José Manuel/0000-0001-9872-6499; Rowitch, David/0000-0002-0079-0060; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Ihrie, Rebecca/0000-0003-0439-0141	NIH [NS 058180]; Damon Runyon Cancer Research Foundation [DRG1935-07]; American Association for Cancer Research/National Brain Tumor Society; American Association for Cancer Research; Pediatric Brain Tumor Foundation of the United States; John G. Bowes Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR024858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028478, R37NS028478, R01NS082745, F32NS058180, R01NS059893] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K26OD010927] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; American Association for Cancer Research/National Brain Tumor Society; American Association for Cancer Research; Pediatric Brain Tumor Foundation of the United States; John G. Bowes Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors are grateful to J. Agudelo and R. Romero for expert technical assistance and to K. X. Probst for illustrations. N.S. was supported by an NIH F32 NRSA postdoctoral fellowship (NS 058180). R.I. was supported by fellowships from the Damon Runyon Cancer Research Foundation (DRG1935-07) and American Association for Cancer Research/National Brain Tumor Society. R.A.I. thanks the American Association for Cancer Research for support. A.A.-B. is the Heather and Melanie Muss Endowed Chair of Neurological Surgery at UCSF. This work was supported by grants from the NIH (to A.A.-B., E.H. and D.H.R.), the Pediatric Brain Tumor Foundation of the United States and by the John G. Bowes Research Fund. D.H.R. is a Howard Hughes Medical Institute Investigator.	Bedard A, 2002, EUR J NEUROSCI, V16, P1917, DOI 10.1046/j.1460-9568.2002.02263.x; BLAKEMORE WF, 1972, J NEUROCYTOL, V1, P69, DOI 10.1007/BF01098647; Bovetti S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006359; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Guerrero-Cazares H, 2011, J COMP NEUROL, V519, P1165, DOI 10.1002/cne.22566; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; Humphrey T, 1940, J COMP NEUROL, V73, P431, DOI 10.1002/cne.900730305; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Kuan CY, 2004, J NEUROSCI, V24, P10763, DOI 10.1523/JNEUROSCI.3883-04.2004; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Longe O, 2009, J COGNITIVE NEUROSCI, V21, P141, DOI 10.1162/jocn.2009.21012; MEYER G, 1989, J COMP NEUROL, V284, P405, DOI 10.1002/cne.902840308; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Nissant A, 2009, NAT NEUROSCI, V12, P728, DOI 10.1038/nn.2298; Nottebohm F, 2004, ANN NY ACAD SCI, V1016, P628, DOI 10.1196/annals.1298.027; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Pencea V, 2001, EXP NEUROL, V172, P1, DOI 10.1006/exnr.2001.7768; Perez-Martin M, 2000, CELL TISSUE RES, V300, P11, DOI 10.1007/s004410000190; Ponti G, 2006, J COMP NEUROL, V498, P491, DOI 10.1002/cne.21043; Rodriguez-Perez LM, 2003, CELL TISSUE RES, V314, P325, DOI 10.1007/s00441-003-0794-1; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sanai N, 2007, SCIENCE, V318, DOI 10.1126/science.1145011; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Szatkowska I, 2004, NEUROSCI LETT, V364, P71, DOI 10.1016/j.neulet.2004.03.084; Wang C., 2011, CELL RES; Weickert CS, 2000, J COMP NEUROL, V423, P359, DOI 10.1002/1096-9861(20000731)423:3<359::AID-CNE1>3.0.CO;2-0; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Zecevic N, 2004, GLIA, V48, P27, DOI 10.1002/glia.20044; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	31	567	578	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2011	478	7369					382	+		10.1038/nature10487	http://dx.doi.org/10.1038/nature10487			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	21964341	Green Accepted, Green Submitted			2022-12-28	WOS:000296021100045
J	Inoue, A; Zhang, Y				Inoue, Azusa; Zhang, Yi			Replication-Dependent Loss of 5-Hydroxymethylcytosine in Mouse Preimplantation Embryos	SCIENCE			English	Article							ACTIVE DNA DEMETHYLATION; PATERNAL GENOME; MAMMALIAN DNA; TET PROTEINS; 5-METHYLCYTOSINE; 5-CARBOXYLCYTOSINE; CONVERSION		[Inoue, Azusa; Zhang, Yi] Univ N Carolina, Howard Hughes Med Inst, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Inoue, Azusa; Zhang, Yi] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zhang, Y (corresponding author), Univ N Carolina, Howard Hughes Med Inst, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu		Zhang, Yi/0000-0002-2789-0811	HHMI; NIH [GM68804]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Wu for critical reading of the manuscript. This work was supported by HHMI and NIH (GM68804). Y.Z. is an Investigator of HHMI.	Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950	9	368	386	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					194	194		10.1126/science.1212483	http://dx.doi.org/10.1126/science.1212483			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21940858	Green Accepted, Green Submitted			2022-12-28	WOS:000295833600037
J	Lathrop, SK; Bloom, SM; Rao, SM; Nutsch, K; Lio, CW; Santacruz, N; Peterson, DA; Stappenbeck, TS; Hsieh, CS				Lathrop, Stephanie K.; Bloom, Seth M.; Rao, Sindhuja M.; Nutsch, Katherine; Lio, Chan-Wang; Santacruz, Nicole; Peterson, Daniel A.; Stappenbeck, Thaddeus S.; Hsieh, Chyi-Song			Peripheral education of the immune system by colonic commensal microbiota	NATURE			English	Article							REGULATORY T-CELLS; DIFFERENTIATION; SELF; GENE	The instruction of the immune system to be tolerant of self, thereby preventing autoimmunity, is facilitated by the education of T cells in a specialized organ, the thymus, in which self-reactive cells are either eliminated or differentiated into tolerogenic Foxp3(+) regulatory T (T-reg) cells(1). However, it is unknown whether T cells are also educated to be tolerant of foreign antigens, such as those from commensal bacteria, to prevent immunopathology such as inflammatory bowel disease(2-4). Here we show that encounter with commensal microbiota results in the peripheral generation of T-reg cells rather than pathogenic effectors. We observed that colonic T-reg cells used T-cell antigen receptors (TCRs) different from those used by T-reg cells in other locations, implying an important role for local antigens in shaping the colonic T-reg-cell population. Many of the local antigens seemed to be derived from commensal bacteria, on the basis of the in vitro reactivity of common colon T-reg TCRs. These TCRs did not facilitate thymic T-reg-cell development, implying that many colonic T-reg cells arise instead by means of antigen-driven peripheral T-reg-cell development. Further analysis of two of these TCRs by the creation of retroviral bone marrow chimaeras and a TCR transgenic line revealed that microbiota indigenous to our mouse colony was required for the generation of colonic T-reg cells from otherwise naive T cells. If T cells expressing these TCRs fail to undergo T-reg-cell development and instead become effector cells, they have the potential to induce colitis, as evidenced by adoptive transfer studies. These results suggest that the efficient peripheral generation of antigen-specific populations of T-reg cells in response to an individual's microbiota provides important post-thymic education of the immune system to foreign antigens, thereby providing tolerance to commensal microbiota.	[Lathrop, Stephanie K.; Rao, Sindhuja M.; Nutsch, Katherine; Lio, Chan-Wang; Santacruz, Nicole; Hsieh, Chyi-Song] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; [Bloom, Seth M.; Stappenbeck, Thaddeus S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Peterson, Daniel A.] Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68583 USA	Washington University (WUSTL); Washington University (WUSTL); University of Nebraska System; University of Nebraska Lincoln	Hsieh, CS (corresponding author), Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA.	chsieh@wustl.edu		Bloom, Seth/0000-0002-0462-4596; Lio, Jerry/0000-0003-3876-6741; Hsieh, Chyi-Song/0000-0001-5976-9250	National Institute of Allergy and Infectious Diseases; Burroughs-Wellcome Fund; National Institutes of Health [5T32AI0071632]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007163, K08AI076609, R01AI079187, R21AI071046] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs-Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Murphy, T. Egawa, Y. Zheng, J. Scott-Browne, J. Fontenot and S. Wetzel for discussion and reading of the manuscript; A. Kau and J. Gordon for discussions and generation of germ-free animals; N. P. Malvin for assistance with bacteriology; and J. Hunn for technical assistance. C. S. H. and co-workers are funded by the National Institute of Allergy and Infectious Diseases and the Burroughs-Wellcome Fund. S. M. B. was supported by National Institutes of Health training grant 5T32AI0071632.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Min B, 2007, EUR J IMMUNOL, V37, P1916, DOI 10.1002/eji.200737236; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nishio J, 2010, J EXP MED, V207, P1879, DOI 10.1084/jem.20100205; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	34	699	727	4	109	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 13	2011	478	7368					250	U142		10.1038/nature10434	http://dx.doi.org/10.1038/nature10434			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21937990	Green Accepted			2022-12-28	WOS:000295782800052
J	Zweig, SC; Popejoy, LL; Parker-Oliver, D; Meadows, SE				Zweig, Steven C.; Popejoy, Lori L.; Parker-Oliver, Debra; Meadows, Susan E.			The Physician's Role in Patients' Nursing Home Care "She's a Very Courageous and Lovely Woman. I Enjoy Caring for Her"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALL-INCLUSIVE CARE; LONG-TERM-CARE; PRESSURE ULCER SCALE; TRANSITIONAL CARE; OLDER AMERICANS; HOSPICE CARE; END; LIFE; RESIDENTS; SERVICES	More than 1.5 million adults live in US nursing homes, and approximately 30% of individuals in the United States will die with a nursing home as their last place of residence. Physicians play a pivotal role in the rehabilitation, complex medical care, and end-of-life care of this frail and vulnerable population. The reasons for admission are multifactorial and a comprehensive care plan based on the Minimum Data Set guides the multidisciplinary nursing home team in the care of the patient and provides assessments of the quality of care provided. Using the cases of 2 patients with different experiences, we describe the physician's role in planning for admission, participating as a team member in the ongoing assessment and care in the nursing home, and guiding care at the end of life. The increasing population of older adults has also promoted community-based and residential alternatives to traditional nursing homes. The future of longterm care will include additional challenges and rich innovations in services and options for older adults. JAMA. 2011;306(13):1468-1478 www.jama.com	[Zweig, Steven C.] Univ Missouri, Interdisciplinary Ctr Aging, Columbia, MO 65212 USA; [Zweig, Steven C.; Parker-Oliver, Debra; Meadows, Susan E.] Univ Missouri, Dept Family & Community Med, Sch Med, Columbia, MO 65212 USA; [Popejoy, Lori L.] Univ Missouri, Sinclair Sch Nursing, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Zweig, SC (corresponding author), Univ Missouri, Interdisciplinary Ctr Aging, Columbia, MO 65212 USA.	zweigs@missouri.edu	Parker-Oliver, Debra/F-7998-2010		National Institute of Nursing Research; SCAN Foundation	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); SCAN Foundation	Dr Parker-Oliver reports receipt of support from the National Institute of Nursing Research. The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	Aigner Mary J, 2004, J Am Med Dir Assoc, V5, P16, DOI 10.1016/S1525-8610(04)70039-0; American Medical Directors Association, 2005, J Am Med Dir Assoc, V6, P411; American Medical Directors Association, CLIN PRACT GUID LONG; Baer WM, 2000, J AM GERIATR SOC, V48, P879, DOI 10.1111/j.1532-5415.2000.tb06883.x; BERCOVITZ A, 2008, NATL HLTH SLAT REPOR, V9, P1; Bern-Klug Mercedes, 2003, J Am Med Dir Assoc, V4, P145, DOI 10.1097/01.JAM.0000061473.13422.CC; Biola H, 2007, J AM GERIATR SOC, V55, P846, DOI 10.1111/j.1532-5415.2007.01179.x; Black K, 2007, J SOC WORK END-LIFE, V3, P39, DOI 10.1300/J457v03n02_04; Blumenthal D, 2001, JAMA-J AM MED ASSOC, V286, P1027, DOI 10.1001/jama.286.9.1027; Boult C, 2010, JAMA-J AM MED ASSOC, V304, P1936, DOI 10.1001/jama.2010.1623; Burton LC, 2003, GERONTOLOGIST, V43, P230, DOI 10.1093/geront/43.2.230; Casarett D, 2005, JAMA-J AM MED ASSOC, V294, P211, DOI 10.1001/jama.294.2.211; Castle NG, 2007, MED CARE, V45, P729, DOI 10.1097/MLR.0b013e3180618b6e; Castle NG, 2010, GERONTOLOGIST, V50, P426, DOI 10.1093/geront/gnq052; Centers for Medicare and Medicaid Services, NURS HOM DAT COMP 20; CohenMansfield J, 1997, J GERONTOL A-BIOL, V52, pM369, DOI 10.1093/gerona/52A.6.M369; Collwill JM, 2008, HEALTH AFFAIR, V27, pW232, DOI 10.1377/hlthaff.27.3.w232; COWLES CM, 2007, NURSING HOME STAT YB, P56; Cravens DD, 2000, FAM MED, V32, P34; *CTR MED MED SERV, 2000, MED MED STAT OP MAN; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; *DEP VET AFF VIREC, RES ASS INSTR MIN DA; Dimant Jacob, 2003, J Am Med Dir Assoc, V4, P231, DOI 10.1097/01.JAM.0000075915.15039.B1; Dimant Jacob, 2002, J Am Med Dir Assoc, V3, P254, DOI 10.1097/00130535-200207000-00007; Doukas DJ, 2003, J AM GERIATR SOC, V51, P1155, DOI 10.1046/j.1532-5415.2003.51383.x; El-Solh AA, 2010, CHEST, V138, P1480, DOI 10.1378/chest.10-1135; ELON R, 1992, J AM GERIATR SOC, V40, P958, DOI 10.1111/j.1532-5415.1992.tb01996.x; EMANUEL LL, ED PHYS END OF LIFE; Feldt K S, 2000, Pain Manag Nurs, V1, P13, DOI 10.1053/jpmn.2000.5831; Field MJ, 1997, APPROACHING DEATH IM; Flory J, 2004, HEALTH AFFAIR, V23, P194, DOI 10.1377/hlthaff.23.3.194; Friedemann ML, 2004, GERONTOLOGIST, V44, P520, DOI 10.1093/geront/44.4.520; Gardner SE, 2005, J GERONTOL A-BIOL, V60, P93, DOI 10.1093/gerona/60.1.93; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; Gaugler JE, 2009, MED CARE, V47, P191, DOI 10.1097/MLR.0b013e31818457ce; Gillick M, 1999, J AM GERIATR SOC, V47, P227, DOI 10.1111/j.1532-5415.1999.tb04582.x; Grabowski DC, 2010, MED CARE, V48, P859, DOI 10.1097/MLR.0b013e3181f49ed9; Hawkins NA, 2005, GERONTOLOGIST, V45, P107, DOI 10.1093/geront/45.1.107; Hedrick SC, 2009, J AGING HEALTH, V21, P190, DOI 10.1177/0898264308328929; Herr K A, 1993, Appl Nurs Res, V6, P39; Hickman SE, 2010, J AM GERIATR SOC, V58, P1241, DOI 10.1111/j.1532-5415.2010.02955.x; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Institute of Medicine (US) Committee on Nursing Home Regulation, 1986, IMPR QUAL CAR NURS H; Jones Adrienne L, 2011, NCHS Data Brief, P1; Joseph A, 1998, J AM GERIATR SOC, V46, P1152; Kane RL, 2003, J AM GERIATR SOC, V51, P1427, DOI 10.1046/j.1532-5415.2003.51461.x; KANE RL, 1989, AM J PUBLIC HEALTH, V79, P1271, DOI 10.2105/AJPH.79.9.1271; Kane RL, 2007, GERONTOLOGIST, V47, P100, DOI 10.1093/geront/47.Supplement_1.100; Kane RL, 2011, JAMA-J AM MED ASSOC, V305, P284, DOI 10.1001/jama.2010.2015; Kane RL, 2010, J AGING SOC POLICY, V22, P321, DOI 10.1080/08959420.2010.507509; Kane RA, 2007, J AM GERIATR SOC, V55, P832, DOI 10.1111/j.1532-5415.2007.01169.x; Kelly A, 2010, J AM GERIATR SOC, V58, P1701, DOI 10.1111/j.1532-5415.2010.03005.x; Kinosian B, 2007, GERONTOLOGIST, V47, P356, DOI 10.1093/geront/47.3.356; Kolarik Russ C, 2002, J Palliat Med, V5, P697, DOI 10.1089/109662102320880516; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; LaMantia MA, 2010, J AM GERIATR SOC, V58, P777, DOI 10.1111/j.1532-5415.2010.02776.x; Lum TY, 2008, HEALTH CARE FINANC R, V30, P35; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Luppa M, 2009, INT PSYCHOGERIATR, V21, P1015, DOI 10.1017/S1041610209990238; Mehr DR, 2001, JAMA-J AM MED ASSOC, V286, P2427, DOI 10.1001/jama.286.19.2427; Miller SC, 2002, J AM GERIATR SOC, V50, P507, DOI 10.1046/j.1532-5415.2002.50118.x; Miller SC, 2010, J AM GERIATR SOC, V58, P1481, DOI 10.1111/j.1532-5415.2010.02968.x; Mukamel DB, 2008, HEALTH SERV RES, V43, P1244, DOI 10.1111/j.1475-6773.2007.00829.x; Muramatsu N, 2008, MED CARE, V46, P829, DOI 10.1097/MLR.0b013e3181791a79; Muramatsu N, 2007, J GERONTOL B-PSYCHOL, V62, pS169, DOI 10.1093/geronb/62.3.S169; Noel-Miller C, 2010, J GERONTOL B-PSYCHOL, V65, P370, DOI 10.1093/geronb/gbq020; Oliver Debra Parker, 2005, J Am Med Dir Assoc, V6, pS21, DOI 10.1016/j.jamda.2005.03.017; OUSLANDER JG, 1994, ANN INTERN MED, V120, P584, DOI 10.7326/0003-4819-120-7-199404010-00010; OUSLANDER JG, 1997, MED CARE NURSING HOM; Pavlik VN, 2001, J AM GERIATR SOC, V49, P45, DOI 10.1046/j.1532-5415.2001.49008.x; PIERCE RP, 1996, NURSING HOME EC, V3, P20; Popejoy LL, 2008, J NURS SCHOLARSHIP, V40, P326, DOI 10.1111/j.1547-5069.2008.00246.x; Quill TE, 2000, JAMA-J AM MED ASSOC, V284, P2502, DOI 10.1001/jama.284.19.2502; Rantz MJ, 2006, J NURS MEAS, V14, P129, DOI 10.1891/jnm-v14i2a005; RANTZ MJ, 2009, FIND BEST ELDERCARE; Resnick HE, 2009, J AM MED DIR ASSOC, V10, P423, DOI 10.1016/j.jamda.2009.03.009; Reuben DB, 2009, JAMA-J AM MED ASSOC, V302, P2686, DOI 10.1001/jama.2009.1871; Reuben DB, 1999, J AM GERIATR SOC, V47, P131, DOI 10.1111/j.1532-5415.1999.tb04569.x; Romer Anna L, 2004, J Palliat Med, V7, P335, DOI 10.1089/109662104773709495; Saliba, 2008, DEV VALIDATION REVIS; Steinman MA, 2010, JAMA-J AM MED ASSOC, V304, P1592, DOI 10.1001/jama.2010.1482; Stone RI, 2007, GERONTOLOGIST, V47, P23, DOI 10.1093/geront/47.Supplement_1.23; Stotts NA, 2001, J GERONTOL A-BIOL, V56, pM795, DOI 10.1093/gerona/56.12.M795; Stuck AE, 2002, JAMA-J AM MED ASSOC, V287, P1022, DOI 10.1001/jama.287.8.1022; Tamura MK, 2009, NEW ENGL J MED, V361, P1539, DOI 10.1056/NEJMoa0904655; Temkin-Greener H, 2002, J AM GERIATR SOC, V50, P125, DOI 10.1046/j.1532-5415.2002.50018.x; Terrell KM, 2006, J AM MED DIR ASSOC, V7, P499, DOI 10.1016/j.jamda.2006.03.004; Thomas W.H., 2003, J SOCIAL WORK LONG T, V2, P141, DOI [DOI 10.1300/J181V02N01_10, 10.1300/J181v02n01_10]; Tombaugh TN, 1996, PSYCHOL ASSESSMENT, V8, P48, DOI 10.1037/1040-3590.8.1.48; U. S. Department of Health and Human Services Centers for Medicare & Medicaid Services, MDS 3 0 NURS HOM SWI; Unwin BK, 2010, AM FAM PHYSICIAN, V81, P1219; *US DEP HHS, NURS HOM CHECKL; US Department of Health and Human Services, NURS HOM COMP; Warshaw GA, 2010, J AM GERIATR SOC, V58, P1780, DOI 10.1111/j.1532-5415.2010.03029.x; Weaver FM, 2008, J AM GERIATR SOC, V56, P345, DOI 10.1111/j.1532-5415.2007.01538.x; Wieland D, 2010, J GERONTOL A-BIOL, V65, P721, DOI 10.1093/gerona/glq040	96	6	6	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 5	2011	306	13					1468	1478		10.1001/jama.2011.1420	http://dx.doi.org/10.1001/jama.2011.1420			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	828MZ	21972309				2022-12-28	WOS:000295506900026
J	Feinberg, J				Feinberg, Judith			Management of Newly Diagnosed HIV Infection	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; CARE; TRANSMISSION; RISK; EXPERIENCE; MORTALITY; ADULTS; RATES							feinberg, judith/0000-0003-4206-7214				Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; *AM ASS HIV MED, 2010, FUND HIV MED 2010 20; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bartlett JG, 2008, JAMA-J AM MED ASSOC, V300, P945, DOI 10.1001/jama.300.8.945; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; *CDC, 2003, MMWR-MORBID MORTAL W, P52581; Centers for Disease Control (CDC), 1990, MMWR Morb Mortal Wkly Rep, V39, P380; CHOU R, 2007, AHRQ PUB 070597EF1, P19; Coco A, 2005, ANN FAM MED, V3, P400, DOI 10.1370/afm.376; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cummiskey J., 2008, Morbidity and Mortality Weekly Report, V57, P660; Department of Defence Intelligence and Security, 2011, AIDS GOV IND ANN REP, P1; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Jenkins TC, 2006, SEX TRANSM DIS, V33, P329, DOI 10.1097/01.olq.0000194617.91454.3f; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; Kitahata MM, 1996, NEW ENGL J MED, V334, P701, DOI 10.1056/NEJM199603143341106; Kitahata MM, 2000, J ACQ IMMUN DEF SYND, V24, P106; Kleinman S, 1998, JAMA-J AM MED ASSOC, V280, P1080, DOI 10.1001/jama.280.12.1080; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; *NAT ACT PLAN COMB, 1992, MMWR-MORBID MORTAL W, V41, P1; *NY DEP HLTH AIDS, 2008, HRSA, P1; *OFF NAT AIDS POL, 2010, NAT HIV AIDS STRATE; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, 2018, RECOMMENDATIONS USE; *PUBL HLTH SERV TA, REC US ANT DRUGS PRE; Q AK, 2010, SCIENCE, V329, P1168; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Thea DM, 1997, AIDS, V11, P437, DOI 10.1097/00002030-199704000-00006; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; *US PREV SERV TASK, 2005, AHRQ PUBL 070597EF2; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weintrob AC, 2003, ARCH INTERN MED, V163, P2097, DOI 10.1001/archinte.163.17.2097; ZOLOPA AR, 2009, PLOS ONE, P4; 2001, MMWR RECOMM REP, P50	39	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2011	155	7							ITC4	10.7326/0003-4819-155-7-201110040-01004	http://dx.doi.org/10.7326/0003-4819-155-7-201110040-01004			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	833OC	21969353				2022-12-28	WOS:000295893800014
J	Kaplan, M				Kaplan, Matt			Genomics in Africa: Avoiding Past Pitfalls	CELL			English	Editorial Material								A landmark genomics project is taking shape in Africa that shifts the power and prominence to local scientists. If successful, the program will offer valuable insights into the inheritance of common diseases and reshape the paradigm of foreign-funded research.										Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257	2	7	7	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2011	147	1					11	13		10.1016/j.cell.2011.09.018	http://dx.doi.org/10.1016/j.cell.2011.09.018			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962498	Bronze			2022-12-28	WOS:000295396700006
J	McCord, RP; Dekker, J				McCord, Rachel Patton; Dekker, Job			Translocation Mapping Exposes the Risky Lifestyle of B Cells	CELL			English	Editorial Material							CHROMOSOMAL TRANSLOCATIONS; TARGETS; GENOME; DNA	Recurrent chromosomal translocations can drive oncogenesis, but how they form has remained elusive. Now, Chiarle et al. (2011) and Klein et al. (2011) characterize the genome-wide spectrum of translocations that form from a single double-stranded break, revealing that specific loci have an intrinsic predisposition for frequent chromosomal rearrangements.	[McCord, Rachel Patton; Dekker, Job] Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA; [McCord, Rachel Patton; Dekker, Job] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Dekker, J (corresponding author), Univ Massachusetts, Sch Med, Program Syst Biol, 364 Plantat St, Worcester, MA 01605 USA.	job.dekker@umassmed.edu		McCord, Rachel/0000-0003-0010-5323	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Shaffer DR, 2006, NAT MED, V12, P14, DOI 10.1038/nm0106-14; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964	10	2	3	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					20	22		10.1016/j.cell.2011.09.005	http://dx.doi.org/10.1016/j.cell.2011.09.005			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962501	Bronze			2022-12-28	WOS:000295396700009
J	Antoci, V; Handler, G; Campante, TL; Thygesen, AO; Moya, A; Kallinger, T; Stello, D; Grigahcene, A; Kjeldsen, H; Bedding, TR; Luftinger, T; Christensen-Dalsgaard, J; Catanzaro, G; Frasca, A; De Cat, P; Uytterhoeven, K; Bruntt, H; Houdek, G; Kurtz, DW; Lenz, P; Kaiser, A; Van Cleve, J; Allen, C; Clarke, BD				Antoci, V.; Handler, G.; Campante, T. L.; Thygesen, A. O.; Moya, A.; Kallinger, T.; Stello, D.; Grigahcene, A.; Kjeldsen, H.; Bedding, T. R.; Lueftinger, T.; Christensen-Dalsgaard, J.; Catanzaro, G.; Frasca, A.; De Cat, P.; Uytterhoeven, K.; Bruntt, H.; Houdek, G.; Kurtz, D. W.; Lenz, P.; Kaiser, A.; Van Cleve, J.; Allen, C.; Clarke, B. D.			The excitation of solar-like oscillations in a delta Sct star by efficient envelope convection	NATURE			English	Article							MAIN-SEQUENCE; STELLAR OSCILLATIONS; SCUTI; AM; GRANULATION; AMPLITUDES; FIELDS	Delta Scuti (delta Sct)(1) stars are opacity-driven pulsators with masses of 1.5-2.5 M-circle dot, their pulsations resulting from the varying ionization of helium. In less massive stars(2) such as the Sun, convection transports mass and energy through the outer 30 per cent of the star and excites a rich spectrum of resonant acoustic modes. Based on the solar example, with no firm theoretical basis, models predict that the convective envelope in delta Sct stars extends only about 1 per cent of the radius(3), but with sufficient energy to excite solar-like oscillations(4,5). This was not observed before the Kepler mission(6), so the presence of a convective envelope in the models has been questioned. Here we report the detection of solar-like oscillations in the delta Sct star HD187547, implying that surface convection operates efficiently in stars about twice as massive as the Sun, as the ad hoc models predicted.	[Antoci, V.; Handler, G.; Kallinger, T.; Lueftinger, T.; Houdek, G.; Kaiser, A.] Univ Vienna, Inst Astron, A-1180 Vienna, Austria; [Handler, G.; Lenz, P.] Copernicus Astron Ctr, PL-00716 Warsaw, Poland; [Campante, T. L.; Grigahcene, A.] Univ Porto, Dept Fis Astron, Ctr Astrofis, Fac Ciencias, P-4150762 Oporto, Portugal; [Campante, T. L.; Kjeldsen, H.; Christensen-Dalsgaard, J.; Bruntt, H.] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark; [Thygesen, A. O.] Nord Opt Telescope, E-38700 Santa Cruz De La Palma, Santa Cruz De T, Spain; [Moya, A.] CSIC, Dept Astrofis, Ctr Astrobiol, Inst Nacl Tecn Aeroesp, E-28691 Madrid, Spain; [Kallinger, T.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Kallinger, T.] Univ Leuven, Inst Sterrenkunde, B-3001 Louvain, Belgium; [Stello, D.; Bedding, T. R.] Univ Sydney, Sydney Inst Astron SIfA, Sch Phys, Sydney, NSW 2006, Australia; [Catanzaro, G.; Frasca, A.] Osserv Astrofis Catania, Ist Nazl Astrofis, I-95123 Catania, Italy; [De Cat, P.] Royal Observ Belgium, B-1180 Brussels, Belgium; [Uytterhoeven, K.] Univ Paris Diderot, Ctr Etud Saclay, Inst Rech Lois Fondament,Commissariat Energia Ato, Serv Astrophys,CEA DSM CNRS,Lab AIM, F-79104 Gif Sur Yvette, France; [Uytterhoeven, K.] Kiepenheuer Inst Sonnenphys, D-79104 Freiburg, Germany; [Uytterhoeven, K.] Inst Astrofis Canarias, Tenerife 38200, Spain; [Uytterhoeven, K.] Univ La Laguna, Dept Astrofis, Tenerife 38205, Spain; [Kurtz, D. W.] Univ Cent Lancashire, Jeremiah Horrocks Inst, Preston PR1 2HE, Lancs, England; [Van Cleve, J.; Clarke, B. D.] NASA, Ames Res Ctr, SETI Inst, Moffett Field, CA 94035 USA; [Allen, C.] NASA, Ames Res Ctr, Orbital Sci Corp, Moffett Field, CA 94035 USA	University of Vienna; Universidade do Porto; Aarhus University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); University of British Columbia; KU Leuven; University of Sydney; Istituto Nazionale Astrofisica (INAF); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Kiepenheuer Institut fur Sonnenphysik; Instituto de Astrofisica de Canarias; Universidad de la Laguna; University of Central Lancashire; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Antoci, V (corresponding author), Univ Vienna, Inst Astron, Turkenschanzstr 18, A-1180 Vienna, Austria.	victoria.antoci@univie.ac.at	Bedding, Timothy/AAU-9400-2021; Catanzaro, Giovanni/ABD-6632-2020; Moya, Andres/AAT-2006-2020; Kallinger, Thomas/N-7501-2019; Stello, Dennis/Q-9754-2019	Bedding, Timothy/0000-0001-5222-4661; Catanzaro, Giovanni/0000-0003-4337-8612; Moya, Andres/0000-0003-1665-5389; Kallinger, Thomas/0000-0003-3627-2561; Stello, Dennis/0000-0002-4879-3519; Bedding, Timothy/0000-0001-5943-1460; Kurtz, Donald/0000-0002-1015-3268; Frasca, Antonio/0000-0002-0474-0896; Houdek, Gunter/0000-0003-1819-810X; Antoci, Victoria/0000-0002-0865-3650	Austrian Fonds zur Forderung der wissenschaftlichen Forschung; AstroMadrid; Spanish grants; Australian Research Council; Austrian Agency for International Cooperation in Education and Research; Deutsche Forschungsgemeinschaft; NASA's Science Mission Directorate; Austrian Science Fund (FWF) [P 21830, P 22691] Funding Source: researchfish	Austrian Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); AstroMadrid; Spanish grants(Spanish Government); Australian Research Council(Australian Research Council); Austrian Agency for International Cooperation in Education and Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NASA's Science Mission Directorate; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank the entire Kepler team, without whom these results would not be possible. V. A., G. Ha. and G. Ho. were supported by the Austrian Fonds zur Forderung der wissenschaftlichen Forschung. V. A. also thanks L. Fossati for his help. A. M. acknowledges the funding of AstroMadrid, who was also supported by Spanish grants. T. R. B. and D. S. acknowledge support from the Australian Research Council. T. L was supported by the Austrian Agency for International Cooperation in Education and Research. K. U. acknowledges financial support from the Deutsche Forschungsgemeinschaft. Funding for this Discovery mission is provided by NASA's Science Mission Directorate.	Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Auriere M, 2010, ASTRON ASTROPHYS, V523, DOI 10.1051/0004-6361/201014848; Ballot J, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/201016230; Balona LA, 2011, MON NOT R ASTRON SOC, V414, P792, DOI 10.1111/j.1365-2966.2011.18454.x; Baudin F, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201014037; Belkacem K, 2009, SCIENCE, V324, P1540, DOI 10.1126/science.1171913; Breger M, 2000, ASTR SOC P, V210, P3; Carquillat JM, 2007, MON NOT R ASTRON SOC, V380, P1064, DOI 10.1111/J.1365-2966.2007.12143.x; Chang HY, 1998, SOL PHYS, V181, P251, DOI 10.1023/A:1005017817714; Chaplin WJ, 2011, SCIENCE, V332, P213, DOI 10.1126/science.1201827; Chaplin WJ, 2009, ASTRON ASTROPHYS, V500, pL21, DOI 10.1051/0004-6361/200911952; Chaplin WJ, 2005, MON NOT R ASTRON SOC, V360, P859, DOI 10.1111/j.1365-2966.2005.09041.x; Gruberbauer M, 2009, ASTRON ASTROPHYS, V506, P1043, DOI 10.1051/0004-6361/200811203; Handler G, 2009, MON NOT R ASTRON SOC, V398, P1339, DOI 10.1111/j.1365-2966.2009.15005.x; Houdek G, 1999, ASTRON ASTROPHYS, V351, P582; Houdek G, 2009, AIP CONF PROC, V1170, P519, DOI 10.1063/1.3246555; Kallinger T, 2010, ASTROPHYS J LETT, V711, pL35, DOI 10.1088/2041-8205/711/1/L35; Kjeldsen H, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201116789; Kjeldsen H, 2008, ASTROPHYS J, V682, P1370, DOI 10.1086/589142; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; KURTZ DW, 1982, MON NOT R ASTRON SOC, V200, P807, DOI 10.1093/mnras/200.3.807; Landstreet JD, 2009, ASTRON ASTROPHYS, V503, P973, DOI 10.1051/0004-6361/200912083; Michel E, 2009, ASTRON ASTROPHYS, V495, P979, DOI 10.1051/0004-6361:200810353; Pamyatnykh AA, 2000, ASTR SOC P, V210, P215; Samadi R, 2002, ASTRON ASTROPHYS, V395, P563, DOI 10.1051/0004-6361:20021322; Samadi R, 2010, ASTRON ASTROPHYS, V509, DOI 10.1051/0004-6361/200911867; Samadi R., 2007, P INT ASTRON UN, V239, P349; Stello D, 2009, MON NOT R ASTRON SOC, V400, pL80, DOI 10.1111/j.1745-3933.2009.00767.x; Turcotte S, 2000, ASTRON ASTROPHYS, V360, P603	30	50	50	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2011	477	7366					570	573		10.1038/nature10389	http://dx.doi.org/10.1038/nature10389			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21918514	Green Published, Green Submitted			2022-12-28	WOS:000295320900035
J	Wojtak, R; Hansen, SH; Hjorth, J				Wojtak, Radoslaw; Hansen, Steen H.; Hjorth, Jens			Gravitational redshift of galaxies in clusters as predicted by general relativity	NATURE			English	Article							NEWTONIAN DYNAMICS; NUCLEAR RESONANCE; SIRIUS-B; SCALES	The theoretical framework of cosmology is mainly defined by gravity, of which general relativity is the current model. Recent tests of general relativity within the Lambda Cold Dark Matter (Lambda CDM) model have found a concordance between predictions and the observations of the growth rate and clustering of the cosmic web(1,2). General relativity has not hitherto been tested on cosmological scales independently of the assumptions of the Lambda CDM model. Here we report an observation of the gravitational redshift of light coming from galaxies in clusters at the 99 per cent confidence level, based on archival data(3). Our measurement agrees with the predictions of general relativity and its modification created to explain cosmic acceleration without the need for dark energy (the f(R) theory(4)), but is inconsistent with alternative models designed to avoid the presence of dark matter(5,6).	[Wojtak, Radoslaw; Hansen, Steen H.; Hjorth, Jens] Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, DK-2100 Copenhagen O, Denmark	University of Copenhagen; Niels Bohr Institute	Wojtak, R (corresponding author), Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, Juliane Maries Vej 30, DK-2100 Copenhagen O, Denmark.	wojtak@dark-cosmology.dk	Hjorth, Jens/M-5787-2014; Hansen, Steen H./E-6198-2015	Hjorth, Jens/0000-0002-4571-2306; Wojtak, Radoslaw/0000-0001-9666-3164; Hansen, Steen H./0000-0002-4691-3935	Danish National Research Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond)	The Dark Cosmology Centre is funded by the Danish National Research Foundation. R. W. wishes to thank D. Rapetti, G. Mamon and S. Gottlober for discussions and suggestions. The mock catalogues of galaxy clusters have been obtained from a simulation performed at the Altix of the LRZ Garching.	Abazajian KN, 2009, ASTROPHYS J SUPPL S, V182, P543, DOI 10.1088/0067-0049/182/2/543; Barstow MA, 2005, MON NOT R ASTRON SOC, V362, P1134, DOI 10.1111/j.1365-2966.2005.09359.x; Bekenstein JD, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.083509; Broadhurst T, 2000, ASTROPHYS J, V533, pL93, DOI 10.1086/312630; CAPPI A, 1995, ASTRON ASTROPHYS, V301, P6; Carroll SM, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.043528; EINSTEIN A, 1916, ASTRON NACHR, V354, P769; GREENSTEIN JL, 1971, ASTROPHYS J, V169, P563, DOI 10.1086/151174; Hao JG, 2010, ASTROPHYS J SUPPL S, V191, P254, DOI 10.1088/0067-0049/191/2/254; Kim YR, 2004, ASTROPHYS J, V607, P164, DOI 10.1086/383218; LOPRESTO JC, 1991, ASTROPHYS J, V376, P757, DOI 10.1086/170323; MILGROM M, 1983, ASTROPHYS J, V270, P371, DOI 10.1086/161131; Pointecouteau E, 2005, MON NOT R ASTRON SOC, V364, P654, DOI 10.1111/j.1365-2966.2005.09590.x; POUND RV, 1959, PHYS REV LETT, V3, P439, DOI 10.1103/PhysRevLett.3.439; POUND RV, 1964, PHYS REV LETT, V13, P539, DOI 10.1103/PhysRevLett.13.539; Rapetti D, 2010, MON NOT R ASTRON SOC, V406, P1796, DOI 10.1111/j.1365-2966.2010.16799.x; Reyes R, 2010, NATURE, V464, P256, DOI 10.1038/nature08857; Schmidt F, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.103002; Skibba RA, 2011, MON NOT R ASTRON SOC, V410, P417, DOI 10.1111/j.1365-2966.2010.17452.x; VESSOT RFC, 1980, PHYS REV LETT, V45, P2081, DOI 10.1103/PhysRevLett.45.2081; Wojtak R, 2007, ASTRON ASTROPHYS, V466, P437, DOI 10.1051/0004-6361:20066813	21	85	85	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 29	2011	477	7366					567	569		10.1038/nature10445	http://dx.doi.org/10.1038/nature10445			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21956329	Green Submitted			2022-12-28	WOS:000295320900034
J	Brunel, V; Cauliez, B; Lacaze, L; Riachi, G; Gargala, G; Francois, A; Lavoinne, A; Scotte, M				Brunel, Valery; Cauliez, Bruno; Lacaze, Laurence; Riachi, Ghassan; Gargala, Gilles; Francois, Arnaud; Lavoinne, Alain; Scotte, Michel			Liver mass in a young adult	LANCET			English	Editorial Material							FIBROLAMELLAR HEPATOCELLULAR-CARCINOMA; PROCALCITONIN; BIOSYNTHESIS		[Brunel, Valery; Cauliez, Bruno; Lavoinne, Alain] Ctr Hosp Univ Rouen, Dept Biochem, Rouen, France; [Lacaze, Laurence; Scotte, Michel] Ctr Hosp Univ Rouen, Dept Digest Surg, Rouen, France; [Riachi, Ghassan] Ctr Hosp Univ Rouen, Dept Hepatogastroenterol, Rouen, France; [Gargala, Gilles] Ctr Hosp Univ Rouen, Dept Microbiol, Rouen, France; [Francois, Arnaud] Ctr Hosp Univ Rouen, Dept Anatomopathol, Rouen, France	CHU de Rouen; CHU de Rouen; CHU de Rouen; CHU de Rouen; CHU de Rouen	Brunel, V (corresponding author), CHU Hop Rouen, Inst Biol Clin, 1 Rue Germont, F-76031 Rouen, France.	valery.brunel@chu-rouen.fr		scotte, michel/0000-0001-9519-7632; Brunel, Valery/0000-0003-3069-6208				CATE CC, 1986, CANCER RES, V46, P812; DEBRAY D, 1994, J PEDIATR GASTR NUTR, V19, P468, DOI 10.1097/00005176-199411000-00019; GKONOS PJ, 1986, J BIOL CHEM, V261, P4386; Liu S, 2009, AM J GASTROENTEROL, V104, P2617, DOI 10.1038/ajg.2009.440; Russwurm S, 2001, SHOCK, V16, P109, DOI 10.1097/00024382-200116020-00004	5	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 24	2011	378	9797					1196	1196		10.1016/S0140-6736(11)61022-2	http://dx.doi.org/10.1016/S0140-6736(11)61022-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829RH	21943702				2022-12-28	WOS:000295601500028
J	Forterre, Y; Dumais, J				Forterre, Yoel; Dumais, Jacques			Generating Helices in Nature	SCIENCE			English	Editorial Material									[Forterre, Yoel] Aix Marseille Univ, IUSTI, CNRS, F-13453 Marseille 13, France; [Dumais, Jacques] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Harvard University	Forterre, Y (corresponding author), Aix Marseille Univ, IUSTI, CNRS, F-13453 Marseille 13, France.	yoel.forterre@polytech.univ-mrs.fr; jdumais@oeb.harvard.edu	Dumais, Jacques/H-7950-2013	Dumais, Jacques/0000-0003-2344-4766				Armon S, 2011, SCIENCE, V333, P1726, DOI 10.1126/science.1203874; Chen Z, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3530441; Chouaieb N, 2006, P NATL ACAD SCI USA, V103, P9398, DOI 10.1073/pnas.0508370103; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Ghafouri R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.138101; Oda R, 1999, NATURE, V399, P566, DOI 10.1038/21154; Sawa Y, 2011, P NATL ACAD SCI USA, V108, P6364, DOI 10.1073/pnas.1017658108; Seffen KA, 2000, INT J MECH SCI, V42, P2055, DOI 10.1016/S0020-7403(99)00056-9; Selinger RLB, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.158103; STEINBRINCK C, 1906, BIOL CTRBL, V26, P657; Verschaffelt J, 1891, MAANDBL NATUURWET, V17, P1	11	104	107	4	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1715	1716		10.1126/science.1210734	http://dx.doi.org/10.1126/science.1210734			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	823KQ	21940886	Green Submitted			2022-12-28	WOS:000295121500032
J	Connor, M				Connor, Martin			PERSONAL VIEW Local innovation can't be driven from the top down	BRITISH MEDICAL JOURNAL			English	Editorial Material											Connor, M (corresponding author), Stanford Univ, Ctr Hlth Policy & Primary Care Outcomes Res, Stanford, CA 94305 USA.	mjconnor@stanford.edu						2011, BRIT MED J, V342, pD2462, DOI DOI 10.1136/BMJ.D2462	1	0	0	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 21	2011	343								d5719	10.1136/bmj.d5719	http://dx.doi.org/10.1136/bmj.d5719			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	826AG	21937563				2022-12-28	WOS:000295323100002
J	Delamothe, T				Delamothe, Tony			ON THE CONTRARY Letter to an unknown health minister	BRITISH MEDICAL JOURNAL			English	Editorial Material												tdelamothe@bmj.com						2011, BRIT MED J, V342, pD3933, DOI DOI 10.1136/BMJ.D3933; 2011, BRIT MED J, V343, pD5869, DOI DOI 10.1136/BMJ.D5869; 2011, BRIT MED J, V343, pD5336, DOI DOI 10.1136/BMJ.D5336; 2011, BRIT MED J, V343, pD5328, DOI DOI 10.1136/BMJ.D5328; 2011, BRIT MED J, V343, pD5567, DOI DOI 10.1136/BMJ.D5567; 2011, BRIT MED J, V343, pD5791, DOI DOI 10.1136/BMJ.D5791; 2011, BRIT MED J, V343, pD6034, DOI DOI 10.1136/BMJ.D6034	7	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 21	2011	343								d6004	10.1136/bmj.d6004	http://dx.doi.org/10.1136/bmj.d6004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	826AG	21937565				2022-12-28	WOS:000295323100022
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA Dorries's abortion amendment and the health bill	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 21	2011	343								d5998	10.1136/bmj.d5998	http://dx.doi.org/10.1136/bmj.d5998			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	826AG	21937555				2022-12-28	WOS:000295323100020
J	Cruz-Flores, S				Cruz-Flores, Salvador			Review: Computed tomographic angiography is highly accurate for diagnosing cerebral aneurysms in symptomatic patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									St Louis Univ, Sch Med, St Louis, MO 63130 USA	Saint Louis University	Cruz-Flores, S (corresponding author), St Louis Univ, Sch Med, St Louis, MO 63130 USA.		Cruz-Flores, Salvador/AAR-1233-2020	Cruz-Flores, Salvador/0000-0003-4998-1471					0	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6							JC3-10	10.7326/0003-4819-155-6-201109200-02010	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930847				2022-12-28	WOS:000295033400009
J	Dietrich, MO; Horvath, TL				Dietrich, Marcelo O.; Horvath, Tamas L.			Synaptic Plasticity of Feeding Circuits: Hormones and Hysteresis	CELL			English	Editorial Material							AGRP NEURONS; LEPTIN; AMPK	The drive to eat is controlled by neuronal circuits in the hypothalamus that respond to hormones signaling hunger or satiety. In this issue of Cell, Yang et al. (2011) reveal an AMPK-dependent synaptic pathway that sustains excitatory stimulation of the NPY/AgRP neurons that promote feeding behavior until satiety signals kick in.	[Dietrich, Marcelo O.; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA; [Horvath, Tamas L.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; [Horvath, Tamas L.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Dietrich, Marcelo O.] Univ Fed Rio Grande do Sul, Programa Posgrad Bioquim, Dept Biochem, BR-90035 Porto Alegre, RS, Brazil	Yale University; Yale University; Yale University; Universidade Federal do Rio Grande do Sul	Horvath, TL (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, 333 Cedar St, New Haven, CT 06520 USA.	tamas.horvath@yale.edu	Dietrich, Marcelo/A-9928-2009	Dietrich, Marcelo/0000-0001-9781-2221				Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; Horvath TL, 2004, NAT REV NEUROSCI, V5, P662, DOI 10.1038/nrn1479; Kohno D, 2008, BIOCHEM BIOPH RES CO, V366, P388, DOI 10.1016/j.bbrc.2007.11.166; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039	9	14	14	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 16	2011	146	6					863	865		10.1016/j.cell.2011.08.031	http://dx.doi.org/10.1016/j.cell.2011.08.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925311	Bronze			2022-12-28	WOS:000295258100009
J	Han, H; Nutiu, R; Moffat, J; Blencowe, BJ				Han, Hong; Nutiu, Razvan; Moffat, Jason; Blencowe, Benjamin J.			SnapShot: High-Throughput Sequencing Applications	CELL			English	Editorial Material									[Han, Hong; Nutiu, Razvan; Moffat, Jason; Blencowe, Benjamin J.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada	University of Toronto			Moffat, Jason/AAC-1110-2020	Moffat, Jason/0000-0002-5663-8586; Han, Hong/0000-0001-8977-9679				Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nutiu R, 2011, NAT BIOTECHNOL, V29, P659, DOI 10.1038/nbt.1882; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Smith AM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq368; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]	9	15	15	8	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 16	2011	146	6					1044	1046		10.1016/j.cell.2011.09.002	http://dx.doi.org/10.1016/j.cell.2011.09.002			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925324	Bronze			2022-12-28	WOS:000295258100027
J	Wan, CH; Zhang, XZ; Gao, XL; Wang, JM; Tan, XY				Wan, Caihua; Zhang, Xiaozhong; Gao, Xili; Wang, Jimin; Tan, Xinyu			Geometrical enhancement of low-field magnetoresistance in silicon	NATURE			English	Article							GIANT MAGNETORESISTANCE; HALL-COEFFICIENT; ROOM-TEMPERATURE; SEMICONDUCTORS; INHOMOGENEITIES; NANOSTRUCTURES; METALS	Inhomogeneity-induced magnetoresistance (IMR) reported in some non-magnetic semiconductors(1-8), particularly silicon(1,6-8), has generated considerable interest owing to the large magnitude of the effect and its linear field dependence (albeit at high magnetic fields). Various theories implicate(9-18) spatial variation of the carrier mobility as being responsible for IMR. Here we show that IMR in lightly doped silicon can be significantly enhanced through hole injection, and then tuned by an applied current to arise at low magnetic fields. In our devices, the 'inhomogeneity' is provided by the p-n boundary formed between regions where conduction is dominated by the minority and majority charge carriers (holes and electrons) respectively; application of a magnetic field distorts the current in the boundary region, resulting in large magnetoresistance. Because this is an intrinsically spatial effect, the geometry of the device can be used to enhance IMR further: we designed an IMR device whose room-temperature field sensitivity at low fields was greatly improved, with magnetoresistance reaching 10% at 0.07 T and 100% at 0.2 T, approaching the performance of commercial giant-magnetoresistance devices(19,20). The combination of high sensitivity to low magnetic fields and large high-field response should make this device concept attractive to the magnetic-field sensing industry. Moreover, because our device is based on a conventional silicon platform, it should be possible to integrate it with existing silicon devices and so aid the development of silicon-based magnetoelectronics.	[Wan, Caihua; Zhang, Xiaozhong; Gao, Xili; Wang, Jimin; Tan, Xinyu] Tsinghua Univ, Dept Mat Sci & Engn, Adv Mat Lab, Beijing 100084, Peoples R China; [Wan, Caihua; Zhang, Xiaozhong; Gao, Xili; Wang, Jimin; Tan, Xinyu] Tsinghua Univ, Beijing Natl Ctr Electron Microscopy, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Zhang, XZ (corresponding author), Tsinghua Univ, Dept Mat Sci & Engn, Adv Mat Lab, Beijing 100084, Peoples R China.	xzzhang@tsinghua.edu.cn	Wan, Caihua/AAU-6980-2020		Ministry of Science and Technology of China [2009CB929202]; National Science Foundation of China [11074141, U0734001]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the Ministry of Science and Technology of China (grant 2009CB929202) and the National Science Foundation of China (grants 11074141 and U0734001). We used the resources of the Beijing National Center for Electron Microscopy.	BAIBICH MN, 1988, PHYS REV LETT, V61, P2472, DOI 10.1103/PhysRevLett.61.2472; Bloom FL, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.257201; Delmo MP, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3238361; Delmo MP, 2009, NATURE, V457, P1112, DOI 10.1038/nature07711; Duvail JL, 1995, J MAGN MAGN MATER, V151, P324, DOI 10.1016/0304-8853(95)00583-8; Guttal V, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.201304; HERRING C, 1960, J APPL PHYS, V31, P1939, DOI 10.1063/1.1735477; Hu B, 2007, NAT MATER, V6, P985, DOI 10.1038/nmat2034; Hu JS, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.214203; Hu JS, 2008, NAT MATER, V7, P697, DOI 10.1038/nmat2259; Husmann A, 2002, NATURE, V417, P421, DOI 10.1038/417421a; Magier R, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.094423; Parish MM, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.094417; Parish MM, 2003, NATURE, V426, P162, DOI 10.1038/nature02073; PARKIN SSP, 1995, ANNU REV MATER SCI, V25, P357, DOI 10.1146/annurev.ms.25.080195.002041; Parkin SSP, 2004, NAT MATER, V3, P862, DOI 10.1038/nmat1256; Schoonus JJHM, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/18/185011; Schoonus JJHM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.127202; Solin SA, 2000, SCIENCE, V289, P1530, DOI 10.1126/science.289.5484.1530; STROUD D, 1979, PHYS REV B, V20, P455, DOI 10.1103/PhysRevB.20.455; STROUD D, 1976, PHYS REV B, V13, P1434, DOI 10.1103/PhysRevB.13.1434; STROUD D, 1975, PHYS REV B, V12, P3368, DOI 10.1103/PhysRevB.12.3368; STROUD D, 1984, PHYS REV B, V30, P447, DOI 10.1103/PhysRevB.30.447; Wu LH, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3569139; Xu R, 1997, NATURE, V390, P57, DOI 10.1038/36306	25	78	81	2	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 15	2011	477	7364					304	U68		10.1038/nature10375	http://dx.doi.org/10.1038/nature10375			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21921912				2022-12-28	WOS:000294852400025
J	Gershon, AS; Warner, L; Cascagnette, P; Victor, JC; To, T				Gershon, Andrea S.; Warner, Laura; Cascagnette, Paul; Victor, J. Charles; To, Teresa			Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study	LANCET			English	Article							HEALTH ADMINISTRATIVE DATABASES; ALZHEIMERS-DISEASE; DATA ALGORITHM; COPD; PREVALENCE; ONTARIO; MORTALITY; CHILDREN; CANADA; ASTHMA	Background Although chronic obstructive pulmonary disease (COPD) is one of the most deadly, prevalent, and costly chronic diseases, no comprehensive estimates of the risk of developing COPD in the general population have been published. We aimed to quantify the lifetime risk of developing physician-diagnosed COPD in a large, multicultural North American population. Methods We did a retrospective longitudinal cohort study using population-based health administrative data from Ontario, Canada (total population roughly 13 million). All individuals free of COPD in 1996 were monitored for up to 14 years for three possible outcomes; diagnosis of COPD by a physician, reached 80 years of age, or death. COPD was identified with a previously validated case definition based on COPD health services claims. The cumulative incidence of physician-diagnosed COPD over a lifetime adjusted for the competing risk of death was calculated by a modified survival analysis technique. Results were stratified by sex, socioeconomic status, and whether individuals lived in a rural or urban setting. Findings A total of 579466 individuals were diagnosed with COPD by a physician over the study period. The overall lifetime risk of physician-diagnosed COPD at age 80 years was 27.6%. Lifetime risk was higher in men than in women (29.7% vs 25.6%), individuals of lower socioeconomic status than in those of higher socioeconomic status (32.1% vs 23.0%), and individuals who lived in a rural setting than in those who lived in an urban setting (32.4% vs 26.7%). Interpretation About one in four individuals are likely to be diagnosed and receive medical attention for COPD during their lifetime. Clinical evidence-based approaches, public health action, and more research are needed to identify effective strategies to prevent COPD and ensure that those with the disease have the highest quality of life possible.	[Gershon, Andrea S.; Warner, Laura; Cascagnette, Paul; Victor, J. Charles; To, Teresa] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; [Gershon, Andrea S.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Gershon, Andrea S.; Victor, J. Charles; To, Teresa] Univ Toronto, Toronto, ON, Canada; [Gershon, Andrea S.; To, Teresa] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Gershon, AS (corresponding author), Inst Clin Evaluat Sci, G1 06, Toronto, ON M4N 3M5, Canada.	andrea.gershon@ices.on.ca	Victor, J Charles/F-8765-2011	Victor, J Charles/0000-0003-1720-9356	Government of Ontario, Canada; Government of Ontario; Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care; University of Toronto, Toronto, Ontario, Canada	Government of Ontario, Canada; Government of Ontario; Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); University of Toronto, Toronto, Ontario, Canada(University of Toronto)	Government of Ontario, Canada.; This study was funded in part by the Government of Ontario who had no role in study design, collection, analysis, interpretation of data, writing of the report, or in the decision to submit the report for publication. This study was also supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care. The opinions, results, and conclusions reported in this paper are those of the authors and are independent of the funding sources. No endorsement by ICES or the Ontario Ministry of Health and Long-Term Care is intended or should be inferred. AG is supported by a Career Scientist Award from the Ontario Ministry of Health and Long Term Care. TT is supported by The Dales Award in Medical Research from the University of Toronto, Toronto, Ontario, Canada.	[Anonymous], 2008, WORLD HLTH STAT 2008; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Barnes PJ, 2004, LANCET, V364, P564, DOI 10.1016/S0140-6736(04)16866-9; Beiser A, 2000, STAT MED, V19, P1495, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1495::AID-SIM441>3.0.CO;2-E; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; *CANC CAR ONT, 2009, CANC CAR ONT DAT HOL; *CANC CAR ONT, 2010, CANC ONT OV STAT REP; DUPLESSIS V, 21601MIE STAT CAN; Fay MP, 2003, STAT MED, V22, P1837, DOI 10.1002/sim.1428; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Gershon AS, 2010, ARCH INTERN MED, V170, P560, DOI 10.1001/archinternmed.2010.17; Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098; Guttmann A, 2010, PEDIATR DIABETES, V11, P122, DOI 10.1111/j.1399-5448.2009.00539.x; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Hall M. J., 2010, NATL HLTH STAT REPOR, V29, P24; Hall MJ, 2010, NATL HLTH STAT REPOR, p[1, 24], DOI DOI 10.3886/ICPSR28162.V1; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Miravitlles M, 2006, RESP MED, V100, P1973, DOI 10.1016/j.rmed.2006.02.024; Murtaugh CM, 2011, J AGING HEALTH, V23, P554, DOI 10.1177/0898264310389491; *NAT HEART LUNG BL, 2011, COPD LEARN MOR BREAT; Pelkonen M, 2006, CHEST, V130, P1129, DOI 10.1378/chest.130.4.1129; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; Soriano JB, 2009, LANCET, V374, P721, DOI 10.1016/S0140-6736(09)61290-3; Statistics Canada, 2010, LIF EXP BIRTH AG 65; To T, 2006, PEDIAT ALLERG IMM-UK, V17, P69, DOI 10.1111/j.1399-3038.2005.00346.x; To T, 2010, AM J RESP CRIT CARE, V181, P337, DOI 10.1164/rccm.200907-1035OC; UKCRC, 2006, UK HLTH RES AN; van Durme YMTA, 2009, CHEST, V135, P368, DOI 10.1378/chest.08-0684	30	198	205	1	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 10	2011	378	9795					991	996		10.1016/S0140-6736(11)60990-2	http://dx.doi.org/10.1016/S0140-6736(11)60990-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HO	21907862				2022-12-28	WOS:000295193200024
